PLoS Biol	26668765	2008-01-23	PMC1054884	15737066	viral recombin dramat impact evolut epidemiolog virus recombin rate depend frequenc genet exchang viral genom infect host cell frequenc coinfect occur recombin rate evalu experiment coinfect cell cultur virus direct quantif biolog level host infect lack studi fill gap cauliflow mosaic viru model distribut neutral marker viral genom coinocul host plant markercontain wildtyp virus frequenc recombin genom evalu postinocul averag viral genom recov singl host infect recombin clearli indic recombin frequent viru estim recombin rate region genom equal process assum ten viral replic cycl occur experimentbas data time coat protein detectionth base replic cycl recombin rate order determin viru recombin rate singl multicellular host infect indic recombin frequent everydai life viru
Crit Care	18216103	2010-05-01	PMC1065064	15566586	introduct critic care physician benefit access medic refer materi evalu feasibl potenti benefit handheld comput base knowledg access system link central academ intens care unit icu multipl communitybas icu method commun hospit icu physician particip prospect intervent studi train internetlink updat handheld comput knowledg access system physician handheld devic clinic environ month intervent period feasibl system evalu track handheld comput conduct survei focu group discuss intervent period particip underw simul patient care scenario design evalu sourc access speed qualiti decis make particip gener admiss order scenario score blind evalu ten physician system regularli nonmed applic median month interquartil rang iqr medic softwar access median month iqr physician complet final scenario chose handheld comput access median time access handheld handheld comput iqr group exhibit improv admiss order score compar resourc benefit barrier technolog identifi conclus updat handheld comput system feasibl pointofcar access medic refer materi improv clinic decis make studi accept system variabl improv train technolog overcom barrier identifi
PLoS Biol	20035236	2015-01-23	PMC1084330	15884975	infect human cell polioviru induc prolifer doublemembran cytoplasm vesicl surfac site viral rna replic origin unknown hallmark cellular autophagosom identifi poliovirusinduc vesicl includ coloc lamp lc human homolog saccharomyc cerevisia atgp stain fluorophor monodansylcadaverin fixat coloc lc lamp observ earli polioviru replic cycl cell infect rhinovirus and cell express polioviru protein bc suffici induc doublemembran vesicl stimul autophagi increas polioviru yield inhibit autophagosom pathwai methyladenin rna interfer mrna encod protein requir autophagi decreas polioviru yield propos polioviru rhinoviru compon cellular machineri autophagosom format subvert promot viral replic autophagi serv innat immun respons microorgan find inconsist role induc autophagosomelik structur clearanc polioviru argu doublemembran structur provid membran support viral rna replic complex enabl nonlyt releas cytoplasm content includ progeni virion infect cell
BMC Public Health	25634147	2011-12-01	PMC1084353	15804368	background emerg infecti diseas sever acut respiratori syndrom sar strike suddenli wonder public overwhelm fear sar deter patient seek routin care hospit andor interrupt patient continu care studi sought estim influenc pregnant women fear sever acut respiratori syndrom sar choic provid mode childbirth length stai lo deliveri sar epidem taiwan method nation health insur data januari decemb populationbas descript analysi conduct assess chang volum market share cesarean rate averag lo provid level sar epidem compar presar period medic center region hospit drop market share childbirth servic peak sar period district hospit clinic increas chang cesarean rate larger increas observ medic center peak sar period term lo reduct averag lo observ hospit level clinic averag lo shorten dai medic center dai region hospit dai district hospit conclus larg amount patient shift matern ward advanc hospit advanc hospit coupl substanti reduct length matern stai fear sar lead seriou concern qualiti care patient access qualiti provid continu care
Virol J	22105176	2014-02-05	PMC1087510	15833113	in aftermath sar epidem progress understand molecular cell biologi sarscov mileston avail viral genom sequenc identif viral receptor develop infecti cdna clone identif viral antigen elicit neutral antibodi larg gap understand sarscov interact host cell rapidli chang viral genom add variabl equat sarscov stori enter phase search prevent strategi cure diseas review highlight progress identifi molecular aspect sarscov biologi relev develop diseas prevent strategi author conclud develop success sarscov vaccin antivir depend progress area futur
BMC Bioinformatics	24501403	2005-01-28	PMC1090557	15817134	background current dna diagnost test identifi organ specif oligonucleotid probe complementari sequenc hybridis dna target speci contrast tradit taxonomi specimen identifi dichotom kei combin charact share member target set specif charact target effici strategi identif combin share bisectionallydistribut charact effici strategi effici separ target progress binari develop practic method find minim set subsequ identifi individu sequenc target combin probe effici strategi tradit taxonom identif dna diagnosi size minim subsequ set depend sequenc divers subsequ length interact paramet distinct cytochrom oxidas subunit gene moth lepidoptera distinguish subsequ nucleotid long subsequ nucleotid long requir distinguish gene speci largest order insect conclus presenceabs subsequ set gene sequenc question tradit dichotom taxonom kei hybridis probe complementari subsequ provid effici identifi individu speci subtyp genotyp sequenc divers subsequ length major factor determin number distinguish subsequ set sequenc
BMC Infect Dis	15681456	2010-08-04	PMC1090578	15819995	background postul genet predisposit influenc suscept sarscoronaviru infect diseas outcom studi suggest delet allel allel angiotensin convert enzym ac gene associ hypoxemia sar patient ac allel preval patient suffer adult respiratori distress syndrom ard previou studi investig associ ac insertiondelet polymorph progress ard requir intens care sar patient method forti genet unrel chines sar patient healthi volunt recruit ac genotyp determin polymeras chain reaction agaros gel electrophoresi differ genotyp distribut allel frequenc ac polymorph sar patient healthi control subject evid ac polymorph associ progress ard requir intens care sar patient multivari logist analysi ag factor associ develop ard ag male sex independ factor associ requir intens care conclus ac polymorph directli increas suscept sarscoronaviru infect associ poor outcom sarscoronaviru infect
PLoS Biol	20686038	2019-10-01	PMC1110908	15884978	a wide rang rna virus program ribosom frameshift product viral fusion protein inspect overlap region orfa orfb sarscov genom reveal coronavirus program ribosom frameshift viru produc fusion protein comput analys frameshift signal predict presenc mrna pseudoknot three doublestrand rna stem structur phylogenet analys conserv potenti threestem pseudoknot frameshift signal coronavirus genbank databas presenc threestem structur support nucleas map twodimension nuclear magnet reson studi find interact stem structur result local distort aform rna distort evid vicin predict abulg stem vitro vivo frameshift assai sarscov frameshift signal function viral frameshift signal promot effici frameshift standard assai system sensit drug genet mutat affect frameshift effici yeast viru mutagenesi studi reveal specif sequenc structur stem effici frameshift identifi rna structur motif capabl promot effici program ribosom frameshift high degre conserv threestem mrna pseudoknot structur coronavirus suggest present novel target antivir therapeut
PLoS Biol	30944180	2003-10-13	PMC1149493	15941360	just protein form distinct structur motif structur commonli adopt rna molecul preval rna pseudoknot
BMC Genomics	14557669	2012-02-01	PMC1156889	15904493	background microbi forens track sourc pathogen diseas natur occur outbreak crimin investig method spr opt snp pcrrflp optim softwar perform comprehens wholegenom analysi forens discrimin multipl sequenc present tool optim forens type singl nucleotid polymorph snp pcrrestrict fragment length polymorph pcrrflp analys multipl isol sequenc speci describ pcrrflp analysi includ predict select optim primer restrict enzym enabl maximum isol discrimin base sequenc spr opt calcul snp pcrrflp variat sequenc group haplotyp cosegreg sequenc perform combinator analys determin set haplotyp provid maxim discrimin input sequenc set combin requir membership fewest haplotyp queri fewest assai perform analys highlight variabl region base exist sequenc data marker heterogen unsequenc isol character relationship unsequenc sequenc isol predict multilocu analys mump sar virus summar phylogenet tree creat base snp pcrrflp full genom compar sar viru illustr purport phylogeni base snp pcrrflp variat match base multipl sequenc align full genom conclus softwar optim select forens marker maxim gain fewest assai accept partial genom sequenc data input sequenc data multipl strain isol speci autom comput approach describ will essenti sens larg amount guid optim effort laboratori softwar sourc code spr opt publicli free nonprofit 
J Inflamm (Lond)	22301138	2016-09-29	PMC1156932	15921526	background respiratori viral infect character infiltr leukocyt includ activ neutrophil lung lead sustain lung injuri contribut chronic lung diseas specif mechan recruit neutrophil lung virusinduc lung inflamm injuri fulli elucid cxcl cxcl act cxcr potent neutrophil chemoattract investig role dsrnainduc lung injuri dsrna poli ic welldescrib synthet agent mimick acut viral infect method week femal balbc mice intratrach inject singlestrand ssrna doublestrand rna dsrna airwai lung harvest design timepoint character elicit chemokin respons result lung injuri dsrna exposur demonstr qualitit histopatholog analysi quantit fac protein mrna analysi bal fluid tissu sampl repeat experi pretreat mice antipmn correspond control antibodi subsequ pretreat separ cohort mice anticxcr correspond control antibodi prior dsrna exposur intratrach dsrna led increas neutrophil infiltr lung injuri balbc mice dsrna respons ssrna poli control treatment express cxcr ligand cxcr parallel neutrophil recruit lung neutrophil deplet studi reduc neutrophil infiltr lung injuri respons dsrna mice pretreat antipmn monoclon ab inhibit cxcr ligandscxcr interact pretreat dsrnaexpos mice anticxcr neutral ab attenu neutrophil sequestr lung injuri conclus find demonstr cxc chemokin ligandcxcr biolog axi critic pathogenesi dsrnainduc lung injuri relev acut viral infect
Respir Res	27578435	2015-02-01	PMC1156954	15888207	background acut phase sever acut respiratori syndrom sar mononuclear cell infiltr alveolar cell desquam hyalin membran format describ dysregul plasma cytokin level persist highresolut comput tomographi hrct abnorm occur sar patient dai recoveri method determin time cours recoveri lung inflamm investig hrct inflammatori profil coronaviru persist bronchoalveolar lavag fluid balf patient recoveri dai dai compar normal control sar patient increas cellular balf increas alveolar macrophag cd cell hrct score increas correl tcell number subpopul invers cdcd ratio tnf il il rant mcp level increas viral particl detect electron microscopi sar patient high hrct score dai hrct score improv patient normal balf cell count patient repeat bronchoscopi puls steroid therapi prolong fever independ factor associ delai resolut pneumon nonrandom retrospect analysi conclus resolut pneumon delai patient sar recoveri associ delai clearanc coronaviru complet resolut occur dai later
BMC Med Inform Decis Mak	25381058	2013-06-19	PMC1166558	15967040	background object studi explor percept local sever acut respiratori syndrom sar extranet potenti support futur commun applic sar extranet singl manag electron limit access system manag local provinci sar control method juli webbas paperbas survei conduct sar steer committe member hamilton assess percept extranet built support committe sar outbreak distribut survei usertest base thinkaloud protocol revis quantit qualit question ask frequenc extranet perceiv resourc rational potenti barrier strength limit potenti futur extranet respons rate respond report visit site rate highli low high site rate compar commun strategi outbreak half respond visit site dai common reason respond visit extranet access sar steer committe minut access hamilton medic advisori commonli cite potenti futur extranet send privat email public health expert surveil encount person barrier site mention time duplic email challeng conclus despit higher rank commun strategi sar outbreak email meet teleconfer web site user gener perceiv local extranet support dissemin local public health emerg
Virol J	23785216	2005-07-13	PMC1177995	15927084	viral fusion protein mediat cell entri undergo seri conform chang result viriontarget cell membran fusion class viral fusion protein encod influenza viru human immunodefici viru hiv promin alpha helic peptid mimic portion alpha helic inhibit structur rearrang fusion protein prevent viral infect envelop glycoprotein flavivirus west nile viru wnv dengu viru denv class ii viral fusion protein compris beta sheet physiochem algorithm wimleywhit interfaci hydrophob scale wwih combin structur data identifi potenti peptid inhibitor wnv denv infect target viral protein viral inhibit assai confirm peptid interfer target viru entri inhibitori concentr ic rang inhibitori peptid sequenc domain wwih score includ domain ii iib stem domain detect dn peptid correspond stem domain denv inhibit infect denv inhibit plaqu format concentr crossinhibit wnv fusioninfect inhibit demonstr dn potent wnv inhibitori peptid wn correspond wnv domain iib inhibit infect denv addit inhibitori peptid noncytotox sequenc specif manner inhibitori peptid identifi serv lead compound develop peptid drug flaviviru infect
PLoS Med	16014947	2016-07-24	PMC1181873	16013892	background mathemat model invalu manag tool epidemiologist shed light mechan underli observ dynam make quantit predict effect control measur explain substanti bias introduc ignor assumpt core vast major model method find analyt method ignor latent period ii make common assumpt exponenti distribut latent infecti period includ latent period underestim basic reproduct ratio infect outbreak data proce illustr point fit epidem model data influenza outbreak final document unrealist priori assumpt concern model structur rise systemat overoptimist predict outcom potenti manag option conclus work aim highlight develop model public health pai care attent intrins assumpt embed classic framework
BMC Bioinformatics	27449759	2007-01-24	PMC1183192	16042814	background algorithm assess similar primer templat develop base hypothesi anneal primer templat transfer process primer sequenc convert vector full potenti hydrogen number or templat sequenc convert vector actual hydrogen bond number form primer anneal consid sourc destin inform coeffici calcul measur fidel transfer process measur similar primer potenti anneal site templat conclus success predict pcr product genom sequenc comput program base algorithm demonstr potenti algorithm area silico pcr gene find
Virol J	17251282	2007-01-01	PMC1183252	15963240	a seri frameshift mutat gene observ culturederiv sever acut respiratori syndrom coronaviru sarscov report viral rna clinic sampl sarscov infect patient heterogen popul wildtyp mutant transcript
BMC Evol Biol	17038051	2014-06-11	PMC1185527	15987510	background rodent primat pregnancyspecif glycoprotein psg gene famili expand independ common ancestor express virtual exclus placent trophoblast speci unknown multipl paralog select diversif function increas dosag monofunct psg analys evolut mous psg sequenc compar rat human baboon psg attempt understand evolut complex gene famili phylogenet tree analys indic primat domain rodent domain exhibit higher degre conserv observ comparison mous n domain mous n domain compar human baboon psg domain exon mous rat psg domain exon undergon sequenc homogenis high nonsynonym substitut rate observ cfg face mous domain context conserv suggest diverg function mous psg rat psg famili appear undergon expans mous exhibit lower diverg rate increas sequenc homogenis cfg face domain contrast primat psg domain rodent psg domain rgd tripeptid motif rgdlike sequenc conserv rodent n domain conclus rel conserv primat domain rodent domain suggest despit independ gene famili expans structur diversif mous human psg retain conserv function human psg gene famili expans homogenis suggest evolut occur concert manner maintain function psg whilst increas gene dosag famili mous gene famili expans coupl local diversif cfg face suggest select increas gene dosag diversif function partial conserv rgd rgdlike tripeptid primat rodent n domain support role motif psg function
PLoS Med	24920815	2013-08-28	PMC1188248	16104827	background clinic relev infect novel human coronaviru nl hcovnl investig systemat determin associ diseas young children lower respiratori tract infect lrti method find fortynin sampl nasopharyng secret children ag lrti analys quantit hcovnlspecif realtim pcr sampl collect hospitalis patient outpati decemb octob region germani prospect populationbas pride studi analys rna respiratori virus fortynin sampl deriv winter season posit hcovnl rna viral rna preval sampl outpati hospitalis patient coinfect respiratori syncyti viru parainfluenza viru observ frequent sampl hcovnl rna detect higher viral load sampl addit respiratori virus median versu copiesml strong associ croup appar hcovnlposit patient high hcovnl load absenc coinfect suffer croup compar hcovnlneg group higher fraction sampl croup patient noncroup patient contain hcovnl rna conclus hcovnl infect occur frequent young children lrti strong associ croup suggest causal relationship
Virol J	22466658	2012-09-26	PMC1190220	16107218	sever acut respiratori syndrom coronaviru sarscov lifethreaten atyp pneumonia infect organ lung liver immun organ induc parenchyma cell apoptosi necrosi genom sarscov close character coronaviru encod replicas major structur protein number nonstructur protein publish studi nonstructur protein plai role replic virul pathogenesi virus potenti sarscov nonstructur protein protein orf predict encod amino acid lack similar protein till report function protein studi gene link egfp tag terminu cell cycl analysi overexpress begfp protein vero co cell induc cell cycl arrest gg phase co cell express begfp induc increas subg phase transfect obviou apoptosi induct fusion protein co cell confirm doubl cell label aad annexin function protein induc cell gg arrest apoptosi provid insight studi mechan sar pathogenesi
Retrovirology	15956573	2007-10-23	PMC1201173	16091143	background major determin retroviru host rang presenc absenc appropri cellsurfac receptor requir viru entri ortholog function receptor wide rang speci amino acid differ render receptor nonfunct case amino acid differ result addit nlink glycosyl block viru infect block retroviru infect overcom treatment cell compound tunicamycin prevent addit nlink oligosaccharid discov treatment cell liposom compos phosphatidylserin ps overcom block infect mediat nlink glycosyl importantli occur appar chang glycosyl state receptor virus occur delai kinet compar previou show enhanc viru infect ps treatment cell express function viru receptor conclus demonstr ps treatment reliev block retroviru infect cell express retrovir receptor render nonfunct glycosyl find implic current model describ inhibit viru entri receptor glycosyl
BMC Pulm Med	17954898	2006-09-13	PMC1208914	16138926	background infecti respiratori diseas transmit noninfect subject infect person expel pathogen microorgan surround environ cough sneez airwai mucu layer interact highspe airflow droplet expel aerosol concentr size distribut plai role diseas transmiss goal reduc aerosoliz respiratori secret interf minim normal mucu clearanc agent capabl increas crosslink mucin glycoprotein network method expos mucu simul ms airflow simul cough machin scm ms rang nonvisc nonelast substanc water ms vari degre viscos elast mucociliari clearanc ms assess frog palat elast filancemet aerosol pattern bullsey target sampl load weigh cough maneuv test mucomodul sodium tetrabor xlb calcium chlorid xl mucociliari transport close normal speed viscoelast sampl compar nonelast nonvisc viscousonli sampl spinnabl rang cm amount ms expel scm increas ad xl concurr particl invers reduc disappear aerosol pattern conclus aerosoliz ms modifi increas cohes reduc number particl expel scm interf minim clearanc frog palat unexpect find ms crosslink increas expector
Global Health	16971444	2013-05-01	PMC1208931	16078989	thi paper describ conceptu framework health implic globalis framework develop identifi main determin popul health main featur globalis process conceptu model explicitli visualis globalis institut econom socialcultur ecolog determin popul health globalis process oper contextu level influenc health distal proxim determin develop framework valuabl insight organis complex involv studi health effect globalis meaning contribut empir serv thinkmodel basi develop futur scenario health
Hum Resour Health	23778667	2010-07-07	PMC1215505	16092972	background influenza pandem inevit estim potenti impact primari care medic workforc zealand plan mitig disrupt pandem challeng method model fluaid softwar center diseas control prevent cdc atlanta appli zealand primari care medic workforc gener practition peak week pandem lead to loss medic work time conserv baselin assumpt workdai lost ill hospitalis prematur death input sever scenario includ greater health effect time spent care sick rel scenario medic workdai lost peak week compress sixweek period pandem wave base case lost workdai ill care hospitalis prematur death conclus prepared plan futur influenza pandem consid impact medic workforc incorpor strategi minimis impact includ infect control measur welldesign protocol improv health sector surg capac
Virol J	20610721	2014-11-25	PMC1215526	16076403	herp simplex viru hsv type virus histori evolut share human gener welladapt virus infect harm capac hide neuron life rare situat primari infect gener involv brain primari hsv infect asymptomat crucial element earli restrict viru replic avoid symptom infect concert action arm innat immun respons earli light struggl inhibit hsv replic will spare host real war huge amount viru infect war will jeopard life host will interest includ viru settl conflict amic weapon unspecif defenc earli strike battl dai hsv infect discuss review gener macrophag orchestr multitud antiherpet action hour attack wave respons cytokin type interferon ifn tumour necrosi factor produc exert direct antivir activ macrophag wave interleukin il cytokin induc product ifn nk cell posit feedback mechan synergist interact intensifi system rise heavi antivir weapon reactiv oxygen speci nitric oxid gener allianc viral enemi heavi weapon control avoid harm host il reaction hamper allow foci hsv replic focus activ relev site hero allianc cytokin macrophag cell plai central role implic futur treatment modal shortli consid
BMC Public Health	25425699	2002-08-01	PMC1232855	16120225	background assess pattern inject drug hiv preval inject drug user idu intern border area major heroin transship rout method crosssect survei idu site lang son provinc vietnam site ning ming counti guangxi provinc china respond recruit peer referr snowbal method countri offici record list idu vietnam risk behavior questionnair administ hiv counsel test conduct particip countri male unmarri major subject countri member ethnic minor group strong geograph gradient length drug inject hiv seropreval year inject hiv seropreval declin vietnames site farthest border chines site farthest border particip china particip vietnam report cross intern border month prior interview cross border idu associ distanc border member ethnic minor group hiv seroposit chines particip conclus reduc intern spread hiv idu will requir program global region nation local cross border level local cross border level program coordin side border suffici scale idu will clean inject equip side border countri resid
Virol J	12097550	2013-08-02	PMC1232869	16115318	background sever acut respiratori syndrom sar caus newli discov coronaviru sarscov effect prophylact postexposur therapi current report chloroquin strong antivir effect sarscov infect primat cell inhibitori effect observ cell treat drug exposur viru suggest prophylact therapeut advantag addit wellknown function chloroquin elev endosom ph drug appear interfer termin glycosyl cellular receptor angiotensinconvert enzym neg influenc virusreceptor bind abrog infect ramif elev vesicular ph inhibit infect spread sar cov clinic admiss concentr conclus chloroquin effect prevent spread sar cov cell cultur favor inhibit viru spread observ cell treat chloroquin prior sar cov infect addit indirect immunofluoresc assai describ repres simpl rapid method screen sarscov antivir compound
Virol J	23913960	2006-09-18	PMC1236967	16122388	the entri sar coronaviru scv cell initi bind spike envelop glycoprotein receptor ac identifi receptorbind domain rbd fragment length includ amino acid residu potenti glycosyl site character role glycosyl identifi residu function interact partner ac clone express character solubl fragment rbd mutat potenti glycosyl site residu shortest fragment bind receptor ac includ residu potenti glycosyl site start residu potenti glycosyl site residu mutat of site alanin glutamin mutat residu alanin longer fragment decreas molecular weight kda suggest glycosyl site function simultan mutat glycosyl site lack express suggest glycosyl site three requir express glycosyl affect bind ac alanin scan mutagenesi fragment identif ten residu reduc bind ac residu appear increas bind mutat residu reduc bind fold mutat residu fold analysi data map mutat determin crystal structur fragment rbd complex ac li li farzan harrison submit suggest exist hot spot rbd surfac contribut portion bind energi find mutat includ glycosyl site affect rbd bind function indic mechan evas immun respons
Genome Biol	16982825	2013-07-23	PMC1242213	16168085	dna microarrai identifi microbi speci environment clinic sampl autom tool reliabl speci identif base observ microarrai hybrid pattern lack algorithm epredict microarraybas speci identif epredict compar observ hybrid pattern theoret energi profil repres speci demonstr applic algorithm viral detect set clinic sampl discuss relev metagenom applic
Int J Health Geogr	26835306	2007-05-23	PMC1242244	16176577	thi eyeopen articl aim introduc health gi commun emerg onlin consum geoinformat servic googl microsoft msn potenti util creat custom onlin interact health map programm interfac provid googl msn creat three interact demonstr map england strateg health author brows onlin googl map api applic program interfac version googl earth kml keyhol markup languag version msn virtual earth map control version googl msn worldwid distribut free geospati tool imageri map commend step ultim wikif map gi discuss provid emerg onlin map trend expect futur implic develop direct associ individu privaci nation secur copyright issu esri announc plan respons googl msn remain envisag plan will materi compar offer googl msn googl msn map tool will evolv futur
Environ Health Perspect	21194389	2009-02-01	PMC1247620	15531441	we appli cartograph geostatist method analyz pattern diseas spread sever acut respiratori syndrom sar outbreak hong kong geograph system gi technolog analyz integr databas contain clinic person detail patient confirm sar februari june elementari map diseas occurr space time simultan reveal geograph extent spread territori statist surfac creat kernel method confirm sar case highli cluster identifi distinct diseas hot spot contextu analysi standard deviat densiti class indic period dai februari dai march prodrom epidem dai june mark declin phase outbreak originanddestin plot direct bia radiu spread superspread event integr gi technolog routin field epidemiolog surveil offer realtim quantit method identifi track geospati spread infecti diseas experi sar demonstr
Genet Vaccines Ther	31355825	2007-06-23	PMC1249587	16115319	sever studi cellmedi immun respons plai crucial role control viral replic candid sar vaccin elicit broad cd tcell immun respons group mice immun combin sarsnucleocapsid immunogen high level specif sarscd tcell respons demonstr mice receiv dna encod sarsnucleocapsid protein xiap adjuv observ coadministr plasmid express nucleocapsid recombin protein montanidecpg induc high antibodi titer immun mice vaccin approach merit investig potenti candid vaccin sar
Environ Health Perspect	17639238	2014-07-09	PMC1257548	15866764	state local health depart continu face unpreced challeng prepar recogn respond threat public health attack septemb ensu anthrax mail highlight public health readi respons hurdl pose intention caus injuri ill time natur disast highlight compar public health readi respons capabl public health readi respons activ conceptu intent attack natur disast humancaus accid consist view feder govern adopt allhazard respons model fundament paradigm adopt paradigm power improv effici efficaci reduc creat complex famili situationspecif prepared respons activ practic public health prepared requir addit model tool provid framework better understand priorit emerg readi respons facilit solut true local health depart level propos extend haddon matrixa conceptu model decad injuri prevent respons strategiesfor purpos
Virol J	25008936	2017-11-06	PMC1260030	16115320	much world popul activ immin danger establish infecti pathogen sporad pandem infect emerg agent threaten rna polymeras rnapol gener enorm genet consequ antigen heterogen permit virus cellular pathogen evad host defenc rnapol morbid prematur mortal molecul extraordinari genet heterogen defin viral quasispeci rnapol infidel caus rapid cumul genom rna mutat process uncontrol catastroph loss sequenc integr inexor quasispeci extinct select replic replic homeostasi epicycl regulatori mechan dynam link rnapol fidel process quasispeci phenotyp divers modul polymeras fidel control quasispeci behaviour prevent happen mediat immun escap importantli ineluct gener broad phenotyp divers viral rna translat protein quasispeci suggest mechan diseas target function disrupt host cell surfac molecul includ hormon lipid cell signal neurotransmitt receptor virus coopt cell entri mechan viral receptor diseas vrd explain socal viral autoimmun classic autoimmun disord diseas includ type ii diabet mellitu form obes viral receptor diseas unifi hypothesi explain diseas wellestablish multifactori unrel aetiolog coronari arteri vascular diseas addit diseas schizophrenia understood lack plausibl coher pathogen explan
BMC Infect Dis	29105570	2007-05-23	PMC1261265	16171519	background sever acut respiratori syndrom sarscov newli emerg viru sar high mortal rate infect peopl success control global sar epidem will requir rapid sensit diagnost test monitor spread develop vaccin antivir compound includ neutral antibodi effect prevent treat diseas method human synthet singlechain fragment variabl scfv eth phage antibodi librari isol scfv nucleocapsid protein sarscov bio panningbas strategi select scfv character geneticsmolecular aspect sarscov protein detect elisa western blot immunocytochemistri human scfv antibodi protein sarscov easili isol select eth phage librari immunotub coat antigen vitro select human scfv recogn elisa western blot studi distinct epitop protein domain detect immunohistochemistri investig sarscov particl infect vero cell conclus human scfv antibodi isol describ studi repres reagent rapid detect sarscov protein sar viru particl infect target cell
BMC Genomics	17522233	2005-06-14	PMC1262710	16174304	background sever acut respiratori syndrom sar epidem human diseas caus novel coronaviru sarscov report asia sar spread worldwid intern travel juli health organ report total peopl afflict sar mortal rate immunopatholog damag account sever respiratori distress genomewid gene express host chang attack sarscov base chang gene express peripher blood identifi signatur gene accur discrimin acut sar patient nonsar control gener suppress gene express predomin sarsinfect blood gene includ involv innat immun defensin eosinophilderiv neurotoxin upregul emploi cluster method rank sever recov sar patient gener associ plot gap express profil signatur gene method discov smooth transit pattern sever normal control acut sar patient rank sar sever correl recoveri period dai clinic pulmonari infect score conclus gap approach prove analyz complex continu biolog system sever rank deriv global express profil regul gene patient elucid pathophysiolog diseas
Environ Health	15956182	2012-01-20	PMC1262740	16219096	background incid needlestick injuri farmer veterinari surgeon consequ inject seriou case present report accident inject bovin vaccin base finger increas pressur flexor sheath caus sign symptom ischemia amput digit requir despit repeat surgic debrid decompress conclus previou report inject oilbas vaccin human hand granulomat inflamm steril abscess caus morbid tissu loss selfinject veterinari vaccin occup hazard farmer veterinari surgeon inject vaccin close compart human finger seriou sequela includ loss inject digit injuri underestim earli debrid irrig inject area decompress best outcom frequent review procedur repeat oper requir
Crit Care	22264283	2014-05-28	PMC1269458	16137358	introduct pneumothorax complic manag mechan ventil sever acut respiratori syndrom sar patient isol intens care unit icu sought determin pneumothorac induc high ventilatori pressur volum associ mortal mechan ventil sar patient method conduct prospect clinic studi fortyon mechan ventil sar patient includ studi sar patient sedat receiv mechan ventil isol icu mechan ventil sar patient divid group pneumothorax demograph data clinic characterist ventilatori variabl posit endexpiratori pressur peak inspiratori pressur airwai pressur tidal volum tidal volum kilogram respiratori rate minut ventil accumul mortal rate dai mechan ventil analyz statist differ pressur volum group mortal group patient develop pneumothorax mechan ventil frequent express higher respiratori rate admiss lower paofio ratio higher paco level hospit compar pneumothorax conclus studi sar patient suffer pneumothorax present tachypn admiss pronounc hypoxem hypercapn hospit variabl signal deterior respiratori function indic develop pneumothorax mechan ventil sar patient meticul respiratori therapi monitor mandatori patient
BMC Health Serv Res	24872583	2013-04-01	PMC1274243	15885149	background main object studi appli autoregress integr move averag arima model realtim predict number bed occupi tan tock seng hospit sar outbreak method retrospect studi design hospit admiss occup data isol bed collect tan tock seng hospit period march st main outcom measur daili number isol bed occupi sar patient covari consid daili number peopl screen daili number peopl admit includ observ suspect probabl case dai event discoveri util strategi analysi firstli split outbreak data data march st april model develop structur arima model attempt model number bed occupi estim maximum likelihood method kalman filter arima model paramet consid simplest parsimoni lowest order model arima model describ predict number bed occupi sar outbreak absolut percentag error mape train set valid set reason hospit set model provid threedai forecast number bed requir total number admiss probabl case admit previou dai independ prognost factor bed occup conclus arima model provid tool administr clinician plan realtim bed capac outbreak infecti diseas sar model plan bedcapac outbreak infecti diseas well
BMC Infect Dis	23288419	2009-05-26	PMC1276795	16229749	background sever acut respiratori syndrom sar newli emerg infecti diseas caus global epidem sequenc analysi sarscoronaviru isol reveal specif genotyp predomin period epidem footprint trace epidemiolog infect monitor viral evolut direct sequenc analysi larg number clinic sampl cumbersom time consum simpl rapid assai screen sarscoronaviru genotyp base fluorogen oligonucleotid probe allel discrimin method thirti sar patient recruit allel discrimin assai develop base fluorogen oligonucleotid probe taqman genotyp sarscoronaviru isol patient carri allel discrimin assai confirm direct sequenc genotyp base allel discrimin assai fulli concord direct sequenc sarscoronaviru genotyp studi characterist genotyp document associ the epidem isol contain report major delet patient epidemiolog studi cohort conclus develop simpl accur method character screen sarscoronaviru genotyp promis tool studi epidemiolog relationship document case outbreak
BMC Health Serv Res	14728778	2011-06-01	PMC1298296	16259634	background commun affect percept fair process intens care unit bed alloc decis impact public condit account reason method perform qualit case studi describ particip percept commun bed alloc decis bed univers affili medicalsurg critic care unit sunnybrook women colleg health scienc centr interview particip critic care physician clinic fellow critic care resourc nurs endus physician commonli refer patient unit member administr staff median bed occup studi period janapril daili admiss discharg median evalu descript ethic framework account reason ar identifi opportun improv critic care physician resourc nurs critic care fellow endus trauma team leader surgeon neurosurgeon anesthesiologist function independ unoffici parallel track bed alloc decisionmak conflict offici design critic care physician sole author commun kei decisionmak indirect exclud decis notabl famili member particip perceiv lack public bed alloc rational conclus public condit improv critic care bed alloc decis decisionmak parallel track describ unavoid usual constraint time urgenc demand formal guidelin direct commun kei particip circumst help improv fair decis
PLoS Pathog	21632762	2020-03-17	PMC1298938	16341254	the coronaviru replicasetranscriptas complex assembl viral cellular protein mediat synthesi genom subgenomes mrna virusinfect cell report genet function analysi temperaturesensit mutant murin hepat viru mhva unabl synthes viral rna infect initi maintain nonpermiss temperatur classic biochem complement analysi lead predict major mhva orfa replicas gene product nonstructur protein nspnsp form singl complement group cistron replicas gene product encod orfb nonstructur protein nspnsp function tran compris three complement group cistron iivi identifi mutat nonstructur protein nsp nsp nsp nsp nsp nsp respons phenotyp mhva mutant allow conclud protein essenti assembl function replicasetranscriptas complex final analysi viral rna synthesi mutant virusinfect cell allow discrimin three phenotyp regard inabl specif mutant synthes viral rna nonpermiss temperatur mutant la appear defect continu negativestrand synthesi mutant alb appear form neg strand util positivestrand rna synthesi mutant alb defect elong posit negativestrand rna basi propos model describ pathwai viral rna synthesi mhvainfect cell biochem analysi mutant allow identifi intermedi pathwai elucid precis function viral replicas protein involv
PLoS Biol	32184199	2009-04-22	PMC1310650	16336043	the human gut reservoir wide varieti microb includ virus rna virus associ gastroenter enter rna viral commun healthi human describ compar metagenom analysi rna virus three fecal sampl healthi human individu studi uncultur virus concentr tangenti flow filtrat viral rna extract clone shotgun viral cdna librari sequenc analysi vast major viral sequenc plant pathogen rna virus abund fecal viru studi pepper mild mottl viru pmmv high concentrationsup virion gram dry weight fecal matter pmmv detect fecal sampl collect healthi individu contin indic plant viru preval human popul number pepperbas food test posit pmmv suggest dietari origin viru intriguingli fecal pmmv infecti host plant suggest human vehicl dissemin plant virus
BMC Mol Biol	19387028	2004-09-01	PMC1314898	16293192	background salmonid fish studi model fish speci report systemat evalu refer gene qrtpcr studi lack stabil potenti refer gene examin tissu atlant salmon salmo salar determin suitabl gene quantit realtim rtpcr analys rel transcript level gene encod rrna ribosom protein actin glyceraldehydepdehydrogenas gapdh paralog gene encod elong factor efaa efab quantifi gill liver head kidnei spleen thymu brain muscl posterior intestin untreat adult fish addit group individu smoltif base calcul perform genorm vba applet determin stabl gene set test gene cdna sampl rank examin gene adult atlant salmon efabefaaactin rrnasgapdh calcul total individu stage smoltif process presmolt smolt smoltifi seawat desmoltifi freshwat gene rank efabefaasactin rrnagapdh conclus work suggest efaa efab gene refer gene qrtpcr examin gene express atlant salmon
BMC Dev Biol	17135444	2010-06-30	PMC1315359	16324220	background realtim quantit pcr sensit effici techniqu examin gene transcript pattern preimplant embryo order gain embryo develop optim assist reproduct technolog critic succes applic realtim pcr care assai design reaction optim valid maxim sensit accuraci studi publish gapd actb rrna singl refer gene prior verif express stabil normal data unstabl control result erron conclus refer gene studi transcript level commonli refer gene actb gapd histon ha tbp hprt sdha ywhaz rrna determin preimplant stage cell cell blastocyst hatch blastocyst order select stabl gene normal quantit data preimplant embryo stage conclus genorm applic ywhaz gapd sdha stabl gene examin embryon stage commonli actb highli regul recommend geometr refer gene accur normal factor allow small express differ reliabl measur
PLoS Med	20592218	2009-10-28	PMC1315361	16354103	the revis intern health regul wilson colleagu long overdu emin face challeng increasingli global world
Respir Res	19864385	2005-12-01	PMC1318487	16283933	background fatal human respiratori diseas associ influenza subtyp hn document hong kong vietnam thailand cambodia demonstr patient hn diseas unusu high serum level ip interferongammainduc protein compar human influenza viru subtyp hn hn virus ahong kong hn potent induc proinflammatori cytokin tumor necrosi factora chemokin ip primari human macrophag vitro suggest cytokin dysregul plai role pathogenesi hn diseas respiratori epitheli cell primari target cell replic influenza virus pertin investig cytokin induct profil hn virus cell method quantit rtpcr elisa compar profil cytokin chemokin gene express induc hn virus ahk hn avietnam avietnam hn human hn viru human primari alveolar bronchial epitheli cell vitro demonstr comparison human hn virus hn hn virus potent induc ip interferon beta rant regul activ normal cell express secret interleukin il primari human alveolar bronchial epitheli cell vitro hn virus vietnam hn appear potent induc ip hn viru conclus hn hn subtyp influenza virus potent induc proinflammatori cytokin chemokin primari human respiratori epitheli cell subtyp hn viru hyperinduct cytokin relev pathogenesi human hn diseas
PLoS Med	16339072	2017-04-26	PMC1324949	16379498	background tuberculosi caus mycobacterium tuberculosi remain lead mortal worldwid ctype lectin dcsign major tuberculosi receptor human dendrit cell reason dcsign interact tuberculosi pathogen variat gene broad rang influenc pathogenesi number infecti diseas includ tuberculosi method find test polymorph cd gene encod dcsign associ suscept tuberculosi sequenc genotyp analys south african cohort exclus popul stratif cohort observ associ cd promot variant and decreas risk develop tuberculosi geograph distribut variant observ allel combin confin eurasian popul conclus observ variant confer protect tuberculosi addit geograph distribut allel phylogenet statu increas frequenc nonafrican popul result host genet adapt longer histori exposur tuberculosi character biolog consequ dcsign variat tuberculosi will crucial better appreci role lectin interact host immun system tubercl bacillu pathogen
PLoS Med	28125358	2015-08-28	PMC1324951	16379499	background cellular local sever acut respiratori syndrom coronaviru sarscov lung patient sar confirm etiolog associ viru diseas understand pathogenesi diseas knowledg comprehens studi investig viral infect cellular level human method find collect largest seri fatal case sar autopsi materi merg patholog materi region involv worldwid sar outbreak hong kong china toronto canada develop monoclon antibodi sarscov nucleoprotein situ hybrid ish analyz autopsi lung tissu patient sar hong kong toronto compar assai pulmonari patholog clinic cours ill patient sarscov nucleoprotein rna detect immunohistochemistri ish alveolar pneumocyt frequent macrophag local detect patient di week ill onset patient di week symptom onset conclus pulmonari alveolar epithelium chief target sarscov macrophag infect subsequ viral replic appear limit week symptom onset evid continu widespread replic period antivir therapi consid futur treatment focus twoweek period acut clinic diseas
PLoS Med	27852864	2011-02-01	PMC1326257	16401173	the pervas burden lung infect receiv proportion attent biomed public health commun argu mizgerd
PLoS Med	21345285	2014-02-26	PMC1351155	16420098	the big project ethic concern surround global health
BMC Public Health	24574391	2016-02-01	PMC1351169	16403223	background studi aim provid awar attribut fraction cancer japanes gener popul method nationwid repres sampl japanes ag older ask percept level concern environment genet risk factor relat cancer prevent omnibu survei interview conduct subject men women risk factor candid attribut fraction cancercaus viral bacteri infect consid highest tobacco smoke stress endocrinedisrupt chemic hand attribut fraction cancer char fish meat alcohol drink consid low compar risk factor candid risk factor attribut fraction respons higher women men subject tend respond higher valu estim epidemiolog evid west attribut fraction cancer specul genet determin cancer consid prevent improv lifestyl conclus awar attribut fraction cancer japanes gener popul domin cancercaus infect occup exposur air pollut food addit major lifestyl factor diet
BMC Bioinformatics	26572912	2018-12-12	PMC1352377	16401352	background highli accur statisticsbas system viral phage genom annot genemark system genefind viru phage genom suffer basic drawback paper put forward altern approach viral phage genefind improv qualiti annot newli sequenc genom system zcurvev viral phage genom satisfactori fair comparison current softwar function genemark total viral genom annot genemark select test consequ averag specif system match averag sensit zcurvev smaller viral genom kb constitut main part viral genom sequenc higher genemark addition genom amsacta moorei entomopoxviru lowest genom gc content sequenc organ accuraci zcurvev better genemark predict hundr falseposit gene zcurvev analyz wellstudi genom hiv hbv sarscov perform zcurvev gener better genemark final zcurvev download local facilit util genemark download base comparison suggest zcurvev serv prefer genefind tool viral phage genom newli sequenc joint applic system zcurvev genemark lead better genefind system zcurvev freeli conclus zcurvev serv prefer genefind tool viral phage genom anonym viral phage genom newli sequenc
BMC Genomics	30541833	2011-03-16	PMC1360066	16417644	background viru taxonomi base morpholog characterist nonphenotyp measur comparison viru famili examin phylogenet signal viru nucleotid usag pattern determin ancestr relationship wellstudi model tail morpholog bacteriophag classif comparison nucleotid usag pattern tetranucleotid usag deviat tud pattern chosen phylogenet signal rrna bacteriophag uniqu tud pattern repres genom signatur conserv host rang analysi tudbas phylogeni indic host influenc bacteriophag evolut phylogeni phage host support coevolut tudbas phylogeni eukaryot virus indic cluster base nucleic acid type genom size similar eukaryot viru phylogeni base tud gene content substanti tud methodolog conclus differ phenotyp tud analysi provid clue viru ancestri infer tud analysi complementari approach morphologybas system analysi viru evolut
BMC Biotechnol	21411570	2014-09-22	PMC1373654	16401354	background develop practic gene pointofcar test devic gpoct devic requir innov detect method demonstr the gene amplif reaction expens equip studi method sequencespecif visual detect minut amount nucleic acid precipit reaction addit cation polym amplicon loop mediat isotherm amplif lamp oligo dna probe label fluoresc dye prepar multipl nucleic acid templat templat amplifi lamp reaction exist probe complet lamp reaction optim amount low molecular weight polyethylenimin pei precipit insolubl lamp ampliconpei complex fluoresc label oligo dna probe hybrid lamp product incorpor precipit precipit emit fluoresc correspond amplifi nucleic acid templat color emit fluoresc detect easili nake ey convent uv illumin conclus presenc absenc minut amount nucleic acid templat detect simpl manner visual assess color lamp ampliconpei complex precipit conclud detect method facilit develop small simpl gpoct devic
BMC Infect Dis	25243477	2017-05-05	PMC1382231	16466582	background develop test diagnosi prognost assess sever acut respiratori syndrom sar base detect sarscoronaviru rna serum realtim quantit revers transcriptas polymeras chain reaction rtpcr studi evalu feasibl autom serum rna extract procedur order increas throughput assai method autom nucleic acid extract platform magna pure lc instrument roch diagnost evalu develop modifi protocol complianc recommend biosafeti guidelin health organ base magna pure total nucleic acid larg volum isol kit extract sarscoronaviru rna modifi protocol compar columnbas extract kit qiaamp viral rna mini kit qiagen quantit perform analyt sensit precis newli develop autom protocol free carryov contamin compar perform standard protocol kit design magna pure lc instrument autom method sensit precis led consist lower serum sarscoronaviru concentr compar columnbas extract method conclus diagnost effici prognost serum sarscov rna rtpcr test critic associ analyt sensit quantit perform contribut rna extract rtpcr compon test recommend columnbas manual rna extract method
BMC Vet Res	27035780	2002-11-01	PMC1386657	16445856	background previou studi demonstr high replic porcin circoviru pcv gnotobiot pig correl absenc pcvneutral antibodi aim studi investig correl spf pig pmw experiment reproduc natur pmwsaffect pig total antipcv antibodi titr pmwsaffect healthi anim seroconvert time point titr pmwsaffect anim lower compar healthi anim healthi anim evolut pcvneutral antibodi coincid total antibodi pmwsaffect anim neutral antibodi sera field studi detect low titr dpi sera experiment inocul spf pig differ evolut specif antibodi isotyp titr pcv healthi pig igm antibodi persist the studi pmwsaffect pig decreas remain low titr titr antibodi isotyp igg igg iga lower pmwsaffect pig compar healthi group mate studi conclus studi describ differ develop humor immun respons pig subclin infect pcv pig experi high level pcvreplic experi led develop pmw observ contribut better understand pathogenesi pcvinfect
Virol J	12409364	2004-05-12	PMC1388193	16451721	a yearold man present nasal obstruct nasal fossa year durat nasal endoscopi reveal inferior turbin head round neoplasm cm diamet cytolog studi nasal scrape specimen disclos numer cluster columnar cell cytomegali promin multinucl markedli spars shorten cilia cytoplasm contain acidophil area small round area stain cell larg intracytoplasm vacuol acidophil pa serolog test nest polym chain reaction pcr techniqu serum nasal pharyng smear reveal epsteinbarr viru ebv infect confirm electron microscopi clinic cytolog featur resolv month initi evalu conclus author advis carri clinic endoscopi serolog evalu endonas neoplasm routin perform cytolog studi nasal scrape specimen sampl test posit ebv nasal nasopharyng endoscopi perform regularli detect evid nasopharyng carcinoma npc
J Autoimmune Dis	15140958	2010-09-22	PMC1397830	16504001	epidemiolog data notion multipl sclerosi ms acquir autoimmun diseas environment factor infecti genet suscept individu case viral induc demyelinatimg encephalomyel human be experiment model presenc igg oligoclon band cerebrospin fluid indic infecti factor viral absenc specif viru identif ms central nervou system support notion hand partial respons patient ms immunosuppress immunomodulatori therapi support evid autoimmun etiolog ms autoimmun hypothesi share critic infecti autoantigen specif caus ms identifi absenc identifi infecti agent viral rule presenc time point concomit long term trigger autoimmun cascad event concept emerg attempt explain autoimmun mechan ongo neurodegener ms basi infecti viral hypothesi
Global Health	20861329	2008-10-01	PMC1403753	16441899	unpreced migrat core dimens contemporari global challeng popul health increas human mobil health outcom shape transnat interact care provid care recipi meet set nationalityethn match option review articl explor transnat compet tc educ prepar ethnic social discord clinic encount relev tc core skill domain analyt emot creativ commun function migrat health medicalschool curriculum elabor pedagog approach prepar transnat healthcar consult present focu clinicalclerkship learn experi educ prepar contemporari medic encount includ comprehens set patientfocus interperson skill adapt wide varieti servic user global practic site possess util address qualiti patient care sociopolit constraint migrat health
Microb Cell Fact	18675785	2001-04-15	PMC1420323	16512917	develop nucleic acidbas detect system main focu group high technolog compani enorm work field broad versatil varieti sens devic optic electr system labeldepend labelfre approach singl multianalyt arrai format wide rang possibl field diversifi competit challeng requir ideal detector suitabl nucleic acid analysi includ high sensit high specif protocol complet short time offer time low detect limit system miniatur autom advantag convent technolog detect need field electr system technolog nucleic acidbas detect enabl mode make miniatur micro nanomet scale biomonitor devic fusion modern micro nanofabr technolog molecular biotechnolog electr biosensor reli convers watsoncrick basepair recognit event electr signal advanc rapidli receiv attent valuabl tool microbi pathogen detect pathogen pose seriou threat human anim plant detect analysi element public health convent method detect pathogen microorgan toxin exist current appli improv molecularbas detect methodolog chang tradit detect techniqu introduc era rapid miniatur autom electr chip detect technolog pathogen identif sector review develop current direct nucleic acidbas electr detect discuss
BMC Infect Dis	11264376	2006-07-19	PMC1421410	16512903	background continu outbreak highli pathogen hn avian influenza asia urgent effort improv current diagnost aid contain viru lower threat influenza pandem report develop pcrbase assai highli specif hn avian influenza viru method onestep reversetranscript pcr assai develop detect hn avian influenza viru specif assai test subtyp influenza viru viral bacteri pathogen field sampl valid field specimen vietnam malaysia assai specif cross reactiv number infuenza strain human respiratori pathogen detect allanto fluid hn posit sampl suggest reliabl sampl sourc accur detect conclus assai develop studi indic primer specif hn influenza viru field test assai highli diagnost tool help identifi control influenza epidem
BMC Health Serv Res	16848925	2015-09-02	PMC1431529	16480500	background scienc syndrom surveil infanc number syndrom surveil system evalu success predict infecti diseas event major syndrom surveil system base emerg depart set vari level enhanc data sourc telephon helplin health care patient satisfact project look telephon helplin sourc data syndrom surveil attempt canada notabl except statement uk nation nh direct system syndrom surveil tool conduct methodsdesign purpos propos studi evalu effect ontario telephon nurs helplin system realtim syndrom surveil system implement success impact outbreak event detect ontario data collect retrospect reason call assign algorithm will link syndrom categori analyt method normal threshold syndrom will ascertain will allow evalu system sensit specif posit predict step will includ prospect monitor syndrom activ tempor spatial discuss studi protocol current report studi grant ethic approv implement hope syndrom surveil system will displai high sensit specif detect true outbreak ontario detect convent surveil system futur will publish peerreview journal contribut grow bodi evid syndrom surveil provid uscentr perspect
Retrovirology	26339053	2014-01-01	PMC1431560	16549011	background abil emerg pathogen infect speci divers pathogen variant exist reservoir degre genom plastic determin abil adapt environ simian immunodefici virus sivcpz sivsm demonstr tremend success infect speci includ human hiv hiv epidem siv diversif studi popul level essenti substrat crossspeci transmiss siv sequenc divers type extent viral diversif individu reservoir anim elucid character intrahost siv divers perform sequenc analys clonal viral envelop env vv gag variant individu sivsminfect sooti mangabei time sivsm demonstr extens intraanim vv length variat amino acid divers le continu variat vv nlink glycosyl consensu sequenc frequenc locat posit select predomin evolutionari forc tempor sequenc shift suggest continu select evolv antibodi respons contrast gag purifi select sivsm vv sequenc diversif great hiv infect human indic extens viral diversif inevit lead aid conclus posit diversifi select natur reservoir host engin driven evolut uniqu adapt sivhiv envelop protein studi emphas retrovir diversif individu host reservoir anim critic substrat facilit crossspeci transmiss
PLoS Med	26966339	2008-12-24	PMC1435785	16608385	osterhau haagman discuss studi plo medicin support cynomolgu macaqu model studi sar pathogenesi test intervent strategi
PLoS Med	19109397	2005-04-27	PMC1435788	16605302	background emerg sever acut respiratori syndrom sar global health caus major econom disrupt adequ anim model requir studi underli pathogenesi sarsassoci coronaviru sarscov infect develop effect vaccin therapeut report find measur clinic diseas nonhuman primat nhp infect sarscov method find order character clinic relev paramet sarscov infect nhp infect cynomolgu macaqu sarscov three group group infect nare bronchu group ii nare conjunctiva group iii intraven nonhuman primat group ii develop mild moder symptomat ill nhp demonstr evid viral replic develop neutral antibodi chest radiograph anim group ii reveal unifoc multifoc pneumonia peak dai postinfect clinic laboratori test chang inocul mucos rout produc promin diseas intraven inocul half group anim infect recombin infecti clone sarscov deriv sarscov urbani strain infecti clone produc diseas indistinguish wildtyp urbani strain conclus sarscov infect cynomolgu macaqu reproduc sever ill major adult human case sar similar milder syndrom sarscov infect characterist young children
Virol J	16103185	2018-09-06	PMC1444920	16571117	background sar coronaviru sarscov etiolog agent sever acut respiratori syndrom sarscov infect tissu nonlymphat origin cytokin profil cell determin cours diseas investig cytokin respons human nonlymphat cell line caco hek fulli permiss sarscov comparison establish cytokineinduc virus reveal sarscov weakli trigger cytokin respons sarscov activ transcript interferon ifn ifn ifn ifn interferoninduc antivir gene isg mxa chemokin rant interleukin il interestingli sarscov induc chemokin ip il colon carcinoma cell caco embryon kidnei cell conclus data indic sarscov suppress antivir cytokin system nonimmun cell larg extent bui time dissemin host synthesi ip il establish marker acutestag sar escap virusinduc silenc cell type progress infiltr immun cell infect lung observ sar patient product chemokin infect tissu cell
Microb Cell Fact	30067309	2009-09-27	PMC1444932	16556312	background brucella abortu facult intracellular pathogen infect cattl human current vaccin reli live attenu strain abortu revert pathogen statu total safe human develop mucos live vaccin foodgrad lactic acid bacterium lactococcu lacti antigen deliveri vector attract altern safer vaccin strategi abortu report construct lacti strain genet modifi produc abortu groel heatshock protein candid antigen cellular locat intracellular secret secret form groel stabli produc lacti suggest detriment groel protein intracellularli produc bacterium trace amount matur groel detect supernat fraction induc lactococc cultur groel precursor remain stack cell fraction attempt rais secret yield groel fuse synthet propeptid secret antigen improv conclus lacti produc secret stabl form groel extracellular medium despit low secret effici groel antigen interact cell envelop lacti secret best achiev product protein yield cellular locat lacti strain secret groel potenti vivo immun
PLoS Med	19687041	2013-03-27	PMC1450020	16640458	background emerg hypervirul subtyp avian influenza underlin devast effect pandem influenza viru acquir abil spread effici human control hamper limit vaccin suppli global spread delai larg increas occur intern air travel expect lead rapid global dissemin previou pandem method find evalu potenti local control measur travel restrict imped global dissemin develop stochast model intern spread influenza base extens coupl epidem transmiss model model capabl accur forecast local global spread epidem pandem influenza scenario restrict air travel surprisingli delai epidem travel ceas epidem detect conclus intervent reduc local transmiss influenza effect reduc rate global spread vulner implement delai air travel restrict plausibl scenario achiev delai small compar time need accumul substanti vaccin stock
BMC Public Health	23536670	2010-09-01	PMC1456961	16597331	background movement evidencebas practic field suggest public health ph challeng better address credibl health risk effect ph practic ph unmet addit review relev literatur studi perform comprehens review exist resourc collect data repres ph group focus identifi current practic express ideal system access method nineteen individu interview conduct employe domain state health depart communic diseas control commun health promot subsequ focu group gather addit data prefer method access deliveri format content qualit method identifi theme interview focu group transcript inform express improv access includ singl portal access good search engin automat notif newli access best practic area interest extend biomed subject matter improv access grei literatur systemat review summari fulltext articl better method index filter search effect wai archiv access inform express prefer improv system familiar pubm listserv introduc system organ deliveri hypothet ideal model organ deliveri develop base inform state prefer deliveri featur model endors subject review conclus critic ph practition met effici propos dual strategi promot increment improv exist deliveri system base express prefer ph user system concurr develop rigor evalu model organ deliveri draw success resourc oper deliv clinic medic practition
BMC Med Ethics	20833378	2016-10-19	PMC1459179	16626488	background number comment sar expos vulner health care system govern structur health care profession hcp hospit system bore brunt sar outbreak continu struggl aftermath crisi hcp clinic care public health sever test sar unpreced demand skill expertis person commit profess sever expos seriou risk morbid mortal evidenc health organ figur show report case hcp di infect despit challeng profession code ethic silent issu duti care communic diseas outbreak provid guidanc expect hcp approach duti care face risk discuss aftermath sar spectr pandem avian influenza imper reconsid oblig hcp patient sever infecti diseas diseas pose risk provid care press organ repres hcp clear indic standard care expect member event pandem paper address issu special oblig hcp infecti diseas outbreak argu press clarifi right respons hcp current context pandem flu prepared right respons codifi profession code ethic final histor account treatment duti care profession health care code ethic summari honest critic examin role hcp communic diseas outbreak need order provid guidelin profession right respons ethic duti oblig paper hope open social dialogu advanc public debat increasingli urgent issu
Microb Cell Fact	27619693	2014-12-08	PMC1459189	16584558	the quantit detect low analyt concentr complex sampl urgent biomed food environment field biosensor hybrid devic compos biolog receptor signal transduc repres valuabl altern biolog analyt instrument high specif biomolecular recognit vast rang exist protein ligand enabl macromolecul effici receptor cover divers applic addit appropri protein engin approach enabl improv receptor function enhanc affin specif ligand bind proteinonli sensor develop receptor signal transduc part protein cell protein produc transduc case chemic coupl requir product process conveni protein platform rigid restrict proper signal transduct occur ligandinduc conform chang context insert protein engin offer possibl develop devic effici respond ligand interact dramat conform chang specif magnitud sens respons adjust conveni level specif analyt speci report will discuss major engin approach design instrument relev exampl proteinonli biosensor
PLoS Med	25488991	2006-05-26	PMC1459482	16683867	background ebola viru hemorrhag fever syndrom associ high mortal human absenc effect therapi ebola viru infect develop vaccin strategi outbreak immun dna andor replicationdefect adenovir vector rad encod ebola glycoprotein gp nucleoprotein np confer specif protect immun nonhuman primat gp exert cytopath effect transfect cell vitro multipl gp form identifi natur rais question optim human vaccin method find address question explor efficaci mutant gp multipl ebola viru strain reduc vitro cytopath analyz protect effect primat challeng model np delet gp transmembran domain elimin vitro cytopath reduc protect efficaci order magnitud contrast point mutat identifi abolish cytopath retain immunogen confer immun protect absenc np minim effect rad dose establish particl log lower conclus express specif gp vector rad suffici confer protect lethal challeng relev nonhuman primat model elimin np vaccin dose reduct rad particl diminish protect simplifi vaccin provid basi select human vaccin candid
BMC Infect Dis	16731945	2015-02-01	PMC1468415	16672072	background cytokin plai role antivir action examin polymorph ifntnf il affect suscept outcom sever acut respiratori syndrom sar method casecontrol studi carri chines sar patient healthi control test polymorph ifntnf il associ sar ifn allel associ suscept sar dosedepend manner individu ifn aa genotyp fold confid interv ci fold ci increas risk develop sar polymorph il tnf associ sar suscept conclus ifn allel risk factor sar suscept
BMC Genomics	25669994	2017-05-05	PMC1481559	16709242	background evolut viral quasispeci influenc viral pathogenesi respons antivir treatment mutant cloud infect organ repres stage genet antigen diversif rna virus foot mouth diseas viru fmdv anim pathogen antigen variant fmdv classic diagnos immunolog rtpcrbase method dna microarrai increasingli analysi gene express singl nucleotid polymorph snp fmdv microarrai describ detect simultan fmdv serotyp encourag develop oligonucleotid microarrai probe fine genet antigen composit fmdv diagnosi vaccin design gain insight molecular epidemiolog pathogen fmdv microarrai design optim detect snp major antigen site viru screen point mutant genom region encod antigen site fmdv csc achiev hybrid pattern mutant includ specif posit neg signal crosshybrid signal intens depend thermodynam stabil probetarget pair arrai bioinformat classif method develop evalu hybrid signal statist analysi procedur allow accur classif variant genom conclus specif approach base microarrai platform aim distinguish point mutant determin antigen host cell tropism gh loop capsid protein vp develop procedur gener applic test specif discriminatori power microarraybas diagnost procedur multipl oligonucleotid probe
Respir Res	30555771	2004-06-11	PMC1481583	16686949	background patient chronic obstruct pulmonari diseas copd experi exacerb condit exacerb event defin term subject descriptor symptom dyspnoea cough sputum worsen warrant chang medic manag reliabl marker reflect patholog mechan underli exacerb sever surrog assess treatment effect clinic studi exist studi variabl suggest marker chang stabl exacerb phase copd attempt find best surrog exacerb review literatur identifi marker chang consist manner sever exacerb event method search standard databas juli major keyword term studi provid demograph spirometri potenti marker clear elig criteria includ studi central tendenc dispers variabl marker report collect tabul sampl size atser exacerb sever level iii criteria similar patient level ii iii data redefin categori exacerb outpati level inpati level ii iii combin approach perform fix metaanalysi report variabl includ total studi report juli studi investig patient copd arteri carbon dioxid tension breath rate statist level exacerb sever inpati set measur weak relationship level set insuffici data permit metaanalysi conclus arteri carbon dioxid breath rate vari consist manner exacerb sever patient set measur weak correl explor futur longitudin studi assess suggest mathemat model techniqu
Virol J	15194770	2012-01-01	PMC1481635	16729896	chloroquin aminoquinolon wellknown antimalari effect biochem properti appli inhibit viral replic report chloroquin inhibit influenza viru replic vitro ic chloroquin influenza virus hn hn lower plasma concentr reach treatment acut malaria potenti chloroquin to limit rang antiinfluenza drug explor antivir drug plai vital role influenza pandem prepared
Virol J	24392458	2006-07-12	PMC1483818	16579862	background amphotrop murin leukemia viru amlv enter mous fibroblast cell niht caveoladepend endocytosi size omegalik shape caveola amlv initi bind cell caveola raft suggest precaveola investig amlv initi bind receptor pit sodiumdepend phosphat transport raft caveola cholesterolrich microdomain high amount cellbound amlv attach larg raft niht time investig larg raft enrich caveolin major structur compon caveola addit natur occurr niht cell result patch smaller raft amlv cell incub parallel vesicular stomat viru glycoprotein vsvg pseudotyp mlv particl pattern larg raft cell incub amlv vsvg pseudotyp mlv particl prefer attach larg microdomain conclus high concentr amlv particl bound larg raft niht cell suggest role microdomain earli amlv bind event
PLoS Med	16840309	2015-10-21	PMC1483912	16796401	background experiment anim data protect sever acut respiratori syndrom coronaviru sarscov infect human monoclon antibodi mab feasibl effect immun prophylaxi human broad coverag strain sarscov control potenti neutral escap variant will requir combin virusneutr noncompet mab properti method find human mab cr complet prevent lung patholog abolish pharyng shed sarscov infect ferret gener vitro sarscov variant escap neutral cr singl pl mutat glycoprotein spike escap viru vitro experi confirm bind cr recombin fragment amino acid residu harbor mutat abolish screen antibodyphag librari deriv blood convalesc sar patient antibodi complementari cr novel mab cr identifi neutral cr escap virus compet cr bind recombin fragment bound fragment deriv civet cat sarscovlik strain sz escap variant gener cr mixtur mab neutral sarscov synergist fashion recogn epitop receptorbind domain dose reduct indic observ cr cr neutral enhanc sarscov infect subneutr antibodi concentr concern antisarscov antibodi convert abort infect primari human macrophag sarscov product conclus combin noncompet human mab cr cr control immun escap extend breadth protect time synergi cr cr allow lower total antibodi dose administ passiv immun prophylaxi sarscov infect
BMC Biotechnol	26488462	2007-04-01	PMC1484482	16643647	background realtim quantit pcr power accur techniqu examin gene transcript pattern biolog condit critic step compar transcript profil accur normalis studi publish realtim pcr hors normalis occur refer gene gapdh actb valid express stabil result unreli conclus demonstr express level call housekeep gene vari consider tissu cell type diseas stage clinic sampl associ malign diseas goal studi establish reliabl set refer gene studi concern normal equin skin equin sarcoid common skin tumour hors studi gene transcript level commonli refer gene actb bm hprt ubb tuba rpl determin normal equin skin equin sarcoid appli genorm applet set gene tuba actb ubb stabl normal skin bm actb ubb equin sarcoid conclus base tuba actb ubb bm actb ubb propos refer gene panel accur normalis quantit data normal equin skin equin sarcoid normal skin equin sarcoid compar geometr ubb actb bm recommend reliabl accur normalis factor
Virol J	17413061	2017-06-13	PMC1488829	16719922	background respiratori syncyti viru rsv infect major bronchiol infant risk factor develop asthma allerg asthmat suscept rsv infect viral exacerb method effect corticosteroid treat rsv infect controversi test fluticason propion fp salmeterol sal versu fp sal fp rsvinduc airwai inflamm mice sensit challeng ovalbumin ova infect rsv infect treat fp sal fp intranas airwai hyperreact ahr inflamm rsv titer examin group treat fp lower ahr compar group treat fp sal group treat fp decreas nonsignific ahr compar control treatment fp decreas percentag eosinophil neutrophil bronchoalveolar lavag fluid lung patholog compar fp sal fp decreas eosinophil neutrophil lymphocyt sal decreas eosinophil neutrophil lymphocyt fp treatment mice infect rsv absenc allergen sensit decreas rsv titer lung reduct neutrophil compar fp sal conclus indic fluticason combin salmeterol effect treatment decreas airwai hyperreact inflamm allergensensit rsvinfect mice
Global Health	29291217	2013-05-06	PMC1502134	16603071	background antimicrobi resist underappreci threat public health nation globe global boom understand intern pattern resist countri experi pattern resist late worri intern spread larg countri group countri leap ahead integr rest china standout case high distinct pattern resist coordin respons help control spread resist literatur limit evid issu method studi pattern antibiot resist three geograph separ cultur econom distinct countri china kuwait unit state gaug rang depth global health threat potenti growth global expand primari measur preval resist specif bacteria specif antibiot propos illustr method aggreg specif bugdrug data aggreg measur summar resist pattern countri studi extent correl countri pattern drug resist find china highest level antibiot resist kuwait studi resist pattern common bacteria china preval resist hospitalacquir infect high rang commun acquir infect rang china rapid growth rate resist averag growth studi span kuwait second averag growth period lowest pattern resist three countri highli correl correl china kuwait kuwait correl pair china conclus antimicrobi resist seriou grow problem three countri strong intern converg countri resist pattern find chang greater intern travel will accompani global futur determin drug resist pattern intern converg diverg prioriti
Emerg Themes Epidemiol	23650365	2013-11-29	PMC1513225	16674820	current migrant mobil individu migrant worker asylum seeker expand global popul grow social demograph polit dispar exist migrant popul place origin destin relat health determin effect dispar observ individu popul level migrat health diseas dispar influenc epidemiolog diseas global nation receiv migrant specif diseasebas outcom vari migrant group locat gener epidemiolog principl appli situat number individu move differ diseas preval tradition migrat health activ design nation applic lack integr intern perspect futur health challeng migrat effect address collabor global undertak paper review epidemiolog relationship health dispar bridg migrat describ grow role migrat popul mobil global diseas epidemiolog implic nation intern health polici program plan present
BMC Bioinformatics	24293627	2016-11-02	PMC1513606	16579851	background bind peptid epitop major histocompat complex protein mhc event cellular immun respons accur predict bind short peptid mhc molecul long princip challeng immunoinformat model mhcpeptid bind emphas quantit predict categor peptid binder nonbind strong binder weak binder method seek predict precis bind affin develop quantit support vector machin regress svr approach call svrmhc model peptidemhc bind affin nonlinear method svrmhc gener model outperform exist linear model addit method adopt factor encod scheme svrmhc take account similar physicochem properti amino acid constitut input peptid appli mhcpeptid bind data three mous class mhc allel svrmhc model produc accur predict produc comparison base receiv oper characterist roc analysi indic svrmhc outperform promin method identifi bind peptid conclus method demonstr perform quantit model mhcpeptid bind identifi strong binder svrmhc promis immunoinformat tool inconsider futur potenti
PLoS Med	27807242	2011-10-31	PMC1518680	16848617	the author describ progress obstacl har rna interfer prevent treat viral infect
BMC Bioinformatics	22042838	2012-11-01	PMC1523220	16643672	background viru detect method gear detect specif singl virus target lack capabl uncov novel virus emerg viral infect address issu develop comput method identifi conserv viral sequenc genu level viral genom genbank establish viru probe librari viru probe identifi virus discern genera emerg uncharacter microarrai approach ident viru test sampl determin signal genu speciesspecif probe genera emerg uncharacter virus determin base hybrid viral sequenc conserv probe exist viral genera detect classif procedur determin ident viru directli detect signal rapid identif viru conclus demonstr valid feasibl strategi small number viral sampl probe design algorithm appli publicli viral sequenc databas strategi separ genu speci probe set enabl straightforward viru ident calcul directli base hybrid signal viru identif strategi great potenti diagnosi viral infect viru genu specif probe databas associ summari tabl at
PLoS Comput Biol	22653487	2005-10-01	PMC1523295	16863395	the develop dna microarrai technolog decad ago led establish function genom activ success scientif disciplin todai ongo develop immunom microarrai technologya spatial address largescal technolog measur specif immunolog responseth challeng function immunom emerg bear similar function genom immunon data identifi biolog marker involv autoimmun diseas allergi viral infect human immunodefici viru hiv influenza diabet respons cancer vaccin review intend provid coher vision nascent scientif field specul futur direct discuss length issu epitop predict immunom microarrai technolog applic comput statist challeng function immunom base discoveri regul mechan cell respons envis immunom microarrai tool advanc system biologi cellular immun respons immunom regulatori network model
Virol J	16210485	2013-08-21	PMC1524727	16737539	lassa viru glycoprotein synthesis precursor pregpc lumen endoplasm reticulum cotransl cleavag signal peptid immatur gpc posttranslation process ntermin subunit gp ctermin subunit gp host cell subtilas skisp glycoprotein precursor eleven potenti nglycosyl site report investig nglycan proteolyt cleavag cell surfac transport disrupt consensu sequenc eleven potenti nglycan attach site individu glycoprotein mutant disrupt nglycosyl site proteolyt process remain nglycosyl site gpc cleavag despit lack proteolyt process cleavagedefect mutant transport cell surfac remain complet endo hsensit find indic nglycan need correct conform gpc order cleav skisp
Virol J	23966408	2009-04-24	PMC1525181	16772029	background studi gamma interferon ifn synerg ifn inhibit herp simplex viru type hsv replic vitro ifn respons repres earli host defens event viral infect fact treatment meliacin plant antivir amelior sever herpet infect femal mice infect intravagin hsv want investig administr meliacin hsv infect mice alter homoestasi ifn host respons purpos studi the compound cinnamoyldihydroxymeliacarpin cdm respons meliacin antivir action hsv inhibit exert ifn ifn combin hsv ifn synerg ifn inhibit hsv replic vero cell treatment ifn ifn weak antivir action hsv plaqu format viral replic onset viral cpe vero cell synergist inhibit interferon combin addit cdm treatment contribut protect cell viru cytopath strong inhibit hsv titer presenc cdm ifn induct induct period infect complet ifn treatment period reduc viru yield addit ifn antivir action conclus report indic presenc cdm alter antivir activ ifn ifn synerg exert combin result envis administr cdm vivo affect biolog activ ifn mediat innat resist hsv infect
Arthritis Res Ther	19286607	2009-11-03	PMC1526600	16507143	macrophagelik synoviocyt fibroblastlik synoviocyt fl activ cell rheumatoid arthriti ra close articular cartilag posit enabl invad cartilag macrophagelik synoviocyt fl express matrix metalloproteinas mmp interact arous great interest articl studi express cd call extracellular matrix metalloproteinas induc monocytesmacrophag fl ra patient potenti role enhanc mmp invas synoviocyt express cd fl deriv ra patient osteoarthr patient express cd monocytesmacrophag rheumat synovi fluid healthi peripher blood analyz flow cytometri level cd mmp mmp mrna fl detect rtpcr role cd mmp product cell invas vitro studi cocultur fl human thp cell monocytesmacrophag gel zymographi invas assai the express cd higher ra fl osteoarthr fl higher monocytesmacrophag rheumat synovi fluid monocytesmacrophag healthi peripher blood rtpcr express cd mmp mmp mrna higher ra fl osteoarthr fl elev secret activ mmp mmp observ ra fl cocultur differenti thp cell ra synovi monocytesmacrophag compar cocultur undifferenti thp cell healthi control peripher blood monocyt invas assai increas number invad cell cocultur ra fl differenti thp cell ra synovi monocytesmacrophag cd antagonist peptid inhibit mmp product invas potenti studi demonstr cd overexpress monocytesmacrophag fl ra patient respons enhanc mmp secret activ invas synoviocyt find cd factor progress joint destruct ra cd potenti therapeut target ra treatment
Respir Res	19772353	2013-04-01	PMC1533820	16834785	background pneumococc pneumonia common death infecti diseas pneumococcilung cell interact test hypothesi pneumococci activ pulmonari epitheli cell cytokin releas cjunnhtermin kinas jnk method human bronchial epitheli cell beasb epitheli hek cell infect pneumonia rx cytokin induct measur rtpcr elisa bioplex assai jnkphosphoryl detect western blot nuclear signal assess electrophoret mobil shift assai emsa chromatin immunoprecipit chip jnk modul small molecul inhibitor sp ap transfect domin neg mutant pneumonia induc releas distinct cc cxc th cytokin growth factor human lung epitheli cell beasb pneumococci infect jnk phosphoryl beasb cell inhibit jnk small molecul inhibitor sp reduc pneumococciinduc il mrna express releas il il regul il promot jnkphosphoryl activ protein ap pneumonia timedepend induc dna bind ap phosphoryl subunit cjun maximum infect recruit serphosphoryl cjun rna polymeras ii endogen il promot pneumonia infect chromatin immunoprecipit ap repressor afo reduc il releas tlroverexpress hek cell induc pneumococci tnf antisenseconstruct target ap subunit fra fra inhibitori pneumococciinduc il releas conclus pneumoniaeinduc il express human epitheli beasb cell depend activ jnk recruit phosphoryl cjun il promot
Respir Res	23547115	2013-05-22	PMC1533821	16827942	pneumonia common diseas caus great divers infecti agent respons enorm morbid mortal worldwid bronchial lung epithelium compris larg surfac host environ attack primari target lung infect act mechan barrier evid suggest lung epithelium function sentinel system pathogen equip transmembran cytosol pathogensens pattern recognit receptor epithelium detect invad pathogen complex signal epitheli cell activ essenti particip initi orchestr subsequ innat adapt immun respons review summar progress focuss molecular mechan pathogen detect host cell signal transduct subsequ activ lung epitheli cell pathogen virul factor point open question analysi lung epitheli function host respons pneumonia pave develop innov highli need therapeut pneumonia addit antibiot
BMC Genomics	23698310	2017-02-15	PMC1534038	16772042	background dna sequenc easier cheaper increas number close viral genom sequenc deposit genbank annot sever limit research maintain comprehens genom databas set viru famili viral bioinformat resourc center viral bioinformat canada research unnecessarili spend time annot viral genom close rel annot virus design implement novel tool genom annot transfer util gatu transfer annot annot refer genom target genom greatli reduc labori task gatu transfer annot refer genom close target genom user final control annot includ gatu detect open read frame target refer genom user varieti bioinformat tool determin orf includ annot process complet gatu save newli annot genom genbank embl xmlformat file softwar code java run varieti comput platform userfriendli graphic user interfac design user train biolog scienc conclus gatu greatli simplifi initi stage genom annot close genom refer intend gene predict tool complet annot system reduc time requir annot gene matur peptid help standard gene name organ transfer refer genom annot target genom program freeli gener public licens access document tutori 
BMC Public Health	28202753	2010-04-06	PMC1538585	16686946	background case definit recogn element public health surveil system assur compar consist surveil data crucial impact sensit posit predict surveil system reliabl case definit rare investig systemat method conduct roundrobin test local health depart lhd state health depart shd germani classifi select case exampl case definit multivari analysi investig factor link classif agreement gold standard defin expert panel total classif lhd shd report sensit posit predict polio case exampl lowest report precis salmonellosi case exampl highest ci case definit checklist format clinic criteria higher report precis case definit narr descript ci report precis higher shd compar lhd ci conclus find led systemat revis german case definit build basi gener recommend creation case definit includ testabl yesno criteria checklist format improv reliabl softwar data transmiss design strict case definit find studi applic case definit countri intern network share structur editori characterist case definit evalu studi revis
Microb Cell Fact	20406307	2014-11-26	PMC1538998	16796731	the live bacteria induc immun respons to carri vaccin compon attract vaccin strategi advantag live bacteri vaccin includ mimicri natur infect intrins adjuv properti possibl administ oral deriv pathogen nonpathogen food bacteria current evalu live vaccin pathogen bacteria demand attenu weaken virul bacteria vaccin deliveri vehicl impli construct recombin strain gene cassett encod antigen increas knowledg mucos immun avail genet tool heterolog gene express concept live vaccin vehicl gain renew interest administr live bacteri vaccin pose risk addit vaccin recombin bacteria releas live recombin organ natur place vaccin debat applic genet modifi organ review overview live bacteri vaccin market describ develop live vaccin focu attenu bacteria foodrel lactic acid bacteria outlin safeti concern identifi hazard associ live bacteri vaccin suggest consid develop
BMC Infect Dis	25428874	2004-02-06	PMC1550407	16824203	background host genet factor plai role suscept resist sar associ coronaviru sarscov infect studi carri investig associ genet polymorph oligoadenyl synthetas oa gene myxoviru resist mxa gene suscept sar chines han popul method hospitalbas casecontrol studi conduct collect sar case close contact uninfect control enrol studi point real time polymeras chain reaction pcr pcrbase restrict fragment length polymorph rflp analysi detect singl nucleic polymorph snp oa mxa gene factor associ sar infect collect pretest questionnair univari multivari logist analys conduct polymorph untransl region utr oa gene associ sar infect compar aa genotyp ag gg genotyp associ protect sar infect or ci gt genotyp posit mxa gene promot associ increas suscept sar infect compar gg genotyp ci associ ag genotyp oa gt genotyp mxa remain multivari analys adjust sar protect measur ci ci conclus snp oa utr mxa promot region appear associ host suscept sar chines han popul
BMC Infect Dis	14766963	2009-04-01	PMC1550408	16834781	background substanti proport respiratori tract diseas suspect infecti origin etiolog unknown case caus describ human bocaviru hbov aim studi investig frequenc potenti clinic relev hbov pediatr patient method test nasopharyng aspir npa pediatr inpati acut respiratori tract diseas univers wrzburg germani presenc hbov dna specif posit pcr reaction confirm sequenc hbov dna npa median ag infant children hbov infect year ag year rang dai year infect hbov yearround occur winter month coinfect hbov posit sampl rsv influenza adenovirus frequent detect coinfect agent sequenc determin pcr product np region reveal high ident nucleotid sequenc year comparison swedish virus st st associ hbov distinct respiratori tract manifest appar conclus hbov frequent npa hospit infant children acut respiratori tract diseas prove clinic relev hbov challeng applic koch revis postul high rate coinfect hbov respiratori tract pathogen associ hbov respiratori tract diseas remain unproven
Crit Care	19189850	2012-04-01	PMC1550819	16356209	introduct sever acut respiratori syndrom sar crisi propos test protocol cardiac arrest patient sar protocol rapidli effect institut teamwork train highfidel simul method phase curriculum design sarsspecif cardiac arrest protocol three step plan protocol repeat simul protocol classroom subsequ simul cardiac arrest hospit ward phase train healthcar worker hcw protocol train involv seminar practic wear mandatori person protect system pp cardiac arrest simul subsequ debrief simul provid insight consid earlier phase develop exampl singl person don pp worn sar patient minut multipl member cardiac arrest team dress simultan time don pp increas minut error infect control medic manag advanc cardiac life support acl correct conclus sar crisi realtim highfidel simul allow train hcw week debrief error manag hcw requir manag sar cardiac arrest wear unfamiliar equip modifi acl protocol insight gain experi will valuabl futur infecti diseas challeng critic care
Crit Care	22233583	2012-01-04	PMC1550925	16611370	introduct aetiolog lower respiratori tract infect young children admit paediatr intens care unit picu difficult establish infect believ caus respiratori virus diagnost studi perform compar convent viral test develop realtim pcr techniqu method sampl children ag year present tertiari picu suspect lower respiratori tract infect test convent method viral cultur immunofluoresc realtim pcr winter season decemb convent method check respiratori syncyti viru influenzaviru parainfluenzaviru rhinovirus adenovirus realtim pcr test respiratori syncyti viru influenzaviru parainfluenzaviru rhinovirus adenovirus human coronavirus oc nl human metapneumoviru mycoplasma pneumonia chlamydia pneumonia total patient includ posit respiratori viru convent method realtim pcr confirm posit addit realtim pcr identifi virus patient yield total patient posit sampl viru detect children conclus realtim pcr respiratori virus sensit reliabl method picu patient lower respiratori tract infect increas diagnost yield twofold compar convent method
PLoS Comput Biol	22219187	2016-01-01	PMC1557587	16948530	liveviru vaccin activ humor cellmedi immun requir singl boost gener provid longer immun protect kill subunit vaccin growth liveviru vaccin attenu minim potenti pathogen effect mechan attenu convent serialtransf viral adapt wellunderstood method attenu base ration engin viral genom offer greater control link defin genet modif chang viru growth to establish link genotyp growth phenotyp develop comput model intracellular growth vesicular stomat viru vsv wellstudi nonseg negativestrand rna viru model incorpor establish regulatori mechan vsv integr kei wildtyp infect step hijack host resourc transcript translat replic assembl releas progeni vsv particl gener wildtyp model allow genom rearrang match experiment observ attenu rank recombin vsv strain alter genom posit nucleocapsid gene final simul captur report experiment show alter posit vsv gene potenti attenu vsv growth overexpress immunogen vsv surfac glycoprotein model will facilit engin liveviru vaccin link genom manipul control chang viru geneexpress growth
BMC Health Serv Res	28220053	2015-07-01	PMC1559606	16889656	background sever acut respiratori syndrom sar epidem threw turmoil half subsequ paper address impact health servic util consid palli hospic care aim studi describ chang hospic inpati util sar epidem in taiwan method data sourc complet dataset inpati admiss nation health insur databas beforeandaft comparison daili monthli util hospic analys limit ward offer inpati servic year comparison extend total hospit bed util patient admit hospic ward peak period sar epidem hospic ward oper hospic util began decreas middl april reach minimum gradual recov level previou novemb hospic mark reduct util hospit bed slower recoveri threemonth lag total patient admit hospic ward mayjun contrast mayjun gender ag diagnosi distribut differ conclus hospic inpati util taiwan sensit emerg epidem gener inpati util wellbalanc network seamless continu care ensur
J Ethnobiol Ethnomed	25708857	2014-05-21	PMC1559680	16893454	thi paper investig common ethnoveterinari medicin hors trinidad west indi british columbia canada area common market pharmaceut involv north american race circuit conduct medicin plant hors widespread data ethnoveterinari medicin hors kei inform interview hors owner trainer breeder jockei groom anim care specialist area trinidad british columbia bc participatori valid workshop held bc extens literatur review botan identif plant plant treat racehors trinidad bc mostevid effect plant plant trinidad bc describ evalu paper alo vera curcuma longa ricinu communi area need trinidad identifi plant respond claim studi conduct temper chines medicin plant bc ethnoveterinari remedi reflect stronger evid efficaci
BMC Infect Dis	24850726	2004-03-02	PMC1560143	16899110	background respiratori syncyti viru rsv pathogen sever ill infant young children studi assess data rsv collect european influenza surveil scheme eiss build rsv surveil system europ method influenza rsv data winter season analys england franc netherland scotland data sentinel physician network sourc hospit collect respiratori specimen test influenza rsv viru cultur polymeras chain reaction amplif data rsv enter time eiss databas rsv contribut notic influenzalik ill england sentinel rsv detect common ag group young children total number sentinel swab test posit rsv scotland franc report highest percentag rsv detect year ag group n netherland rsv detect person ag year conclus recommend respiratori specimen collect influenza surveil test systemat rsv emphas commun deriv data data hospit rsv surveil rsv data eiss enter time manner consid eiss model develop rsv surveil system equival influenza surveil europ
BMC Public Health	14993176	2006-01-26	PMC1562405	16907978	background march outbreak sever acut respiratori syndrom sar occur northern vietnam outbreak began travel arriv hong kong sought medic care small hospit hospit hanoi initi seriou substanti transmiss event hospit subsequ limit spread commun method survei hospit personnel exposur patient symptom diseas outbreak addition serum specimen collect assai antibodi sarsassoci coronaviru sarscov antibodi jobspecif attack rate calcul nest casecontrol analysi perform assess risk factor acquir sarscov infect fiftythre clinic nonclin staff consent particip exclud job categori worker highest sar attack rate occur nurs work outpati inpati gener ward nurs assign oper roomintens care unit experienc lowest attack rate clinic staff serolog evid sarscov infect detect individu includ nonclin worker identifi sar case report fever cough enter patient room view patient behavior associ highest risk infect univari analysi odd ratio confid interv conclus studi highlight job categori activ associ increas risk sarscov infect demonstr broad divers hospit worker vulner outbreak find help guid recommend protect vulner occup group implic respiratori infect influenza
Emerg Themes Epidemiol	16439530	2005-01-01	PMC1562421	16907980	surprisingli human mix pattern relev spread closecontact infect measl influenza meningococc diseas studi aim estim number partnership individu stabil degre mix assort respect ag defin level put atrisk event casual physic contact convers intim contact sexual natur ask univers student volunt record detail contact level three separ dai intim contact stabl short time period evid repeat casual contact individu contact increasingli assort intimaci increas will aid develop parameteris model close contact diseas direct outbreak investig
Respir Res	16273643	2010-11-29	PMC1563466	16904002	background caveola involv divers cellular function signal transduct cholesterol homeostasi endo transcytosi serv entri site microorgan occurr epithelium airwai expect examin method western blot realtim quantit pcr analysi abrad tracheal epithelium laserassist microdissect combin subsequ mrna analysi examin express cav cav major caveolar coat protein rat tracheal epithelium fluoresc immunohistochemistri perform locat caveola cav airwai epithelium rat mice human electronmicroscop analysi identif caveola clsmfret analysi determin interact cav cav situ western blot laserassist microdissect identifi protein transcript cav cav airwai epithelium realtim quantit rtpcr analysi abrad tracheal epithelium reveal higher express cav cav immunoreact cav cav coloc cell membran basal cell basolater ciliat epitheli cell larg airwai rat human label cav cav observ epitheli cell small bronchi convent doublelabel indirect immunofluoresc combin clsmfret analysi detect associ cav epitheli cell presenc caveola confirm electron microscopi contrast human rat cavimmunoreact caveola confin basal cell mice epitheli caveola absent cavdefici mice implic requir caveolar protein epitheli caveola format conclus caveola caveolin integr membran compon basal ciliat epitheli cell indic crucial role cell type addit physiolog role involv airwai infect
BMC Genomics	21115835	2009-07-22	PMC1564015	16911805	background mast cell establish effector igetrigg allerg reaction immun respons parasit infect studi indic mast cell plai role adapt innat immun suggest innov view regul immun respons profil transcriptom human mast cell sensit ig stimul fcri aggreg data gene examin gene differenti regul stimul mast cell compar restingunstimul mast cell major function categori upregul gene includ cytokin chemokin gene involv innat adapt immunerespons observ increas express genetranscript igesensit data valid realtimepcr elisa western blot confirm ig trigger mast cellimmedi respons calcium signal degranul proteinphosphoryl conclus report repres substanti advanc understand genom wide effect trigger passiv sensit activ stimul human mast cell support mast cell potenti involv wide rang inflammatori respons
BMC Infect Dis	19625413	2014-07-15	PMC1564025	16914034	background inanim surfac describ sourc outbreak nosocomi infect aim review summar data persist nosocomi pathogen inanim surfac method literatur systemat review medlin languag restrict addit cite articl report assess standard textbook topic review report experiment evid durat persist nosocomi pathogen type surfac includ gramposit bacteria enterococcu spp includ vre staphylococcu aureu includ mrsa streptococcu pyogen surviv month dry surfac gramneg speci acinetobact spp escherichia coli klebsiella spp pseudomona aeruginosa serratia marcescen shigella spp surviv month bordetella pertussi haemophilu influenza proteu vulgari vibrio cholera persist dai mycobacteria includ mycobacterium tuberculosi sporeform bacteria includ clostridium difficil surviv month surfac candida albican nosocomi fungal pathogen surviv month surfac persist yeast torulopsi glabrata describ month shorter candida parapsilosi dai virus respiratori tract corona coxsacki influenza sar rhino viru persist surfac dai virus gastrointestin tract astroviru hav polio rota viru persist month bloodborn virus hbv hiv persist week herp virus cmv hsv type persist hour dai conclus common nosocomi pathogen surviv persist surfac month continu sourc transmiss regular prevent surfac disinfect perform
PLoS Med	24941423	2017-01-18	PMC1564166	16968120	background sar outbreak present clinician lifethreaten diseas experi treat effect treatment option health organ expert panel sar treatment request systemat review comprehens summari treatment sarsinfect patient order guid futur treatment identifi prioriti method find respons request conduct systemat review publish literatur ribavirin corticosteroid lopinavir ritonavir lpvr type interferon ifn intraven immunoglobulin ivig sar convalesc plasma vitro studi sar patient search clinic trial evid treatment acut respiratori distress syndrom sourc data literatur databas medlin embas biosi cochran central regist control trial central februari data public extract evid studi classifi predefin criteria total sar treatment studi vitro studi three acut respiratori distress syndrom studi met inclus criteria vitro studi ribavirin lopinavir type ifn inhibit sarscov tissu cultur sarsinfect patient report ribavirin studi classifi inconclus harm studi convalesc plasma ivig three ifn type lpvr inconclus studi steroid inconclus classifi caus harm conclus despit extens literatur report sar treatment determin treatment benefit patient sar outbreak harm clinic trial design valid standard protocol dosag time accru data real time futur outbreak monitor specif advers effect help inform treatment
PLoS Med	28100617	2014-02-03	PMC1564167	16968121	background despit success biolog agent therapi autoimmun inflammatori diseas rheumatoid arthriti ra patient fail respond adequ treatment make continu search therapi extrem prevail hypothesi reactiv oxygen speci ro promot inflamm challeng polymorph ncf decreas oxid burst increas diseas sever mous rat arthriti model base find develop therapi arthriti oxid burstinduc substanc method find treatment rat phytol tetramethylhexadeceneol increas oxid burst vivo correct the genet polymorph arthritispron ncf rat importantli phytol treatment decreas autoimmun respons amelior acut chronic phase arthriti compar standard therapi ra antitumour necrosi factor methotrex phytol equal good better therapeut properti final phytol mediat hour administr involv modul cell activ inject prevent adopt transfer diseas arthritogen cell conclus treatment arthriti rospromot substanc phytol target newli discov pathwai lead autoimmun inflammatori diseas introduc novel class therapeut treatment ra chronic inflammatori diseas
PLoS Med	24491580	2004-12-20	PMC1564183	16968115	background influenc air travel influenza spread subject numer investig simul empir evid provid understand role airlin travel largescal influenza spread mount threat influenza pandem simul studi conclud air travel restrict impact cours pandem assess empir data role airlin volum yearli interregion spread influenza unit state method find measur rate interregion spread time influenza unit state season weekli influenza pneumonia mortal center diseas control prevent season character bandpass filter domest airlin travel volum novemb surround thanksgiv holidai predict rate influenza spread intern airlin travel influenc time influenza mortal flight ban terrorist attack septemb subsequ depress air travel market provid natur experi evalu flight restrict decreas air travel associ delai prolong influenza season conclus provid empir evid role airlin travel longrang dissemin influenza influenc intern air travel time influenza introduct influenc domest air travel rate interregion influenza spread pandem prepared strategi account benefit airlin travel restrict influenza spread
Virol J	15613297	2011-01-12	PMC1564392	16948846	background widespread interest innat immun modul defens strategi infecti pathogen rotaviru model system develop cellbas moderatethroughput screen mt assai identifi compound reduc rotaviru infect vitro longterm goal discov immunomodulatori agent enhanc innat respons viral infect natur product librari consist compound screen assai compound reduc infect cytotox identifi time cours analysi compound character effect inflammatori gene express inhibit replic pretreat time minim hour compound mangostin glycyrrhetin acid activ nfb induc il secret assai adapt viru system amen full autom adapt highthroughput format conclus identif compound effect inflammatori antivir gene express confer resist rotaviru infect vitro suggest assai appropri platform discoveri compound potenti amplifi innat antivir respons
Environ Health Perspect	21228237	2013-08-01	PMC1570072	16966082	the health sector compon nation assess publish synthes anticip health impact climat variabl chang categori health outcom impact attribut temperatur extrem weather event storm flood air pollut water foodborn diseas vector rodentborn diseas health sector assess hsa conclud climat variabl chang increas morbid mortal risk climatesensit health outcom net impact uncertain object studi updat hsa base public address potenti impact climat variabl chang unit state health outcom categori literatur publish hsa support initi conclus data refin quantit exposurerespons relationship health point extrem heat event air pollut unit state continu high capac plan respond climat chang progress literatur implement adapt strategi measur larg knowledg gap remain substanti addit improv understand weather climat directli indirectli influenc human health fill knowledg gap will help better defin potenti health impact climat chang identifi specif public health adapt increas resili
Virol J	28500595	2015-02-26	PMC1592083	16987422	background infecti bronchiti highli contagi constitut common difficult poultri diseas control ibv endem countri rais chicken exist dozen serotypesgenotyp amino acid differ protein vaccin challeng strain ibv result poor protect tropism ibv includ respiratori tract tissu proventriculu caecal tonsil alimentari tract oviduct kidnei infecti bronchiti viru ibv strain close massachusett mass serotyp isol broiler chicken suffer sever renal respiratori distress isol serolog identifi dotelisa character rtpcr genotyp gene sequenc analysi align sequenc isol ibv strain reveal high homolog isol mass serotyp inocul strain reproduc diseas experiment dayold chicken mortal sever renal moder respiratori distress mark histopatholog chang kidnei trachea observ experiment infect chicken protect studi live attenu vaccin low protect rate spite high sequenc homolog protect base criteria viru reisol attempt trachea tracheal renal histopatholog ibv antigen detect immunofluoresc antibodi techniqu kidnei section conclus period evalu crossprotect capabl ibv vaccin versu recov field isol perform ensur optimum control ibv
Emerg Themes Epidemiol	25714162	2004-05-12	PMC1594563	17014728	individu reason expect freedom decis health individu wish conflict individu best interest individu right restrict benefit limit individu behaviour person wish good popul gener discuss issu right individu conflict individu popul benefit relat infecti diseas
BMC Health Serv Res	15140961	2017-07-03	PMC1609112	17026763	background provinci transfer author centr ptac establish emerg respons ontario canada sever acut respiratori syndrom sar outbreak prior data relat interfacil patient transfer collect systemat manner emerg set comprehens databas complex data collect process establish time ontario populationbas data patient movement healthcar facil popul twelv ptac databas store patient transfer data larg databas populationbas patient transfer databas ptac databas believ largest exampl hous novel dataset patient transfer databas valid paper present valid ptac databas method random sampl patient interfacil transfer record compar correspond institut patient record send healthcar facil measur agreement includ sensit calcul common data variabl randomli select patient transfer record correspond institut patient record locat data variabl categori patient demograph facil identif time transfer reason urgenc transfer strong agreement level commonli data variabl accuraci rate rang error rate rang variabl sensit valu rang conclus high level agreement institut patient record ptac data field compar studi support valid ptac databas time populationbas patient transfer databas establish creat emerg situat data collect depend frontlin medic worker ptac data achiev high level valid higher purpos built databas creat nonemerg set
BMC Microbiol	28708965	2017-11-01	PMC1609170	17020602	background believ animaltohuman transmiss sever acut respiratori syndrom sar coronaviru cov the sar outbreak worldwid spike protein best character protein sarscov plai kei role sarscov overcom speci barrier accomplish interspeci transmiss anim human suggest major target select pressur process adapt evolut protein exact posit select site associ process remain unknown investig adapt evolut protein identifi twelv amino acid site protein posit select pressur base phylogenet tree epidemiolog investig sar outbreak divid three epidem group interspeci earlymid late epidem group studi posit select detect group repres cours sarscov interspeci transmiss viral adapt human host contrast purifi select detect late group indic protein experi variabl posit select pressur reach stabil total site interspeci epidem group site earlymid epidem group identifi posit select identifi site group site suggest posit select site changeabl group larger proport posit select site locat receptorbind domain rbd heptad repeat hrhr region interspeci epidem group greater percentag site occur hrhr region rbd earlymid epidem group function domain protein experi posit select epidem group addit three specif replac fs ls human sarscov strain interspeci epidem group reveal select sweep forc evolut gene jump sarscov human host residu posit select site associ receptor recognit andor membran fusion crucial residu animaltohuman transmiss sarscov subsequ adapt human host conclus variat posit select pressur posit select site contribut adapt evolut protein anim human
BMC Bioinformatics	28642032	2018-04-09	PMC1618411	17038191	background phage displai basic explor proteinprotein interact site network appli develop drug vaccin diagnost promis method epitop map algorithm assist autom phage displai base epitop map attract group exist tool implement onlin servic make conveni commun access util evalu mimox free web tool help map nativ epitop antibodi base user suppli mimotop antigen structur mimox code perl modul bioperl project section mimox simpl interfac clustalw align set mimotop simpl statist method deriv consensu sequenc emb jalview java applet view manag align second mimox map singl mimotop consensu sequenc set mimotop correspond antigen structur search cluster residu repres nativ epitop naccess evalu surfac access candid cluster jmol embed view interact context initi case studi mimox reproduc map exist tool findmap dex provid novel ration conclus webbas tool call mimox develop phage displai base epitop map publicli onlin servic area conveni commun access util evalu complement exist program mimox freeli 
Health Res Policy Syst	29632005	2019-01-22	PMC1618830	17038194	if sustain humantohuman transmiss hn realiti will longer deal sporad avian flu born migratori flight path bird aviat flu wing subson speed commerci air conduit corner planet earth air transport featur differenti dai transmiss scenario inabl prevent spread influenza intern air travel reckon health organ constitut major weak current global prepared plan pandem flu despit lesson sar surpris aviationrel health polici option rigor evalu scientif aim strengthen public health measur air transport front energet pursu
BMC Infect Dis	30667224	2012-08-31	PMC1618839	17026751	background soest counti health depart inform unusu larg number patient hospit atyp pneumonia method exploratori interview patient mention visit farmer market sheep lamb serolog test confirm diagnosi fever ask local health depart germani identii notifi fever patient visit farmer market investig risk factor infect conduct case control studi case fever patient control randomli select soest citizen cohort studi vendor market sheep exhibit market herd origin sheep herd held vicin soest test coxiella burnetii burnetii total report fever case link outbreak incub period dai interquartil rang dai case control studi identifi close proxim stop second sheep pen risk factor vendor meter sheep pen increas risk diseas compar locat farther wind plai role clinic attack rate adult children estim case hospit ew lamb herd test posit burnetii antibodi conclus size point sourc natur outbreak permit assess fundament seldom studi epidemiolog paramet consequ outbreak recommend pregnant sheep displai public trimest test anim pet zoo regularli burnetii
BMC Public Health	22941090	2017-10-25	PMC1618842	16984658	background system routin public health surveil reli central collect identifi individu identifi person health phi record individu identifi patient record essenti condit mandat report tuberculosi sexual transmit diseas routin requir effect syndrom surveil public concern routin collect larg quantiti phi support nontradit public health function altern surveil method reli central identifi phi databas increasingli desir method nation bioterror syndrom surveil demonstr program ndp exampl altern model phi system initi process secur infrastructur health care provid collect hold data uniform softwar distribut support ndp highli aggreg count data transfer datacent statist process displai detail patient level health care provid elucid signal observ aggreg data ad hoc queri describ benefit disadvantag associ distribut process model routin autom syndrom surveil conclus welldefin surveil requir model deploi low risk inadvert disclosur phi featur particip surveil system feasibl organ appeal individu phi hold design implement distribut system support nonroutin public health requir
BMC Infect Dis	29070690	2013-06-26	PMC1624840	17049088	background minor probabl sar case caus transmiss assess epidemiolog clinic factor sar patient associ increas probabl transmiss method epidemiolog clinic data probabl sar patient admit tan tock seng hospit casecontrol approach patient probabl sar subsequ transmit diseas patient analys case patient transmiss control multivari logist regress analysi patient analysi transmiss transmiss covari posit associ transmiss univari analysi includ delai isol dai ill admiss nonisol facil preexist chronic respiratori diseas immunosuppress diseas oxygen short breath vomit higher lactat dehydrogenas level higher neutrophil count multivari analysi three factor delai isol admiss nonisol facil higher lactat dehydrogenas level iul conclus clinic epidemiolog factor help explain transmiss observ instanc other
BMC Immunol	23804635	2014-05-21	PMC1636068	17076905	background major obstacl design effect vaccin hiv hypervari hiv envelop glycoprotein hiv vaccin candid util envelop glycoprotein singl viru isol elicit broadli reactiv humor immun hypothesis cocktail hiv gp protein multipl epitop increas breadth immun respons hiv compar evalu immunogen hiv vaccin gp protein combin fourteen gp primari hiv isol immun hamster amplifi character gp primari subtyp isol syncytium nonsyncytium induc properti express protein chines hamster ovari cho cell line purifi protein combin fourteen gp vaccin golden hamster polyval vaccin higher antibodi titer hiv subtyp isol mn sf compar group receiv gp protein polyval vaccin higher neutral antibodi respons hiv primari isol interestingli polyval vaccin group highest prolif immun respons substanti proport crosssubtyp cd reactiv hiv subtyp ae conclus polyval approach achiev modest increas breadth humor cellular immun qualit chang vaccin gp quantit improv vaccineinduc immun
BMC Microbiol	24850744	2016-10-01	PMC1660542	17094812	background coagulaseneg staphylococcu epidermidi major frequent infect relat implant medic devic pathogen epidermidi attribut capac form biofilm surfac medic devic greatli increas resist convent antibiot chronic infect urgent design novel antibiot staphylococci infect kill cell embed biofilm report seri novel inhibitor histidin kinas hk yycg protein epidermidi discov structurebas virtual screen sbv small molecular leadcompound librari experiment valid candid deriv sbv target homolog model yycg hatpasec domain epidermidi compound displai activ inhibit epidermidi growth displai bactericid effect plankton biofilm cell epidermidi compound bind yycg protein inhibit autophosphoryl vitro indic potenti inhibitor yycgyycf twocompon system tc essenti epidermidi importantli compound affect stabil mammalian cell hemolyt activ concentr studi conclus novel inhibitor yycg histidin kinas potenti lead develop antibiot infect staphylococci structurebas virtual screen sbv technolog screen potenti inhibitor bacteri tcss rapid efficaci tradit screen technolog
Virol J	27734858	2015-12-07	PMC1676004	17121680	background molecular level concern differ andor similar alcohol hepat viru induc liver diseas global transcript profil oligonucleotid microarrai perform liver biopsi patient cirrhosi caus chronic alcohol consumpt chronic hepat viru hcv global gene express pattern vari depend etiolog liver diseas greater number differenti regul gene hcvinfect patient gene express chang observ hcvinfect cirrhot liver expectedli associ activ innat antivir immun respons compar sever ctp class cirrhosi etiolog identifi gene express pattern differenti ethanolinduc cirrhosi class ctp class ethanolcirrhot liver uniqu express pattern gene implic inflammatori respons includ macrophag activ migrat lipid metabol oxid stress gene conclus stage liver cirrhosi differenti base gene express pattern ethanolinduc hcvinduc diseas addit gene regul innat antivir immun respons mechan respons differenti chronic liver damag hcv ethanol close regul lipid metabol effect macrophag activ deposit extracellular matrix compon
Health Res Policy Syst	26643325	2016-07-10	PMC1712227	17156457	background health organ organis recognis rigor process ensur health care recommend inform best evid thirteenth seri review prepar background advic advisori committe health achiev object review literatur applic transfer adapt guidelin method search databas exist systemat review relev primari methodolog review titl citat retriev abstract full text articl citat appear relev topic check refer list articl relev question snowbal techniqu addit definit come concern belong nation term intern conclus base evid consider organis logic argument kei question answer identifi systemat review address kei question individu studi project publish peer review literatur internet develop intern recommend resourc develop high qualiti recommend limit internation develop recommend facilit access pool resourc reduc unnecessari duplic involv intern scientist prioriti intern health problem problem low middleincom countri advantag greatest factor influenc transfer recommend set consid systemat flag includ modifi factor variat valu cost avail resourc central local prepar systemat review evid profil coordin central collabor organ produc systemat review central develop evid profil adapt specif local circumst consider model involv central coordin work undertaken centr locat avail resourc cost presenc modifi factor valu assess local support undertak assess need guidelin applic provid local support adapt implement recommend develop tool build capac learn intern experi intern network support evidenceinform health polici evidenceinform polici network evipnet recommend adapt provid detail guidanc adapt intern recommend local adapt process systemat transpar involv stakehold report kei factor influenc decis includ flag intern guidelin reason modif made
BMC Musculoskelet Disord	27395034	2007-10-24	PMC1712335	17156487	background earli recoveri arthroplasti need help benchmark progress appropri decis concern patient rehabilit purpos studi model earli recoveri physic function patient undergo total hip tha knee tka arthroplasti physic perform selfreport measur method sampl conveni subject complet test ag year underw tha ag year tka postop patient treat standard care pathwai rehabilit protocol repeat measur design patient assess multipl time point postop month outcom measur includ lower extrem function scale lef physic function subscal western ontario mcmaster univers osteoarthr womac pf minut walk test mwt time test tug time stair test st averag recoveri curv measur character hierarch linear model predictor recoveri sequenti model valid basic development model slope recoveri greater week seconddegre polynomi growth term week squar provid reason fit data studi interv pattern recoveri observ selfreport measur physic function perform measur contrast model womac pf lef site arthroplasti predictor physic perform measur model patient post tka initi demonstr higher function site arthroplasti predict rate chang patient post tha week surgeri tha group surpass function patient post tka conclus knowledg predict growth curv will assist clinician referenc patient progress determin critic time point measur chang studi contribut evid highlight benefit physic perform measur learn patient actual level disabl
PLoS Med	17957181	2012-02-23	PMC1716185	17194199	background sever acut respiratori syndrom coronaviru sarscov identifi etiolog agent sever acut respiratori syndrom diseas character sever pneumonia death sarscov zoonot viru cross speci barrier origin bat speci includ civet raccoon dog domest cat swine rodent sarscov vaccin confer longterm protect vulner senesc popul epidem strain zoonot strain emerg anim reservoir report comprehens investig sar vaccin efficaci young senesc mice homolog heterolog challeng method find venezuelan equin enceph viru replicon particl vrp express epidem urbani sarscov strain spike glycoprotein vrp nucleocapsid protein strain vrpn demonstr vrp vrpn vaccin provid complet short longterm protect homolog strain challeng young senesc mice test vrp vaccin efficaci heterolog sarscov phylogenet analys synthet biologi revers genet construct chimer viru icgdo encod synthet glycoprotein gene genet diverg human strain gdo cluster zoonot sarscov icgd replic effici human airwai epitheli cell lung young senesc mice highli resist neutral antisera direct urbani strain vrp vaccin provid complet shortterm protect heterolog icgd challeng young mice limit protect vaccin senesc anim vrpn vaccin fail protect homolog heterolog challeng enhanc immunopatholog eosinophil infiltr lung sarscovchalleng mice vrpninduc patholog present dai peak dai persist dai mediat cellular immun respons conclus studi identifi gap challeng vaccin design control futur sarscov zoonosi vulner elderli popul avail sarscov viru bear heterolog glycoprotein robust challeng inoculum evalu vaccin efficaci zoonot strain sourc futur outbreak
Crit Care	22295161	2010-06-29	PMC1751045	17022805	introduct respiratori virus major respiratori tract infect preval virusposit respiratori sampl signific patient requir mechan ventil remain unknown method conduct cohort studi consecut adult ventil hour admit bed medic intens care unit month period respiratori sampl time intub assess cultur indirect immunofluoresc assai molecular method systemat tracheobronchi aspir patient virusneg respiratori sampl time intub consid unexpos serv control group fortyf virus isol patient rhinoviru commonli isol viru byherp simplex viru type viru influenza multivari analysi control acut pathophysiolog chronic health evalu ii score patient respiratori disord admiss adjust odd ratio confid interv chronic obstruct pulmonari diseaseasthma patient adjust odd ratio confid interv admiss novemb march adjust odd ratio confid interv independ associ virusposit sampl patient admit respiratori disord tracheobronchi aspir posit respiratori virus time intub adjust hazard ratio confid interv independ associ better surviv control simplifi acut physiolog score ii admiss cardiogen shock cardiac arrest remain patient virusposit sampl intub predict surviv conclus confirm pathogen role respiratori virus intens care unit rhinoviru prognost virusassoci respiratori disord better respiratori disord
PLoS One	20616085	2011-12-28	PMC1762333	17183647	background rapid respons outbreak emerg infecti diseas imped uncertain diagnos delai commun understand ineffici respons contribut epidem theori develop understand studi societ learn emerg outbreak patient remov acceler gather dissemin method find develop extens standard outbreak model simpl stochast epidem account societ learn express expect outbreak size distribut epidem durat rapid learn notic final outbreak size learn exhibit diminish return relax exampl estim learn rate outbreak sever acut respiratori syndrom sar singapor evid relax week outbreak inconclus estim societ learn occur half actual rate expect final size outbreak reach case three time observ number infect contrast expect outbreak size societ learn effect case conclus rate societ learn greatli affect final size diseas outbreak justifi invest earli warn system attent diseas outbreak govern author public submit burden emerg infect includ risk global pandem effici reduc improv procedur rapid detect outbreak alert public health offici aggress educ public start outbreak
PLoS One	22205023	2008-11-01	PMC1762347	17183670	the distribut multihost pathogen host rang condit popul dynam structur host coinfect pathogen consequ evolut host pathogen hostpathogen coevolut interest distribut pathogen host rang random associ host pathogen pathogen share host analys issu propos indic observ pattern host infect pathogen observ pattern coinfect test analys pattern conform random reflect associ appli test preval plant virus wild plant speci evidenc hostviru associ host virus select virus host interestingli hostselect virus preval suggest host specialis success strategi multihost pathogen analys virus tend associ posit coinfect host develop indic test provid tool analys strong common associ group pathogen will help understand model popul biologi multihost pathogen
PLoS One	18692098	2005-12-01	PMC1762349	17183651	most individu infect sar coronaviru sarscov spontan recov clinic intervent immunolog correl associ patient recoveri current unknown report sequenti monitor recov patient twoyear period character tempor chang sarscovspecif antibodi respons cytotox cell ctl respons persist robust antibodi ctl respons studi subject studi period moder declin year onset symptom identifi potenti major ctl epitop protein base elispot analysi pool peptid despit potent immun respons clinic recoveri peripher lymphocyt count recov patient restor normal level summari studi time character tempor dynam chang humor ctl respons natur histori sarsrecov individu support notion high sustain level immun respons correl diseas outcom find direct implic futur design develop effect therapeut agent vaccin sarscov infect
PLoS One	16105977	2014-05-19	PMC1762437	17205139	previou studi hiv pgag immun mice demonstr target antigen cellular compart major histocompat complex type ii mhc ii complex molecul dna antigen formul encod gag chimera mous lysosomeassoci membran protein mlampgag studi analyz magnitud breadth gagspecif tlymphocyt antibodi respons elicit rhesu macaqu immun dna encod human lampgag hlampgag chimera elispot analys indic averag gagspecif ifn respons elicit hlampgag chimera detect three nake dna immun immun macaqu reach averag spotform cell sfc pbmc high ifn elispot respons detect cddeplet cell indic cd tcell plai major role respons tcell respons of macaqu test elispot overlap amino acid aa peptid pool ten peptid encompass complet gag protein sequenc mamu immun macaqu respond twelv pool mamu macaqu pool indic hlampgag dna antigen formul elicit broad tcell respons gag addition strong hivspecif igg respons igg antibodi titer increas dna inject indic strong amnest bcell respons highli elev macaqu three immun serum macaqu recogn peptid aa peptid librari cover complet gag amino acid sequenc addit hivspecif iga antibodi plasma extern secret includ nasal wash data support find increas immunogen genet vaccin encod lamp chimera includ respons dna vaccin nonhuman primat
BMC Med	24843159	2008-07-02	PMC1764026	17166291	background epidemiolog focus evalu convent method control strategi event epidem pandem travel restrict suggest effici reduc spread contagi diseas threaten public health paper studi depth effect travel restrict studi investig level travel restrict speed geograph spread outbreak diseas sever acut respiratori syndrom sar method stochast simul model incorpor survei data travel pattern municip sweden collect year test scenario travel restrict travel distanc km ban account level complianc ban journei drastic reduc speed geograph spread outbreak complianc result robust rate intermunicip transmiss intens conclus studi support travel restrict effect mitig futur diseas outbreak
BMC Bioinformatics	18596085	2013-04-07	PMC1764468	17254296	background genom sequenc data step gener part list life understand underli principl biocomplex genom sequenc initi human model organ target effort understand principl evolut applic envisag improv human health effort culmin develop dedic resourc larg number viral genom sequenc group individu interest studi antigen variat strain speci independ effort enabl virus attain statu bestrepres taxa highest number genom lack concert effort viral genom sequenc remain entri public repositori virgen curat resourc viral genom analys releas grown term coverag viral famili develop modul annot analysi current releas includ data twentyf famili broad host rang releas taxonom descript virus virgen ictv nomenclatur wellcharacteris strain identifi repres entri viral speci nonredund dataset subsequ annot analys sequencedbas bioinformat approach virgen archiv precomput data genom proteom comparison data modul structur viral protein pdb incorpor uniqu featur virgen predict conform sequenti epitop antigen protein inhous develop algorithm step revers vaccinolog conclus structur organ genom data facilit data mine tool opportun knowledg discoveri approach achiev goal carri function annot compar genom virgen comprehens viral genom resourc serv annot analysi pipelin develop curat public domain viral genom data step curat annot genom data applic valuead deriv data substanti case studi
BMC Public Health	23378666	2008-04-16	PMC1764890	17192198	background conflict profession duti fear influenza transmiss famili member health care profession hcp method survei employe univers hospit ethic issu aris manag influenza pandem respond agre profession accept hcp abandon workplac pandem order protect famili disagre statement opinion higher rate disagr physician nurs compar administr respond decis report work pandem left individu hcp disagre statement hcp perman dismiss report work pandem respond agre hcw children care influenza patient conclus modest major hcp minor hospit administr recognis oblig treat patient despit potenti risk profession ethic guidelin allow balanc societi person risk need help hcp fulfil duti case pandem influenza
Acta Vet Scand	18417574	2012-03-23	PMC1766361	17204146	mycoplasma alkalescen argininemetabol mycoplasma associ mastiti arthriti cattl routin bacteriolog examin bronchoalveolar lavag sampl calv pneumonia singl herd denmark identifi alkalescen sampl organ sole bacterilog find sampl combin mannheimia haemolytica haemophilu somni salmonella dublin report isol alkalescen denmark
PLoS Med	22447593	2007-05-01	PMC1769412	17227133	background proteom analysi amniot fluid presenc biomark characterist intrauterin inflamm sought valid prospect clinic util proteom profil mass restrict score method find enrol consecut women singleton pregnanc admit preterm labor preterm prematur ruptur membran women clinic indic amniocentesi rule intraamniot infect proteom fingerprint score gener fresh sampl amniot fluid surfaceenhanc laser desorpt ioniz seldi mass spectrometri presenc absenc biomark score interpret relationship amniocentesistodeliveri interv placent inflamm earlyonset neonat sepsi neonat admit newborn special care unit women sever amniot fluid inflamm score shorter amniocentesistodeliveri interv women score inflamm minim score inflamm median rang d versu d versu d minim degre inflamm associ preterm birth membran statu associ score sever histolog chorioamnion neonat hematolog indic earlyonset sepsi correl score adjust gestat ag birth ci compar laboratori test routin diagnos amniot fluid inflamm infect score highest accuraci detect inflamm white blood cell count cellsmm combin gram stain score best rapid predict intraamniot infect posit amniot fluid cultur conclus high score associ preterm deliveri histolog chorioamnion earlyonset neonat sepsi studi proteom analysi amniot fluid accur test diagnosi intraamniot inflamm addit score gram stain best combin test rapidli predict infect
Virol J	17353353	2009-03-01	PMC1774570	17194306	background genom coronavirus structur nonstructur gene includ socal accessori gene group coronavirus encod singl accessori protein spike envelop gene human coronaviru hcov prototyp viru split gene encod put orfa orfb protein determin primari hcove isol exhibit unusu genom organ analyz orfab region current clinic isol netherland three earli isol collect common cold unit ccu salisburi uk dutch isol ident orfab region amino acid level ccu isol ident dutch isol nucleotid level close prototyp hcove remark analys reveal laboratori adapt prototyp hcove nucleotid delet orfab region clinic isol carri singl orf nt size encod singl protein amino acid homologu orf protein encod hcovnl pedv conclus genom organ group coronavirus hcovnl pedv hcove ident extens cultur hcove laboratori strain truncat orf indic protein essenti cell cultur highli conserv amino acid sequenc orf protein clinic isol suggest protein plai role vivo
PLoS Pathog	19135223	2009-04-01	PMC1779296	17238286	prophylaxi high dose neutral antibodi typic offer protect challeng virus produc acut infect studi investig abil neutral human monoclon antibodi kz protect ebola viru rhesu macaqu antibodi fulli protect guinea pig infect rhesu macaqu mgkg neutral human monoclon antibodi kz intraven challeng plaqueform unit ebola viru second dose mgkg antibodi challeng control anim expos viru absenc antibodi treatment passiv transfer neutral human monoclon antibodi fail protect macaqu challeng ebola viru minim explos viral replic infect inabl antibodi impact infect neutral escap appear ebola viru mechan infect propag vivo macaqu uniqu insensit high concentr neutral antibodi
PLoS Med	19250860	2016-11-01	PMC1779818	17253901	singh colleagu discuss threat region global public health pose xdrtb kwazulunat propos measur control outbreak
BMC Bioinformatics	27872939	2008-02-13	PMC1783863	17244370	background condit strand bia number gs equal cs dna strand total number equal strand consider local deviat equal asymmetri nucleotid composit extens analyz prokaryot eukaryot genom chromosom organ transcript orient process organ carri analysi intrastrand nucleotid distribut graphic method develop graphdna java applic simpl userfriendli interfac visual dna nucleotid composit program accept genbank embl fasta file input displai multipl dna nucleotid composit graph skew walk singl window allow direct comparison sequenc illustr dna skew character poxviru coronaviru genom conclus graphdna platformindepend open sourc tool analysi nucleotid trend dna sequenc multipl sequenc format read multipl sequenc plot singl window
PLoS One	18272716	2014-01-01	PMC1791715	17299582	background neg binomi distribut commonli biologi model overdispers count data attent focus neg binomi dispers paramet substanti literatur exist estim attent focus dataset highli overdispers accuraci confid interv estim typic explor methodolog articl present simul studi explor bia precis confid interv coverag maximumlikelihood estim highli overdispers distribut addit explor smallsampl bia neg binomi estim studi address estim dataset influenc type event undercount diseas transmiss data subject select bia success outbreak conclus maximum likelihood estim bias upward small sampl size underreport zeroclass event bias downward factor consid confid interv estim asymptot sampl varianc tend exhibit coverag nomin level overestim compris great major coverag error estim outbreak dataset increas bia estim add upward bia estim vari invers degre overdispers find overestim degre overdispers rare dataset
Genome Biol	25030927	2003-07-01	PMC1794587	17109749	protein microarrai provid versatil method analysi protein biochem activ exist dna microarrai analyt method translat protein microarrai differ technolog report approach procat correct background bia spatial artifact identifi signal filter nonspecif spot normal signal protein abund procat power flexibl approach analyz type protein microarrai
Infect Agent Cancer	12805436	2012-03-01	PMC1796861	17266760	a quantit pcr method establish quantifi human bocaviru hbov genom copi clinic specimen children lower respiratori tract infect lrti china total respiratori tract specimen test sputum sampl posit genom copi rang sampl main clinic symptom patient posit hbov dna pneumonialik syndrom repres high fever cough hbov etiolog agent lrti children china
Microb Cell Fact	22085393	2019-07-29	PMC1796898	17254338	with advanc robot comput capabl fabric high qualiti glass slide coincid increas genom public databas microarrai technolog increasingli laboratori fact field vari toxicolog evolutionari biologi drug develop product diseas character diagnost develop cellular physiolog stress respons forens benefit research familiar microarrai current articl review address fundament principl technolog proper design experi microarrai technolog simpl conceptu practic requir care plan detail understand limit inher consider exceedingli difficult ascertain valuabl microarrai data text aim outlin kei featur microarrai technolog pai attent current applic outlin public experiment design statist method potenti review meant comprehens substant highlight concept detail step conduct interpret microarrai experi collect includ text will highlight versatil microarrai technolog provid glimps futur hold
PLoS Pathog	31355779	2017-11-15	PMC1797619	17305426	viral membran fusion proce sequenc step driven trigger conform chang viral envelop glycoprotein socal fusion protein highresolut structur snapshot viral fusion protein prefus postfus conform difficult defin intermedi structur fusion pathwai transient natur flavivirus possess class ii viral fusion protein mediat fusion acid ph convert dimer trimer hairpinlik structur fusion process tickborn enceph viru exposur virion alkalin acid ph trap particl intermedi conform dimer dissoci interact target membran fusion peptid proceed merger membran treatment low ph lead fusion suggest monom correspond asyetelus intermedi requir convert prefus dimer postfus trimer nonphysiolog condit allow dissect flaviviru fusion process identif separ step membran insert multipl copi monom preced format hairpinlik trimer sequenc event insight understand dynam process viral membran fusion
Virol J	30222502	2003-10-01	PMC1810241	17326843	background respiratori infect neurovirul vaccinia viru vv strain western reserv wr acut infect lung dissemin viru organ lethal mice mechan lethal wellunderstood studi analyz viru replic host immun respons intranas infect lethal nonleth dose vv wr strain virul wyeth strain wr strain replic vigor lung brain wyeth strain differ viru titer brain mice infect higher lethal dose lower nonleth dose wr strain suggest amount viru replic brain sole determin factor lethal wr strain grew better primari mous lung cell wyeth strain lethal infect wr strain associ reduc number lymphocyt alter phenotyp cell lung compar nonleth infect wr wyeth strain sever thymu atrophi reduct cd cd doubl posit cell observ lethal infect conclus lethal induc intranas infect high dose wr strain caus higher replic viru lung cell immun suppress earli phase infect uncontrol viru replic lung
Virol J	14573573	2011-10-12	PMC1810517	17324273	background coronavirus infecti diseas human includ sever acut respiratori syndrom sar continu potenti emerg anim speci major factor host rang coronaviru receptor util host cell case coronavirusreceptor interact understood notabl except receptor util group coronavirus includ avian infecti bronchiti viru ibv felin aminopeptidas fapn serv function receptor group coronavirus includ felin infecti periton viru fipv canin coronaviru transmiss gastroenter viru tgev human coronaviru hcove report suggest role fapn ibv entri miguel pharr gt wang role felin aminopeptidas receptor infecti bronchiti viru review arch virol transient transfect constitut express fapn bhk cell rescu fipv tgev infect nonpermiss bhk cell fapn express rescu infect prototyp ibv strain mass account previou suggest fapn serv ibv receptor felin cell infect prototyp strain ibv mass low suscept compar primari chick kidnei cell bhk cell suscept ibv strain includ ark arkdpi iowa effici level infect increas fapn express conclus conclud fapn function receptor ibv ident current investig
Virol J	21998418	2017-07-18	PMC1828050	17343744	background complet genom sequenc astrovirida includ human nonhuman mammalian avian speci consensu topolog astrovirus deriv nucleotid substitut fulllength genom nonsynonym nucleotid substitut three orf analys synonym substitut displai loss tree structur suggest satur substitut model deviant pattern synonym substitut viru speci analyz complet astrovirida famili infer adapt molecular evolut site branch high rate synonym mutat observ nonhuman viru speci deviant pattern synonym substitut capsid structur gene purifi select domin forc astroviru gene codon site valu dnd ratio indic sitespecif molecular adapt viru evolut site glycin residu rgd motif orf human astroviru serotyp rgd integrin recognit motif astroviru speci conclus phylogenet analysi direct maximum likelihood approxim allow inclus evolutionari histori improv estim dn ds site enhanc valu dnd promin domain charg environment commun fi vp domain orfa domain dedic intrins viru function fi vp orfb viru polymeras integrin recognit plai kei role astroviru target cell attach
J Ethnobiol Ethnomed	28422322	2007-06-01	PMC1831764	17324258	background medicin plant option livestock farmer allow allopath drug certifi organ program afford allopath drug minor health problem livestock method conduct semistructur interview particip purpos sampl medicin plant treat rang condit draft manual prepar data evalu particip participatori workshop plant rumin health diet repres plant famili plant abscess berberi aquifoliummahonia aquifolium echinacea purpurea symphytum officinal bovista pila bovista plumbea achillea millefolium usnea longissima curcuma longa salix scouleriana salix lucida caprin arthriti caprin arthriti encephalitiseuphrasia officinali matricaria chamomilla ey problem wound injuri treat bovista spp usnea longissima calendula officinali arnica sp malva sp prunella vulgari echinacea purpurea berberi aquifoliummahonia aquifolium achillea millefolium capsella bursapastori hypericum perforatum lavandula officinali symphytum officinal curcuma longa syzygium aromaticum pseudotsuga menziesii coccidiosi plant diarrhea scour plantago major calendula officinali urtica dioica symphytum officinal pinu ponderosa potentilla pacifica althaea officinali anethum graveolen salix alba ulmu fulva mastiti treat achillea millefolium arctium lappa salix alba teucrium scorodonia galium aparin anethum graveolen rubu sp increas milk productiontaraxacum officinal zea mai symphytum officinal udder edema ketosi treat gaultheria shallon vaccinium sp symphytum officinal hedera helix alchemilla vulgari fed retain placenta conclus plant show high level valid hedera helix retain placenta euphrasia officinali ey problem plant high valid wound injuri includ hypericum perforatum malva parviflora prunella vulgari treatment high valid endoparasit includ juniperu communi pinu ponderosa anxieti pain treat melissa officinali nepeta caesarea
BMC Infect Dis	17544561	2019-01-24	PMC1832202	17355639	background plan public health respons pandem influenza reli predict model impact intervent strategi evalu focus produc predict local specif condit design publicli plan tool appli public health administr provid tool reproduc explicitli formul structur design oper optim combin compet requir precis realism gener influsim determinist compart model base system differenti equat extend classic seir model clinic demograph paramet relev pandem prepared plan allow produc time cours cumul number influenza case outpati visit appli antivir treatment dose hospit death work dai lost sick associ econom aspect softwar program java oper platform independ execut regular desktop comput conclus influsim onlin softwar effici assist public health planner design optim intervent pandem influenza reproduc infect dynam pandem influenza complex comput simul offer time reproduc higher comput perform better oper
BMC Evol Biol	30674714	2016-05-18	PMC1839080	17359548	background mechan larg dna virus increas genom size addit modul acquir virus host genom gene duplic phylogenet analysi larg dna virus method base align difficult presenc horizont gene transfer event composit vector approach sensit event appli reconstruct phylogeni larg dna virus consist biologist systemat outlier provid unclassifi virus cladist relationship famili conclus composit vector approach phylogenet tree larg dna virus compar biologist systemat provid recov phylogeni virus
Virol J	27189860	2017-11-29	PMC1839082	17352827	nucleic acid polymeras structur motif function aspart acid conserv class nucleic acid polymeras motif remain understood rnadepend rna polymeras mutat residu alanin polioviru replicon mutant replic reduc level addit mutat ac motif yield high level replic polioviru polymeras conserv residu essenti polioviru replicon function
BMC Infect Dis	29048984	2016-10-01	PMC1845150	17359545	background preval selfreport prevent behavior respons anticip local humantohuman hn transmiss outbreak factor associ behavior examin method random anonym crosssect telephon survei hong kong chines adult public hong kong adopt selfprotect behavior wear face mask public venu increas frequenc handwash behavior protect wear face mask experienc influenzalik ill ili seek medic consult make declar cross border ili compli quarantin polici multivari analys indic factor ag fulltim employ perceiv suscept perceiv efficaci prevent measur perceiv higher fatal compar sar perceiv chanc major local outbreak worri selffamili member contract viru associ inclin adopt selfprotect measur analys educ level variabl perceiv efficaci perceiv major local outbreak associ behavior direct protect conclus event humantohuman hn outbreak public hong kong adopt prevent measur help spread viru commun
J Ethnobiol Ethnomed	27564783	2014-08-01	PMC1847427	17376227	given increas tradit medicin possibl ensur success integr public health framework explor paper discuss link biodivers tradit medicin address implic public health explor biodivers ecosystem servic global human health risk human impact ecosystem biodivers human health welfar
BMC Infect Dis	23337126	2009-07-29	PMC1847518	17371589	background host genet factor determin tuberculosi tb slca nramp gene studi extens genet associ tb inconsist find addit studi look sex ag relationship slca polymorph tb method casecontrol studi conduct total pulmonari tb patient sex agematch control tb recruit subject ethnic chines basi linkag disequilibrium pattern three genet marker slca nearbi ilrb locu select examin associ tb suscept marker genotyp singl strand conform polymorph analysi fragment analysi amplifi product statist differ allel genotyp frequenc link marker slcab classic call dn utr slca locu patient control stratif sex posit associ identifi femal group allel genotyp frequenc stratif ag posit associ demonstr young ag group ag year allel genotyp frequenc posit find remain correct multipl comparison differ male group older ag group differ marker slca marker ilrb marker conclus studi confirm associ slca tb suscept demonstr time associ restrict femal young ag group
PLoS One	19640987	2014-01-29	PMC1847702	17440617	background ubiquitin ubiquitinlik protein ubl design modifi polypeptid eukaryot coval bind ubiquitin ubl substrat protein revers specif hydrolas set cystein proteas ce clan target ubiquitin ubl homolog eukaryot prokaryot virus find clone analyz coli protein elad distantli eukaryot ce clan member ulpsenp proteas famili specif sumo nedd misannot put sulfatasephosphatas elad effici specif deubiquitin enzym vitro interestingli elad intestin pathogen coli strain conspicu absent extraintestin pathogen strain expec homolog proteas acanthamoeba polyphaga mimiviru alpha betaand gammaproteobacteria conclus express ulpsenprel hydrolas bacteria extend plant pathogen medic relev strain escherichia coli legionella pneumophila rickettsia chlamydia salmonella elad ortholog ssel identifi virul factor deubiquitin activ counterpoint phylogenet function examin reveal ancient eukaryot ulpsenp proteas potenti ubiquitinspecif hydrolysi suggest earli common origin peptidas clan
Virol J	24478444	2018-11-01	PMC1851004	17386116	background sever acut respiratori syndrom sar caus larg outbreak pneumonia beij china revers transcriptas polymeras chain reaction rtpcr detect quantifi sarscov sera selfcollect throat wash fecal sampl patient laboratoryconfirm sar manag singl institut sarscov detect rate sera highest dai ill detect highest throat wash dai onset symptom highest sarscov rtpcr rate viral load log fecal sampl collect week onset clinic ill fecal sampl frequent sarscov rtpcr posit dai occasion sera sarscov detect week ill conclus context extens outbreak major pressur hospit resourc patient selfcollect sampl altern nasopharyng aspir laboratori confirm sarscov infect
Virol J	30622783	2013-07-02	PMC1852297	17397531	backgroundaim role humor immun hepat viru hcv infect understood increas interest character neutral antibodi serum hcvinfect patient focu reduct assai evalu neutral antibodi respons rang noncytopath virus base develop hcv cell cultur system genotyp jfhstrain develop focu reduct assai hcvneutral antibodi method focu reduct assai base standard microneutr assai immunostain foci tissu cultur plate count neutral antihcv antibodi titer purifi serum immunoglobulin sampl seventyseven individu determin focu reduct neutral assai titer determin log reciproc antibodi dilut reduc number viral foci igg antibodi purifi serum order avoid facilit hdl hcv entri assai cutoff elisa rna hcvneg sampl log correspond dilut assai compar commerci hcv elisa exhibit specif sensit valu good reproduc intraassai interassai coeffici variat assai crossreact antihiv antihb heterophil antibodyposit sampl neutral antibodi titer log homolog sampl hcv genotyp infect patient harbor genotyp jfh log heterolog sampl patient infect genotyp type confirm presenc broadli crossneutr antibodi report hcv pseudoparticl system conclus studi present simpl specif reproduc cell culturebas assai determin hcvneutral antibodi human sera assai tool gaug relationship neutral antibodi respons viral load kinet acut chronic infect patient investig erad prevent hcv infect neutral antibodi
BMC Biotechnol	24319606	2003-10-01	PMC1852797	17411439	background embryon chicken egg midth centuri grow wide rang anim virus high titer egg limit product recombin protein describ system base sendai viru minigenom produc larg amount heterolog viral glycoprotein allanto caviti embryon egg solubl form human respiratori syncyti viru hrsv human metapneumoviru hmpv fusion protein devoid transmembran cytoplasm domain produc allanto fluid sendai minigenom system step rescu cell cultur sendai viru minigenom encod protein interest help wild type sendai viru second step propag recombin defect virus helper viru allanto caviti chicken embryon egg passag optim protein product compar product protein cultur supernat cell infect vaccinia recombin yield allanto fluid fold higher mutant form solubl protein easili construct sitedirect mutagenesi express egg approach conclus simplic economi sendai minigenom system high yield achiev allanto fluid egg attract method express solubl glycoprotein aim structur studi
BMC Evol Biol	14573572	2007-06-27	PMC1853084	17359539	background phylogeni rapidli evolv pathogen difficult resolv small number substitut accumul short time diverg improv resolut phylogeni propos insert delet indel addit substitut accomplish joint estim align phylogeni bayesian framework draw infer markov chain mont carlo joint estim align phylogeni sidestep bias stem condit singl align account ensembl nearoptim align introduc novel markov chain transit kernel improv comput effici propos nonloc topolog rearrang block sampl align topolog paramet addit extend previou indel model increas biolog realism place indel preferenti longer branch demonstr abil indel increas phylogenet resolut exampl drawn withinhost viral sequenc sampl demonstr align uncertainti account final codonbas substitut model affect align qualiti phylogenet infer unrealist forc indel codon conclus indic indel improv phylogenet resolut diverg pathogen align uncertainti consid analys
PLoS One	17596360	2010-08-30	PMC1855431	17502915	a broad spectrum detect platform sequenc level resolut target region impact public health case manag expand understand etiolog diseas develop respiratori pathogen microarrai rpm demonstr capabl platform purpos newli develop rpm analyz wellcharacter nasal wash specimen patient present febril respiratori ill washington metropolitan region specimen rpm compar composit refer assai viral bacteri cultur appropri rtpcrpcr panel rpm assai agreement organ detect compar refer method addition rpm provid sequenc allow phylogenet classif circul influenza virus clinic specimen allow monitor genet variat antigen variabl predict multipl pathogen detect specimen notabl increas abund respiratori colon esp pneumonia viral infect firstev comparison broadspectrum viral bacteri identif technolog type larg batteri convent gold standard assai confirm util approach medic surveil investig complex etiolog ill caus respiratori coinfect
PLoS One	21798778	2013-09-16	PMC1868897	17520018	the sever acut respiratori syndrom coronaviru sarscov genom predict encod function open read frame lead express structur nonstructur protein product function larg number viral orf understood unknown order gain insight function mode action interact protein clone viral orfeom perform genomewid analysi intravir protein interact intracellular local pairwis interact test yeasttwohybrid matrix analysi posit nonredund interact includ interact identifi interact subsequ confirm coip mammalian cell nsp nsp orfb wide rang interact viral protein nsp interact replicas protein nsp nsp nsp nsp nsp nsp nsp nsp nsp indic crucial role major player replic complex machineri nsp essenti viral replic vitro nsp accessori protein orfb plai pivot role viral replic delet viru displai normal plaqu size growth characterist vero cell expect virushost interplai pathogen larg number interact enhanc global stabil sar proteom network plai unreal role regul proteinprotein interact interact identifi provid valuabl materi futur studi
PLoS One	24043791	2005-09-01	PMC1876810	17551582	despit intens ongo kei aspect spatialtempor evolut foot mouth diseas fmd epidem great britain gb remain unexplain develop markov chain mont carlo mcmc method estim epidemiolog paramet outbreak rang simpl transmiss model simplifi assumpt infecti farm complet observ equival assum farm proactiv cull diagnos fmd infecti infect estim transmiss paramet vari time highlight impact control measur progress epidem demonstr statist evid assort contact pattern anim speci predict risk map transmiss potenti geograph area gb present fit model
Virol J	16145100	2010-06-03	PMC1878474	17477867	chloroquin aminoquinolin malaria therapi emerg investig antivir drug broad spectrum antivir activ explor low phdepend influenza virus affect antivir effect chloroquin clinic achiev concentr test antivir effect drug select human avian virus belong subtyp displai ph requir correl respons chloroquin nhcl lysosomotrop agent increas ph intracellular vesicl timeofaddit experi inhibitori chloroquin maxim drug time infect lost postinfect time correspond viruscel fusion clear correl ec chloroquin vitro electrostat potenti ha subunit ha mediat viruscel fusion process studi highlight critic host cell factor intravesicular ph determin antiinfluenza activ chloroquin lysosomotrop agent
BMC Infect Dis	20484391	2018-01-10	PMC1878480	17456233	background interferongamma kei cytokin protect respons intracellular pathogen singl nucleotid polymorph snp locat intron human ifn gene put influenc secret cytokin impact infect outcom demonstr tuberculosi complex diseas aim investig put associ ifngta snp american tegumentari leishmaniasi atl influenc snp secret ifn vitro method brazilian atl patient cutan cl mucos leishmaniasi healthi volunt evalu genotyp region ifn gene carri amplif refractori mutat system armspcr leishmaniainduc ifn product peripher blood mononuclear cell pbmc cultur supernat assess elisa differ ta snp frequenc case control versu cl patient cutan leishmaniasi case exhibit aa genotyp produc lower level ifn tatt genotyp mucos case high low ifn produc clearli demonstr differ cytokin product observ ifng carrier conclus ta polymorph associ suscept sever leishmaniasi despit ifng ta snp involv pathogenesi leishmaniasi influenc amount cytokin releas cl patient prevent diseas develop hand case potenti polymorph regulatori gene tnf il involv interf ifn secret
PLoS Med	29321332	2017-02-01	PMC1880850	17535101	background prophylact therapeut strategi combat human infect highli pathogen avian influenza hpai hn virus need gener neutral antihn human monoclon antibodi mab test efficaci prophylaxi therapi murin model infect method find epsteinbarr viru immort memori cell vietnames adult recov infect hpai hn virus supernat cell line screen viru neutral assai cell line secret neutral antibodi clone mab purifi crossreact antibodi strain hn test vitro neutral assai prophylact therapeut efficaci vivo test mice vitro mab fla fld neutral clade clade ii hn virus whilst fla fld neutral clade virus vivo fla fla confer protect lethal mice challeng avietnam hn dosedepend manner mab prophylaxi provid statist reduct pulmonari viru titer reduc associ inflamm lung restrict extrapulmonari dissemin viru therapeut dose fla fla fld fld provid robust protect lethal postinfect avietnam hn mab fla fld fld fla therapeut activ vivo clade ii viru aindonesia hn conclus studi provid proof concept fulli human mab neutral activ rapidli gener peripher blood convalesc patient mab effect prevent treatment hn infect mous model panel neutral crossreact mab prophylaxi adjunct treatment human case hn influenza
PLoS Med	27865780	2005-05-12	PMC1880862	17535110	the editor discuss initi prepar respond global public health threat rapid advic guidelin group revis intern health regul
BMC Biol	15890958	2013-09-23	PMC1884140	17490473	background polymorph activ compon nicotinamid adenin dinucleotid phosphat nadph oxidas complex neutrophil cytosol factor ncf identifi regul arthriti sever mice rat discoveri search nadph oxidaseactiv substanc potenti approach treat autoimmun disord rheumatoid arthriti ra compound induc ncfdepend oxid burst phytol strong amelior arthriti rat underli molecular mechan clearli understood aim studi geneexpress profil understand protect arthriti activ nadph oxidas immun system subcutan administr phytol lead accumul compound inguin lymph node peak level reach dai administr global geneexpress profil inguin lymph node perform dai induct pristaneinduc arthriti pia phytol administr differenti express gene divid pathwai consist gene regul interferon ifn regul pathwai associ arthriti develop ifn regul pathwai associ diseas protect phytol importantli molecular pathwai confirm differenti arthritissuscept dark agouti rat ncfda allel allow low oxid burst arthritisprotect dancf rat ncfe allel allow stronger oxid burst conclus natur occur genet polymorph ncf gene modul activ nadph oxidas complex regul sever arthriti ncf allel enhanc oxid burst protect arthriti oper ifnassoci pathwai arthritisdriv allel oper ifnassoci pathwai treatment arthritissuscept rat nadph oxidaseactiv substanc phytol protect arthriti interestingli treatment led restor oxidativeburst induct strikingli ifndepend pathwai diseaseprotect ncf polymorph
BMC Vet Res	24062443	2019-01-01	PMC1884148	17484782	background quantif gene express tissu sampl requir refer gene normalis transcript number sampl refer gene stabil vari tissu tissu diseas state evalu stabil refer gene commonli human gene express studi realtim revers transcript pcr mathemat algorithm establish refer gene stabli express normal diseas canin articular tissu canin cell line stimul lipolysaccarid lp optim refer gene compar gene express data normal diseas infrapatella fat pad rpla ywhaz ideal refer gene compar normal osteoarthrit oa cartilag rpla sdha best refer gene compar normal ruptur canin cranial cruciat ligament bm tbp best refer gene normalis gene express data normal lp stimul cell line sdha ywhaz sdha hmb dh express stabil valu dh number refer gene requir reduc pairwis variat cell line cartilag cranial cruciat ligament fat tissu refer gene stabil level gene express conclus refer gene demonstr stabl express canin articular tissu identifi singl refer gene identifi stabl express tissu type studi underlin necess select refer gene basi tissu diseas specif express profil evalu highlight requir identif refer gene greater express stabil canin articular tissu gene express studi
PLoS One	30844806	2019-07-03	PMC1888730	17565384	eudoc dock program predict smallmoleculebound protein complex identifi drug lead chemic databas expand applic eudoc program supramolecular chemistri test abil reproduc crystal structur smallmolecul complex select crystal structur smallmolecul guesthost complex eudoc reproduc crystal structur guest structur massweight root squar deviat mwrmsd rel correspond crystal structur addit averag interact energi guesthost complex kcalmol half test smallmoleculebound protein complex kcalmol interact energi calcul eudoc complex reproduc mwrmsd neighbor host crystal structur guesthost complex includ multimer host system complex reproduc mwrmsd water molecul exclud host system demonstr influenc crystal pack small molecul complex eudoc predict smallmolecul complex design materi molecular sensor multimer inhibitor proteinprotein interact
Theor Biol Med Model	31270229	2014-09-17	PMC1892008	17547753	background time variat transmiss potenti rare examin regard pandem influenza paper reanalyz tempor distribut pandem influenza prussia germani daili number death total septemb februari distribut time delai onset death order estim effect reproduct number defin actual averag number secondari case primari case time discretetim branch process appli backcalcul incid data assum three serial interv dai estim reproduct number exhibit clear associ estim choic serial interv longer assum serial interv higher reproduct number estim reproduct number declin monoton time indic pattern secondari transmiss vari time tendenc consist differ estim reproduct number pandem influenza studi high estim origin long serial interv model assumpt transmiss rate take account time variat appli entir epidem curv conclus find order offer robust assess critic clarifi detail natur histori diseas includ serial interv heterogen pattern transmiss addit human contact behavior influenc transmiss individu countermeasur household quarantin maskwear explor construct effect nonpharmaceut intervent
Virol J	25231316	2012-04-01	PMC1892777	17555580	cyclooxygenas cox plai role viral infect respect replic pathogenesi investig role cox mous hepat coronaviru mhv infect cycl block cox activ inhibitor rna interfer mhv infect cell cox inhibitor reduc mhv infect postbind step earli replic cycl viral rna viral protein synthesi subsequ loss progeni viru product cox activ appear requir effici mhv replic provid potenti target anticoronavir therapi
BMC Public Health	22474009	2011-08-01	PMC1894789	17535426	background state local health depart unit state acceler effort prepar highimpact public health emerg compon activ develop conduct exercis program assess capabl train staff build relationship paper summar lesson learn tabletop exercis public health emerg prepared process develop conduct evalu method develop conduct evalu tabletop exercis partnership state local health depart particip evalu action report tabletop exercis evalu form identifi aspect exercis public health emerg respons particip challeng highlight lesson learn tabletop exercis design design exercis involv substanti collabor repres particip health depart assur scenario credibl focus attent local prepared prioriti logist feasibl implement execut exercis health depart struggl common set challeng relat diseas surveil epidemiolog investig commun command control health care surg capac contrast perform strength vari particip site reflect specif attribut individu health depart commun experi actual public health emerg emphasi prior prepared effort conclus design conduct evalu tabletop exercis describ report benefit collabor plan involv stakehold particip health depart exercis develop facilit particip agenc exercis identifi strength vulner emerg prepared addit work need develop reliabl metric gaug exercis perform inform followup action step develop reevalu exercis design assess impact postexercis intervent
BMC Public Health	21727183	2012-12-26	PMC1894965	17535440	background extraordinari infect control measur limit access medic care greater toronto area sever acut respiratori syndrom sar outbreak object studi determin period infect control measur associ chang popul mortal sar method observ studi death registri data poisson regress interrupt timeseri analysi examin allcaus mortal rate exclud death sar sar outbreak popul ontario group greater toronto area rest ontario base level restrict deliveri clinic servic sar outbreak chang mortal greater toronto area period sar outbreak compar correspond time period rate ratio allcaus mortal sar outbreak confid interv ci compar ci compar interrupt time seri analysi chang mortal rate greater toronto area associ period sar outbreak conclus limit access medic servic sar outbreak toronto observ impact shortterm popul mortal effect morbid longterm mortal assess effort futur infecti diseas outbreak influenza agent consid effect access essenti health care servic
PLoS Med	23269787	2010-08-25	PMC1896205	17593895	background advanc diseasesurveil system deploi worldwid provid earli detect infecti diseas outbreak bioterrorist attack method improv detect capabl system broad practic impact current gener surveil system vulner dramat unpredict shift healthcar data monitor shift occur major public event olymp result popul surg public closur shift occur epidem pandem result quarantin worriedwel flood emerg depart convers public stai hospit fear nosocomi infect surveil system robust shift healthcar util adjust baselin alertthreshold util level util shift trigger alarm result publichealth crise major public event threaten undermin healthsurveil system time need method find address challeng introduc class epidemiolog network model monitor relationship healthcar data stream monitor data stream extract extra relationship data stream model potenti improv detect capabl system model relat natur potenti increas system robust unpredict baselin shift implement model evalu effect histor emerg depart data hospit singl metropolitan area record period autom epidemiolog geotempor integr surveil realtim public healthsurveil system develop children hospit informat program harvardmit divis health scienc technolog behalf massachusett depart public health perform experi semisynthet outbreak magnitud simul baselin shift type magnitud the network model provid better detect local outbreak greater robust unpredict shift refer timeseri model approach conclus integr network model epidemiolog data stream interrelationship potenti improv current surveil effort provid better local outbreak detect normal circumst robust perform face shift healthcar util epidem major public event
BMC Infect Dis	20739537	2015-04-01	PMC1899505	17540042	background chemokin plai role inflamm antivir action examin polymorph rant ip mig affect suscept outcom sever acut respiratori syndrom sar method test polymorph rant ip mig associ sar hong kong chines sar patient control confirm beij chines sar patient control rant allel associ sar suscept hong kong chines ci individu rant cg gg genotyp fold ci fold ci increas risk develop sar allel confer risk death genedosag depend manner cg gg individu fold ci fold ci increas risk replic rant data beij chines allel associ suscept sar cg ci gg ci associ admiss intens care unit death sar conclus rant allel plai role pathogenesi sar
J Transl Med	25664975	2006-08-01	PMC1904179	17553144	although risk transfusiontransmit infect todai lower suppli safe blood product remain subject contamin identifi human pathogen continu improv implement donor select sensit screen test effect inactiv procedur ensur elimin reduct risk acquir transfus transmit infect addit ongo educ uptod infecti agent transmit blood compon promot report advers event compon transfus transmit diseas surveil collabor parti involv transfus medicin includ nation haemovigil system crucial protect secur blood product suppli emerg bloodborn pathogen
BMC Bioinformatics	16882658	2013-03-06	PMC1913542	17559689	background wide affymetrix microarrai broaden field biolog probeset annot issu standard affymetrix probeset annot gene level probeset precis link gene probeset intens interpret gene express increas knowledg gene multipl transcript variant clearli bring necess updat genelevel annot refin transcriptlevel perform rigor align affymetrix probe sequenc comprehens pool current transcript sequenc link probeset intern protein gener transcriptlevel proteinlevel annot tabl popular affymetrix express arrai mous genom arrai human genom ua arrai applic annot reexamin exist express data set increas express consist synonym probeset strengthen express correl interact protein conclus refin standard affymetrix annot microarrai probeset gene level transcript level protein level achiev reliabl interpret experiment data lead discoveri profound regulatori mechan
BMC Med Inform Decis Mak	23303217	2011-09-28	PMC1919360	17567912	background real time surveil detect abnorm diseas pattern base differ pattern observ predict model histor data outbreak detect strategi depend specif fals alarm rate interpret alarm evalu specif tradit model autoregress serfl trim season waveletbas gener linear appli year emerg depart visit respiratori infect syndrom pediatr hospit find specif model nonconst function dai week month year studi develop outbreak detect method call expectationvari model base gener addit model achiev constant specif account expect number visit varianc number visit expectationvari model achiev constant specif three time scale earlier detect improv sensit compar tradit method circumst conclus model varianc visit pattern enabl realtim detect constant specif time constant specif public health practition better interpret alarm better evalu costeffect surveil system
PLoS One	21957308	2013-05-22	PMC1919423	17653289	background famili ubiquitinlik molecul ubl compris member sequenc structur function similar ubiquitin isg homolog ubiquitin vertebr upregul induct type interferon isg coval attach protein analog ubiquitin actual support ubiquitin conjug factor specif proteas revers modif ubiquitin ubl hydrolyz coval bond ctermini substrat protein tail region ubiquitin isg ident hypothes promiscu deubiquitin proteas dub exist capabl recogn ubiquitin isg clone express human dub repres major clade usp proteas famili util suicid inhibitor base ubiquitin isg identifi usp usp isot usp isot usp isgreact proteas addit bona fide isgspecif proteas usp ubp usp proteasomeassoci dub isg isopeptidas activ increas complex proteasom conclus evolutionari standard isg newcom ubl util conjug deconjug machineri establish rel ubiquitin function overlap posttransl modifi extens appreci explain innocu phenotyp isg null mice
PLoS One	23698304	2015-09-21	PMC1920550	17653272	to identifi malaria antigen vaccin develop select helic coil coil domain protein predict parasit erythrocyt stage correspond synthet peptid expect mimic structur nativ epitop chemic synthes peptid recogn human immun sera preval peptid specif antibodi affinitypurif malaria immun sera immun mice antibodi cross reaction specif origin peptid react nativ parasit protein infect erythrocyt activ inhibit vitro parasit growth circular dichroism studi indic select peptid assum partial high helic content demonstr bioinformaticschem synthesi approach describ lead rapid identif molecul target biolog activ antibodi identifi suitabl vaccin candid strategi principl extend vaccin discoveri wide rang pathogen
BMC Genomics	26401072	2015-03-06	PMC1925091	17597519	background mammalian angiotensin convert enzym ac plai kei role blood pressur regul multipl acelik protein exist nonmammalian organ ac homologu ac identifi mammal report identif characteris gene encod third homologu ac term ac mammalian genom ac gene locat chromosom downstream ac gene multipl sequenc align molecular model emploi characteris predict ac protein mous rat cow dog predict protein mutat critic residu involv catalysi includ catalyt glu hexxh zinc bind motif gln est reversetranscript pcr indic gene express human predict ac protein intact hexxh motif delet insert gene est identifi conclus genom mammalian speci gene encod novel singl domain acelik protein ac mous rat cow dog ac catalyt glu replac gln put zinc bind motif indic speci ac lack catalyt activ zinc metalloproteas human evid ac gene express presenc delet insert sequenc indic ac pseudogen
Genome Biol	25673302	2016-09-07	PMC1929155	17531104	dna microarrai genom sensor great potenti clinic diagnost bias inher random pcramplif crosshybrid effect inadequ microarrai analysi limit detect sensit specif studi relationship viral amplif effici hybrid signal targetprob anneal specif custom microarrai platform novel featur platform includ develop robust algorithm accur predict pcr bia dna amplif improv pcr primer design power statist concept infer pathogen ident probe recognit signatur compar realtim pcr microarrai platform identifi pathogen accuraci sensit specif panel patient specimen find microarrai robust accur diagnosi pathogen substanti microarrai technolog clinic diagnost
BMC Public Health	27605677	2009-10-27	PMC1934907	17634112	background communitywid prepared pandem influenza issu featur promin new media current prioriti health author countri small medium busi sector major provid privat sector employ australia prepared sector pandem influenza studi aim investig associ individu percept prepared pandem influenza small medium busi owner manag method semistructur facetofac interview conduct small medium busi owner manag south wale western australia elig small medium busi defin employe binomi logist regress analysi identifi predictor consid impact plan need help prepar pandem influenza cent particip report busi plan pandem influenza cent report thought impact pandem influenza busi cent state requir help prepar pandem belief sever pandem influenza abil respond independ predictor plan pandem influenza percept risk pandem influenza predictor consid impact need help prepar pandem conclus find small medium busi australia current prepar pandem influenza belief risk sever abil respond effect threat pandem influenza predictor prepared campaign target small medium busi emphasis sever consequ busi pandem occur time reassur effect strategi capabl implement small medium busi deal pandem
BMC Infect Dis	19770157	2018-05-02	PMC1939851	17629919	background influenza pandem prepared plan current develop refin nation intern level attent administr antivir drug contact reduct effect mitig strategi advantag limit se effect intervent depend factor explor sensit analys base mathemat model method freeli plan tool influsim investig pharmaceut nonpharmaceut intervent mitig influenza pandem examin intervent schedul restrict stockpil contact reduct social distanc measur isol case determin cours pandem wave success intervent time applic antivir drug combin quick implement contact reduct measur requir protract peak epidem reduc height delai initi antivir treatment parsimoni limit stockpil result pessimist outcom lead paradox stockpil deplet earlier compar earli distribut antivir drug conclus pharmaceut nonpharmaceut measur exclus protract pandem wave essenti win time wait vaccin develop product height peak epidem easili overtax gener practition hospit public health system caus bottleneck basic emerg medic care
BMC Public Health	29717637	2005-12-12	PMC1939990	17650342	background factor structur item gener health questionnair ghq studi survei subject experienc niigatachuetsu earthquak richter scale japan method psycholog distress measur year earthquak ghq subject respons rate suffer earthquak ghq score binari chronic likert score method confirmatori factor analysi reveal factor structur ghq categor regress analysi perform evalu relationship background factor ghq score confirmatori factor analysi reveal model consist factor chronic method best goodnessoffit model factor structur recoveri scale factor social dysfunct remark impair compar factor dysphoria categor regress analysi reveal factor includ advanc ag associ psycholog distress advanc ag impair recoveri factor social dysfunct score total ghq score conclus twofactor structur ghq conserv survei month year earthquak impair recoveri abil cope daili problem subject experienc earthquak remark year earthquak
PLoS Pathog	16352560	2007-01-17	PMC1941747	17696607	attenu viral vaccin gener target essenti pathogen factor report ration design attenu recombin coronaviru vaccin base delet code sequenc nonstructur protein nsp cell cultur nsp mous hepat viru mhv sarscoronaviru homolog reduc cellular gene express nsp mhv replic vitro vivo analyz recombin mhv encod delet nspcode sequenc recombin mhv nsp mutant grew tissu cultur sever attenu vivo replic spread nsp mutant viru restor wildtyp level type interferon ifn receptordefici mice indic nsp interfer effici type ifn system importantli replic nsp mutant viru profession antigenpres cell convent dendrit cell macrophag induct type ifn plasmacytoid dendrit cell impair low dose nsp mutant mhv elicit potent cytotox cell respons protect mice homolog heterolog viru challeng present attenu strategi paradigm develop highli effici coronaviru vaccin
PLoS Pathog	17229691	2005-03-01	PMC1941749	17696609	the pathogenesi sever acut respiratori syndrom coronaviru sarscov mediat disproport immun respons abil viru circumv innat immun function genom analyz earli host respons sarscov infect lung adolesc cynomolgu macaqu macaca fasciculari lung patholog observ human adult sar analysi gene signatur reveal induct strong innat immun respons character stimul cytokin chemokin gene includ interleukin il il ip correspond host respons acut respiratori distress syndrom oppos vitro experi sarscov induc wide rang type interferon ifn nuclear transloc phosphoryl signal transduc activ transcript lung macaqu immunohistochemistri reveal antivir signal pathwai differenti regul distinct subset cell studi emphas induct earli ifn signal critic confer protect sarscov infect highlight strength combin function genom immunohistochemistri unravel pathogenesi sar
PLoS Biol	15709076	2006-07-26	PMC1945040	17696647	positivestrand rna virus largest genet class virus includ seriou human pathogen positivestrand rna virus replic genom associ intracellular membran rearrang singl doublemembran vesicl exact site rna synthesi crucial topolog relationship relev membran vesicl interior surround lumen cytoplasm gener defin appli electron microscop tomographi complementari approach flock hous viru fhvinfect drosophila cell provid analysi replic complex sole fhv rna replic factor protein fhvspecif bromouridin triphosph incorpor local inner outer mitochondri membran insid nm vesicl spherul fhvinduc compart viral rna synthesi fhv spherul outer mitochondri membran invagin interior connect cytoplasm neck channel nm diamet suffici ribonucleotid import product rna export tomograph biochem impli fhv spherul averag three rna replic intermedi interior membranespan selfinteract protein identifi spherul site protein nascent rna accumul defin spherul topolog dimens stoichiometri reveal natur detail organ function fhv rna replic complex insight appear relev positivestrand rna virus support propos structur evolutionari parallel retroviru doublestrand rna viru virion
Virol J	16873249	2014-11-01	PMC1950496	17598900	background pcrbase detect identif virus assum stabl genom high mutat rate lead extens chang viral nucleic acid sequenc make dedic pcr primer problemat bioterror viral consensu sequenc genet modifi countermeasur rtpcr dna chip detect great develop rapid univers viru detect identif technolog report viral genom dna rna separ host nucleic acid plasma filtrat nucleas digest randomli amplifi singl pcr mixtur primer design resist primerdim amplif vvvvvvvvaa or primer term novel pcr method random multiplex rtpcr hundr overlap pcr amplif occur simultan method successfullydetect partial sequenc separ virus human plasma virusspecif reagent adenoviru type coxsackieviru respiratori syncyti viru method sensit genom equivalentsml repres fastest detect unknown virus conclus studi develop random multiplex rtpcr lead diagnost assai univers detect virus donat blood product patient suffer idiopath diseas state viral etiolog
PLoS Pathog	25483547	2012-10-18	PMC1950948	17722980	understand mechan help promot protect immun respons pathogen major challeng biomed goal design innov therapeut vaccin strategi natur killer nk cell directli contribut control viral replic help orchestr global antivir defens unknown address question advantag welldefin molecular interact involv recognit mous cytomegaloviru mcmv nk cell congen mutant mice wildtyp versu genet engin virus examin consequ antivir cd cell respons specif defect abil nk cell control mcmv system allow demonstr knowledg time nk cell acceler cd cell respons viral infect vivo identifi underli mechan abil nk cell limit ifn product level immunosuppress host achiev earli control cytomegaloviru dramat reduc activ plasmacytoid dendrit cell pdc cytokin product preserv convent dendrit cell cdc compart acceler antivir cd cell respons convers exogen ifn administr resist anim ablat cdc delai cd cell activ face nk cell control viral replic collect data demonstr abil nk cell respond earli cytomegaloviru infect critic contribut balanc intens innat immun respons dampen earli immunopatholog promot optim initi antivir cd cell respons extent nk cell respons benefit host direct antivir effect extend prevent innat cytokin shock promot adapt immun
BMC Mol Biol	23087112	2008-04-02	PMC1976117	17651481	background realtim revers transcriptas quantit polymeras chain reaction realtim rtqpcr accur measur gene express biolog system comparison sampl requir transform data process call normalis refer housekeep gene candid gene select basi constitut express sampl allow quantif chang gene express refer gene identifi organ univers optim tissu type diseas situat microarrai data identifi refer gene gener total rna isol normal osteoarthrit canin articular tissu bone ligament cartilag synovium fat rtqpcr assai design appli articular tissu refer gene express stabil rank compar three mathemat algorithm twelv potenti refer gene identifi microarrai data gene mitochondri ribosom protein mrp stabli express articular tissu evalu gene hira interact protein isoform hirp stabli express tissu evalu commonli refer gene glyceraldehydephosph dehydrogenas gapdh stabli express tissu evalu consist agreement rank order refer gene observ bestkeep genorm method tend agre ident stabli express gene stabli express gene tissu refer gene identifi microarrai data normalis convent manner stabl identifi microarrai data normalis realtim rtqpcr methodolog conclus microarrai data normalis convent manner filter simpl stepwis procedur identifi refer gene will demonstr good measur stabil mitochondri ribosom protein refer gene worthi investig canin tissu diseas method refer gene stabil assess will gener agre stabli express gene coregul present
PLoS One	18385249	2011-10-12	PMC1976596	17895966	bacteri viral upper respiratori infect uri produc highli variabl clinic symptom identifi etiolog agent proper treatment depend correct identif pathogen involv antibiot provid benefit viral infect describ rapid sensit genotyp assai microarrai uri identif standard amplif hybrid techniqu electrochem detect ecd semiconductorbas oligonucleotid microarrai assai develop detect bacteri pathogen bordetella pertussi streptococcu pyogen chlamydia pneumonia mycoplasma pneumonia viral pathogen adenoviru coronaviru oc hk influenza parainfluinza type and respiratori syncyti viru platform form basi fulli autom diagnost system flexibl custom suit addit pathogen multipl probe flexibl platform allow test probe empir select highli reactiv probe iter evalu ecd enzymat reaction creat electr signal read directli arrai imag analysi expens delic optic scan equip assai sensit specif excel multiplex format
PLoS One	21994442	2007-01-01	PMC1989136	17912345	background human rhinovirus hrv preval human pathogen consist serotyp classifi group sequenc variat hrv infect wide spectrum clinic outcom rang asymptomat infect sever lower respiratori symptom defin role specif strain hrv ill difficult tradit serolog requir viral cultur neutral test serotypespecif antisera insensit labori method find directli type hrv nasal secret infant frequent respiratori ill develop sensit molecular type assai base phylogenet comparison bp variabl sequenc noncod region homolog sequenc serotyp nasal sampl infant test multiplex pcr assai respiratori virus hrv common viru sampl type complet sampl hrv identifi surprisingli hrv match serotyp nucleotid diverg nearest refer hrv novel virus strain hrv segreg hrva hrvb human enteroviru distinct genet group strain cultur tradit cell line conclus molecular analysi hrv detect sick infant unrecogn strain includ strain repres hrv group find indic number hrv strain consider larger serotyp identifi tradit diagnost techniqu provid evid hrv group
PLoS One	17200195	2015-02-01	PMC2034598	17957264	the sar coronaviru sarscov spike largest viral spike molecul share function class viral fusion protein previou structur studi membran fusion protein crystallographi static molecular fragment isol transmembran domain studi produc purifi irradi sarscov virion retain morpholog fusogen cell cultur cryoelectron microscopi imag process investig conform chang occur entir spike intact virion bind viral receptor angiotensinconvert enzym ac ac bind structur chang appear initi step viral membran fusion precis local receptorbind fusion core domain entir spike receptor bind subsequ membran fusion distinct step spike bind three ac molecul sarscov spike ideal model system studi receptor bind membran fusion nativ state emploi cryoelectron microscopi singleparticl imag analysi
BMC Genomics	25680079	2007-01-31	PMC2072959	17697331	background develop technolog practic resequ genom bacterium experiment manipul critic accuraci techniqu establish confid mutat detect order evalu accuraci genom resequenc microarraybas compar genom sequenc servic provid nimblegen system resequenc coli strain kohara refer complet sequenc tradit sequenc method cg detect small sequenc differ larg delet element insert detect larg chromosom invers addit confirm cg detect snp delet element insert genom sequenc attribut chang occur creation lambda clone librari fals posit rate snp kb genom sequenc conclus cg effect detect multipl mutat bacterium rel highli costeffect prone error mutat occur repeat sequenc sequenc high degre secondari structur undetect critic follow region interest snp call indic delet element insert
PLoS Med	17267508	2004-10-26	PMC2080649	18031197	indonesia refus share sampl hn viru health organ distress danger global public health argu author
PLoS Med	15507655	2015-12-09	PMC2100141	18052607	the author discuss humor immun respons hiv approach design vaccin induc viral neutral protect antibodi
PLoS Negl Trop Dis	26656704	2017-04-28	PMC2100376	18060089	background despit serious denguerel diseas estim case dengu fever case dengu hemorrhag feverdengu shock syndrom year clear understand dengu pathogenesi remain elus lack diseas model anim complex immun interact dengu infect studi host respons immunopathogenesi difficult develop genom technolog microarrai high throughput quantit pcr allow research studi gene express chang broader scale approach investig host respons dengu virusinfect cell line patient develop dengu fever methodologyprincip find microarrai high throughput quantit pcr method monitor host respons dengu viral replic cell infect model dengu patient blood sampl identifi differenti express gene three major pathwai nfb initi immun respons type interferon ifn ubiquitin proteasom pathwai highli upregul gene chemokin ip itac ligand cxcr receptor increas express ip itac peripher blood ten patient earli onset fever confirm elisa highli upregul gene ifn pathwai viperin overexpress cell reduct viral replic upregul gene ubiquitinproteasom pathwai prompt test proteasom inhibitor alln reduc viral replic conclusionsignific unbias gene express analysi identifi host gene associ dengu infect valid function studi part host respons potenti biomark diseas control dengu viral replic repres viabl target drug therapi
J Immune Based Ther Vaccines	28455446	2012-01-18	PMC2104530	17953756	background clear vaccin therapeut potenti biolog weapon mass destruct emerg diseas anthrax caus bacterium bacillu anthraci biolog warfar agent bioterrorist weapon antibiot therapi effect earli stage anthrax infect expos individu symptomat anthraci exotoxin accumul bipartit exotoxin major contribut factor morbid mortal observ acut anthrax infect method recombin anthraci protect antigen pa coval coupl novel nontox muramyl dipeptid ntmdp deriv hyperimmun goat three time cours week goat plasmapheres igg fraction affin purifi fab deriv character vitro vivo protect lethal toxin mediat intox antipa igg confer protect cell toxin neutral assai mice expos ld bacillu anthraci am spore intranar inocul demonstr surviv postinfect administ singl bolu dose mgkg bodi weight antipa igg post spore challeng antipa fab fragment retain neutral protect level vitro vivo conclus protect afford gmpgrade caprin immunotherapeut postexposur pilot murin model suggest effect treat postexposur symptomat human anthrax patient bioterror event indic recombin pa coupl ntmdp potent induc neutral antibodi promis vaccin candid anthrax eas product eas coval attach immunostimulatori activ ntmdp indic superior adjuv alum tradit adjuv vaccin formul
BMC Evol Biol	22258263	2012-09-26	PMC2110893	17945019	background impact pathogen evolut mammalian immun system debat protein regul immun respons serv cellular receptor pathogen forefront pathogendriven host evolut cea carcinoembryon antigen gene famili code protein tremend speciesspecif variat human rodent cea gene famili lineag placent mammal expect gain insight evolut rapidli diverg cea famili analyz cea famili dog describ complet cea gene famili dog gene code itimbear immunoregulatori molecul ceacam rise expans canin cea gene famili gene duplic human mice murin human ceacam carcinoembryon antigenrel cell adhes molecul secret gpianchor dog ceacam repres itambear transmembran protein protein ceacam exhibit complet sequenc ident ligandbind domain ceacam antagon signal motif cytoplasm tail comparison nonsynonym synonym substitut indic ceacam domain strongest purifi select canin ceacamrel ceacam addit ceacam express pattern rest immun cell tissu ceacam activ ceacam mrna ceacam mrna differenti regul conclus ceacam ceacam pair immun receptor identifi cea gene famili express cell involv finetun cell respons direct gene convers accompani purifi select express immun cell suggest possibl ceacam evolv respons select pressur impos speciesspecif pathogen
J Orthop Surg	23015702	2015-04-29	PMC2146995	17937789	background increas bone marrow lipid deposit steroidassoci osteonecrosi impli abnorm fat metabol plai role develop increas lipid deposit explain elev adipogenesi marrow mesenchym stem cell msc remain unclear close associ elev adipogenesi steroidassoci develop object studi design test hypothesi close associ elev adipogenesi steroidassoci develop method rabbit model induc base establish protocol dynamicmri emploi local intraoss perfus evalu bilater femora week induct bone marrow harvest evalu abil adipogen differenti marrow msc cellular mrna level involv adipogenesisrel gene peroxisom proliferatoractiv receptor gamma ppar bilater femora dissect examin marrow lipid deposit quantifi fat cell number fat cell size lipid deposit area lesion investig associ adipogenesi lipid deposit perfus function regard occurr rabbit divid lesion group lesion group investig associ adipogenesi lipid deposit perfus function regard extens rabbit divid subsingleles group son group lesion submultipleles group mon group lesion local intraoss perfus lower mon group compar son group marrow fat cell number area larger mon group compar son group adipogen differenti abil msc ppar express mon group elev compar son group conclus find support hypothesi close associ elev adipogenesi steroidassoci osteonecrosi develop
Microb Cell Fact	25926649	2017-03-14	PMC2148055	17927824	the yeast saccharomyc cerevisia wellestablish model system understand fundament cellular process relev higher eukaryot organ viru area saccharomyc cerevisia proven fruit review will discuss main achiev yeastbas studi basic appli viru includ analysi function individu protein pathogen virus elucid kei process viral replic develop system allow replic higher eukayot virus yeast yeast antivir drug develop vaccin product
PLoS Pathog	28292961	2011-06-13	PMC2151085	18260686	accord current model retroviru infect receptor bind surfac subunit su envelop glycoprotein env trigger conform chang transmembran subunit tm mediat viru fusion cell membran understand occur investig role receptor tva avian leukosi virusa alva infect find tva bind induc format reactiv thiolat cy cyss su chemic genet inactiv cyss complet abrog alv fusion infect remark cyss mediat isomer sutm disulfid bond requir tvainduc activ tm includ prehairpin associ membran low ph assembl helic bundl find indic contrari current model receptor activ tm suffici alv fusion infect format reactiv thiolat addit receptordepend step
BMC Med Inform Decis Mak	21670307	2017-06-02	PMC2203979	17919318	background time seri method commonli detect diseas outbreak signatur signal influenza outbreak anthrax attack vari respiratoryrel diagnost syndrom data sourc typic involv compon time seri method model baselin background distribut time seri process assum outbreak signatur ii detect outbreak signatur filterbas time seri method method consid time seri model chest radiograph data midwest children emerg depart model incorpor covari patient visit count smooth ambient temperatur seri time seri depend daili weekli season scale respiratoryrel outbreak signatur detect base filter onestepahead predict error time seri model respiratorycomplaint background simul experi base stochast model anthrax attack illustr the choic filter statist model radiographattribut outbreak signatur detect conclus demonstr season autoregress integr averag time seri model sarima covari model respiratoryrel time seri data find homogen time seri model respiratorycomplaint background midwest emerg depart studi simul balanc specif sensit timeli detect outbreak signatur differ emerg depart choic filter linear exponenti filter provid good balanc
BMC Health Serv Res	28574743	2015-12-15	PMC2204002	17999757	background influenza pose concern epidem respiratori infect intervent design prevent spread respiratori infect famili physician fp offic posit influenc health canadian main purpos paper estim explicit cost intervent method cost analysi respiratori infect control conduct cost estim perspect provinci govern addit threshold analysi conduct estim threshold intervent effect gener potenti save term avert healthcar cost intervent exce explicit cost inform requir implicit cost save high element cost hospit event contact influenza number patient pass physician offic pertin point proport infect peopl requir hospit import exist literatur indirect approach calcul threshold uncertain piec reduct probabl infect spread direct result intervent intervent worthwhil week intervent cost amount total prorat length flu season prorat entir calendar year variabl cost incur week project amount particip medic practic fix train cost practic equival week intervent week flu season entir oneyear period conclus base conserv estim direct cost save indic outreach facilit intervent program cost effect achiev reduct probabl infect order percentag point facilit intervent initi tailor environ famili medic practic walkin clinic promis improv respiratori infect control physician offic
PLoS One	26491099	2009-11-01	PMC2204050	18231581	in respons viral infect express numer host gene includ number proinflammatori cytokin chemokin upregul transcript translat level cell infect coronaviru transcript translat gene differenti induc drastic induct express transcript level observ cell infect coronaviru induct gene translat level minim moder investig underli mechan yeast twohybrid screen carri sarscov protein bait reveal subunit eukaryot initi factor eif eiff interact ntermin region sarscov spike protein interact subsequ confirm coimmunoprecipit immunofluoresc stain parallel experi confirm eiff interact protein coronaviru avian coronaviru infecti bronchiti viru ibv interact led inhibit translat report gene in vitro express system intact cell interestingli ibvinfect cell stabli express flagtag eiff higher translat il il suggest interact coronaviru protein eiff plai function role control express host gene gene induc coronaviru infect cycl studi reveal novel mechan exploit coronaviru regul viral pathogenesi
PLoS One	20352075	2008-11-05	PMC2204055	18231585	background heighten increas concern influenza pandem sought better understand influenza pandem devast epidem previou centuri methodologyprincip find data commun maryland usa ship experienc welldocu outbreak influenza likelihoodbas method nonparametr method estim serial interv reproduct number cours outbreak analysi basic reproduct number lower maryland commun enclos popul ship se addition effect reproduct number declin epidem level ship dai commun dai serial interv ship consist se se serial interv commun vari se se conclusionssignific illustr consid popul dynam make statement epidemiolog paramet influenza method emploi estim reproduct number serial interv easili replic popul diseas
Crit Care	18987156	2010-06-01	PMC2206456	17362525	introduct accur time diagnosi communityacquir bacteri infect patient system inflamm remain challeng clinician laboratori combin marker oppos singl improv diagnosi surviv compar diagnost characterist novel routin biomark sepsi combin method prospect cohort studi includ patient system inflammatori respons syndrom suspect communityacquir infect conduct medic emerg depart depart infecti diseas univers hospit multiplex immunoassai measur solubl urokinasetyp plasminogen activ supar solubl trigger receptor express myeloid cell strem macrophag migrat inhibitori factor mif parallel standard measur creactiv protein crp procalcitonin pct neutrophil composit marker construct includ linear combin three best perform marker includ area receiv oper characterist curv auc compar perform individu marker total patient elig analysi bacteri infect auc detect bacteri inflamm confid interv ci supar ci strem ci mif ci pct ci neutrophil count ci crp ci composit threemark test ci composit sixmark test auc sixmark test greater singl marker conclus combin marker improv diagnost accuraci detect bacteri versu nonbacteri inflamm measur supar strem mif limit singl marker pct crp exhibit accept diagnost characterist trial registr nct 
Virol J	20545782	2009-01-22	PMC2216015	18053162	the choic appropri housekeep gene normalis purpos essenti requir design qpcr experi qpcr measur viral cellular gene transcript level context viral infect virus interfer host cell pathwai compon tradit housekeep gene encod studi determin reliabl housekeep gene context heavili studi viral infect human immunodefici viru type herp simplex viru type cytomegaloviru varicella zoster viru infect varieti cell type viru strain research virus shortlist potenti housekeep gene normalis qpcr experi
PLoS One	19053779	2014-03-21	PMC2229842	18286178	the effect collabor tool grow multidisciplinari proteomewid project distribut team common data dispar store separ locat contextu collabor molecular model environ cme interact communitybas collabor system allow research organ visual data twodimension threedimension basi share manag collabor real time cme store industrystandard databas access appropri permiss comput network directori servic anonym internet cme applic web browser system address aspect collabor context manag cme allow research atom structur model imag contextu basi attach share annot specif atom molecul specif region imag annot provid addit atom structur imag data evalu amend project member
Microb Cell Fact	24471431	2016-12-21	PMC2231387	18072968	leptospirosi seriou infect diseas caus pathogen strain leptospira spirochet human anim long expect find effect vaccin prevent leptospirosi immun high risk human anim leptospirosi vaccin vaccin unsuccess clinic applic despit decad million dollar spent review advanc recombin outer membran protein omp vaccin lipopolysaccharid lp vaccin inactiv vaccin attenu vaccin dna vaccin leptospirosi review comparison vaccin lead develop potenti method combat leptospirosi facilit leptospirosi vaccin vaccin ontolog databas built scientist work leptospirosi vaccin start tool
Immunome Res	28003365	2007-08-30	PMC2244602	18179690	background applic peptid base diagnost therapeut mimick protein antigen experienc renew interest select design rational peptid driven tcell epitop predict experiment model structur bcell epitop predict hydrophil plot experi structur ration select peptid product function alter neutral antibodi practic imposs altern antigen reduct requir synthes peptid success candid is central technic interest investig integr bcell epitop predict variabl antigen conserv pattern posttransl modif ptm predict improv state art field applic machinelearn method promis result find protein region lead product function alter antibodi character distinct increas cumul sum three present paramet concept maxim antigen minim variabl minim likelihood posttransl modif identif relev site lead biolog interest observ antigen approach work individu area roc curv aroc valu hand portion reveal equival low aroc valu indic nongaussian distribut third antigen seemingli intang approach exist distinct class bioinformat detect epitop predict separ side studi hand curat dataset valid protect classif base dataset machinelearn method improv predict power class separ equilibr dataset conclus comput method automat select rank peptid stimul protect function alter antibodi integr variabl posttransl modif pattern conserv bcell antigen improv ration select random guess find antigen approach work better dataset protein essenti side method optim presum best applic peptid tend unmodifi invari answer diagnosi treatment pathogen infect addit potenti improv applic machinelearn method random forest
BMC Immunol	17762021	2013-03-27	PMC2245908	18211710	background class major histocompat complex mhc molecul bind cell short peptid deriv intracellular process protein peptid repertoir specif molecul larg extent determin molecular structur accommod socal main anchor posit present peptid receptor extrem polymorph polymorph influenc peptidebind repertoir despit polymorph class molecul cluster set molecul bind overlap peptid repertoir decad ago introduc concept cluster human leukocyt antigen hla allel defin group denomin supertyp basi main anchor specif util origin supertyp classif subsequ arrang deriv demonstr larg number epitop identif studi origin approach report provid updat classif hlaa class allel supertyp analysi incorpor larg amount class mhc bind data sequenc decad result hlaa allel examin assign origin supertyp allel expect associ repertoir overlap multipl supertyp interestingli current analysi identifi addit supertyp specif conclus result updat analysi hla supertyp associ defin hlaa allel expect facilit epitop identif vaccin design studi investig diseas associ correl immun addit approach util transpar allow util classif approach go forward
Retrovirology	23678200	2009-12-09	PMC2248597	18186934	background identifi unusu variant molonei friend ecotrop mous gammaretrovirus alter host rang cytopath cell wild mous speci mu dunni cytopath attribut amino acid substitut critic env residu involv receptor interact sf molonei variant spl sa friend mous leukemia viru fs mlv dunni cell carri variant cat cell surfac viru receptor dcat examin role receptor variant cytopath host rang express dcat mcat nih origin cell infect ecotrop mlv evalu transfect suscept viru infect virusinduc syncytium format dcat transfect mcat transfect suscept virusinduc cytopath cytopath respons accompani accumul unintegr viral dna dcat transfect reproduc rel resist dunni cell molonei mlv mcat transfect rel resist nih cell spl western analysi glycosyl inhibitor mutagenesi remov receptor glycosyl site identifi role cellspecif glycosyl modul viru entri conclus viru entri virusinduc syncytium format cat receptor mediat small number critic amino acid residu receptor viru env viru entri modul glycosyl cellular protein cell virusspecif
BMC Public Health	20007278	2007-10-17	PMC2249581	18201388	background intern concern emerg infecti diseas eid bioterrorist attack public health requir earli outbreak detect system diseas surveil team organ establish hospit emerg departmentbas syndrom surveil system edsss capabl automat transmit patient data electron hospit respons emerg care countri center diseas control taiwan taiwancdc start march report describ challeng step involv develop edsss time improv public health decisionmak method june march compar surveil system consult physician pediatrician intern medicin physician involv infecti diseas control syndrom surveil team taiwan work realtim outbreak diseas surveil rod laboratori univers pittsburgh creat taiwan edsss system evalu analyz daili electron data receiv realtim hospit particip system april march taiwan edsss identifi winter summer spike syndrom group influenzalik ill respiratori syndrom ill total number visit higher weekend nation holidai dai chines lunar year weekdai identifi increas upper lower total gastrointestin gi syndrom group start novemb clear spike enteroviruslik infect coincid school semest edsss surveil influenzalik ill enterovirusesrel infect improv taiwan pandem flu prepared diseas control capabl conclus taiwan edsss repres nationwid realtim syndrom surveil system establish asia experi report encourag countri develop surveil system system adapt cultur languag environ better global surveil infecti diseas intern collabor
Respir Res	17942560	2018-12-13	PMC2253533	18234086	background tnf contribut pathophysiolog airwai inflamm exampl nasal administr tnf produc late phase coappear granulocyt plasma exud marker mucos surfac object studi examin indic granulocyt presenc activ respons intranas tnf challeng method healthi subject patient allerg rhiniti examin season subject nasal challeng tnf shamcontrol crossov design nasal lavag carri prior hour post challeng nasal biopsi post challeng nasal lavag fluid level myeloperoxidas mpo eosinophil cation protein ecp analyz indic neutrophil eosinophil activ il macroglobulin analyz marker proinflammatori cytokin product plasma exud nasal biopsi number neutrophil eosinophil monitor nasal lavag fluid level mpo record hour post tnf challeng increas healthi subject patient allerg rhiniti cf sham challeng macroglobulin increas healthi subject patient allerg rhiniti lavag fluid level ecp il tnf challeng tnf increas number subepitheli neutrophil number eosinophil conclus tnf produc nasal inflammatori respons human characteris late phase hour post challeng neutrophil activ plasma exud
BMC Genomics	30545855	2012-11-19	PMC2254600	18179705	background emerg health threat zoonot origin overwhelm major caus agent rna virus includ limit hiv influenza sar ebola dengu hantaviru increas better understand global viral divers enabl better surveil predict pandem threat will requir rapid flexibl method complet viral genom sequenc adapt sispa methodolog genom sequenc rna dna virus demonstr util method type sourc virus obtain complet genom sequenc virus rang size kb median depth coverag techniqu gener full viral genom sequenc presenc host contamin viral prepar cell cultur supernat allanto fluid fecal matter conclus method describ great util gener genom assembl virus sequenc virus greatli diverg famili uncharacter virus fulli describ mix viral infect
Mol Vis	23166232	2011-03-01	PMC2254967	18334931	purpos human endonucleas integr apoptosi unwant harm cell elimin rapid turnov ocular surfac epithelium microbi colon eyelid continu sourc dna tear determin princip sourc endonucleas activ tear method endonucleas human tear identifi sephadex gel filtrat dna hydrolyz activ measur convers puc plasmid dna circular form agaros gel fraction endonucleas activ isol combin conasepharos dna oligo dt cellulos anion exchang chromatographi molecular weight dna hydrolyz protein estim zymogram calibr size exclus chromatographi dnase activ character activ varieti ph ion concentr presenc inhibitor includ nicl zncl gactin aurintricarboxyl acid ata determin mode hydrolysi cleav end dna digest tear dnase analyz label termin deoxynucleotidyl transferas polynucleotid kinas pretreat alkalin phosphatas tear lipocalin tl account dna catalyt activ tear second endonucleas kda respons activ depend enzym endonucleas enhanc activ physiolog ph inhibit aurintricarboxyl acid catalyz hydrolysi dna produc ohp end enzym distinguish inhibitori nicl size cleav dna fragment conclus magnesium depend extracellular endonucleas identifi tear major human extracellular nucleas tl princip endonucleas human tear fluid tear endonucleas uniqu characterist differ human endonucleas
BMC Public Health	20732424	2012-02-08	PMC2258284	18234083	background grow epidem emerg infecti diseas rais set approach includ health promot school hp framework promot better health hygien built concept hp framework hong kong healthi school award scheme includ person health skill kei aspect improv student hygien knowledg practic studi examin differ student percept knowledg health behaviour school adopt hp framework adopt method crosssect studi multistag random sampl conduct school award hsa school involv award scheme adopt concept hp nonhp hsa group primari school secondari school enter studi student student sampl nonhp group primari school secondari school enter studi student student sampl selfadminist questionnair measur instrument student hsa categori better statist signific person hygien practic knowledg health hygien access health hsa school report better school health polici higher degre commun particip better hygien environ conclus student school adopt hp framework posit health behaviour profil nonhp school causal relationship establish hp appear viabl approach address communic diseas
BMC Bioinformatics	22318146	2019-09-01	PMC2259420	18315850	background tcell epitop promiscu bind multipl allel human leukocyt antigen hla supertyp prime target develop vaccin immunotherapi relev larg proport human popul presenc cluster promiscu tcell epitop immunolog hotspot observ antigen cluster exploit facilit develop epitopebas vaccin select small number hotspot elicit requir tcell activ function larg size pathogen proteom includ variant strain comput tool autom screen select immunolog hotspot hotspot hunter webbas comput system largescal screen select candid immunolog hotspot pathogen proteom analysi antigen divers allow screen select hotspot specif common hla supertyp hla class a class ii dr system artifici neural network support vector machin method predict engin soft comput principl emploi integr predict produc method robust predict perform experiment valid predict hotspot hunter identifi major real hotspot user predict hotspot singl protein sequenc set align protein sequenc repres pathogen proteom featur global view local hotspot proteom set enabl analysi antigen divers shift hotspot protein variant system allow integr predict supertyp identif hotspot common multipl supertyp target select featur system shortlist candid peptid hotspot formul epitopebas vaccin effect multipl variant pathogen applic larg proport human popul conclus hotspot hunter publicli access gener comput tool aid epitopebas vaccin design
Virol J	31700931	2016-03-01	PMC2263041	18218114	background speci flaviviru genu pose public health problem increas case dengu japanes enceph viru asia frequent outbreak yellow fever viru africa south america ongo spread west nile viru america geograph burden flaviviru diseas flaviviru infect indistinct confus febril ill review specif publish primer describ univers primer pair detect wide rang flavivirus includ virus recognis subgroup bioinformat analysi publish fulllength flaviviru genom reveal conserv region target primer degener primer flavf flavr design region gener base pair cdna product region amplifi encod methyltransferas rnadependentrnapolymeras ns code sequenc onestep rtpcr test success standard condit rna flaviviru strain repres speci cdna viru isol sequenc phylogenet analys databas search confirm ident templat rna conclus comprehens test reveal broad specif primer discuss advantag univers primer
PLoS One	26803471	2017-02-09	PMC2263130	18350167	background cytotox cell ctl crossreact believ plai pivot role gener immun respons extent mechan ctl crossreact remain unknown studi ctl clone recogn highli divers peptid share obviou sequenc ident emerg realiz field cell receptor tcr recogn multipl distinct ligand princip find analyz peptid scan hiv epitop slfntvatl sfl tcr specif posit depend biochem amino acid substitut drastic affect recognit inspir develop gener model tcr peptid recognit amino acid similar matric model predict crossreact divers set ctl epitop model demonstr seemingli distinct cell epitop low sequenc ident fact biochem expect addition analysi hiv immunogen data model ctl tendenc respond peptid resembl selfantigen conclus cell crossreact extent greater earlier appreci explain amino acid similar present paper will help resolv longlast discuss field cell crossreact
Respir Res	28177862	2014-03-13	PMC2266731	18215329	background acut respiratori ill ari childhood caus respiratori virus result morbid associ cost famili societi despit ubiqu lack interdisciplinari epidemiolog econom collect primari impact data associ indirect cost famili ari children method conduct month cohort studi preschool children impact diari record pcr test nosethroat swab virus ari appli valu estim virusspecif cost ari impact diari communitymanag ill januari januari cost ari au confid interv influenza ill cost compar rsv expens singleviru ill confid interv overlap carer time usual activ dai hour influenza ari minut ari categori conclus societ perspect communitymanag ari cost burden famili societi point estim cost communitymanag influenza ill healthi preschool ag children three time greater ill caus rsv respiratori virus indirect cost carer time usual activ kei cost driver ari children parentcollect specimen enhanc ari surveil reduc potenti hawthorn caus complianc studi procedur find reinforc integr epidemiolog econom ari children allow comprehens costeffect assess prevent therapeut option
PLoS One	24627473	2016-03-11	PMC2266793	18350141	background common cold questionnair ccq discrimin viral infect peopl acut asthma unknown aim assess abil ccq detect viral infect monitor recoveri viral induc asthma exacerb confirm virolog test methodologyprincip find studi subject yr admit hospit acut asthma diagnos posit neg viral infect molecular virolog test respiratori sampl ccq asthma histori asthma control questionnair complet repeat week sensit specif respons chang ccq assess receiv oper curv roc analysi size calcul ccq discrimin viral nonvir infect subject asthma sensit specif roc analysi differenti posit neg viru subject asthma ccq larg respons chang recoveri size subject recov viral exacerb remain posit virolog test followup despit improv clinic symptom ccq reflect clinic improv subject provid addit complement virolog test conclusionssignific ccq instrument monitor respons viral infect peopl asthma reliabl differenti viral nonvir asthma exacerb achiev ccq requir specif virolog test combin virolog test ccq outcom measur evalu therapi viralinduc asthma
PLoS Pathog	26969707	2012-06-27	PMC2267009	18369467	the reoviru fusionassoci small transmembran fast protein function virusencod cellular fusogen mediat effici cellcel viruscel membran fusion ectodomain residu unclear diminut viral fusion protein mediat initi stage membran contact close membran apposit fusion reaction preced actual membran merger fast protein lack specif receptorbind activ natur biolog context promot cellcel fusion reli cadherin promot close membran apposit fast protein reliant cadherin engag mediat membran apposit indic abil effici util adhesin fusion reaction indic surrog adhes protein bridg membran close nm apart enhanc fast proteininduc cellcel fusion activ actin remodel requir maxim fusion activ fast protein exampl membran fusion protein evolv function opportunist fusogen design exploit convert natur occur adhes site fusion site capac surrog noncogn adhesin activ actin remodel enhanc cellcel fusion activ fast protein featur perfectli suit structur function evolut fusogen minim fusion compon virusencod cellular fusion machin provid basi reconcil rudimentari structur fast protein capac fuse cellular membran
BMC Biol	22745375	2018-09-05	PMC2267159	18197965	background studi organ interact fusion domain fusion peptid fp transmembran domain tmd influenza viru envelop glycoprotein role membran fusion essenti cellular traffick biomolecul spermegg fusion fluoresc gel electrophoresi experi reveal tight selfassembl tmd model membran weak nonrandom interact tmd fp membran complex central tmd oligom pack fp antiparallel fashion fp insert membran alter bind tmd infrar studi exhibit enhanc membran perturb complex format model built illustr role tmd late stage influenza virusmedi membran fusion reaction conclus tmd oligom anchor fusion protein membran minim destabil membran associ fp complex exert synergist membran perturb contribut complet membran fusion late phase fusion proteininduc fusion cascad present work character natur interact tmd membran tmd complex fp step lead pore initi dilat virusinduc fusion data propos fusion model highlight kei role tmdfp interact implic fusion reaction mediat type viral fusion protein understand molecular mechan membran fusion assist design antivir drug
PLoS One	30185587	2016-07-24	PMC2268738	18382652	background human rhinovirus hrv frequent detect pathogen acut respiratori tract infect arti preval recurr structur clinic impact individu member complet code sequenc unknown highli diverg hrv strain report catalogu molecular clinic featur distinguish diverg hrv strain undertook time silico analys polyprotein sequenc perform retrospect review medic record case variant prototyp strain hrvqpm detect methodologyprincipl find genom analys reveal diverg strain resid clade call hrv shortest polyprotein picornavirus investig structurebas amino acid align identifi conserv motif share member genu rhinoviru substant delet insert uniqu diverg strain delet region encod protein tradition involv antigen serv hrv hev receptor footprint hrv strain cultur creat homolog model predict hrvqpm structur protein silico comparison confirm hrvqpm close major group hrv hrvqpm frequent detect infant expiratori wheez persist cough admit hospit requir supplement oxygen viru detect posit individu observ contribut object clinic impact rang mild sever conclus diverg strain meet classif requir exist speci genu rhinoviru enteroviru hrv strain partit speci put call human rhinoviru popul member detect high frequenc individu respiratori symptom requir hospit admiss
Clin Dev Immunol	27439538	2012-01-01	PMC2270750	17162377	human immunodefici viru hiv infect repres major health threat develop costli treatment infect individu multipl highli effici antihiv drug afford industri countri effici vaccin strategi requir prevent spread infect molecular biologi coronavirus featur human coronaviru hcov indic hcov ebas vaccin vector class highli effici vaccin receptor hcov human aminopeptidas hapn cd express human dendrit cell dc macrophag indic target hcov ebas vector profession antigen present cell achiev receptormedi transduct second hcov structur gene replac multipl transcript unit encod antigen viruslik particl vlp hcov ebas vector rna abil transduc human dc mediat heterolog gene express cell final coronaviru infect associ respiratori enter diseas natur transmiss coronavirus occur mucos surfac human hcov common cold infect upper respiratori tract hcov infect encount children reinfect occur frequent adult preexist immun hcov will impact vaccin effici hcov ebas vector human
Virol J	22027386	2017-11-29	PMC2270820	18269761	background enter caus spectrum virus fulli characteris test stool sampl cell cultur viru isol type current method studi vidisca viru identif method appli untyp viru isol human parechoviru hpev type strain design bnist genom contemporari hpev determin complet genom sequenc novel strain result recombin structur protein gene ancestor contemporari hpev strain nonstructur protein gene unknown ancestor close hpev contrast nonstructur protein gene hpev prototyp strain nonstructur protein gene bnist hpev prototyp strain cosegreg bootscan analysi prototyp strain conclus hpev nonstructur protein gene form distinct element pool circul hpev nonstructur protein gene complex hpev evolut requir connect viru ecolog diseas pattern human
BMC Genomics	29187543	2015-02-25	PMC2270836	18251995	background felin immunodefici viru fiv natur infect multipl speci cat human immunodefici viru human fiv infect aidslik diseas mortal domest cat feli catu serv natur model hiv infect human african lion panthera leo exot felid speci diseas etiolog introduc fiv infect clear studi indic fiv moder sever cd deplet studi compar genom method evalu full provir genom geograph distinct fiv subtyp isol freerang lion genom organ fivpl subtyp bp lion serengeti nation park tanzania fivpl subtyp bp isol lion okavango delta botswana resembl fiv genom sequenc puma palla cat domest cat ltr gag pol vif orfa env rev ltr region compar analys fulllength fiv consist subtyp fivfca palla cat fivoma puma fivpco subtyp recapitul speciesspecif monophyli fiv mark high level genet divers speci fivpl gene region env lion subtyp monophylet margin palla cat fivoma fiv sequenc analys indic su tm region env vari subtyp fivpl subtyp domest cat fivfca fivpl subtyp fivoma reflect recombin strain wild conclus studi demonstr necess wholegenom analysi complement populationgenebas studi limit util uncov complex event recombin lead function differ virul pathogen fulllength lion lentivirus integr advanc compar genom human pathogen emerg diseas wild popul endang speci
Source Code Biol Med	25717099	2016-12-01	PMC2275240	18302744	background construct complex spatial simul model network epidemiolog daunt task larg amount data involv parameter data frequent resid larg georeferenc databas process assign compon model construct model simul analyz epidemiolog scenario workflow achiev effici comput tool autom timeconsum task paper simul softwar epigrass aim help design simul networkepidem model kind node behavior network epidemiolog model repres spread directli transmit diseas bustransport network connect midsiz citi brazil topolog context start point epidem great control prevent perspect conclus epigrass facilit greatli construct simul analysi complex network model output model standard gi file format facilit postprocess analysi sophist gi softwar
Dev Immunol	27552081	2010-01-01	PMC2276095	12739787	primari biliari cirrhosi pbc autoimmun diseas character intrahepat bile duct destruct product antimitochondri antibodi ama absenc anim model strike imped defin molecular basi diseas previou work suggest sjlj mice immun pyruv dehydrogenas complex pdce major mitochondri autoantigen pbc lead develop lymphoid cell infiltr portal tract model system coin autoimmun cholang hypothes patholog augment immun occur presenc ifn inject sjlj mice immun pdce purpos control casein subgroup mice treat exogen ifn expect mice immun pdce ifn develop high titer ama contrast mice immun casein develop antinuclear antibodi importantli liver mice immun pdce andor immun casein displai lymphoid cell infiltr portal tract irrespect bile duct size differ experiment control group histolog analysi autoimmun cholang mice antigen nonspecif
Dev Immunol	20933203	2011-05-01	PMC2276106	12885151	the plagu board health fear enter german troop milanes enter likewis paus invad ravag great itali manzoni bethroth 
Virol J	21531955	2012-04-01	PMC2276200	18267012	background la cross viru lacv famili bunyavirida identifi human pathogen isol yearold girl fatal enceph la cross wisconsin lacv major pediatr enceph north america infect person year result sever diseas central nervou system cn initi step establish anim model support vaccin develop examin lacv infect pathogenesi immunogen weanl mice rhesu monkei intraperiton inocul mice lacv replic organ reach cn replic high titer caus death neurolog diseas peripher site lacv replic highest titer nasal turbin presum lacv enter cn olfactori neuron nasal olfactori epithelium mous infecti dose lethal dose lacv administ intranas intraperiton lacv highli infecti rhesu monkei infect anim pfu infect asymptomat monkei develop strong neutral antibodi respons conclus mice lacv gain access cn blood stream olfactori neuron abil effici infect mice intranas rais possibl lacv rout infect natur host rhesu monkei suscept lacv infect develop strong neutral antibodi respons inocul pfu mice rhesu monkei anim model lacv vaccin immunolog test rhesu monkei model optim
Virol J	22349524	2007-04-01	PMC2288602	18282283	background member baculovirida encod type protein mediat viruscel membran fusion penetr host cell align primari amino acid sequenc indic baculoviru fusion protein group nucleopolyhedrovirus npv form gp superfamili structur viral penetren determin gp superfamili includ glycoprotein gp encod member thogotoviru genu orthomyxovirida entri protein baculovirus group ii npv granulovirus class penetren class iii penetren encod member rhabdovirida herpesvirida intern fusion domain compris beta sheet beta sheet domain extend alpha helic domain membran proxim stem domain carboxyl termin anchor sequenc structuralfunct motif character class iii penetren locat collinearli gp group baculovirus glycoprotein encod thogotovirus structur model base prototyp class iii penetren vesicular stomat viru glycoprotein vsv establish thogoto viru thov gp autographa california multipl npv acmnpv gp demonstr feasibl cystein linkag glycosyl site thov gp acmnpv gp appear model locat glycosyl site vsv conclus protein gp superfamili class iii penetren
PLoS One	17413076	2007-06-20	PMC2288676	18414668	background interleukin il describ proinflammatori cytokin report induc bacteria treatment cultur cell il product exogen pathogen infect human individu method find studi il level increas serum sampl cohort patient infect influenza viru compar healthi individu proinflammatori factor cyclooxygenas coxassoci prostaglandin upregul fold express il influenza viru infect human lung epitheli cell block select cox inhibitor ns aspirin antiinflammatori drug indic il induc cox inflammatori cascad interestingli coxassoci pge product activ influenza viru infect suppress overexpress il increas ilspecif sirna suggest feedback mechan il cox conclus il induc influenza viru infect cox inflammatori cascad provid il potenti target antiinflammatori medicin screen
Immun Ageing	26468537	2007-11-14	PMC2291031	18289372	background safeti immunogen mfadjuv subunit influenza vaccin submf fluad novarti vaccin evalu elderli chines subject year ag preliminari phase openlabel studi assess safeti dai postvaccin compar observerblind randomis control clinic trial perform assess safeti immunogen versu nonadjuv subunit influenza vaccin subunit agripp novarti vaccin subject randomis receiv submf subunit vaccin toler vaccinerel seriou advers event report phase trial observerblind studi local system reaction gener vaccin dai postvaccin injectionsit indur frequent subunit group mild pain inject site fever frequent submf recipi vaccin induc increas geometr titr gmt three strain test versu baselin gmt ahn ahn higher submf group p gmt ratio ahn ahn higher submf group p percentag subject achiev seroprotect seroconvers dai greater submf recipi reach signific ahn conclus mfadjuv subunit influenza vaccin toler elderli chines subject induc higher level immunogen nonadjuv subunit influenza vaccin popul high risk influenzarel complic clinic trial registri nct
BMC Infect Dis	18003804	2014-06-30	PMC2291466	18312678	background host genet factor plai role occurr progress sarscov infect studi investig relationship tumor necrosi factor tnf gene polymorph occurr sarscov infect role prognosi patient lung interstiti fibrosi femor head osteonecrosi method associ genet polymorph tnf gene suscept sever acut respiratori syndrom sar conduct hospitalbas casecontrol studi includ sar patient health care worker healthi control relationship tnf gene polymorph interstiti lung fibrosi femor head osteonecrosi carri casecas studi discharg sar patient pcr sequenc base type pcrsbt method determin polymorph tnf gene locu promot region univari logist analysi conduct analyz collect data compar tt genotyp ct genotyp locu associ protect sar orci tt genotyp ct cc associ risk femor head necrosi orsci glucocorticoid adjust ct ci combin ct cc genotyp ci site tnf gene time ac genotyp manifest risk associ femor head necrosi orci adjust ci cure sar patient compar cc genotyp conclus snp tnf gene promot region associ sarscov infect snp affect interstiti lung fibrosi cure sar patient ctcc ac genotyp risk factor femor head necrosi discharg sar patient
BMC Infect Dis	27591245	2018-01-17	PMC2292190	18307785	background hepat ha lowincid nonendem diseas canada unit state larg differ ha incid canada haendem countri travel contributor hepat preval canada smaller incid differenti canada us moder higher ha incid volum travel canadian time higher travel volum endem countri travel constitut sourc low moder risk canadian travel knowledg travel includ potenti risk factor ha infect canadian epidemiolog analys object studi dynam model investig effect hepat incid canada implement vaccin vari volum travel canadian method develop analyz agestructur compartment model transmiss vaccin hepat canada model parameter data seropreval case report travel pattern potenti hepat preval hepat preval canada captur term repres infect canadian travel model suggest ha case canada mid attribut travel univers vaccin programm attain coverag young children mid reduc canadian incid year conclus data parameter model consid exploratori analysi plausibl assumpt determin ha preval canada current suppos intern travel continu grow make vaccin polici relev popul countri border multicountri model will wider predict aid polici develop
BMC Biotechnol	29343585	2013-07-08	PMC2315644	18371201	background describ technic solut optim pichia pastori shake flask cultur exampl product stabl human type ii collagen product recombin protein pastori perform control gene express strong aox promot induc addit methanol optim process aox promot pastori gener bioreactor fedbatch ferment control continu addit methanol avoid methanol toxif carbonenergi starvat develop feed protocol studi aoxcontrol recombin protein product shake flask shake flask limit possibl measur control appli onlin po monitor demonstr puls feed methanol long phase methanol exhaust consequ low express aox control gene provid solut appli fedbatch strategi shake flask present solut appli wireless feed unit flexibl posit allow computercontrol feed profil human collagen ii exampl quasicontinu feed profil simplest fedbatch ferment higher product level human collagen ii product higher proteolyt stabil compar control cultur increas express human collagen prolyl hydroxylas monitor mrna protein level conclus recommend standard protocol methanol addit shake flask puls feed nonoptim lead repeat long phase methanol starvat problem solv appli fedbatch technolog present wireless feed unit onlin monitor system offer flexibl simpl lowcost solut initi optim product shake flask perform parallel fedbatch strategi appli earli screen step laboratori access highcost complic bioreactor system
PLoS Pathog	23964302	2019-01-01	PMC2322833	18451981	sarscoronaviru sarscov replic transcript mediat replicationtranscript complex rtc virusencod nonstructur protein nsp primari constitu sarscov nsp produc autoprocess larg precursor polyprotein rtc believ associ characterist virusinduc doublemembran structur cytoplasm sarscovinfect cell investig link structur viral rna synthesi dissect rtc organ function isol activ rtc infect cell develop robust assai vitro activ synthesi genom rna subgenom mrna faithfulli reproduc rtc vitro system positivestrand rna synthes protein synthesi requir rtc activ vitro rtc activ enzymat put membranespan nsp viral rna cosedi heavi membran structur pellet rtc requir addit cytoplasm host factor reconstitut vitro activ newli synthes subgenom rna appear releas genom rna remain associ rtccontain fraction rtc activ destroi deterg treatment suggest role membran rtc appear protect membran newli synthes viral rna replicasetranscriptas subunit proteas nucleaseresist suscept degrad addit nonion deterg data establish vital function depend sarscov rna synthesi virusinduc membran structur
BMC Bioinformatics	30850053	2010-06-23	PMC2322988	18366693	background hierarch cluster tree hct dendrogram singular decomposit svd dimensionreduc repres map popular method twowai sort genebyarrai matrix map emploi gene express profil hct dendrogram tend optim local coher cluster pattern svd lead eigenvector identifi better global group transit structur studi propos flip mechan convent agglom hct ranktwo ellips improv svd algorithm sort purpos seriat chen extern refer hct produc permut good local behaviour ranktwo ellips seriat best global group pattern smooth transit trend algorithm automat integr desir properti method user access cluster visual environ gene express profil preserv coher local cluster identifi global group trend conclus demonstr exampl propos method possess better numer statist properti meaning biomed insight sort algorithm sort proxim matric gene arrai addit genebyarrai express matrix greatli aid search comprehens understand gene express structur softwar propos method 
BMC Bioinformatics	17768509	2013-08-01	PMC2335115	18366721	background larg number thesauri biomed domain lack coverag term variant form automat thesauru construct base pattern suggest hearst clear automat construct pattern semant relat domain pattern captur synonymi assumpt extant resourc parser limit factor languag desir find pattern syntact analysi final consist applic result desir pattern form synonym set sound method automat gener regular express pattern expand seed pattern heurist search develop featur vector base occurr term pair develop pattern allow binari classif term pair synonym nonsynonym model result probabl graph find synonym set equival wellstudi problem find optim set cover achiev precis recal method outperform handmad resourc mesh wikipedia conclus conclud automat method plai practic role develop thesauri expand exist small amount train data resourc parser conclud accuraci improv group synonym set
BMC Biotechnol	23767796	2017-04-05	PMC2362111	18384691	background exon skip oligonucleotid eso omethyl om morpholino chemistri restor dystrophin express muscl fiber mdx mous current test phase clinic trial duchenn muscular dystrophi dmd eso remain limit effect inadequ deliveri profil synthet cation copolym polyethylen imin pei polyethylen glycol peg regard effect agent enhanc deliveri nucleic acid applic examin pegpei copolym facilit esomedi dystrophin express intramuscular inject tibiali anterior ta muscl mdx mice util set pegpei copolym kda pei kda peg bind om eso high affin form stabl nanoparticul low surfac charg three weekli intramuscular inject of eso complex peikpeg copolym dystrophinposit fiber normal level dystrophin express week initi inject greater inject eso complet ineffect effort enhanc biocompat cellular uptak peikpeg peikpegk copolym function coval conjug nanogold ng adsorbt colloid gold cg surprisingli inject dose regimen differ dystrophin express western blot ngpeikpeg cgpeikpegk nonfunction peikpeg copolym doserespons experi cgpeikpegk copolym total eso rang yield maximum dystrophin express improv dystrophin express normal level week twiceweekli inject ngpeikpeg copolym complex eso inject inject dose regimen dystrophinposit fiber stain treat muscl group reveal overt sign cytotox conclus conclud pegyl peik copolym effici carrier local deliveri om eso warrant develop potenti therapeut treatment dmd
PLoS One	28381581	2009-09-01	PMC2364642	18478070	background jena viru jv bovin noroviru enter diseas cattl repres potenti model studi enter noroviru infect pathogenesi posit sens rna genom jv organis orf nonstructur protein orf major capsid protein orf minor capsid protein lack cell cultur system studi jv replic meant work reli vitro system studi nonstructur protein synthesi process princip find three major orf protein identifi vitro translat jv rna nterm protein detect nterm encod genom sequenc gs test ireslik function bicistron system displai evid ireslik activ site translat initi jv determin predict nucleotid insert epitop gs jv nterm protein identifi vitro rna transfect cell conclus vitro transcriptiontransl system current best system analys protein synthesi process jv studi human norovirus jv initi appear express ntermin protein present possibl encod rna sequenc regulatori function involv translat initi ireslik manner case determin site translat initi nterm protein detect epitop tag vitro vivo larger predict nterm protein detect process form vivo demonstr initi translat orf polyprotein activ viral proteas find indic block norovir replic cultur cell li elsewher
PLoS One	19501622	2009-05-06	PMC2367437	18478121	background cytokin plai role antivir action examin polymorph interleukin il receptor ilrb affect suscept outcom sever acut respiratori syndrom sar method casecontrol studi carri chines sar patient healthi control genotyp snp il rb gene agtc gc ct determin pcrrflp haplotyp estim genotyp data expectationmaximis algorithm comparison patient close contact individu ct ct tt genotyp fold confid interv ci fold ci increas risk develop sar three polymorph differ detect allel genotyp frequenc patient control addition estim frequenc multiplelocu haplotyp reveal potenti risk haplotyp gcct sar infect conclus data indic genet variant ilrbconf genet suscept sar infect associ progress diseas chines popul
Genome Biol	19420084	2013-05-10	PMC2375028	17868443	dna microarrai offer possibl test presenc thousand microorgan singl experi lack reliabl bioinformat tool analysi data develop detectiv packag statist softwar detectiv offer power simpl visual normal signific test tool detectiv perform better publish softwar larg publicli dataset
PLoS Pathog	23667257	2014-10-01	PMC2376094	18516228	throughout process pathogenhost coevolut virus develop batteri distinct strategi overcom biochem immunolog defens host virus acquir capac subvert host cell apoptosi control inflammatori respons evad immun reaction elimin infect cell program cell death ancestr defens mechan infect disabl host cell apoptosi repres oblig step viral life cycl convers virus advantag stimul apoptosi kill uninfect cell immun system induc breakdown infect cell favor viral dissemin viral polypeptid homolog hostderiv apoptosisregulatori protein member bcl famili viral factor homolog host protein target kei compon apoptot machineri summar current knowledg viral modul mitochondri apoptosi focus mechan viral protein control host cell death apparatu
PLoS One	24747011	2019-08-13	PMC2386233	18509464	background footandmouth diseas fmd highli contagi diseas livestock sever econom loss suscept clovenhoof anim tradit inactiv vaccin prove effect lead outbreak fmd incomplet inactiv fmdv escap live viru vaccin product workshop urgent develop novel fmdv vaccin safer effect econom tradit vaccin methodolog princip find recombin silkworm baculoviru bmpac contain intact pa proteas code region fmdv asia hnkcha develop indirect immunofluoresc test sandwichelisa verifi bmpac express target cassett express product silkworm dilut fold antigen immun cattl specif antibodi induc vaccin anim challeng virul homolog viru anim complet protect clinic symptom allevi delai remain pd bovin protect dose test perform assess bovin potenc subunit vaccin result subunit vaccin achiev pd dose conclus strategi develop subunit fmdv vaccin
Int J Health Geogr	31409714	2015-06-10	PMC2386448	18402711	background earli detect diseas outbreak enabl public health offici implement diseas control prevent measur earliest time time period geograph diseas surveil system base cylindr spacetim scan statist extens diseas surveil satscan softwar pure spatial set method propos detect spatial diseas cluster spatial scan statist aim detect irregularli shape cluster detect circular spatial scan statist base flexibl pure spatial scan statist propos flexibl shape spacetim scan statist earli detect diseas outbreak perform propos spacetim scan statist compar cylindr scan statist benchmark data order compar perform develop spacetim power distribut extend pure spatial bivari power distribut daili syndrom surveil data massachusett usa illustr propos test statist conclus flexibl spacetim scan statist suit detect monitor diseas outbreak irregularli shape area
J R Soc Interface	26063435	2010-06-01	PMC2386895	18055417	in network node preferenti contact node assort mix dissimilar disassort mix number contact pattern contact support epidem dynam efficaci control measur contact trace aim identifi isol node infecti contact stochast simul investig effect mix pattern epidem dynam contacttrac efficaci uncontrol epidem outbreak occur lower infect rate assort mix network faster initi epidem growth rate shorter epidem durat disassort mix network contact trace perform better assort mix epidem size larg trace rate low perform better disassort mix higher contact rate assort mix network diseas spread highli connect node balanc contact trace identifi node convers true disassort mix diseas trace target highli connect node small epidem contact trace effect disassort network greater resili assort network link remov multistep contact trace effect singlestep trace assort mix smaller disassort mix network
PLoS One	23637477	2012-10-02	PMC2386973	18509538	background primari health care gener practic will frontlin respons pandem influenza framework guid systemat plan task apprais plan relev gener practic aim develop framework will facilit plan gener practic apprais pandem plan australia england usa zealand canada methodologyprincip find adapt haddon matrix develop framework popul cell multimethod studi incorpor peerreview grei literatur interview gener practition practic nurs senior decisionmak desktop simul exercis framework analys publiclyavail jurisdict plan manageri level countri framework identifi function domain clinic care influenza public health respons intern environ macroenviron gener practic plan address domain plan ignor sketchi noninfluenza clinic contribut gener practic public health surveil collabor gener practic address plan interrelationship broader health system frequent conclus studi provid framework guid gener practic plan pandem influenza framework help identifi critic shortcom plan engag gener practic effect plan challeng govern structur primari health care weak identifi implic practic research
BMC Genomics	23003343	2004-04-08	PMC2387173	18423000	background infecti salmon anemia viru isav multisystem diseas respons sever loss salmon aquacultur better understand factor explain variat resist individu famili essenti develop strategi diseas control approach compar global gene express microarrai fish dy earli late time cours infect highli pathogen isav tissu gill heart liver spleen infect atlant salmon cohabit isav glesvaer isol collect three stage time cours experi earli em cumul mortal cm dai postinfect dpi intermedi cm dpi late lm cm dpi mortal viral load equal em drop markedli lm fish gene express analys salmonid fish cdna microarrai sfa realtim qpcr reveal larg group gene highli upregul tissu em implic innat antivir respons cellular stress despit equal level mhc class em lm increas splenic cardiac express immunoglobulinlik gene lm suit adapt immun marker activ hepat respons isav character differ em lm express chaperon gene involv eicosanoid metabol develop classif high low resist phenotyp base small number gene process qpcr analys liver linear discrimin analysi gene lipoxygenas activ protein cytochrom galectin annexin suffici correct assign individu em lm uninfect group insepar em three prognost marker involv metabol inflammatori regul conclus studi add understand molecular determin resist acut isav infect suscept individu character high viral replic dramat activ innat immun respons provid protect abil endur high level infect sustain period associ lower inflammatori respons subsequ protect viral clearanc confer activ adapt immun
PLoS Pathog	15073334	2012-02-27	PMC2390764	18535660	virion thought essenti protein govern viru egress host cell initi replic target cell time influenza virion viral protein analys envelop virus reveal protein host cell detect virion address true influenza viru complementari mass spectrometri approach perform comprehens proteom analysi purifi influenza viru particl addit aforement virusencod protein detect presenc hostencod protein includ cytoplasm membranebound protein group function categori cytoskelet protein annexin glycolyt enzym tetraspanin interestingli number report virion viru famili proteas treatment virion combin immunoblot analysi verifi presenc cellular protein determin locat core influenza viru particl immunogold label confirm presenc membranebound host protein influenza viru envelop identif cellular constitu influenza virion implic understand interact influenza viru host bring step closer defin cellular requir influenza viru replic host protein incorpor ar essenti role repres novel target antivir drug attenu virus vaccin purpos
BMC Med Res Methodol	22371588	2019-01-30	PMC2394529	18405357	background graphic displai allow research summaris commun kei find studi diagnost present easili interpret convei test characterist diagnost accuraci potenti clinic practic predict method discuss type graphic displai commonli encount primari diagnost accuraci studi systemat review studi systemat review graphic displai diagnost primari studi systemat review identifi primari studi systemat review fiftysix percent primari studi systemat review graphic displai dotplot boxand whisker plot commonli graph primari studi includ studi roc plot common type plot includ systemat review includ review primari studi systemat review includ probabilitymodifi plot conclus graphic displai current underus primari diagnost accuraci studi systemat review studi diagnost accuraci studi includ multipl type graphic order provid detail overview diagnost accuraci commun inform clinic practic predict work requir improv graphic displai better commun util test clinic practic implic test individu patient
PLoS One	30701479	2017-02-01	PMC2398778	18545680	virus adapt host evad defens mechan cellular metabol benefit alter cell metabol sideeffect antivir respons contribut symptom develop virul viru spill usual host speci novel will fail infect transmit host case viru transmit persist fix benefici mutat allow better exploit host situat repres case emerg viru report evolut experi plant viru allow infect evolv nave host serial passag viral genom accumul chang three nonsynonym amino acid substitut viral vpg protein respons appear symptom substitut viral protein epistat contribut exacerb sever dna microarrai analys evolv ancestr virus affect global pattern host gene express radic wai major differ gene involv stress pathogen respons activ infect evolv viru suggest select favor viral strategi escap host defens
PLoS Pathog	28148802	2016-03-30	PMC2398782	18551169	coronavirus induc infect cell format doubl membran vesicl site rna replic format vesicl observ indic role endoplasm reticulum format mous hepat coronaviru mhv replic complex rc mhv replic sensit brefeldin bfa consist express dominantneg mutant arf mimic action drug inhibit mhv infect profoundli immunofluoresc analysi quantit electron microscopi demonstr bfa block format rc se reduc number mhv rna replic sensit bfa mdck cell express bfaresist guanin nucleotid exchang factor gbf individu knockdown golgiresid target bfa transfect small interf rna sirna gbf big big critic involv mhv rna replic arf cellular effector gbf appear involv mhv replic sirna target small gtpase inhibit mhv infect collect demonstr gbfmediat arf activ requir effici mhv rna replic reveal earli secretori pathwai mhv replic complex format close connect
Virol J	27190593	2013-08-28	PMC2413216	18495043	background previou studi demonstr envelop protein dengu virus purifi select pressur genet differ fulllength viral genom denv studi complet genom sequenc denv strain collect geograph locat isol year determin sequenc divers select pressur site denv genom gene analyz maximum likelihood bayesian approach phylogenet analysi reveal taiwan indigen denv isol denguedhf epidem sporad case three genotyp ii iii associ denv circul indonesia thailand sri lanka sequenc divers select pressur genom region denv genotyp examin understand global denv evolut highest nucleotid sequenc divers fulli sequenc denv strain nonstructur protein sd envelop protein gene region sd analysi posit select pressur denv occur nonstructur protein gene region posit select site detect posit ns gene conclus studi confirm envelop protein purifi select pressur present higher sequenc divers detect posit select pressur nonstructur protein genotyp ii indic denv origin southeast asia monitor emerg denv strain epidem potenti better epidem prevent vaccin develop
BMC Public Health	23986588	2008-11-19	PMC2423372	18518971	background healthcar worker hcw will kei player respons pandem influenza will front exposur infect respond effect pandem reli major medic nurs laboratori hotel servic staff continu work plan assum pandem normal healthcar servic level will provid anticip caseload increas essenti care will provid abil nh provid expect servic level entir depend hcw continu work normal methodsdesign studi design twophas multimethod studi incorpor focu group questionnair survei phase qualit method will collect view purpos sampl hcw determin rang factor associ respons prospect work pandem influenza phase find focu group combin literatur will inform design survei determin generalis factor enabl estim proport hcw factor andor continu work influenza pandem discuss greater normal health risk healthcar worker work pandem worker concern infect famili membersfriend hcw will liabl worker care sick famili member friend vital motiv hcw will continu work crisi factor influenc decis worknot work identif subsequ manag factor implement strategi will allevi concern fear hcw remov potenti barrier work
PLoS One	19019822	2013-09-01	PMC2423471	18560560	background isg ubiquitinlik protein highli induc type interferon cooper activ specif ubiquitin enzym isg conjug substrat increas evid point role protein isgyl antivir antitumor defens princip find identifi isg monkei owm hypereffici protein modifi western blot analysi visual effici conjug owmisg rel huisg human hu monkei mous mo celllin substrat owmisg identifi tandem affin purif lcmsm identif outnumb huisg ubiquitinconjug enzym identifi novel isgyl substrat introduct mutat huisg improv isgyl capac addit qktadn mutat yield huisg variant isgyl effici compar owmisg homolog model structur superposit situat interact interfac activ enzym analysi ubel residu interfac reveal strike homolog owmubel huub activ enzym ubiquitin observ effici activ agmisg huisg moisg huub provid explan owm hyperisgyl conclus studi disclos poor conjug compet huisg compar owmisg map critic determin effici conjug hyperisgyl greatli assist isgyl studi enhanc function posit regul interferonrel immun respons antitumor modul
Virol J	24041193	2011-02-08	PMC2426676	18519001	background human metapneumoviru hmpv infect acut lower respiratori tract ill infant immunocompromis elderli current licens prevent measur hmpv infect variant hmpvnl requir trypsin supplement growth tissu cultur delet gene evalu replic rhmpvm viru vitro vivo vitro studi ablat increas propens insert nucleotid polyu tract genom rna addit viral transcript upregul level genom rna remain compar rhmpv delet alter ratio hmpv genom copi transcript vivo rhmpvm attenu compar rhmpv lung nasal turbin hamster hamster immun dose rhmpvm protect challeng pfu wild type wt hmpvnl conclus hmpv alter regul transcript influenc fidel polymeras complex viral genom replic hamster model rhmpvm attenu protect suggest delet result potenti live vaccin candid thorough knowledg hmpv polymeras complex role hmpv replic studi develop potenti live hmpv vaccin candid lack express
PLoS One	21301484	2011-08-10	PMC2440516	18612413	background protein ubiquitin andor degrad ubiquitinproteasom system recogn critic mechan regul numer essenti cellular function the viral pathogenesi increasingli appar murin cardiomyocyt demonstr plai kei role replic coxsackieviru cvb human pathogen associ diseas elucid underli mechan examin interplai cvb focus role ubiquitin viral lifecycl methodologyprincip find assess situ hybrid western blot plaqu assai proteasom inhibit decreas cvb rna replic protein synthesi viral titer hela cell appar chang proteasom activ cvb infect viral infect led accumul proteinubiquitin conjug accompani decreas protein express free ubiquitin implic role ubiquitin upsmedi viral replic smallinterf rna demonstr genesilenc ubiquitin reduc viral titer downregul protein ubiquitin subsequ alter protein function andor degrad inhibit deubiquitin enzym enhanc inhibitori effect proteasom inhibitor cvb replic final immunoprecipit coxsackievir polymeras posttranslation modifi ubiquitin modif prerequisit function transcript regul viral genom conclus coxsackieviru infect promot protein ubiquitin contribut effect viral replic ubiquitin modif viral polymeras
PLoS One	21835786	2013-10-16	PMC2440799	18612429	background govern prepar potenti influenza pandem data assess impact intervent facemask worn gener popul access afford intervent effect worn routin circumst methodolog assess transmiss reduct potenti provid person respir surgic mask homemad mask worn varieti activ healthi volunt simul patient princip find type mask reduc aerosol exposur stabl time unaffect durat wear type activ high degre individu variat person respir effici surgic mask effici homemad mask mask type children protect outward protect mask wear mechan head effect protect mask wear healthi volunt conclusionssignific type gener mask decreas viral exposur infect risk popul level spite imperfect fit imperfect adher person respir provid protect mask worn patient offer great degre protect aerosol transmiss
PLoS One	24131722	2006-03-01	PMC2440807	18612434	cd prominin transmembran glycoprotein consid marker repres subset popul cancer stemlik cell report isol cdposit cell lccd cdneg cell lccd tissu sampl ten patient nonsmal cell lung cancer lc lc cell line lccd displai higher oct express abil selfrenew repres reservoir prolif potenti gener lung cancer cell lccd lccd highli coexpress multipl drugresist marker abcg resist chemotherapi agent cisplatin etoposid doxorubicin paclitaxel radiotherapi treatment oct sirna lentivir vector block capabl lccd form sphere facilit lccd differenti lccd addit knockdown oct express lccd inhibit abil tumor invas coloni format increas apoptot activ caspas poli adpribos polymeras parp final vitro vivo studi confirm treatment chemoradiotherapi lccd improv treatment oct sirna conclus demonstr oct express plai crucial role maintain selfrenew cancer stemlik chemoradioresist properti lccd futur warrant upregul express oct lccd malign lung cancer
PLoS One	16553546	2004-04-01	PMC2441860	18628832	the pathogenesi sar coronaviru cov remain understood current studi recombin baculoviru gener express spike protein sarslik coronaviru slcov isol bat vacb envelop membran protein sarscov coinfect insect cell recombin baculovirus led selfassembl viruslik particl bvlp demonstr electron microscopi incorpor protein vacb bs vlp confirm western blot immunogold label bvlp upregul level cd cd cd cd enhanc secret il il tnf immatur dendrit cell dc immun respons compar immatur dc inocul bvlp vlp form protein human sarscov bvlp stronger abil stimul dc term cytokin induct evidenc fold higher product il tnf studi indic ifn il popul cd cell increas cocultiv dc preexpos bvlp sarscov vlp observ differ dcstimul activ bvlp sar cov vlp protein agreement slcov dna vaccin evok vigor antibodi respons stronger cell respons sarscov dna mice data demonstr time slcov vlp form membran protein origin slcov isol bat bs human sarscov activ immatur dc enhanc express costimulatori molecul secret cytokin find studi provid vaccin develop understand pathogenesi sarslik cov
BMC Biotechnol	15071006	2005-12-12	PMC2443125	18573204	background human immunodefici viru type hiv infect peopl worldwid subsaharan africa high preval hiv subtyp southern africa necessit develop cheap effect vaccin product plant number techniqu develop hiv prgag promis hiv vaccin candid compar express truncat gag capsid subunit nicotiana spp transgen plant transient express agrobacterium tumefacien recombin tobamoviru vector investig influenc subcellular localis recombin protein chloroplast endoplasm reticulum er protein yield partial purifi select vaccin candid test stimul humor cellular immun respons mice transient transgen express hiv antigen success express prgag low system agrobacteriummedi transient express yield best pkg fresh weight chloroplast target protein level highest transient transgen express transientlyexpress immunogen mice homolog vaccin boost humor cell immun respons prime gag dna vaccin pthgagc conclus transient agroinfiltr best express of recombin protein test express higher level prgag highlight plastid signal peptid enhanc product recombin protein meant vaccin protein effect boost cell humor respons mice prime dna vaccin pthgagc show plantproduc protein potenti vaccin
BMC Public Health	16352564	2014-11-01	PMC2443801	18554408	background enter outbreak associ child care centr ccc document internation canada current literatur focus identifi potenti risk factor introduct transmiss enter diseas examin risk factor happen risk understood manag staff ccc challeng experi respond enter ill purpos studi explor understand knowledg action ccc staff enter ill outbreak identifi challeng staff encount manag method focu group conduct staff regul ccc southern ontario focu group held particip open end style interview data analyz content analysi ccc staff plai role prevent manag enter ill staff indepth knowledg children centr person experi assist make decis enter ill decis action differ guidanc provid public health offici face challeng time monei staf parent conclus ccc staff reli experi judgment coordin public health assist decisionmak manag enter ill outbreak advic guidanc public health offici ccc staff consist flexibl adapt varieti situat meet regulatori public health requir
BMC Evol Biol	25483511	2005-09-27	PMC2443812	18541033	precis date viral subtyp diverg enabl research correl diverg geograph demograph occurr histor data absent overwhelm major viral sequenc sampl time scale commensur rate substitut permit infer time subtyp diverg current research strategi approach task requir strong condit molecular clock assumpt substitut rate underli structur substitut rate process time subtyp diverg understood highli variabl simpl method estim rate substitut time diverg assum molecular clock accomplish blend estim substitut rate triplet date sequenc sequenc draw distinct viral subtyp provid zerothord approxim rate subtyp exampl calcul time diverg three gene influenza subtyp ahn subtyp outgroup time diverg year ago previou estim rang year ago
PLoS One	32169846	2011-10-19	PMC2453318	18629345	two sequenc major histocompat complex mhc region domest cat mbp separ ancient chromosom break mya chromosom invers annot detail gene annot mhc complet identifi code region human homologu function gene pseudounidentifi gene genscan blastn blastp repeatmask program region span mbp sequenc encod classic class ii antigen three dra three drb antigen lack function dp dq region antigen process molecul doadob dmadmb tapasin lmplmptaptap class iii gene nineteen class genesgen fragment flaia flai three class gene flaih ik encod function classic class antigen base deduc amino acid sequenc promot structur second region span mbp sequenc encod class gene crossspeci conserv gene exclud class ii function relatedassoci gene framework gene includ three olfactori receptor gene identifi felin endogen retroviru baboon retroviru deriv sequenc ec endogen retroviru sequenc brown bat endogen retroviru fervmlu fervmlu kbp interv middl class region mhc snp examin base comparison bac sequenc mhc homozyg wg sequenc snp mbp snp bp time higher rate averag heterozyg region wg snp bp genom higher snp rate observ human mhc snp bp
PLoS One	22013221	2015-06-17	PMC2464710	18648661	the conserv insect pollin draw attent report declin bee speci ecosystem servic provid issu brought head devast loss honei bee north america call coloni collaps disord understand bee declin wild bumbl bee bombu spp suffer seriou declin circumstanti evid suggest pathogen spillov commerci rear bumbl bee extens pollin greenhous crop construct spatial explicit model pathogen spillov bumbl bee laboratori experi literatur estim paramet valu spillov crithidia bombi destruct pathogen commonli commerci bombu monitor wild bumbl bee popul greenhous evid pathogen spillov compar fit model pattern bombi infect observ field model predict three month spillov transmiss commerci hive infect wild bumbl bee greenhous travel wave diseas predict form suddenli infect wild bombu spread greenhous rate kmwk field observ larg epizoot wave infect preval bombi greenhous consist model spillov allow bombi invad wild bumbl bee speci greenhous evid pathogen spillov commerci bee contribut ongo declin wild bombu north america improv manag domest bee exampl reduc parasit load overlap wild congen diminish elimin pathogen spillov
Proc Biol Sci	26085159	2019-03-21	PMC2475551	18505720	on averag speci human viru report year construct cumul speci discoveri curv human virus go fit statist model data shape curv suggest process viru discoveri complet gener credibl interv pool undiscov viru speci extrapol curv gener estim speci discov predict level health threat virus will conclud novel viru speci anticip public health plan systemat viru discoveri programm cover human potenti anim reservoir human virus consid
Crit Care	30963037	2012-11-01	PMC2481447	18460218	introduct anim studi acut lung injuri ali nebulis heparin limit damag fibrin deposit alveolar space microcircul human studi undertaken assess feasibl safeti potenti anticoagul effect administr nebulis heparin patient ali method open label phase trial escal dose nebulis heparin perform total ventil patient ali studi group administ total udai second group udai third group udai fourth group udai assess lung function includ paofio ratio lung complianc alveolar dead space fraction monitor anticoagul includ activ partial thromboplastin time aptt thrombin clot time bronchoalveolar lavag fluid collect prothrombin fragment tissu plasminogen activ level assess analysi varianc compar effect dose seriou advers event occur dose chang time paofio ratio lung complianc alveolar dead space fraction level dose trend increas aptt thrombin clot time level higher dose p highest dose aptt reach second cessat nebulis heparin aptt fell second bronchoalveolar lavag sampl trend reduc prothrombin fragment level higher dose tissu plasminogen activ level dose conclus administr nebulis heparin mechan ventil patient ali feasibl nebulis heparin associ seriou advers event higher dose increas aptt level larger trial requir investig safeti efficaci nebulis heparin trial consider system anticoagul effect trial registr australian clinic trial registri actrn
PLoS Pathog	23190778	2004-10-20	PMC2483250	18670648	fatal human respiratori diseas associ pandem influenza viru pandem hn virus character sever lung patholog includ pulmonari edema extens inflammatori infiltr quantifi cellular immun respons infect mous lung flow cytometri demonstr mice infect highli pathogen hp hn hn influenza virus exhibit high number macrophag neutrophil lung compar mice infect low pathogen lp virus mice infect pandem viru hn human isol consider similar lung cellular lung immun cell subpopul composit cellular immun tempor dynam interestingli similar observ hp hn viru consist elicit higher level proinflammatori cytokin lung primari human macrophag reveal critic differ pathogenesi hn infect infect hp influenza virus hn pandem viru lead rapid cell recruit macrophag neutrophil lung suggest cell plai role acut lung inflamm associ hp influenza viru infect addit primari macrophag dendrit cell suscept hn influenza viru infect vitro infect mous lung tissu
Reprod Biol Endocrinol	15496474	2004-05-01	PMC2483279	18620581	background rna interfer rnai valuabl tool investig gene function purpos studi examin avail target cell type effici rnai mous seminifer epithelium method experiment model base transgen mice express egfp enhanc green fluoresc protein rnai induc vivo transfect plasmid vector encod short hairpin rna shrna target egfp shrna transfect vivo microinject seminifer tubul rete testi squar wave electropor transfect report express red fluoresc protein hcred cell type effici transfect rnai evalu sertoli cell main transfect cell reduct level egfp protein detect cell transfect vivo vitro effici vivo transfect low conclus adult seminifer epitheli cell vivo posttranscript gene silenc mediat rnai shrna effici sertoli cell level rnai detect vivo vitro indic sertoli cell silenc machineri repress express endogen gene rnai
BMC Public Health	15107369	2014-10-20	PMC2483710	18620595	background mycobacterium tuberculosi infect ongo public health problem taiwan nation tuberculosi registri campaign case manag system implement studi examin monitor system identifi character delai treatment tb patient method record tuberculosi case treat taiwan nation tuberculosi registri campaign initi treatment dai diagnosi consid long treatment delai studi includ patient dai delai treatment dai patient treat diagnosi relationship number tb patient dai delai treatment diagnosi exhibit powerlaw distribut long tail powerlaw distribut indic extrem number occur neglect tuberculosi patient treat unusu long delai requir close observ follow conclus studi tb control gener acceptabl taiwan delai treatment increas risk transmiss improv protocol manag confirm tb case minim diseas transmiss
PLoS One	25331705	2015-06-01	PMC2483940	18682853	copi number variat cnv region human genom associ multipl diseas algorithm mathemat sound computation effici accur analyz cnv dna sampl util nanofluid devic digit arrai numer algorithm util comput copi number variat associ statist confid interv base probabl theori statist provid formula close approxim
BMC Evol Biol	25697779	2015-06-03	PMC2515104	18637173	background molecular event evolutionari forc underli lethal mutagenesi viru viru extinct excess mutat understood appli time phylogenet method partit analysi quasispeci paq monitor genet distanc intrapopul structur mutant spectra footandmouth diseas viru fmdv quasispeci subject mutagenesi base nucleosid analogu phylogenet paq analys reveal highli dynam variat intrapopul divers fmdv quasispeci popul divers suffer strike expans presenc mutagen compress presenc mutagen analogu discontinu mutat decreas sensit mutagen select pattern mutat popul agreement behavior correspond nucleotid analogu fmdv vitro mutat accumul prefer genom site dnd ratio indic oper neg purifi select popul subject mutagenesi evid unusu elev genet distanc fmdv popul approach extinct conclus phylogenet paq analysi provid adequ procedur describ evolut viral sequenc subject lethal mutagenesi method defin chang intrapopul structur precis mutat frequenc shannon entropi paq sensit variat intrapopul genet distanc strong neg purifi select oper fmdv popul subject enhanc mutagenesi quantif provid evid extinct impli unusu increas intrapopul complex support lethal defect model viru extinct
PLoS Pathog	26041291	2011-12-23	PMC2515348	18725937	hn highli pathogen avian influenza hpai virus serious asian poultri industri recurr virus pose threat emerg global pandem influenza point mutat reassort lead strain effect transmit human studi phylogenet evid interlineag reassort hn hpai virus isol human cat bird indonesia identifi potenti genet parent reassort genom segment parsimoni analys viral phylogeographi reassort virus origin greater jakarta surround subsequ spread region west java provinc addit bayesian method elucid genet divers dynam reassort strain genet parent reveal rapid initi growth genet divers reassort virus rel genet parent demonstr interlineag exchang genet plai pivot role determin viral genet divers focal popul studi reveal stronger diversifi select pb gene lineag preced subsequ emerg reassort virus discuss correspond mutat drive adapt onward transmiss newli form reassort virus
PLoS One	22263103	2004-07-29	PMC2522280	18776932	mathemat model describ global spread infecti diseas influenza sever acut respiratori syndrom sar tuberculosi tb consid sampl intern airport network support diseas spread consensu citi select select citi airport flight data commerci airlin report offici airlin guid oag examin network characterist network sampl select rule addit examin size sampl base largest flight volum largest metropolitan popul bia network characterist increas reduct sampl size small number area includ largest airport largest citi mostconnect citi central citi describ dynam global spread influenza analysi suggest small number citi captur network adequ describ global spread diseas influenza weak traffic flow small airport contribut nois mask spread ground transport
Cases J	15306400	2011-08-24	PMC2526065	18671866	we report case system lupu erythematosu sle year caucasian woman complic pneumonia sever respiratori failur requir icu treatment mechan ventil symptom develop gener control sle cours sudden immunosupres therapi methotrex cyclosporin methylprednisolon fulmin cours diseas interstiti pattern high resolut comput tomographi hrct neg repeat sputum blood bronchoaspir cultur enabl diagnosi fulmin lupu pneumon respons puls cyclophosphamid methylprednisolon good complic leukopenia hrct confirm remiss pulmonari chang fulmin lupu pneumon rare life threaten complic sle differenti diagnosi requir exclus pneumonia induc pathogen pneumocysti jirovevecii carinii mycobacterium sp intens immunosuppress therapi close cooper icu pulmonolog rheumatolog depart case minim risk fatal outcom
PLoS Pathog	21865394	2010-02-01	PMC2526176	18787698	a varieti human diseas associ gammaherpesvirus includ neoplasm lymphocyt burkitt lymphoma endotheli cell kaposi sarcoma gammaherpesviru infect result product lytic infect character express viral gene rapid cell lysi latent infect character limit viral gene express cell lysi report character endotheli cell infect murin gammaherpesviru hv viru phylogenet biolog human gammaherpesvirus endotheli cell support hv replic vitro uniqu proport cell escap lysi prolifer remain viabl cultur extend time infect endotheli cell nonadher alter size complex cellsurfac protein express cell uniformli infect express lytic transcript program base detect abund viral gene transcript gfp fluoresc viral genom viral surfac protein express addition endotheli cell continu produc infecti virion late dai postinfect outcom longterm infect promot hv vcyclin absenc vcyclin viabil reduc infect importantli infect primari endotheli cell demonstr increas viabil rel infect primari fibroblast increas viabil depend vcyclin final provid evid infect endotheli cell vivo immunedefici mice extend viabil viru product infect endotheli cell indic endotheli cell provid sourc prolong viru product identifi celltyp specif adapt gammaherpesviru replic infect endotheli cell clear healthi individu persist infect endotheli cell provid sourc continu viru replic immunecompromis individu context gammaherpesvirusassoci patholog frequent occur
BMC Res Notes	20007351	2016-03-10	PMC2527504	18710500	background extens sequenc effort place atlant cod gadu morhua year number est genbank reach despit north atlant fisheri potenti aquacultur gene express examin exist speci systemat evalu refer gene stabil quantit realtim rtpcr qrtpcr studi lack stabil potenti refer gene examin tissu atlant cod popul determin suitabl gene qrtpcr analys rel transcript level gene encod actin actb elong factor efa actinrel protein arp glyceraldehydepdehydrogenas gapdh ubiquitin ubi acid ribosom protein arp ribosom protein s ribosom protein rpl rpl rpl quantifi gill brain liver head kidnei muscl middl intestin juvenil fish three wild popul farm atlant cod refer gene stabil investig genorm normfind tool base calcul perform genorm determin stabl gene set test gene cdna sampl arp ubi rpl stabl gene tissu calcul normfind gene rpl efa rank prefer gene conclus work suggest ubi arp refer gene qrtpcr examin gene express studi wild popul atlant cod
PLoS One	26968698	2012-09-05	PMC2527531	18784843	background isol human antibodi current displai technolog limit constraint protein express fold posttransl modif describ discoveri platform util selfinactiv sin lentivir vector surfac displai highaffin singlechain variabl region scfv antibodi fragment human cell lentiviru particl methodologyprincip find bival scfvfc human antibodi fuse frame transmembran tm anchor moieti allow effici highlevel express human cell optim tm identifi addit amino acid hiv gp envelop incorpor motif increas scfvfc express human cell incorpor lentivir particl antibodydisplai human cell viru particl bound antigen sulfat cdr tyrosin residu properti broaden antibodi bind affin antigen recognit demonstr high level scfvfc express stabl integr achiev human cell transduct ir bicistron sin lentivector encod zsgreen scfvfc fusion protein express cassett fold enrich antibodi express cell achiev round antigen coupl magnet bead preselect fac sort final scfvfc displai human cell directli function biolog screen remark sensit conclusionssignific antibodi displai platform will complement exist technolog virtu provid properti uniqu lentivirus antibodi express human cell turn aid discoveri novel therapeut human mab
BMC Med Inform Decis Mak	22802440	2004-08-01	PMC2527556	18667084	background ideal method encourag uptak clinic guidelin hospit strategi suggest studi evalu impact academ detail computeris decis support system cdss clinician prescrib behaviour patient commun acquir pneumonia cap method manag patient present emerg depart three success time period evalu baselin academ detail cdss period rate empir antibiot prescrib concord recommend studi time compar pre post period interrupt time seri analysi odd ratio concord therapi academ detail period adjust ag ill sever suspicion aspir compar baselin period computeris decis support period compar academ detail period month computeris decis support period improv appropri antibiot prescrib demonstr greater expect occur time academ detail base predict binari logist model conclus deploy computeris decis support system associ earli improv antibiot prescrib practic greater chang academ detail sustain intervent requir evalu
BMC Vet Res	15269074	2015-09-23	PMC2531098	18700011	background enter redmouth erm diseas yersiniosi contagi diseas salmonid rainbow trout caus agent gramneg bacterium yersinia ruckeri diseas diagnos isol identif caus agent detect pathogen fluoresc antibodi test elisa pcr assai diagnost method labori time consum train personnel loopmedi isotherm amplif lamp assai develop evalu detect ruckeri etiolog agent enter red mouth erm diseas salmonid assai optimis amplifi yruiyrur gene encod ruckeri quorum sens system presenc specif primer set bst dna polymeras isotherm temperatur hour amplif product detect visual inspect agaros gel electrophoresi realtim monitor turbid format lamp amplicon digest hphi restrict enzym demonstr amplifi product uniqu specif assai verifi absenc amplif product test bacteria assai fold higher sensit compar convent pcr detect ruckeri pure bacteri cultur tissu homogen infect fish conclus ermlamp assai repres practic altern microbiolog approach rapid sensit specif detect ruckeri fish farm assai carri hour heat block water bath laboratori furnitur advantag ermlamp assai promis tool molecular detect enter red mouth diseas fish farm
BMC Infect Dis	26401043	2013-02-11	PMC2532688	18717989	background rabi major publichealth problem develop countri china reemerg human rabi china epidemiolog studi attent paid reason phenomenon parallel find previou report purpos studi character current trend human rabi china to defin better recommend improv postexposur prophylaxi pep schedul deliv rabi patient method updat epidemiolog data human rabi case januari juli retriev surveil databas report diseas manag ministri health china analys investig effici postexposur treatment rabi detail rabi patient includ antirabi treatment injuri incid ascertain guangdong provinci jurisdict risk factor patient predispos regimen patient receiv type pep analys identifi reason pep failur analysi larg number human rabi case rabi china control period larg jump number report rabi case peak incid rate peopl reach level remain analys pep rabi case collect guangdong provinc and patient seek medic servic receiv pep analysi pep rabi patient receiv type pep indic patient receiv proper time treatment wound postexposur vaccin rabi immunoglobulin conclus issu underreport rabi previou year factor appar upward trend human rabi year analysi pep guangdong provinc evid suggest failur receiv pep major factor number human case china data underlin greatli improv avail time applic highqual antirabi biolog vaccin immunoglobulin treatment human bite victim control dog rabi pet vaccin scheme plai huge role reduc rate human exposur educ public health care staff veterinarian will help chang current situat
PLoS Pathog	23401522	2019-02-13	PMC2533695	18818738	viral surveil program diagnost lab occasion infecti sampl fail type cell cultur serolog nucleic acid test sampl origin insect pool skunk brain human fece sewer effluent collect patholog inocul suckl mice studi sequenceindepend amplif partial purifi viral nucleic acid small scale shotgun sequenc mous brain muscl tissu singl viral agent identifi sampl viru viral genom acquir sequenc plasmid insert virus deriv human fece sewer effluent belong picornavirida famili amino acid ident picornavirus complet polyprotein sequenc viru strong similar simian picornaviru sequenc provision sapeloviru genu insect skunk deriv viral sequenc exhibit amino acid ident rang to segment genom virus reovirida famili isol highli diverg speci orthoreoviru genu speci orbiviru genu demonstr simpl inexpens rapid metagenom approach effect identifi highli diverg virus homogen tissu acut infect mice
PLoS Biol	30760529	2011-06-27	PMC2535663	18798692	positivestrand rna virus larg group includ human pathogen sarscoronaviru sarscov replic cytoplasm infect host cell replic complex commonli associ modifi host cell membran membran structur support viral rna synthesi rang distinct spherular membran invagin elabor web pack membran vesicl gener ultrastructur morphogenesi exact role viral replic remain defin character doublemembran vesicl dmv implic sarscov rna synthesi appli electron tomographi cryofix infect cell threedimension imag coronavirusinduc membran alter high resolut analysi defin uniqu reticulovesicular network modifi endoplasm reticulum integr convolut membran numer interconnect dmv diamet nm vesicl packet aris dmv merger convolut membran abundantli immunolabel viral replicas subunit doublestrand rna presum reveal site viral rna synthesi local dmv interior discern connect dmv interior cytosol analysi rais question mechan dmv format actual site sarscov rna synthesi data document extens virusinduc reorgan host cell membran network organ viral replic hide replic rna antivir defens mechan biochem studi viral enzym complex ultrastructur descript replic network will aid dissect earli stage coronaviru life cycl virushost interact
BMC Mol Biol	21709152	2010-11-01	PMC2535778	18771595	background phi polymeras base amplif method amplifi dna minim chang sequenc rel abund biomed applic rna viru detect microarrai challeng phi dna polymeras amplifi rna small cdna fragment base revers transcript viral rna genom ligat cdna fragment prior phi polymeras base amplif adapt quantitect transcriptom kit qiagen purpos design method transcriptom amplif wta wta amplifi cdna panel rna virus repres divers riboviru genom size amplifi rang genom copi number wta yield quantiti amplifi dna high gl target copi amplif factor vari demonstr coamplif occur viral rna mix bacteri dna conclus report scientif literatur show modifi wga wta approach appli viral genom rna size amplifi viral rna wta consider better sensit accuraci detect compar random rtpcr
BMC Biotechnol	21041640	2010-04-23	PMC2543005	18764933	background venezuelan equin enceph viru veev belong alphaviru group speci famili pathogen human recogn potenti agent biolog warfar terror object work gener recombin antibodi detect veev potenti bioterror assault natur outbreak veev work human antiveev singl chain fragment variabl scfv isol time human nave antibodi gene librari optim select process total eleven scfv identifi immunolog specif assess specif detect veev strain tc select antibodi fragment prove activ formalin inactiv viru particl recogn select antibodi fragment western blot analysi veev protein immunohistochemistri veev infect cell antiveev scfv phage clone crossreact alphaviru speci western equin enceph viru weev eastern equin enceph viru eeev antigen complex react chikungunya viru chikv detect reagent conclus time studi describ select antibodi human pathogen viru human nave scfv antibodi gene librari complet activ viru particl antigen broad sensit applic scfvpresent phage immunolog detect diagnosi alphaviru speci demonstr select antibodi fragment will improv fast identif veev case biolog warfar terrorist attack natur outbreak
BMC Genomics	20414733	2005-03-01	PMC2553098	18793412	bacil calmettegurin bcg attenu strain mycobacterium bovi current vaccin tuberculosi global distribut propag bcg contribut vitro evolut vaccin strain thought partial account outcom bcg vaccin trial previou effort molecular techniqu effect identifi larg sequenc polymorph bcg daughter strain lack resolut identifi smaller chang studi nimblegen tile arrai genom comparison bcg strain approach tandem dna resequenc identifi novel larg sequenc polymorph includ delet duplic specif bcg strain uncov polymorph phopphor locu importantli polymorph affect gene encod establish virul factor includ cell wall complex lipid esx secret system phopphor twocompon system studi demonstr major virul factor bcg strain provid molecular mechan vaccin phenotyp includ advers profil tuberculin reactiv protect efficaci find implic develop gener vaccin
PLoS One	15802951	2015-07-30	PMC2553179	18827877	analys viral proteinprotein interact step understand viral protein function underli molecular mechan studi adopt mammalian twohybrid system screen genomewid intravir proteinprotein interact sar coronaviru sarscov therefrom reveal number novel interact partli confirm vitro biochem assai three pair interact identifi detect direct nonstructur protein nsp nsp nsp nsp nsp nsp interact multifunct nsp nsp nsp uniqu protein member nidoviral larg rna genom includ coronavirus torovirus implic mechan replicationtranscript complex assembl function virus sarscov replicon express luciferas report control transcript regul sequenc viral protein sud domain nsp nsp provid tran stimul replicon report activ indic protein regul coronaviru replic transcript collect find provid basi platform character function mechan coronaviru protein
PLoS Pathog	26172429	2009-09-23	PMC2553261	18846208	poreform toxin pft constitut singl largest class proteinac bacteri virul factor bacteri pathogen host respons toxin complex understood find endoplasm reticulum unfold protein respons upr activ exposur pft caenorhabd elegan mammalian cell activ upr protect vivo pft anim lack irexbp atf arm upr sensit pft wildtyp anim upr act directli cell target pft loss upr lead normal respons unrel toxin pathogen bacterium indic pftprotect role specif mitogenactiv protein mapk kinas pathwai cellular defens pft find upr kei downstream target mapk pathwai respons pft loss function mapk pathwai lead failur pft properli activ irexbp arm upr uprmedi activ respons pft distinct canon uprmedi respons unfold protein term activ function sensit data demonstr upr fundament intracellular pathwai oper intrins cellular defens bacteri attack
BMC Bioinformatics	19776127	2017-07-18	PMC2553803	18783594	background pathogen detect dna microarrai potenti fast comprehens diagnost tool pathogen detect chip current util random primer specif primer rtpcr step bia inher random pcr amplif seriou problem larg inaccuraci hybrid signal paper studi effici random pcr amplif hybrid signal describ model predict amplif effici random primer target viral genom predict allow filter falseneg probe genom lie region poor random pcr amplif improv accuraci pathogen detect subsequ propos loma algorithm gener random primer good amplif effici wetlab valid gener random primer improv amplif effici conclus blind random primer attach univers tag randomtag primer pcr reaction pathogen sampl lead success amplif design randomtag primer consider perform pcr
BMC Infect Dis	28719693	2011-08-05	PMC2556339	18793441	background baselin data monitor popul perceiv threat pandem influenza perceiv behav event pandem influenza aim develop modul question telephon health survei percept threat pandem influenza prepared compli specif public health behaviour event pandem influenza method modul question develop field test adult south wale depart health inhous comput assist telephon interview cati facil question modifi field test adult modul incorpor south wale popul health survei quarter repres sampl adult complet modul respons weight state popul reliabl question accept kappa rang state popul thought pandem influenza extrem occur extrem concern famili pandem influenza occur level chang live life possibl pandem influenza event pandem influenza major popul vaccin isol wear face mask peopl higher level threat percept compli specif public health behaviour conclus state popul thought pandem influenza extrem occur higher proport concern famili pandem occur baselin data collect survei will monitor chang time popul percept threat prepared compli specif public health behaviour
PLoS One	21821742	2016-05-01	PMC2561066	18923707	background studi wild anim respond nativ parasit essenti understand immun system function natur environ immun defenc bring increas surviv resourc cost physiolog trait includ reproduct test hypothesi wild common shrew sorex araneu produc larg number offspr breed season short life span forgo invest immun immun system mainten increas longev bring opportun mate predict adult shrew shorter expect lifespan respond effect young anim infect methodologyprincip find examin haemolymphat tissu wildcaught common shrew light transmiss electron microscopi appli conjunct immunohistolog compar composit function tissu shrew ag extent type inflammatori reaction observ respons natur parasit infect ag mount system specif immun respons adult shrew sign lymphat tissu exhaust lymphat follicl adult smaller subadult wald exhibit greater level deplet wald conclusionssignific contrari expect shrew respond effect natur parasit indic immunosenesc adult pancrea aselli uniqu lymphoid organ aid provid effici immun respons storag larg number plasma cell allow older anim react effect encount parasit infect novel agent eventu deplet plasma cell reserv factor nearsynchron mortal adult shrew observ shortli breed
PLoS Pathog	27162653	2016-05-09	PMC2563037	18949029	high affin antigenspecif cell plai critic role protect immun respons epitop enhanc elicit potent cell respons subsequ lead stronger memori pool molecular basi enhanc unclear consensu peptidebind motif major histocompat complex molecul hkb design heteroclit version mous hepat virusspecif subdomin determin demonstr singl amino acid substitut secondari anchor residu posit increas stabil engin determin complex hkb structur basi enhanc stabil associ local alter pmhc conform result substitut recombin virus encod engin determin prime ctl respons react wildtyp epitop higher function avid protect select viru mutat second ctl determin consequ diseas progress persist infect mice collect find provid basi enhanc immunogen engin determin will serv templat guid develop heteroclit cell determin applic prevent ctl escap chronic viral infect tumor immun
PLoS One	27196775	2017-08-01	PMC2565067	18941622	background aim hepat viru hcvrelat liver diseas progress rapidli individu coinfect human immunodefici viru hiv underli immunolog mechan unknown examin hivspecif tcell identifi liver hcvhiv coinfect individu promot liver inflamm bystand immun respons method exvivo intrahepat lymphocyt hcv monoinfect hcvhiv coinfect individu assess immun respons hiv hcv antigen polychromat flow cytometri hcvhiv liver biopsi frequenc lymphocyt lower percentag cd tcell compar hcv biopsi coinfect intrahepat hivspecif cd cd tcell produc ifn tnf detect compar frequenc hcvspecif coinfect individu viralspecif cd tcell produc fibrogen cytokin tnf mono coinfect individu intrahepat hcvspecif tcell function compar hivspecif tcell coinfect haart associ reconstitut intrahepat cd tcell associ reduct hiv hcvspecif intrahepat cytokin respons conclus accumul function hivspecif tcell liver hcvhiv coinfect repres bystand role hiv induc faster progress liver diseas
Ann Clin Microbiol Antimicrob	29103421	2006-09-20	PMC2566554	18817537	background year realtim pcr lead techniqu nucleic acid detect quantif assai potenti greatli enhanc effici clinic laboratori choic primer probe sequenc critic accur diagnosi clinic current primerprob signatur design strategi limit signatur evalu method lack method assess qualiti signatur predict number true posit fals posit fals neg hit public sequenc data realtim pcr signatur describ literatur blast search base approach collect hit primerprob combin amplifi realtim pcr chemistri compar hit sequenc ncbi taxonomi tree signatur design detect publish signatur high specif fals posit low sensit high fals neg rate high sensit need offer revis methodolog signatur design design multipl signatur requir detect sequenc strain methodolog produc signatur predict higher sensit specif conclus current method realtim pcr assai design unaccept low sensit clinic applic addition sequenc data assai reassess redesign standard protocol gener assess qualiti assai great realtim pcr capac greatli improv clinic diagnost improv assai design evalu method present will expedit adopt techniqu clinic lab
BMC Evol Biol	16987975	2012-09-25	PMC2567993	18801176	background femal endoparasit ichneumonid wasp inject viruslik particl caterpillar host suppress immun particl classifi ichnoviru virion resembl ascoviru virion transmit parasit wasp attack caterpillar ascovirus replic dna produc virion polydnaviru dna consist wasp dna replic wasp genom direct particl synthesi structur similar ascoviru ichnoviru particl biologi transmiss ichnovirus evolv ascovirus molecular evid hypothesi lack famili uniqu poxd ntpase protein glypta fumiferana ichnoviru three diadromu pulchellu ascoviru protein encod orf align techniqu protein ichnoviru ortholog ascoviru virion protein conclus provid molecular evid support origin ichnovirus ascovirus later transfer ascovir gene ichneumonid wasp genom exampl symbiogenesi larg dna virus eukaryot organ discuss limit evid complementari studi reveal passiv later transfer viral gene polydnavir bacteri wasp genom occur repeatedli intim coupl recombin replic viral genom evolut impact passiv later transfer evolutionari relationship polydnavirus virus larg doublestrand genom consid context theori symbiogenesi
PLoS One	23010928	2007-06-20	PMC2569416	18958172	preexist immun human adenoviru serotyp ad common gener popul bypass preexist immun maxim ad vaccin efficaci vaccin intramuscular nasal oral po rout ad express ebola zair glycoprotein adzgp fulli protect nave mice lethal challeng ebola presenc preexist immun mice vaccin surviv frequenc ifn cd cell reduc by anim vaccin po rout neutral antibodi detect serum treatment group preexist immun compromis frequenc ifn cd cell nave preexist immun pei antiebola neutral antibodi nab reciproc dilut group number inf cd cell detect bronchioalveolar lavag fluid bal immun compromis preexist immun ad nave sfcmillion mnc pei preexist immun reduc nab level bal group improv immun respons oral vaccin adbas vaccin pegyl mice modifi vaccin surviv challeng reduc level ifn cd cell dai administr peg unmodifi pegyl increas nab level fold provid insight degre cell mediat immun protect ebola viru modif viru capsid influenc type immun respons elicit adbas vaccin
Virol J	17581984	2009-08-01	PMC2569924	18822184	background report apathogen tula hantaviru induc apoptosi vero epitheli cell assess molecular mechan induc apoptosi studi effect hantaviru infect cellular signal pathwai promot cell surviv observ tula virusinduc cell death process augment extern tnf tnf involv pathogenesi hantaviruscaus hemorrhag fever renal syndrom hfr investig effect hfrscaus hantavirusinfect cell studi apathogen tula topografov pathogen puumala seoul hantavirus abil regul cellular signal pathwai observ direct virusmedi downregul extern signalregul kinas erk surviv pathwai activ dramat enhanc tnf fold erk inhibit correl viral replic effici vari drastic hantavirus studi conclus demonstr presenc cytokin tnf increas hfr patient hantavirus capabl inactiv protein promot cell surviv erk impli hantavirusinfect epitheli cell barrier function compromis diseas individu partial explain mechan renal dysfunct proteinuria hfr patient
BMC Public Health	19540545	2016-01-01	PMC2571100	18831770	background australia experienc outbreak highli infecti equin influenza govern diseas control measur place control erad diseas measur includ movement restrict quarantin properti studi conduct assess psychosoci impact diseas paper report preval factor influenc psycholog distress outbreak method data collect onlin survei link direct popul number industri group psycholog distress determin kessler psycholog distress scale main outcom measur total peopl particip studi extrem high level nonspecif psycholog distress report respond studi report high psycholog distress compar level australian gener popul analysi backward stepwis binari logist regress analysi reveal live high risk infect red zone ci diseas buffer amber zone ci greater risk high psycholog distress live uninfect white zone preval high psycholog distress greater infect ei zone state elev level psycholog distress experienc horseown nation statist analysi indic group vulner high psycholog distress younger peopl lower level formal educ qualif respond princip sourc incom horserel industri high psycholog distress primari sourc incom link horserel industri ci conclus methodolog studi good intern valid limit generalis identifi bound sampl target popul accur studi collect psycholog distress data popul diseas outbreak potenti inform involv assess potenti psycholog impact human infecti diseas pandem influenza
PLoS Pathog	30090376	2018-07-04	PMC2572002	18989460	phylogenet analys provid strong evid amino acid chang spike protein anim human sar coronavirus sarscov zoonot transfer result posit select studi support amino acid chang anim human virus result interspeci adapt role neutral antibodi nab drive sarscov evolut intraspeci transmiss unknown detail examin sarscov infect anim human convalesc sera provid evid nab pressur lead strategi effect block viru evolut pathwai broaden activ nab focus domin neutral epitop contemporan crossstrain nab respons sarscov spike protein exist natur infect vitro immun pressur epitop strainspecif nab recapitul domin escap mutat anim human virus strategi block nab escapenatur occur evolut pathwai gener broad nab bnab activ escap mutant strain explor structurebas amino acid chang activationinduc cytidin deaminas aid hot spot light chain cdr complementar determin region introduc shuffl natur occur nonimmun human vl chain repertoir target mutagenesi success gener bnab demonstr nabmedi immun pressur drive forc posit select intraspeci transmiss sarscov somat hypermut shm singl vl cdr markedli broaden activ strainspecif nab strategi investig studi structur combin chainshuffl hotspot cdr mutagenesi exploit broaden neutral activ improv antivir nab therapi directli manipul viru evolut
PLoS Pathog	29970199	2010-08-04	PMC2572141	18989459	the type interferon ifn system defens viral infect virus develop mechan counteract respons interferon antagonist activ influenza virus observ level ifn gene induct action viral nonstructur protein ns data indic influenza virus suppress ifn gene induct inhibit type ifn signal mechan involv induct suppressor cytokin signal soc protein studi base observ cell infect influenza viru subsequ stimul ifn phosphoryl signal transduc activ transcript protein stat reduc impair stat activ action viral protein appear induc accumul viral triphosph rna cell soc protein potent endogen inhibitor janu kinas jakstat signal closer examin reveal soc soc mrna level increas rna nuclear factor kappa nfbdepend type ifnindepend manner earli viral replic cycl direct viral induct soc mrna protein express appear relev suppress antivir respons soc defici cell sustain phosphoryl stat correl elev express type ifndepend gene consequ progeni viru titer reduc soc defici cell cell soc express knockeddown sirna data provid evid influenza virus suppress type ifn signal level jakstat activ inhibitori induct soc gene express impair antivir respons
PLoS Biol	20686017	2003-08-01	PMC2573941	18959488	how understand rna virus usurp transform intracellular architectur host cell replic
Virol J	12869709	2008-07-30	PMC2575341	18925940	background europ northsouth downhil cline frequenc chemokin receptor ccr allel bp delet ccr rais interest question evolutionari biologist suggest the european colon princip roman instrument progress decreas frequenc southward statist analys suggest strong neg correl allel frequenc histor paramet includ colon date mediterranean civilis gene flow colon nativ popul extrem low colon respons spread diseas suggest dissemin parasit naiv popul induc breakdown ruptur fragil pathocenosi chang balanc diseas equilibrium state reach neg select null allel human diseas zoonos cat instrument decreas allel frequenc diffus europ gradual process princip roman cat zoonos transmit man implic felin lentiviru fiv ccr coreceptor discuss viru infect primat cell vitro induc clinic sign macaqu histor region null low frequenc ccr allel coincid histor rang wild felid speci harbor speciesspecif fiv conclus propos hypothesi actual european ccr allel frequenc result neg select diseas spread cat zoonosi plausibl hypothesi futur studi provid ccr plai antimicrobi role fiv pathogenesi studi ancient dna provid evid implic zoonos actual ccr distribut
PLoS Pathog	18667425	2014-06-04	PMC2576454	19008951	the earli system product interferon ifn essenti compon antivir host defens mechan thought contribut toxic side effect accompani gene therapi adenovir vector investig ifn respons human adenovirus ad mice compar respons normal myeloid mdc plasmacytoid pdcdeplet mice measur ifn mrna express organ cell type vivo ad elicit strong rapid ifn product exclus splenic mdc knockout mice strain ad wild type mutant uvinactiv map kinas inhibitor demonstr adinduc ifn respons requir tolllik receptor tlr cytosol sensor rna rigimda dna dai recognit interferon regulatori factor irf depend viral endosom escap signal map kinas sapkjnk irf ad induc ifn il vivo distinct pathwai confirm ifn posit regul il respons final measur tnf respons lp adinfect wild type ifnr mice ifn kei mediat adinduc hypersensit lp find indic endosom tlr signal pdc tlrindepend viru recognit splenic mdc produc robust earli ifn respons respons bulk ifn product induc adenoviru vivo signal requir tlrdepend cytosol ifn induct mechan novel cytosol viral induct pathwai hypersensit compon microbi flora invad pathogen explain toxic side effect adenovir gene therapi contribut pathogenesi adenovir diseas
Genet Vaccines Ther	24732460	2010-05-05	PMC2577087	18940009	in develop novel chimer htnvilg dna vaccin plasmid genet link il gene segment dna test candid vaccin chimer gene express eukaryot express system pcdna htnvilg express kda fusion protein co cell fusion protein activ parent protein balbc mice vaccin chimer gene elisa cell microcultur neutral test vitro detect humor immun respons immun balbc mice lymphocyt prolifer assai detect cellular immun respons the chimer gene simultan evok specif antibodi glycoprotein il immun mice group elicit neutral antibodi titer lymphocyt prolifer assai stimul index splenocyt chimer gene il higher group ilbas htnv dna induc humor cellular immun respons specif htnv candid dna vaccin htnv infect
BMC Public Health	20444893	2015-03-26	PMC2577657	18842127	background tuberculosi tb detect nation tb control program china passiv casefind guidelin influenc access health servic patient healthcar seek behavior intrigu topic correl men women knowledg tb healthcar seek behavior method crosssect studi separ carri yangzhong counti rural area china studi systemat sampl method includ subject conduct investig tb knowledg gener popul studi sourc popul screen peopl ag year stratifi clustersampl villag identifi prolong cough patient household individu interview carri gender differ knowledg tb healthcar seek behavior analyz gener popul men women knew prolong cough durat week longer symptom suspici tb fewer women men knew local appoint health facil tb diagnosi treatment current free tb servic polici women learn tb share initi contrari onset prolong cough women seek healthcar men larg women prefer visit lower level nonhospit health facil villag clinic drugstor conclus tb dot program rural chines gender issu consid reduc diagnost delai tb improv men women access qualifi health facil tb care strengthen awar tb improv access healthcar servic essenti tb control strategi current vertic tb control system
BMC Infect Dis	25960925	2018-04-01	PMC2577677	18947382	background antibiot recommend sever acut exacerb chronic obstruct pulmonari diseas aecopd admit intens care unit icu serum procalcitonin pct tool select patient lower probabl develop bacteri infect measur investig popul method conduct singl center prospect cohort studi consecut copd patient admit icu aecopd septemb septemb sputum sampl tracheal aspir test presenc bacteria virus pct level measur time admitt hour hour sensit immunoassai thirti aecopd patient includ requir ventil support admiss median interquartil rang pct level assess patient gl iqr time admiss gl iqr hour gl iqr hour highest pct pctmax level gl patient gl patient suggest low high probabl bacteri infect speci bacteria speci virus detect patient patient posit pseudomona aeruginosa pctmax gl three pctmax gl patient posit haemophilu influenza pctmax gl presenc absenc virus influenc pct time admiss gl conclus likelihood bacteri infect low copd patient admit icu aecopd pct gl suggest inappropri antibiot studi assess impact procalcitoninbas therapeut strategi critic copd patient
PLoS Pathog	29537337	2016-02-01	PMC2582959	19043556	ebola viru ebov human pathogen present public health concern emergingreemerg viru potenti biolog weapon substanti progress decad develop candid prevent vaccin protect nonhuman primat ebov prospect vaccin base recombin vesicular stomat viru vsv robust confer protect administ postexposur treatment concern rais replicationcompet vsv vector express ebov glycoprotein vector toler individu alter compromis immun system patient infect hiv ebov outbreak occur area central western africa high hiv incid rate popul order address concern evalu safeti recombin vsv vector express zair ebolaviru glycoprotein vsvgzebovgp rhesu macaqu infect simianhuman immunodefici viru shiv anim evid ill associ vsvgzebovgp vaccin suggest vaccin safe immunocompromis popul goal studi evalu safeti candid vaccin platform interest determin alter immun statu affect vaccin efficaci vaccin protect shivinfect macaqu death zebov challeng evalu cd cell anim anim succumb lethal zebov challeng lowest cd count suggest cd cell plai role mediat protect zebov
PLoS One	26741826	2010-01-25	PMC2583042	19030226	first discov earli reovirus respiratori enter orphan virus associ diseas name orphan virus group report isol melaka viru patient acut respiratori diseas provid data suggest orthoreoviru capabl humantohuman transmiss bat origin report melakalik reoviru name kampar viru isol throat swab year male patient kampar perak malaysia suffer high fever acut respiratori diseas vomit time viru isol serolog studi indic kampar viru transmit case individu caus respiratori diseas contact case sequenc analysi small class genom segment indic kampar melaka virus close confirm viru neutral assai show effect twowai cross neutral serum viru neutral the exact origin kampar viru unknown epidemiolog trace reveal hous case surround fruit tree frequent visit fruit bat high probabl kampar viru origin bat transmit human bat drop contamin fruit discoveri kampar viru highlight increas trend emerg bat zoonot virus expand understand bat sourc unknown virus
Virol J	20100751	2008-10-01	PMC2583970	18937850	background cotton blue diseas cbd global cotton crop patholog respons major econom loss preval major cottonproduc state brazil typic cbd symptom includ stunt internod shorten leaf roll intens green foliag yellow vein atyp cbd symptom includ reddish wither leav observ brazilian cotton field poleroviru name cotton leafrol dwarf viru clrdv associ cbd understand distribut genet divers clrdv brazil analyz cbdsymptomat plant suscept cotton varieti origin cottongrow state report clrdv divers plant typic atyp cbd symptom compar viral coat protein rna polymeras rdrp intergen region genom sequenc conclus viru widespread distribut low genet divers three diverg isol associ atyp cbd symptom diverg isol clrdvrelat coat protein distinct rdrp sequenc aros recombin event base taxonom rule famili luteovirida propos three isol repres isol speci genu poleroviru
BMC Med Genomics	18781156	2002-04-07	PMC2584050	18950519	background gastric cancer surviv remain poor reliabl method identifi highli curabl earli stage diseas multiprotein profil gastric fluid anatom site patholog reveal diagnost proteom fingerprint method protein profil gener gastric fluid sampl gastric cancer benign gastritid patient undergo elect clinicallyind gastroscopi surfaceenhanc laser desorptionion timeofflight mass spectrometri multipl proteinchip arrai proteom featur compar signific analysi microarrai algorithm twowai hierarch cluster second blind sampl set gastric cancer clinic benign gastritid valid signific analysyi microarrai proteom featur upregul downregul gastric cancer sampl multimark cluster distinct proteom profil independ ag ethnic eighteen cancer sampl cluster sensit noncanc sampl cluster second group noncanc sampl cluster cancer sampl includ premalign lesion adenomat polyp intestin metaplasia valid second sampl set sensit specif posit predict combin data select peptid sequenc identifi pepsinogen pepsin activ peptid downregul alphadefensin upregul conclus simpl reproduc multimark proteom assai supplement clinic gastroscop evalu symptomat patient enhanc diagnost accuraci gastric cancer premalign lesion
J Occup Med Toxicol	11934357	2007-08-03	PMC2585571	18990205	background increas evid exist heavi metal modul helper cell respons elicit patholog manifest interleukin il crucial innat cytokin regul xenobiot agent studi aim test il profil indic heavi metalsinduc immunomodul method human immunocompet cell activ monoclon antibodi heatkil salmonella enterica cultur absenc presenc cadmium cd acet mercur hg chlorid vivo experi set balbc mice expos subleth dose cd hg salt week cytotox assess mttreduct assai modul cytokin profil evalu enzymelink immunosorb assai elisa cytometr beadbas arrai cba realtim polymeras chain reaction rtpcr relev method cytokin quantif explor modul il profil cd hgexpos human pbmc dosedepend ifn level thpolar respons skew thth ratio vivo correl downregul il level case investig metal conclus infer il profil repres relev indic heavi metalinduc immun modul ii evalu cytokin profil cba relev adequ replac method elisa rtpcr basic immun diagnost iii target il therapeut approach promis modifi ththassoci immun disord
PLoS Pathog	17678556	2006-03-31	PMC2587711	19079577	two cardin manifest viral immun effici clearanc acut infect capac vaccin secondari viral exposur norovirus contribut cell viral clearanc vaccin elucid report cd cd cell requir effici clearanc primari murin noroviru mnv infect intestin intestin lymph node longlast protect immun gener oral live viru vaccin system vaccin mnv capsid protein effect protect mucos challeng vaccin capsid protein distantli human lordsdal viru provid partial protect fulli effect vaccin requir broad immun respons includ cd cell cd cell cell specif immun cell type vari intestin intestin lymph node perforin interferon gamma requir clearanc mnv infect adopt transfer lymphocyt vaccin host studi prove feasibl mucos system vaccin mucos noroviru infect demonstr tissu specif noroviru immun cell indic effici vaccin strategi induc potent cd cd cell respons
PLoS Pathog	16581910	2007-08-01	PMC2587915	19079579	a novel human coronaviru sarscov emerg suddenli caus human case death worldwid anim model fail faithfulli recapitul clinic cours sarscov human viru host factor mediat diseas pathogenesi remain unclear laboratori develop recombin mouseadapt sarscov rma lethal balbc mice contrast intranas infect young weekold cbl mice rma nonleth infect character high titer replic lung lung inflamm destruct lung tissu loss bodi weight provid model identifi host mediat protect report mice defici myd myd adapt protein mediat tolllik receptor tlr ilr ilr signal suscept rma infect genet absenc myd enhanc pulmonari patholog greater mortal dai postinfect myd mice higher viral load lung tissu cours infect despit increas viral load express multipl proinflammatori cytokin chemokin lung tissu recruit inflammatori monocytesmacrophag lung sever impair myd mice compar wildtyp mice mice defici chemokin receptor contribut monocyt recruit lung suscept rmainduc diseas exhibit sever lung patholog mydmic data mydmedi innat immun signal inflammatori cell recruit lung requir protect lethal rma infect
Asia Pac Fam Med	17670827	2017-09-22	PMC2588555	19014538	there three influenza pandem flu pandem highest mortal rate influenza viru infect human bird mutat mechan antigen drift antigen shift current hn avian flu viru limit outbreak poultri person direct contact infect poultri mortal rate infect human high avian influenza ai endem asia result unregul poultri rear rural area bird live close proxim human increas chanc genet reassort avian human influenza virus produc mutant strain easili transmit human global pandem sar person influenza infect contagi onset casedefin symptom limit effect case isol control strategi research carefulli orchestr public health measur limit spread ai pandem implement case appear control ai pandem nation global strategi need nation strategi includ sourc surveil control adequ stockpil antivir agent time product flu vaccin healthcar system readi global strategi earli integr respons curb diseas outbreak sourc util global resourc continu open commun critic
J Neuroinflammation	28937879	2011-11-01	PMC2588578	18947414	background worldwid billion peopl chronic infect toxoplasma gondii unknown consequ method better understand longterm effect pathogenesi common persist brain infect mice infect time human year equival earli mid adulthood studi month appear behavior neurolog function brain mri studi addit analys pathogenesi includ correl brain weight neurolog find histopatholog focus brain region full genom microarrai immunohistochemistri character inflammatori cell determin presenc tachyzoit bradyzoit electron microscopi studi marker inflamm serum histopatholog genet resist mice cytokin nramp knockout mice effect inocul isol parasit treatment sulfadiazin pd ligand studi twelv month infect time equival middl earli elderli ag mice behavior neurolog deficit brain mri mild moder ventricular dilat lower brain weight correl greater magnitud neurolog abnorm inflamm full genom microarrai brain reflect inflamm caus neuron damag gfap effect host cell protein process ubiquitin ligas synaps remodel complement increas express pdl ligand allow persist lcmv brain infect cd fatti acid translocas oxid ldl receptor mediat innat immun respons beta amyloid associ proinflamm alzheim diseas immunostain detect inflamm intraneuron cyst practic free tachyzoit rare bradyzoit perivascular leptomening inflammatori cell contigu aqueduct sylviu hippocampu cd cd cell activ microglia perivascular area brain parenchyma genet resist chronic infect mice inflamm conclus outbr mice chronic adult acquir gondii infect neurolog behavior abnorm secondari inflamm loss brain parenchyma perivascular inflamm promin contigu aqueduct sylviu hippocampu resist mice perivascular inflamm mous model chronic gondii infect rais question persist parasit brain inflamm neurodegener genet suscept host
Crit Care	22005305	2005-03-01	PMC2592769	18950526	introduct clinic observ anim model provid evid develop acut lung injuri ali phenomenon acut diffus lung inflamm critic patient influenc genet factor associ studi main tool explor common genet variat underli ali suscept andor outcom aim assess qualiti posit genet associ studi ali suscept andor outcom adult order highlight consist major limit method conduct broad pubm literatur search june origin articl english support posit associ genet variant contribut allcaus ali suscept andor outcom studi evalu base current recommend point qualiti score system deriv criteria gene consid unit replic gene categor biolog process gene ontolog search identifi total studi report posit find gene involv respons extern stimulu cell signal transduct gene encod interleukin mannosebind lectin surfact protein angiotensinconvert enzym replic studi averag studi intermedi qualiti score median interquartil rang conclus qualiti associ studi improv year better design studi includ replic previou find larger sampl size extend popul group european descent need identifi firm genet modifi ali
Virol J	15735160	2014-10-31	PMC2603006	19014487	background coronavirus broad rang diseas anim human human coronaviru hcov nl associ common cold viral plaqu assai enabl character viru infect allow purifi viru stock solut essenti drug screen hitherto cell cultur hcovnl low level viru replic weak diffus cytopathogen effect establish practic plaqu assai human pathogen cell cultur test suscept hcovnl infect human colon carcinoma cell caco replic viru fold effici commonli african green monkei kidnei cell llcmk caco cell cytopathogen effect dai post infect avicel agaros carboxymethylcellulos overlai prove suitabl plaqu assai best achiev avicel produc larg clear plaqu dai infect util plaqu assai agros overlai demonstr purifi viru increas viral infect log pfuml conclus caco cell support hcovnl better llcmk cell enabl cytopathogen plaqu assai avicel overlai favour plaqu quantif agaros overlai prefer plaqu purif hcovnl viru stock increas infect will benefici antivir screen anim model diseas experiment task
BMC Public Health	25362048	2016-05-01	PMC2605461	18973664	background attack sever acut respiratori syndrom sar develop qualifi public health leader urgenc build infrastructur need address public health emerg previou studi report train individu leader approach system scientif train model improv develop purpos studi develop deliv evalu participatori leadership train program emerg respons method fortyon public health leader provinc complet entir emerg prepared train program china program evalu anonym questionnair semistructur interview held prior train posttrain month train followup emerg prepared train posit shift knowledg selfassess skill public health leader ninetyf percent particip report train model scientif feasibl respons particip program avian influenza outbreak plan evalu leadership train program demonstr success approach method posit impact integr leadership train initi conclus emerg prepared train program met aim object satisfactorili improv emerg capabl public health leader suggest leadership train model effect feasibl improv emerg prepared capabl
PLoS One	26880796	2008-07-16	PMC2606062	19122813	background equin herpesviru type ehv member alphaherpesvirina spread nasal secret respiratori diseas neurolog disord abort viru equin pathogen current ehv vaccin partial protect effect metaphylact therapeut agent small interf rna sirna deliv intranas prove valuabl altern infect control sirna essenti ehv gene encod viral helicas ori glycoprotein evalu potenti decreas ehv infect mous model methodologyprincip fnding sirna therapi vitro reduc viru product plaqu size viral titer reduc fold pmol singl sirna pmol sirna combin sirna therapi vivo reduc viral replic clinic sign intranas treatment requir transport vehicl prove effect infect conclusionssignific sirna treatment potenti prevent earli treatment ehv infect
BMC Genomics	18632870	2013-08-21	PMC2607299	19046445	background febril respiratori ill fri high impact public health global econom pose difficult challeng differenti diagnosi issu detect genet divers pathogen human rhinovirus hrv enterovirus hev frequent fri resequenc pathogen microarrai technolog demonstr potenti differenti diagnosi respiratori pathogen simultan high confid design method select probe genet divers virus lack hrv hev test case assess gener design strategi detect serotyp genet divers virus minim number probe sequenc hrv hev capabl detect serotyp hrv hev determin implement resequenc pathogen microarrai rpmflu tessara rpmflu specif design probe valid hrv hev strain strain detect identifi speci level hrv strain hev strain differenti serotyp level conclus studi fundament evalu simultan detect differenti identif genet divers rna virus minim number prototyp sequenc demonstr newli design rpmflu provid comprehens specif analysi hrv hev sampl implic design strategi will applic genet divers virus
BMC Microbiol	23966403	2008-11-01	PMC2613400	19038059	background absenc effect drug control sar reli rapid identif case appropri manag close contact effect vaccin sar develop specif sensit laboratori test sar effect vaccin nation author gene encod truncat nucleocapsid spike protein sarscov clone express vector pqe fusion express escherichia coli fusion protein analyz reactiv sar patient sera antisera human coronavirus hcov hcov oc elisa ifa immunoblot assai evalu antigenspecif humor antibodi tcell respons mice fusion protein inject weekold balbc mice neutral test tcell analysi perform evalu antivir efficaci immun balbc mice challeng intranas sarscov dai post inject viral load determin fluoresc quantit rtpcr serolog diagnost sensit specif truncat sn fusion protein deriv sar viru crossreact human coronavirus high titer antibodi srascov appear immun mice neutral test antibodi fusion protein inhibit sarscov cell prolifer fusion protein induc antigenspecif tcell respons fluoresc quantit rtpcr balbc mice challeng intranas sarscov dai post inject complet protect viru replic conclus truncat sn fusion protein suitabl immunodiagnost antigen vaccin candid
PLoS One	19727424	2007-11-13	PMC2613559	19159014	mucos vaccin offer great advantag induc protect immun respons prevent viral transmiss dissemin report find headtohead comparison viral vector modifi vaccinia ankara mva novel replicationcompet modifi vaccinia tian tan mvtt induc neutral antibodi nab intramuscular mucos vaccin mice mvtt attenu variant wildtyp vtt histor smallpox vaccin million chines peopl spike glycoprotein sarscov test antigen gene construct ident genom locat vector gener vaccin candid mvtt mva ident dose mvtt induc lower level fold anti sarscov neutral antibodi nab mva intramuscular inocul mvtt capabl induc consist tofold higher level nab mva inocul intranas intraor rout level mvttsinduc nab respons fold higher induc intramuscular rout experi preexposur wildtyp vtt intranas intraor rout impair nab respons rout mvtt vaccin preexist antivtt nab respons efficaci intranas intraor vaccin tofold better intramuscular inocul despit subcutan preexposur wildtyp vtt data implic peopl maintain low level antivtt nab histor smallpox vaccin mvtt attract live viral vector mucos vaccin
PLoS One	17999949	2011-03-02	PMC2613561	19137067	background influenza pneumonia high mortal year pandem episod kill million peopl influenzarel mortal various ascrib ineffect host respons fail limit viral replic excess host inflammatori respons lung injuri impair ga exchang bacteri superinfect sought determin lung inflamm promot impair host surviv influenza pneumonia method find distinguish influenzarel death induc robust lung inflamm expos mice aerosol bacteri lysat prior challeng live viru treatment induc express inflammatori cytokin il tnf bronchoalveolar lavag fluid fold greater caus lethal influenza infect augment inflamm associ strike resist host mortal surviv reduc viral titer bacteri superinfect viru infect lung observ mice repeatedli expos bacteri lysat clinic desir influenza epidem tachyphylaxi induc viral resist bacteri lysat administ viral challeng mortal benefit ribavirin aerosol bacteri lysat host surviv synergist improv surviv conclus data indic innat immun resist influenza effect stimul ineffect excess inflamm major mortal influenza pneumonia
BMC Health Serv Res	21367909	2014-10-16	PMC2613902	18990210	background sar epidem healthcar util medic servic decreas longterm impact sar hospit perform discuss method municip hospit taipei citi shut month sar design sar infecti diseas hospit citi studi collect outpati inpati emerg servic volum year april march year averag monthli servic amount standard deviat compar patient volum hospit outpati number access depart arima model outpati volum presar year develop averag monthli servic volum outpati visit base year visit month number year base year averag emerg servic volum visit month base year base year three year averag inpati servic volum inpati dai month base year base year three year emerg servic volum recov level nonsignific differ second year sar addit depart famili medicin metabol nephrolog reach patient number arima model suitabl outpati volum presar year mape arima model presar year year conclus studi demonstr hospit complet shut sar diseas impact longer previou report depart experi recov period find studi identifi subspecialti vulner infecti diseas design hospit hospit consid subspecialti includ medic structur
Evol Bioinform Online	25323704	2009-03-01	PMC2614192	19204824	thi investig aim compar infer antelop phylogeni rrna cytochromeb cytb dloop segment mitochondri dna three comput model includ bayesian ba maximum parsimoni mp unweight pair group method arithmet upgma respect nucleotid sequenc three oryx speci oryx leucoryx oryx dammah oryx gazella outgroup addax nasomaculatu align subject ba mp upgma model compar topolog respect phylogenet tree rrna region possess highest frequenc conserv sequenc cytb dloop transit transvers rrna compar cytb transit transvers dloop transit transvers compar taxa three mitochondri segment clearli differenti genu addax oryx ba upgma model topolog gammacorrect bayesian tree ident irrespect marker type upgma tree rrna dloop sequenc ident oryx dammah group oryx leucoryx bayesian tree upgma tree base cytb phylogeni oryx dammah group oryx gazella low bootstrap support mp model fail differenti genu addax oryx find demonstr effici robust ba upgma method phylogenet analysi antelop mitochondri marker
PLoS One	19131084	2014-12-03	PMC2614347	19137069	lung cancer lead cancerrel mortal worldwid lack tumor specif remain major drawback effect chemotherapi doselimit toxic ligandmedi drug deliveri system render chemotherapi specif tumor cell toxic normal tissu studi isol novel peptid ligand phagedisplai peptid librari bound nonsmal cell lung cancer nsclc cell line target phage bound nsclc cell line normal cell target phage synthet peptid recogn surgic specimen nsclc posit rate of specimen sever combin immunodefici scid mice bear nsclc xenograft target phage bound tumor mass tumor home abil target phage inhibit cognat synthet peptid control wtymut peptid target peptid coupl liposom carri doxorubicin vinorelbin therapeut chemotherapeut agent surviv rate mice human lung cancer xenograft markedli increas target liposom increas drug accumul tumor tissu fold compar free drug enhanc cancer cell apoptosi higher concentr bioavail doxorubicin current studi suggest tumorspecif peptid creat chemotherapi target tumor cell treatment nsclc design target gene transfer vector diagnosi malign
PLoS Biol	25473061	2006-12-20	PMC261870	14624234	becaus constant threat pose emerg infecti diseas limit exist approach identifi pathogen great demand technolog method viral discoveri describ dna microarraybas platform novel viru identif character central approach dna microarrai design detect wide rang virus novel member exist viral famili microarrai contain highli conserv mer sequenc fulli sequenc refer viral genom genbank outbreak sever acut respiratori syndrom sar march hybrid microarrai reveal presenc uncharacter coronaviru viral isol cultiv sar patient character viru kb unknown viru genom clone physic recov viral sequenc hybrid individu arrai element sequenc fragment confirm viru member coronaviru famili combin arrai hybrid direct viral sequenc recoveri prove gener strategi rapid identif character novel virus emerg infecti diseas
PLoS One	17182688	2016-12-30	PMC2625438	19156204	background immunopathogenesi chikungunya viru circul level immun mediat growth factor analyz patient infect singaporean chikungunya fever outbreak earli establish biomark associ infect andor diseas sever method find adult patient laboratoryconfirm chikungunya fever infect refer communic diseas centretan tock seng hospit period januari februari includ retrospect studi plasma fraction analyz multiplexmicrobead immunoassai patient common clinic featur fever arthralgia rash conjunct profil cytokin chemokin growth factor discrimin clinic form chikungunya healthi control patient classifi nonsever sever diseas level plasma cytokin growth factor elev statist analysi increas il il decreas rant associ diseas sever conclus comprehens report product cytokin chemokin growth factor acut chikungunya viru infect biomark distinguish mild diseas sever form chikungunya fever enabl identif patient poor prognosi monitor diseas
Virol J	28038565	2015-09-14	PMC2628353	19102764	an infecti bronchiti viru arkansa dpi ark dpi virul strain sequenc analyz compar ibv strain coronavirus genom ark dpi consist nucleotid exclud poli tail compris ten open read frame compar sequenc analysi ark dpi ibv strain strike similar conn grai jmk ark circul time period comparison ark genom coronavirus demonstr close relationship turkei coronaviru nonstructur gene untransl region utr clike proteinas clpro polymeras rdrp sequenc ident grai strain structur gene ident ark ident jmk conn ident conn strain recombin site intergen region spike gene gene independ recombin event occur entir genom ark dpi involv ibv strain suggest genom rna recombin occur genom number site specul ark dpi strain origin conn strain diverg evolv independ point mutat recombin field strain
BMC Genomics	26371252	2014-07-23	PMC2628393	18973670	background genom store build maintain organ complet sequenc genom opportun studi compar global properti genom analyz aspect content homo sapien mu musculu drosophila melanogast caenorhabd elegan arabidopsi thaliana saccharomyc cerevisia escherichia coli genom virtual bp oligom appear vertebr genom bp oligom speci rang oligom melanogast bp elegan bp thaliana bp cerevisia bp coli bp frequenc uniqu oligom genom follow pattern identifi set mer nucleotid mer human genom probe detect microb human sampl human sampl probe detect current fulli sequenc prokaryot fulli sequenc virus human genom compact sequenc space random genom identifi frequent mer human genom prove pcr primer identifi bacterium anaeromyxobact dehalogenan exception low divers oligom size genom gc content entropi code region human genom higher noncod region chromosom chromosom high proport code dna high entropi chromosom opposit low frequenc code region high entropi conclus measur frequenc oligom design pcr assai identifi chromosom organ hidden structur recogn detect novel microb human tissu
J Transl Med	25056903	2013-08-05	PMC2628881	19077207	member carcinoembryon antigen famili ceacam express depend tissu capabl regul divers function includ tumor promot tumor suppress angiogenesi neutrophil activ member famili ceacam ceacam ceacam ceacam recogn cda cdb cdc cdd mab express human neutrophil cda cdb cdc cdd antibodi increas neutrophil adhes human umbil vein endotheli cell monolay increas neutrophil adhes caus cd antibodi block cd mab associ upregul cdcd neutrophil surfac examin potenti interact ceacam neutrophil signal effect neutrophil adhes human umbil vein endotheli cell set cd mab test desensit stimul combin mab addit cd mab absenc calcium desensit neutrophil stimul cd mab current data desensit neutrophil ceacam select desensit ceacam cell remain respons neutrophil ceacam addit cell desensit ceacam respons stimul ceacam cda mab contrast desensit cell ceacam ceacam left cell unrespons cd mab cell desensit combin ceacam remain respons unrel control protein cd independ neutrophil ceacam signal ceacam appear plai uniqu role neutrophil ceacam model ceacam dimer form signal complex accommod observ interact occur cell express ceacam
PLoS Pathog	23918369	2010-07-01	PMC2629125	19197350	rift vallei fever viru rvfv genu phleboviru famili bunyavirida negativestrand rna viru tripartit genom rvfv transmit mosquito fever sever hemorrhag ill human fever high rate abort livestock nonstructur rvfv nss protein inhibit transcript host mrna includ interferon mrna major virul factor studi explor novel function rvfv nss protein test replic rvfv lack nss gene presenc actinomycin actd amanitin serv surrog host mrna synthesi suppress function nss presenc hosttranscript inhibitor replic rvfv lack nss protein carri nss induc doublestrand rnadepend protein kinas pkrmediat eukaryot initi factor eif phosphoryl lead suppress host viral protein translat rvfv nss promot posttranscript downregul pkr earli cours infect suppress phosphoryl eif accumul data suggest combin rvfv replic nssinduc host transcript suppress induc pkrmediat eif phosphoryl nss facilit effici viral translat downregul pkr inhibit pkrmediat eif phosphoryl distinct function nss suppress host transcript includ type interferon mrna downregul pkr work prevent host innat antivir function allow effici replic surviv rvfv infect mammalian host
J Ethnobiol Ethnomed	20579746	2013-03-18	PMC2630947	19138420	bear bile tradit chines medicin tcm thousand year modern investig wide rang pharmacolog action toxicolog side pure compound cure hepat biliari disord decad extens consumpt bear bile bear endang speci bear farm establish china extract bear bile live bear freedrip fistula techniqu bear farm extrem inhuman bear di ill chronic infect liver cancer effort nongovernment organ mass media chines govern bear farm ultim time systemat to find altern bear bile review focus literatur laboratori clinic bear bile substitut altern english chines databas examin substitut altern bear bile three aspect pure compound deriv bear bile bile anim herb tcm discuss strategi stop trade bear bile issu bear bile potenti altern candid exist problem altern work futur
BMC Biotechnol	23324616	2014-08-27	PMC2631500	19014469	background human monoclon antibodi mab gener result immun respons effect therapeut antibodi case infecti diseas immun respons protect human cytomegaloviru hcmv ubiquit opportunist viru seriou pathogen agent transplant patient therapeut armamentarium hcmv hyperimmun globulin antivir associ sever side effect emerg drugresist strain neutral human mab decis altern prevent primari reactiv hcmv infect patient purpos studi gener neutral mab hcmv immunolog repertoir immun donor aim design effici technolog reli discret sequenti step human blymphocyt stimul tlragonist il second addit remov cell infect ebv strategi clone secret igg neutral hcmv infect character mab neutral infect combin hcmv strain target cell potenc fold higher hcmv hyperimmun globulin current transplant recipi recombin human monoclon igg suitabl prophylact therapeut tool clinic applic gener conclus technolog describ proven reproduc effici rapid report techniqu adopt low cost cell biologi laboratori develop fulli human mab immunotherapeut us
BMC Genomics	25165113	2007-03-28	PMC2631582	19099596	background sodium channel heteromultimer integr membran protein belong superfamili ion channel mutat gene encod sodium channel protein link inherit genet disord febril epilepsi brugada syndrom ventricular fibril long qt syndrom channelopathi associ insensit pain spite effect sodium channel proteinsgen human health publicli resourc focus sodium channel support explor sodium channel report dragon databas explor sodium channel human ddesc comprehens sodium channel entiti gene protein metabolit enzym toxin chemic pharmacolog effect diseas concept human anatomi pathwai pathwai reaction potenti link ddesc compil base text datamin allow user explor potenti associ entiti sodium channel human automat gener novel hypothes conclus ddesc publicli resourc sodium channel human explor level databas freeli access academ nonprofit user worldwid web 
BMC Vet Res	17392374	2016-02-01	PMC2632637	19014526	background rotaviru rv member reovirida famili etiolog agent acut viral gastroenter young rotavirus wide host rang infect broad rang anim speci rotaviru infect exot anim paper report characteris rv strain giraff calf report describ identif detail molecular characteris rotaviru strain detect dayold giraff giraffa camelopardali present acut diarrhea rv strain detect giraff character molecularli gp detail sequenc analysi vp vp reveal ident amino acid sequenc level bovin rv borv conclus studi demonstr continu surveil rv strain anim popul will facilit identif rotaviru host report extend typic epidemiolog studi broader host rang will contribut time identif emerg strain type
Retrovirology	27757250	2007-04-11	PMC2633348	19077215	background elit nonprogressor plasma viral load copiesml antiretrovir naiv constitut tini fraction hivinfect individu year followup cohort longterm nonprogressor ltnp identifi individu transfusionacquir hiv infect remain ltnp year infect retain elit ltnp statu examin mechan differenti delai progressor ltnp cohort surviv advantag confer subject host genet factor hla chemokin receptor tlr polymorph viral attenu factor defect nef associ slow progress antivir immun respons differenti cours diseas second decad infect stabl pspecif prolif respons associ control viraemia retent nonprogressor statu respons absent declin viraem subject strong gagdomin cytotox lymphocyt ctl respons identifi ltnp pol dominantctl nefdefect hiv infect ctl associ control viraemia combin prolif respons ctl prevent late diseas progress individu sustain viral suppress ctl recognis numer gag epitop strong restrict respons immunodomin epitop effect time fail viraemia cours studi viral escap mutant hla brestrict gagp epitop detect individu declin neg prolif respons occur concurr increas viraemia conclus detect viraemia studi entri predict loss ltnp statu andor diseas progress differenti slow progressor elit ltnp retain potent virolog control sustain immunolog suppress viraemia independ associ preserv prolif respons strength breadth ctl respons declin protect respons preced correl loss nonprogressor statu andor sign diseas progress
Int J Mol Sci	17428862	2005-01-28	PMC2635621	19330066	sampl blood kidnei liver randomli select slaughter pig analyz ochratoxin hplc addit order occurr nephropathi histolog examin carri liver sampl contain ota rang ngg incid ota serum kidnei maximum concentr ngml ngg histopatholog examin kidnei confirm tubulopathi edema cell vacuol addit hemorrhag necrosi proxim kidnei tubul cell found
Int J Mol Sci	15681402	2008-09-19	PMC2635728	19325804	despit fact nonvir nucleic acid deliveri system gener consid effici viral vector gain interest year superior safeti profil compar viral counterpart synthet vector cation polym branch dendrim cation liposom cellpenetr peptid cpp repres assort fairli unrel sequenc essenti characteris high content basic amino acid length residu cpp capabl mediat cellular uptak hydrophil macromolecul peptid nucleic acid sirna aptam antisenseoligonucleotid internalis cell low rate appli numer sequenc report cellpenetr properti transport varieti cargo mammalian cell year appar endocytosi major rout internalis mechan underli cellular transloc cpp understood subject controversi discuss review will summaris latest develop peptidebas cellular deliveri nucleic acid cargo will discuss mechan entri intracellular fate cargo correl studi uptak versu biolog activ cargo technic problem pitfal
Int J Mol Sci	18793145	2005-05-26	PMC2635754	19325820	develop antivir focus vaccin treatment specif viral agent effect approach limit situat etiolog agent unknown target viru undergon mutat recombin reassort augment innat immun respons effect altern diseas amelior nonspecif broadspectrum immun respons induc doublestrand dsrna poli iclc oligonucleotid odn unmethyl deocycytidyldeoxyguanosinyl cpg motif offer protect bacteri viral pathogen genet makeup zoonot origin drug resist
PLoS One	15919828	2011-11-29	PMC2644758	19240806	background amplif reaction reveal singl virus viral coinfect caus acut bronchiol infant rv appear grow involv earli respiratori diseas remain controversi object determin prospect respect role rsv rv hmpv coinfect sever acut bronchiol young infant method princip find infant median ag month enrol prospect studi infant year hospit episod bronchiol winter epidem season high risk sever diseas sever assess record sao admiss daili clinic score scale durat oxygen supplement length hospit virus identifi amplif reaction rsv rv hmpv dual rsvrv viru coinfect rv compar rsv dual rsvrv infect caus sever diseas lower clinic score p shorter time oxygen supplement dai dai dai shorter hospit stai dai dai dai convers rsv infant longer durat hospit comparison rsvrv hmpv multivari analys type viru carri independ associ durat hospit conclus studi underlin role rv earli respiratori diseas frequent carri young infant acut bronchiol rsv caus sever diseas convers rv lesser sever addit dual rsvrv infect observ sever
Curr Genomics	22124328	2014-02-01	PMC2647156	19412418	the hla region encod molecul plai kei role immun system strong associ hla region autoimmun diseas aid establish fifti year associ compon hla class ii encod hladrbdqadqb haplotyp detect aid includ rheumatoid arthriti type diabet grave diseas molecul encod region plai kei role exogen antigen present cd cell indic pathwai aid initi progress compon hla class iii region investig associ aid apart associ hlab ankylos spondyl difficult determin addit suscept loci independ strong linkag disequilibrium ld hla class ii gene advanc statist analysi ld recruit larg aid dataset allow investig hla class iii region revisit associ hla class region independ hla class ii effect detect aid includ strong associ hlab type diabet hlac multipl sclerosi grave diseas provid evid role bacteri viral infect cd cell aid onset advanc determin primari associ hla region aid will increas understand mechan diseas pathogenesi aid develop novel therapeut target futur
Interdiscip Perspect Infect Dis	24506781	2018-10-31	PMC2648660	19266090	season variat smallpox transmiss press ecolog question relev bioterror prepared studi reanalyz histor dataset record monthli case death addit time seri analys report data estim spectral analysi effect reproduct number calendar time meteorolog variabl extract report india compar smallpox mortal annual cycl smallpox transmiss clearli monthli report estim shortterm epidem data clearli exhibit annual peak januari mortal reveal neg associ correl humid find smallpox transmiss greatli vari season enhanc dry weather
BMC Bioinformatics	30381484	2008-10-15	PMC2648740	19208150	background sar coronaviru main proteinas sar covmpro enzym replic sever acut respiratori syndrom viru activ site region sar covmpro divid subsit understand bind mode sar covmpro specif substrat contribut structuralbas drug design purpos investig bind mode sar covmpro octapeptid region subsit molecular dock molecular dynam md simul approach turn helix chain residu sar covmpro directli involv inducedfit model enzymesubstr complex subsit enzym neg charg region presenc glu md simul glu enzym plai kei role electrostat bond ply octapeptid conclus md simul carri sar covmprooctapeptid complex hypothesi propos glu sar covmpro residu subsit involv bind ply octapeptid
PLoS One	18601651	2014-03-10	PMC2649436	19270739	background iberian lynx lynx pardinu consid endang felid speci order save speci spanish author implement captiv breed program recruit lynx wild context retrospect survei preval select felin pathogen freerang lynx initi methodolog princip find systemat analyz preval viral protozoan cytauxzoon feli bacteri hemotrop mycoplasma infect remain freerang iberian lynx doana sierra morena area southern spain except felin immunodefici viru fiv evid infect test felin pathogen iberian lynx fourteen lynx felin leukemia viru felv provirusposit eleven antigenem felv posit anim test neg viral infect sixmonth period provirusposit antigenem lynx di infect felv infecti agent associ mortal sequenc felv surfac glycoprotein gene reveal common origin ten eleven sampl ten sequenc close felva origin isol cat usa endogen felv sequenc detect conclusionssignific conclud felv infect origin domest cat invad lynx habitat data time frame coinfect outcom felvinfect contrast domest cat felv strain lynx highli virul speci data argu vaccin lynx domest cat lynx habitat order prevent spread viru reduct domest cat popul lynx popul maintain
Clin Mol Allergy	24614365	2005-03-01	PMC2651109	19154602	virus predomin infecti asthma exacerb develop addit evid suggest viral infect causal role develop childhood asthma articl will describ gener percept link infect asthma chang centuri focu develop provid insight contribut virus asthma pathogenesi highlight area includ contribut sever earli life viral infect asthma incept genet determin sever viral infect infanc differ innat adapt immun system cytokin respons viral infect asthmat nonasthmat subject potenti vaccin strategi prevent sever earli life virallyinduc ill
PLoS Genet	15750141	2014-08-14	PMC2652835	19300501	popul human immunodefici viru type hiv undergo surprisingli larg amount genet drift infect patient despit larg popul size predict determinist model propos explain phenomenon implicitli assum process viru replic contribut genet drift develop assai measur amount genet drift hiv popul replic cell cultur assai reli creation hiv popul size measur variat frequenc neutral allel assai hiv undergo ten time genet drift expect popul size defin number infect cell cultur larg portion increas genet drift nonsynchron infect target cell infect synchron genet drift viru fold higher expect popul size stochast natur biolog process involv viral replic contribut increas genet drift hiv popul propos appreci effect will allow better understand evolutionari forc act hiv infect patient
PLoS Biol	25125497	2009-01-01	PMC2653555	19278295	rabi elimin domest dog popul western europ north america continu kill thousand peopl africa asia year quantit understand transmiss dynam domest dog popul critic assess global elimin canin rabi report extens observ individu rabid anim tanzania gener uniqu detail analysi transmiss biologi explain epidemiolog featur includ level variat epidem trajectori basic reproduct number rabi low studi area rural africa histor global rang find strong support feasibl control endem canin rabi vaccin wildlif area larg wild carnivor popul rapid turnov domest dog popul major obstacl success control develop countri regular puls vaccin will requir maintain populationlevel immun campaign analys sustain intern commit global elimin rabi domest dog popul danger vector human realist goal
PLoS One	18796313	2011-05-17	PMC2653722	19287488	coronaviru protein essenti compon virion plai pivot role virion assembl bud matur protein integr viral envelop three transmembran domain flank short aminotermin ectodomain larg carboxytermin endodomain studi copurif protein coronaviru infecti bronchiti viru ibv actin understand cellular factor involv virion assembl bud matur process ibv bait yeast twohybrid screen identif actin interact partner interact subsequ confirm coimmunoprecipit immunofluoresc microscopi mammalian cell mutat amino acid protein abolish interact introduct ak mutat infecti ibv clone system block infect clone viral rna replic subgenom mrna transcript activ detect disrupt actin filament cellperm agent cytochalasin earli stage infect cycl led detect viral protein synthesi infect cell releas viru particl cultur media treatment late stage infect cycl affect releas viru particl media suggest disrupt actin filament block virion assembl bud releas viru particl studi reveal essenti function actin replic cycl coronaviru
BMC Public Health	21586499	2016-05-11	PMC2654560	19216738	background healthcar worker hcw will plai kei role respons pandem influenza uk healthcar system abil cope influenza pandem will depend larg extent number hcw work crisi uk emerg plan will improv planner better understand reason uk hcw absente motiv work influenza pandem paper report qualit studi explor uk hcw view work influenza pandem order identifi factor influenc willing abil work identifi potenti sourc perceiv duti hcw work method qualit studi focu group interview hcw rang role grade tend feel motiv sens oblig work influenza pandem number barrier prevent identifi perceiv barrier abil work includ oneself transport difficulti childcar respons perceiv barrier willing work includ prioritis wellb famili member lack trust goodwil nh lack risk expect crisi fear litig feel employ staff serious barrier abil barrier willing difficult separ conclus particip tend feel gener oblig work influenza pandem barrier work generalis reduc nh workforc pandem barrier identifi barrier willing abil suggest pandem plan account possibl staff absent reason current anticip uk plan document staff physic attend work unwil barrier mitig employ ill transport infrastructur number remedi step lesson impact provid accommod build reciproc provis guidanc barrier work lie abilitywilling continuum absente reduc step prevent barrier willing perceiv barrier abil
PLoS Pathog	27170751	2010-02-08	PMC2654722	19325881	brome mosaic viru bmv protein multipl kei role viral rna replic local perinuclear endoplasm reticulum er membran peripher membran protein induc er membran invagin rna replic complex form recruit stabil bmv polymeras apol rna replic templat site establish activ replic complex replic rna cap ntpase rna helicas function identifi bmv amphipath helix helix nmr analysi defin structur propens insert hydrophob membranemimick micel helix essenti effici aer membran associ normal perinuclear er local delet mutat helix abolish rna replic strikingli mutat helix rise dramat opposit function phenotyp impli helix act molecular switch regul intric balanc separ function class helix delet amino acid substitut markedli inhibit amembran associ abolish er membran invagin viral rna templat recruit replic doubl amedi increas apol accumul second class helix mutat maintain effici amembran associ amplifi number ainduc membran invagin fold enhanc viral rna templat recruit fail stimul apol accumul provid insight pathwai rna replic complex assembl helix critic assembl function viral rna replic complex includ central role target replic compon control mode action
Virol J	20142477	2011-04-01	PMC2654877	19138419	viral infect frequent cite major environment factor involv subacut thyroid autoimmun thyroid diseas review examin data role virus develop thyroid focus human data review virolog data type thyroid level evid epidemiolog data serolog data circul virus direct evid thyroid tissu infect interpret epidemiolog serolog data cautiou prove pathogen respons diseas direct evid presenc virus compon organ retrovirus hfv mump subacut thyroid retrovirus htlv hfv hiv sv gravess diseas htlv enteroviru rubella mump viru hsv ebv parvoviru hashimoto thyroid remain determin respons thyroid diseas innoc bystand studi need clarifi relationship virus thyroid diseas order develop strategi prevent andor treatment
BMC Biotechnol	21460211	2015-11-09	PMC2656497	19187544	background common method gmo detect base amplif gmospecif dna amplicon polymeras chain reaction pcr appli loopmedi isotherm amplif lamp method amplifi gmorel dna sequenc intern commonlyus motif control transgen express eventspecif planttransgen junction test specif sensit techniqu gmo studi detect gmo equival background dna dilut templat detect singl copi templat lamp conclus work gmo detect carri lamp routin screen specif event detect sensit abil amplifi target high background dna demonstr highlight advantag isotherm amplif appli gmo detect
BMC Infect Dis	26554031	2017-03-01	PMC2656517	19171043	background epidemiolog studi strong associ ureaplasma urogenit tract diseas human healthi human colon ureaplasma role pathogen remain controversi order to defin role host diseas develop rodent model urinari tract infect uti fischer rat anim inocul steril broth log cfu ratadapt strain ureaplasma parvum infect anim exhibit distinct profil asymptomat uti uti complic struvit urolithiasi inoculum dose parvum incid uti anim inocul cfu parvum remain infect inoculum dose influenc immun respons parvum asymptomat uti character minim immun respons monocyt lymphocyt limit lesion elev urinari level ifn il mcp uti complic struvit format character exagger immun respons neutrophil lesion extens uroepitheli hyperplasia predomin il il grokc urin anim asymptomat uti high rate kidnei infect conclus complic associ parvum infect depend hostspecif factor ureaplasma microbi load immun respons rat occur human ureaplasm associ diseas model infect tool elucid parvumhost interact confer uti diseas
PLoS One	28251928	2014-03-25	PMC2657001	19293944	background sustain outbreak highli pathogen avian influenza hpai hn avian speci increas risk reassort adapt human abil spread chicken reduc threat help maintain capac eggbas vaccin product vaccin offer potenti control avian diseas major concern current vaccin potenc inabl protect evolv avian influenza virus methodolog princip find abil dna vaccin encod hemagglutinin ha protein hpai hn serotyp evalu abil elicit neutral antibodi protect homolog heterolog hpai hn strain challeng mice chicken dna immun needl syring pressur inject devic vaccin elicit antibodi neutral multipl strain hpai hn combin respons dosedepend breadth determin choic influenza viru ha vaccin monoval trival ha vaccin test mice confer protect lethal hn avietnam challeng week vaccin chicken protect observ heterolog strain hpai hn vaccin trival serotyp dna vaccin dose low dna intramuscular needl inject needlefre devic conclusionssignific dna vaccin offer gener approach influenza viru immun applic multipl anim speci addit abil substitut plasmid encod strain enabl rapid adapt vaccin newli evolv field isol
Virol J	24668816	2020-02-14	PMC2657138	19196466	background infecti bronchiti viru induc diseas respiratori system ibv strain variabl tissu tropism affect oviduct kidnei proventricul associ ibv strain aim studi investig immunohistochemistri ihc tissu tropism avian infecti bronchiti viru ibv strain experiment infect chicken embryo chicken embryo inocul allanto sac eid ibv dai ag postinocul pi embryo chorioallanto membran cam sampl fix paraffinwax embed allanto fluid collect titrat chicken embryo kidnei cell cek sensit ihc detect ibv antigen cam inocul egg match viru reisol detect cek ihc antigen ibv detect nasal epithelium trachea lung spleen myocardi vasculatur liver gastrointestin tract kidnei skin sclera ey spinal cord brain neuron inocul embryo consist viru isol denot wide tissu tropism ibv chicken embryo importantli infect vasculatur smooth muscl proventriculu ibv strain conclus ihc addit tool diagnosi ibv infect chicken allow studi foster deeper understand pathogenesi infect ibv strain virul underlin embryon tissu addit cam sourc gener ibv antigen diagnost purpos
Microb Cell Fact	32060123	2014-11-03	PMC2658664	19183481	background cellular protein patp lsmp dhhp requir replic positivestrand virus potenti target antivir drug priorit host target antivir drug screen compar metabolom analysi saccharomyc cerevisia refer strain mat leu ly ura delet strain pat lsm dhh perform gcm analysi permit quantif polar metabolit identif of metabolit variat strain identifi partial squar latent structur discrimin analysi plsda analysi reveal differ pat refer strain character euclidian distanc normal peak area growth rate specif product rate ethanol glycerol strain conclus hypothes human analog yeast patp best drug target candid
PLoS Pathog	25368412	2004-07-01	PMC2658809	19343214	the abil nw clade arenaviru enter cell human transferrin receptor tfr strictli correl abil hemorrhag fever amapari amav tacarib tcrv nonpathogen nw clade arenavirus human tfr close nw arenavirus hemorrhag fever pseudotyp virus bear surfac glycoprotein gp amav tcrv infect cell tfr ortholog mammalian speci includ respect natur host small rodent neacomi spinosu fruit bat artibeu jamaicensi mutat residu human tfr function receptor tcrv mutat residu function receptor amav data support vivo role tfr replic nw clade arenavirus modest chang gp nonpathogen arenavirus human tfr emerg human pathogen
BMC Genomics	15243082	2011-05-02	PMC2660370	19196461	background haemophilu parasui hp swine pathogen glsser diseas character fibrin polyseros mening arthriti molecular mechan underli pathogenesi diseas remain understood resist porcin immun system hp invas studi investig global chang gene express spleen hp infect affymetrix porcin genechip total differenti express de transcript identifi porcin spleen dai hp infect uniqu gene differenti express pattern base analysi blastx gene ontolog de gene involv immun respons includ gene inflammasom retn sa sa sa adhes molecul cldn cspg cd lgal transcript factor zbtb slca cebpd cebpb acutephas protein complement saa ltf hp differenti gene epitheli cell keratinocyt tgm msab csta gene antigen process present hlab hladrb immunostimul analys indic mrna level sa sa sa porcin pk cell increas sustain administr lipopolysaccharid lp polyic addit map de gene porcin health trait qtl region gene distribut porcin qtl region final de gene valid quantit pcr conclus find demonstr unrecogn chang gene transcript associ hp infect vivo potenti cascad identifi studi clearli merit investig data provid clue natur immun respons mammal identifi candid gene resist hp
BMC Health Serv Res	21587153	2015-08-05	PMC2661074	19216792	background gener consensu influenza pandem inevit health care worker hcw essenti health system respons studi explor hcw attitud pandem influenza aim studi explor hcw knowledg attitud intend behaviour pandem influenza method crosssect investig conveni sampl clinic nonclin hcw tertiaryreferr teach hospit sydnei australia conduct june octob selfadminist questionnair distribut hospit person ward depart main outcom measur intent work attend quarantin antivir perceiv prepar respond categor main group occup nurs medic alli ancillari studi hcw perceiv pandem influenza seriou half correctli defin respond believ depart prepar pandem work pandem patient colleagu influenza main determin variat studi occup factor demograph health belief nonclin staff unsur intent respond consid neuraminidas inhibitor antivir medic oseltamivirzanamivir protect pandem influenza believ vaccin benefit conclus identifi issu undermin best pandem plan low level confid antivir effect measur secondli nonclin worker overlook group lack knowledg awar undermin pandem plan issu includ high level confid dietari measur protect influenza belief ancillari worker antibiot protect health care worker strategi includ clinic ancillari staff ensur adequ busi continu hospit hcw educ psychosoci support staff commun improv knowledg appropri pandem intervent confid antivir
BMC Immunol	26246575	2007-10-17	PMC2662797	19298652	background acut infect respiratori pathogen pneumonia viru mice pvm local product proinflammatori chemokin ccl neutrophil recruit respons pvm infect reduc dramat ccl mice work demonstr cclmediat neutrophil recruit coordin interferongamma ifn neutrophil recruit respons pvm infect diminish fivefold ifn receptor genedelet mice neutrophil ifnr mice express transcript ccl receptor ccr respond function ccl vivo absenc pvm infect ccl overexpress elicit neutrophil recruit absenc ifn interestingli supplement ifn restor neutrophil recruit sustain weight loss ccloverexpress ifn mice cclmediat neutrophil recruit result pulmonari edema respiratori failur characterist sever viral infect suggest ccl ifn suffici promot neutrophil recruit patholog activ conclus find reveal heretofor unrecogn hierarch interact ifn ccl demonstr ifn crucial cclmediat neutrophil recruit vivo
PLoS One	17942557	2012-06-14	PMC2663817	19357776	the plasmodium falciparum cystein proteas falcipain falcipain degrad host hemoglobin provid free amino acid parasit protein synthesi hemoglobin hydrolysi describ order process initi aspart proteas cystein proteas inhibitor complet block process suggest cystein proteas initi hemoglobin hydrolysi character specif role falcipain three approach random p amino acid substrat librari falcipain falcipain demonstr strong prefer cleavag site leu posit second overlap peptid span globin proteolysisdepend label hydrolysi cleavag site third intact hemoglobin numer cleavag product identifi hemoglobin hydrolysi malaria parasit highli order process proce rapid cleavag falcipain multipl site falcipain falcipain strong specif leu small peptid substrat agreement specif optim small molecul inhibitor identifi consist princip role falcipain falcipain hydrolysi hemoglobin falciparum possibl develop small molecul inhibitor optim specif antimalari agent
PLoS Pathog	22700978	2004-09-14	PMC2663820	19381259	acut gastroenter ag common ill ag group worldwid caus estim three death annual virus rotaviru adenoviru calicivirus major ag patient causal agent despit extens diagnost test propos novel virus reason diagnost gap molecular screen investig cluster undiagnos case larger case control studi etiolog pediatr ag degener oligonucleotid prime dop pcr nonspecif amplifi viral dna fecal specimen amplifi dna clone sequenc analysi novel viru detect elucid analysi genom indic member bocaviru genu parvovirina variant nucleotid level closest formal recogn rel human bocaviru hbov propos second speci bocaviru hbov fecal sampl collect case control pair ag studi test bocavirusspecif pcr hbov sequenc confirm detect case ag preval compar control group children hbov preval exceed rotaviru astroviru preval noroviru genogroup adenoviru univari analysi match pair mcnemar test odd ratio associ ag hbov infect confid interv cours screen second novel bocaviru detect design hbov speci hbov preval hbov low associ ag hbov hbov newli discov bocavirus hbov thirdmostpreval viru rotaviru astroviru associ pediatr ag studi
Hum Resour Health	15367599	2004-01-01	PMC2666626	19327137	debat resourcerich countri health care profession help plight subsaharan africa appear lock mindset domin gloomi statist onewai monetari aid establish project link primari care clinic base twowai share educ onewai aid unit kingdom colleagu learn malawi factfind visit malawi help clarifi aspect health care relev health care profession develop includ unit kingdom commentari articl focus encourag debat discuss rethink relationship colleagu health care environ consid work theme twowai share learn onewai aid
Int J Health Geogr	15147652	2018-11-01	PMC2666650	19291326	background fall issu great public health concern studi focus outdoor fall urban commun hong kong urban environment hazard placespecif depend built featur landscap characterist habitu activ fall examin respect local situat paper spatial analysi method map fall occurr examin environment attribut fall urban commun hong kong nearest neighbour hierarch nnh standard deviat ellips sde techniqu offer addit insight circumst environment factor contribut fall affirm multifactori natur fall specif locat select group popul conclus techniqu detect hot spot fall yield meaning enabl identif high risk locat combin descript spatial analys benefici polici maker prevent measur devis base type environment risk factor identifi analys prelud establish hypothes focus studi
Proteome Sci	30996690	2009-07-29	PMC2666657	19323824	background ozon major compon air pollut exposur power oxid agent exacerb lung condit involv innat immun surfact proteina spa plai role innat immun particip directli host defens exert opsonin function indirectli abil regul alveolar macrophag innat immun cell mechan respons ozoneinduc pathophysiolog oxid stress understood method emploi dimension differ gel electrophoresi ddige discoveri proteom approach coupl malditoftof compar bronchoalveolar lavag bal proteom wild type wt spa knockout ko mice assess impact ozon filter air express bal protein panther databas publish literatur identifi protein three function group identifi protein focus analysi protein fell three categori defens immun redox regul protein metabol modif chaperon respons oxid stress acut ozon exposur ppm hour chang level express protein group protein redox group decreas protein involv protein metabol increas roughli equal number increas decreas defens immun group respons wt ko mice respect percent chang consist greater ko mice chang achiev statist signific ko mice level express filter airexpos ko mice closer ozoneexpos wt mice filter airexpos wt mice conclus postul spa plai role reactiv oxid scaveng wt mice absenc ko mice presenc absenc ozon exposur pronounc presum chronic oxid stress
BMC Public Health	19641063	2014-05-12	PMC2666722	19284644	background despit seri prevent measur high incid sever acut respiratori syndrom sar observ health care worker hcw sar epidem studi aim determin prevent measur effect protect hcw infect effect method retrospect studi perform frontlin health care worker care sar patient second affili hospit third affili hospit sun yatsen univers hcw igg sar igg sar defin case group control group logist regress conduct explor risk factor sar infect hcw adjust ag gender marit statu educ level profession titl depart individu work multivari logist regress analysi indic incid sar hcw posit associ perform tracheal intub sar patient method air ventil ward avoid facetofac interact sar patient number pair glove worn hcw care seriou sar case conclus measur good air ventil sar ward effect minim prevent sar transmiss hcw hospit
BMC Infect Dis	31434737	2001-07-15	PMC2670846	19284571	background border quarantin includ influenza pandem plan detail guidelin formul includ consider optim quarantin length motiv situat small island nation will experi introduct pandem influenza airport examin potenti effect quarantin border control measur method analys detail epidemiolog characterist influenza effect quarantin border island model rel reduct risk releas infecti individu commun explicitli account presenc asymptomat infect individu potenti benefit ad rapid diagnost test quarantin process consid predict effect prevent releas infecti individu commun achiev quarantin period longer dai rapid diagnost test combin quarantin length quarantin achiev effect shorten dai sensit analysi reveal quarantin dai quarantin dai combin rapid diagnost test prevent secondari transmiss caus releas infecti individu plausibl rang preval sourc countri modest number incom travel individu conclus quarantin border island nation contribut prevent arriv pandem influenza delai arriv small island nation recommend consider quarantin dai quarantin dai combin rapid diagnost test avail
PLoS Pathog	11413307	2013-01-01	PMC2671596	19424420	the abil pathogen escap host immun respons crucial establish persist infect influenc virul recombin observ contribut process gener novel genet variant distinct recombin pattern describ viral pathogen influenc bias recombin process rel select forc act newli form recombin understand influenc determin recombin contribut pathogen genom proteom evolut previou recombinationdriven protein evolut focus simpl protein context direct evolut experi studi recombin envelop gene hiv primari isol belong subtyp recombin natur hivaid pandem character earli step gener recombin provid novel insight evolutionari forc shape recombin pattern viral popul combin effect mechanist process determin locat recombin breakpoint hiv envelop gene purifi select act dysfunct recombin explain entir distribut breakpoint gene natur constraint account surpris pauciti recombin breakpoint infect individu highli variabl gene appar random hiv evolut recombin fact predict anticip addit domin purifi select local area hiv genom defin region function constraint recombin appear strong point vulner aspect hiv biologi
Aust New Zealand Health Policy	23405047	2018-10-01	PMC2672090	19358710	background intern health regul emerg global spread infecti diseas trigger reassess rich countri support capac develop communic diseas control low medium incom countri lmic lmic three type public health train universitybas model stream train specialis worker fieldbas program low rate product teach base prioriti host countri second model effici accord worker suffici statu enabl impact polici third potenti capac develop measur lmic practic face challeng limit abil promot capac develop discuss describ australia master appli epidemiolog mae model establish fieldbas train strengthen control communic diseas central attribut model partner complement health depart initi enhanc workforc skill health system perform evidencebas polici program practic summari mae experi throw light wai australia collabor region capac develop initi kei share vision region approach integr train initi strengthen servic pool human financi technic resourc focu communic diseas find recommend generalis area public health
PLoS Pathog	30185285	2014-12-10	PMC2673688	19436701	transmiss avian influenza virus bird human rare event avian influenza virus infect ciliat epithelium human airwai vitro vivo vitro model human ciliat airwai epithelium hae demonstr human avian influenza virus effici infect temperatur human distal airwai avian human influenza virus restrict infect cooler temperatur human proxim airwai data support hypothesi avian influenza virus ordinarili adapt temperatur avian enter tract rare infect human differ host airwai region temperatur critic residu posit avian influenza viru polymeras subunit pb identifi confer temperaturedepend mammalian cell revers genet avian residu attenu human viru account infect c determin mechan temperatur restrict avian influenza virus hae gener recombin human influenza virus avictoria hn apr hn genet background contain avian avianlik glycoprotein virus avictoria lq sg mutat hemagglutinin ha neuraminidas achickitali apr achickitali exhibit temperatur restrict approach wholli avian influenza virus data influenza virus bear avian avianlik surfac glycoprotein reduc capac establish product infect temperatur human proxim airwai temperatur restrict limit zoonot transmiss avian influenza virus suggest adapt avian influenza virus effici infect repres critic evolutionari step enabl humantohuman transmiss
PLoS One	25505063	2012-10-01	PMC2674933	19404494	background host respons viral infect includ immun activ program cell death mitochondri antivir signal adaptor mav ip visa cardif critic host defens viral infect induc type interferon ifni role virusinduc apoptot respons elucid princip find mav apoptosi independ function initi ifni product mavsinduc cell death requir mitochondri local caspas depend displai hallmark apoptosi mav fibroblast resist sendai virusinduc apoptosi function screen identifi hepat viru nsa sever acut respiratori syndrom coronaviru sarscov nonstructur protein nsp inhibitor mavsinduc apoptosi method immun evas signific studi describ novel role mav control viral infect induct apoptosi identifi viral protein inhibit host respons
Open Virol J	23028052	2015-12-01	PMC2675550	19440455	hendra nipah virus emerg paramyxovirus infect diseas anim human diseas manifest gener vascul multipl organ sever respiratori central nervou system high case fatal persontoperson transmiss associ niv outbreak reemerg hev emphas necess effect therapeut novel agent year henipaviru reveal complet understand pathogenesi consequ viabl approach vaccin therapeut emerg strategi target earli step viral replic includ receptor bind membran fusion anim model develop prove valuabl evalu efficaci therapeut agent regim assess protect host immun drug pharmacokinet will crucial advanc therapeut compound
PLoS Pathog	27257648	2011-08-10	PMC2677460	19461876	to support replic virus advantag numer cellular factor process largescal screen identifi hundr factor virus exploit influenza viru infect posttranslation activ pipk cellular inhibitor interferoninduc dsrnaactiv eif kinas pkr report infect pipk knockout mice influenza viru increas lung patholog immun cell apoptosi pkr activ mortal analysi lung transcript profil includ induc reconstruct pandem viru reveal increas express gene associ cell death immun inflammatori respons experi repres mammalian infect model demonstr role pipk antivir respons pipk repres class molecul cellular inhibitor host defens cihd pipk activ viru infect inhibit virusinduc apoptosi inflamm prolong host surviv prolong viral replic
Respir Res	21832018	2004-11-23	PMC2678087	19386108	chronic obstruct pulmonari diseas copd treatabl prevent diseas state characteris progress airflow limit fulli revers copd diseas lung appreci manifest diseas lung lead notion copd system diseas current diagnosi copd reli descript measur enabl classif symptom lung function limit exist diagnost strategi copd discuss system biologi approach diagnosi build current molecular knowledg diseas describ approach reli labelfre sens technolog highthroughput surfac plasmon reson spr describ
BMC Vet Res	15561861	2007-11-27	PMC2679002	19389228	introduct order identifi prioriti build integr surveil system effect model predict human risk zoonot diseas improv understand practic option link surveil data anim human conduct analysi literatur character linkag anim human health data discuss find relat zoonot surveil linkag human anim data method canari databas onlin bibliograph databas animalsentinel studi search articl classifi linkag categori studi identifi assign linkag categori involv descript analyt molecular human outcom human anim health descript linkag common anim human health outcom present quantit linkag rare analyt linkag util anim data quantit predict human risk categori includ molecular linkag human outcom health outcom anim human discuss limit anim data quantit predict human risk list method literatur perform analyt linkag lack analyt linkag literatur sole technolog barrier includ access electron databas statist softwar packag geograph system gi problem lack understand research anim data sentinel human health research perform zoonot surveil awar animalsentinel approach predict human risk consid analyt method link anim human data qualit work order examin research decis linkag strategi anim human data
Parasit Vectors	18042961	2016-11-14	PMC2679399	19426446	the extinct speci globe acceler directli indirectli human activ biolog impoverish habitat fragment climat chang increas toxif rapid global movement peopl live organ work synergist diminish ecosystem function unpreced level diseas emerg driven humaninduc environment degrad pose threat surviv health biodivers emerg disciplin conserv medicin address concern entiti human global climat habitat destruct alter biodivers includ wildlif popul domest anim pathogen parasit pollut conserv medicin focus explicit linkag entiti crisi disciplin conserv medicin ultim will depend applic solv problem perspect scientif find conserv medicin provid input biomed educ polici manag ecosystem habitat imperil speci sentinel speci present select provid insight state health ecosystem base userdefin research conservationist policymak object diseas parasit toxic climat chang habitat destruct coupl util vulner speci perceiv stress scientif gener sentinel speci empow stakehold decisionmak mitig action support predict capabl util speci select consid relev conservationist societi larg educ outreach social scienc wild canid serv excel sentinel speci emerg canin vectorborn diseas canin vectorborn diseas antibodi pathogen identifi wild canid includ viscer leishmaniosi lyme diseas heartworm hepatozoonosi anaplasmosi report relat wildlifedomest anim interact globalis transloc habitat fragment climat chang pathogen relationship wild canid describ perform elucid role extant speci wild canid epidemiolog canin vectorborn diseas
PLoS One	28830113	2012-04-24	PMC2682562	19478856	background possibl human hn pandem fact hn virus resist antivir drug newer strategi effect therapi warrant previou studi singl mab immun prophylaxi protect hn infect singl mab effect neutral broad rang strain hn control potenti neutral escap mutant methodsprincip find select mab recogn epitop hemagglutinin molecul mab neutral vitro escap mutant combin effect neutral virus clade influenza hn virus combin chimer mab administ passiv pre post challeng mld mous lethal dose hpai hn influenza virus protect mice clade virus clade test efficaci singl dose combin mab versu dose dose combin therapi earli clearanc viru lung complet prevent lung patholog hn infect mice escap variant detect therapi conclusionssignific studi provid proof concept synergist action mab combin requir prevent gener escap mutant enhanc therapeut efficaci passiv therapi hn infect combin therapi allow lower dose antibodi administ passiv therapi influenza infect reduc econom cost outbreak
PLoS One	22532677	2018-08-01	PMC2682565	19479060	rna interfer rnai power inhibit viral infect select sirnaresist virus major concern rnai antivir therapeut studi conduct lentivir vector hshort hairpin rna shrna express cassett deliv small interf rna sirna mammalian cell vector express enhanc green fluoresc protein egfp surrog marker stabl shrnaexpress cell line establish inhibit effici ration design sirna target conserv region influenza viru genom assess sirna target influenza gene sim potent inhibit viral replic sim effect hn viru highli pathogen avian influenza viru hn addit inhibit sim inhibit np mrna accumul protein express long term inhibit sim demonstr emerg sirnaresist mutant influenza quasispeci observ studi suggest gene optim rnai target antivir therapi find provid develop rnaibas prophylaxi therapi human influenza viru infect
BMC Infect Dis	30068648	2013-05-30	PMC2683852	19405982	background pathogenesi sever acut respiratori diseas syndrom sar fulli understood casecontrol studi report associ suscept sar mannanbind lectin mbl china downstream protein mbl variant mblassoci serin proteas masp gene associ sar coronaviru sarscov infect popul method thirti individu sar chosen analysi masp polymorph pcr direct sequenc tag singl nucleotid polymorph tagsnp chosen pairwis tag algorithm frequenc tag snp rs rs rs rs ascertain sar patient control subject beckman snpstream ultra high throughput genotyp platform associ allel genotyp masp tagsnp suscept sarscov beij guangzhou popul diplotyp rs rswere analyz associ suscept sar statist evid associ observ beij guangzhou sampl group homogen demograph genet paramet join analysi statist evid associ conclus data role masp polymorph sar suscept northern southern china
Evol Bioinform Online	23719292	2017-09-01	PMC2684125	19461973	research routin adopt molecular clock assumpt conduct sequenc analys estim date viral origin human comput method examin extent practic result inaccur retrodict fail account dynam molecular evolut affect greatli estim case date overestim ag sarscovhuman infect instanc
Evol Bioinform Online	28601703	2009-10-21	PMC2684143	19468314	genom signatur data vector deriv composit statist dna selforgan map som neural network method conceptualis relationship complex data genom signatur paramet som train phase investig accuraci output map conclud larger som longer train sensit phylogenet classif unknown dna sequenc classif larger som accur increas number iter train phase som increas accuraci improv sensit optim length dna sequenc kmer genom signatur deriv shorter valu effect gener indic small rapidli train som gener good larger longer train analysi genom signatur gener applic som complex data set microarrai data
BMC Plant Biol	19846633	2011-08-17	PMC2684537	19397807	background phaseolu vulgari common bean second legum crop soybean consequ yield loss fungal infect uromyc appendiculatu bean rust strong consequ resist gene identifi confer resist bean rust infect downstream gene mechan involv bean resist infect character subtract bean cdna librari compos unisequ construct enrich sequenc regul bean rust race virul strain race avirul strain cultivar earli gallatin carri resist gene construct librari allow identif bean est ad sequenc plant regul select bean gene respons bean rust infect confirm qrtpcr plant gene express race hour infect process vari time point hour inocul presenc avr gene race lead hypersensit respons bean plant biphas pattern gene express observ gene regul respons fungal infect conclus enrich public databas bean est add genom resourc crop plant analysi gene respons bean rust infect foundat studi mechan fungal diseas resist express pattern bean gene rust infect share featur legum infect biotroph fungi find suggest vulgarisu appendiculatu pathosystem serv model explor legumerust interact
BMC Public Health	21849459	2018-07-25	PMC2684743	19426508	background aspect heath care sector ask account perform pose uniqu challeng local public health unit tradit focu popul health emphasi diseas prevent health promot protect relianc measur health statu imprecis partial pictur perform health unit provinci institut clinic evalu scienc base ontario canada introduc publichealth specif balanc scorecard framework conceptu deliber decis undertaken health unit adopt framework discuss pose ponder answer kei question assist appli framework develop indic question involv develop perform indic level perform measur primari intend audienc type indic popul health statu determin quadrant type indic popul resourc servic quadrant type indic popul commun engag quadrant type indic popul integr respons quadrant link quadrant compar we move baselin report card continu qualiti improv manag tool summari inclus participatori process chosen defin creat indic popul quadrant exampl indic popul quadrant scorecard present kei decis highlight facilit process
PLoS Negl Trop Dis	30045987	2012-07-20	PMC2685481	19503815	background pcr evolv promis tool cruzi detect diagnosi control chaga diseas gener techniqu hamper complex lack standard methodolog develop phase evalu cruzi oligoctest simpl standard dipstick format detect pcr amplifi cruzi dna specif sensit assai evalu blood sampl chaga nonendem endem control person biolog sampl patient reservoir anim vector collect chile princip find lower detect limit cruzi oligoctest pg fg dna cruzi lineag ii test specif confid interv ci control sampl sensit ci ci ci human rodent vector sampl conclus cruzi oligoctest high sensit specif divers panel biolog sampl tool step simplifi standard molecular diagnosi chaga diseas
BMC Health Serv Res	22820337	2003-12-11	PMC2685796	19435526	background aim studi assess outsourc situat taiwanes hospit compar differ hospit ownership accredit level method combin kind method questionnair survei indepth interview ceo sampl hospit hospit notforprofit public hospit sampl hospit data taiwan depart health qualifi list hospit accredit return questionnair analyz statistica version softwar nonmed item medic wast common trash highest rate percent outsourc gift store percent linen percent follow close lowest rate outsourc util mainten percent medic item highest rate outsourc ambul unit percent hemodialysi center close rate percent depart nutrit pharmaci nurs outsourc rate lower percent taiwan hospit conserv willing outsourc medic item the satisfact pair ttest nonmed item higher score medic item factor analysi three factor medic item outsourc perform financ human resourc medic item factor oper satisfact exam factor valid reliabl satisfact model confirm factor analysi cfa conduct structur equat model sem method model fit conclus hospit public hospit benefit outsourc reviv fulltimeequival human resourc limit
Biomark Insights	14671089	2006-04-01	PMC2688344	19578519	colorect cancer crc second common cancerrel death europ prognosi depend stage diagnosi current suitabl tumour marker earli detect crc retrospect studi discrimin crc serum protein profil surfac enhanc laser desorpt ionisationtim flight mass spectrometri selditof ms aim prospect valid profil addition assess applic followup surgeri investig tissu protein profil patient crc adenomat polyp ap serum tissu sampl collect patient malign indic colonoscopi patient ap crc colonoscopi serum sampl control con patient ap crc tissu sampl ap crc analys describ peak intens compar nonparametr test discrimin power differenti express protein assess support vector machin svm confirm decreas serum level apolipoprotein crc current popul differ observ con ap apolipoprotein ci level chang month postsurgeri gradual return normal level observ protein differ ap crc tissu peak mass apolipoprotein peak increas crc compar ap prospect valid serum decreas apolipoprotein crc serum protein profil yield svm classifi suitabl sensit specif classif patient group
PLoS One	16597852	2010-08-18	PMC2688756	19503812	background epidemiolog intervent aim control spread infecti diseas mechan carri associ cost methodolog describ flexibl statist framework gener optim epidemiolog intervent design minim total expect cost emerg epidem simultan propag uncertainti underli diseas model paramet decis process strategi produc framework adapt vaccin schedul iter adjust reflect anticip trajectori epidem current popul state updat paramet estim conclus simul studi base classic influenza outbreak demonstr advantag adapt intervent nonadapt term cost resourc effici robust model misspecif
Microb Cell Fact	20719951	2007-03-01	PMC2689190	19442264	bacteria simpl cost effect host produc recombin protein physiolog featur limit obtain nativ form protein specif structur class instanc polypeptid undergo extens posttransl modif extent product protein depend disulfid bridg stabil consid difficult coli eukaryot prokaryot organ cytoplasm reduc consequ disulfid bond format impair subcellular compart disulfid bridg stabil protein structur high abund secret protein eukaryot cell bond form oxid environ endoplasm reticulum export process bacteria possess special subcellular compart export system enzymat activ aim format qualiti control disulfid bond oxid periplasm articl review strategi exploit physiolog mechan bactera produc properli fold disulfidebond protein
PLoS Med	17389543	2013-12-01	PMC2694988	19554084	in articl plo medicin holger schnemann colleagu describ process health organ rapidli develop clinic manag guidelin emerg situat situat includ outbreak emerg infecti diseas author discuss develop rapid advic guidelin pharmacolog manag avian influenza hn viru infect guidelin recommend antivir drug oseltamivir dose daili dai debat nichola white argu dose inadequ robert webster elena govorkova combin antivir therapi tim uyeki remind clinic care patient hn entail antivir treatment issu appli therapi patient hospit sever diseas novel swineorigin influenza hn viru infect
Virol J	24297769	2009-11-11	PMC2696427	19497115	background anatid herpesviru ahv alphaherpesviru associ latent infect mortal duck gees current worldwid waterfowl product sever describ fluoresc quantit realtim pcr fqpcr method develop fast measur ahv dna base taqman mgb technolog detect limit assai standard dna copi sensit log higher convent gelbas pcr assai target gene realtim pcr reproduc satisfactori low intraassai interassai coeffici variat conclus high sensit specif simplic reproduc ahv fluorogen pcr assai combin wide dynam rang high throughput method suitabl broad spectrum ahv etiolog applic
BMC Microbiol	19906918	2013-12-01	PMC2697166	19486515	background number scarlet fever occurr report fluctuat consider central taiwan nation isol streptococcu pyogen collect scarlet fever patient central taiwan character emm sequenc standard pulsedfield gel electrophoresi pfge method nation weekli report data collect investig epidemiolog trend total emm type identifi pyogen isol preval emm type emm emm emm emm emm pfge analysi smai suggest except strain common emm type belong clone larg emm clone dna resist cleavag smai preval emm clone major pfge strain minor strain minor strain emerg popul disappear major strain remain preval year declin larg fluctuat scarlet fever case associ shuffl preval emm clone dramat drop scarlet fever case central taiwan countri associ occurr sever acut respiratori syndrom sar outbreak occur latefebruari midjun taiwan conclus occurr scarlet fever central taiwan caus emm type account isol collect pyogen strain defin pfge genotyp emerg last year fluctuat number scarlet fever case year attribut shuffl preval emm clone sar outbreak 
Biotechnol J	24055466	2008-02-20	PMC2699044	19226552	mammalian cell express system choic therapeut protein requir complex posttransl modif tradition cell grown medium supplement serum animalor humanderiv compon support viabil product protein typic excipi stabil final drug formul transmiss hepat hepat hiv plasmaderiv factor viii concentr catastroph consequ hemophilia patient regulatori concern inher potenti transmiss infecti agent heterogen lack reliabl serum suppli trend emerg elimin plasmaderiv addit product formul recombin protein therapeut practic began product treatment hemophilia progress expand entir industri plasmafre method produc recombin therapeut accomplish cell cultur media final product formul animalor humanderiv addit number recombin therapeut protein treatment diseas produc plasmafre process object improv safeti elimin bloodborn pathogen reduc immunogen review describ factor drove develop plasmafre protein therapeut exampl advanc manufactur remov human animalderiv product step recombin protein product
PLoS One	18287238	2012-10-01	PMC2699471	19568424	background lactat dehydrogenaseelev viru ldv natur infecti agent mice virus ldv widespread rapid transient activ cell cell lymphoid tissu blood mechan activ fulli describ focu current studi princip find induc earli lymphocyt activ ifn cytokin induc ldv infect neutral ifn plasma infect mice ablat abil activ lymphocyt vitro primari sourc virusinduc ifn vivo plasmacytoid dendrit cell pdc deplet cell prior ldv infect test lymphocyt activ deplet pdc vivo erad ldvinduc ifn respons lymphocyt activ primari receptor pdc singl strand rna virus ldv tolllik receptor tlr pattern recognit receptor infect tlrknockout mice reveal ifn respons lymphocyt activ depend tlr signal vivo interestingli viru level tlr knockout mice pdcdeplet mice indistinguish control indic ldv resist system ifn respons conclus indic ldvinduc activ lymphocyt recognit ldv nucleic acid tlr pattern recognit receptor pdc respond lymphocyteinduc ifn respons
BMC Public Health	22835485	2015-07-01	PMC2700101	19473550	background thailand join health organ effort prepar threat influenza pandem regular monitor prepared health facil assess percept frontlin respons health personnel studi aim document pattern percept health personnel threat influenza pandem method methodolog appli set health personnel charg influenza pandem prepared three southernmost provinc thailand subject ask rank statement issu influenza pandem predesign score sheet quasinorm distribut continu point bipolar scale rang disagre agre factor analysi method emploi identifi pattern base similar dissimilar health personnel three main pattern percept influenza pandem moder correl coeffici pattern rang pattern health personnel label pessimist perceiv low selfefficaci pattern ii label optimist perceiv threat low sever low vulner pattern iii label mix perceiv low selfefficaci low vulner three pattern subject high expect execut recommend measur mitig impact threat influenza pandem multimeasur high factor score pattern conflict area vulner impact influenza pandem factor score high low neutral pattern ii iii conclus strong consist percept respons efficaci influenza pandem low prioriti convinc health personnel efficaci recommend measur lack selfefficaci subgroup indic program manag improv selfconfid health personnel particip emerg respons
PLoS One	26136579	2007-02-01	PMC2700284	19572016	coronaviru host cell specif determin specif interact viral spike protein host cell receptor avian coronaviru infecti bronchiti ibv adapt embryon chicken egg primari chicken kidnei ck cell monkei kidnei cell vero human anim cell report acquisit cellcel fusion activ amino acid mutat protein determin infect ibv cultur cell express protein deriv vero ckadapt strain effici induct membran fusion express protein clone third passag ibv chicken embryo ep appar syncytia format construct chimer construct sitedirect mutagenesi point mutat lf amino acid posit heptad repeat region protein respons acquisit cellcel fusion activ gd point mutat domain acquir propag veroadapt ibv vero cell enhanc cellcel fusion activ protein reintroduct gene veroadapt ibv allow recoveri variant introduc compensatori mutat distant region requir restor cellcel fusion activ protein carri infect recov variant cultur cell studi demonstr acquisit cellcel fusion activ protein determin select andor adapt coronaviru chicken embryo cultur cell human anim origin
BMC Immunol	17317569	2013-02-12	PMC2700820	19505311	background sar outbreak uniqu opportun studi human respons novel viru report dendrit cell dc involv immun escap mechan sarscov studi focuss gene express tolllik receptor tlr chemokin receptor ccr death receptor ligand sarscov infect dc compar adult cord blood cb dc find explan agedepend sever sar result demonstr sarscov modul tlr tlr gene express induc express ccr ccr ccr strong induct tnfrelat apoptosisinduc ligand trail fa ligand gene express sarscov infect dc interestingli express gene studi higher cb dc adult dc conclus upregul chemokin ccr facilit dc migrat infect site lymph node increas trail induc lymphocyt apoptosi find explain increas lung infiltr lymphoid deplet sar patient explor biolog signific find warrant
PLoS One	23403421	2016-03-01	PMC2701634	19578544	revers transcriptas human immunodefici viru hiv plai kei role initi viral replic target develop antihiv drug previou studi mutat ya ia turn glnarg abrog viral replic replic capac activ discord studi investig alanin substitut site affect viral replic activ protein undetect viral particl mutant prgagpol mutant properli express transport incorpor proteas inhibit assai demonstr correl degrad mutant activ viral proteas nativ gel analysi indic mutat amino acid conform chang lead format higher order oligom dimer increas protein instabl suscept viral proteas residu critic stabil resist viral proteas conserv amino acid residu strain hiv lent support conclus knowledg gain prove drug design
Genet Vaccines Ther	26994705	2015-04-15	PMC2702340	19505299	background hepat core protein attract target hcv vaccin aim extermin hcv infect cell highli immunogen natur infect core appear low immunogen experiment set aim design hcv vaccin prototyp base core devis immun regimen lead potent anticor immun respons circumv immunogen limit earlier observ method plasmid encod core translat initi signal pcmvcore kozak sequenc pcmvcorekozak hcv ir pcmvcoreir design express varieti eukaryot cell polyprotein correspond hcv amino acid aa express coli cbl mice immun dose pcmvcorekozak pcmv balbc mice immun pcmvcore pcmvcorekozak pcmvcoreir empti pcmv ii lastli balbc mice immun core aa prime boost pcmvcorekozak prime core aa boost iii antibodi respons htincorpor cytokin secret corecor peptidestimul splenocyt assess immun plasmid differ coreexpress capac mous fibroblast transfect pcmvcore pcmvcoreir pcmvcorekozak express ng core cell singl immun highli express pcmvcorekozak induc specif ifn il weak antibodi respons singl immun plasmid direct low level core express induc level cytokin strong tcell prolifer pcmvcoreir antibodi titer pcmvcore boost pcmvcorekozak induc low antibodi respons corespecif tcell prolifer ifn secret subsid plasmid inject led decreas specif il secret best heterolog pcmvcorekozak primeprotein boost regimen gener mix ththcellular respons corespecif antibodi titer conclus administr highli express hcv core gene larg dose repeat inject smaller dose suppress corespecif immun respons induc heterolog dna primeprotein boost regimen circumv neg effect intracellular core express
BMC Health Serv Res	25878106	2012-03-01	PMC2703635	19505330	background consider discuss surround advanc hospit provid better childbirth care local commun hospit studi examin shift childbirth servic advanc hospit medic center region hospit local commun hospit clinic district hospit sampl popul track sevenyear period includ month sever acut respiratori syndrom sar epidem taiwan sar epidem pregnant women avoid matern servic advanc hospit concern rais maintain qualiti matern care increas demand childbirth servic local commun hospit studi analyz impact shift matern servic hospit level neonat mortal matern death method populationbas studi conduct data taiwan nation health insur annual statist monthli counti neonat moral rate base presar sampl januari decemb estim linear regress model includ trend continu variabl repres yearli chang binari variabl month counti control season countyspecif effect estim coeffici predict neonat mortal rate countymonth compar differ observ mortal rate sar period predict rate examin shift matern servic sar epidem neonat mortal rate analysi total observ insignificantli neg standard predict error sar period result subsampl area advanc hospit neg standard predict error sar period find indic despit increas local commun hospit neonat mortal sar epidem increas decreas area advanc hospit conclus increas matern servic local commun hospit occur sar epidem taiwan observ increas neonat matern mortal associ increas demand local commun hospit
BMC Biotechnol	22179147	2014-10-01	PMC2703641	19523201	background bud baculovirus util vaccin product antibodi function analysi transmembran protein studi produc purifi recombin bombyx mori nucleopolyhedroviru rbmnpvhprr displai human prorenin receptor hprr connect flag peptid sequenc surfac particl bind analysi hprr human prorenin rbmnpvhprr produc silkworm larva purifi hemolymph size exclus chromatographi rapid method bmnpv titer determin hemolymph perform quantit realtim pcr qpcr correl coeffici bmnpv determin endpoint dilut qpcr method rbmnpvhprr bacmidinject silkworm larva produc recombin baculoviru plaqu form unit pfu hemolymph time higher transfect solut bm cell purif yield sephacryl sf column chromatographi fold larval hemolymph dai postinject pi fold dai pi protein pattern rbmnpvhprr purifi dai ratio envelop protein kda vp nucleocapsid protein increas dai pi hprr detect purifi rbmnpvhprr dai pi conclus success purif rbmnpvhprr indic baculoviru product silkworm larva purif hemolymph sephacryl sf column chromatographi provid econom approach obtain purifi bmnpv stock high titer largescal product hprr util bind analysi screen inhibitor hprr
PLoS One	25275122	2004-01-01	PMC2703826	19593433	background replic coronavirus take place cytoplasm doubl membran vesicl dmv origin endoplasm reticulum er three transmembran nonstructur protein nsp nsp nsp understood membran anchor coronaviru replic complex nsp local er membran express recruit replic complex infect cell reveal transmembran region ctermini expos cytosol methodologyprincip find determin crystal structur ctermin hydrophil domain nsp nspc mhv strain cs sitedirect mutant highli conserv amino acid region to possess fold wildtyp wt structur featur monom link cysci disulfid bond asymmetr unit monom arrang ctermini opposit orient form open conform mutat cy ser affect monom structur mutant dimer adopt strikingli conform crystal pack crosslink ctermini parallel ntermini monom form close conform wt nspc exist dimer solut dissoci easili monom reduc environ conclusionssignific nspc expos reduc cytosol monom nspc physiolog structur serv basi function studi nsp
PLoS Biol	14681353	2016-12-15	PMC2705187	19621064	dysfunct cftr cystic fibrosi cf airwai epithelium perturb normal regul ion transport lead reduc volum airwai surfac liquid asl mucu dehydr decreas mucu transport mucu plug airwai cftr express ciliat epitheli cell surfac submucos gland ductal epithelium submucos gland acinar cell critic question develop gene transfer strategi cf airwai diseas airwai region requir cftr function epitheli cell requir cftr express restor normal asl volum regul mucu transport cf airwai epithelium vitro model human cf ciliat surfac airwai epithelium cf hae test human parainfluenza viru piv vector engin express cftr pivcftr deliv suffici cftr cf hae restor mucu transport correct cf phenotyp pivcftr deliv cftr airwai surfac epitheli cell express cftr protein cf hae fold endogen level noncf hae effici cftr deliveri fulli correct basic bioelectr defect cl epitheli ion transport restor asl volum regul mucu transport level approach noncf hae determin number cf hae surfac epitheli cell requir express cftr restor mucu transport normal level amount pivcftr express cftr surfac epitheli cell cf hae correl increas asl volum mucu transport rate data demonstr time knowledg restor normal mucu transport rate cf hae achiev cftr deliveri surfac epitheli cell vivo experiment appropri model will requir determin level mucu transport will afford clinic benefit cf patient predict futur goal correct gene transfer cf human airwai vivo attempt target surfac epitheli cell achiev mucu transport rate compar noncf airwai
BMC Pulm Med	27981468	2004-01-01	PMC2705343	19450259	background herp simplex viru type hsv describ respiratori tract infect critic patient individu immunocompromis continu matter debat circumst hsv relev pathogen pneumon role critic ill investig prospect intervent studi compar systemat data role hsv pneumon outpati autoimmun diseas mainten regimen immunosuppress method retrospect review chart patient rheumatoid arthriti vascul system lupu erythematosu sle outpati clinic german univers hospit year episod admiss ward diagnosi pneumoniapneumon identifi type pneumonia clinic featur retrospect studi patient rheumatoid arthriti vascul sle admit ward diagnos pneumoniapneumon bronchoscopi total case pulmonari infect associ hsv lower respiratori tract identifi case suggest caus role hsv sole agent caus pneumon prove clinic respons antivir treatment remain case hsv appear bystand bacteri infect mainten therapi leflunomid inhibit hsv assembl vitro associ milder cours pneumon patient detect hsv associ stronger immunosuppress regimen vasculit diseas conclus studi analyz frequenc hallmark case hsv associ pneumon occur compar larg cohort patient rheumatolog autoimmun diseas area controversi studi evid hsv isol pneumon immunocompromis studi provid estim frequenc relev hsv infect bacteri agent outpati autoimmun diseas
Virol J	15534914	2018-02-01	PMC2705359	19534833	the glycosyl membran protein sever acut respiratori syndrom associ coronaviru sarscov main structur compon virion mediat assembl bud viral particl membran topolog sarscov function signific nglycosyl complet understood interact surfac glycoprotein biochem immunofluoresc analys consist short glycosyl ntermin ectodomain three transmembran segment long immunogen ctermin endodomain nglycosyl site highli conserv group coronavirus studi recombin sarscov express glycosylationdefici reveal nglycosyl influenc shape virion infect cell cultur function analysi truncat protein ntermin amino acid compris three transmembran domain suffici mediat accumul golgi complex enforc recruit viral spike protein site viru assembl bud ergic
BMC Public Health	29480460	2014-06-19	PMC2706246	19515246	background statist algorithm routin detect outbreak welldefin syndrom influenzalik ill method appli detect emerg diseas preexist paper present method aim facilit detect outbreak priori knowledg clinic present case method method visual represent symptom diseas code patient consult intern classif primari care version icpc surveil data transform colorcod cell rang white red reflect increas frequenc observ sign graphic refer frame mimick bodi anatomi simpl visual observ colorchang pattern time concern singl code combin code enabl detect set interest method demonstr retrospect analys data set descript patient refer hospit gener practition gp particip french sentinel network descript patient directli consult hospit emerg depart inform imag colorchang alert pattern emerg case health consequ august heat wave visual gp data pass unnot convent surveil system flu epidem routin detect standard statist techniqu recogn visual data conclus human visual patternrecognit capac detect onset unexpect health event impli conveni imag represent epidemiolog surveil welltrain epidemiolog watcher condit met imagin epidemiolog watcher signal epidemiolog alert base imag wall present local region andor nation surveil pattern special field epidemiologist assign valid signal detect
Virol J	24947513	2012-08-06	PMC2706813	19552824	background diarrhea third lead infecti death worldwid estim respons death year infecti diarrhea establish diarrhea case unknown etiolog effort identifi novel virus causal agent diarrhea high throughput mass sequenc analyz stool sampl collect patient acut diarrhea sequenc limit similar picornavirus detect stool sampl collect australia child acut diarrhea combin mass sequenc rtpcr race race bp fragment viral genom sequenc phylogenet analysi demonstr viru highli diverg close member genu kobuviru tent name novel viru klasseviru detect klasseviru rtpcr diarrhea specimen collect patient st loui unit state untreat sewag collect barcelona spain conclus klasseviru undescrib picornaviru global widespread three contin investig determin klasseviru human pathogen need
PLoS One	22869823	2017-06-21	PMC2707627	19617915	background glioblastoma frequent malign primari brain tumor poor prognosi translat therapeut strategi glioblastoma experiment phase clinic limit insuffici anim model lack featur human tumor lentivir gene therapi attract therapeut option human glioblastoma valid clinic relev anim model methodologyprincip find rodent xenograft model recapitul invas angiogen featur human glioblastoma analyz transduct pattern therapeut efficaci lentivir pseudotyp vector lymphocyt choriomening viru glycoprotein lcmvgp vesicular stomat viru glycoprotein vsvg pseudotyp lentivir vector effici transduc human glioblastoma cell vitro vivo contrast pseudotyp gammaretrovir vector evalu clinic therapi glioblastoma ineffici gene transfer vitro vivo pseudotyp lentivir vector transduc cancer stemlik cell character cd nestin soxexpress abil form spheroid neural stem cell medium express astrocyt neuron differenti marker serum condit therapeut approach suicid gene herp simplex viru thymidin kinas hsvtk fuse egfp lentivir vector mediat complet remiss solid tumor mri highli surviv benefit compar control group recurr tumor surviv egfpposit tumor cell advoc prodrug applic cycl enhanc prolong therapeut conclusionssignific conclus lentivir pseudotyp vector promis candid gene therapi glioma patient ineffici gene deliveri gammaretrovir vector clinic therapi gbm confirm high reproduc invas glioma anim model translat research
J Inflamm (Lond)	28637751	2015-07-28	PMC2708161	19545424	background peptidylprolin isomeras protein mitosi gene interact pin regul turnov induc nitric oxid synthas ino murin aortic endotheli cell maec stimul coli endotoxin lp interferon ifn degrad ino reduc calpain inhibitor suggest pin affect induct calpainsensit inflammatori protein cyclooxygenas cox maec method maec transduc lentiviru encod inact control short hairpin sh rna target pin reduc pin cell treat lpsifn calpain inhibitor carbobenzoxyvalinylphenylalanin zvf pd cycloheximid cox inhibitor determin pin deplet cox calpain lp ifn induc cox treatment lp ng ifn induc cox protein fold control shrna maec induct greater fold pin shrna cell coxdepend prostaglandin product increas fold kd maec increas control cell addit increas cox protein pin deplet posttranscript induct cox mrna lpsifn cell lack pin loss cox protein treatment cycloheximid block protein synthesi reduc cell lack pin comparison control cell indic degrad enzym reduc zvf pd enhanc induct cox lpsifn zvf slow loss cox treatment cycloheximid cox degrad exogen calpain vitro contrast ino physic interact cox pin detect suggest effect pin calpain cox affect cox degrad cathepsin activ unalt deplet pin reduc calpain activ comparison control shrna cell conclus pin reduc calpain activ slow degrad cox maec recapitul inhibitor calpain sensit cox ino calpain pin limit induct calpain substrat maintain calpain activ endotheli cell
PLoS One	31214462	2009-07-01	PMC2710004	19623263	the genu orthopoxviru speci virus includ caus agent smallpox variola viru addit smallpox member genu capabl caus human infect includ monkeypox cowpox zoonot rodentborn poxvirus singl assai accur identifi orthopoxvirus provid valuabl tool rapid broad orthopoviru identif develop panorthopoxviru assai identif member genu base pcr reaction target orthopoxviru dna rna helicas polymeras gene amplicon detect electrosprai ionizationmass spectrometri pcresim ibi system demonstr assai detect identifi divers collect orthopoxvirus provid subspeci character virus blood rabbitpox infect rabbit assai sensit stochast limit pcr detect viru blood plaqueform unit millilit rabbitpox virusinfect rabbit
J Occup Med Toxicol	19570858	2009-08-01	PMC2710320	19549302	thi articl review biolog occup medicin literatur hn pandem influenza impact infect control cost busi continu set health care commun literatur hn biologi review includ treatment infect control mechan pertain occup medicin plan activ potenti arriv pandem avian influenza grow rapidli publish molecular biologi hn remain pauciti literatur occup medicin impact organ review summar basic scienc surround hn influenza rais kei concern pandem plan occup medicin profession workplac health care set will impact greatli hn pandem occup physician will plai essenti role corpor prepar respons busi continu strategi
PLoS One	19524994	2011-07-01	PMC2712091	19633719	background human rhinovirus hrv highli preval acut respiratori infect children classifi three speci hrva hrvb hrvc character sequenc untransl region utr vpvp region genom increas interest novel hrv strain identif worldwid distribut carri clinic molecular diagnosi hrv strain year studi children acut respiratori infect visit district hospit shanghai methodologyfind clone sequenc nt fragment cover utr vpvp capsid gene sixtyfour hrvinfect outpati diagnos children acut low respiratori tract infect sampl coinfect hrva hrvb hrvc compar analysi vpvp sequenc hrv high divers strain hrva hrvb speci preval of strain belong identifi hrvc speci analyz fragment utr character subspeci hrvc hrvcc cluster differ hrva hrvb hrvca previou recombin region sequenc hrva fulllength sequenc strain hrvca hrvcc subspeci compar analysi confirm close relationship structur protein appar addit recombin event gene utr hrvca strain doubl tripl infect hrvc respiratori syncyti viru andor bocaviru diagnos hrvinfect patient correl sever clinic outcom observ conclus studi high divers hrv strain bronchiti pneumonia children predomin hrvc hrva hrvb observ subspeci hrvc identifi divers to recombin hrva strain hrvc strain appear higher clinic impact hrva hrvb respiratori compromis
PLoS Pathog	30404801	2015-09-14	PMC2712770	19649323	although viral infect minor symptom number result seriou ill viral diseas symptom result direct viral replic host cell indirect immunopatholog consequ dendrit cell dc kei determin viral diseas outcom activ immun respons viral infect direct cell distinct helper type respons virus skew cytokin secret dc induc andor downregul immun system aim facilit prolong releas progeni interact dc virus absenc diseas complet recoveri natur function dc prevail lead chronic ill death function outmanoeuvr virus exploit dc
PLoS One	26289159	2004-01-13	PMC2713419	19641620	intravascularthrombosi extravascularlipiddeposit kei pathogen event consid interrupt intraoss blood suppli develop steroidassoci osteonecrosi clinic emploi agent capabl simultan target kei pathogen event experiment studi demonstr constitut flavonoid glycosid deriv herb epimedium ef compos flavonoid compound common stem nuclear exert dosedepend inhibit thrombosi lipiddeposit reduc incid steroidassoci rabbit direct action common metabolit potenti cellular target involv pathogen pathwai underli mechan explain counteract endothelium injuri excess adipogenesi find encourag design clinic trial investig potenti ef prevent steroidassoci on
Transfus Med	14722270	2014-11-12	PMC2713854	19392949	dengu common arthropodborn infect worldwid peopl year endem countri dengu viru singlestrand rna viru major serotyp infect serotyp confer homotyp immun heterolog immun secondari infect serotyp lead sever diseas major rout transmiss occur aed aegypti mosquito vector dengu transmit blood transfus organ transplant infect spectrum clinic ill rang asymptomat infect undifferenti fever dengu fever dengu haemorrhag fever dhf dengu shock syndrom dss dengu spread rapidli area increas frequenc major outbreak trend observ increas ag infect patient will impact blood suppli avail blood donor defer dengu infect exposur infect risk transmiss transfus blood asymptomat viraem donor will increas screen test dengu effect pathogen reduct process blood suppli implement costli measur carefulli consid demand platelet fresh frozen plasma will rise increas number dhfdss evidencebas guidelin clinic blood compon manag patient dhfdss establish inappropri will contribut challeng face blood servic
Acta Crystallogr D Biol Crystallogr	25392228	2007-12-19	PMC2714721	19622868	coronavirus famili positivestrand rna virus includ pathogen human anim larg coronaviru genom kb encod nonstructur protein nsp deriv replicas polyprotein autoproteolyt process nsp assembl viral replicationtranscript complex nsp nsp nsp believ anchor enzym complex modifi intracellular membran largest coronaviru nsp subunit hydrophob predict embed membran report conserv ctermin domain aminoacid residu delin predict face cytoplasm isol solubl domain librarybas construct screen prototyp crystal structur resolut nsp felin coronaviru unmodifi semetsubstitut protein crystal condit tetragon crystal belong space group phase problem initi solv singl isomorph replac anomal scatter sira molecular replac sirasderiv composit model structur consist singl domain helic content displai uniqu fold engag proteinprotein interact
Ital J Pediatr	18094154	2019-05-29	PMC2717562	19555507	background childhood asthma caribbean advanc preval morbid viral respiratori tract infect report trigger exacerb infect asthma spars caribbean territori examin distribut respiratori virus associ season acut stabl asthmat children trinidad method crosssect studi wheez children attend emerg depart nebulis stabl control subject yr ag asthma clinic nasal specimen collect dry januari raini june decemb season multitarget sensit specif highthroughput respiratori multicod assai test respiratoryviru sequenc distinct group human rhinoviru respiratori syncyti viru parainfluenza viru influenza viru metapneumoviru adenoviru coronaviru enteroviru wheez children higher preval respiratori virus compar stabil asthmat versu acut asthmat thrice infect respiratori viru ci predomin pathogen detect acut versu stabl asthmat rhinoviru rv respiratori syncyti viru rsv enteroviru strong odd rhinovir infect observ nebulis children compar stabl asthmat ci rv preval year dry raini season associ frequent detect viru dry raini season conclus emerg wheez ill childhood link infect rhinoviru trinidad tropic environ viralinduc exacerb asthma independ season tropic climat clinic virolog investig recommend role infect rhinoviru caribbean childhood wheez
Biomark Insights	31142674	2010-03-10	PMC2717845	19662225	sixteen longsag librari clinic stage cervic intraepitheli neoplasia enabl identifi novel cellsurfac biomark indic cin stage compar gene express profil cervic tissu earli advanc stage cin gene identifi novel genet marker fiftysix cellsurfac gene product differenti express progress cin cell surfac protein examin establish capac optic contrast agent bind contrast agent visual will allow realtim assess physiolog state diseas process bring vast benefit cancer care data discuss public submit ncbi gene express omnibu geo httpwwwncbinlmnihgovgeo access geo seri access number gse
BMC Public Health	20219910	2003-02-15	PMC2718884	19607669	background countri effect diseas surveil system earli detect outbreak revis intern health regul ihr enter forc health organ member state expand tradit infecti diseas notif includ surveil public health event potenti intern caus agent clearli establish guidelin countri conduct surveil type emerg diseas syndrom report enforc discuss commonli establish concept syndrom surveil develop region encompass prediagnost real time fashion investig public health action syndrom surveil north america europ typic thought highli complex technolog driven autom tool earli detect outbreak low technolog applic syndrom surveil worldwid augment tradit surveil summari paper review exampl novel applic detect vectorborn diseas foodborn ill sexual transmit infect hope demonstr syndrom surveil basic version feasibl effect tool surveil develop countri facilit complianc ihr guidelin
Curr Oncol	12552021	2008-09-10	PMC2722059	19672425	purpos radiotherapi oncolog emerg aspect manag cancer patient emergencieswhich includ malign spinal cord compress brain metastas superior vena cava obstruct uncontrol tumour hemorrhag requir treatment hospit hour weekend hospit holidai remain consensu radiat oncologist indic appropri radiotherapi treatment weekend treatment decis remain subject main aim studi document incid indic patient receiv emerg treatment weekend schedul hospit holidai singl institut secondari aim investig complianc treatment institut qualiti assur polici local provinci method septemb septemb patient treat weekend defin commenc pm fridai conclud schedul workdai hospit holidai retrospect identifi oncolog patient system schedul modul relev patient datainclud patient ag sex primari cancer site specif radiat field rational treatment refer hospit total treatment dose radiat dose fraction inpati outpati statu durat treatmentwer collect subsequ analyz comparison local polici perform subject year period patient prescrib urgent radiotherapi weekend hospit holidai cohort treat saturdai sundai saturdai sundai patient present lung prostat breast cancer top reason referr emerg weekend treatment includ spinal cord compress brain metastas superior vena cava obstruct indic treatment gener qualiti assur polici implement local provinci conclus patient treat weekend hospit holidai gener treat appropri intent treatment indic studi compli provinci polici pattern care studi literatur local polici appear robust polici improv allow cohes radiat oncologist pattern care group patient comparison practic institut valuabl kei step develop sound guidelin member radiotherapi commun follow
BMC Infect Dis	18786990	2012-11-12	PMC2722662	19630992	background nosocomi infect major threat patient intens care unit icu limit data exist epidemiolog icuacquir infect china retrospect studi carri determin current statu nosocomi infect china method retrospect review nococomi infect icu tertiari hospit east china perform nosocomi infect defin definit center diseas control prevent patient nosocomi infect rate incid densiti rate nosocomi infect excess length stai distribut nosocomi infect site determin pathogen antimicrobi suscept profil investig patient admit period time patient nosocomi infect rate patient dai lower respiratori tract infect lrti account infect urinari tract infect uti bloodstream bsi gastrointestin tract gi infect chang lrti uti bsi infect rate year gi rate decreas in addit baumannii albican epidermidi frequent pathogen isol patient lrti uti bsi rate isol resist commonli antibiot rang conclus high stabl rate nosocomi infect icu tertiari hospit china year differ distribut infect site pathogen antibiot suscept profil report western countri guidelin surveil prevent nosocomi infect implement order reduc rate
PLoS One	23148211	2006-12-12	PMC2722738	19688094	background weekli proport laboratori test posit influenza public health surveil system identifi period influenza activ aim estim sensit influenza test canada base nation respiratori viru surveil system method find weekli number influenzaneg test model function laboratoryconfirm posit test influenza respiratori syncyti viru rsv adenoviru parainfluenza virus season trend poisson regress sensit calcul number influenza posit test divid number influenza posit test modelestim number fals neg test sensit influenza test estim ci vari depend season region conclus estim sensit influenza test report nation laboratori surveil system consider report test characterist laboratori test number factor explain differ includ sampl qualiti specimen procur issu test characterist improv diagnosi permit better estim burden influenza
BMC Med	17164340	2014-10-29	PMC2727531	19635124	background pneumonia main ill death children year ag better describ epidemiolog viral communityacquir pneumonia cap develop countri method juli june examin nasopharyng aspir npa case pneumonia health organ criteria children month recruit random trial zinc supplement field clinic bhaktapur nepal specimen examin respiratori syncyti viru rsv influenza viru type infa infb parainfluenza viru type piv piv piv human metapneumoviru hmpv multiplex revers transcriptas polymeras chain reaction pcr assai identifi viru isol npa specimen valid pcr result yield rsv infa piv piv hmpv infb piv cap occur epidem pattern substanti tempor variat three year studi largest peak pneumonia occurr coincid peak rsv infect occur epidem raini season winter monthli number rsv infect posit correl rel humid rs temperatur rainfal hmpv epidem occur three winter season monthli number hmpv case associ rel humid rs conclus respiratori rna virus detect npa cap case studi commonli isol virus rsv infa piv rsv infect contribut observ cap epidem occurr viral cap commun reflect overlap microepidem respiratori virus highlight challeng develop implement effect public health control measur
Case Rep Med	25359769	2012-12-05	PMC2729489	19707475	liquoric activ substanc glycyrrhizin inhibit convers precursor cortisol cortison inhibit enzym betahydroxysteroid dehydrogenas imbib liquoric act hyperaldosteron present typic symptom includ high blood pressur low blood potassium muscl pain weak articl apprais physiolog pharmacolog effect health liquoric critiqu product liquoric describ typic case report liquoriceinduc hypertens apprais oral effect consumpt liquoric product
PLoS One	17121693	2016-10-11	PMC2729920	19718434	background case fatal ratio cfr ratio death infecti diseas number case assess virul calcul ratio cumul number death case cours epidem result bias cfr studi develop simpl method unbias estim confirm cfr ccfr confirm case denomin earli stage epidem death methodologyprincip find method adjust bias ccfr factor underestim inform time symptom onset death examin approach analyz outbreak sever acut respiratori syndrom hong kong unbias ccfr estim investig publish epidemiolog dataset novel swineorigin influenza hn viru infect usa canada observ death permit estim distribut time onset death uncertainti address sensit analysi maximum likelihood estim unbias ccfr influenza lie rang assum paramet space factor underestim estim influenza virul compar earli estim mexico death model permit estim conserv upper bound ccfr conclus mind ccfr entir popul vulner variat subpopul underdiagnosi method assess virul earli stage epidem inform polici maker public
PLoS One	27729455	2015-06-16	PMC2730015	19714250	dna sequenc normal characterbas represent appear formid mix nucleotid appar order nucleotid frequenc distribut sequenc studi extens simpl rule chargaff centuri ago equat total number purin pyrimidin duplex dna sequenc difficult trace relationship base studi charact represent dna sequenc graphic represent provid clue novel represent dna sequenc provid overview base distribut composit sequenc provid insight hidden structur report observ base graphic represent intrapurin intrapyrimidin differ sequenc conserv gene gener follow quadrat distribut relationship arisen mutat sequenc evolutionari time scale hitherto undescrib relationship gene sequenc consid report hypothes relationship characterist sequenc barrier larg scale sequenc alter overrid characterist monitor process inbuilt dna sequenc relationship rais possibl intron sequenc plai role maintain characterist indic intronl phenomena
Proteome Sci	26077642	2014-12-03	PMC2731080	19664241	background predict function unknown protein essenti goal bioinformat sequenc similaritybas approach function predict inadequ absenc sequenc sequenc similar protein sequenc statist weak studi aim develop accur predict method identifi protein function irrespect sequenc structur similar highli accur predict method capabl identifi protein function base sole protein sequenc properti describ method analys identifi specif featur protein sequenc highli correl protein function determin combin protein sequenc featur best characteris protein function thirtythre featur repres subtl differ local region full region protein sequenc introduc basi featur extract sole protein sequenc model built predict function protein broad rang cellular compon molecular function biolog process accuraci protein function predict random forest featur select rang local sequenc broad rang applic predict protein function conclus accur predict method machinelearn approach base sole protein sequenc properti primari contribut paper propos pnprd featur repres global andor local differ sequenc base posit andor neg charg residu assist predict protein function addit identifi compact featur subset predict function protein indic sequencebas classifi provid good broad rang protein propos featur predict function combin tradit featur support creation discrimin featur set specif protein function
PLoS Pathog	25473044	2012-03-21	PMC2734983	19855817	interspeci transmiss pathogen result emerg infecti diseas human domest wild anim genom tool highthroughput sequenc mrna express profil microarraybas analysi singl nucleotid polymorph provid unpreced wai analyz divers genom emerg pathogen molecular basi host respons compar contrast outcom emerg infect close pathogen host speci delin host pathwai determin outcom zoonot transmiss adapt newli invad speci ultim challeng link pathogen host genom data biolog outcom zoonot transmiss translat integr data novel intervent strategi eventu will allow effect control newli emerg infecti diseas
PLoS Pathog	22438550	2013-11-08	PMC2736567	19806178	a number paramyxovirus respons acut respiratori infect children elderli immunocompromis individu airwai inflamm exacerb chronic diseas asthma understand molecular pathogenesi infect search cellular target virul protein human parainfluenza viru type hpivc hpivc interact directli ctermin domain stat grb protein measl nipah virus fail bind stat explain report capac hpivc block type interferon signal interact grb unexpect adaptor protein bridg epiderm growth factor egf receptor mapkerk pathwai signal cascad involv airwai inflammatori respons report hpiv infect transient express hpivc increas cellular respons egf assess elk transactiv phosphoryl level erk ribosom subunit protein translat initi factor eif inhibit mapkerk pathwai prevent viral protein express infect cell altogeth data provid molecular basi explain role hpivc virul factor determin pathogenesi demonstr paramyxovirida evolv singl virul factor block type interferon signal boost simultan cellular respons growth factor
BMC Med Genomics	24212098	2009-10-01	PMC2736983	19656400	background gene express studi requir appropri normal method method stabli express refer gene suitabl refer gene appear uniqu tissu identifi optim set stabli express gene human blood normal method wholegenom affymetrix human arrai examin sampl male femal ag includ control subject patient tourett syndrom stroke migrain muscular dystrophi autism top stabli express gene broad rang express level identifi valid best candid gene perform quantit rtpcr subset gene trap decr fpg farp mapr pex gin cry csnkg agalt commonli emploi refer gene gapdh actb bm hmb ppib report stabli express blood express stabil rank analysi perform genorm normfind algorithm refer gene rank base express stabil minimum number gene need nomal calcul genorm fewest stabli express gene need acur normal rna express studi human blood combin trap fpg decr ppib confirm rank best candid control gene altern algorithm normfind conclus refer gene identifi studi stabli express blood human gender multipl diseas condit ag importantli function cell express independ gene normal gene microarrai rtpcr blood studi human physiolog metabol diseas
PLoS One	19461111	2015-12-01	PMC2738425	19756151	background grai wolv cani lupu reintroduc yellowston nation park ynp year absenc recoveri effort popul close monitor pup surviv reduc suggest diseas outbreak methodologyprincip find analyz sympatr wolf coyot cani latran red fox vulp vulp serolog data ynp span identifi longterm pattern pathogen exposur identifi associ risk factor examin evid diseaseinduc mortal wolv surviv data high constant exposur canin parvoviru wolf seropreval coyot canin adenoviru wolf pup yr adult yr coyot juvenil yr adult yr canin herpesviru wolf coyot juvenil young adult yr adult yr suggest pathogen enzoot ynp wolv coyot averag of wolv exhibit exposur protozoan parasit neospora caninum individu odd exposur tend increas ag tempor variabl wolf coyot fox exposur canin distemp viru cdv tempor variabl evid distinct multihost outbreak and smaller isol outbreak wolv interior ynp year high wolfpup mortal in northern region park correl peak cdv seropreval suggest cdv contribut observ mortal conclusionssignific pathogen examin appear jeopard longterm popul canid ynp cdv appear capabl caus shortterm popul declin addit cdv maintain frequenc futur epizoot expect futur manag northern rocki mountain wolf popul
BMC Bioinformatics	26459826	2006-01-01	PMC2739203	19682364	background grow divers biolog data tag uniqu identifi uid associ polynucleotid protein ensur effici computermedi data storag mainten process identifi inform peopl substitut biolog meaning name present facilit util dissemin sequencebas knowledg substitut commonli manual tediou exercis prone mistak omiss introduc snad sequenc annotationbas design mediat automat convers sequenc uid associ multipl align phylogenet tree suppli plain text list biolog meaning name acronym convers direct precompil userdefin templat exploit wealth annot cognat entri extern databas exampl demonstr tool gener name practic purpos virolog conclus tool control annotationbas convers sequenc uid biolog meaning name acronym develop servic foster link qualiti sequenc annot effici commun knowledg dissemin research
PLoS One	16391044	2017-02-01	PMC2739295	19763259	background process secretas typei membran protein substrat trigger signal cascad releas intracellular domain icd nuclear transloc modul transcript gene regul divers arrai cellular biolog process list secretas substrat grow enzym cancer alzheim diseas therapeut target map secretas activ suscept gene transcript sharpen view specif gene molecular function biolog pathwai methodologyprincip find identifi gene molecular function transcription secretas activ cellular transcriptom chines hamster ovari cho cell enhanc inhibit secretas activ analyz compar cdna microarrai function cluster fatigo identifi gene reveal underrepres group multipl activ function singl gene pronounc transcript suscept secretas activ evalu realtim pcr valid gene strikingli decreas transcript ptprg amn increas transcript upp support data cell cycl disturb relev cancer stem cell neurodegen diseas map interact protein encod valid gene exclus reli evidencebas data reveal broad effect wnt pathwai member includ wnta dvl intriguingli transcript tera gene unknown function secretas activ alter analyz human alzheim diseas brain cortic conclusionssignific investig effect secretas activ gene transcript reveal cluster molecular function gene hold potenti better understand biologi secretas role cancer alzheim diseas patholog
Virol J	29104445	2004-11-24	PMC2739521	19698190	dure outbreak sar prototyp viru isol patient frankfurtgermani strain frankfurt oppos sarscoronaviru strain frankfurt nucleotid delet transmembran domain orf protein overexpress hek cell fulllength protein variant delet caus interferon beta induct cleavag procaspas studi role orf context viru replic clone full genom cdna copi frankfurt bacteri artifici chromosom downstream rna polymeras promot transfect cap rna transcrib construct yield infecti viru indistinguish origin viru isol presum frankfurt ancestor intact orf reconstruct caco huh cell vero cell variant carri orf delet replic advantag parent viru fold increas viru rna supernat associ chang induct secret type interferon alter induct apoptosi cell cultur pretreat cell interferon beta caus delet viru replic higher titer parent strain fold vero cell fold caco cell syrian golden hamster inocul intranas plaqu form unit viru titer infecti viru viral rna lung increas fold delet viru differ explain earlier observ enhanc virul frankfurt hamster compar sarscoronaviru refer strain identifi sarscov protein attenu factor sarscoronaviru genom attenu focus earli phase infect invivo orf contribut delai accumul viru patient suggest limit spread sar epidem
J Hematol Oncol	15564515	2017-06-13	PMC2739531	19709441	background gener enhanc express antichymotrypsin clusterin clu antitrypsin aat haptoglobin chain hap leucin rich glycoprotein lrg sera patient epitheli ovarian carcinoma eoca report studi compar express serum acutephas protein app patient stage cancer alter stage correl express high abund serum app demonstr sera patient studi express hap aat appear demonstr posit correl three initi stage cancer invers correl detect express lrg clu patient diagnos stage iv cancer express serum app conform alter progress chang conclus highlight potenti prognost signific select high abund serum app patient eoca
PLoS Comput Biol	28606192	2004-10-01	PMC2740835	19779555	as kei factor endem epidem dynam geograph distribut virus frequent interpret light genet histori infer histor dispers migrat pattern virus restrict modelfre heurist approach provid insight tempor set spatial dynam introduct probabilist model evolut offer uniqu opportun engag statist endeavor introduc bayesian framework infer visual hypothesi test phylogeograph histori implement charact map bayesian softwar sampl timesc phylogeni enabl reconstruct time viral dispers pattern accommod phylogenet uncertainti standard markov model infer extend stochast search variabl select procedur identifi parsimoni descript diffus process addit propos prior incorpor geograph sampl distribut character altern hypothes spatial dynam visual spatial tempor summar infer virtual globe softwar describ bayesian phylogeographi compar previou parsimoni analysi investig influenza hn origin hn epidemiolog linkag sampl local analysi rabi west african dog popul reveal viru diffus enabl endem mainten continu epidem cycl analys conclud phylogeograph framework will asset molecular epidemiolog easili gener infer biogeogeographi genet data organ
J Biomed Sci	15365101	2017-09-01	PMC2741444	19725950	to search cellular gene upregul vaccinia viru vv infect differenti displayrevers transcriptionpolymeras chain reaction ddrtpcr assai examin express mrna mockinfect vvinfect hela cell mitochondri gene protein electron transport chain gener atp ii upregul vv infect upregul level vv infect confirm western blot analysi upregul reduc mapk inhibitor apigenin demonstr inhibit vv replic induct express occur viral dna replic ara inhibitor poxvir dna replic block induct atp product increas host cell vv infect oligomycin inhibitor atp product reduc atp level hr viru infect mockinfect cell inhibit viral protein express viru product suggest increas atp product requir effici vv product induct express bcl independ pathwai
PLoS One	28892451	2018-11-21	PMC2743193	19774076	background destruct architectur subsequ function integr lung pulmonari viral infect attribut extent pathogen replic hostgener inflamm associ recruit immun respons presenc antigen dispar pulmonari virus emerg novel virus assur recurr lung damag infect resolut primari viral infect develop safe broad spectrum immunoprophylact strategi capabl enhanc protect immun respons lung limit immunemedi lung damag immunoprophylact strategi describ util protein cage nanoparticl pcn acceler clearanc divers respiratori virus primari infect host immun respons lung damag methodologyprincip find mice pretreat pcn independ specif viral antigen protect subleth lethal dose influenza virus mouseadapt sarscoronaviru mous pneumoviru treatment pcn increas surviv mark enhanc viral clearanc acceler induct viralspecif antibodi product decreas morbid lung damag enhanc protect appear depend prior develop induc bronchusassoci lymphoid tissu ibalt lung respons pcn treatment mediat cd cell cell depend mechan conclusionssignific immunoprophylact strategi describ util infectionindepend induct natur occur ibalt prior infect pulmonari viral pathogen strategi nonspecif enhanc primari immun respiratori virus restrict antigen specif inher typic vaccin strategi pcn treatment asymptomat applic importantli amelior damag inflamm associ recruit immun respons lung
BMC Pregnancy Childbirth	30463962	2018-01-10	PMC2744663	19723332	background optimismpessim healthrel qualiti life compar cultur method three sampl pregnant women final trimest recruit china ghana unit state particip complet survei includ life orient test revis lotr optimismpessim measur short form sf qualiti life measur question address health demograph factor threecountri set creat analysi match women ag gestat ag enrol number previou pregnanc anova posthoc pairwis comparison compar cohort multivari regress analysi creat model identifi variabl associ optimismpessim lotr score vari cultur sampl ghanaian pregnant women optimist pessimist chines pregnant women optimist pessimist subscal analysi kei variabl predict varianc optim score countri origin work monei level educ treat emot issu medic qualiti life score vari countri sampl pronounc differ occur vital measur pregnant women report lower vital score chines ghanaian pregnant women sampl conclus rais question countri origin influenc optimismpessim pregnant women warrant explor underli conceptu optimismpessim health qualiti life countri
PLoS Pathog	29321322	2012-05-09	PMC2745574	19798426	ifn plai critic role limit viral spread restrict viral tropism protect mice neurotrop coronaviru infect ifn depend mechan underli innat antivir function cn understood role rnase viral encephalomyel explor base function inhibit translat induc apoptosi propag ifn pathwai rna degrad intermedi infect rnase defici rl mice subleth demyelin mous hepat viru variant reveal major mice succumb infect dai pi rnase defici affect control infecti viru diminish ifn express cn increas morbid mortal attribut alter proinflammatori signal composit cell infiltr cn uniqu phenotyp infect rl mice manifest earlier onset increas sever demyelin axon damag brain stem spinal cord evid enhanc neuron infect increas tissu damag coincid sustain brain stem infect foci microglia infect grei matter increas apoptot cell data demonstr novel protect role rnase viral induc cn encephalomyel reflect viral control propag ifn mediat signal protect function associ cell type specif region restrict viral replic grei matter amelior neurodegener demyelin
PLoS One	22573863	2006-11-28	PMC2745575	19779614	the niaid nation institut allergi infecti diseas biodefens proteom program aim identifi target potenti vaccin therapeut diagnost agent concern bioterror includ bacteri parasit viral pathogen program includ proteom center gener divers type pathogenhost data includ mass spectrometri microarrai transcript profil protein interact protein structur biolog reagent biodefens resourc center wwwproteomicsresourceorg develop bioinformat framework emploi proteincentr approach integr support mine analysi larg heterogen data underli approach data warehous comprehens protein gene identifi map annot extract molecular databas valuead annot provid kei protein experiment find control vocabulari avail pathogen host omic data integr framework allow global analysi data comparison experi organ illustr case studi present identif hypothet protein differenti gene protein express host system mous macrophag human hela cell infect bacteri bacillu anthraci salmonella typhimurium viral orthopox pathogen suggest protein priorit addit analysi function character analysi vacciniahuman protein interact network supplement protein accumul level led identif human keratin type ii cytoskelet protein potenti therapeut target comparison complet genom pathogen variant coupl experiment complet proteom allow identif priorit ten potenti diagnost target bacillu anthraci integr analysi data set multipl center reveal potenti function signific hidden relationship pathogen host protein provid system approach basic understand pathogen target identif
PLoS Negl Trop Dis	17251145	2013-04-01	PMC2745658	19787037	the diagnosi rabi routin base clinic epidemiolog exposur report rabiesendem countri diagnost test convent assai appear neg undertaken late diseas despit clinic diagnosi tendenc time unreli test rare optim entir depend natur qualiti sampl suppli cours three decad applic molecular biologi aid develop test result rapid detect rabi viru test enabl viral strain identif clinic specimen current number molecular test complement convent test rabi diagnosi challeng st centuri develop rabi diagnost technic natur test challeng st centuri diagnost test develop twofold firstli achiev internation accept valid test will lead accept organis global secondli area test need develop region financi logist barrier prevent implement develop countri poor healthcar infrastructur recognis molecularbas diagnost assai will unafford routin costbenefit ratio measur adopt rapid afford rabi diagnost test develop countri highlight share transfer technolog laboratori twin develop develop countri importantli develop countri benefit molecular method tool capabl differenti diagnosi human diseas clinic symptom antemortem test human rabi molecular techniqu barrier insurmount expect test accept implement need will provid substanti improv rabi diagnosi surveil advent molecular biologi technolog initi combin advanc biologi disciplin will support develop techniqu capabl high throughput test low turnaround time rabi diagnosi
J Immune Based Ther Vaccines	23478444	2009-06-15	PMC2746192	19735569	experi year ago demonstr inject sequenc dna encod pathogen stimul immun realiz dna vaccin numer potenti advantag convent vaccin approach includ inher safeti rapid product time attribut dna vaccin ideal develop emerg pathogen advanc optim aspect dna vaccin acceler approach concept realiti contemporari human trial licens human dna vaccin approv anim health indic rapid manufactur capabl dna vaccin emerg infecti diseas includ current novel hn influenza pandem preexist immun limit advanc dna vaccin approach potenti power weapon protect emerg pandem human pathogen
BMC Gastroenterol	19416076	2003-08-01	PMC2746226	19698126	background studi aim assess nationwid trend incid sever gallston diseas taiwan adult ag method retrospect longitudin studi conduct taiwan nation health insur databas collect patient incid sever gallston diseas acut cholecyst biliari pancreat acut cholang gallstonerel procedur elect nonelect cholecystectomi endoscop retrograd cholangiopancreatographi ercp led hospit admiss identifi icdcm diagnost procedur code annual incid rate gallstonerel complic procedur calcul confid interv ci estim assum poisson distribut hospit admiss rate sever gallston diseas increas advanc ag agestandard rate ci popul men women men higher rate acut cholecyst lower rate elect cholecystectomi men women ag hospit admiss gallstonerel complic procedur increas ag incid biliari pancreat acut cholang hospit admiss gallston receiv ercp increas substanti chang incid acut cholecyst despit decreas rate elect cholecystectomi conclus populationbas studi substanti increas rate admiss sever gallston diseas ag concurr incid biliari pancreat acut cholang risen ag 
Health Qual Life Outcomes	12876183	2007-11-21	PMC2748069	19674476	background wisconsin upper respiratori symptom survei wurss illnessspecif healthrel qualityoflif questionnair outcom instrument object question wurss assess symptom function impair associ common cold instrument measur chang time respons minim differ mid detect wurss descript statist area time sever curv auc sampl size trial requir detect mid auc criteria factor analysi underli dimension structur common cold reliabl item domain summari score repres wurss consider wurss compar wurss jackson sf studi design set peopl jacksondefin cold recruit commun madison wisconsin particip enrol hour cold symptom monitor dai ill half sampl fill wurss morn wurss even half revers daili order extern compar sf hour recal gener health measur yield separ physic mental health score eightitem jackson cold assess symptom function impair qualiti life particip monitor persondai particip ag year sd major femal white repres substant educ incom divers wurss item demonstr perform embed wurss standalon wurss minim differ mid guyatt respons wurss wurss factori analysi suggest dimens structur wurss three dimens structur wurss composit reliabl coeffici rang cronbach alpha rang wurss version correl jackson scale w sf physic health w sf mental health w conclus wurss wurss perform illnessspecif qualityoflif evalu outcom instrument construct valid support data present wurss cover symptom wurss exhibit perform term reliabl respons importancetopati converg measur
Virol J	18032504	2016-08-15	PMC2749830	19737402	the genu toroviru order nidoviral includ number speci infect livestock virus linear positivesens ssrna genom kb encod larg polyprotein express genom rna addit protein express nest set cotermin subgenom rna report describ bioinformat discoveri code orf overlap the polyprotein code sequenc orfa read frame orf strong code signatur fact conserv amino acid level overlap region orfa propos orf util nonaug initi codon conserv cug codon strong kozak context upstream orfa aug initi codon novel amino acid protein dub k
Virol J	27528677	2015-09-16	PMC2751755	19754946	background goos parvoviru gpv dependoviru associ latent infect mortal gees current sever gees product worldwid object studi develop fluoresc quantit realtim polymeras chain reaction pcr fqpcr assai fast accur quantif gpv dna infect gosl aid understand regular distribut pattern nosogenesi gpv vivo detect limit assai standard dna copi sensit log higher convent gelbas pcr assai target gene realtim pcr reproduc satisfactori low intraassai interassai coeffici variat conclus high sensit specif simplic reproduc gpv fluorogen pcr assai combin high throughput method suitabl broad spectrum gpv etiologyrel applic
PLoS Genet	26378161	2019-04-01	PMC2752168	19855822	it argu arriv genom era shift paradigm vaccin therapeut develop microbiolog sequencebas approach genom sequenc provid unattain rout investig mechan underpin pathogenesi genom transcriptom metabolom structur genom proteom immunom exploit perfect identif target design vaccin drug predict effect patient human genom studi provid insight aspect host biologi infecti diseas evergrow bodi genom data genomebas approach will plai critic role futur enabl time develop vaccin therapeut control emerg infecti diseas
PLoS One	30753961	2005-02-11	PMC2752805	19809496	background mothertochild transmiss mtct main hiv infect children worldwid ctype lectin receptor dendrit cellspecif icamgrab nonintegrinrel dcsignr cdl liverlymph nodespecif icamgrab nonintegrin lsign interact pathogen includ hiv express maternalfet interfac hypothes influenc mtct hiv method find investig potenti role dcsignr mtct hiv carri genet associ studi dcsignr wellcharacter cohort hivinfect mother infant recruit harar zimbabw infant harbour copi dcsignr andor haplotyp hh hh hh fold increas risk utero iu hiv infect fold increas risk intrapartum ip hiv infect adjust number matern factor implic h haplotyp share singl nucleotid polymorph snp promot region pa intron inta associ increas risk iu p ip inta hiv infect promot variant reduc transcript activ vitro homozyg infant bear pa inta mutat observ fold decreas level placent dcsignr transcript disproportion express membranebound isoform compar infant noncarri conclus dcsignr plai crucial role mtct hiv impair placent dcsignr express increas risk transmiss
Virol J	15709046	2008-10-08	PMC2753318	19765297	background borna diseas viru bdv type member bornavirida famili virus induc fatal neurolog diseas hors sheep anim propos role psychiatr diseas human bdv glycoprotein extens glycosyl protein migrat appar molecular mass kilodalton kda bdv posttranslation cleav cellular subtilisinlik proteas furin subunit kda amino termin protein gp kda carboxyl termin protein gp class iii viral fusion protein vfp encod member rhabdovirida herpesvirida baculovirida intern fusion domain compris beta sheet beta sheet domain extend alpha helic domain membran proxim stem domain carboxyl termin anchor proteom comput analys structuralfunct motif character class iii vfp locat collinearli bdv structur model establish bdv base postfus structur prototyp class iii vfp vesicular stomat viru glycoprotein vsv conclus encod member bornavirda class iii vfp gammapenetren
BMC Bioinformatics	18842892	2004-07-29	PMC2753849	19758451	background arrai compar genom hybrid fast costeffect method detect genotyp compar genom sequenc unknown bacteri isol method microarrai applic requir adequ coverag probe target region interest unbias tile probe entir length genom flexibl design approach wholegenom tile requir genom sequenc advanc accur analysi uncharacter bacteria arrai queri fulli repres set sequenc speci pangenom prior microarrai includ singl strain arrai conserv sequenc gene famili arrai omit gene sequenc variant pangenom paper present probe select algorithm panarrai tile multipl genom minim number probe arrai built cluster gene famili panarrai unbias probecentr approach reli annot gene cluster multialign probe evenli tile sequenc pangenom consist level coverag minim requir number probe probe conserv multipl strain pangenom select addit probe span polymorph region genom viabil algorithm demonstr arrai design bacteri pangenom design probe arrai fulli tile genom listeria monocytogen strain overlap probe greater twofold coverag conclus panarrai oligonucleotid probe select algorithm tile multipl genom sequenc minim number probe capabl fulli tile genom speci singl microarrai chip uniqu pangenom tile arrai provid maximum flexibl analysi uncharacter strain
J Health Popul Nutr	15306390	2012-02-08	PMC2754025	18330067	acut viral bronchiol common respiratori infecti diseas infanc prospect studi carri infant ag month evalu nutrit breastfeed statu risk factor unfavour evolut previouslyhealthi infant care hospit immunofluoresc test viru anthropometr assess perform outcom length oxygenus length hospit stai type hospit unit need seventythre percent infant wellnourish undernourish nutrit risk overweight obes eightyon percent undernourish nutrition atrisk infant wellnourish overweight obes infant receiv exclus breastfeed median length hospit stai dai oxygenus hour nutrit statu affect clinic cours previouslyhealthi infant acut viral brochiol durat exclus breastfeed type breastfeed invers length oxygenus length hospit stai shorter exclus breastfeed observ infant assign paediatr ward intens care unit conclus longer durat breastfeed associ better clinic outcom
BMC Infect Dis	22318134	2014-11-24	PMC2754485	19772586	background serum procalcitonin pct consid predict likeli develop bacteri infect emerg set studi describ pct level overtim relationship bacteri infect chronic obstruct pulmonari diseas copd critic patient pneumonia method conduct prospect cohort studi icu univers hospit consecut copd patient admit pneumonia septemb septemb includ respiratori sampl test presenc bacteria virus procalcitonin sequenti assess patient classifi probabl presenc bacteri infect thirti patient includ pct level assess patient median valu gl iqr time admiss gl iqr hour gl iqr hour highest pct pctmax level gl patient greater gl patient suggest low high probabl bacteri infect fifteen bacteria virus detect patient bacteria detect patient pctmax level gl contrast bacteria detect patient estim bacteri infect pct level pctmax gl conclus base pct level cut gl appropri gl propos sever lower respiratori tract infect predict probabl bacteri infect sever copd patient pneumonia studi test procalcitoninbas antibiot strategi need copd patient sever pneumonia
PLoS One	25329858	2012-04-18	PMC2754531	19816578	we demonstr replac gene avirul strain beaudett infecti bronchiti viru ibv gene virul strain recombin viru beaurm vitro cell tropism virul viru avirul order investig structur accessori gene plai role pathogen replac beaudett strain recombin ibv chimaer viru replicas gene deriv beaudett rest genom demonstr exchang larg region ibv genom kb transient domin select method recoveri viabl recombin ibv demonstr interchang complet replicas gene replac replicas gene beaudett deriv gene analysi chimaer viru avirul indic structur accessori gene deriv virul isol ibv restor virul loss virul associ beaudett strain resid replicas gene
PLoS Biol	17715225	2007-08-29	PMC2757898	19855827	in likelihood matter time public health system will face major biolog threat intention dispers origin newli emerg infecti diseas increas reactiv biodefens proactiv increas prepared achiev goal essenti scientif public health commun fulli embrac genom revolut novel bioinformat comput tool great stride understand novel emerg threat develop genom graduat special field scienc tool will routin laboratori clinic set technolog afford genom proactiv build prepared respons biolog threat piec includ major continu fund advanc nextgener sequenc technolog bioinformat infrastructur open access data metadata set place genom plai central role public health system
PLoS Biol	17728234	2012-01-06	PMC2757903	19855828	infecti diseas global coordin genomicbas movement link sequenc effort develop respons tool mitig impact exist emerg threat
PLoS One	22319149	2017-05-03	PMC2757906	19823675	background small molecul inhibitor rna viru replic potent antivir drug dissect select step replic process identifi antivir compound tomato bushi stunt viru tbsv model posit strand rna viru test acridin deriv chlorpromazin cpz quinacrin qc activ prionbas diseas methodologyprincip find report cpz qc compound inhibit tbsv rna accumul plant protoplast vitro assai reveal inhibitori effect compound manifest step tbsv replic qc multipl step includ inhibit select bind replic protein viral rna templat requir recruit viral rna replic ii reduct minusstrand synthesi tombusviru replicas iii inhibit translat uncap tbsv genom rna contrast cpz inhibit vitro assembl tbsv replicas bind cpz intracellular membran rna viru replic conclusionsignific cpz effect inhibitor plant virus includ tobacco mosaic viru turnip crinkl viru cpz broad rang antivir activ inhibitor constitut effect tool studi similar replic strategi rna virus
PLoS One	28148840	2016-12-01	PMC2759292	19834602	background virus interact exploit host cellular machineri multipl propag mekerk signal pathwai posit regul replic rna virus signal pathwai hepat viru hcv replic product understood method studi advantag wellcharacter mekerk inhibitor mekerk domin neg mutant investig role mekerk signal pathwai hcv gene express replic inhibit mekerk signal enhanc hcv gene express minusstrand rna synthesi viru product addit enhanc independ interferon ifn antivir activ requir prior activ mekerk signal pathwai mek erk erk involv hcv replic regul hcv rna translat conclus demonstr neg regulatori role mekerk signal pathwai hcv replic potenti risk target signal pathwai treat prevent neoplast transform hcvinfect liver cell
J Biomed Sci	27262925	2003-09-01	PMC2759930	19778418	background envelop glycoprotein hepat viru hcv mediat bind viru target cell receptor precis role viral entri remain elus method understand involv fusion peptidelik domain posit residu envelop glycoprotein hcv infect mutant ala asn substitut residu conserv hcv protein flavivirus fusion protein paramyxovirus construct sitedirect mutagenesi effect membran fusion viral infect examin mutat synthesi cell surfac express envelop protein alter format noncoval ee heterodim bind larg extracellular loop cd cy residu locat posit involv intra intermolecular disulfid bond format except ga mutant increas cell fusion mutant displai reduc margin inhibit cell fusion capac compar wildtyp wt ee ga mutant except human immunodefici viru type hivhcv ee pseudotyp analys higher onecycl infect mutant exhibit greatli partial reduc viral entri versu wt pseudotyp ga dn mutant wtlike profil ee incorpor hiv particl ca ga ga pseudotyp bound huh cell effect wt pseudotyp reduc infect pseudotyp abil inhibit cell fusion conclus indic specif residu structur fusion peptidelik domain requir mediat cell fusion viral entri
AIDS Res Ther	12954672	2018-11-07	PMC2761414	19799780	hiv infect gut associ lymphoid tissu galt earli transmiss multipl rout infect galt consequ serv major reservoir hiv infect constantli hiv cd cell intestin lumen examin hypothesi monitor hiv rnadna cd mrna fecal sampl chronic infect subject antiretrovir therapi art compar level hiv rnadna urin blood subject hiv dna rna cd mrna detect fece sampl infect subject detect plasma viral load detect subject art undetect plasma viral load urin sampl hiv dna detect infect subject detect plasma viral load subject art undetect plasma viral load phylogenet analysi envelop sequenc hiv reveal distinct viru popul concurr collect serum fece urin sampl subject addit studi demonstr time presenc cd mrna fecal specimen hiv infect subject assess galt pathogenesi hiv infect
BMC Infect Dis	30404792	2016-10-19	PMC2761921	19788751	background island nation explicit compon influenza pandem plan provid travel warn restrict incom travel potenti restrict quantifi method develop probabilist model paramet publish model influsim travel data pacif island countri territori pict indic pict travel data escap major pandem viral strain low contagi impos tight travel volum reduct cours pandem contagi viral strain pict probabl escap total number travel pandem exce r pict aim probabl pandem arriv conclus island nation reli intens travel volum restrict avoid arriv pandem influenza subsequ wave island nation plan multipl addit intervent screen quarantin rais probabl remain pandem free achiev substanti delai pandem arriv
PLoS Pathog	27795416	2018-05-23	PMC2762542	19851468	sever acut respiratori syndrom caus substanti morbid mortal epidem featur human diseas duplic balbc mice infect mouseadapt version viru ma develop respiratori diseas high morbid mortal sever diseas correl slow kinet viru clearanc delai activ transit respiratori dendrit cell rdc drain lymph node dln consequ defici virusspecif cell respons defect correct mice treat liposom clodron deplet alveolar macrophag inhibitori am believ prevent develop immun respons environment antigen allerg respons interact lung dendrit cell cell inhibitori effect nullifi mice am pretreat poli ic directli activ am rdc tolllik receptor tlr adopt transfer activ rest bone marrowderiv dendrit cell bmdc protect mice lethal ma infect relev sar human character prolong viru persist delai develop sarscovspecif immun respons individu sever diseas
Thorax	29575495	2013-12-26	PMC2764123	19574243	background pseudomona aeruginosa common bacteri pathogen patient cystic fibrosi cf current infect control guidelin aim prevent transmiss contact respiratori droplet rout consid possibl airborn transmiss hypothesis subject cf produc viabl respir bacteri aerosol cough method crosssect studi undertaken children adult cf chronic infect aeruginosa cough aerosol sampl system enabl fraction respiratori particl size cultur viabl gramneg nonfer bacteria cough aerosol collect min voluntari cough sputum induct procedur toler standardis quantit cultur genotyp techniqu aeruginosa isol cough aerosol subject produc sputum sampl aeruginosa sputum pair cough aerosol indistinguish molecular type case genotyp isol ambient room air viabl aerosol collect voluntari cough particl aerodynam diamet aeruginosa burkholderia cenocepacia stenotrophomona maltophilia achromobact xylosoxidan cultiv respiratori particl size rang posit room air sampl associ high total count cough aerosol magnitud cough aerosol associ higher forc expiratori volum higher quantit sputum cultur conclus cough patient cf produc viabl aerosol aeruginosa gramneg bacteria respir size rang suggest potenti airborn transmiss
Virol J	24371236	2015-07-09	PMC2765438	19818146	background cytotox tlymphocyt immun respons control hiv replic infect human immun pathwai viral peptid infect cell present tlymphocyt polymorph human leukocyt antigen hla hla allel exert select pressur peptid region immun escap mutat occur target site enabl viru adapt infect host pattern ongo immun escap revers associ human hla allel studi extens mutat revert transmiss host hla allel escap mutat incur fit cost todat attempt studi perman loss ctl epitop escap mutat fit set determin extent adapt hiv three wellcharacter hla allel initi exposur viru human cytotox immun respons transmiss chimpanze gener chimpanze consensu sequenc approxim viru sequenc initi transmit human host method base peptid bind affin hla crystal structur predict peptid target hla allel sequenc codonbas phylogenet model quantifi averag select pressur act region period zoonosi event correspond branch phylogenet tree lead common ancestor of hiv sequenc evid adapt evolut period observ region recognis hla common african popul evid adapt evolut observ site target hlab rare allel african popul conclus ancestr hiv viru experienc period posit select pressur immun respons associ hla allel common infect human popul propos perman escap immun respons target unconstrain region viru
BMC Infect Dis	26158319	2011-08-10	PMC2765446	19807908	background outbreak pandem flu influenza hn swine flu earli provid major challeng health servic previou pandem led stockpil good victimis popul group cancel travel boycot food pork examin initi behaviour attitudin respons influenza hn swine flu dai pandem alert level region differ respons method respond complet crosssect internet paperbas questionnair studi malaysia europ measur assess chang transport usag purchas preparatori good pandem perceiv risk group indic anxieti assess estim mortal rate season flu effect season flu vaccin chang pork consumpt respond concern flu victim malaysian european report reduc public transport malaysia europ flight cancel malaysia europ purchas preparatori materi face mask malaysia europ malaysia europ intend european malaysian discuss pandem friend group high risk infect includ immun compromis mention respond pig farmer elderli prostituteshighli sexual activ homeless data collect europ greatli underestim mortal rate season flu believ season flu vaccin protect swine flu reducedstop eat pork purchas antivir drug intend pandem worsen conclus initi respons influenza larg region differ anxieti malaysian anxiou reduc travel bui mask food discuss famili friend reinforc exist anxieti level group homosexu prostitut homeless perceiv greater risk lead increas prejudic pandem european underestim mortal season flu requir protect season flu inocul
PLoS Pathog	21835784	2018-10-05	PMC2765826	19888339	nipah viru broadli tropic highli pathogen zoonot paramyxoviru genu henipaviru natur reservoir speci pteropu fruit bat nipah viru repeatedli caus outbreak decad associ sever fatal diseas human anim ferret model nipah viru pathogenesi describ respiratori neurolog diseas infect anim sever diseas occur viral dose low tcid dai infect underli patholog ferret close resembl nipah viru infect human character widespread multisystem vascul viru replic highli vascular tissu includ lung spleen brain recover viru varieti tissu ferret model crossreact neutral human monoclon antibodi target henipaviru glycoprotein evalu vivo potenti therapeut agent ferret receiv ten hour high dose oralnas nipah viru challeng protect diseas control di studi success postexposur passiv antibodi therapi nipah viru human monoclon antibodi
Health Res Policy Syst	30235060	2015-09-25	PMC2765941	19785747	sever influenza pandem place histori assum pandem emerg human viru adapt avian viru strain mexico develop nation prepared respons plan influenza pandem focus risk commun health promot healthcar epidemiolog surveil strateg stockpil develop plan challeng april influenza ahn strain swine origen detect mexico situat face decis action allow control epidem wave countri document describ critic moment face explicitli point lesson learn focus decid support govern nation pandem influenza plan coordin govern level presenc solidar intern organ time daili diagnosi posit popul prevent hygien measur recommend health author intern commun will mexican experi interest global health
BMC Med Res Methodol	26403694	2020-03-02	PMC2766390	19804650	background quantit survei articl applic bibliometr effect tool grasp trend medic field type survei appli infecti diseas previou studi insuffici underestim articl publish nonenglish region journal method combin scopu pubm databas scientif literatur english nonenglish keyword directli link infecti diseas control identifi intern region infecti diseas journal order ascertain newli select journal appropri survei wide rang articl compar number origin articl review regist select journal infecti diseas categori scienc citat expand sci infecti diseas categori subsequ appli newli select journal survei number origin articl review origin asian countri period journal written english nonenglish languag newli select infecti diseas journal journal publish origin articl review asian origin regist sci infecti diseas categori asian origin categori asian trend analysi journal japan highest percentag origin articl review area notic increas articl reveal studi period china india taiwan larg number high increas rate origin articl asian countri adjust public origin articl countri popul gross domest product gdp singapor taiwan product conclus survei select journal sensit sci infecti diseas categori viewpoint avoid underestim number infecti diseas articl asian origin survei method applic grasp global trend diseas method requir develop
Implement Sci	32274354	2007-04-25	PMC2766417	19828086	background despit support meter dose inhal spacer devic mdispac pediatr emerg depart ped acut exacerb asthma uptak practic slow object studi determin barrier support implement mdispac identifi factor associ earli late adopt mdispac canadian ped method compar case studi design classifi tertiari care pediatr hospit ped base stage implement data collect focu group interview physician regist nurs rn respiratori therapist rt individu interview patient care medic director site initi code base ottawa model omru categori element influenc uptak innov fifti healthcar profession healthcar institut particip studi lack leadership form champion lack consensu benefit mdispac staff perceiv resist patientspar perceiv increas cost workload associ mdispac preval barrier adopt mdispac common strategi earlyadopt site includ activ particip profession group adopt process addit wellplan execut educ compon staff patient famili earli adopt site mdispac includ clinic protocolpathwai conclus potenti barrier support implement identifi will help ed adopt mdispac futur intervent intend increas mdispac ped will sensit barrier identifi studi
Virol J	17460051	2011-01-01	PMC2770056	19821998	background vesicular stomat viru vsv prototyp rhabdoviru best studi member order mononegaviral compel evid envelop virion releas infect cell carri numer host cellular protein plai role viral replic cellular protein incorpor vsv virion systemat studi reveal host protein composit virion vsv member mononegaviral proteom approach identifi cellular protein purifi vsv virion creat snapshot stage virushost interact guid futur experi aim understand molecular mechan viruscel interact highli purifi prepar vsv virion three cell line human mous hamster origin analyz presenc cellular protein mass spectrometri confirm presenc previouslyidentifi cellular protein vsv virion identifi number addit protein virion total sixtyfour cellular protein identifi multipl prepar combin immunoblot proteinas protect assai verifi presenc protein integrin heat shock protein kda heat shock cognat kda protein annexin elong factor virion conclus knowledg systemat studi host protein composit virion vsv member order mononegaviral futur experi need determin identifi protein interact vsv interact benefici neutral antivir respect vsv replic identif host proteinsviru interact benefici viru excit provid wai combat viral infect control host compon
PLoS One	21975583	2007-10-01	PMC2770169	19888418	background natur cat popul felin immunodefici viru fiv transmit bite individu factor densiti cat popul sexratio strong effect frequenc fight individu appear popul risk factor fiv methodologyprincip find studi popul risk factor data fiv preval cat popul northeastern franc investig kei social factor cat popul densiti cat sexratio number male ag male femal popul overcom problem depend infect statu data sexuallystructur dynam stochast model ag male femal p maletofemal transmiss rate multipl test effect realiti final studi area data explain simpl model invok risk factor conclus conclus hostparasit system gener fluctuat stochast transmiss process natur larg explain larger variabl observ diseas preval popul expect final determin confid interv simpl model paramet aid manag diseas
PLoS One	17698038	2013-01-30	PMC2773421	19924243	background entri envelop virus host cell requir activ viral envelop glycoprotein cleavag intracellular extracellular proteas order gain insight molecular basi proteas cleavag impact effici viral entri investig suscept recombin nativ fulllength sprotein trimer trispik sever acut respiratori syndrom coronaviru sarscov cleavag airwai proteas methodologyprincip find purifi trispik protein cleav vitro three airwai proteas trypsin plasmin tmprssa high perform liquid chromatographi hplc amino acid sequenc analys identifi arginin residu r potenti proteas cleavag site proteasedepend enhanc sarscov infect demonstr ac express human bronchial epitheli cell hbe airwai proteas regul infect sarscov fashion depend previou receptor bind role arginin residu mutant construct ra ra rara mutat r affect express sprotein differenti efficaci pseudotyp sarscovpp ra sarscovpp mutant exhibit lack viru entri enhanc proteas treatment conclusionssignific sar sprotein suscept airwai proteas cleavag proteas mediat enhanc viru entri depend specif conform sar sprotein ac bind data direct implic cell entri mechan sarscov respiratori system expand possibl identifi potenti therapeut agent sarscov
PLoS One	23363823	2005-10-13	PMC2773932	19915717	sever acut respiratori syndrom sar caus coronaviru sarscov acut infecti diseas mortal typic clinic featur associ sar pulmonari fibrosi associ lung failur aftermath sar epidem progress understand underli molecular mechan infect larg gap remain knowledg sarscov interact host cell onset infect rapidli chang viral genom add variabl equat focus novel concept microrna mirnamedi hostviru interact bronchoalveolar stem cell basc onset infect correl bascmicrornom target basc viral genom work encompass mirna arrai data analysi target predict mirnamrna enrich analysi develop complex interact map diseaserel factor mirna basc sar pathwai will provid clue diagnost marker view interplai lead diseas progress observ reveal basc sca cd cd pecam subset oct ac epitheli coloni cell bronchoalveolar duct junction prime target cell sarscov infect upregul basc mirna coopt sarscov suppress replic evad immun elimin success transmiss take place viral nucleocapsid spike protein target coopt downregul mir mir basc control stage basc differenti activ inflammatori chemokin downregul ac effect account success viral transmiss replic basc caus continu deterior lung tissu appar loss capac lung repair investig reveal mode exploit cellular mirna machineri viru advantag
Acta Vet Scand	16227251	2005-08-01	PMC2776595	19878595	background sweden subtyp verocytotoxinproduc escherichia coli vtec origin defin phage type carri vtx gene major report human infect year includ sporad case outbreak plausibl explan thi subtyp better adapt colonis cattl excret greater concentr longer period vtec subtyp method experiment studi calv inocul coloni form unit cfu strain ccug repres subtyp vtec ptvtxvtxc uninocul calv cohous inocul calv initi vtec strain isol dairi herd natur occur infect farm link human infect strain faecal sampl collect month period analys vtec immunomagnet separ im im posit sampl analys direct plate elucid shed pattern sampl collect pharynx inocul calv prove cultureposit faec hour inocul uninocul calv dai postinocul calf persist cultureposit dai remaind vtec count faec decreas week pharyng sampl cultureneg vtec conclus studi contribut concern dynam specif subtyp vtec colonis dairi calv subtyp vtec ptvtxvtxc frequent isol swedish cattl major report human infect sweden year calv inocul repres strain specif subtyp number bacteria declin week calf classifi highshedd excret high level bacterium prolong period
Curr Pharm Des	26648515	2003-12-01	PMC2778081	19075740	cellular uptak therapeut oligonucleotid subsequ intracellular traffick target site repres major technic hurdl biolog effect potenti drug laboratori worldwid focu develop suitabl deliveri system nonvir system cation polym cation liposom polymer nanoparticl cellpenetr peptid cpp repres attract concept bypass problem poor membran permeabl charg macromolecul uptak se case repres main obstacl nucleic acid deliveri vitro increasingli appar intracellular traffick bottleneck consequ order optim deliveri system sidebysid analysi nucleic acid cargo intern correspond biolog requir determin efficaci review will concentr peptidemedi deliveri sirna steric block oligonucleotid discuss method quantit assess amount cargo correl number biolog effect appli easi handl report system illustr current limit nonvir nucleic acid deliveri system data exampl discuss option enhanc traffick molecul entrap cellular compart
PLoS One	14652258	2009-09-09	PMC2778948	19956642	background furin repres crucial member secretori mammalian subtilas proprotein convertas pc proprotein convertas subtilisinkexin pcsk superfamili link cancer tumorgenesi viral bacteri pathogenesi result consid major target intervent diseas methodologyprincip find report time synthesi biolog evalu newli design potent furin inhibitor highli reactiv betaturn induc radic gener enediynyl amino acid eda moieti eda insert p residu hfurin peptid deriv primari cleavag site furin prodomain hexadecapeptid deriv inhibit furin vitro ic nm measur fluorogen substrat bocrvrrmca inhibit furinmedi cleavag fluorogen peptid deriv hsarscov spike protein ic nm addition block furinprocess growth factor propdgfa vegfc link tumor genesi cancer circular dichroism studi inhibitor displai betaturn structur western blot confirm abil protect furin protein degrad conclusionsignific find impli potenti therapeut agent intervent cancer furinassoci diseas
Mol Microbiol	19740921	2012-01-01	PMC2779471	17176260	pregnancyassoci malaria pam caus plasmodium falciparuminfect erythrocyt i bind chondroitin sulphat csa placenta pamassoci clonal variant surfac antigen vsa pregnancyspecif vsa vsapam includ pfemp variant varcsa target iggmedi protect immun pam report investig specif natur acquir immun pam human monoclon igg antibodi react exclus intact csaadher i express vsapam react western blot highmolecularweight kda protein react dblx dbl domain varcsa express baculoviru construct surfac transfect jurkat cell panel recombin antigen repres dblx domain falciparum field isol evalu bcell epitop divers parasit isol identifi bind site monoclon antibodi chimer dblx construct find highfrequ memori respons vsapam indic varcsa primari target natur acquir pamspecif protect immun demonstr human monoclon antibodi conformation intact recombin antigen vsa character
BMC Public Health	22641221	2013-04-10	PMC2779504	19922686	a descript communic diseas histori develop mathemat model diseas transmiss includ reason mathemat model histori mathemat model foundat laid late nineteenth centuri the accomplish mathemat model challeng futur purpos demonstr mathemat model understand manag infecti diseas transmiss
PLoS One	23576515	2007-07-01	PMC2779851	19997505	background late april novel influenza viru hn gener refer swine flu spread globe infect hundr thousand peopl dai initi outbreak mexico extens media coverag high degre uncertainti transmiss mortal rate associ viru caus widespread concern popul spread infecti diseas influenc behavior chang social distanc earli phase epidem data risk percept behavior respons novel viru collect substanti delai epidem cours methodologyprincip find report onlin survei gather data risk percept influenza ahn outbreak dai widespread media coverag april find initi high level concern level anxieti wane percept viru threat data provid evid emot statu mediat behavior respons intriguingli princip compon analysi reveal strong cluster anxieti swine flu bird flu terror three threat receiv great deal media attent fundament uncertainti gener inordin amount fear visavi actual threat conclusionssignific respond behavior vari predict wai interest find affect variabl selfreport anxieti epidem mediat likelihood respond will engag protect behavior understand protect behavior social distanc vari specif factor mediat help design epidem control strategi
Respir Res	17369487	2013-07-02	PMC2780994	19874627	background highli pathogen avian influenza hpai hn viru entrench poultri asia africa continu infect human zoonot caus acut respiratori diseas syndrom death evid viru spread respiratori tract dissemin infect primari target cell hpai hn viru human lung alveolar epitheli cell alveolar epithelium adjac lung microvascular endothelium form host barrier initi infect dissemin influenza hn infect human polar cell polar influenza viru entri egress secret cytokin chemokin viru infect cell central pathogenesi human hn diseas aim studi influenza hn viru replic host innat immun respons polar primari human alveolar epitheli cell lung microvascular endotheli cell relev pathogenesi human hn diseas method vitro model polar primari human alveolar epitheli cell lung microvascular endotheli cell grown transwel cultur insert compar infect influenza subtyp hn hn virus apic basolater surfac demonstr influenza hn hn virus effici infect alveolar epitheli cell apic basolater surfac epithelium releas newli form viru apic side epithelium contrast influenza hn viru hn viru effici infect polar microvascular endotheli cell apic basolater aspect mechanist explan hn viru infect lung system circul epidemiolog evid implic ingest viruscontamin food sourc infect instanc data suggest viremia secondari exampl gastrointestin infect lead infect lung hpai hn viru potent induc cytokin ip rant il comparison hn viru alveolar epitheli cell virusinduc chemokin secret apic basolater aspect polar alveolar epithelium conclus predilect virus rout entri egress infect cell understand pathogenesi influenza hn infect help unravel pathogenesi human hn diseas
BMC Health Serv Res	24319610	1999-12-15	PMC2781002	19895692	background methodolog approach estim distanc health servic studi focus cardiac catheter servic euclidean manhattan minkowski distanc metric estim distanc patient resid hospit distanc metric typic produc accur estim actual measur metric singl model travel network distanc metric actual measur directli spatial analyt model euclidean distanc appropri metric minkowski distanc promis method distanc estim metric contrast road distanc travel time measur optim minkowski distanc implement spatial analyt model method road distanc travel time calcul postal code resid patient undergo cardiac catheter pertin hospit minkowski metric optim approxim travel time road distanc distanc estim distanc measur compar descript statist visual map method optim minkowski metric implement spatial weight matrix spatial regress model identifi socioeconom factor associ cardiac catheter minkowski coeffici best approxim road distanc best approxim travel time good predictor road distanc provid best singl model travel patient resid hospit euclidean metric optim minkowski metric altern implement regress model compar minkowski method produc reliabl tradit euclidean metric conclus road distanc travel time measur accur estim directli implement spatial analyt model euclidean distanc underestim road distanc travel time manhattan distanc overestim optim minkowski distanc partial overcom shortcom singl model travel network method flexibl suitabl analyt model accur tradit metric ultim increas reliabl spatial analyt model
PLoS Med	10572179	2004-05-26	PMC2782135	20016686	maria yazdanbakhsh peter kremsner argu better awar surveil clinic manag common febril diseas africa influenza
BMC Microbiol	15163702	2013-09-25	PMC2782262	19682357	background amino acid substitut target enzym ergp azol antifung contribut clinicallyrelev azol resist candida albican simpl molecular method rapid detect erg gene mutat advantag screen tool identifi potentiallyresist strain track movement complement dna sequenc develop padlock probe roll circl amplif rcabas method detect seri mutat albican erg gene refer azoleresist isol mutat method estim frequenc erg mutat type australian clinic albican isol reduc suscept fluconazol fluconazolesuscept isol rca compar dna sequenc rca assai correctli identifi erg mutat refer albican isol appli test strain rca method agreement dna sequenc erg mutationspecif probe missens mutat detect sequenc isol reduc fluconazol suscept detect rca missens mutat detect method fluconazolesuscept strain dna sequenc reveal mutat nonsuscept isol homozyg nucleotid chang except mutat lead amino acid substitut fluconazolesuscept strain heterozyg amino acid substitut common set isol de kt vi vi substitut uniqu isol reduc fluconazol suscept isol ge gs kr yh sf rk dna sequenc reveal novel substitut gv isol conclus sensit rca assai describ simpl robust rapid method detect erg polymorph excel concord erg sequenc valuabl tool track emerg spread azoleresist albican studi epidemiolog erg mutat rca method applic studi azol resist fungi
BMC Microbiol	24068007	2015-09-01	PMC2782265	19674441	background human immunodefici viru type hiv major caus pathogen acquir immun defici syndrom aid larg number hivrel studi base three nonhuman model anim chimpanze rhesu macaqu mous differ hosthiv interact human model organ remain unexplor descript capih compar analysi protein interact hiv webbas interfac provid compar human three model organ context hosthiv protein interact capih identifi genet chang occur hivinteract host protein total ortholog protein set capih identifi amino acid substitut insertionsdelet potenti posttransl modif occur compar speci capih interact interfac displai hosthiv protein interact network presenceabs ortholog protein model organ network genet chang occur protein node function domain potenti protein interact hot site genet chang capih interfac freeli access httpbioinfodbbnhriorgtwcapih conclus capih exemplifi larg diverg exist diseaseassoci protein human model anim newli develop medic test model anim enter clinic trial advis compar analys perform ensur proper translat animalbas studi case aid hosthiv protein interact differ great extent compar speci integr protein network comparison speci will light aid studi
Respir Res	26210298	2012-01-25	PMC2783028	19909524	background inflammatori process lung injuri lead pulmonari fibrosi pf describ pf mice infect hn viru method eightweekold balbc mice inocul intranas mid achickenhebeihn virus lung injuryfibrosi evalu observ hydroxyprolin concentr lung index histopatholog dai postinocul hninocul mice present stage pulmonari diseas period infect acut stage infectedmic typic diffus pneumonia inflammatori cellular infiltr alveolar interstiti edema hemorrhag dai postinocul restor stage infectedmic develop pf sever dai postinocul surviv mice underw sever interstiti intraalveolar fibrosi thicken alveolar wall collaps alveoli larg fibrot area dramat elev hydroxyprolin level hninfect mice deposit collagen lung confirm fibrosi lung dry lungtobodi weight ratio increas infect group associ format pf hninfect mice conclus find hninfect mice develop typic pf restor period will contribut investig fibrogenesi potenti therapeut intervent human hn diseas
Aging (Albany NY)	22276951	2016-10-24	PMC2784685	19946382	dyslipidemia character increas triglycerid lowdens lipoprotein ldl level decreas highdens lipoprotein hdl level atherogen lipid profil predispos risk individu coronari arteri diseas incomplet understood mechan apolipoprotein apod atyp apolipoprotein canon apolipoprotein produc liver intestin apod express mammalian tissu apod share degre homolog amino acid sequenc apolipoprotein apod structur lipocalin divers famili lipidbind protein respons transport lipid small hydrophob molecul metabol plasma apod hdl lesser extent low densiti lipoprotein ldl lowdens lipoprotein vldl genet variant apod associ abnorm lipid metabol increas risk develop metabol syndrom increas apod deposit detect atherosclerot lesion human establish cardiovascular diseas mice prematur atherosclerosi apod associ antioxid antistress activ contribut lifespan expans fruit fli elderli subject patient alzheim exhibit markedli elev apod product brain apod emerg player lipid metabol ag focu review advanc understand apod lipid metabol address apod dysregul contribut pathogenesi dyslipidemia atherosclerosi will discuss function implic apod ag
PLoS Med	27791106	2008-04-28	PMC2784942	20016689	jonna mazet colleagu describ work tanzaniabas hali project adopt health approach address emerg zoonos recogn interconnected human anim environment health
BMC Bioinformatics	19066576	2018-08-22	PMC2787530	19930702	background autom surveil internet time sensit method alert global emerg infecti diseas threat healthmap gener onlin system design monitor visual realtim basi diseas outbreak alert report onlin new media public health sourc healthmap specif interest nation intern public health organ intern travel task surveil autom discoveri geograph refer contain retriev outbreak alert task refer geopars typic approach geopars demand expens train corpu alert manual tag human human reader perform kind task lexic contextu knowledg develop approach reli small expertbuilt gazett limit human input focus learn context geograph refer appear set experi approach exhibit substanti capac discov geograph locat initi lexicon conclus analysi provid framework futur autom global surveil effort reduc manual input improv timeli report
PLoS One	30135128	2008-04-10	PMC2788226	20011515	background bat suspect natur reservoir host number emerg zoonot virus includ nipah viru hendra viru sever acut respiratori syndrom coronaviru ebola viru discoveri sarslik coronavirus chines horsesho bat attempt isol slcov bat fail attempt isol batborn virus mammalian cell line unsuccess stabl bat cell line need help investig tool assist studi bat immunolog virushost interact methodologyfind black fly fox pteropu alecto captur wild transport live laboratori primari cell cultur prepar varieti method cultur media primari cell cultur organ cell immortalis occur spontan retrovir system immortalis cell transfer stabl product simian viru larg antigen human telomeras revers transcriptas protein initi infect experi clone unclon cell line hendra nipah virus demonstr vari degre infect effici cell line infect cell tissu type conclusionssignific approach develop optimis studi applic bat speci process gener cell line number bat speci methodolog establish studi
BMC Bioinformatics	18403718	2010-04-01	PMC2788353	19958512	background aminotermin signal peptid sp short region guid target secretori protein correct subcellular compart cell cleav passeng protein reach destin explos growth sequenc technolog led deposit vast number protein sequenc necessit rapid function annot techniqu subcellular local kei featur myriad softwar predict tool develop autom task assign sp cleavag site sequenc review perform reliabl commonli sp predict tool signal peptid data manual curat organ three dataset repres eukaryot gramposit gramneg bacteria dataset evalu thirteen predict tool publicli signalp hmm ann version maintain consist achiev best accuraci three benchmark experi rang predict tool narrow perform gap conclus major tool evalu studi encount difficulti discrimin secretori nonsecretori protein challeng clearli remain pinpoint correct sp cleavag site composit score scheme emploi signalp help explain accuraci predict task divid number separ step allow score tackl aspect predict
PLoS One	20129638	2013-05-08	PMC2790604	20016834	background flaviviru infect cell produc infecti virion subvir particl form assembl prm envelop protein believ undergo matur process dengu recombin subvir particl produc cell cultur modifi chimer protein nativ form prm methodologyprincip find codon optim strategi effici express nativ viral protein product recombin subvir particl rsp dengu viru dv serotyp stabl hela cell express dv prme establish helaprm rsp analyz immunofluoresc transmiss electron microscopi protein endoplasm reticulum er assembl rsp observ biochem character dv rsp secret reveal prm protein cleavag homodimer protein releas supernat indic rsp undergo matur process dengu viru puls chase experi hour requir secret dv rsp helaprm develop semiquantit assai screen human sirna librari target gene involv membran traffick knockdown gene reduct dv rsp secret observ increas rsp level cell supernat conclusionssignific data describ effici product rsp nativ prm envelop protein dengu serotyp dengu rsp correspond produc cell line safe novel tool studi viral egress develop vaccin drug dengu viru
PLoS One	25534600	2005-05-01	PMC2791231	20020050	the sever acut respiratori syndrom coronaviru sarscov report apoptosi infect cell protein includ accessori protein proapoptot protein local endoplasm reticulum ergolgi compart role caus er stress investig transient transfect cell cell express protein er stress base activ gene er chaperon grp grp er stress differenti modul unfold protein respons upr includ inositolrequir enzym ir activ transcript factor atf pkrlike er kinas perk pathwai individu test aexpress cell perk pathwai activ aexpress cell base increas phosphoryl eukaryot initi factor alpha eif inhibitori effect dominantneg form eif grp promot activ increas translat activ transcript factor atf mrna atfdepend activ cebp homolog protein chop gene promot activ perk innat immun suppress type interferon ifn signal protein induc serin phosphoryl ifn alphareceptor subunit ifnar degrad motif increas ifnar ubiquitin confoc microscop analysi increas transloc ifnar lysosom compart flow cytometri reduc level ifnar aexpress cell provid mechanist detail proapoptot effect sarscov protein potenti role attenu interferon respons innat immun
PLoS One	15963157	2017-11-01	PMC2791869	20027293	background june health organ declar phase novel influenza ahn pandem septemb novel viru report contin impact countri northern hemispher limit return viru second wave encount popul nonimmun vaccin model control strategi reduc spread goal defer epidem wave countri detect earli stage methodologyprincip find construct determinist seir model ag distribut size popul germani base observ number import case earli find epidemiolog characterist describ fraser scienc propos twostep control strategi initi effort trace quarantin select prophylact treatment contact case second step measur focus household case result peak epidem delai week case detect cumul attack rate chang dose antivir number treatment cours popul sensit analysi case detect rate variat major effect delai conclusionssignific control strategi reduc spread diseas earli phase pandem wave lead substanti delai epidem prophylact treatment offer contact case amount antivir need limit
PLoS One	28768664	2011-01-13	PMC2792043	20020057	background influenza virus seriou infect prevent treat vaccin antivir agent vaccin effect number limit influenza strain resist current antiinfluenza drug increasingli isol necessit explor novel antiinfluenza therapi methodologyprincip find investig potenti aurintricarboxyl acid ata potent inhibitor nucleic acid process enzym protect madindarbi canin kidnei cell influenza infect neutral red assai ata protect rtpcr elisa confirm ata reduc viral replic releas pretreat cell ata fail inhibit viral replic preincub viru ata effect reduc viral titer suggest ata elicit inhibitori effect directli interact viru electron microscopi reveal ata induc viral aggreg cell surfac prompt determin ata inhibit neuraminidas ata compromis activ virusderiv recombin neuraminidas oseltamivirresist hn strain hy sensit ata final observ addit protect infect cell simultan treat ata amantadin hydrochlorid antiinfluenza drug inhibit mion channel influenza viru conclusionssignific collect data ata potent antiinfluenza agent directli inhibit neuraminidas effect antivir compound combin amantadin hydrochlorid
BMC Immunol	21233414	2017-09-26	PMC2792222	19958537	background spike protein major structur glycoprotein coronaviru cov causal agent sever acut respiratori syndrom sar protein potent target sarsspecif cellmedi immun respons mechan cov pathogenesi sar role special ctl viru clearanc uncharacter describ studi lead identif novel hlaarestrict epitop conserv region protein sarscov sequenc analyz predict candid peptid conserv region protein base hlaa bind proteosom cleavag candid peptid test hlaa bind assai candid peptid sp vlndilsrl induc specif ctl vivo pbl healthi hlaa donor hlaakb transgen mice immun plasmid encod fulllength protein immun mice releas ifn lyse target cell stimul sp peptidepuls autolog dendrit cell comparison candid conclus sp natur process epitop propos sp epitop help character mechan viru control immunopatholog sarscov infect
PLoS One	28949786	2004-08-12	PMC2793014	20027307	background express minor virion structur protein vp caliciviru murin noroviru mnv believ occur unusu mechan termin codondepend reiniti translat process translat upstream open read frame orf termin codon proport subunit remain associ mrna reiniti aug downstream orf typic close proxim consist vp start codon aug mnv overlap codon upstream vp orf uaa pentanucleotid uaa ug princip find confirm mnv vp express regul terminationreiniti defin mrna sequenc requir effici reintiat depend nt rna upstream uaa ug site chemic enzymat probe reveal rna region highli structur includ essenti stretch base complementari rrna helix motif rel posit motif respect uaa ug site impact effici process terminationreiniti mnv insensit initi inhibitor edein conclus terminationreiniti signal mnv close resembl influenza bm virus strategi basepair mrna rrna plai role tether subunit mrna termin vp codon data indic accur recognit vp orf aug prerequisit effici reiniti translat system
PLoS One	15308692	2017-07-07	PMC2794544	20041158	to estim frequenc molecular epidemiolog clinic associ infect newli describ speci variant human rhinovirus hrv diagnost respiratori sampl refer diagnost test edinburgh screen vpencod regionbas select polymeras chain reaction pcr hrvc parallel pcr test respiratori virus hrvc third frequent detect respiratori syncyti viru rsv adenoviru infect episod detect subject month infect target young median ag month infect year occur year peak incid earli winter month hrvc detect frequent subject lower lrt upper respiratori tract urt diseas control respiratori symptom hrvc monoinfect second frequent detect viru rsv diseas present case hrv variant classifi vpvp sequenc genotyp defin type increas current total worldwid sequenc comparison untransl region utr major group speci describ hrvca remaind form phylogenet distinct utr group hrvcc multipl bidirect recombin event hrvca hrvcc variant hrv speci repres parsimoni explan interspers phylogeni relationship vpvpencod region differ ag distribut season diseas associ identifi hrvca hrvcc variant hrvcinfect subject markedli reduc detect frequenc rsv respiratori virus provid evid major interf hrvc suscept respiratori viru infect hrvc diseas associ preval evid interf effect respiratori virus mandat incorpor rhinovirus futur diagnost virolog screen
PLoS One	28856034	2009-01-01	PMC2795195	20046873	background initi report novel influenza strain hnpdm estim case fatal rate cfr season influenza juli argentina report case death repres cfr potenti explan increas cfr includ viru reassort genet drift infect vulner popul viru genom sequenc argentinian sampl repres sever mild diseas indic evid reassort mutat associ resist antivir drug genet drift contribut virul evid increas frequenc risk factor hnpdm diseas methodsprincip find examin nasopharyng swab sampl np case hnpdm infect argentina masstag pcr test addit microbi agent studi popul consist hnpdminfect subject sampl june juli thirtynin sever diseas defin death hospit mild diseas addit agent potenti pathogen identifi sampl includ streptococcu pneumonia haemophilu influenza human respiratori syncyti viru n human rhinoviru n human coronavirus oc klebsiella pneumonia acinetobact baumannii serratia marcescen staphylococcu aureu methicillinresist aureu mrsa presenc pneumonia correl sever diseas pneumonia sever case versu mild case onethird hnpdm np pneumonia subject sever diseas pneumoniaeposit np subject year ag adjust odd ratio sever diseas presenc pneumonia confid interv ci conclusionssignific associ pneumonia morbid mortal establish current previou influenza pandem studi demonstr prognost signific noninvas antemortem diagnosi pneumonia infect provid insight clinic manag
Environ Health	18988270	2004-07-10	PMC2796493	20102582	ar pathogen outdoor air health issu will problem futur work group call airpath outdoor environ human pathogen air set univers colleg london uk aim open discuss creat network investig scienc impact outdoor pathogen object paper review discuss area sourc human pathogen outdoor air current develop futur techniqu we identifi atrisk group relat activ environ prepar anticip challeng environment chang emerg diseas control prevent pathogen outdoor environ work benefit wider commun polici maker provid concis overview aspect consider work
BMC Infect Dis	15175231	2015-04-01	PMC2797517	19961583	background streptococcu pneumonia common commun acquir pneumonia bacteremia excess wintertim mortal pneumonia centuri season invas pneumococc diseas ipd describ understood improv understand environment influenc diseas season urgenc global climat chang method evalu case ipd report philadelphia counti pennsylvania poisson regress model incorpor season smoother identifi associ weekli weather pattern case count associ acut daytodai environment fluctuat ipd occurr evalu casecrossov approach modif ag sex strata explor metaregress model creat stratumspecif estim ipd incid greatest wintertim spectral decomposit reveal peak week consist annual period adjust season yearli increas report temperatur weekli incid associ clearski uv irr unit increas ci uv highest young strata decreas ag shorter time scale associ increas ambient sulphur oxid link diseas risk highest tertil exposur ci conclus confirm wintertim predomin ipd major urban center major predictor ipd philadelphia extend period low uv radiat explain observ wintertim season mechan action diminish light exposur diseas occurr direct effect pathogen surviv host immun function alter ohvitamind metabol find diminut futur ipd risk climat chang expect wintertim season driven temperatur
BMC Microbiol	25834017	2011-05-11	PMC2797526	19958557	background porcin rotaviru infect morbid mortal swine industri necessit develop effect vaccin prevent infect immun respons associ protect mucos natur induct mucos immun prevent porcin rotaviru infect lactobacillu casei express major protect antigen vp porcin rotaviru ppgvp vpltb heatlabil toxin subunit echerichia coli ppgvpltb fusion protein immun mice oral express recombin ppgvp ppgvpltb confirm sdspage western blot analysi surfacedisplai express casei verifi immunofluoresc mice oral immun recombin proteinexpress casei produc high level serum immunoglobulin igg mucos iga iga titter mice immun ppgvpltb higher titter ppgvpimmun mice induc antibodi demonstr neutral effect rv infect conclus demonstr vp administ context casei express system effect method stimul mucos immun ltb serv stimul mucos immun suggest strategi adapt pig
PLoS One	21561912	2010-10-01	PMC2797616	20062534	background studi suggest autophagi util cell protect mechan listeria monocytogen infect methodologyprincip find find autophagi measur role vacuolar escap intracellular growth primari cultur bone marrow deriv macrophag bmdm defici autophagi atg provid evid pore form activ cholesteroldepend cytolysin listeriolysin llo induc autophagi subsequ infect monocytogen infect bmdm monocytogen induc microtubuleassoci protein light chain lc lipid consist autophagi activ mutant lack llo infect bmdm express lcgfp demonstr wildtyp monocytogen encapsul lcgfp consist autophagi activ mutant lack llo bacillu subtili express llo cytolysin perfringolysin pfo induc lc coloc lc lipid llocontain liposom recruit lcgfp indic llo suffici induc target autophagi absenc infect role autophagi variabl effect depend cell type assai atg mous embryon fibroblast monocytogen primari vacuol escap defect bacteria escap grew atg bmdm conclusionssignific propos membran damag caus llo trigger bacterialtarget autophagi autophagi affect fate wildtyp intracellular monocytogen primari bmdm
PLoS One	21487503	2004-05-12	PMC2797643	20062542	background part india chandipura viru chpv emerg enceph caus pathogen epidem sporad form pediatr diseas rapid cours lead mortal absenc specif treatment effect rna interfer rnai evalu method find efficaci synthet short interf rna sirna short hairpin rna shrna protect mice chpv infect assess target gene gene role viral replic lethal natur real time step rtpcr plaqu assai assess gene silenc pacgfpnchpvp sirna effici reduc express gene invitro quantit assai document log reduct viru titer sirna transfect hr post infect pi sirna combin result enhanc effici sirna toler mismatch center compar shrna sirna effect inhibit chpv replic extend surviv mice infect intracrani ld chpv treat cation lipid complex sirna simultan infect ld treatment dose sirna simultan second hr pi surviv surviv mice log chpv titer brain histopatholog chang antibodi respons gene express profil sirna treat mice interferon respons dose sirna hr hr pi second dose hr surviv suggest potenti applic therapi conclus highlight therapeut potenti sirna treat rapid fatal chandipura enceph
BMC Med Genet	15140959	2005-08-31	PMC2797785	20003397	background dcsignr call cdl extens studi role host genet predisposit viral infect variabl number tandem repeat vntr neckregion dcsignr highli polymorph polymorph investig genet predisposit infecti diseas conflict report infect major human death mechan natur select hypothes vntr polymorph dcsignr human life span method collect pericentenarian individu ag femal ag male geograph match control ag han chines vntr polymorph neck region determin pcr genotyp call separ pcr product agaros gel total genotyp allel popul genotyp distribut allel frequenc homozygot proport differ pericentenarian control group gender differ lifespan ubiquit observ anim kingdom stratifi sampl gender genotyp femal pericentenarian group femal control group margin level signific differ correct bonferroni method suggest differenti dcsignr vntr genotyp sex studi warrant confirm preliminari find investig mechan underli function conclus studi indic absenc associ neck region polymorph dcsignr longev han chines popul question dcsignr affect longev genderspecif pattern remain open
Alcohol Res Health	16140741	2006-12-12	PMC2798743	20041042	human studi identifi classifi brain system predispos individu develop alcohol disord modifi alcohol anim model alcohol essenti mechanist understand chronic voluntari alcohol consumpt compuls brain system damag damag resolv current knowledg neurosci alcohol depend evolv interchang gather human alcohol anim model alcohol studi human anim model provid support involv specif brain structur cours alcohol addict includ prefront cortex basal ganglia cerebellum amygdala hippocampu hypothalamicpituitaryadren axi
BMC Health Serv Res	17185361	2009-06-01	PMC2801490	20003505	background purpos studi establish teach hospit accredit standard anew hope taiwan teach hospit live expect societi ensur qualiti teach method develop process last year separ three stage stage center leadership meet consensu build second draft standard expert focu group third pilot studi subsequ revis teach hospit accredit standard categori standard educ resourc item teach train plan outcom item item develop clinic faculti continu educ item academ exchang commun educ item administr item conclus standard proven feasibl pose reason challeng pilot studi hope standard will strengthen teach improv qualiti hospit servic time
BMC Infect Dis	19634389	2009-12-03	PMC2803793	20015403	background global erad program poliomyel laboratori diagnosi plai critic role isol polioviru pv stool sampl acut flaccid paralysi afp case studi develop revers transcriptionloopmedi isotherm amplif rtlamp system rapid highli sensit detect enteroviru includ pv identifi stool sampl posit enteroviru includ pv method primer set design rtlamp detect enteroviru prefer pvlike ntr viral genom sensit rtlamp system evalu prototyp strain enteroviru detect enteroviru stool extract examin rtlamp system detect copi viral genom pvsabin strain min rtlamp primer set rtlamp system prefer human enteroviru speci hevc strain includ pv exhibit sensit prototyp strain heva hevb detect limit copi stool extract pv hevc heva isol cell cultur system posit rtlamp method posit rate posit rate rtlamp system stool extract hevb isol lower hevc posit rate stool sampl neg enteroviru isol cell cultur system sampl posit rtlamp posit rate sampl enteroviru identifi sequenc analysi util seminest pcr system conclus rtlamp system develop studi high sensit compar cell cultur system detect pv heva hevc sensit hevb rtlamp system direct detect enteroviru stool extract
Interdiscip Perspect Infect Dis	19965751	2012-01-11	PMC2804041	20069111	method diagnosi infecti diseas stagnat year major advanc clinic diagnost test introduct pcr technolog investig test form backbon modern microbiolog laboratori base labourintens technolog microscopi malaria press includ rapid test sacrif sensit valuead test pointofcar test high lowresourc set year focus altern method improv diagnosi parasit diseas includ immunoassai molecularbas approach proteom mass spectrometri platform technolog review summar progress approach parasit diagnosi discuss merit disadvantag test
Virol J	22238297	2013-08-01	PMC2804611	20025741	influenza viru infect preval diseas human antibodi hemagglutinin prevent infect hemagglutinin major constitu current vaccin antibodi direct highli conserv extracellular domain mediat protect influenza infect anim model activ vaccin gener consid best approach combat viral diseas passiv immun attract altern acut expos immun comprom individu young children elderli describ novel method rapid isol natur human antibodi mammalian cell displai approach isol human monoclon antibodi direct highli conserv extracellular domain influenza protein identifi antibodi bound peptid high affin recogn nativ cellsurfac express protect mice lethal influenza viru challeng therapeut treatment dai infect effect suggest mspecif monoclon great potenti immunotherapeut agent influenza infect
BMC Public Health	23848522	2019-02-01	PMC2804616	20015400	background restrict measur quarantin draw sharp relief dynam interplai individu right citizen hand collect right commun concern infecti diseas outbreak sar pandem influenza intensifi understand public percept quarantin social distanc measur method conduct telephon survei gener popul greater toronto area ontario canada computerassist telephon interview cati technolog final sampl individu achiev standard randomdigit dial data indic strong public support quarantin requir seriou legal sanction fail compli support conting implement legal safeguard protect inappropri provis psychosoci support conclus engend strong public support quarantin restrict measur govern offici public health policymak implement comprehens system support safeguard educ inform frontlin public health worker engag public larg open dialogu ethic restrict measur infecti diseas outbreak
BMC Immunol	30307795	2010-03-29	PMC2804704	20017901	background mycobacterium tuberculosi mtb major morbid mortal combat pathogen immun cell releas cytokin includ tumor necrosi factor tnf pivot develop protect granuloma previou bacillu calmett guerin bcg mycobacterium model investig immun respons mtb stimul induct tnf mitogenactiv protein kinas mapk human blood monocyt mapk phosphatas mkp regul mapk activ examin mkp plai role bcginduc mapk activ cytokin express primari human blood monocyt treat bcg assai mkp express demonstr exposur bcg increas express mkp addition induct mkp regul mapk extracellular signalregul kinas erk surprisingli mkp express block specif sirna decreas level phosphomapk mapk erk tnf induc bcg conclus tnf pivot granuloma format indic unexpect posit function mkp mycobacteri infect oppos usual phosphatas activ
Virol J	20351207	2013-11-06	PMC2805634	20034394	background spike protein sar coronaviru sarscov mediat entri viru target cell includ receptor bind membran fusion close viral membran protein three distinct motif juxtamembran aromat central highli hydrophob stretch cystein rich motif investig role aromat hydrophob part entri sar cov cellcel fusion investig describ sar pseudotyp particl system sarspp fluorescencebas cellcel fusion assai mutagenesi aromat domain crucial sarspp entri cell role pore enlarg introduct lysin residu hydrophob stretch block entri suggest border actual transmembran domain surprisingli replac glycin residu situat close aromat domain lysin residu toler introduct lysin adjac glycin model propos fusion later flexibl transmembran domain plai critic role tryptophan cystein conclus aromat domain plai crucial role entri sar cov target cell posit aromat domain hydrophob domain rel essenti characterist membran fusion process
Virol J	24198430	2004-08-01	PMC2805635	20040105	ebnac ebvencod nuclear protein essenti prolifer ebv infect blymphocyt ebnac amino acid yeast hybrid screen interact growth arrest dnadamag protein gadd protein overexpress gadd interact ebnac nuclear cytoplasm compart amino acid gadd includ ppa interact hsv icp homolog domain requir interact interact lost mutant ebnac dvievid aviavia abolish ebnac coactiv abil sumo interact bcell gadd ebnac complex ppa microcystin sepharos affin purif lymphoblastoid cell ebnac protein level condit hydroxytamoxifen surprisingli ebnac maintain phosphoryl eif serin ii protect er stress induc activ unfold protein respons measur xbp versu xbp protein express ntermin atf cleavag report assai overexpress gadd enhanc ebnac abil coactiv ebna activ lmp promot collect data ebnac interact gadd activ upstream compon upr eif phosphoryl prevent downstream upr event xbp activ atf cleavag
Brain Pathol	15258011	2009-10-01	PMC2805866	19243383	sinc incept global gene express profil platform mid increas public differenti express gene process epileptogenesi mesial tempor lobe epilepsi presenc latenc period manifest seizur chronic epilepsi opportun therapeut intervent molecular biologi level global express profil techniqu gene publish demonstr differenti express mesial tempor epilepsi major chang specif laboratori experiment condit gene demonstr chang public review current statu gene express profil epileptogenesi standard guidelin greater accuraci reproduc result
BMC Genomics	19857081	2010-01-01	PMC2806348	20003521	background delta smelt hypomesu transpacificu pelag fish speci list endang usa feder californian state endang speci act consid indic ecosystem health habitat rang limit sacramentosan joaquin estuari california usa anthropogen contamin multipl stressor system currentus insecticid major concern interrog tool requir monitor effect contamin delta smelt potenti popul declin speci creat microarrai investig genomewid effect caus stressor appli tool assess effect pyrethroid insecticid esfenvaler larval delta smelt select gene investig molecular biomark quantit pcr analys exposur esfenvaler swim behavior larval delta smelt concentr low gl differ express measur gene involv neuromuscular activ alter express gene associ immun respons apoptosi redox osmot stress detoxif growth develop appear invok esfenvaler exposur swim impair correl express aspartoacylas aspa enzym involv brain cell function associ numer human diseas select gene investig molecular biomark strong link determin measur downregul aspa observ behavior respons fish expos environment relev pyrethroid concentr conclus studi microarrai technolog approach screen gener molecular biomark endang nonmodel organ identifi specif gene directli link subleth toxicolog endpoint chang express level neuromuscular gene measur swim impair develop microarrai appli larval fish expos esfenvaler contamin sacramentosan joaquin estuari permit identif specif biomark provid insight factor contribut delta smelt popul declin
Respir Res	19909375	2018-07-19	PMC2806365	20040086	background urokinas uk ukgh hour infusionuk accp recommend regimen treat acut pulmonari embol pe unclear dose time reduc compar efficaci safeti ukg hour uk uk regim select pe patient method random trial involv patient conduct patient acut pe randomli assign receiv uk uk efficaci determin improv heart dysfunct perfus defect post uk treatment bleed incid death rate pe recurr evalu improv heart dysfunct lung perfus defect observ group bleed incid low group major bleed directli associ uk infus occur patient uk group uk group mortal rate low report fatal recurr uk group uk group rate bleed death pe recurr compar separ hemodynam instabl massiv anatom obstruct subgroup differ conclus uk regimen exhibit efficaci safeti uk regimen acut pe trial registr clinic trial regist httpclinicaltrialsgovctshownct identifi nct 
PLoS One	30026186	2016-03-01	PMC2806912	20090947	influenza hn viru continu enzoot poultri transmit zoonot human swineorigin hn viru emerg pandem virul human remain modest comparison zoonot hn diseas human respiratori epithelium primari target cell influenza virus elucid viral tropism host innat immun respons influenza hn viru human bronchial epithelium help understand pathogenesi establish primari cultur undifferenti differenti normal human bronchial epitheli nhbe cell infect highli pathogen influenza hn viru avietnam season influenza hn viru ahong kong viral replic kinet cytokin chemokin respons compar qpcr elisa vitro cultur differenti nhbe cell acquir physiolog properti normal human bronchi tissu express high level link sialic acid receptor human airwai trypsinlik hat proteas contrast low express nondifferenti nhbe cell compar hn viru hn viru replic effici induc stronger type interferon respons undifferenti nhbe cell contrast differenti cultur hn viru replic effici elicit lower interferonbeta respons comparison hn viru data differenti bronchial epitheli cell major influenc cell permiss human hn avian hn virus host innat immun respons reduc viru replic effici partial account lower interferonbeta respons influenza hn viru infect differenti nhbe cell influenza infect bronchial epithelium will lead tissu damag associ epithelium regener data gener undifferenti nhbe cultur relev diseas pathogenesi
PLoS One	26727924	2013-12-18	PMC2806919	20090954	human lung epitheli cell target encount invad sever acut respiratori syndromeassoci coronaviru sarscov cell support growth sarscov infect capabl secret inflammatori cytokin initi eventu aggrav host innat inflammatori respons caus detriment immunemedi patholog lung comprehens evalu complex epitheli signal sarscov crucial pave better understand sar pathogenesi base microarraybas function genom report global gene respons cell clone bronchial epitheli cell deriv calu cell tempor spatial activ nuclear factor nfb activ protein ap interferon regulatori factor irf infect cell hr post infect pi activ antivir gene includ interferon ifn inflammatori mediat ifnstimul gene isg time ifn ifn capabl exert unrecogn nonredund complementari abil limit sarscov replic express detect infect bronchial epitheli cell hr pi collect highlight mechan sequenti event antivir signal pathwai trigger sarscov bronchial epitheli cell identifi novel cellular target futur studi aim advanc strategi sar
Bioinform Biol Insights	24352473	2013-09-01	PMC2808184	20140073	background precis determin conform epitop neutral antibodi repres kei step ration design novel vaccin power experiment method gain insight physic chemic natur conform epitop select linear peptid bind high affin monoclon antibodi interest phage displai technolog structur character conform epitop mimotop straightforward the interpret peptid sequenc phage displai experi focus linear sequenc analysi find consensu sequenc common sequenc motif fulli autom search method episearch predict locat conform epitop surfac antigen algorithm peptid sequenc phage displai experi input rank surfac expos patch frequenc distribut residu peptid patch test perform episearch algorithm experiment data set phage displai experi human epiderm growth factor receptor herneu antibodi mab boc target domain fviii antibodi mab mab hiv envelop protein gp mab target hiv capsid protein sar coronaviru spike protein exampl conform epitop determin xrai crystal structur antibodyantigen complex highest score patch episearch cover case residu experiment observ conform epitop input option program includ map singl peptid set peptid antigen structur the calcul visual interact web server avail user access episearch web server httpcurieutmbeduepisearchhtml
BMC Public Health	23774793	2017-11-01	PMC2808319	20034405	background commun quarantin controversi decis prepar inform specif quantit evid benefit casestudi report sar outbreak discuss role quarantin commun transmiss literatur yield quantit estim reduct secondari case attribut quarantin area health polici costeffect analysi method data ontario canada sar outbreak novel express impact quarantin present secondari case count differ sccd reflect reduct averag number transmiss aris sar case quarantin rel quarantin onset symptom sccd estim poisson neg binomi regress model ident link function compar number secondari case case quarantin rel nonquarantin case invers statist propos number need quarantin nnq prevent addit secondari transmiss estim sccd fewer secondari case quarantin versu nonquarantin case nnq expos individu commun quarantin prevent addit case transmiss commun analysi suggest quarantin effect prevent measur estim lack statist precis conclus rel health polici area literatur quarantin lack quantit express effect agreement best report differ outcom attribut control measur hope discuss present calcul express impact popul control measur studi quarantin effect present methodolog statist challeng discuss need understand cost benefit enact quarantin includ discuss quantit benefit commun decisionmak public evalu
Crit Care	29107643	2015-07-15	PMC2811892	20003352	introduct human host immun respons infect variant ahn pandem influenza viru nvhn understood util system cytokin antibodi level evalu differ earli immun respons mild sever patient infect nvhn method profil cytokin chemokin evalu haemagglutin inhibit activ quantit qualit measur host immun respons serum dai symptom onset cohort nvhn infect patient sever patient requir hospit respiratori insuffici admit intens care unit mild patient exclus flulik symptom group healthi donor includ control differ level mediat group assess parametr umann whitnei test associ variabl determin calcul spearman correl coeffici viral load perform serum realtim pcr target neuraminidas gene increas level innateimmun mediat ip mcp mip absenc antinvhn antibodi character earli respons nvhn infect hospit mild patient high system level typeii interferon ifn group mediat involv develop thelper il il il il thelper tnf il ilp respons exclus hospit patient il ilp il constitut hallmark critic ill studi invers associ il il pao critic patient conclus infect nvhn induc typic innat respons mild sever patient sever diseas respiratori involv character earli secret th cytokin associ cell mediat immun commonli link pathogenesi autoimmuneinflammatori diseas exact role th mediat evolut nvhn mild sever diseas merit investig detriment benefici role cytokin plai sever ill
PLoS One	26001777	2018-07-06	PMC2815781	20140251	for decad type influenza viru infect human attribut viral subtyp ahn ahn contrast avian vertebr speci reservoir type influenza viru genom divers host strain repres combin viral hemagglutinin viral neuraminidas subtyp viral genom segment reassort mutat emerg reservoir spawn influenza viru strain immin epidem pandem threat human health poultri product tradit method detect differenti influenza viru subtyp timeconsum laborintens culturebas remark insensit antibodybas molecular diagnost assai base revers transcriptasepolymeras chain reaction rtpcr short assai cycl time high analyt sensit specif diagnost test determin viral gene nucleotid sequenc distinguish strain variant detect pathogen specimen decisionqu strain variantspecif pathogen gene sequenc critic public health infect control surveil epidemiolog medicalveterinari treatment plan resequenc pathogen microarrai rpmflu robust highli multiplex target gene sequencingbas altern tradit cultur biomarkerbas diagnost test rpmflu singl simultan differenti diagnost assai subtyp combin type influenza virus viral bacteri pathogen influenzalik ill pathogen target rpmflu coinfect compound morbid andor mortal patient influenza inform specif singl rpmflu test repres specimenspecif viral gene sequenc determin viru type ahn subtyp virul hostrang resist antivir agent
PLoS Pathog	29980611	2003-09-11	PMC2816698	20140199	the innat immun respons essenti control west nile viru wnv infect respons propag regul adapt immun vivo defin ip central adaptor protein rigilik receptor rlr signal essenti trigger innat immun effect develop regul adapt immun pathogen wnv ip mice exhibit increas suscept wnv infect mark enhanc viral replic dissemin earli viral entri cn infect cultur bonemarrow bm deriv dendrit cell dc macrophag mac primari cortic neuron ipsdepend rlr signal essenti trigger ifn defens control viru replic kei target cell infect intriguingli infect ip mice displai uncontrol inflamm includ elev system type ifn proinflammatori cytokin chemokin respons increas number inflammatori dc enhanc humor respons mark complet loss viru neutral activ increas number virusspecif cd cell nonspecif immun cell prolifer peripheri cn uncontrol inflammatori respons associ lack regulatori cell expans occur acut wnv infect enhanc inflammatori respons absenc ip coupl failur protect wnv infect data defin innateadapt immun interfac mediat ipsdepend rlr signal regul quantiti qualiti balanc immun respons wnv infect
PLoS One	12970436	2012-09-01	PMC2817000	20161706	background urgent medic innov approach control influenza emphas widespread resist circul subtyp hn virus lead antivir drug oseltamivir pandem threat pose occurr human infect highli pathogen avian hn virus evolv swineorigin hn influenza pandem discov class human monoclon antibodi abil neutral broad spectrum influenza virus includ h h subtyp potenti prevent treat influenza human report latest efficaci data repres antibodi novel class methodologyprincip find evalu prophylact therapeut efficaci human monoclon antibodi cr lethal challeng highli pathogen avian hn viru ferret optim model human influenza infect surviv rate clinic relev diseas sign chang bodi weight temperatur viru replic lung upper respiratori tract macro microscop patholog investig prophylact administr mgkg cr prior viral challeng complet prevent mortal weight loss reduc amount infecti viru lung abolish shed viru pharyng secret prevent hninduc lung patholog administ therapeut dai challeng mgkg cr prevent death anim blunt diseas evidenc decreas weight loss temperatur rise reduc lung viral load shed lung damag conclusionssignific data demonstr prophylact therapeut efficaci class human monoclon antibodi highli stringent clinic relev anim model influenza justifi clinic develop approach intervent season pandem influenza
Adv Bioinformatics	21945356	2019-03-27	PMC2817497	20150956	synonym codon usag protein code gene thirti complet sequenc mycobacteriophag genom studi multivari statist analysi major factor influenc codon usag identifi composit bia codon prefer highli express gene codon highli prefer codon strong neg correl effect number codon nc gc content observ show codon usag effect gene nucleotid composit translat select identifi plai role shape codon usag oper level translat accuraci high level heterogen genom length gene identifi influenc codon usag phage genom mycobacteriophag cooper identifi highli bias genom better translat effici compar host specif trna gene
PLoS One	24210098	2006-09-27	PMC2818714	20161764	on june health organ declar outbreak novel influenza hn pandem limit suppli antivir vaccin countri individu wai reduc spread pandem hn option cost effect easi implement experi sar hn epidem peopl wear facemask protect infect quantifi impact facemask reduc spread diseas construct analyz mathemat model popul peopl wear facemask pandem quantifi impact mask spread influenza estim paramet valu effect facemask data studi respir surgic facemask respir effect reduc suscept infect popul wear reduc number influenza hn case conclud model worn properli facemask effect intervent strategi reduc spread pandem hn 
Virol J	17005682	2006-11-10	PMC2819038	20078868	background human pathogen coronaviru nl hcovnl group alpha coronaviru commonli associ respiratori tract infect addit nonstructur structur protein coronavirus accessori protein function unknown studi focus hcovnl open read frame orf highli conserv accessori protein coronavirus insilico analysi amino acid sequenc hcovnl orf predict tripl membranespan protein express infect caco llcmk cell confirm immunofluoresc western blot analysi protein detect endoplasmat reticulumgolgi intermedi compart ergic coronaviru assembl bud take place subcellular local studi recombin orf protein transfect huh cell reveal occurr ergic golgi lysosom compart fluoresc microscopi differ tag envelop membran nucleocapsid protein orf protein coloc extens ergic ntermin flagtag orf protein antiserum specif cterminu verifi propos topolog extracellular nterminu cytosol cterminu invitro translat analysi subsequ endoglycosidas digest orf protein nglycosyl nterminu analysi purifi viral particl reveal orf protein incorpor virion addit structur protein conclus studi extens express analysi group hcovorf protein evid orf protein structur nglycosyl virionincorpor protein
Int J Environ Res Public Health	17569723	2019-02-07	PMC2819778	20195435	avian colibacillosi salmonellosi consid major bacteri diseas poultri industri worldwid colibacillosi salmonellosi common avian diseas communic human articl vital epidemiolog pathogenesi diagnosi control public health concern avian colibacillosi salmonellosi better understand address review articl will assist poultri research poultri industri continu progress reduc elimin avian colibacillosi salmonellosi poultri flock reduc potenti hazard public health pose bacteri diseas
Int J Environ Res Public Health	30753384	2013-11-30	PMC2819789	20195446	the basic reproduct number summari measur transmiss potenti infecti diseas estim earli epidem growth rate likelihoodbas method estim develop studi correct concept actual reproduct number offer simpl framework estim assum exponenti growth case propos method appli hiv epidem european countri yield valu rang consist base eulerlotka equat method permit calcul expect spreadsheet
Virol J	24296690	2014-02-26	PMC2820015	20064199	hiv particl assembl mediat viral gag protein occur plasma membran coloc hiv envelop lipid rich microenviron cell signific viral protein modul envelop associ microdomain plasma membran enrich glycosylphosphatidylinositolanchor protein primari cd cell natur target hiv understood primari cd cell natur target hiv vivo gag modul hiv envelop associ gm gangliosid cd rich cellular compart deterg resist membran data strengthen evid gagenv interact envelop associ lipid raft gpianchor protein effici assembl matur virion product infect primari cd cell
PLoS One	24574399	2011-09-21	PMC2822845	20174643	background april case pandem hn influenza hnsw viru detect franc virolog surveil undertaken refer laboratori french defenc zone methodologyprincip find report virolog analys perform public hospit marseil month outbreak nasal swab test rapid influenza diagnost test ridt rtpcr assai epidemiolog characterist suspect case analyz includ detect influenza viru respiratori virus three month total patient test includ patient infect hnsw viru distribut ag group ridt analyz ii sera receiv april randomli select inpati test standard hemagglutin inhibit assai antibodi novel hnsw viru iii earli late juli viral isol character sequenc complet hemagglutinin neuraminidas gene iiii epidemiolog characterist cluster case occur juli summer camp analyz conclusionssignific studi present virolog epidemiolog data infect pandem ahn viru europ distribut ag group to report season hn seropreval data european popul previou exposur individu year influenza virus antigen pandem hn viru genom analysi indic strain harbour aminoacid pattern neuraminidas gene appear secondarili tend supplant strain final contrast previou report data support ridt detect infect children context investig group case
Virol J	21940406	2018-09-26	PMC2823673	20082709	background grow concern rais pandem potenti highli pathogen avian influenza hpai hn virus consequ urgent develop effect safe vaccin diverg hn influenza virus studi design tetrabranch multipl antigen peptid mapbas vaccin design memap sequenc overlap highli conserv extracellular domain matrix protein hpai hn viru investig immun respons crossprotect clade hn virus result memap vaccin induc strong mespecif igg antibodi respons dose immun mice memap presenc freund aluminium alum adjuv memap vaccin limit viral replic attenu histopatholog damag challeng mous lung memapbas vaccin protect immun mice clade vn clade szh hn viru challeng counteract weight lost elev surviv rate lethal challeng hn virus conclus memap present hn viru great potenti develop effect subunit vaccin prevent infect broad spectrum hpai hn virus
PLoS Pathog	30258004	2004-04-01	PMC2824749	20174607	the gene express plusstrand rna virus polycistron genom depend translat replic genom mrna synthesi subgenom sg mrna arterivirus coronavirus distantli member nidoviru order emploi uniqu mechan discontinu minusstrand rna synthesi gener subgenomelength templat synthesi nest set sg mrna nonstructur protein nsp arteriviru equin arter viru eav multifunct regul viral rna synthesi virion biogenesi implic control balanc genom replic sg mrna synthesi emploi revers forward genet gain insight multipl regulatori role nsp analysi reveal rel abund viral mrna tightli control intric network interact involv nsp subdomain distinct nsp mutat quantit balanc viral mrna speci data implic nsp control accumul fulllength subgenomelength minusstrand templat viral mrna synthesi moder differenti chang viral mrna abund nsp mutant alter viral protein level progeni viru yield greatli reduc pseudorevert analysi provid compel genet evid balanc eav mrna accumul critic effici viru product report proteinmedi mrnaspecif control nidoviru rna synthesi reveal exist integr control mechan finetun replic sg mrna synthesi viru product establish major role nsp coordin arteriviru replic cycl
PLoS One	23118695	2011-04-08	PMC2825274	20179772	the rapid emerg subsequ spread novel influenza ahn viru hn prompt health organ declar pandem st centuri highlight threat influenza public health healthcar system widespread resist class influenza antivir adamantan neuraminidas inhibitor occur pandem season virus render drug margin util treatment modal worldwid virtual hn season hn strain resist adamantan rimantadin amantadin major season hn strain resist oseltamivir prescrib neuraminidas inhibitor nai address effect therapi evalu vitro activ tripl combin antivir drug tcad regimen compos drug mechan action drugresist season hn influenza virus amantadin ribavirin oseltamivir combin test amantadin oseltamivirresist influenza virus vitro infect model mdck cell data tripl combin highli synergist drugresist virus synergi tripl combin greater synergi doubl combin test includ combin nai surprisingli amantadin oseltamivir contribut antivir activ tcad regimen amantadin oseltamivirresist virus concentr activ singl agent concentr clinic achiev data demonstr tcad regimen compos amantadin ribavirin oseltamivir highli synergist resist virus includ hn tcad regimen overcom baselin drug resist class approv influenza antivir repres highli activ antivir therapi season pandem influenza
Proc Biol Sci	21478364	2007-09-27	PMC2825776	19692402	some zoonot pathogen sporad infect human rare propag succeed overcom speci barrier establish human popul adapt driven select pressur human host plai role allow pathogen cross speci barrier simpl mathemat model studi potenti epidemiolog marker adapt circumst ongo adapt signal larg cluster human infect pathogen caus hundr case transmiss indic speci barrier cross final case report monitor detect immin emerg event distinguish evolutionari scenario adapt signal larg cluster infect emerg occur prior warn lack transmiss rule adapt zoonos occur zoonot case continu sporad zoonot infect onward humantohuman transmiss offer extra pathogen adapt final simpl method monitor outbreak sign emerg discuss public health implic
PLoS Negl Trop Dis	17921318	2009-11-04	PMC2826407	20186330	background canin rabi thousand human death year africa continu increas contin methodologyprincip find paper identifi common reason lack effect canin rabi control africa a low prioriti diseas control result lack awar rabi burden epidemiolog constraint uncertainti requir level vaccin coverag possibl sustain cycl infect wildlif oper constraint includ access dog vaccin insuffici knowledg dog popul size plan vaccin campaign limit resourc implement rabi surveil control address issu turn present data field studi model approach tanzania includ burden diseas evalu detail epidemiolog studi oper data vaccin campaign demograph ecolog set econom analys costeffect dog vaccin human rabi prevent conclusionssignific conclud insurmount problem canin rabi control africa elimin canin rabi epidemiolog practic feasibl mass vaccin domest dog domest dog vaccin costeffect approach prevent elimin human rabi death
Acta Vet Scand	19889777	2010-05-01	PMC2828449	20053278	the descript distribut phylogeni felin coronavirus fcov studi cat suspect felin infecti periton fip malaysia ascit fluid andor biopsi sampl subject revers transcript polymeras chain reaction rtpcr target conserv region untransl region utr fcov genom percent sampl anim posit presenc fcov fcov posit cat cat male year ag fcov posit case includ domest short hair dsh persian siames cat nucleotid sequenc select amplifi product fip case determin sequenc comparison reveal field isol homolog point mutat extent homolog decreas compar refer strain branch pattern phylogenet tree distinct cluster malaysian isol fall main genet cluster find provid genet fcov malaysia
Virol J	20491978	2004-10-26	PMC2829536	20144216	background influenza respiratori diseas serious threaten human health fact influenza viru critic contribut mortal induc influenza cytokin storm produc excess immun respons trigger viru result inflammatori reaction lung tissu fatal lung tissu injuri increas influenza mortal antivir drug immunosuppress drug includ infect treatment present hypothesi complement center inflammatori reaction complement system activ bodi will strong inflammatori reaction tissu injuri patholog process studi prove inflammatori injuri lung tissu caus influenza viru close complement activ inhibit complement activ reduc inflammatori injuri lung tissu complement physiolog defens patholog damag medium systemat inhibit result side effect includ infect design target complement inhibitor complement activ site cr target vector complement inhibitor cd crry target inflammatori site special inhibit complement activ local injuri local inflammatori reaction inhibit test hypothesi crcd crcrry target complement inhibitor fusionexpress biolog activ examin vivo vitro test cr target complement inhibitor treat mous influenza viral pneumonia model pb treatment group control surviv lung tissu injuri mice observ cr target complement inhibitor pneumonia induc influenza viru evalu implic hypothesi cr target complement inhibitor expect ideal drug viral pneumonia
BMC Biotechnol	15507608	2012-07-11	PMC2831817	20163718	background fibroblast growth factor fgf promis drug candid combat metabol diseas highlevel express purif recombin fgf rfgf escherichia coli coli difficult rfgf form inclus bodi bacteria make difficult purifi high concentr bioactiv rfgf overcom problem fuse fgf sumo small ubiquitinrel modifi polymeras chain reaction pcr express fuse gene coli blde induc iptg sumofgf express high level concentr reach total protein exceed solubl protein fuse protein purifi deae sepharos ninta affin chromatographi cleav sumo proteas puriti rfgf high perform liquid chromatographi hplc higher low endotoxin level euml vivo anim experi rfgf produc method decreas concentr plasma glucos diabet rat streptozotocin stz inject conclus studi demonstr sumo fuse fgf promot solubl express coli make conveni purifi rfgf better method produc rfgf pharmaceut develop
BMC Public Health	22787223	2010-11-01	PMC2831836	20170529	background fever undifferenti clinic featur enhanc sensit syndrom surveil system studi spatiotempor associ febril patient allow earli detect case cluster indic immin threat infecti diseas outbreak commun method captur consecut emerg depart visit led hospit district hospit hong kong period sep oct record demograph data provision diagnos temperatur present residenti locat patientepisod geocod residenti address appli geograph system technolog studi geograph distribut case associ buffer zone spatial case cluster defin three spatial associ febril patient three consecut dai sixti patientepisod elig analysi fever oral temperatur present patientepisod residenti care home elderli rche detect total case cluster studi period cluster case older ag resid rche median patient rang time span dai rang dai cluster twenti cluster patient live build block rche conclus technic feasibl perform surveil febril patient studi spatiotempor associ earli detect impend infecti diseas threat
Virol J	20800257	2012-04-01	PMC2831879	20144233	the sar coronaviru sarscov open read frame orf encod amino acid accessori protein sequenc homolog protein protein viru particl interact host protein implic involv pathogen process includ apoptosi inhibit cellular protein synthesi activ mitogen activ protein kinas studi data demonstr sarscov protein interact human apahydrolas asymmetr diadenosin tetraphosph hydrolas ec apahydrolas respons metabol allarmon nucleotid apa involv regul cell prolifer dna replic rna process apoptosi dna repair interact apahydrolas identifi yeast twohybrid screen interact confirm coimmunoprecipit cultur human cell transient express vhi tag ha tag apahydrolas human tissu cultur cell transient express apahydrolas tag egfp dsred protein coloc cytoplasm
BMC Biol	22492163	2010-02-04	PMC2832619	20132533	background rapidli evolv gene famili involv immun respons reproduct biolog function assign carcinoembryon antigen cea gene famili gain insight evolutionari forc shape cea gene famili analys gene famili mammalian speci includ monotrem marsupi lineag phylogenet analysi provid convinc evid primordi cea gene famili mammal consist gene includ immun inhibitori receptorencod ceacam cearel cell adhes molecul ancestor analysi substitut rate nucleotid sequenc code ligand bind domain ceacam indic select diversif consequ exploit ceacam varieti viral bacteri pathogen cellular receptor depend extent amplif ancestr ceacam number ceacamrel gene vari consider mammalian speci lagomorph bat analys speci itam immunoreceptor tyrosinebas activ motif itamlik motifcontain protein exist igvlik ligand bind domain close ceacam human ceacam protein function ceacam decoi receptor granulocyt mediat uptak destruct specif bacteri pathogen itamlik motif close relationship ceacam itamencod rel appear maintain gene convers reciproc recombin surprisingli secret ceacam resembl immunomodulatori ceacamrel trophoblastspecif pregnancyspecif glycoprotein psg human rodent evolv limit set mammal appear psglike gene correl invas trophoblast growth speci conclus phylogenet studi provid evid pathogenhost coevolut particip fetalmatern conflict process led highli speciesspecif divers mammalian cea gene famili
Virol J	19861680	2012-08-22	PMC2832772	20100346	background overlap gene common rna virus serv mechan optim code potenti compact genom annot overlap gene difficult convent genefind softwar number complementari approach systemat identifi undetect overlap gene rna viru genom articl gather number promis candid overlap gene interest commun overlap gene predict present astrovirus seadornavirus cytorhabdovirus coronavirus famili astrovirida reovirida rhabdovirida coronavirida respect
Virol J	22915803	2009-08-01	PMC2834657	20167059	background hepat viru hcv bloodborn flaviviru infect million peopl worldwid concern stabil hcv reliabl procedur inactiv viru method current studi thermost cell culturederiv hcv hcvcc jfh strain environment temperatur room temperatur abil heat uvc light irradi aldehyd deterg treatment inactiv hcvcc evalu infecti titer treat viral sampl determin focusform unit ffu assai indirect immunofluoresc assai hcv ns hepatoma huhcd cell highli permiss hcvcc infect mtt cytotox assai perform determin concentr aldehyd deterg longer cytotox hcvcc cultur medium surviv room temperatur dai viru stabl drastic loss infect week hcvcc cultur medium sensit heat inactiv min incub c min requir elimin hcvcc infect addit normal human serum hcvcc alter viral stabil suscept heat uvc light irradi wavelength nm intens wcm effici inactiv hcvcc min exposur formaldehyd glutaraldehyd ionic nonion deterg destroi hcvcc infect effect treatment conduct presenc cell cultur medium human serum conclus provid quantit evid potenti varieti approach inactiv hcv abil hcvcc surviv ambient temperatur warrant precaut handl dispos object materi contamin hcv
PLoS Med	19608822	2012-09-01	PMC2834705	20231868	karen edmond anita zaidi highlight approach reduc burden neonat sepsi worldwid
Viruses	22958246	2006-10-30	PMC2835314	20221421	coronavirus infect speci anim includ human caus acut chronic diseas organ system murin coronaviru mous hepat viru mhv infect mous anim model studi central nervou system diseas includ enceph demyelin diseas multipl sclerosi hepat studi adapt immun respons mhv scant type interferon ifn respons mhv relationship mhv ifn respons paradox type ifn respons crucial aspect host defens mhv natur host induct ifn infect mous fibroblast cell line vitro mhv resist antivir effect ifn mous fibroblast cell line human cell mhv circumst compromis antivir effect ifn signal nucleocapsid protein nsp nsp protein mhv report ifn antagonist activ primari cell type plasmacytoid dendrit cell pdc macrophag ifn induc mhv infect antivir state establish primari cell type neuron astrocyt hepatocyt fail produc ifn infect vivo depend ifn produc pdc macrophag protect mhv mhv induct ifn abil induc antivir state respons interferon extrem cell type depend ifn induc protect mhv pathogenesi requir orchestr activ cell type cell type involv limit mhv replic liver immun privileg cn
Viruses	17075062	2011-06-01	PMC2836126	20224751	assai simultan detect multipl potenti agent bioterror limit multiplex pcr rtpcr enzym hybrid assai mpcreha mrtpcreha develop simultan detect cdc categori bioterror agent bio dna assai develop detect variola major vm bacillu anthraci ba yersinia pesti yp francisella tularensi ft varicella zoster viru vzv bio rna assai mrtpcreha develop detect ebola viru ebola lassa fever viru lassa rift vallei fever rvf hantaviru sin nombr speci hsn dengu viru serotyp sensit specif assai test genom dna recombin plasmid posit control rna transcript control surrog spike clinic sampl common respiratori pathogen analyt sensit limit detect lod dna asssai genom dna copiesml ba ft yp lod vzv organ tcidml lod recombin control rang copiesml ba ft yp vm rna assai demonstr lod rna transcript control copiesml extract copiesml extract ebola rvf lassa hsn lod dengu organ dilut dengu ldml ldml dengu lod extract recombin plasmid dna control copiesml input copiesreact ebola rvf lassa hsn crossreact primer probe assai detect common respiratori pathogen target analyt clinic sensit estim surrog clinic sampl test biot dna assai sampl test biot rna assai clinic specif biot dna assai biot rna assai surrog sensit assai ci ft ba px yp vm vzv dengu ci ba px dengu spike clinic specimen specif biot multiplex assai spike specimen ci compar assai cultur serolog pcr biot dna mpcreha biot rna mrtpcreha rapid sensit specif assai detect categori bioterror agent standard thermocycl
BMC Struct Biol	21572336	2018-08-15	PMC2836360	20170556	background catalyt activ influenza neuraminidas facilit elut progeni virion infect cell prevent selfaggreg mediat catalyt site locat bodi region activ site molecul led develop effect inhibitor oseltamivir zanamivir high rate mutat interspeci reassort viral sequenc report oseltamivir resist strain underlin determin addit target site develop futur antivir compound comput studi hn gene sequenc identifi base highli conserv region termin gene extend graphic numer analys larger number hn sequenc hn swine flu sequenc access genbank graphic represent model gene sequenc graphic slide window method gswm protein sequenc scan sequenc block amino acid time protein sequenc descriptor defin model protein slide scan method allow compar strain block level variabl statist correl averag solvent access residu block singl amino acid posit variabl correl indic impact stretch variabl chemic environ close ctermin gswm descriptorvari increas averag solvent access asa support conserv predict secondari structur termin rna visual evid crystallograph structur conclus identifi termin segment conserv rna protein sequenc surfac expos structur chemistri reveal probabl role stretch tetramer stabil particip biolog process associ conserv surfac residu rna doubl hairpin secondari structur segment major hn strain support observ paper propos conserv region probabl site design inhibitor broadspectrum pandem control flu virus structur
PLoS One	29570986	2016-05-13	PMC2836373	20300175	background studi drugtarget interact network topic drug develop timeconsum costli determin compoundprotein interact potenti drugtarget interact experi complement silico predict method provid time manner methodsprincip find realiz drug compound encod function group protein encod biolog featur includ biochem physicochem properti optim featur select procedur adopt mrmr maximum relev minimum redund method classifi protein famili target protein divid group enzym ion channel gprotein coupl receptor nuclear receptor independ predictor establish nearest neighbor algorithm oper engin predict interact drug protein group result success rate jackknif crossvalid test achiev predictor conclusionsignific indic network predict system establish promis encourag
BMC Vet Res	27226534	2005-07-01	PMC2837645	20175881	background structur contact individu plai role incurs spread contagi diseas human anim popul case avian influenza movement live bird risk factor geograph dissemin viru poultri flock live bird market lbm contribut epidemiolog avian influenza demograph characterist presenc hpai hn viru lineag relationship poultri produc live poultri trader lpt oper lbm adequ document hpai hnaffect se asian countri aim studi document studi flow live poultri poultri trade network northern vietnam explor potenti role risk hpai hn result indic lpt trade year oper retail market sourc poultri flock locat commun histori hpai hn outbreak lpt trade longer year oper wholesal market the network analysi indic lpt tend link commun infect statu conclus studi evid inform polici aim encourag biosecur practic lpt oper authoris lbm lpt plai role hpai hn transmiss contribut perpetu hpai hn viru circul group commun impact current diseas prevent control intervent enhanc dissemin outbreak risk implement formal data record scheme lbm incom outgo lpt
Virol J	16020687	2012-03-01	PMC2838858	20202190	measl caus measl viru mev common infect children mev member genu morbilliviru close rinderpest viru rpv pathogen cattl mev thought evolv environ cattl human live close proxim understand evolutionari histori mev answer question diverg time mev rpv investig diverg time relax clock bayesian phylogenet estim reveal mev evolutionari rate substitutionssiteyear conclud diverg time common ancestor current mev earli centuri diverg mev rpv occur centuri result unexpect emerg mev consid occur prehistor ag mev origin viru nonhuman speci caus emerg infecti diseas centuri case investig measl cours emerg infecti diseas
BMC Biotechnol	22733325	2012-10-17	PMC2841091	20146813	background despit current knowledg mutat gene nonsyndrom sensorineur hear loss snhl unifi clinic test develop comprehens detect mutat multipl gene design affymetrix resequenc microarrai capabl resequenc gene mutat snhl gjb gjb cdh kcne kcnq myoa otof pd myo slca tmie tmprss ushc hear loss arrai develop facil highlight approach adopt enhanc applic resequenc arrai clinic set leverag sequenc intens pattern featur respons diminish coverag accuraci develop novel algorithm sprofil resolv nocal gseq allow rang sequenc call maintain accuraci base dideoxi sequenc comparison conclus find provid insight critic issu diseasecent resequenc protocol suitabl clinic applic support arraybas resequenc technolog valuabl molecular diagnost tool pediatr snhl genet diseas substanti genet heterogen
PLoS One	23077320	2005-01-28	PMC2841200	20305786	groundnut bud necrosi viru gbnv member genu tospoviru famili bunyavirida infect larg number leguminosa solanacea plant india view elucid function nonstructur protein nss encod small rna genom rna nss protein gbnv tomato karnataka overexpress coli purifi ninta chromatographi purifi rnss protein exhibit rna stimul ntpase activ activ metal ion depend inhibit adenosin imido triphosph atp analog rnss hydrolyz datp interestingli addit ntpase datpas activ rnss exhibit atp independ rnadna phosphatas activ complet inhibit amp phosphat remov ssdna ssrna dsdna dsrna confirm rnss novel phosphatas activ ka mutat walker motif gxxxxgkt complet loss atpas activ phosphatas activ unaffect hand mutat walker motif dexx partial loss activ demonstr time nss bifunct enzym particip viral movement replic suppress host defens mechan
PLoS Pathog	15681451	2017-10-01	PMC2841620	20333243	virus cellular machineri enter infect cell studi address cell entri mechan nonenvelop adenovirus ad protein vi intern capsid protein rapidli expos cell surfac attach intern remain partial associ capsid intracellular transport ppxy motif protein vi recruit nedd ubiquitin ligas bind ubiquityl protein vi ppxy motif involv rapid microtubuledepend intracellular movement protein vi ad mutat ppxy motif effici escap endosom defect microtubuledepend traffick nucleu likewis deplet nedd ligas attenu nuclear accumul incom ad particl infect data provid evid virusencod ppxy motif requir viru entri signific pathogen
BMC Public Health	29276302	2010-11-11	PMC2841672	20226093	background pandem young adult infect increas potenti univers explos diseas outbreak centr outbreak manag essenti reduc impact institut surround commun onlin survei aim measur percept respons staff student pandem hn major univers sydnei australia method survei onlin june septemb sampl includ academ staff gener staff student univers total survei complet respond awar australian pandem situat report anxieti disinterest asianborn respond pandem seriou compar respond region respond lifestyl chang result pandem respond adopt specif behaviour chang adopt simplest health behaviour hand hygien adopt specif behaviour chang link anxieti asian origin student attend univers unwel compar staff member posit respons student indic potenti expand onlin teach learn resourc continu educ disast set willing receiv pandem vaccin associ season influenza vaccin uptak previou year conclus respons pandem subject chang pre earli midoutbreak stage lesson institut prepar second wave futur diseas outbreak includ promot posit public health behaviour young peopl student
J R Soc Interface	21070145	2013-10-28	PMC2842609	19535416	statist infer mechanist model partial observ dynam system activ area exist infer method place substanti restrict form model fit natur scientif hypothes entertain data evalu contrast socal plugandplai method requir simul model free restrict util plugandplai approach context investig measl transmiss dynam novel methodolog enabl answer question previou analys unabl address demonstr plugandplai method permit develop model infer framework applic data larg small popul novel insight natur heterogen mix comment includ extrademograph stochast deal environment stochast model misspecif approach applic epidemiolog ecolog system
PLoS One	24167297	2012-05-01	PMC2843722	20352112	effort develop broadli protect vaccin highli pathogen avian influenza hpai hn viru focus highli conserv influenza gene product viral nucleoprotein np ion channel matrix protein highli conserv strain influenza subtyp investig rel efficaci np compar ha protect hpai hn viru mice previou studi vaccin np recombin dna andor adenoviru vector adjuv confer protect lethal challeng absenc ha find protect efficaci np diminish virul dose challeng viru increas explor question model relev human diseas ferret immun dnarad vaccin encod np ha npm hanpm ha hanpm vaccin confer protect stringent viru challeng genebas vaccin np provid moder level protect low challeng dose insuffici confer protect immun high challeng dose hn ferret immunogen requir combinatori vaccin ha confer protect high dose lethal viral challeng
BMC Infect Dis	22300798	2015-11-23	PMC2844401	20187976	background infecti diseas outbreak critic learn concern knowledg attitud behavior public crucial improv commun effort public health offici clinician aim studi identifi awar attitud practic influenza hn saudi public method crosssect studi adult subject recruit shop mall riyadh jeddah conduct subject interview questionnair test knowledg attitud precautionari measur relat hn influenza pandem half particip high concern low level knowledg minim precautionari measur adjust variabl educ level predictor level concern greater precautionari measur particip male older better educ knowledg onethird particip convinc moh report diseas true particip report receiv health provid conclus high concern translat higher complianc precautionari recommend low level knowledg diseas public frequent commun physician public recommend help dispel myth diseas spread better role public plai limit spread diseas
PLoS Comput Biol	26596952	2006-11-01	PMC2845652	20361048	the trace infecti contact control strategi infecti diseas earli case novel infect endem sexual transmit infect mathemat model consid case partner notif sexual transmit infect model simpl allow gener conclus drawn contact network structur consid addit contact trace standard mass action model gener inadequ consid impact mutual contact cluster develop improv exist pairwis network model demonstr ceteri paribu cluster improv efficaci contact trace larg region paramet space result revers case highli effect contact trace develop stochast simul comparison simpl rewir method allow gener appropri compar network contribut gener theori networkbas intervent infecti diseas
BMC Infect Dis	17079322	2014-09-15	PMC2846943	20205702	typhoid enter fever common diseas develop countri current diagnost test inadequ studi pathogenesi genom provid insight organ enter fever better understand microorgan explain current typhoid methodolog limit diagnost develop strategi consider challeng discuss current posit typhoid diagnost highlight technolog improv potenti wai advanc area
BMC Infect Dis	25220505	2011-11-16	PMC2846944	20205928	background sever acut respiratori syndrom sar outbreak infect individu lead death epidemiolog studi sar compar epidemiolog featur region aim studi identifi similar differ sar epidemiolog three popul host viral genotyp method compar epidemiolog analysi sar base integr dataset sar patient hong kong beij taiwan epidemiolog clinic characterist incub onsettoadmiss onsettodischarg onsettodeath period case fatal ratio cfr present symptom describ compar region explor influenc demograph clinic variabl larg differ cfr three region three region incub period progress shorten onsettoadmiss interv epidem adjust sex health care worker statu nosocomi set older ag associ higher fatal adjust odd ratio aor confid interv ag aor confid interv ag compar ag year presenc preexist comorbid condit associ greater mortal aor confid interv conclus larg discrep crude fatal ratio three region partli explain epidemiolog clinic heterogen find underlin common data collect platform emerg epidem order identifi explain consist differ eventu clinic public health outcom infecti diseas outbreak increasingli highli interconnect world
Virol J	22090124	2015-10-01	PMC2847567	20236536	in mammalian cell nucleolar local influenza ns requir presenc ctermin nucleolar local signal nucleolar local signal strain influenza virus ns accumul nucleolu mammalian cell contrast ns test studi accumul nucleolu avian cell absenc describ ctermin nucleolar local signal nucleolar local ns avian cell appear reli nucleolar local signal conserv influenza viru strain
BMC Public Health	26253126	2007-02-08	PMC2847980	20233450	background strategi public health offici pandem physician recommend isol infect individu studi undertaken height australian pandem hn outbreak measur selfreport willing compli physician recommend stai dai compar respons current strain pandem influenza avian influenza season influenza common cold method data collect queensland social survei qss consist standard introduct demograph question question incorpor costshar arrang question respond anticip complianc physician advic stai common cold season influenza pandem hn influenza avian influenza incorpor qss respons record balanc likert scale rang veri discord respons diseas analys mcnemar test associ demograph variabl anticip complianc analys pearson chisquar chisquar linearbylinear associ confirm multivari logist regress establish statist signific selfreport anticip complianc increas common cold season influenza pandem hn influenza avian influenza versu season influenza anticip complianc differ pandem hn avian influenza ag sex associ anticip complianc set season influenza common cold notabl health commun servic worker compli physician advic stai season influenza conclus ninetyf percent peopl report compli physician advic stai dai diagnos pandem hn avian influenza expect compli set season influenza fewer expect compli diagnos common cold subpopul worthwhil target public health messag aim increas rate selfimpos isol season influenza includ male younger peopl healthcar worker
BMC Infect Dis	17289713	2016-09-14	PMC2848042	20178573	background survei assess knowledg attitud complianc standard precaut health careassoci infect hai associ determin healthcar worker hcw emerg depart itali method anonym questionnair selfadminist hcw randomli select nonacadem acut gener public hospit compris question demograph occup characterist knowledg risk acquir andor transmit hai fromto patient standard precaut attitud guidelin risk perceiv acquir hai practic standard precaut sourc hcw risk acquir hepat hcv human immunodefici viru hiv patient practic year work fewer hour week knew hcw transmit hcv hiv patient knew hcv hiv infect seriou receiv educ cours scientif journal glove mask protect eyewear hand hygien remov glove control measur nurs provid care fewer patient knew hcw hand vehicl transmiss nosocomi pathogen hcw transmit hcv hiv patient receiv educ cours scientif journal nurs know hcw hand vehicl transmiss nosocomi pathogen obtain educ cours scientif journal need associ higher perceiv risk acquir hai hcw glove perform hand hygien measur remov glove nurs provid care fewer patient knew hand hygien remov glove control measur conclus hcw high knowledg posit attitud low complianc concern standard precaut nurs higher knowledg perceiv risk appropri hai control measur physician hcw answer correctli appropri control measur receiv educ cours scientif journal
PLoS One	27629904	2014-10-29	PMC2848673	20376320	background rift vallei fever viru rvfv member genu phleboviru famili bunyavirida negativestrand rna viru tripartit genom rvfv transmit mosquito fever sever hemorrhag ill human livestock fever high abort rate methodologyprincip find sequenc analysi wildtyp rvfv zh prepar consist major viral subpopul singl nucleotid heterogen nucleotid segment residu encod glycin major viral envelop gn protein carri residu encod glutam acid correspond site zhderiv virus rzhmg rzhma carri ident genom sequenc the recov revers genet system intraperiton inocul rzhma mice caus rapid effici viral accumul sera liver spleen kidnei brain kill mice dai rzhmg caus low viremia titer replic effici rzhma organ attenu virul mice remark earli dai postinfect rzhmg virus carri emerg major viru popul replic virus retain input residu rzhmainfect mice conclusionssignific data demonstr singl nucleotid substitut gn protein rvfv mous virul viru popul carri virul viral genotyp emerg major viral popul dai mice inocul attenu viru
BMC Infect Dis	25355758	2009-03-19	PMC2850906	20170501	background nonpharmaceut intervent npi defens pandem influenza intervent dampen viru spread reduc contact infect suscept person curtail essenti societ activ appli judici optim control theori approach model balanc compet object epidem spread npi cost method appli optim control epidemiolog compartment model develop trigger npi implement object minim expect persondai lost influenza death npi implement model perform multivari sensit analysi base latin hypercub sampl studi effect input paramet optim control polici addit studi investig effect departur model assumpt includ exponenti termin time linear npi implement cost optim polici deriv control model linear npi implement cost linear cost lead bangbang polici npi appli maximum strength state criteria met multivari sensit analys present indic npi cost death rate recoveri rate influenti determin polici structur death rate basic reproduct number recoveri rate influenti determin expect cumul death appli npi polici cumul death exponenti gamma termin time close impli outcom appli bangbang polici insensit exponenti assumpt quadrat cost lead multilevel polici npi appli vari strength level base state criteria indic linear cost lead costli implement fewer death conclus applic optim control theori provid valuabl insight develop effect control strategi pandem find highlight establish sensit time surveil system pandem prepared
PLoS Comput Biol	19299732	2016-01-01	PMC2851561	20386735	the dynam infecti diseas spread direct persontoperson transmiss influenza smallpox hivaid depend underli host contact network human contact network exhibit strong commun structur understand commun structur epidem provid insight prevent spread diseas commun chang structur contact network pharmaceut nonpharmaceut intervent empir simul network investig spread diseas network commun structur find commun structur major impact diseas dynam network strong commun structur immun intervent target individu bridg commun effect simpli target highli connect individu structur relev contact network gener vaccin suppli limit great effici vaccin algorithm requir full knowledg network develop algorithm act local network identifi target success immun intervent algorithm gener outperform exist algorithm vaccin suppli limit network strong commun structur understand spread infecti diseas design optim control strategi major goal public health social network mark pattern commun structur base empir simul data demonstr commun structur diseas dynam implic design control strategi
PLoS Pathog	27350726	2005-05-09	PMC2851658	20386712	sever acut respiratori syndrom coronaviru sarscov infect caus sever stage lung diseas organ phase diffus alveolar damag elderli virushost interact govern develop acut stage lung diseas death unknown address question evalu role innat immun signal protect human urbani recombin mous adapt sarscov design rma contrast model viral pathogenesi infect type type ii type iii interferon knockout mice background urbani ma virus clinic diseas outcom includ transient weight loss denud bronchiol alveolar inflamm recoveri ident infect wildtyp mice suggest type ii iii interferon signal plai minor role regul sar pathogenesi mous model contrast infect stat mice sever diseas high viru titer extens pulmonari lesion mortal dai postinfect rma urbani virus nonleth balbc mice urbani sarscov infect stat mice caus dissemin infect involv liver spleen tissu dai find demonstr sarscov pathogenesi regul stat depend type ii iii interferon receptor independ mechan contrast document role innat immun propos stat protect mice role antagonist unrestrain cell prolifer
BMC Health Serv Res	15883361	2014-12-01	PMC2851711	20307302	background work hospit extraordinari infecti diseas outbreak stress contribut healthcar worker choos reduc patient contact psycholog train healthcar worker prior influenza pandem reduc stressrel absente establish train method chang behavior attitud resourceintens widespread studi test feasibl effect expens altern interact computerassist train cours design build resili stress work pandem method dosefind studi compar prepost chang three durat train measur variabl mediat stressrespons pandem train confid support train pandemicrel selfefficaci cope style interperson problem hospit worker cours randomli assign short session median cumul durat minut medium session minut long session minut version intentiontotreat analysi cours associ improv confid support train pandem selfefficaci interperson problem particip underutil cope problemsolv seek support overutil escapeavoid experienc improv cope comparison dose improv interperson problem medium long cours short cours trend higher dropout rate longer durat train conclus computerassist resili train healthcar worker appear benefit merit studi pandem condit compar three dose cours suggest medium cours optim
PLoS One	25268048	2002-06-15	PMC2852402	20404914	background human ceacam cellcel adhes molecul multipl function includ insulin clearanc liver vasculogenesi endotheli cell lumen format mammari gland bind human pathogen princip find three genom bac clone human ceacam gene microinject pronuclei fertil fvb mous oocyt embryo implant oviduct pseudopregn femal allow develop term dna newborn mice evalu pcr presenc human ceacam gene fece pcr posit offspr screen express human ceacam assai pcr posit line posit human ceacam express stabl transmiss gener expect transmiss frequenc heterozygot liver lung intestin kidnei mammari gland prostat posit dual express murin human ceacam mimic human tissu peripher blood bone marrow granulocyt stain human ceacam bound neisseria opa protein human neutrophil conclus transgen anim serv model bind human pathogen human ceacam
PLoS One	12021359	2004-09-27	PMC2854681	20418944	the transfer scientif data emerg challeng dataset continu grow size demand open access share increas current method file transfer scale larg file long transfer time studi biotorr websit allow open access share scientif data popular bittorr peertop file share technolog biotorr allow file transfer rapidli share bandwidth multipl institut reliabl file transfer builtin error check file share technolog biotorr multipl featur includ keyword search categori brows rss feed torrent comment discuss forum biotorr httpwwwbiotorrentsnet
PLoS Pathog	15452268	2015-09-30	PMC2858705	20421945	sarscoronaviru sarscov genom express depend synthesi set mrna presum cap direct synthesi viral protein infect cell sixteen viral nonstructur protein nsp nsp constitut unusu larg replicas complex includ methyltransferas put involv viral mrna cap format sadenosyllmethionin adometdepend guaninenmethyltransferas nmtase activ attribut nsp nsp predict adometdepend nucleosideomethyltransferas reconstitut complet sarscov mrna cap methyl vitro mrna cap methyl requir third viral protein nsp act essenti trigger complet rna cap format oblig sequenc methyl event initi nsp methyl cap rna transcript gener cap megppparna select omethyl omtas nsp complex activ nsp rise cap megpppaomerna sensit vitro inhibit assai activ aurintricarboxyl acid activ sarscov infect cell target mtase ic valu micromolar rang provid valid basi anticoronaviru drug design
PLoS Pathog	26423940	2007-10-24	PMC2858710	20421950	newcastl diseas viru ndv pathogen strain avian paramyxoviru apmv seriou diseas threat poultri industri worldwid viral divers high apmv genotyp recogn base phylogenet reconstruct gene sequenc modifi live vaccin develop decreas econom loss caus viru vaccin deriv avirul genotyp ii strain develop global australian strain belong genotyp develop vaccin asia studi evalu consequ attenu live viru vaccin evolut apmv genotyp phylogenet incongru tree base individu gene complet code region full length apmv genom suggest recombin sequenc data set subsequ recombin genom identifi contain sequenc genotyp ii popul histori vaccinerel genotyp ii strain distinct apmv genotyp genotyp ii emerg late centuri evolv slowli genotyp emerg despit vaccin effort genotyp ii virus experienc constant popul growth contrast contemporari genotyp popul declin late addition genotyp ii virus circul presenc homotyp vaccin pressur uniqu select profil compar nonvaccinerel strain collect data vaccin live attenu virus chang evolut apmv maintain larg effect popul size vaccinerel genotyp allow coinfect recombin vaccin wild type strain appli uniqu select pressur viral glycoprotein
PLoS Negl Trop Dis	17978761	2011-12-14	PMC2860491	20436958	chikungunya viru mosquitoborn emerg pathogen major health impact human fever diseas headach rash nausea vomit myalgia arthralgia indigen tropic africa larg outbreak report part south east asia neighbor island in europ posit case confirm unit state travel return outbreak area current vaccin antivir treatment threat emerg global pandem peculiar problem associ season epidem warrant develop effect vaccin review summar evid support concept
PLoS Med	22170925	2016-12-05	PMC2860492	20436959	as plo medicin seri global health diplomaci laihan chan colleagu provid case studi china grow engag global health diplomaci sar epidem
PLoS Negl Trop Dis	27920168	2007-02-14	PMC2860510	20436917	background unexpectedli high seropreval pathogen potenti human parvoviru bv observ malariaendem countri parallel local chloroquin cq firstlin treatment malaria aim studi assess cq common antimalari drug bv infect vitro epidemiolog consequ children papua guinea png methodologyprincip find viral rna dna protein analyz cell type infect bv presenc rang antimalari drug relationship bv infect statu prior aminoquinolin anemia assess png children year ag particip casecontrol studi sever infect cqtreat cell synthesi viral rna dna protein higher occur earlier control cell cq facilit bv infect minim intracellular degrad incom particl amodiaquin antimalari drug bv igm seroposit frequent children sever anemia hemoglobin gl healthi control children bv igm pcr posit aminoquinolin associ lower admiss hemoglobin concentr conclusionssignific data aminoquinolin drug metabolit exacerb bvassoci anemia promot bv replic consider choos nonaminoquinolin drug partner artemisinin compound combin antimalari therapi
BMC Public Health	17301158	2013-12-30	PMC2861057	20353568	background behaviour respons expect influenza pandem occur method survei compris question base risk percept theori pmt conduct dutch sampl fear influenza pandem occur high particip feel inform gener practition local health author consid trustworthi sourc consid urgent pertain protect measur particip report intent compli recommend protect measur respons efficaci low maladapt behaviour expect increas number individu school closur expect lead decreas work forc particip indic want antivir drug suppli insuffici conclus messag health protect behaviour local health author anticip balanc overreact underreact protect recommend health profession conflict compani polici unclear employe will react
PLoS One	24355931	2017-10-25	PMC2861591	20454449	background syndrom surveil increasingli detect unusu ill debat detect local outbreak evalu syndrom surveil detect local outbreak lowerrespiratori infect lri swamp true signal fals alarm method find retrospect hospit data simul prospect surveil lrielev total lri includ hospit patient place resid coverag popul larg outbreak legionnair diseas netherland posit control test outbreak detect local lri elev spacetim permut scan statist detect lri cluster evalu lriclust detect assess clustersign higher proport specif hospit discharg diagnos legionnair diseas overlap region influenza elev evalu number spacetim signal reduc restrict scan statist space time scanstatist detect local lri cluster repres averag cluster year legionnair diseas outbreak detect lriclust clustersign gener increas proport legionnair diseas patient cluster coincid local influenza andor respiratori syncyti viru activ cluster appear data artifact cluster defin repres undetect lrioutbreak restrict time spatial window scan statist detect legionnair diseas outbreak loss timeli signal gener time declin conclus knowledg studi systemat evalu perform spacetim syndrom surveil nationwid high coverag data longer period syndrom surveil detect local lrioutbreak time manner independ laboratorybas outbreak detect compar cluster year observ prompt investig syndrom hospitalsurveil valuabl tool detect local lrioutbreak
PLoS Pathog	29070693	2014-05-28	PMC2861712	20442788	the filovirus marburg ebola nonseg negativestrand rna virus caus sever hemorrhag fever high mortal rate human nonhuman primat sequenc event lead releas filoviru particl cell understood contrast mechan propos proceed submarinelik bud helic nucleocapsid emerg parallel plasma membran perpendicular rocketlik protrus infect cell marburg viru bsl contain condit reconstruct sequenc step bud process three dimens electron tomographi plasticembed cell find highli infecti filament particl releas earli stage infect bud proce later associ intracellular nucleocapsid length plasma membran rapid envelop initi nucleocapsid lead protrud intermedi scission local membran instabl rear viru prolong infect increas vesicul plasma membran correl chang shape infect releas virus observ demonstr cellular determin viru shape reconcil contrast model filoviru bud allow describ sequenc event place bud releas marburg viru propos repres gener sequenc event filament rodshap virus
BMC Cell Biol	24872591	2014-11-01	PMC2864199	20398401	background acquisit resist anoiki facilit surviv cell independ matrixdefici condit cell tumor progress product suspens cultur cell biomed engin evid suggest cd adhes molecul associ surviv cell tumor metastasi cellcel contact plai role resist anoiki function cd mediat cellcel contact anoikisresist remain limit selfcontradictori anoikisresist clone hekar deriv anoikissensit parent human embryon kidnei cell surviv anoiki format cellcel contact express habgcd member cd famili upregul protein locat cellcel junction upregul habgcd suspend hekar cell suppress anoiki mediat format cellcel adhes anoiki resist hekar cell requir ecadherinmedi cellcel contact knockdown habgcd ecadherin inhibit cellcel contact format increas anoiki sensit habgcd downregul ecadherin express hekar cell suppress knockdown ecadherin ecadherin sirna block ecadherin bind activ specif antibodi edta habgcd express final pretreat ly phosphoinositid kinas pikakt inhibitor disrupt cellcel contact decreas cell number case cell treat extracellular signalregul kinas erk inhibitor pd conclus provid evid habgcdmedi cellcel contact confer anoiki resist ecadherindepend manner cellcel contact mediat resist anoiki implic pik pathwai highli relev cell model hekar understand role habgcd cellcel contact anoiki resist help understand surviv cell anchorageindepend growth cell tumor metastasi suspens cultur produc biomed engin contribut better understand biologi hek cell spheroid major workhors produc human therapeut agent viral vaccin
BMC Infect Dis	25455030	2003-07-28	PMC2864274	20403201	background septemb pandem hn influenza vaccin adult children ag year australia accept novel vaccin influenc percept risk includ risk infect risk death sever ill risk seriou vaccin sideeffect survei sampl resid sydnei australia ascertain risk percept attitud pandem willing accept pandem hn influenza vaccin method sampl resid crosssect intercept design phase member public approach shop pedestrian mall undertak survei septemb octob survei measur perceiv risk serious diseas behaviour chang accept pandem hn vaccin issu relat uptak perceiv safeti respond major felt low low risk acquir hn respond believ diseas serious extrem affect health half report respons swine flu outbreak undertaken investig behaviour chang selfreport likelihood accept vaccin novel hn conclus particip high risk acquir pandem hn half sampl indic accept vaccin particip vaccin season influenza receiv hn vaccin concern safeti possibl side effect vaccin develop process address
J Oncol	12885925	2006-08-01	PMC2864512	20454584	solid tumor recruit blood vessel support growth uniqu molecul express tumor endotheli cell function target antiangiogen therapi cancer current effort focus develop therapeut agent capabl target cancer cell tumorassoci microenviron includ tumor blood vessel therapi hold promis high efficaci low toxic recogn strategi improv therapeut effect convent chemotherapeut encapsul anticanc drug target liposom bind cell surfac receptor express tumorassoci endotheli cell antiangiogen drug deliveri system target tumor blood vessel tumor cell articl review mechan advantag potenti method peptideconjug liposom destroi tumor blood vessel anticanc therapi
BMC Cancer	16886061	2010-11-03	PMC2868050	20346172	background clinic cours human papillomaviru hpv associ bowenoid papulosi condyloma acuminatum anogenit tumor unknown evalu molecul relev cellular prolifer regul apoptosi hpv associ anogenit tumor method investig level telomeras activ inhibitor apoptosi protein iap famili ciap ciap xiap cmyc mrna express level specimen bowenoid papulosi specimen condyloma acuminatum anogenit area phosphoryl akt pribosom protein s pebind protein ebp express level examin immunohistochemistri anogenit tumor posit telomeras activ posit telomeras activ detect bowenoid papulosi condyloma acuminatum compar normal skin contrast express level bowenoid papulosi indic ciap ciap xiap mrna upregul compar condyloma acuminatum sampl p normal skin p bowenoid papulosi high risk hpv promot iap famili cmyc condyloma acuminatum activ gene immunohistochem pakt ps express associ posit telomeras activ pebp express conclus combin analysi iap famili cmyc mrna express telomeras activ level paktp express provid clinic relev molecular marker hpv associ anogenit tumor
Int J Mol Sci	21048012	2011-09-06	PMC2869232	20480005	a shortcom correl distanc method base composit vector align develop phylogenet analysi complet genom distanc proper distanc metric strict mathemat sens paper propos correlationrel distanc metric replac dynam languag approach genom dataset emploi evalu effect replac biolog point view find proper distanc metric yield tree topolog asto distanc agre tree life base rrna major basic branch proper correlationrel distanc metric propos improv dynam languag approach phylogenet analysi
Int J Mol Sci	21900274	2014-01-27	PMC2869241	20479989	andrographolid deriv inhibit glucosidas investig relationship activ structur andrographolid deriv train set chosen andrographolid deriv princip compon analysi pca method quantit structureact relationship qsar establish d qsar method crossvalid standard error illustr dqsar model identifi molecular fragment crossvalid standard error demonstr dqsar model capabl explor spatial distribut fragment suggest propos combin d qsar model predict glucosidas inhibit activ andrographolid deriv
PLoS One	24490814	2005-11-23	PMC2871037	20498717	background highli pathogen avian influenza hpai viru hn multiorgan diseas death poultri econom loss poultri industri addit pose major public health threat transmit directli infect poultri human high mortal rate effect vaccin hpai hn protect commerci poultri provid control measur reduc likelihood birdtobird birdtohuman transmiss methodologyprincip find studi evalu vaccin potenti recombin solubl trimer subtyp hemagglutinin sh produc mammalian cell secret purifi sh biolog activ demonstr bind ligand sialic aciddepend manner protect chicken dosedepend manner lethal challeng hn singl vaccin protect anim challeng viru determin quantit rtpcr rna isol trachea cloaca swab mice vaccin sh provid complet protect challeng hpai hn conclusionssignific demonstr sh constitut attract vaccin antigen protect chicken mammal hpai hn recombin solubl hemagglutinin prepar produc high yield short lead time enabl rapid respons circul pandem influenza virus
PLoS One	16306602	2012-03-20	PMC2871038	20498718	background pandem influenza hn viru emerg help clinician triag adult acut respiratori ill score system influenzalik ill ili implement hospit civil de guadalajara mexico method medic histori laboratori radiolog collect emerg room er patient acut respiratori ill calcul iliscor patient evalu admiss iliscor clinician assess risk develop complic nasal throat swab collect intermedi highrisk patient influenza test rtpcr disposit iliscor oseltamivirtr versu untreat clinic characterist pandem influenza hn patient versu testneg patient compar pearson fisher exact wilcoxon ranksum test er patient initi hospit iliscor rest discharg includ ambulatori patient oseltamivir median iliscor untreat median iliscor fourteen untreat patient return hospit oseltamivir median iliscor patient test rtpcr pandem influenza season influenza detect twenti imag hospit pandem influenza patient bilater infiltr compar imag hospit testneg patient patient confirm pandem influenza present dai symptom onset requir mechan ventil di conclus triag system iliscor compliment clinician judgment need oseltamivir inpati care help hospit staff manag surg demand servic
BMC Microbiol	22605688	2007-08-22	PMC2871271	20406467	background carcinoembryon antigenrel cell adhes molecul ceacam immunoglobulin igrel glycoprotein serv cellular receptor varieti gramneg bacteri pathogen associ human mucosa neisseria gonorrhoea meningitidi moraxella catarrhali haemophilu influenza possess wellcharacter ceacambind adhesin ceacam typic involv cellcel attach epitheli differenti neovascularis regul tcell prolifer ceacam famili member homologu mammalian lineag unknown bacteri adhesin human pathogen recogn ceacam orthologu mammal sequenc comparison aminotermin igvariablelik domain ceacam reveal highest sequenc diverg human murin canin bovin orthologu strand compris bacteriabind ccfgface igfold gfptag solubl aminotermin domain ceacam demonstr bacteri pathogen select associ human mammalian ceacam orthologu fulllength human ceacam mediat intern neisseria gonorrhoea transfect cell murin ceacam fail support bacteri intern demonstr sequenc diverg ceacam orthologu function consequ regard bacteri recognit cellular invas conclus establish select interact humanrestrict bacteri pathogen human ceacam coevolut microbi adhesin correspond receptor mammalian cell contribut limit host rang highli adapt infecti agent
PLoS Negl Trop Dis	17715238	2016-07-20	PMC2872638	20502515	background ultrasonographi allow noninvas examin liver spleen understand schistosomiasi morbid methodologyprincip find peopl southwest china year particip test schistosoma japonicum infect stool standard measur liver spleen ultrasound evalu relationship schistosomiasi infect ultrasounddetect patholog impact target treatment morbid parenchym fibrosi network pattern liver uniqu japonicum associ infect time ultrasound ci infect intens test trend adjust ag sex year associ prior infect statu intens adjust ci test trend despit prompt treatment infect declin parenchym fibrosi time statist individu sever parenchym fibrosi grade enrol revers normal grade year liver abnorm consist associ japonicum infect conclusionssignific parenchym fibrosi appropri measur japonicum morbid document reduct diseas control effort ultrasound measur limit epidemiolog region infect level sever fibrosi revers treatment effort reduc exposur japonicum consid combin treatment prevent schistosomiasi morbid
PLoS Negl Trop Dis	27440901	2009-02-01	PMC2872645	20502522	vener syphili multistag sexual transmit diseas caus spirochet bacterium treponema pallidum tp describ cohort patient ag year secondari syphili ss identifi network public sector primari health care provid cali colombia elig particip studi subject requir cutan lesion consist ss reactiv rapid plasma reagin test rprtiter confirmatori treponem test fluoresc treponem antibodi absorpt test ftaab subject enrol women afrocolombian mestizo low socioeconom statu three subject newli diagnos hiv infect studi entri durat sign symptom patient dai patient report symptomat month rang dai typic palmar plantar exanthem ss common dermal manifest diffus hypo hyperpig macul papul trunk abdomen extrem three patient patchi alopecia blood wb sampl punch biopsi materi subset ss patient assai presenc tp dna polymeras gene pola target realtim qualit quantit pcr method twelv wb sampl studi quantifi tp dna rang tp pola copiesml blood posit wb dna extract hour collect tp dna skin biopsi test strain type analysi attempt skin wb sampl detect tp dna arp repeat size analysi tpr rflp pattern strain type identifi d wb sampl suffici dna type clinic microbiolog observ present cali syphili seropreval data provid addit evid vener syphili highli endem region colombia underscor health care provid region acut awar clinic manifest ss studi time quantit evid proport untreat ss patient substanti number circul spirochet tp persist blood skin ss patient despit presenc circul treponem opson antibodi robust proinflammatori cellular immun respons characterist stage diseas fulli understood requir studi
PLoS One	19047579	2001-08-15	PMC2872666	20502691	background sever diseas patient infect pandem influenza viru unclear methodologyprincip find cellular immunolog profil blood detail clinic postmortem find three patient rapidli progress infect includ pregnant patient di strike find reduct natur killer nk cell preserv activ effector cd lymphocyt viraemia patient nk cell comparison control group suggest reduct nk cell uniqu sever patient conclusionsignific report markedli reduc nk cell three patient sampl rais hypothesi nk role lymphocyt control viral burden host confront influenza viru subtyp
BMC Res Notes	11462055	2006-04-26	PMC2873344	20398263	background limit number speci specif antibodi fish protein differenti gene express analys vital studi host immun respons quantit realtim revers transcript pcr qrtpcr power tool purpos accuraci method will depend care select gene express stabl intern control experiment set find express stabil commonli housekeep gene betaactin actb elong factor alpha efa ubiquitin ubq glyceraldehydphosph dehydrogenas gapdh tubulin alpha tuba monitor salmonid cell line chse rt infect fastidi fish pathogen facult bacterium piscirickettsia salmoni aquabirnaviru ipnv infecti pancreat necrosi viru genorm analysi ubq efa appear stabl efa upregul late stage salmoni infect rt actb good perform case consid three stabl gene panel contrast infectiondepend differenti regul gapdh tuba demonstr conclus base data present cell cultur model chse rt initi choic ubq actb efa refer gene qrtpcr assai studi salmoni ipnv host immun respons
Virol J	16641296	2009-04-13	PMC2873380	20433729	thi studi evalu effici pediatr midturbin nasal flock swab parent children ag month year sign symptom respiratori diseas nasal sampl collect child randomis sequenc train pediatrician parent realtim polymeras chain reaction influenza viru detect rate sampl collect method cohen kappa cycl threshold valu comparison pediatriciancollect sampl sensit specif parent collect confid interv ci ci posit neg predict valu ci ci children satisfi parent collect median valu standard deviat find midturbin nasal flock swab design infant children parent reduc influenza viru detect rate direct involv parent increas patient accept simplifi collect suggest novel swab design consid epidemiolog survei vaccin efficaci studi
PLoS One	19364769	2013-01-01	PMC2873403	20502660	background toronto sar outbreak sarscov transmit hospit despit adher infect control procedur consider controversi procedur behaviour associ greatest risk sarscov transmiss method retrospect cohort studi conduct identifi risk factor transmiss sarscov intub laboratori confirm sar patient hcw involv care sar patient requir intub toronto outbreak identifi hcw provid care intub sar patient treatment transport enter patient room direct patient contact hour hour intub elig studi data collect patient chart review hcw intervieweradminist questionnair gener estim equat gee logist regress model classif regress tree cart identifi risk factor sar transmiss laboratoryconfirm intub sar patient identifi hcw involv care particip studi sarscov transmit hcw patient hcw infect patient multivari gee logist regress model presenc room fiberopt intub ecg unprotect ey contact secret patient apach ii score patient pafi ratio associ increas risk transmiss sarscov cart analys covari explain greatest amount variat sarscov transmiss covari repres individu patient conclus close contact airwai sever patient failur infect control practic prevent exposur respiratori secret associ transmiss sarscov rate transmiss sarscov vari patient
BMC Genomics	23207147	2015-07-10	PMC2873475	20403183	background ferret mustela putoriu furo repres attract anim model studi respiratori diseas includ influenza despit biomed number reagent molecular immunolog analysi restrict parallel sequenc effort produc extens est express sequenc tag dataset deriv normal ferret cdna librari mrna ferret blood liver lung spleen brain produc sequenc read assembl partial ferret gene gene combin ferret sequenc genbank develop ferret specif microarrai platform arrai detect tissu specif express pattern confirm quantit real time pcr assai set ferret gene transcript profil test tissu indic housekeep gene conclus tool develop studi allow function genom analysi develop reagent ferret model possibl
J Biomed Sci	26160613	2002-04-15	PMC2873498	20426849	background urgent develop innov therapi control advanc cancer combin antigenspecif immunotherapi employ immunomodulatori agent emerg plausibl approach control advanc cancer method current studi explor combin dna vaccin encod calreticulin crt link human papillomaviru type hpv antigen crte tlr agonist imiquimod abil gener especif immun respons antitumor effect tumorbear mice observ treatment crte dna combin imiquimod lead enhanc especif cd cell immun respons decreas number myeloidderiv suppressor cell tumor microenviron tumorbear mice treatment crte dna combin imiquimod lead improv antitumor effect prolong surviv treat mice addit treatment imiquimod led increas number nk cell cell tumor microenviron macrophag nk cell plai role antitumor effect mediat treatment crte dna combin imiquimod conclus data suggest combin therapeut hpv dna vaccin topic treatment tlr agonist imiquimod enhanc antitumor immun induc dna vaccin current studi implic futur clinic translat
BMC Public Health	11907209	2008-10-01	PMC2874530	20385030	background effici plan appropri public health intervent epidem govern consider factor gener popul knowledg epidem fear psycholog respons level complianc govern measur commun trust sourc survei french gener popul rare method crosssect studi conduct in repres sampl subject live rhnealp region southeast franc investig selfreport knowledg infecti diseas anxieti gener epidem risk refer avian influenza data reaction epidem confid level sourc collect respond knowledg aid avian influenza respond adequ knowledg avian influenza percentag higher inhabit ain district avian influenza epidem report express anxieti diseas total respond knowledg avian influenza state chang behaviour epizooti epidem perceiv real threat respond event highli contagi outbreak major respond follow advic author studi popul express high level confid physician scientist strong reserv politician deputi media conclus survei conduct month avian influenza outbreak epidem perceiv major threat studi popul the event highli infecti diseas popul compli advic public author
BMC Bioinformatics	18632980	2012-06-15	PMC2874555	20423529	background updat am algorithm identif posttransl modif ptm site protein base sequenc artifici neural network ann method queri protein sequenc dissect overlap short sequenc segment ten physicochem featur describ amino acid residu long segment repres point dimension space databas sequenc segment confirm experi posttransl modif site train set ann effici classif type modif predict power method estim recal sensit precis valu area receiv oper characterist roc curv leaveoneout test loocv differ perform differ optim neural network observ am tool integr heterogen classif scheme singl consensu scheme boost precis recal valu independ ptm type comparison current stateofth art method conclus standalon version am present effici indentifi posttransl modif proteom train dataset precompil binari am tool sourc code httpcodegooglecompautomotifserv apach licens scheme
PLoS Med	22706063	2018-07-02	PMC2876121	20520802	in wake sar epidem hn pandem plo medicin editor journal publish effici mechan share
PLoS Pathog	29967306	2009-06-08	PMC2880586	20532161	rotavirus lead sever dehydr diarrhea children worldwid rotavirusinduc immun respons cell respons extens character innat immun mechan involv control rotaviru infect increas level system type interferon ifn correl acceler resolut rotaviru diseas multipl rotaviru strain includ rhesu rotaviru rrv demonstr antagon type ifn product varieti epitheli fibroblast cell type mechan includ degrad multipl interferon regulatori factor viral nonstructur protein report demonstr stimul highli purifi primari human peripher plasmacytoid dendrit cell pdc live inactiv rrv induc substanti ifn product subset pdc rrv replic character pdc respons viral stimulu flow cytometri luminex reveal rrv replic small subset human primari pdc rrvpermiss small subset ifn product diminish pdc activ matur observ independ viral replic enhanc cell viru replic product ifn pdc rrv exposur requir viral dsrna surfac protein viral replic activ trypsin cleavag vp demonstr minor subset purifi primari human peripher pdc permiss rrv infect pdc retain function rrv stimulu addition studi demonstr trypsinindepend infect primari peripher cell rotaviru allow establish extraintestin viremia antigenemia importantli data provid evid ifn induct primari human pdc dsrna viru simultan demonstr impair ifn product primari human cell rrv replic rotaviru infect primari human pdc power experiment system studi mechan underli pdcmediat innat immun viral infect reveal novel dsrnadepend pathwai ifn induct
Virol J	19506055	2003-01-15	PMC2880969	20433759	a multiplex revers transcriptionnest polymeras chain reaction rtnpcr method develop detect differenti wildtyp vaccin strain canin distemp viru cdv pair primer p specif cdv correspond highli conserv region cdv genom common primer pair firstround pcr nest pcr primer specif cdv wildtyp strain forward primer common revers primer second round nest pcr primer p specif cdv wildtyp strain vaccin strain forward primer common revers primer second round nest pcr fragment bp amplifi vaccin strain genom rna fragment bp wildtyp strain genom rna rtnpcr fragment bp bp amplifi mix sampl vaccin wildtyp strain amplif achiev uninfect cell cell infect newcastl diseas viru ndv canin parvoviru cpv canin coronaviru ccv rabi viru rv canin adenoviru cav rtnpcr method detect field sampl suspect canin distemp heilongjiang jilin provinc sampl shandong provinc result sampl wildtypelik vaccinestrainlik rtnpcr method effect detect differenti wildtyp cdvinfect dog dog vaccin cdv vaccin clinic detect epidemiolog surveil
BMC Infect Dis	12502800	2011-12-22	PMC2881921	20459845	background influenza includ avian influenza major public health threat develop develop countri rapid accur detect kei compon strategi spread infect effici diagnosi influenzalikeil essenti protect health infrastructur event major influenza outbreak method develop multiplex pcr mtpcr assai simultan diagnosi respiratori virus caus influenzalik ill includ specif recognit influenza haemagglutinin subtyp h test clinic specimen diagnost refer laboratori compar standard techniqu sensit specif assai higher individu assai base direct antigen detect standard pcr rang control templat clinic specimen mtpcr assai provid differenti diagnos quantit viru clinic sampl conclus mtpcr power tool differenti diagnosi influenzalik ill clinic diagnost laboratori
PLoS Pathog	22194291	2005-10-27	PMC2883599	20548955	antivir monoclon antibodi mab repres promis therapeut mabsbas immunotherapi conduct consid blunt viral propag therapeut effect independ viru neutral modul endogen immun respons induct longterm antivir immun remain paramount challeng treat chronic infect ask neutral mab addit blunt viral propag exert immunomodulatori effect protect outcom support idea report mice infect frcase murin retroviru dai birth die leukemia month mount nonprotect immun respons rapidli subject short immunotherapi neutral mab surviv healthi mount longlast protect antivir immun strong humor cellular immun respons interestingli administ mab mediat lysi infect cell antibodydepend cell cytotox adcc mechan addit form immun complex ic infect cell enhanc antivir ctl respons fcrmediat bind dendrit cell dc importantli endogen antivir antibodi gener mabtreat mice displai properti allow contain viral propag enhanc memori cellular respons disappear administ mab data demonstr neutral antivir mab immunomodulatori agent capabl stimul protect immun last long the treatment role infectedcellsantibodi complex induct mainten protect immun enhanc primari memori antivir tcell respons indic target infect cell virus antibodi crucial elicit effici longlast antivir tcell respons consid design antivir mabbas immunotherapi
BMC Genet	16254327	2013-12-01	PMC2885306	20465856	background polymorph mannosebind lectin gene mbl affect concentr function effici protein haplotypespecif sequenc identifi mbl haplotyp associ enhanc suscept diseas work appli method chromosom gabones european adult three haplotyp group propos phylogenet nomenclatur standard mbl studi major phylogenet branch link polymorph associ high mbl product present high fst valu imbed region high nucleotid divers tajima valu compar small sampl size unphas genotyp data differ haplotyp frequenc estim fu li fst conclus extens test select neutral confirm stochast evolutionari factor major role shape polymorph gene worldwid
Retrovirology	23804121	2011-06-15	PMC2885308	20482880	background platelet associ hiv blood infect individu modul viral dissemin viru directli transmit bloodstream ctype lectin dcsign novel hiv attach factor clec express platelet facilit hiv transmiss platelet tcell studi molecular mechan clecmedi hiv transmiss bind studi solubl protein indic clec contrast dcsign recogn viral envelop protein cellular factor express kidneyderiv cell subsequ analys reveal cellular mucinlik membran glycoprotein podoplanin clec ligand express cell incorpor virion releas cell knockdown podoplanin cell shrna virion incorpor podoplanin requir effici clecdepend hiv interact cell line platelet flow cytometri reveal evid podoplanin express viabl tcell peripher blood mononuclear cell pbmc podoplanin detect hiv infect tcell apoptot bystand cell hiv infect cultur react antipodoplanin antibodi induct apoptosi cell pbmc suggest unexpect link apoptosi podoplanin express despit absenc detect podoplanin express hiv produc pbmc transmit tcell clecdepend manner indic tcell express unidentifi clec ligand conclus virion incorpor podoplanin mediat clec interact hiv deriv cell incorpor cellular factor respons clecdepend captur pbmcderiv virus evid podoplanin express connect apoptosi find deserv investig
Virol J	21680512	2013-09-17	PMC2885340	20459851	hand foot mouth diseas hfmd common contagi diseas children mild lifethreaten manifest caus enterovirus coxsackievirus human enteroviru hev highli variabl clinic manifest spring larg unpreced hfmd outbreak fuyang citi anhui provinc central southeastern china high aggreg fatal case studi epidemiolog clinic investig laboratori test genet analys perform identifi causal pathogen outbreak case report march hospit sever fatal hev confirm etiolog pathogen outbreak phylogenet analys entir vp capsid protein sequenc fuyang hev isol belong cluster subgenotyp addit genet recombin region rnadepend rna polymeras major compon viral replic complex genom fuyang hev strain coxsackieviru cva recombin viru conclus emerg recombin hev respons hfmd outbreak fuyang citi china 
BMC Infect Dis	24045953	2016-12-15	PMC2885389	20462419	background avian influenza ai public health challeng ongo spread pandem potenti nonpharmaceut measur prevent spread ai pandem effect measur depend behaviour popul risk percept central element chang behaviour studi aim investig perceiv vulner sever precautionari behaviour ai netherland consecut survei trend risk percept selfreport precautionari behaviour method webbas survei conduct includ respond oneyear period time trend analyz linear regress analys multivari analysi studi determin precautionari behaviour infect ai consid sever health problem score scale perceiv vulner lower score perceiv sever remain high perceiv vulner decreas oneyear period cover half respond report prevent measur report stai wild bird poultri multivari logist regress analysi factor associ prevent measur time survei higher ag lower level educ nondutch ethnic vaccin influenza higher perceiv sever higher perceiv vulner higher efficaci lower level knowledg ai think ai efficaci stronger predictor precautionari behaviour seldom ai ci compar ai ci conclus fact perceiv sever ai appear high remain time offer good point departur specif risk commun promot precautionari action commun aim improv knowledg diseas prevent action focu perceiv person vulner efficaci prevent measur
PLoS One	28087713	2011-04-13	PMC2885414	20559424	background declin serum concentr hydroxyvitamin fall winter distanc increas equat factor season increas preval influenza viral infect studi determin serum hydroxyvitamin concentr correl incid acut viral respiratori tract infect methodologyfind prospect cohort studi serial monthli concentr hydroxyvitamin measur fall winter healthi adult blind natur substanc measur particip evalu develop acut respiratori tract infect investig blind hydroxyvitamin concentr incid infect particip concentr vitamin determin ninetyf enrol particip complet studi light skin pigment lean bodi mass supplement vitamin correl higher concentr hydroxyvitamin concentr ngml associ twofold reduct risk develop acut respiratori tract infect mark reduct percentag dai conclusionssignific mainten hydroxyvitamin serum concentr ngml higher reduc incid acut viral respiratori tract infect burden ill caus fall winter temper zone find studi provid direct call futur intervent studi examin efficaci vitamin supplement reduc incid sever specif viral infect includ influenza gener popul subpopul lower hydroxyvitamin concentr pregnant women dark skin individu obes
BMC Genomics	21490188	2005-07-13	PMC2886062	20423525	background glycyrrhiza uralensi popular medicin plant flavor food tobacco limit genom transcriptom data biosynthet pathwai glycyrrhizin major bioactiv compound uralensi current unclear identif candid gene involv glycyrrhizin biosynthet pathwai will contribut understand biosynthet medicin chemistri compound gs flx platform titanium regent produc substanti express sequenc tag est dataset veget organ uralensi total est averag read length bp gener est combin uralensi est genbank combin est assembl uniqu sequenc contig singleton total uniqu gene element repres independ transcript annot blast search evalu swissprot kegg tair nr nt databas assembl sequenc annot gene name gene ontolog term respect gene glycyrrhizin metabol gene encod enzym total step glycyrrhizin skeleton synthesi pathwai identifi novel gene encod cytochrom enzym glycosyltransferas glycyrrhizin metabol total unigen homolog cytochrom ps glycosyltransferas cytochrom candid gene classifi cyp famili glycosyltransferas candid gene classifi categori analysi final cytochrom enzym glycosyltransferas select candid involv glycyrrhizin biosynthesi organspecif express pattern analysi base realtim pcr conclus gs flx platform titanium reagent studi highqual est databas uralensi base est analysi novel candid gene secondari metabolit pathwai glycyrrhizin includ novel gene encod cytochrom ps glycosyltransferas assist organspecif express pattern analysi unigen encod cytochrom ps unigen encod glycosyltransferas select candid involv glycyrrhizin biosynthesi
J Gen Virol	16014939	2001-03-01	PMC2886958	18931070	although group coronavirus sever acut respiratori syndromecoronaviru sarscov nl receptor angiotensin convert enzym ac entri host cell despit common receptor consequ entri sever respiratori distress case sarscov frequent mild respiratori infect nl wholli recombin system investig abil viru receptorbind protein spike protein bind ac solut cell surfac assai find nl protein weaker interact ac sarscov protein solut bind residu requir contact confirm acebind site nl li residu loweraffin interact ac partli explain patholog consequ infect sarscov nl
PLoS One	11238222	2011-09-07	PMC2887847	20585451	background decad increas interest lactic acid bacteria mucos deliveri vehicl vaccin antigen microbicid therapeut investig mechan mucos vaccin base recombin lactic acid bacteria break immunolog toler gut order elicit protect immun respons methodologyprincip find analyz lipid modif ospa local antigen deliveri vehicl number biochemistri techniqu examin ospaexpress plantarum break oral toler gut stimul human intestin epitheli cell peripher blood mononuclear cell monocyt deriv dendrit cell measur cytokin product leader peptid ospa target protein cell envelop plantarum respons protein export membran mutat lipid site ospa redirect protein local cell envelop lipidatedospaexpress plantarum induc secret proinflammatori cytokin il intestin epitheli cell addit break oral toler gut thth cell mediat immun product pro antiinflammatori cytokin human dendrit cell product igga igg antibodi conclusionssignific lipid modif ospa express plantarum modul immun respons antigen thth immun respons
PLoS Negl Trop Dis	21900533	2009-08-01	PMC2889823	20582307	background import case threaten rabi reemerg rabiesfre area dog human rabi case import franc rabiesfre countri summer event led unpreced media warn french public health director investig medic practic evolut offici elimin rabi impact subsequ episod rabi import nation newspap coverag demand deliveri antirabi prophylaxi regular transmiss epidemiolog develop french antirabi medic center armc network armc discuss indic rabi postexposur prophylaxi rpep methodologyprincip find annual data collect nation refer center rabi nrcr exhaust databas armc analyz weekli number patient consult armc rpep antirabiesimmunoglobulin arig prescript rate determin autoregress integr movingaverag model regress autocorrel error appli examin episod rabi event nation newspap coverag demand deliveri rpep slight continu declin rabiesded public health facil attend observ summer event patient consult rpep arig prescript increas elev medic resourc persist despit commun effort secondari human anim case conclus find demonstr appropri respons reemerg rabi case effect newspap report secondari case occur ensu demand medic resourc longlast effect rabiesrel public health resourc expens henceforth face event decisionmak anticip broad impact media commun counter emerg risk maintain optim public health organ implement postcrisi commun strategi
PLoS Negl Trop Dis	19728527	2007-12-26	PMC2889824	20582308	viral fusogen envelop protein target develop inhibitor viral entri report approach comput design peptid inhibitor dengu viru denv envelop protein highresolut structur data preentri dimer form protein predict strategi comput optim bind pseudoenergi design multipl peptid sequenc low micromolar viral entri inhibitori activ activ peptid dnopt oan design displac region domain ii hing domain idomain ii beta sheet connect fifti percent inhibitori concentr focu form unit assai antivir peptid interfer viruscel bind interact directli protein chang viral surfac biolay interferometri cryoelectron microscopi peptid character intermedi state membran fusion process investig denv receptor molecul lead compound drug discoveri
BMC Cancer	18160451	2001-03-15	PMC2891641	20537192	background genet test hereditari colorect cancer hcrc psycholog consequ test recipi prospect longitudin studi investig factor predict psycholog resili adult undergo genet test hcrc method longitudin studi carri april august hong kong chines hcrc famili member recruit offer genet test hereditari gastrointestin cancer registri determin psycholog outcom genet test selfcomplet questionnair administ predisclosur baselin week month year result disclosur valid psycholog inventori cognit style hope measur baselin psycholog distress depress anxieti measur time point particip subject individu men women ag year fap hnpcc famili complet studi includ mutat gene carrier pattern outcom trajectori creat establish norm outcom measur depress anxieti includ chronic dysfunct recoveri delai dysfunct and resili logist regress analys conduct hope baselin predict resili depress anxieti emploi outcom indic small number particip chronic dysfunct delai dysfunct group combin nonresili group comparison resili group subsequ analysi low frequenc particip exhibit recoveri trajectori anxieti depress exclud analysi regress equat baselin hope predictor resili outcom trajectori depress depress anxieti anxieti conclus current find hope predict resili hcrc genet test hong kong chines intervent increas level hope benefici psycholog adjust crc genet test recipi
BMC Infect Dis	11222704	2011-03-01	PMC2891756	20509887	background sar pandem hong kong panic worri preval commun gener public avoid stai public area avoid behavior greatli impact daili routin commun local economi studi examin preval avoid behavior avoid go visit crowd place visit hospit neg psycholog respons gener popul hong kong initi stage hn epidem method sampl respond recruit populationbas survei random telephon number respond complet structur questionnair telephon interview precommun spread phase hn epidem hong kong studi respond current avoid go visit crowd place hospit whilst felt worri contract hn sign emot distress femal older respond unconfirm belief mode transmiss feel worri emotion distress hn outbreak adopt avoid behavior perceiv high sever suscept hn doubt adequaci government prepared feel emotion distress conclus preval avoid behavior high cognit includ unconfirm belief mode transmiss perceiv sever suscept associ avoid behavior emot distress variabl public health educ provid clear messag rectifi relev percept
Acta Vet Scand	21233434	2014-04-23	PMC2891787	20525326	background bovin respiratori syncyti viru brsv bovin corona viru bcv cattl worldwid object evalu effect infect gener health reproduct paramet measur herd level explor associ antibodi statu herd characterist method collect pool milk sampl primipar cow swedish dairi herd septemb sampl analys immunoglobulin antibodi bcv brsv indirect enzymelink immunosorb assai herd level data septemb august access retrospect locat herd map geograph system ten herd antibodi neg virus compar herd posit bcv brsv posit herd higher bulk tank milk somat cell count bmscc compar neg herd median analyz health reproduct paramet consist favour herd neg virus differ statist higher proport herd profession technician artifici insemin farm personnel herd neg bcv compar posit herd conclus result herd antibodi posit bcv andor brsv higher bmscc compar herd neg bcv brsv tendenc neg herd better gener herd health compar posit higher proport bcv neg herd extern technician ai farm personnel indic avoid infect regular visit neg herd locat close proxim posit herd indic local spread airborn transmiss herd great herd stai free infect transmiss viru circul area
PLoS One	23529928	2004-09-27	PMC2891989	20585574	background hospitalacquir infect nosocomi pneumonia seriou mortal hospit patient admit intens care unit icu despit number studi report caus agent pneumonia complet molecular techniqu veget tobacco dna detect bronchoalveolar lavag patient ventilatorassoci pneumonia vap methodologyprincip find studi studi bronchoalveolar lavag bal patient admit icu ventilatorassoci pneumonia bal fluid assess molecular test cultur blood cultur identifi plant dna patient ventilatorassoci pneumonia inhal confirm case suspect case inhal frequent patient plant dna patient plant dna three patient nicotiana tabacum chloroplast dna identifi three patient smoker case cucurbita pepo moru bombyci triticum aestivum dna identifi case twentythre bacteri speci virus fungal speci identifi patient molecular cultur techniqu pathogen microorgan identifi report foodborn tobacco plantassoci pathogen conclusionssignific studi plant dna identifi bal fluid pneumonia patient explor aspir pneumonia signific presenc plant dna role pathogenesi pneumonia unknown remain investig identif plant potenti marker aspir patient pneumonia
PLoS One	15452254	2011-03-28	PMC2892040	20585587	background prgag gag polyprotein hiv serv scaffold virion assembl essenti progeni virion bud matur gag local plasma membran pm membran late endosom allow releas infecti viru directli cell membran andor exocytosi host factor involv gag traffick site unknown activ cd cell primari target hiv infect express class ii transcript activ ciita mhc class ii isotyp hladr gag hladr local pm membran endosom special vesicular mhc class ii compart miic hiv produc cell transient hladr express induc intracellular gag accumul impair viru releas methodologyprincip find demonstr stabl transient express ciita hiv produc cell induc hladrassoci intracellular retent gag increas infect virion phenomena recapitul class ii antigen present pathwai ciitamedi transcript activ viru gene interestingli demonstr ciita apart transcript effect act cytoplasm enhanc prgagpol gagpol level viral proteas gag process account increas infect virion ciitaexpress cell conclusionssignific studi demonstr ciita enhanc hiv gag process evid novel posttranscript cytoplasm function wellknown transactiv
Virol J	21444809	2005-11-01	PMC2892456	20515509	a duplex realtim revers transcriptas polymeras chain reaction rtpcr assai improv simultan detect highli pathogen hn avian influenza viru pandem hn influenza viru suitabl earli diagnosi influenzalik patient epidemiolog surveil sensit duplex realtim rtpcr assai tcid tissu cultur infect dose hn tcid pandem hn singletarget rtpcr pandem hn sensit hn primer probe cross reactiv detect subtyp influenza virus respiratori tract virus observ thirtysix clinic specimen test compar singl realtim rtpcr result duplex assai consist singl realtim rtpcr sequenc analysi
PLoS One	16272506	2012-06-08	PMC2892467	20592764	public health administr effect model predict excess influenzaassoci mortal monitor viral chang associ studi evalu matchingmismatch vaccin strain typesubtyp pattern chang taiwan influenza virus impact postsar sever acut respiratori syndrom public health effort excess influenzaassoci mortal elderli neg binomi model develop estim taiwan monthli influenzaassoci mortal elderli calcul three winter annual excess influenzaassoci mortal pneumonia influenza pi respiratori circulatori allcaus influenza season obtain influenza viru sequenc monthsyear death pi excess investig molecular variat vaccinemismatch influenza virus compar hemagglutinin ha circul vaccin strain higher isol rate hn vaccinemismatch influenza virus greater monthli pi mortal posit associ neg higher match hn public health effort postsar excess pi mortal winter higher year sd analysi reveal vaccinematch circul influenza virus associ lower excess pi mortal postsar winter presar winter stratif vaccinematch postsar substanti trend lower elderli excess pi mortal winter mismatch vaccin postsar period match vaccin presar period importantli three excess mortal highest interhospit nosocomi infect peak vaccinemismatch hn virus circul year high excess pi mortal exhibit lower amino acid ident percentag ha vaccin circul strain higher number variat epitop model help futur decis maker estim excess pi mortal effect select test viru strain antigen variat evalu public health strategi effect
PLoS One	22685135	2010-03-01	PMC2892511	20593027	varicellazost viru vzv glycoprotein ge essenti viru infect bind cellular receptor insulindegrad enzym id uniqu amino termin extracellular domain previou work id plai role vzv infect viru celltocel spread sole rout vzv spread vitro report recombin solubl id ride enhanc vzv infect earli step infect associ increas viru intern increas celltocel spread vzv mutant lack id bind domain ge impair syncytia format membran fusion pretreat cellfre vzv ride markedli enhanc stabil viru rang condit ride interact ge elicit conform chang ge render suscept proteolysi coincub ride ge modifi size ge propos conform chang ge elicit id enhanc infect stabil viru lead increas fusogen vzv infect abil ride enhanc infect cellfre vzv wide rang incub time temperatur suggest ride increas stabil varicella zoster vaccin
Virol J	20070197	2016-06-16	PMC2893155	20470403	background year attent spread influenza continu human outbreak hn hn pandem focu influenza respiratori virus increas accept decad intern travel jet aircraft major vector global spread influenza epidemiolog differ tropic temper region observ want studi indoor environment condit enclos locat tropic winter temper zone contribut aerosol spread influenza travel survei consist read temperatur versu rel humid rh enclos locat air travel visit tropic nation compar read australian citi includ ground transport hotel shop offic publicli access locat time cours read aircraft influenza transmiss risk contour map develop versu rh empir equat creat estim risk rel temperatur rh time parameter influenza transmiss risk transmiss risk contour equat transmiss risk countri locat compar influenza report countri higher risk enclos locat tropic includ automobil transport luxuri buse luxuri hotel bank branch temper locat high risk conclus environment control recommend public health mitig focus higher risk enclos locat public health method develop track potenti vulner aerosol influenza method present influenza model account differenti aerosol transmiss rh explain anomali influenza epidemiolog addit season temper climat
PLoS One	27312869	2008-06-25	PMC2893165	20596532	background function role elrposit cxc chemokin viral induc demyelin assess inocul neuroattenu jhm strain mous hepat viru jhmv cn suscept mice acut encephalomyel evolv chronic demyelin diseas model white matter patholog observ human demyelin diseas multipl sclerosi methodologyprincip find jhmv infect induc rapid sustain express transcript specif elr chemokin ligand cxcl cxcl bind receptor cxcr enrich spinal cord chronic infect inhibit cxcr signal neutral antiserum delai clinic recoveri cxcr neutral associ increas sever demyelin independ viral recrudesc modul neuroinflamm block cxcr associ increas number apoptot cell white matter tract suggest oligodendrocyt jhmv infect enrich oligodendrocyt progenitor cell opc cultur reveal apoptosi associ elev express cleav caspas mute bcl express inclus cxcl jhmv infect cultur restrict caspas cleavag increas bcl express associ decreas apoptosi cxcr defici oligodendrocyt refractori cxcl mediat protect jhmv induc apoptosi activ caspas regul bcl conclusionsignific find highlight unappreci role cxcr signal protect oligodendrocyt lineag cell apoptosi inflammatori demyelin initi viral infect cn
PLoS One	18579604	2012-07-30	PMC2893203	20596536	background midjun state victoria australia appear highest notif rate pandem hn influenza hypothesis commun transmiss pandem influenza establish victoria time test novel viru commenc contrast true pandem part australia includ western australia wa method data detail case followup patient confirm infect victoria wa demonstr differ pandem curv australian state opposit side contin model pandem state susceptibleinfectedremov model bayesian infer account import case epidem transmiss occur earlier victoria wa victorian case local acquir three brother famili contrast case wa associ import victoria plausibl model input data estim effect reproduct number victorian epidem requir invok earlier commenc transmiss explain observ data requir model epidem wa conclus strong circumstanti evid support model suggest commun transmiss pandem influenza establish victoria wa time test novel viru commenc australia viru enter victoria establish time identifi mexico
PLoS One	22847428	2015-08-01	PMC2894058	20613878	acid depend infect hela vero cell btv occur earlyendosom viru uptak clathrinmedi endocytosi forzan al virol report btv infect bhk cell depend low endosom ph viru entri infect inhibit dominantneg mutant ep ap aa splice variant dynamin inhibit clathrinmedi endocytosi addit infect inhibit deplet cellular cholesterol suggest viru entri mediat lipidraft depend process caveolaemedi endocytosi viru entri infect inhibit dominantneg dynamin mutant entri inhibit gener dynamin inhibitor dynasor indic viru entri dynamin depend entri btv colocalis lamp transferrin suggest viru deliv lateendosom compart pass earlyendosom btv entri infect inhibit eipa cytochalasind macropinocytosi inhibitor entri viru colocalis dextran marker macropinocytosisfluidphas uptak extend earlier observ btv btv infect bhk cell entri mechan clathrin cholesterolindepend requir dynamin share characterist common macropinocytosi
PLoS One	26293869	2019-04-04	PMC2894071	20614006	porcin reproduct respiratori syndrom prr econom diseas swine industri worldwid great econom loss year prr viru prrsv replic porcin alveolar macrophag pam dendrit cell dc develop persist infect antibodydepend enhanc ad interstiti pneumonia immunosuppress molecular mechan prrsv infect understood report genomewid host transcript respons classic north american type prrsv nprrsv strain ch infect solexaillumina digit gene express dge system tagbas highthroughput transcriptom sequenc method analys systemat relationship pulmonari gene express profil nprrsv infect infect patholog nprrsv appear util multipl strategi replic spread infect pig includ subvert host innat immun respons induc antiapoptot antiinflammatori state develop ad upregul express virusinduc proinflammatori cytokin chemokin adhes molecul inflammatori enzym inflammatori cell antibodi complement activ result develop inflammatori respons nprrsv infect process nprrsvinduc immunosuppress mediat apoptosi infect cell caus deplet immun cell induc antiinflammatori cytokin respons unabl erad primari infect system analysi will benefit better understand molecular pathogenesi nprrsv infect develop novel antivir therapi identifi genet compon swine resistancesuscept prr
Virol J	31285696	2005-05-01	PMC2894783	20478047	background sever acut respiratori syndromeassoci coronaviru sarscov spread rapidli high casemort rate nucleocapsid protein np sarscov critic pathogen studi sought discov host protein interact sarscov np surfac plasmon reson biomolecular interact analysi sprbia matrixassist laser desorptionion time flight malditof mass spectrometri proteasom subunit human fetal lung diploid fibroblast bs cell bound sarscov np interact confirm glutathion stransferas gst fusion protein pulldown techniqu coloc signal sarscov np proteasom subunit bs cell detect indirect immunofluoresc confoc microscopi subunit proteasom larg multiprotein complex compon ubiquitinproteasom pathwai involv varieti basic cellular process inflammatori respons conclus knowledg report sarscov np interact proteasom subunit host cell data enhanc understand molecular mechan sarscov pathogen sarscov interact host cell
BMC Infect Dis	15963171	2011-12-01	PMC2894833	20504379	background infecti diseas surveil laboratori confirm case timeconsum time lag number suspect case number confirm case studi propos dynam statist model estim daili number case daili cumul number infect case appli histor dengu fever data method durat diseas onset laboratori confirm assum follow gamma distribut nonparametr distribut condit probabl case real case unconfirm case calcul probabl observ confirm case integr estim daili number case cumul number infect case distribut onsettoconfirm time posit case neg case daili case cumul epidem curv estim propos method lower absolut rel bia valu estim sole base dailyconfirm case conclus propos method accur realtim estim daili case daili cumul number infect case model move window rel suspect case dynam updat paramet propos method will realtim evalu diseas outbreak case classif requir timeconsum laboratori process identifi confirm case
BMC Biol	22105170	2016-05-11	PMC2895587	20619006	blood pipelin immun system assess chang transcript abund blood genomewid scale afford comprehens view statu immun system health diseas review summar work approach identifi therapeut target biomark signatur field autoimmun infecti diseas technolog methodolog advanc will carri blood transcriptom field forward discuss
PLoS Pathog	27170754	2017-06-21	PMC2895667	20617182	reoviru infect lead apoptosi cultur cell murin central nervou system cn nfbdriven transcript proapoptot cellular gene requir effector phase apoptot respons extrins deathreceptor signal pathwai intrins pathwai involv mitochondri injuri implic reovirusinduc apoptosi mechan pathwai activ relationship nfb signal reoviru infect unknown proapoptot bcl famili member bid activ proteolyt cleavag reoviru infect understand reoviru integr host signal circuit induc apoptosi examin proapoptot signal infect biddefici cell reoviru growth absenc bid cell lack bid fail undergo apoptosi nfb activ requir bid cleavag subsequ proapoptot signal examin function signific biddepend apoptosi reoviru diseas monitor fatal enceph caus reoviru presenc absenc bid surviv biddefici mice enhanc comparison wildtyp mice peror intracrani inocul reoviru decreas reoviru virul bidnul mice accompani reduct viral yield find defin role nfbdepend cleavag bid cell death program initi viral infect link bid viral virul
BMC Public Health	28637754	2014-08-01	PMC2896940	20529345	background asiapacif southeast asia receiv substanti attent anticip epicentr pandem activ invest earlier review pandem prepared plan region reveal translat strateg plan oper plan lack countri low resourc object studi understand pandem prepared programm health system context challeng constraint specif asian countri cambodia indonesia lao pdr taiwan thailand viet nam prepandem phase start hn method studi reli system rapid assess sysra toolkit evalu prioriti diseas programm account programm gener health system wider sociocultur polit context compon review extern context stewardship organis arrang financ resourc gener alloc healthcar provis system qualit quantit data collect second half base review publish data interview kei inform explor current pattern health programm pandem respons studi health system countri vari regard epidemiolog context health care financ health servic provis pattern pandem prepar countri develop nation govern pandem prepared nation pandem influenza prepared plan avian human influenza ahi respons plan govern arrang natur plan differ develop countri focu surveil rapid contain poultri transmiss prepar pandem stage limit interfac linkag health system context pandem prepared programm countri explor conclus health system context influenc countri prepar pandem time invest pandem prepar asian countri contribut improv health system surveil laboratori capac monitor evalu public commun number suggest improv present strengthen pandem prepar mitig overcom underli health system constraint
BMC Evol Biol	25171002	2012-07-01	PMC2898692	20565983	background vast sequenc diverg viru group present great challeng alignmentbas analysi viru phylogeni problem caus uncertainti align exist tool phylogenet analysi base multipl align directli appli wholegenom comparison phylogenom studi virus grow interest alignmentfre method phylogenet analysi complet genom data alignmentfre method dynam languag dl method propos group appli phylogenet analysi bacteria chloroplast genom paper dl method analyz wholeproteom phylogeni larg dsdna virus parvovirus data set larg differ genom size tree analys good agreement latest classif larg dsdna virus parvovirus intern committe taxonomi virus ictv conclus method recov phylogeni larg dsdna virus parvovirus insight affili number unclassifi virus comparison alignmentfre method cv tree method recov phylogeni larg dsdna virus suitabl resolv phylogeni parvovirus smaller genom size
Biol Direct	22944661	2013-06-01	PMC2898770	20565756	background coleth synthet lethal document genet situat separ nonleth mutat lethal combin genom mutat call synthet lethal sl coleth invari posit sl set sl link coupl choic target drug design fastescap rna virus mutat viral escap loss affin drug induc synthet lethal amino acid sequenc align hiv proteas detect potenti sl coupl potenti sl set invari posit structur protein focus close access protein surfac bind put drug align hiv proteas amino acid sequenc identifi potenti sl coupl invari posit appli distanc access filter three candid drug design target flap cantilev fulcrum amino acid posit conclus three replicationcrit target locat activ site kei antiescap strategi biolog evid target posit perform essenti biolog function mutat variat escap antivir medic lethal limit apparit drugresist strain review articl review arcadi mushegian shamil sunyaev clau wilk
Acta Vet Scand	23522610	2014-09-01	PMC2898781	20492637	background bovin coronaviru bcv bovin respiratori syncyti viru brsv infect current widespread swedish dairi cattl popul survei antibodi level bulk tank milk high nationwid preval bcv brsv larg variat region swedish beef cattl popul investig perform preval geograph distribut bcv brsv crosssect serolog survei bcv brsv carri swedish beef cattl explor geograph pattern infect method blood sampl collect anim locat herd analyz presenc antibodi bcv brsv moran calcul assess spatial autocorrel identif geograph cluster perform spatial scan statist anim detect posit bcv brsv predomin locat centralwestern southern part sweden moran indic global spatial autocorrel bcv brsv appear spatial area southern sweden skaraborg skne higher preval bcv area identifi highpreval cluster brsv area southeast sweden kronobergbleking lower preval infect expect bcv brsv area middlewest sweden vrmlanddalarna lower preval brsv area beef herd densiti higher risk highpreval cluster conclus form basi investig betweenherd dynam risk factor infect order design effect control strategi
PLoS Negl Trop Dis	24709055	2009-08-26	PMC2903468	20644615	background venezuelan equin enceph viru veev respons vee epidem occur south central america veev envelop glycoprotein mediat cell membran fusion bind receptor elicit viru neutral antibodi construct e epitop map murin monoclon antibodi mmab epitop ecdefgh bound veevneutr antibodi map amino acid aa human antibodi repertoir veev epitop engag human virusneutr antibodi specif treatment vee virusneutr mmab potent protect therapeut agent mice challeng veev peripher aerosol rout fulli human mab hmab virusneutr activ prevent clinic treatment human vee method phagedisplai isol veevspecif hfab human bone marrow donor hfab character sequenc specif test veev subtyp crossreact indirect elisa vitro viru neutral capac especif neutral hfab fn convert igg bind site identifi competit elisa mmab prepar sequenc antibodi neutralizationescap variant find veevreact hfab construct human epitop map alphavir surfac protein e identifi neutralizationassoci epitop uniqu human immun respons aa resolut cryoelectron microscopi map sindbi viru protein probabl surfac locat human veev epitop conclus veevneutr capac hmab nigg exhibit human mmab hy igg hy igg limit veev infect mice prophylact therapeut administr cocktail fn hy igg bind epitop provid enhanc prophylaxi immunotherapi veev reduc possibl gener harm viru neutralizationescap variant vivo
Mediators Inflamm	19717445	2007-10-31	PMC2903949	20672047	in order establish infect virus suppress escap host immun defens system immunolog focus innat immun host defens pattern recognit molecul tolllik receptor tlr rigilik receptor rlr nodlik receptor nlr microbi compon recogn vagu common molecular shape socal pathogenassoci molecular pattern pamp pamp induc inflammatori reaction mediat activ transcript factor nfb interferon lead antivir immun respons virus capac suppress escap pattern recognit moleculemedi antimicrobi respons wai paper review strategi virus modul pattern recognit moleculemedi innat immun respons
Proteome Sci	17977985	2004-08-18	PMC2904733	20529248	background hepat viru hbv major liver infect human lack appropri cell cultur system support hbv infect effici cellular molecular mechan hepadnaviru infect remain incomplet understood duck heptat viru dhbv natur infect primari duck hepatocyt pdh provid valuabl model system studi hepadnaviru infect vitro report explor global chang cellular protein express dhbv infect pdh twodimens gel electrophoresi de combin malditoftof tandem mass spectrometri msm effect hepadnaviru infect hepatocyt investig dhbv infect pdh de analysi proteom profil pdh infect dhbv analyz postinfect compar uninfect pdh differenti express protein spot reveal de analysi select protein spot spot identifi correspond protein msm analysi match ortholog protein gallu gallu ana platyrhyncho avian speci includ alphaenolas lamin aconitas cofilin annexin downregul express betaactin annexin confirm western blot analysi potenti role differenti express protein virusinfect cell discuss conclus differenti express protein dhbv infect pdh reveal de involv carbohydr metabol amino acid metabol stress respons cytoskeleton process provid insight understand interact hepadnaviru hepatocyt molecular mechan hepadnaviru pathogenesi
AIDS Res Ther	15315997	2005-02-24	PMC2908552	20604950	background search diseas biomark human peripher fluid favor approach prevent therapeut year comparison normal versu diseas state identifi overexpress suppress critic protein ill directli alter patient cellular homeostasi analysi hiv infect serum attract medium identifi alter protein express eas noninvas method collect sampl correspond insight vivo interact viru infect cellstissu util proteom techniqu global identifi differenti express serum protein respons hiv infect undertak complic innat protein profil human serum deplet of abund serum protein twodimension gel electrophoresi coupl identif protein matrixassist laser desorptionion timeofflight malditof mass spectrometri allow identif differenti express low abund serum protein analyz compar serum sampl hiv infect subject treat highli activ antiretrovir therapi haart latent infect progress aid despit absenc treatment long term nonprogressor ltnp identifi uniqu serum protein differenti express ltnp hiv patient contribut abil patient combat hiv infect absenc haart focus cdk cell cycl inhibitor pinka treatment hiv latent infect cell line pinka decreas viral product despit express endogen cell conclus identif uniqu protein serv indic alter viral state respons infect natur phenotyp variabl respons hiv infect popul
PLoS Pathog	15731233	2012-08-29	PMC2908624	20661432	plasmacytoid dendrit cell pdcmediat protect cytopath viru infect involv molecular cellular tissuescal organismscal event order better understand multiscal interact implement system immunolog approach focus analysi structur dynam oper principl virushost interact constrain initi spread pathogen highresolut experiment data set come welldescrib mous hepat viru mhv model calibr basic modul includ mhv infect primari target cell pdc macrophag ms basic build block gener valid integr mathemat model vivo infect dynam paramet estim system indic capita basi infect pdc secret suffici type ifn protect ms cytopath viral infect extrem high protect capac pdc secur spleen capabl function sink viru produc peripher organ liver pdc popul spleen ensur robust protect viru variant downmodul ifn secret abil pdc protect sever diseas caus viru variant exhibit enhanc liver tropism higher replic rate appear limit system immunolog analysi suggest antivir therapi cytopath virus limit viral replic peripher target organ
BMC Bioinformatics	22933274	2007-08-20	PMC2909221	20584331	background analysi oligonucleotid microarrai data pathogen surveil discoveri challeng task target templat concentr nucleic acid integr host nucleic acid composit profound signal distribut exploratori analysi fluoresc signal distribut clinic sampl reveal deviat normal suggest distributionfre approach appli posit predict fals posit rate examin assess util three wellestablish nonparametr method analysi viral arrai hybrid data mannwhitnei spearman correl coeffici chisquar test three test chisquar prove conclus accept microarrai routin clinic diagnost will requir technolog accompani simpl reliabl analyt method report implement chisquar test yield combin low fals posit rate high degre predict accuraci
PLoS One	17709464	2003-07-01	PMC2909231	20668535	background pneumonia lead infecti diseas killer worldwid burden china understood data publish nonenglish literatur methodologyprincip find systemat review chines englishlanguag literatur studi primari data pneumonia incid mortal mainland china studi met inclus criteria qualiti studi highli variabl children year incid rang episod personyear mortal rang death popul incid mortal stabl decreas studi period higher rural compar urban area conclusionssignific pneumonia continu major public health challeng young children china estim pneumonia incid mortal vari reliabl surveil data prevent effort need achiev document addit declin area higher incid mortal rural set
Algorithms Mol Biol	12843048	2014-01-09	PMC2909241	20573197	background rna exhibit varieti structur configur consid structur tantamount noncross watsoncrick gubas pair secondari structur addit crossseri base pair interact call pseudoknot observ spectrum rna function context studi natur rna structur search ribozym design artifici rna interest find rna sequenc fold specif structur analyz induc neutral network establish invers fold algorithm rnainvers rnassd inforna limit rna secondari structur paper invers fold algorithm inv deal noncross canon pseudoknot structur paper invers fold algorithm inv detail analysi inv includ pseudocod inv allow design noncross nonplanar rna pseudoknot noncross rna structuresa class difficult construct dynam program routin inv freeli httpwwwcombinatoricscncbpcinvhtml conclus algorithm inv extend invers fold capabl rna pseudoknot structur comparison rnainvers idea instanc consid set compet structur result inv find novel sequenc rna secondari structur context compet structur exhibit crossseri interact
Proteome Sci	24407286	2013-12-11	PMC2909931	20534109	background infecti bronchiti viru ibv coronaviru domest chicken caus major econom loss poultri industri complex ibv life cycl small number viral structur protein virushost relationship remain discov goal perform twodimension gel electrophoresi fraction coupl mass spectrometri identif approach perform comprehens proteom analysi purifi ibv particl apart virusencod structur protein detect host protein purifi virion group function categori includ intracellular traffick protein molecular chaperon macromolcular biosynthesi protein cytoskelet protein signal transport protein protein degrad chromosom associ protein ribosom protein function protein interestingli total host protein report virion viru famili major vault protein tenp protein ovalbumin scaveng receptor protein identif host protein proteom method presenc protein purifi ibv prepar verifi western blot immunogold label detect conclus the standard proteom profil ibv facilit understand pathogen mechan
BMC Pediatr	24335315	2012-09-10	PMC2910686	20604923	background pneumonia pneumonia mp report communityacquir pneumonia case aim evalu differ clinic featur children mp ag chest radiograph pattern method diagnosi mp examin admiss discharg serolog test indirect microparticl agglutinin assai cold agglutinin titer total children mp group ag year ag patient year ag patient year ag patient group pneumonia pattern bronchopneumonia group patient segmentallobar pneumonia group patient eightysix patient seroconvert increas antibodi titer hospit three ag group oldest children longest durat fever highest creactiv protein crp valu sever pneumonia pattern patient segmentallobar pneumonia older longer fever durat lower white blood cell wbc lymphocyt count compar with bronchopneumonia patient group sever pulmonari lesion prolong fever highest crp highest rate seroconvert lowest lymphocyt count thrombocytosi observ patient admiss patient discharg conclus mp older children prolong fever sever pulmonari lesion sever pulmonari lesion associ absenc diagnost igm antibodi present lymphocyt count shortterm pair igm serolog test mandatori earli definit diagnosi mp
PLoS One	22966198	2006-03-29	PMC2910733	20676400	adenovir ad vector varieti vaccin applic includ cancer infecti diseas tradition adbas vaccin design express antigen transgen express antigen case convent adbas vaccin suboptim clinic suboptim attribut preexist ad serotyp ad immun order circumv antigen express transgen incorpor antigen capsidincorpor strategi develop adbas vaccin develop context diseas strategi embodi incorpor antigen peptid capsid structur viral vector major capsid protein hexon util capsid incorpor strategi hexon natur role gener antiad immun respons numer represent ad virion strategi develop incorpor heterolog peptid epitop major surfaceexpos domain ad capsid protein hexon studi focus gener multival vaccin vector present hiv antigen ad capsid protein hexon express hiv antigen transgen novel vector util hvr incorpor site twentyfour amino acid region hiv membran proxim ectodomain region mper deriv hiv glycoprotein gp gp studi illustr multival antihiv vector elicit cellular antihiv respons vaccin vector hiv antigen hvr elicit hiv epitopespecif humor immun respons
Health Qual Life Outcomes	16571824	2010-12-01	PMC2911409	20626865	background current studi explor preval depress mood chines undergradu student examin cope pattern degre flexibl flexibl pattern associ mood method set questionnair assess cope pattern cope flexibl depress symptom administ student men women total particip complet entir set questionnair report frequenc stress life event criterion need calcul varianc perceiv control find higher level depress symptom associ higher level event frequenc event impact lower level perceiv control cope effect ratio strategi situat fit depress symptom associ cognit flexibl varianc perceiv control gender moder of report associ conclus find indic chines univers student depress symptom report experienc greater number neg event nondepress univers student addit undergradu depress symptom undergradu util maladapt cope method find highlight potenti intervent aim help undergradu student lower cope flexibl develop skill cope stress life event
BMC Vet Res	21056544	2006-08-29	PMC2912257	20609252	background escherichia coli serogroup emerg zoonot bacteri pathogen caus rang symptom selflimit bloodi diarrhea sever hemorrhag coliti hemolyticurem syndrom human beef dairi cattl consid anim reservoir pathogen virul characterist coli eaea gene encod kda surfac protein intimin intimin requir attach effac interact enterohemorrhag coli human bovin neonat enterocyt studi undertaken test hypothesi adapt mucos immun respons direct intimin will reduc prevent enter colon fecal shed coli cattl cattl oral inocul milk control milk live attenu salmonella enterica serovar dublin vector milk live attenu recombin dublin express intimin vaccin dai dai calv challeng oral coli evalu vaccin recombin dublin express intimin reduc level coli fecal shed dai vaccin calv vector strain intiminexpress dublin strain level vector strain longer period compar level recombin vaccin strain calv receiv intiminexpress vaccin ceas shed dublin dai dai calv challeng coli dai determin fecal shed coli amount coli fece measur dai postchalleng observ transient clearanc coli fece vaccin calv magnitud fecal coli shed correl presenc intiminspecif fecal iga conclus oral vaccin live attenu recombin dublin express intimin reduc enter colon fecal shed coli transient clearanc coli associ enhanc igamedi mucos immun respons
BMC Pediatr	29707364	2013-08-08	PMC2914048	20646293	background sever acut respiratori syndrom sar outbreak toronto outpati clinic sickkid hospit close prevent diseas transmiss respons decis neonat neurodevelopment follow nnfu clinic staff select patient schedul appoint mailtelephon assess ag stage questionnair asq postponeskip visit object studi compar development assess outcom group nnfu clinic patient sar versu nonsar three standard clinic appoint method compar diagnost accuraci identif development delai patient manag referr therapi commun diagnosi strategi sar aprilmai standard assess method patient aprilmai nonsar case data patient visit month compar descript statist patient sar group nonsar patient gestat ag sex entri diagnosi ag clinic visit group nnfu clinic staff mail asq famili sar return contact telephon criteria identifi infant risk select mail asq phone interview clearli defin patient chart identif development delai sar versu respond mail questionnair referr therapi rate nonsar group lost follow rate sar group compar nonsar differ rate development delai group identifi visit conclus poor advanc plan led haphazard assess patient infecti diseas outbreak futur pandem plan consid plan outpati care hospit manag patient
PLoS Negl Trop Dis	23864330	2017-07-12	PMC2914747	20689813	background product nativ antigen serodiagnosi helminth infect labori hamper batchtobatch variat serodiagnosi echinococcosi cystic diseas screen test reli crude purifi echinococcu granulosu hydatid cyst fluid resolv limit associ nativ antigen serolog test standard highli pure antigen produc chemic synthesi offer consider advantag provid appropri diagnost sensit specif achiev methodologyprincip find make grow collect genom proteom data appli set bioinformat select criteria collect protein sequenc includ conceptu translat nucleotid sequenc data tapeworm echinococcu multiloculari echinococcu granulosu approach target alphahel coiledcoil intrins unstructur region parasit protein expos host immun system protein multiloculari protein granulosu peptid amino acid length design peptid chemic synthes spot microarrai screen reactiv sera infect human peptid react cutoff valid enzymelink immunosorb assai elisa peptid identifi fail differenti multiloculari granulosu infect peptid perform best reach sensit specif candid deriv echinococcu multiloculari antigen strong reactiv sera patient infect multiloculari granulosu conclusionssignific studi proof principl discoveri diagnost relev peptid bioinformat select complement screen highthroughput microarrai platform data singl peptid provid suffici diagnost sensit pool peptid antigen improv sensit combin peptid lead diagnost test replac complement convent immunodiagnosi echinococcosi strategi prove diagnost develop pathogen
BMC Public Health	28701392	2016-02-01	PMC2916908	20667076	background effect influenza pandem manag requir understand factor influenc behavior chang aim determin differ knowledg attitud practic cohort explor pertin factor influenc behavior tropic singapor method perform crosssect knowledg attitud practic survei singapor militari midaugust earlyoctob personnel exposur group laboratoryconfirm hn case close contact case healthcar worker gener personnel particip respond ag se year close contact highest knowledg score case highest practic score strong correl knowledg practic score knowledg attitud score predictor higher practic score higher knowledg score malai ethnic exposur group lower educ level predictor higher attitud score malai ethnic higher knowledg score predictor higher knowledg score contact conclus knowledg influenc attitud practic pandem person experi influenc practic behavior effort target educ gener popul improv practic current pandem futur epidem
BMC Public Health	26873679	2011-01-12	PMC2918554	20626872	background influenza pandem higher educ institut larg popul young adult seriou outbreak center outbreak manag essenti diseas control aim examin univers student knowledg attitud pandem influenza ahn vaccin prevent measur method crosssect studi conduct year univers student yeditep univers istanbul turkei st novemb data sociodemograph characterist student percept level knowledg attitud influenza pandem prevent measur collect selfadminist questionnair questionnair distribut student affili sanita univers club student health scienc studi group perceiv person risk influenza high perceiv moder view low indic unknown risk percept male lower femal risk percept student health scienc lower student scienc studi group indic main sourc hn mass media health scienc student tend reli internet sourc student vast major interview indic vaccin major concern vaccin safeti side effect vaccin particip carri prevent measur vast major believ hand wash face mask quarantina effect measur prevent conclus particip knowledg hn pandem diseas gap confus area futur plan manag strategi pandem outbreak higher educ institut strategi develop promot posit health behaviour univers student compat intern guidelin main sourc mass media polici develop attract attent student scientificbas sourc
Virol J	21228244	2013-01-30	PMC2918564	20663162	the bibl describ case woman high fever cure lord jesu christ base provid gospel mark matthew luke diagnosi etiolog febril ill discuss infecti diseas continu threat human influenza dawn human histori postul correct woman fever bibl earli descript human influenza diseas infecti diseas continu threat human influenza dawn human histori analys case high fever happen year ago biblic time discuss etiolog
BMC Public Health	23365447	2014-11-05	PMC2919480	20678192	background earli stage swine flu influenza hn outbreak larg major patient contact health servic ill uk nh direct telephon servic patient qualit interview identifi main reason peopl approach nh direct concern swine flu identifi aspect contact reassur framework approach method patient particip semistructur interview patient telephon nh direct concern swine flu assess ill reason seek advic swine flu includ presenc unexpectedli sever flulik symptom uncertainti catch swine flu concern pressur friend employ seek peac mind particip speak nh direct reassur help aspect includ swine flu rule receiv altern explan symptom clarif swine flu transmit perceiv credibl nh direct report increas anxieti particip subsequ sought addit advic swine flu conclus futur major incid involv form chemic biolog radiolog hazard larg number unexpos peopl seek health advic data provid telephon triag help instanc advic trust preexist servic
BMC Microbiol	25378490	2008-06-25	PMC2919482	20663197	background chlamydia induc persist infect associ wide rang chronic diseas human anim mix infect chlamydia porcin epidem diarrhea viru pedv result gener persist chlamydi infect test hypothesi vitro model dual infect cell cultureadapt pedv chlamydia abortu chlamydia pecorum vero cell establish infect cultur investig immunofluoresc transmiss electron microscopi tem reinfect experi chlamydiainfect cell normal inclus hpi dual infect chlamydia abortu reveal heterogen mix inclus type includ small inclus consist aberr bodi ab mediums inclus consist ab reticul bodi normal inclus aberr inclus observ dual infect experi chlamydia pecorum pedv tem examin mix infect chlamydia abortu chlamydia pecorum reveal aberr chlamydi inclus reticulatelik pleomorph ab diamet redifferenti elementari bodi eb detect reinfect experi coinfect cell produc fewer eb monoinfect cell conclus studi confirm pedv coinfect alter development cycl member speci famili chlamydiacea manner welldescrib persist induct method interestingli appear partial speciesspecif chlamydia pecorum appear sensit pedv coinfect chlamydia abortu evidenc tem observ homogen popul aberr inclus pedv chlamydia pecorum coinfect
PLoS Pathog	18579717	2010-12-15	PMC2920842	20711359	emerg influenza strain lead rapid global spread viru minim antibodi immun preexist cd tcell immun direct conserv intern viral region greatli amelior diseas mutat escap cell epitop substanti issu viru control vaccin design mutat result loss cell recognit variant gener crossreact cell respons studi revers genet modifi influenza np peptid partiallysolv expos residu npna mutat assess avail effect mechan underli influenzaspecif crossreact cell respons engin viru induc diminish cd cell respons select narrow cell receptor tcr repertoir region v partial explain hdbnpna structur loss contact npna peptid hdb includ contact posit plai role mediat tcrpmhci interact despit differ common crossreact tcr detect nave immun npnaspecif tcr repertoir npna epitop prime memori tcell equival recal respons mutant wildtyp wt viru markedli lower wtwt challeng decreas cd respons elicit heterolog challeng delai viral clearanc infect lung mice expos wt viru poor low avid respons secondari infect mutant protect efficaci crossreact cd cell recognis mutant viral epitop depend peptidemhci structur interact function avid studi support vaccin strategi includ immun commonli select crossreact variant mutat partiallysolv expos residu characterist compar npna
BMC Res Notes	21159873	2008-03-26	PMC2921379	20633290	background advanc dna sequenc technolog allow research progress analys singl organ deep sequenc sampl organ suffici sequenc depth detect subtl variat member speci mix speci share biomark rrna gene tradit sequenc analys sampl homogen popul base multipl sequenc align msa sequenc separ row similar align base column visual format intuit small set align sequenc represent cumbersom sequenc depth cover loci hundr thousand read deep find develop and softwar librari suit applic written perl statist analys deep sequenc fundament data structur underli and posit profil nucleotid distribut genom posit result multipl sequenc align msa tool includ root squar deviat rmsd plot allow visual comparison multipl sampl positionbyposit basi comput base convers frequenc transitiontransvers rate variat shannon entropi intersampl cluster visual dendrogram multidimension scale md plot thresholddriven consensu sequenc gener polymorph detect estim empir determin sequenc qualiti valu conclus sequenc technolog evolv deep sequenc will increasingli costeffici inter intrasampl comparison homogen sequenc will common provid softwar packag demonstr applic empiricallyderiv dataset investig download softwar sourceforg httpssourceforgenetprojectsandestool
BMC Infect Dis	18367528	2011-12-14	PMC2922213	20663229	background studi perform better assess percept motiv factor behavior associ hand wash prevent hn influenza transmiss peak pandem period korea method crosssect survei questionnair complet student univers campu suwon korea decemb survei includ question individu percept motiv factor behavior associ hand wash prevent hn influenza transmiss compar year prior particip report increas hand wash frequenc femal student practic frequent hand wash women perceiv effect hand wash lower ill sever person suscept hn infect higher studi particip femal perceiv hand wash effect ill sever greater wash hand frequent conclus korean student increas frequenc hand hygien practic pandem gender differ exist attitud behavior hand hygien diseas prevent factor hand wash behavior identifi the hn sar pandem suggest public educ campaign hand hygien effect alter individu hand hygien habit peak period influenza transmiss
Respir Res	22171261	2014-11-03	PMC2923116	20696083	background common cold preval contagi viral diseas human lack safe effect antivir treatment iotacarrageenan broadli activ respiratori virus invitro excel safeti profil studi investig efficaci safeti iotacarrageenan nasal sprai patient common cold symptom method random doubleblind placebocontrol exploratori trial human subject suffer earli symptom common cold receiv iotacarrageenan salin solut three time daili dai compar placebo administr iotacarrageenan nasal sprai reduc symptom common cold viral load nasal lavag patient earli symptom common cold proinflammatori mediat fgf fractalkin gro gcsf il il ip il ifn reduc iotacarrageenan group conclus iotacarrageenan nasal sprai appear promis treatment safe effect treatment earli symptom common cold larger trial indic confirm result
J Biomed Sci	26958719	2005-02-01	PMC2923119	20682079	enteroviru type ev proteas exhibit strong transcript activ yeast cell transcript activ proteas independ proteas activ ev proteas retain transcript activ truncat amino acid nterminu lost activ truncat amino acid nterminu delet amino acid cterminu acid domain cterminu protein essenti transcript activ delet amino acid eam acid domain lost transcript activ ev protein retain proteas activ ev proteas detect cytoplasm nucleu confoc microscopi analysi coxsacki viru proteas exhibit transcript activ yeast cell expect acid domain cterminu coxsacki viru proteas identifi truncat acid domain loss transcript activ interestingli acid region polioviru proteas critic viral rna replic transcript activ ev coxsacki viru proteas plai role viral replic andor pathogenesi
PLoS One	15695719	2007-12-01	PMC2923618	20805891	background commonli accept belief cancer cell modifi transcript state progress diseas propos progress cancer cell malign phenotyp effici track highthroughput technolog follow gradual chang observ gene express profil emploi shannon mathemat theori commun method base theori quantifi diverg cancer cell transcript profil appear cell origin tissu relev propos method evalu microarrai dataset public domain method principl applic highthroughput method methodologyprincip find melanoma prostat cancer dataset illustr emploi shannon entropi jensenshannon diverg trace transcript chang progress diseas establish variat measur correl establish biomark cancer progress theori measur allow identifi novel biomark progress sudden transcript chang lead malign phenotyp time methodolog valid larg number gene process implic progress melanoma prostat cancer conclusionssignific quantit guid rule unifi hallmark cancer cancer cell transcriptom chang lead measur observ transit normal shannon entropi valu measur highthrougput technolog time tumor cell increment diverg normal tissu profil increas disord creation state directli measur unifi hallmark allow the jensenshannon diverg identifi arrow time process gene express profil help map phenotyp molecular hallmark specif cancer subtyp deep mathemat basi approach allow principl hopefulli gener applic diseas
Cancer Cell Int	18022293	2014-07-30	PMC2924328	20682078	background leukemia lifethreaten cancer todai acut promyelogen leukemia apl common type leukemia natur compound exhibit antitumor effect lycorin natur alkaloid extract amaryllidacea exhibit antileukemia effect vitro vivo surviv rate hl cell expos lycorin decreas cell growth slow cell regener potenti inhibit hl cell exhibit typic apoptot characterist lycorin suppress leukemia growth reduc cell surviv induc apoptosi tumor cell purpos work elucid mechan lycorin induc apl cell hl cell treat concentr lycorin express tnf upregul concentrationdepend manner realtim quantit revers transcriptasepolymeras chain reaction western blot lycorin downregul prelat gene express includ cdc cyclin cdk cyclin promot bid truncat decreas ib phosphoryl block nfb nuclear import cytochrom releas mitochondria observ confoc laser microscopi conclus tnf signal transduct pathwai pmediat cellcycl inhibit involv apoptosi hl cell induc lycorin contribut develop lycorinebas antileukemia drug
Vet Med Int	25078906	2009-01-14	PMC2926681	20798771	felin coronavirus fcov infect fcov result divers rang sign clinic inappar infect highli fatal diseas call felin infecti periton fip fip seriou viral diseas cat effect vaccin cur treatment fip diagnost protocol fcov greatli assist manag control viru clinic find fip nonspecif help make differenti diagnosi haematolog biochem abnorm fip case nonspecif current serolog test low specif sensit detect activ infect crossreact fcov strain low pathogen felin enter coronavirus fecv revers transcriptas polymeras chain reaction rtpcr detect fcov rapid sensit interpret context clinic find definit diagnosi fip establish histopatholog examin biopsi paper describ compar diagnost method fcov includ account viru biologi epidemiolog pathogenesi
PLoS Negl Trop Dis	19144714	2015-09-16	PMC2927428	20808767	background fruit bat speci rousettu aegyptiacu identifi potenti reservoir highli pathogen filoviru marburg viru establish basi molecular understand biologi filovirus reservoir host adapt set molecular tool investig filoviru replic develop cell deriv speci rousettu aegyptiacu methodologyprincip find infect ebola marburg virus cell produc viral titer compar vero cell tcid analysi electron microscop analysi infect cell reveal morpholog sign filoviru infect describ human monkeyderiv cell line cell detect unusu high amount intracellular viral protein correl accumul high number filovir nucleocapsid cytoplasm establish protocol produc marburg infecti viruslik particl cell infect nave target cell investig primari transcript cell line test establish protocol reliabl rescu recombin marburg virus cell conclusionsignific data indic cell highli suitabl investig biologi filovirus cell deriv presum reservoir
BMC Infect Dis	26673332	2012-10-26	PMC2927599	20691095	background frequent occurr ferret badgerassoci human rabi case southeast china highlight lack laboratorybas surveil urg revisit potenti anim rabi transmiss determin ferret badger contribut human dog rabi case origin ferret badgerassoci rabi region activ rabi survei conduct determin frequenc rabi infect seropreval dog ferret badger method retrospect survei rabi epidem perform zhejiang jiangxi anhui provinc southeast china brain tissu ferret badger dog assai fluoresc antibodi test rabi viru isol sequenc phylogenet analysi sera ferret badger dog titrat rabi viru neutral antibodi vna test ferret badger present higher percentag rabi seroconvers dog endem region reach maximum collect sampl ferret badgerassoci rabi virus isol sequenc phylogenet cluster separ group nucleotid sequenc reveal homolog ferret badger isol homolog dog isol nucleoprotein glycoprotein gene rabi endem region conclus data ferret badgerassoci rabi form independ enzoot origin dog longterm rabi infest southeast china eventu role fb rabi public health remain unclear manag ferret badger bite rabi awar control region need
PLoS One	23104982	2011-03-01	PMC2929207	20805994	background base clinic represent diseas symptom multipl sclerosi mscl patient divid major subtyp relaps remit rr mscl primari progress mscl proteom analysi cerebrospin fluid csf detect number protein elev mscl patient aim differenti rr subtyp mscl compar csf protein methodologyprincip find csf sampl handl protocol quantit mass spectrometri measur report comparison mscl versu rr mscl observ number differenti abund protein protein jag vitamin dbind protein protein jag three time abund mscl compar rr mscl vitamin dbind protein detect rr mscl sampl protein valid independ techniqu western blot elisa differenti abund comparison mscl type conclusionssignific main find compar studi observ proteom profil csf rr mscl patient overlap larg extent number differ observ protein jag ligand multipl notch receptor involv mediat notch signal suggest literatur notch pathwai involv remyelin mscl lesion aberr normal homeostasi vitamin bound vitamin dbind protein implic mscl year vitamin directli indirectli regul differenti activ cd tlymphocyt prevent develop autoimmun process involv neuroprotect element mscl
BMC Public Health	20924362	2015-06-15	PMC2931476	20718996	background background pandem threat pose sar avian hn influenza studi delib forum elucid inform commun perspect aspect pandem plan method delib forum carri member south australian commun forum support qualit studi adult youth systemat review literatur involv extend group academ expert polici maker forum discuss record simultan transcript analys themat particip alloc scarc resourc antivir drug pandem vaccin base desir preserv societi function time crisi particip divid accept social distanc quarantin measur measur adopt thought reason financi household psycholog support essenti addit provid support particip gener impos strict sanction violat quarantin social distanc measur conclus recommend forum implement pandem plan sever pandem will challeng imposs implement success public engag pandem plan pandem effect commun kei point practic pandem judici support measur assist quarantin social isol measur
J R Soc Interface	26076321	2001-06-15	PMC2935601	20410190	recent outbreak novel infecti diseas sar influenza hn highlight threat crossspeci pathogen transmiss introduc popul pathogen adapt host evolv order escap extinct theoret argument empir studi suggest factor explain pathogen emerg includ host contact structur pathogen adapt pathwai mutat rate multityp branch process model spread introduc pathogen evolv strain extend previou model networkbas approach separ host contact pattern pathogen transmiss allow arbitrari adapt pathwai gener lead novel predict impact hypothes risk factor pathogen fit depend host popul circul riskiest contact distribut adapt pathwai depend initi transmiss emerg probabl sensit mutat probabl number adapt step requir possibl larg adapt step simultan point mutat recombin dramat situat increas mutat probabl increas risk emerg notabl except deleteri mutat avail
BMC Syst Biol	11356974	2013-12-20	PMC2936296	20727158	background innat immun respons defenc invad pathogen regul complex signal transcript network system biologi approach promis light regul innat immun analysi model network kei initi step process contextu catalogu compon system molecular interact compris network innatedb httpwwwinnatedbcom molecular interact pathwai databas develop facilit systemslevel analys innat immun describ innatedb curat project manual annot human mous innat immun interactom rich contextu detail novel curat softwar system develop ensur interact curat highli accur datastandard compliant manner interact protein dna rna curat biomed literatur data illustr innatedb curat innat immun interactom greatli enhanc network pathwai annot systemslevel analysi discuss challeng face curat effort provid line evid analysi innat immun interactom potenti identifi novel signal transcript posttranscript regul innat immun addition analys provid insight crosstalk innat immun pathwai biolog process adapt immun cancer diabet intriguingli suggest link pathwai implic innat immun respons conclus summari curat innatedb interactom wealth enabl systemslevel analysi innat immun
Virol J	24440876	2007-06-27	PMC2939558	20735849	background previou studi guinea pig infect transmit human influenza virus guinea pig anim model better understand influenza infect assess vaccin strategi fulli character model antibodi respons infectionreinfect human influenza awyom hn immun homolog recombin hemagglutinin ha protein studi serolog sampl collect test antiha immunoglobulin elisa antivir antibodi hemagglutin inhibit recognit linear epitop peptid scan pepscan anim inocul infecti viru demonstr pronounc viral replic subsequ serolog convers anim immun homolog ha antigen infect rapid rise antibodi titer ha glycoprotein elisa assai antivir antibodi measur assai detect second inocul pepscan data identifi recogn newli defin linear epitop conclus infect andor recombin ha immun guinea pig hn wyom influenza viru rapid product viralspecif antibodi demonstr strong immunogen major viral structur protein anim model influenza infect sensit immun respons support util guinea pig anim model influenza infect immun
Virol J	17596301	2003-10-27	PMC2939561	20799985	a conserv nucleic acid fragment nucleocapsid gene swine transmiss gastroenter coronaviru tgev chosen target special primer design loopmedi isotherm amplif lamp develop detect tgev incub product specif confirm hphi digest standard curv high accuraci tgev quantiz construct ad sybr greeni lamp reaction assai establish studi detect tgev crossreact virus demonstr high specif serial sampl dilut templat detect limit lamp pg rna time sensit pcr compar nestpcr
PLoS Pathog	14581523	2012-09-14	PMC2940758	20862324	arenavirida synthes viral mrna short cap primer presum acquir cellular transcript capsnatch mechan report crystal structur function character ntermin residu nl protein prototyp arenaviru lymphocyt choriomening viru nl domain bind cleav rna resolut crystal structur nl reveal type ii endonucleas architectur ntermin influenza viru pa protein superimposit structur mutagenesi revers genet studi reveal uniqu spatial arrang kei activ site residu pddexk type ii endonucleas signatur sequenc endonucleas domain conserv activ viru famili arenavirida bunyavirida orthomyxovirida propos arenaviru nl domain arenavirida capsnatch endonucleas
BMC Infect Dis	23093989	2013-01-09	PMC2941683	20799934	background april pandem influenza ahn viru emerg spread global object studi describ independ risk factor hospit mortal treatment corticosteroid patient influenza ahn infect method retrospect clinic data adult patient confirm infect influenza ahn hospit beij china octob decemb risk factor hospit mortal identifi multivari logist regress analysi patient male ag year comorbid patient common organ dysfunct includ acut respiratori failur alter mental statu septic shock acut renal failur oseltamivir initi patient patient receiv antivir therapi hour symptom onset fiftytwo patient treat system corticosteroid median daili dose twentyseven patient di hospit stai diabet odd ratio confid interv ci lactat dehydrogenas ldh level ci independ risk factor hospit death septic shock alter mental statu corticosteroid associ trend higher hospit mortal ci conclus hospit patient hn influenza rel poor outcom risk factor hospit help clinician identifi highrisk patient addit corticosteroid regard routin pharmacolog therapi
BMC Bioinformatics	23302888	2003-04-01	PMC2941692	20813045	background technolog enabl measur type genom epigenom scale rang atom nuclear data increasingli structur natur difficult coordin data set legitim integr visual dispar data set reveal structur relationship appar data isol appli objectori technolog develop download visual tool genom integr displai epigenom data prescrib threedimension physic model human genom order integr visual larg volum data novel statist mathemat approach develop reduc size data knowledg tool develop visual human genom threedimens describ major featur genom discuss multiscal data framework repres basic physic model demonstr issu benefit multiresolut data integr conclus genom softwar visual tool explor wide rang structur genom epigenet data data sourc differ scale integr hierarch framework easili adapt develop concern structur physic genom addit tool simpl annot mechan incorpor nonstructur genom uniqu abil manipul larg amount multiresolut data divers sourc uncov complex structur relationship genom
J Neuroinflammation	12634360	2009-11-11	PMC2942816	20828397	background neuroinflamm complex process involv cell immun system central nerv system cn polymorphonuclear neutrophil pmn abund class white blood cell typic type leukocyt recruit site inflamm cn astrocyt abund glial cell popul particip local innat immun respons trigger varieti insult studi investig impact astrocyt pmn function method primari astrocyt cultur deriv postnat cbl mice primari neutrophil isol week cbl mice pmn respiratori burst analyz hdcfda assai phagocytosi assai neutrophil incub fitclabel coli phagocytosi coli determin flow cytomet pmn degranul determin myeloperoxidas assai cytokin express determin realtim pcr determin involv signal pathwai protein lysat prepar western blot conduct assess activ akt erk vivo neutrophil primari astrocyt cultur studi demonstr astrocyt differenti regul neutrophil function depend interact cell type direct indirect direct cellcel contact astrocyt attenu neutrophil apoptosi respiratori bust degranul enhanc neutrophil phagocyt capabl proinflammatori cytokin express indirect interact neutrophil astrocyt attenu apoptosi enhanc necrosi neutrophil augment neutrophil phagocytosi respiratori burst inhibit neutrophil degranul addit astrocyt augment akt erk activ neutrophil conclus astrocyt differenti regul neutrophil function direct indirect interact cell type diversifi action astrocyt neutrophil provid protect potenti microbi infect compromis bloodbrain barrier integr neuropatholog condit complex action astrocyt neutrophil provid insight har inflammatori respons promot cn repair
BMC Bioinformatics	29870741	2017-05-17	PMC2942859	20822531	background decreas cost sequenc improv technolog easier common resequenc larg genom parallel sequenc small genom complet sequenc small genom dai increas number publicli genom type genom rapidli sequenc microbi viral genom respons infecti diseas accur gene predict challeng persist decod newli sequenc genom accur effici gene predict program highli desir rapid cost effect surveil rna virus full genom sequenc develop vigor viral genom orf reader web applic tool gene predict influenza viru rotaviru rhinoviru coronaviru subtyp vigor detect protein code region base sequenc similar search accur detect genom specif featur frame shift overlap gene embed gene predict matur peptid context singl polypeptid open read frame genotyp capabl influenza rotaviru built program compar vigor describ gene predict program zcurvev genemark flan specif sensit vigor greater rna viral genom test conclus vigor user friendli webbas genom annot program viral agent influenza rotaviru rhinoviru coronaviru sar coronaviru gene predict program rotaviru rhinoviru public access vigor accur predict protein code gene viral type capabl assign function predict open read frame genotyp influenza viru predict softwar design perform high throughput annot closur valid postsequenc product pipelin
Environ Health Perspect	28515297	2008-05-01	PMC2944079	20435545	background spread influenza highli pathogen avian influenza hn present threat human health avian influenza outbreak downwind area asian dust storm ad virus transport dust storm object develop techniqu measur ambient influenza avian influenza virus techniqu measur concentr virus ad dai background dai assess relationship ambient influenza avian influenza virus air pollut method highvolum air sampler parallel filter cassett evalu spike sampl unspik sampl air sampl monitor ad season filter cassett coupl realtim quantit polymeras chain reaction qpcr assai air sampl monitor ad season januari quantifi ambient influenza viru filtrationrealtim qpcr method ad dai background dai knowledg report describ concentr influenza viru ambient air spike unspik sampl concentr influenza viru sampl filter cassett higher highvolum sampler concentr ambient influenza viru higher ad dai background dai conclus data impli possibl longrang transport influenza viru
Virol J	18396047	2015-01-20	PMC2944171	20836894	background dengu fever viral reemerg diseas peopl tropic subtrop countri colombia viru detect earliest diseas major public health concern serotyp viru report huge outbreak report countri involv dengu viru serotyp denv studi origin genet divers distribut bp correspond carboxyl terminu envelop gene colombian isol order reconstruct phylogenet relationship estim time diverg analyz denv colombian isol belong defin genotyp viru isol clasifi genotyp repres sole introduct spread oldest strain close detect time america caribbean detect year disappear year split gener lineag evolv separ major aminoacid chang analyz region conclus denv circul colombia phylogenet relationship strain isol cover period time suggest viral strain detect year belong genotyp origin correspond multipl reintroduct event viral strain circul neighbor countri viral strain studi form monophylet group evid polyphylet origin report rapid spread pattern high evolut rate denv lineag
BMC Infect Dis	25605460	2012-01-01	PMC2944349	20822509	background renov adult intens care unit icu instal ten singl room enhanc infect control program conduct control spread methicillinresist staphylococcu aureu mrsa hospit method icu renov patient colon infect mrsa nurs singl room contact precaut incid mrsa infect icu monitor phase baselin period phase icu renov phase implement hand hygien campaign alcoholbas hand rub phase patient infect extend spectrum betalactamas esblproduc escherichia coli klebsiella speci chosen control manag open cubicl standard precaut major chang bed occup rate nurs workforc protocol environment cleans studi period stepwis reduct icu onset nonbacteraem mrsa infect observ phase phase phase patientdai icu onset bacteraem mrsa infect reduc phase phase phase patientdai infect esblproduc organ correspond reduct usag densiti broadspectrum antibiot fluoroquinolon increas phase trend improv icu onset mrsa infect segment regress analysi demonstr comparison sever acut respiratori syndrom sar epidem suggest death fellow healthcar worker occup acquir infect overwhelm complianc infect control measur conclus provis singl room isol facil promot hand hygien practic complianc infect control measur reli person commit increas person safeti threaten
PLoS One	24175205	2005-10-21	PMC2944876	20886082	background standard epidemiolog theori claim structur popul competit multipl pathogen strain determinist process mediat basic reproduct number imag text individu strain theori base analysi simul empir studi challeng predictor success princip find quantiti imag text valid predictor structur popul size infinit articl popul size finit dynam infect multistrain pathogen stochast process outcom predict evolutionari entropi theoret measur describ uncertainti infecti ag infect parent randomli chosen infect evolutionari entropi characteris demograph stabil robust popul infect statist paramet determin durat infect quantit pathogen strain standard epidemiolog theori base imag text measur select advantag limit popul size infin entrop select theori standard model approxim entrop select theori valid increas popul size conclus epidemiolog analysi base entropi explain empir observ emerg pathogen strain human influenza antigen drift phase exploit entropi perspect discuss epidemiolog pattern current hn swine flu outbreak
Curr Genomics	16227331	2018-03-14	PMC2945003	21286315	the proteom collect protein contemporari organ evolv recombin duplic limit set domain protein domain essenti main compon globular protein princip level protein function protein interact understood aspect domain evolut atom structur biochem function the amino acid sequenc chang bring fold function protein architectur increas wealth sequenc annot data brought genom evolutionari relationship constantli reveal unknown structur model phylogeni infer investig help predict function newli discov protein assist map unforeseen pathwai evolut reveal crucial coevolv inter intramolecular interact turn will help describ protein domain shape cellular interact network dynam regul cell addition studi design optim protein domain therapi review aim describ basic concept protein domain evolut illustr develop molecular evolut provid valuabl insight field compar genom protein interact network
BMC Public Health	29547975	2016-11-23	PMC2945945	20815888	background emerg influenza hnv face st centuri global pandem sever acut respiratori syndrom sar avian influenza hn prompt develop pandem prepared plan nation system public health law essenti public health stewardship implement public health polici intern coher will contribut effect region global respons undertaken law work tool diseas control europ cofund european union investig extent law europ support constrain pandem prepared plan nation differ constrain control effort method undertook survei nation public health law european state questionnair design diseas scenario base pandem influenza questionnair review workshop analys differ nation law support hinder region respons pandem influenza respond examin impact nation law movement good servic peopl border time pandem capac surveil case detect case manag commun control deploy strategi prevent contain mitig recoveri identif common disconnect state result studi differ europ extent nation pandem polici pandem plan integr public health law differ legisl legitimaci strateg plan state differ rang natur intervent measur author law extent border close movement person good pandem access healthcar nonresid person state propos emerg power overrid human right protect state propos limit intervent author public health law conclus differ creat problem european strategi evolv influenza pandem seriou public health challeng novel diseas influenza emerg pandem potenti insuffici understand europ role law pandem plan state build capac public health law support diseas prevent control polici suggest state guidanc eu manag pandem guidanc assist greater common legal approach state
Respir Res	27872356	2013-08-14	PMC2946301	20843364	background respiratori syncyti viru rsv infect restrict respiratori epithelium studi document presenc rsv system circul consist viru detect blood correl diseas sever method balbc mice inocul live rsv heatinactiv rsv medium subset rsvinfect mice treat antirsv antibodi postinocul rsv rna load measur pcr peripher blood dai postinocul correl upper lower respiratori tract viral load system cytokin respons lung inflamm pulmonari function immunohistochem stain defin local rsv antigen respiratori tract peripher blood rsv rna load detect peripher blood dai postinocul peak dai correl nasal lung rsv load airwai obstruct blood ccl cxcl express treatment antirsv antibodi reduc blood rsv rna load improv airwai obstruct immunostain identifi rsv antigen alveolar macrophag peripher blood monocyt conclus rsv rna detect peripher blood infect live rsv timecours parallel viral load assess respiratori tract correl rsvinduc airwai diseas
PLoS One	23946454	2008-03-19	PMC2947515	20927383	background proteasom inhibitor bortezomib repres advanc treatment multipl myeloma mm bortezomib inhibit activ proteasom induc cell death varieti tumor cell mechan cytotox understood methodologyprincip find investig differenti phosphoproteom proteasom inhibit stabl isotop label amino acid cell cultur silac combin phosphoprotein enrich lcmsm analysi total phosphoprotein identifi phosphoprotein fold greater chang bortezomib treatment phosphoprotein express alter encompass major protein class includ larg number nucleic acid bind protein sitespecif phosphopeptid quantit reveal ser phosphoryl stathmin increas bortezomib treatment suggest mechan associ bortezomibinduc apoptosi mm cell studi demonstr stathmin phosphoryl profil modifi respons bortezomib treatment regul stathmin phosphoryl specif serthr residu particip cellular respons induc bortezomib conclusionssignific systemat profil phosphoryl chang respons bortezomib treatment advanc global mechanist understand action bortezomib myeloma cell identifi uncharacter signal protein myeloma cell
PLoS One	18448489	2011-07-01	PMC2948498	20957032	background unusu high number sever pneumonia case consider mortal observ pandem hn viru infect global india mild critic case admit treat govern hospit initi phase pandem studi undertaken earli phase pandem methodolog role viral load host factor pathogenesi assess examin mild mp critic patient cip healthi control pune india sequenti blood lung aspir sampl collect cip viral load cytokineschemokin level determin plasma lung aspir patient tlr level determin stain fac analysi gene profil cell lung aspir pbmc taqman low densiti arrai antibodi titr isotyp ha protein base elisa princip find critic patient expir plasma sampl neg viru irrespect patient categori sequenti lung sampl cip lower viral load question associ viral replic sever antirphnhaigg titr higher critic patient categori circul exclus igg isotyp critic patient exhibit increas tlr decreas tlr express diseas sever correl increas plasma level ilra il il ccl ccl il major immunefunct gene downregul pbmc upregul cell lung aspir critic patient distinct pattern differenti fatal surviv patient observ sequenti sampl examin paramet conclus diseas sever associ pronounc impair host immun respons
Virol J	21734771	2001-11-15	PMC2949843	20849641	background porcin reproduct respiratori syndrom viru prrsv envelop viru bear sever econom consequ swine industri worldwid previou studi envelop virus incorpor cellular protein associ virion membran plai role viral infect studi sought proteom profil cellular protein incorpor associ virion highli virul prrsv strain gdby provid foundat investig role incorporatedassoci cellular protein prrsv infect experi sixti cellular protein identifi highli purifi prrsv virion twodimension gel electrophoresi coupl mass spectrometr approach identifi cellular protein group function categori includ cytoskelet protein chaperon macromolecular biosynthesi protein metabolismassoci protein calciumdepend membranebind protein function protein identifi protein report studi envelop virus guanin nucleotidebind protein tyrosin monooxygenasetryptophan monooxygenas peroxiredoxin galectin protein presenc select cellular protein actin tubulin annexin heat shock protein hsp calcium bind protein highli purifi prrsv virion valid western blot immunogold label assai conclus studi demonstr incorpor cellular protein prrsv virion valuabl investig effect individu cellular protein viral replic assembl pathogenesi
Virol J	11602703	2008-04-27	PMC2949849	20858246	rna interfer rnai technolog power tool function genom allow rapid drug target discoveri vitro valid target cell cultur rnai repres promis novel therapeut option treat human diseas cancer select gene silenc rnai achiev essenti nucleic acid base method cytoplasm deliveri short doublestrand ds interf rna oligonucleotid sirna gene silenc transient natur suitabl applic ii nuclear deliveri gene express cassett express short hairpin rna shrna process endogen interf rna lead stabl gene downregul process involv nucleic acid base drug highli charg cross cell membran free diffus vivo deliveri rnai therapeut technolog enabl rnai therapeut travers biolog membran barrier vivo virus vector deriv carri precis task major deliveri system shrna summar compar current viral deliveri system exampl vivo applic indic trend develop replic virus shrna deliveri cancer cell
PLoS Med	18438401	2010-07-01	PMC2950129	20957189	gabriel leung angu nicol provid reflect intern respons hn influenza pandem includ what chang anticip futur flu pandem
PLoS One	21178463	2015-09-30	PMC2950840	20949131	background clike proteas clpro sever acut respiratori syndromecoronaviru requir autoprocess polyprotein potenti target treat coronavir infect methodologyprincip find thorough understand substrat specif proteas substrat librari imag text variant creat perform satur mutagenesi autocleavag sequenc posit substrat sequenc insert cyan yellow fluoresc protein cleavag rate monitor vitro fluoresc reson energi transfer rel cleavag rate substrat sequenc correl structur properti p posit prefer residu high sheet propens prefer small hydrophob residu prefer hydrophob residu branch gln best residu posit observ cleavag detect met substitut posit prefer small residu p posit strong prefer residu substitut noteworthi solvent expos site p posit favour posit charg residu neg charg suggest electrostat interact plai role catalysi superact substrat combin prefer residu posit fold higher activ wildtyp sequenc conclusionssignific demonstr strong structureact relationship clpro substrat substrat specif profil studi provid insight ration design peptidomimet inhibitor
PLoS One	26424572	2017-04-01	PMC2953511	20976271	autopsi studi human highli pathogen avian influenza viru hn infect multipl human organ lung organ damag viral replic andor dysregul cytokin chemokin uncertainti exist partli limit number case analys studi full autopsi includ organ system conduct confirm hn human fatal case male year hour death addit respiratori system lung bronchu trachea viru isol cerebr cortex cerebr medullari substanc cerebellum brain stem hippocampu ileum colon rectum uret aortopulmonari vessel lymphnod real time rtpcr evid matrix hemagglutinin gene posit liver spleen addit posit tissu viru isol immunohistochemistri insitu hybrid stain accord evid viral infect real time rtpcr bronchu quantit rtpcr suggest high viral load associ increas host respons viral load organ cell immunolog system target viru infect pathogenesi hpai hn viru associ viru replic immunopatholog lesion addit immun cell exclud plai role dissemin viru vivo
PLoS One	28319790	2005-03-01	PMC2953514	20967280	background sourc influenc health protect behaviour influenza pandem emerg infecti diseas epidem uncertain methodolog data crosssect telephon interview hong kong adult june test theori dataderiv hypothes associ trust formalinform understand selfefficaci perceiv suscept worri hand hygien social distanc structur equat model multigroup comparison princip find trust formal governmentmedia influenza associ greater report understand ahn ahn prevent selfefficaci turn associ hand hygien trust inform interperson neg associ perceiv person ahn suscept neg associ perceiv selfefficaci posit associ influenza worri trust inform posit associ influenza worri turn associ greater social distanc multigroup comparison gender differ path trust formal understand ahn trust inform understand ahn understand ahn perceiv selfefficaci conclusionssignific trust governmentmedia associ greater selfefficaci handwash trust inform associ perceiv health threat avoid behaviour risk commun consid gender differ
PLoS One	15722333	2004-07-01	PMC2954148	20976274	yersinia pesti etiolog agent plagu kill peopl record histori mankind antibiot provid relief patient high bacteremia patient infect antibiot resist strain plagu virul factor pesti capsid protein lowcalcium respons lcr vprotein vantigen proven target activ passiv immun mous monoclon antibodi mab vantigen passiv protect mice murin model plagu antiyersinia pesti monoclon antibodi prophylact therapeut treatment human identifi antifspecif human mab antivspecif human mab m pan nave phagedisplai fab librari vantigen fab convert igg bind protect activ evalu bound weakli peptid locat nterminu protect mous antif mab bind bound vantigen peptid indic linear epitop bind peptid panel peptid suggest epitop conform better protect m pesti challeng plagu mous model synergist observ three antibodi combin incomplet complet protect achiev time postchalleng antibodi studi determin potenti therapeut prophylact pesti infect human
PLoS One	15362465	2007-01-17	PMC2954790	20976281	background electron medic record emr rich sourc har epidem surveil ask structur emr data coupl computer process freetext clinic entri enhanc detect acut respiratori infect ari methodolog manual review emr record outpati visit uncov refer case ari logist regress backward elimin determin candid structur emr paramet diagnost code vital sign order test imag medic contribut detect refer case develop computer freetext search identifi clinic note document nonneg ari symptom heurist build casedetect algorithm best combin retain structur emr paramet the text analysi princip find adjust group diagnost code identifi refer ari patient sensit specif posit predict ppv of addit structur clinic paramet consid contribut ari detect prescript cough remedi elev bodi temperatur diagnost code paramet increas detect sensit specif ppv declin ad text analysi increas sensit ppv drop algorithm requir satisfi queri structur emr paramet text analysi disclos ppv retain sensit conclus structur emr paramet freetext analys combin algorithm detect ari case level sensit precis highlight potenti path repurpos emr facilit discoveri epidem mass casualti
Virol J	17229702	2007-04-25	PMC2954857	20858291	background differenti diagnos japanes enceph viru jev infect flaviviru west nile viru wnv dengu viru dv infect greatli hinder serolog crossreact viru specif epitop benefit develop jev specif antibodi detect method identifi jev specif epitop fulli map character continu bcell epitop prmm protein jev map epitop prmm protein design set partial overlap fragment span prm fuse gst express express vector linear epitop vnkkeawldstkatri detect enzymelink immunosorb assai elisa remov amino acid residu individu carboxi amino termin peptid confirm minim unit linear epitop prmm keawldstkat epitop highli conserv jev strain epitop crossreact wnvposit denvposit sera conclus epitop jev specif lineal bcell epitp provid basi develop epitopebas viru specif diagnost clinic techniqu
Virol J	17460117	2010-03-23	PMC2955716	20863409	background spike protein coronavirus associ cellular molecul mediat infect target cell character cellular protein requir viru infect essenti understand viral life cycl provid cellular target antivir therapi identifi neural cell adhes molecul ncam novel interact partner phecov protein phage displai cdna librari cell construct librari screen solubl phecov glycoprotein coimmunoprecipit assai ncam bind partner spike protein solubl form antincam antibodi block associ phecov cell doublestrand sirna target ncam inhibit phecov infect conclus novel interact identifi ncam spike protein associ critic phecov infect
PLoS One	20332209	2010-07-14	PMC2956640	20976137	although metagenom emploi pathogen discoveri cost complex prevent practic frontlin diagnost unknown infecti diseas demonstr util metagenomicsbas strategi panvir microarrai virochip deep sequenc identif character pandem hn influenza viru nasopharyng swab collect earliest stage pandem mexico canada unit state virochip detect novel viru close swine influenza virus priori deep sequenc yield read correspond hn influenza sampl percentag align sequenc correspond hn rang coverag influenza genom sampl detect hn deep sequenc titer limit detect specif rtpcr percentag sequenc read linearli correl viru titer deep sequenc provid insight upper respiratori microbiota host gene express respons hn infect unbias analysi combin sequenc data outbreak sampl reveal hn genom assembl de novo refer sequenc includ assembl fulllength genom segment indic streamlin metagenom detect strategi replac multipl convent diagnost test requir investig outbreak novel pathogen provid blueprint comprehens diagnosi unexplain acut ill outbreak clinic public health set
PLoS One	20631148	2018-10-24	PMC2956653	20976145	the ongo emerg human infect origin wildlif highlight better knowledg microbi commun wildlif speci tradit diagnost approach limit evalu microbi biota healthi mule deer odocoileu hemionu analys lymph node metatranscriptom cdna librari individu pool sampl prepar retropharyng lymph node rna enrich polyadenyl rna sequenc roch life scienc technolog proteincod ribosom rna rrna sequenc taxonom profil protein rrna specif databas repres bacteri phyla detect librari base proteincod transcript indic viabl microbiota lymph node resid skin rumen ubiquit mule deer habitat domin classifi bacteri speci base detect rrna proteincod transcript identifi proteobacteri speci helicobact close helicobact cetorum helicobact pylorihelicobact acinonychi complex acinetobact acinetobact schindleri virus novel gamma retroviru member poxvirida retrovirida identifi addition evalu bacteri divers amplicon sequenc hypervari region rrna demonstr taxonom divers higher metatranscriptom approach data provid complet pictur microbi divers wildlif host advanc metatranscriptom studi microbiota wildlif tissu will facilit detect novel organ pathogen potenti human anim
Int J Microbiol	30355759	2013-07-31	PMC2958490	20981303	the diagnosi respiratori viru infect evolv year emerg pathogen develop novel detect method advanc improv sensit turnaround time diagnost test respiratori virus rais issu cost clinic signific detect multipl virus singl specimen molecular method articl review advanc specimen collect detect method diagnosi respiratori viru infect discuss perform characterist limit method
Retrovirology	23903541	2006-06-01	PMC2959034	20923574	background identif broad neutral epitop hiv envelop spike paramount hiv vaccin develop broad neutral epitop identifi surfac nativ hiv envelop spike recognit antibodi depend conform chang envelop spike hiv envelop spike transientlyexpos neutral epitop difficult identifi studi construct singl chain fv scfv deriv human monoclon antibodi genet link glycosylphosphatidylinositol gpi attach signal gpi attach signal scfv target lipid raft plasma membran addit demonstr gpianchor scfv secret counterpart neutral hiv degre breadth potenc gpianchor scfv exhibit extrem potent broad neutral activ multipl clade hiv strain test gpianchor scfv exhibit potent neutral activ secretori counterpart final demonstr express gpianchor scfv lipid raft plasma membran human cd cell confer longterm resist hiv infect hiv envelopemedi cellcel fusion infect hiv captur transfer human dc conclus gpianchor scfv gener effect identifi antibodi react transientlyexpos neutral epitop envelop protein hiv envelop virus gpianchor scfv breadth potenc great potenti develop antivir agent hiv prevent therapi
BMC Infect Dis	16757623	2004-06-25	PMC2959060	20920320	background data predict patient pandem influenza hn infect complic cours spars retrospect studi admiss serum creactiv protein crp level serv predictor ill sever method includ consecut adult patient present emerg depart maydecemb flulik ill confirm diagnosi pandem influenza hn infect serum crp level measur hour present patient proven addit concurr acut ill bacteremia exclud roc curv analysi kaplanmei curv cox proport hazard model evalu predict abil crp prognost factor seventeen enrol patient admit intens care unit icu requir mechan ventil three di median admiss serum crp level higher patient requir subsequ icu care mechan ventil patient mgl mgl mgl mgl cox proport hazard model identifi admiss serum crp level auscultatori find lung independ prognost factor icu admiss admiss serum crp level independ prognost factor mechan ventil thirti dai present the patient admiss serum crp level mgl lower tertil requir icu admiss mechan ventil time point patient admiss serum crp level mgl upper tertil need admit icu upper tertil group requir mechan ventil differ rate lower upper tertil group logrank icu mechan ventil conclus studi group serum crp level earli admiss stage patient present pandem hn influenza infect serv gaug predict diseas cours assist patient manag
Virol J	15220402	2005-02-04	PMC2965154	20946645	background dengu virus den wildest transmit mosquitoborn pathogen tropic subtrop region worldwid infect den sever flulik ill fatal hemorrhag fever rna interfer trigger longlength dsrna consid potent antivir pathwai mosquito limit studi small interf rna sirna conduct nt sirna target membran glycoprotein precursor gene den synthes transfect mosquito cell challeng den stabil sirna cell monitor flow cytometri antivir sirna evalu measur cell surviv rate mtt method viral rna quantit realtim rtpcr presenc cell sirna dai transfect dai incub den reduc cytopath increas cell surviv rate reduc viral rna copi ct detect transfect cell conclus data synthet sirna den membran glycoprotein precursor gene effect inhibit den viral rna replic increas cell surviv rate sirna offer potenti strategi prevent treatment den infect
PLoS One	15695582	2010-03-31	PMC2966397	21060827	coronavirus cov mild sever diseas human anim host rang environment spread underestim current investig potenti medic relev infecti bronchiti viru ibv belong gammacoronavirus costli respiratori viral diseas chicken role wild bird epidemiolog ibv understood studi examin cloacal faecal sampl collect wild bird speci beringia area presenc cov perform statist phylogenet analys detect divers cov rtpcr wild bird beringia area sequenc analysi detect virus gammacoronavirus ibv find wild bird carri gammacoronavirus asymptomat conclud cov widespread wild bird beringia geograph spread frequenc higher realis avian cov effici dissemin larg distanc genet reservoir futur emerg pathogen cov consid great anim health econom impact ibv emerg novel coronavirus sarscoronaviru investig role wildlif reservoir cov infect biologi epidemiolog
PLoS One	20357215	2017-12-20	PMC2966401	21060829	background molecular diagnost method complement exist tool improv diagnosi malaria requir good laboratori infrastructur restrict refer laboratori studi adopt molecular tool routin malaria endem countri will requir simpler molecular platform develop loopmedi isotherm amplif lamp method simpl improv better endem countri studi attempt improv method malaria diagnosi simpl portabl devic capabl perform amplif detect fluoresc lamp platform refer realamp method methodolog find publish genusspecif primer test util method dna deriv speci malaria parasit initi character clinic sampl falciparum determin sensit specif system compar microscopi nest pcr method addition directli boil parasit prepar compar convent dna isol method realamp method simpl allow realtim detect dna amplif time amplif vari gener minut humaninfect plasmodium speci detect sensit specif realamp detect falciparum compar microscopi and compar standard nest pcr method addit method consist detect falciparum directli boil blood sampl conclus realamp method great potenti field usabl molecular tool diagnosi malaria tool provid altern convent pcr base diagnost method field clinic oper program
PLoS Pathog	29435062	2006-07-01	PMC2973827	21079686	increas intracellular zn concentr zincionophor pyrithion pt effici impair replic varieti rna virus includ polioviru influenza viru virus attribut interfer viral polyprotein process studi demonstr combin zn pt low concentr zn pt inhibit replic sarscoronaviru sarscov equin arter viru eav cell cultur rna synthesi distantli nidovirus catalyz rnadepend rna polymeras rdrp core enzym multiprotein replic transcript complex rtc activ assai rtc isol cell infect sarscov eavthu elimin pt transport zn plasma membranew zn effici inhibit rnasynthes activ rtc virus enzymat studi recombin rdrp sarscov nsp eav nsp purifi coli subsequ reveal zn directli inhibit vitro activ nidoviru polymeras zn block initi step eav rna synthesi case sarscov rdrp elong inhibit templat bind reduc chelat zn mgedta inhibitori dival cation revers novel experiment tool vitro studi molecular detail nidoviru replic transcript
Biol Direct	16847084	2010-08-18	PMC2973933	20937149	background difficult measur precis phenotyp complex live organ propos method calcul minim amount genom need construct organ effect measur organism complex permut combin formula shannon concept demonstr calcul correl intuit organism phenotyp complex defin tradit taxonomi evolutionari theori virus human be effect gradual increas thousand bit hundr million bit simpler organ the complex organ the human genom estim effect function sequenc conclus effect quantit measur phenotyp complex live organ estim function fraction genom review articl review dr lavanya kannan nomin dr arcadi mushegian dr chao chen dr rietman nomin dr marc vidal
Immunome Res	20719948	2014-05-19	PMC2981880	21067543	immunoinformat emerg branch informat scienc long ago pullul tree knowledg bioinformat disciplin appli informat techniqu problem immun system great extent immunoinformat typifi epitop predict method disappointingli limit design discoveri vaccin area proper comput support gener lack extant vaccin base isol epitop correspond chemicallytr attenu pathogen correspond individu protein extract pathogen correspond complex carbohydr chapter attempt review progress asyetunderexplor area immunoinformat comput discoveri protein antigen effect develop antigen predict method reduc laboratori resourc requir identifi pathogen protein candid subunit vaccin review place antigen predict firmli context explor role revers vaccinolog design discoveri vaccin highlight compet ultim complementari methodolog approach subcellular locat predict identifi antigen sequenc similar sophist statist approach predict probabl antigen characterist explor system immunom approach predict immunogen prove help predict antigen
Immunome Res	24841273	2001-04-01	PMC2981881	21067547	virus fast evolv pathogen continu adapt highli variabl environ live reproduc strategi devot inhibit viru replic control spread host cope extrem heterogen popul potenti avoid medic intervent comput techniqu phylogenet method broaden pictur viral evolut time space mathemat model contribut progress unravel dynam viru replic fit virul integr multipl comput mathemat approach experiment data help predict behavior viral pathogen anticip escap dynam piec plai critic role aspect vaccin develop viral strain select vaccin ration attenu virus review aspect viral evolut address quantit discuss comput method potenti improv vaccin design
J Neuroinflammation	11282586	2018-05-30	PMC2984415	21034511	background wnvassoci enceph wnve character increas product proinflammatori mediat glial cell activ eventu loss neuron wnv infect neuron rapidli progress destruct infect nonneuron brain cell limit role neuron patholog consequ proinflammatori cytokin releas result wnv infect unclear object studi examin role kei cytokin secret wnvinfect neuron mediat neuroinflammatori marker neuron death method transform human neuroblastoma cell sknsh infect wnv multipl infect moi and wnv replic kinet express profil kei proinflammatori cytokin analyz plaqu assai qrtpcr elisa cell death measur sknsh cell presenc absenc neutral antibodi kei proinflammatori cytokin cell viabil assai tunel flow cytometri nave primari astrocyt treat uvinactiv supernat mock wnvinfect sknsh cell activ astrocyt measur flow cytometri elisa wnvinfect sknsh cell induc express il tnf dose timedepend manner coincid increas virusinduc cell death treatment cell antiil tnf reduct neurotox effect wnv treatment nave astrocyt uvinactiv supernat wnvinfect sknsh cell increas express glial fibrillari acid protein kei inflammatori cytokin conclus time neuron potenti sourc proinflammatori cytokin wnvinfect brain neuronderiv cytokin contribut wnvinduc neurotox cytokin releas neuron mediat activ astrocyt data defin specif role wnvinduc proinflammatori cytokin provid framework develop antiinflammatori drug muchneed therapeut intervent limit symptom associ wnve
PLoS One	29848753	2019-04-10	PMC2984494	21103348	mutat slca preval hereditari deaf deaf correspond mous model slca abnorm enlarg cochlear lumen goal studi determin cochlear enlarg origin defect cochlear fluid transport malfunct fluid transport connect compart vestibular labyrinth endolymphat sac embryon inner ear slca slca mice examin confoc microscopi vivo dai organ cultur cultur allow observ intact ligat partial resect inner ear cochlear lumen format base cochlea embryon dai enlarg evid slca compar slca mice slca slca mice separ cochlea vestibular labyrinth ligat reduc cochlear lumen resect endolymphat sac led enlarg cochlear lumen slca mice caus enlarg enlarg cochlear lumen slca mice ligat resect perform alter cochlea lumen conclus data cochlear lumen format initi fluid secret vestibular labyrinth temporarili control fluid absorpt endolymphat sac failur fluid absorpt endolymphat sac lack slca express appear initi cochlear enlarg mice human lack function slca express
PLoS Comput Biol	30971475	2014-11-10	PMC2987833	21124942	although vaccin pose best prevent influenza infect strain select optim implement remain difficult antigen drift lack understand global spread detect viral movement sequenc analysi complic skew geograph season distribut viral isol propos probabilist method account sampl bia spatiotempor cluster model region season transmiss binomi process analysi hn confirm eastsoutheast asia sourc season variant increas resolut observ transmiss countri level hn data reveal viral spread tropic network analysi suggest china hong kong origin season hn strain unit state region increas vaccin maxim disrupt global spread viru techniqu provid promis methodolog analysi season viru continu surveil influenza
Virol J	25385825	2008-02-01	PMC2988023	21047436	background spike protein sarscov mediat receptorbind induc neutral antibodi identifi receptorbind domain rbd protein major target neutral antibodi anim model propos rbdbase vaccin antigen immunogen rbd human character panel serum sampl recov sar patient includ antibodi respons rbd measur elisa microneutr assai rbd protein induc potent antibodi respons recov sar patient rbdspecif antibodi persist high titer three year followup affin purifi antirbd antibodi possess robust neutral activ conclus rbd sarscov highli immunogen human mediat protect respons rbdbase vaccin diagnost approach develop
BMC Public Health	18303361	2006-11-15	PMC2988738	21044300	the pandem hn influenza compound season influenza pose global challeng despit announc postpandem period august thewho hn viru continu circul season viru year nation health author remain vigil unpredict behaviour viru major popul live countri inadequ resourc purchas vaccin stockpil antivir drug basic hygien measur wear face mask hygien practic hand wash reduc spread respiratori virus immin issu translat measur daytodai practic experi sever acut respiratori syndrom sar hong kong gener practition gp discharg duti despit risk infect sar event highlight inadequ interfac primari secondari care valuabl health care resourc inappropri match commun wai gp contribut combat influenza pandem prompt detect monitor epidem miniepidem viral ill commun empow rais health literaci commun advoc person hygien precauti measur gp assist develop protocol primari care manag patient flulik ill conduct clinic audit standard prevent treatment measur gp adequ liaison public health agenc facilit earli diagnosi patient influenza articl summaris primari care action phase pandem discuss novel role gp altern sourc health care patient care secondari care level health care system remain sustain public health crisi
BMC Med Genet	17108024	2009-12-09	PMC2989958	21067616	background dendrit cellspecif intercellular adhes molecul grab nonintegrin dcsign pathogen recognit receptor innat immun system dcsign promot variant plai role suscept infecti diseas nasopharyng carcinoma npc malign common southern china dcsign promot variant effect suscept npc unknown aim studi ascertain potenti involv dcsign promot singl nucleotid polymorph snp npc suscept method conduct case control studi base cantones popul includ npc patient control match ag sex bp dcsign promot region directli sequenc sampl sequenc align snp search inspect dnastar analysi program haplotyp frequenc estim haploview associ snp risk npc analyz chisquar test noncondit logist regress analysi spss softwar total variant observ dcsign promot region dcsign gg aa associ npc risk adjust odd ratio or confid interv ci p subject carri risk allel dcsign fold ci increas risk develop npc haplotyp analysi reveal aaag associ protect npc associ permut test run conclus studi indic dcsign promot variant appear involv suscept npc detail mechan studi
PLoS Negl Trop Dis	20007283	2005-06-30	PMC2990691	21124882	background japanes enceph je caus mosquitoborn flaviviru endem entir southeast asian adjoin region current therapeut intervent je make dread encephalitid effect counter viru inhibit viral replic antisens molecul direct viral genom octaguanidinium dendrimerconjug morpholino vivomorpholino uncharg antisens oligom enter cell live organ endocytosi subsequ escap endosom cytosolnuclear compart cell hypothes vivomorpholino gener specif region untransl region jev genom administ experiment model je will antivir neuroprotect methodologyprincip find mice infect jev gp strain intraperiton administr morpholino mgkg bodi weight daili treatment surviv anim monitor dai death sacrif brain process immunohistochem stain protein extract plaqu assai immunoblot analysi perform brain homogen reduc viral load viral protein express greater surviv infect anim neuroprotect observ thionin stain brain section cytokin bead arrai reduct level proinflammatori cytokin brain morpholino treatment elev infect correspond reduc microgli activ brain oxid stress reduc stressrel signal molecul posit modul morpholino treatment vitro studi decreas infect viral particl product morpholino treatment conclusionssignific administr vivomorpholino effect increas surviv anim neuroprotect murin model je oligom repres potenti antivir agent merit evalu
BMC Infect Dis	15994805	2018-02-14	PMC2990753	21062471	background health care worker hcw present frequent concern health famili health high level psycholog distress previou diseas outbreak sar outbreak associ social isol intent absente aim assess hcw concern anxieti perceiv suffici intend behavior ahn influenza pandem associ psycholog distress method septemb st healthcar worker hcw tertiari teach hospit complet item questionnair concern worri ahn influenza pandem cassileth style questionnair parti ghq half studi hcw report worri ahn influenza pandem degre anxieti moder high median frequent concern infect famili friend health consequ diseas perceiv risk infect consid moder high median hcw restrict social contact fewer felt isol famili member friend hospit work low percentag indent leav avoid infect worri degre worri associ intend absente restrict social contact psycholog distress perceiv suffici aspect ahn influenza moder high the ahn influenza consid clear median perceiv suffici prognosi infect independ associ degre worri pandem conclus proport hcw experienc moder high anxieti pandem degre worri independ correl psycholog distress perceiv suffici ahn influenza prognosi associ reduc degre worri hospit manag consultationliaison psychiatri servic provid hcw order offer favour work condit time extrem distress current futur pandem
Mar Drugs	29444942	2007-08-01	PMC2992996	21116410	marin spong current richest sourc pharmacolog activ compound marin environ bioactiv molecul secondari metabolit main function enabl andor modul cellular commun defens produc function enzym cluster spong andor associ symbiot microorgan natur product lead compound spong promis pharmaceut agent approv antivir agent clinic advanc late stage clinic trial drug treatment human immunodefici viru hiv herp simplex viru hsv antivir lead marin origin report nucleosid araa vidarabin isol spong tethya crypta inhibit viral dna polymeras dna synthesi herp vaccinica varicella zoster virus discoveri type virus emerg drug resist strain develop antivir lead compound continu spong deriv antivir lead compound hopedto develop futur drug discuss review suppli problem major bottleneck develop compound drug clinic trial advanc field metagenom high throughput microbi cultiv rais possibl techniqu lead costeffect larg scale product compound perspect biotechnolog method respect marin drug develop discuss
Virol J	17434557	2017-07-12	PMC2994542	21073718	background hendra viru hev nipah viru niv newli emerg zoonot paramyxovirus discov outbreak queensland australia peninsular malaysia classifi henipaviru genu virus infect broad rang mammalian speci caus sever oftenleth diseas human anim repeat outbreak continu occur extens laboratori studi host cell infect stage hev niv role envelop glycoprotein hamper highli pathogen natur restrict biosafeti level bsl contain circumv problem develop henipaviru envelop glycoprotein pseudotyp lentiviru assai system luciferas gene green fluoresc protein gfp gene encod human immunodefici viru type hiv genom conjunct hev niv fusion attach glycoprotein function retroviru particl pseudotyp henipaviru glycoprotein displai proper target cell tropism entri infect depend presenc hev niv receptor ephrinb target cell function specif assai confirm lack reportergen signal particl bear glycoprotein prepar assai viru entri block infect carri presenc fusion inhibit ctermin heptad hr peptid wellcharacter crossreact neutral human mab specif henipaviru glycoprotein solubl ephrinb receptor addit util assai demonstr examin influenc cytoplasm tail fusion activ incorpor pseudotyp viru particl gener test panel truncat mutant niv hev conclus demonstr specif henipaviru entri assai develop niv hev glycoprotein pseudotyp reportergen encod retroviru particl assai conduct safe bsl condit will tool measur henipaviru entri studi glycoprotein function context viru entri assai character neutral antibodi viru entri inhibitor
PLoS One	28701403	2006-12-15	PMC2994772	21152402	background novel influenza pandem viru hnpdm caus consider morbid mortal worldwid aim studi evalu clinic cours durat viral shed hnpdm evolut emerg antivir resist hospit cancer patient sever hnpdm infect winter brazil method perform prospect singlecent cohort studi cancer center rio de janeiro brazil hospit patient cancer confirm diagnosi influenza hnpdm evalu main outcom measur studi inhospit mortal durat viral shed viral persist function molecular analys hnpdm suscept oseltamivir total hospit patient suspect influenzalik ill screen total diagnos hnpdm infect hospit mortal cohort thirteen patient requir intens care median ag studi cohort year year eighteen patient receiv chemotherapi previou month neutropen onset influenza total patient evalu durat viral shed displai prolong viral shed median rang dai associ emerg resist hnpdm viru viral evolut observ sequenti collect sampl conclus prolong influenza hnpdm shed observ cancer patient oseltamivir resist detect data sever cancer patient constitut pandem viru reservoir major implic viral propag
PLoS One	17158916	2010-02-05	PMC2994777	21152405	there increas concern impact veterinari drug livestock pathogen factor damag wildlif health threaten avian scaveng feed medic livestock carcass conduct comprehens studi fail egg dead nestl beard vultur gypaetu barbatu attempt elucid proxim breed failur declin product spanish pyrene high concentr multipl veterinari drug fluoroquinolon fail egg nestl associ multipl intern organ damag livestock pathogen caus diseas septicaemia swine pathogen infecti bursal diseas combin impact drug diseas stochast factor result devast effect exacerb high risk extinct consid current conserv program beard vultur scaveng speci danger veterinari drug highli pathogen poultri virus
Interdiscip Perspect Infect Dis	20139279	2019-07-01	PMC2995904	21151699	the infer popul dynam molecular sequenc data method surveil infecti diseas examin heterogen contact shape genealog parasit agent extens simul find contact heterogen strong structur genealog reflect epidemiolog relev quantiti proport popul infect compar simul beast reconstruct find contact heterogen increas number sequenc isol requir estim quantiti cours epidem data contactnetwork structur will requir addit sequenc data accur estim parasit agent genealog conclud network model will progress area
BMC Genomics	31475214	2016-08-03	PMC2996934	20576142	background domest cat offer enorm genom potenti veterinari descript hereditari diseas model occurr deadli felin virus felin leukemia viru felv felin coronaviru fecv felin immunodefici viru fiv homologu human scourg cancer sar aid realiz biomed potenti high densiti singl nucleotid polymorph snp map requir order accomplish diseas phenotyp associ discoveri descript remedi gener pair fosmidend sanger sequenc read cat combin data publicli cat genom sequenc sequenc read assembl form genom assembl allow discoveri three snp reduc potenti fals posit snp low coverag assembl low upperlimit sequenc coverag high lowerlimit qualiti discrep base potenti variant site domest cat breed femal abyssinian femal american shorthair male cornish rex femal european burmes femal persian femal siames male ragdol femal african wildcat sequenc lightli report total common snp suitabl domest cat snp genotyp arrai addit snp detect african wildcat domest cat breed empir sampl discov snp test sequenc cat snp valid rate conclus data provid larg collect map felin snp cat genom will allow develop snp genotyp platform map felin diseas
PLoS One	27489275	2006-12-20	PMC2997101	21151943	cluster hierarch cluster method understand analys data wide varieti knowledg domain notabl util system data classifi evolutionari context paper introduc hierarch cluster problem defin novel object function call arithmeticharmon cut problem find cut imag texthard imag texthard fixedparamet tractabl indic problem polynomi time algorithm approxim exact parameter local search base techniqu produc workabl algorithm implement memet algorithm problem demonstr effect arithmeticharmon cut number dataset includ cancer type dataset corona viru dataset favor perform compar current hierarch cluster techniqu imag textmean graclu normalizedcut arithmeticharmon cut metric overcom difficulti hierarch method repres interclust differ intraclust similar
BMC Public Health	17182757	2006-11-22	PMC2998491	21078169	background case influenza ahn swine flu confirm uk april novel viru identifi mexico rapidli evolv pandem swine flu outbreak pandem year encount major influenza outbreak studi examin public understand pandem explor peopl deciph threat perceiv control risk method purpos sampl recruit seventi three peopl women men focu group discuss time second wave swine flu case discuss evid public overreact peopl believ threat contract swine flu inevit assess selfefficaci protect low respond assess greater risk health vaccin diseas find led apathi uk govern recommend health protect behaviour suboptim level vaccin uptak gener peopl confus differ season influenza swine flu vaccin conclus suggest gap public understand hinder attempt commun novel flu virus futur gener support govern handl pandem public awar campaign deem ineffectu peopl chang current hand hygien practic support media deem overreport swine flu pandem
Environ Health	17121802	2012-09-17	PMC3000394	21078183	background damp mold qualit review associ varieti advers respiratori health effect includ respiratori tract infect publish metaanalys provid quantit summari associ respiratori infect demonstr causal relationship dampnessrel agent prevent exposur respiratori tract infect public health strategi report quantit metaanalys publish studi examin associ damp mold home respiratori infect bronchiti method primari studi meet elig criteria transform report odd ratio or confid interv ci log scale fix random effect model appli log or varianc studi contain multipl estim or model account correl multipl studi analyz set analys perform elig studi set restrict studi control ag gender smoke socioeconom statu subgroup studi assess explor heterogen funnel plot assess public bia summari estim or random effect model base studi rang ci exclud null case analysi model restrict analys base control multipl confound variabl chang find or ci random effect model studi adjust major confound variabl bronchiti respiratori infect respiratori infect exclud nonspecif upper respiratori infect respiratori infect children infant public bia evid estim attribut risk proport rang conclus residenti damp mold associ substanti statist increas respiratori infect bronchiti associ confirm causal effect control damp mold build prevent substanti proport respiratori infect
Parasite Immunol	22985881	2011-05-01	PMC3001033	19493213	pregnancyassociatedplasmodium falciparum malaria pam major morbid mortal african women offspr pam character accumul infect erythrocyt i adher chondroitin sulphat csa placent intervil space human monoclon igg antibodi specif variant surfac antigen vsa express csaadher i vsapam vitro select parasit nonpregn donor express vsapam select vsapam express preferenti transcript varcsa corrobor current effort develop pamspecif vaccin base varcsa
BMC Infect Dis	21598272	2004-07-29	PMC3001727	21083874	background european repres major intern travel clinician encount return patient essenti role recogn commun travelassoci public health risk method investig morbid travel associ infecti diseas european travel analys diagnos demograph clinic travelrel predictor diseas return travel present eurotravnet centr presum travel associ condit gastrointestin gi diseas account ill febril system ill dermatolog condit respiratori ill death record sepsi caus escherichia coli pyelonephr dengu shock syndrom plasmodium falciparum malaria gi condit includ bacteri acut diarrhea giardiasi amebasi febril system ill identifi pathogen malaria account case dengu includ chikungunya rickettsi diseas leptospirosi brucellosi epstein barr viru infect tickborn enceph tbe viral hepat dermatolog condit domin bacteri infect arthropod bite cutan larva migran anim bite requir rabi postexposur prophylaxi leishmaniasi myasi tungiasi case leprosi respiratori ill includ case tuberculosi includ case multidrug resist extens drug resist tuberculosi case influenza ill case legionnair diseas sexual transmit infect sti account total diagnos includ hiv infect syphili total case vaccin prevent diseas report purpos travel destin specif risk factor identifi diagnos chaga diseas immigr travel south america falciparum malaria immigr subsaharan africa travel europ associ health risk distinct profil eastern western europ conclus broad spectrum travel associ diseas diagnos eurotravnet core site diagnos vari region visit travel spectrum travel associ morbid dispel misconcept travel close europ health risk
BMC Infect Dis	15306395	2014-09-01	PMC3001728	21110854	background studi compar nasal swab invas nasopharyng aspir npa detect respiratori virus comparison perform immunocompet children upper respiratori tract symptom rang poor sensit swab higher sensit npa aim investig sensit flock nasal swab fn immunocompromis adult febril neutropenia method month adult hematolog disord present febril neutropenia enrol studi pair sampl fn npa collect outer nasal caviti nasopharynx sampl analyz panel respiratori virus quantit polymeras chain reaction indirect measur cell yield method copi number human beta actin gene determin cohen kappa calcul measur agreement method wilcoxon signedrank test comparison cell yield total pair sampl total patient collect twenti pair viru detect specimen in npa fn fn sensit viru rhinoviru npa superior fn collect epitheli cell conclus sensit low replac npa sampl techniqu patient categori
PLoS Negl Trop Dis	24980786	2007-11-20	PMC3001904	21179504	leptospirosi widespread zoonot infect resid tropic region infect anim human temper region agent leptospirosi compris member genu leptospira includ nonpathogen saprophyt speci leptospirosi vari sever mild nonspecif ill sever diseas includ multiorgan failur widespread endotheli damag hemorrhag to investig pathogen leptospir affect endotheli cell compar respons endotheli cell line infect pathogen versu nonpathogen leptospir microarrai analys suggest pathogen interrogan nonpathogen biflexa trigger chang express gene product involv cellular architectur interact matrix chang opposit direct infect biflexa predict increas maintain cell layer integr interrogan lead chang predict disrupt cell layer integr bacteri strain caus necrosi apoptosi cell prolong incub pathogen interrogan result disrupt endotheli cell layer assess microscopi abil bacteria cross cell layer disrupt endotheli layer integr abrog addit endotheli protect drug lisinopril physiolog relev concentr adhes interrogan endotheli cell bacteria disrupt endotheli barrier function promot dissemin bacteria contribut sever diseas manifest addit supplement antibiot therapi lisinopril deriv endotheli protect activ decreas sever leptospirosi
PLoS One	18025432	2004-05-01	PMC3002947	21179494	human adenoviru adhu vector robust vaccin platform presenc naturallyacquir neutral antibodi reduc vector efficaci potenti readministr studi evalu immun respons protect vaccin replicationincompet porcin adenoviru pav vector altern vaccin adhu avian influenza hn diseas model vaccin efficaci evalu balbc mice vaccin dose pav vector express optim ahanoi hn hemagglutinin antigen pavha compar adhuha control pavha rapidli gener antibodi respons neutral antibodi titer dai stronger cellular immun respons detect dai compar adhuha pavha vaccin administ dai challeng demonstr improv surviv lower viru load evalu longterm vaccin efficaci month postvaccin better protect pavha adhuha vaccin importantli oppos adhu pav vector neutral human antibodi pool individu pavbas vector capabl mediat swift strong immun respons offer promis altern adhu
J Inflamm (Lond)	15131154	2003-04-15	PMC3003652	21108806	by virtu direct contact environ lung constantli challeng infecti noninfecti stimuli necessit robust highli control host respons coordin innat adapt arm immun system mammalian tolllik receptor tlr function crucial sentinel microbi noninfecti antigen respiratori tract mediat host innat immun select induct inflammatori respons harm environment exposur toler innocu antigen requir maintain tissu homeostasi integr convers dysregul innat immun respons manifest sustain selfperpetu tissu damag control tissu repair articl review aspect tolllik receptor function relev develop acut lung injuri chronic obstruct lung diseas resist frequent associ microbi infect
PLoS One	12663759	2007-05-29	PMC3003686	21179411	we demonstr antigen chemic coupl surfac liposom consist unsatur fatti acid crosspres antigenpres cell apc cd cell process induct antigenspecif cytotox lymphocyt studi mechan liposomecoupl antigen crosspres cd cell apc investig confoc laser scan microscop analysi demonstr antigen coupl surfac unsaturatedfattyacidbas liposom receiv process mhc class class ii compart antigen coupl surfac saturatedfattyacidbas liposom receiv process class ii compart addit flow cytometr analysi demonstr antigen coupl surfac unsaturatedfattyacidliposom apc environ true saturatedfattyacidliposom kind inhibitor dimethylamilorid dma cytochalasin inhibit pinocytosi phagocytosi apc cultur apc prior antigen puls dma cytochalasin reduc uptak liposomecoupl antigen analysi intracellular traffick liposom antigen confoc laser scan microscopi reveal portion liposomecoupl antigen apc deliv lysosom compart agreement reduct antigen uptak apc antigen present apc inhibit dma reduct ifn product antigenspecif cd cell antigen coupl surfac liposom consist unsatur fatti acid pinocytos apc load class mhc process pathwai present cd cell liposomecoupl antigen expect applic develop vaccin induc cellular immun
Hepat Res Treat	17535926	2016-07-24	PMC3003998	21188201	recommend treatment chronic hepat interferon andor nucleostid analogu lead satisfactori result induct hbvspecif cell therapeut vaccin immunotherapi innov strategi overcom viru persist vaccin commerci hbv vaccin patient result effect control hbv infect suggest formul therapeut vaccin need woodchuck marmota monax preclin model develop therapeut approach chronic hepadnavir infect innov approach combin antivir treatment nucleostid analogu dna vaccin protein vaccin test woodchuck model paper summar data concern therapeut immun gene therapi recombin viral vector approach woodchuck encourag addit potenti innov immunomodulatori strategi evalu anim model
PLoS One	27190247	2010-05-13	PMC3004854	21187950	we describ benefit reconstruct ancestr sequenc ra resequenc microarrai rapid pathogen identif enterobacteriacea rpob sequenc model demonstr sharp improv call rate accuraci rass compar extant sequenc improv attribut lower sequenc diverg rass expand sequenc space cover microarrai extens novel microarrai design strategi virus antimicrobi resist element toxin straightforward
BMC Public Health	20467043	2012-04-01	PMC3005570	21143820	background overwhelm complex respons need sever acut respiratori syndrom sar epidem public health profession small island state barbado measur place improv respons event pandem method data studi collect barbado nation influenza surveil system revit compris ten sentinel site send weekli notif acut respiratori ill ari sever acut respiratori ill sari offic nation epidemiologist hn pandem meet nation pandem plan committe technic command committe conven pharmaceut nonpharmaceut intervent npi implement result meet form basi present paper june barbado report case hn june octob laboratori confirm case hn addit case occur januari outbreak period juneoctob surveil team receiv report ari case compar case period total hospit rate sari year peopl compar peopl barbado pandem respons character strong surveil system combin activ passiv surveil good risk commun strategi strengthen public privat sector partnership effect region intern collabor commun restrict strategi school workplac closur cancel group event util public health measur delai spread viru health care facil struggl provid adequ isol facil conclus number confirm case small surg ari sari case indic impact viru island moder result hn virolog surveil improv local region intern partnership strengthen
BMC Public Health	22511816	2013-01-01	PMC3005574	21143824	global nuclear prolifer bioterror emerg infect challeng nation capac achiev maintain global secur centuri emerg infecti diseas threat develop preliminari version intern health regul ihr health organ current hr major differ compar earlier version includ substanti shift contain border contain sourc event shift small diseas list smallpox plagu cholera yellow fever requir report public health threat shift preset measur tailor respons flexibl deal local situat ground ihr call account call strengthen nation capac surveil control prevent alert respons intern public health emerg tradit short list requir report global partnership collabor human right oblig account procedur monitor evolv regul measur revolv fund vaccin procur pan american health organ paho global health secur maintain respons urban yellow fever paraguai influenza hn pandem 
BMC Public Health	23611287	2003-11-01	PMC3005580	21143830	laboratori core capac countri develop implement intern health regul ihr laboratori servic plai major role kei process detect assess respons notif monitor event develop countri easili adapt wellorgan routin laboratori servic resourcelimit countri consider capac build gap exist paper discuss effort african field epidemiolog network afenet support laboratori capac develop africa region effort rang promot graduat level train program build advanc technic manageri leadership skill inservic short cours train peripher laboratori staff number specif project focu extern qualiti assur basic laboratori system strengthen laboratori manag accredit equip calibr harmon train materi network provis prepackag laboratori kit support outbreak investig evid indic posit effort laboratori capac region opportun exist support rollout project attend addit critic area biosafeti biosecu conclud afenet approach strengthen nation subnat system provid model adopt resourcelimit set subsaharan africa
BMC Public Health	14600110	2006-04-26	PMC3005581	21143831	background uganda current implement intern health regul ihr context integr diseas surveil respons idsr ihr requir countri assess abil nation structur capac resourc meet minimum requir surveil respons report describ the assess undertaken uganda method conduct descript crosssect assess protocol develop health organis data collect tool adapt local administ conveni sampl hr stakehold frequenc analys perform ugandan nation law relev ihr exist adequ support full implement ihr correspondingli design ihr nation focal point nfp surveil activ oper commun limit health sector district design diseas surveil offic idsr technic guidelin case definit infecti zoonot diseas surveil surveil guidelin health facil case definit health facil prioriti diseas list surveil guidelin case definit report tool base idsr strategi lack ihr rapid respons team nation district level lack food safeti chemic radionuclear expert guidelin outbreak respons food chemic radionuclear hazard comprehens prepared plan incorpor ihr lack nation district level nation laboratori polici exist strateg plan draft critic gap hamper effici function nation laboratori network final point entri ihr implement design conclus assess highlight critic gap guid ihr plan process ihr action plan develop foster nation intern public health secur
Immunome Res	16641297	2010-10-01	PMC3009956	21129215	background toxoplasmosi loss life cognit motor function sight vaccin greatli need prevent diseas purpos studi immmunosens approach develop foundat develop vaccin protect human hlaa supertyp three peptid identifi high bind score hlaa supertyp bioinformat algorhythm high measur bind affin hlaa supertyp molecul abil elicit ifn product human hlaa supertyp peripher blood cd cell seroposit seroneg person peptid administ univers cdt cell epitop padr akfvaawtlkaaa formul lipopeptid administ glase pamci we creat prepar induc ifn reduc parasit burden hlaaan hlaa supertyp allel transgen mice glase novel emulsifi synthet tlr ligand facilit develop helper cell respons peptid includ express tachyzoit bradyzoit sporozoit type ii parasit approach identifi initi peptid identifi addit peptid bioinformat bind affin assai studi respons hlaa human cell lastli immun hlaa transgen mice pool peptid administ padr glase pamci effect elicit ifn produc cd splenic cell protect immun includ peptid ksfkdilpk sag amltafflr gra rsfkdllkk gra stfwpcllr sagc ssayvfsvkspa avvsllrllkspa immun elicit robust protect measur reduc parasit burden luciferas transfect parasit luciferin novel hla transgen mous model imag xenogen camera conclus toxoplasma gondii peptid elicit hlaa restrict ifn produc cd cell human mice peptid administ adjuv reduc parasit burden hlaa transgen mice work foundat immunosens base vaccin defin novel adjuv newli identifi peptid vaccin prevent toxoplasmosi hlaa supertyp allel
PLoS Negl Trop Dis	20883160	2018-11-01	PMC3014977	21245921	background ctype lectin dcsign cd major dengu receptor human dendrit cell singl nucleotid polymorph snp promot region cd ag rs suscept infecti diseas reason variat dcsign gene broad influenc viral replic host immun respons method find studi rs snp associ suscept dengu fever df andor dengu hemorrhag fever dhf genotyp analysi taiwanes cohort gener monocytederiv dendrit cell mddc individu aa ag genotyp rs studi viral replic immun respons function valid total dna sampl genotyp includ df dhf nondengu febril ill ofi popul control strong associ ggag genotyp rs risk dhf compar df ofi control aa genotyp associ protect dengu infect compar ofi control mddc individu ag genotyp higher cell surfac dcsign express higher tnf ilp ip product aa genotyp respons dengu infect viral replic mddc ag genotyp lower aa genotyp genotyp mddc reveal increas viral replic addit antiip neutral antibodi conclusionssignific rs snp cd promot contribut suscept dengu infect complic dhf snp ag genotyp cell surfac dcsign express immun augment viral replic
PLoS One	30385576	2013-05-15	PMC3016318	21245928	background infrar thermal imag scanner iti appear attract option mass screen travel influenza publish data perform airport method iti measur cutan temperatur airlin travel agre tympan temperatur measur respiratori sampl predict iti tympan temperatur c influenza infect assess receiv oper characterist roc curv estim sensit specif posit predict ppv find front face iti predict tympan temperatur area roc curv ci set sensit specif ppv popul travel febril definit identifi influenza viru infect travel type type iti predict influenza infect area roc curv sensit specif ppv of influenzaposit travel tympan temperatur screen ci three influenza symptom conclus iti perform moder detect fever studi season epidem influenza type proport influenzainfect travel febril low iti better chanc identifi travel influenzainfect febril ill common influenza infect influenza infect influenza infect afebril find iti effect entri screen travel detect influenza infect intent prevent entri viru countri
PLoS Pathog	23678171	2012-04-01	PMC3017121	21253575	interferoninduc transmembran protein ifitm identifi viral restrict factor inhibit infect mediat influenza viru iav hemagglutinin ha protein ifitm protein restrict infect mediat entri glycoprotein gp marburg ebola filovirus marv ebov consist observ interferon restrict filoviru iav entri process ifitm protein inhibit replic infecti marv ebov observ distinct pattern ifitmmedi restrict compar iav entri process marv ebov restrict ifitm restrict ifitm murin ifitm restrict iav effici inhibit filoviru entri demonstr replic infecti sar coronaviru sarscov entri mediat sarscov spike protein restrict ifitm protein profil ifitmmedi restrict sarscov filovirus iav trypsin treatment receptorassoci sarscov pseudovirion bypass depend lysosom cathepsin bypass ifitmmedi restrict ifitm protein reduc cellular cathepsin activ limit access virion acid intracellular compart data indic ifitmmedi restrict local late stage endocyt pathwai ifitm protein differenti restrict entri broad rang envelop virus modul cellular tropism independ viral receptor express
BMC Genomics	22514506	2012-02-01	PMC3017867	21108826	background identifi bacteria virus complex sampl diseas diagnost product safeti environment character arraybas method proven util detect singl assai reason cost microb thousand sequenc method design panmicrobi detect arrai mda detect virus includ phage bacteria plasmid develop novel statist analysi method identifi mixtur organ complex sampl hybrid arrai arrai broader coverag bacteri viral target base sequenc data probe target microbi detectiondiscoveri arrai literatur familyspecif probe select sequenc viral bacteri complet genom segment plasmid probe design toler sequenc variat enabl detect diverg speci homolog sequenc organ match human genom sequenc blind test spike sampl singl multipl virus mda correctli identifi speci strain clinic fecal serum respiratori sampl mda detect character multipl virus phage bacteria sampl famili speci level confirm pcr conclus mda identifi suit virus bacteria complex sampl
Biochem Res Int	22418848	2018-06-27	PMC3017892	21234377	protein rna chaperon activ ubiquit protein plai role cellular mechan prevent rna misfold loosen misfold structur atp consumpt rna chaperon activ studi vitro vivo oligonucleotid ribozymebas assai function structur divers common chaperon mechan univers motif identifi grow databas protein rna chaperon activ establish base evalu chaperon activ describ assai exact mechan understood more believ disord region protein plai role mechan protein possess rna chaperon activ discuss here
Interdiscip Perspect Infect Dis	29950422	2011-05-02	PMC3017939	21234337	unlik local transmiss pandem influenza hn frequent driven school children case identifi longdist intran intern travel adult studi examin relationship probabl temporari extinct agedepend nextgener matrix focus impact assort prefer mix captur good approxim assort heterogen mix popul contribut nonmainten host host type sustain transmiss risk major epidem greatli diminish mix pattern assort scenario higher proport nonmainten host case elev probabl extinct despit presenc epidemiolog factor undoubtedli influenc delai import subsequ epidem domin adult import case repres factor explain delai geograph spread observ pandem
Epidemiol Perspect Innov	21536720	2012-05-21	PMC3018365	21159178	background effect respond infecti diseas outbreak requir wellinform respons quantit method analyz outbreak data estim kei paramet character spread outbreak includ reproduct number serial interv assum data collect complet realiti report delai undetect case lack sensit specif test diagnos diseas lead report error case count provid insight impact report error estim kei paramet proport case report chang studi period estim kei epidemiolog paramet bias data influenza ahn outbreak la gloria mexico provid estim paramet account report error bias report issu account conclus failur account miss data lead mislead inaccur estim epidem paramet
Int J Alzheimers Dis	22615273	2005-08-16	PMC3018626	21234306	herp simplex implic alzheim diseas viral infect produc alzheim diseas patholog mice viru express protein short contigu amino acid stretch aa vatch viralmatch homolog apo clusterin picalm complement receptor gene product relev alzheim diseas homolog protein express pathogen implic alzheim diseas homolog reiter dna level suggest gene associ studi track infect identifi kei gene demonstr role pathogen caus agent vatch interfer function human counterpart act dummi ligand decoi receptor interactom interfer immunogen antibodi gener respons infect target human counterpart produc protein knockdown gener autoimmun respons kill neuron human homologu resid scenario support immun activ alzheim diseas data classifi alzheim diseas autoimmun disord creat pathogen mimicri kei alzheim diseaserel protein prevent vaccin regular pathogen detect elimin stem immunosuppress antibodi adsorptionrel therapi
PLoS One	22431644	2009-12-01	PMC3020143	21264321	cd cell provid broad immun virus recogn type viral protein develop vaccin capabl induc longliv memori cd cell desir prevent diseas vaccin current exist design cd cell vaccin role cd cell induct mainten memori cd cell remain uncertain studi necess cd cell induct mainten memori cd cell investig mice immun liposomecoupl ctl epitop peptid ovaderiv ctl epitop peptid chemic coupl surfac liposom inocul mice primari secondari ctl respons induc confirm cd cellelimin mice suggest cd cell requir gener memori cd cell case immun liposomecoupl peptid surfacelink liposom antigen capabl induc longliv memori cd cell contribut cd cell applic develop vaccin prevent viral infect virus evad humor immun vari surfac protein influenza virus hiv hcv sar coronavirus ebola virus
PLoS One	19952110	2008-12-30	PMC3021518	21264238	the synthesi inact enzym precursor zymogen serv mechan regul execut select catalyt activ desir time andor site zymogen activ proteolyt cleavag virus encod proteas execut kei proteolyt step viral life cycl describ proof concept therapeut approach fight viral infect erad viral infect cell exclus limit viru product spread hepat viru hcv model design hcv ns proteaseactiv zymogen chimer toxin denot zymoxin recombin construct bacteri plant toxin diphtheria toxin dta ricin chain rta fuse ration design inhibitor peptidesdomain hcv ns proteasecleav linker toxin fuse bind transloc domain pseudomona exotoxin order enabl transloc mammalian cell cytoplasm toxin exhibit ns cleavag depend increas enzymat activ ns proteas cleavag vitro higher level cytotox observ zymoxin appli ns express cell hcv infect cell demonstr potenti therapeut window increas toxin activ correl ns proteas activ treat cell therapeut window larger cell express recombin ns hcv infect cell suggest zymoxin approach appropri applic lifethreaten acut infect higher level activ proteas expect
PLoS One	19116267	2009-12-04	PMC3022008	21264266	the spread infecti diseas commerci airlin travel realist threat light feasibl detect airborn pathogen sensor integr studi conduct comput investig contamin transport aircraft cabin perform studi consider sensor sensit timetoansw size weight power best commerci offtheshelf cot devic conduct comput fluid dynam simul investig three type scenario nomin breath breath minut cough time hour nomin breath sneez time hour nomin breath scenario implement infecti passeng expel air sneez cough state frequenc scenario implement addit case infecti passeng expel sneez hour comput base minut sampl specif cot aerosol collector biosensor biosensor provid answer minut manual prepar step includ princip find steadyst bacteria concentr aircraft high detect case infecti passeng exhal scenario and infecti passeng activ exhal scenario breath fail gener suffici bacteri particl detect scenario gener suffici viral particl detect feasibl sensit sensor cot devic current andor sampl individu passeng need detect bacteria virus aircraft
BMC Immunol	19966311	2018-09-14	PMC3023737	21194475	background immun spike protein sever acut respiratori syndrom sarscoronaviru cov mice produc neutral antibodi prevent infect caus sarscov polyethylenimin pei cation polym effect deliv plasmid dna studi immun respons balbc mice immun intranas rout sar dna vaccin pci peipci complex form examin size peipci nanoparticl appear nm express mrna protein confirm vitro mice immun peipci nanoparticl produc higher sspecif igg sera mucos secretori iga lung wash mice treat pci compar mice challeng pci number cell peipci vaccin mice elev costimulatori molecul cd cd class ii major histocompat complex molecul iad increas cdc dendrit cell cervic lymph node mice peipci vaccin percentag ifn tnf ilproduc cell higher peipci vaccin mice control mice conclus intranas immun peipci nanoparticl induc antigen specif humor cellular immun respons
Mol Cancer	30217848	2010-05-19	PMC3024302	21211062	cancer vaccin promis tool hand clinic oncologist tumorassoci antigen excel target immun therapi vaccin design optim design cancer vaccin combin best tumor antigen effect immunotherapi agent andor deliveri strategi achiev posit clinic vaccin deliveri system rout immun physicalchem deliveri method cancer therapi goal induc immun tumorassoci antigen basic deliveri approach includ physic deliveri achiev higher level antigen product formul microparticl target antigenpres cell apc demonstr effect anim model develop vaccin deliveri system will improv effici clinic trial futur nanoparticl np dendrim polymer np metal np magnet np quantum dot emerg effect vaccin adjuv infecti diseas cancer therapi cellpenetr peptid cpp attract carrier applic drug deliveri gene transfer dna vaccin review will focu util vaccin deliveri system prevent treatment cancer will discuss clinic applic futur prospect cancer vaccin develop
PLoS One	20484516	2011-06-22	PMC3024431	21283725	background influenza viru infect highli contagi sever respiratori disord rise thousand death year efficaci current approv defens strategi includ vaccin neuraminidas inhibitor limit viru frequent acquir resist antigen drift reassort establish novel effect therapeut strategi effect irrespect viral subtyp methodologyprincip find identifi rasphosphoinositid kinas pik signal pathwai hostcel regulatori mechan influenza viru entri bind ra pik involv clathrinindepend endocytosi endosom matur intracellular transport virus result decreas infecti efficaci subtyp influenza virus cell lack raspik interact influenza viru infect trigger ra activ subsequ pik activ earli endosom conclusionssignific demonstr raspik signal axi act hostori mechan viral intern viru incorpor process conserv viru subtyp speci signal pathwai provid target potent welltoler prophylact therapeut broad rang virus
Virol J	21697464	2019-02-20	PMC3024955	21223600	the filovirida famili compris ebola marburg virus lethal hemorrhag fever effect antivir therapi licens vaccin current human pathogen envelop glycoprotein gp ebola viru mediat entri target cell cytotox map highli glycosyl mucinlik region surfac subunit gp gp mechan underli cytotox properti gp unknown gain insight basi gpinduc cytotox hekt cell transient transfect fulllength mucindelet mucin ebola gp plasmid gp local examin rel nucleu endoplasm reticulum er golgi earli late endosom deconvolut fluoresc microscopi fulllength ebola gp observ accumul er contrast gpmucin uniformli express cell local er ebola major matrix protein vp coexpress gp investig influenc gp local gp vp coexpress alter gp local er vp coexpress nucleoprotein np local plasma membran np accumul distinct cytoplasm structur line vimentin structur consist aggresom serv assembl site filovir nucleocapsid collect data fulllength gp gpmucin accumul er close proxim nuclear membran underscor cytotox properti
Virol J	30787149	2015-04-13	PMC3024956	21205330	background rotaviru rv main sever gastroenter children effect vaccin regim rv reduc morbid mortal previou studi demonstr efficaci viruslik particl form rv vp vp vlp recombin adenoviru express rv vp rad elicit protect immun rv efficaci primeboost strategi incorpor vlp rad induc protect immun rv address assess immun effect regimen mice includ rad primevlp boost radvlp vlp primerad boost vlprad rad vlp mice immun vlprad regimen elicit stronger humor mucos cellular immun respons immun regimen rv challeng experi highest reduct viral shed achiev vlprad group compar radvlp vlp rad treatment group reduct rv shed mice correl fecal igg iga conclus vlp primerad boost regimen effect confer immunoprotect rv challeng mice find lai groundwork altern strategi novel rv vaccin develop
PLoS One	25871730	2018-01-05	PMC3025933	21283679	in respiratori infect children diagnost remain neg suggest patient infect unknown pathogen viru discoveri cdnaaflp vidisca viru discoveri method base recognit restrict enzym cleavag site ligat adaptor subsequ amplif pcr direct discoveri unknown pathogen nasopharyng swab difficult high concentr ribosom rna rrna act competitor current studi optim vidisca adjust revers transcript enzym decreas rrna amplif revers transcript hexam oligonucleotid anneal rrna residu cdna synthesi rrna templat reduc oligonucleotid anneal rrna extend dideoxycmodif modif reduct rrna amplif establish improv vidisca sensit high throughput sequenc vidisca eighteen nasopharyng swab analys respiratori virus identifi proper viru major sampl test median load vidisca posit sampl viral genom copiesml rang e optim vidisca subsequ highthroughputsequenc enhanc sensit drastic opportun perform viru discoveri directli patient materi
PLoS One	29305370	2017-11-27	PMC3026784	21283623	background cane toad bufo chaunu marinu notori vertebr pest introduc australia year effort identifi natur occur marinusspecif pathogen biolog control agent unsuccess explor altern approach entail genet modifi pathogen broad host specif longer caus diseas carri gene disrupt cane toad life cycl speci specif manner methodologyprincip find adult beta globin gene select model gene proof concept autoimmun biocontrol method cane toad previou report inject bullfrog tadpol adult beta globin alter form beta globin express metamorph reduc surviv marinu establish time switch tadpol adult globin exist inject marinu tadpol purifi recombin adult globin protein assess behaviour swim speed tadpol jump length metamorph development time metamorphosi weight length development stage protein profil adult globin genet adult globin mrna level measur unabl detect differ treat control anim globin deliveri bohl iridoviru australian ranaviru isol belong iridoviru famili reduc surviv metamorph alter form beta globin express metamorph conclusionssignific time switch tadpol adult globin occur marinu induc autoimmun disrupt metamorphosi short develop time marinu tadpol preclud approach
PLoS One	29180486	2003-07-01	PMC3026800	21283579	the broadspectrum antivir arbidol arb inhibit cell entri envelop virus block viral fusion host cell membran better understand arb mechan action investig interact phospholipid membran peptid demonstr arb associ phospholipid micromolar rang nmr reveal arb interact polar headgroup phospholipid membran interfac fluoresc studi interact arb tryptophan deriv membran peptid reconstitut liposom arb interact tryptophan micromolar rang interestingli appar bind affin lipid tryptophan residu compar arb ic hepat viru hcv membran fusion tryptophan residu membran protein bind preferenti membran interfac data arb increas strength viru glycoprotein interact membran dual bind mode involv aromat residu phospholipid complex inhibit expect viral glycoprotein conform chang requir fusion process find pave design drug exhibit arblik interfaci membran bind properti inhibit earli step viru entri attract target combat viral infect
PLoS One	12832676	2013-05-28	PMC3029370	21304591	develop effect vaccin prevent influenza highli pathogen avian influenza hpai caus influenza viru iav subtyp hn challeng goal studi design construct recombin influenza vaccin candid fuse hemagglutinin ha fragment aanhuihn fc human igg hafc foldon fc hafdc evalu immun respons crossprotect diverg strain hn viru recombin vaccin induc strong immun respons vaccin mice react ha protein inactiv heterolog hn viru protein crossneutr infect homolog strain clade heterolog strain belong clade hn pseudovirus three heterolog strain clade hn live viru importantli immun vaccin candid hafdc provid complet crossclad protect highdos lethal challeng strain hn viru cover clade test mous model studi suggest recombin fusion protein hafdc develop efficaci univers hn influenza vaccin provid crossprotect infect diverg strain highli pathogen hn viru
Virol J	23716702	2013-04-24	PMC3030507	21241515	background pneumonia caus adenoviru infect sever adenoviru serotyp commonli associ lower respiratori tract diseas outbreak report outbreak case sever pneumonia death infant shaanxi provinc china sampl adenoviru ad primari pathogen coinfect strain adenoviru strain enteroviru isol pharynx swab posit amplif adenoviru three coinfect respiratori syncyti viru posit rhinoviru posit parainfluenza neg adenoviru type adenoviru posit sampl hadv three hadv weak perform sequenc entir hexon gene adenoviru sequenc analyz adenoviru serotyp isol show nucleic acid homolog strain compar refer strain hadv genbank access number ay acut phase serum sampl patient sampl posit elisa detect hadv iga neutral titer convalescentphas sampl time higher acutephas sampl pair conclus conclud adenoviru viral pathogen hadv coinfect respons outbreak report infant pneumonia outbreak caus adenoviru serotyp shaanxi provinc china
J R Soc Interface	23616657	2012-07-11	PMC3033019	20573630	there limit understand kei determin spatial spread influenza pandem opportun elucid spatial determin spread larg scale better character spread major wave fit rang citytoc transmiss model mortal data collect popul centr england wale citi graviti model citytoc contact explor popul size distanc spread diseas test assumpt densiti depend connect citi emploi bayesian markov chain mont carlo method estim paramet model popul infect distanc densiti depend infer transmiss tree countri england wale model estim degre densiti depend connect citi prefer devianc criterion comparison earli major wave long distanc infect interact predomin local infect event epidem widespread fewer dispers citi statist power lack estim popul size depend degre densiti depend prefer model depend distanc find paramet estim england wale dataset appli data likelihood penalti
J Neuroinflammation	22787216	2015-02-01	PMC3033336	21235806	background complement protein activ product associ neuropatholog alzheim diseas ad receptor antagonist suppress neuropatholog murin model ad tg xtg genet defici cq tg mous model accumul fibrillar plaqu complement suffici tg reactiv glia decreas neuron integr improv suggest detriment consequ complement activ ad goal studi defin role classic complement activ pathwai progress patholog xtg mous develop tangl addit fibrillar plaqu close reflect human ad patholog assess influenc complement model ad higher level complement hemolyt activ method xtg mice defici cq xtgq gener xtg xtgq backcross bub mous strain higher vitro hemolyt complement activ mice ag perfus brain section stain patholog marker analyz proinflammatori marker express xtgq mice amount fibrillar amyloid reactiv glia hyperphosphoryl tau cqsuffici xtg ag analyz xtg xtgq bub background develop patholog earlier origin xtg background presenc cq neuropatholog proinflammatori marker contrast transgen model ad cq c immunoreact undetect plaqu xtg background associ reactiv astrocyt surround plaqu importantli properdin compon altern complement pathwai associ plaqu model conclus contrast investig transgen model ad develop neuropatholog xtg mice progress slower murin model influenc fibrillar amyloid mediat activ classic complement pathwai suggest altern complement pathwai activ cindepend cleavag account detriment effect mice prevent receptor antagonist pauciti complement activ factor slower kinet progress patholog xtg model diseas
PLoS Pathog	25611534	2018-09-02	PMC3033372	21304939	refold viral class membran fusion protein nativ state trimerofhairpin structur promot entri virus cell structur bovin leukaemia viru transmembran glycoprotein tm identifi group asparagin residu membranedist trimerofhairpin strikingli conserv diverg virus asparagin essenti surfac displai prefusogen envelop substitut residu dramat disrupt membran fusion data indic electrostat interact chlorid ion asparagin residu promot assembl profoundli stabil fusionact structur requir viral envelopemedi membran fusion blv tm structur reveal chargesurround hydrophob pocket central coil coil interact basic residu cluster pocket critic membran fusion form target peptid inhibitor envelop function chargesurround pocket electrostat interact small ion common class fusion protein suggest small molecul target motif prevent assembl trimerofhairpin therapeut inhibitor viral entri
Respir Res	30285588	2004-05-01	PMC3033824	21261956	background type ii alveolar epitheli cell aecii role innat immun system propos plai role antigen present lymphocyt contradictori publish concern surfac express molecul lymphocyt respons mix lymphocyt cultur aecii cell fresh cell explain observ discrep studi aim defin relev model accessori antigen present cell carefulli compar model express surfac molecul effici antigen present method compar flow cytometri surfac express major marker involv immunolog synaps cell popular model type ii alveolar epitheli cell freshli isol cell hladr cd cd icosl cd cd surfac express studi rest condit ifntnf treatment inflammatori cytokin modul marker major differ cell type low surfac express hladr cell compar constitut express freshli isol aecii surfac express costimulatori molecul famili low cd icosl bh absent cd freshli isol cell cell ifn tnf increas express classic costimulatori molecul cd icam cd lfa adhes molecul implic independ costimulatori signal express cell type conclus constitut express mhc class ii molecul altern costimulatori molecul freshli isol aecii render cell good model studi antigen present
BMC Res Notes	15115856	2008-11-19	PMC3035198	21214902	background health organ alert hn influenza pandem led implement measur admiss patient flulik symptom instruct adopt greek nation health system aim studi retrospect examin characterist subject admit unit infecti diseas symptom indic hn infect identifi differ hn posit neg patient patient emerg depart flulik symptom sore throat cough rhinorhea nasal congest fever admit unit infecti diseas pharyng nasopharyng swab swab test realtim reversetranscriptasepolymerasechainreact rtpcr find patient divid group group compris hn posit patient group control group compris hn neg patient group differ term patient ag comorbid length hospit temperatur elev hypoxemia renal liver function differ sever admiss creactiv protein crp white blood count wbc higher group group admiss obes patient group patient group bodi mass bmi lower hn posit hn neg patient conclus major patient group young male adult crp wbc bmi higher hn neg patient final clinic cours patient group mild unev
PLoS One	19019082	2010-01-01	PMC3035654	21347434	terminationdepend reiniti coordin regul express bm openread frame orf dicistron influenza segment rna start codon bm orf overlap codon orf pentanucleotid uaa ug ribosom termin codon reiniti translat overlap aug bm synthesi requir presenc translat nt rna upstream uaa ug termin upstream ribosom bind site turb region tether ribosom subunit mrna termin short region turb motif complementar helix rrna implic process provid evid direct interact mrna rrna antisens oligonucleotid target function analysi yeast cell turb bind initi factor eif protein stimul reiniti wildtyp defect turb exogen stabilis ribosomemrna interact posit turb respect uaa ug overlap crucial termin downstream complementari sequenc inhibit process reduc tether report mrna restart codon move downstream terminationreiniti inhibit abolish site reiniti flexibl reiniti distant aug inhibit eifgdeplet rrl suggest tether subunit move distanc requir linear scan
PLoS One	20375547	2004-05-12	PMC3036576	21347398	realtim pcr techniqu commonli detect viral genom human specimen requir valid extern intern control ec ic ic clinic sampl monitor extract revers transcript amplif step order detect falseneg pcrinhibit error technic procedur perform larg scale evalu bacteriophag ic routin molecular diagnosi allow propos simpl standard procedur design specif ec dna rna virus ii dna ms rna phage ic routin diagnosi technic format phage ic optimis valid subsequ ms ic evalu routin realtim pcr rtpcr virolog diagnost test seri clinic sampl repres distinct specimen type laboratori detect varieti dna rna virus frequenc ineffici detect ic analyz natur sampl inhibitor enzymat reaction detect high frequenc specif sampl type heparin blood bone marrow bronchoalveolar liquid stool ms phage ic prove costeffect flexibl adapt technic procedur realtim pcr detect virolog repres valuabl strategi enhanc qualiti routin molecular diagnosi laboratori inhous design diagnost system conveni associ specif synthet ec high rate inhibitor observ varieti specimen type stimul elabor improv technic protocol extract amplif nucleic acid
Int J Environ Res Public Health	15141005	2013-09-25	PMC3037052	21318006	the main purpos studi investig climat chang blood vesselrel heart diseas hypertens estim associ econom damag paper panel data model conting valuat method cvm approach appli empir indic number death cardiovascular diseas increas variat temperatur increas importantli number death cardiovascular diseas increas altern ipcc climat chang scenario the cvm approach person pai us year order avoid increas mortal rate cardiovascular diseas caus climat chang
BMC Infect Dis	24067959	2014-12-10	PMC3037318	21266085	background describ knowledg attitud critic care clinician hn influenza pandem method survei conduct intens care unit provinc china questionnair distribut complet three fiftysix respond report experi care hn patient despit fact respond ultim finish hn train program admit knowledg hn influenza total respond express willing care hn patient independ variabl associ increas likelihood care patient logist regress analysi physician nurs profession odd ratio knowledg train prior patient care odd ratio confid to protect patient odd ratio conclus critic care clinician report poor knowledg hn influenza finish relev knowledg train program implement appropri educ program improv complianc infect control measur willing work pandem
PLoS Pathog	28989404	2005-01-01	PMC3037360	21347350	grow experiment evid indic addit physic virion compon nonstructur protein hepat viru hcv intim involv orchestr morphogenesi dispens hcv rna replic nonstructur viral protein ns suggest plai central role hcv particl assembl despit genet evid understand ns proteinprotein interact role product infecti particl coimmunoprecipit andor fluoresc reson energi transfer fluoresc lifetim imag microscopi analys studi interact ns viroporin hcv glycoprotein addit alanin scan insert mutagenesi mutat context infecti viru investig function role ns hcv assembl final subcellular local ns mutant analyz confoc microscopi data demonstr molecular interact ns context infecti viru ns accumul time endoplasm reticulumderiv dot structur coloc envelop glycoprotein compon replic complex close proxim hcv core protein lipid droplet locat essenti viru assembl ns transmembran region crucial interact subcellular local specif mutat core envelop protein nsa report abolish viral assembl chang subcellular local ns protein observ indic ns protein attract envelop protein assembl site crosstalk nonstructur protein viru assembl
PLoS One	16094718	2014-10-26	PMC3037951	21347303	background hand foot mouth diseas hfmd outbreak lead clinic fatal complic increas late asia pacif region outbreak hfmd peak warmer season year underli factor annual pattern reason upsurg trend establish studi analyz shortterm chang weather incid hfmd singapor method rel risk weekli hfmd case temperatur rainfal estim period time seri poisson regress model allow overdispers smooth allow nonlinear relationship weather weekli hfmd case adjust season longterm time trend addition autocorrel control weather allow lag hfmd incid week weekli temperatur rainfal statist associ hfmd incid time lag week increas maximum temperatur elev risk hfmd incid ci simultan mm increas weekli cumul rainfal mm increas risk hfmd ci mm opposit mm increas rainfal decreas incid ci differ minimum maximum temperatur greater elev risk hfmd ci conclus find strong associ hfmd weather exact reason associ studi maximum temperatur moder rainfal preced hfmd incid help control curb upsurg trend hfmd
Acta Vet Scand	25363763	2009-12-01	PMC3038973	21269522	background felin endogen retroviru contain genom cat viru contamin live canin vaccin base cultur felin cell vivo infect acut subacut pathogen viral prolifer viru evalu experiment infect dog method specif pathogen free dog divid three group group consist femal male dog dog subcutan inocul neck stock viru group inactiv viru suspens group cell cultur medium group neg control assess blood cell count biochem properti blood sampl group collect dai inocul prior inocul and dai postinocul result experiment period dai dog inocul viru clinic sign increas rectal temperatur abnorm blood biochem characterist includ creactiv protein compar neg control reisol viru buffi coat cell group dog addition detect proviru genom dna isol peripher blood leukocyt lymph node spleen sternal bone marrow cell conclus sign viru prolifer subcutan infect dog potenti risk caus infect viru dog assess studi suspect viru virul dog
PLoS One	20174457	2009-12-09	PMC3041802	21364999	background coronavirus sever acut respiratori syndrom sar coronaviru scov mous hepat viru mhva evolv strategi disabl innat immun system product replic spread infect papainlik proteas domain plp catalyt domain nonstructur protein nsp mhva encod deubiquitinas dub inactiv ifn regulatori factor irf type interferon ifn respons princip find provid evid plp target tankbind kinas tbk upstream kinas irf ifn signal pathwai overexpress experi plp deubiquitin tbk reduc kinas activ inhibit ifn report activ albeit promiscu deubiquitin cellular protein plp inactiv tbk ifn respons tnf receptor associ factor traf defici cell suggest target tbk suffici plp inhibit irf activ notion support vitro kinas assai prior treatment tbk plp inhibit kinas activ phosphoryl irf intrigu plp overexpress system mhva infect system prove plp form inact complex tbk irf cytoplasm presenc plp stabil hypophosphoryl irftbk complex dosedepend manner conclus plp inactiv tbk prevent irf nuclear transloc inhibit ifn transcript activ identif conserv dub activ plp suppress ifn signal provid clue develop therapeut coronavirus infect
Ital J Pediatr	20007272	2004-08-01	PMC3042010	21281502	streptococc pharyng common patholog paediatr ag joint agreement manag condit author recommend perform microbiolog investig suspect bacteri case order treat confirm case antibiot prevent suppur complic acut rheumat fever differ author consid pharyng streptococc benign selflimit diseas consequ routin perform microbiolog test point judici antibiot reserv antimicrobi treatment wellselect case calcul number patient need treat prevent complic upper respiratori tract infect includ sore throat centor score order evalu risk streptococc infect debat interpret test vari consider penicillin consid treatment oral amoxicillin accept better palat suitabl option macrolid reserv rare case prove allergi lactam cephalosporin patient allerg penicillin except type hypersens propos treat relaps
BMC Infect Dis	15289516	2005-05-12	PMC3044667	21299840	background direct immunofluoresc assai dfa rapid inexpens method detect respiratori virus surveil epidemiolog studi publish base sole dfa includ respiratori picornavirus human metapneumoviru hmpv wish evalu dfa epidemiolog studi longterm observ respiratori virus includ respiratori picornavirus hmpv method children hospit respiratori ill univers hospit bern screen dfa common respiratori virus includ adenoviru respiratori syncyti viru rsv influenza parainfluenza viru assai respiratori picornavirus hmpv describ epidemiolog pattern respiratori virus detect dfa nasopharyng aspir collect patient year period addit assai respiratori picornavirus hmpv rais proport posit dfa respiratori picornavirus common virus detect patient year season pattern ag distribut studi virus agre report literatur hmpv epidem unexpect size observ conclus dfa valid rapid flexibl inexpens method addit assai respiratori picornavirus hmpv broaden rang viral detect dfa pcr era adapt method long term surveil respiratori virus pediatr popul
PLoS One	15890949	2003-03-01	PMC3044706	21383981	background analysi nih fund strongest predictor fund disabilityadjust lifeyear dali explain varianc fund congress request institut medicin iom evalu priorityset criteria nih fund iom recommend greater consider diseas burden examin associ current burden fund chang time method analyz public data nih fund common condit measur diseas burden health organ global burden diseas studi nation databas assess relationship diseas burden nih fund dollar univari multivari loglinear model evalu measur diseas burden sensit analys examin associ futur burden current futur measur diseas burden newli standard nih account method univari multivari analys diseasespecif nih fund level increas burden diseas measur dali account fund level variat factor predict fund multivari model condit receiv fund greater expect base diseas burden aid diabet mellitu perinat condit depress injuri chronic obstruct pulmonari diseas underfund estim futur burden current futur diseas burden altern nih account method conclus current level nih diseasespecif fund correl modestli diseas burden correl improv decad
BMC Bioinformatics	12584316	2014-02-03	PMC3045299	21272346	background investig covari interact group associ standard regress analys relationship respons variabl exposur difficult character relationship nonlinear linear model techniqu captur nonlinear content statist learn sl techniqu kernel capabl address nonlinear problem make parametr assumpt techniqu produc find relev epidemiolog interpret simul casecontrol studi contrast embed characterist separ boundari produc specif sl techniqu logist regress lr model repres parametr approach sl techniqu compris kernel map combin perceptron neural network lr model epidemiolog interpret sl method modifi produc analog interpret gener odd ratio comparison sl approach capabl gener odd ratio main effect risk factor interact better captur nonlinear relationship exposur variabl outcom comparison lr conclus integr sl method epidemiolog improv understand interpret complex exposurediseas relationship
PLoS One	24550280	2011-06-07	PMC3045447	21364899	background earli detect lung cancer improv chanc success treatment lung soft tissu complex threedimension configur convent xrai imag base pure absorpt low contrast imag soft tissu contrast agent difficult adequ lung lesion convent xrai imag method studi emerg imag techniqu inlin xrai phase contrast imag ilxpci power techniqu enabl highresolut investig soft tissu contrast agent appli ilxpci observ lung intact mous purpos defin quantit microstructur lung find threedimension model lung establish provid excel view lung airwai highlight ilxpci visual assess alveoli rare studi three dimens precis view individu alveolu achiev morpholog paramet diamet alveolar surfac area measur paramet great diagnosi diseas alveolu alveolar scar conclus indic ilxpci abil repres complex anatom structur lung offer perspect diagnosi respiratori diseas guid futur work studi respiratori mechan alveoli level
PLoS One	21548588	2018-01-11	PMC3046172	21386965	the nasopharynx ecolog nich commens bacteria potenti respiratori invas pathogen streptococcu pneumonia haemophilu influenza neisseria meningitidi disturb balanc nasopharyng np microbiom involv onset symptomat infect pathogen occur fall winter unknown season infect pattern associ concomit chang np microbiota young children gener prone respiratori invas infect character np microbiota healthi children barcod pyrosequenc vv hypervari region srrna gene compar microbiota composit children sampl winterfal children sampl spring sequenc gener repres taxonom phyla specieslevel phyla type otu predomin phyla proteobacteria firmicut bacteroidet actinobacteria fusobacteria moraxella haemophilu streptococcu flavobacteria dolosigranulum corynebacterium neisseria predomin genera interindividu variabl high otu level core microbiom defin microbiota profil vari season fallwint predomin proteobacteria rel abund sequenc versu spring fusobacteria absolut abund children versu spring spring predomin bacteroidet rel abund versu fallwint absolut abund versu fallwint firmicut increas brevibacillu lactobacillu speci absolut abund versu fallwint bacteroidet speci gener healthi ecosystem observ season effect attribut antibiot viral coinfect np microbiota young children highli divers appear season differ independ antibiot viral coinfect
Biol Direct	29322778	2006-10-19	PMC3046898	21324187	background elhaik graur josic comment genom order zcurv elhaik al direct quantiti defin denot correspond base frequenc zcurv three dimension curv repres dna sequenc manner uniqu reconstruct elhaik al major claim previou map system regular tetrahedron calcul radiu inscrib sphere mathemat error exponenti distribut narrowli distribut rang base chargaff second pariti rule pr equival shannon entropi deriv zcurv suffer dimension base analysi bacteri genom compon contribut varianc elhaik al mistakenli neglect paramet formula text calcul radiu inscrib sphere exponenti distribut restat previou conclus rang paraphras suggest rang elhaik al incorrectli disregard deviat pr treat deviat altogeth reduc variabl function singl variabl appli treatment dna sequenc basi demonstr invalid elhaik al confus numer small biolog insignific disregard distribut purinepyrimidin aminoketo base compon variat gc content rich locat replic origin bacteri archaeal genom studi gene recognit speci conclus elhaik al confus singl number zcurv seri coordin distinct case studi zcurv invalid equival deriv critic elhaik graur josic wrong review articl review erik van nimwegen
Virol J	17053248	2011-09-14	PMC3046927	21310026	background human metapneumoviru hmpv identifi viru acut respiratori tract infect arti infant children studi seroepidemeolog hmpv limit china assess seropreval hmpv infect china test total serum specimen presenc antihmpv igg antibodi children adult free acut respiratori ill beij china hmpv nucleocapsid protein antigen control human serum antibodi protein human respiratori syncyti viru hrsv viral agent respons ari children seroposit rate hmpv increas steadili ag mo ag rate drop mo yr ag seroposit rate hrsv increas steadili ag mo ag children ag month year seroposit rate antihrsv igg antibodi higher hmpv addition igg antibodi titer hmpv hrsv higher adult young children consist seroposit rate geometr titer antihmpv igg antibodi lower antihrsv igg antibodi children ag month year conclus indic hrsv exposur hmpv ubiquit beij popul seropreval antihmpv igg antibodi lower hrsv children month year suggest number repeat infect respons infect
Curr Genomics	21918226	2011-12-01	PMC3048312	21532834	genet materi plant distribut nucleu plastid mitochondria plastid central role carri photosynthesi plant cell plastid transform popular altern nuclear gene transform advantag high protein level feasibl express multipl protein polycistron mrna gene contain lack pollen transmiss progress plastid engin addit model plant tobacco transplastom crop plant gener possess higher resist biotic abiot stress molecular pharm mini review will discuss featur plastid dna advantag plastid transform will exampl transplastom plant develop plastid engin applic plastid transform
PLoS One	21971426	2012-03-09	PMC3048401	21390235	background madagascar despit influenza surveil establish etiolog preval virus influenza caus influenzalik ill ili methodologyprincip find juli june collect respiratori specimen patient present ili symptom public privat clinic antananarivo capit citi madagascar ili defin bodi temperatur cough symptom sore throat rhinorrhea headach muscular pain maximum durat dai screen specimen multiplex real time revers transcript andor polymeras chain reaction assai detect respiratori virus detect respiratori virus sampl influenza viru common viru rhinoviru rsv adenoviru coronaviru oc influenza viru parainfluenza viru parainfluenza viru coinfect occur infect patient rhinoviru detect viru children year detect viru associ ili ag group compar year risk detect viru higher risk detect rsv adenoviru rhinoviru adenoviru infect occur year round rsv influenza viru coronaviru oc defin period circul conclus studi respiratori virus plai role ili malagasi commun children year data provid better understand viral etiolog outpati ili describ time virus ag group period circul
Virol J	22408109	2016-12-05	PMC3048564	21310053	background outbreak avian influenza ai caus infect low pathogen hn virus occur poultri seriou econom loss asia middl east difficult erad hn viru low pathogen frequent caus appar infect control ai assess hn viru acquir pathogen h virus studi investig nonpathogen hn viru achickenyokohamaaq hn acquir pathogen chicken pair dibas amino acid residu introduc cleavag site ha molecul rgysub hn basic amino acid residu ha cleavag site replic mdck cell absenc trypsin consecut passag air sac chick acquir intraven pathogen chicken addit passag chicken inocul intraven passag viru rgysubp hn di indic pathogen compar highli pathogen avian influenza virus hpaiv defin organ anim health oie chicken inocul viru intranas rout surviv show clinic sign hand avirul hn strain aduckhokkaidovac vac hn acquir intranas pathogen pair dibas amino acid residu introduc cleavag site ha passag air sac inocul chick conclus demonstr hn viru potenti acquir intraven pathogen chicken morbid nasal rout infect lower hn hpaiv
BMC Fam Pract	27930303	2012-06-01	PMC3050701	21332976	background clinic proven overthecount otc treatment option increasingli selfmanag acut sore throat aim studi determin analges sensori benefit amylmetacresoldichlorobenzyl alcohol amcdcba throat lozeng formul variant amcdcba warm lozeng amcdcba cool lozeng compar unflavour nonmed placebo lozeng relief acut sore throat upper respiratori tract infect method multicentr randomis doubleblind singledos studi adult patient acut sore throat randomli assign receiv amcdcba warm lozeng amcdcba cool lozeng unflavour nonmed lozeng match size shape demulc baselin assess patient receiv assign lozeng complet rate assess timepoint minut post dose analges properti assess compar sever throat sore sore throat relief rate difficulti swallow throat numb function sensori emot benefit assess amcdcba warm amcdcba cool lozeng induc analges function sensori emot effect compar unflavour nonmed lozeng sore throat relief improv throat sore difficulti swallow throat numb observ earli minut last hour post dose sensori benefit warm cool associ amcdcba warm amcdcba cool lozeng experienc dose case last long lozeng dissolv emot benefit feel better happier distract frustrat report amcdcba throat lozeng variant differ advers event compar unflavour nonmed lozeng conclus amcdcba warm amcdcba cool lozeng welltoler effect otc treatment option offer function sensori emot benefit patient acut sore throat rapid efficaci effect provid trial registr isrctn isrctn
Virol J	22712035	2006-11-28	PMC3050824	21342525	background human cytomegaloviru hcmv preval congenit viral infect unit state europ caus morbid mortal mother child hcmv opportunist pathogen immunocompromis individu includ human immunodefici viru hiv infect patient aid solid organ allogen stem cell transplant recipi current treatment hcmvassoci diseas insuffici emerg druginduc resist cytotox necessit novel approach limit hcmv infect aim studi develop therapeut peptid target glycoprotein gb major glycoprotein hcmv highli conserv herpesvirida famili inhibit fusion viral envelop host cell membran prevent hcmv entri infect wimleywhit interfaci hydrophob scale wwih region gb identifi displai high potenti interact lipid bilay cell membran hydrophob surfac protein abil synthet peptid analog wwihsposit sequenc hcmv gb inhibit viral infect evalu human foreskin fibroblast hff infect townegfp strain hcmv moi preincub peptid rang concentr nm gfpposit cell visual hour postinfect fluoresc microscopi analyz quantit flow cytometri peptid inhibit hcmv infect demonstr inhibitori concentr curv indic peptid possess distinct biophys properti peptid inhibit viral infect concentr and inhibit concentr m peptid inhibit infect concentr m concentr peptid individu fail inhibit viral infect combin inhibit hcmv infect concentr conclus peptid design target put fusogen domain gb provid basi develop novel therapeut prevent hcmv infect
PLoS One	17476782	2012-10-24	PMC3050921	21408132	background streptococcu sui infect emerg zoonosi increas public health problem south east asia common acut bacteri mening adult vietnam risk factor underli diseas method find casecontrol studi appropri hospit match commun control patient conduct june potenti risk factor assess standard questionnair investig throat rectal sui carriag case control pig realtim pcr cultur swab sampl recruit case sui mening hospit control commun control multivari analysi risk factor identifi sui infect compar control group includ eat high risk dish includ dish undercook pig blood pig intestin ci ci occup pig ci ci exposur pig pork presenc skin injuri ci ci sui specif dna detect rectal throat swab patient cultur rectal sampl detect sampl healthi individu patient sui infect conclus case control studi largest prospect epidemiolog assess diseas identifi risk factor associ sui bacteri mening eat high risk dish popular part asia occup exposur pig pig product prepar pork presenc skin lesion risk factor address public health campaign aim prevent sui infect
Vet Res	23097437	2009-01-21	PMC3052182	21345199	avian paramyxovirus apmv frequent isol domest wild bird separ serotyp apmv case apmv infect nonavian speci investig apmv present consid human vaccin vector studi evalu replic pathogen apmv serotyp hamster hamster inocul intranas viru monitor clinic diseas patholog histopatholog viru replic seroconvers basi criteria apmv serotyp replic hamster apmv produc mild inappar clinic sign hamster apmv produc moder diseas gross lesion observ pulmonari surfac hamster infect apmv petechi ecchymot hemorrhag replic of apmv apmv confirm nasal turbin lung indic tropism respiratori tract histolog infect lung lesion consist bronchointerstiti pneumonia vari sever nasal turbin blunt loss cilia epithelium line nasal septa major apmvinfect hamster exhibit transient histolog lesion resolv dai post infect dpi hamster infect apmv produc serotypespecif neutral antibodi confirm viru replic demonstr apmv serotyp capabl replic hamster minim diseas patholog
Vet Res	19158265	2018-05-20	PMC3053234	21366902	antimicrobi resist primari public anim health issu persist spread resist strain popul contribut mainten reservoir lead treatment failur experiment trial carri studi horizont transmiss fluoroquinoloneresist escherichia coli strain inocul nave pig nave contact pig posit count fluoroquinoloneresist coli dai contact reinfect inocul pig caus newli contamin anim suspect maximum likelihood method base susceptibleinfectioussuscept si model determin transmiss paramet transmiss level identifi depend quantiti bacteria infect individu lowshedd bacteri count resist coli faec cfug ii high shedder bacteri count cfug transmiss anim pivot explain persist resist bacteria pig herd
PLoS One	29595997	2008-09-16	PMC3055876	21412418	background vaccin core compon mitig influenza pandem phn vaccin program efficaci depend popul complianc examin gener popul decisionmak phn vaccin modifi theori plan behaviour tbp methodolog conduct longitudin studi collect data introduct phn vaccin hong kong structur equat model sem test modifi tpb explanatori util vaccin uptak adult princip find subject complet baselin followup survei report likelyveri likelycertain vaccin intent month report receiv phn vaccin percept low risk phn concern advers effect vaccin primari justif avoid phn vaccin greater perceiv vaccin benefit concern vaccin sideeffect greater adher social norm vaccin anticip higher regret vaccin perceiv higher selfefficaci vaccin histori season influenza vaccin associ higher intent receiv phn vaccin turn predict selfreport vaccin uptak social norm anticip regret vaccin intent posit associ account varianc vaccin plan turn subsequ predict selfreport vaccin uptak account varianc report vaccin behaviour conclusionssignific perceiv low risk phn perceiv high risk phn vaccin inhibit phn vaccin uptak tpb addit compon contribut intend vaccin uptak social norm anticip regret associ vaccin intent plan vaccin plan proxim determin uptak phn vaccin intent intent unreli predictor futur vaccin uptak
PLoS One	18796655	2005-05-01	PMC3056798	21423764	lossoffunct mutat slcapendrin preval deaf deaf vestibular dysfunct correspond mous model slca associ enlarg acidif membran labyrinth relat onset express hco transport pendrin lumin ph enlargementassoci epitheli cell stretch determin express immunocytochemistri cell stretch digit morphometri ph doublebarrel ionselect electrod pendrin express endolymphat sac embryon dai cochlear hookregion utricl saccul ampulla upper turn cochlea epitheli cell stretch slca mice began ph chang occur cochlea endolymphat sac postnat dai stria vasculari outer sulcu reissner membran epitheli cell utricular saccular transit cell stretch sensori cell cochlea utricl saccul differ slca slca mice structur develop stria vasculari includ vascular retard slca mice conclus data demonstr enlarg stretch nonsensori epitheli cell preced lumin acidif cochlea endolymphat sac stretch lumin acidif alter celltocel commun lead observ retard develop stria vasculari step path deaf slca mice human lack function pendrin express
Evid Based Complement Alternat Med	15860716	2009-06-01	PMC3057194	21423688	tylosema esculentum marama bean tuber food tradit medicin diarrhoea southern africa rotavirus rv major diarrhoea infant young children immunocompromis peopl domest anim work determin antirv activ marama bean tuber ethanol water extract case intestin enterocyt cell human infant adult pig clab adult bovin cieb origin marama cotyledon ethanol extract mce cotyledon water extract mcw rv cytotox cell test seed coat tuber extract variabl level cytotox marama cotyledon ethanol water extract mce mcw resp mgml seed coat extract msce seed coat water extract mscw mgml ethanol increas cell surviv enhanc surviv cytopath effect rv vitro preincub treatment marama extract enhanc nitric oxid releas cell enhanc ter cm enterocyt barrier coincub rv marama cotyledon seed coat extract inhibit virion infect interfer replic accumul nitric oxid marama extract promis microbicid rv
Virol J	19485756	2014-12-02	PMC3059288	21375748	background exhal breath condens ebc sampl consid invent novel method isol respiratori virus method studi volunt experienc upper airwai infect recruit winter earli spring half winter ninetynin ebc screen commonli circul respiratori virus investig effici viru isol ebc nasal swab parallel subset volunt combin ecov devic rtube allow registr exhal volum breath frequenc collect number exhal viral particl liter air minut theoret estim viral screen detect virus ebc andor nasal swab rhinoviru human respiratori syncyti viru influenza influenza rhinoviru detect ebc ebc influenza posit report viral detect rate ebc lower detect rate observ nasal swab conclus promis ebc collect rtube reliabl diagnosi respiratori infect
Proteome Sci	25668673	2008-10-08	PMC3060854	21385394	background avian infecti bronchiti ib seriou diseas econom chicken caus avian infecti coronaviru ibv remain limit compar protein express profil chicken embryon tissu respons ibv infect ovo studi analyz chang protein express trachea kidnei tissu chicken embryo ibv infect ovo twodimension gel electrophoresi de coupl matrixassist laser desorptionion timeofflight tandem mass spectrometri malditoftof ms differenti express protein tracheal tissu differenti express protein kidnei tissu identifi protein cytoskeleton bind calcium ion stress respons antioxid macromolecular metabol alter protein confirm mrna level realtim rtpcr western blot analysi confirm chang annexin hspb ibv infect conclus best knowledg perform analysi proteom chang chicken embryon trachea kidnei tissu ibv infect ovo data facilit better understand pathogenesi ibv infect
PLoS One	18842706	2012-03-01	PMC3060926	21437206	the antigen structur membran protein hemagglutinin ha ahn influenza viru dissect highthroughput screen method complex antisera approach involv gener yeast cell librari displai pool random peptid control length cell surfac round fluorescenceactiv cell sort fac antisera mous goat human amino acid residu frequenc appear antigen peptid primari sequenc structur level determin identifi hot spot antigen region unexpectedli antigen structur antisera antigen region identifi locat conserv ha stem region respons membran fusion find corrobor studi crossneutr subtyp antibodi recogn ha stem region antigen peptid identifi provid clue creat peptid vaccin better access memori cell better induct crossneutr antibodi ha protein scheme studi enabl direct map antigen region viral protein recogn antisera dissect antigen structur viral protein
Virol J	22180660	2018-02-14	PMC3061939	21385403	background classic swine fever viru csfv belong genu pestiviru famili flavivirida virul strain classic swine fever viru csfv sever diseas pig character immunosuppress thrombocytopenia dissemin intravascular coagul econom loss pig industri worldwid method reveal proteom chang swine serum acut stage lethal csfv infect pig inocul virul csfv shimen strain remaind serv uninfect control serum sampl dai postinfect swine stage clinic symptom increas rectal temperatur sampl treat remov serum albumin immunoglobulin igg subject twodimens differenti gel electrophoresi quantit intens analysi reveal protein spot show fold quantit alter express ten spot identifi malditof ms ltq ms express protein increas decreas csfvinfect pig function protein includ blood coagul antiinflammatori activ angiogenesi conclus protein alter express implic pathogenesi classic swine fever provid clue identif biomark classic swine fever earli diagnosi
J Biomed Sci	29444939	2013-02-01	PMC3062584	21385449	antigenspecif immunotherapi dna vaccin emerg attract approach control tumor novel cancer therapi involv employ vascular disrupt agent dimethylxanthenoneacet acid dmxaa current studi aim test combin dmxaa treatment human papillomaviru type hpv dna vaccin enhanc antitumor effect especif cd cell immun respons treat mice determin treatment dmxaa gener therapeut effect tc tumor enhanc antigenspecif immun respons tumor bear mice combin dmxaa treatment dna vaccin gener potent antitumor effect especif cd cell immun respons splenocyt tumor bear mice dmxaamedi enhanc suppress especif cd cell immun respons gener crte dna vaccin depend time administr dmxaa applic antigenspecif vaccin addit determin induc nitric oxid synthas ino plai role immun suppress caus dmxaa administr dna vaccin studi implic futur clinic translat
Interdiscip Perspect Infect Dis	23600505	2011-09-28	PMC3062985	21437001	the scienc network revolutionis dynam interact element argu epidemiolog embrac potenti network theori disciplin review grow bodi concern spread infecti diseas network focus interplai network theori epidemiolog review split main section examin type network relev epidemiolog multitud wai network characteris statist method appli infer epidemiolog paramet realis network final simul analyt method determin epidem dynam network breadth area cover everexpand number public comprehens review work imposs provid personalis overview area network epidemiolog greatest progress year greatest potenti provid novel insight consider analyt approach statist method rapidli expand field review restrict attent epidemiolog issu
PLoS One	24920802	2006-02-16	PMC3063785	21455300	in abrisban hn season influenza viru strain acquir oseltamivirresist mutat hy neuraminidas gene previou studi demonstr mutat impair replic capac influenza viru vitro vivo abrisban hy oseltamivirresist mutant complet outcompet wildtyp wt strain influenza season primari ahn circul strain combin plaqu viral yield assai simpl mathemat model approxim valu extract basic viral kinet paramet vitro infect stgalimdck cell latent infect period time newli infect cell start releas virion wt strain hy mutant infect time time singl infecti cell infect min wt min hy mutant singlecycl viral yield experi provid qualit confirm find preliminari increas fit success abrisban hy mutant increas infect compens impair delai viral releas consist evid mechanist origin fit reduct recoveri express method appli reconcil seemingli contradictori plaqu yield assai complementari view replic kinet requir fulli captur strain fit
PLoS One	16497657	2017-06-01	PMC3063798	21455313	background domin viral etiolog respons acut respiratori infect ari understood hospit children resourcelimit tropic countri morbid mortal caus ari highest improv etiolog insight need improv clinic manag prevent object conduct threeyear prospect descript studi sever respiratori ill children month year ag largest referr hospit infecti diseas southern vietnam method molecular detect viral speci subtyp perform three type respiratori specimen nose throat swab nasopharyng aspir multiplex rtpcr kit seeplex rv detect seegen addit monoplex realtim rtpcr total children enrol novemb januari virus identifi case includ respiratori syncyti viru influenza viru human bocaviru enteroviru human coronaviru human metapneumoviru parainfluenza viru adenoviru human rhinoviru coinfect multipl virus detect patient combin diagnost yield nose throat swab nasopharyng aspir conclus part rsv influenza predomin viral pathogen detect vietnames hospit children combin nasal throat swab specimen choic sensit molecular detect broad panel viral agent requir better understand clinic signific singl versu multipl viral coinfect address role bacteri coinfect involv sever respiratori ill
PLoS One	28636442	2010-09-01	PMC3064566	21464976	background intern wildlif trade lead threat biodivers conserv convent intern trade endang speci wild fauna flora cite initi monitor regul intern trade wildlif credibl depend qualiti trade data report perform cite report focuss commerci trade nonn reptil amphibian thailand illustr trend speci composit number wildcaught captivebr specimen methodologyprincip find base data wcmccite trade databas establish total individu speci reptil amphibian includ global threaten speci import thailand major individu list captivebr smaller number wildcaught small number individu speci import thailand volum speci divers increas rapidli proport captivebr anim differ greatli year wildcaught individu sourc african countri captivebr individu asian countri includ noncit parti discrep export import thailand report import individu speci origin kazakhstan kazakhstan report export speci discrep involv smaller number individu speci import reptil thailand macao conclusionsignific increas import amphibian reptil thailand errat pattern proport captivebr specimen volum suggest caprici market error report larg discrep respect origin point misreport violat rule intent cite
PLoS One	21339837	2012-02-22	PMC3064580	21464989	background despit decadeslong bacillu atrophaeu var globigii bg simul biolog warfar bw agent knowledg genom composit limit abil differenti signatur deliber adapt select natur variat lack bacteri agent character lineag bgwith long histori simul bw oper focus classic bacteriolog marker metabol profil wholegenom shotgun sequenc wg archiv strain dai type strain compar simul strain laboratori media sampl produc multipl coloni morphotyp differ archiv isol trace microevolutionari histori isol wg data archiv presentdai strain morphotyp bacilluswid phylogenet analysi identifi subtili nearest neighbor atrophaeu genom atrophaeu averag ident subtili nucleotid level wg variant reveal strain mix highli popul uncov progress accumul mutat militari isol metabol profil microscop examin bacteri cultur reveal enhanc growth militari isol lactatecontain media militari strain exhibit hypersporul phenotyp conclus analysi reveal genom phenotyp signatur strain adapt deliber select trait desir simul organ demonstr power wholegenom modern systemslevel approach character microbi lineag develop valid forens marker strain discrimin reveal signatur deliber adapt
PLoS One	22357281	2003-06-01	PMC3064590	21464946	background plasmodium falciparum malaria endem area placent malaria pm complic malaria recurr malaria primigravida women irrespect acquir protect childhood caus interact parasiteexpress varcsa antigen chondroitin sulfat csa placent intervil space lack protect antibodi pm impair fetal develop excess inflamm process infect pregnanc women acquir immun pm confer antibodi varcsa ideal vaccin pm will induc antibodymedi immun respons block adhes infect erythrocyt placenta princip find antibodi rais rat individu domain varcsa block bind csa studi immun mice rat rabbit individu domain fulllength protein correspond fcr varcsa variant inher higher immunogen ctermin domain compar ntermin locat domain irrespect antibodi induc singl domain fulllength protein speciesspecif antibodi respons were direct singl domain fulllength varcsa protein conclusionssignific bind inhibitori antibodi appear conform bcell epitop nonbind inhibitori antibodi react highli ctermin varcsa molecul highli polymorph dbl domain differenti speciesspecif induct antibodi respons allow direct analysi function versu nonfunct bcell epitop
BMC Infect Dis	12782660	2014-04-09	PMC3065410	21401965	background infect caus human rhinovirus hrv trigger wheez young children wheezi ill increasingli recognis morbid african children contribut hrv aim studi determin role hrv acut wheez south african children method twenti children present consecut tertiari children hospit wheez ill novemb prospect enrol nasal swab revers transcript pcr screen sampl hrv presenc human metapneumoviru human bocaviru human coronavirusnl assess sampl pcrbase assai gener vial cultur pool monoclon antibodi detect common respiratori virus sampl phylogenet analysi determin circul hrv speci perform portion hrvposit sampl categor characterist analys fisher exact test hrv detect children year ag present symptom hrvposit neg group ill manag ambulatori therapi hospit treatment admit intens care inhospit death speci hrv detect hrvc common hrva hrvb infect respiratori virus occur hrvposit children hrvneg sampl conclus hrv commonest viral infect young south african children acut wheez infect associ mild moder clinic diseas
PLoS One	24719424	2008-11-01	PMC3065461	21464929	influenza viru ns protein multifunct virul factor consist rna bind domain rbd short linker effector domain ctermin tail understood ns multimer autoregul action rbd dimer function conserv apo dimer propos helixhelix strandstrand analyz rbd fulllength ns structur includ novel crystal structur ed diverg human avian virus form monomer mutant data reveal helixhelix interfac strictli conserv homodimer contact mutant ns unabl form helixhelix dimer compromis abil bind dsrna effici impli multimer influenc rbd activ bioinformat work suggest helixhelix interfac variabl transient allow monom twist rel separ regard mab recogn ns residu complet buri helixhelix interfac help highlight potenti conform popul ns put term helixclos helixopen virusinfect cell helixclos conform appear enhanc dsrna bind helixopen conform allow inaccess interact host factor data support model ns regul rbd remain dimer infect switch quaternari state order expand function space concept applic small multifunct protein
J Pregnancy	18803612	2014-06-20	PMC3065811	21490743	thi examin matern optimismpessim associ unplan cesarean deliveri china associ remain control clinic factor associ csection sampl primipar women third trimest pregnanc survei larg tertiari care hospit beij china postdeliveri data collect medic record bivari analysi optim pessim unplan csection optim pessim enter regress model optim longer statist pessim remain adjust clinic factor previou abort previou miscarriag pregnanc complic infant gestat ag infant birthweight labor durat birth complic selfrat difficulti pregnanc suggest matern mindset pregnanc role mode deliveri need elucid potenti causal pathwai test potenti intervent
J Drug Deliv	24951555	2017-01-01	PMC3065884	21490752	the purpos studi evalu vitro gene deliveri mediat asialofetuinappend cation liposom afliposom associ cyclodextrin cydafliposom hepatocyteselect nonvir vector cyd afliposom associ plasmid dna pdna cyclodextrin cyd pdnacydafliposom highest gene transfer activ hepg cell cytotox addit cyd enhanc encapsul ratio pdna afliposom increas gene transfer activ entrap ratio pdna afliposom increas cyd stabil liposom membran afliposom inhibit releas calcein afliposom stabil cyd involv enhanc gene transfer activ pdnacydafliposom potenti cyd enhanc transfect effici afliposom
Virol J	29063574	2015-09-03	PMC3066118	21401943	background hepat viru hbv major etiolog factor inflamm damag liver hepatocellular carcinoma transcript factor plai role disord gene express liver injuri caus hbv molecular mechan observ defin studi observ circul prostaglandin pge synthesi increas patient chronic hepat infect detect elev cyclooxygenas cox express hbv hbxexpress liver cell likewis associ hbx cebp contribut induct cox cox promot hypomethyl hbvposit cell specif demethyl cpg dinucleotid nfat site cox promot increas bind affin nfat cognat site promot increas cox express pge accumul dna methylatransferas dnmtb plai kei role methyl cox promot decreas bind promot respons region demethyl cpg site increas bind transcript factor hbvposit cell conclus indic upregul cox hbv hbx mediat demethyl event recruit multipl transcript factor bind promot
PLoS One	29769954	2003-05-15	PMC3066183	21479259	background describ human rhinoviru hrv detect sakaeo provinc thailand method septemb august test hospit patient acut lower respiratori ill outpati control fever respiratori symptom hrv polymeras chain reaction molecularlytyp select hrv compar hrv detect hospit patient control estim enrol adjust incid hrv detect hospit patient control children highest frequenc hrv detect hospit year year year control year year year enrol adjust hospit hrv detect rate highest person ag year personsyear year year three hrv speci identifi hrva common speci ag group includ children ag year adult ag group hrvc common speci year year ag group compar control hospit adult year children hrv detect odd ratio confid interv ci ci hospit children hrva ci hvrc ci detect conclus hrv rate high hospit children elderli asymptomat children substanti hrv detect hrv speci hrva hrvc detect epidemiologicallyassoci hospit ill treatment prevent modal effect hrv reduc hospit hrv thailand
PLoS One	12719562	2005-01-13	PMC3066203	21479269	the lewztmci rat anim model syndrom deaf aros spontan mutat homozyg anim locomotor abnorm later circl behavior addition impair vision observ anim behavior studi syndrom deaf retin degener featur usher syndrom human studi mutat identifi base substitut tc exon myo lead amino acid exchang leucin leu prolin pro carboxytermin myth domain protein tail region myo mrna express retina demonstr time help insitu hybrid pcr character visual phenotyp rat examin scotop photop electroretinographi addition histolog analys retina conduct complet loss sight detect sever degener photoreceptor cell interestingli manifest diseas sole depend mutat environment factor lewztmci rat featur entir rang symptom human usher syndrom strain appropri model diseas find displai mutat bind domain myosin xv nonsyndrom hear loss lead syndrom disord includ retin dysfunct
PLoS One	15650189	2015-10-05	PMC3068181	21479189	background establish function shape cell architectur cell polar protein propos particip lymphocyt migrat home scan activ antigen receptor stimul pal central compon cell polar network express function lymphocyt remain unknown investig pal cell contribut cellreceptor tcrmediat activ methodologyprincip find combin rtpcr immunoblot assai pal constitut express human lymphocyt jurkat cell sirnabas knockdown pal hamper tcrinduc activ optim prolifer lymphocyt provid evid pal deplet select hinder tcrdriven activ transcript factor nfb conclus cell polar protein pal express lymphocyt particip optim activ nfb tcr stimul
Trials	26434947	2004-08-01	PMC3068961	21388549	background swine origin influenza ahn infect hn emerg earli rapidli spread human infect individu symptom mild selflimit small number develop sever clinic syndrom character profound respiratori failur hospit mortal rang support care neuraminidas inhibitor main treatment influenza data observ intervent studi cours influenza favor influenc agent classic consid influenza treatment multipl observ studi suggest hmgcoa reductas inhibitor statin exert class attenu inflamm collabor hn adjuv treatment chat pilot trial sought investig feasibl conduct trial global pandem critic patient hn goal inform design larger trial power determin impact statin outcom methodsdesign multin pilot random control trial rct daili enter rosuvastatin versu match placebo administ dai treatment critic patient suspect probabl confirm hn infect propos random critic adult moder high suspicion hn infect requir mechan ventil receiv antivir therapi hour site investig coordin clinic pharmacist will blind treatment assign pharmaci staff will awar treatment assign propos approach inform consent includ priori consent substitut decis maker sdm waiv defer consent primari outcom chat trial proport elig patient enrol studi secondari outcom will evalu adher medic administr regimen proport primari secondari endpoint collect number patient receiv openlabel statin consent withdraw approv consent model recruit rate discuss aspect studi design includ includ central random preserv alloc conceal ensur studi blind compar match placebo novel consent model pose challeng investig conduct pandem studi implement requir trial design pragmat initi short time period amidst uncertainti scope durat pandem trial registr number isrctn
PLoS Pathog	15258616	2019-12-11	PMC3068995	21483486	influenza viru iav enter host cell bind hemagglutinin glycoprotein sialyl host cell receptor dynamindepend clathrinmedi endocytosi cme gener consid iav infect pathwai observ occurr uncharacter altern entri rout manipul entri paramet establish experiment condit allow separ analysi dynamindepend independ entri iav entri iav phosphatebuff salin complet inhibit dynasor specif inhibitor dynamin dynasoreinsensit entri pathwai function presenc fetal calf serum find confirm small interf rna target dynamin presenc serum iav entri pathwai oper condit entri fulli block combin treatment dynasor amilorid deriv eipa hallmark inhibitor macropinocytosi drug sensit dynaminindepend entri pathwai inhibitor dominantneg mutant actomyosin dynam number specif inhibitor growth factor receptor tyrosin kinas downstream effector point involv macropinocytosi iav entri consist iav particl solubl fitcdextran coloc cell vesicl addit classic dynamindepend clathrinmedi endocytosi pathwai iav enter host cell dynaminindepend rout characterist macropinocytosi
PLoS One	31846608	2017-01-01	PMC3069061	21483820	background earli event midgut epitheli cell aed aegypti mosquito dynam reorgan rough endoplasm reticulum rer whorl structur coincid onset blood meal digest base previou studi show feed amino acid meal induc tor signal ae aegypti proteom rnai function identifi midgut epitheli cell protein contribut rer whorl format methodologyprincip find adult femal ae aegypti mosquito maintain sugar unf fed amino acid meal midgut epitheli cell analyz electron microscopi protein biochemistri size number rer whorl midgut epitheli cell decreas feed kdelcontain protein alter express level lcmsm mass spectrometri analyz midgut microsom protein isol unf amino acid fed mosquito protein identifi chosen candid whorl form protein three candid protein copi coatom subunit alpha beta beta appear higher level microsom fraction unf mosquito rnai knockdown alphacopi express electron microscopi reveal size number rer whorl dramat reduc unf mosquito extend region swollen rer preval fed mosquito lastli defici alphacopi earli trypsin protein synthesi secret hr post blood meal pbm express late phase proteas hr pbm complet block conclus alphacopi requir format rer whorl midgut epitheli cell unf aa aegypti mosquito express late phase midgut proteas
BMC Neurol	27925805	2012-11-01	PMC3071317	21435231	background long term advers effect sever acut respiratori syndrom sar viral diseas understood method sleep physiolog somat mood symptom toronto subject healthcar worker femal male ag yr remain unabl return occup month rang month sar compar healthi femal subject clinic similar patient fibromyalgia syndrom fm postsar subject compar drug free femal patient ag yr fulfil criteria fibromyalgia chronic postsar character persist fatigu diffus myalgia weak depress nonrestor sleep associ remrel apneashypopnea elev sleep eeg cyclic altern pattern alpha eeg sleep anomali post sar patient symptom pre postsleep fatigu post sleep sleepi symptom patient fm symptom patient chronic fatigu syndrom postsar fm group sleep instabl indic high sleep eeg cyclic altern pattern rate postsar group lower rate alpha eeg sleep anomali compar fm patient postsar group report presleep postsleep musculoskelet pain symptom conclus clinic sleep featur chronic postsar form syndrom chronic fatigu pain weak depress sleep disturb overlap clinic sleep featur fm chronic fatigu syndrom
Virol J	23123061	2009-04-18	PMC3071789	21418610	on coronaviru strain isol brain tissu ten piglet evid clinic manifest vomit diarrhea dyskinesia jilin provinc china antigen genom character viru isol phevjlsp base multiplex pcr neg stain electron microscopi sequenc analysi hemagglutininesteras gene piglet diagnos porcin hemagglutin encephalomyel viru phev necropsi perform piglet major patholog chang includ mening hyperemia mening hemorrhag cortic hemorrhag minor chang observ organ histopatholog chang includ satellitosi neuronophagia cerebr cortex mice infect isol viru histopatholog chang symptom observ piglet exhibit typic chang nonsuppur enceph porcin hemagglutin encephalomyel viru damag nervou system impact organ viral strain isol phevjlsp sipe area jilin provinc china evolution closest hevn stain north american strain indic viral strain evolv phev north america
Virol J	19377073	2007-12-05	PMC3071790	21418614	a year activ surveil program influenza virus avian speci livebird market lbm bangkok thailand conduct sampl collect influenza viru subtyp hn hn isol healthi muscovi duck three virus character genom sequenc subsequ phylogenet analysi genet comparison phylogenet analysi viral gene virus cluster eurasian lineag influenza virus genet analysi hn hn virus displai low pathogen avian influenza characterist ha cleavag site receptor bind site conserv resembl lpai virus studi report isol hn hn virus bird lbm thailand genet divers virus circul lbm addit coinfect hn hn muscovi duck observ
PLoS One	18057251	2013-10-04	PMC3071823	21494680	nipah viru niv recogn in zoonot diseas outbreak associ highli lethal febril enceph human respiratori diseas pig period deadli outbreak document persontoperson transmiss potenti viru agent agroterror reinforc effect therapi prevent report describ vaccin potenti niv viruslik particl niv vlp compos three niv protein coexpress protein optim condit quantifi amount vlp viruslikevaccin desir properti includ describ vlp paramyxoviru particl fusogen induc syncytia format pcr arrai analysi niv vlpinduc activ innat immun defens pathwai surfac structur niv vlp imag cryoelectron microscopi dens order repetit consist deriv structur paramyxoviru measl viru vlp compos three viral protein design intracellular process appear niv virion size morpholog surfac composit vlp consist parent viru importantli retain antigen potenti final particl formul adjuv induc neutral antibodi respons balbc mice find indic vaccin potenti particl will basi undertak futur protect efficaci studi anim model niv diseas
PLoS One	24051429	2009-02-25	PMC3073942	21494599	new delhi metallobetalactamas ndm enzym bacteria resist broad rang betalactam antibiot drug inactiv betalactam antibiot drug hydrolyz indepth understand hydrolysi mechan threedimension structur ndm develop structur frame enzymeligand complex deriv dock imipenem meropenem typic betalactam antibiot drug ndm receptor reveal ndmimipenem complex antibiot drug hydrolyz sit bind pocket ndm form residu case ndmmeropenem complex antibiot drug hydrolyz bind pocket form twelv residu constitu residu bind pocket explicitli defin graphic label anticip find report provid insight develop antibiot drug overcom resist problem
PLoS One	19324683	2014-09-17	PMC3073975	21494554	the famili type interferon ifn consist ifn ifn produc stimul virus infect nonvir pathogen cours bacteri infect cytokin benefici detriment ifn primari member type ifn initi cascad ifn product address question cell respons ifn express infect intracellular pathogen listeria monocytogen genet approach newli establish report mice maximum ifn express observ hour post infect spleen surprisingli hour post infect colon cervic inguin lymph node colon lymph node independ type ifn signal bacteri dose strain cell specif report function condit delet defin cell express lysm major ifn produc cell defin tipdc highest neutrophil granulocyt dendrit cell plasmacytoid dendrit cell contribut type ifn product
Vet Res	25231300	2018-08-01	PMC3074528	21435235	porcin circoviru type pcv causal agent postwean multisystem wast syndrom pmw pcv small singlestrand circular dna virus cluster main genogroup pcva pcvb genogroup specif highlyconserv motif amino acid amino acid pcv capsid protein aim studi verifi motif locat capsid protein specif pcv genogroup contribut virul parent dna clone pcva pcvb construct mutant dna clone pcvamotif pcvbmotif exchang capsid motif genogroup dna clone character vitro vivo cell transfect dna clone produc infecti virus specificpathogenfre piglet transfect infecti dna clone pcvbmotif virul attenu pcvamotif virul drastic reduc compar parent virul amino acid posit capsid protein determin virul isol environ motif involv
PLoS One	30233866	2008-04-01	PMC3078118	21525985	background fulli human monoclon antibodi direct specif pathogen high therapeut potenti difficult gener methodologyprincip find memori cell immort express induc activ mutant transcript factor signal transduc activ transcript stat activ stat inhibit differenti cell increas replic life span clone cell line produc antibodi presenc interleukin turn stat method monoclon antibodi model antigen tetanu toxin conclusionssignific describ novel simpl method immort antigenspecif human cell isol human monoclon antibodi stat overexpress emploi isol antigen specif antibodi human memori cell
PLoS One	18221889	2011-04-01	PMC3078135	21525999	us random pcr amplif plasmid subclon dna sequenc detect bocaviru sequenc porcin stool sampl primer walk sequenc complet genom highli diverg bocavirus provision name porcin bocaviru isol pbovh porcin bocaviru isol pbova differ ns protein phylogenet analysi indic pbovh close kb central region porcin bocaviruslik viru pbolikev sweden describ pbova close porcin bocaviru genom pbov pbov china describ fecal sampl collect ag asymptomat swine chines provinc preval pbovh pbova virus pig coinfect pbova strain highli conserv pbovh strain divers group genotyp correspond describ pbov pbov describ partial bocaviru genom label v total three major porcin bocaviru clade describ studi will requir elucid pathogen impact divers bocavirus combin porcin virus
PLoS One	21420028	2010-08-02	PMC3078930	21533115	background acut respiratori infect ari lead morbid mortal children worldwid studi aim determin viral atyp bacteri sever clinic manifest ari preschool children lowincom famili northeast brazil method clinicaldemograph data nasopharyng aspir npa prospect collect children year present ari year paediatr ae depart diseas sever group presenc lower respiratori tract sign hospit admiss oxygen clinic manifest ari base discharg diagnosi hospit condit predomin bronchiol pneumonia episod viral wheezeasthma upper respiratori tract infect multiplex pcr detect common respiratori viral atyp bacteri pathogen npa find children median ag month recruit pathogen detect sampl coinfect common respiratori syncyti viru rsv adenovirus adv rhinovirus hrv bocaviru hbov human metapneumoviru hmpv mycoplasma pneumonia mpp preval detect coinfect rate sever clinic manifest ari apart rsv associ sever diseas sever case bronchiol mpp associ sever case pneumonia mpp detect children admit hospit pneumonia interpret studi underlin viral atyp bacteri pathogen ari preschool children highlight complex epidemiolog pathogen ag group gener virus atyp bacteria detect sever clinic manifest ari rsv mpp associ sever case bronchiol pneumonia respect
BMC Public Health	20679228	2015-02-18	PMC3079644	21435263	background health offici face challeng commun public emerg infecti diseas unknown sever hnswine flu pandem phn statement intend creat awar convei serious infecti diseas threat draw accus scaremong offici accus complac statement commun context new journalist reliant offici sourc understand issu pivot select emphasis aspect offici discours deem newsworthi to public paper present casestudi new commun emerg phn method conduct content analysi televis new item phn examin new current affair item broadcast freetoair sydnei televis channel april report octob prior vaccin releas statement serious diseas public minimis contagion govern respons emerg phn lead health stori week top week new item identifi yield statement analysi serious situat provid advic viewer involv assur govern coverag focus infectionmort rate spread viru public calm vulner group direct indirect advic viewer govern reassur effect manag conclus report phn sydnei australia gener nonalarmist convei phn seriou daili infect rate talli commentari chang pandem alert level seldom contextualis assist viewer understand person relev suggest futur report emerg infecti diseas enhanc
Virol J	25694520	2009-06-24	PMC3079669	21450075	background polioviru caus agent poliomyel human enteroviru member famili picornavirida rapidli evolv virus analysi codon usag reveal molecular evolut virus synonym codon usag pattern poliovirus genom acquir method rel synonym codon usag rscu valu effect number codon enc valu nucleotid content dinucleotid investig compar analysi codon usag pattern open read frame orf poliovirus isol includ genotyp genotyp genotyp result extent codon usag bia polioviru sampl low enc gener correl base composit codon usag bia suggest mutat pressur natur select main factor determin codon usag bia poliovirus depend rscu data wa variat bia codon usag three genotyp geograph factor codon usag pattern exist genotyp poliovirus gene length vaccin deriv poliovirus dvpv wild virus live attenu viru observ variat synonym codon usag viru gene rel abund dinucleotid cpg orf poliovirus expect valu dvpv attenu viru poliovirus genotyp conclus studi theoret understand polioviru evolut dvpv genotyp potenti develop polioviru vaccin
PLoS One	19553209	2013-01-01	PMC3080360	21533129	the sever acut respiratori syndrom sar epidem character increas pathogen elderli earli exacerb innat host respons sarscov zoonot pathogen enter human popul intermedi host palm civet prevent futur introduct zoonot sarscov strain subsequ transmiss human popul heterolog diseas model need test efficaci vaccin therapeut late human zoonot isol human zoonot sarscov strain infect cynomolgu macaqu radiolog histopatholog chang mild human case viral replic higher anim infect late human phase isol compar zoonot isol differ number host gene differenti regul host respons three sarscov strain top pathwai function appar earli infect major gene associ interferon signal pathwai studi character critic diseas model evalu licensur therapeut strategi sarscov human us
Genet Vaccines Ther	23297263	2015-08-26	PMC3080791	21477292	background envelop glycoprotein lymphocyt choriomening viru lcmv effici pseudotyp lentivir vector strain lcmv exploit high affin interact dystroglycan dg bind cell surfac subsequ fuse low ph endosom lcmv strain low dg affin util unknown receptor displai uniqu tissu tropism pseudotyp nonprim felin immunodefici viru fiv vector lcmv deriv glycoprotein high low affin dg evalu properti vitro vivo method pseudotyp fiv lcmv strain envelop glycoprotein engin point mutat envelop glycoprotein lf diminish dg affin direct bind altern receptor hypothes chang alter vivo tissu tropism enhanc gene transfer neonat anim mice hepat dg express greatest late gestat neonat time point displai surfac fiv lentiviru lf mutant glycoprotein bound weakli immobil dg addition lcmv pseudotyp fiv vector transduct neutral preincub solubl dg mutant glycoprotein pseudotyp vector vivo gene transfer adult mice envelop yield low transduct effici hepatocyt intraven deliveri mark contrast neonat gene transfer lcmv envelop notabl fivlf vector confer abund liver lower level cardiomyocyt transduct detect luciferas assai bioluminesc imag galactosidas stain conclus development regul receptor lcmv express abundantli neonat mice lcmv pseudotyp vector applic neonat gene transfer abbrevi armstrong armb baculoviru autographa californica gp gp chargecoupl devic ccd dystroglycan dg felin immunodefici viru fiv glycoprotein precursor gpc firefli luciferas luc lymphocyt choriomening viru lcmv nuclear target galactosidas ntlacz optic densiti od pb wv tween pbst rel light unit rlu rou sarcoma viru rsv transduc unit millilit tuml vesicular stomat viru vsvg wheat germ agglutinin wga reduct bind c
Environ Health Perspect	26311884	2014-10-29	PMC3080933	21118783	background link concentr particul matter pm respiratori morbid investig numer studi object aim studi analyz role particl size fraction respect respiratori health beij china method data particl size distribut nm pm pm nitrogen dioxid sulfur dioxid concentr meteorolog variabl collect daili march decemb concurr daili count emerg room visit erv respiratori diseas peke univers third hospit estim pollut effect singl twopollut gener addit model control meteorolog timevari covari timedelai associ estim polynomi distribut lag cumul effect singl lag model associ respiratori erv concentr nm particl number surfac area concentr magnitudethat increas respiratori erv interquartil rang increas air pollut concentr gener particl nm posit associ erv particl nm advers associ respiratori erv fraction ultrafin particl estim twopollut model consist conclus level air pollut beij advers associ respiratori erv concentr better surrog evalu respiratori health effect ambient air pollut pm particl number concentr beij
PLoS One	25355894	2003-04-15	PMC3081318	21544192	background simian hemorrhag fever viru shfv caus lethal outbreak hemorrhag diseas captiv primat distribut wild primat remain obscur describ discoveri genet character direct pyrosequenc novel diverg shfv variant coinfect singl male red colobu monkei kibal nation park uganda methodologyprincip find virus detect directli blood plasma pyrosequenc prior viru isol minim pcr amplif shfv variant shfvkrc shfvkrc highli diverg nucleotid sequenc ident shfv type strain lvr nucleotid sequenc ident demonstr greater phylogenet divers shfv document arteriviru variant genom architectur type strain three open read frame arterivirus conclusionssignific repres document shfv wild primat confirm unusu genet architectur shfv rel arterivirus demonstr degre evolutionari diverg shfv roughli equival degre diverg arteriviru speci presenc highli diverg shfv variant coinfect singl individu repres degre withinhost viral divers exce report arteriviru expand knowledg natur histori divers arterivirus underscor wild primat reservoir novel pathogen
PLoS One	12663803	2018-01-10	PMC3081840	21541353	dure comparison infect mndk cdindepend human immunodefici viru type hiv strain cell line hela cell suscept te cell hybridoma cell hela cell suscept cell suggest cellular factor enhanc mndk infect cell screen cdna express librari hela cell cystatin isol enhanc mndk infect cathepsin proteas natur ligand cystatin upregul hela cell specul high level cathepsin activ inhibitori cdindepend infect cystatin enhanc infect impair excess cathepsin activ consist idea pretreat hela cell cathepsin inhibitor fold enhanc mndk infect cathepsin activ low ph acid endosom examin potenti role endosom cdindepend infect suppress endosom acidif endocytosi inhibitor ep domin neg mutant reduc infect mndk cddepend infect impair endocytosi endosom acidif cathepsin activ involv cdindepend entri hiv
PLoS One	29321328	2008-03-01	PMC3082571	21541296	avian influenza surveil bangladesh passiv reli poultri farmer report suspect outbreak highli pathogen hn influenza activ surveil effort focus livebird market present preval influenza infect bird live bird market poultri market countri isol nonpathogen hn subtyp virus hn hn hn hn hn hn subtyp observ highli pathogen hnsubtyp viru observ extrem low preval surveil sampl current risk infect human retail poultri market bangladesh neglig high preval subtyp potenti interact highli pathogen hnsubtyp reassort attenu host morbid highlight activ surveil poultri market
PLoS One	18325350	2012-01-11	PMC3083406	21556151	background googl flu trend develop estim influenzalik ill ili rate internet search ili correl actual influenza viru infect method find influenza activ data three surveil system googl flu trend cdc outpati ili surveil network cdc ili surveil influenza virolog surveil system cdc viru surveil pearson correl coeffici confid interv ci calcul compar surveil data analysi perform investig outlier observ determin extent correl surveil data pearson correl coeffici describ googl flu trend cdc viru surveil studi period ci correl cdc ili surveil cdc viru surveil period ci outlier observ comparison influenza season exclus outlier observ improv correl googl flu trend cdc viru surveil ci cdc ili surveil cdc viru surveil ci conclus analysi demonstr googl flu trend highli correl rate ili lower correl surveil laboratoryconfirm influenza outlier observ occur influenza season character earli intens influenza activ alter health care seek behavior physician test practic internet search behavior
Int J Mol Sci	22238319	2006-05-01	PMC3083680	21541033	oxid stress consid major risk factor contribut increas lipid peroxid declin antioxid degen diseas glycyrrhizin cure allerg diseas medicin properti studi evalu role glycyrrhizin lipid peroxid antioxid statu blood nasal mucosa allerg rhiniti ar mice mice divid group normal control mice model control mc mice three glycyrrhizintr mice group lycopenetr mice sensitizationassoci increas lipid peroxid observ blood nasal mucosa mc mice activ antioxid enzym superoxid dismutas sod catalas cat glutathion peroxidas gshpx total antioxid capac taoc level glutathion gsh decreas blood nasal mucosa mc mice compar normal control mice normal lipid peroxid antioxid defens report glycyrrhizintr lycopenetr mice glycyrrhizin treatment enhanc ifn reduc il level glycyrrhizintr mice find demonstr glycyrrhizin treatment enhanc antioxid statu decreas incid free radicalinduc lipid peroxid improv immun activ blood nasal mucosa ar mice
PLoS One	16689659	2012-10-01	PMC3084774	21559474	current progress develop vaccin decreas incid fatal nonfat infect increas longev technolog develop combat emerg gener infecti diseas dna vaccin demonstr great potenti wide varieti diseas technolog gener immun respons vaccin combin deliveri electropor ep enhanc plasmid express immun ep system effect invas pain make desir vaccin lab develop noninvas electrod multielectrod arrai mea li flat surfac skin penetr tissu studi evalu mea dna vaccin hepat viru infecti model util guinea pig model skin thick morpholog human plasmid encod hepat surfac antigen hbsag deliv intraderm mea guinea pig skin increas protein express plasmid deliveri mea compar inject hour treatment influx cellular infiltr experiment group humor respons increas durat intens compar inject group electrod requir studi mea potenti electr mediat intraderm dna vaccin
PLoS One	22840606	2018-09-29	PMC3084784	21559424	structur group lilr leukocyt immunogloblin iglik receptor iglik transcript ilt leukocyt iglik receptor lir cd member term hlai human leukocyt antigen class molecul bind region hypothes bind hlai group lilr lilra secretori lilr greatli control inhibitori immun respons induc lilrb lilrb hlabind lilr molecul lilra bind lilra hlai report crystal structur lilra domain evalu dd domain domain bind classic nonclass hlai biacor surfac plasmon reson analysi spr lilra bind classic hlaa nonclass hlag reduc affin compar lilrb lilrb polymorph amino acid lilra structur support notion
PLoS One	30305999	2014-02-19	PMC3084832	21559411	melanoma lethal skin cancer thought immunogen natur focu cellmedi immun respons limit knowledg exist role matur cell describ approach includ cellbas elisa evalu matur igg antibodi respons melanoma human peripher blood cell observ increas antibodi respons melanoma patient primari metastat melanoma cell compar healthi volunt interestingli detect reduct antibodi respons melanoma advanc diseas stage patient cohort melanoma patientderiv cell cultur compar cultur healthi control produc antibodi recogn melanoma cell lastli patientderiv melanomaspecif monoclon antibodi select studi antibodi effect kill melanoma cell vitro antibodymedi cellular cytotox data demonstr presenc matur system cell respons melanoma patient reduc diseas progress ad previou report tumorreact antibodi patient sera suggest merit futur work elucid clinic relev activ humor immun respons cancer
PLoS One	24554650	2010-02-24	PMC3086881	21559329	dure summer itali experienc epidem caus chikungunya viru larg outbreak document temper climat countri laboratori confirm case concentr border villag northeastern itali compris inhabit seropreval estim work provid estim transmiss potenti viru assess efficaci measur undertaken public health author control epidem spread aim develop model describ tempor dynam compet vector aed albopictu explicitli depend climat factor coupl epidem transmiss model describ spread epidem human mosquito cumul number notifi case predict model averag ci good agreement observ data probabl observ major outbreak introduct infect human case estim rang basic reproduct number rang larger depend densiti mosquito turn depend season meteorolog effect local abiot factor confirm increas risk tropic vectorborn diseas temper climat countri consequ global epidem control perform time intervent transmiss potenti chikungunya viru sensibl high
Virol J	20181726	2013-01-01	PMC3087699	21496278	background hepat viru caus agent type viral hepat occasion acut hepat synonym codon usag pattern hav genom process evolut studi kei genet determin codon usag hav examin extent codon usag bia hav high picornavirida pattern synonym codon usag hav genom locat base composit close correl codon usag bia determin high codon bia hav mutat pressur natur select conclus hav present higher codon usag bia member picornavirida composit constraint element influenc variat synonym codon usag hav genom mutat pressur suppos major factor shape hyperendem codon usag pattern hav
PLoS One	23219434	2004-12-16	PMC3087751	21573230	background genet polymorph gene encod adrenerg receptor ar pivot role function autonom nervou system heart rate variabl hrv indic autonom function bottomup genotypephenotyp analysi investig associ ar gene polymorph heart rate dynam method total healthi han chines adult male femal ag year rang year recruit genotyp three common ar polymorph ar sergli ar arggli ar glnglu subject underw hour electrocardiogram monitor rest appli informationbas similar ib measur pairwis dissimilar heart rate dynam studi subject aid agglom hierarch cluster analysi categor subject major cluster distribut ar arggli genotyp nonrandom nonlinear hrv measur deriv ib method lower arg homozygot gly carrier nonrandom neg correl parasympatheticrel hrv variabl posit correl hrv indic reflect sympathovag shift sympathet activ conclus demonstr bottomup categor approach combin ib method hierarch cluster analysi detect subgroup subject hrv phenotyp associ ar polymorph provid evid ar polymorph associ accelerationdeceler pattern heart rate oscil reflect underli mode autonom nervou system control
PLoS Pathog	15604146	2010-05-19	PMC3088723	21573141	recombin evid impact viru evolut emerg pathotyp gener immens literatur distribut phenotyp effect caus genomewid random homolog recombin formal investig previou data subject promot implicit view viral recombin genom deleteri lethal nucleotid ident parent sequenc decid challeng view creat bank nearrandom recombin viral speci genu begomoviru famili geminivirida exhibit nucleotid ident test infect planta accumul recombin clone randomli extract bank bank creat dnashufflinga technolog initi appli random shuffl individu gene implement time shuffl fulllength viral genom describ system allow direct clone fulllength infecti geminiviru genom provid uniqu opportun gener hundr mosaic viru genom directli testabl infect subset randomli chosen recombin sequenc individu inocul tomato plant compar parent virus surprisingli recombin infecti accumul level compar intermedi parent clone indic experiment system despit fact parent genom differ lethal andor larg deleteri effect recombin rare strike contrast common view emerg previou studi publish virus
PLoS One	20484443	2007-03-24	PMC3089605	21573100	transmiss gastroenter viru tgev porcin coronaviru lithium chlorid licl effect dna virus herp simplex viru vaccinia viru report inhibitori licl avian infecti bronchiti coronaviru ibv infect rna viru current studi action mechan licl cell infect tgev investig plaqu assai dimethylthiahiazozydiphenyl tetrazoliumbromid mtt assai cell infect tgev inhibit dosedepend manner licl virusinfect cell cell infect cell virus pretreat drug inhibit tgev infect vitro licl observ viru dose cell line inhibitori licl tgev infect transcript confirm rtpcr realtim pcr target viral clproteas gene timeofaddit drug tgev infect indic licl act initi late stage tgev infect product viru detect postinfect drug treatment immunofluoresc flow cytometri analys base stain annexin propidium iodid stain nuclei indic earli late cell apoptosi induc tgev inhibit effici abil licl inhibit apoptosi investig analysi caspas express data indic licl inhibit tgev infect exert antiapoptot inhibitori licl observ porcin epidem diarrhea coronaviru report concern inhibitori lithium salt ibv cell cultur indic licl potent agent porcin avian coronavirus
PLoS One	17385026	2007-05-30	PMC3089607	21573102	sialic acid sa link galactos gal configur receptor avian human influenza virus demonstr chicken tracheal ciliat cell express link sa goblet cell express link sa addit plant lectin malii maamali bound surfac goblet cell suggest salink oligosaccharid galgalnac subtermin residu goblet cell link sa detect singl tracheal basal cell low multipl infect moi avian influenza viru hn exclus detect ciliat cell suggest ciliat cell major target cell hn viru moi ciliat goblet basal cell permiss aiv infect result clearli elucid receptor distribut avian influenza viru chicken tracheal epitheli cell illustr primari cell model evalu cell tropism respiratori virus poultri
BMC Bioinformatics	17537928	2005-06-01	PMC3090355	21489240	background viral zoonosi transmiss viru primari vertebr reservoir speci human requir ubiquit cellular protein receptor protein zoonosi occur direct transmiss vertebr human intermedi reservoir environment factor virus categor genotyp ssdna dsdna ssrna dsrna virus rna virus exhibit high mutat rate problemat reason zoonot virus rna virus chang envelop protein facilit bind receptor host speci studi sought predict zoonot propens analysi receptor characterist hypothes major barrier interspeci viru transmiss receptor sequenc vari speciesin specif amino acid sequenc receptor determin abil viral envelop protein attach cell analys hostcel receptor sequenc hydrophobicityhydrophil characterist analys properti similar receptor speci statist discrimin analysi predict likelihood transmiss speci conclus studi attempt predict zoonosi simpl comput analysi receptor sequenc differ method predict zoonot potenti newli discov viral strain
Virol J	15923443	2013-12-18	PMC3090357	21481279	hcv envelop protein name e plai role cell entri main pathwai direct fusion plasma membran receptormedi endocytosi fusion hcv envelop protein trigger low ph endosom lysosomotrop agent la chloroquin ammonium chlorid nhcl weak base penetr lysosom proton form increas intracellular ph investig antivir la chloroquin nhcl ph depend endocytosi hcv pseudoparticl hcvpp genotyp produc infect liver cell toxicolog effect chloroquin nhcl test liver cell mtt cell prolifer assai antivir screen chloroquin nhcl liver cell infect hcvpp genotyp presenc absenc concentr chloroquin nhcl luciferas activ determin luminomet demonstr chloroquin nhcl reduct viru infect mm concentr inhibit hcv fusion step increas lysosom ph will better option treat chronic hcv
Parasit Vectors	24352457	2008-02-11	PMC3090364	21489237	the intern promin accord health concept coordin activ involv human anim health modern incarn long tradit compar medicin root ancient civil golden era centuri explos knowledg field infecti diseas modern health focu zoonot pathogen emerg wildlif product anim speci health challeng rabi canin reservoir review consid role small companion anim health address major vectorborn infecti diseas share man dog cat leishmaniosi borreliosi bartonellosi ehrlichiosi rickettsiosi anaplasmosi challeng lie ahead field health discuss role newli form small anim veterinari associ health committe
PLoS One	18314500	2007-07-30	PMC3091021	21573031	virus common sourc infect immunocompet individu consid clinic meaning risk factor critic work examin associ viral infect diagnos hospit stai document admiss outcom icu patient evid immunosuppress admiss populationbas retrospect cohort studi univers healthsystem consortium uhc academ center year uhc allianc nonprofit academ medic center total critic patient analysi hospit complic examin patient group cohort absenc infect bacteri infect viral infect bacteri viral infect hospit admiss viral infect diagnos hospit increas risk complic season pattern viral infect specif virus associ poor outcom includ influenza rsv cmv hsv patient viral bacteri infect hospit greatest risk mortal rr ci multiorgan failur rr ci septic shock rr ci viral infect plai unrecogn role outcom icu patient serv biolog marker plai activ role develop advers complic interact coincid bacteri infect
BMC Public Health	17662167	2018-11-01	PMC3091536	21199571	background risk percept behaviour respons case emerg infecti diseas aim studi examin percept behaviour gener public earli phase influenza hn pandem netherland method crosssect followup onlin survei survei april survei june survei august adult ag year particip repres internet panel invit survei survei followup survei main outcom measur time trend risk percept feel anxieti behaviour respons survei factor associ prevent measur strong intent compli governmentadvis prevent measur futur survei august level knowledg influenza hn increas perceiv sever flu perceiv selfefficaci intent compli prevent measur decreas perceiv reliabl govern decreas august versu feel anxieti decreas june remain stabl june august perceiv vulner increas respond prevent measur versu prevent measur associ children household high anxieti high selfefficaci agreement statement avoid pai attent media influenza hn strong intent compli governmentadvis prevent measur futur associ higher ag high perceiv sever high anxieti high perceiv efficaci measur high selfefficaci find government reliabl conclus decreas trend time perceiv sever anxieti consist realiti clinic pictur influenza turn mild cours time intern health author initi overestim case fatal rate public stai calm remain high intent compli prevent measur
BMC Public Health	30392829	2016-03-21	PMC3091577	21050482	background profession hospit worker japan challeng pandem hn maintain hospit function critic situat pandem understand factor increas decreas willing work previou hospitalbas studi examin question hypothet event examin actual pandem survei factor influenc motiv hesit hospit worker work japan pandem hn method selfadminist anonym questionnair demograph charact stress factor distribut employe three core hospit kobe citi japan collect june juli month pandem hn japan total questionnair distribut valid questionnair receiv worker strong motiv strong hesit work demograph charact stressrel question categoris type odd ratio motiv hesit work factor increas motiv lower hesit increas motiv increas hesit increas motiv hesit strong feel support nation local govern multivari motiv ci hesit ci protect hospit multivari motiv ci hesit ci higher motiv lower hesit protect includ precaut prevent ill worker famili provid care reduc malpractic threat financi support famili worker die duti respond answer protect nation local govern weak answer protect hospit weak conclus factor conflict effect increas motiv hesit worker feel protect nation local govern hospit valuabl increas motiv lower hesit work
BMC Genomics	27001840	2015-06-02	PMC3091641	20663124	background rate emerg human pathogen steadili increas novel agent origin wildlif bat remark natur reservoir of pathogen virus human bat genom project current underwai circumst promis speed discoveri host factor coevolut bat virus genom assembl will provid low coverag make infer gene immunolog interest errorpron wildlif genom project underwai intend provid shallow coverag develop statist method assembl gene famili partial genom method take full advantag qualiti score gener basecal softwar incorpor complet probabilist error model overcom limit inher infer gene famili member partial sequenc valid method infer human ifna gene genom trace archiv infer typei interferon gene singl typeii interferon gene bat pteropu vampyru myoti lucifugu confirm infer direct clone sequenc ifna ifnb ifnd ifnk vampyru demonstr transcript infer gene interferoninduc stimuli conclus statist trace assembl describ reliabl method extract forthcom partial shallow genom sequenc project facilit studi wider varieti organ ecolog biomed signific human possibl
BMC Genomics	26038383	2014-03-07	PMC3091733	20961419	background resequenc microarrai call pathogenid develop explor strategi sequenc select design dedic influenza virus base consensu sequenc specif gene gener global align larg number influenza viru sequenc databank ha h h h n molecular type chosen test consensu sequenc comput tile microarrai total influenza viru sampl host origin human pig hors bird isol period year studi influenza virus correctli identifi case accur time emerg conclus pathogenid microarrai demonstr abil type subtyp influenza virus level viral variant minimum number tile sequenc valid strategi consensu sequenc exist natur microarrai design versatil rapid high discriminatori power pathogenid microarrai prove critic detect identifi viral genom reassort event novel viru epidem pandem potenti assist health author effici decis patient treatment outbreak manag
PLoS One	24601662	2015-05-10	PMC3091864	21573005	background studi assess effect pandem trival season vaccin prevent influenzalik ill ili ahn pandem franc compar vaccin effect ili versu laboratoryconfirm pandem ahn influenza assess bia caus nonspecif endpoint observ data methodolog princip find estim vaccin effect formula ppvpcvppvpcv ppv proport vaccin popul pcv proport vaccin influenza case peopl consid vaccin three week receiv dose vaccin ili pandem ahn laboratoryconfirm case surveil network gener practition epidem influenza isol pandem ahn pandem season vaccin uptak popul nation health insur databas telephon survei effect estim adjust ag week presenc residu bias explor calcul vaccin effect influenza period effect pandem vaccin prevent ili confid interv pandem confirm influenza effect season vaccin ili pandem confirm influenza conclus effect pandem vaccin prevent confirm pandem ahn influenza field high consist publish find lower ili unsurpris ili case caus influenza trival season vaccin statist effect prevent ili confirm pandem influenza better prevent confirm pandem influenza prevent ili lack differ indic select bia
PLoS One	25960542	2013-02-28	PMC3091876	21572957	public health surveil undergo revolut driven advanc field technolog countri experienc vast improv collect ingest analysi visual dissemin public health data resourcelimit countri lag challeng technolog infrastructur public health resourc cost proprietari softwar suit autom global electron biosurveil sage collect modular flexibl freelyavail softwar tool electron diseas surveil resourcelimit set sage tool concert exist surveil applic sage tool en mass endtoend biosurveil capabl flexibl allow develop inexpens custom sustain diseas surveil system abil rapidli assess anomal diseas activ lead effici limit resourc better complianc health organ intern health regul
BMC Public Health	23449786	2012-10-24	PMC3092412	21388562	the arm forc health surveil center global emerg infect surveil respons system afhscgei mission perform surveil emerg infecti diseas affect unit state militari mission accomplish orchestr global portfolio surveil project capacitybuild effort outbreak investig train exercis portfolio involv fund partner impact countri articl discuss current biosurveil landscap programmat detail organ implement kei contribut forc health protect global public health 
PLoS One	23100349	2012-08-29	PMC3093381	21589915	bat reservoir coronavirus cov zoonot virus sampl fece andor anal swab insectivor bat famili speci locat colorado detect alphacoronaviru rna bat speci big brown bat eptesicu fuscu preval longleg bat myoti volan preval brown bat myoti lucifugu preval western longear bat myoti evoti preval juvenil bat posit cov rna adult bat rural sampl site cov rna detect big brown longleg bat three sequenti summer studi cov rna detect big brown bat urban matern roost sampl period test individu tag big brown bat posit cov rna sampl cov rna neg nucleotid sequenc rdrp gene fell main cluster distinct bat nucleotid sequenc amplicon gene spike gene bigbrown longleg bat indic cov capabl infect bat genera data ongo evolut cov bat creat possibl continu threat emerg host speci alphacoronaviru rna detect high preval big brown bat roost close proxim human habit direct contact peopl suggest potenti opportun exist crossspeci transmiss virus cov surveil studi bat america warrant
BMC Infect Dis	22932899	2011-01-18	PMC3094225	21510889	background season respiratori syncyti viru rsv epidem occur annual temper climat result pediatr morbid increas health care cost rsv epidem gener occur octob april size time vari epidem season difficult predict accur predict epidem characterist support manag resourc treatment method goal examin empir relationship earli exponenti growth rate total epidem size time util specif paramet compartment model transmiss account variat season rsv epidem curv rsv test data primari children medic center collect children year ag juli june simpl linear regress explor relationship three epidem characterist final epidem size dai peak epidem length exponenti growth calcul week daili case data compartment model transmiss fit data paramet estim help describ variat season rsv epidem curv regress indic exponenti growth correl epidem characterist transmiss model indic start time epidem transmiss paramet covari epidem season conclus conclus exponenti growth empir season epidem characterist variat epidem start transmiss paramet epidem year explain variat season epidem size relationship public health health care provid infecti diseas research
Trials	21245143	2016-07-13	PMC3094234	21492416	background acut lower respiratori infect commonest morbid prevent mortal indigen infant infanc critic time postnat lung growth develop sever repeat lower airwai injuri young children increas likelihood chronic pulmonari disord life global bronchiol common form acut lower respiratori infect infanc compar nonindigen australian infant indigen infant greater bacteri densiti upper airwai sever bronchiol episod studi test hypothesi antimicrobi antiinflammatori properti azithromycin improv clinic outcom indigen australian infant hospitalis bronchiol method conduct dual centr randomis doubleblind placebocontrol parallel group trial northern australia indigen infant ag month expect number admit region hospit darwin northern territori townsvil queensland clinic diagnosi bronchiol fulfil inclus criteria randomis alloc conceal azithromycin mgkgdose placebo administ weekli three dose clinic data record daili nasopharyng swab collect enrol time discharg hospit primari outcom length oxygen requir durat stai base judg readi respiratori discharg main secondari outcom readmiss respiratori ill month leav hospit descript virolog bacteriolog includ develop antibiot resist data nasopharyng sampl will report discuss publish studi involv patient popul set macrolid antibiot treatment durat produc conflict randomis placebocontrol trial azithromycin indigen infant hospitalis bronchiol design determin reduc shortterm longterm morbid respiratori ill australian indigen infant high risk develop chronic respiratori ill azithromycin efficaci reduc morbidli indigen infant hospitalis bronchiol intervent lead improv short term long term health benefit trial registr australia zealand clinic trial regist anzctr actrn
Virol J	27413096	2012-01-01	PMC3094301	21510909	background nephropathogen avian infecti bronchiti ib caus unpreced econom loss commerci chicken industri china investig preval nephropathogen ib china ibv isol provinc identifi dwarf embryo test rtpcr strain isol winter spring wide ag rang ib outbreak dai viru recoveri trial strain death distress bird nephriti learn molecular evolutionari characterist circul field strain code region major spike protein gene strain rtpcr amplifi sequenc compar publish repres strain nucleotid amino acid sequenc analysi indic gene strain refer strain displai homolog rang to protein major pandem strain contain amino acid cleavag site hrrrr rrfrr phylogenet analysi reveal field isol ibv china belong abranch qxibvbranch hnbranch isol belong graybranch mbranch strain evolutionarili distant vaccin strain conclus studi suggest nephropathogen ibv alik strain china 
Evid Based Complement Alternat Med	24701402	2018-08-09	PMC3094709	20028719	the scutellaria speci lamiacea sourc flavonoid treat varieti diseas tradit medicin spite report cytotox antitumor effect speci genu anticanc research iranian speci litwinowii conduct cytotox properti total methanol extract litwinowii fraction investig cancer cell line includ ag hela mcf pc nih role apoptosi toxic explor cell cultur dmem medium incub concentr herb plant extract cell viabil quantit mtt assai apoptot cell determin propidium iodid stain dna fragment flow cytometri subg peak scutellaria litwinowii inhibit growth malign cell dosedepend manner solvent fraction litwinowii methylen chlorid fraction toxic compar fraction ic valu fraction ag hela mcf pc cell line determin gml scutellaria litwinowii induc subg peak flow cytometri histogram treat cell compar control cell indic apoptot cell death involv litwinowii toxic scutellaria litwinowii exert cytotox proapotot effect varieti malign cell line consid potenti chemotherapeut agent cancer treatment
Evid Based Complement Alternat Med	30093393	2010-07-07	PMC3096453	20008902	essenti oil star anis phenylpropanoid sesquiterpen exampl transanethol eugenol eudesmol farnesol caryophyllen caryophyllen oxid essenti oil examin antivir activ herp simplex viru type hsv vitro antivir activ analyz plaqu reduct assai mode antivir action determin addit drug uninfect cell viru prior infect herpesvirusinfect cell star anis oil reduc viral infect phenylpropanoid inhibit hsv infect sesquiterpen suppress herp viru infect star anis essenti oil isol compound exhibit antihsv activ direct inactiv free viru particl viral suspens assai test drug interact dosedepend manner herpesviru particl inactiv viral infect star anis oil rich transanethol reveal high select hsv isol compound caryophyllen displai high select presenc caryophyllen essenti oil contribut antivir abil indic phenylpropanoid sesquiterpen essenti oil contribut antivir activ hsv
BMC Infect Dis	20610717	2017-10-01	PMC3096599	21539735	background entri screen start search febril intern passeng infrar thermoscann emploi fever screen japan aim retrospect assess feasibl detect influenza case base fever screen sole measur method dataset collect narita intern airport pandem contain confirm influenza case diagnosi place airport earli stage pandem second contain select suspect fraction passeng selfreport detect infrar thermoscann screen septemb januari sensit fever detect hn estim diagnost perform infrar thermoscann detect hyperthermia cutoff level c estim sensit fever detect hn case arriv estim confid interv confirm hn case hn case antipyret medic arriv sensit specif infrar thermoscann detect hyperthermia rang posit predict appear low conclus sensit entri screen product sensit fever detect influenza case sensit infrar thermoscann detect fever addit presenc confound factor unrestrict medic passeng relianc fever feasibl entri screen measur
Virol J	28655566	2019-02-05	PMC3096946	21496223	background document untransl region utr positivestrand rna virus kei cisact regulatori sequenc highord structur element regulatori element control porcin arteriviru replic investig role conserv stemloop sl resid utr genom type ii porcin reproduct respiratori syndrom viru prrsv provid genet evid demonstr sl type ii prrsv utr nsl structur function substitut counterpart type prrsv esl function nsl depend gc rich stem structur ternaryloop size irrelev rna synthesi serial delet stem integr nsl crucial subgenom mrna synthesi extens basepair stem region delet altern nsllike structur sequenc util viru replic conclus conclud phylogenet conserv sl utr crucial prrsv viru replic subgenom mrna synthesi particular
PLoS One	30721153	2005-01-01	PMC3097202	21673789	background mass strand sperm whale physet macrocephalu remain peculiar unexplain event rare occur mediterranean sea solar cycl chang geomagnet field variat water temperatur weather condit coast geograph featur human activ propos decemb pod male sperm whale strand adriat coast southern itali sixth instanc basin methodologyprincip find complet necropsi perform three whale bodi good condit carri sampl tissu histopatholog virolog bacteriolog parasitolog screen vein ga emboli sampl ag determin genet studi gastric content evalu stabl isotop toxicolog specimen anim group determin genet photoidentif mediterranean popul death includ biolog agent ga fat embol syndrom associ direct sonar exposur environment pollut tissu concentr high organochlorin xenobiot gastric content morpholog tissu examin prolong starvat caus turn mobil lipophil contamin adipos tissu chemic compound subsequ enter blood circul impair immun nervou function conclusionssignific multifactori underli sperm whale mass strand propos base postmortem investig detail analys geograph histor background sperm whale wrong adriat sea danger trap mediterranean sperm whale seismic survei regard potenti cofactor evid direct impact detect
PLoS One	16038039	2013-01-14	PMC3097204	21611125	background scaveng abil suffici dival metal ion pivot pathogen bacteria surviv host atpbind cassett abctyp metal transport provid consider amount transit metal bacteri growth troa substrat bind protein uptak multipl metal ion function structur troa homologu epidem streptococcu sui isol sstroa character methodologyprincip find determin crystal structur sstroa highli pathogen streptococc toxic shock syndrom stsscaus streptococcu sui complex zinc induct coupl plasma mass spectrometri icpm analysi reveal aposstroa bind zn mn metal bind sstroa nanomolar affin stabil protein thermal unfold zn mn induc distinct conform chang sstroa compar apo form confirm circular dichroism cd nuclear magnet reson nmr spectra nmr data reveal znmn bind sstroa site adjac region final fold metalbound protein compact correspond apoprotein conclusionssignific find reveal mechan uptak metal ion sui mechan reason explan sstroa oper metal transport
PLoS One	23319741	2010-11-01	PMC3097245	21625607	import advanc immunodiagnosi tuberculosi tb base detect mycobacterium tuberculosi mtbspecif cell sensit specif immunolog approach low specif marker antigenspecif cell cell produc cytokin overlook approach studi mtbspecif peptid esatcfp stimul express cdl cd cell cell pleural fluid cell pfc patient tubercul pleurisi tbp cdcdl cdcdl cell express ifn il tnf il il stimul mtbspecif peptid addit cdcdl cell polyfunct cell simultan produc ifn il tnf displai effector effector memori phenotyp cdracdroccrcdlico determin specif cdcdl cell incub pfc estacfp peptid sort live cdcdl cdcdl cell flow cytometri demonstr sort cdcdl cdcdl fraction princip produc ifn il tnf il il restimul estacfp peptid data indic express cdl mtbspecif cd cell good marker evalu isol mtbspecif cell diagnosi tb
Biomed Imaging Interv J	20934458	2007-01-17	PMC3097804	21611071	thi retrospect descript studi chest imag find patient confirm ahn tertiari referr centr patient posit initi chest radiograph cxr find common find bibas airspac opac perihilar reticular alveolar infiltr select case highresolut comput tomographi ct imag groundglass chang widespread reticular chang atelectasi
BMC Bioinformatics	17229712	2007-01-01	PMC3098112	20144194	background polypeptid backbon potenti form amyloid fibril associ number degen disord likelihood amyloidosi occur physiolog condit depend amino acid composit protein explor naiv bayesian classifi weight decis tree predict amyloidogen immunoglobulin sequenc averag accuraci base leaveoneout loo cross valid bayesian classifi gener amyloidogen sequenc consist averag accuraci holdout test set compris nonamyloidogen sequenc loo cross valid accuraci increas train set augment holdout test set comparison averag classif accuraci holdout test set decis tree nonamyloidogen sequenc predict averag loo cross valid accuraci bayesian classifi depend train set size accuraci holdout test set decis tree nonamyloidogen predict accuraci conclus exploratori studi indic classif method promis provid straightforward predict amyloidogen sequenc number sequenc satisfi premis studi limit consequ smaller ideal train set size increas size train set clearli increas accuraci expans train set includ deriv align method sound accuraci classifi improv addit factor structur physicochem data consid develop type classifi applic evalu engin antibodi adapt evalu engin protein gener
Malar J	17242751	2007-02-01	PMC3098821	21529346	background develop plantbas vaccin plasmodium vivax vivax candid protein chosen merozoit surfac protein msp major asexu blood stage antigen current consid strong vaccin candid second circumsporozoit protein csp compon sporozoit bcell epitop method synthet chimer recombin bp gene encod pvmsp progli linker motif pvcsp synthes gene name mlc encod total amino acid recombin gene modifi regard codon usag optim gene express brassica napu ti plasmid induc gene transfer system mlc chimer recombin gene express napu gene express confirm polymeras chain reaction pcr betaglucuronidas report gene gu assai western blot mlc chimer recombin protein express napu molecular weight kda exhibit clinic sensit clinic specif assess enzymelink immunosorb assai elisa oral immun balbc mice mlc chimer recombin protein induc antigenspecif igg product addition threlat cytokin il tnf ifn increas spleen balbc mice conclus chimer mlc recombin protein produc napu potenti antigen diagnosi valuabl vaccin candid oral immun vivax malaria
Pulm Med	17308726	2008-07-28	PMC3099744	21637367	it obviou interstiti lung diseas viral lung infect progress rapidli exhibit featur lung morpholog final histopatholog featur common lung disord diffus alveolar damag dad histopatholog dad consid repres stage phenomenon acut behav interstiti pneumonia acut interstiti pneumonia aip acut exacerb idiopath pulmonari fibrosi ipf acut worsen dad occur patient nonspecif interstiti pneumonia nsip sever viral lung infect dad histopatholog lung better understand mechan underli dad reaction need clarifi treatment seriou lung diseas urgent intern effort studi dadassoci lung diseas prognosi patient dismal
PLoS One	18663227	2014-10-03	PMC3100328	21629775	although ecolog coinfect increasingli recogn analys microbi pathogen dynam wildlif focu ad hoc subset speci technolog limit detect demonstr express profil immunolog gene pattern recognit receptor cytokin transcript factor identifi preconcept likelihood acut microbi infect wildlif wood mous popul uk model identifi tempor cluster individu extrem express immunolog mediat multipl loci typic acut microbi infect cluster circumstanti associ demograph perturb summertim wood mous popul anim cluster higher individu macroparasit burden contemporari normal express pattern extrem transcript profil observ induc infecti agent implic macroparasit player mediat individu suscept resili infect form survei describ combin gener nucleic acid sequenc method broad detect microbi infecti agent individu anomal immunolog transcript profil power tool reveal unrecogn ecolog infecti agent circul wildlif popul
PLoS One	25281754	2008-09-01	PMC3100331	21629778	vuvuzela plastic blow horn sport fan achiev intern recognit fifa cup soccer tournament south africa hypothesis vuvuzela facilit gener dissemin respiratori aerosol investig quantiti size aerosol emit instrument plai healthi volunt ask blow vuvuzela individu concentr particl expel air measur channel laser particl counter durat blow veloc air leav vuvuzela record allow comparison activ undertaken sport event individu ask shout measur repeat paper cone confin exhal air triplic measur individu peak particl count litr vuvuzela litr shout repres log differ ci major particl captur vuvuzela shout micron diamet peak airflow record vuvuzela shout litr second conclud plastic blow horn vuvuzela capac propel extrem larg number aerosol atmospher size penetr lower lung respiratori pathogen spread contamin aerosol emit infect person investig requir assess potenti vuvuzela contribut transmiss aerosol born diseas recommend precautionari measur peopl respiratori infect advis blow vuvuzela enclos space risk infect other
Pulm Med	19693370	2018-07-16	PMC3100576	21637372	the pathogenesi acut exacerb idiopath pulmonari fibrosi ipf remain elucid evalu role inflammatori mediat acut exacerb concentr high mobil group protein hmgb chief mediat acut lung injuri inflammatori cytokin measur bronchoalveolar lavag fluid serial sampl ipf patient onset acut exacerb hmgb gradual increas alveolar fluid onset acut exacerb posit correl monocyt chemotact protein mcp potent fibrogen mediat lung tissu ipf patient autopsi acut exacerb intens cytoplasm stain hmgb observ alveolar epitheli cell alveolar capillari augment lesion capillari endotheli cell remark reduc express thrombomodulin intrins antagonist hmgb pathogen role hmgb mcp late phase acut exacerb ipf
Int J Mol Sci	30012613	2011-11-09	PMC3100839	21614200	protein microarrai power tool system biologi infecti diseas proteom microarrai assembl protein pathogen will plai increasingli role discoveri diagnost marker vaccin therapeut distinct format protein microarrai develop applic includ abundancebas functionbas method depend applic design issu consid multiplex label label free detect method develop challeng futur demand infecti diseas will impact applic protein microarrai discoveri valid biomark
PLoS One	22072787	2003-10-07	PMC3101222	21629701	the genu perkinsu occupi precari phylogenet posit gain better understand relationship perkinsid dinoflagel alveol analyz nuclearencod splicedlead sl rna mitochondri gene intron preval multiprotein phylogeni contrast canon nt sl dinoflagel dinosl marinu shorter nt longer nt sl sequenc dinosl major sl rna transcript rang size nt marinu nt chesapeaki larger typic nt dinoflagel sl rna phylogenet tree base predict protein sequenc marinu branch base dinoflagel clade includ ancient taxa oxyrrhi amoebophrya sister clade apicomplexan case cluster apicomplexan sister dinoflagel clade perkinsu spp gene examin intron higher intron preval dinoflagel examin perkinsu spp mitochondri cytochrom cytochrom oxidas subunit gene cdna reveal mrna edit transcript translat frameshift introduc agg ccc codon aggi code glycin ccccu prolin presenc numer uncharacter marin alveol group perkinsuslik lineag separ perkinsid core dinoflagel expand support affili genu perkinsu independ lineag perkinsozoa posit phyla apicomplexa dinoflagellata
PLoS Pathog	14561285	2016-01-11	PMC3102710	21637813	cellular viral sadenosylmethioninedepend methyltransferas involv regul process metabol detoxif signal transduct chromatin remodel nucleic acid process mrna cap sever acut respiratori syndrom coronaviru nsp protein sadenosylmethioninedepend nucleosideomethyltransferas activ presenc activ partner nsp report nspnsp complex structur resolut nsp bound nsp surfac area nsp function assai identifi kei residu involv nspnsp associ rna bind catalysi snlike mechan crystal structur inhibitor sinefungin bound sadenosylmethionin bind pocket tighter complex nspyfnsp provid structur insight regul rna cap enzym rna virus
PLoS One	26752023	2009-08-01	PMC3103500	21637748	background accessori protein sarscov small protein amino acid structur solv local extranuclear region postul possess nuclear export signal ne role ne function understood princip findingsmethodolog report demonstr absenc nuclear local signal nl enter nucleu passiv transport cell cycl inhibitor nuclear entri independ cell cycl interact cellular protein crm export nucleu activ ne reveal ne activ influenc halflif host cell death export signal defici sarscov protein induc apoptosi transient transfect cell elev caspas activ conclusionsignific nuclear shuttl interact crm essenti proper degrad block nuclear export protein induc apoptosi phenomenon critic provid novel role accessori protein sarscov
PLoS Med	29060084	2017-05-10	PMC3104979	21655318	background infect pregnanc potenti advers impact birth outcom evalu associ receipt inactiv influenza vaccin pregnanc prematur small gestat ag sga birth method find conduct cohort analysi surveil data georgia unit state pregnanc risk assess monitor system live birth june septemb matern influenza vaccin primari intervent evalu studi receipt influenza vaccin trimest pregnanc main outcom measur prematur gestat ag birth wk sga birth weight percentil gestat ag infant born put influenza season octob mother vaccin influenza pregnanc prematur compar infant unvaccin mother born period adjust odd ratio ci magnitud associ matern influenza vaccin receipt reduc likelihood prematur increas period local influenza activ adjust ci greatest widespread influenza activ period adjust ci compar newborn unvaccin women newborn vaccin mother lower odd sga adjust ci period widespread influenza activ adjust unadjust or preinfluenza activ period conclus studi demonstr associ immun inactiv influenza vaccin pregnanc reduc likelihood prematur local region widespread influenza activ period associ preinfluenza activ period period widespread influenza activ associ matern receipt influenza vaccin reduc likelihood sga birth articl editor summari
BMC Med	28488435	2016-12-01	PMC3108322	21521505	background viral respiratori infect common worldwid rang complet benign diseas lifethreaten ill symptom unspecif etiolog diagnosi rare establish lack suitabl diagnost tool improp antibiot common set detriment light develop bacteri resist suggest diagnost test reduc antibiot prescript rate object studi evalu access multiplex polymeras chain reaction pcr assai panel etiolog diagnosi acut respiratori tract infect arti impact antibiot prescript rate primari care clinic set method adult patient symptom arti prospect includ nasopharyng throat swab analys multiplex realtim pcr method target thirteen virus bacteria patient recruit outpati unit octob april sampl collect dai inclus initi visit dai followup visit patient randomis openlabel treatment protocol receiv rapid delai result dai twelv dai primari outcom measur antibiot prescript rate initi visit secondari outcom total antibiot prescript rate studi period total sampl patient randomis fortyon exclud leav patient analysi group patient randomis rapid result of patient receiv antibiot initi visit compar patient delai result group followup differ group rapid result group delai result group conclus access rapid method etiolog diagnosi arti reduc antibiot prescript rate initi visit outpati set sustain better defin follow manag patient result test warrant investig trial registr clinicaltrialsgov identifi nct
Pulm Med	27756680	2009-07-10	PMC3109313	21660284	highaltitud pulmonari edema hape lifethreaten diseas high altitud nonacclimat healthi individu rapidli ascend high altitud earli detect earli diagnosi earli treatment essenti maintain safeti peopl ascend high altitud construct worker tourist paper discuss method criteria earli diagnosi predict hape discuss prevent strategi option onsit treatment object improv understand hape highlight prevent earli diagnosi earli treatment hape improv safeti individu ascend high altitud
PLoS One	19592662	2011-08-01	PMC3110205	21687739	honei bee api mellifera plai critic role global food product pollin numer crop honei bee popul unit state canada europ suffer unexplain increas annual loss phenomenon coloni collaps disord ccd epidemiolog analysi ccd confound rel dearth bee pathogen field studi identifi constitut abnorm pathophysiolog condit honei bee coloni critic character spectrum exogen infecti agent healthi hive time conduct prospect studi larg scale migratori bee keep oper highfrequ sampl pair comprehens molecular detect method includ custom microarrai qpcr ultra deep sequenc establish season incid abund virus nosema sp crithidia mellifica bacteria ultra deep sequenc analysi identifi novel rna virus abund observ compon honei bee microbiom virus honei bee demonstr episod viral incid distinct pathogen pattern summer winter timepoint peak infect common honei bee virus nosema occur summer level trypanosomatid crithidia mellifica lake sinai viru novel viru peak januari
PLoS Med	21621287	2004-12-30	PMC3110256	21687693	background wintertim cooccurr peak influenza invas pneumococc diseas ipd document wintertim peak caus pathogen causal uncertain aim investig relationship influenza infect ipd ontario canada complementari methodolog tool method find evalu total number posit influenza test central ontario episod ipd torontopeel area ontario canada januari octob report populationbas surveil assess relationship season wave form influenza ipd fast fourier transform order examin relationship pathogen yearli timescal three complementari statist method timeseri method neg binomi regress casecrossov method evalu shortterm influenza dynam pneumococc risk annual period wintertim peak demonstr ipd period influenza regular longterm effect phase amplitud term pneumococc influenza season sine wave correl metaanalysi confirm heterogen influenza pneumococc phase term contrast influenza grangercaus pneumococc diseas shortterm associ ipd influenza demonstr week lag casecrossov odd ratio confid interv case ipd influenza case neg binomi regress analysi incid rate ratio confid interv case ipd influenza case conclus data support hypothesi influenza influenc bacteri diseas incid enhanc shortterm risk invas colon individu absenc correl season waveform hand suggest bacteri diseas transmiss lesser extent articl editor summari
Viruses	15626758	2010-11-05	PMC3111045	21666766	rift vallei fever rvf emerg zoonot diseas distribut subsaharan african countri arabian peninsula diseas caus rift vallei fever viru rvfv famili bunyavirida genu phleboviru viru transmit mosquito viru replic domest rumin high rate mortal abort rvfv infect human selflimit acut febril ill small number case progress neurolog disord partial complet blind hemorrhag fever thrombosi review describ patholog rvf human patient anim model summar role viral virul factor host factor affect rvfv pathogenesi
PLoS Pathog	21036828	2011-08-31	PMC3111541	21695242	transmiss gastroenter viru tgev genom three accessori gene gene member coronaviru genu encod hydrophob protein aa studi gene function recombin tgev viru lack gene engin rtgev mutant parent rtgevwt virus growth viral rna accumul kinet tissu cultur cell infect rtgev viru increas cytopath caus enhanc apoptosi mediat caspas activ macromolecular synthesi analysi rtgev viru infect led host translat shutoff increas cellular rna degrad compar rtgevwt infect increas eukaryot translat initi factor eif phosphoryl enhanc nucleas rnase activ observ rtgev viru infect cell suggest remov gene promot intensifi dsrnaactiv host antivir respons protein conserv sequenc motif mediat bind protein phosphatas catalyt subunit ppc kei regul cell antivir defens identifi postul tgev protein counteract host antivir respons associ ppc fact pulldown assai demonstr interact tgev protein protein mutant lack ppc bind motif interact protein requir infect eif dephosphoryl inhibit cell rna degrad inocul newborn piglet rtgev rtgevwt virus rtgev viru present acceler growth kinet patholog compar parent viru indic gene counteract host cell defens modifi tgev persist increas tgev surviv acquisit gene tgev genom provid select advantag viru
BMC Infect Dis	21880764	2005-03-21	PMC3112099	21575222	background china greatest risk pandem hn huge popul high residenti densiti unclear comprehens neg attitud emerg infecti diseas gener popul lead unnecessari worri panic object studi investig chines public respons hn pandem provid baselin data develop public educ campaign respons futur outbreak method closeend questionnair develop chines center diseas control prevent appli assess knowledg attitud practic kap pandem hn respond recruit urban rural area china sampl probabl proport size pp method respond clear food spread hn virusand report pandem impact life immun rate season flu hnvaccin farmer lower educ level main transmiss rout cough talk face face femal colleg educ higher percept risk complianc prevent behavior relationship knowledg risk percept ci knowledg practic ci studi subject regard behavior ahn vaccin factor current studi popul includ percept life disturb ci safeti ahn vaccin ci knowledg free vaccin polici ci state prioriti vaccin strategyor ci season influenza vaccin behavior ci conclus ahn epidem caus public panic knowledg ahn resid optimist public educ campaign side effect vaccin knowledg state vaccin strategi account
Virol J	15781480	2014-02-13	PMC3113310	21595942	background outcom viru infect depend precis coordin viral gene express genom replic abil control regul process analysi infect process virus tool bio gene technolog effici kill cancer cell trigger immun respons tumor method construct tissu celltyp specif virus typic suffer low targetcel specif high risk revers novel univers method regul viral infect therapeut applic virusbas system method aberrantli splice intron introduc crucial geneexpress unit adenoviru vector alphaviru dnarna layer vector effect viral gene express replic andor releas infecti genom studi cell cultur transfect cell spliceswitch oligonucleotid correct introduc function defect demonstr viral gene express replic andor releas infecti genom block introduct aberrantli splice intron insert intron adenoviru vector reduc express target gene fiftyfold insert alphaviru dnarna layer vector dramat releas infecti transcript suppress subsequ replic spread viru insert aberrantli splice intron hundredfold reduct infect dnarna layer vector system observ effect revert deliveri spliceswitch oligonucleotid correct splice defect conclus spliceswitch technolog origin develop genet diseas therapi control gene express viral vector approach repres novel univers power method control gene express replic viral spread extens virusinduc cytotox effect basic studi viru infect virusbas gene anticanc therapi
PLoS One	24524681	2006-12-01	PMC3113848	21695140	background apic membran antigen ama beststudi bloodstag malaria vaccin candid ama vaccin test malaria nave popul induc function activ antibodi judg growth inhibit assai gia vaccin fail induc higher growthinhibitori activ adult live malaria endem area vaccin induc function activ antibodi malariaexpos children inhibit gia baselin children level baselin inhibit method total igg purifi plasma collect pediatr trial immun pool total igg set total igg purifi adult immun ama ustot igg total igg amaspecif nonama igg affin purifi function activ igg evalu gia competit elisa perform ustot igg nonama igg malariaexpos children amaspecif igg malariaexpos children vaccine growthinhibitori activ concentr mix ustot igg nonama igg children interfer gia interestingli interfer higher nonama igg higher titer pool nonama igg compet antiama antibodi ustot igg competit elisa conclus children live malaria endem area fraction igg interfer biolog activ antiama antibodi judg gia mechan interfer resolv studi caus direct competit nonama igg ama protein studi indic antimalaria igg induc natur exposur interfer biolog antibodi induc amabas vaccin target popul
J Med Case Reports	16959328	2014-05-05	PMC3113999	21599907	emerg infecti diseas problem medicin case report document episod earli emerg phase small outbreak case report consid weak evid medic literatur report emerg infecti diseas doubt case report provid case seri review studi editori focus case report emerg infecti diseas medic societi public area highli welcom journal serv futur point refer
PLoS One	24799566	2014-10-13	PMC3114850	21695128	background accur data childhood pneumonia aetiolog essenti region mortal high order inform casemanag guidelin potenti prevent strategi bacteri conjug vaccin yield blood cultur low lung aspir cultur higher diagnost yield aim determin diagnost yield increas polymeras chain reaction pcr detect bacteria streptococcu pneumonia haemophilu influenza virus lung aspir fluid method total children radiolog focal lobar segment consolid lung aspir perform bacteri cultur pcr detect bacteria virus pneumocysti jirovecii children pneumococc aetiolog pneumococc bacteri load calcul blood lung aspir fluid blood cultur identifi bacteri pathogen patient addit pcr lung aspir sampl caus pathogen bacteri viral pneumocysti identifi singli coinfect children commonest bacteri organ spneumonia influenza commonest viru identifi adenoviru human bocaviru hbov singl coinfect conclus select group african children lung aspir pcr improv diagnost yield studi confirm major role spneumonia virus aetiolog childhood pneumonia africa
PLoS One	25313032	2009-05-01	PMC3115951	21698289	background doublestrand rna depend protein kinas pkr kei regul antivir innat immun respons mammalian cell pkr activ regul kilo dalton cellular inhibitor pipk inact state complex hsp normal condit case influenza viru iav infect pipk dissoci hsp inhibit pkr activ influenza viru compon respons pkr inhibit pipk activ hitherto unknown princip find human heat shock protein hsp identifi interact partner influenza viru nucleoprotein iav np yeast twohybrid screen interact confirm coimmunoprecipit studi mammalian cell transfect iav np express plasmid iav nphsp interact valid mammalian cell infect season pandem strain influenza virus cellular local studi np hsp coloc nucleu iav infect mammalian cell express np coincid dissoci pipk hsp decreas pkr phosphoryl observ plasmid base express np mammalian cell lead decreas pkr phosphoryl inhibit np express influenza viru replic led pkr activ concomit increas eif phosphoryl inhibit np express led reduc irf phosphoryl enhanc ifn product concomit reduct viru replic data np viral factor respons pipk activ subsequ inhibit pkrmediat host respons iav infect signific find demonstr novel role iav np inhibit pkrmediat antivir host respons help understand pipk mediat inhibit pkr activ iav infect
PLoS One	19279492	2017-08-01	PMC3115971	21698249	torovirus gastroenter caus agent infect anim speci human torovirus diseas describ time prototyp member genu equin toroviru bern viru bev induc apoptosi infect cell late time postinfect observ bev infect cell electron microscopi reveal hour postinfect cell exhibit morpholog characterist apoptot cell base find analyz apoptot marker observ protein synthesi inhibit rrna dna degrad nuclear fragment caspasemedi cleavag parp eifgi pkr eif phosphoryl process place peak viru product determin cell death receptor mitochondri pathwai involv apoptosi process induc bev bevinduc apoptosi late time postinfect viral progeni produc facilit viral dissemin vivo contribut viral pathogenesi
J Viral Hepat	28666653	2007-10-01	PMC3116152	20546498	summari determin structur core capsid unusu variant hepat viru genotyp hbvg resolut cryoelectron microscopi structur reveal surfac featur prototyp hbva genotyp hbvg novel uniqu bp insert downstream core gene start codon twelv amino acid insert ntermin core protein codon precor region prevent express hbeag hbvg replic patient associ coinfect genotyp hbv suggest hbvg reduc replic effici vivo local ntermin insert hbvg form addit mass core surfac adjac dimerspik model structur addit residu densiti posit insert interfer transloc nucleic acid pore core interior compart insert partial obscur residu core surfac plai role envelop secret virion affect structur rearrang trigger envelop dna secondstrand synthesi
Retrovirology	17652456	2006-03-01	PMC3118345	21569301	background gene trap insert mutagenesi highthroughput approach discov cellular gene particip viral infect screen librari cell select surviv lytic infect varieti virus cell harbor disrupt adam disintegrin metalloproteas allel surviv reoviru infect subsequ adam rna interfer replic hiv silenc adam express small interf rna sirna hour infect inhibit hiv replic primari human monocytederiv macrophag cd cell line agreement adam overexpress increas hiv replic adam downregul inhibit viral revers transcript indic viral entri uncoat independ adam express integr hiv cdna reduc adam downregul cell concomit ltr circl format detect suggest hiv enter nucleu adam silenc inhibit downstream report gene express viral protein translat interestingli metalloproteas domain adam requir hiv replic adam secretas proteolyt releas extracellular intracellular domain adam plasma membran support product infect conclus propos adam facilit replic level nuclear traffick collect data support model adam cleav adam secretas adam intracellular domain directli facilit hiv nuclear traffick adam repres novel cellular target class develop antiretrovir drug
BMC Genomics	16380562	2006-05-24	PMC3118785	21554741	background previou studi reveal diseas form streptococc toxic shock syndrom stss associ specif streptococcu sui serotyp ss strain achiev better understand pathogen evolut ss wholegenom level compar genom analysi ss strain select basi virul geograph origin perform nimblegen tile arrai result demonstr ss isol highli diverg genom pathogen island pai recogn uniqu chines epidem strain caus stss partial includ virul avirul strain abctyp transport system encod hypothes greatli contribut catastroph featur stss identifi polymorph gene encod candid virul factor plcr lipas sortas pilusassoci protein respons regul rev ctsr basi analysi region differ rd entir genom select ss strain model microevolut strain propos clue streptococcu pathogen evolut conclus deep compar genom analysi pai genom ss strain reveal detail virul strain acquir gene contribut stss lead better environment monitor epidem ss strain
PLoS One	16723558	2004-05-01	PMC3119054	21701677	some approach develop retriev data automat multipl remot biolog data sourc requir research remain onlin wait return requir highli network connect network overload exist approach design address problem retriev remot data mobil network environ resourc mobil devic limit network connect low qualiti mobil user onlin address aforement problem integr agent migrat approach multiag system overcom high latenc limit bandwidth problem move comput requir resourc servic importantli approach fit mobil comput environ present paper system architectur migrat strategi secur authent agent migrat demonstr remot data retriev genbank illustr feasibl propos approach
PLoS Negl Trop Dis	15138176	2009-06-01	PMC3119640	21713020	human experi primari dengu viru denv infect develop antibodi preferenti neutral homolog serotyp respons infect individu gener crossreact antibodi heterolog denv serotyp nonneutr dengu crossreact nonneutr antibodi enhanc infect fc receptor bear cell exacerb diseas actual bind site human antibodi denv particl defin character specif neutral potenc polyclon serum antibodi memori bcell deriv monoclon antibodi hmab individu expos primari denv infect denvspecif hmab serotyp crossreact weakli neutral hmab bound viral premembran protein site viru preserv viral envelop protein produc solubl recombin antigen protein modifi screen procedur detect rare antibodi bound isol map human antibodi neutral homolog serotyp denv mab indic individu expos primari denv infect small fraction total antibodi respons respons viru neutral
PLoS One	19527651	2002-11-01	PMC3119673	21712984	background highli refin surveil data ahn influenza pandem crucial quantifi spatial tempor characterist pandem spatialtempor dynam pandem influenza south america provid quantit descript agespecif morbid pandem pattern administr area peru method daili case influenzalikeil test ahn influenza viru infect laboratoryconfirm ahn influenza case report epidemiolog surveil system peru ministri health decemb analyz geograph spread pandem wave associ winter school vacat period demograph factor absolut humid estim reproduct number quantifi associ winter school vacat period ag distribut case nation pandem curv reveal bimod winter pandem wave peak limit school ag children lima metropolitan area second peak geograph widespread reproduct number estim lima metropolitan area rest peru associ time school vacat period chang ag distribut case earlier pandem onset correl larg popul size contrast associ pandem dynam absolut humid conclus indic substanti spatial variat pandem pattern peru pandem wave vari time impact ag region peru data hierarch transmiss pattern pandem influenza ahn driven larg popul center higher reproduct number pandem wave explain high contact rate schoolag children ag group earli wave
Virol J	12368326	2013-11-20	PMC3119933	21492483	background studi porcin encephalomyocard viru emcv viruslik particl vlp gener baculoviru express system test immunogen protect efficaci vivo vlp gener sf cell infect recombin baculoviru confirm nm transmiss electron microscopi tem immun mice crude protein vlp protect emcv infect swine increas neutral antibodi titer observ immun crude protein vlp addit high level neutral antibodi fold maintain test period second immun sever inject site reaction observ immun swine healthi immun period conclus recombin emcv vlp repres vaccin candid protect emcv infect pig farm
Microb Cell Fact	24257604	2006-03-28	PMC3120639	21595909	background express human viru surfac protein mammalian glycoprotein effici cell higher eukaryot yeast limit highlevel express activ viral surfac glycoprotein yeast understood identifi bottleneck perform detail studi overexpress recombin mump hemagglutininneuraminidas muhn measl hemagglutinin meh yeast saccharomyc cerevisia combin analysi recombin protein proteom approach overexpress recombin muhn meh protein larg aggreg inact total insolubl nativ condit major recombin protein immatur form nonglycosyl precursor fraction yeast lysat reveal core viral surfac protein aggreg consist muhn meh disulfidelink multim involv eukaryot translat elong factor eefa close associ small heat shock protein shsp remov denatur condit complex larg hsp bound aggreg core peripher easili remov high salt concentr proteom analysi reveal accumul unglycosyl viral protein precursor specif cytosol unfold protein respons uprcyto yeast cell character action regul small hsp versu larg chaperon hsp hsp hsp famili contrast environment stress respons synthesi recombin muhn meh larg hsp upregul shsp interestingli amount eefa increas stress respons conclus ineffici transloc muhn meh precursor er membran bottleneck highlevel express yeast overexpress recombin protein induc upr cytosol counterpart uprcyto repres subset protein involv heatshock respons involv eefa explain mechan larg chaperon small hsp upregul stress respons studi highlight differ viral surfac protein express yeast mammalian cell stage secretori pathwai
Virol J	16569857	2008-01-16	PMC3120787	21619646	background herp simplex viru type hsv infect number diseas rang simpl cold sore danger kerat lethal enceph interact viru host cell critic viral replic extens investig laboratori studi test hypothesi hsv lytic infect trigger express multifunct transcript factor egr mechan induct mediat signal pathwai nfb creb method sirc vero hek cell line infect hsv egr transcript protein detect rtpcr western blot local express profil egr investig immunofluoresc microscopi analys recruit transcript factor egr promot infect studi chromatin immunoprecipit chip inhibitor dominantneg mutant assess mechan egr induct effect address immunofluoresc microscopi western blot analys egr absent uninfect cell protein detect hour post treatment respons directli proport titer viru infect recombin hsv express egfp egr detect infect cell chip assai demonstr nfb camp respons element bind protein creb recruit egr promot infect addit studi inhibitor nfb dominantneg creb repress egr induct hsv infect conclus collect demonstr egr express rapidli hsv infect novel induct nfbcrebmedi transactiv egr induct plai kei role viral gene express replic inflamm diseas progress
Virol J	18199643	2007-03-07	PMC3120790	21639929	background avian influenza virus hn subtyp highli preval avian speci virus gener mild moder diseas infect wide varieti speci includ chicken quail turkei duck gees pheasant partridg pigeon transmit mammalian speci includ human acceler effort devis protect strategi stronger immun respons induc mous model immun bvdualha vaccin dna vaccin encod antigen complet protect lethal challeng hn viru observ mice conclus bvdualha util vaccin candid hn viru infect
BMC Public Health	17360568	2012-01-01	PMC3121631	21592390	background health care provid hcp plai role public health emerg prepared respons phepr awar public health threat emerg inform hcp public health issu phepr messag provid guidelin updat facilit surveil hcp will recogn control communic diseas prevent excess death mitig suffer public health agenc phepr messag hcp reach target audienc effect inform public health agenc phepr messag hcp reach target audienc effect inform conduct literatur review investig system tool public health gener phepr commun hcp identifi specif characterist messag deliveri mechan format associ effect phepr commun method systemat review peer nonpeerreview literatur focus question public health system exist commun phepr messag public health agenc hcp system evalu criteria evalu system evalu discov character effect wai public health agenc commun phepr messag hcp identifi system tool commun phepr messag public health agenc hcp articl assess phepr commun system messag method outcom studi compar effect deliveri format devic messag discov potenti high hcp experi messag overload redund phepr messag multipl format andor deliveri system conclus detail descript phepr messag public health hcp scarc literatur rare evalu systemat fashion meet presentdai futur emerg prepared attent to evalu effect system scientif rigor manner
BMC Bioinformatics	21817949	2013-04-10	PMC3121648	21635786	background current method protein function predict reli sequencebas comparison queri protein function annot provid seriou limit sequenc similaritybas approach identifi residu conserv protein low confid assign residueresidu correspond protein level sequenc ident compar protein poor multipl sequenc align method satisfactorystil provid reliabl low level sequenc ident goal current work develop algorithm help overcom difficulti facilit identif structur function relev residueresidu correspond compar protein structur stralsv structurealign sequenc variabl algorithm detect close structur fragment quantifi residu frequenc tight local structur align appli stralsv studi rnadepend rna polymeras polioviru demonstr algorithm determin region protein uniqu share structur similar protein consid distantli quantifi residu frequenc residueresidu pair extract local structur align infer potenti structur function specif residu determin highli conserv deviat consensu demonstr consider detail structur phylogenet deriv stralsv analys conclus stralsv structurebas algorithm identifi align structur fragment similar refer protein stralsv analysi quantifi residueresidu correspond identifi residu structur function unusu unexpect residu sequenc posit stralsv provid web servic httpproteinmodelorgastsstralsv
Virol J	23570618	2016-11-01	PMC3121704	21595869	background human bocaviru hbov discov parvoviru associ mild sever lower respiratori tract infect children aim work determin human bocaviru nasopharyng aspir npa infant qualit pcr determin acut human bocaviru infect estim immunoglobulin igm antibodi serum enzym link immunosorb assai twenti npa specimen patient respiratori manifest posit hbov qualit pcr elisa reveal posit hbov igm antibodi patient posit pcr control posit techniqu correl studi elisa pcr reveal high associ agreement pcr detect npa sampl hbov posit case patient identifi elisa high sensit efficaci pcr elisa sensit rtpcr sensit efficaci elisa versu rtpcr conclus hbov infect diagnos npa children convent pcr rapid sensit techniqu elisa reliabl serolog analysi diagnosi acut hbov infect estim igm antibodi serum
PLoS One	27467538	2018-11-14	PMC3121745	21731708	background gold standard respiratori viru test nasopharyng np swab collect healthcar worker midturbin mt swab altern eas collect selfcollect patient object studi compar respiratori viru isol flock mt swab compar flock np swab method octob healthi adult ag year recruit cohort symptom influenza ask np mt swab onset fever respiratori symptom acut onset swab test viral respiratori infect seeplex rv multiplex pcr detect kit seventi pair simultan np mt swab collect symptomat subject twenti pair posit np mt swab sixti pair concord sampl hcv ochku sampl rhinoviru ab posit np neg mt sampl hcv enl hcv ochku respiratori syncyti viru influenza posit mt neg np conclus flock mt swab sensit diagnosi multipl respiratori virus eas mt collect swab mt swab prefer method respiratori cell collect outpati studi light data larger studi perform ensur hold true data collect patient prefer collect method
PLoS Negl Trop Dis	30429338	2003-08-01	PMC3125144	21738801	background rabi fatal enceph caus lyssavirus evid lyssaviru circul emerg southeast asian bat crosssect studi conduct thailand assess rabiesrel knowledg practic person regularli expos bat bat habitat object identifi defici rabi awar describ occurr bat exposur explor factor associ transderm bat exposur method survei administ conveni sampl adult guano miner bat hunter game warden residentspersonnel buddhist templ mass bat roost occur questionnair elicit demograph experi bat exposur rabi knowledg particip ask describ action respons bat bite action bite rabid anim bivari analysi compar respons group multivari logist regress explor factor independ associ bitten scratch bat find peopl interview identifi bat potenti sourc rabi histori bat bite scratch report state would respons bat bite guano miner group indic anim bite mechan rabi transmiss respond appropri bat bite scratch guano mine bat hunt bat cave roost area time year associ histori bat bite scratch conclus find indic educ outreach rais awar bat rabi promot exposur prevent ensur appropri healthseek behavior batinflict wound atrisk group thailand
Vet Res	12876182	2010-02-25	PMC3125225	21592358	the success replic viral agent host complex process lead speci specif viru interspeci transmiss difficult despit difficulti natur host switch frequent virus lower vertebr fish virus virus to infect wide rang speci review will focu document report broad host rang variat host specif host shift event hypothes virus genera ranaviru novirhabdoviru betanodaviru isaviru herpesviru
BMC Biotechnol	20184396	2014-02-05	PMC3125328	21635725	background antibodi constitut power tool studi protein function protein local proteinprotein interact diagnost therapeut purpos highthroughput antibodi develop requir faster methodolog lower antigen consumpt describ novel methodolog select human monoclon recombin antibodi combin vitro protein express phage displai antibodi librari antibodi microarrai applic combin methodolog permit gener human singlechain variabl fragment scfv protein green fluoresc protein gfp thioredoxin trx short time low purifi protein scfv specif reactiv respect target work elisa western blot scfv recognis low ng protein respect target western blot conclus work describ novel miniatur methodolog human monoclon recombin antibodi target shorter time methodolog protein protocol easili adapt highthroughput procedur antibodi product
Virol J	24501399	2007-02-01	PMC3126774	21619712	twentyseven nanopeptid deriv matrix protein porcin reproduct respiratori syndrom viru prrsv screen abil elicit recal interferon ifn respons splenocyt balbc mice dna vaccin booster vaccin recombin vaccinia viru rwrprrsvm identifi peptid amino acid residu kfitsrcrl fgymtfvhf cd cytotox lymphocyt ctl epitop peptid elicit number ifn secret cell compar nonapeptid irrelev nonapeptid bioinformat analysi hkdrestrict ctl epitop hddrestrict ctl epitop multipl amino acid sequenc align prrsv sequenc submit genbank indic ctl epitop conserv consid mechan cellular immun respons prrsv
BMC Cell Biol	17156899	2009-04-22	PMC3126779	21639891	background nucleoli compos protein repres conspicu compart nucleu plai crucial role proper execut cellular process nucleoli carri ribosom biogenesi sequest associ kei molecul regul cell cycl progress tumorigenesi apoptosi stress respons nucleoli dynam compart character constant flux macromolecul complex dynam composit nucleolar proteom challeng link modif nucleolar composit downstream effect contribut quantit immunofluoresc method reli computerbas imag analysi demonstr effect techniqu monitor dynam associ protein rna nucleoli physiolog condit protocol describ emploi studi stressdepend chang nucleolar concentr endogen gfptag protein method appli measur de novo rna synthesi associ nucleoli techniqu describ easili combin autom high throughput screen ht platform make larg data set analyz biolog process locat nucleoli conclus protocol set stage analyz quantit fashion kinet shuttl nucleolar protein singl cell level larg number cell procedur describ compat high throughput imag acquisit analysi ht autom platform provid basi quantifi nucleolar compon activ numer sampl experiment condit grow amount nucleolar proteom improv quantit microscopi describ expect produc insight complex biolog function orchestr nucleolu
Viruses	19386706	2009-09-01	PMC3127449	21731813	network model contact process allow pathogen spread host remain unclear model best describ network question cluster network roughli defin propens triangl form dynam diseas spread perform simul studi signal epidem transmiss tree cluster simul susceptibleexposedinfectiousremov seir epidem reinfect network fix degre sequenc level cluster compar tree network degre sequenc cluster level find variat tree simul network level cluster bare greater simul network level cluster suggest cluster detect transmiss data reinfect occur
PLoS Comput Biol	19754694	2013-07-26	PMC3127811	21738461	the mitochondri protein repertoir vari depend cellular state protein compon modif caus mitochondri dna mtdna deplet wide rang human diseas nuclearencod mitochondri protein mt proteom chang dysfunct state studi investig system alter mtdnadeplet mitochondria network analysi gene express data modular quantifi proteom data protein function network system properti mitochondri dysfunct analyz discov upregul downregul protein organ predomin subnetwork exhibit distinct biolog process downregul network modul involv typic mitochondri function upregul protein respons mtdna repair regul mt protein express transport comparison proteom transcriptom data reveal cell attempt compens mtdna deplet modul coordin expressiontransport mt protein demonstr mt protein composit chang remodel function organ mitochondri protein network respons dysfunct cellular state human mt protein function network provid framework understand cell respond mitochondri dysfunct
BMC Public Health	24426285	2019-04-01	PMC3128025	21649919	background despit advanc surveil prevent pneumonia influenza pi remain lead mortal unit state elderli adult experi sever morbid influenzaassoci diseas highest rate season migrat compar subpopul object studi assess spatiotempor pattern influenzaassoci hospit elderli time geographi intens pi high season migrat individu florida state examin close harmon regress assess spatial tempor pattern pi hospit state resid method data medicareelig hospit unit state pi icdcm code abstract popul hospit classifi state resid provid state admiss compar admit octob march admit april septemb compar hospit profil data florida resid outofst resid state primari resid time year inseason outofseason observ distinct season pattern nonresid pi hospit compar typic winter destin state california arizona texa florida state state gener experienc higher proport nonresid pi summer month aprilseptemb state higher nonresid pi tradit peak influenza season octobermarch conclus studi quantifi spatiotempor pi hospit pattern elderli focus chang pattern season popul migrat understand migrat influenzaassoci diseas pattern vulner popul critic prepar prevent influenza outbreak vulner popul
BMC Infect Dis	31604530	2012-04-01	PMC3128050	21649905	background acut otiti media perfor aomwip remot indigen children month life streptococcu pneumonia haemophilu influenza moraxella catarrhali primari bacteri pathogen otiti media load predict clinic ear state hypothesi anteced respiratori viral infect increas bacteri densiti progress perfor method total nasopharyng swab indigen children retrospect examin panel respiratori virus screen pcr densiti pneumonia influenza catarrhali estim quantit real time pcr data report clinic ear state catarrhali influenza pneumonia respiratori virus common includ rhinoviru hrv polyomaviru hpyv adenoviru hadv bocaviru hbov coronaviru hcov geometr bacteri load higher children acut otiti media aom compar children evid otiti media children infect hadv time aom perfor conclus studi confirm posit associ nasopharyng bacteri load clinic ear state exacerb respiratori virus indigen children hadv independ associ acut ear state
Philos Trans R Soc Lond B Biol Sci	22173144	2018-09-05	PMC3130384	21624924	formal quantit approach predict likelihood infecti diseas outbreak diseas will spread control wellestablish methodolog includ risk factor analysi risk model dynam model predict model art drive effort area build undoubt success quantit model epidemiolog control human anim diseas aid influenza footandmouth diseas bse attent paid develop holist framework captur role underli driver diseas risk demographi behaviour land climat chang time consider room improv quantit analys output commun polici maker stakehold start point gener accept guidelin good practic develop predict model
PLoS One	30252202	2006-04-26	PMC3130781	21760897	background allogen bone marrow transplant allobmt cur therapi varieti hematolog diseas benefit includ graftversustumor gvt activ limit graftversushostdiseas gvhd carcinoembryon antigen cell adhes molecul ceacam transmembran glycoprotein epithelium cell tumor regul varieti physiolog patholog process tumor biologi leukocyt activ energi homeostasi previou studi ceacam neg regul inflamm inflammatori bowel diseas model method studi ceacam regul gvhd gvt allogen bone marrow transplant allobmt mous model vivo ceacam cell caus increas gvhd mortal gvhd colon greater number donor cell posit activ marker cdhi cdllo addition ceacam cd cell greater express guttraffick integrin cd cd cell increas number gut posttranspl ceacam recipi experienc increas gvhd mortal gvhd colon alloreact cell displai increas activ addition ceacam mice increas mortal decreas number regener small intestin crypt radiat exposur convers ceacamoverexpress cell caus attenu targetorgan system gvhd correl decreas donor cell number target tissu mortal final graftversustumor surviv ceacam lymphoma model improv anim receiv ceacam control cell conclus conclud ceacam regul cell activ gvhd target organ damag number donor cell lymphoid organ gvhd target tissu recipi allobmt ceacam regul tissu radiosensit express donor graft host tissu suggest target ceacam repres potent strategi regul gvhd gvt allogen transplant
PLoS Pathog	16641270	2014-07-21	PMC3131267	21750671	the inhibitori receptor program death pd capac maintain peripher toler limit immunopatholog damag precis role fulmin viral hepat fh describ investig function mechan pd fh pathogenesi induc murin hepat viru strain mhv high level pdposit cd cd cell nk cell macrophag observ liver spleen lymph node thymu tissu mhv infect pddefici mice exhibit higher express effector molecul initi fibrinogen deposit fibrinogenlik protein fgl wildtyp wt litterm result sever tissu damag produc mortal rate higher fluoresc doublestain reveal fgl pd coexpress cell quantit rtpcr demonstr higher level ifn tnf mrna transcript occur pddefici mice respons mhv infect convers vivo blockad ifn tnf led effici inhibit fgl express greatli attenu develop tissu lesion ultim reduc mortal upregul fgl pddefici mice determin mediat ifn tnf pd signal plai essenti role decreas immunopatholog damag induc mhv manipul signal strategi fh immunotherapi
PLoS One	25049413	2010-07-01	PMC3131282	21750710	machupo viru macv highli pathogen arenaviru hemorrhag fever human macv pathogen arenavirus enter cell gp attach glycoprotein bind cellular receptor transferrin receptor tfr tfr residu essenti interact describ cocryst macv gp bound tfr suggest gp residu associ creat macv gp variant test tfr bind viru entri evalu function signific addit residu human simian cell residu essenti expend gptfr interact macv entri macv gp residu critic interact tfr conserv arenavirus indic common basi receptor interact find open avenu ration develop viral entri inhibitor
Viruses	20617918	2017-12-01	PMC3133461	21755021	elicit antibodi potent broad neutral activ hiv immun remain challeng monoclon antibodi mab isol human hiv infect exhibit activ vaccin immunogen base structur epitop success elicit broadli neutral mab bnmab immunoglobulin ig gs igg highli somat hypermut imped elicit ig ms igm averag diverg germlin antibodi relev develop vaccin immunogen underexplor compar igg describ identif character human igmderiv mab hiv select larg phagedisplai naiv human antibodi librari construct blood lymph node spleen healthi donor antibodi bound high affin recombin envelop glycoprotein gp env hiv isol clade enhanc neutral infect hiv primari isol ccr coreceptor neutral cxcr isol test weakli antibodi low degre somat hypermut extens character bound highli conserv region partial overlap coreceptor bind site close overlap cd bind site exist conserv structur direct immun respons nonneutr enhanc antibodi repres strategi viru escap neutral immun respons studi will strategi plai role hiv infect human role mechan infect enhanc newli identifi mab reagent character conserv nonneutr weakli neutral enhanc epitop modifi remov candid vaccin immunogen
PLoS One	29312755	2012-02-25	PMC3133621	21779388	the size von willebrand factor vwf control adamtsdepend proteolysi associ hemostat activ factor regul adamtsdepend vwf proteolysi interact vwf includ coagul factor viii platelet glycoprotein heparin sulfat acceler cleavag vwf convers thrombospondin decreas rate vwf proteolysi adamt compet adamt domain vwf investig murin monoclon antibodi mab human vwf affect suscept vwf proteolysi adamt vitro mab domain human vwf evalu effect vwf cleavag adamt fluid shear stress staticdenatur condit addition epitop antivwf mab sz map recombin protein combin enzymelink immunosorb assai western blot analysi indic mab sz inhibit proteolyt cleavag vwf adamt concentrationdepend manner fluid shear stress staticdenatur condit bind epitop sz mab locat central domain vwf data antivwf mab vwfa domain ag reduc proteolyt cleavag vwf adamt shear stress suggest role region interact adamt
J Drug Deliv	22367226	2009-09-23	PMC3134826	21773041	the develop synthet peptidebas vaccin advantag comparison vaccin base live attenu organ inactiv kill organ toxin peptidebas vaccin revert virul form allow better conserv produc easili safe gener weaker immun respons vaccin inclus adjuv andor vaccin deliveri system need vaccin deliveri system micro nanoparticul attract particul natur increas crosspresent peptid addit passiv activ target antigen present cell particul adjuv directli activ innat immun system vivo summar micro nanoparticul vaccin deliveri system field synthet peptidebas vaccin strategi increas immunogen
PLoS Pathog	19776135	2009-11-01	PMC3136464	21779173	adenovirus dna virus natur infect vertebr includ human monkei wide rang clinic ill human infect individu strain convention thought speciesspecif appli virochip panvir microarrai identifi novel adenoviru tmadv titi monkei adenoviru deadli outbreak close coloni monkei titi monkei callicebu cupreu california nation primat center cnprc titi monkei hous build develop upper respiratori symptom progress fulmin pneumonia hepat monkei infect di human euthan wholegenom sequenc tmadv reveal adenoviru speci highli diverg share pairwis nucleotid ident adenovirus cultiv tmadv success human lung adenocarcinoma cell primari establish monkei kidnei cell onset outbreak research closest contact monkei develop acut respiratori ill symptom persist week convalesc serum sampl seroposit tmadv clinic famili member despit contact cnprc test posit screen set random adult blood donor western unit state detect tmadvspecif neutral antibodi individu find rais possibl zoonot infect tmadv humantohuman transmiss viru popul unusu high case fatal rate outbreak titi monkei nativ host speci tmadv natur reservoir viru unknown discoveri tmadv novel adenoviru capac infect monkei human suggest adenovirus monitor close potenti crossspeci outbreak
PLoS One	19625461	2008-10-01	PMC3136934	21779366	background neuron astrocyt gener common neural precursor neurogenesi preced astrocyt format embryogenesi mechan neural develop underli suppress desuppress differenti gene cell fate specif understood methodologyprincip find vitro system ntera cell induc differenti astrocytelik lineag reveal novel role sina maintain suppress gfap ntera cell sina coupl mecp bound gfap promot occup correl repress gfap transcript repress sina mecp essenti mechan underli inhibit cell differenti commit astrocytelik lineag sina mecp depart promot activ stat simultan bound promot exon gfap olig export nuclei cytoplasm suggest threedimension higherord structur provok stat bind promot proxim code region stat recruit cbpp exon target promot histon hk hk acetyl cbppmediat histon modif facilit chromatin remodel enhanc hk trimethyl recruit rna polymeras ii activ gfap gene transcript conclusionssignific provid evid exchang repressor activ complex epigenet modif critic strategi cellular differenti lineagespecif gene express
PLoS One	18925704	2013-10-09	PMC3138747	21789179	the major physiolog function milk transport amino acid carbohydr lipid miner mammalian offspr casein major milk protein secret form micel consist protein calciumphosph analys role milk protein casein inactiv correspond gene mice absenc casein protein curtail secret milk protein calciumphosph suggest role casein establish casein micel contrast secret albumin synthes mammari epithelium milk reduc absenc casein inhibit transcript casein gene casein defici sever delai pup growth lactat lifelong bodi size reduct compar control anim transient effect physic behaviour develop pup data support critic role casein casein micel assembl confirm lactat critic window metabol program milk protein concentr decis factor determin adult bodi weight
J Gen Virol	24109243	2014-07-02	PMC3139419	21307223	the arteriviru famili order nidoviral singlestrand positivesens rna virus includ porcin respiratori reproduct syndrom viru equin arter viru eav replic enzym translat genom rna structur protein encod set small partial overlap gene genom proxim region express synthesi set subgenom mrna gener function monocistron bicistron mrna encod gp protein orf encod major glycoprotein gp extens phylogenet analys indepth comput analysi reveal arteriviruswid conserv addit auginiti orf term orfa overlap orf pattern substitut sequenc align indic orfa subject function constraint amino acid level analysi substitut synonym site orf reveal greatli reduc frequenc substitut portion orf overlap orfa aa orfa protein gp express subgenom mrna translat initi mechan involv leaki ribosom scan inactiv orfa express revers genet yield sever crippl eav mutant displai lower titr tini plaqu phenotyp defect partial complement orfaexpress cell indic novel protein eighth structur protein arterivirus express arteriviru infect
PLoS One	24991014	2009-01-28	PMC3139623	21811589	chikungunya viru chikv insect born viru genu alphaviru acut febril ill human prolong arthralg diseas joint extrem reemerg viru form outbreak year pose seriou public health problem chikv posit sens singl strand rna genom nt open read frame viral genom encod polyprotein precursor nsp process structur protein nsp nsp nsp nsp sequenc base analys helicas domain nterminu proteas domain cterminu nsp detail biochem analysi ntpaserna helicas rna phosphatas activ recombin chikvnspt protein conserv ntpasehelicas motif nterminu partial papain proteas domain cterminu carri protein hydrolyz ntp dttp better effici atp datp gtp dgtp hydrolysi atp prefer substrat enzym chikvnspt triphosphatas rtpase activ remov phosphat rna ntpase rtpase activ protein complet depend ion rtpase activ inhibit atp show share bind motif ntp rna enzymat activ drastic reduc mutat ntp bind motif gkt cofactor ion bind motif dexx suggest common catalyt site
PLoS One	19176632	2012-04-18	PMC3139658	21811620	bat natur reservoir spectrum infecti zoonot diseas includ emerg henipavirus hendra nipah virus henipavirus observ natur experiment seriou fatal diseas mammal speci includ human interestingli infect fly fox henipavirus occur absenc clinic diseas extrem variat diseas pattern human bat led investig effect henipaviru infect innat immun respons bat cell line report henipaviru infect result induct interferon express virus inhibit interferon signal confirm interferon product signal block bat cell differ viral protein express level human bat host addit lack clinic sign bat henipaviru infect suggest bat control henipaviru infect unidentifi mechan interferon respons report henipaviru infect bat cell investig aspect innat immun system
J Parasitol Res	22513723	2011-04-01	PMC3140032	21785696	thi paper present type interplai parasit host show histori parasit effect parasit outcom war invas migrat develop numer region globe impact parasit diseas societi cours human evolut emphas press chang the parasit phenomenon propos term cohabit accur parasit live bacteria mammal consortium live be pangenom term parasitolog replac cohabitolog parasit host compos adapt system parasitizedhost cohabitantcohabit suggest switch paradigm base attrit destruct found adapt live togeth
PLoS One	19386712	2011-03-16	PMC3142118	21799777	control sever outbreak remain problem infecti diseas area time problem will sever popul densiti urban center grow social interact plai role determin infecti diseas spread organ peopl social line rise nonspati network infect spread infect network diseas transmiss mode ident highli diseas spread infect network estim common infect epidem sever diseas transmiss mode proofofconcept studi demonstr effect epidem mitig base estim infect network gener artifici social network size averag degre roughli cluster characterist start sir epidem network censor simul incid reconstruct infect network effici fragment estim network remov smallest number node identifi graph partit algorithm final demonstr effect target strategi compar tradit untarget strategi slow reduc size advanc epidem
Virol J	21411529	2011-06-15	PMC3142240	21679431	background planthopp sever affect crop caus mechan damag feed vector plant viru speci analysi gene express persist infect planthopp unveil molecular basi viral transmiss quantit realtim rtpcr rtqpcr current accur sensit method quantit gene express analysi order normal quantit data refer gene constant express experiment procedur need partial sequenc commonli refer gene actin tubulin tub glyceraldehyd phosphat dehydrogenas gapdh elong factor alpha efa ribosom protein rp polyubiquitin ubi delphacod kusch planthopp capabl persist transmit plant fijiviru mal de ro cuarto viru mrcv isol time specif rtqpcr primer design express stabil gene assai mrcvinfect nave planthopp genorm normfind bestkeep tool analysi ubi suitabl gene intern control quantit gene express studi mrcvinfect planthopp tub efa variabl efa upregul mrcv infect conclus rtqpcr platform gene express analysi mrcvinfect planthopp vector delphacod kusch develop work report refer gene select virusinfect insect serv preced futur gene express studi mrcv virusplanthopp pathosystem
PLoS One	21680514	2006-10-18	PMC3143116	21799782	the global spread infecti diseas facilit abil infect human travel thousand mile short time span rapidli transport pathogen distant locat mathemat model actual potenti spread specif pathogen assist public health plan case event model gener parsimoni consid compon system greatest extent demonstr discuss assumpt rel parameter structur treatment airlin travel mathemat model find common structur treatment travel lead underestim speed spread connect travel critic realist spread pattern model involv travel improv simpl structur chang requir attent detail parameter
Clin Trials	17050595	2012-04-04	PMC3145214	21730079	background asthma exacerb season greatest risk elementaryag student occur shortli return school summer break suggest season children viral respiratori tract infect regular hand wash effect method prevent spread viral respiratori infect achiev hand wash recommend school difficult design studi evalu hand sanit elementari school exacerb children asthma purpos describ process redesign trial respons chang safeti profil hand sanit chang hand hygien practic school method origin trial random longitudin subjectblind placebocontrol communitybas crossov trial primari aim evalu increment effect hand sanit addit usual hand hygien practic decreas asthma exacerb elementaryag children three event occur requir major modif origin studi protocol safeti concern aros hand sanit activ ingredi substitut placebo hand sanit commun prefer chang hand hygien practic school revis protocol random longitudin communitybas crossov trial primari aim evalu increment effect twostep hand hygien process hand hygien educ institution provid alcoholbas hand sanit versu usual care decreas asthma exacerb enrol complet student school intervent began august will continu studi limit chang design allow directli measur effect hand sanit supplement tradit hand wash practic conclus balanc rigor studi design accept commun requir investig activ involv commun collabor adapt studi protocol fit chang commun practic
PLoS One	22491448	2013-09-30	PMC3146468	21829490	background increas robust improv resist pathogen major select object livestock breed resist trait difficult imposs measur directli potenti indirect criteria measur immun trait underli hypothesi level focu specif pathogen defin individu immunocompet predict respons pathogen gener variat depend genet environment epigenet factor aim estim rel genet report larg genet survei innat adapt pig famili bred environ methodologyprincip find fifti studi larg white pig vaccin mycoplasma hyopneumonia analyz combin princip compon analysi pca genet paramet estim includ specif specif antibodi seric inflammatori protein cell subset hemogram flow cytometri vivo product cytokin ifn tnf il il il ifn il il il phagocytosi lymphocyt prolifer herit weak moder high herit valu phenotyp genet correl weak trait includ cell subset pca reveal cluster innat adapt conclusionssignific demonstr variat innat adapt genet control swine report smaller number trait laboratori limit redund trait observ confirm high degre complementar innat adapt data provid genet framework choos includ select criteria multitrait select programm aim improv product health trait
Philos Trans R Soc Lond B Biol Sci	24082102	2011-06-29	PMC3146780	21893549	the royal societi conven meet th novemb review current wai vaccin develop deploi recommend process acceler meet brought academ industri repres sponsor regul govern advisor repres intern public health agenc broad geograph background discuss held chatham hous rule highthroughput screen vaccin antigen candid drive forc vaccin discoveri multistakehold smallscal manufactur facil capabl rapid product clinic grade vaccin current expand human veterinari area tier regulatori standard differenti tailor experiment commerci vaccin allow acceler vaccin efficaci test improv crossfertil knowledg industri academia human veterinari vaccin develop lead rapid applic promis approach technolog product develop identif bestpractic develop checklist product develop plan implement programm lowcost opportun shorten timelin vaccin progress laboratori bench peopl it
BMC Infect Dis	21715659	2008-02-13	PMC3146830	21752259	background apriljuli outbreak hn scotland west scotland specialist virolog centr wossvc glasgow test clinic sampl hn patient clinic diagnos hn posit studi sought determin respiratori pathogen misdiagnos case hn time method examin sampl laboratori apriljuli patient clinic diagnos hn base accept criteria full respiratori screen real time revers transcriptas polymeras chain reaction rtrtpcr assai total respiratori pathogen detect confid interv sampl submit numer pathogen detect common rhinoviru confid interv parainfluenza confid interv confid interv adenoviru confid interv conclus studi highlight problem clinic algorithm detect hn clinician frequent misdiagnos common respiratori pathogen hn springsumm outbreak scotland undesir consequ relat treatment infect control public health surveil
BMC Public Health	18272713	2003-12-11	PMC3146865	21718518	background nonpharmaceut strategi vital curtail impact influenza intens studi public health strategi explicitli util weekend report capabl reduc influenza infect studi aim explor weekendextens strategi season pandem flu outbreak method weekendextens strategi design extend regular twodai weekend three dai combin continu discontinu pattern effect evalu establish agentbas spatial explicit simul model urban area buffalo ny extens dai weekendextens strategi remark reduc diseas attack rate season flu threedai continu extens suffici suppress epidem confin spread diseas pandem flu weekendextens strategi produc mitig effect extens exce three dai sensit analysi indic complianc level weekendextens strategi effect conclus attempt incorpor weekend influenza mitig strategi appropri extens regular twodai weekend potenti measur fight influenza outbreak minim interrupt normal rhythm socioeconomi concept weekend extens lack vaccin stockpil countri limit health resourc case unknown emerg infecti diseas
Proteome Sci	14671099	2007-09-13	PMC3148531	21703014	background actinobacillu pleuropneumonia app swine pathogen worldwid identif character novel antigen app vaccin candid underwai studi immunoproteom approach identifi app protein antigen elicit immun respons serotyp natur infect swine serotyp virul strain simmun rabbit protein total cell lysat serotyp app separ twodimension electrophoresi de western blot analysi reveal immunoreact protein spot separ ph rang spot ph rang convalesc sera swine immunoreact protein spot separ ph rang ph rang hyperimmun sera simmun rabbit protein includ antigen apxiia protect surfac antigen outer membran protein subunit nqra remain antigen report immunoreact protein app time knowledg conclus identifi total immunoreact protein app serotyp virul strain repres protein includ novel immunoreact factor research vaccin candid
Virol J	17850689	2011-07-20	PMC3148564	21708006	background cardiovirus positivestrand rna virus picornavirida famili enter infect rodent detect lower frequenc mammal pig human be cardioviru genu consist distinct speci encephalomyocard viru emcv theiloviru thv lot differ speci studi differ codon usag emcv thv compar enc valu emcv thv higher correl cg cg emcv thv r repect thv cg cg axi axi correl emcv rscu valu emcv speci prefer codon thv spice codon genu aga arg auu il ucu ser gga gly chosen preferenti correspond analysi detect major trend axi account total variat major trend second axi account total variat plot serotyp region coordin conclus extent codon usag bia emcv thv low mutat pressur main factor determin codon usag bia cg content plai role codon usag bia thv emcv synonym codon usag pattern emcv thv gene gene function geographi specif host specif serotyp factor effect codon bia thv locat variat synonym codon usag viru gene
J Med Case Reports	21775539	2016-03-01	PMC3148995	21718493	introduct case report describ rare condit communityacquir adenoviru pneumonia immunocompet adult diagnosi achiev multiplex realtim revers transcriptas polymeras chain reaction rtpcr assai highlight novel molecular diagnost techniqu patient hospit acut respiratori ill perform literatur search publish case summari clinic laboratori radiolog featur condit case present yearold immunocompet caucasian woman admit hospit acut febril respiratori ill associ rash blood test nonspecif abnorm test bacteri pathogen neg condit rapidli deterior hospit requir mechan ventil inotrop support multiplex realtim rtpcr assai perform respiratori specimen detect respiratori virus neg influenza posit adenoviru dna patient recov support treatment antibiot stop dai conclus communityacquir adenoviru pneumonia immunocompet adult civilian present nonspecif acut febril respiratori ill abrupt onset respiratori failur requir mechan ventil laboratori radiolog featur typic viral infect nonspecif novel multiplex realtim rtpcr test respiratori virus enabl rapidli diagnosi case technolog patient acut respiratori ill potenti util ration antibiot improv infect control measur
Virol J	26947079	2006-10-13	PMC3149004	21749712	background oral lichen planu olp decreas qualiti life spontan pain eat toothbrush uncomfort feel mouth addit olp associ hcvrelat liver diseas investig visual analogu scale va effect oral care gel refrecareh patient olp associ hcv infect olp patient ag year hcvrelat liver diseas recruit va score determin biochem examin blood type olp includ eros patient reticular refrecareh oral care gel therapeut dentifric hinokitiol appli patient thin layer oral membran meal bedtim dai applic refrecareh improv qualiti life term dry mouth breath odor oral fresh oral pain rest oral pain mealtim tast disord loss appetit sleep disord depress mood jitteri va score dry mouth breath odor oral fresh sleep disord increas dai applic refrecareh p p va score oral pain mealtim tast disord increas dai applic refrecareh absenc side effect conclus refrecareh improv qualiti life olp hepatologist educ patient oral hygien provid treatment liver diseas
PLoS One	17041212	2009-11-01	PMC3149051	21829638	mani natur productderiv lectin red algal lectin griffithsin grft potent vitro activ virus displai dens cluster oligomannos nlink glycan nlg surfac envelop glycoprotein oligomannos nlg host protein treatment antivir lectin trigger undesir side effect antivir lectin concanavalin banana lectin cyanovirinn cvn interact lectin undescrib cellular moieti report induc undesir side effect includ secret inflammatori cytokin activ host tcell grft cvn bind surfac human epitheli peripher blood mononuclear cell pbmc exclus oligosaccharidedepend interact contrast antivir lectin grft treatment induc minim chang secret inflammatori cytokin chemokin epitheli cell human pbmc measur cell viabil upregul marker tcell activ addit grft appear retain antivir activ bound surfac pbmc final rna microarrai studi cvn cona regul express multitud cellular gene grft treatment effect minim alter gene express profil human ectocerv cell studi indic grft outstand safeti profil evid induc toxic tcell activ deleteri immunolog consequ uniqu attribut natur productderiv lectin
BMC Infect Dis	19883590	2004-09-01	PMC3151229	21767379	background transmiss infecti diseas human popul complex process requir advanc individualbas model captur spacetim detail observ realiti method individu spacetim activitybas model istam appli simul effect nonpharmaceut control measur includ refrain social activ school closur household quarantin hypothet influenza outbreak urban area set control measur test refrain social activ complianc level ineffect household quarantin effect peak number case total number case larg differ complianc level household quarantin decreas peak number case complianc level decreas delai outbreak peak dai total number case decreas rang baselin coupl control measur household quarantin school closur effect strategi spacetim distribut infect class activ bundl ab suggest epidem outbreak strengthen children spread adult sensit analysi studi demonstr earlier implement control measur lead greater efficaci infecti diseas larger basic reproduct number effect nonpharmaceut measur limit conclus simul household quarantin effect control measur school closur household quarantin implement achiev greatest benefit agentbas model appli futur evalu efficaci control measur rang diseas outbreak rang set suffici case knowledg transmiss process fine scale
PLoS One	15343375	2007-08-01	PMC3151298	21850266	the epithelialmesenchym transit emt renal epitheli cell rtec pivot role develop renal fibrosi interact lymphocyt functionassoci antigen lfa leukocyt ligand intracellular adhes molecul icam plai essenti role inflammatori reaction pathogenet role emt rtec remain clarifi studi investig the interact lfa peripher blood mononuclear cell pbmc icam hk cell stimul tgf emt rtec icam highli express hk cell tgf stimul chemokin ccl cxcl increas hk cell cocultur pbmc hk cell prestimul tgf ngml hktgf express activ form lfa increas pbmc total lfa express chang express activ form lfa pbmc increas cocultur ccl cxcl knockdown hktgf express epitheli cell junction marker ecadherin occludin decreas mesenchym marker vimentin fibronectin increas hktgf cocultur pbmc hr hktgf pbmc phosphoryl erk smad smad increas hktgf pbmc snail slug signal increas hktgf pbmc migrat invas hk cell induc full emt high dose ngml longterm hr tgf stimul increas hktgf pbmc increas suggest hk cell stimul tgf induc conform activ lfa pbmc increas cxcl direct interact lfa pbmc icam hk cell activ erk signal acceler emt hk cell induc tgf
BMC Infect Dis	17670839	2012-03-01	PMC3152767	20353566	background issu global alert pandem influenza hn nation health agenc began screen travel entri airport port border cross delai local transmiss method review entri screen polici adopt nation ascertain date offici report laboratoryconfirm import hn case laboratoryconfirm untrac local hn case implement entri screen polici associ averag addit dai delai local transmiss compar nation implement entri screen lower bound confid interv consist addit delai upper bound extend dai addit delai conclus entri screen lead shortterm delai local transmiss novel strain influenza viru resourc requir implement balanc expect benefit entri screen
Virol J	22285270	2009-01-01	PMC3152912	21729293	background fiv infect frequent compromis pregnanc experiment condit accompani aberr express placent cytokin trophoblast produc numer immunomodul plai role placent develop pregnanc mainten hypothes fiv infect dysregul trophoblast immunomodul express aberr express molecul potenti inflamm compromis pregnanc purpos project evalu express repres protnf ifn il il il ilp ilp il gmcsf antiinflammatori cytokin il il il cd secondari costimulatori molecul express activ cell fiv primari receptor chemokin receptor cxcr fiv coreceptor sdf chemokin ligand cxcr fiv gag trophoblast earlyand lateterm pregnanc method anticytokeratin antibodi immunohistochemistri identifi trophoblast select collect cell laser captur microdissect extract total rna captur cell popul real time revers transcriptionpcr quantifi gene express detect il il il il ilp ilp cxcr trophoblast earlyand lateterm pregnanc express cytokin increas earli late pregnanc normal tissu clear proinflammatori microenviron evid trophoblast fivinfect queen stage pregnanc reproduct failur accompani downregul proand antiinflammatori cytokin cd detect trophoblast fiv gag detect ten trophoblast specimen collect fivinfect queen conclus felin trophoblast express arrai proand antiinflammatori immunomodul express increas earli late pregnanc normal tissu nonviabl pregnanc associ decreas express immunomodul regul trophoblast invas speci detect fiv rna trophoblast rare suggest high rate reproduct failur fivinfect queen direct result viral replic trophoblast influenc placent immun cell trophoblast function pregnanc mainten fivinfect cat requir addit studi
Toxins (Basel)	18773917	2007-03-07	PMC3153180	22069564	protein toxin confer defens predationgraz superior pathogen compet produc organ toxin perfect evolut poison animalspl pathogen bacteria decad lot effort invest studi mechan action contribut pathogen develop antidot neutral action parallel group turn explor pharmaceut potenti toxin effici impair essenti cellular process andor damag integr target cell review summar major advanc field toxin base therapeut offer comprehens descript mode action appli toxin
PLoS One	17344285	2015-06-10	PMC3153931	21857914	gillassoci viru gav infect penaeu monodon shrimp type speci okaviru ronivirida invertebr nidovirus current electrophoret mobil shift assai emsa histag fulllength truncat protein emploi examin nucleic acid bind properti gav nucleocapsid protein vitro emsa fulllength protein bind synthet singlestrand ssrna test independ sequenc ssrna includ sens region gav genom sens region rna segment mourilyan viru crustacean bunyalik viru gav protein bound doublestrand dsrna prepar gav orfb gene region bacteriophag genom ssdna emsa protein construct variablelength ntermin andor ctermin truncat local rna bind domain amino acid aa ntermin sequenc span met arg rna bind protein aa portion sequenc prolinearginin rich examin domain detail aa peptid mpvrrplppqpprnarli encompass sequenc synthes bind nucleic acid fulllength protein emsa data indic fundament role gav protein prolineargininerich domain nucleat genom ssrna form nucleocapsid synthet peptid form higherord complex presenc rna domain plai role proteinprotein interact stabil helic structur gav nucleocapsid
Virol J	26063432	2008-08-01	PMC3154182	21714915	background molecular polymeras chain reaction pcr base assai increasingli diagnos viral respiratori infect conduct epidemiolog studi molecular assai gener evalu compar convent direct fluoresc antibodi dfa viral cultur techniqu publish direct comparison molecular method institut sought perform realworld comparison molecular respiratori viral diagnost method experienc respiratori viru laboratori method test nasal throat swab specimen infant respiratori ill common respiratori virus multiplex assai respiratori multicodeplx assai rma individu realtim rtpcr rtrtpcr assai detect virus specimen discord rma assai detect human metapneumoviru hmpv respiratori syncyti viru rsv rtrtpcr detect influenza specul primer differ account discrep redesign primer probe influenza rma assai hmpv rsv rtrtpcr assai test repeat compar primer led improv detect hmpv rsv rtrtpcr assai rma assai remain term influenza detect conclus absenc gold standard clinic laboratori regularli correl molecular assai pcr base assai laboratori standard virolog method ensur consist accuraci
PLoS One	18556606	2005-10-13	PMC3154197	21853040	a common techniqu sensit specif diagnost viru detect clinic sampl pcr identifi virus assai diagnost microarrai probe human pathogen replac hundr individu pcrreaction remov clear clinic hypothesi suspect pathogen establish diagnost platform random amplif subsequ microarrai identif viral pathogen clinic sampl phi polymeraseamplif divers set clinic sampl gener viral materi success identif microbi detect arrai demonstr potenti microarrai techniqu broadspectrum pathogen detect conclud method detect dna rna viru sampl differenti viru subtyp propos assai diagnost analysi virus clinic sampl
PLoS One	16227244	2013-04-01	PMC3155524	21857979	background methicillinresist staphylococcu aureu mrsa nosocomi pathogen intens care unit icu worldwid includ taiwan neonat icu nicu endem mrsa methodologyprincip find control mrsa spread nicu implement seri infect control measur stepwis includ reinforc hand hygien januari augment asept care insert site central venou cathet juli introduct alcoholbas handrub april surveil cultur mrsa cohort care colon patient march februari surveil cultur subsequ decolon mrsa august juli implement measur mrsa healthcareassoci infect hai densiti reduc episod patientdai episod patientdai mrsa bloodstream infect reduc case case compar period surveil cultur decolon rate mrsa colon infect decreas period surveil decolon molecular analysi clinic isol studi period endem clone domin disappear commun clone increas conclusionsignific infect control measur mrsa hai control area high level endem mrsa infect nicu
PLoS Negl Trop Dis	23466910	2016-09-01	PMC3156690	21858242	the chikungunya viru infect zone spread africa part asia north america europ origin thought trigger diseas mild symptom chikungunya viru caus largescal fatal widespread econom loss link viru genet mutat evolut pauciti chikungunya immunolog progress investig serum level cytokineschemokin acut phase chikungunya diseas and month postinfect followup patient italian outbreak cxclmig cclmcp il cxclip rais acut phase compar followup sampl il tnf il il ifn il low initi acut phase level increas time point analysi symptom sever associ cxclmig cxclip igg level data insight chikungunya diseas establish subsequ convalesc imper treatment contain evolv frequent reemerg diseas
Comput Math Methods Med	26344899	2004-05-01	PMC3157160	21860658	the basic reproduct ratio fundament concept mathemat biologi threshold paramet intend quantifi spread diseas estim averag number secondari infect wholli suscept popul indic invas strength epidem diseas di diseas persist measur diseas strength estim effect control measur form backbon diseasemanag polici aspect matter flaw diseas persist diseas die model malaria valu depend method sole common properti threshold survei estim valu varieti diseas examin altern propos accompani caveat method calcul underli model assumpt evid threshold concept meaningless
PLoS One	15100436	2007-10-03	PMC3157400	21858150	background influenzalik ill ili caus varieti pathogen clinic observ help recognis myxoviru infect implement appropri prevent measur limit molecular tool underestim role common pathogen object earli week flu pandem clinic virolog survei conduct adult paediatr patient ili refer french univers hospit pari tour aim investig pathogen involv ili describ associ symptom method hnv pandem influenza diagnosi perform real time rtpcr assai viral aetiolog investig molecular multiplex assai respifind clinic data collect prospect physician standard questionnair week endonas swab collect patient sampl posit hnv respiratori pathogen detect hnv neg sampl posit respiratori agent singl infect mix infect preval virus hnv neg singl infect rhinoviru parainfluenza virus adenoviru hnv case identifi patient year year differ clinic symptom observ patient infect hnv pathogen conclus highlight high frequenc noninfluenza virus involv ili preepidem period flu alert lack specif clinic sign associ influenza infect rapid diagnost screen larg panel respiratori pathogen critic defin survei epidem situat provid critic patient manag
PLoS One	17913894	2010-03-25	PMC3158760	21886787	subtyp specif influenza viru iav determin surfac glycoprotein hemagglutinin ha neuraminidas ha distinct subtyp hh exist exist epidem strain hn iav chang frequent annual season epidem occasion pandem notori influenza pandem introduct pandem ahn iav hnpdm viru human reemphas public health concern hn iav studi identifi conserv epitop specif ha subtyp diagnost immun specif epitop hn iav complet assess studi linear epitop hnpdm viral ha protein identifi peptid scan librari overlap peptid convalesc sera hnpdm patient epitop aa immunodomin patient evok high titer antibodi mice multipl sequenc align silico coverag analysi epitop highli conserv influenza ha coverag complet absent subtyp coverag unidentifi linear epitop locat wellrecogn antigen site ha peptid elisa method base epitop develop high correl pearson correl coeffici hemagglutin inhibit test highli conserv subtypespecif immunodomin epitop form basi develop novel assai serodiagnosi activ surveil hn iav
Ann Intensive Care	20340160	2007-10-24	PMC3159899	21906331	a decad pass intens care unit icu bed critic patient cancer initi report dismal prognosi data increas number patient solid hematolog malign benefit intens care support dramat decreas mortal rate advanc manag underli malign support organ dysfunct led surviv gain patient lifethreaten complic malign infecti toxic advers effect oncolog treatment review will apprais prognost factor discuss perspect manag critic patient cancer prognost signific factor chang time exampl neutropenia autolog bone marrow transplant bmt advers prognost implic decad ago hematologist oncologist select patient icu admiss base characterist malign underli malign rare influenc shortterm surviv icu admiss data clearli support benefit icu support unselect critic allogen bmt recipi outcom need subgroup increas surviv report critic patient cancer outlin easytous evidencebas icu admiss triag criteria help avoid depriv life support patient cancer benefit lastli propos agenda address unansw question
Evid Based Complement Alternat Med	17959675	2019-12-13	PMC3159992	21869903	object assess benefici advers effect xiaoyaosan depress search strategi electron databas search decemb inclus criteria includ random clinic trial test xiaoyaosan placebo antidepress combin antidepress antidepress data extract analys studi select data extract qualiti assess data analys conduct cochran standard random trial involv patient includ methodolog qualiti evalu gener low pool xiaoyaosan combin antidepress effect comprehens score hamd score sd compar antidepress xiaoyaosan superior antidepress score hamd xiaoyaosan placebo score sd advers effect report trial xiaoyaosan conclus xiaoyaosan appear effect improv symptom patient depress poor methodolog qualiti major includ trial potenti benefit xiaoyaosan confirm rigor trial design report trial follow intern standard
BMC Public Health	31835015	2017-01-14	PMC3160373	21740552	background hospit epicentr newli circul infect healthcar worker hcw high risk acquir infecti diseas contract emerg infect studi aim explor european hcw percept attitud monitor absenc symptom report surveil newli circul infect method qualit studi themat analysi conduct focu group methodolog fortynin hospitalbas hcw hospit recruit focu group england hungari germani greec hcw perceiv risk factor occupation acquir infecti diseas exposur patient undiagnos infect breakdown infect control procedur immunonaveti symptomat colleagu concern lack monitor guidelin infecti hcw pose risk staff patient felt employ fail posit interest health staf demand loss incom pressur attend work unwel uk hungari greec particip felt monitor staff absenc routin disclosur symptom appropri provid effect effici system demonstr germani legisl privaci confidenti identifi barrier hcw highlight knowledg structur improv timeli recognit emerg infect includ increas suspicion awar staff standardis homogen absenc report system conclus monitor absenc infecti diseas symptom report hcw feasibl surveil emerg infect set prerequisit will tackl driver symptomat hcw attend work
PLoS One	28117797	2019-04-15	PMC3160845	21887246	we introduc method estim incid curv cocircul infecti pathogen infect probabl symptom profil deconvolut method util weekli surveil data symptom defin popul addit data symptom sampl virolog confirm infecti episod illustr method numer simul data survei conduct univers michigan campu describ data estim accur
PLoS One	30989427	2009-06-17	PMC3160895	21887285	the predict antibodyprotein antigen interact difficult huge variabl character structur antibodi region antigen bound antibodi call epitop experiment data indic antibodi react panel distinct epitop posit reaction challeng dream aim understand exist rule predict reactiv peptideepitop capabl bind human antibodi dream provid train set peptid experiment identifi high low reactiv human antibodi basi train set particip challeng ask develop predict model reactiv test set provid evalu perform model implement develop logist regress model predict peptid reactiv face challeng machin learn problem initi featur gener basi knowledg report dataset predict model second best perform challeng develop method base cluster approach insilico gener list posit neg peptid sequenc request dream bonu round addit challeng paper describ develop model term reactiv predict highlight open issu concern propens peptid react human antibodi
PLoS One	19535460	2001-03-01	PMC3161043	21887283	the delhi metallolactamas ndm report in swedish patient studi report klebsiella pneumonia ndm posit strain escherichia coli ndm posit strain highli resist antibiot test tigecyclin colistin longer reli treat infect ndm major global health threat studi perform model studi structur ndmantibiot complex reveal hydrolyt mechan highli conserv addit detail analysi indic flexibl hydrophob loop evolut positivecharg loop lead ndm posit strain potent extens antibiot resist compar mbl biolog experi reveal molecular basi antibiot catalysi ndm enzymat level ndm enzym highli potent degrad carbapenem antibiot suscept tigecyclin abil slow hydrolysi veloc meropenem ndm mutagenesi experi includ ka ke displai downregul meropenem catalysi prove accuraci model effect antibiot ndm posit pathogen studi will provid clue investig molecular basi extend antibiot resist ndm acceler search antibiot ndm posit strain clinic studi
PLoS One	11230424	2017-04-12	PMC3161733	21887228	the purpos current studi identifi potenti ligand develop novel diagnost test highli pathogen avian influenza viru hpai subtyp hn virus phage displai technolog hn virus immobil target biopan process mer phage displai random peptid librari round pan three phage express peptid hawdpipardpf aawhlivalapn atshlhvrlpsk specif bind activ hn virus isol put bind motif hn virus identifi dna sequenc term minimum quantiti virus phagebas elisa better antiserumbas elisa manual semiquantit endpoint rtpcr detect hn virus importantli select phage bear specif peptid hn virus capabl differenti viru avian virus enzymelink immunosorb assai
PLoS One	28404849	2010-12-29	PMC3161750	21887302	it report lactoferrin lf particip host immun respons sever acut respiratori syndrom coronaviru sarscov invas enhanc nk cell activ stimul neutrophil aggreg adhes investig role lf entri sar pseudoviru hekeacemyc cell reveal lf inhibit sar pseudoviru infect dosedepend manner analysi suggest lf block bind spike protein host cell indic lf exert inhibitori function viral attach stage lf disrupt interact spike protein angiotensinconvert enzym ac function receptor sarscov previou studi lf coloc distribut cellsurfac heparan sulfat proteoglycan hspg experi confirm conclus treatment cell heparinas exogen heparin prevent bind spike protein host cell inhibit sar pseudoviru infect demonstr hspg provid bind site sarscov invas earli attach phase addit ac hspg essenti cellsurfac molecul involv sarscov cell entri lf plai protect role host defens sarscov infect bind hspg block preliminari interact sarscov host cell find provid understand sarscov pathogenesi aid treatment deadli diseas
PLoS One	21191013	2011-04-01	PMC3161751	21887301	th cellmedi immun respons site activ infect restrict growth mtuberculosi mtb spontan resolut patient tubercul pleurisi tbp studi stimul cd cell pleural fluid cell pfc patient tbp express higher level cd pbmc patient tuberculosi tb healthi donor cdcd cell express tbet ilr stimul mtbspecif antigen cdcd cell express higher level ifn il tnf cdcd cell demonstr cdcd cell mtbspecif cell addit cdcd cell polyfunct cell simultan produc ifn il tnf displai effector effector memori phenotyp cdraccrcdlcd percentag cdcd cell posit correl polyfunct cell interestingli sort cdcd cdcd fraction flow cytometri produc ifn il tnf regul cdcd treg cell base express cd direct quantit qualit method detect evalu vivo gener mtbspecif polyfunct cd cell pfc patient tbp method potenti diagnosi enrich isol mtbspecif cell investig
PLoS One	20729636	2009-11-06	PMC3161824	21915247	positivestrand rna viru replic involv viral protein cellular protein replic step brome mosaic viru bmv wellestablish model dissect virushost interact virus rna replic gene express encapsid reproduc yeast saccharomyc cerevisia laboratori identifi nonessenti host gene loss inhibit enhanc bmv replic fold isol addit bmvmodul host gene classic genet underscor gene essenti cell growth contribut bmv rna replic frequenc greater nonessenti gene systemat identifi novel essenti host gene bmv rna replic test collect yeast strain singl essenti gene promot replac doxycyclinerepress promot allow repress gene express ad doxycyclin growth medium strain arrai of essenti yeast gene identifi essenti host gene deplet express reproduc inhibit enhanc bmv rna replic relev host gene involv ribosom biosynthesi cell cycl regul protein homeostasi cellular process bmv apol level increas strain deplet heat shock protein hsf proteasom compon pre rpt suggest gene affect bmv rna replic directli indirectli modul apol local posttransl modif interact partner investig divers function newli identifi essenti host gene advanc understand bmvhost interact normal cellular pathwai mode viru control
PLoS One	19897716	2007-03-14	PMC3162560	21887225	protein essenti macromolecul life carri cellular process protein aggreg perform function proteinprotein interact ppi network model aggreg expect uncov biologi ppi network topolog ppi network predict protein function role protein pathwai diseas receiv attent debat remain open network properti biolog central bc gene protein product involv ag cancer infecti diseas signal drugtarget pathwai exhibit topolog central compar rest protein human ppi network help resolv debat design networkbas approach appli insight biolog function diseas hypothes bc gene topolog central tc role human ppi network propos concept topolog central design central measur captur complex wire protein network identifi tc protein resid dens extend network neighborhood notion domin find domin set dss ppi network set protein protein ds neighbor ds clearli ds tc role enabl effici commun network part find statist enrich bc gene tc node outperform exist method indic gene involv kei biolog process occupi topolog complex dens region network correspond spine connect network part pass cellular signal effici network knowledg studi explor domin context ppi network
J Cardiothorac Surg	17360845	2014-10-29	PMC3162889	21767391	lung transplant treatment option patient advanc lung diseas surviv rate lung transplant recipi improv major obstacl limit better surviv bronchiol obliteran syndrom bo decad surviv lung retransplant improv transplant recipi bo manuscript review bo current therapeut strategi includ outcom lung retransplant
J Neuroinflammation	25355889	2015-04-15	PMC3162898	21812954	background activ glial cell tolllik receptor tlr intracellular pathogen recognit receptor promot releas toxic acut phase reactant tnf nitric oxid extracellular space prolong glial activ thought occur persist viral infect cn contribut neurodegener demyelin effect virusinduc glial activ oligodendrocyt fulli understood method determin effect glial activ oligodendrocyt viabil treat primari glial cultur isol neonat rat mice rna viral mimic polyic case tlr ligand tlr express determin western blot cytokin level measur rtpcr elisa intracellular cytokin stain oligodendrocyt precursor preol viabil determin alamar blue assai immunocytochemistri result stimul mix glial cultur polyic microglia activ tnf product preol toxic toxic polyic indirect fail affect preol viabil pure cultur despit fact preol express tlr polyicinduc loss preol abolish tnf tnfr defici mix glial cultur suggest tnftnfr signal requir polyic toxic microglia astrocyt express function tlr microglia produc tnf cultur consist find tlr agonist trigger tnf product preol toxic mix glial cultur conclus activ microglia polyic promot tnftnfrdepend oligodendrogli cell death data indic ongo viral infect cn microgli tnf detriment oligodendrocyt
Sci Pharm	25878116	2015-11-23	PMC3163371	21886894	human african trypanosomiasi hat call sleep sick caus subspeci parasit hemoflagel trypanosoma brucei occur subsaharan africa current chemotherapi human trypanosomias reli drug develop year ago undesir toxic side effect drugresist develop antitrypanosom drug prioriti area area lag review focu synthet comput base approach group develop newer antitrypanosom analogu improv efficaci oral bioavail the paper attempt investig relationship physiochem paramet antitrypanosom activ help develop potent antitrypanosom agent sleep sick
PLoS One	26595738	2013-02-06	PMC3163911	21904596	genet background plai role process sarscov infect sar develop protein interact nucleocapsid protein sar coronaviru sarscov heremansschmid glycoprotein ahsg requir macrophag deactiv endogen cation associ inflammatori regul cytochrom famili cypfa oxidas inactiv leukotrien ltb human neutrophil liver investig associ polymorph inflammationassoci gene sar develop linkag disequilibrium ld map gene built haploview data chbjpt version hapmap total ten tag snp select genotyp guangzhou cohort studi adjust ag sex ahsg snp cypf snp associ sar suscept rs adjust odd ratio aor confid interv ci rs aor ci rs aor ci valid associ ten tag snp genotyp beij cohort adjust ag sex rs aor ci associ sar suscept combin analysi studi confirm tag snp rs ahsg suscept variant aor ci statist analysi rs genotyp data patient healthi control hcw cohort expos sar viru support find snp rs transcript activ ahsg promot regul ahsg serum level studi demonstr aa genotyp rs lead higher ahsg serum concentr associ protect sar develop
PLoS Pathog	23388726	2005-06-01	PMC3164637	21909260	the oblig intracellular pathogen chlamydia trachomati replic membranebound inclus acquir host sphingomyelin sm process essenti replic inclus biogenesi previou studi demonstr sm acquir brefeldin bfasensit vesicular traffick pathwai paradox pathwai dispens bacteri replic find suggest lipid transport mechan involv acquisit host sm work interrog role specif compon bfasensit bfainsensit lipid traffick pathwai defin contribut sm acquisit infect trachomati hijack compon vesicular nonvesicular lipid traffick pathwai sm acquisit sm separ pathwai util pathogen wai trachomati select coopt three bfa target gbf regul arfdepend vesicular traffick earli secretori pathwai vesiclemedi sm acquisit arfgbfdepend pathwai sm acquisit essenti inclus membran growth stabil requir bacteri replic contrast trachomati coopt cert lipid transfer protein kei compon nonvesicular er transgolgi traffick ceramid precursor sm trachomati replic demonstr trachomati recruit cert er bind partner vapa sm synthas sm sm inclus propos protein establish onsit sm biosynthet factori inclus hypothes sm acquir certdepend transport ceramid subsequ convers sm trachomati replic sm acquir gbfdepend pathwai essenti inclus growth stabil reveal novel mechan intracellular pathogen redirect sm biosynthesi replic nich
PLoS One	15956420	2012-09-27	PMC3166170	21912629	we replac spike gene apathogen ibv strain beaur pathogen strain serotyp apathogen viru beaurm confer protect challeng construct recombin ibv beaur genet backbon beaur express spike protein pathogen ibv strain uk belong serogroup beaudett previou find beaurm clinic sign observ gene pathogen viru confer pathogen ribv beaur protect studi homolog protect beaur confer protect challeng wild type viru absenc clinic sign ibv rna assess qrtpcr fact viru isol trachea remov bird infect beaur challeng ibv uk degre heterolog protect challeng observ albeit lower level confirm extend previou find conclus swap ectodomain protein precis effect gener genet defin candid ibv vaccin
BMC Bioinformatics	23019323	2006-11-15	PMC3166288	21812952	background nucleolar local sequenc nolss short target sequenc respons local protein nucleolu larg number protein experiment detect nucleolu central role subnuclear compart cell nolss regulatori element control cellular traffic protein report nolss systemat character group target motif carri describ nod web server command program predict presenc nolss protein web server user submit protein sequenc nod input form provid graphic output nol score function protein posit web server conveni make predict protein command version nod return predict complet proteom nod base describ humantrain artifici neural network predictor stringent independ test predictor experiment valid nolscontain eukaryot viral protein nod sensit posit predict estim conclus nod tool provid predict nucleolar local sequenc divers eukaryot virus nod interact onlin httpwwwcompbiodundeeacuknod download local
PLoS One	17108019	2018-09-19	PMC3166308	21912667	background avian influenza ai highli pathogen fatal prevent behavior handwash wear face mask recommend psychosoci factor influenc peopl decis adopt prevent behavior studi aim explor risk percept factor associ handwash wear face mask prevent ai methodologyprincip find intervieweradminist survei conduct tradit market worker shopper taiwan decemb januari factor associ recommend ai prevent behavior tradit market wear face mask wash hand contact poultri includ correct knowledg fatal rate ai adjust odd ratio aor know sever case ai aor inform local ai outbreak aor live northeastern taiwan aor senior highschool educ aor univers higher educ aor gender interact particip senior highschool educ male engag recommend ai prevent behavior femal counterpart aor conclusionssignific specif concern ai risk percept associ recommend ai prevent behavior correct knowledg fatal rate ai inform sever case local outbreak ai link increas ai prevent behavior find underscor transpar deal epidem practic implic prevent policymak effect promot recommend ai prevent behavior public
Clin Proteomics	30232180	2005-04-01	PMC3167199	21906349	introduct sulfur mustard bi chlroethyl sulphid sm chemic warfar agent remain threat human health aim studi identifi protein express signatur biomark reflect chronic lung damag induc sm exposur method prior analysi plasma fraction ethanol precipit dimension sdspage fraction protein profil healthi expos patient lung diseas establish select protein spot identifi maldi tof msm haptoglobin isoform detect plasma lung diseas patient healthi control amyloid isoform detect plasma lung diseas patient healthi control low molecular weight protein enrich ethanol supernat compar ethanol precipit conclus previou studi ongo tissu remodel involv sm expos lung damag patient find improv patient care suitabl therapi
Emerg Health Threats J	15798110	2017-06-28	PMC3167643	22460287	vectorborn infecti diseas malaria dengu chikungunya west nile fever increasingli identifi major global human health threat develop develop countri success failur vector control rest natur scale behaviour respons expos popul largescal adopt recommend protect behaviour repres critic challeng address better understand individu perceiv react risk infect french oversea territori face largescal outbreak epidem chikungunya fever la union mayott success outbreak dengu fever caribbean island martiniqu assess popul perceiv respond risk natur scale protect clinic statu socioepidemiolog survei conduct island outbreak survei address three crucial interconnect question relev period person infect viru identifi factor shape risk acquir diseas socio demograph characterist live condit induc higher likelihood infect impact risk percept protect behaviour adopt mosquito bite ground survei gener framework propos help draw knowledg need reveal factor associ higher probabl infect outbreak emerg lesson learnt inform health author effort improv risk commun programm term target content messag explor strategi ensur sustain protect behaviour author compar three epidem vectorborn diseas elucid psychosoci factor determin popul perceiv respond risk infecti diseas
Emerg Health Threats J	28659436	2011-11-01	PMC3167650	22460280	intern popul mobil underli factor emerg public health threat risk manag global risk limit transmiss pathogen mobil popul link zone diseas emerg lowpreval nonendem area rapid highvolum intern movement background human movement global process econom trade transport environ climat chang civil secur influenc health impact diseas emerg concurr global system regulatori framework diseas surveil report affect organiz public awar event potenti public health signific intern regul direct diseas mitig control pace grow challeng associ volum speed divers dispar modern pattern human movement thesi human popul mobil major determin global public health support articl review publish literatur perspect determin health geneticsbiolog behavior environ socioeconom populationbas diseas preval differ exist nation intern health polici regul interregion shift popul demograph health outcom paper highlight emerg threat risk public health identifi gap exist framework manag health issu associ migrat suggest chang approach popul mobil global public health propos integr approach includ broad spectrum stakehold rang individu healthcar provid polici maker intern organ involv global health manag influenc global health event
Emerg Health Threats J	21940915	2014-06-30	PMC3167651	22460282	in event pandem pose widespread infect high death rate utilitarian mandat reduc harm relev moral trump ethic consider primaci utilitarian approach dictat posit assist cessat seriou outbreak role provid servic administ health care ensur respond support protect highest degre
Emerg Health Threats J	25017401	2013-11-22	PMC3167654	22460397	emerg infecti diseas eid current major threat public health worldwid eid event involv zoonot infecti agent central africa gener gabon privileg area emerg zoonot eid human incurs gabones forest exploit purpos lead intensifi contact human wildlif gener increas risk emerg zoonot diseas gabon endem potenti endem viral infecti diseas report zoonot origin involv famili virus notori dengu yellow fever ebola marburg rift vallei fever chikungunya virus potenti eid wildlif gabon plenti inventori gabones public health system cover geograph countri allow good access sanitari effici monitor emerg diseas access treatment prevent better urban area medic structur develop financi concentr popul equal distribut urban rural area spite gabon good field investig emerg reemerg zoonot eid gabones health structur cirmf advantag locat offer high qualiti research facil studi pathogen wildlif ecolog aim better understand contact transmiss mechan pathogen wildlif human emerg zoonot eid break speci barrier pathogen
Emerg Health Threats J	24266364	2004-10-01	PMC3167656	22460396	the emerg infect resurg oneshealth threat stem environment contamin purpos act bioterrorismcal worldwid effort improv earli outbreak detect goal amelior current futur risk case problem outbreak detect logist straightforward mathemat easi singl case diseas great concern constitut outbreak vast major maladi simpl analyt solut exist step develop reliabl sensit effect surveil system demonstr enorm complex transmiss manifest detect control emerg health threat commun explor potenti futur innov earli outbreak detect system overcom pitfal current surveil modern advanc assembl data techniqu collat process technolog enabl integr analysi will facilit paradigm outbreak definit detect anticip move forward direct will provid highli desir sensit specif earli detect requir meet emerg challeng global diseas surveil
Emerg Health Threats J	15472347	2015-12-09	PMC3167658	22460392	although ignor human rhinovirus hrv frequent respiratori tract infect rti group close novel rhinovirus discov base uniqu phylogenet posit distinct genom featur classifi separ speci hrvc discoveri hrvc virus detect patient worldwid report preval test specimen suggest speci contribut proport rti unrecogn hrvc predomin hrv speci higher detect rate speci hrva hrvb hrvc infect appear peak fall winter temper subtrop countri predomin raini season tropic children hrvc associ upper rti asthma exacerb wheez episod common complic viru detect children bronchiti bronchiol pneumonia otiti media sinus system infect complic pericard adult hrvc associ sever diseas pneumonia exacerb chronic obstruct pulmonari diseas larger clinic studi asymptomat control requir better defin signific hrvc infect adult popul basi vp sequenc analysi potenti distinct subgroup hrvc identifi complet genom sequenc need better defin genet divers hrvc
Virol J	26656689	2018-06-01	PMC3168426	21843374	background posit control integr compon sensit molecular diagnost tool mutat screen scenario pandem newli emerg diseas difficult acquir posit control host work describ develop synthet oligocassett posit control accur highli sensit diagnosi mutat relev influenza viru drug resist influenza antivir drug resist mutat exampl emploi util synthet pair long oligonucleotid complementari sequenc end util format oligonucleotid dimer dna polymer gener bp dsdna specif neuraminidas inhibitor nai resist mutat templat clone appli posit control downstream assai conclus approach improv develop diagnosi resist mutat term time accuraci effici sensit paramount monitor emerg spread antivir drug resist influenza strain broader applic molecular diagnost applic rapid molecular test relev mutat event pandem
PLoS One	29856201	2007-06-06	PMC3168876	21918681	annexin anxa protein implic divers cellular function includ exocytosi dna synthesi cell prolifer propos involv rna metabol associ cellular mrna identifi anxa rna bind protein rbp bind ibv infecti bronchiti viru pseudoknot rna confirm bind anxa ibv pseudoknot rna ultraviolet crosslink bind rna pseudoknot anxa protein vitro cell rna pseudoknot locat frameshift region ibv bait cellular rbp test anxa regul frameshft ibv pseudoknot rna dual luciferas assai overexpress anxa reduc frameshift effici ibv pseudoknot rna knockdown protein strikingli increas frameshift effici anxa cellular rbp modul frameshift effici viral rna enabl antivir cellular protein hint role rna metabol cellular mrna
Acta Crystallogr Sect F Struct Biol Cryst Commun	17553888	2006-03-14	PMC3169389	21904037	the seattl structur genom center infecti diseas ssgcid consortium research seattl biom emerald biostructur univers washington pacif northwest nation laboratori establish appli structur genom approach drug target infecti diseas organ ssgcid current fund fiveyear period nation institut allergi infecti diseas niaid determin threedimension structur protein varieti categori pathogen target select engag infecti diseas drugtherapi commun identifi drug target essenti enzym virul factor vaccin candid biomed relev combat infecti diseas proteinexpress system purifi protein ligand screen threedimension structur produc ssgcid constitut valuabl resourc drugdiscoveri freeli greater scientif commun issu acta crystallographica entir devot work ssgcid cover detail highthroughput pipelin present seri structur broad arrai pathogen organ background provid structur genom infecti diseas essenti compon ssgcid pipelin discuss survei progress present
J Transl Med	16537637	2015-09-23	PMC3169469	21762538	background hepat viru major chronic liver diseas lead perman liver damag hepatocellular carcinoma death present treatment interferon ribavirin limit benefit advers side effect anemia depress fatigu flulik symptom herbal plant centuri diseas includ viral diseas major sourc compound treat bacteri viral diseas materi studi design studi antivir glycyrrhizin gl hcv purpos hcv infect liver cell treat gl toxic dose hcv titer measur quantit real time rtpcr discuss demonstr gl inhibit hcv titer dose depend manner reduct hcv concentr compar studi interferon alpha investig synergist effect antivir compound interferon alpha data gl exhibit synergist combin interferon verifi transient transfect liver cell hcv core plasmid prove gl dose depend inhibit express hcv core gene mrna protein level gapdh remain constant conclus gl inhibit hcv full length viral particl hcv core gene express function dose depend manner synergist interferon futur gl interferon will better option treat hcv infect
Virol J	26401031	2012-03-20	PMC3169512	21806805	background despit success erad smallpox whole vaccin programm pox viru infect remain consider health threat smallpox bioterror agent continu occurr zoonot pox viru infect document relev deepen understand viru host interact permiss pox infect independ host surfac receptor correl abil viru infiltr antivir host respons directli depend host proteom set report proteom hek cell infect vaccinia viru strain ihdw analyz dimension gel electrophoresi maldipsdtof ms bottomup approach cellular viral proteom vacv ihdw infect hek cell uvinactiv vacv ihdwtreat noninfect cell compar derivat peptid sulfophenyl isothiocyan spitc carri ziptipc column enabl protein identif peptid primari sequenc provid improv sn ratio signal intens psd spectra express human protein modul viral infect effect uvinactiv infecti virus host proteom concern energi metabol protein associ gene express proteinbiosynthesi effect attribut viru entri virion protein modul protein involv apoptosi clearli correl infecti virus conclus proteom analysi infect cell insight apoptosi modul regul cellular gene express regul energi metabol confid protein identif clearli improv peptid derivat spitc solid phase support identifi protein describ context poxviru infect characteris identifi mean apoptosi modul pathogenesi
PLoS Pathog	22434910	2005-05-26	PMC3169548	21931555	recognit virus pattern recognit receptor prr interferon ifn induct kei event antivir innat immun respons target viral immun evas vaccinia viru vacv protein identifi inhibitor prrinduc ifn express function screen select vacv open read frame express individu mammalian cell member famili bcllike poxviru protein inhibit innat immun signal pathwai prr activ nfb ifn regulatori factor irf activ ifn promot induct data present inhibit irf activ transloc nucleu inhibit nfb activ inhibit irf irf activ downstream kinas tank bind kinas tbk ib kinas ikk phosphoryl activ irf inhibit tbk ikkindepend irf activ induct promot constitut activ form irf irf indic act level tbkikk complex consist notion immunoprecipit tbk complex scaffold protein tank sintbad nap express earli infect nucleu cytoplasm mutant virus cl gene delet mutat protein express replic cell cultur attenu vivo model infect compar wild type revert control contribut vacv virul inhibit prrinduc activ irf irf
BMC Res Notes	15919902	2014-08-01	PMC3170337	21849040	purpos hn vaccin gener debat concern safeti issu gener popul physician question safe vaccin investig safeti inactiv monoval hn pandem influenza vaccin method focus hn pandem influenza vaccin pandemrix appli report questionnair popul healthcar worker hcw medic student major univers hospit total individu vaccin consist hcw medic student vaccin rate employe higher major individu vaccin novemb total vaccin report lead advers reaction local reaction report myalgia arthralgia fatigu headach conclus data data nation intern institut point safe pandem influenza vaccin
Viruses	25010893	2014-04-02	PMC3172725	21927676	marburg ebola virus sever hemorrhag diseas human high fatal rate earli target cell filovirus monocyt macrophag dendrit cell infect spread liver spleen organ blood lymph flow hallmark filoviru infect deplet noninfect lymphocyt molecular mechan lead observ bystand lymphocyt apoptosi understood limit knowledg fate infect cell filoviru diseas review will explor intracellular event lead viru amplif cell damag filoviru infect will discuss cellular dysfunct cell death correl diseas pathogenesi
PLoS One	24566924	2013-08-23	PMC3173486	21935489	the emerg influenza virus resist exist class antivir drug rais concern novel antivir agent therapeut prophylacticali surfact protein spd belong famili ctype lectin effector molecul innat immun system activ bacteria virus includ influenza virus studi evalu potenti recombin porcin spd antivir agent influenza virus iav vitro determin rang antivir activ thirti iav subtyp hn hn hn origin bird pig human select test sensit recombin spd virus hemagglutin inhibit assai recombin porcin spd potent recombin human spd higher order oligomer form spd strongest antivir activ porcin spd activ broad rang iav strain neutral varieti hn hn iav includ pandem hn virus tissu section ferret human trachea demonstr recombin porcin spd prevent attach human season hn hn viru receptor epitheli cell upper respiratori tract conclud recombin porcin spd hold promis novel antivir agent influenza develop evalu vivo warrant
PLoS One	23977432	2015-08-10	PMC3174162	21935396	the induct strong mucos immun respons essenti build success hiv vaccin highli attenu recombin hiv vaccinia viru administ mucos high dose immun unabl induc strong mucos antibodi respons order solv problem studi interact recombin hiv vaccinia viru tiantan strain rvttgagpol mucos epitheli cell caco cell layer balbc mice evalu impact viru hiv antigen deliveri specif immun respons demonstr rvttgagpol infect caco cell layer nasal lung epithelia balbc mice progeni virus express releas apic surfac balbc mice infect limit respiratori system observ blood polar distribut limit antigen deliveri bodi limit immun respons improv stimul unpolar bud viru hiv antigen treat caco cell balbc mice colchicin balbc mice degre infect antigen express epithelia result specif immun respons increas correspondingli data polar bud limit antigen deliveri immun respons unpolar distribut increas antigen express deliveri enhanc specif immun respons conclus optim mucos hiv vaccin strategi
PLoS One	26261336	2007-11-21	PMC3174196	21935418	introduct mechan ventil mv mice increasingli requir experiment studi condit allow stabl ventil mice hour fulli defin addit previou studi document vital paramet lung mechan incomplet aim studi establish experiment condit paramet physiolog rang period purpos examin effect frequent short recruit manoeuvr rm healthi mice method mice ventil low tidal volum vt mlkg high tidal volum vt mlkg posit endexpiratori pressur peep cmho rm perform min min lung mechan forc oscil techniqu blood pressur bp electrocardiogram ecg heart frequenc hf oxygen satur bodi temperatur monitor blood gase neutrophilrecruit microvascular permeabl proinflammatori cytokin bronchoalveolar lavag bal blood serum histopatholog lung examin mv repetit rm min stabl respiratori mechan ventil rm worsen lung mechan alveolar collaps lead impair ga exchang hf bp anaesthesia ventil microvascular permeabl highest atelectat lung neutrophilrecruit structur chang strongest lung ventil high tidal volum cytokin il kc tnf ip elev bal serum ventil mice reduc recurr rm lung mechan oxygen pulmonari inflamm improv increas peep conclus recurr rm maintain lung mechan physiolog rang low tidal volum ventil healthi mice prevent atelectasi reduc develop pulmonari inflamm
PLoS One	18032495	2008-04-22	PMC3174198	21935470	the rna guanylyltransferas gtase involv synthesi mgppprna cap structur eukaryot mrna gtase member coval nucleotidyl transferas superfamili includ dna rna ligas gtase catalyz twostep reaction initi util gtp substrat form coval enzymegmp intermedi gmp moieti transfer diphosph rna transcript second step reaction form gppprna structur current studi combin virtual databas screen homolog model biochem assai search novel gtase inhibitor approach demonstr mycophenol acid mpa inhibit gtase reaction prevent catalyt transfer gmp moieti acceptor rna mpa repres novel type inhibitor rna guanylyltransferas inhibit second step catalyt reaction addit mpa cerevisia cell lead reduct cap mrna final biochem assai demonstr mpa inhibit dna ligas inhibit second step reaction biolog implic find mpamedi inhibit member coval nucleotidyl superfamili discuss
PLoS One	18427094	2012-04-27	PMC3174965	21949746	background differ clinic present outcom patient infect pandem influenza hn phn compar respiratori virus fulli elucid methodologyprincip find retrospect studi perform hospit patient peak phn season singl respiratori viru detect molecular assai target virusessubtyp rvp luminex xtag fiftytwo percent patient octob decemb singl respiratori viru phn rhinoviru rsv ab parainfluenza adenoviru coronaviru metapneumoviru season influenza detect individu phn compar virus fever cough sore throat nausea vomit abdomin pain lower white blood count l pvalu patient cough gastrointestin complaint presenc subject feverchil independ rais likelihood phn fiftyf percent cohort receiv antibacteri agent receiv oseltamivir receiv steroid mortal rate cohort wa higher individu phn compar virus conclusionssignific peak pandem influenza season rhode island half patient admit influenzalik symptom respiratori virus influenza a high proport patient treat antibiot phn infect higher mortal compar respiratori virus
BMC Infect Dis	22544935	2017-07-01	PMC3175217	21880131	background sever diseas caus pandem influenza ahnviru character presenc hypercytokinemia origin exacerb cytokin respons unclear observ uncontrol influenza viru replic influenc cytokin product object studi evalu relationship host cytokin respons viral level pandem influenza critic patient method twenti three patient admit icu primari viral pneumonia includ studi quantit pcr base method target influenza gene develop quantifi pharyng viral load addit multiplex base assai systemat evalu host cytokin respons viral infect admiss icu correl studi cytokin level viral load calcul spearman correl coeffici fifteen patient need intub ventil mechan ventil icu hospit viral load pharyng swab fold higher group patient worst respiratori condit admiss icu pharyng viral load directli correl plasma level proinflammatori cytokin il ilp ifn chemotact factor mip gmcsf angiogen mediat vegf immunomodulatori cytokin ilra correl studi demonstr exist posit associ level mediat evidenc simultan regul respons viru conclus sever respiratori diseas caus pandem influenza viru character exist direct associ viral replic host cytokin respons reveal potenti pathogen link sever diseas caus influenza subtyp hn
PLoS One	28187911	2010-04-02	PMC3176773	21949749	background mosquitoborn infecti diseas pose sever threat public health area current method pathogen detect surveil depend prior knowledg etiolog agent involv effici approach requir screen wild mosquito popul detect unknown pathogen methodologyprincip find studi explor gener sequenc identifi viral agent wildcaught mosquito extract total rna mosquito speci south china small bp length rna molecul purifi reversetranscrib cdna sequenc illumina gaiix instrument bioinformat analys identifi put viral agent conduct confirm pcr identifi nonenvelop singlestrand dna densoviru wildcaught culex pipien molestu mosquito major viral transcript region cover small viral rna peak high coverag strand sequenc ratio small rna indic molecul deriv viral rna transcript small viral rna overlap enabl contig assembl viral genom sequenc identifi small rna revers repeat region viral untransl region transcript expect conclusionssignific demonstr time high throughput sequenc small rna feasibl identifi viral agent wildcaught mosquito detect dna virus sequenc small rna insect underli mechan small viral rna biogenesi unclear data research high throughput small rna sequenc pathogen surveil wild mosquito vector
Virol J	20363828	2008-12-10	PMC3177912	21902821	background pig consid suscept influenza viru infect host origin earlier studi receptor avian sialic acidalphatermin saccharid saalpha swinehuman saalpha influenza virus upper respiratori tract experiment natur infect pig report influenza viru avian human sourc method studi investig receptor distribut entir respiratori tract pig specif lectin maackia amurensi maa ii sambucu nigra sna predilect site swine influenza viru siv subtyp hn hn avian influenza viru aiv subtyp hn investig respiratori tract experiment infect pig immunohistochem method siv antigen distribut bronchi epitheli cell nose trachea bronchiol alveolar type ii epitheli cell sever anim aiv lower respiratori tract alveolar type ii epitheli cell occasion bronchiolar epitheli cell saalpha predomin receptor area respiratori tract averag line epitheli cell contrari saalpha epitheli cell nose trachea bronchi small amount bronchiol alveoli reach averag epitheli cell interestingli receptor express saalpha markedli diminish influenza infect area compar noninfect area conclus differ predilect site siv aiv viru differ distribut saalpha saalpha receptor indic distribut influenza viru receptor pig human challeng theori pig act mix vessel human avian influenza virus aiv prefer infect alveolar type ii epitheli cell pig correspond find human emphasis resembl speci
PLoS One	19252833	2012-02-01	PMC3179484	21966414	sever studi highlight role plai murin natur killer nk cell control influenza infect human nk cell respons acut influenza infect includ infect pandem hn influenza viru document examin chang nk cell phenotyp function plasma cytokin level associ influenza infect vaccin absolut number peripher blood nk cell cdbright nk cell decreas acut influenza infect nk cell subset expand intramuscular influenza vaccin nk cell expos influenza antigen activ higher proport nk cell express cd studi subject infect season influenza strain vaccin led increas level cd nk cell notabl cdbright cd nk cell decreas amount subset peripher blood influenza infect individu studi subject infect pandem hn influenza viru final acut influenza infect associ low plasma concentr inflammatori cytokin includ ifn mip il il high level antiinflammatori cytokin il ilra altogeth data role cdbright nk cell subset respons influenza involv recruit infect tissu local product andor uptak inflammatori cytokin
PLoS One	22071509	2016-11-10	PMC3179511	21966512	background hepat viru hev nonenvelop plusstrand rna viru acut hepat capsid protein open read frame orf induc endoplasm reticulum stress orf express cell methodologyprincip find studi hev orf activ express proapoptot gene cebp homolog protein chop orf stimul chop promot aar amino acid respons element minor extent ers endoplasm reticulum stress respons element activ transcript factor atf protein bind activ aar regulatori site chop promot orf express lead increas phosphoryl eukaryot initi factor alpha eif turn initi translat atf mrna proapoptot gene chop trigger initi endoplasm reticulum stress induc apoptosi activ chop orf studi induc apoptosi bclassoci protein bax transloc mitochondria microarrai analysi reveal orf specif increas express chaperon hsp hspb cochaperon hsp coimmunoprecipit coip silico molecular dock analysi suggest hev orf interact hsp addit hsp nuclear accumul orf express cell conclusionssignific data provid insight simultan occur counteract effect hev orf strategi prevent host suicid complet viral replic cycl
Virol J	27834729	2009-01-21	PMC3179960	21902836	background chikungunya viru chikv surpris massiv reemerg outbreak indian ocean reach europ exhibit except sever physiopatholog infant elderli patient context analyz innat immun host respons trigger chikv autophagi compon innat immun respons involv host defens elimin pathogen autophag process observ hijack viru replic provid evid hallmark autophagi hek infect cell involv chikv replic method test capac chikv mobil autophag machineri perform fluoresc microscopi experi hekgfplc stabl cell lc distribut time cours chikv infect confirm perform electron microscopi hek infect cell test chikvinducedautophagi viral replic block autophag process pharmacolog ma genet inhibit sirna transcript beclin autophag protein analyz percentag infect cell viral rna load releas supernat induct autophagi rapamycin viral replic test increas number gfplc posit cell punctat stain enhanc number gfplc dot cell chikv trigger autophag process hek infect cell confirm electron microscopi analysi numer membranebound vacuol characterist autophagosom observ infect cell inhibit autophagi biochem reagent rna interfer dramat decreas chikv replic conclus autophagi plai promot role chikv replic investig detail relationship autophagi viral replic will greatli improv knowledg pathogenesi chikv provid insight design candid antivir therapeut
PLoS One	19158246	2004-11-24	PMC3180459	21966536	background procoagul membran microvesicl mv deriv platelet leukocyt circul receptormedi activ cellcel interact apoptosi platelet sentinel marker tolllik receptor tlr activ experi design evalu time cours mechan direct interact platelet leukocyt acut activ tlr bacteri lipopolysaccharid lp methodologyprincip find blood agematch male femal wild type wt tlr gene delet dtlr mice incub ultrapur coli lp ngml hour design period leukocyt antigen posit platelet platelet antigen posit leukocyt cellderiv mv quantifi flow cytometri number platelet leukocytederiv mv increas hour vitro exposur blood lp lp stimul number platelet stain posit platelet leukocytespecif antigen increas blood deriv wt dtlr mice block inhibit tlr signal mediat trif dai singl intraven inject lp ngmous nggm bodi wt wt mice platelet stain leukocyt antigen granulocyt monocyt apoptot bodi stain posit platelet antigen conclusionssignific hour exposur lp leukocyt exchang surfac antigen platelet tlr activ vivo leukocyt express platelet antigen retain singl exposur lp turn platelet pool acut express leukocyt antigen platelet hour exposur lp sustain express platelet antigen leukocyt singl acut exposur lp vivo explain associ platelet leukocyt respons bacteri infect chang thrombot propens blood
PLoS One	15564471	2011-06-01	PMC3181264	21980438	bat rich reservoir host varieti virus capabl spillov suscept mammal lethal consequ abil bat remain asymptomat viral infect rapid control viral replic earli immun respons innat antivir mechan type iii interferon ifn repres defenc viral infect mammal famili ifn pteropid bat insight type iii ifn system bat describ character type iii ifn receptor ifnr black fly fox alecto character ifnr ilr gene type iii ifn receptor complex bat ifnr complex wide tissu distribut cellular level epitheli immun cell respons ifn treatment demonstr bat ifnr chain act function receptor knowledg report repres descript ifn receptor speci bat respons bat cell ifn support role type iii ifn system epitheli immun cell bat
Ir Vet J	21427361	2010-07-07	PMC3182126	21917151	calfhood diseas major impact econom viabil cattl oper second three review seri consid manag diarrhoeic diseas prewean calv neonat calf diarrhoea oral rehydr therapi singl therapeut measur carri farmer success instig diarrhoea develop continu feed milk milk replac diarrhoeic calv prevent malnourish weight loss calv indiscrimin antibiot treatment uncompl diarrhoea discourag system calv benefit system antibiot treatment prevent septicaemia concurr diseas ancillari treatment specif prevent measur discuss eimeriosi high econom impact farm industri direct cost treatment calf loss decreas perform clinic subclin anim emphasi li prophylact metaphylact treatment degre damag intestin mucosa diarrhoea develop therapeut intervent unreward
PLoS One	20610424	2018-03-01	PMC3183080	21980532	background reflect true extent spread phnv influenza pandem commun level infect mild clinic symptom studi aim assess prospect studi attack rate phn viru reunion island risk factor infect season methodologyprincip find serosurvei conduct austral winter frame prospect popul studi pair sera collect individu belong household passag pandem wave antibodi phnv titer hemagglutin inhibit assai hia titer consid posit seropreval week detect phnv reunion island peopl year ag adult year elderli year baselin correct cumul incid rate ag group declin antibodi titer occur passag epidem wave seroconvers rate phn correl neg ag ag group seroconvers occur individu seroneg inclus compar initi seroposit conclus seroincid phnv infect three time estim clinic surveil indic third infect occur commun level escap medic detect peopl year ag group preepidem titer prevent seroconvers protect infect concern rais long term stabil antibodi respons
Virol J	29256824	2014-05-28	PMC3184106	21910859	background transmiss gastroenter viru tgev sialic acid bind activ believ enteropathogen appear dispens infect cultur cell aim studi determin sialic acid bind infect cultur cell unfavor condit comparison tgev strain mutant avian coronaviru ibv concern depend sialic acid bind activ method infect virus analyz plaqu assai adsorpt time min prior infect cultur cell treat neuraminidas deplet sialic acid cell surfac mocktreat second approach pretreat viru porcin intestin mucin perform plaqu assai min adsorpt time student ttest verifi signific result desialyl cell minor infect tgev strain purdu adsorpt period min allow initi infect adsorpt time reduc min infect desialyl cell decreas tgev pur mutant defici sialic acid bind lower titer parent viru min adsorpt time adsorpt time min titer lower tgev pur tgev strain tgev miller ibv beaudett reduct infect neuraminidas treatment cultur cell irrespect virion adsorpt time conclus sialic acid bind activ facilit infect tgev unfavor environment condit depend sialic acid bind activ effici infect differ analyz tgev strain
Viruses	25369598	2008-12-03	PMC3185462	21994534	human bocaviru hbov discov molecular viru screen techniqu respiratori sampl respiratori diseas children hbov distribut worldwid respiratori sampl fece urin serum hbov infect young children coinfect respiratori virus exacerb effort link hbov specif symptom purpos review overview hbov highlight find
Viruses	19052082	2016-08-01	PMC3185464	21994537	thi studi realtim pcr assai screen small sampl volum comprehens rang respiratori pathogen initi thermocycl limit cycl avoid competit reagent secondari realtim multiplex pcr supplementari seminest human metapneumoviru picornaviru pcr assai requir complet acut respiratori pathogen profil potenti pathogen detect pernas aspir collect children acut respiratori symptom multipl pathogen detect sampl tandem multiplex realtim pcr effici method rapid detect multipl pathogen
Viruses	27154756	2005-05-01	PMC3185465	21994538	after human coronavirus oc nl human coronaviru hku hcovhku fourth human coronaviru discov hcovhku group coronaviru cultiv content hcovhku genom lowest coronavirus complet genom sequenc coronavirus hcovhku extrem codon usag bia attribut importantli sever cytosin deamin hcovhku genom uniqu tandem copi base acid tandem repeat unknown function nterminu nsp insid acid domain upstream papainlik proteas three genotyp hcovhku homolog recombin genom observ incid hcovhku infect highest winter human coronavirus hcovhku infect report global median rang incid hcovhku associ upper lower respiratori tract infect selflimit common method diagnos hcovhku infect rtpcr realtim rtpcr rna extract respiratori tract sampl nasopharyng aspir npa pol nucleocapsid gene target amplif monoclon antibodi gener direct antigen detect npa antibodi detect escherichia coli bl baculovirusexpress recombin nucleocapsid hcovhku igg igm detect sera patient normal individu western blot enzymelink immunoassai
Viruses	15860708	2010-06-01	PMC3185486	21994544	the intern fecvfipv mutat theori three correl test sibshalfsib kitten healthi contact cat unrel cat di fip geograph dispar region coronaviru fece extraintestin fip lesion cat accessori structur gene sequenc snp delet caus truncat gene product isol diseas tissu cat suffer fip fecal isol cat intact gene accessori structur gene appear normal fecal lesion virus deliteri mutat gene uniqu cat indic origin cat subsequ pass horizont compartment parent mutant form absolut viru lesion type fece cat viru ident fecal type occasion identifi diseas tissu gene mutant studi horizont transmit parent fecal viru transmit contact cat di fip housem high rate mutabl structur accessori gene cat lead minor genet variant variant identifi diseas tissu fece cat laboratori cat inocul mixtur close variant fip cat develop diseas variant genet drift exist isol geograph distinct region western us
Viruses	19597128	2013-11-01	PMC3185490	21994549	bovin herpesviru bohv infect cell protein bicp transcript regulatori protein stimul product infect transient transfect assai bicp inhibit interferon depend transcript bicp induc degrad interferon stimulatori factor irf cellular transcript factor crucial activ beta interferon ifn promot activ studi conclud interact bicp irf inhibit transactiv ifn promot activ chc zinc ring gene finger locat amino terminu bicp function bicp recombin viru singl amino acid chang conserv cystein residu chc zinc ring finger bicp grow cultur cell reactiv latenc cattl confirm chc zinc ring finger crucial viral growth pathogenesi bicp delet mutant induc plaqu permiss cell induc autophagi cell type depend manner summari abil bicp stimul product infect repress ifn depend transcript plai crucial role bohv infect cycl
Viruses	23688437	2018-01-16	PMC3185500	21994554	typei interferon ifni cytokin essenti vertebr antivir defens includ herpesvirus ifni potent direct antivir activ mediat multipl immunoregulatori function promot dampen antivir adapt immun respons plasmacytoid dendrit cell pdc profession produc ifni respons virus includ herpesvirus test strong evid pdc plai major role initi orchestr innat adapt antivir immun respons depend activ pattern pdc respons protect detriment host summar discuss current knowledg pdc implic physiopatholog mous human herpesviru infect discuss pdc function manipul immunotherapeut set promot health diseas
Viruses	29194012	2010-06-10	PMC3185515	21994563	hcovnl identifi respiratori viru pathogenesi fulli unravel anim model current lack examin rhesu macaqu encount hcovnl infect life examin level antibodi hcovnl time anim till year three anim observ steep rise antibodi follow indic natur infect hcovnl
Viruses	20538854	2009-10-01	PMC3185524	21994575	defect interf di rna subvir rna produc multipl rna virus errorpron viral replicas dirna parasit rna deriv associ parent viru advantag viralcod protein factor multipl advanc field di rna biologi led greater understand gener evolut dirna mechan symptom attenu dirna versatil tool hand virologist complex surrog templat understand biologi helper virus eas genet manipul rapid discoveri cisact rna replic element requir replic recombin dirna exploit discov host factor modul tomato bushi stunt viru replic viral rna recombin review discuss current model gener evolut dirna role viral host factor dirna replic mechan diseas attenu
Viruses	19822888	2014-06-11	PMC3185532	21994559	the interferoninduc doublestrand dsrnadepend protein kinas pkr limit viral replic eifmedi block translat negativestrand rna virus activ pkr respons rna long remain elus dsrna canon activ pkr detect cell infect virus review focu activ rna molecul viru famili negativestrand rna virus discuss identifi noncanon activ triphosph rna vrnp influenza viru updat strategi select rna dna virus prevent activ pkr
Viruses	24920770	2006-01-01	PMC3185535	21994588	human rhinovirus hrv common cold complic respiratori infect hrv speci associ lower respiratori infect exacerb asthma type distribut strain connect kind lower respiratori condit clearli analys presenc hrv sputum specimen deriv militari recruit prediagnos asthma time acut respiratori infect cia studi analysi perform hrv hev realtim rtpcr assai subsequ studi type distribut hrv strain genet type vpvp genom region total specimen hrvposit hevposit differ hrv detect asthmat nonasthmat patient genet type strain belong hrva hrvb strain constitut hrvposit strain hrvc strain type time hrvposit case hevd strain type hev posit strain partial vp region three belong hrva three hevd hrva strain discov studi period hrvc strain origin winter spring specimen interestingli type hrvb strain origin summer season specimen
Viruses	17006978	2011-10-01	PMC3185540	21994565	the wu polyomaviru wupyv novel member famili polyomavirida detect respiratori tract specimen shotgun sequenc intriguingli viral genom detect respiratori tract specimen children respiratori diseas level coinfect establish respiratori virus rang studi report detect wupyv stool serum wupyv infect distinguish viral infect clinic symptom respiratori tract diseas pneumonia bronchiti frequent observ patient harbour wupyv detect viremia suggest system infect data prove wupyv human pathogen investig necessari
Viruses	21852642	2009-10-08	PMC3185542	21994570	sever human monoclon antibodi hmab antibodi fragment includ best character term structurefunct fab exhibit potent broad hiv neutral activ elicit blike antibodi vivo vaccin immunogen base hiv envelop glycoprotein env success highli diverg closest correspond germlin antibodi diverg hypothes high degre specif somat hypermut preclud bind hiv envelop glycoprotein env closest germlin antibodi identifi antibodi intermedi pathwai matur help design novel vaccin immunogen guid immun system enhanc elicit support hypothesi germlinelik monoval bival scfv fc fusion protein igg lack measur bind env measur elisa sensit rang evid confirm expand find panel env contrast germlinelik scfv bound env high nm affin to explor matur pathwai antibodi identifi intermedi antibodi test neutral activ intermedi antibodi neutral hiv isol weak potenc contrast germlinelik scfv neutral subset test hiv isol compar effici matur help explain high immunogen coreceptor bind site gp abund cdinduc cdi antibodi hivinfect patient cdi antibodi matur pathwai help identifi antigen bind germlin intermedi antibodi env conceptu novel type candid vaccin candid vaccin base immunogen help guid immun system complex matur pathwai elicit antibodi ident antibodi properti
Viruses	19815576	2007-05-01	PMC3185546	21994587	infecti bronchiti viru ibv highli contagi respiratori urogenit tract diseas chicken maryland md strain isol diseas chicken flock delmarva peninsula region understand genet divers phylogenet relationship exist strain md complet nucleotid sequenc code region kb md determin compar ibv strain coronavirus smn gene order case ibv strain spike gene md exhibit ident se strain delet spike gene noncod region gene untransl region utr arklik strain phylogenet analysi sequenc align demonstr md chimera gene segment close se conn jmk strain current studi evid genom mutat intergen recombin place evolut ibv strain md
Viruses	17434199	2017-06-29	PMC3185548	21994611	it mucos tissu largest surfac area human bodi front natur host defens pathogen fact infecti diseas pathogen gain entri suscept human host open mucos surfac human immunodefici viru type hiv sexual transmit viru target vagin gastrointestin mucosa entri site viral transmiss seed replic amplif hiv establish earli replic vagin rectal mucos tissu induct suffici mucos immun initi site hiv transmiss essenti protect vaccin despit fact current convent vaccin strategi remain unsuccess prevent hiv infect suffici financi support resourc to develop vaccin elicit protect mucos immun sexual transmiss interestingli chines ancestor invent variol intranas administr year ago led discoveri success smallpox vaccin final erad diseas hope mankind develop mucos aid vaccin will ultim help control aid pandem order discov effect mucos aid vaccin deep understand mucos immunolog test mucos vaccin strategi
Viruses	28465343	2009-07-08	PMC3185569	21994614	the type interferon system plai critic role limit spread viral infect virus induc product interferon ifn bind ifn receptor ifnar trigger jakstat signal cascad induct interferonstimul gene isg isg function inhibit viral replic regul host immun respons isg ubiquitinlik molecul isg induc protein ubiquitin ifn induc conjug cascad isg coval link varieti cellular protein suggest regul cellular process studi perform year isg plai central role host antivir respons virus mice lack isg displai increas suscept multipl virus virus develop immun evas strategi directli target isg pathwai work underwai determin mechan isg function antivir molecul therapi target pathwai develop futur
Viruses	19587037	2011-03-30	PMC3185573	21994622	ubiquitin plai critic role cellular process grow number virus evolv strategi exploit ubiquitinproteasom system includ member poxvirida famili member poxviru famili encod btbkelch ankyrinfbox protein interact cullin cullin base ubiquitin ligas multipl member poxviru famili encod ubiquitin ligas intrins activ review describ numer mechan poxvirus emploi manipul ubiquitinproteasom system
Viruses	21450819	2006-06-28	PMC3185581	21994630	respiratori virus diseas human character abrupt onset symptom studi human anim model symptom appear dai week infect initi symptom manifest viru recognit element innat immun respons earli viru replic undetect interv infect emerg symptom call incub period clinic score incub period describ viru infect underli mechan asymptomat phase comprehens document review studi interact human pathogen respiratori rna virus host emphasi mechan virus inhibit immun discuss concept stealth phase defin time infect earliest detect inflammatori respons propos stealth phase phenomenon respons suppress symptom incub period viral antagon inhibit major pathwai innat immun system allow extend time unhind viru replic
Viruses	16809333	2011-05-18	PMC3185585	21994625	positivestrand rna rna virus exploit host cell machineri subvert host protein membran alter cellular pathwai infect achiev robust replic rna virus polioviru pv build special intracellular compart call viral replic organel work altanbonnett laboratori insight format polioviru replic organel uniqu subcellular structur individu replic complex result dynam cellular membran remodel
Viruses	21593260	2014-05-07	PMC3185589	21994638	an ideal anim model studi human diseas util rout infect mimic natur transmiss pathogen abil diseas infecti dose equival caus diseas human diseas cours morbid mortal human diseas addition anim model mode transmiss mimic human case develop small anim model studi monkeypox viru mpxv extens short period time pathogen model studi antipoxviru agent will review mpxv small anim model develop studi therapeut agent
Viruses	22205743	2002-02-01	PMC3185593	21994631	the continu emerg reemerg pathogen repres ongo major threat popul hantavirus famili bunyavirida associ human diseas consid confin eurasia occurr outbreak in southwestern unit state led great increas studi virologist worldwid hantavir genotyp describ larg major half pathogen human hantavirus persist infect reservoir host america human diseas manifest cardiopulmonari compromis hantaviru cardiopulmonari syndrom hcp casefat ratio common viral serotyp habitat disturb largerscal ecolog disturb includ climat chang factor increas human caseload hcp consid featur influenc structur host popul dynam lead viral outbreak macromolecular determin hantavirus regard potenti contribut pathogen
Viruses	11773370	2009-12-01	PMC3185605	21994645	coval modif polyethylen glycol peg nontox polym food cosmet pharmaceut prepar year profoundli influenc pharmacokinet pharmacolog toxciolog profil protein peptidebas therapeut review summar histori pegyl peg chemistri highlight technolog context design develop recombin virus gene transfer vaccin diagnost purpos specif emphasi applic technolog adenoviru potent viral vector highli character toxic profil anim model
Viruses	20095306	2013-05-15	PMC3185611	21994652	the flaviviru genu includ virus remark abil produc diseas larg scale expans increas endem dengu west nile virus america exemplifi medic epidemiolog rapid detect viral infect induct innat antivir respons crucial determin outcom infect intracellular pathogen receptor rigi mda plai central role detect flaviviru infect initi robust antivir respons virus capabl produc acut ill human clear flavivirus util varieti mechan modul interferon respons nonstructur protein flavivirus reduc express interferon depend gene block phosphoryl enhanc degrad downregul express major compon jakstat pathwai studi indic interferon modul factor develop sever flavivir ill suggest increas understand viralhost interact will facilit develop novel therapeut treat viral infect improv biolog model studi flaviviru pathogenesi
Viruses	23678167	2012-03-20	PMC3185704	21994738	the aim manuscript describ modern advanc knowledg virus viral evolut appli field diseas ecolog conserv review progress virolog provid exampl inform empir field ecolog appli conserv includ discuss need breakthrough wai bridg commun gap field lab effort foster interdisciplinari effort includ tabl list definit kei term understand dynam zoonot pathogen reservoir host emphas tool assess risk factor spillov test hypothes treatment andor intervent strategi conclus highlight smart surveil viral discoveri effort predict model shift predict approach todai global societi hn pandem demonstr identif postemerg late prevent global spread integr molecular virolog ecolog techniqu will allow earlier recognit danger pathogen ideal jump wildlif reservoir human livestock popul seriou public health conserv issu
Viruses	22429763	2014-09-01	PMC3185718	21994689	influenza viru preval ancient infect human world popul infect influenza viru annual lead high morbid mortal infant elderli immunocompromis influenza outbreak lead roughli death year current vaccin antiinfluenza drug limit high mutat rate viru side effect year rna interfer trigger synthet short interf rna sirna rapidli evolv potent antivir regimen properli design sirna function potent inhibitor influenza viru replic sirna outperform tradit small molecul antivir number area eas design modest cost fast turnaround specif tissu deliveri remain major bottleneck clinic applic rnai gener intranas applic sirna respiratori virus includ limit influenza viru experienc success optim review here
Viruses	25068401	2014-05-02	PMC3185727	21994699	the discoveri character rna interfer rnai pathwai scientif develop year rnai cellular pathwai small rna control express gene degrad homolog rna prevent translat rna partial homolog impact basic biologi major front the discoveri microrna mirna regul cellular process requir viral infect includ hepat viru hcv second front small interf rna sirna robust tool mammalian cellular genet led identif hundr cellular gene hcv infect major push adapt rnai technolog clinic review explor impact rnai understand hcv biologi progress design rnaibas therapeut hcv remain obstacl
Viruses	24795379	2016-12-28	PMC3185738	21994708	the drastic increas number coronavirus discov coronaviru genom sequenc unpreced opportun perform genom bioinformat analysi famili virus coronavirus possess largest genom kb rna virus content vari variabl number small orf conserv gene orfab spike envelop membran nucleocapsid downstream nucleocapsid gene coronaviru lineag phylogenet three genera alphacoronaviru betacoronaviru gammacoronaviru betacoronaviru consist subgroup exist fourth genu deltacoronaviru includ bulbul coronaviru hku thrush coronaviru hku munia coronaviru hku emerg molecular clock analysi gene loci reveal time common ancestor humancivet sar coronaviru estim substitut rate substitut site year recombin coronavirus notabl strain murin hepat viru mhv strain infecti bronchiti viru mhv bovin coronaviru felin coronaviru fcov type canin coronaviru gener fcov type ii three genotyp human coronaviru hku hcovhku codon usag bia coronavirus observ hcovhku show extrem bia cytosin deamin select cpg suppress clone major independ biolog forc shape codon usag bia coronavirus
Viruses	28031438	2017-10-16	PMC3185791	21994773	viru infect elicit innat respons involv antivir factor activ factor turn block viral countermeasur ensu battl host virus crucial determin viru establish foothold andor induc adapt immun respons comprehens systemslevel understand repertoir antivir effector context virushost respons provid advantag devis novel strategi interfer initi establish infect effort identifi cellular factor comprehens unbias manner genomewid sirna screen system biologi omic methodolog reveal potenti antivir effector virus human immunodefici viru type hiv hepat viru hcv west nile viru wnv influenza viru review describ discoveri novel viral restrict factor discuss integr method system biologi comprehens identifi intim interact virus cellular innat resist
Viruses	29165604	2001-02-01	PMC3185800	21994782	sever independ group publish autophagi requir optim rna replic dengu viru denv initi postul autophagosom plai structur role replic complex format cryoem tomographi denv replic complex denv replic endoplasm reticulum er cisterna invagin classic autophagosom report autophagi plai indirect role denv replic modul cellular lipid metabol denvinduc autophagosom deplet cellular triglycerid store lipid droplet lead increas oxid energi product exampl viru trigger autophagi modul cellular physiolog review summar data discuss question implic autophagi denv replic
Viruses	11152533	2001-03-01	PMC3185804	21994781	human tlymphotrop viru type htlvi infect estim person worldwid number diseas associ viru includ adult tcell leukemia atl htlvassoci myelopathytrop spastic paraparesi hamtsp htlvi uveiti htlviassoci infect dermat increas risk develop hamtsp associ blood transfus screen htlv blood bank implement japan unit state franc netherland process includ detect enzym immunoassai eia confirmatori western blot wb recombin protein specif htlvi env glycoprotein incorpor wb strip htlvi seroposit defin presenc antibodi gp gp env protein band p gag band htlvii seroposit confirm presenc rgpii numer case document serum sampl reactiv eia incomplet band pattern displai subsequ confirmatori wb signific htlviii seroindetermin unclear higher incid exposur htlviii estim
Viruses	11160748	2011-04-01	PMC3185811	21994783	autophagi cellular process catabol cytoplasm compon maintain energi homeostasi stress respons autophagi machineri interconnect wide rang cellular pathwai enhanc spread pathogen limit highli activ area year independ laboratori report autophagi vesicl accumul hepat viru hcv infect cell autophagi protein function provir factor requir hcv replic review summar current interplai autophagi hcv mechan autophagi protein favor hcv propag
PLoS One	21050067	2008-06-01	PMC3186774	21991334	introduct establish strateg prioriti german nation public health institut rki guid institut midterm strateg decis priorit infecti pathogen nation surveil epidemiolog method delphi process intern rki extern expert metricconsensu approach score pathogen ten threetier criteria addit expert invit weight criterion lead calcul median weight score multipli rank pathogen total weight score divid prioriti group pathogen score eightysix expert particip weight case fatal rate rate criterion twentysix pathogen rank highest prioriti group pathogen internation recognis human immunodefici viru mycobacterium tuberculosi influenza viru hepat viru neisseria meningitid pathogen frequent caus larg outbreak campylobact spp nosocomi pathogen associ antimicrobi resist pathogen highest prioriti group includ helicobact pylori respiratori syncyti viru varicella zoster viru hantaviru discuss pathogen highest prioriti group high profil nation intern health polici document high score pathogen helicobact pylori respiratori syncyti viru hantaviru indic underrecognis current german public health framework process strengthen respect surveil system start priorit methodolog work modular structur set
PLoS Med	18582206	2019-03-26	PMC3186812	21990967	background emerg influenza pandem estim sever probabl sever outcom hospit infect public health prioriti influenza infect subclin serosurveil need allow reliabl realtim estim infect attack rate iar sever method find test sera collect wave pandem hong kong viral microneutr estim iar infectionhospit probabl ihp serial crosssect serolog data hospit data serolog data weekli real time reliabl ihp estim wk wk wk epidem peak individu ag y ratio iar preexist seropreval decreas ag major determin timeli reliabl estim began serosurveil wk commun transmiss confirm specimen week individu ag y reliabl ihp estim ag group wk peak old specimen week gener reliabl estim peak ratio iar preexist seropreval ag group low perform serial crosssect serosurveil deterior test specif preexist seropreval potenti limit mitig choos higher titer cutoff seroposit epidem doubl time longer serial crosssect serosurveil specimen week yield reliabl estim iar reach conclus serial crosssect serolog data clinic surveil data allow reliabl realtim estim iar sever emerg pandem serosurveil pandem consid articl editor summari
Viruses	30913880	2013-03-18	PMC3187592	21994724	although gener regard pathogen virus mutualist number exampl extrem mutual symbiogenesi studi exampl mutual common virus rare thought benefici effect host mutual popul dynam virus topic address experiment potenti understand mutual viru mutualist elucid understand dynam
Viruses	23249609	2015-04-01	PMC3187600	21994673	commentari wolf mc freiberg zhang akyolataman grock hong pw li watson nf fang aq aguilar hc al broadspectrum antivir target entri envelop virus proc natl acad sci 
Viruses	25765920	2015-11-02	PMC3187604	21994671	positivesens rna virus respons frequent devast diseas human anim plant develop effect vaccin antivir therapi target pathogen hinder incomplet understand molecular mechan involv viral replic common featur positivesens rna virus manipul host intracellular membran assembl function viral rna replic complex review will discuss interplai cellular membran positivesens rna viru replic will focu potenti structur function role cellular lipid process
Viruses	26575627	2014-01-01	PMC3187687	21994798	pathogen bacteri viral origin hijack pathwai oper eukaryot cell wai order gain access host establish eventu produc progeni detail molecular character subvers mechan devis pathogen infect host cell crucial gener target therapeut intervent review data indic coronavirus coopt membran carrier deriv endoplasm reticulum protein regul dispos misfold polypeptid replic addit model describ potenti mechan coronavirus emploi hijack
Viruses	23821643	2005-02-01	PMC3187689	21994806	recombin famili coronavirida document thought contribut factor emerg evolut coronavir genotyp speci coronaviru limit data frequenc extent recombin coronavirus natur avian gammacoronavirus emerg turkei coronaviru attribut sole recombin studi fulllength genom avian gammacoronaviru infecti bronchiti viru ibv isol sequenc fulllength ibv genom genbank analyz recombin evid recombin sequenc analyz distribut entir genom area highest occurr recombin locat region genom code nonstructur protein and structur spike glycoprotein extent recombin observ suggest princip mechan gener genet antigen divers ibv data indic reticul evolutionari chang recombin ibv plai major role origin adapt viru lead genet type strain viru
Viruses	15695669	2013-08-07	PMC3187694	21994795	while autophagi antivir defens picornavirida avoid case subvert pathwai promot replic evid indic picornavirus hijack autophagi order induc autophagosomelik membran structur genom rna replic express picornaviru protein induc machineri autophagi mechan virus emploi autophagi appear differ picornavirus upregul autophagi order promot viral replic member famili inhibit degrad autolysosom explor unusu relationship medic famili virus degrad mechan innat immun
Viruses	23926347	2002-10-01	PMC3187698	21994803	although singl strand ss dna virus infect human domest anim gener major diseas arthropod born ssdna virus plant result serious constrain food product temper region plant animalinfect ssdna virus appar metagenom survei ssdna molecul exist larg number divers ssdna virus terrestri aquat environ host rang virus span tree life compon global ecosystem line evid pivot evolutionari process gener global ssdna viru divers genet recombin high rate homolog recombin nonhomolog recombin genom compon reassort occur ssdna viru speci role type recombin plai daytodai biologi longer term evolut virus focu ecolog biochem select factor underli pattern genet exchang detect ssdna virus discuss consid assess adapt recombin ssdna viru evolut
PLoS One	12351731	2003-11-01	PMC3187809	21998709	type interferon ifn compris famili cytokin signal common cellular receptor induc plethora gene antivir activ recombin ifn treatment hepat viru infect multipl sclerosi malign capabl type ifn suppress viru replic result cytopath effect frequent measur bioactiv assai timeconsum requir appropri biosafeti contain studi improv ifn assai present base recombin vesicular stomat viru vsv replicon encod report protein firefli luciferas green fluoresc protein vector lack essenti envelop glycoprotein gene vsv propag proteinexpress transgen cell mammalian avian cell turn suscept infect complement replicon particl infect cell express report protein high level hour post infect human fibroblast treat serial dilut human ifn prior infect report express suppress method sensit faster classic ifn bioassai base vsv cytopath effect addit antivir activ human ifn interleukin type iii ifn determin calu cell ifn ifn acidst ifn resist alkalin treatment antivir activ canin porcin avian type ifn analys cell line deriv correspond speci safe bioassai will rapid sensit quantif multispeci type ifn antivir cytokin
BMC Health Serv Res	14623831	2014-12-01	PMC3189394	21929812	background surveil intervent resourceus activ strategi mitig unwant effect diseas resourc scarc alloc diseas mitig involv loss altern sourc benefit peopl societi maximum benefit resourc gain diseas mitig compar resourc cost guid decis object achiev optim net outcom discuss econom criteria guid decis aim optimis net benefit scarc resourc assess benefit diseas mitig except technic complex mitig econom evalu straightforward technic relationship surveil intervent argu analysi magnitud distribut benefit cost strategi outcom net term requir mitig consid three conceptu distinct stage stage sustain mitig object sustain free accept statu prevent increas pathogen elimin occur role surveil document pathogen remain defin threshold earli warn increas incid chang risk enabl earli respons pathogen contain situat assess stage ii investig surveil obtain critic epidemiolog decid appropri intervent strategi reduc erad diseas stage iii implement stage iii surveil inform choic time scale intervent document progress intervent direct preval reduct popul summari articl origin project develop conceptu framework practic tool econom evalu surveil explor technic relationship mitig sourc econom surveil intervent sourc econom cost crucial framework link kei technic relationship propos three conceptu distinct stage mitig identifi avian influenza salmonella foot mouth diseas present illustr framework
PLoS One	25225206	2006-08-01	PMC3189917	22016769	sever human monoclon antibodi mab neutral potenti subtyp describ three mab hj hgn hk patient hiv cohort institut tropic medicin itm aim gener immun antibodi equival plasma describ select character patient plasma mab rang neutral assai includ peripher blood mononuclear cell pbmc base assai replic primari virus cell base assai pseudovirus pv princip criterion select patient plasma activ extend incub phase pbmc assai neutral ab deriv memori cell select elisa envelop protein solid phase mab subsequ test highthroughput hospv assai assess function neutral studi indic strong profil patient plasma sole antibodi repres newli isol mab assai diverg larg indic neutral ab epitop hiv envelop plasma synergi ab spectrum mab cover rang crossreact plasma carefulli select patient irrespect neutral assai mab relev immunogen discoveri bind recombin glycoprotein immun respons target vivo observ illustr remain challeng requir success immunogen design develop
PLoS One	16893997	2008-11-01	PMC3189918	22022385	gp major envelop protein epsteinbarrviru confer bcell tropism viru interact lineag marker cd util gp gener tailor exosom ident tropism exosom target cotransf function protein normal malign human cell demonstr cotransf function cd protein tailor gp exosom malign blast patient chronic lymphocyt leukemia bcll render blast immunogen tumorreact autolog cell intriguingli engulf gp exosom bcll cell present gpderiv peptid restimul ebvspecif cell redirect strong antivir cellular immun respons patient leukem cell essenc gp confer bcell tropism exosom exosom engin simultan trigger viru tumorspecif immun respons simultan exploit gp tropism molecul tailor exosom neoantigen malign cell novel attract strategi immunotherapi bcll bcell malign
PLoS One	19030681	2018-06-27	PMC3189932	22016778	tolllik receptor tlr detect doublestrand ds rna activ innat immun respons polyic excel agonist tlr cell line human peripher blood mononuclear cell viral dsrna tend poor agonist lead hypothesi addit factor requir allow tlr respond viral dsrna tlr signal examin lung epitheli cell quantifi cytokin product human embryon kidnei cell quantifi luciferas report level recombin hepat viru polymeras enhanc tlr signal lung epitheli beasb cell media polyic viral dsrna polymeras genotyp jfh hcv poor enhanc tlr signal mutat favor conform bind better partial duplex rna polymeras coloc tlr endosom rnabind capsid protein cp positivestrand rna virus hepadenaviru hepat viru hbv potent enhanc tlr signal polyic viral dsrna truncat version hbv cp lack argininerich rnabind domain unabl enhanc tlr signal demonstr viral rnabind protein enhanc dsrnadepend innat immun respons initi tlr
J Trop Med	29950410	2019-07-24	PMC3191740	22007241	occurr virus acut respiratori tract infect nigerian children examin respiratori swab collect children refer hospit clinic acut respiratori symptom februari valid realtim rtpcr techniqu reveal nucleic acid viru group specimen human rhinovirus parainfluenza virus third children adenovirus enterovirus human metapneumoviru human bocaviru influenza viru common season occurr influenza viru respiratori syncyti viru detect rare conclud major group respiratori tract virus caus ill nigerian children
PLoS One	31341046	2011-06-13	PMC3192121	22022432	the genu orbiviru includ insect tickborn virus orbiviru genom compos segment dsrna encod structur protein vpvp nonstructur protein nsn open read frame orf span entir length genom segment seg encod vp viral helicas bioinformat analysi identifi overlap orf orfx seg orfx encod nonstructur protein identifi ns western blot confoc fluoresc microscopi antibodi rais recombin ns bluetongu viru btv insectborn great island viru giv tickborn demonstr protein synthesis btv giv infect mammalian cell btv ns express culicoid insect cell ns form aggreg cytoplasm nucleu consist identif nuclear localis signal ns sequenc bioinformat analys indic ns coiledcoil protein bind nucleic acid associ membran similar nucleolar protein utp processom subunit recombin ns giv protect dsrna degrad endoribonucleas rnase iii famili indic interact dsrna btv ns half put size giv ns protect dsrna rnase iii cleavag ns giv btv protect dna degrad dnase ns associ lipid droplet cell infect btv giv transfect plasmid express ns
PLoS One	21670291	2018-03-07	PMC3192122	22022474	background st march confirm case pandem influenza hn includ death report mainland china distribut characterist confirm case initi phase pandem countri unknown studi aim character geograph distribut patient characterist hn infect pandem identifi potenti risk factor associ advers patient outcom china retrospect analys hospit case confirm hn infect methodologyprincip find proport hazard model emploi detect risk factor advers outcom geostatist map character distribut confirm hn patient mainland china number case increas slowli rapidli june august year confirm case report provinc beij guangdong shanghai zhejiang fujian top region incid viru infect adjust gender ag chronic pulmonari diseas gener symptom delai dai hospit admiss hr ci delai onset hnspecif respiratori symptom hr ci associ advers patient outcom conclusionssignific pandem influenza east southeast coastal provinc popul citi sever region mainland china higher risk high level traffic high popul densiti high popul mobilityassoci hn transmissionth clinic symptom mild initi phase infect delai hospit admiss delai appear respiratori symptom major risk factor poor patient outcom find implic futur pandem prepared respons
BMC Musculoskelet Disord	29260651	2016-10-19	PMC3192716	21958301	background puls electromagnet field pemf stimul treat nonunion fractur femor head osteonecrosi effect prevent steroidinduc osteonecrosi purpos studi investig effect pemf stimul prevent steroidinduc osteonecrosi rat explor underli mechan method seventytwo male adult wistar rat divid three group treat pemf stimul group pemf group intraven inject lipopolysaccharid lp gkg dai intramuscularli inject methylprednisolon acet mpsl mgkg dai subject pemf stimul dai week methylprednisolonetr group mpsl group inject dose lp mpsl pemf group exposur pemf control group ps group inject salin mode time point incid osteonecrosi serum lipid level mrna protein express transform growth factor tgf proxim femur measur week mpsl salin inject incid osteonecrosi pemf group lower observ mpsl group osteonecrosi observ ps group serum lipid level lower pemf ps group mpsl group compar mpsl ps group mrna express tgf increas reach peak week pemf treatment remain high week declin week protein express tgf increas reach peak week pemf treatment remain high week conclus pemf stimul prevent steroidinduc osteonecrosi rat underli mechan involv decreas serum lipid level increas express tgf
PLoS One	27795425	2010-09-22	PMC3192755	22022394	bat increasingli recogn reservoir host larg number virus highli virul infect human livestock anim bat zoonot virus discov year reovirus respiratori enter orphan virus to acut respiratori infect human includ melaka kampar virus discov malaysia belong genu orthoreoviru famili reovirida report describ isol highli viru adult patient suffer acut respiratori ill malaysia direct evid bat origin epidemiolog studi indic potenti exposur patient bat onset diseas current studi demonstr spillov event strain orthoreovirus bat human occur regular basi call intens systemat surveil fulli assess true public health impact newli discov batborn zoonot reovirus
PLoS One	20861244	2012-06-01	PMC3192798	22022603	an adenoviru vector encod mous interferon alpha subtyp mdef evalu efficaci lethal vaccinia viru wr strain respiratori infect mice mdef administ singl intranas treatment prophylact therapeut dose plaqu form unitsmous prophylact treatment dai prior infect protect anim death protect treatment dai preinfect minim weight loss occur infect surviv anim rechalleng viru dai primari infect protect death indic mdef compromis immun respons initi infect postexposur therapi vaccinia viru exposur protect afford dose mdef dose effect comparison abil mdef dai prior infect inhibit tissu viru titer lung infect paramet lung liver spleen viru titer inhibit extent treatment lung weight lung hemorrhag score indic pneumon lung viru titer fold lower placebo group infect paramet mdef treat mice baselin contrast viral titer lung infect paramet high placebo group dai infect demonstr longact prophylact treatment capac mdef combat vaccinia viru infect
PLoS Pathog	22571706	2018-07-01	PMC3192843	22022266	the cap structur distinct featur eukaryot mrna eukaryot virus gener modifi viral rna mimic cellular mrna structur rna stabil protein translat viral immun escap sar coronaviru sarscov encod sadenosyllmethionin samdepend methyltransferas mtase sequenti methyl rna cap guanosinen ribos posit catalyz nsp nmtase nsp omtas uniqu featur sarscov nsp requir nonstructur protein nsp stimulatori factor execut mtase activ report biochem character sarscov omtas crystal structur nspnsp complex bound methyl donor sam sarscov nsp mtase methyl mgppparna mgpppgrna contrast nsp mtase function sequenceindepend manner demonstr nsp requir nsp bind mgppparna substrat sam cofactor structur analysi reveal nsp possess canon scaffold mtase associ nsp ratio structur nspnsp interact interfac nsp stabil sambind pocket extend substrat rnabind groov nsp consist find biochem assai nspnsp interfac repres better drug target viral mtase activ site develop highli specif anticoronaviru drug
Retrovirology	30044982	2004-11-01	PMC3193818	21943056	background type interferon ifn exhibit direct antivir effect distinct immunomodulatori properti studi analyz type ifn subtyp prophylact adenovirusbas antiretrovir vaccin mice friend retroviru fv hiv mice vaccin adenovir vector encod fv env gag protein combin vector encod ifn ifn ifn ifn ifn ifn ifn coadministr adenovir vector encod ifn ifn ifn ifn improv immun protect vaccin mice subsequ fv challeng infect high control fvinduc splenomegali reduc viral load level protect correl augment virusspecif cd cell respons enhanc antibodi titer mice vaccin hiv adenovir vector encod hiv env gagpol combin type ifn encod vector cd cell respons enhanc ifn subtyp conclus indic ifn subtyp potenti improv protect adenovirusbas vaccin retrovirus correl augment virusspecif cd cell antibodi respons coexpress select type ifn valuabl tool develop antiretrovir vaccin
PLoS One	15656475	2009-10-07	PMC3194813	22022592	identif type human enteroviru hev pathogen detect therapi previou phylogenybas type method base multipl sequenc align specif gene hev stabl respect choic gene report novel method identif type hev base deriv genom calcul kmer base barcod imag genom hev human virus fix k genom barcod defin term kmer frequenc distribut genom combin kmer phylogenet tree construct barcodebas distanc neighborjoin method set repres nonhev human virus hev sequenc tree clear separ hev virus nonhev virus accuraci separ hev distinct clad consist multipl sequenc alignmentbas phylogeni detail analys hev type method indic better agreement hev
PLoS Negl Trop Dis	19812072	2014-04-01	PMC3196478	22028943	zair ebolaviru zebov infect associ high lethal primat zebov target mononuclear phagocyt activ infect secret mediat believ trigger initi stage pathogenesi character respons target cell zebov infect understand pathogenesi point therapeut intervent gene express profil primari human macrophag expos zebov determin dna microarrai quantit pcr gain insight cellular respons cell entri chang mrna concentr encod cellular protein observ protein implic zebov infect inflammatori mediat elev acut phase diseas blood zebovinfect human interestingli cellular respons occur hour ebola virion exposur prior viru gene express observ support hypothesi virion bind entri mediat spike glycoprotein gp primari stimulu initi respons zebov virion lp viruslik particl consist zebov matrix protein vp gp vlpvpgp trigger compar respons macrophag includ proinflammatori proapoptot signal contrast vlpvp particl lack gp caus aberr respons suggest gp bind macrophag plai role cellular respons
Retrovirology	24769781	2012-01-11	PMC3196705	21843316	background foami virus fv orthoretrovirus express pol separ precursor protein gagpol fusion protein uniqu packag strategi involv recognit bride viral rna pol precursor gag potenti gagpol protein interact ensur pol particl encapsid prototyp fv pfv gagpol fusion protein construct gener examin pfv replic compat orthoretrovirallik pol express analysi nonparticleassoci secret pol precursor protein discov extracellular wild type pfv particl prepar origin copurifi simpl virion enrich protocol analysi method extracellular wild type pfv particl matur pprrt pin pol subunit character pfv gagpol fusion construct reveal pfv pol express orthoretrovir manner compat pfv replic long proteolyt process gag pol protein pfv gagpol translat hiv ribosom frameshift signal product replicationcompet virion cell particleassoci pol level reduc comparison wild type infram fusion pfv gag pol orf led increas cellular pol level particl incorpor margin elev report orthoretrovir construct fulllength infram pfv gagpol fusion construct wildtypelik particl releas infect characterist contrast infram pfv gagpol fusion ctermin gag orf truncat nonremov gag peptid addit pol displai wildtyp particl releas reduc particl infect pfv gagpol precursor fusion protein inactiv proteas highli defici regular particl releas coexpress pgag copackag protein conclus nonparticl associ pfv pol appear natur releas infect cell unknown mechan absenc particleassoci pol precursor suggest rapid process particl incorpor analysi pfv gagpol fusion construct demonstr orthoretrovirallik pol express compat fv replic princip long fusion protein process orthoretrovirus pfv particl releas infect toler larger differ rel cellular gagpol level
PLoS One	22238295	2009-02-01	PMC3197151	22043297	a highli conserv rnamotif unknown function call stemlooplik motif sm identifi the genom virus belong rna viru famili infect broad rang mammal bird speci includ astrovirida picornavirida coronavirida calicivirida sm extrem conserv motif ideal target screen virus harbour studi detect character novel virus harbour motif pigeon smspecif amplif sampl feral pigeon wood pigeon viru harbour sm novel virus identifi character virus belong genu avastroviru astrovirida famili propos novel speci includ genu feral pigeon astroviru wood pigeon astroviru novel virus pigeon picornaviru pigeon picornaviru belong picornavirida famili presum genu sapeloviru novel picornavirus harbour adjac sm call sm suggest increas function sm copi
PLoS One	19165722	2013-03-01	PMC3197180	22043275	control strategi enforc health agenc major type practic influenza outbreak type practic voluntari prevent behavior individu receiv vaccin antivir drug wear face mask type practic effect concurr influenza contain attent paid combin effect articl estim combin effect establish simul model urban area buffalo ny usa three control strategi investig includ target antivir prophylaxi tap workplaceschool closur commun travel restrict combin three control strategi simul regard individu prevent behavior effect compar simul outcom weaker control strategi suffic influenza epidem individu voluntarili adopt prevent behavior render weaker strategi effect expect prevent behavior individu save medic resourc control strategi avoid unnecessari socioeconom interrupt add human behavior dimens simul control strategi offer insight diseas contain health polici maker recommend review current control strategi comprehend prevent behavior pattern local popul make decis influenza contain
PLoS Pathog	23874060	2002-08-07	PMC3197620	22028657	chikungunya viru chikv reemerg alphaviru caus diseas indian ocean region outbreak addit fever rash arthriti sever case chikv infect observ infant challeng notion innat immun respons infant immatur defect demonstr human infant neonat mice gener robust type interferon ifn respons chikv infect contribut insuffici complet control infect character mechan type ifn control chikv infect evalu role isg defin central player host respons neonat mice lack isg profoundli suscept chikv infect surprisingli ubel mice lack isg enzym unabl form isg conjug displai increas lethal chikv infect point nonclass role isg differ viral load observ wildtyp wt isg mice dramat increas proinflammatori cytokin chemokin observ isg mice suggest innat immun respons chikv contribut lethal studi insight control chikv infect establish model isg function immunomodulatori molecul blunt patholog level innat effector molecul host respons viral infect
PLoS Pathog	12167619	2013-11-04	PMC3197621	22028656	sever acut respiratori syndrom viru sarscov lack envelop gene rsarscov attenu vivo identifi factor contribut rsarscov attenu gene express cell infect sarscov gene compar twentyf stress respons gene preferenti upregul infect absenc gene addit gene involv signal transduct transcript cell metabol immunoregul inflamm apoptosi cell cycl differenti differenti regul cell infect rsarscov gene administr protein tran reduc stress respons cell infect rsarscov respiratori syncyti viru treat drug tunicamycin thapsigargin elicit cell stress mechan addit sarscov protein downregul signal pathwai inositolrequir enzym ir unfold protein respons pkrlike er kinas perk activ transcript factor atf pathwai reduc cell apoptosi activ ir pathwai restor cell homeostasi apoptosi induc measur protect host limit viru product dissemin express proinflammatori cytokin reduc rsarscoveinfect cell compar rsarscovinfect cell suggest increas stress respons reduct inflamm absenc gene contribut attenu rsarscov
PLoS One	24191027	2010-06-16	PMC3198457	22039434	the ideal clinic diagnost system deliv rapid sensit specif reproduc minim requir special laboratori facil skill technician describ integr diagnost platform filmarrai fulli autom detect identif multipl organ singl sampl hour unprocess biologicclin sampl subject nucleic acid purif revers transcript highord nest multiplex polymeras chain reaction amplicon melt curv analysi biochem reaction enclos dispos pouch minim pcr contamin risk filmarrai potenti detect greater nucleic acid target time featur system wellsuit molecular detect infecti agent valid filmarrai technolog achiev develop panel assai capabl identifi common viral bacteri respiratori pathogen initi test system cultur organ clinic nasal aspir children demonstr analyt clinic sensit specif compar exist diagnost platform demonstr autom identif pathogen correspond target amplicon accomplish analysi dna melt curv amplicon
BMC Med	20554960	2006-06-14	PMC3198886	21968214	while growth urban worldwid improv live migrant hinterland rais health risk popul densiti concentr poverti transmiss infecti diseas will megac region evolv social infect breed ground rapid transmiss diseas critic spatial entiti protect promot popul health address question pearl river delta region prd base data chines sourc experi york greater london tokyo pari grappl challeng protect popul health provid popul access health care servic respect lesson compar experi prd notabl cover entir popul health care servic target special program highest risk diseas respect prd growth rate sheer scale uniqu megac region face challeng will requir solut
Evid Based Complement Alternat Med	16775348	2016-01-19	PMC3199055	22028733	introduct posttraumat stress disord ptsd accompani poor gener psycholog statu gp studi investig effect chines herbal formula gp earthquak survivor ptsd method random doubleblind placebocontrol trial compar chines herbal formula xiaotanjieyufang xtjyf placebo sichuan earthquak survivor ptsd patient random xtjyf placebo group baselinetoendpoint score chang three global indic symptom checklistrevis sclr rate respons scl global sever gsi primari endpoint subanalysi scl factor sleep qualiti score secondari endpoint discuss compar placebo xtjyf group improv three scl global indic patient xtjyf group report improv placebo group xtjyf group perform better control scl factor somat obsessivecompuls behavior depress anxieti hostil sleep qualiti score xtjyf produc seriou advers event find xtjyf effect safe treatment option improv gp patient ptsd
Vet Res	26787699	2016-01-07	PMC3199250	21982125	in order understand mechan neuroinvas highli pathogen avian influenza viru hpaiv central nervou system cn chicken specif pathogen free chicken inocul hn hpaiv blood cerebrospin fluid csf nasal caviti brain tissu sampl dai postinocul dpi infect control chicken viral antigen topograph distribut presenc influenza viru receptor brain role olfactori rout viru cn invas studi immunohistochemistri techniqu viral rna load csf blood quantifi quantit realtim revers transcriptionpolymeras chain reaction viral antigen observ distribut cn show bilater symmetr distribut nuclei diencephalon mesencephalon rhombencephalon viral rna detect blood csf dpi indic viru cross bloodcsfbarri earli infect earli dissemin favour presenc sia gal sia gal receptor brain vascular endotheli cell sia gal receptor ependym choroid plexu cell viral antigen observ olfactori sensori neuron olfactori bulb weak stain suggest viru pathwai enter brain sequenc viru appear topograph distribut hn hpaiv indic viral entri occur haematogen rout earli gener spread csf
BMC Emerg Med	29769974	2016-08-25	PMC3199257	21982119	background emerg depart globe follow triag system order cope overcrowd intent triag improv emerg care priorit case term clinic urgenc discuss emerg depart triag medic care lead advers consequ delai provid care compromis privaci confidenti poor physicianpati commun fail provid care altogeth decid life save save consequ challeng ethic qualiti emerg care articl ethic analysi routin emerg depart triag principl biomed ethic respect autonomi benefic nonmalefic justic provid start point help identifi ethic challeng emerg depart triag offer comprehens ethic view address ethic issu emerg depart triag comprehens ethic view care ethic perspect offer addit insight summari integr the analysi principl biomed ethic care ethic perspect triag propos integr clinic ethic base framework emerg depart triag plan comprehens ethic perspect incorpor principlesbas careori approach
Ir Vet J	27933788	2005-04-01	PMC3199273	21967764	anim health ireland produc clear guidelin control bovin viral diarrhoea bvd infect irish cattl herd cours develop guidelin clear framework region andor nation bvd control requir increas uptak bvd control farm level reduc preval diseas paper assess econom impact bvd epidemiolog aspect diseas control model bvd control intern experi bvd control programm technic knowledg test technolog exist erad bvd countri embark control diseas identif prompt elimin pi cattl will form basi control programm trade anim curtail pregnant pregnant carri pi foetus pose threat intern experi indic systemat coordin programm success voluntari programm good initi progress ultim fail farm commun bui propos programm support failur bui programm creat demand bvd control farmer inform stem econom loss improv product will primari motiv individu farm level
Virol J	15815038	2015-07-28	PMC3199808	21794150	background airborn virus remain major public health issu worldwid detect quantif airborn virus essenti order provid public health risk assess find studi optim simpl low cost method sampl airborn virus low melt agaros lma plate convent microbi air sampl devic develop lma plate permit direct nucleic acid extract captur virus preliminari elut step molecular detect quantif airborn virus perform realtim quantit rtpcr qrtpcr techniqu method test adenovirus adv norovirus nov gii repres dna rna virus method test outdoor experi detect quantifi human adenovirus hadv airborn environ wastewat treatment plant conclus great advantag lma nucleic acid extract perform directli lma plate elut nucleic acid total free inhibitori substanc coupl qpcr procedur complet three hour
Virol J	31214460	2014-12-31	PMC3200163	21967756	background base previou studi observ relev studi hypothesi antivir activ quercetin rhamnosid qr flavonoid relat abil antioxid method investig effect qr cytopath effect cpe cpe reduct assai product dna fragment reactiv oxygen speci ro induc pedv infect studi dna fragment assai flow cytometri cours studi discov qr extrem potent compound pedv addit qr pedvinfect vero cell directli reduc format visibl cytopath cpe qr induc dna fragment ro increas infect pedv decreas nacetyllcystein nac increas ro decreas qr antivir activ antioxid nac pyrrolidin dithiocarbam pdtc vitamin deriv trolox notic conclus conclud inhibit pedv product qr simpli gener action antioxid highli specif antioxid nac pdtc trolox inact pedv infect
PLoS One	25552712	2009-08-05	PMC3200317	22039436	sever arenavirus viral hemorrhag fever sever diseas casefat rate hospit individu rang limit prophylaxi treatment option medic countermeasur need virus classifi nation institut allergi infecti diseas niaid top prioriti biodefens categori pathogen recombin consensu interferon alpha cifn licens protein broad clinic appeal cifn great therapeut util biodefens applic hinder short vivo halflif mode frequenc administr costli product address limit describ def replicationdefici adenoviru vector drive express cifn pre postexposur prophylaxi acut arenavir infect model hamster intranas administr def prior challeng pichind viru picv highli effect protect anim mortal prevent viral replic liverassoci diseas protect observ singl dose def week prior picv challeng def efficaci administ treatment postviru exposur protect def attribut express cifn dose control empti vector adenoviru protect hamster lethal picv challeng effect countermeasur highli stabl easili administ elicit long last protect immun need arena viral infect def technolog potenti address issu serv broadspectrum antivir enhanc host defens number viral pathogen
PLoS Pathog	19656889	2011-03-23	PMC3203186	22046136	sever virus encod factor promot host mrna degrad silenc gene express unclear cellular mrna turnov pathwai engag assist process kaposi sarcomaassoci herpesviru phenotyp enact host shutoff factor sox soxinduc mrna turnov twostep process mrna cleav intern sox degrad cellular exonucleas xrn sox bypass regulatori step deadenyl decap requir xrn activ sox recruit translat mrna cosedi translat initi complex deplet polysom cleav mrna intermedi accumul fraction indic recognit occur earli stage translat exampl viral protein command cellular mrna turnov pathwai destroi host mrna suggest xrn pois deplet messag undergo translat mammalian cell
PLoS Pathog	21430047	2006-03-14	PMC3203193	22046132	coronavirus cov human anim pathogen induc fatal respiratori gastrointestin neurolog diseas outbreak sever acut respiratori syndrom sar demonstr human vulner coronaviru cov epidem vaccin therapeut human anim cov knowledg host cell protein pivot virushost interact defin broadspectrum antivir target studi system biologi approach emploi genomewid yeasttwo hybrid interact screen identifi immunopilin ppia ppib ppih ppig fkbpa fkbpb interact partner cov nonstructur protein nsp molecul modul calcineurinnfat pathwai plai role immun cell activ overexpress nsp infect live sarscov increas signal calcineurinnfat pathwai enhanc induct interleukin compat latestag immunopathogen longterm cytokin dysregul observ sever sar case convers inhibit cyclophilin cyclosporin cspa block replic cov genera includ sarscov human cove nl felin cov avian infecti bronchiti viru nonimmunosuppress deriv cspa serv broadrang cov inhibitor applic emerg cov ubiquit pathogen human livestock
Proc Biol Sci	16537610	2012-11-01	PMC3203494	21525058	influenza spread human popul multiplewav outbreak success reinfect individu short time interv explicitli report pandem rapid reinfect role reinfect drive multiplewav outbreak remain understood investig issu focu twowav influenza ahn epidem occur remot island tristan cunha dai island experienc attack experienc attack formul mathemat model invok varieti antigen immunolog reinfect mechan maximumlikelihood analysi confront model predict report incid time seri demonstr mechan retain host delai defici humor immun respons primari influenza infect reinfect strain initi second epidem wave mechan support previou empir studi combin genet ecolog advoc better understand account heterogen human immun respons essenti analysi multiplewav influenza outbreak pandem plan
Viruses	23077141	2018-01-11	PMC3205387	22069521	we develop felin model lentivir crossspeci transmiss puma lentiviru plv fivpco infect domest cat diseas infect plv protect cat cd tcell declin caus subsequ infect virul felin immunodefici viru fiv previou studi implic innat immun andor cellular restrict mechan fiv diseas attenu plvinfect cat studi evalu viral infect cytokin mrna transcript tissu reservoir month post infect quantit tissu provir load viral mrna load rel transcript il ilp ifn tissu cat expos fiv plv virus analyz paramet multivari statist approach distribut intens fiv infect ifn transcript differ singl coinfect cat character higher fiv provir load ifn express coinfect cat tissu variabl fiv mrna load ifn constrain coinfect versu singli infect cat tissu singleinfectedcoinfect ratio fiv mrna load compar fiv provir load indic activ viral transcript inhibit coinfect indic previou plv infect increas activ tissu innat immun constrain abil fiv product infect tissu reservoir infect month independ fiv provir load support model innat immun andor modul target cell suscept plai kei role plvinduc protect fiv diseas
Viruses	29322882	2013-10-16	PMC3205390	22069524	frog viru fv best character member famili iridovirida fv studi provid insight replic famili member serv model viral transcript genom replic virusmedi hostshutoff broad outlin fv replic elucid precis role viral protein remain unknown current studi knock kd mediat antisens morpholino oligonucleotid asmo small interf rna sirna knock ko replac target gene select marker homolog recombin ectop viral gene express recombin viral protein enabl research systemat ascertain replic virulencerel gene function addit applic molecular tool ecolog studi provid novel wai field biologist identifi potenti pathogen quantifi infect trace evolut ecolog viral speci review summar current studi fv iridovirus infect ectotherm describ gener principl ascertain fv serv model famili studi util ranavirus megalocytivirus confirm extend understand iridoviru replic collect futur effort will elucid molecular event viral replic intrins extrins factor contribut diseas outbreak role host immun system protect diseas
Vet Med Int	24498542	2014-12-01	PMC3206505	22135772	newli emerg infecti diseas neid increas rapidli present alarm challeng global health argu effect manag global health basic strategi includ three essenti tactic form action directli focus natur institut coordin disciplinari integr approach health manag level action illustr exampl livestock sector asia clear exampl three tactic form place develop countri food secur threat vietnam develop comprehens strategi final ecosystem health approach global health manag advoc approach move tradit singl disciplinari approach stronger guidanc need direct ecohealth applic manag global health
PLoS One	25343382	2006-05-01	PMC3206854	22073191	recent advanc highthroughput technolog gener gene protein sequenc data unpreced rate scale enabl entir omicsbas approach analysi complex biolog process amount complex data singl experi produc serious challeng research limit bioinformat expertis handl analyz interpret data understood biolog context unmet tool allow nonbioinformat user interpret larg data set develop method nnalign gener applic biolog problem quantit peptid data method effici identifi underli sequenc pattern simultan align peptid sequenc identifi motif associ quantit readout provid webbas implement nnalign allow nonexpert endus submit data option adjust method paramet return receiv train method includ visual represent identifi motif subsequ predict method appli unknown proteinspeptid appli method data set includ peptid microarrayderiv set data point nnalign onlin httpwwwcbsdtudkservicesnnalign
PLoS One	16827414	2019-05-28	PMC3206940	22073294	background coronavirus cov classifi alphacoronaviru group betacoronaviru group gammacoronaviru group base divers protein sequenc clike proteas clpro catalyz proteolyt process polyprotein viral replic potenti target anticoronavir infect methodologyprincip find profil substrat specif clpro human cov nl group human cov oc group sever acut respiratori syndrom coronaviru sarscov group infecti bronchiti viru ibv group measur activ substrat librari of variant singl substitut posit correl structur properti side chain volum hydrophob secondari structur propens substitut residu clpro prefer gln posit leu posit basic residu posit small hydrophob residu posit small residu p posit despit clpro group cov share similar substrat specif differ substrat specif observ posit ibv clpro prefer ppro sarscov clpro prefer pval combin favor residu posit identifi superact substrat sequenc varlqsgf cleav effici clpro rel activ vprlqsgf cleav ibv clpro rel activ conclusionssignific comprehens substrat specif clpro group cov profil studi provid insight ration design broadspectrum peptidomimet inhibitor target proteas
BMC Res Notes	31138703	2010-04-09	PMC3208482	22011414	background develop dna resequenc microarrai includ mitochondri dna mtdna sequenc mutat detect failur microarrai identifi base compar refer sequenc design ncall studi reexamin ncall distribut mtdna sampl sequenc affymetrix mitochip base hypothesi ncall repres insert delet indel mtdna find analys patient mtdna sampl mitochip ncall proprietari gseq softwar reduc freewar onlin algorithm resqmi sprofil util sprofil decreas ncall homoplasm heteroplasm mutat level compar gseq softwar resqmi produc chang mutat load produc longer ncell stretch reason analysi resqmi attempt convent dna sequenc longer ncall stretch sprofil reveal insert point mutat analysi singlebas ncall mtdna sampl point mutat conclus studi analys ncall produc gseq softwar mitochipv narrow focu longer stretch ncall reveal sprofil convent sequenc identifi uniqu insert point mutat shorter ncall harbour point mutat absenc delet ncall suggest probe confirm bind ncall studi support content gseq capabl assign base conjunct sprofil
BMC Infect Dis	20382757	2018-08-10	PMC3210101	22023788	background tuberculosi tb remain health problem roma popul serbia studi highlight increas awar tb reduc associ stigma reduc incid tb enabl earlier diagnosi effect treatment studi investig knowledg belief transmiss symptom treatment tb attitud patient tb roma popul belgrad method focusgroup method consid appropri investig knowledg belief tb total roma peopl ag year particip three focusgroup discuss particip knew tb pulmonari diseas contagi saliva commonli mention mode transmiss individu thought albeit hesitantli tb transmit shake hand infect individu factor contribut tb particip mention bad live condit low qualiti lack food stress particip quot chest pain cough haemoptysi loss appetit loss weight weak sweat basic symptom tb particip believ effect treatment includ rest prescrib medicin inhal fresh air eat strong food bacon pork approach consid antibiot addit particip mention folk medicin rel friend lesser extent televis main sourc tb particip appreci person contact doctor sourc conclus conclud particip awar serious tb mode transmiss misconcept find confid doctor express roma peopl
Mar Drugs	30097535	2012-10-31	PMC3210601	22072992	four tetromycin deriv tetromycin tetromycin isol streptomyc axinella polt cultiv mediterranean spong axinella polypoid structur assign extens d nmr spectroscopi hresim analysi compound test antiparasit activ leishmania major trypanosoma brucei proteas inhibit cystein proteas falcipain rhodesain cathepsin cathepsin viral proteas sarscov mpro plpro compound antiparasit activ brucei timedepend inhibit cathepsin llike proteas ki valu low micromolar rang
PLoS One	23115293	2003-08-01	PMC3210785	22087287	n previou studi canin coronaviru type ii ccovii activ extrins intrins apoptot pathwai canin fibrosarcoma cell cell investig role sirtuin forkhead box foxo famili experiment model nortern blot western blot analysi demonstr mitochondri sirt sirt protein express increas post infect pi onward nuclear sirt express increas pi decreas pi reach level control pi sirtuin interact withand regul activ foxo famili protein observ foxoa foxo express increas stabli pi onward addit ccovii induc remark increas express tnfrelat apoptosisinduc ligand trail observ slight upregul faslfa pi decreas protein infect viru infect increas bax transloc mitochondria decreas bcl express cytosol timedepend manner data foxo transcript factor mediat proapoptot effect ccovii activ extrins apoptosi pathwai sirtuin famili member sirt sirt involv intrins apoptot pathwai propos trail mediat cell death induc ccovii vitro infect
BMC Immunol	12885985	2006-12-01	PMC3212807	22011168	background balanc function proantiinflammatori mediat complex innat respons investig varieti experiment inflammatori set annexina anxa mediat endogen antiinflamm afford regul leukocyt traffick activ context role lung patholog scarc investig despit highli express lung cell appli bleomycin lung fibrosi model anxa null mice dai timecours monitor potenti impact mediat control inflammatori fibrot phase analys wildtyp mice reveal strict spatial tempor regul anxa gene upregul epitheli cell infiltr granulocyt dai augment protein level alveolar macrophag dai absenc anxa caus increas degre inflamm dai ii index fibrosi assess deposit hydroxyprolin lung dai alter anxa null mice parallel augment tgf ifn tnf gener compar wildtyp mice final treatment wild type anim anxa peptidomimet prophylact dai therapeut dai onward amelior sign inflamm fibrosi conclus collect data reveal pathophysiolog relev endogen anxa lung inflamm importantli fibrosi open insight pharmacolog treatment lung fibrosi
Virol J	17145913	2008-06-30	PMC3212826	22029605	human enteroviru ev infect hand foot mouth diseas children year infect occasion induc sever neurolog complic vaccin drug clinic control ev epidem studi treatment lycorin reduc viral cytopath cpe rhabdomyosarcoma cell inhibit viru replic analysi inhibitori lycorin viral protein synthesi suggest lycorin block elong viral polyprotein translat lycorin treatment mice challeng lethal dose ev reduct mortal clinic score patholog chang muscl mice achiev inhibit viral replic mice infect moder dose ev lycorin treatment protect paralysi lycorin potenti drug candid clinic treatment evinfect patient
Virol J	18587411	2012-05-23	PMC3212842	22032619	background three year suspect poultri farm provinc china diagnos avian infecti bronchiti ib survei final ibv strain confirm dwarf embryo test rtpcr assai viru recoveri trial isol caus bird di distress nephriti accord clinic record base epidemiolog analysi field isol nephropathogen ib vaccin farm china yl strain vaccin evalu antibodi titer challeng test immunoprotect test indic practic applic vaccin base field strain fine facilit control nephropathogen ib conclus studi aim set guid safeguard nephropathogen ibvcaus diseas china
BMC Med Genet	22623799	2008-04-30	PMC3213239	22013876	background antisens oligom induc exon skip aim reduc sever duchenn muscular dystrophi redirect splice prerna process caus mutat bypass shorter partial function becker muscular dystrophylik dystrophin isoform produc normal exon gener target restor dystrophin read frame appreci subset dystrophin mutat intraexon potenti compromis oligom effici necessit personalis oligom design patient antisens oligom easili personalis remain unclear patient polymorph antisens oligom target sequenc will requir costli process produc valid patient specif compound method report preclin test panel splice switch antisens oligom design excis exon dystrophin transcript normal dystroph patient cell patient cell harbour singl base insert exon li target sequenc oligom effect remov exon anticip mutat compromis oligom bind effici despit mismatch oligom design optimis excis exon normal dystrophin mrna remov mutat exon effici mutationspecif oligom conclus rais possibl mismatch ao therapeut applic case negat necess produc patientspecif compound
BMC Bioinformatics	18448543	2012-10-10	PMC3213686	21679460	background develop extend opensourc loopmedi isotherm amplif lamp signatur design program call lava lamp assai versatil analysi lava creat respons limit exist lamp signatur program lava identifi combin primer region basic lamp signatur combin primer region lamp signatur loop primer lamp signatur identifi primer conserv target organ sequenc primer combin optim base length melt temperatur space primer site compar lamp signatur candid staphylococcu aureu creat lava primerexplor includ signatur sampl target strain mycobacterium tuberculosi conclus design demonstr softwar identifi signatur candid appropri lamp assai softwar download httplavadnagooglecodecom
PLoS One	23055554	2018-05-25	PMC3214059	22096568	antibodi repertoir librari construct convention harvest mrna immun cell examin germlin rearrang immunoglobulin ig variabl region gene sourc antibodi repertoir immun phagedisplai scfv librari prepar splenocyt genom dna templat addit novel frameshift pcr fspcr step introduc rescu codon enhanc divers complementaritydetermin region cdr germlin scfv librari initi character hapten antigen phenyloxazolon phox sequenc analysi phoxselect scfv indic cdr consist novel conserv motif order illustr divers cdr increas fspcr step second scfv librari construct singl scfv clone lgc templat despit show bind characterist phox scfv clone lgcderiv antibodi librari lower nonspecif bind parent lgc clone determin germlin librari repres endogen immun statu specif scfv clone nucleocapsid protein sarsassoci coronaviru scov nave immun germlin scfv librari librari yield specif antin scfv exhibit bind characterist recombin protein immun librari larger number specif antin scfv clone ident nucleotid sequenc conclus highli diversifi antibodi librari effici construct germlin rearrang immunoglobulin variabl gene sourc antibodi repertoir fspcr diversifi cdr
PLoS One	29802199	2018-03-01	PMC3214079	22096610	background vaccin develop malaria complex diseas remain challeng scientif commun elucid genom proteom transcriptom of complex pathogen basi ration vaccin design identifi proteomewid scale novel target antigen recogn cell antibodi expos individu current algorithm effect identifi target antigen genom sequenc data challeng cell target pathogen plasmodium protein express convent platform problemat cellfre vitro transcript translat ivtt strategi prove success report novel approach proteomewid scale identif antigen target cell respons ivtt product princip find conduct seri vitro vivo experi ivtt protein unpurifi absorb carboxyl polybead affin purifi nickel resin magnet bead vitro studi human cmv ebv influenza viru protein antigenspecif cytokin product elispot cytometr bead arrai assai cell stimul purifi unpurifi ivtt antigen vitro vivo studi mice immun plasmodium yoelii circumsporozoit dna vaccin ivtt protein boost antigenspecif cytokin product purifi ivtt antigen nickel resin method ivtt antigen purif prove optim human murin system conclus work proof concept potenti highthroughput approach identifi cell target complex parasit viral bacteri pathogen genom sequenc data ration vaccin develop emerg reemerg diseas pose threat public health
Clin Dev Immunol	29278789	2012-03-20	PMC3216312	22110538	follow hn pandem ongo sporad aviantohuman transmiss hn virus emphasi better understand determin pathogenesi sever influenza infect current literatur focus viral genet impact host immun novel risk factor sever infect hn pandem understand host genet determin suscept sever respiratori ill current lack better defin role genet variabl influenza infect identifi kei polymorph impair host immun respons correl protect will better identifi atrisk popul target therapeut intervent vaccin paper will summar immunogenet factor associ suscept sever phn hn infect will identifi genet pathwai polymorph high relev futur studi
Int J Hypertens	22356166	2002-06-15	PMC3216391	22121476	the reninangiotensin system ra critic regul hypertens action vasoact peptid ang ii gener action angiotensinconvert enzym ac mediat increas blood pressur discoveri ac metabolis ang ii vasodilatori ang dimens tradit ra result huge interest ac decad potenti therapeut lower blood pressur elev excess ang ii studi focus ac help reveal action ang vasodil antifibrot antiprolif effect investig focus ac reveal varieti role catalyt viral receptor amino acid transport paper focus ac biolog role pai attent regul ac express light entranc human recombin ac clinic trial discuss potenti ac therapeut highlight pertin question remain unansw ac
PLoS One	12021344	2015-08-28	PMC3217956	22110607	object test incid common cold colleg student china associ ventil rate crowded dormitori method phase studi crosssect studi student live dorm room build respond questionnair incid durat common cold previou month phase ii air temperatur rel humid concentr measur hour dorm room build summer winter outto indoor air flow rate night calcul base measur concentr phase colleg student report incid common cold previou month report infect last week student person dorm room time incid common cold time year durat week compar student person room phase ii measur dorm room outto indoor air flow rate chines standard ls person heat season doserespons relationship outto indoor air flow rate person dorm room proport occup annual common cold infect time ventil rate lsperson dorm build associ report common cold time compar lsperson conclus crowd dormitori low outto indoor airflow rate associ respiratori infect colleg student
Genome Biol	26320212	2006-12-07	PMC3218861	21477297	we optim probe design copi number variat cnv snp genotyp plasmodium falciparum genom demonstr variabl length isotherm probe superior static length probe sampl prepar hybrid condit mitig effect host dna contamin field sampl microarrai workflow present identifi cnv snp accuraci singl hybrid field sampl human dna contamin
PLoS Genet	17156499	2001-09-01	PMC3219607	22125497	knowledg distribut mutat fit effect dmfe essenti evolutionari model year properti dmfe carefulli describ microorgan case singl environ studi explor environment variat dmfe environment effect relev evolut multihost parasit emerg pathogen character dmfe collect twenti singlenucleotid substitut mutant tobacco etch potyviru tev set host environ host speci natur infect tev belong famili solanacea three partial suscept host belong three plant famili viru genotypebyhost speci interact sustain differ genet varianc fit pleiotrop mutat host second dmfe markedli solanacea nonsolanacea host exposur tev genotyp nonsolanacea host led larg reduct viral fit varianc remain constant skew increas tail solanacea host distribut contain excess deleteri mutat nonsolanacea fraction benefici mutat larger result suggest tev easili broaden host rang improv fit host knowledg dmfe natur host allow make predict properti altern host
Virol J	11483763	2012-04-11	PMC3219666	21951835	background felin coronaviru compris pathogen biotyp consist felin infecti periton viru fipv felin enter coronaviru fecv divid serotyp examin preval korean cat infect felin coronaviru fcov type ii fecal sampl cat pet feral fourteen cat fcovposit includ infect type fcov type ii fcov type ii coinfect low seropreval fcov identifi chronic cat healthi cat conclus preval fcov infect high comparison countri higher preval type fcov korean felin preval fcov antigen antibodi korean cat expect gradual increas rise number strai companion cat
PLoS Pathog	22494341	2017-10-01	PMC3219706	22114553	sinc case fever thrombocytopenia leukopenia syndrom ftl emerg henan provinc china patient report tick bite suggest infect contribut ftl ticktransmit microbi pathogen test pcrrtpcr andor indirect immunofluoresc assai ifa sampl collect test posit human granulocyt anaplasmosi hga suggest pathogen involv unbias metagenom approach screen survei microb associ ftl blastx analysi deduc protein sequenc reveal novel bunyaviru ident tehran viru access hq sera ftl patient phylogenet analysi close uukuniemi viru phleboviru genu viru distinct candid viru examin associ ftl sampl collect henan provinc rtpcr viral cultur seroepidemiolog survei undertaken rtpcr acutephas serum sampl contain viral rna patient pair acut convalesc sera serolog evid infect seroconvers exhibit fold increas antibodi titer viru viru isol patient acutephas serum sampl name henan fever viru hnf viru wholegenom sequenc confirm viru novel bunyaviru genet similar bunyavirus close uukuniemi viru maximum ident segment maximum queri coverag releas genbank sequenc sftsv ident ident novel bunyaviru hnf viru correl ftl
PLoS Pathog	28901902	2016-01-06	PMC3219726	22114563	follow infect central nervou system cn immun system face challeng elimin pathogen caus damag neuron limit capac renew thought neuron protect direct attack cytotox lymphocyt ctl express major histocompat class mhc molecul steadi state current knowledg specif neuronctl interact base studi artifici induc mhc express neuron load exogen peptid appli ctl clone line differenti cultur remain uncov modal interact infect neuron antivir cd cell cours natur diseas model neuroinflamm caus neurotrop borna diseas viru bdv virusspecif ctl demonstr main immun effector trigger diseas test pathogen properti brainisol cd cell pure neuron cultur infect bdv observ bdv infect cortic neuron trigger regul mhc molecul render suscept recognit antivir ctl freshli isol brain acut infect rat realtim imag analyz spatiotempor relationship neuron ctl brainisol ctl exhibit reduc mobil establish stabl contact bdvinfect neuron antigen mhcdepend manner interact induc rapid morpholog chang neuron kill impair electr activ earli sign neuron apoptosi detect hour initi contact infect neuron recogn effici brainisol antivir cd cell uncov unusu modal ctlinduc neuron damag
Ir Vet J	26739058	2005-07-13	PMC3220626	22018053	calfhood diseas major impact econom viabil cattl oper three review seri develop focus calf health birth wean paper the three seri review diseas prevent manag refer pneumonia focus prewean calf pneumonia wean suckler calv consid kei risk factor time wean wean suckler calf combin addit stressor includ chang nutrit environment chang transport pain husbandri procedur castrat dehorn reduct cumul effect multipl stressor time wean vaccin programm precondit reduc subsequ morbid mortal feedlot studi calv hous individu calv hous outdoor shelter associ decreas risk diseas pose greater manag challeng success group hous calv special emphasi equal ag group keep group stabl form manag pneumonia calv reliant sound understand aetiolog relev risk factor effect approach diagnosi treatment earli sign pneumonia includ increas respiratori rate fever depress singl factor determin success therapi calv pneumonia earli onset treatment subsequ adequ durat treatment efficaci econom viabil vaccin respiratori diseas calv remain unclear
PLoS One	16014971	2012-09-16	PMC3222642	22132172	background major influenza transmiss occur home school workplac frequent touch commun item situat transmiss fomit unclear data exist surviv viru commonli touch surfac measur viabil time hn influenza strain appli varieti materi commonli household workplac methodolog princip find influenza apuertorico pr acambridgeaho pandem hn virus inocul wide rang surfac work environ sampl set time incub stabilis temperatur humid viru genom measur rtpcr plaqu assai pr fluoresc focu format pandem hn assess surviv viabl viru conclusionssignific genom viru detect surfac applic drop copi number except unseal wood surfac contrast viru viabil drop rapidli live viru recov surfac test hour applic nonpor materi hour fallen level detect surfac conclud influenza transmiss fomit occur long period surfac contamin reinocul occur situat involv high probabl influenza transmiss data hierarchi prioriti surfac decontamin multisurfac environ hospit
J Med Case Reports	22894960	2019-06-01	PMC3223529	22018019	introduct media sensation hn outbreak influenc decision process clinic diagnosi case present report case patient present coexist hn viru legionella infect yearold caucasian man yearold caucasian woman case sign symptom includ vomit progress respiratori diseas lead respiratori failur refractori hypoxemia leukopenia lymphopenia thrombocytopenia elev level creatin kinas hepat aminotransferas consist critic ill hn viru infect infecti disord mimic hn viral infect legionnair diseas swine flu hn pandem occur autumn itali legionnair diseas highli suspect peak incid occur earli fall suspicion legionella infect base clinic histori xrai abnorm fundament success resolut conclus case report patient hn screen legionella current common practic sign symptom infect similar
Pan Afr Med J	31160479	2017-04-03	PMC3224071	22187606	as subsaharan africa inhabit live numer public health challeng public health initi unit state presid emerg plan aid relief presid malaria initi success reduc mortal prioriti diseas compet train public health workforc oper multidiseas surveil respons system build sustain success address public health problem subsaharan africa appear weather global econom downturn remark increas middl class demand stronger public health system protect commun epidem intellig servic ei program center diseas control prevent cdc backbon public health surveil respons year exist ei adapt internation creat field epidemiolog train program fetp countri cdc rockefel foundat collabor uganda zimbabw ministri health local univers creat year public health school wall phswow base fetp model fetp model adapt creat field epidemiolog laboratori train program feltp kenya conduct joint competencybas train field epidemiologist public health laboratori scientist provid master degre particip complet feltp model implement addit countri subsaharan africa feltp phswow cover peopl subsaharan africa enrol public health profession describ process develop feltp cover countri subsaharan africa strategi develop local train public health workforc oper multidiseas surveil respons system
BMC Res Notes	28373566	2003-07-01	PMC3224397	21955389	background outbreak respiratori ill caus influenza hn viru occur worldwid patient requir intens care unit icu admiss noninvas ventil niv patient controversi aerosol dispers contamin environ healthcar cowork method describ respiratori profil mortal rate benefit niv patient confirm diagnosi influenza ahn admit icu year total case influenza hn confirm hospit realtim rtpcr patient admit icu patient ag rang year median acut respiratori failur arf patient median acut physiolog chronic health evalu ii score rang patient develop arf need niv need invas mv admiss success rate niv higher describ hospit mortal rate influenza hn arriv brazil diseas endem alert countri popul awar symptom healthcar system treatment allow patient properli treat influenza hn healthcar worker protect measur avoid contamin conclus studi high success low mortal rate noninvas ventil patient influenza hn
Adv Prev Med	12819288	2014-04-02	PMC3226423	22162813	health care facil ventil design greatli diseas transmiss aerosol desir control infect hospit time reduc carbon footprint motiv unconvent solut build design associ control measur paper consid indoor sourc type infecti aerosol pathogen viabil infect behavior respons environment condit aerosol dispers heat mass transfer deposit respiratori tract infect mechan discuss emphasi experiment model approach kei build design paramet describ includ type ventil system mix displac natur hybrid air exchang rate temperatur rel humid air flow distribut structur occup engin disinfect air filtrat uv radiat architectur program sourc activ manag health care facil paper describ major find suggest futur method ventil design health care facil prevent airborn infect risk
PLoS One	24696472	2018-10-15	PMC3226564	22140457	aberr activ caspas emerg major contributor pathogenes neurodegen disord alzheim huntington diseas commerci assai measur caspas activ commonli veid peptid substrat method suit assess caspas activ presenc confound proteas activ encount cell tissu sampl report develop method overcom limit protein substrat lamin highli specif caspas cleavag amino acid neoepitop antibodi cleav lamin develop electrochemiluminescencebas elisa assai suitabl detect quantifi caspas activ highli apoptot cell extract method sensit veidbas assai adapt highcont imag platform highthroughput screen method screen character caspas inhibitor compound intervent decreas intracellular caspas activ applic neurodegen disord
Clin Dev Immunol	30322911	2009-03-01	PMC3227431	22162720	the human zona pellucida glycoprotein hzp virtu critic role fertil propos promis candid antigen develop contracept vaccin direct imper map minim motif cell epitop bce avoid zpspecif oophoritogen cell epitop tce zpbase immunogen studi base map marmoset bonnet monkei zp mstzp bmzp predict epitop hzp confirm minim motif epitop hzp defin serum recombin hzpa hzpb biosynthet peptid strategi defin minim motif qplwll hzp mqvtdd hzp eenw hzp snswf egp hzp antigen peptid hzp hzp specif antibodi respons peptid evalu produc hightit antibodi immun anim capabl react zp human oocyt rhzpb protein rhzp rhzp rhzp epitop peptid fuse truncat gst protein
PLoS One	19258537	2005-08-15	PMC3227585	22164200	member tolllik receptor tlr gene famili occupi kei role mammalian innat immun system function sentri detect invad pathogen provok host innat immun respons util custom nextgener sequenc approach allelespecif genotyp assai detect valid biallel variant bovin tlr gene includ nonsynonym singl nucleotid polymorph snp put nonsens snp bayesian haplotyp reconstruct median join network reveal haplotyp share bo tauru tauru bo tauru indicu breed locu special beef dairi breed differenti despit averag polymorph densiti marker bp collect tagsnp tag insertiondelet mutat indel suffici predict variat variabl site bo subspeci hybrid tagsnp tagindel predict captur variat variabl site tauru polyphen sift analys amino acid aa replac encod bovin tlr snp indic aa substitut expect impact protein function classic newli develop test divers provid strong support balanc select oper tlr tlr purifi select act tlr investig persist continu linkag disequilibrium adjac variabl site support presenc select act tlr tlr casecontrol studi emploi valid variant bovin tlr gene recogn bacteri ligand reveal snp elicit small effect suscept mycobacterium avium spp paratuberculosi infect dairi cattl studi will broadli impact domest cattl provid foundat explor avenu bovin translat genom potenti markerassist vaccin
PLoS One	16103198	2018-11-01	PMC3227592	22140483	despit effect combin antiretrovir treatment cart hiv evid indic residu infect persist cell type intensif cart decreas residu viral load immun activ cart restrict synthesi infecti viru curtail hiv transcript translat integr unintegr viral genom infect cell treat patient full viral suppress lowlevel viremia treat individu develop minor hiv associ neurocognit deficit hand residu viru immun activ therapeut agent need curtail hiv transcript residu viru studi luteolin dietari supplement profoundli reduc hiv infect report cell primari lymphocyt hivinhibit luteolin independ viral entri fact wildtyp vsvpseudotyp hiv infect inhibit luteolin unabl inhibit viral revers transcript luteolin antivir activ latent hiv reactiv model effect ablat cladeb tatdriven ltr transactiv report assai tat express subcellular local conclud luteolin confer antihiv activ tat function level biosafeti profil abil cross bloodbrain barrier luteolin serv base flavonoid develop potent antihiv deriv complement cart
PLoS One	30252528	2014-05-20	PMC3227604	22140516	the worldwid spread hn avian influenza increas report resist current drug high prioriti develop antiinfluenza drug uniqu function assist virus bind cellular surfac kei step subsequ penetr infect cell hemagglutinin ha main target drug design influenza viru develop potent ha inhibitor zinc fragment databas search find optim compound core hop techniqu result neo compound subsequ molecular dock studi molecular dynam simul neo assum favor conform bind pocket ha stronger bind interact receptor neo promis candid develop power drug treat influenza find report provid insight stimul strategi area
PLoS One	24847143	2007-09-01	PMC3227611	22140523	bat harbor highli pathogen zoonot virus includ rabi marburg henipavirus overt clinic symptom anim suspect bat evolv effect mechan suppress viral replic investig interferon ifn respons induct secret signal epitheliallik cell relev abund african fruit bat speci eidolon helvum helvum immort cell line gener potenti induc react ifn confirm biolog assai adapt applic bat cell cultur enabl comparison landmark ifn properti common mammalian cell line helvum cell fulli capabl react viral artifici ifn stimuli helvum cell highest ifn mrna induct highli product ifn protein secret evid effici ifn stimul gene induct alphaviru infect model onyongnyong viru exhibit strong ifn induct evad ifn respons translat transcript shutoff alphaviru infect novel ifncompet cell line will allow compar zoonot batborn virus order model mechan viral mainten emerg bat reservoir
PLoS One	17767687	2007-02-01	PMC3227662	22140536	the infect virus neighbor cell consid benefici term evas host antiviru defens system pathwai viral infect door viru transmiss cellcel fusion form syncytium product progeni virion mediat virion viru diffus gener design celltocel transmiss influenza virus believ transmit cellfre viru infect cell uninfect cell demonstr influenza viru util celltocel transmiss pathwai apic membran handov virion surfac infect cell adjac host cell live cell imag techniqu recombin influenza viru neuraminidas gene replac green fluoresc protein gene spread infect cell adjac cell form infect cell cluster type viru spread requir ha activ proteas treatment celltocel transmiss block amantadin inhibit acidif endosom requir uncoat influenza viru particl endosom indic function hemagglutinin endosom acidif ion channel essenti celltocel influenza viru transmiss celltocel transmiss influenza viru progeni virion remain associ surfac infect cell bud progeni virion pass adjac uninfect cell evid celltocel transmiss occur influenza viru lead caution local infect proce treat neuraminidas inhibitor
Interdiscip Perspect Infect Dis	17255311	2011-07-12	PMC3228346	22162687	by definit zoonot pathogen strict hostspeci specialist infect human nonhuman reservoir speci major zoonot pathogen infect amplifi multipl vertebr speci natur quantit impact distribut abund pathogen diseas risk zoonot pathogen emerg domin respons public health scientist search singl reservoir ignor speci influenc transmiss focu singl primari reservoir host speci delai biolog understand public health intervent speci amplifi regul pathogen overlook investig evolutionari ecolog strategi newli discov emerg pathogen commun potenti actual host speci will fruit biolog understand public health
PLoS One	21749228	2016-07-01	PMC3229576	22164298	sever acut respiratori coronaviru sarscov emerg roughli case worldwid mortal anim reservoir sarscov precursor exist likelihood futur outbreak human popul high sarscov papainlik proteas plp attract target pharmaceut develop essenti viru replic conserv human coronavirus yeastbas assai establish plp activ reli abil plp induc pronounc slowgrowth phenotyp express cerevisia induct slowgrowth phenotyp place hour time cours provid basi conduct screen small molecul restor growth inhibit function plp chemic suppressor slowgrowth phenotyp identifi member nih divers set librari nsc potent inhibit sarscov replic cell cultur toxic effect cell inhibit sarscov replic influenza viru replic nsc plp proteas deubiquitinas antiinterferon activ investig compound alter activ suppressor nsc demonstr abil inhibit plp proteas activ cellbas assai identif inhibitor demonstr strong function connect plpbase yeast assai inhibitori compound sarscov biologi data nsc novel mechan inhibit sarscov replic involv unknown activ plp altern direct cellular target modifi bypass plp function yeast mammalian cell
PLoS One	27373336	2006-10-18	PMC3229585	22164286	object purpos studi examin chang health statu china adult popul year rapid econom growth medic system improv method data third fourth chines nation health servic survei cover resid resid ag year analyz chines respond report diseas smoke decreas men women regular exercis improv stratifi analys reveal subpopul dispar rate ratio presenc chronic diseas greater increas women elderli han nation unmarri widow illiter rural region east china group conclus chines adult wors health statu in term presenc chronic diseas china reform health care will face complex challeng come year deterior health statu chines adult
PLoS One	17050611	2015-01-01	PMC3229600	22164304	hcv infect major chronic liver diseas liver cancer unit state address pathogenesi caus hcv infect studi focus direct cytopath effect individu hcv protein object identifi specif role pathogenesi approach preclud examin interact hcv protein organel better understand cytopath effect cellular respons hcv protein human hepatoma cell constitut replic hcv rna encod fulllength polyprotein nonstructur protein cell constitut express structur protein core model state persist hcv infect examin combin hcv protein cellular pathogenesi increas reactiv oxygen speci ro gener mitochondria mitochondri injuri degener increas lipid accumul common hcv proteinexpress cell express structur nonstructur protein express nonstructur protein led increas oxid stress cytosol membran bleb endoplasm reticulum accumul autophagocyt vacuol alter cellular redox state hand chang level autophagi suggest direct link oxid stress hcvmediat activ autophagi widespread cytopath effect cell fulllength hcv polyprotein modest antioxid respons exhibit increas popul doubl time concomit decreas cyclin contrast cell express nonstructur protein launch vigor antioxid respons upregul antioxid enzym popul doubl time cyclin level compar control cell final cytopath effect core protein appear focu mitochondria remark disturb cytosol
Aging (Albany NY)	25844070	2013-06-30	PMC3229973	21990137	a distinct conform transit helixrich cellular prion protein prpc sheetrich patholog isoform prpsc hallmark prion diseas group fatal transmiss encephalopathi includ spontan acquir form prpsclike intermedi form character format insolubl aggreg proteaseresist prp speci term insolubl prpc iprpc identifi uninfect mammalian brain cultur neuron cell provid insight molecular mechan diseas explor molecular characterist spontan form iprpc cultur neuroblastoma cell express wildtyp mutant human prp link famili prion diseas observ prp mutat residu thr ala prpta residu phe ser prpf glycosyl nlink glycosyl site ta mutat intracellular retent increas format iprpc autophagi increas fs cell decreas ta cell indic iprpc form intracellular compart increas prpta aggreg attribut inhibit autophagi
PLoS One	23812210	2012-06-13	PMC3230622	22163042	the nairovirus group tickborn virus includ pathogen man crimean congo hemorrhag fever viru livestock anim dugb viru nairobi sheep diseas viru nsdv nsdv larg part east africa indian subcontin ganjam viru investig abil nsdv antagonis induct action interferon pathogen apathogen isol activ inhibit induct type interferon block signal pathwai type type interferon transient express viral protein section viral protein activ map ovarian tumourlik proteas domain otu viral rna polymeras viru infect express otu domain transfect cell led great reduct incorpor ubiquitin isg protein host cell protein point mutat otu inhibit proteas activ prevent antagonis interferon induct action interestingli mutat peripher site appar abil otu inhibit ubiquitin isgyl remov abil otu block induct type action type interferon lesser abil block type interferon action suggest target ubiquitin isg involv action viral otu
PLoS One	22696521	2014-07-23	PMC3230632	22162996	the interest broadrang antiinfluenza monoclon antibodi mab strengthen identif antihemagglutinin ha mab endow heterosubtyp neutral activ design univers prophylact therapeut tool major singl mab describ bind neutral viral isol belong highli diverg subtyp cluster habas influenza phylogenet group group includ subtyp h h group includ subtyp describ human mab name pnsia capabl bind neutral test isol belong phylogenet group includ hn hn hn hn subtyp isol belong group includ hn isol period pandem pnsia capabl neutral isol belong subtyp respons report pandem subtyp pandem potenti region recogn pnsia identifi stem region ha includ residu highli conserv influenza subtyp deep character pnsia featur repres help improv antiinfluenza therapeut strategi provid tool develop univers vaccin strategi
Viruses	25055998	2004-11-09	PMC3230854	22163347	as intracellular parasit virus requir host cell order replic face seri cellular respons infect respons activ doublestrand rna dsrnaactiv protein kinas pkr pkr phosphoryl subunit eukaryot translat initi factor eif turn global protein synthesi inhibit format stress granul sg studi sg interfer replic cycl virus review address virus evolv control strategi sg level ensur effici replic cycl cellular stress respons trigger viral infect
Sensors (Basel)	15534303	2012-09-10	PMC3231440	22163925	microfluidicsbas labonchip loc system activ area revolutionis highthroughput sequenc fast sensit accur detect varieti pathogen loc serv portabl diagnost tool devic provid optimum control nanolitr volum fluid integr bioassai oper allow devic rapidli sens pathogen threat agent environment monitor loc system microfluid biochip offer advantag compar convent identif procedur tediou expens time consum paper aim provid broad overview devic easi oper sensit fast portabl reliabl complementari tool control pathogen agent damag environ
Microb Cell Fact	22966194	2006-09-01	PMC3231930	21995317	foodgrad lactic acid bacteria lab safe consum centuri human ferment food good candid develop novel oral vector constitut attract altern attenu pathogen mucos deliveri strategi review summar lab mucos deliveri vector therapeut protein dna vaccin work base model lab lactococcu lacti develop effici genet tool includ express signal host strain heterolog express therapeut protein antigen cytokin enzym recombin lactococci strain test prophylact therapeut effect anim model human papillomaviru type hpvinduc tumor mice ii partial prevent bovin lactoglobulin blgallerg reaction mice iii regul bodi weight food consumpt obes mice strikingli tool transpos lactobacillu genu year laboratori notabl antioxid lactobacillu casei strain construct test chemicallyinduc coliti model parallel develop strategi base lacti deliv dna mucos level lacti modul host respons dna deliveri todai consid consist data group demonstr reinforc interest lab lactococci lactobacilli strain develop novel therapeut protein mucos deliveri vector test human clinic trial
PLoS Negl Trop Dis	16936230	2014-01-13	PMC3232203	22163058	background rift vallei fever viru rvfv diseas livestock human transmit mosquito inhal physic contact bodi fluid infect anim sever clinic case character acut hepat hemorrhag meningoenceph andor retin dynam rvfv infect cell type infect vivo understood methodologyprincip find rvfv strain express human renilla luciferas hrluc green fluoresc protein gfp gener inocul suscept ifnardefici mice investig tissu tropism mice natur target cell vivo wholeorgan imag flow cytometri intraperiton inocul hrluc signal observ thymu spleen liver macrophag infiltr tissu adipos tissu surround pancrea express viru liver rapidli turn major luminesc organ mice succumb sever hepat brain remain weakli luminesc infect fac analysi rvfvgfpinfect mice macrophag dendrit cell granulocyt main target cell rvfv crucial role cell monocytemacrophagedendrit lineag rvfv infect confirm slower viral dissemin decreas rvfv titer blood prolong surviv macrophag dendrit celldeplet mice treatment clodron liposom dermal nasal inocul viral dissemin observ lymph node drain inject ear lung increas surviv time conclusionssignific find reveal high level phagocyt cell harbor rvfv viral infect ifnardefici mice demonstr bioluminesc fluoresc virus light pathogenesi rvfv infect
PLoS One	24417618	2001-11-15	PMC3232237	22163050	the aim studi identifi potenti ligand develop novel diagnost test pathogen bovin rotaviru brv phage displai technolog virus immobil target incub mer phage displai random peptid librari round biopan phage specif bind activ brv isol dna sequenc indic phage displai peptid hvhpplrphsdk hatnhlptphnr ypthhahttpvr potenti ligand brv specif peptideexpress phage develop phagebas elisa differenti brv virus compar quantit realtim pcr qpcr phagemedi elisa suitabl captur brv detect limit approach gml sampl high sensit specif low crossreact phagebas elisa confirm receiv oper characterist roc analysi
Int J Mol Sci	11602711	2006-08-01	PMC3233434	22174628	the refer gene commonli accept reliabl approach normal qrtpcr reduc error quantif gene express suitabl refer gene sheep identifi restrict rang tissu specif data blood aim studi identifi set refer gene normal qrtpcr ovin blood design pcr assai commonli emploi refer gene belong function class determin express stabil blood sampl control diseasestress sheep sdha ywhaz consid suitabl intern control stabli express diseas statu genorm normfind softwar genorm indic sdhahprt ywhazgapdh sdhaywhaz best refer gene combin control diseasestress combin sheep group studi valid panel optim control gene identif gene differenti express qrtpcr access tissu potenti discov physiolog diseas marker tool improv product trait identifi express quantit trait loci addit outcom studi set intronspan primer sequenc suitabl gene express experi emploi sybr green chemistri ovin tissu cell
Int J Mol Sci	16757010	2016-07-27	PMC3233444	22174638	novel dna sequenc techniqu refer nextgener sequenc ng provid high speed throughput produc enorm volum sequenc applic diagnost set articl provid overview applic ng diagnost virolog ng techniqu highthroughput viral genom sequenc sequenc influenza virus detect viral genom variabl evolut host investig human immunodefici viru human hepat viru quasispeci monitor lowabund antivir drugresist mutat ng techniqu appli metagenomicsbas strategi detect unexpect diseaseassoci virus discoveri novel human virus includ cancerrel virus final human virom healthi diseas condit describ ngsbase metagenom
PLoS Pathog	27466418	2019-02-06	PMC3234229	22174679	small rna virus evolv mechan increas capac short genom describ identif character novel open read frame orf encod murin noroviru mnv subgenom rna altern read frame overlap vp code region orf translat viru infect result protein local mitochondria revers genet demonstr express orf requir viru replic tissu cultur loss fit cost virus lack abil express orf restor express repeat passag tissu cultur function analysi indic protein produc orf antagon innat immun respons infect delai upregul number cellular gene activ innat pathwai includ ifnbeta apoptosi raw macrophag cell increas viru infect absenc orf express vivo analysi wt mutant viru lack abil express orf demonstr role orf express infect virul stat mice infect viru lack abil express orf delai onset clinic sign compar mice infect wt viru quantit pcr histopatholog analysi sampl infect mice demonstr infect viru express orf delai infect system light find propos virul factor vf protein identif vf repres character altern open read frame protein caliciviru famili immun regulatori function mnv vf protein provid perspect futur noroviru biologi pathogenesi
PLoS Pathog	30728254	2018-02-01	PMC3234230	22174678	the adapt chikungunya viru chikv vector aed albopictu mosquito major factor contribut ongo reemerg seri largescal epidem arthrit diseas part initi step chikv adapt albopictu determin involv av amino acid substitut envelop glycoprotein aros attent paid subsequ chikv evolut adapt mutat converg select geograph locat determin select secondstep adapt mutat chikv arthropodborn virus occur natur test addit envelop glycoprotein amino acid chang identifi kerala india substitut elq caus increas abil chikv develop dissemin infect albopictu chikv fit altern mosquito vector aegypti vertebr cell line infecti virus viruslik replicon particl express eq el residu determin elq act level infect albopictu midgut epitheli cell addit observ initi adapt substitut eav stronger chikv fit albopictu elq explain observ time differ requir select sweep mutat natur indic continu chikv circul albopictushuman cycl select addit secondstep mutat facilit effici viru circul persist endem area increas risk sever expand chik epidem
PLoS Pathog	29500690	2011-02-01	PMC3234231	22174683	translat readthrough codon ribosom recod event varieti virus includ plusstrand rna tombusvirus translat viral rnadepend rna polymeras rdrp tombusvirus mediat strategi investig process varieti vitro vivo approach indic readthrough gener rdrp requir novel longrang rnarna interact span distanc kb occur larg rna stemloop locat proxim codon rna replic structur term riv the viral genom interestingli longdist rnarna interact modul mutuallyexclus rna structur riv repres type rna switch longrang rnarna interact viral rna replicas assembl requir effici readthrough product rdrp multipl replicationassoci rna element involv modul readthrough event tombusvirus propos integr mechanist model describ regulatori network advantag provid qualiti control system cull truncat viral genom earli stage replic process ii mediat cispreferenti replic viral genom iii coordin translat readthrough rdrp viral genom replic base compar sequenc analysi experiment data basic element regulatori model extend member tombusvirida virus famili
PLoS Pathog	21345147	2004-12-16	PMC3234236	22174690	sar coronaviru scov nonstructur protein nsp potent inhibitor host gene express possess uniqu mode action bind ribosom inactiv translat function induc host mrna degrad previou studi demonstr nsp induc rna modif report mrna short untransl region rna cleavag encephalomyocard viru intern ribosom entri site ir region dicistron rna templat ir element hepat cricket paralysi virus cellfre vitro translat system studi reveal nsp induc endonucleolyt rna cleavag untransl region cap mrna templat experi dicistron mrna carri ires nsp induc endonucleolyt rna cleavag ribosom load region type type ii picornaviru ir element classic swine fever viru ir character hepat viruslik ir nspinduc rna cleavag templat mrna exhibit appar prefer specif nucleotid sequenc rna cleavag site remark scov mrna cap structur poli tail typic host mrna suscept nspmediat rna cleavag importantli presenc leader sequenc protect scov mrna nspinduc endonucleolyt rna cleavag escap viral mrna nspinduc rna cleavag strategi viru circumv action nsp lead effici accumul viral mrna viral protein infect
PLoS One	15616586	2013-06-20	PMC3235143	22174870	object studi object systemat identifi exist systemat review chines herbal medicin chm publish cochran librari assess methodolog qualiti includ review methodologyprincip find perform systemat search cochran databas systemat review cdsr issu identifi review chm total fiftyeight review elig studi twentyon includ review tradit chines medicin tcm practition coauthor review includ primari studi remain review includ median studi particip review assess uptod prior question address review broad scope review combin studi herbal medicin oqaq qualiti score item ci review assess methodolog qualiti primari studi includ primari studi adequ sequenc gener adequ alloc conceal nonempti review review report inconclus conclud benefit chm limit poor qualiti inadequ quantiti includ studi review report search median electron databas review search chines databas conclus cdsr includ larg number chm review studi identifi area improv half includ review particip tcm practition uptod cochran criteria review pool herbal medicin ignor search chines databas
Biochem Res Int	23788638	2017-08-01	PMC3235436	22191032	membran raft small nm sterol sphingolipidenrich domain compartment cellular process membran raft plai role viral infect cycl viral virul virus divid main class envelop dna viru envelop rna viru nonenvelop dna viru nonenvelop rna viru gener viru infect cycl classifi section earli stage entri process late stage assembl bud releas process viru particl viral cycl membran raft scaffold cellular signal transduct associ symptom caus viral infect paper describ function membran raft viral lifecycl host cellular respons viru classif stage viru lifecycl virusinduc signal transduct
Clin Dev Immunol	28558267	2014-09-01	PMC3235441	22190970	the discoveri interferonlambda ifn famili consider contribut understand role interferon viral infect cancer ifn protein belong type iii ifn group type iii ifn structur type ii ifn ifn function ident type ifn ifn contrast type type ii ifn respons type iii ifn highli celltyp specif epitheliallik cell lesser extent immun cell respond ifn pattern respons control differenti express ifn receptor contrast ifn result limit side effect patient group anim model potent antitumor role ifn will open challeng era current ifn therapi
Clin Dev Immunol	25254916	2011-09-01	PMC3235500	22203863	multipl sclerosi ms autoimmun diseas central nervou system cd cell form core immunopathogen cascad lead chronic inflamm tradition cell interferonproduc cd cell driven interleukin il consid encephalitogen cell ms experiment autoimmun encephalomyel eae anim model ms current cell ilproduc cd cell consid plai fundament role immunopathogenesi eae paper highlight grow evid cell plai core role complex adapt immun eaem discuss role associ immun cell cytokin constitut modern immunolog basi develop novel clinic preclin immunomodulatori therapi ms discuss paper
Comput Math Methods Med	21896794	2017-01-01	PMC3235663	22203886	thi studi analyz meteorolog clinic econom factor term effect monthli revenu visitor volum monthli data januari septemb analyz spearman correl crosscorrel analys perform identifi correl independ variabl revenu visitor volum autoregress integr move averag arima model quantifi relationship independ variabl revenu visitor volum accuraci evalu compar model forecast actual valu absolut percentag error sensit predict error model train time evalu arima model indic maximum temperatur rel humid rainfal nontrauma trauma visit correl posit revenu minimum temperatur correl neg revenu minimum temperatur stock market fluctuat correl posit trauma visitor volum maximum temperatur rel humid stock market fluctuat correl posit nontrauma visitor volum maximum temperatur rel humid correl posit pediatr visitor volum minimum temperatur correl neg pediatr visitor volum model perform forecast revenu visitor volum
PLoS One	29131066	2017-02-11	PMC3237560	22194946	in uk attempt control incid bovin tuberculosi btb cattl cull wildlif host european badger mele mele produc equivoc cullinginduc social perturb badger popul lead unexpect outcom test predict perturb hypothesi determin impact cull oper badger popul movement surviv individu influenc epidemiolog btb badger data dervi studi area uk govern randomis badger cull trial rbct cull oper remov individu sett badger remov target social group cull btb preval increas badger social group neighbour remov cub seventi individu adult badger fit radiocollar yield locat fix site novemb decemb rang area anim surviv remov group increas respons cull overlap summer rang individu neighbour social group treatment popul increas respons cull movement rate individu social group low increas cull remov neighbour social group increas btb preval neighbour group associ badger movement group move individu test posit btb increas frequenc individu badger movement group emerg btb observ respons cull direct evid link phenomena hypothesis social disrupt caus cull increas direct contact diseas transmiss surviv badger increas social stress surviv popul caus immunosuppress enhanc express diseas
PLoS Pathog	19506275	2015-02-26	PMC3240602	22194687	host factor recruit viral replicas complex aid replic plusstrand rna virus paper delet eukaryot translat elong factor bgamma eefb reduc tomato bushi stunt viru tbsv replic yeast host knock eefb level plant host decreas tbsv accumul eefb bind viral rna resid host protein tombusviru replicas complex addit vitro assai cell extract prepar yeast strain lack eefb demonstr role minusstrand synthesi open structur viral rna reduc possibl reutil strand templat repeat strand synthesi replicas eefb plai synergist role eukaryot translat elong factor tombusviru replic stimul proper posit viral rnadepend rna polymeras promot region viral rna templatethes role translat factor tbsv replic separ canon role host viral protein translat
PLoS One	25725003	2009-11-20	PMC3241677	22194875	idiopath renal hypouricaemia inherit form hypouricaemia associ abnorm renal handl uric acid excess urinari wast uric acid hypouricaemia patient asymptomat persist urinari abnorm manifest renal stone diseas hypouricaemia manifest exercis induc acut kidnei injuri identifi macedonian british patient hypouricaemia present varieti renal symptom sign includ renal stone diseas hematuria pyelonephr nephrocalcinosi identifi heterozyg missens mutat slca encod urat transport protein urat correl genet find function character urat handl determin uptak experi hek cell data highlight the urat renal urat transport determin serum urat concentr clinic phenotyp includ nephrolithiasi prompt clinician suspect inherit form renal hypouricaemia
J R Soc Interface	20019862	2010-09-15	PMC3243390	21752808	current schistosomiasi transmiss suppress low level histor endem area china widespread praziquantel human bovin popul applic niclosamid snail control reemerg transmiss signal sustain intervent repeat chemic intervent advantag ongo invest rural infrastructur schistosomiasi transmiss potenti need identifi villag environment modif effect base retrospect analysi data villag sichuan provinc link basic reproduct number promis meet lack method estim spatial compon propos metric estim import cercaria miracidia neighbour villag lead uncertainti estim find prioriti effort develop method measur freeswim form parasit surfac water underscor high cost limit sensit current method diagnos human infect mount evid inadequaci snail survei identifi environ support low level transmiss
PLoS One	20844028	2004-06-25	PMC3244406	22205966	highli pathogen avian influenza hpai hn virus circul poultri popul part asia africa middl east caus human infect high mortal rate subtyp hemagglutinin ha evolv phylogenet distinct clade subclad base virus isol avian speci human infect hpai hn virus clade develop strategi produc protect antibodi respons hn virus multipl clade antigen group current studi optim signal peptid design dna vaccin express ha antigen hn virus cross reactiv analysi sera immun rabbit antibodi respons elicit polyval formul includ ha antigen clade elicit broad protect antibodi respons multipl kei repres hn virus clade data present report support develop polyval dna vaccin strategi threat potenti hn influenza pandem
PLoS One	15220459	2009-10-01	PMC3245290	22216319	the bone marrow heterogen popul cell involv regener repair diseas organ includ lung studi isol character progenitor epitheli cell bone marrow week germfre pig microscop cultur cell epitheliallik morpholog phenotyp cell express stem cell marker octamerbind transcript factor oct stagespecif embryon antigen ssea alveolar stem cell marker clara cell secretori protein ccsp epitheli cell marker pancytokeratin pank cytokeratin occludin cultur epitheli cell growth medium progenitor epitheli cell express type type ii pneumocyt marker examin suscept cell influenza viru progenitor epitheli cell express sialic acid receptor util avian mammalian influenza virus target influenza viru replic addition differenti type ii type pneumocyt support replic influenza viru data indic identifi uniqu popul progenitor epitheli cell bone marrow airwai reconstitut potenti model cellbas therapi infecti noninfecti lung diseas
PLoS Comput Biol	19797737	2011-12-21	PMC3245300	22215997	the hn influenza pandem claim live pandem develop drug resist complic effort control treat widespread ill util tradit chines medicin databasetaiwan tcm databasetaiwan screen compound simultan target overcom current difficulti viru mutat top three candid de novo deriv xylopin rosmaricin bioactiv de novo deriv valid multipl machin learn predict model abil de novo compound maintain comfacomsia contour form kei interact impli bioactiv addit pyridinium fragment critic form stabl interact support molecular dynam md simul md hydrophob interact torsion angl consist support find dock multipl anchor lack bind residu prone mutat tcm de novo deriv resist drug resist advantag convent hn treatment oseltamivir tcm de novo deriv suitabl candid dualtarget drug influenza
Vet Res	22190716	2011-11-09	PMC3245447	22067072	group rotavirus gar common diarrhea suckl pig number genotyp identifi porcin gar attempt studi molecular epidemiolog virus associ diarrhea outbreak farm extend period time investig molecular characterist gar caus outbreak diarrhea suckl pig farrowtofinish farm cours year genotyp gar detect outbreak demonstr genet divers farm gp detect outbreak gp gp second gp third gp gp combin untyp genotyp fourth sequenc analysi detect gar reveal genet divers introduct gar strain gene reassort gar strain farm gar strain carri untyp genotyp novel porcin gar bear genotyp confirm rotaviru classif work group
PLoS One	22072764	2014-05-27	PMC3246463	22216187	bat global distribut group mammal high ecolog increasingli recogn natur reservoir host viral agent signific human anim health studi evalu pool blood sampl phylogenet distant bat famili fly fox pteropodida eidolon helvum west africa speci leafnos fruit bat phyllostomida artibeu jamaicensi artibeu lituratu central america sequenceindepend viru discoveri techniqu vidisca combin high throughput sequenc detect novel parvovirus parvlik viru name ehbtpv eidolon helvum ghana member put genu artibeu jamaicensi panama ajbtpv virus circul correspond bat coloni rate ajbtpv artibeu lituratu virus detect blood infect anim high concentr to copiesml ajbtpv ehbtpv ehbtpv addition detect organ collect bat brain lung liver spleen kidnei intestin spleen kidnei identifi site viral replic take place studi bat parvovirus share common ancestor parvovirus human livestock provid evid varieti parvovirina activ infect bat distribut anim geograph origin ecolog climat rang
PLoS One	24493010	2015-06-20	PMC3247292	22216354	background bat receiv increas attent infecti diseas studi recogn statu reservoir speci infecti agent bat capabl long distanc dispers complex social structur uniqu microb spread mammalian speci infect studi bat limit identif specif pathogen present potenti health threat human impact infecti agent individu host bat mortal unknown neglect studi publish methodologyprincip find deceas bat european speci famili vespertilionida collect geograph region germani anim repres individu case incident close roost site human habit urban urbanlik environ bat carcass subject postmortem examin investig histopatholog bacteriolog virolog trauma diseas repres death bat compar analysi patholog find microbiolog microbi agent impact bat succumb infecti diseas fatal bacteri viral parasit infect bat investig conclusionssignific data demonstr diseas infecti agent death european bat speci clear season individu variat diseas preval infect rate indic matern coloni suscept infecti agent underlin role host physiolog immun roost behavior risk factor infect bat
BMC Int Health Hum Rights	26092112	2012-09-01	PMC3247839	22166059	global accompani rapid spread infecti diseas strain work condit health worker global postsar canadian occup health infect control research studi better protect health worker train perceiv kei posit safeti cultur led develop commun technolog ict tool conduct better workplac inspect workplac audit tool develop supplement worker questionnair ict invit join ecuadorean colleagu promot occup health infect control tool collect adapt improv includ facetofac onlin problembas learn scenario south african govern invit team work local colleagu improv occup health infect control improv webbas health system track incid exposur occup injuri diseas hn pandem struck onlin infect control cours adapt translat spanish novel skillbuild learn tool permit health worker practic select person protect equip tool origin develop collabor countri caribbean region pan american health organ paho experi led strengthen focu build capac health safeti committe modul creat inform work product develop herald innov interact lead inclus toolkit internation tool canada improv collabor adapt process south central america south africa intern collabor occup health infect control research led improv framework develop tool guidelin system knowledgetransf experi highlight partnership northern southern research term share resourc experi knowledg
PLoS Pathog	22884661	2009-06-19	PMC3248566	22241985	bluetongu viru btv caus agent major diseas livestock bluetongu decad accept segment dsrna genom btv encod structur nonstructur protein nonstructur protein ns ns nsnsa plai kei role viral replic cycl studi btv express fourth nonstructur protein design ns encod open read frame segment overlap open read frame encod vp ns amino acid residu length highli conserv btv serotypesstrain ns express earli postinfect local nucleoli btv infect cell revers genet ns dispens btv replic vitro mammalian insect cell affect viral virul murin model bluetongu infect interestingli ns confer replic advantag btv btv cell interferon ifninduc antivir state btv ns confer replic advantag btv reassort entir segment btv btv mutant ns ident homolog btv protein collect studi suggest ns plai role virushost interact mechan plai btv counteract antivir respons host addit distinct nucleolar local ns express viru replic exclus cytoplasm offer avenu investig multipl role plai nucleolu biologi cell
PLoS One	19542440	2012-02-15	PMC3250439	22235288	background acut respiratori distress syndrom ard induc pandem hn influenza viru report consid main death critic patient hn infect anim model develop ard caus infect hn viru mous model ard induc hn viru methodolog princip find mice inocul aswineshandong sd hn influenza variant gd mutat hemagglutinin clinic symptom record dai lung injuri assess lung water content histopatholog observ arteri blood ga leukocyt count bronchial alveolar lavag fluid blood viru titer cytokin level lung measur time postinocul mice infect sd viru typic ard symptom character lethal dai postinocul highli edemat lung inflammatori cellular infiltr alveolar interstiti edema lung hemorrhag progress sever hypoxemia elev level proinflammatori cytokin chemokin conclusionssignific suggest establish ard mous model induc virul hn variant previou adapt benefit evalu pathogenesi therapi human ard caus hn viru
PLoS One	22335491	2008-02-26	PMC3250451	22235312	background multipl infect common natur host popul interspecif parasit interact host individu serious impact circul parasit emerg manag infecti diseas studi essenti field detect parasit interact render difficult fact larg number coinfect individu observ parasit share common risk factor correct fals interact method account parasit risk factor methodologyprincip find paper propos method presenceabs data serolog method enabl calcul expect frequenc singl doubl infect individu independ hypothesi compar observ chisquar statist method term correct chisquar robust compar preexist method base logist regress correct chisquar prove robust small sampl size logist regress approach easier implement propos rule thumb ratio sampl size number paramet ten appli serolog data virus infect cat approach reveal pairwis interact felin herpesviru parvoviru caliciviru infect fiv felin equival hiv modifi risk infect virus conclusionssignific work point interact investig experiment condit provid userfriendli program tutori exampl offer opportun anim human epidemiologist detect interact interest field crucial step challeng multipl infect
PLoS One	18299299	2009-08-26	PMC3250453	22235309	ceacam multifunct iglik cell adhes molecul express epitheli cell organ ceacaml ceacam isoform produc differenti splice predomin rat liver previou work downregul isoform occur rat hepatocellular carcinoma isol anchorag depend clone design tnt express detect level ceacam stabl transfect nt cell wild type ceacam express vector induc anchorag independ growth vitro tumorigen phenotyp vivo phenotyp quantifi point examin function ceacam transmembran domain examin ceacam transmembran domain ntermin gxxxg dimer sequenc ctermin tyrosin residu studi stabil transmembran domain helixhelix interact examin effect transmembran domain mutat nt cell transfect transmembran domain mutant carri glycin leucin tyrosin valin substitut mutat transmembran tyrosin residu greatli enhanc growth vitro vivo mutat transmembran dimer motif contrast reduc anchorag independ growth tumorigen nt cell express ceacam glycin leucin tyrosin valin mutat displai growthenhanc phenotyp tyrosin mutant dramat transmembran domain mutat constitut strong evid transmembran domain determin ceacam function protein transmembran domain dimer sequenc andor ctermin tyrosin residu
PLoS One	19710146	2012-09-05	PMC3251557	22238581	background exposur popul beij china phn increas respiratori ill limit etiolog clinic characterist influenzalik ill ili ensu adult phn pandem method clinic epidemiolog data ili adult collect total throat swab test twelv respiratori virus multiplex rtpcr clinic characterist influenza outpati versu testneg patient compar pearson mannwhitnei test swab test phn viru isol consult rate ili compar viru detect sampl influenza viru flua account virus frequenc cough associ influenza viru infect posit rate flua consist chang ili rate period reduct incid ili compar influenza season incid peak januari beij north china conclus exposur phn impact typic influenza season peak flua remain predomin viru beij symptomat cough associ flua infect posit rate influenza viru consist chang ili rate period reduct incid ili compar 
PLoS Pathog	22956656	2010-09-21	PMC3252376	22241994	hcv infect major risk factor liver cancer liver transplant worldwid overstimul host lipid metabol liver hcvencod protein viral infect creat favor environ viru propag pathogenesi studi hypothes target cellular enzym act master regul lipid homeostasi repres power approach develop novel class broadspectrum antivir infect associ human flavivirida virus hepat viru hcv assembl pathogenesi depend interact lipid droplet ld master regul cholesterol metabol pathwai host subtilisinkexinisozym ski site proteas sp skisp plai critic role proteolyt activ sterol regulatori element bind protein srebp control express kei enzym cholesterol fattyacid biosynthesi report develop skispspecif proteinbas inhibitor applic block srebp signal cascad demonstr skisp inhibit effect block hcv establish infect hepatoma cell inhibitori mechan associ dramat reduct abund neutral lipid ld ld marker adipos differentiationrel protein adrpperilipin reduct ld format inhibit viru assembl infect cell importantli confirm skisp kei host factor hcv infect specif activ sitedirect smallmolecul inhibitor skisp pf studi identifi skisp novel regul hcv lifecycl potenti hostdirect therapeut target hcv infect liver steatosi identif increas number human virus host ld infect skisp inhibitor allow develop novel broadspectrum biopharmaceut lead novel indirectact antivir option current standard care
PLoS One	20854710	2006-08-15	PMC3253127	22238695	background infecti diseas contribut declin local extinct wildlif speci includ african wild dog lycaon pictu mitig diseas threat challeng partli uncertainti diseas dynam difficult identifi best manag approach seriou impact suscept popul frequent occur generalist pathogen maintain popul abund domest reservoir host spill abund host speci case diseas control direct reservoir host appropri pathogen transmiss threaten host popul mai control manag host speci methodologyprincip find investig interspecif intraspecif transmiss rout compar african wild dog exposur canin pathogen behaviour measur opportun contact domest dog wild dog domest dog contact associ exposur canin parvoviru ehrlichia cani neospora caninum rabi viru exposur canin distemp viru canin coronaviru contact wild dog appear increas risk exposur pathogen conclusionssignific find combin data manag direct domest dog help protect wild dog popul rabi viru canin distemp viru analys need determin manag approach includ intervent appropri pathogen
PLoS One	16912299	2013-01-01	PMC3254615	22253731	the global trade wildlif histor contribut emerg spread infecti diseas unit state world largest import wildlif wildlif product minim pathogen surveil preclud assess health risk pose practic report detail find pilot project establish surveil methodolog zoonot agent confisc wildlif product initi find sampl collect intern airport identifi part origin nonhuman primat nhp rodent speci includ baboon chimpanze mangabei guenon green monkei cane rat rat pathogen screen identifi retrovirus simian foami viru andor herpesvirus cytomegaloviru lymphocryptoviru nhp sampl demonstr illeg bushmeat import unit state conduit pathogen spread implement diseas surveil wildlif trade will help facilit prevent diseas emerg
Int J Alzheimers Dis	25215133	2014-07-11	PMC3255168	22254144	alzheim diseas suscept gene app gammasecretas involv herp simplex life cycl suspect pathogen pneumonia pylori neoforman burgdorferri gingivali immun defenc pathogen promot betaamyloid deposit tau phosphoryl caus agent effect condit gene antimicrobi effect betaamyloid localis appgammasecretas immunocompet dendrit cell gamma secretas cleavag numer pathogen receptor network concern pathogen dispos effect abrog presenc betaamyloid autoantibodi elderli autoantibodi nerv growth factor tau observ alzheim diseas antibodi pathogen homolog human autoantigen pathogen protein ngf tau antibodi promot betaamyloid deposit neurofibrillari tangl cholinerg neuron loss autoantibodi antiatpas potenti agent destruct format dictat sequenc homolog pathogen human protein pathogen strain human gene pathogen elimin ag popul remov culpabl autoantibodi reduc incid offer hope cure afflict
PLoS One	25015234	2007-03-01	PMC3256159	22247782	background filovirus includ ebola viru unusu filament anim virus structur data arrang stoichiometri organis compon molecul filovirus lack partial to work level biolog contain studi uniqu insight structur deadli pathogen methodolog princip find investig structur ebola viru combin cryoelectron microscopi cryoelectron tomographi subtomogram averag singl particl imag process report threedimension structur architectur ebola viru establish multipl copi rna genom packag produc polyploid viru particl extrem degre length polymorph helic ebola viru inner nucleocapsid rna nucleoprotein stabil outer layer vpvp bridg elucid structur membraneassoci glycoprotein nativ state indic put receptorbind site occlud molecul major neutral epitop expos surfac proxim viral envelop matrix protein vp form regular lattic envelop contact nucleocapsid irregular conclus studi demonstr modular organ ebola viru accommod wellord symmetr nucleocapsid flexibl tubular membran envelop
PLoS One	17360156	2004-08-05	PMC3256233	22253918	virusinduc apoptosi viral mechan regul cell death program kei issu understand virushost interact viral pathogenesi human anim virus coronaviru infect mammalian cell induc apoptosi studi global gene express profil determin ibvinfect vero cell hour postinfect affymetrix arrai avian coronaviru infecti bronchiti viru ibv model system reveal upregul transcript level proapoptot bak prosurviv myeloid cell leukemia mcl confirm vivo vitro ibvinfect embryon chicken egg chicken fibroblast cell mammalian cell transcript translat level interestingli onset apoptosi occur earlier ibvinfect mammalian cell silenc short interf rna target mcl simcl delai cell silenc sibak ibv progeni product releas increas infect mcl knockdown cell compar infect control cell contrari observ infect bak knockdown cell ibv infectioninduc upregul gadd regul express mcl inhibit mitogenactiv proteinextracellular signalregul kinas mekerk phosphoinositid kinas pikakt signal pathwai chemic inhibitor knockdown gadd sirna demonstr involv erstress respons regul ibvinduc mcl express illustr sophist regulatori strategi evolv coronaviru modul virusinduc apoptosi viral replic replic cycl
Int J Mol Sci	15297608	2006-11-15	PMC3257128	22272131	human chymas target treatment cardiovascular diseas seri theoret method pharmacophor model databas screen molecular dock densiti function theori dft calcul investig identif novel chymas inhibitor kei factor crucial bind interact chymas inhibitor perform highli correl pharmacophor model hypo hydrogen bond acceptor three hydrophob aromat featur gener valid hypo appli databas screen hit compound subject druglik filtrat molecular dock studi final three structur divers compound high gold fit score interact kei activ site amino acid identifi potent chymas hit dft studi perform confirm clear trend electron properti inhibitori activ ic data valid hypo dft method exert help develop potent hit chymas addit combin dock orbit energi molecular electrostat potenti analysi demonstr good endeavor gain insight interact chymas inhibitor
PLoS One	17108077	2010-08-11	PMC3257236	22253733	background caus agent sever acut respiratori syndrom sar coronaviru sarscov genom encod uniqu group specif accessori protein unknown function accessori protein orf identifi viral interferon antagonist lab uncov role upregul ap transcript activ downstream gene plai role sarscov pathogenesi consider interest current studi aim identifi novel host cellular interactor protein methodologyprincip find studi yeast twohybrid coimmunoprecipit techniqu identifi host transcript factor runxb runt transcript factor isoform novel interact partner sarscov protein chromatin immunoprecipitaion chip report gene assai express jurkat cell recruit runx bind element led increas runxb transactiv potenti il promot kinas assai pharmacolog inhibitor treatment impli affect runxb transcript activ regul erk depend phosphoryl level addition mrna level mip runxb target gene upregul sarscov infect monocytederiv dendrit cell elev express monocyt cell conclusionssignific unveil novel interact sarscov host factor runxb specul physiolog relev upregul cytokin chemokin level state sar viru infect
PLoS One	20702415	2006-03-29	PMC3257271	22253928	isol island provid valuabl opportun studi persist virus wildlif popul includ popul size threshold critic commun size strawcolour fruit bat eidolon helvum identifi reservoir henipavirus serolog evid lago bat viru lbv viru isol serolog evid continent africa sampl remot popul helvum annobonensi fruit bat annobn island gulf guinea investig antibodi virus exist isol subspeci henipaviru serolog analys luminex multiplex bind inhibit assai viru neutralis test western blot lyssaviru serolog analys lbv modifi fluoresc antibodi viru neutralis test lbv mokola viru lentiviru pseudoviru neutralis assai undertaken sampl isol fruit bat annobn lack connect popul expect popul size island small allow persist virus thought acut immunis infect presenc antibodi henipavirus detect luminex bind assai confirm altern assai neutralis antibodi lbv detect bat assai demonstr clear evid exposur multipl individu henipavirus remot popul helvum annobonensi fruit bat annobn island situat clear lbv seropreval henipavirus lbv annobn notabl helvum continent locat studi sampl techniqu assai whilst crosssect serolog studi wildlif popul provid detail viral dynam popul valuabl presenc absenc virus utilis inform futur studi
Nutrients	16571830	2017-07-13	PMC3257684	22254105	immunoglobulin form compon immunolog activ milk colostrum central immunolog link occur mother transfer passiv immun offspr mechan transfer vari mammalian speci cattl provid immun rich colostrum milk larg quantiti make secret potenti sourc immun product benefit human immun milk term describ rang product bovin mammari gland test human diseas colostrum milk sourc immunoglobulin intend neonat speci produc secret speci view context type immunoglobulin secret mechan immunoglobulin secret mechan neonat adult consum milk gain immunolog benefit stabil immunoglobulin undergo process milk undergo digest intestin addit consider evalu milk immunoglobulin review summar fundament knowledg immunoglobulin colostrum milk immun milk
Vet Res	28636348	2016-02-24	PMC3258204	22185601	limit transmiss spread influenza viru pig popul differ immun status studi assess differ transmiss pattern quantifi spread tripl reassort hn influenza viru nave vaccin pig popul estim reproduct ratio infect number secondari infect caus infecti individu determinist susceptibleinfectiousrecov sir model fit experiment data ten pig distribut ten isol room nonvaccin nv ii vaccin heterolog vaccin iii vaccin homolog inactiv vaccin ho studi multipl replic replic infect nonvaccin pig contact pig week transmiss influenza evalu daili analyz individu nasal swab rtpcr statist differ estim observ vaccin nonvaccin pig statist reduct transmiss observ vaccin group ci the ho group compar ro nv pig transmiss group delai variabl compar nv group transmiss detect ho group studi indic influenza vaccin decreas suscept influenza infect decreas influenza transmiss
Vet Res	26912619	2007-01-01	PMC3259045	22136667	fece anim collect farm region brittani franc sampl directli collect rectum anim identifi ear tag number anim sampl three time week ag dna extract stool sampl nest pcr perform amplifi partial srdna kda glycoprotein gene cryptosporidium parasit detect farm calv parasit cryptosporidium amplifi fragment sequenc cryptosporidium speci identif reveal presenc parvum ryana bovi anim infect cryptosporidium ubiquitum preval speci ag anim parvum caus cryptosporidium infect weekold calv weekold anim analysi anim infect success parvum ryana bovi studi period parvum gp genotyp identifi iia subtyp repres iiaagr work confirm previou studi countri show zoonot parvum domin speci young calv
Virol J	17183041	2012-10-08	PMC3260119	22185375	for detect wheat yellow mosaic viru wymv establish revers transcript loopmedi isotherm amplif rtlamp method primer explor softwar set primer design rtlamp assai reaction condit optim rtlamp perform time primer set agaros gel analysi wymv detect min primer set iii min three primer set min reaction time rtlamp primer set primer set iii min reaction select viru detect avian myeloblastosi viru amv molonei murin leukemia viru mmlv rtlamp primer set mmlv chosen cheap price result specif assai amplifi wymv sensit comparison rtlamp time sensit convent reversetranscriptasepolymeras chain reaction rtpcr rtlamp simpl specif sensit conveni timesav method wymv detect
PLoS One	23045622	2004-08-01	PMC3260287	22272359	enteroviru ev infect handfootandmouth diseas hfmd sever case induc neurolog disord culmin fatal outbreak ev south east asia peopl caus neurolog disord individu control ev infect public health intervent remain minim treatment symptomat human scaveng receptor class member scarb report cellular receptor ev express human scarb gene niht cell tscarb studi mechan ev entri infect demonstr human scarb serv cellular receptor ev entri disrupt express scarb sirna interfer ev infect subsequ inhibit express viral capsid protein tscarb vero cell sirna specif clathrin dynamin chemic inhibitor clathrinmedi endocytosi capabl interf entri ev tscarb cell hand caveolin specif sirna inhibitor caveolaemedi endocytosi confirm clathrinmedi pathwai involv ev infect endocytosi ev phdepend requir endosom acidif requir intact membran cholesterol summari mechan ev entri scarb receptor attach cellular entri clathrinmedi phdepend endocyt pathwai studi receptor endocyt mechan ev infect develop effect medic prophylact treatment enteroviru
PLoS One	15297520	2009-09-04	PMC3261175	22279577	clecm ctype lectin gene serv cell adhes receptor pathogen recognit receptor recogn pathogen public health concern highli polymorph variabl number tandem repeat vntr neckregion clecm associ genet predisposit infecti diseas gain insight origin evolut vntr clecm studi african middl eastern european asian oceania american total chromosom human genom divers panel hgdpceph panel sampl cover allel vntr locu human popul identifi limit number haplotyp basic repeat subunit base pair length haplotyp sequenc ident determin chromosom vntr allel repeat length repeat analyz composit orient subunit subunit configur repeat number vntr locu popul fact virtual ident impli vntr allel exist dispers modern human africa analys indic divers profil locu worldwid popul gener migrat tribe neutral evolut find support hypothesi origin vntr allel arisen independ separ mutat event caus differenti allel advantag natur select suggest previou report base snp data
PLoS One	19734234	2016-10-10	PMC3261190	22279582	swine influenza acut respiratori diseas pig caus swine influenza viru siv highli virul siv strain mortal importantli pig long consid mix vessel gener novel influenza virus pandem potenti constant threat public health emerg subsequ pandem spread pandem hn hnpdm detect pig farm creat risk gener reassort infect human pathogenesi siv hnpdminfect pig remain character proinflammatori antivir cytokin respons consid correl intens clinic sign swine macrophag indispens effect clearanc siv pig lung studi report uniqu pattern cytokin respons swine macrophag infect hnpdm role mitogenactiv protein map kinas regul host respons examin proinflammatori cytokin il il il tnf induc induct erkdepend ifn ifninduc antivir mx oa sharpli induc induct effect abolish erk inhibit induct ccl rant complet inhibit inhibitor erk jnk appear regul fasl tnf critic apoptosi pig macrophag nfb activ hnpdminfect cell activ suppress erk inhibit indic crosstalk map kinas nfb respons pig macrophag data map kinas activ nfb induct rig lead induct ifn swine macrophag understand host respons underli mechan help identifi venu effect control siv assist prevent futur influenza pandem
J R Soc Interface	27030263	2014-08-01	PMC3262428	21831890	data collect outbreak essenti better understand infecti diseas transmiss design effect control strategi analysi data challeng depend observ typic observ outbreak miss data paper discuss strategi tackl ongo challeng analysi outbreak data gener statist model estim transmiss risk factor discuss algorithm estim paramet level miss data problem comput time larg dataset reduc appropri discret suffici statist simpl assumpt natur histori diseas discuss approach integr parametr model fit tree reconstruct method coher statist analys method test real simul dataset larg outbreak structur popul
PLoS One	25325241	2014-08-06	PMC3262788	22276113	genom structur annot identif demarc boundari function element genom gene noncod rna protein regulatori element prerequisit system level analysi current genom annot program identifi function element genom small noncod rna srna genom transcriptom analysi complementari method identifi novel gene small rna regulatori region operon structur improv structur annot bacteria identif noncod rna reveal widespread occurr function gene regul stress virul noncod transcript histophilu somni caus agent bovin respiratori diseas brd bovin infertil abort septicemia arthriti myocard thrombot meningoenceph studi report singl nucleotid resolut transcriptom map somni strain rnaseq method rnaseq base transcriptom map identifi srna somni genom srna predict report earlier studi identifi novel potenti protein code open read frame absent current genom annot transcriptom map allow identif operon total gene structur genom compar genom sequenc nonvirul strain pt disproportion number srna locat genom region uniqu strain total genom observ suggest number newli identifi srna strain involv strainspecif adapt
Adv Virol	25100848	2009-12-02	PMC3265210	22312333	felin coronaviru fcov envelop singlestrand rna viru famili coronavirida order nidoviral fcov pathogen wild domest cat mild symptomless enter infect kitten fcov associ lethal system diseas felin infecti periton fip precis fip pathogenesi remain unclear hypothes suggest review fcov studi attempt elucid exist theori pathogenesi fcov infect
Adv Virol	19955325	2011-10-11	PMC3265223	22312365	oncolyt viru therapi base abil virus effect infect kill tumor cell destroi normal tissu virus natur prefer tumor cell virus requir modif tropism enter replic cell review aim describ transduct target strategi current emploi redirect virus surfac receptor tumor cell three major strategi distinguish involv incorpor target specif viral surfac protein ii incorpor scaffold viral surfac protein allow attach target moieti iii bispecif adapt mediat target viru moieti tumor cell strategi kei featur advantag limit discuss exampl potenti sustain multiround infectiona desir characterist erad tumorsparticular attent virus engin selftarget genom express bispecif adapt protein
Adv Virol	21990424	2007-12-12	PMC3265292	22315599	the human coronavirus hcov hcovnl hcovhku discov coronavirus circul associ acut respiratori infect ari detect hcovnl hcovhku specimen collect march patient ari ag year ag attend beij children hospit thirtytwo specimen test posit hcovnl hcovhku realtim rtpcr luminex xtag rvp fast kit coinfect respiratori syncyti viru parainfluenza viru common patient infect viru type hcovhkuinfect patient predomin clinic symptom cough fever expector hcovnlinfect patient cough fever rhinorrhea phylogenet studi hcovhku nucleoprotein gene conserv compar ncbi refer sequenc ab gene hcovnl variat
Adv Virol	18077704	2017-09-01	PMC3265307	22315601	sinc identif viru diseas caus canin coronaviru ccov adequ investig role viru plai canin enter ill establish emerg sar human attent focus coronavirus consequ high mutat frequenc rnaposit strand virus ccov evolv biomolecular techniqu develop decad viru strain serotyp subtyp identifi infect dog consid widespread natur ccov infect dog popul studi carri focus epidemiolog relev virus underlin investig biologi ccov pathogenet role infect paper report evolutionari process ccov note diagnost method
Adv Virol	28785175	2016-01-02	PMC3265309	22312347	a human coronaviru respons sever acut respiratori syndrom sar identifi rais concern coronavirus agent seriou infecti diseas coronavirus year major agent respiratori enter system infect domest companion anim felin canin coronavirus widespread dog cat popul lead fatal diseas felin infecti periton fip pantrop canin coronaviru infect cat dog paper aspect genet host cell tropism pathogenesi felin canin coronavirus fcov ccov will discuss view illustr studi fcov ccov improv gener understand pathobiolog coronavirus
Adv Virol	26799652	2015-03-25	PMC3265313	22312351	the main rout transmiss sar cov infect presum respiratori droplet viru detect bodi fluid excreta stabil viru temperatur rel humid smooth surfac studi dri viru smooth surfac retain viabil dai temperatur rel humid typic aircondit environ viru viabil rapidli lost log higher temperatur higher rel humid rel humid better stabil sar coronaviru low temperatur low humid environ facilit transmiss commun subtrop area hong kong spring aircondit environ explain asian countri tropic area malaysia indonesia thailand high temperatur high rel humid environ major commun outbreak sar
PLoS One	25810539	2016-07-20	PMC3266233	22295056	acut lung injuri ali syndrom high associ mortal character sever hypoxemia pulmonari infiltr patient critic ill conduct investig genom wide associ gwa approach identifi put risk variant ali genom wide genotyp perform illumina human quad beadchip perform twostag gwa studi third stage function character discoveri phase phase compar european american traumaassoci ali case european american populationbas control carri forward top singl nucleotid polymorph snp replic phase phase compris nest casecontrol design sampl traumaassoci ali case atrisk trauma nonali control ongo cohort studi snp replic level phase subject function valid phase express quantit trait loci eqtl analys stimul blymphoblastoid cell line blcl famili trio snp discoveri phase replic phase includ loci prior evid role ali pathogenesi function evalu replic snp reveal rs exert cisregulatori mrna express ppfia gene ppfia encod liprin alpha protein involv cell adhes integrin express cellmatrix interact studi support feasibl futur multicent gwa investig ali risk identifi ppfia potenti function candid ali risk gene futur research
Pan Afr Med J	19130930	2006-02-14	PMC3266674	22359694	the lack highli train field epidemiologist public health system ghana plan unit establish ghana ministri health public health school start decis develop academicyear gener mph cours persist welltrain epidemiologist support public health surveil outbreak investig respons system develop field epidemiolog laboratori train programm feltp nation prioriti school public health ministri health request technic financi assist unit state center diseas control prevent cdc organ programm collabor start organ short cours diseas outbreak investig respons serv ghana health servic staff success short cours led develop feltp octob feltp curriculum award master philosophi appli epidemiolog diseas control approv academ board univers ghana programm start academ year cohort resid enrol track programm consist physician veterinarian laboratori scientist cohort resid graduat third cohort submit dissert await the fourth cohort start second year field placement cohort start semest field activ graduat includ diseas outbreak investig respons evalu diseas surveil system nation level analysi dataset diseas region level resid total oral present poster present region global scientif confer ghana feltp gfeltp promot introduct health concept feltp host usaidsupport workshop west africa integr strengthen collabor anim human health sector fetp model gfeltp lead host afenet center train public health leadership manag short cours manag improv public health intervent develop afenet member countri gfeltp pretest integr avian influenza outbreak pandem influenza cours prepar introduc materi curriculum feltp network leadership posit graduat program appoint human anim public health servic improv diseas surveil outbreak investig respons testimoni health author appreci output graduat fora strong indic gfeltp meet object
PLoS Pathog	27440887	2008-08-01	PMC3266934	22291594	the hemagglutininesteras envelop glycoprotein corona toro orthomyxovirus mediat revers virion attach oacetyl sialic acid oacsia concert action distinct receptorbind lectin receptordestroi sialat oacetylesteras esteras domain target oacetyl sia lineag murin coronavirus esteras substrat lectin ligand specif chang dramat virus evolv oacetyl sia crystal structur lectin domain mous hepat viru mhv strain resolv nativ state complex receptor analogu data shift oacsia receptor usag entail chang ligand bind topolog surprisingli modest chang receptorbind site architectur find illustr eas virus chang receptorbind specif potenti consequ host organ andor cell tropism pathogenesi
BMC Infect Dis	16476170	2014-05-27	PMC3267697	22168387	background human bocaviru hbov newli discov parvoviru associ acut respiratori tract ill arti gastrointestin ill studi analyz characterist hbovposit sampl arti patient wide ag distribut guangzhou southern china method throat swab collect analyz children adult arti month period hbov complet genom yearold femal patient isol determin hbov dna detect sampl children year adult year season peak detect june hbovposit sampl codetect potenti pathogen mycoplasma pneumonia highest frequenc upper lower respiratori tract ill common symptom patient diagnos pneumonia chest radiographi adult patient system influenzalik symptom phylogenet analysi complet genom reveal close relationship hbov distant relationship hbov hbov conclus hbov detect children adult arti guangzhou southern china elderli peopl suscept hbov singl lineag hbov detect wide ag distribut patient arti
BMC Public Health	18509089	2013-08-23	PMC3267779	22111590	background sentinel surveil sever acut respiratori infect hospit influenzalik ill ambulatori clinic recommend assist global pandem influenza prepared healthcar util pattern will affect generaliz data sentinel site potenti estim burden diseas object studi measur healthcar util pattern guatemala inform establish sentinel surveil system influenza respiratori infect allow estim diseas burden method stratifi twostag cluster survei sampl select household depart santa rosa train interview screen household resid selfreport pneumonia year influenzalik ill ili month ask healthcar util ill episod survei household resid octob decemb identifi case pneumonia case ili treatment pneumonia sought children year person ag year older children year person ag year older report pneumonia privat clinic frequent report sourc care ili treatment sought children year person ag year older govern ambulatori clinic frequent sought sourc care ili children year person ag year older conclus sentinel surveil influenza respiratori infect base govern health facil guatemala will underestim burden diseas adjust healthcar util practic will permit accur estim incid influenza respiratori pathogen commun
PLoS One	24867946	2009-02-10	PMC3270028	22312431	virus evolv elabor mechan evad inactiv complex system sensor signal molecul host innat immun respons human coronaviru hcov nl sever acut respiratori syndrom sar cov papainlik proteas plp antagon innat immun signal mediat sting stimul interferon gene mitaerismyp sting resid endoplasm reticulum activ form dimer assembl mav tbk ikk lead irf activ subsequ induct interferon ifn express membran anchor plp domain human hcovnl plptm sarscov plprotm inhibit stingmedi activ irf nuclear transloc induct irf depend promot catalyt activ inact form cov plp coimmunoprecipit sting viral replicas protein coloc sting hcovnlinfect cell ectop express catalyt activ plptm block sting dimer format neg regul assembl stingmavstbkikk complex requir activ irf sting dimer reduc cell infect sarscov level ubiquitin form sting rigi tbk irf reduc cell express wild type catalyt mutant plptm contribut disrupt signal requir ifn induct describ mechan cov cov plp neg regul antivir defens disrupt stingmedi ifn induct
Int J Hypertens	23977437	2016-08-01	PMC3270559	22315665	despit reduct cardiovascular cv event endorgan damag current pharmacolog strategi cv diseas remain primari death pharmacolog therapi base renin angiotensin system ra blockad extens treatment hypertens heart failur cv remodel spite success preval endorgan damag residu risk remain high novel approach discov effect treatment residu cv remodel risk aceang axi target counterbal vasoconstrictiveprolif ra axi ang hydrolyz slower ang bind ang ii type receptor review current experiment evid suggest activ aceang axi protect heart vessel kidnei advers cardiovascular remodel hypertens heart failur
Virol J	19208801	2011-05-16	PMC3271998	22201648	background dengu major mosquitoborn diseas current effect antivir vaccin effort find antivir focus bioflavonoid plantderiv polyphenol compound potenti health benefit studi antivir activ type bioflavonoid dengu viru type denv vero cell evalu antidengu activ compound determin stage denv infect replic cycl denv replic measur foci form unit reduct assai ffura quantit rtpcr select si determin ratio cytotox concentr cc inhibitori concentr ic compound half maxim inhibitori concentr ic quercetin dengu viru viru adsorpt cell ic decreas cell treat continu viru infect dai postinfect si valu quercetin highest compar bioflavonoid studi naringin exhibit antiadsorpt effect denv ic si daidzein weak antidengu activ ic denv infect cell treat viru adsorpt si compound hesperetin exhibit antivir activ denv find foci form unit reduct assai ffura corrobor find qrtpcr assai quercetin daidzein reduc denv rna level inhibit denv rna level naringin hesperetin conclus studi quercetin demonstr antidenv inhibitori activ bioflavonoid includ daidzein naringin hesperetin minim inhibit denv viru replic find report select group bioflavonoid includ quercetin fisetin exhibit inhibitori activ dengu viru group flavonoid flavonol investig discov common mechan inhibit dengu viru replic
Int J Hypertens	26916219	2010-02-01	PMC3272817	22319643	angiotensin ang recogn biolog activ compon reninangiotensin system ra discoveri angiotensinconvert enzym homologu ac reveal metabol pathwai involv ang synthesi enzym form ang ang ii effici hydrolysi ang ang subsequ ang format addition establish proteincoupl receptor ma function ligand site ang axi form aceangma repres endogen counter regulatori pathwai ra action opposit vasoconstrictorprolif arm ra constitut aceang iiat receptor review will discuss find concern biolog role aceangma arm cardiovascular pulmonari system will highlight initi develop potenti therapeut strategi base axi
PLoS One	21576468	2017-02-01	PMC3273463	22328920	the complianc influenza vaccin poor health care worker hcw misconcept safeti effect influenza vaccin propos educ prospect studi demonstr hcw influenza vaccin safe respiratori virus rv respiratori symptom month influenza vaccin hcw survei advers event ae occur vaccin ae report hcw sever ae observ subset hcw month week detect respiratori symptom rv diagnos direct immunofluoresc assai dfa real time pcr symptomat hcw influenza detect episod respiratori symptom rv episod incid densiti influenza rv episod hcwmonth educ natur studi persuad hcw develop posit attitud influenza vaccin
Virol J	20143950	2003-07-01	PMC3274478	22269698	background nation institut health classifi hepat emerg diseas hepat viru hev major acut hepat develop countri interestingli increas number sporad case hev infect describ industri countri zoonosi domest livestock despit increas relev pathogen clinic virolog commerci antibodi assai base fragment hev open read frame orf orf largest orf polyprotein current test format method synthes full length hev genotyp cdnabank construct complet hev gene librari consist respect hev orf domain bacteri express purif recombin hev protein denatur condit serum profil experi sera patient infect statu perform microarrai format spss softwar assess antigen potenti orf domain comparison commerci hev antigen genotyp perform receiv oper characterist logist regress correl analysi hev antigen produc method serum profil experi exhibit qualiti characterist commerci antigen serum profil experi detect domain orfantigen compar diagnost signific establish epitop orf orf obviou addit increas sensit specif achiev diagnost test reveal bioinformat analysi addition ctermin domain potenti transmembran protein orf respons igg igm seroreact data genotyp specif seroreact homolog orfantigen conclus diagnost identifi orf epitop improv sensit specif broaden qualiti exist test system orf orfantigen commonli diagnost assai hold potenti serolog differenti genotyp infect systemat approach suitabl method investig hev domain serolog antigen epitop screen nativ viral domain prefer tool develop serolog test compon
PLoS One	28065589	2017-06-12	PMC3274521	22347419	we clone glucuronidas gene atgu aspergillu terreu li encod amino acid aa transform glycyrrhizin glycyrrhetin acid monoglucuronid gamg glycyrrhetin acid ga base sequenc align ctermin nonconserv sequenc low ident speci partial sequenc atgust aa amplifi determin effect nonconserv sequenc enzymat properti atgu atgust express coli bl produc atgus atgust optimum temperatur ph atgus atgust condit thermal stabil atgust enhanc metal ion ni opposit effect atgus atgust atgust mm oneseventh atgus mm catalyt effici atgust fold higher atgus mm reveal truncat nonconserv sequenc improv catalyt effici atgu conform analysi illustr differ secondari structur atgus atgust circular dichroism cd the truncat nonconserv sequenc prefer alter influenc stabil catalyt effici enzym
PLoS One	12835748	2017-10-30	PMC3275580	22347478	most biolog process describ seri interact protein molecul interact turn describ term atom structur annot protein function set interact state atom resolut better understand relat protein interact biolog function conduct exhaust allagainstal atom structur comparison bind site ligand includ small molecul protein nucleic acid identifi recur elementari motif integr elementari motif associ subunit defin composit motif repres contextdepend combin elementari motif demonstr function similar better infer composit motif similar compar similar protein sequenc individu bind site integr composit motif associ protein function defin metacomposit motif regard timeindepend diagrammat represent biolog process metacomposit motif provid richer annot biolog process sequenc cluster serv basi bridg atom structur higherord biolog phenomena classif integr bind site structur
BMC Public Health	28607078	2008-05-01	PMC3276487	22136080	background respiratori infect lead childhood death bangladesh promot respiratori hygien reduc infect transmiss form explor commun percept respiratori infect method conduct indepth interview focu group discuss commun member school children explor respiratori hygien percept practic social norm urban rural set conduct unstructur observ respiratori hygien practic public market inform familiar term respiratori infect name diseas relat respiratori dysfunct inform report commun identifi number good behavior respiratori hygien observ peopl practic inform cite hotcold weather chang cold water catch cold associ transmiss respiratori infect close contact sick person breath cough droplet spit share sick person utensil food inform suggest avoid contact effect method prevent respiratori infect inform perceiv handwash cough sneez prevent ill felt typic feasibl practic conclus commun percept respiratori infect includ concern imbal hot cold persontoperson transmiss peopl awar measur prevent respiratori infect practic intervent leverag commun understand persontoperson transmiss encourag practic identifi good behavior respiratori hygien reduc respiratori diseas transmiss
BMC Res Notes	29084893	2010-04-26	PMC3278401	22166307	background preval sever hn pandem appear vari popul geograph region sought investig variabl transmiss hn pandem health region includ urban centr remot isol commun provinc manitoba canada method richard model fit daili number laboratoryconfirm case estim transmiss refer basic reproduct number doubl time turn point outbreak spring fall wave hn pandem health region observ consider variat estim rang confid interv rang averag gener time dai shorter doubl time remot isol commun compar urban centr suggest rapid spread diseas commun wave second wave effect reproduct number estim lower remot isol commun outbreak appear driven higher transmiss urban centr conclus consider geograph variat transmiss pandem outbreak highlight estim inform health respons find indic project transmiss largescal epidem faithfulli character earli spread diseas remot isol commun
BMC Bioinformatics	18289626	2008-09-01	PMC3278842	22373185	background infect parasit nematod common morbid fatal develop nation three major class drug treat human nematod infect addition scientif knowledg mechan action reason resist drug understood commerci incent design drug endem develop countri limit virtual screen academ set plai vital role discov novel drug neglect diseas studi propos build robust machin learn model classifi screen compound activ parasit nematod set compound activ parasit nematod collat literatur sourc includ pubchem inact set deriv drugbank databas support vector machin svm algorithm model develop stratifi tenfold cross valid evalu perform classifi best radial basi function kernel svm method achiev accuraci independ test set model develop indentifi novel compound potenti anthelmint activ conclus studi svm approach predict compound activ parasit nematod suggest effect comput approach antiparasit drug discoveri accuraci lower report studi model robust intention emploi stringent criteria select inact dataset make difficult model classifi compound method present altern approach exist tradit method predict hitherto novel anthelmint compound
PLoS One	20421436	2008-10-29	PMC3280267	22355331	the human respiratori tract heavili expos microorgan viral respiratori tract pathogen rsv influenza rhinovirus major morbid mortal respiratori tract diseas virus limit transmiss virus pathogen tissu transmit respiratori tract chart human virom compart studi nasopharyng aspir sampl submit karolinska univers laboratori stockholm sweden march diagnosi respiratori tract infect metagenom sequenc strategi character virus unbias view sampl viru enrich sequenc total read viral origin autom classif pipelin snapshot respiratori tract virom patient reveal speci strain virus viral sequenc classifi three major famili paramyxovirida picornavirida orthomyxovirida studi identifi novel type rhinoviru identifi number undescrib viral genet fragment unknown origin
Viruses	18703349	2019-09-03	PMC3280510	22355444	dengu virus denv caus agent dengu fever df dengu hemorrhag fever dhf review current state knowledg human antibodi respons dengu identifi knowledg gap larg bodi work demonstr antibodi neutral enhanc denv infect investig mous monoclon antibodi mab studi interact denv antibodi studi indic antibodi neutral denv multihit phenomenon requir bind multipl antibodi neutral virion potent neutral mous mab bind surfac expos epitop domain iii dengu envelop protein challeng face dengu field extend studi mous mab better understand human antibodi respons human antibodi respons complex involv polyclon respons primari secondari infect denv serotyp review studi conduct immun sera mab isol peopl expos dengu infect denguespecif antibodi human immun sera weakli neutral bind multipl denv serotyp human antibodi potent type neutral denv repres small fraction total denvspecif antibodi respons neutral antibodi appear bind novel epitop includ complex quaternari epitop preserv intact virion studi establish human mous antibodi recogn distinct epitop dengu virion lead theori propos explain increas risk sever diseas secondari case antibodi depend enhanc ad postul weakli neutral antibodi infect bind second serotyp enhanc infect fcr bear myeloid cell monocyt macrophag review human anim cell cultur studi relev ad hypothesi understand human antibodi neutral enhanc denv will better evalu exist vaccin develop gener novel vaccin
PLoS One	18971306	2009-08-01	PMC3280993	22359619	highli pathogen avian influenza virus hpaiv sever diseas human effect vaccin antivir therapi current control fatal outbreak lack understand virusmedi immunopatholog studi hemagglutinin ha hn viru investig signal pathwai relationship dysregul innat immun reaction ha hn avian influenza trigger abnorm innat immun signal pulmonari epitheli cell unusu process involv activ janu kinas jak exclus associ chain essenti signal cytokin receptor select jak inhibitor jak knockout mice time demonstr abil target activ jak counteract injuri lung protect immunocyt acut hypercytokinemia induc destruct challeng hn ha vitro vivo basi data appear efficaci select jak inhibit base abil block multipl cytokin protect superinflammatori respons pathogenassoci molecular pattern pamp attack find highlight potenti select jak inhibitor treat fatal immunopatholog caus hn challeng
PLoS One	31479137	2007-04-12	PMC3281048	22359565	thi studi aim analys trend notifi infecti diseas china histor context english chines literatur search diseas categoris type diseas transmiss rout tempor trend morbid mortal rate calcul major infecti diseas type strong govern commit public health respons improv qualiti life led erad contain wide rang infecti diseas china infecti diseas burden experienc dramat drop revert maintain gradual upward trend notifi diseas contain low endem level local smallscal outbreak remain common tuberculosi bacteri infect reemerg preval countri sexual transmit infect rapid exponenti growth phase spread core group gener popul human immunodefici viru hiv account death case infecti diseas china zoonot infect sever acut respiratori syndrom sar rabi influenza pose constant threat chines resid remain deadli diseas type infect individu secondgener surveil behaviour risk vector associ pathogen transmiss scale implement public health intervent target hiv relev coinfect address transmiss associ highli mobil popul reduc risk crossspeci transmiss zoonot pathogen
PLoS One	19681702	2010-07-01	PMC3281143	22359682	hepat viru hcv infect major chronic liver diseas global health threat hcv vaccin current treatment antivir therapi associ advers side effect prevent therapi recurr hepat post liver transplant ns serin proteas hcv replic repres prime target develop anti hcv therapi describ therapeut approach erad hcv infect cell base protein deliveri ns proteaseactivat recombin toxin name zymoxin toxin inactiv fusion ration design inhibitori peptid nscleavabl linker deliv cell ns proteas inhibitori peptid remov reactiv cytotox activ zymoxin describ suffer limit requir high level proteas activ basal activ unactiv form narrow potenti therapeut window solut overcam major limit gener zymoxin convert mazf ribonucleas toxic compon coli chromosom mazef toxinantitoxin system nsactiv zymoxin introduc cell gene deliveri construct express cassett encod singl polypeptid incorpor toxin fragment potent natur antidot maze link nscleavabl linker coval pair inhibitor ribonucleas toler express nave healthi cell contrast activ proteolysi induc low level ns erad ns express model cell hcv infect cell zymoxin valuabl tool erad cell infect intracellular pathogen express intracellular proteas
PLoS One	17431234	2012-04-18	PMC3282722	22363606	background spread infecti diseas wildlif popul influenc pattern betweenhost contact habitat hotspot place attract larg number individu social group alter contact pattern diseas propag habitat hotspot wildlif epidemiolog focus interindividu contact occur hotspot increas diseas transmiss territori anim epidemiolog contact occur anim cross territori conspecif en rout habitat hotspot phenomenon receiv attent investig contact case infecti individu visit hotspot case individu travel hotspot methodolog princip find develop simul epidemiolog model investig case scenario transmiss hotspot occur find hotspot exacerb epidem ii infecti individu travel hotspot vulner individu resid intermedi distanc hotspot nearbi iii epidemiolog vulner popul highest number hotspot intermedi conclus signific alter anim movement vicin habitat hotspot increas spread infecti diseas diseas transmiss occur hotspot interestingli anim visit nearest hotspot creat addit artifici hotspot reduc number effici diseas control measur
PLoS One	21197421	2005-02-01	PMC3282796	22363774	the interferon induc transmembran protein ifitm famili transmembran protein inhibit cell invas virus hiv influenza ifitm gene subfamili larger famili transmembran tm protein call dispanin refer common tm structur mine dispanin eukaryot speci cover major eukaryot group investig evolutionari histori bayesian maximum likelihood approach infer phylogenet tree identifi ten human gene ifitm gene form dispanin famili dispanin emerg eukaryot common ancestor choanoflagel metazoa famili expand vertebr form subfamili ad interestingli find famili phyla bacteria propos horizont transfer eukaryot bacteria common ancestor choanoflagel metazoa bacteri eukaryot sequenc consider conserv protein structur conclus introduc novel famili dispanin nomenclatur base evolutionari origin
PLoS One	22514338	2007-10-01	PMC3283680	22363739	background southeast asia focu consider invest pandem influenza prepared wide variat socioeconom condit health system capac region impact vari degre pandem mitig oper aim estim compar resourc gap potenti mortal associ gap respond pandem influenza territori asia method find collect health system resourc data cambodia indonesia jakarta bali lao pdr taiwan thailand vietnam appli mathemat transmiss model simul mildtomoder pandem influenza scenario estim resourc gap attribut mortal provinc level territori wide variat exist resourc capac territori substanti mortal predict result resourc gap refer avoid mortal poorer area sever nationwid shortag mechan ventil estim major avoid mortal territori taiwan resourc oseltamivir hospit bed human resourc inequit distribut countri estim resourc gap avoid mortal highli sensit model paramet defin transmiss clinic sever pandem scenario geograph pattern observ territori remain rang paramet valu explor conclus find implic geograph term resourc type invest need potenti impact resourc mobil mitig diseas burden influenza pandem effect mobil resourc administr boundari minim avoid death
BMC Infect Dis	15695679	2008-12-17	PMC3285078	22280120	background previou control studi nonpharmaceut intervent npi facemask intensifi hand hygien prevent household transmiss influenza produc definit aim investig efficaci accept toler npi household influenza patient method conduct cluster random control trial pandem season ensu influenza season includ household influenza posit case absenc respiratori ill preced dai studi arm wear facemask practic intensifi hand hygien mh group wear facemask group control group main outcom measur laboratori confirm influenza infect household contact daili questionnair examin adher toler intervent recruit household control mh household household contact case influenza hn pdm infect hn pdm infect total secondari attack rate intentiontotreat analysi statist mh intervent secondari infect analys household intervent implement symptom onset case secondari infect pool mh group lower compar control group adjust odd ratio ci perprotocol analysi odd ratio reduc particip group adjust odd ratio ci except mh case adher good adult children contact case conclus household transmiss influenza reduc npi facemask intensifi hand hygien implement earli dilig concern accept toler intervent reason recommend trial registr studi regist clinicaltrialsgov identifi nct
PLoS One	17913545	2012-04-17	PMC3285191	22384119	the mammalian tickborn flaviviru group mtbfg virus associ human anim diseas enceph hemorrhag fever contrast mosquitoborn flavivirus recombin event frequent evolutionari dynam mtbfg believ essenti clonal assumpt challeng report homolog recombin tickborn enceph viru tbev perform thorough analysi publicli genom group compel evid identifi recombin time demonstr recombin larg statist support strong phylogenet evid occur mtbfg loup viru lineag put parent recombin strain breakpoint test statist signific phylogenet method investig time diverg recombin parent strain bayesian framework recombin estim occur window year unravel tempor set event adduc hypothes ecolog condit account observ recombin
PLoS One	19091867	2015-03-01	PMC3285200	22384166	viral infect implic pathogenesi multipl sclerosi epsteinbarr viru ebv frequent investig candid torqu teno viru ttv discuss context mechanist aspect remain unresolv report viral replic measur genom amplif quantit pcr ttvhd isol isol multipl sclerosi brain seri ebvposit neg lymphoblastoid burkitt lymphoma cell line demonstr replic transfect ttv genom dai post transfect evalu cell line quantit amplif indic statist enhanc ttv replic ebvposit cell line includ ebvconvert bjab comparison ebvneg burkitt lymphoma cell bjab suggest helper ebv infect replic ttv studi interact ebv ttv etiolog progress multipl sclerosi
PLoS One	22511783	2015-06-15	PMC3285652	22384022	background tradit nucleic acid amplif test naat detect hiv dna rna restrict laboratori set time equip technic expertis requir avail rapid naat applic resourcelimit pointofcar poc set fill great hiv diagnost allow time diagnosi confirm infect statu facilit diagnosi acut infect screen evalu infant born hivinfect mother isotherm amplif method reversetranscript loopmedi isotherm amplif rtlamp exhibit characterist ideal poc set typic quicker easier perform allow integr lowtech portabl heat devic methodologysignific find studi evalu hiv rtlamp assai portabl noninstru nucleic acid amplif nina heat devic gener heat exotherm reaction calcium oxid water nina heat devic exhibit stabl temperatur amplif reaction consist amplif three separ devic thermalcycl perform nina heater valid blood specimen hiv infect patient conclus rtlamp isotherm amplif method conjunct chemic heat devic portabl rapid robust naat platform potenti facilit hiv test resourcelimit set poc
BMC Genomics	25766293	2006-02-01	PMC3287582	22369688	background medic biolog technolog advanc stimul develop test system provid huge vari amount molecular clinic data grow data volum pose challeng process system center addition routin genom laboratori typic character high parallel test constant procedur chang paper describ formal approach address challeng implement genet test manag system appli human genom laboratori introduc human genom center system cegh brazil system support constant chang human genom test provid patient updat base valid genet knowledg approach common repositori process plan ensur reusabl specif instanti monitor execut process defin relat databas rigor control flow specif base process algebra acp main differ approach work join aspect process scalabl achiev relat databas implement correct process process algebra softwar allow user defin genet test requir knowledg busi process notat process algebra conclus paper present cegh system laboratori manag system lim base formal framework support genet test manag mendelian disord studi prove feasibl usabl benefit rigor approach valid perform genet test easi user interfac
Acta Vet Scand	25888573	2015-11-23	PMC3287958	22280887	background sweden knowledg role enteropathogen escherichia coli neonat calf diarrhea occurr antimicrobi resist coli young calv unknown therapeut concern knowledg requir prudent antimicrobi method case control studi esherichia coli isol faecal sampl dairi calv phenotyp biochem fingerprint analyz virul gene pcr antimicrobi suscept test determin minimum inhibitori concentr mic farm manag data collect fisher exact test univari multivari logist regress analysi perform coli test antimicrobi suscept resist substanc multiresist virul gene isol total of investig virul gene detect rare detect virul gene espp irp fyua common resist coli fulli suscept isol virul gene terz associ calf diarrhea particip herd median herd size lactat cow herd calf diarrhea problem larger cow higher calf mortal calf group feeder compar herd calf diarrhea problem associ calf diarrhea divers enter coli conclus antimicrobi resist common coli prewean dairi calv occur calv herd experienc calf diarrhea problem indic factor antimicrobi influenc epidemiolog resist coli enteropathogen coli uncommon neonat calf diarrhea swedish dairi herd practic calf diarrhea regard holist context infecti agent calf immun manag practic advic routin antimicrobi treatment recommend bacteriolog cultur test antimicrobi suscept virul factor guid decis treatment
PLoS One	16461478	2010-04-19	PMC3288082	22384201	the recognit pathogenderiv structur ctype lectin chemotact activ mediat cclccr axi critic step determin host immun respons fungi studi design investig presenc singl nucleotid polymorph snp dcsign dectin dectin ccl ccr gene influenc risk develop invas pulmonari aspergillosi ipa twentyseven snp select hybrid functionaltag approach genotyp haematolog patient fiftyseven diagnos proven probabl ipa eortcmsg criteria associ analysi reveal carrier dectin rs tt dectin rs gg genotyp dcsign rs dcsign rs dcsign dcsign allel increas risk ipa infect ci ci ci ci ci ci increas frequenc galactomannan posit patient carri dectin rst allel dectin rsgg genotyp addit healthi individu genotyp decreas level dectin mrna express compar callel carrier suggest role dectin rs polymorph determin level dectin consequ level suscept ipa infect snpsnp interact epistasi analysi reveal interact model includ snp dectin dectin ccl ccr gene synergist genet effect valid larger cohort dectin dcsign dectin ccl ccr genet variant influenc risk ipa infect develop riskadapt prophylaxi
BMC Plant Biol	26407032	2010-06-18	PMC3288756	22168212	background accumul evid specif pattern histon posttransl modif ptm crosstalk determin transcript outcom regulatori mechan histon code plant remain unknown studi demonstr time salin stress induc phd plant homeodomain finger domain protein gmphd read histon code underli methyl hk gmphd interact dna bind protein includ gmgnat acetyl transferas gmelongin a transcript elong factor gmiswi chromatin remodel protein gmphd recogn specif histon methyl hk prefer dimethyl hk illustr interact gmphd gmgnat regul selfacetyl gmgnat acetyl histon gmgnat exhibit prefer acetyl histon hk histon crosstalk methyl hk acetyl hk consist put role gene regul salin stress gmphd bind promot confirm salin induc gene soybean conclus propos model suggest nuclear protein gmphd capabl regul crosstalk histon methyl histon acetyl lysin residu gmphd recruit chromatin remodel factor transcript factor salt stress induc gene regul express respons salin stress
PLoS Negl Trop Dis	20067811	2014-01-01	PMC3289595	22389731	dengu virus denv envelop singlestrand positivesens rna virus transmit aed spp mosquito genet distinct serotyp design denv denv subdivid distinct genotyp dengu scientif commun long contend infect serotyp confer lifelong protect subsequ infect serotyp irrespect viru genotyp hypothesi increas scrutini role denv genotyp variat protect repeat infect dengu vaccin trial move increasingli fieldtest urgent develop tool better defin role genotyp variat denv infect immun better understand genotyp variat denv neutral protect design construct panel isogen recombin denv infecti clone express envelop glycoprotein denv genotyp philippin genotyp thailand genotyp ii sri lanka cuba genotyp iii puerto rico genotyp iv panel explor natur envelop variat influenc denvpolyclon serum interact recombin virus test neutral assai immun sera primari denv infect neutral titer vari fold depend express envelop glycoprotein observ variabl neutral titer suggest residu chang glycoprotein effect denv specif humor immun influenc antibodi mediat protect diseas enhanc set natur infect vaccin genotyp differ tempor spatial microevolut denv background heterotyp neutral recombin synthet tool describ valuabl test hypothes genet determin denv immunopathogenesi
PLoS One	20562343	2018-12-12	PMC3289638	22389685	background acut respiratori tract infect arti repres seriou global health burden report address preval respiratori virus rv adult arti attend emerg depart potenti impact respiratori viru infect patient remain unknown methodologyprincip find determin epidemiolog clinic profil common discov respiratori virus adult arti attend beij year consecut studi conduct april nose throat swab sampl arti patient check respiratori virus multipl revers transcript polymeras chain reactionrtpcr assai common respiratori virus includ influenza virus flu adenovirus adv picornavirus pic respiratori syncyti viru rsv parainfluenza virus piv combin realtim rtpcr human metapneumoviru hmpv human coronavirus hcov oc nl hku viral pathogen detect patient sampl patient test posit viru pic domin agent detect flua hcov adv hmpv piv flub detect rsv total preval domin viru infect detect differ previou report coinfect rate high hcove pic adv flua pattern clinic symptom associ respiratori virus conclus pattern rv involv adult arti attend china differ report high preval virus pic flua hcov adv report highlight the develop safe effect therapeut approach virus
PLoS One	25254027	2013-01-02	PMC3289664	22389704	despit consider number studi report caus agent pneumonia complet identifi comprehens appli modern tradit laboratori diagnost techniqu identifi microbiota patient admit develop pneumonia intens care unit icu threeyear period test bronchoalveolar lavag bal patient ventilatorassoci pneumonia communityacquir pneumonia nonventil icu pneumonia aspir pneumonia compar patient pneumonia control sampl test amplif rdna rdna gene clone sequenc pcr target specif pathogen includ cultur amoeba cocultur detect antibodi select agent urinari antigen test base molecular test identifi wide repertoir bacteri speci report pneumonia put bacteri phylotyp rdna gene diverg phylotyp identifi fungal speci report pneumonia virus patient microorgan singl bal sd pathogen consid typic icu pneumonia pseudomona aeruginosa streptococcu speci detect commonli control pneumonia patient strikingli highlight exist core pulmonari microbiota differ microbiota form pneumonia document
PLoS One	30541934	2017-05-31	PMC3289677	22389721	noroviru nov rna detect stool weekold cat enter felin shelter york state sequenc analysi complet capsid nov ident suggest spread uniqu nov strain shelter fulllength genom sequenc nt felin nov cueu determin capsid protein vp region viru displai highest amino acid ident anim genogroup iv genotyp giv nov lionpistoiait dogbariit find document discoveri novel felin caliciviru vesivirus extend spectrum nov host rang epidemiolog studi felin novspecif diagnost tool experiment infect cat requir understand nov pathogen role speci
ScientificWorldJournal	23283961	2017-03-08	PMC3289979	22454602	background kawasaki diseas kd acut system vascul unknown etiolog diagnosi kd depend clinic manifest preval coronari arteri abnorm caa cardiac sequela myocardi infarct coronari aneurysm seriou complic kd method divid kd children ag group month month year year paramet compar group infant month fulfil kd major diagnost criteria dai prone develop incomplet kd lowest cholesterol level greatest chanc caa laboratori featur associ caa longest time need confirm diagnosi lower hemoglobin level lower albumin level higher platelet count infant year develop higher percentag leukocytosi steril pyuria group fewer patient neck lymphadenopathi
PLoS One	28566313	2010-09-09	PMC3290546	22393386	nipah viru niv emerg zoonot paramyxoviru regular outbreak east asia mortal rate exceed major cellular target niv infect endotheli cell neuron better understand virushost interact analyz transcriptom profil niv infect primari human umbil vein endotheli cell assess vitro vivo method hamster model brain sampl nivinfect patient niv infect induc gene involv interferon respons endotheli cell top ten upregul gene identifi chemokin cxcl interferoninduc protein ip chemoattract involv gener inflammatori immun respons neurotox nivinfect hamster develop patholog human express cxcl mrna induc organ kinet niv replic final intens stain cxcl brain patient succumb lethal niv infect outbreak malaysia confirm induct chemokin fatal human infect studi shed light niv pathogenesi indic role cxcl cours infect suggest chemokin serv potenti marker lethal niv enceph
PLoS Pathog	28273006	2010-04-01	PMC3291616	22396651	while influenza virus common respiratori pathogen sporad report conjunct human infect demonstr abil viru diseas respiratori tract ocular surfac repres potenti site viru replic portal entri establish respiratori infect properti govern ocular tropism influenza virus mechan viru spread ocular respiratori tissu potenti differ respiratori diseas initi exposur rout understood establish ferret model ocular inocul explor develop viru pathogen transmiss influenza viru exposur ocular rout multipl subtyp human avian influenza virus mount product viru infect upper respiratori tract ferret ocular inocul addition detect ocular tissu acut phase infect hn virus maintain abil system spread lethal infect inocul ocular rout replicationindepend deposit viru inoculum ocular respiratori tissu limit nare upper trachea tradit intranas inocul viru deposit upper lower respiratori tract tissu despit high titer replic transmiss season virus upper respiratori tract ferret inocul ocular rout viru transmiss nave contact respiratori droplet reduc ocular inocul data improv understand mechan viru spread ocular exposur highlight differ establish respiratori diseas viru transmiss inocul volum rout
PLoS Pathog	20831712	2004-12-01	PMC3291617	22396645	vaccin highli effect prevent infecti diseas constant threat emerg pathogen necessit develop innov vaccin principl confer rapid protect case emerg increas evid point cell immun plai critic role vaccin viral diseas vaccin efficaci associ induct antibodi respons analyz immunolog mechan rapidli protect vaccinia viru immun mousepox surrog model human smallpox fast protect lethal system poxviru diseas sole depend cd cd cell respons induc vaccin highli attenu modifi vaccinia viru ankara mva convent vaccinia viru note cd cell critic requir allow mva induc cd cell expans perforinmedi cytotox kei mechan mva induc protect contrast select compon innat immun system cellmedi respons fulli dispens prevent fatal diseas immun dai challeng conclus data clearli demonstr perforindepend cd cell immun plai kei role mva confer short term protect lethal mousepox rapid induct cell immun serv paradigm treatment fit scenario protect emerg vaccin
PLoS One	19996738	2009-06-01	PMC3291649	22396796	natur hiv proteas pr homodimer research interact hiv gagpol molecul trigger activ embed pr mediat gag gagpol cleavag gagpol assembl domain pr contribut pr activ influenc pr dimer interact gagpol context determin enhanc pr dimer interact facilit pr activ singl tandem repeat leucin zipper lz pr cterminu look correl enhanc gag process effici increas gagprlz multimer capac reduct viruslik particl vlp produc hiv mutant lz fuse pr result enhanc gag cleavag effici vlp product restor wt level pr activ inhibit assembl defect consid pr activitydepend correl lz enhanc gag cleavag enhanc gagpr multimer pr dimer interact facilit forc gagpr multimer lead prematur gag cleavag result prematur pr activ conclus placement heterolog dimer domain downstream pr enhanc prmediat gag cleavag effici impli structur conform primari sequenc pr major determin hiv pr activ
PLoS Pathog	25048432	2018-05-03	PMC3291650	22396652	the innat immun respons defens virus pathogen respond specif microbi molecul influenza viru iav produc doublestrand rna intermedi replic life cycl activ intracellular pathogen recognit receptor rigi induc product proinflammatori cytokin antivir interferon understand mechan regul innat immun respons iav virus kei develop novel therapeut strategi myeloid cell specif knockout mice examin role ubiquitinedit protein respons myeloid cell iav infect defici macrophag hyperrespons doubl strand rna iav infect illustr enhanc nfb irf activ concomit increas product proinflammatori cytokin chemokin type interferon vivo associ increas number alveolar macrophag neutrophil lung iav infect mice surprisingli myeloid cell specif knockout mice protect lethal iav infect challeng gener belief excess host proinflammatori respons associ iavinduc lethal condit inhibit of interest manag iav infect
Sensors (Basel)	19634388	2012-02-15	PMC3291918	22408533	antibodybas sensor permit rapid sensit analysi rang pathogen associ toxin critic assess implement format provid refer principl problem potenti onsit analysi emphasi detect foodborn bacteri pathogen escherichia coli listeria monocytogen addit exampl relat monitor fungal pathogen virus mycotoxin marin toxin parasit provid
Evid Based Complement Alternat Med	29720574	2013-02-01	PMC3292204	22454679	object aim studi measur reliabl extern valid amstar appli sampl tcm systemat review studi design method test agreement reliabl construct valid feasibl amstar comparison oqaq statist analys perform spss random sampl tcm systemat review select databas interrat agreement individu item amstar moder kappa ci icc amstar oqaq total score item exclud item ci conclus room improv item tool reliabl valid easi methodolog qualiti assess systemat review tcm
PLoS One	22114176	2017-01-25	PMC3292545	22396728	emerg virus includ nipah hendra lujo junin virus enorm potenti spread rapidli nipah viru emerg zoonosi evolv capac humantohuman transmiss diseas caus pathogen untreat requir high biocontain condit univers method rapidli identifi screen candid antivir urgent need develop modular antivir platform strategi reli simpl bioinformat genet pathogen central platform envelop glycoprotein cdna establish multicycl replic system bsl condit viral pathogen requir bsl bsl facil gener monoclon antibodi nipah cdna immun rat antibodi neutral nipah hendra live virus effect henipaviru inhibitor valid screen strategi propos strategi contribut respons capabl emerg infecti diseas provid initi antivir develop identifi novel virus
BMC Infect Dis	23261843	2001-06-15	PMC3292988	22284435	background emerg medic admiss depart ed mad prompt recognit appropri infect control manag patient highli infecti diseas hid viral hemorrhag fever sar fundament avoid nosocomi outbreak method euronhid european network highli infecti diseas project collect data ed mad european countri locat facil nationalregion referr centr hid develop checklist onsit visit februari novemb isol room facil room anteroom dedic entranc neg pressur hepa filtrat exhaust air centr isol room characterist personnel train recognit hid facil manag protocol hid conclus prepared level safe appropri manag hid partial adequ survei ed mad
PLoS One	28122975	2015-07-01	PMC3293820	22403676	rapid accur detect identif virus caus respiratori tract infect patient care diseas control despit fact assai identif etiolog agent patient suffer respiratori tract diseas aim current studi develop diagnost set detect respiratori virus sensit low copi reaction evalu assai train clinic sampl set viral nucleic acid identifi case improv assai perform facilit identif novel speci emerg strain cultur fulli differenti human airwai epithelium preamplifi infecti virus addit step detect pathogen sampl test base hypothes lack etiolog agent clinic sampl report observ studi result presenc unknown viral speci imperfect detect method us
Environ Health Perspect	11371518	2012-01-25	PMC3295348	22113877	background incid outbreak frequenc distribut infecti diseas gener expect chang consequ climat chang limit region guid decis make object survei govern offici design compet bodi scientif advic concern infecti diseas examin degre concern potenti effect climat chang infecti diseas percept institut capac respect countri method nation infecti diseas expert european econom area countri survei project infecti diseas pattern relat climat chang countri nation capac cope larg major respond agre climat chang affect vectorborn countri repres foodborn waterborn rodentborn diseas countri addit indic institut improv need ongo surveil program collabor veterinari sector manag anim diseas outbreak nation monitor control climatesensit infecti diseas health servic infecti diseas outbreak diagnost support epidem conclus expert respons gener consist peerreview literatur relationship climat chang vector waterborn diseas foodborn diseas shortcom institut capac manag climat chang vulner identifi assess address impact vulner adapt assess
PLoS Negl Trop Dis	25786081	2015-03-04	PMC3295819	22413033	background ten million dengu case lifethreaten complic occur annual tool need distinguish dengu febril ill addit natur histori pediatr dengu earli ill communitybas set welldefin method data multiyear ongo pediatr dengu cohort studi children ag year managua nicaragua examin frequenc clinic sign symptom dai ill gener model associ sign symptom earli phase ill entir cours ill test dengueposit odd ratio or confid interv calcul gener estim equat gee repeat measur adjust ag gender onefourth children test dengueposit meet case definit suspect dengu frequenc sign symptom vari dai ill dengu statu diseas sever multivari gee model increas odd test dengueposit associ fever headach retroorbit pain myalgia arthralgia rash petechia posit tourniquet test vomit leukopenia platelet cellsml poor capillari refil cold extrem hypotens estim or tend higher sign symptom cours ill compar earli phase ill conclus daybydai analysi clinic sign symptom longitudin statist analysi associ test dengueposit differ earli phase ill compar entir cours ill find stress consid dai ill develop predict algorithm realtim clinic manag
Virol J	22308474	2007-10-01	PMC3296551	22188662	background avian leukosi viru alv major infecti diseas impact poultri industri worldwid despit intens effort effect vaccin develop alv mutat lead resist form dire develop antivir agent treatment alv infect rna interfer rnai consid effect antivir strategi studi avian leukosi viru subgroup alvj provir genom includ gag gene treat target rnai pair mirna sequenc design synthes target region gag gene screen target gag gene effect suppress replic alvj avoid gener escap variant viru infect express vector multitarget mirna construct multitarget serial strategi region gag pol env gene multitarget mirna plai synergist role inhibit alvj replic inhibit effici viral replic rang conclus strategi multitarget mirna effect method inhibit alv replic acquisit resist mutat
Scand J Trauma Resusc Emerg Med	25741010	2008-07-01	PMC3296571	22309772	background hospit cornerston health care commun continu function face disast hospit incid command system hic method hospit oper emerg declar hospit equip evalu strength vulner manag system occurr actual disast main object studi measur decis make perform hic job action sheet tabletop exercis method observ studi conduct st august st twenti three iranian hospit includ tabletop exercis develop hospit turn base highest probabl risk job action sheet hic measur perform indic consid hic fair perform determin intermedi high maximum score descript statist ttest univari analysi varianc particip hospit hospit disast manag plan perform hic intermedi particip hospit hospit high level perform perform level individu section intermedi fair logist financ section demonstr higher level perform public hospit higher perform univers hospit conclus decis make perform iranian hospit measur tabl top exercis indic propos hic intermedi poor addit studi demonstr hic job action sheet templat measur hospit respons simul assess prepared correl outcom remain studi
PLoS One	17872527	2019-08-05	PMC3296753	22412934	sever acut respiratori syndrom sar zoonot diseas caus sarsrel coronaviru sarscov emerg global health concern origin outbreak control classic public health measur real risk sarscov reemerg natur reservoir origin form virul pathogen strain case viru difficult control absenc effect antivir drug vaccin wellstudi sarscov isol hku develop vaccinia virusbas sarscov revers genet system robust biosaf sarscov genom clone separ vaccinia viru vector vsarscovprim vsarscovprim cdna subsequ ligat creat genomelength sarscov cdna templat vitro transcript sarscov infecti rna transcript transfect rna transcript permiss cell led recoveri infecti viru recsarscov character plaqu produc recsarscov size parent sarscov isol hku smaller sarscov isol frankfurt compar analysi replic kinet kinet recsarscov replic sarscov frankfurt titer viru releas cultur supernat fold revers genet system final gener recsarscov report viru express renilla luciferas order facilit analysi sarscov gene express human dendrit cell hdc parallel renilla luciferas gene insert genom human coronaviru hcove approach demonstr contrast hcove sarscov mediat effici heterolog gene express hdc
BMC Complement Altern Med	18441099	2011-02-01	PMC3297520	22314101	abstract background standard korean red ginseng extract bestsel influenzalik ill ili remedi korea controversi efficaci korean red ginseng krg reduc ili incid remain aim studi assess efficaci krg extract ili incid healthi adult methodsdesign will conduct random doubleblind placebocontrol studi onset influenza season total subject year ag will recruit gener popul subject will instruct capsul dai krg extract placebo period month primari outcom measur assess frequenc ili onset particip subject secondari variabl measur will includ sever durat ili symptom ili symptom will score subject point scale discuss studi random placebo control trial evalu efficaci krg extract compar placebo will provid valuabl clinic physiolog effect krg extract reduct ili incid includ flu upper respiratori tract infect studi pragmat design ensur studi find implement clinic practic krg extract effect reduct strategi ili incid trial registr nct
BMC Syst Biol	31387963	2015-01-01	PMC3297540	22189154	background respiratori viral infect host injuri occur inappropri host respons studi sought uncov host transcript respons underli differ high lowpathogen infect compendium studi includ respons influenza subtyp hn reconstruct influenza viru sar coronaviru metaanalysi deriv multipl gene express signatur compar signatur capac segreg biolog condit pathogen predict pathogen test data set highestperform signatur express continuum low medium highpathogen sampl suggest direct analog relationship express pathogen signatur compris gene includ subnetwork chemokin implic dysregul cell recruit injuri conclus highli pathogen virus elicit express of kei gene lower pathogen virus higher degre increas degre express result uncontrol coloc inflammatori cell type lead irrevers host damag
PLoS One	21164083	2014-08-01	PMC3297595	22412845	multipl sclerosi ms demyelin diseas unknown origin central nervou system estim american gbvc hepat flaviviru serum of blood donor origin associ hepat believ nonpathogen lymphotrop viru fifti frozen specimen brain deceas person ms normal control brain specimen rna extract ribosom rna deplet sequenc illumina gaii bp read compar nonredund databas deriv viral sequenc genbank organ taxa individu read align viral databas consid hit normal ms specimen hit rate viral taxon compar distribut hit normal control seventeen ms control brain extract sequenc yield sequenc read overrepresent sequenc viral taxa observ ms sampl sequenc resembl virus implic pathogenesi ms enrich diseas brain specimen sequenc gb viru gbvc flaviviru isol brain enrich ms sampl gbvc brain specimen confirm specif amplif singl ms brain specimen ms brain sampl entir kb sequenc gbvc isol report studi feasibl deep sequenc detect occult viral infect brain deceas person ms isol gbvc human brain report here
Acta Vet Scand	26435942	2017-01-01	PMC3298528	22289165	background aim studi detect associ bovin herpesviru bhv statu herd respiratori diseas brd occurr reproduct perform pregnant heifer cow associ managementrel factor higher brd occurr estim method serum sampl collect cow youngstock dairi cattl herd analyz antibodi bhv bovin respiratori syncyti viru brsv bovin viral diarrhoea viru bvdv mycoplasma bovi questionnair collect data concern herd manag factor reproduct perform occurr clinic sign respiratori diseas year evalu veterinarian farm manag multipl correspond analysi mca logist regress analysi perform identifi quantifi risk factor low moder preval brsv antibodi youngstock associ high occurr respiratori diseas cow incalf heifer employe farm particip spread diseas larger herd size looseh cow hous youngstock separ cow pregnanc purchas anim factor high occurr respiratori diseas symptom pregnant heifer cow highest risk abort increas insemin number insemin pregnanc occur herd moder preval bhv antibodi cow conclus bhv associ acut respiratori diseas adult dairi cattl reproduct perform brsv possess main role respiratori diseas complex adult dairi cattl
Biol Proced Online	25015856	2014-08-27	PMC3298716	22304896	background understood tumor cell express tumorassoci antigen taa low immunogen exampl carcinoembryon antigen cea express human colon cancer cell view lowimmunogen taa activ host immun specif taa suppress tumor growth cancer therapi develop enhanc immun effici cea mice receiv fuse partial cea gene exogen sarscov fragment oral vaccin attenu salmonella typhimurium strain transform plasmid encod ceasarscov fusion gene balbc mice elicit increas tnf il serum addit smaller tumor volum observ ctceabear mice receiv ceasarscov gene therapi comparison administ cea conclus administr fuse ceasarscov fragment provid promis strategi strengthen antitumor efficaci lowimmunogen endogen tumor antigen
Virol J	27997480	2012-04-02	PMC3298799	22340040	background porcin reproduct respiratori syndrom viru prrsv chronic econom devast diseas pig ag frequent mutat viral genom result virus immun escap mutant irrespect regular vaccin control prrsv remain challeng swine farmer prrsvinfect pig innat cytokin ifn inhibit adapt arm immun delai elucid cellular innat cytokin respons earli stage prrsv infect week pig maintain commerci pig farm infect analyz pig pen pig prrsv infect respons pig penmat assess dai infect contact neighbor pig virem dai postinfect virem pig greater reduct nk cellmedi cytotox fold increas ifn product detect blood pig enhanc secret il il il ifn prrsv infect pig observ addit reduc frequenc myeloid cell cdcd cell cdcd cell upregul frequenc lymphocyt bear natur regulatori cell phenotyp detect virem pig interestingli virem contact pig compar immun cell modul conclus replic prrsv infect contact pig respons rapid modul nk cellmedit cytotox alter product immun cytokin prrsvinduc immunolog chang observ simultan cellular cytokin level earli postinfect appear respons delai gener adapt immun studi perform pig maintain commerci environment condit studi practic implic design protect vaccin
Virol J	25165025	2015-02-01	PMC3298800	22340205	background goatpox econom diseas goat sheepproduc area vaccin strategi develop control diseas complet success hairpin express vector induc gene silenc larg number studi virus studi attempt studi gtpv interest exploit improv method control goat pox particip rnai provid effect protect gtpv studi suppress goatpox viru gtpv replic knockdown virion core protein rna interfer short interf rna sirna sequenc sirna sirna sirna sirna region gtpv orf select sens antisens sirnaencod sequenc separ hairpin loop sequenc design short hairpin rna shrna express cassett control human promot orf amplicon gener pcr clone pegfpn vector name pegfp pegfp sirna express cassett p p cotransfect bhk cell fluoresc detect flow cytometr analysi retro transcript pcr rtpcr real time pcr check effici rnai the orfspecif sirna effect downregul express orf vero cell transfect shrna express vector pgfp pgfp pgfp pgfp infect gtpv gtpvorf effect inhibit site decreas cytopath cpe induc gtpv present indic dnabas sirna effect inhibit replic gtpv fold reduct viral titer vero cell conclus studi demonstr vectorbas shrna methodolog effect inhibit gtpv replic vero cell simultan work repres strategi control goatpox facilit experiment approach analysi viral cellular gene function gtpv infect
PLoS One	22449252	2008-11-01	PMC3299779	22428032	in field herpesviru exact molecular mechan virus reactiv latenc remain elus kaposi sarcomaassoci herpesviru kshv exist latent state cell support lytic infect specif time kshv reactiv latenc exceedingli intric process mediat integr viral cellular factor lab describ earli growth respons egr essenti compon kshv reactiv process abil mediat transcript kshv orf gene encod replic transcript activ rta viral compon control switch latent lytic infect electrophoret mobil shift assai emsa chromatin immunoprecipit chip experi reveal egr bind kshv orf promot orfp gcrich bind domain express profil cellular egr kshvencod orf follow pattern de novo kshv infect overexpress egr signal compon downstream rafmekerk kshvinfect cell activ kshv lytic replic perform physiolog relev experi analyz dietari supplement resveratrol kshvinfect cell time demonstr resveratrol lower erk activ express egr kshvinfect cell suppress viru reactiv latenc find will undoubtedli contribut futur studi combat kshv diseas condit herpesvirusesinduc pathogenesi
PLoS One	25723284	2017-10-15	PMC3302803	22427871	background concern rais transmiss emerg infecti diseas patient healthcar worker hcw vice versa recogn prevent time manner effect strategi block transmiss pandem hn influenza hcw methodologyprincip find infect control program implement survei prevent nosocomi outbreak hn influenza bed tertiarycar academ hospit total employe kaohsiung chang gung memori hospit record temperatur receiv onlin educ control practic influenza infect administr record provid vaccin record occup characterist hcw earli recognit pandem hn influenza case semistructur questionnair analyz rout patient contact household contact unspecifi contact surveil span august januari hcw confirm novel hn influenza quantit realtim revers transcript polymeras chain reaction preval patient contact household contact unspecifi contact infect preval novel hn infect lower vaccin hcw unvaccin hcw higher viral load throat swab hcw patient household contact infect unspecifi contact infect copiesml log conclus surveil system daili temperatur record onlin educ hcw low attack rate hn influenza transmiss hn influenza vaccin attack rate decreas mass vaccin unspecifi contact infect rate higher patient contact household contact infect highlight public educ influenza transmiss addit hospit infect control
PLoS One	18832004	2014-11-11	PMC3303816	22432004	background pandem season respiratori virus major global health concern genet divers respiratori virus emerg drug resist strain target disrupt human hostviru interact potenti therapeut strategi treat multivir infect avail largescal genom dataset focus hostpathogen interact discov novel drug target potenti opportun drug reposit methodsresult studi perform largescal analysi microarrai dataset involv host respons infect influenza viru respiratori syncyti viru rhinoviru sarscoronaviru metapneumonia viru coxsackieviru cytomegaloviru common gene pathwai rigor iter analysi pipelin relev host mrna express dataset identifi analyz qualiti gene differenti express map pathwai enrich analysi repurpos drug target databas literatur search total common biolog pathwai identifi respiratori virus analyz repres fifteen laboratori cell type arrai platform larg overlap gener immun respons observ top twenti pathwai ad valid analysi strategi top pathwai differenti express gene virus therapeut indic exist small molecul biolog agent target protein encod gene ilb tnf casp mmp pathwai enrich analysi identifi potenti novel host respons parkinubiquitin proteasom system parkinup pathwai involv progress neurodegen parkinson diseas conclus studi suggest multipl divers respiratori virus invok common host respons pathwai analysi pathwai suggest potenti opportun therapeut intervent
PLoS One	28959932	2012-06-01	PMC3303824	22432012	synthesi interferon ifn innat respons cytoplasm infect bacteri pathogen studi listeria monocytogen limit immun detect ifn synthesi deacetyl peptidoglycan render bacterium resist lysozym degrad examin signal requir massiv ifn product infect murin macrophag mutant strain monocytogen pgda unabl modifi peptidoglycan report identif unconvent signal pathwai ifn gene requir tlr bacteri intern induct ifn independ maltirap adaptor protein requir trif transcript factor irf irf pathwai stimul lesser degre wildtyp monocytogen oper resid inflammatori macrophag deriv periton caviti bone marrowderiv macrophag novelti find li descript tlr trif critic compon lead induct ifn gene uncov individu macrophag popul adopt strategi link pathogen recognit signal ifn gene express
PLoS One	25142864	2013-02-01	PMC3303828	22432020	the preval preexist immun adenovirus major human popul advers impact develop adapt immun respons adenoviru vectorbas vaccin address issu prime balbc mice intranas intramuscularli vari dose wild type wt human adenoviru subtyp develop immun immun anim rout inocul vector hadhanp express hemagglutinin ha nucleoprotein np avietnam hn influenza viru immunogen protect low level vector immun virusneutr titer induc prime mice plaqu form unit pfu hadwt advers impact protect efficaci vaccin high level vector immun virusneutr titer induc prime mice pfu hadwt overcom increas vaccin dose altern rout vaccin increas prime dose pfu allow partial protect strategi overcom variabl level human immun adenovirus lead better util vectorbas vaccin
Sensors (Basel)	23682295	2009-02-01	PMC3304132	22438730	recent drug discoveri effort util high throughput screen ht larg chemic librari identifi compound modifi activ discret molecular target molecular target approach drug screen pharmaceut biotechnolog industri amount knowledg protein structur comput simul molecular target approach requir structur target molecul understand physiolog function approach drug discoveri limit identif novel drug altern phenotyp pathwayscreen approach drug discoveri gain popular academ sector approach opportun identifi promis drug candid enabl novel biolog pathwai unveil report assai power tool phenotyp screen compound librari report gene assai encod secret protein enabl screen hit molecul live cell anim cell animalbas screen enabl simultan evalu drug metabol toxic biolog activ drug candid identifi screen increas biolog efficaci lower risk side effect human articl review report bioassai system phenotyp drug discoveri
Virol J	29503665	2010-10-06	PMC3305475	22369052	japanes enceph virusjev tickborn enceph virustbev eastern equin enceph viru eeev symptom enceph establish accur easi method detect virus essenti prevent treatment associ infecti diseas current multipl antigen detect method clinic elisaarrai detect multipl antigen easi handl inexpens enorm potenti pathogen detect elisaarrai method simultan detect enceph virus develop studi monoclon antibodi encephalitisassoci virus prepar develop elisaarrai elisaarrai assai base sandwich elisa format consist viral antibodi print directli microtit plate allow direct detect virus develop elisaarrai prove specif higher sensit compar convent elisa method valid viral cultur three chicken egg inocul infect patient serum demonstr develop elisaarrai sensit easi potenti clinic us
J Neuroinflammation	19532096	2016-10-13	PMC3305694	22145790	background multipl sclerosi ms character patholog traffick leukocyt central nervou system cn murin ms model experiment autoimmun encephalomyel eae demonstr antagon chemokin receptor cxcr block endotheli cell sequestr cxcl enhanc ablumin local cxcrexpress leukocyt cxcr antagon led decreas parenchym entri leukocyt amelior ongo diseas eae note anim receiv high dose cxcr antagonist recov baselin function assess standard clinic score function recoveri reflect axon integr util diffus tensor imag dti evalu axon injuri cxcr antagonist versu vehicletr mice recoveri eae method cblj mice underw adopt transfer mogreact cell treat daili cxcr antagonist vehicl dai evalu dti assess axon injuri imag spinal cord underw histolog analysi myelin oligodendrocyt stain luxol fast blue lfb immunofluoresc myelin basic protein mbp glutathion stransferas gst detect nonphosphoryl neurofila nhf perform detect injur axon statist analysi eae score dti paramet nonphosphoryl nhf immunofluoresc anova bonferroni posthoc test statist analysi consid vivo dti map spinal cord ventrolater white matter vlwm axial diffus nave cxcr antagonisttr mice indistinguish vehicletr anim exhibit decreas axial diffus quantit differ injur axon assess detect nonphosphoryl nhf consist axial diffus measur qualit myelin content presenc oligodendrocyt treatment group expect radial diffus valu quantit assess persist inflammatori infiltr reveal decreas parenchyma cxcr antagonisttr mice versu control conclus data cxcr antagon prevent persist inflamm preserv axon integr target cxcr modifi diseas sever recoveri eae suggest role molecul phase diseas
PLoS One	20926577	2016-01-27	PMC3306400	22438922	background preexist immun vaccinia tian tan viru vtt larg vaccin campaign smallpox prior earli china major issu applic vttvector base vaccin essenti establish sensit highthroughput neutral assai understand epidemiolog vacciniaspecif immun current popul china methodologyprincip find antivaccinia viru vacv neutral assai attenu replicationcompet vtt carri firefli luciferas gene photinu pyrali rtvfluc establish standard critic paramet includ choic cell viral infect dose infect time current studi evalu mainten virusspecif immun smallpox vaccin conduct nonrandom crosssect analysi antivir antibodymedi immun respons volunt examin year vaccin rtvfluc neutral assai detect neutral antibodi nab vaccinia viru abil differenti strain vaccinia viru neutral titer measur assai tradit plaqu reduct neutral test prnt assai low preval nab vtt individu born beij anhui provinc china antivtt nab titer low nab detect sampl individu born differ observ titer preval gender ag rang geograph origin conclus simplifi sensit standard reproduc highthroughput assai develop quantit nab vaccinia strain current studi insight futur develop vttbase vaccin beij anhui provinc china
BMC Vet Res	27738775	2008-01-23	PMC3307427	22280482	background genera chlamydia develop refin diagnost techniqu allow identif speci capabl infect pig epidemiolog clinic zoonot impact speci unknown studi aim investig presenc chlamydia spp intestin grow pig conjunctiv swab finish pig relat find clinic sign histolog pig intestin lesion consist chlamydi infect pcr fortysix pig posit sampl inhibit sequenc dna extract identifi chlamydia sui immunohistochemistri sampl posit relationship detect macroscop visibl intestin lesion high degre infect realtim pcr differ detect pig conjunct ct emploi ct emploi conclus chlamydia sui demonstr sampl correl clinic sign detect correl sampl high degre infect presenc clinic sign intens pig product system studi predispos transmiss mainten infect increas infecti load risk diseas pig
PLoS One	26819316	2009-06-01	PMC3307712	22442662	alcohol abus associ increas lung infect molecular understand underli mechan complet airwai epitheli ion transport regul homeostasi airwai surfac liquid essenti airwai mucos immun lung host defens airliquid interfac cultur calu epitheli cell basolater expos physiolog relev concentr ethanol mm hour adenosinestimul ion transport measur uss chamber ethanol exposur reduc epitheli shortcircuit current isc dosedepend manner ion current activ adenosin chlorid conduct mediat cystic fibrosi transmembran conduct regul cftr campactiv chlorid channel alloxazin specif inhibitor ab adenosin receptor abar abolish adenosinestimul chlorid transport suggest abar major receptor respons regul chlorid transport cell ethanol reduc intracellular camp product adenosin stimul ethanolsuppress chlorid secret restor camp analog inhibitor block camp degrad impli ethanol exposur dysregul cftrmediat chlorid transport airwai suppress adenosineabarcamp signal pathwai contribut alcoholassoci lung infect
PLoS Negl Trop Dis	18216100	2005-05-01	PMC3308941	22448291	the filovirus marburg viru ebola viru sever hemorrhag fever high mortal human nonhuman primat promis filoviru vaccin develop system base recombin vesicular stomat viru rvsv express individu filoviru glycoprotein gp place vsv glycoprotein main concern replicationcompet vaccin includ rvsv filoviru gp vector safeti address concern perform neurovirul studi cynomolgu macaqu vaccin administ intrathalam anim receiv rvsv vector express zair ebolaviru zebov gp anim receiv rvsv vector express lake victoria marburgviru marv gp three anim receiv rvsvwild type wt vector anim receiv vehicl control three anim rvsvwt sever neurolog symptom anim receiv vehicl control rvsvzebovgp rvsvmarvgp develop symptom histolog analysi reveal major lesion neural tissu three rvsvwt anim lesion observ anim filoviru vaccin vehicl control group data rvsv filoviru gp vaccin vector lack neurovirul properti associ rvsvwt parent vector support develop vaccin platform human us
PLoS One	19285129	2017-05-02	PMC3308943	22448222	the azurophil granul human neutrophil defensin call human neutrophil peptid hnp hnp tridisulfidelink antimicrobi peptid involv intracellular kill organ phagocytos neutrophil peptid produc inact precursor prohnp process activ microbicid unidentifi convertas prohnp express coli affinitypurifi propeptid isol speci matur hnp sequenc nativ disulfid linkag fold prohnp nonn disulfid link prohnp conform misfold prohnp nativ hnp liber cnbr treatment fold prohnp microbicid staphylococcu aureu peptid deriv misfold prohnp inact hypothes neutrophil elastas ne proteinas pr cathepsin cg serin proteas coloc hnp azurophil granul prohnp activ convertas fold prohnp convert matur hnp ne pr cg gener hnp variant ntermin dipeptid extens ne pr cleav fold prohnp produc peptid indistinguish nativ hnp purifi neutrophil microbicid activ vitro deriv natur hnp peptid equival contrast misfold prohnp conform degrad extens condit ne pr possess prohnp convertas activ requir presenc nativ hnp disulfid motif high fidel activ precursor vitro
PLoS One	15855455	2015-07-16	PMC3309005	22448284	we earlier establish model persist viral cn infect week immunolog normal genet unmodifi mice recombin measl viru mv model infect investig role regulatori cell treg regul immun respons brain assess persist cn infect modul manipul treg peripheri cd cd foxp treg expand deplet persist phase cn infect consequ virusspecif immun respons extent persist infect analyz virusspecif cd cell recognis hdbpresent viral hemagglutinin epitop mvh rivinrehl quantifi brain pentam stain expans treg intraperiton ip applic superagonist anticd antibodi induc transient immunosuppress caus increas viru replic spread cn contrast deplet treg diphtheria toxin dt dereg deplet regulatori cellsmic induc increas virusspecif cd effector cell brain caus reduct persist infect data indic manipul treg peripheri util regul viru persist cn
PLoS One	28462731	2010-02-02	PMC3309934	22470502	thi investig evalu distribut airborn adenoviru mycoplasma pneumonia public area pediatr depart children hospit northern taiwan airborn viral bacteri concentr evalu week year filter sampl airflow rate liter minut hour pediatr outpati depart hour pediatr emerg room realtim polymeras chain reaction assai conduct analysi air sampl pediatr emerg room adenoviru fortysix percent air sampl pediatr outpati depart contain mycoplasma pneumonia dna product high detect rate airborn adenoviru dna juli august pediatr public area airborn mycoplasma pneumonia detect juli pediatr emerg room peak level august januari pediatr outpati depart airborn particl contain adenoviru mycoplasma pneumonia preval pediatr public area potenti relationship airborn viralbacteri particl human infect examin keyword adenoviru mycoplasma pneumonia filter sampl realtim polymeras chain reaction hospit pediatr public area
J Clin Med Res	26151319	2006-08-23	PMC3311442	22481989	background chlorin pulmonari irrit ga acut damag respiratori system paper sociodemograph clinic characterist accident expos patient chlorin ga report emerg treatment modal discuss method emerg depart applic retrospect analyz evalu accident chlorin ga exposur year patient classifi group sever clinic laboratori find base literatur durat land stai emerg depart group expos discharg hour second group moder expos treat observ hour third group sever expos hospit patient initi treat combin humidifi oxygen corticosteroid bronchodil averag ag year ci femal children twentyfour patient includ second third group present symptom cough nausea vomit conjunctiva hyperemia group group symptom dyspnea second group second group symptom palpit weak chest tight third group cough dyspnea patient patient di conclus author recommend symptomat expos patient specif treatment symptomat treatment suffici keyword accident chlorin exposur chlorin ga chlorin intox emerg depart
Global Health	20124557	2014-10-01	PMC3313850	22233652	background intern health regul ihr develop aim govern intern respons public health risk emerg document requir health organ member state detect assess notifi report potenti public health emerg intern concern pheic specif timelin annex ihr outlin decisionmak criteria stateappoint nation focal point nfp report potenti pheic critic compon effect function ihr method aim studi review evalu function annex whoreport state parti specif object ascertain nfp awar knowledg annex practic tool activ implement perceiv userfriendli qualit telephon interview quantit onlin survei administ nfp octob februari total nfp particip qualit quantit studi qualit interview nfp strong work knowledg annex perceiv tool relev guid decis institution manag legisl commun system support nfp perceiv annex human diseasecentr emphas reduc applic potenti pheic involv bioterrorist attack infecti diseas anim radionuclear chemic spill water foodborn contamin quantit survei respond report excellentgood knowledg annex report alwaysusu annex assess potenti pheic indic countri legal regulatori administr provis annex indic annex alwaysusu facilit decis notifi potenti pheic conclus evalu includ larg sampl whoreport state parti ihr annex perceiv guid decis notifi potenti pheic scope expand train guidanc applic ihr annex specif context continu monitor evalu function ihr imper promot global health secur
PLoS One	16928748	2017-03-12	PMC3313918	22479434	xenotrop murin leukemia virusrel viru xmrv gammaretroviru origin identifi human prostat cancer patient subsequ link chronic fatigu syndrom studi xmrv recombin mous retroviru associ human diseas question demonstr xmrv envelop envmedi pseudovir infect block lysosomotrop agent cellular proteas inhibitor suggest xmrv entri phdepend full length xmrv env unabl induc syncytia format cellcel fusion cell overexpress viral receptor xpr truncat ctermin amino acid residu cytoplasm tail ct xmrv env induc substanti membran fusion permiss cell nonpermiss cho cell lack function xpr receptor increas fusion activ truncat correl enhanc su shed cultur media suggest conform chang ectodomain xmrv env notic truncat ct xmrv env proxim membranespan domain sever impair env fusogen dramat decreas env incorpor momlv oncoretrovir hiv lentivir vector greatli reduc viral transduct collect studi reveal xmrv entri requir low ph low phdepend host proteas cytoplasm tail xmrv env critic modul membran fusion cell entri data impli addit cellular factor xpr involv xmrv entri
PLoS One	25141764	2014-05-07	PMC3314701	22470518	the substanti winter influenza peak temper climat lead hypothesi cold andor dry air causal factor influenza variabl examin relationship cold andor dry air daili influenza pneumonia mortal cold season york metropolitan area conduct retrospect studi relat daili pneumonia influenza mortal york citi surround daili air temperatur dew point temperatur measur atmospher humid daili air mass type identifi high mortal dai period emploi tempor smoother lag account latenc period time infect death unpair ttest compar high mortal event nonev nonparametr bootstrap regress analysi examin characterist longer mortal episod statist associ period low dew point temperatur normal pneumonia influenza mortal dai durat sever high mortal episod invers correl morn dew point temperatur prior episod week moist polar air mass common air mass character low dew point temperatur likewis normal mortal dai support content cold dry air influenza mortal suggest warn system provid lead time effect mitig effect
Viruses	28385826	2007-10-12	PMC3315214	22470834	the domest cat afflict multipl virus serv power model human diseas includ cancer sar hivaid cat virus diseas studi decad reveal detail insight concern transmiss virul origin pathogenesi review genet advanc question tradit wisdom origin virul felin infecti periton fip diseas pathogen potenti felin immunodefici viru fiv wild nondomest felida speci restrict felin leukemia viru felv mediat immun impair domest cat felida speci interpret indic evolutionari conclus implic deadli infecti agent domest nondomest felid
Viruses	24807820	2018-12-01	PMC3315215	22470835	ebolaviru ebov marburgviru marv compos filoviru famili neg strand rna virus infect broad rang mammalian cell studi indic cellular entri famili virus requir seri cellular protein interact molecular mechan uniqu filovirus commonli viral glycoprotein detail entri pathwai highlight viru entri cell initi interact viral glycoprotein subunit gp adher factor receptor surfac host cell epitheli cell demonstr tim serv receptor famili virus cell surfac receptor cell type remain unidentifi receptor bind viru intern endosom macropinocytosi mechan acidifi endosom heavili glycosyl gp cleav smaller form low phdepend cellular proteas cathepsin expos residu receptor bind site rb detail molecular event cathepsindepend trim gp current incomplet process gp interact endosomallysosom membran niemann pick npc protein express npc requir product infect suggest gpnpc interact late step entri process addit event gp process andor reduc event requir gener fusionreadi form glycoprotein achiev sequenc filoviru gp subunit mediat viralcellular membran fusion mechan describ envelop virus multistep entri pathwai highlight complex highli orchestr path intern fusion appear uniqu filovirus
Virol J	18059307	2004-07-29	PMC3315793	21414233	background porcin circoviru type pcv caus agent postwean multisystem wast syndrom pmw porcin dermat nephropathi syndrom pdn caus heavi loss global agricultur decad rapid detect pcv effect prophylaxi treatment pmw loopmedi isotherm amplif lamp assai detect pcv studi three pair primer special design recogn distinct sequenc orf gene gene li pcv viru genom sequenc encod rep protein involv viru replic time temperatur condit amplif pcv gene optim min analysi clinic sampl indic lamp method highli sensit detect limit pcv lamp assai copi limit convent pcr copi assai crossreact pcv porcin reproduct respiratori syndrom viru porcin epidem diarrhea viru transmiss gastroenter pig viru rotaviru sampl test establish lamp system detect posit conclus newli develop lamp detect method pcv specif sensit rapid simpl complement extend previou method pcv detect altern approach detect pcv
PLoS One	30480497	2009-06-01	PMC3316688	22479637	interferoninduc transmembran ifitm protein restrict entri process pathogen virus includ flavivirus west nile viru dengu viru denv denv infect cell directli antibodydepend enhanc ad fcreceptorbear cell process thought contribut sever diseas secondari infect investig ademedi denv infect bypass ifitmmedi restrict ifitm protein protect secondari infect observ ifitm protein restrict ademedi direct infect compar effici myelogen leukemia cell data ifitm protein contribut control secondari denv infect
PLoS One	15306389	2006-03-01	PMC3316689	22479609	background human bocaviru hbov newli discov parvoviru increas evid support role etiolog agent lower respiratori tract infect lrti object studi assess impact hbov viral load clinic characterist children hbov posit suffer sever lrti method lower respiratori tract aspir hospit children sever lrti bronchoscopi hbov detect realtim pcr infecti agent examin pcr andor direct fluoresc assai thirtyon patient test posit hbov respiratori tract aspir fifteen sampl high viral load copiesml sixteen sampl low viral load copiesml durat present wheez hospit longer children high viral load hbov children low viral load dai wheez correl viral load hbov conclus confirm hbov frequent detect patient sever lrti wheez common symptom present patient posit hbov high hbov viral load etiolog agent lrti led sever lower respiratori tract symptom longer durat wheez hospit
BMC Public Health	19285068	2004-11-12	PMC3317576	21356131	background epidem multipl infect wave document human diseas notabl influenza pandem pathogen evolut coinfect behaviour chang propos mechan occurr subsequ outbreak public health intervent remain undetermin method develop meanfield stochast epidemiolog model diseas transmiss perform simul control measur drug treatment isol individu influenc epidem profil gener sequenc infect wave characterist demonstr impact paramet repres effect advers consequ intervent measur treatment emerg drug resist spread pathogen popul pathogen resist strain evolv drug pressur multipl outbreak variabl characterist magnitud time context level drug isol capac plai role occurr subsequ outbreak simul influenza infect case studi indic intens intervent earli stage epidem delai spread diseas result infect wave larger magnitud conclus find highlight intervent paramet process public health decisionmak evalu control measur face substanti uncertainti epidemiolog characterist emerg infecti pathogen critic factor influenc popul health includ evolutionari respons pathogen pressur intervent measur epidem consid design effect strategi address shortterm target compat longterm diseas outcom
Int J Mol Sci	16517856	2008-05-07	PMC3317743	22489183	serum albumin studi protein abund protein plasma typic concentr princip transport fatti acid plasma crystal structur human serum albumin hsa free complex fatti acid hemin local anesthet character crystallograph model bovin serum albumin bsa presum poor diffract power exist hexagon bsa crystal crystal diffract data bsa crystal form hang drop method mpeg precipit agent present crystal belong space group unitcel paramet dehydr increas diffract limit bsa crystal improv pack protein molecul crystal lattic survei success case protein crystal dehydr confirm procedur initi screen method improv diffract limit exist crystal
Virol J	15542667	2019-02-25	PMC3317838	22273112	background primari establish human hepatoma cell line evalu hepat viru hcv infect vitro huh cell highli permiss infecti hcv understand hcv lifecycl benefit identif addit permiss cell line assembl panel hepat nonhepat cell line assess abil support hcv infect infect human hepatoma cell line plcprf hepb cell culturederiv hcv hcvcc albeit lower level achiev huh cell better understand reduc permiss plc hepb cell hcvcc infect perform studi evalu abil cell support specif step viral lifecycl entri replic egress spread earli event hcv infect entri replic initi cumul equival margin reduc plc hepb cell step viral life cycl steadyst replic de novo viru product andor spread impair degre plc hepb cultur compar huh cell cultur interestingli observ interferon stimul gene isg express differenti upregul plc hepb cell viral infect conclus conclud restrict observ hcv infect cell line attribut hcvinduc innat signal identif cell line capabl support authent hcvcc infect reduc level expand current repertoir cell line amend studi hcv vitro aid elucid hcv biologi cellular determin modul hcv infect
PLoS Negl Trop Dis	18463206	2011-09-02	PMC3317900	22509415	background buruli ulcer bu caus mycobacterium ulceran ulceran emerg public health problem rural commun subsaharan africa earli diagnosi prompt treatment prevent disfigur complic associ late stage diseas progress present simpl rapid test appropri earli diagnosi lowresourc set ulceran preval methodolog compar convent pocket warmer loop mediat isotherm amplif lamp method heat block pocket warmer heat sourc amplif reaction detect ulceran clinic specimen purifi crude dna prepar detect rate lamp assai investig compar pcr refer assai detect ulceran thirti clinic specimen suspect bu case examin lamp pcr princip find lower detect limit lamp method copi copi convent lamp purifi dna extract convent lamp pcr concordantli detect posit case pocket warmer lamp detect case sampl posit lamp assai pcr crude extract clinic specimen conclusionsignific lamp method simpl rapid test detect ulceran clinic specimen obtain purifi dna gener isotherm condit remain major challeng lamp method field condit improv dna extract amplif condit pwlamp point care diagnost test bu
PLoS One	30936994	2013-06-01	PMC3317930	22509258	dengu viru denv major mosquitoborn pathogen infect peopl year effect treatment vaccin highli crossreact infectionenhanc premembran prmspecif antibodi domin antidenv immun respons human rais concern vaccin candid nativ dengu prm sequenc studi isol broadli crossreact prmspecif antibodi screen nonimmun human fabphag librari serotyp denv antibodi capabl restor infect virtual noninfecti immatur denv imdenv fcrbear cell remark crossreact cryptic epitop envelop protein locat didii junction evidenc sitedirect mutagenesi cryptic epitop inaccess antibodi bind nativ viru particl expos properli fold find gener antiprm antibodi enhanc denv infect complet avoid immun strategi emploi protein subunit protein
PLoS One	21834587	2011-03-15	PMC3319594	22496880	familywid molecular diagnost assai valuabl tool initi identif virus outbreak limit cost surveil studi discoveri paramyxovirus call assai detect unknown paramyxovirus round pcr amplif develop rtpcr assai consist singl degener primer set detect member paramyxovirida famili includ viru genera subfamili paramyxovirina pneumovirina primer anneal domain iii polymeras gene the revers primer anneal conserv motif gdnq propos activ site nucleotid polymer assai fulli optim detect paramyxovirus test clinic specimen hospit patient test posit paramyxovirus convent assai detect novel familywid test highthroughput fluorescencebas rtpcr version assai develop screen larg number specimen larg number sampl collect wild bird test detect avian paramyxovirus type barnacl whitefront gees type barnacl gees avian metapneumoviru type time europ mallard greylag gees common gull singl round familywid rtpcr assai describ tool detect unknown paramyxovirus screen larg sampl collect human anim
PLoS One	23675878	2010-01-13	PMC3320630	22496790	background spontan preterm birth spb gestat week major perinat mortal morbid pathogenesi remain unclear studi spb hamper limit avail marker spb predeliveri clinic sampl easili compar gestat agematch normal control hypothes spb involv aberr placent rna express rna transcript detect predeliveri matern plasma sampl compar gestat agematch control princip find gene express microarrai profil essenti human gene observ probe signal chang fold spb placenta compar spontan term birth stb placenta gene repres probe observ overrepresent function rna stabil extracellular matrix bind acut inflammatori respons rtquantit pcr observ differ rna concentr gene spb stb placenta stb term elect cesarean deliveri placenta notabl rna transcript observ placent microarrai signal higher threshold indic possibl detect matern plasma ilrl mrna test plasma sampl women detect plasma sampl collect present preterm labor week women eventu spb detect sampl collect match gestat week women preterm labor fisher exact test conclus identifi spbassoci rna transcript detect matern plasma illustr ilrl mrna frequent detect predeliveri matern plasma sampl collect women spb gestationalag match control
Int J Pept	21406540	2007-05-02	PMC3321295	22536270	angiotensinconvert enzym ac share homolog angiotensinconvert enzym ac inhibit ac inhibitor main role ac degrad ang ii format angiotensin ang oppos action ang ii increas ang ii level thought upregul ac activ ac defici mice ang ii level doubl wildtyp mice whilst ang level undetect ac plai crucial role ra oppos action ang ii consequ benefici role diseas hypertens diabet cardiovascular diseas express decreas surprisingli current therapeut strategi ac involv augment express ac adenovirus recombin ac compound diseas afford organ protect
Comput Math Methods Med	20071547	2013-11-13	PMC3321566	22545064	program ribosom frameshift prf serv intrins translat regul mechan emploi virus control ratio structur enzymat protein viral mrna prf adapt htype pseudoknot stimul prf relationship thermodynam stabil frameshift effici pseudoknot fulli understood singlemolecul forc spectroscopi reveal frequenc prf correl unwind forc requir disrupt pseudoknot unwind work dissip irrevers torsion restraint pseudoknot complementari singlemolecul techniqu comput model insight global motion ribosom structur transit frameshift elucid atom detail advanc biophys tool help develop antivir therapi target ubiquit prf mechan virus
PLoS One	17475762	2011-05-27	PMC3322158	22496863	human cytomegaloviru hcmv ubiquit herpesviru infect fibroblast epitheli endotheli hematopoiet cell ten year group provid direct evid dendrit cell dc fulli support hcmv lytic cycl demonstr ctype lectin dendrit cellspecif intercellular adhes moleculegrab nonintegrin dcsign promin role dock hcmv monocytederiv dc mddc dcsignhcmv interact demonstr crucial earli event enhanc infect tran cmvbear cell noninfect cell transinfect render suscept cell fulli permiss hcmv infect hcmv enter mddc studi demonstr vhle hcmv virion endotheliodendrotrop strain intern mddc macropinocytosislik process actin cholesteroldepend phindepend manner observ accumul virion larg uncoat vesicl endosom featur virion remain intact particl retain infecti potenti hour transinfect properti specif mddc monocytederiv macrophag monocyt donor unabl allow accumul subsequ transmiss viru data allow delin earli mechan intern entri endotheliodendrotrop hcmv strain human mddc propos dc serv trojan hors convei cmv entri site locat favor occurr latenc acut infect
PLoS One	24227863	2013-04-01	PMC3322171	22496898	exposur oxid air pollut associ increas respiratori morbid suscept infect ozon commonli encount oxid air pollut effect influenza infect human greater mexico citi area primari site spring influenza hn pandem coincid high level environment ozon proteolyt cleavag viral membran protein hemagglutinin ha essenti influenza viru infect studi ha cleavag cellassoci facilit type ii transmembran serin proteas ttsp human airwai trypsinlik proteas hat transmembran proteas serin tmprss activ regul antiproteas secretori leukocyt proteas inhibitor slpi base observ sought determin acut exposur ozon modul cellular proteaseantiproteas express function defin role viral infect util vitro model differenti human nasal epitheli cell nec determin effect ozon influenza cleavag entri replic ozon exposur disrupt proteaseantiproteas balanc airwai liquid determin function form hat tmprss slpi secret human airwai epithelium acut exposur ozon invers alter express level addit antioxid reduc viru replic induct slpi addit determin ozoneinduc cleavag viral ha protein cellassoci secret endogen proteas suffici activ ha lead increas viral replic data indic preexposur ozon disrupt proteaseantiproteas balanc human airwai lead increas influenza suscept
BMC Bioinformatics	21622778	2008-10-08	PMC3322362	22192482	background rnaprotein interact rpi plai role wide varieti cellular process rang transcript posttranscript regul gene express host defens pathogen high throughput experi identifi rnaprotein interact provid valuabl complex rnaprotein interact network expens time consum reliabl comput method predict rnaprotein interact propos rpiseq famili classifi predict rnaprotein interact sequenc sequenc rna protein input rpiseq predict rnaprotein pair interact rna sequenc encod normal vector ribonucleotid mer composit protein sequenc encod normal vector mer composit base letter reduc alphabet represent variant rpiseq present rpiseqsvm support vector machin svm classifi rpiseqrf random forest classifi nonredund benchmark dataset extract proteinrna interfac databas pridb rpiseq achiev auc area receiv oper characterist roc curv third dataset mrnaprotein interact perform rpiseq competit publish method requir featur mrna halflif annot put rna protein partner addit rpiseq classifi train pridb data correctli predict major noncod rnaprotein interact npinterderiv network coli cerevisia melanogast musculu sapien conclus experi rpiseq demonstr rnaprotein interact reliabl predict sequencederiv rpiseq offer inexpens method comput construct rnaprotein interact network provid insight function noncod rna rpiseq freeli webbas server httppridbgdcbiastateedurpiseq
PLoS One	23249910	2010-01-22	PMC3325274	22511971	the immunogen efficaci betapropiolactoneinactiv caprin herpesviru cphv vaccin adjuv mf test goat subcutan immun goat develop high titer cphvspecif serum vagin igg high serum viru neutral vn titer peripher blood mononuclear cell pbmc stimul vitro inactiv cphv produc high level solubl ifngamma exhibit high frequenc ifngamma produc cell solubl il undetect hand control goat receiv inactiv cphv vaccin adjuv produc low serum antibodi respons vagin challeng virul cphv perform vaccin goat nave goat assess efficaci vaccin vagin diseas detect goat vaccin inactiv cphv mf anim undetect level infecti challeng viru vagin wash goat vaccin inactiv cphv absenc adjuv exhibit sever diseas compar nave goat titer challeng viru nave goat detect quantit latent cphv dna sacral ganglia challeng goat reveal inactiv cphv mf vaccin reduc latent viral load compar nave goat goat vaccin inactiv cphv absenc adjuv vaccin compos inactiv cphv mf adjuv immunogen induc effect immun vagin cphv infect goat
PLoS One	18842722	2013-06-06	PMC3325917	22514697	sapoviru genu calicivirus enter diseas human anim consider genet divers sapovirus classifi genogroup base phylogenet analysi fulllength capsid protein sequenc mammalian speci includ human pig mink dog identifi anim host sapovirus report sapovirus bat spite biolog divers report target surveil studi bat speci hong kong specimen bat speci hipposidero pomona posit sapovirus rtpcr complet fulllength genom sequenc kb length three strain organ genom compar sapovirus interestingli possess genom featur atyp sapovirus high gc content minim cpg suppress phylogenet analysi viral protein suggest bat sapoviru descend ancestr sapoviru lineag close porcin sapovirus codon usag analysi bat sapoviru genom greater codon usag bia rel sapoviru genom summari report discoveri genom character bat caliciviru appear evolv condit earli diverg sapoviru lineag
PLoS One	20140172	2004-03-01	PMC3326065	22514648	background anim faec compris commun microorgan includ bacteria virus scarc divers virus faec pig describ protocol optim purif total fraction viral particl pig faec genom purifi dna rna virus simultan amplifi pcr subject deep sequenc bioinformat analys effici method monitor process control consist three bacteriophag ms morpholog genom type defin amount bacteriophag sampl abund assess quantit pcr prepar procedur procedur appli pool faecal sampl pig sampl sequenc read gener bacteriophag identifi sequenc analysi read total read sequenc ident publish viral sequenc origin bacteriophag mammalian virus sequenc ident plant virus abund detect porcin virus kobuviru rotaviru astroviru enteroviru sapoviru picobirnaviru addit sequenc ident chimpanze stoolassoci circular ssdna viru identifi genom analysi indic viru tent design pig stoolassoci circular ssdna viru pigscv repres novel pig viru conclus establish protocol enabl simultan detect dna rna virus pig faec includ identif unknown virus appli studi investig aetiolog epidemiolog ecolog diseas implement process control serv qualiti control ensur compar method method optim
Mol Vis	23742046	2019-05-22	PMC3327440	22511850	purpos purpos current studi examin ocular pathogenesi immun reaction mice intravitr dispas inject method three microlit dispas concentr ul inject vitreal caviti weekold mice hematoxylin eosin stain immunofluoresc analysi electroretinogram ey perform assess ocular chang enzymelink immunospot assai intracellular stain singlecel suspens spleen detect immun chang week observ period neutrophil main inflammatori infiltr cell appear anterior chamber cluster differenti cd label cell label macrophag cd label natur killer cell vitreal caviti retina dispaseinject mice dai inject prolif vitreoretinopathi pvrlike sign appear week gradual increas reach peak valu week statist differ bwave amplitud pvr salinecontrol ey enzymelink immunospot assai intracellular stain specif cd cd label cell involv dispaseinject mice conclus data neutrophil anterior chamber pvrlike sign retina specif immun reaction involv intravitr dispas inject mice
PLoS One	15013977	2014-08-13	PMC3327712	22523556	the angiotensin convert enzym ac kei catalyt compon reninangiotensin system mediat precis regul blood pressur counterbalanc effect inhibit ac improv patholog cardiovascular diseas whilst ac cardioprotect fail heart mechan ac mediat cardioprotect function fulli elucid demonstr ac ac bind integrin subunit rgdindepend manner cell adhes substrat cellular express ac enhanc cell adhes evid solubl ac sace capabl suppress integrin signal mediat fak addit sace increas express akt lower proport signal molecul phosphoryl akt ac plai role cellcel interact act finetun integrin signal express cleavag ac plasma membran influenc cellextracellular matrix interact signal mediat cell surviv prolifer ectodomain shed ac plai role process patholog cardiac remodel
PLoS One	31118255	2004-11-30	PMC3328332	22529911	interferon alpha ifn therapi despit good efficaci cure hcv infect lead major side effect induc strong peripher tcell lymphocytopenia analyz earli consequ ifn therapi thymic function peripher tcell homeostasi patient acut chronic phase hcvinfect hivhcv coinfect patient evolut tcell subset tcell homeostasi estim flow cytometri thymic function measur quantif tcell receptor excis circl trec estim intrathym precursor tcell prolifer month initi ifn therapi month therapi profound lymphocytopenia observ tcell subset includ nave tcell thymic emigr rte associ inhibit intrathym precursor tcell prolifer interleukin il plasma concentr rapidli drop lymphocytopenia progress consequ higher consumpt cytokin neutral solubl cd decreas il plasma concentr ifn therapi correl declin hcv viral load thymic activ rte concentr blood data demonstr ifnbas therapi rapidli impact thymopoiesi consequ perturb tcell homeostasi side detriment continu ifn therapi lead increas level infecti risk hivhcv coinfect patient altogeth studi suggest therapeut potenti il mainten peripher tcell homeostasi ifntreat patient
Evid Based Complement Alternat Med	25122864	2012-04-30	PMC3328953	22550539	integr medicin innov china model clinic practic bridg tcm thirti year great achiev integr medicin research clinic practic clinic achiev includ three innov methodolog diseasesyndrom combin excav classic theori tradit chines medicin tcm prevent cure refractori diseas develop idea strategi integr medicin futur includ stand frontier field intern medicin improv capabl prevent cure refractori diseas move prevent control strategi forward improv cur common frequent diseas excav classic theori tcm broaden treatment system modern medicin improv innov level high effect drug basi classic prescript herb tcm rerecogn theori formula correspond syndrom tcm enhanc level clinic evid base evidencebas medicin integr medicin will greater achiev creat medicin pharmacolog tremend contribut great rejuven chines nation human health care
ScientificWorldJournal	15572443	2015-01-01	PMC3329954	22566769	infecti bronchiti ib viral diseas poultri aim studi investig distribut avian infecti bronchiti viru isol irfibv serotyp experiment infect chicken ninetyonedayold commerci broiler divid randomli group seventi experiment twenti control group chick experiment group inocul intranas eld viru three week ag sampl tissu collect dai postinocul chicken exhibit mild respiratori sign depress viral rna detect kidnei lung trachea dai pi oviduct dai test dai pi caecal tonsil consist dai pi remark clinic sign viru detect appear dai pi data indic number infect chicken viral rna detect tissu reduc increas antibodi titer dai pi demonstr irfibv viru wide tissu distribut respiratori urogenit digest system
Int Arch Med	24900494	2018-09-01	PMC3331808	22443897	background influenza pandem south korea aim studi evalu epidemiolog clinic laboratori characterist infect children adult method evalu epidemiolog characterist patient infect hn influenza viru patient ag rang mo clinic laboratori find inpati children pneumonia adult pneumonia singl hospit epidem major infect patient greater case occur twomonth period rate admiss pneumonia rate admiss pneumonia total durat fever frequenc underli diseas valu creactiv protein erythrocyt sediment rate tend increas ag increas highest rate group pneumonia found boi girl children femal male adult adult patient pneumonia higher leukocyt count lower lymphocyt differenti group pneumonia children group conclus immunolog reaction viral insult associ ag sex underli diseas unknown herd immun affect popul patient underli diseas older patient immunolog insuffici associ immunolog consumpt underli diseas
BMC Pulm Med	27134630	2008-01-01	PMC3331822	22436202	background influenza hn viru transmit direct indirect airborn rout noninfect subject infect patient cough expel number size droplet surround environ aerosol object current studi character human cough aerosol pattern aim develop standard human cough bioaerosol model influenza pandem control method healthi nonsmok particip open bench studi best effort cough laser diffract system accur timedepend quantit measur size number droplet expel cough aerosol voluntari cough gener droplet rang micron size droplet onemicron size repres total number measur droplet contain cough aerosol ag sex weight height corpor mass statist aerosol composit term size number droplet conclus develop standard human cough aerosol model quantit character pattern size number droplet mode persontoperson transmiss ird cough bioaerosol small size droplet predomin total number droplet expel cough cough aerosol singl sourc direct indirect andor airborn transmiss respiratori infect influenza hn viru studi design open bench observ cough aerosol studi
Int J Cell Biol	30005716	2015-12-17	PMC3332201	22567012	virion kind nanoscal pathogen infect live cell anim plant bacteria infect intrins properti virion biolog process good model studi nanoparticl enter cell infect virus emploi strategi cell develop respect respons paper chose bombyx mori cypoviru bmcpv interact midgut cell silkworm sever acut respiratori syndrom sar associ coronaviru interact vero cell exampl demonstr respons eukaryot cell type viru previou studi bacteriophagebacteria interact introduc elucid bacteriophag conquer barrier cell wall prokaryot cell transport genom host
BMC Public Health	18360908	2016-01-27	PMC3332281	22325707	background quebec influenza hn pandem manag topdown style left involv player critic view frustrat aim describ physician percept infecti diseas specialistsmed microbiologist idmm public healthprevent medicin specialist phpm issu encount pandem manag physician level highlight suggest improv futur healthcar emerg method april quebec idmm phpm physician invit anonym complet webbas learn assess survei includ openend multiplechoic question descript statist report frequenc distribut multipl choic respons themat content analysi analys qualit data gener survei help understand respond experi percept pandem respond report difficulti frustrat practic pandem themat analysi reveal core theme describ problem experienc pandem manag coordin resourcerel difficulti coordin issu includ commun clinic practic guidelin decisionmak role respons epidemiolog investig public health expert advisori committe resourc issu includ laboratori resourc patient manag vaccin process conclus quantit qualit data improv coordin better definit role respons increas technolog merg commun transpar decision process increas flexibl contradict clinic practic guidelin sourc increas laboratoryclin capac felt critic proper manag infecti diseas emerg
PLoS One	29769971	2007-04-01	PMC3334901	22536395	in studi propos novel bacteri vaccin strategi nonpathogen bacteria complement trait desir induct protect immun illustr proof principl novel vaccin strategi model organ intracellular immun listeria introduc low copi number bacplasmid harbour virul gene cluster vgc monocytogen lm nonpathogen innocua linn strain examin abil induc protect cellular immun strain linnvgc attenu virul vivo reduc host detriment inflammatori respons compar lm lm linnvgc induc product type interferon protect mediat listeriaspecif cd cell ration vaccin design avirul strain equip capabl induc protect lack detriment inflammatori effect offer great promis futur studi nonpathogen bacteria vector vaccin
PLoS One	26814540	2009-10-01	PMC3334916	22536342	for year hivaid wreak havoc absenc effect vaccin hiv develop antihiv agent urgent need identifi antivir activ scorpionvenompeptidederiv mucroporinm three rna virus measl virus sarscov hn investig panel scorpion venom peptid deriv design chosen assess antihiv activ scorpion venom peptid deriv kn identifi potent antihiv peptid screen assai ec gml low cytotox host cell select si kn inhibit member standard refer panel hiv subtyp pseudotyp viru pv ccrtropic cxcrtropic nl pv strain inhibit cxcrtropic replicationcompet strain hiv subtyp viru bind assai kn hiv pv octet red system suggest antihiv activ correl direct interact kn hiv envelop demonstr peptid kn inhibit hiv direct interact viral particl promis candid compound develop microbicid hiv
PLoS One	17413070	2013-10-30	PMC3334963	22536348	background manila clam ruditap philippinarum worldwid cultur bivalv speci commerci diseas speci result larg econom loss knowledg molecular mechan immun respons bivalv clam scarc fragmentari sequenc rna immunestimul philippinarum hemocyt pyrosequenc identifi gene involv immun defens infecti diseas methodolog princip find highthroughput deep sequenc philippinarum pyrosequenc technolog yield highqual read averag read length bp read assembl contig the translat nucleotid sequenc protein annot frequent contig includ larg number immunerel gene detail analysi presenc put member immun pathwai process apoptosi toll signal pathwai complement cascad sequenc molecul describ bivalv complement pathwai compon conclus studi repres transcriptom analysi pyrosequenc conduct philippinarum focus immun system will provid rich sourc data discov identifi gene will serv basi microarrai construct studi gene express identif genet marker discoveri immun sequenc product larg varieti contig plai role defens mechan ruditap philippinarum
PLoS One	19822891	2006-01-01	PMC3335026	22536332	cough airflow dynam studi varieti experiment method studi realtim noninvas shadowgraph imag appli addit analys cough airflow produc healthi volunt twenti healthi volunt women ag year men ag year ask cough freeli sleev current cdc recommend studi analyz cough airflow dynam femal case maximum detect cough propag distanc rang maximum deriv veloc ms maximum detect project area rang maximum deriv expans rate ms male case maximum detect cough propag distanc rang maximum deriv veloc ms maximum detect project area rang maximum deriv expans rate ms peak veloc measur visibl exhal airflow optim compar favor report method valid previou approach natur set propag distanc repres lower limit inabl shadowgraph method visual cough airflow temperatur cool ambient air limit methodolog qualit highspe video footag volunt cough sleev demonstr method rare complet block cough airflow deceler split redirect airflow eventu reduc propag effect intervent depend optimum posit arm nose mouth cough unsightli stain sleev unaccept some
PLoS One	24173023	2008-11-26	PMC3335060	22536382	background sever acut respiratori syndrom sar emerg china spread countri brought control concern reemerg deliber releas sar coronaviru vaccin develop initi evalu inactiv viru vaccin ferret nonhuman primat viruslikeparticl vaccin mice induc protect infect challeng anim exhibit immunopathologictyp lung diseas design candid vaccin human alum adjuv evalu mous model sar vlp vaccin vaccin ferret nhp viru vaccin rdnaproduc protein balbc cbl mice vaccin dai and sacrif serum antibodi measur challeng live viru dai dai challeng mice sacrif lung viru histopatholog vaccin induc serum neutral antibodi increas dosag andor alum increas respons reduct sarscov dai challeng vaccin prior live sarscov mice exhibit histopatholog chang lung dai challeng includ anim vaccin balbc cbl live viru influenza vaccin pb suggest infect occur histopatholog anim sarscov vaccin uniformli thtype immunopatholog promin eosinophil infiltr confirm special eosinophil stain patholog chang control group lack eosinophil promin conclus sarscov vaccin induc antibodi protect infect sarscov challeng mice vaccin led occurr thtype immunopatholog suggest hypersensit sarscov compon induc caution proceed applic sarscov vaccin human indic
PLoS One	16418524	2004-11-01	PMC3335077	22536366	the influenc rel humid ambient temperatur transmiss influenza virus establish control laboratori condit interplai meteorolog factor actual influenza epidem clear contribut wind epidem spread scarc appli geostatist surviv analysi data larg outbreak equin influenza ahn quantifi associ hazard infect air temperatur rel humid rainfal wind veloc whilst control premiseslevel covari pattern diseas spread space time describ extract map instantan hazard curv meteorolog condit premis locat estim krige daili meteorolog data analys timelag timevari predictor generalis cox regress meteorolog covari timelag three dai associ hazard influenza infect correspond close incub period equin influenza hazard equin influenza infect higher rel humid lowest dai daili maximum air temperatur wind speed hour direct nearbi infect premis associ increas hazard infect combin detail influenza outbreak meteorolog data provid empir evid underli environment mechan influenc local spread outbreak influenza analysi support extend find studi influenza transmiss conduct laboratori condit relationship describ direct manag diseas risk influenza outbreak hors gener advanc understand transmiss influenza virus field condit
PLoS One	19036814	2012-04-16	PMC3335118	22539946	thi articl data thomson reuter web scienc map analys scientif landscap synthet biologi articl draw advanc data visualis analyt aim inform upcom intern polici debat govern synthet biologi subsidiari bodi scientif technic technolog advic sbstta unit nation convent biolog divers map techniqu identifi synthet biologi best understood rang institut research fund agenc involv debat convent focu moratorium field releas synthet organ cell genom base empir evid propos guidanc provid fund agenc respect letter spirit convent biolog divers make invest build recommend unit state presidenti commiss studi bioethic issu demonstr promot independ transpar monitor develop synthet biologi modern tool public polici understand engag synthet biologi enhanc onlin interact tool step forward process exist data scientif literatur synthet biologi onlin interact workbook research polici maker civil societi explor data draw conclus themselv
J Pathog	15528730	2015-01-01	PMC3335463	22567321	mani gene implic schizophrenia viral prenat adult infect toxoplasmosi lyme diseas autoantigen target kei pathologyrel protein factor interrel suscept gene encod protein homolog pathogen autoantigen homolog pathogen protein suggest riskpromot effect gene risk factor condit depend protein match pathogen suscept gene product pathogen protein dummi ligand decoi receptor interactom interfer protein immunogen suggest antibodi mediat knockdown multipl schizophrenia gene product contribut diseas explain immun activ brain lymphocyt schizophrenia preponder immunerel gene variant schizophrenia genom schizophrenia pathogenet autoimmun disord caus pathogen gene immun system act prevent pathogen elimin curabl remov culpabl antibodi antigen
PLoS One	22511760	2007-09-12	PMC3338466	22558229	acut viral infect damag host uncontrol viral replic replic defici viral vector induc system inflammatori respons overact host innat immun respons viral vector led devast consequ macrophag innat immun cell recogn virus induc inflammatori respons earli stage infect tissu resid macrophag easili activ mere presenc viru suggest activ requir addit signal cell tissu order trigger inflammatori respons crosstalk epitheli cell macrophag gener synergist inflammatori respons adenovir vector infect investig atp involv activ macrophag induc inflammatori respons acut adenovir infect macrophageepitheli cell cocultur system demonstr atp signal px receptor pxr requir induct inflammatori mediat atppxr signal regul inflammasom activ inhibit defici pxr caspas reduc il secret intranas administr replic defici adenovir vector mice caus high mortal wildtyp mice symptom acut respiratori distress syndrom mice defici pxr caspas increas surviv addit wildtyp mice treat apyras inhibitor pxr caspas higher rate surviv improv surviv pxr defici mice correl diminish level il il reduc neutrophil infiltr earli phase infect indic atp releas viral infect inflammatori regul activ inflammasom pathwai regul inflammatori respons
PLoS One	28232891	2017-05-24	PMC3338532	22563403	aerosol gener procedur agp expos health care worker hcw pathogen caus acut respiratori infect ari risk transmiss ari agp fulli sought determin clinic evid risk transmiss ari hcw care patient undergo agp compar risk transmiss hcw care patient undergo agp search pubm embas medlin cinahl cochran librari univers york crd databas euroscan lilac indian medlar medicu se asia intern health technolog agenc internet languag articl independ review screen abstract predefin criteria fulltext articl select relev studi abstract data disagr resolv consensu outcom interest risk ari transmiss qualiti evid rate grade system identifi casecontrol retrospect cohort studi evalu transmiss sar hcw procedur report increas risk transmiss includ pool orci tracheal intub cohort casecontrol noninvas ventil cohort tracheotomi casecontrol manual ventil intub cohort intub associ procedur endotrach aspir suction bodi fluid bronchoscopi nebul treatment administr high flow manipul mask bipap mask defibril chest compress insert nasogastr tube collect sputum find procedur capabl gener aerosol associ increas risk sar transmiss hcw risk factor transmiss consist associ multipl studi identifi tracheal intub
PLoS One	17855523	2015-11-01	PMC3338671	22558400	background white back planthopp wbph sogatella furcifera horvth great damag crop direct feed transmit plant virus southern rice blackstreak dwarf viru srbsdv transmit wbph great threat rice product east asia methodologyprincip find de novo transcriptom assembl massiv parallel pyrosequenc construct transcriptom wbph profil altern gene express respons srbsdv infect transcript level read highqual dna sequenc unigen gener illumina technolog virulifer nonvirulifer wbph wbph gene ontolog distribut close rice planthopp nilaparvata lugen laodelphax striatellu microsatellit loci predict evolutionari analysi compar analysi transcriptom gener virulifer nonvirulifer wbph provid list candid transcript elicit respons viral infect pathwai analys subset transcript indic srbsdv infect perturb primari metabol ubiquitinproteasom pathwai addit of gene cell cytoskeleton organ pathwai obviou chang data demonstr srbsdv infect activ immun regulatori system wbph rna interfer autophagi antimicrobi peptid product conclusionssignific emploi massiv parallel pyrosequenc collect est virulifer nonvirulifer sampl wbph unigen time describ direct effect reovirida famili plant viru global gene express profil insect vector highthroughput sequenc studi will provid road map futur investig fascin interact reovirida virus insect vector provid strategi crop protect
PLoS One	28539447	2013-11-27	PMC3340391	22558104	avian paramyxoviru apmv serotyp isol avian speci apmv newcastl diseas viru wellcharacter serotyp high morbid mortal econom loss caus highli virul strain pathogenesi replic virul tropism apmv serotyp evalu prototyp strain apmv serotyp cell cultur chicken duck cell cultur apmv induc syncytium format chicken df cell apmv replic effici approach apmv apmv replic lower intermedi titer lower death time mdt assai chicken egg intracerebr pathogen icpi test dayold spf chick demonstr apmv type avirul evalu replic primari neuron cell vitro brain dayold chick type apmv neurotrop viru neurovirul intranas infect dayold weekold chicken replic apmv type restrict respiratori tract apmv neuroinvas neurotrop neurovirul spleen experiment intranas infect weekold mallard duck apmv produc clinic sign apmv exhibit restrict viral replic apmv includ apmv upper respiratori tract isol sourc indic avirul apmv type mallard duck link presenc furin cleavag site protein syncytium format system spread virul wellestablish apmv pathotyp evid apmv serotyp
PLoS One	26133963	1997-07-01	PMC3340400	22558251	the type ii transmembran serin proteas tmprss hat activ influenza virus sarscoronaviru tmprss cell cultur plai role viral spread pathogenesi infect host unclear extent proteas express viral target cell human tissu hat tmprss coexpress link sialic acid major receptor determin human influenza virus human respiratori tract coexpress ac sarscoronaviru receptor tmprss frequent upper lower aerodigest tract except vocal fold epiglotti trachea final activ influenza viru conserv human avian porcin tmprss suggest proteas activ influenza viru reservoir intermedi human host sum tmprss hat express influenza sarscoronaviru target cell support viral spread human host
Virol J	24284329	2017-01-18	PMC3341187	22416942	background analysi codon usag reveal molecular evolut virus synonym codon usag pattern porcin circoviru pcv genom process evolut studi understand evolutionari characterist pcv effect natur select host codon usag pattern viru pattern kei determin codon usag pcv examin method carri comprehens analysi codon usag pattern pcv genom calcul rel synonym codon usag rscu effect number codon enc dinucleotid nucleic acid content pcv genom pcv genom lower content gc codon prefer result nucleotid constraint major impact synonym codon usag the correspond analysi indic codon usag pattern pcv genotyp subgenotyp chang greatli differ codon usag pattern viru circoviridaether compar pcv host synonym codon usag suggest natur select pressur host factor affect codon usag pattern pcv pcv genotyp ii synonym codon usag pig pcv genotyp molecular mechan pcv genotyp ii diseas calcul rel abund dinucleotid indic composit dinucleotid plai kei role variat synonym codon usag pcv geograph factor gener averag hydrophob aromat format codon usag pattern pcv conclus studi synonym codon usag pattern pcv genom result interact mutat pressur natur select host studi theoret understand characterist synonym codon usag pcv genom molecular evolut pcv
PLoS Negl Trop Dis	9233814	2005-10-10	PMC3341331	22563515	background dengu viru denv public health threat tropic subtrop region therapeut antibodi viral envelop protein repres promis immunotherapi diseas control methodologyprincip find gener seventeen novel mous monoclon antibodi mab high reactiv protein dengu viru type denv mab dissect recombin protein domain iii ediii iii ediii denv plaqu reduct neutral test prnt mous protect assai lethal dose denv identifi serotypespecif mab high neutral activ denv infect ediii target mab db strongest neutral mab divers denv strain phage displai viruslik particl vlp residu ediii astrand kei mab db bind ediii convert db human version retain potenc neutral denv enhanc viral infect db therapeut efficaci mortal induc strain denv mous model postexposur trial conclusionssignific novel epitop map strategi combin phage displai vlp identifi astrand epitop strong neutral activ studi introduc potenti therapeut antibodi capabl provid broad protect divers denv infect enhanc activ human
BMC Infect Dis	28100616	2009-11-04	PMC3342178	22458535	background avian influenza consider threat global public health prevent control depend awar protect behaviour gener popul high riskgroup studi aim explor knowledg attitud practic avian influenza poultri worker nepal method studi base crosssect studi design structur questionnair administ facetofac interview poultri worker ag rupandehi district nepal major respond male ag sd awar ai case detect nepal poultri worker risk infect major sourc ai radio tv newspap knowledg prevent measur high regard behaviour hand wash medium low regard clean disinfect procedur protect cloth poultri worker tv newspap afraid contract ai higher knowledg emploi compar owner poultri farm high level knowledg associ practis prevent behaviour hand specif govern control measur high degre accept major studi particip thought govern control compens measur insuffici conclus studi knowledg practic avian influenza poultri worker nepal highlight target lack knowledg structuralmateri barrier build prepared major outbreak situat
Proteome Sci	16217017	2015-03-18	PMC3342233	22463732	background infecti bronchiti viru ibv discov coronaviru endem region intens impact poultri product studi twodimension gel electrophoresi de twodimension fluoresc differ gel electrophoresi dige coupl matrixassist laser desorptionion timeofflight tandem mass spectrometri malditoftofm explor global proteom profil trachea kidnei tissu chicken stage infect vivo highli virul ckchldli strain infecti bronchiti viru ibv embryopassag attenu ckchldli strain fiftyeight differenti express protein identifi demonstr protein function cytoskeleton organ antioxid stress stress respons chang pattern abund chicken infect highli virul ckchldli strain embryopassag attenu stain addit dynam transcript alter select protein analyz realtim rtpcr western blot analysi confirm chang abund heat shock protein hsp beta annexin annexin conclus proteom alter describ chang protein express correl ibv viru virul chicken valuabl insight interact ibv host assist investig pathogenesi ibv coronaviru infect
PLoS One	19889762	2019-04-10	PMC3343003	22570724	background viral infect patient hematolog malign concern allogen hematopoiet stem cell transplant hsct recipi year chang treatment regimen nontranspl patient hematolog malign potenti increas incid viral infect group studi prospect investig preval broad rang respiratori virus nasopharyng aspir npa virus commonli reactiv allogen hsct methodologyprincip find patient hematolog malign therapi induc neutropenia screen broad rang common respiratori virus nasopharynx virus commonli detect sever immunosuppress patient peripher blood quantit pcr detect virus viral pathogen detect patient detect rate blood npa polyoma bk viru rhinoviru domin pathogen blood npa patient chronic lymphocyt leukemia cll patient fever overrepres virusposit group viral find npa associ upper respiratori symptom urt conclusionssignific respiratori viral infect low titer virus blood patient neutropenia common patient cll patient fever independ associ infect viral find npa associ urt indic activ infect find motiv studi virus impact patient categori potenti role caus agent fever neutropenia
PLoS Pathog	25787284	2008-01-30	PMC3343006	22570613	the coronaviru protein small membran protein singl predict hydrophob domain hd defin role infect protein thought promot virion assembl occur golgi region infect cell implic releas infecti particl bud protein ion channel activ vitro role channel activ infect establish membran topolog protein consider debat protein adopt topolog infect hd infecti bronchiti viru ibv protein requir effici releas infecti viru activ correl disrupt secretori pathwai report singl residu hydrophob domain thr requir secretori pathwai disrupt substitut residu thr toler mutat thr impact viru assembl judg viruslik particl product suggest alter secretori pathwai assembl independ activ examin membran topolog ibv function gener mutant version adopt transmembran membran hairpin topolog transmembran topolog requir disrupt secretori pathwai effici viruslik particl product hairpin version unabl disrupt secretori pathwai produc particl find report identifi properti protein function provid insight protein perform multipl role infect
Acta Crystallogr Sect E Struct Rep Online	30971473	2011-05-01	PMC3343981	22589890	in titl pyrazolon deriv chno fivememb ring planar rm deviat cbound benzen ring inclin plane dihedr angl form dihedr angl supramolecular layer form crystal structur cho chn interact assembl doubl layer ch interact pyrazol cbound benzen ring ring centroidcentroid distanc doubl layer stack axi connect interact cbound benzen ring ring centroidcentroid distanc 
Int J Mol Sci	18235434	2008-04-10	PMC3344243	22606007	the complex hideandseek game hiv host immun system impair develop effici vaccin addit high variabl viru imped longterm control viral replic small antivir drug year phage displai technolog intens field hiv explor epitop landscap recogn monoclon polyclon hivspecif antibodi provid preciou data immunodomin neutral epitop parallel biopan experi combinatori antibodi fragment librari conduct viral target host receptor identifi hiv inhibitor applic phage displai technolog appli character enzymat specif hiv proteas phage particl repres valuabl altern carrier displai hiv antigen immun system elicit antivir respons review present summar studi conduct regard natur phage librari target displai mode biopan procedur
PLoS One	21074851	2015-09-01	PMC3344869	22574157	medi mt bispecif tcell engag bite antibodi develop treatment patient cancer express carcinoembryon antigen cea medi bind cea cancer cell cd cell induc tcell mediat kill cancer cell understand molecular basi human cea recognit medi polymorph splice form cea affect medi activ map epitop medi cea mutagenesi homolog model approach medi recogn conform epitop domain compris amino acid critic residu nonsynonym singlenucleotid polymorph snp rs rs identifi epitop region low homozygos rate search nation center biotechnolog genbank databas identifi singl uncharacter mrna splice variant cea lack portion ntermin domain domain larg portion domain realtim quantit polymeras chain reaction analysi multipl cancer widespread express fulllength cea tumor frequent concord express cea splice variant epitop absent cea splice variant medi bind mediat tcell kill cell sole express form cea addit splice variant interfer medi bind activ coexpress fulllength cea medi broadli target ceaposit tumor regard express short splice variant cea data medi activ will impact snp splice variant cea
PLoS One	18401437	2009-05-01	PMC3344904	22574190	most current strategi antivir therapeut target viru directli altern approach drug discoveri enhanc immun respons broad rang virus base clinic observ human success genet strategi experiment model reason improv interferon ifn signal system better protect viral infect aim identifi small molecular weight compound mimic benefici improv antivir defens develop cellbas highthroughput screen ht assai identifi small molecul enhanc ifn signal pathwai compon assai base phenotyp screen increas ifnstimul respons element isr activ fulli autom robust format applic assai system librari compound includ approv approv drug led identif compound isr activ chose anthracyclin antibiot idarubicin valid mechan base activ subm rang idarubicin action increas isr activ manifest member drug class independ cytotox topoisomeras inhibitori effect endogen ifn signal product observ compound confer consequ increas ifnstimul gene isg express antivir doserang cellcultur system inocul encephalomyocard viru emcv antivir compound concentr observ cytotox provid proof concept activ compon ifn signal pathwai improv ifn efficaci antivir immun defens valid ht approach identifi small molecul achiev therapeut benefit
Viruses	29075652	2018-12-01	PMC3347032	22590676	the coronaviru protein small membran protein role assembl virion studi indic protein function infect assembl includ viru egress host stress respons addition protein ion channel activ interact host protein multipl membran topolog goal review highlight properti function protein specul relat
Viruses	19388846	2003-02-15	PMC3347033	22590677	the rapid emerg aid human period led extens effort understand fulli etiolog agent chronic progress acquir immunodefici diseas mammalian speci lentivirus gene sequenc homolog human immunodefici viru hiv speci includ sheep goat hors cattl cat monkei speci lentivirus compris genu retrovirida famili persist infect lead vari degre morbid mortal depend viru host speci involv felin immunodefici viru fiv immun system diseas domest cat feli catu involv deplet cd popul lymphocyt increas suscept opportunist infect death virus domest cat fiv occur varieti nondomest felid overview current state knowledg larg ancient group virus fiv south america
Viruses	30149120	2011-02-02	PMC3347317	22590680	innat immun defens viral infect turn virus evolv evad host immun surveil result virus persist host develop chronic infect type interferon ifn potent antivir cytokin trigger viral infect porcin reproduct respiratori syndrom prr diseas pig character neglig induct type ifn viral persist extend period ifn product rigimda jakstat pathwai major signal pathwai studi indic prr viru arm modul type ifn respons infect review describ viral strategi modul type ifn respons three nonstructur protein nsp nsp nsp structur protein nucleocapsid protein identifi character plai role ifn suppress nfb pathwai nsp earli protein late protein suggest addit signal pathwai involv addit ifn pathwai understand molecular base virusmedi modul host innat immun signal will help design gener vaccin control prr
Viruses	12551995	2011-01-05	PMC3347323	22590686	coronaviruscel entri program involv viruscel membran fusion mediat viral spike protein coronaviru protein acquir membran fusion compet receptor interact proteolysi acidif endosom review describ current understand protein interact respons entri trigger focu receptor proteas prompt entri highlight type ii transmembran serin proteas ttsp activ viru fusion protein proteas essenti cofactor permit coronaviru infect conceiv proxim cellsurfac receptor pois split enter spike protein fragment refold mediat membran fusion review conclud note understand coronaviru entri inform antivir therapi
Viruses	21289144	2019-04-18	PMC3347326	22590689	acut respiratori ill ari unconfirm infecti aetiolog peak time year molecular diagnost assai reduc number unconfirm ari compar serolog culturebas techniqu screen inpati outpati respiratori specimen span late autumn earli spring identifi presenc human coronaviru hcov occas specimen respiratori viru detect preval peak august late winter southern hemispher detect specimen test hcovhku hcovoc compris hcov detect posit specimen develop novel revers transcriptas realtim pcr rtrtpcr hcov detect object clinic sever score assign posit hcov patient sever score random select young children posit respiratori syncyti viru time specimen popul cooler month sensit specif rtrtpcr identifi concurr circul hcov quarter cooccur viru children ag year
Acta Naturae	21209103	2017-11-15	PMC3347541	22649628	immun nake gene dnaimmun perspect modern approach prophylact therapeut vaccin pathogen cancer allergi panel dna immunogen develop clinic trial immunogen dna vaccin appli human consider improv approach increas dna vaccin immunogen approach impli modif encod immunogen chang process present pattern antiimmunogen respons eukaryot express vector construct encod chimer protein compos immunogen special target signal sequenc review describ number signal fuse immunogen target predefin subcellular compart review exampl applic dnaimmun
Evid Based Complement Alternat Med	30996140	2015-01-01	PMC3348640	22611430	object heart failur hf global public health problem earli literatur studi manifest shenfu inject sfi commonli tradit chines patent medicin hf china articl intend systemat evalu efficaci safeti sfi hf method extens search perform english chines electron databas novemb ninetynin random control trail rct collect irrespect languag author extract data assess trial qualiti independ revman data analysi compar routin treatment andor devic support sfi combin routin treatment andor devic support better clinic rate mortal heart rate ntprobnp minut walk distanc ultrason cardiographi sfi combin routin treatment improv heart function hf patient differ blood pressur sfi routin treatment group advers event report thirteen trail thirteen specif symptom seriou advers report conclus sfi appear effect treat hf rigor design rct warrant insuffici methodolog rigor major includ trial
BMC Vet Res	29142077	2017-03-01	PMC3349470	22439903	background felin leukaemia viru felv felin immunodefici viru fiv major morbid mortal domest wild felid despit clinic felin retrovirus grow interest cat pet felv fiv malaysia present insuffici properli advis veterinarian pet owner crosssect studi carri januari decemb determin preval risk factor associ felv fiv domest cat peninsular malaysia plasma sampl harvest blood domest cat screen evid felv antigen fiv antibodi immunochromatograph kit addition data cat demograph health collect structur questionnair evalu potenti risk factor felv fiv statu cat evalu studi ci posit felv antigen ci seroposit fiv antibodi ci evid virus factor increas risk felv seroposit includ sex ag behaviour sick live multicat household seroposit respons fiv associ sex neuter statu ag behaviour health statu conclus studi indic felv fiv common domest cat peninsular malaysia factor cat demograph health ag sex behaviour health statu type household predictor seroposit statu felv fiv peninsular malaysia high preval felv fiv observ studi concern view immunosuppress potenti pathogen specif measur control prevent screen routin vaccin need ensur felv fiv control cat popul peninsular malaysia
BMC Health Serv Res	25393187	2006-11-22	PMC3349562	22276746	background major china centr diseas control cdc counti level clinic public health care tb case hospit health facil refer suspect tb case cdc year integr model emerg cdc remain basic manag unit tb control gener hospit design provid clinic care tb patient studi aim explor factor influenc integr tb servic gener hospit gener knowledg aid scaleup integr tb servic china method studi adopt qualit approach interview site east west china analysi conduct themat framework approach prosper site east china coordin better method resourc alloc patientorient servic compar poorer site west develop public health organ appear influenc effect integr occur understand staff hospit better capac treat tb patient cdc strong rational integr econom polit interest barrier effect integr site share challeng attract retain skill workforc tb servic role health bureau direct western site participatori collabor approach adopt eastern site conclus process integr identifi similar differ site affluent east china poorer west china integr tb servic hospit address challeng stakehold motiv resourc alloc effect interorganiz collabor help improv effici qualiti tb servic kei tb control servic deliveri integr hospit china
BMC Public Health	27903584	2011-07-11	PMC3350431	22463370	background year comput simul model support develop pandem influenza prepared polici policymak rais concern practic model review paper examin extent current literatur address concern identifi enhanc current model higher oper method survei pubm sourc publish literatur simul model influenza pandem prepared identifi model publish consid singleregion countri provinc citi outbreak multiprong mitig strategi develop plan examin literatur base concern rais policymak examin concern adequaci valid data epidemiolog data support model appear adequ valid updat outbreak demograph data improv interfac access retriev translat model paramet concern credibl valid model assumpt model simplifi realiti reduc comput burden simplif permiss interfer perform assess mitig strategi agre concern social behavior inadequ repres pandem influenza model review model consid socialbehavior aspect includ contact rate withdraw work school symptom appear care sick rel complianc social distanc vaccin antivir prophylaxi concern degre access model palpabl three model current access public model seek public access policymak prefer model scalabl popul size download oper person comput scale model larger popul requir comput handl person comput laptop limit state exist model includ review limit document discuss choic relev paramet valu conclus adequ address concern policymak continu model enhanc critic area includ updat epidemiolog data pandem smooth handl larg demograph databas incorpor broader spectrum socialbehavior aspect updat contact pattern adapt methodolog collect human mobil data improv comput effici access
PLoS One	17122013	2004-06-25	PMC3350496	22606336	the ferret commonli model studi infecti diseas genom sequenc anim model character limit number fulli annot cdna current genbank major gene involv innat adapt immun respons lack restrict molecular genet analysi host respons ferret model enabl de novo identif transcription activ ferret gene respons infect perform denovo transcriptom sequenc anim infect hn acalifornia includ splenocyt induc bacteri lipopolysaccharid allow identif transcript induc gramneg bacteria pool normal cdna librari order delimit risk sequenc highli express gene normal cdna librari remov possibl assess express chang individu anim increas identif low abund transcript studi identifi partial ferret transcript includ gene ortholog involv innat adapt immun respons
Open Biol	21749971	2011-09-01	PMC3352089	22645657	certain disulfid bond leucocyt membran protein labil reduc inflamm structur chang result downstream function effect exampl integrin activ studi wide rang membran protein labil disulfid bond includ cd common gamma chain receptor cytokin includ interleukin interleukin il il cysci disulfid bond mous cd suscept reduct enzym thioredoxin trx gamma interferoninduc lysosom thiolreductas protein disulfid isomeras commonli secret immun activ cysci disulfid bond reduc in vivo lipopolysaccharid lpsinduc acut model inflamm condit lead reduct cysci disulfid bond cd inhibit prolifer ildepend cell clone concomit inhibit stat signal pathwai reduc condit prolifer ilindepend cell clone reduc disulfid bond il postul reduct cysci disulfid cd inhibit il bind receptor complex publish data cysci disulfid bond expos surfac cd close contact il il respect receptor complex addit mutant cy residu human cd lead immunodefici loss il bind wider implic regul cytokin receptor gener activ modul redox regul mechan caus chang redox environ occur inflamm activ immun system
Int J Emerg Med	15220426	2010-01-01	PMC3352303	22503137	background convention nebul shortact agonist salbutamol reliev acut exacerb asthma worldwid respiratori outbreak discourag routin nebul previou studi combin budesonideformoterol symbicort astrazeneca effect mainten reliev antiasthmat medic method perform random openlabel studi march august compar bronchodilatori effect symbicort nebul salbutamol acut exacerb mild moder asthmat attack emerg depart initi object paramet measur includ oxygen satur peak expiratori flow rate pefr respiratori rate clinic reassess subject paramet visual analog scale va point likert scale breathless second read object paramet measur point likert scale patient ask describ symptom relief wors wors chang better better total patient enrol patient random receiv nebul salbutamol receiv symbicort treatment arm pair wilcoxon sign rank test statist improv oxygen satur pefr respiratori rate individu treatment group pre posttreat compar effect symbicort nebul salbutamol averag improv oxygen satur treatment arm pefr lmin lmin respiratori rate min min subject evalu patient report improv va averag cm cm patient treatment arm report better better point likert scale report chang wors conclus studi suggest statist differ symbicort nebul salbutamol reliev min postintervent
Scand J Trauma Resusc Emerg Med	21760531	2006-09-01	PMC3352321	22480164	background healthcar profession concern perform mouthtomouth ventil risk procedur healthcar profession fear attitud start cpr impact train object examin chang attitud healthcar profession perform cpr train method healthcar profession swedish hospit ask answer questionnair train question relat physic mental discomfort attitud cpr statist analysi gener mcnemar test improv item reflect aspect attitud cpr group health care profession physician nurs assist nurs physiotherapist occup therapist social welfar offic psychologist biomed analyst felt secur cpr knowledg educ aspect anxieti prior cardiac arrest nurs assist nurs improv concern infect perform mouth mouth ventil reduc mark reduct physician conclus hospitalbas set posit outcom educ train cpr concern healthcar profession attitud perform cpr felt secur knowledg cardiopulmonari resuscit aspect attitud resuscit nurs assist nurs appear group markedli influenc concern infect diseas low
PLoS One	23516023	2007-11-26	PMC3352918	22615777	the nonstructur protein nsp sever acut respiratori syndrom coronaviru sarscov helicas separ doublestrand rna dsrna dna dsdna polar energi nucleotid hydrolysi determin minim mechan helicas function nsp clear unwind lag increas length doublestrand region nucleic acid suggest presenc intermedi unwind process elucid natur intermedi carri transient kinet analysi nsp helicas activ demonstr enzym unwind nucleic acid discret step basepair bp catalyt rate step second net unwind rate basepair second nsp sarscov rnadepend rna polymeras rdrp enhanc fold catalyt effici nsp increas step size nucleic acid rnarna dnadna unwind specif sarscov nsp chang nsp activ observ footandmouthdiseas viru rdrp place nsp data provid experiment evid nsp nsp function concert manner improv effici viral replic enhanc understand nsp function sarscov rna synthesi
BMC Genomics	16704356	2016-06-13	PMC3353197	22530940	background infecti laryngotrach viru iltv gallid herpesviru infect high mortal huge econom loss poultri industri protect chicken iltv infect chickenembryo origin ceo tissuecultur origin tco vaccin transmiss vaccin iltv vaccin unvaccin chicken sever respiratori diseas host cell respons virul iltv infect determin microarrai analysi studi microarrai analysi perform understand hostvaccin iltv interact host gene transcript level chicken oligo microarrai were compar virul iltv infect total rna extract vaccin iltv infect chicken embryo lung cell dai post infect dpi compar dpi subject microarrai assai color hybrid method data analysi jmp genom ingenu pathwai analysi ipa program differenti express gene group number function categori includ tissu develop cellular growth prolifer cellular movement inflammatori respons gene network creat ipa program intermolecular connect interestingli differenti express gene bmp corf npy express distinctli vaccin iltv infect compar virul iltv infect conclus comprehens knowledg gene express biolog function host factor vaccin iltv infect provid insight host cellular defens mechan compar virul iltv
ScientificWorldJournal	25287059	2016-02-04	PMC3353321	22654650	bat sourc coronavirus close sever acut respiratori syndrom sar viru numer studi carri identifi bat virus sarscoronaviru batsarslik cov reversetranscribedpolymeras chain reaction assai qualit pcr underestim preval infect epidemiolog evalu bat viral ecolog work sybr greenreal time pcr assai develop diagnos infect sarsrel coronavirus bat guano appli screen tool survei carri greater horsesho bat rhinolophu ferrumequinum sampl itali assai high sensit reproduc applic bat screen preval method suitabl screen tool epidemiolog survei presenc batsarslik cov consequ realist scenario viral preval popul
PLoS One	27446383	2009-06-01	PMC3353973	22666328	fusion viral target cell membran obligatori step infect envelop viru block process clinic valid therapeut strategi viral fusion driven special protein specif viru common mechan format complex heptad repeat hr region hr region initi separ intermedi term prehairpin bridg viral cell membran fold form helic bundl hb drive membran fuse hrderiv peptid inhibit viral infect bind prehairpin intermedi prevent transit hb antivir activ hrderiv peptid differ consider envelop virus weak inhibitor potenc increas peptid engin strategi sequencespecif optim timeconsum seek wai increas potenc chang nativ sequenc report attach hr peptid cholesterol group cholesteroltag dramat increas antivir potenc simultan increas halflif vivo antivir potenc increas combin cholesteroltag dimer hrderiv sequenc exampl human parainfluenza viru nipah viru hiv cholesteroltag dimer repres strategi boost hr peptid potenc level case compat vivo contribut emerg respons outbreak exist novel virus
ScientificWorldJournal	26842828	2013-07-12	PMC3354554	22629172	kawasaki diseas kd character system vascul unknown etiolog highdos intraven immunoglobulin ivig effect therapi kd reduc preval coronari arteri lesion cal format sialyl igg report interact lectin receptor specif intracellular adhes molecul grab nonintegrin homologrel signr mice dendrit cellspecif intercellular adhes molecul grab nonintegrin dcsign human trigger antiinflammatori cascad studi conduct investig polymorph dcsign cd promot ag rs respons suscept cal format kd patient custom taqman snp genotyp assai total subject kd patient control investig identifi snp rs studi associ genotyp allel frequenc rs control subject kd patient domin model promot variant dcsign gene associ occurr ivig resist cal format kd allel dcsign promot rs risk allel develop kd
ScientificWorldJournal	19476514	2011-03-10	PMC3354684	22645426	background kawasaki diseas kd character system vascul unknown etiolog previou studi express cd ligand cd cell correl coronari arteri lesion cal diseas progress kd studi japan suggest role cdl pathogenesi cal help explain excess number male kd reproduc taiwanes popul studi conduct investig cd polymorph kd cal format method total subject kd patient control investig identifi tag singlenucleotid polymorph tsnp cd rs rs taqman allel discrimin assai associ cd tsnp rs control kd patient domin model kd patient polymorph cd rs associ cal format recess model haplotyp analysi yield polymorph cd susceptibilitydiseas activ kd conclus studi time polymorph cd associ suscept kd cal format taiwanes popul
PLoS Pathog	23852383	2014-11-25	PMC3355089	22615563	ubiquitin posttransl modif mediat divers cellular function includ endocyt transport molecul kaposi sarcomaassoci herpesviru kshv envelop herpesviru enter endotheli cell clathrinmedi endocytosi ubiquitin proteasom activ regul kshv entri endocytosi remain unknown inhibit proteasom activ reduc kshv entri endotheli cell intracellular traffick nuclei prevent kshv infect cell threedimension analys reveal accumul kshv particl cytoplasm compart identifi eea endosom vesicl proteasom inhibit kshv particl coloc ubiquitinbind protein epsin ep ubiquitin mediat intern kshv receptor integrin kshv particl coloc activ form ligas ccbl knockdown ccbl inhibit phosphoryl reduc viral entri intracellular traffick decreas kshv infect demonstr ubiquitin mediat intern kshv cognat receptor integrin identifi ccbl potenti ligas facilit process
PLoS Pathog	21265542	2002-06-01	PMC3355091	22615569	immunolog checkpoint inhibitori cd receptor cdr plai dual role balanc immun system microbi infect hand inhibitori signal prevent excess immun mediat patholog hand impair clearanc pathogen studi influenc inhibitori cdcdr axi clearanc patholog viru infect model find lack cdr signal enhanc type interferon ifn product viral clearanc improv outcom mous hepat corona viru mhv infect femal mice mhv clearanc depend toll receptor tlrmediat type ifn product sex differ tlr respons report human hypothes cdr ligat suppress tlr respons releas inhibit enlarg sex differ tlr signal hypothesi support find vivo administr synthet tlr ligand lead enhanc type ifn product femal cd mice cdr ligat inhibit tlr signal vitro influenza viru infect viral clearanc determin sex cdr signal absenc cdr influenza viru infect enhanc lung neutrophil influx patholog femal cdcdr sex host factor determin outcom viral infect data predict sex bia benefici patholog immun respons viru infect therapeut target cdcdr
PLoS Pathog	25423046	2015-01-01	PMC3355096	22615568	nucleic acid sens cell kei featur antivir respons gener result typei interferon product tissu protect detect doublestrand rna virusinfect cell promot concomit conflict event dsrnadepend protein kinas pkr phosphoryl translat initi factor alpha eif inhibit protein synthesi cytosol dexdh box rna helicas induc express type iifn cytokin demonstr phosphatas cofactor growth arrest dna damageinduc protein gaddpppra compon unfold protein respons upr absolut requir type iifn il product mous embryon fibroblast mef respons dsrna gadd express mef depend pkr activ link cytosol microbi sens atf branch upr link antivir immun underlin extrem suscept gadddefici fibroblast neonat mice chikungunya viru infect
PLoS One	11991994	2018-07-30	PMC3355165	22615877	adjuv potenti antigenspecif protect immun respons kei element promot vaccin effect report onchocerca volvulu recombin protein rovasp induc activ matur nave human dc innat adjuv promot balanc th respons bystand vaccin antigen mice vaccin antigen promot thbias respons base pronounc induct thassoci igga iggb antibodi respons upregul product cytokin includ il ifn tnf il protein rovasp adjuv induc antiselfantibodi verifi host respons will affect adjuvant rovasp subsequ vaccin vaccin antigen studi establish rovasp adjuvant mice cours sequenti vaccin vaccin model system receptorbind domain rbd sarscov spike protein commerci influenza viru hemagglutinin ha vaccin compris three viru strain adjuvant rovasp retain efficaci vaccin high level antirovasp antibodi sera mice administr second vaccin demonstr util adjuv human immun nonhuman primat nhp rbd rovasp rovasp induc high titr function protect antirbd antibodi respons nhp notabl rovasp adjuv induc high titer antibodi nhp studi provid sound scientif foundat futur strategi develop novel protein adjuv
PLoS One	26261767	2010-06-01	PMC3356272	22624001	there urgent potent inhibitor dengu viru denv replic treatment andor prophylaxi infect viru report aglycon analogu antibiot teicoplanin code lcta inhibit denvinduc cytopath cpe dosedepend manner viru infect complet inhibit concentr advers host cell find corrobor quantif viral rna level cultur supernat antivir activ observ flavivirus yellow fever viru tickborn enceph viru tbev potent antivir activ observ tbev timeofdrugaddit experi indic lcta inhibit earli stage denv replic cycl virucid exclud observ corrobor fact lcta lack activ denv subgenom replicon encod structur protein replic microsopybas bind fusion assai emploi didlabel virus lcta target earli stage bindingentri infect lcta effici inhibit infect denv particl preopson antibodi inhibit antibodydepend enhanc ad conclus lcta exert vitro activ flavivirus denv interf earli step viral replic cycl
ScientificWorldJournal	30061706	2009-08-01	PMC3357934	22654630	virus common opportunist infect transplant risk viral infect function specif viru encount intens immun suppress prevent graft reject host factor govern suscept cytomegaloviru common opportunist pathogen transplant recipi numer virus outcom case prevent measur pretranspl screen prophylact antivir therapi posttranspl viral monitor limit impact infect advanc laboratori monitor antivir therapi improv outcom studi viral latenc reactiv cellular effect viral infect will provid clue futur strategi prevent treatment viral infect paper will summar major viral infect transplant discuss strategi prevent manag potenti pathogen
Comput Math Methods Med	21822500	2008-08-01	PMC3357941	22649483	estim case fatal ratio cfr novel strain influenza viru earli stage pandem kei epidemiolog task conduct rapid respons experi epidem sever acut respiratori syndrom sar influenza hn pose technic challeng estim cfr real time studi aim develop simpl method estim cfr base dataset confirm case death address technic issu assess reliabl valid propos method examin minimum length time requir assign cfr includ confid interv estim cfr prespecifi cutoff mont carlo simul smaller transmiss potenti longer compar estim cfr cutoff policymak public health respons base cfr estim deriv propos method data success estim longer month
PLoS One	19705010	2010-08-01	PMC3358292	22629438	angiotensinconvert enzym ac express kidnei renoprotect enzym convert angiotensin ang ii ang ac detect urin patient chronic kidnei diseas measur urinari ac activ protein level renal transplant patient ag yr male diabet healthi control ag yr male determin factor associ elev urinari ac patient urin transplant subject assai ac mrna protein subject inhibitor reninangiotensin system urinari ac level higher transplant patient compar control ac activ ac protein elisa western analysi transplant patient diabet mellitu increas urinari ac activ protein level compar nondiabet ac mrna level differ urinari ac activ protein increas diabet transplant subject ac mrna level differ nondiabet subject adjust confound variabl diabet associ urinari ac activ protein level femal gender associ urinari mrna level ac ac data indic urinari ac increas renal transplant recipi diabet increas shed tubular cell urinari ac marker renal reninangiotensin system activ patient
PLoS One	18718423	2008-06-11	PMC3358305	22629350	in chronic hcv infect treatment failur defect host immun respons highli demand improv therapi strategi vv tcell inhibit hcv replic vitro ifn releas phosphoantigen phag stimul aim work analyz vv tcell function chronic hcv infect studi role ifn function capabl ifn product vv tcell analyz vitro hcvinfect patient healthi donor hd phag stimul ifn vivo phagifn administr plasma ifn level analyz fasciculari monkei quantit analysi ifn mrna level stabil vv tcell evalu chronic hcv infect vv tcell effectoractiv phenotyp impair ifn product interestingli ifn improv ifn respons phag vitro hd hcvinfect patient vivo macaca fasciculari primat final ifn increas ifnmrna transcript stabil phagactiv vv tcell altogeth function impair vv tcell chronic hcv infect partial restor ifn studi aim evalu antivir impact phagifn combin provid insight design combin strategi improv hcv infect treatment outcom
PLoS One	20452380	2018-05-03	PMC3359987	22655077	west nile viru wnv bloodborn pathogen system infect seriou neurolog diseas human anim common rout infect mosquito bite viru cross number polar cell layer gain access organ tissu central nervou system resist transcellular movement macromolecul epitheli endotheli cell mediat tight junction complex number studi document wnv infect neg impact barrier function tight junction intracellular mechan occur understood studi report endocytosi subset tight junction membran protein includ claudin jam occur wnv infect epitheli endotheli cell process ultim lysosom degrad protein depend gtpase dynamin microtubulebas transport final infect polar cell flaviviru dengu viru result loss tight junction membran protein neurotrop flavivirus wnv modul host cell environ differ hemorrhag flavivirus implic understand molecular basi neuroinvas
PLoS One	18550677	2013-12-23	PMC3360650	22662275	the continu spread highli pathogen avian influenza hpai hn viru underscor effect antivir approach avfluigg potent broadreact hnneutral human monoclon antibodi mab show great potenti therapeut purpos basi vaccin develop antigen epitop neutral mechan fine character studi demonstr avfluigg target novel conformationdepend epitop globular head region hn hemagglutinin ha select mimotop random peptid librari combin comput algorithm sitedirect mutagenesi epitop map three conserv discontinu site iiii locat close threedimension structur ha haspecif human mab effici block virusreceptor bind postattach step fab fragment exert postattach inhibit consist avfluigg inhibit hamedi cellcel membran fusion dosedepend manner block acquisit phinduc proteas sensit neutral mechan avfluigg simultan block viral attach receptor host cell interf ha conform rearrang associ membran fusion present data provid critic develop novel antivir therapeut vaccin hpai hn viru
PLoS One	31007619	2011-10-01	PMC3360666	22701536	epitop map affinityselect peptid popular epitop predict correspondingli webbas tool develop year perform tool vari circumst address problem emploi ensembl approach incorpor popular web tool mimopro pepdsearch advantag offer method user option specif purpos epitopepeptid map combin oper union find associ peptid method increas sensit find potenti epitop region antigen surfac combin oper intersect achiev extent mutual verif method increas likelihood locat genuin epitop region antigen relat interact peptid consist intersect union indirect suffici condit assess likelihood success peptideepitop map averag test combin oper pepmapp outperform mimopro pepdsearch pepmapp multipurpos map tool epitop predict affinityselect peptid web server freeli access httpinformaticsnenueducnpepmapp
Int J Cell Biol	24367104	2016-06-21	PMC3362037	22666256	autophagi catabol pathwai conserv eukaryot allow cell rapidli elimin larg unwant structur aberr protein aggreg superflu damag organel invad pathogen hallmark transport pathwai sequestr cargo degrad lysosom doublemembran vesicl call autophagosom kei actor mediat biogenesi carrier autophagyrel gene atg long time assum autophagi bulk process studi highlight capac pathwai exclus elimin specif structur better fulfil catabol necess cell start unveil regul mechan select type autophagi clearli emerg structur target destruct accur enwrap autophagosom action specif receptor adaptor paper will discuss impact select type autophagi understand autophagi
Mediators Inflamm	21852633	2012-10-01	PMC3362132	22665949	virus frequent respiratori infect viral respiratori infect hospit morbid mortal varieti patient popul lung inflamm induc infect common respiratori pathogen influenza respiratori syncyti viru accompani increas lung product prostaglandin leukotrien lipid mediat wide rang effect host immun function defici pharmacolog inhibit prostaglandin leukotrien product dampen inflammatori respons acut infect respiratori viru mediat serv appeal therapeut target diseas caus respiratori viral infect
PLoS One	27327437	2006-02-22	PMC3362556	22666484	background human bocaviru hbov newli identifi human parvoviru hbov associ upper lower respiratori tract infect gastroenter children seroepidemiolog hbov popul caribbean method crosssect studi conduct univers hospit west indi kingston jamaica blood sampl collect pediatr patient test presenc hbovspecif antibodi viruslikeparticl base enzymelink immunosorb assai elisa hbovspecif antibodi sampl collect pediatr popul seropreval hbov highest year seroepidemiolog profil suggest children expos hbov year life jamaica conclus hbov infect common children jamaica hbov seropreval rate caribbean report area world
PLoS Negl Trop Dis	22996451	2006-11-01	PMC3362645	22666515	background liver fluke infect livestock econom loss billion worldwid annum diseas increas livestock worldwid reemerg human diseas current commerci vaccin drug efficaci adult worm juvenil liver fluke vaccin deem essenti shortliv chemotherapi prone resist unsustain option develop develop countri protein superfamili provid number lead liver fluke vaccin candid form glutathion transferas gst famili sigma class gst close lead schistosom vaccin candid sm reveal proteom liver fluke function characteris methodologyprincip find manuscript purifi recombin form hepatica sigma class gst possess prostaglandin synthas activ influenc activ host immun cell immunocytochemistri western blot protein surfac fluke express egg newli excyst juvenil excretorysecretori fraction adult assess potenti hepatica sigma class gst vaccin goatbas vaccin trial reduct worm burden reduct patholog associ liver fluke infect conclusionssignific hepatica sigma class gst multifunct role hostparasit interact gener detoxif bile acid sequestr pgd synthas activ
BMC Public Health	16492317	2020-01-01	PMC3362781	22452874	background surveil sever acut respiratori infect sari sentinel hospit recommend estim burden sever influenzacas monitor patient admit respiratori infect ri berlin hospit to case definit cd determin proport case influenza ahnpdm phn compar sensit specif cd captur pandem phn case method establish risurveil restrict adult ag year framework phn vaccin effect studi requir activ identif ricas hospit informationsystem screen daili newli admit ripati nasopharyng swab consent patient test pcr influenzaviru subtyp clinic cd compar term captur phnposit hospit ripati appli sensit specif analys broadest case definit cd inclus ricas narrowest case definit cd ident sari case definit recommend ecdcwho studi period identifi ricas met ecdcwho sari case definit percentag saricas intern medicin admiss decreas calendarweek week patient test pcr phnposit case definit narrow cd contrast sari requir short breath yield largest area receiveroperatorcurv heterogen proport patient admit ri hospit conclus comprehens surveil ri case feasibl network commun hospit set hospit includ ensur repres misclassif failur symptom hospit informationsystem rule high proport hospit pcrposit phnpatient fulfil sari casedefinit includ short breath difficulti breath assess influenzarel diseas burden hospit broader altern case definit consid
PLoS One	17203732	2010-08-18	PMC3364185	22666453	background high global preval latent tb infect ltbi kei challeng endem set distinguish patient activ tb patient overlap clinic symptom activ tb coexist ltbi current method insuffici accur plasma proteom fingerprint resolv difficulti provid molecular snapshot defin diseas state develop pointofcar diagnost method plasma clinic data prospect patient attend commun tb clinic peru household contact plasma subject highthroughput proteom profil mass spectrometri statist pattern recognit method defin mass spectral pattern distinguish patient activ tb symptomat control ltbi patient activ tb symptomat control patient respiratori symptom activ tb investig activ tb patient distinguish undifferenti symptomat control accuraci sensit specif symptomat control ltbi accuraci sensit specif symptomat control ltbi accuraci sensit specif conclus activ tb distinguish accur ltbi symptomat clinic attend plasma proteom fingerprint translat biomark deriv studi robust afford pointofcar format will implic recognit control activ tb high preval set
Virol J	31368294	2010-08-25	PMC3364910	22490115	background acut respiratori tract infect major morbid mortal young children develop countri viral aetiolog acut respiratori infect develop countri limit studi identifi virus associ acut lower respiratori tract infect children year method nasopharyng sampl blood cultur collect children year hospit acut lower respiratori tract infect virus bacteria identifi revers transcriptas realtim polymeras chain reaction convent biochem techniqu patient recruit ci posit virus respiratori syncyti viru rsv detect ci patient adenovirus adv ci parainfluenza piv type ci influenza virus ci concomit viral bacteri coinfect occur patient detect differ clinic sign symptom sever pathogen isol total of posit virus detect raini season respiratori syncyti viru predomin conclus studi demonstr burden respiratori virus major childhood acut respiratori infect tertiari health institut ghana data address studi viral associ respiratori tract infect
BMC Vet Res	20719956	2008-06-03	PMC3366893	22414223	background mortal morbid document white veal industri despit high level antimicrobi drug resist object studi determin epidemiolog morbid mortal dairi beef crossbr white veal product total calv hous product cohort product cycl mortal determin necropsi morbid daili record produc total mortal risk wa higher beef veal product compar dairi crossbr main mortal pneumonia calv risk rumin disord idiopath periton enterotoxaemia enter belgian blue beef calv die pneumonia enterotoxaemia arthriti detect bovin viral diarrhea viru necropsi associ chronic pneumonia pleuriti calv treat individu morbid rate case calf dai risk incid rate respiratori diseas diarrhea arthriti otiti case calf dai risk morbid peak three week arriv gradual declin the product cycl conclus studi provid insight epidemiolog morbid mortal white veal calv belgium hous frequent hous system europ necropsi find identifi risk period differ product system guid veterinarian produc profit ethic prevent therapeut protocol
PLoS One	20739481	2019-01-23	PMC3366922	22675552	viral metagenom librari promis untap sourc reagent enzym deep sequenc function screen viral metagenom dna nearboil thermal pool identifi clone express thermost dna polymeras pol activ pol demonstr high thermost innat revers transcriptas activ describ biochemistri pol report singleenzym revers transcript pcr rtpcr wildtyp pol proofread exonucleas domain confer high fidel pcr easiertous exonucleasedefici deriv incorpor pyroscript rtpcr master mix compar oneenzym tth twoenzym mmlv rttaq rtpcr system quantit detect ms rna influenza rna mrna target specif sensit polbas rtpcr higher tth pol compar three common twoenzym system perform simplifi setup enzym potenti altern molecular diagnost
PLoS One	18523003	2015-11-04	PMC3366946	22675528	two hepat viru hbv cd recombin isol western china direct evid indic virus aros result recombin genotyp result converg studi search evid intraindividu recombin famili cluster case cocircul genotyp cd recombin studi individu famili hbv infect identifi individu mix hbv genotyp coinfect restrict fragment length polymorph proceed clone dna sequenc recombin signal detect rdp softwar confirm split phylogenet tree famili mix hbv genotyp coinfect resampl three famili individu hbv genotyp coinfect individu tripl infect hbv genotyp cd recombin genotyp clonal analysi patient indic cd recombin ident isol cd cd novel recombin cd simultan parent strain recombin form recombin patient indic detect mix infect recombin limit time window recombin natur hbv preclud possibl simpl phylogenet taxonomi standard requir classifi hbv sequenc
PLoS One	30674628	2015-11-09	PMC3366999	22675502	wet market common part promot emerg spread mainten livestock pathogen includ zoonos survei conduct order assess potenti vietnames cambodian live bird market lbm sustain circul highli pathogen avian influenza viru subtyp hn hpaiv hn thirti vietnames cambodian lbm visit structur interview conduct market manag vietnames cambodian trader multivari cluster analysi construct typolog trader base poultri manag practic result practic larg poultri surplu unsold poultri reoffer sale dai poultri trader promot condit favor perpetu hpaiv hn lbm trader oper lbm locat dens popul area ha noi phnom penh profil seller oper lbm reliabl predict basic locat type market consequ lbm largest combin risk factor viru reservoir easili identifi allow control strategi appropri target find relev resourcescarc set extens develop lbm system commonli southeast asia
PLoS Negl Trop Dis	26537255	2007-12-03	PMC3367991	22679523	background elev aspart aminotransferas ast alanin aminotransferas alt promin acut dengu ill health organ dengu guidelin defin ast alt unitslit ul criterion sever dengu aim assess clinic relev discriminatori ast alt dengu hemorrhag fever dhf sever dengu methodologyprincip find retrospect studi classifi polymeras chain reaction posit dengu patient treat tan tock seng hospit singapor criteria dengu sever dengu patient dhf sever dengu elev ast alt occur ast alt ul acut liver failur patient di median ast alt valu higher increas dengu sever criteria discriminatori nonsever sever dengu ast area receiv oper characterist roc curv confid interv ci dengu fever df dhf ast area roc curv ci overlap ast alt valu patient dengu warn sign sever dengu df dhf conclus aminotransferas level increas conjunct dengu sever ast alt valu discrimin df dhf nonsever sever dengu
PLoS One	26958916	2015-07-22	PMC3367995	22679491	pandem hn influenza hnpdm current domin circul influenza strain worldwid sever case hnpdm infect character prolong activ immun respons specif role inflammatori mediat diseas understood inflammatori cytokin il implic season sever pandem hn influenza hnpdm infect investig role il sever hnpdm infect il featur host respons human mice infect hnpdm elev level il associ sever diseas patient hospit hnpdm infect notabl serum il level associ requir critic care admiss predict fatal outcom cblj balbcj bsfj mice infect amexico hnpdm consist trigger sever diseas increas il level lung serum lethal cblj mous model hnpdm infect global gene express analysi indic pronounc il associ inflammatori respons subsequ examin diseas outcom il defici mice infect hnpdm differ surviv weight loss viral load patholog observ il defici wildtyp mice infect find il potenti diseas sever biomark suitabl therapeut target case sever hnpdm infect mous data
J Nanobiotechnology	18060019	2006-04-01	PMC3368735	22436172	background detect immunogen protein remain task life scienc nourish understand pathogen illumin potenti vaccin candid broaden spectrum biomark applic diagnost tool tradition immunoscreen express librari polyclon sera nitrocellulos membran screen proteom lysat gel electrophoresi perform method featur inconveni disadvantag screen express librari expos novel antigen bacteria lead abund fals posit signal high cross reactiv polyclon antibodi protein express host method present overcom disadvantag procedur protein describ immunogen assess immunogen abil method protein immunogen behaviour suggest potenti immunogen incorpor fusion tag prior gene interest attach express fusion protein coval microarrai enhanc specif bind protein compar nitrocellulos help reduc number fals posit enabl screen immunogen protein shorter time sampl statist reliabl valid method emploi gene campylobact jejuni nctc conclus method present offer approach screen bacteri express librari illumin novel protein immunogen featur provid power attract altern exist method help detect identifi vaccin candid biomark potenti virulenceassoci factor immunogen behaviour further knowledg virul pathogen studi bacteria
J Neuroinflammation	26202229	2004-12-13	PMC3368782	22405261	background neuropatholog caus acut viral infect brain associ develop persist neurolog deficit identif immun effector respons injur brain acut infect develop therapeut strategi reduc neuropatholog maintain immun control viru method ident braininfiltr leukocyt determin microscopi flow cytometri acut time point intracrani infect mice theiler murin encephalomyel viru behavior consequ immun cell deplet assess morri water maze inflammatori monocyt defin cdhicdbfgra neutrophil defin cdhicdbfgra brain infect flow cytometri braininfiltr leukocyt collect lysm gfp report mice confirm identif neutrophil inflammatori monocyt brain microscopi section infect lysmgfp mice infiltr cell concentr hippocamp format immunostain confirm neutrophil inflammatori monocyt local hippocamp format infect immunodeplet inflammatori monocyt neutrophil neutrophil preserv hippocamp neuron immunodeplet inflammatori monocyt preserv cognit function assess morri water maze conclus neutrophil inflammatori monocyt rapidli robustli respond theiler viru infect infiltr brain inflammatori monocyt preced neutrophil cell type hippocamp format timepoint consist role trigger hippocamp patholog deplet inflammatori monocyt neutrophil gr antibodi hippocamp neuroprotect preserv cognit function specif deplet neutrophil antibodi fail preserv neuron suggest inflammatori monocyt kei effector brain injuri acut picornaviru infect brain effector cell therapeut target immunomodulatori immunosuppress therapi aim reduc prevent central nervou system patholog associ acut viral infect
PLoS One	16597880	2006-11-01	PMC3368904	22701693	human herpesviru type hhvb strong induc ifnalpha capac promot respons block respons vitro studi address inactiv hhvb induc ifn lambda respons extent interferon alpha lambda affect thth polar inactiv hhvb induc ifnlambda il ifnlambda ila respons plasmacytoid dc induct mediat tlr hhvb promot respons block respons human mice neutral ifnalpha ifnlambda block hhvbinduc enhanc respons mlr affect hhvinduc dampen respons blockag tlr counteract hhvb effect thth balanc addit ifnalpha ifnlambda promot ifngamma product block il il product purifi cd tcell lack of ifnlambda correl absenc ifnlambda receptor ilralfa chain cell surfac rest activ cd tcell conclud inactiv hhvb strong induc ifnlambda plasmacytoid dc induct tlrdepend human cd tcell express ifnlambda receptor refractori ifnlambda treatment hhvbinduc alter thth balanc mediat tlr ifnalpha
PLoS One	15596844	2013-01-01	PMC3369836	22685582	ow uniqu function regul glucos lipid cholesterol metabol ppar peroxisom proliferatoractiv receptor drawn special attent develop drug treat type diabet combin lipid benefit pparalpha agonist fibrat glycem advantag ppargamma agonist thiazolidinedion dual ppar agonist approach improv metabol effect minim side effect caus agent promis strategi design effect drug type diabet studi power core hop glide dock techniqu novel class ppar dual agonist discov base compound gw wellknown dual agonist pparalpha ppargamma modifi farglitazar structur observ molecular dynam simul novel agonist possess function gw activ pparalpha ppargamma favor conform bind receptor valid outcom adm absorpt distribut metabol excret predict agonist hold high potenti drug candid find report stimul strategi provid insight discov effect dual agonist treat type diabet core hop techniqu allow rapidli screen novel core help overcom unwant properti gener lead compound improv core properti escap notic current strategi correspond comput procedur util find novel effect drug treat ill
PLoS One	17228565	2007-05-15	PMC3372491	22701601	background order identifi novel chemic class secretas bace inhibitor altern score protocol princip compon analysi pca propos summar the origin score function rerank the virtual screen bace method train set bace inhibitor inact divers compound three rankbas virtual screen method individu score convent consensu score pca judg hit number top rank list dock pose gener surflex score function surflexscor dscore gscore chemscor pmfscore pose extract pose group twelv score function surflexscor dscore gscore chemscor pmfscore ligscor ligscor plp plp jain ludi ludi pose rank test set chemic compound sigmaaldrich corpor chemic directori dock surflex rank three rank method motion select potenti activ compound experiment test train set pca approach yield consist superior rank compar convent consensu score singl score test set top compound convent consensu score experiment test inhibitor reli pca score protocol test top compound low micromolar inhibitor emerg bace fluoresc reson energi transfer fret assai conclus pca method extend convent consensu score quantit statist manner appear consider potenti chemic screen applic
PLoS One	24175228	2006-05-12	PMC3374814	22719945	haemoglobin degrad erythrocyt life stage major function food vacuol fv plasmodium falciparum target antimalari drug interfer metabol pathwai kill parasit multispan food vacuol membran protein multidrug resist protein pfmdr chloroquin resist transport pfcrt modul resist drug food vacuol investig format behaviour food vacuol membran gener induc gfp fusion chloroquin sensit resist form pfcrt protein induc express system allow follow newlyinduc fusion protein corrobor previou report direct traffick rout ergolgi food vacuol membran parasit allow definit food vacuol compart ring stage parasit haemozoin crystal appar elucid secondari pfcrtlabel compart adjac food vacuol late stage parasit demonstr addit demonstr brefeldin sensit traffick pfcrt disrupt dynasor competit inhibitor dynaminmedi vesicl format chloroquin sensit alter parasit overexpress chloroquin resist sensit form pfcrt fuse gfp suggest pfcrt mediat chloroquin transport gfp fusion protein
PLoS One	17517625	2012-02-29	PMC3375254	22720031	cytokin express pattern cell regul precommit stabl effector phenotyp modif moder stabl phenotyp quantit chang cytokin product respons acut signal epiderm growth factor famili member amphiregulin express cell receptoractiv mous cd cell cell help elimin helminth infect report detail analysi regul amphiregulin express human cell subset signal cell receptor induc amphiregulin express cell subset human peripher blood includ naiv memori cd cd cell th vitro cell line subset memori cd cell express chemokin receptor cytokin cell type amphiregulin synthesi inhibit antagonist protein kinas a downstream compon camp signal pathwai enhanc ligand increas camp directli activ protein kinas prostaglandin adenosin natur ligand stimul adenylyl cyclas activ enhanc amphiregulin synthesi reduc synthesi cytokin contrast mous cell amphiregulin synthesi human cell regul acut signal precommit cell cytokin pattern appropri cytokin involv repair attack function inflammatori respons
PLoS One	16699025	2014-07-02	PMC3375263	22719948	increas number hn influenza virus iv respons human death north africa southeast asian bind hemagglutinin ha viral surfac host sialic acid sa receptor requisit step infect process phylogenet analysi reveal hn virus divid clade base ha sequenc human iv center clade clade clade protein sequenc align clade indic high conserv receptorbind domain rbd essenti bind sa receptor glycosyl site n particip receptor recognit work attempt construct serial hn ha model includ divers glycosyl simul bind process sa receptor silico sagal sagal receptor adopt distinct topolog straight fishhooklik presenc nglycan decreas affin ha receptor sagal analog steric clash huge glycan glycosyl site locat adjac ha monom effect prevent bind sagal analog
PLoS One	22379103	2018-09-05	PMC3376151	22719912	background addit sar associ coronavirus nonsar human coronavirus hcov recogn common respiratori pathogen etiolog clinic impact hcov chines adult acut upper respiratori tract infect urti character systemat molecular detect excel sensit methodologyprincip find studi detect nonsar hcov speci realtim rtpcr nasopharyng swab collect march februari specimen test presenc common respiratori virus newli identifi virus human metapneumoviru hmpv human bocaviru hbov nasopharyng swab posit hcov speci detect case oc case hku case nl case hcove circul month surveil detect rate oc nl yeartoyear variat p higher detect frequenc hku patient ag year hcov posit patient coinfect undifferenti human rhinovirus influenza flu common virus detect hcov coinfect respiratori syncyti viru rsv human parainfluenza viru piv hbov detect low rate adult patient urti conclusionssignific nonsarsassoci hcov frequent detect realtim rtpcr assai adult urti beij hcove led preval infect studi suggest nonsarsassoci hcov contribut urti adult patient china
PLoS One	24752688	2001-01-01	PMC3377622	22723955	antivir defens liver acut infect hepatotrop viru murin cytomegaloviru mcmv involv complex cytokin cellular interact mechan viral sens liver promot cytokin cellular respons remain unclear studi undertaken investig role nucleic acidsens tolllik receptor tlr initi antivir immun liver infect mcmv examin host respons uncb mutant mice signal properli tlr tlr tlr acut mcmv infect determin liver antivir defens depend signal molecul infect uncb mutant mice reveal reduc product system liver proinflammatori cytokin includ ifn ifn il tnf compar wildtyp uncb defici contribut transient hepat acut infect evidenc augment liver patholog elev system alanin aminotransferas level viral clearanc impair uncb mutant mice despit intact virusspecif cd cell respons liver altogeth combin role nucleic acidsens tlr promot earli liver antivir defens mcmv infect
Virol J	30185593	2011-08-10	PMC3377956	22044910	background rabbit haemorrhag diseas viru rhdv pathogeni rabbit haemorrhag diseas highli infecti fatal diseas wild domest rabbit research reveal number calicivirida specialti genom reproduct report firstli analyz genom open read framework orf aspect codon usag bia research indic mutat pressur natur determin rhdv high codon bia codon usag bia contrari orf orf factor regul express vp encod orf vp encod orf neg select constraint rhdv genom impli vp plai role rhdv lifecycl conclus conjectur vp benefici replic releas viru induc infect cell apoptosi initi rhdv the princip compon analysi orf rscu firstli separ rhdv genotyp enc valu indic orf orf independ evolut rhdv
PLoS Negl Trop Dis	11119619	2013-04-18	PMC3378604	22724041	background entomolog survei simulium vector compon criteria determin onchocerca volvulu transmiss interrupt focal elimin parasit achiev infect vector popul rare area control succeed larg number fli examin certifi transmiss interrupt current accomplish pcr pool screen larg number fli effici process limit size pool screen turn determin constraint impos biochemistri assai current method dna purif pool vector black fli reli silica adsorpt method appli screen pool maximum individu latin american vector individu african vector methodologyprincip find evalu altern method dna purif pool screen black fli reli oligonucleotid captur onchocerca volvulu genom dna homogen prepar pool latin american african vector oligonucleotid captur assai reliabl detect volvulu infect larva pool african latin american fli repres twofour fold improv convent assai captur assai requir equival amount technic time conduct convent assai twofour fold reduct labor cost insect assai reduc reagent cost pool fli insect assai conclusionssignific oligonucleotid captur assai repres substanti improv procedur detect parasit preval vector popul major metric emploi process certifi elimin onchocerciasi
PLoS One	21835814	2017-03-22	PMC3379973	22745738	t cell epitop accur monitor avian influenza viru aiv immun respons ration design vaccin cell epitop identifi hn aiv viru nucleoprotein np chicken time studi homolog model techniqu construct threedimension structur peptidebind domain chicken mhc class molecul commonli encount uniqu haplotyp b b hn aiv np computation pars octapeptid nonapeptid peptidebind motif mhc class molecul b b haplotyp seventyf peptid sequenc model mhc class moleculebind abil analys molecular dock twentyf peptid ten predict potenti cell epitop chicken peptid unrel peptid manual synthes cell respons test vitro spleen lymphocyt collect spf chicken immunis npexpress plasmid pcaggsnp stimul synthes peptid secret chicken ifn prolifer cd cell test elisa kit flow cytometri secret chicken ifn prolifer cd lymphocyt increas monitor cell stimul peptid np np indic peptid np pkktggpii np krgindrnf np cell epitop chicken haplotyp method investig applic predict cell epitop antigen chicken studi extend understand mechan immun respons aiv chicken
PLoS One	23550601	2017-03-01	PMC3380027	22745751	background poisson regress model estim influenzaassoci diseas burden advantag adjust multipl season confound studi discuss judg adequaci confound adjust studi aim compar perform commonli adopt model select criteria term provid reliabl valid estim health impact influenza method assess model select criteria quasi akaik criterion qaic quasi bayesian criterion qbic partial autocorrel function residu pacf gener crossvalid gcv separ appli select poisson model best fit mortal dataset simul assumpt season confound perform criteria evalu bia rootmeansquar error rmse estim predetermin coeffici influenza proxi variabl criteria subsequ appli empir hospit dataset confirm find simul studi gcv consist provid smaller bias rmse influenza coeffici estim qaic qbic pacf simul scenario sensit analysi predetermin influenza coeffici studi period lag week gcv consist outperform criteria appli select criteria estim influenzaassoci hospit conclus gcv criterion recommend select poisson model estim influenzaassoci mortal morbid burden proper adjust confound find help standard poisson model approach influenza diseas burden studi
PLoS One	28331093	2015-03-12	PMC3380856	22768049	cultur genet reli distinct isol transmiss system cultur process chang human select environ affect individu surviv reproduc evalu mode subsist nativ american popul frequenc abcaargci polymorph correl examin evolutionari consequ agricultur construct nich mesoamerica consid genecultur coevolut model purpos genotyp individu affili nativ american popul data nativ american group analysi combin snp cluster neutral region dataset unravel scenario involv cy evolutionari histori estim ag cy compat origin occur american contin correl frequenc archeolog data zea pollen mesoamericacentr america neutral coalesc simul fstbase natur select analysi maiz domest drive forc increas frequenc cy region repres exampl genecultur coevolut involv autochthon american allel
PLoS One	25766240	2013-08-11	PMC3382199	22761854	background speci human bocavirus hbov identifi base phylogenet analysi report hbov associ respiratori diseas hbov detect enter infect preval hbov human studi region address global methodologyprincip find crossreact antivp antibodi detect hbov mous human serum preval specif antivp igg antibodi hbov determin ag group healthi individu ag year beij china competit elisa assai base viruslik particl hbov seropreval hbov children ag year seropreval hbov healthi adult year seroposit rate hbov higher hbov hbov hbov individu older year igg seroconvers hbov hbov hbov pair sera collect children respiratori tract infect posit hbov pcr analysi conclusionssignific data indic hbov preval hbov hbov hbov popul sampl beij china suggest hbov speci plai differenti role diseas
Mediators Inflamm	27066803	2015-07-31	PMC3384978	22761540	human respiratori syncyti viru rsv acut sever lower respiratori tract ill infant young children rsv upregul proinflammatori cytokin plateletactiv factor paf receptor receptor streptococcu pneumonia pulmonari epitheli cell clarithromycin cam antimicrobi agent immunomodul suppress rsvinduc product interleukin interleukin regul activ normal tcell express secret rant cam suppress rsvinduc paf receptor express adhes fluoresceinlabel pneumonia cell cell rsvinduc pneumonia adhes thought mediat host cell paf receptor cam exhibit antimicrobi immunomodulatori activ studi suppress rsvinduc adhes respiratori diseasecaus bacteria pneumonia host cell cam suppress immunolog disord prevent secondari bacteri infect rsv infect
J R Soc Interface	23934716	1999-02-15	PMC3385754	22337627	us sequenc data infer popul dynam plai increas role analysi outbreak common method base coalesc infer extens test simul epidem simul data test abil parametr nonparametr method infer effect popul size code popular beast packag reconstruct epidem dynam consid rang simul centr scenario consid plausibl pandem influenza conclus gener exponenti grow epidem highlight systemat bias nonparametr effect popul size estim promin bia lead fals infer slow epidem spread real epidem grow exponenti sampl strategi reduc elimin bias parametr method correct bias infect popul size larg explor poor sampl strategi overrepres epidemiolog link cluster case dramat exacerb bia uncontrol manner final simpl diagnost indic base coalesc densiti easili appli reconstruct phylogeni identifi timeperiod effect popul size estim bias illustr applic hn pandem
Viruses	26193345	2016-08-10	PMC3386620	22754651	regulatori cell treg subset cell respons maintain peripher immun toler homeostasi hallmark treg express forkhead box foxp transcript factor natur regulatori cell ntreg distinct popul cell express cd foxp ntreg develop thymu function maintain peripher immun toler cd cdcd cdcd cell induc acquir regulatori function antigen stimul depend cytokin milieu induc adapt treg frequent express high level interleukin receptor cd atyp treg express foxp cd surfac express cd type regulatori cell tr cell produc il helper cell produc tgf function induc treg presum maintain immun homeostasi context chronic inflamm infect induct treg coronavir infect protect sever form diseas attribut host respons arterivirus exploit cell subset dampen immun respons allow viral persist treg induct activ pathogenesi diseas describ porcin reproduct respiratori syndrom viru lactat dehydrogenas elev viru mous hepat viru review discuss develop biologi regulatori cell context arterivir coronavir infect
Viruses	10022847	2015-11-09	PMC3386621	22754646	porcin reproduct respiratori syndrom viru prrsv poor induc type interferon inhibit effici induct type interferon porcin transmiss gastroenter viru tgev synthet dsrna molecul poli ic mechanist basi prrsv interfer induct type interferon natur host cell remain defin purpos review summar kei find support posttranscript control type interferon natur host cell propos role translat control regul type interferon induct prrsv
Viruses	27512061	2013-02-13	PMC3386628	22754655	tolllik receptor tlr sens viral infect induc product type interferon ifn cytokin chemokin viral recognit tlr pattern recognit receptor prr proven celltyp specif trigger tlr select ligand benefici viral infect macrophag antigenpres cell express tlr kei role innat adapt immun virus coronavirus cov singlestrand positivesens rna virus acut chronic infect product infect macrophag investig interplai cov prr infanc assess trigger tlr tlr tlr tlr select ligand suscept ja macrophag cell infect murin coronaviru mous hepat viru mhv stimul tlr tlr tlr affect mhv product contrast prestimul tlr polyinosinicpolycytidyl acid poli ic hinder mhv infect induct ifn macrophag demonstr activ tlr synthet ligand poli ic mediat antivir immun diminish mhva suppress mhvjhm mhv viru product macrophag
PLoS One	26958925	2010-11-02	PMC3387173	22768032	technolog comprehens identif biothreat environment clinic specimen need protect citizen case biolog attack challeng dozen bacteri viral speci biolog attack close nearneighbor organ harmless biothreat agent neighbor thought biothreat cluster bioclust short abil comprehens detect biothreat cluster resolut suffici distinguish neighbor extrem low fals posit rate requir technolog solut problem achiev coupl biothreat groupspecif pcr electrosprai ioniz mass spectrometri pcresim biothreat assai describ detect ten bacteri viral biothreat cluster niaid prioriti pathogen hhsusda select agent list detect of biothreat cluster valid analysi broad collect biothreat organ neighbor prepar spike biothreat nucleic acid nucleic acid extract filter environment air analyt experi carri determin breadth coverag limit detect linear sensit specif assai breadth demonstr test divers collect organ biothreat cluster biothreat assai configur detect target organ cluster misidentifi nearneighbor organ threat coupl biothreat clusterspecif pcr electrosprai ioniz mass spectrometri simultan breadth coverag discrimin neighbor extrem low fals posit rate requir amplicon precis base composit biothreat agent detect mass spectrometri
BMC Genomics	23408632	2014-08-27	PMC3388012	22452820	background sequenc pathogen mycobacterium tuberculosi mtb strain hrv decad biologi pathogen remain understood genom sequenc mtb strain close bacteria opportun appli power compar genom understand evolut mtb pathogenesi conduct compar analysi genom tuberculosi databas tbdborg includ strain mtb bovi addit mycobacteria corynebacteria streptomyc rhodococcu jostii rha nocardia farcinia acidothermu cellulolyticu rhodobact sphaeroid propionibacterium acn bifidobacterium longum result highlight function lipid metabol regul reveal variat evolutionari profil gene implic satur unsatur fatti acid metabol suggest dna repair molybdopterin cofactor pathogen mycobacteria analyz sequenc conserv gene express data identifi conserv noncod region includ predict promot regulatori motif correspond valid motif potenti noncod rna experiment confirm express conclus analysi protein evolut highlight gene famili associ adapt environment mycobacteria oblig pathogenesi famili includ fatti acid metabol dna repair molybdopterin biosynthesi analysi reinforc find suggest small noncod rna common mycobacteria expect data provid foundat understand genom biologi mtb compar context onlin tbdborg
PLoS One	20860410	2014-11-03	PMC3390370	22792357	pregnanc lead risk factor sever complic influenza viru infect women infect second third trimest increas risk sever cardiopulmonari complic prematur deliveri death establish murin model aerosol influenza infect pregnanc find alter innat antivir respons pregnant mice includ decreas level ifn il ifn earli time point infect find reduc cytotox cell activ delai viral clearanc demonstr pregnanc level estrogen estradiol induc kei antiinflammatori phenotyp immun respons viru independ hormon pregnancyrel stressor conclud elev estrogen level result attenu antivir immun respons pregnancyassoci morbid occur context antiinflammatori phenotyp
PLoS Pathog	25165116	2010-05-03	PMC3390409	22792066	the anaphasepromot complex apc ubiquitin ligas control ubiquitin degrad multipl cell cycl regulatori protein infect human cytomegaloviru hcmv widespread pathogen phosphoryl apc coactiv cdh multifunct viral kinas pul promot degrad apc subunit unknown mechan proteom approach identifi hcmv protein pula interact apc importantli determin express pula suffici proteasomedepend degrad apc subunit apc apc apc disrupt requir pula bind apc identifi prolinearginin amino acid pair residu pula critic abil bind regul apc point mutant viru prolinearginin mutat alanin praa grew wildtyp level doubl mutant viru viral abil regul apc abrog praa point mutat ul delet markedli attenu compar ul delet viru suggest mutat synthet lethal hcmv exploit viral factor ensur success disrupt apc overcom restrict viru infect studi reveal hcmv protein pula novel apc regul uncov uniqu viral mechan subvert apc activ
PLoS Pathog	25599080	2011-09-07	PMC3390413	22792062	tumor necrosi factor receptorassoci factor traf central mediat induc type interferon ifn product respons intracellular doublestrand rna dsrna report identif seca protein ertogolgi vesicular transport system novel compon traf interactom network notabl noninfect cell traf associ marker erexitsit er ertogolgi intermedi compart ergic cisgolgi apparatu dsrna dsdna sens golgi apparatu fragment cytoplasm punctat structur traf allow coloc interact mitochondri antivir signal mav essenti mitochondriabound rigilik helicas rlh adaptor contrast retent traf ertogolgi vesicular transport system blunt abil traf interact mav viral infect consequ decreas type ifn respons deplet seca led drastic disorgan golgi parallel reloc traf condit unabl associ mav consequ dsrna dsdna sens ablat seca inhibit irf activ antivir gene express reciproc mild overexpress seca hecb cell increas activ ifn isg nfb depend promot viral infect ectop express mav tankbind kinas tbk traf enrich immunocomplex compos seca tbk infect propos model dsdna dsrna sens induc format membranebound compart origin golgi mediat dynam associ traf mav lead optim induct innat immun respons
PLoS One	21900532	2003-01-15	PMC3393700	22808228	the innat abil human cell silenc endogen retrovirus rna sequenc encod microrna suggest cellular rnai machineri major host mount defens respons dai retrovirus cellular mirna target hybrid specif sequenc htlv hiv viral transcript varieti host immun respons retrovir infect viru mechan assist evas viral inhibit control cellular rnai pathwai retrovirus hijack enzymat catalyt compon rnai pathwai case produc novel viral mirna assist activ viral infect promot latent state htlv tax contribut dysregul rnai pathwai alter express kei compon pathwai survei uninfect htlv infect cell reveal drosha protein lower level htlv infect cell line infect primari cell compon dgcr dramat alter coloc tax drosha nucleu vitro coimmunoprecipit presenc proteasom inhibitor indic tax interact drosha target specif area cell proteasom presenc tax observ prevent primari mirna cleavag drosha final chang cellular mirna express htlv infect cell mimick add drosha addit antagomir cellular mirna downregul viru
PLoS One	15767458	2003-07-28	PMC3393705	22808239	background mothertochild transmiss mtct main hiv infect children worldwid dendrit cellspecif icam grabbingnonintegrin dcsign cd hiv receptor enhanc transmiss cell express placent macrophag method find investig associ dcsign genet variant risk mtct hiv zimbabwean infant character impact associ mutat dcsign express interact hiv dcsign promot pc pa exon variant associ increas risk intrauterin iu hiv infect promot variant decreas dcsign express vitro placent cd macrophag hofbauer cell hiv unexpos infant hiv expos infant exon proteinmodifi mutat increas hiv captur transmiss cell vitro conclus studi compel evid support role dcsign iu hiv infect
PLoS One	12502857	2007-02-28	PMC3393746	22808132	hendra viru hev infect human character influenza ill progress pneumonia enceph lead death pathogenesi hev infect understood lack mous model limit opportun pathogenet project reassess role mice anim model hev infect mice suscept hev infect intranas exposur ag mice reliabl develop encephalit diseas propos anterograd rout neuroinvas brain olfactori nerv support evid develop enceph absenc viremia sequenti distribut viral antigen pathwai olfact brain intranas challeng anim studi mice develop transient lower respiratori tract infect progress viremia system vascul common anim model studi report anim model hev enceph will allow detail studi neuropathogenesi hev infect mode viral spread sequestr central nervou system investig mechan moder develop viremia system diseas inform develop improv treatment option human patient
Mol Biol Int	12885908	2014-12-29	PMC3395148	22811910	togeth gag protein env glycoprotein major retrovir structur protein essenti form infecti viru particl env synthes process transport microdomain plasma membran take advantag host machineri traffick cellular glycoprotein incorpor env progeni virion mediat interact env gag case addit involv host factor gener model propos explain incorpor retrovir env glycoprotein virion actual mechan process unclear partli structur data env protein cytoplasm tail lack paper present current understand synthesi traffick virion incorpor retrovir env protein
PLoS One	17329356	2013-12-01	PMC3395712	22808150	background toxoplasma gondii abort ocular neurolog disord warmblood host immun mammal wide sourc hyperimmun sera approach includ diagnosi studi hostparasit interact mammalian antibodi limit product necess anim bleed low yield interfer rheumatoid factor complement activ affin fc mammalian receptor igi antibodi avoid limit altern appli gondii model methodologyprincip find studi immun hen solubl tachyzoit antigen gondii stag purifi egg yolk antibodi igi inexpens simpl method high yield puriti degre igi antistag antibodi present high avid recogn broad rang parasit antigen mark differ observ reactiv profil antibodi produc immun hen mice interestingli igi antibodi neospora caninum eimeria spp react stag igi antibodi suitabl detect gondii form paraffinembed section cultur cell monolay conclusionssignific costeffect high product yield vari rang applic polyclon igi antibodi tool studi involv gondii
Viruses	25548275	2011-06-15	PMC3397358	22816036	anim coronavirus infecti bronchiti viru ibv arterivirus porcin reproduct respiratori syndrom viru prrsv manifest highli contagi infect specif nativ host aris critic econom damag anim industri review discuss progress studi virushost interact anim human coronaviru arteriviru infect emphasi ibvhost cell interact interact directli involv viral replic lead alter signal pathwai cell stress respons innat immun facilit viral replic pathogenesi
Viruses	24084524	2014-09-01	PMC3397359	22816037	coronavirus envelop positivestrand rna virus replic cytoplasm deliv nucleocapsid host cell reli fusion envelop host cell membran spike glycoprotein mediat viru entri primari determin cell tropism pathogenesi classifi class fusion protein respons bind receptor host cell mediat fusion host viral membranesa process driven major conform chang protein review discuss coronaviru entri mechan focus trigger coronavirus initi conform chang protein receptor bind low ph exposur proteolyt activ highlight common coronaviru protein class viral fusion protein distinct featur confer distinct tropism pathogen host interspeci transmiss characterist coronavirus
PLoS Med	21680501	2014-12-17	PMC3398960	22815656	background role public report improv hospit qualiti care controversi report hospitalacquir infect rate introduc multipl health care system relationship infect rate understudi object determin mandatori public report hospit associ reduct hospit rate clostridium difficil infect method find conduct longitudin populationbas cohort studi ontario canada largest provinc april march includ patient admit acut care hospit poisson regress develop model predict hospit agespecif monthli rate difficil diseas patientdai prior introduct public report septemb compar observ monthli rate difficil infect postintervent period rate predict preintervent predict model preintervent period case difficil infect hospit dai rate increas patientdai in calendar year introduct public report declin observ rate difficil coliti ontario case patientdai lower predict rate ci case patientdai period public report associ ci reduct difficil case project case avert year ci specif difficil rate communityacquir gastrointestin infect urinari tract infect unchang limit studi observ studi design rule influenc unmeasur tempor confound conclus public report hospit difficil rate associ substanti reduct popul burden infect futur will requir discern direct mechan difficil infect rate reduc respons public report articl editor summari
PLoS One	25273940	2010-09-01	PMC3399821	22815996	translat initi picornaviru rna driven intern ribosom entri site ir element locat upstream initi codon rna structur organ rnaprotein interact plai fundament role intern initi ir activ analyz context report gene lack region viral genom translat effici aim understand vulner ir translat start region small molecul context viral genom design set custom rnaseresist omethyl antisens oligoribonucleotid om aon base rna structur data aon monitor capac interfer viral rna translat inhibit viru yield footandmouth diseas viru fmdv rna translat initi infram aug codon om aon complementari aug inhibit viral multipl effici target aug respons viral rna aon target ir region denot differ tissu cultur cell cellfre system reinforc analyz viral rna respons live cell importantli identifi specif motif ir element target viral inhibitor tissu cultur cell cellfre system identifi target defin access region small molecul disturb rna structur organ rnaprotein interact need initi translat fmdv rna
PLoS One	25520500	2005-10-01	PMC3401186	22911695	molecular imag gain attent approach studi progress inflamm diseas dynam fdeoxyfluorodglucos ffdg radiotrac pet imag coupl ct fdgpetct gain insight spatiotempor progress inflammatori respons ferret infect clinic isol pandem influenza viru hn hnpdm thorac region mock hnpdminfect ferret imag prior infect dai postinfect dpi dpi fdgpetct imag reveal area consolid caudal lobe correspond elev ffdg uptak maximum standard uptak valu suvmax dai consolid ct inflamm ffdg appear left caudal lobe dpi ct imag extens area patchi groundglass opac ggo consolid largest lesion high suvmax viral shed replic detect nasal throat rectal swab nasal turbin lung dpi dai conclus molecular imag infect ferret reveal progress consolid ct correspond ffdg uptak strong posit correl measur suvmax bronchiolitisrel patholog score spearman importantli extens area patchi ggo consolid ct ferret model dpi report human hnpdm infect summari molecular imag studi lower respiratori infect hnpdm fdgpet insight spatiotempor progress inflamm realtim
PLoS One	20655566	2010-07-28	PMC3402445	22911825	the lack anim model human noroviru hunov hinder develop therapeut strategi studi demonstr commonli cholesterollow statin medic simvastatin increas hunov replic in vitro replicon system enhanc hunov infect gnotobiot gn pig model contrast oral treatment interferon ifn reduc hunov infect young piglet histoblood group antigen enterocyt treat oral mgkgdai simvastatin dai pig inocul oral gii hunov hsu strain treat simvastatin dai simvastatin induc earlier onset longer durat hunov fecal shed treat pig frequent higher fecal viral titer simvastatin impair poli icinduc ifn express macrophag dendrit cell lower tolllik receptor tlr express mechan interferon regulatori factor nuclear factor kappa signal pathwai enhanc earlier infect hunov simvastatintr pig coincid inhibitori simvastatin innat immun contrast increas hunov shed simvastatin induc viral shed treatment period reduc curtail hunovinocul pig pretreatedtr human ifn find indic ifn potenti antivir therapi hunov base intrigu novel find gn pig model confirm hunov infect alter treatment simvastatin ifn collect find indic gn pig model test immunomodul efficaci antivir hunov
Vet Res	20668122	2017-01-01	PMC3403912	22546085	the felin infecti periton viru fipv member felin coronaviru famili fip incur fatal cat cyclosporin csa immunosuppress agent target nuclear factor pathwai activ tcell nfat bind cellular cyclophilin cyp dosedepend inhibit fipv replic vitro fk immunosuppressor pathwai bind cellular fkbind protein fkbp cyp affect fipv replic cell growth viabil chang presenc csa fk factor affect nfat pathwai fcwf cell csa exert inhibitori effect nfat pathwai conclus csa inhibit fipv replic vitro studi need verifi practic csa antifipv treatment vivo
PLoS One	25552710	2010-08-06	PMC3404073	22911752	rapidli spread infecti diseas seriou risk public health dynam factor caus outbreak diseas better understood mathemat model fit data investig dynam hepat outbreak kitgum region northern uganda data determin imag text outbreak secondli model estim critic level latrin bore hole coverag need erad epidem imag text imag text lastli investig relationship coinfect factor malaria hepat imag text hepat provid better understand dynam hepat outbreak
PLoS One	28091625	2012-02-15	PMC3404083	22911786	background sever fever thrombocytopenia syndrom viru sftsv hemorrhag feverlik ill newli discov bunyaviru china pathogenesi sftsv infect understood suggest immun mechan includ cytokin chemokin plai role diseas pathogenesi studi investig host cytokin chemokin profil serum sampl patient sftsv infect northeast china explor correl cytokin level diseas sever method princip find acut phase serum sampl patient diagnos sftsv infect includ patient divid group sever nonsever base diseas sever level tumor necrosi factor tnf transform growth factor tgf interleukin interferon ifn ifn induc protein ip rant measur serum sampl commerci elisa statist analysi increas tnf ip ifn associ diseas sever conclus cytokinemedi inflammatori respons character cytokin chemokin product imbal respons diseas progress patient sftsv infect
PLoS One	20693244	2016-01-20	PMC3404102	22848470	gastroenter common ill caus consider morbid mortal worldwid despit improv detect method diagnost gap remain human bocaviru hbov associ respiratori infect frequent detect stool sampl case gastroenter tent associ hbov type hbov gastroenter aim studi determin role hbov gastroenter archiv dna sampl casecontrol infecti intestin diseas studi iid dna extract stool sampl case control test presenc hbov dna sampl screen real time pcr panhbov assai posit sampl test genotyp specif assai hbov detect preval observ case control genotypespecif assai hbovposit sampl genotyp hbov control whilst hbov frequent associ case gastroenter proport hbov posit type type specif assai total posit low viral load sampl distribut untyp hbov strain case control conclus hbov includ hbov appear gastroenter uk popul
PLoS One	22345456	2005-07-08	PMC3405069	22848428	human leukotrien hydrolas hltah final ratelimit enzym arachidon acid pathwai convert unstabl epoxid lta proinflammatori lipid mediat ltb hydrolas function ltah bifunct enzym exhibit aminopeptidas activ prefer arginyl tripeptid mutat includ eq ra ka complet partial abolish function enzym crystal structur mutat structur chang address loss function molecular dynam simul lta tripeptid complex structur function mutat perform investig structur conform chang script observ differ catalyt function observ proteinligand hydrogen bond distanc catalyt compon correl experiment studi confirm base structur observ function hold catalyt metal ion locat catalysi act ntermin recognit residu peptid bind comparison bind mode substrat reveal structur chang explain residu requir align substrat activ site studi provid valuabl util design potent hltah inhibitor antiinflammatori agent
PLoS One	26792733	2004-02-27	PMC3405091	22848436	exhal breath condens ebc increasingli noninvas method diseas diagnosi environment exposur assess hydrophob surfac ic droplet scaveng simpl impact condens base collect method report human subject recruit exhal devic min exhal breath form tini droplet hydrophob surfac subsequ scaveng roll deioniz water droplet collect ebc analyz cultur dna stain scan electron microscop sem polymeras chain reaction pcr colorimetri vitek bacteria virus experiment data reveal bacteria virus ebc rapidli collect method develop observ effici ebc min cultur dna stain sem qpcr method detect high bacteri concentr cfum exhal breath includ viabl dead cell type sphingomona paucimobili kocuria variant domin ebc sampl vitek system sem imag reveal bacteria exhal breath detect size rang enabl remain airborn longer time present risk airborn transmiss potenti diseas qpcr influenza hn virus detect ebc sampl devic restrict sole condens develop method easili achiev impact condens laboratori impact current practic ebc collect report work proofofconcept demonstr perform noninvas diseas diagnosi bacterimia viru infect valid includ effect influenc matrix
Evid Based Complement Alternat Med	16274510	2017-11-30	PMC3405817	22911608	isati indigotica chines tradit medicin clinic treatment viru infect tumor inflamm antivir activ remain unclear studi probe antivir activ indigotica extract marker compound japanes enceph viru jev indigotica methanol extract indigo indirubin prove cytotox compon show inhibitori concentrationdepend jev replic vitro timeofaddit experi prove extract indigo indirubin potent antivir pretreat infect simultan treatment infect posttreat entri antivir action agent correl block viru attach exhibit potent virucid activ indirubin strong protect abil mous model lethal jev challeng studi yield antijev agent
PLoS One	14990688	2011-08-17	PMC3407093	22848713	demyelin axon degener determin progress neurolog disabl patient multipl sclerosi ms cell resid central nervou system cn activ particip develop progress subsequ control autoimmun diseas individu contribut understood astrocyt abund cn cell type highli sensit environment cue implic detriment protect outcom autoimmun demyelin experiment autoimmun encephalomyel eae induc transgen mice express signal defect dominantneg interferon gamma ifn receptor astrocyt determin influenc inflamm astrocyt activ inhibit ifn signal astrocyt influenc diseas incid onset initi progress symptom blood brain barrier bbb integr composit acut cn inflammatori respons increas demyelin peak acut diseas absenc ifn signal astrocyt correl sustain clinic symptom peak diseas diminish clinic remiss increas mortal sustain astrocyt activ grai matter demonstr critic role ifn signal astrocyt neuroprotect diminish diseas remiss associ escal demyelin axon degener sustain inflamm cn infiltr leukocyt composit alter decreas il il correl sustain diseas data indic astrocyt plai critic role limit cn autoimmun diseas depend neuroprotect signal pathwai mediat engag ifn receptor
PLoS One	26078631	2006-06-01	PMC3407222	22848548	prpsc believ serv templat convers prpc abnorm isoform process requir contact protein impli critic contact site convers hypothes antibodi bind prpcor prpsc hinder prevent format prpcprpsc complex slow prevent convers process system analyz antibodi prpsc format neuroblastoma cell persist infect mouseadapt scrapi stain ii protein misfold cyclic amplif pmca prpsc templat seed seri incub sonic convert prpc prpsc system yield case demonstr prpspecif monoclon antibodi mab vari abil inhibit prpcprpsc convers process base numer vari mab analyz inhibitori appear epitop specif prpc conform cell membran local influenc target prp region amino carboxi
Viruses	21849453	2007-02-27	PMC3407894	22852040	photodynam inactiv pdi inactiv microorgan photosensit inactiv mammalian virus bacteriophag photosensit appli success decad centuri fact mammalian virus pose threat public health bacteriophag frequent model mammalian virus understand mechan photodynam procedur involv photoinactiv aim review summar main approach develop photodynam inactiv bacteriophag mammalian virus ii discuss compar state art mammalian virus pdi phage photoinactiv special focu relev mechan molecular target factor viral inactiv process
Viruses	16757604	2009-04-20	PMC3407897	22852043	three lectin sugar bind specif investig antivir activ human parainfluenza viru type hpiv lectin concanavalin con len culinari agglutinin lca peanut agglutinin pna inhibit cell fusion hemadsorpt induc hpiv viru nucleoprotein np gene synthesi inhibit fusion hemagglutininneuraminidas hn gene synthes indirect immunofluoresc studi con inhibit viru np hn protein synthes lca complet inhibit pna inhibit np protein synthesi recombin green fluoresc proteinexpress hpiv matrix protein rghpivm viru entri cell complet prevent lectin consider reduc number virus releas compar viru infect cell lectin bound cell surfac min aggreg observ min con lca disrupt actin microfila microtubul pna indic inhibitori effect lectin caus consider prevent viru adsorpt cell lectin bind receptor
Mar Drugs	17327210	2014-02-01	PMC3407925	22851920	the develop topic microbicid offer addit strategi reduc spread human immunodefici viru hiv carbohydratebind agent cba specif high mannos carbohydr surfac heavili glycosyl envelop hiv endow potent antihiv activ fact number algal lectin cyanovirinn microvirin microcysti viridi lectin scytovirin oscillatoria agardhii agglutinin griffithsin consid potenti microbicid candid prevent sexual transmiss hiv topic applic inhibit infect cell cellfre viru effici prevent viru transmiss virusinfect cell uninfect cd target tlymphocyt dcsigndirect captur hiv transmiss cd lymphocyt review focus structur properti carbohydr specif algal lectin antivir activ hiv envelop virus safeti profil viral resist pattern
Adv Virol	19380790	2016-03-23	PMC3410301	22888349	extracellular vesicl microvesicl exosom microvesicl varieti molecul includ protein lipid nucleic acid microvesicl appear origin multivesicular bodi bud plasma membran review converg microvesicl biogenesi aspect viral assembl releas pathwai herpesvirus retrovirus recruit element microvesicl biogenesi pathwai function viru releas addit noninfecti pleiotrop viruslik vesicl releas viral cellular compon highlight heterogen microvesicl function viral infect address microvesicl block enhanc infect immun dysregul bystand action immun system final endogen retroviru retrotransposon element deposit genom million year ago releas cell microvesicl suggest viral origin microvesicl system evolutionari conserv system virusvesicl codepend need elucid complex function microvesicl produc viral infect reveal therapeut intervent strategi
Front Microbiol	24506782	2009-06-01	PMC3410596	22876240	our understand antibodi gener function help develop effect vaccin antibodybas therapeut virus hiv sar coronaviru sar cov hendra nipah virus henipavirus broadli neutral antibodi bnab hiv observ patient elicit bnab remain major challeng compar viral target hypothes hiv evolv strategi evad immun system absent weak bind germlin antibodi conserv epitop suffici initi andor maintain effect immun respons explor hypothesi sequenc analysi larg nave librari human igm antibodi select antibodi sar cov receptorbind domain rbd solubl protein sg henipavirus human igm repertoir sequenc divers germlin usag recombin pattern junction divers lower extent somat mutat studi identifi antibodi matur intermedi bnab hiv virus observ normal individu compar genet divers somat mutat level structur function data comput analysi will provid framework understand underli genet molecular determin matur pathwai antivir bnab appli novel approach design effect vaccin immunogen antibodybas therapeut
PLoS Pathog	27009951	2005-10-20	PMC3410853	22876187	the coronavirus cov envelop virus anim human associ enter respiratori diseas sever acut respiratori syndrom common cold subset cov cell surfac aminopeptidas apn membranebound metalloproteas cell entri receptor virus envelop spike glycoprotein mediat attach viru particl apn subsequ cell entri block neutral antibodi describ crystal structur receptorbind domain rbd close cov strain transmiss gastroenter viru tgev porcin respiratori cov prcv complex receptor porcin apn papn neutral antibodi data provid detail architectur dimer papn ectodomain interact cov protrud receptorbind edg determin virusbind specif recess glycancontain surfac membranedist region papn ectodomain comparison rbd tgev prcv cov suggest conform receptorbind region determin cell entri receptor specif receptorbind edg major antigen determin tgev envelop target neutral antibodi provid compel view cov cell entri immun neutral aid design antivir cov vaccin apn consid target cancer therapi structur report facilit develop anticanc drug
PLoS One	19394707	1995-09-01	PMC3411667	22870331	canin hepaciviru chv identifi domest dog hors find chv genet viru close hepat viru hcv rais question hcv evolv result close contact dog andor hors human aim studi investig nsa serin proteas chv cleav human mitochondri antivir signal protein mav tollil receptor domaincontain adaptor induc interferonbeta trif proteolyt activ chv nsa evalu bacteriophag lambda genet screen human mav trifspecif cleavag site engin lambda ci repressor infect escherichia coli cell coexpress repressor chv nsa construct lambda phage replic fold effici cell express chv proteas variant carri inactiv substitut sa compar hcv nsa construct genotyp assai indic chv disrupt human innat antivir defens signal pathwai suggest evolutionari relationship chv hcv
PLoS One	16239502	2015-07-28	PMC3411673	22870291	chronic tonsillar diseas health problem lead larg number surgic procedur worldwid pathogenesi diseas order investig role respiratori virus chronic adenotonsillar diseas develop crosssect studi determin rate viral detect common respiratori virus detect taqman real time pcr qpcr nasopharyng secret tonsillar tissu peripher blood children chronic tonsillar diseas symptom acut respiratori infect respiratori viru detect patient viral coinfect rate frequent detect virus human adenoviru human enteroviru human rhinoviru human bocaviru human metapneumoviru human respiratori syncyti viru qpcr vari sampl site human adenoviru human bocaviru human enteroviru detect tissu human rhinoviru frequent detect secret rate viru detect remark high tonsil tissu adenoid close palatin tonsil addit viru detect rate higher hypertroph smaller adenoid case human enterovirus detect frequent larger palatin tonsil smaller persistencelat dna virus tonsillar tissu document case rna virus respiratori virus highli preval adenoid palatin tonsil patient chronic tonsillar diseas persist virus tonsil stimul chronic inflamm plai role pathogenesi diseas
PLoS One	8589626	2010-06-01	PMC3411792	22879986	background regul immun system human fc receptor fcr demonstr plai role pathogenesi infecti diseas aim studi identifi associ fcgr polymorph cryptococc mening methodologyprincip find case control genet associ studi genotyp function polymorph lowaffin fcr includ fcgra hr fcgra fv fcgrb nana fcgrb patient cryptococc mening healthi control multiplex snapshot technolog patient cryptococc mening predispos factor patient cryptococc mening fcgrb ii genotyp overpres ci fcgrb genotyp underpres ci comparison control group cryptococc mening patient predispos factor fcgrb ii genotyp frequent detect ci fcgrb genotyp frequent detect ci control differ fcgra hr fcgra fv fcgrb nana genotyp frequenc patient control conclusionsignific time associ cryptococc mening fcgrb genotyp suggest fcriib plai role central nervou system infect cryptococcu hivuninfect individu
PLoS One	31214468	2006-03-29	PMC3411849	22880122	variou cell type lymphoid nonlymphoid tissu produc antiinflammatori cytokin interleukin il murin cytomegaloviru mcmv infect function il liver acut infect cell gener cytokin site extens investig studi demonstr product il liver elev cbl mice late acut mcmv infect il green fluoresc protein gfp report knockin mice design ilintern ribosom entri site iresgfpenhanc report tiger nk cell identifi major il express cell liver infect cell leukocyt absenc il mice exhibit mark elev proinflammatori cytokin number mononuclear cell lymphocyt infiltr liver infect ildefici enhanc liver injuri improv viral clearanc site collect indic ilproduc cell liver provid protect collater injuri modul inflammatori respons associ mcmv infect
Proteome Sci	20404223	2007-06-15	PMC3413529	22571704	background newcastl diseas viru ndv envelop rna viru bear sever econom loss poultri industri worldwid previou virion proteom studi envelop virus carri multipl host cellular protein intern extern life cycl address occur ndv infect perform comprehens proteom analysi highli purifi ndv la sota strain particl addit viral structur protein detect thirti cellular protein associ purifi ndv la sota particl identifi cellular protein compris function categori includ cytoskeleton protein annexin molecular chaperon chromatin modifi protein enzymesbind protein calciumbind protein signal transductionassoci protein three host protein report virion viru famili includ signal transductionassoci protein syntenin ra small gtpase tumorassoci protein tumor protein presenc select cellular protein actin tubulin annexin heat shock protein hsp ezrin associ purifi ndv particl valid western blot immunogold label assai conclus current studi present standard proteom profil ndv demonstr incorpor cellular protein ndv particl valuabl elucid viral infect pathogenesi
Virol J	16571794	2008-04-01	PMC3413536	22559908	background alter plasma concentr vitamin mannos bind lectin mbl compon innat immun associ pathogenesi viral infect object studi find plasma concentr mbl vitamin patient dengu fever df dengu hemorrhag fever dhf the plasma concentr vitamin mbl assess df case dhf case healthi control elisa base method vitamin concentr higher df dhf case compar healthi control p vitamin concentr df dhf case dengu case classifi primari secondari infect secondari dhf case higher concentr vitamin compar secondari df case mbl concentr healthi control dengu case mbl concentr observ lower dhf case compar df case mbl level df dhf case base immun statu percentag primari dhf case mbl level lower ngml compar primari df case conclus studi suggest higher concentr vitamin associ secondari dhf defici mbl associ primari dhf
PLoS One	17573530	2010-11-17	PMC3414488	22905091	background tradit serflingtyp approach influenzalik ill surveil requir long histor timeseri retrospect evalu short histor timeseri recogn onset commun outbreak respiratori tract infect rti method data refer proport diagnos upper lower rti total diagnos housecal visit perform privat network medic specialist so doctor metropolitan area athen greec januari octob refer standard classif observ gener epidem threshold analyz full year period evalu alert gener method simpl regress cumul sum cusum rang input paramet data previou run week period method appli previou week contain nonaberr observ cusum model specif set paramet perform margin better simpl regress group best sensit specif simpl regress cusum model upper rti correspond lower rti conclus shortterm data housecal visit reliabl identifi respiratori tract outbreak commun simpl regress cusum method surveil model larg histor databas unavail inaccur tradit method optim
PLoS One	18439102	2019-04-01	PMC3414522	22905124	human infect influenza virusesseason pandem zoonoticwhich differ present mild upper respiratori tract diseas sever fatal pneumonia extrarespiratori spread differ spatial tempor dynam infect understood inocul ferret season hn pandem hn phn highli pathogen avian hn influenza viru perform detail virolog patholog analys time point dai post inocul dpi describ clinic sign hematolog paramet hn infect restrict nose peak dpi phn infect peak dpi occur level respiratori tract hn infect occur alveoli peak longer period dpi associ lesion spatial distribut viru infect sever peak dai neutrophil monocyt count peripher blood correl inflammatori cell influx alveoli paramet measur lower respiratori tract diseas rel lung weight lung tissu allow best quantit distinct viru group extrarespiratori spread tissuesinclud central nervou systemfor hn infect phn infect hn infect studi season pandem zoonot influenza virus differ spatial tempor dynam infect respiratori tract extrarespiratori tissu ferret
J Neuroinflammation	21084470	2013-09-25	PMC3419086	22642802	background interplai ifn il neutrophil cn inflammatori diseas complex crossregulatori factor posit neg feedback loop interact hinder abil distinguish rel contribut neutrophil th cellderiv effector molecul secondari mediat tissu damag morbid method enceph induc gliatrop murin coronaviru model assess direct contribut neutrophil ifn il virusinduc mortal cn inflammatori condit select manipul adopt transfer virusprim wildtyp wt ifn defici gko memori cd cell infect scid mice coupl antibodymedi neutrophil deplet cytokin blockad transfer gko memori cd cell infect scid mice induc rapid mortal compar recipi wt memori cd cell despit viru control demyelin contrast recipi wt cd cell extens neutrophil infiltr il express cn recipi gko cd cell provid model directli assess contribut diseas recipi wt cd cell deplet ifn express il spare mortal despit abund cn neutrophil infiltr indic mortal mediat excess cn neutrophil accumul contrast il deplet rescu recipi gko cd cell rapid mortal diminish neutrophil reduc gmcsf associ pathogen cell cn autoimmun model cotransf wt gko cd cell prolong surviv ifn depend manner il transcript reduc conclus data demonstr il mediat detriment clinic consequ ifndepriv environ independ extens neutrophil accumul gmcsf upregul ifn overrid detriment il effector respons mechan downstream transcript regul
PLoS One	31003196	2010-07-01	PMC3419696	22905259	bluetongu viru btv member famili reovirida reemerg anim diseas infect cattl sheep outbreak europ press efficaci antivir present identif character novel virostat molecul btv aminothiophenecarboxyl acid deriv name compound virostat efficaci improv chemic modif lead de novo synthes compound effect concentr ec c determin m cytotox concentr cc cc select si c btv inhibitori cc btvinduc apoptosi confirm inhibit caspas activ post btv infect cc inhibit btv induc cpe late hpi indic late stage viral lifecycl cc reduc twolog progeni viru product number genom viral rna copi interestingli activ host autophagi viral protein express inhibit post btv infect cell treat c suggest cc virostat agent inhibit host autophagi activ investig need pin exact mechan cc find suggest compound potent lead compound potenti novel mechan action btv
BMC Pediatr	24067951	2011-06-22	PMC3420249	22726254	background young children persist wheez pose diagnost therapeut challeng pediatrician aim evalu bacteri bronchial infect reason respons convent asthma therapi identifi characteris predomin pathogen involv method retrospect analys microbiolog cytolog find select popul young wheezer symptom unrespons inhal corticosteroid ic therapi underw flexibl bronchoscopi bronchoalveolar lavag bal procedur measur limit contamin risk quantit bacteri cultur bal fluid signific cutoff colonyform unitsml modern microbiolog method detect wide panel pathogen characteris bacteri isol children ag month structur anomali conduct airwai evalu bacteri bal cultur patient haemophilu influenza isol streptococcu pneumonia moraxella catarrhali influenza isol nonencapsul strain definit distinguish nonhaemolyt haemolyticu respiratori virus detect case mix bacterialvir infect cytolog reveal mark neutrophil inflamm conclus bacteri infect bronchial tree common persist preschool wheezer explan respons ic therapi nontyp influenza predomin pathogen involv pneumonia catarrhali
Case Rep Rheumatol	21629605	2014-12-01	PMC3420729	22957292	acut fibrin organ pneumonia afop describ histolog pattern character presenc fibrin ball alveolar space term undifferenti connect tissu diseas uctd identifi autoimmun system diseas fulfil criteria classifi definit connect tissu diseas afop report associ uctd report case yearold caucasian femal dry cough progress dyspnea month diagnos organ pneumonia base clinic histori radiolog imag manifest raynaud phenomenon sicca syndrom boot glove neuropath pain previou hypothyroid antinuclear antibodi rheumatoid factor specif autoantibodi neg salivari gland biopsi electroneuromyiographi normal capillaroscopi scleroderma pattern capillari delet ectasia experienc clinic radiolog worsen despit submit cyclophosphamid puls develop hemorrhag di thoracotomi pulmonari specimen histolog pattern afop paper rare associ afop uctd
PLoS One	21697468	2004-07-27	PMC3420884	22916196	clara cell noncili secretori bronchiolar epitheli cell serv detoxifi harm inhal substanc clara cell function stemprogenitor cell repair bronchiol clara cell secretori protein ccsp express pulmonari clara cell clara cell marker addit ccsp promot commonli direct gene express lung transgen model discoveri ccsp immunoreact plasma membran airwai line cell prompt explor possibl enrich clara cell flow cytometri establish novel simpl method isol ccspexpress cell clara cell combin mechan enzymat dissoci flow cytometri sort technolog dissoci cell lung express ccsp prepar cell express ccsp notabl common stem cell marker includ cd cd sca sox express ccsp cell ccsp cell form spheroid coloni vitro effici parallel studi vivo confirm small popul ccspexpress cell mous airwai demonstr stem celllik properti label retent harbor rare bronchioalveolar stem cell basc termin bronchiol tb conclud ccsp cell exhibit number stem celllik featur includ stem cell marker express bronchospher coloni format selfrenew abil clara cell isol flow cytometri sort method investig function primari clara cell stem cell mous model
PLoS One	25387086	2003-12-01	PMC3422262	22912897	background madagascar etiolog preval acut respiratori infect ari rural tropic area data need determin viral atyp bacteri etiolog children defin clinic manifest ari method year conduct prospect studi ari children month commun hospit ampasimanjeva locat southeast madagascar respiratori sampl analyz multiplex realtim rtpcr includ virus atyp bacteria episod ari group clinic manifest welldocu diagnosi commun acquir pneumoniacap group acut lower respiratori infect alri group ii upper respiratori tract infect cough urti cough group iiiand upper respiratori tract infect cough urti cough group iv children includ studi februari februari virus andor atyp bacteria respiratori pathogen detect sampl rate coinfect human rhinoviru hrv metapneumoviru hmpv ab coronavirus hcov parainfluenza viru hpiv respiratori syncyti viru rsv ab detect hrv singl detect clinic group hmpv ab cap group hpiv alri group ii rsv ab predomin group urti cough group iii adenoviru hadv detect cough group iv interpret studi describ time etiolog respiratori infect febril children year malaria rural area madagascar highlight role respiratori virus clinic defin popul ari
PLoS One	15280455	2016-11-01	PMC3422334	22912836	background realtim pcr arrai rapid detect multipl viral pathogen highli case sampl volum time test limit elig test tissu organ donor find develop realtim pcr arrai capabl simultan detect human viral pathogen human immunodefici viru type hiv hepat viru hbv hepat viru hcv human tcell leukemia viru htlv vaccinia viru vacv west nile viru wnv twenti primer design combin bioinformat approach experiment test primer set target viral pathogen select set arrai sybr green chemistri specif sensit virusspecif primer set select arrai evalu analyt panel amount virus spike human plasma arrai detect genom equival geqml hiv hcv geq hiv subtyp hbv genotyp wnv detect geqml plasma hiv subtyp group crf ae ag isol evalu panel consist hiv hiv clinic isol reveal crossreact hiv hiv specif primer type hiv viral isol identifi specif primer set target conserv genom area pcr arrai correctli identifi viral infect panel quantifi clinic plasma sampl posit hiv hcv hbv low geq pcr reaction conclus viral arrai describ demonstr adequ perform test donor clinic sampl improv sensit broad spectrum hiv subtyp develop
PLoS One	14632641	2010-04-28	PMC3422341	22912837	in decad clostridium difficil emerg gut pathogen symptom difficil infect rang mild diarrhea pseudomembran coliti colectomi death main virul factor difficil toxin toxin gene encod toxin tcda tcdb pathogen locu paloc gene encod sigma factor tcdr put antisigma factor tcdc role tcdr sigma factor toxin express undisput role tcdc antisigma factor inhibit toxin express current subject debat clarifi role tcdc toxin express gener isogen clostronbas mutant tcdc clostridium difficil strain erm cttcdc determin transcript level paloc gene express level toxin wild type strain tcdc mutant strain minor differ transcript level paloc gene wild type cttcdc strain total toxin level differ difficil erm tcdc major regul toxin express condit test
PLoS One	27942512	2005-07-01	PMC3423416	22916109	signal bone morphogenet protein bmp implic earli lung develop adult lung homeostasi tissueinjuri repair precis mechan action spatiotempor pattern bmpsignal process remain inadequ describ address util transgen harbor bmprespons egfpreport allel breegfp construct detail spatiotempor map canon bmppathwai activ lung develop homeostasi adultlung injuri repair demonstr pseudoglandular stage branch morphogenesi progress develop lung canon bmppathwai activ vascular network subepitheli smooth muscl layer proxim airwai activ bmppathwai evid epitheli compart embryon dai cell neg epitheliallineag marker locat proxim portion airwaytre cluster adjac neuroepithelialbodi neb substanti portion alveolar epitheli cell pathwai activ isol mesenchymefre distal epitheli bud cultur matrigel suggest absenc report activ region stem dynam crosstalk endoderm mesenchym epitheli cell activ bmppathwai enrich progenitor capabl form coloni threedimension matrigel cultur lung morphogenesi approach complet egfpexpress declin adult lung express bare detect tissueinjuri naphthalen bleomycin canon bmppathwai reactiv bronchial alveolar epitheli cell manner reminisc earli lung develop tissu area reparatori progenitor cell resid studi illustr dynam activ canon bmppathwai lung develop adult lung tissuerepair highlight involv process earli develop pulmonari vasculatur manag epitheli progenitor pool lung develop repair adult lung tissueinjuri
BMC Vet Res	20427329	2013-01-30	PMC3424113	22748160	background progress pneumonia preval broiler lai hen diseas occurr dai hatch last dai morbid mortal broiler object studi isol identifi pathogen respons progress pneumonia establish anim model drug screen serum sampl collect intens farm provinc china analys current clinic survei breed broiler breed layer broiler lai hen seroposit ort antibodi intens farm ort isol identifi pcr biochem assai hn virus isol newcastl diseas viru ndv infecti bronchitisviru ibv exclud typic pneumonia airsaccul observ broiler inocul intraperiton ort isol coinfect ort hn viru isol surviv rate bird inocul orthn viru ort hn viru hn viru ort ort hn viru conclus studi ort infect domest poultri occur frequent china ort infect induc higher econom loss mortal hn aiv isol ort hn viru report report coinfect poultri pathogen report coinfect broiler ort hn viru coinfect associ outbreak broiler airsaccul china caus extens econom loss
Malar J	15961624	2004-11-01	PMC3425236	22873707	background analysi lack manag vector control system diseaseendem countri respect effici sustain oper method three locat select scale provinc municip barangai villag data diseas incid programm activ programm manag collect onsit meet focu group discuss adapt diseas control strategi epidemiolog situat barangai microstratif bring gain effici accompani capac build local situat analysi better select target vector control intervent barangai integr approach vector control aim improv ration resourc evid multidiseas strategi detect respons combin vector control method collabor health sector appar involv barangai health worker reorient job descript creation diseas surveil unit engag barangai leader exist commun structur help mobil local resourc voluntari servic vector control locat local author commun involv plan implement evalu malaria control trigger local programm ownership conclus strategi contribut improv effici sustain vector control oper microstratif integr vector control health sector multidiseas approach involv local author empower commun capac build situat analysi vector surveil address nation polici guidelin
PLoS One	23365422	2004-01-01	PMC3425550	22927911	background dengu viru denv infect common mosquitoborn viral diseas threaten human health type interferon ifn cytokin product crucial innat immun system report denv serotyp denv induc low level interferon regulatori factor nfb activ lead reduc product ifn earli phase infect determin denv infect hamper type ifn activ cytokin product trigger tolllik receptor tlr signal methodologyprincip find quantit rtpcr low level ifn inflammatori cytokin interleukin il il tumor necrosi factor tnf mrna detect denvinfect bonemarrowderiv dendrit cell denv infect repress cytokin product trigger tlr signal elucid molecular mechan underli suppress event measur nfb activ nuclear transloc luciferas report assai nfb activ trigger tlr ligand block denv infect extracellular signalregul kinas erk activ suppress denv infect conclusionssignific downregul host innat immun denv weak induc type ifn cytokin denv block tlrtrigger erknfb activ cytokin product
PLoS One	15520802	2011-08-15	PMC3427170	22937142	the discoveri novel virus anim expand knowledg viral divers emerg zoonos highthroughput sequenc ht technolog million billion sequenc read allow comprehens survei genet content sampl prior nucleic acid amplif studi screen rectal swab sampl healthi bat pig cattl strai dog strai cat monkei ht metagenom approach complet genom novel papillomaviru pv miniopteru schreibersii papillomaviru type mscpv nucleotid ident canin papillomaviru cpv identifi specimen common bentw bat schreibersii kb length gc content genom organ pv despit higher nucleotid ident genom mscpv cpv maximumlikelihood phylogenet analysi gene sequenc mscpv erethizon dorsatum papillomaviru edpv close estim diverg time mscpv edpvmscpv common ancestor million year ago infer strict clock gene estim limit lack reliabl calibr point codiverg host shift nucleotid sequenc viru limit similar anim pv convent approach pcr consensu primer detect novel viru sampl bat papillomaviru rapv mscpv asymptomat bat appar mucos skin lesion rapv detect basosquam carcinoma fruit bat rousettu aegyptiacu propos mscpv member novel dyolambdapapillomaviru genu
Philos Trans R Soc Lond B Biol Sci	14726460	2014-01-17	PMC3427559	22966141	there viru speci to infect human discov yellow fever viru three speci year extrapol discoveri curv suggest substanti pool undiscov human viru speci appar slowdown rate discoveri speci famili indic bound potenti rang divers twothird human virus infect nonhuman host mammal bird specialist human virus mammalian avian origin substanti proport mammalian virus capabl cross speci barrier human half capabl transmit human half transmit major outbreak predictor speci jump identifi includ phylogenet conserv cell receptor inevit human virus will continu emerg mammal bird forese futur reason effect global surveil system novel virus need
Philos Trans R Soc Lond B Biol Sci	21844166	2001-08-15	PMC3427560	22966142	earli detect diseas outbreak human anim popul crucial effect surveil emerg infecti diseas mark geograph dispar capac earli detect outbreak limit effect global surveil strategi link surveil approach emerg neglect endem zoonos renew focu exist diseas problem develop countri potenti overcom limit achiev addit health benefit poor report major constraint surveil emerg endem zoonos barrier report identifi lack tangibl benefit report ii lack capac enforc regul iii poor commun commun institut sector iv complex intern regulatori environ redirect surveil effort focu endem zoonos develop countri offer pragmat approach overcom barrier support region surveil capac current weakest addit approach address health develop problem equit sustain mechan build cultur surveil core capac need zoonot pathogen includ emerg diseas threat
Philos Trans R Soc Lond B Biol Sci	24521067	2011-02-16	PMC3427567	22966143	mani seriou emerg zoonot infect arisen bat includ ebola marburg sarscoronaviru hendra nipah number rabi rabiesrel virus consist observ wildlif sourc emerg zoonos human popul mechan underli recogn associ ecosystem health human health remain understood respond appropri ecolog social econom condit facilit diseas emerg transmiss repres substanti societ challeng context diseas emerg wildlif wildlif habitat conserv turn will preserv vital ecosystem structur function broader implic human wellb environment sustain simultan minim spillov pathogen wild anim human be review propos novel framework holist interdisciplinari investig zoonot diseas emerg driver spillov bat pathogen case studi studi develop gain detail interdisciplinari understand combin cuttingedg perspect natur social scienc link polici impact public health land conserv
PLoS One	11462008	2014-10-01	PMC3428329	22952832	dure decad role wildlif emerg pathogen transmiss domest anim point convers attent paid pathogen transmiss domest anim wildlif focu case game restock impli releas million anim worldwid year conduct year studi camargu southern franc investig influenc handrear mallard releas avian influenza viru dynam surround wildlif sampl mallard cloacal swab game duck facil releas high infect rate caus hn strain detect game bird facil sampl detect strain shot duck sampl the hunt season infect rate rang handrear duck hn strain fulli sequenc multipl reassort event eurasian low pathogen strain interestingli hn strain caus human infect egypt australia segment sequenc clearli distinct australian belong larg cluster egyptian observ mutat link increas virul transmiss mammal antivir resist hn strain identifi indic potenti role handrear mallard influenza viru epizoot account risk viral exchang game bird facil wild habitat duck rear condit measur implement limit transmiss wildlif domest anim measur control transmiss domest anim wild equal reinforc
PLoS One	21325418	2013-07-29	PMC3429428	22937163	lassa viru hemorrhag fever character immunosuppress nucleoprotein lassa viru term np bind viral genom addit enzymat activ exonucleas digest doublestrand rna dsrna dsrna strong signal innat immun system viral infect digest dsrna np exonucleas activ appear suppress innat immun signal infect cell fold np enzym conserv activ site complet conserv exonucleas deddh famili np atyp exonucleas prefer dsrna strict specif substrat crystal structur lassa viru np complex dsrna find exonucleas klenow fragment doublestrand nucleic acid complex lassa np remain basepair split bind pair complementari strand achiev reloc basic loop motif typic exonucleas posit find singl glycin contact substrat strand singl tyrosin stack base complementari nonsubstr strand respons uniqu substrat specif work templat develop antivir drug specif viral host exonucleas fold activ site illustr amino acid chang confer altern specif biolog phenotyp enzym
PLoS One	25144509	2017-12-01	PMC3429441	22937119	the relev human parainfluenza virus hpiv epidemiolog acut respiratori infect ari china unclear septemb nasopharyng aspir npa hospit pediatr patient ag month beij collect screen hpiv common respiratori virus realtim rtpcr sixtytwo sampl posit hpiv posit hpiv posit hpiv indic hpiv predomin viru studi period phylogenet tree base hn hemagglutininneuraminidas sequenc hpiv indic three distinct cluster ab circul tempor region cluster cluster divid subclust c c hpiv beij isol belong subclust group isol provinc china neighbor countri japan genet analysi base entir hn gene reveal hpiv isol beij highli ident nucleotid level divid close lineag cb find suggest cocircul multipl lineag hpiv beij region studi period studi describ epidemiolog molecular character hpiv china
Int J Mol Sci	23893738	2017-07-25	PMC3430227	22942696	houttuynia cordata tradit chines herb unresolv genet taxonomi lead potenti problem conserv util resourc intersimpl sequenc repeat issr marker assess level distribut genet divers individu popul cordata china issr analysi reveal low genet variat popul high genet differenti popul genet structur reflect histor associ popul genet cluster analysi basal clade compos popul southwest china popul continu eastward distribut structur genet divers cordata demonstr speci surviv southwest china glacial ag subsequ experienc eastern postglaci expans base genet analysi propos target popul conserv includ
Int J Mol Sci	28844381	2016-04-06	PMC3430281	22942750	a simpl reliabl method ultraperform liquid chromatographi photodiod arrai detector uplcpda develop control qualiti radix isatidi dri root isati indigotica chemic fingerprint analysi quantit analysi bioactiv constitu includ rsgoitrin progoitrin epiprogoitrin gluconapin adenosin uridin guanosin hypoxanthin quantit analysi compon good regress test rang recoveri method rang uplc fingerprint radix isatidi sampl compar perform chemometr procedur includ similar analysi hierarch cluster analysi princip compon analysi chemometr procedur classifi radix isatidi finish product sampl group crude herb prepar slice adulter baphicacanthi cusia rhizoma radix combin quantit chromatograph fingerprint analysi qualiti assess radix isatidi finish product
PLoS Pathog	28743705	2012-03-15	PMC3431310	22956907	human bocaviru hbov identifi etiolog agent wheez young children acut respiratorytract infect studi sequenc fulllength hbov genom includ termini viral dna extract nasopharyng aspir infect patient clone fulllength hbov genom demonstr dna replic encapsid ssdna genom releas hbov virion human embryon kidnei cell hbov virion gener cell linebas product system exhibit typic icosahedr structur nm diamet capabl product infect polar primari human airwai epithelia hae apic surfac infect hae hallmark lung airwaytract injuri includ disrupt tight junction barrier loss cilia epitheli cell hypertrophi notabl polar hae cultur immort airwai epitheli cell cufi origin deriv cystic fibrosi patient support product infect hbov establish revers genet system gener cell linebas cultur system studi hbov infect will advanc studi hbov replic pathogenesi
Crit Care Res Pract	27049174	2009-11-01	PMC3432327	22957224	thi paper base relev literatur articl author clinic experi present goalori respiratori manag critic patient acut respiratori distress syndrom ard help improv clinician abil care patient earli recognit ard modifi risk factor avoid aggrav factor hospit stai nonprotect mechan ventil multipl blood product transfus posit fluid balanc ventilatorassoci pneumonia gastric aspir help decreas incid earli extens clinic laboratori imag evalu risk patient allow correct diagnosi ard assess comorbid calcul prognost indic care treatment plan rapid administr antibiot resuscit measur case sepsi septic shock associ protect ventilatori strategi earli shortterm paralysi associ differenti ventilatori techniqu recruit maneuv adequ posit endexpiratori pressur titrat prone posit extracorpor membran oxygen techniqu sever ard help improv prognosi revalu ard patient third dai evolut sequenti organ failur assess sofa biomark respons infect therapi allow chang initi treatment plan help decreas ard mortal
Clin Dev Immunol	22420367	2011-03-01	PMC3432373	22956971	enteroviru ev herpangina hand foot mouth diseas sever complic central nervou system cn brain stem enceph pulmonari edema sever complic lead death ev replic leukocyt endotheli cell dendrit cell product immun inflammatori mediat shape innat acquir immun respons complic diseas cytokin innat immun favor develop antivir immun respons cytokin chemokin plai role pathogenesi ev brain stem enceph cn system inflammatori respons infect plai distinctli role pathogenesi ev pulmonari edema administr intraven immunoglobulin milrinon phosphodiesteras inhibitor modul inflamm reduc sympathet overact improv surviv patient ev autonom nervou system dysregul pulmonari edema
BMC Vet Res	20198110	2007-08-01	PMC3433334	22839692	background felin leukaemia viru felv pathogen caus fatal ill cat worldwid high demand product protect diseas durat immun provid inactiv felv vaccin versifel felv administ cat target ag determin kitten receiv vaccin ag week subsequ challeng month felva glasgow isol studi younger ag control kitten persist felv antigenaemia confirm challeng viru sever efficaci contrast control cat requir level persist antigenaemia maximum cat middl durat studi longer studi apart anim short durat studi cat vaccin versifel felv neg persist antigenaemia consid treatment success conclus conclus agerel resist infect virul felv challeng evid earli month ag vaccin versifel felv aid protect cat felv diseas three year primari vaccin kitten
BMC Vet Res	21738831	2016-02-22	PMC3433389	22709971	background ebola virus viral hemorrhag fever human nonhuman primat endem africa reston ebolaviru rebov caus epizoot cynomolgu monkei macaca fasciculari associ human diseas late rebov infect identifi swine time philippin method total swine sera collect rebovaffect farm in pangasinan bulacan test presenc rebovspecif antibodi multipl serodiagnosi system total swine sera collect nonepizoot region tarlac test clarifi preval rebov infect gener swine popul philippin swine sera farm posit rebov antibodi multipl serodiagnosi system hand swine sera collect tarlac posit reaction diagnosi system conclus high preval rebov infect swine farm suggest swine suscept rebov infect multipl serolog assai studi thought futur surveil reobv infect swine philippin
PLoS One	17442307	2000-02-01	PMC3433438	22973452	background therapeut option patient cutan tcell lymphoma ctcl therapi cur studi demonstr ctcl cell overexpress cc chemokin receptor ccr methodologyprincip find studi xenograft model ctcl establish recombin adenoassoci viral serotyp aav vector express human singlechain variabl fragment scfvfc fusion scfvfc minibodi anticcr monoclon antibodi mab evalu cur treatment human ccr tumorbear mice treat intraven infus aav virion encod aavh minibodi antitumor activ vivo increas surviv aavh minibodi notabl increas number tumorinfiltr lyg fcriiiacda murin neutrophil tumor xenograft aavcontrol minibodi treat mice ccr tumorbear mice cotreat aavh minibodi infus human peripher blood mononuclear cell pbmc mark tumor infiltr human cda cd nk cell observ minibodi induc vitro adcc activ mous neutrophil human nk cell conclusionssignific data demonstr vivo antitumor activ minibodi mediat cda immun effector cell adcc mechan data demonstr util aavminibodi gene transfer system rapid evalu candid antitumor mab potenc potenti novel therapi ctcl
PLoS One	26903655	2005-12-26	PMC3433488	22962601	background evidencebas prioriti set increasingli ration distribut scarc health resourc guid futur health sought quantifi contribut wide rang infecti diseas infecti diseas burden highincom set methodologyprincip find healthadjust life year hali composit measur compris prematur mortal reduc function diseas estim burden infecti diseas associ syndrom ontario data death estim vital statist data diseas incid estim report diseas healthcar util cancer registri data supplement local model studi nation intern epidemiolog studi infecti agent associ syndrom account lost hali death incid case popul annual burdensom infecti agent hepat viru streptococcu pneumonia escherichia coli human papillomaviru hepat viru human immunodefici viru staphylococcu aureu influenza viru clostridium difficil rhinoviru top ten pathogen account total infecti diseas burden mark sexspecif differ diseas burden observ pathogen main limit studi exclus infecti diseas data avail issu consid impact coinfect comorbid inabl assess burden milder infect result healthcar util conclusionssignific infecti diseas continu substanti health burden highincom set ontario burden attribut small number infecti agent effect intervent identifi find guid public health polici plan research
Acta Vet Scand	10711275	2010-08-30	PMC3434114	22554105	background porcin circoviru type pcv associ diseas complex includ reproduct failur aim studi identifi subtyp pcv associ reproduct failur pig state paulo brazil investig coinfect infecti organ find sampl abort foetus mummifi foetus farrowtofinish swine farm infect pcv locat state paulo test pcv polymeras chain reaction pcr posit sampl addition test porcin parvoviru ppv leptospira spp brucella spp pcr pcv detect sampl ppv brucella spp leptospira spp case eleven pcv strain sequenc determin genotyp conclus find indic frequenc pcv infect abort porcin foetus state paulo low coinfect pathogen common involv pcv associ reproduct failur repeat characterist amino acid motif region pcv capsid protein associ abort sow
PLoS One	16378975	2013-06-19	PMC3434151	22957026	background dendrit cellspecif intercellular adhes moleculegrab nonintegrin dcsignr bind human immunodefici viru hiv gp envelop glycoprotein hostpathogen interact hiv infect studi associ variabl number tandem repeat vntr polymorph dcsignr gene hiv suscept produc controversi method find conduct metaanalysi data contain literatur clarifi find total studi consist hiv patient control healthi control hiv expos seroneg hesn control includ odd ratio or confid interv ci assess main analys stratifi analys ethnic sampl size perform divid control group healthi control hiv expos seroneg hesn control explor genet model detect associ vntr polymorph predisposit hiv infect the repeat allel carrier ci homozyg ci reduc risk hiv expos seroneg hesn control stratifi analys ethnic sampl size confirm find low moder degre heterogen studi conclus find demonstr vntr polymorph dcsignr gene associ moder host suscept hiv infect bp delet chemokin receptor gene ccr dcsignr vntr repeat allel role resist hiv infect asian popul
PLoS One	20805477	2015-11-30	PMC3434157	22957101	background critic patient hn influenza treat intens care unit icu repres risk nosocomi transmiss critic care clinician patient despit larg bodi literatur guidelin recommend infect control practic numer barrier identifi icu lead poor complianc person protect equip ppe ppe critic care clinician extens evalu pandem influenza studi examin knowledg attitud selfreport behavior barrier complianc ppe icu healthcar worker hcw pandem influenza methodologyprincip find survei instrument consist question develop mail hcw icu provinc china total physician nurs profession survei includ analysi fiftysix percent respond report receiv train program pandem influenza care hn patient report adequ knowledg patient protect respond correctli identifi compon ppe report high complianc ppe patient care multivari analysi vaccin hn influenza posit attitud ppe organiz factor avail ppe icu patient influenza precaut reprimand noncompli supervisor associ high complianc neg attitud ppe violat ppe independ predictor low complianc conclusionsignific knowledg selfreport complianc recommend ppe chines critic care clinician suboptim perceiv barrier address order close gap percept knowledg behavior
PLoS Pathog	23784858	2017-01-02	PMC3435252	22969429	interferoninduc transmembran ifitm protein famili viral restrict factor inhibit entri process pathogen virus includ influenza viru iav vitro report iavinfect knockout mice lack ifitm locu chromosom exhibit acceler diseas progress greater mortal higher pulmonari system viral burden compar wild type control observ phenotyp ifitmspecif knockout mice indistinguish mice lack entir ifitm locu ifitm express iav target cell includ alveolar type ii pneumocyt trachealbronchi respiratori epitheli cell robust ifitm express observ tissu absenc infect murin ifitm promot ifitm induc type ii interferon ifitm upregul gp cytokin il oncostatin cell express appropri receptor suggest multipl cytokin signal contribut ifitm express cell tissuespecif manner collect find establish central role ifitm limit acut influenza vivo provid insight ifitm express regul
Front Cell Infect Microbiol	26884691	2009-08-12	PMC3435510	22973560	brucella spp undul fever human brucellosi varieti anim innat adapt immun control brucella infect tolllik receptor tlr repres group pattern recognit receptor prr plai critic role host innat immun respons develop adapt immun current report investig role tlr signal clearanc brucella develop adapt immun tlr tlr myd mice aerosol exposur melitensi consist previou report myd requir effici clearanc brucella three organ lung spleen liver reveal thskew immun respons tlr mice late infect support tlr requir effici clearanc brucella lung spleen liver tlr requir effici clearanc brucella lung exhibit minor contribut clearanc spleen demonstr contribut clearanc liver lymphocyt prolifer assai tlr involv develop cellmedi memori respons brucella antigen antibodi detect reveal tlr requir gener earli antigenspecif igg late stage infect tlr transient requir igm product iga product contrast myd essenti antigen specif igg product late infect requir igm gener cours infect surprisingli despit promin role myd clearanc tissu mydknockout mice express higher level serum iga confirm role myd control infect spleen provid evid promin contribut protect tissu addit tlr tlr contribut control spleen infect contribut clearanc lung infect describ
Sensors (Basel)	28125378	2016-08-01	PMC3436031	22969402	sinc develop polymeras chain reaction pcr techniqu genom retriev lesser amount dna pcrbase amplif requir highprecis instrument perform temperatur cycl reaction cumbersom routin clinic us isotherm approach elimin complic associ thermocycl applic diagnost devic isotherm dna amplif studi extens paper describ basic concept isotherm amplif approach review progress diagnost devic develop
Antimicrob Resist Infect Control	19706706	2019-05-15	PMC3436662	22958911	background sever acut respiratori syndrom sar outbreak high complianc healthcar worker hand hygien driven fear postsar period confirm practic sustain singapor gener hospit bed acut tertiari care hospit hand hygien program revis earli singapor sign pledg health organ clean care safer care program find multiprong approach design hand hygien program includ system chang train educ evalu feedback remind workplac institut safeti climat hand hygien complianc rate improv januari improv annual complianc moment staff categori healthcareassoci mrsa infect reduc patientdai conclus leadership support program evidenc visibl leadership presenc messag releas resourc kei factor help program true success hospit recognis global hand hygien expert centr januari multiprong intervent work improv complianc reduc healthcar associ infect
Arch Public Health	27479659	2014-01-29	PMC3436681	22958353	background microbiolog refer laboratori critic develop highqual clinic public health servic belgium refer laboratori perform activ voluntari basi lack legal statu method pathogen group pathogen necessit nation refer center nrc priorit base diagnost epidemiolog relev term refer pathogen develop nrc pathogen group pathogen instal belgium fulfil core function offer refer diagnost collect refer materi share scientif advic particip nation intern network collabor workgroup contribut surveil activ conclus nrc focal point nation intern network public health microbiolog
PLoS One	31092567	2011-03-01	PMC3436764	22970251	background upper respiratori tract infect urti major reason hospit childhood urti viral etiolog diagnosi urti correct clinic decis treatment method data viral spectrum urti limit shanghai children method nasopharyng swab collect group children ag year hospit acut respiratori infect juli shanghai vrdal multiplex pcr common respiratori virus perform collect specimen compar seeplex rv ac detect kit respiratori virus virus detect patient vrdal multiplex pcr case mix infect seeplex rv ac detect kit virus detect patient coinfect case identifi virus includ human rhinoviru case influenza viru parainfluenzaviru parainfluenzaviru human enteroviru parainfluenzaviru respiratori syncyti viru adenoviru coronaviru enl human bocaviru influenza viru respiratori syncyti viru parainfluenzaviru coronaviru ochku human metapneumoviru conclus high frequenc respiratori infect coinfect detect children acut respiratori infect symptom shanghai seeplex rv ac detect method reliabl high throughput tool vrdal method simultan detect multipl respiratori virus
J Biomed Sci	24478441	2011-06-01	PMC3438048	22889374	background enteroviru ev highli infecti agent plai etiolog role hand foot mouth diseas associ sever neurolog complic caus mortal largescal outbreak current effect vaccin specif clinic therapi ev method unmodifi nucleotid small interf rna sirna classic modifi omethyl fluoro modif sirna design target highli conserv untransl region utr ev genom emploi antiev agent realtim taqman rtpcr western blot analysi plaqu assai carri evalu specif viral inhibit sirna transfect rhabdomyosarcoma cell sirna target ev genom utr delai allevi cytopath effect ev infect increas cell viabil evinfect cell inhibitori ev replic sequencespecif dosagedepend correspond decreas viral rna vp protein viral titer appropri modifi sirna exhibit rna interfer rnai activ dramat increas serum stabil comparison unmodifi counterpart conclus sequenc identifi highli conserv utr target effect inhibit ev replic rnai strategi appropri modifi sirna provid promis approach optim sirna overcom barrier rnaibas antivir therapi broader administr
Virol J	21342806	2006-01-13	PMC3439294	22834653	background rotavirus singl sever diarrhea young children worldwid develop specif potent access antivir treatment restrain rotaviru infect remain control rotaviru diseas method plant extract nutrit applic screen vitro ma cell antivir activ rhesu rotaviru rrv extract aspalathu lineari burmf rdahlgren test loss transepitheli resist ter caco cell caus simian rotaviru sa infect aqueou extract nelumbo nucifera gaertn fruit urtica dioica root aspalathu lineari burmf rdahlgren leav glycyrrhiza glabra root olea europaea leav strong antivir activ inhibitori concentr ic gml pure compound glycyrrhetin acid glycyrrhiza glabra strongest antivir activ ic luteolin vitexin aspalathu lineari ic m apigeninoglucosid melissa officinali ic combin glycyrrhiza glabra nelumbo nucifera gaertn urtica dioica nelumbo nucifera gaertn synergi antivir activ aspalathu lineari burmf rdahlgren posit mainten ter conclus indic nutrit intervent extract nelumbo nucifera gaertn aspalathu lineari burmf rdahlgren urtica dioica glycyrrhiza glabra olea europaea treatment diarrhea caus rotaviru infect
Virol J	21632751	2010-04-01	PMC3439333	22866888	background avian hn influenza virus challeng laboratori environ difficult collect air small size low concentr effort gener effect method hn air remov ensur safeti laboratori personnel studi design investig characterist aerosol hn produc laboratori manipul studi normal laboratori procedur process influenza viru carri independ amount viru pollut onsit atmospher measur zootomi grind centrifug pipet magnet stir egg inocul experiment zoogenet infect perform addit common accid associ process simul includ break glass contain syring inject influenza viru solut ruptur centrifug tube microclust sampl ambient air pollut collect devic collect air sampl collect virus test activ measur abil induc hemagglutin chicken red blood cell propag chicken embryo direct inocul detect reversetranscript pcr ha test the air sampl normal centrifug group negativecontrol group neg group posit hn conclus find numer sourc aerosol laboratori oper involv hn laboratori personnel awar exposur risk accompani routin procedur involv hn process proactiv measur prevent accident infect decreas risk viru aerosol leakag laboratori
Virol J	16415003	2005-02-01	PMC3439358	22873773	respiratori viral infect trigger asthma attack lead sever morbid report molecular method chronolog associ human coronaviru hku infect asthma exacerb year month asthmat girl treatment healthi
PLoS One	20048675	2013-08-01	PMC3439372	22984519	background limit exist epidemiolog acut febril respiratori ill tropic south american countri venezuela object studi examin epidemiolog influenzalik ill ili hospit maracai venezuela methodologyprincip find perform prospect surveil studi person ili present care hospit maracai venezuela octob decemb respiratori specimen clinic particip viral isol identif immunofluoresc antibodi molecular method emploi detect respiratori virus adenoviru influenza parainfluenza respiratori sincyti viru particip studi median ag year rang month year virus identifi subject particip coinfect viru influenza virus includ pandem hn frequent detect pathogen account virus detect adenoviru parainfluenza viru respiratori syncyti viru ili studi pandem hn viru commonli isol influenza viru initi appear wave pandem observ peak august second higher preced peak octob influenza ahn reemerg predomin respiratori viru detect conclusionssignific influenza virus commonli detect viral organ patient acut febril respiratori ill present hospit maracai venezuela pandem hn influenza viru complet replac circul influenza virus initi appear season influenza ahn common influenza viru postpandem phase
PLoS One	15699418	2005-03-28	PMC3439446	22984581	human bocaviru hbov novel parvoviru associ respiratori tract diseas gastrointestin ill adult pediatr patient investig epidemiolog genet variat hbov guangzhou south china screen throat swab sampl children adult acut respiratori infect symptom hbov march februari analyz complet genom sequenc hbov strain specimen screen hbov realtim pcr common respiratori virus rtpcr pcr hbov detect sampl pediatr patient inpati children adult patient detect hbov posit emerg case hbov posit case copathogen includ influenza viru rsv parainfluenza adenoviru coronaviru complet genom sequenc hbov strain genbank jn jn analyz phylogenet analysi hbov strain hbov genet close st genbank access number dq recombin analysi confirm hbov strain gz intragenotyp recombin strain hbov variant
PLoS One	23782161	2006-07-01	PMC3440351	22984554	object aim studi weigh commun level respect role plai pandem influenza phn viru cocircul human noninfluenza respiratori virus nirv wave phn pandem method populationbas prospect cohort studi conduct reunion island austral winter week allow identif household member develop symptom influenzalik ill ili three consecut nasal swab collect household member individu dai postili report test phn nirv rtpcr success wave viral infect identifi wave phn domin cocircul nirv sharpli interrupt second wave exclus compos nirv human rhinovirus hrv coronavirus hcov data interfer occur nirv phn cocircul household nirv infect phn neg individu phn posit peer rel risk ci viral shed shorter patient coinfect phn nirv nirv compar infect viru viru phn nirv intens cocircul nirv hrv brought phn detect threshold prevent spread pandem influenza viru suscept popul induct extens herd immun conclus nirv coinfect influenza epidem cofactor contribut shape outbreak modul attack rate warrant broad spectrum studi fulli understand viral epidem
Int J Inflam	15795256	2011-02-02	PMC3440856	22988542	background atherosclerosi chronic inflammatori diseas acut clinic manifest repres acut chronic inflamm neutrophil gelatinaseassoci lipocalin ngal granul human neutrophil divers function aim studi evalu hypothesi level ngal blood reflect inflammatori process stage coronari arteri diseas method studi patient sa ua nstemi stemi healthi control serum ngal measur admiss coronari angiographi differ observ median serumngalngml patient sa iqr compar ua nstemi stemi patient control increment sa stemi observ posit correl serumng hscrp spearman coeffici rho neutrophil count conclus patient coronari arteri diseas serum level ngal increas reflect degre inflammatori process patient acut coronari syndrom serum level ngal high neg predict reflect inflammatori statu sever coronari clinic syndrom
Front Microbiol	21289121	2010-09-27	PMC3441198	23024641	activitybas protein profil abpp newli emerg techniqu activ sitedirect probe monitor function statu enzym serin hydrolas largest famili enzym mammal serin hydrolas identifi specif role serin hydrolas involv varieti physiolog function includ digest immun respons blood coagul reproduct abpp investig hostviru interact understand molecular pathogenesi viru infect monitor alter serin hydrolas viral infect insight catalyt activ enzym will help identifi novel target diagnost therapeut applic review present abpp detect analyz function annot host cell serin hydrolas result hostviru interact
BMC Res Notes	21382632	2012-06-20	PMC3441218	22591859	background genom assembl consid challeng problem comput biologi studi extens research extrem difficult build gener assembl reconstruct origin sequenc contig creat specif assembl solv specif case will fruit creat gener assembl find paper arapan wholegenom assembl program dedic handl small genom contig revers complement contig case genom consist number segment implement algorithm detect segment demonstr influenza viru arapan program base de bruijn graph implement sophist fast method reconstruct origin sequenc neglect erron kmer method explor graph shortest longest path specif reliabl path base coverag level kmer length arapan short read test raw data download ncbi trace archiv conclus find accuraci assembl high result check european bioinformat institut ebi databas ncbi blast sequenc similar search ident genom coverag compar effici arapan wellknown assembl deal small genom accuraci arapan higher accuraci assembl assembl process fast requir second arapan free public binari file arapan httpsourceforgenetprojectsdnascissorfil
BMC Public Health	20876353	2016-09-01	PMC3443008	22770504	background charcoal burn seal room emerg second common suicid hong kong caus death year charcoal burn suicid victim uniqu sociodemograph profil econom activ men commit suicid specif time tempor pattern charcoal burn suicid method suicid data victim usual work ag regist death file censu statist depart hong kong total case charcoal burn suicid analyz twostep procedur examin tempor asymmetri incid suicid second investig asymmetri influenc sex andor econom activ statu poisson regress analys emploi model monthli daili pattern suicid econom activ statu sex find reveal pronounc monthli daili tempor variat pattern charcoal burn suicid hong kong consist previou find suicid death spring peak april mondai common high risk dai group sex determin pattern variat charcoal burn suicid magnitud variat influenc econom activ statu victim conclus tradit classif suicid method violent nonviol elid tempor variat specif method interact sex econom activ statu observ studi indic sex consider investig influenc econom activ statu tempor variat suicid find suggest suicid prevent effort time subgroupspecif
Virol J	22718813	2010-06-01	PMC3443020	22546080	background nuclear factorkappab nfb induc transcript factor plai kei role inflamm immun respons regul cell prolifer surviv previou studi group demonstr porcin reproduct respiratori syndrom viru prrsv infect activ nfb marc cell alveolar macrophag nucleocapsid protein identifi nfb activ structur protein encod prrsv remain unclear nonstructur protein nsp contribut nfb activ studi identifi nsp activ nfb investig potenti mechan screen individu nsp prrsv strain wuh nsp exhibit great potenti activ nfb marc hela cell overexpress nsp induc ib degrad nuclear transloc nfb nsp induc nfbdepend inflammatori factor includ interleukin il il cox rant compar nsp classic prrsv strain nsp highli pathogen prrsv hpprrsv strain possess amino acid aa delet nsp displai greater nfb activ aa delet demonstr associ nfb activ function domain analys reveal hypervari region hv nsp essenti nfb activ conclus data indic prrsv nsp multifunct protein particip modul host inflammatori respons suggest role nsp pathogenesi diseas outcom
BMC Bioinformatics	27617977	2015-03-06	PMC3443659	22823405	background cluster dna sequenc function group problem bioinformat propos alignmentfre algorithm mbkm base distanc measur dmk cluster gene sequenc method transform dna sequenc featur vector occurr locat order relat ktupl dna sequenc hierarch procedur appli cluster dna sequenc base featur vector propos distanc measur cluster method evalu cluster function gene phylogenet analysi method compar blastclust cdhitest experiment method effect classifi dna sequenc biolog characterist discov underli relationship sequenc conclus introduc novel cluster algorithm base sequenc similar measur effect classifi dna sequenc biolog characterist discov relationship sequenc
Evid Based Complement Alternat Med	20334888	2015-11-13	PMC3443820	22991573	complementari altern medicin sought encompass wide rang approach begun ancient china time xia dynasti india vedic period longlast cur easi avail natur heal poor sideeffect gain clinic practic conduct review describ effect limit herbal product chronic liver diseas focus attent quercetin curcumin describ pharmacokinet biolog properti benefici effect antioxid role metabol alcohol viral hepat consid oxid stress common pathwai chronic liver diseas etiolog main limit applic cam lack random placebocontrol clinic trial real proof efficaci product anecdot success person experi frequent drive forc accept cam popul
PLoS One	25589575	2015-10-01	PMC3445523	23029064	flotillin flotillin regul signal transduct pathwai growth factor signal flotillin express increas patholog condit neurodegen disord cancer despit signal transduct transcript regul flotillin analyz express flotillin transcript level identifi flotillin downstream target mitogen activ kinas erk promot activ flotillin increas growth factor stimul mapk depend manner overexpress serum respons factor earli growth respons gene increas flotillin mrna protein express promot activ express endogen flotillin increas treatment retino acid overexpress retinoid receptor bind partner rar ppar data indic express flotillin detect cultur cell finetun respons extern stimuli regul critic outcom signal cascad flotillin involv
Viruses	26561745	2015-03-25	PMC3446766	23012629	viru discoveri combin sequenc unbias amplif gener sequenc stateoftheart determin perform unbias amplif techniqu oper institut vidisca effici respiratori sampl input perform assai clinic materi blood stool sampl investig sensit vidisca fecessuspens serum sampl posit quantifi noroviru human immunodefici viru type perform vidisca serum sampl equal perform respiratori materi estim lower threshold viral genom copi estim threshold fecessuspens viral genom copi decreas sensit fece suspens sequenc share recogniz ident sequenc sequenc origin bacteria phage complet sequenc
PLoS One	26035278	2011-11-01	PMC3446906	23029207	rift vallei fever viru rvfv belong genu phleboviru famili bunyavirida high rate abort fetal malform infect rumin caus neurolog disord blind lethal hemorrhag fever human rvfv classifi categori prioriti pathogen select agent current therapeut rvf patient nss protein major virul factor rvfv inhibit host transcript includ interferon ifn mrna synthesi promot degrad dsrnadepend protein kinas pkr nss selfassoci cterminu aa nss aa bind sinaassoci protein sap inhibit activ ifn promot hypothes nss function abolish truncat specif domain coexpress nonfunct nss intact nss will result attenu nss function dominantneg unexpectedli rvfv nss truncat aa lack function ifn mrna synthesi inhibit degrad pkr truncat nss stabl infect cell nuclear local inhibit nss lack aa truncat nss exhibit dominantneg function nssmediat ifn suppress pkr degrad coexpress cell infect rvfv truncat nss intact nss interact rvfv nss presenc intact cterminu selfassoci domain conform integr nss stabil cellular local biolog function rvfv nss coexpress truncat nss exhibit dominantneg phenotyp
Influenza Res Treat	25810545	2006-01-13	PMC3447284	23074653	the norwegian pig popul free influenza virus pandem influenza outbreak autumn provid opportun studi clinic impact infect entir nave pig popul paper describ casecontrol studi clinic impact pandem influenza hn infect nucleu multipli herd norwai infect spread led seroconvers of norwegian nucleu multipli herd year posit neg herd identifi base surveil data norwegian veterinari institut telephon interview conduct pig herd owner manag novemb januari pig clinic sign report case herd vari morbid durat respiratori diseas reduc reproduct perform clinic sign report ag group
Influenza Res Treat	21987744	2011-09-08	PMC3447290	23074667	we analyz data ncdcph georgia sampl outpati influenzalik ill ili inpati sever acut respiratori syndrom sari refer test influenza viru pcr analysi influenza pandem total number laboratoryconfirm influenza case death influenza type type death underli medic condit report pandem influenza strain influenza type death predomin preexist condit coronari heart diseas
Influenza Res Treat	16414986	2018-04-27	PMC3447295	23074658	as point institut medicin exist pandem mitig model lack dynam decis support capabl develop largescal simulationdriven optim model gener dynam predict distribut vaccin antivir network region pandem outbreak model incorpor measur morbid mortal social distanc translat cost lost product medic expens perform strategi compar reactiv myopic polici sampl outbreak fla usa popul million comparison implement level vaccin antivir avail administr capac sensit analysi perform assess impact variabl critic factor polici perform model intend support public health polici make effect distribut limit mitig resourc
Influenza Res Treat	21905149	2004-12-06	PMC3447297	23074652	us peptid nanoparticl technolog design novel vaccin construct repres monomer monom tetramer tetram form group specif pathogen free spf chicken immun intramuscularli monom tetram adjuv week second boost chicken challeng eid hn low pathogen avian influenza lpai viru mespecif antibodi respons vaccin construct test elisa vaccin chicken exhibit increas mespecif igg respons construct compar nonvaccin group vaccin construct tetram elicit higher antibodi respons adjuv hand viru neutral assai indic immun protect neutral antibodi level protect evalu quantit real time pcr dai postchalleng hn lpai measur viru shed trachea cloaca tetram adjuv offer statist protect subtyp hn lpai reduct ai viru shed the selfassembl polypeptid nanoparticl promis potenti platform develop vaccin ai
Influenza Res Treat	29703817	2018-07-05	PMC3447298	23074661	cvte proprietari extract effect prevent upper respiratori infect uri healthi adult institution communitydwel senior multicent random doubleblind placebocontrol trial carri determin effect cvte prevent uri influenzavaccin communitydwel adult communitydwel adult random receiv placebo treatmentd month primari analysi incid laboratoryconfirmedclin uri lccu includ influenza perform receiv dose secondari analysi perform studi complet includ incid sever durat uri meet jacksonbas criteria safeti cvte incid lccu itt group placebo mg group jacksonconfirm uri lower treat group cvte supplement reduc sever durat jacksonconfirm uri indic cvte safe group prevent symptom uri larger sampl size warrant
Influenza Res Treat	15583121	2018-12-12	PMC3447299	23074650	the aim studi assess factor associ increas risk percept pandem influenza australia sampl consist australian adult ag year older complet short three item pandem influenza question modul incorpor nsw health adult popul health survei quarter adjust covari multivari analysi indic live rural region perceiv high risk pandem influenza occur poor selfrat health perceiv high likelihood pandem high concern selffamili directli event occur spoke languag english low incom younger peopl year chang live live possibl pandem influenza compar spoke english middlehigh incom earner older ag group data australian popul baselin risk percept demograph subgroup current potenti futur pandem compar monitor
Influenza Res Treat	29976676	2009-02-25	PMC3447300	23074659	the hn highli pathogen avian influenza hpai outbreak japan outbreak year japan epidem outbreak occur southeast asia knowledg transmiss rout respons hpai outbreak countri remain elus studi suggest field laboratori studi focus mechan transmiss blow fli consid control hn avian influenza outbreak epidem area high densiti fly speci year paper review field laboratori entomolog studi discuss possibl blow fli transmit hn virus
Influenza Res Treat	30541828	2005-02-24	PMC3447302	23074654	pandem hn influenza viru detect norwegian pig octob norwai regard free swine influenza intensifi screen reveal posit herd three month viru rapidli transmit suscept popul includ close breed herd high biosecur human introduct spread viru pig mild clinic sign observ infect pig surveil siv reveal norwegian pig herd antibodi pandem hn viru surveil indic pig born posit herd activ phase seroconvert suggest ongo infect herd surveil continu spread infect herd caus introduct viru circul 
Virol J	19244324	2011-03-16	PMC3447679	22559869	background countri predomin field isol infecti bronchiti viru ibv classifi qxlike strain commerci vaccin specif type ibv current urgent develop novel vaccin prevent qxlike ibv infect recombin marek diseas viru mdv rmdv express subunit spike protein qxlike infecti bronchiti viru ibv construct insert ibv gene genom cvirispen strain mdv specif pathogenfre spf chicken vaccin rmdv protect challeng qxlike ibv observ mild clinic sign diseas short virusshed period low mortal addition rmdv confer full protect chicken virul mdv cvirispen strain conclus demonstr rmdv effect promis recombin vaccin prevent qxlike ibv infect
Virol J	15731234	2007-06-19	PMC3447699	22738661	background pig implic mix reservoir gener pandem influenza strain control swine influenza veterinari public health signific human influenza vaccin strain commerci swine influenza vaccin regularli replac make vaccin provid limit protect antigen divers virus develop broadli protect swine influenza vaccin efficaci homolog heterolog viru infect studi form dna vaccin construct fuse consensu hha mha repres major ha sequenc hn swine influenza virus fuse conserv ctl epitop np consensu hha mnha protect efficaci homolog heterolog challeng test balbc mice immun particlemedi epiderm deliveri gene gun dna vaccin vaccin elicit substanti antibodi respons mnha induc cellmedi immun respons mha hn strain repres evolut antigen cluster challeng vaccineimmun mice homosubtyp challeng indic dna vaccin prevent homosubtyp viru infect complet vaccin heterolog protect efficaci test challeng hn swine influenza viru reassort pandem strain mnha reduc lung viral titer challeng group histopatholog observ obviou reduct lung pathogenesi compar mha control group conclus combin util consensu ha conserv ctl epitop confer complet partial protect homolog heterolog challeng mous model provid basi develop univers swine influenza vaccin
Front Microbiol	21411533	2015-06-11	PMC3448134	23049526	microarrai revolution studi microbiolog provid highthroughput method examin thousand gene singl test overcom limit cultureindepend approach function gene arrai fga probe wide rang gene involv varieti function interest microbi ecolog carbon degrad fixat metal resist microorgan cultur uncultur comprehens fga geochip arrai target ten thousand gene involv geochem cycl carbon nitrogen phosphoru sulfur metal resist reduct energi process antibiot resist contamin degrad phylogenet gyrb develop geochip studi perform fga power tool rapid sensit specif examin microbi commun highthroughput manner geochip wellsuit link geochem process microbi commun function structur technolog examin microbi commun situ bioremedi varieti contamin site studi expand understand biodegrad bioremedi process associ microorgan environment condit respons review overview fga develop focu geochip highlight specif geochip studi involv situ bioremedi
PLoS One	17576979	2013-06-01	PMC3448645	23029170	the neg transcript regul ica locu tcar regul protein involv biosynthesi polynacetylglucosamin pnag absenc tcar increas pnag product promot biofilm format staphylococci structur tcar apo form complex structur antibiot analyz detail mechan multipl antibiot resist regul marr famili protein tcar unclear restrict bind abil doublestrand dna dsdna electrophoret mobil shift assai emsa electron microscopi em circular dichroism cd biacor analysi tcar interact singlestrand dna ssdna identifi role marr famili protein tcar preferenti bind mer ssdna doublestrand dna inhibit viral ssdna replic contrast ssdna bind properti observ marr famili protein tetr famili protein suggest studi artifact simpl charg interact tcar ssdna novel role tcar regul dna replic anticip work will extend understand marr famili protein broaden develop therapeut strategi staphylococci
PLoS One	25918347	2004-06-25	PMC3454321	23029269	in term highli pathogen natur remain defin immun patholog sarscoronaviru sarscov infect identifi correl immun help develop vaccin sever coronavir infect sarscov infectionreinfect ferret model function genom approach gain insight sar immunopathogenesi identifi correl immun protect sarscovchalleng ferret infect sarscov immun sar viru vaccin identifi gene express signatur lung ferret associ primari immun respons sarscov infect ferret receiv ident second inoculum acut sarscov infect prompt coordin innat immun respons domin antivir ifn respons gene irg express reinfect ferret lack integr express irg preval acut infect express specif irg absent challeng ferret immun inactiv alohadjuv viru sar vaccin candid protect sarscov infect lung lack ifnmedi immun enhanc infect ferret inocul vaccin sarscov reveal irg correl protect immun data insight molecular pathogenesi sarscov sarslikecov infect resourc develop cov antivir therapeut vaccin
Evid Based Complement Alternat Med	23438650	2012-10-22	PMC3457740	23024696	object investig safeti risk efficaci benefit echinacea purpurea extract prevent common cold episod larg popul month period method healthi subject alloc receiv alcohol extract freshli harvest purpurea herba root placebo particip requir record advers event rate coldrel issu diari investig period nasal secret sampl acut cold screen virus total advers event occur echinacea placebo treatment particip experienc advers event studi drug advers drug reaction safeti echinacea noninferior placebo echinacea reduc total number cold episod cumul episod dai group painkil medic episod echinacea inhibit viral confirm cold prevent envelop viru infect echinacea maxim effect recurr infect prevent effect increas therapi complianc adher protocol conclus compliant prophylact intak purpurea month period appear provid posit risk benefit ratio
PLoS One	15220404	2012-11-14	PMC3458112	23049903	rna silenc directli involv antivir defens wide varieti eukaryot organ includ plant fungi invertebr presum vertebr anim studi rna silencingmedi antivir defenc vertebr hamper overlap antivir mechan heterolog system studi interplai rna silenc vertebrateinfect virus report vp protein avian birnaviru infecti bursal diseas viru ibdv displai addit capac bind long doublestrand rna abil interact doublestrand small rna molecul demonstr ibdv vp prevent silenc mediat degrad report mrna silenc suppress activ depend rna bind abil find antisilenc activ ibdv vp share homolog protein express insect fishinfect birnavirus final ibdv vp function replac wellcharacter hcpro silenc suppressor plum pox viru potyviru unabl infect plant absenc activ silenc suppressor altogeth support idea vp protect viral genom host sentinel includ rna silenc machineri
BMC Infect Dis	22969049	2015-04-01	PMC3458996	22963041	background deviceassoci infect dai plai nosocomi infect activ surveil infect control need disclos specif situat hospit cope problem effect examin rate dai antimicrobialresist pathogen dai inhospit mortal intens care unit icu method prospect surveil conduct mix medic surgic icu major teach hospit trend analysi perform logist regress assess prognost factor mortal rate dai episod devicedai common dai type catheterassoci urinari tract infect urinari catheterdai decreas dai rate rate ventilatorassoci pneumonia vap ventilatordai remain low crude rate dai inhospit mortal infect antibioticresist vap pathogen decreas common antimicrobialresist pathogen methicillinresist staphylococcu aureu imipenemresist acinetobact baumannii increas rapid rate rate antimicrobi resist enterobacteriacea increas control confound factor dai independ prognost factor dai mortal confid interv ci inhospit mortal ci conclus decreas rate dai infect resist bacteria impact sever acut respiratori syndrom attribut activ infect control improv adher 
BMC Med Genet	23152556	2011-02-23	PMC3459791	22938636	background previou metaanalysi report posit associ insertiondelet polymorph angiotensinconvert enzym gene ac risk acut lung injuri aliacut respiratori distress syndrom ard updat metaanalysi addition assess associ polymorph aliard mortal method search electron databas octob term angiotensinconvert enzym gene acut lung injuri acut respiratori distress syndrom review studi report relationship polymorph ac aliard human studi met inclus criteria compris aliard patient healthi control patient aliard three genet model allel domin recess model ac polymorph associ suscept aliard genet model ac polymorph associ mortal risk aliard asian subject pallel pdomin precess find remain correct multipl comparison conclus associ ac polymorph genotyp mortal risk aliard asian
PLoS One	25675838	2017-08-23	PMC3459844	23029447	complex interact effector cell foxp regulatori cell treg contribut clinic outcom cancer autoimmun infecti diseas previou work il revers tregmedi suppress cdfoxp cell tconv prolifer treg express tbet ifn site inflamm il induc ifn product treg vitro investig loss immunosuppress occur ifn express treg treat mous lymphocyt cultur il ifn express decreas abil treg suppress tconv prolifer il treatment decreas treg frequenc foxp level treg il increas ilr express tconv cd cell diminish express treg decreas il product tconv cd cell il mediat chang favor outgrowth nontreg addition treatment second cytokin il decreas il express augment tconv cd cell prolifer notabl il modifi level ilr nontreg cell il multipl effect modifi balanc treg nontreg support role rel level ilr ifn express ilmedi revers treg immunosuppress
PLoS One	21346059	2012-06-07	PMC3459853	23029405	background tumor necrosi factor tnf tnf receptor superfamili tnfrmediat immun respons plai essenti role pathogenesi sever sepsi studi examin associ tnf lymphotoxin lta singl nucleotid polymorph snp sever sepsi produc conflict object studi investig genet variat tnf lta tnfrsfa tnfrsfb associ suscept death sever sepsi chines han popul methodologyprincip find ten snp tnf lta tnfrsfa tnfrsfb genotyp sampl patient sever sepsi sepsi healthi control rs snp promot region tnf associ risk sever sepsi minor allel frequenc rs higher sever sepsi patient healthi control padj odd ratio oradj sepsi patient padj oradj investig correl rs genotyp tnf concentr peripher blood mononuclear cell pbmc healthi volunt expos lipopolysaccharid lp vivo associ rs tnf serum level sever sepsi patient exposur lp tnf concentr cultur supernat pbmc higher subject aaag genotyp gg genotyp patient sever sepsi individu aaag genotyp higher tnf serum concentr gg genotyp padj associ snp candid gene dai mortal patient sever sepsi conclusionssignific find suggest function tnf gene snp rs associ suscept sever sepsi lethal chines han popul
PLoS One	28835499	2012-01-30	PMC3460856	23029501	sinc plasmidbas revers genet rg system revolution influenza virus studi unusu encount clone difficulti influenza gene attempt recov viru de novo overcom shortcom sought develop partial full plasmidfre rg system influenza gene choic assembl rg compet unit virtu overlap pcr reaction cdna copi viral gene segment control rna polymeras promot pol termin signal refer flu pcr amplicon transfect tissu cultur cell ha flu pcr amplicon plasmid encod remain influenza rg unit effici viru rescu likewis transfect includ ha flu pcr amplicon rg plasmid effici viru rescu addit influenza virus recov full set flu pcr amplicon plasmid
PLoS One	22679024	2009-09-29	PMC3460915	23029506	background anterior gradient homolog agr function protein critic role divers rang biolog system includ vertebr tissu develop inflammatori tissu injuri respons cancer progress clinic studi agr protein overexpress wide rang human cancer includ carcinoma esophagu pancrea breast prostat lung make protein potenti cancer biomark gener biochem function agr human cell remain undefin signal mechan drive agr inhibit clearli illustr great interest develop molecular probe recogn agr detect elucid agrassoci molecular mechan methodologyprincip find beadbas flow cytometri monitor selex technolog identifi group dna aptam bind agr kd valu nanomolar rang round select aptam cb chosen studi high bind affin specif optim shorten cb special grich characterist grich region bind motif character reveal intramolecular parallel gquadruplex cd spectroscopi uv spectroscopi experi confirm stabil gquadruplex structur depend natur monoval ion format gquadruplex structur bind capac cb target design kind alloster molecul beacon amb probe select sensit detect agr conclusionsignific work develop aptam probe specif recognit agr structur studi identifi bind motif aptam intramolecular parallel gquadruplex structur structur bind affin depend natur monoval ion design agramb agr sensit select detect aptam probe great potenti serv tool earli diagnosi prognosi cancer fundament elucid biochem function agr
BMC Infect Dis	22290816	2007-05-09	PMC3462143	22867003	background dengu reach endem statu taiwan implement fever screen program airport earli detect febril passeng dengu infect studi intend assess perform airport screen procedur dengu infect method analyz data nation surveil system taiwan center diseas control includ import dengu case report sentinel airport clinic domest case ci confirm import dengu case appar symptom febril virem stage detect airport fever screen program estim posit predict ci neg predict fluctuat number symptomat import dengu case identifi airport associ total number import dengu case base regress analysi biweekli surveil rxy addition fluctuat pattern cumul number import dengu case month lead time parallel domest dengu case base consecut year surveil rxty rxty conclus moder sensit detect dengu airport examin studi indic limit fever screen program prevent import screen program assist rapid triag selfquarantin symptomat dengu case virem stage border contribut activ sentinel surveil block viral transmiss suscept popul neighbor famili virem travel includ symptom critic prevent dengu epidem reinforc mosquito bite prevent household vector control dengueendem denguecompet hotspot epidem season essenti highli recommend
BMC Infect Dis	19596449	2003-11-15	PMC3462154	22891685	background exist standard nonmolecular diagnost method viral cultur immunofluoresc dfa timeconsum labor intens limit sensit multiplex molecular assai costli develop rapid sensit diagnosi respiratori viral pathogen method gexpbas multiplex rtpcr assai gexp assai develop detect simultan sixteen respiratori viru typessubtyp seventeen set chimer primer initi rtpcr pair univers primer subsequ cycl rtpcr specif gexp assai examin posit control viru typesubtyp sensit evalu perform assai serial tenfold dilut vitrotranscrib rna rna virus plasmid adv hbov target sequenc gexp assai evalu clinic specimen compar luminex xtag rvp fast assai gexp assai achiev sensit copi singl viru copi premix viral target analys clinic specimen gexp assai demonstr gexp assai rvp fast assai complet agreement specimen gexp assai sensit rvp fast assai detect hrv piv sensit detect hmpv adv rsvb hbov process gexp assai detect sampl complet hour conclus conclus gexp assai rapid costeffect sensit specif high throughput method detect respiratori viru infect
PLoS One	17494640	2008-10-01	PMC3462188	23049677	six volunt experienc sever inflammatori respons phase clinic trial monoclon antibodi design stimul regulatori cell respons trial began volunt experienc cytokin storm dramat increas cytokin concentr monoclon antibodi tgn rais serum concentr pro antiinflammatori cytokin hih valu dai lymphocyt monocyt concentr plummet subject healthi prior indic immun defici event provid unusu opportun studi dynam interact cytokin measur paramet respons histori cytokin model set linear ordinari differenti equat gener search procedur identifi paramet model respons fit data fivedai measur period eighteenthord model reveal plausibl causeandeffect relationship cytokin show cytokin induc inhibit cytokin suggest perturb il il il induct ifn il greatest inhibit cytokin concentr tnf major proinflammatori factor ifn three cytokin faster initi median respons tgn infus principalcompon analysi data reveal three cluster cytokin respons tnf il il ifn il il il il il il il il tnf highest degre variabl respons uncertain initi condit exogen effect paramet estim studi illumin detail cytokin storm event demonstr linear model interpret complex coupl biolog system dynam empir data
PLoS One	14602896	2006-12-18	PMC3462742	23056267	the induct immun toler formid challeng organ transplant dendrit cell dc plai role orchestr immun respons mediat protect immun respons induc antigen specif toler previou studi demonstr fmslike tyrosin kinas receptor flt ligand fltl plai essenti role regul dc commit develop report synerg fltl lowdos rapamycin rapa protect allograft rejction fltl combin rapa prolong murin cardiac allograft surviv time compar untreat recipi recipi treat rapa fltl mechanist studi reveal fltl combin lowdos rapa induc gener tolerogen dc product cd foxp regulatori cell il secret observ enhanc autophagi cardiac allograft asset contribut enhanc allograft surviv data fltl combin lowdos rapa effect therapeut approach induc toler clinic set transplant
PLoS One	18772339	2008-12-03	PMC3463586	23056170	recognit viru infect innat pattern recognit receptor prr includ membraneassoci tolllik receptor tlr cytoplasm rigilik receptor rlr activ cascad signal transduct pathwai lead product type interferon ifn proinflammatori cytokin orchestr elimin virus demonstr prrmediat innat immun plai essenti role defend viru infect occasion overwhelm product proinflammatori cytokin sever inflamm blood vessel leakag tissu damag effort identifi small molecul select enhanc prrmediat antivir detriment inflammatori respons discov compound ro aminophenylbihbenzimidazolamin promot tlr rlr ligandinduc ifn gene express antivir respons select activ mitogenactiv protein kinas mapk pathwai impli pharmacolog modul prr signal transduct pathwai favor induct benefici antivir respons novel therapeut strategi
PLoS One	17178783	2018-12-10	PMC3463591	23056310	to studi renalas express distribut renal tissu cell renalas code dna vaccin construct antirenalas monoclon antibodi produc dna immun hybridoma techniqu investig immunolog test western blot detect express distribut renalas renal tissu cell antirenalas monoclon antibodi prepar dna immun techniqu studi antirenalas monoclon antibodi renalas express glomeruli tubul mesangi cell podocyt renal tubul epitheli cell cell supernat renalas wildli express kidnei includ glomeruli tubul mesangi cell podocyt tubul epitheli cell secret tubul epitheli cell primarili
PLoS One	19052087	2010-12-29	PMC3463600	23056193	recent studi infecti diseas attempt construct realist paramet interperson contact pattern diaryapproach survei ensur diarybas contact pattern provid accur baselin data polici implement dens popul taiwan collect contact diari nation sampl stage systemat probabl sampl rigor inperson interview repres sampl contact diari record total widerang facetofac interperson contact hour period contact occur respond household activ ag group schoolchildren ag averag daili contact time activ ag group paramet contact pattern help modifi sophist nation simul system year model spread pandem diseas taiwan base actual repres data enabl research infer find popul analys aim facilit implement appropri effect strategi control emerg pandem diseas infect
PLoS Pathog	30679987	2010-08-11	PMC3464218	23055924	dengu viru denv pathogen high impact human health replic wide rang cell involv immun respons effici infect human denv evad inhibit fundament element innat immun system type interferon respons denv circumv host immun respons express protein antagon cellular innat immun document inhibit type ifn product proteolyt activ denv nsb proteas complex human monocyt deriv dendrit cell mddc report identifi human adaptor molecul sting target nsb proteas complex character mechan inhibit type ifn product primari human mddc viral factor human mous primari cell lack sting enhanc denv replic convers mutat version sting cleav denv nsb proteas induc higher level type ifn infect denv addition denv nsb degrad mous version sting phenomenon sever restrict replic denv mous cell suggest sting plai kei role inhibit denv infect spread mice
Virol J	21191006	2008-09-05	PMC3466123	22709374	background gastrointestin symptom uncommon manifest influenza viru infect studi aim investig presenc influenza virus stool adult patient consult gener practition uncompl acut diarrhea ad proport concurr infect enter influenza virus method casecontrol studi conduct decemb april stool specimen collect test influenza virus season ahn pandem ahn enter virus astroviru group rotaviru human enter adenoviru noroviru genogroup novgi genogroup ii novgii gener practition enrol case control stool specimen collect posit enter virus analys test posit influenza viru influenza posit patient report respiratori symptom influenzaposit patient detect enter viru posit influenza codetect novgi novgii astroviru control test posit enter andor influenza virus investig conclus studi simultan detect influenza enter virus rare event report time gener practic presenc season pandem influenza virus stool adult patient consult uncompl ad simultan investig enter influenza virus patient complain gastrointestin symptom futur studi better identifi agent respons ad
PLoS One	20702616	2006-10-09	PMC3466325	23056330	vaccin base live virus attract immunogen costeffect deliv multipl rout live viru vaccin reactogen side effect fever myalgia inject site pain reduc accept clinic studi link vaccineinduc reactogen side effect product proinflammatori cytokin interleukin il human object determin il contribut patholog immun recombin vesicular stomat viru rvsv vaccin vector identifi strategi il mediat patholog reduc compromis immunogen rvsv vaccin induc local system product il vivo accumul il correl acut patholog rvsv immun rvsvinduc patholog reduc mice defici il receptor type ilr mice fulli protect lethal rechalleng high dose vsv result demonstr il contribut reactogen rvsv dispens induct protect immun amount il detect mice defici caspas inflammasom adaptor molecul asc rvsv immun produc wild type anim caspas asc mice partial protect rvsvinduc patholog data support idea il express vivo respons vsv activ caspas ascindepend mechan rvsv vector engin suppress induct il signal ilr reactogen vivo retain immunogen protect capac rvsv highli desir vaccin vector oncolyt therapi better toler human vaccine
PLoS One	17480053	2005-06-07	PMC3468516	23071799	background purpos success drug treatment sepsisrel acut lung injuri ali remain major clinic problem studi design assess benefici effect posttreat oroxylin oroa flavonoid amelior lipopolysaccharid lpsinduc lung inflamm fatal experiment approach rat inject lp mgkg iv induc ali oroa mgkg iv hr hr lp challeng twenti hr lp challeng biochem chang blood lung tissu morphologicalhistolog alter lung associ inflamm injuri examin therapeut oroa assess measur surviv rate endotoxem mice kei lp mgkg iv alter wbc count elev plasma tumor necrosi factor tnf nitric oxid increas pulmonari edema thicken alveolar septa decreas surviv rate chang amelior oroa mgkg iv administ hr hr lp challeng posttreat attenu lpsinduc activ nuclear factorb nfb releas high mobil group box hmgb lung tissu posttreat oroa mgkg ip administ hr hr lp challeng mice increas surviv rate conclus implic oroa administ induct ali lp prevent rever lung tissu injuri increas surviv rate posit posttreat effect oroa oroa candid manag lung inflamm lpsinduc endotoxemia septic shock
Iran J Parasitol	17030805	2014-02-19	PMC3469194	23109952	background hadjelia truncata nematod lesion gizzard line pigeon lead death aim studi introduc alphitobiu diaperinu intermedi host hadjelia truncata method truncata infect identifi pigeon flock ahvaz citi khuzestan provinc iran perform fecal examin autopsi adult larval stage beetl collect litter pigeon hous identifi morpholog beetl larva cultur medium fece infect pigeon nematod larval stage natur experiment cultur infect adult beetl fed group pigeon collect beetl identifi alphitobiu diaperinu averag length width adult beetl mm mm infect rate natur experiment infect beetl larval stage nematod adult nematod collect gizzard experiment infect pigeon identifi truncata nematod infect rate pigeon feed infect larva collect natur experiment infect beetl conclus diaperinu serv natur intermedi host truncata
PLoS One	16244207	2007-02-27	PMC3469491	23071819	influenza viru iav segment negativestrand rna genom iav balanc replic transcript multipl genom segment understood develop dual competit assai base cotransfect firefli gaussia luciferaseencod genom segment plasmid encod iav polymeras subunit nucleoprotein limit amount polymeras subunit express firefli luciferas segment neg presenc gaussia luciferas counterpart indic competit report genom segment competit reliev increas decreas rel amount firefli gaussia report segment balanc luciferas express level ident untransl region utr segment length gener appear genom segment displai inher higher express level effici competitor segment natur genom segment test abil suppress report gene express shorter genom segment gener reduc firefli luciferas express larger extent ns segment largest balanc report segment dramat introduct utr panhandlestabil mutat report genom segment carri mutat effici compet natur genom segment infect cell data indic iav genom segment compet polymeras competit segment length code region utr competit appar earli infect limit amount polymeras contribut regul segmentspecif replic transcript
PLoS One	24554656	2009-02-05	PMC3469568	23071829	background cmvspecif tcell crucial control cmvreplic posttranspl regulatori tcell treg associ toler immun state contribut cmvreplic tcell subset treg il produc tcell studi context explor treg frequenc cmvreplic transplant method prospect evalu transplant patient cmvviremia quantifi cmvspecif cd cd tcell treg cdcdfoxp frequenc flowcytometri patient requir antivir treatment subset compar antivir treatment requir spontan clearanc viremia higher initi cmvspecif cd tcell lower treg observ patient spontan clearanc p ratio cmvspecif cd tcell treg allow predict viral clearanc sensit specif month treatment correl observ patient protect cmvrelaps ratio cmvspecif cd tcell treg allow predict relaps sensit specif respons correl virolog outcom conclus studi novel insight treg subpopul cmvreplic transplant preliminari data measur cmvspecif cd tcell treg predict spontan clearanc viremia relaps
BMC Pediatr	17327211	2009-01-26	PMC3471019	22974166	background asthma major public health problem huge social econom burden peopl worldwid viral respiratori infect major acut asthma exacerb contribut asthma incept high risk young children suscept genet background acut exacerb associ decreas lung growth acceler loss lung function add cost morbid associ asthma discuss prevent viral infect establish prevent strategi explor good person hygien handwash avoid cigarett smoke reduc respiratori viral infect eat healthi balanc diet activ probiot supplement bacterialderiv product om reduc recurr infect suscept children practic antivir therapi current suitabl widespread summari hand hygien best measur prevent common cold healthi balanc diet activ probiot supplement immunostimul om reduc recurr infect asthmat children
Sensors (Basel)	19194803	2012-02-06	PMC3472858	23112630	labonachip provid conveni accur diagnosi tool paper plasticbas microfluid immunosensor chip diagnosi swine flu hn develop immobil hemagglutinin antigen gold surfac genet engin polypeptid fluoresc dyelabel antibodi ab quantifi concentr ab immunosensor chip fluoresc techniqu increas detect effici reduc error three chamber three microchannel design microfluid chip protocol appli diagnosi infecti diseas microfluid devic
PLoS One	19166361	2011-07-01	PMC3472981	23091628	although studi provid strong evid support develop hcv viruslik particl vlpbase vaccin fact heterolog viral vector andor multipl dose regim requir induc protect immun indic improv immunogen studi evalu anion selfadjuv lipopeptid tlr agonist pamci epamci enhanc immunogen vlp hcv structur protein core e genotyp coformul lipopeptid vlp margin improv dendrit cell dc uptak abil concomitantli induc dc matur small dose featur observ vlp presenc aluminium hydroxidebas adjuv alum dramat improv vlp especif antibodi respons observ vlpepamci vaccin mice dose nonadjuv tradition alumadjuv vlp requir match antibodi titr singl dose vlp formul lipopeptid result correl higher number specif antibodi secret cell detect spleen vlpepamci vaccin mice greater abil sera mice neutralis bind uptak vlp huh cell vaccin hlaa transgen mice formul induc better vlpspecif ifnmedi respons compar nonadjuv vlp compar level achiev coadminist complet freund adjuv immunogen hcv vlp improv addit novel adjuv target deliveri dc constitut viabl vaccin strategi treatment hcv
PLoS One	22315415	2006-03-01	PMC3473018	23091644	viral infect detect case host innat immun system patternrecognit receptor prr sensor pathogenassoci molecular pattern pamp induc product cytokin type interferon ifn identif mammalian teleost fish cytoplasm viral rna sensor rigilik receptor rlr mitochondri adaptor mitochondri antivir signal mav protein call ip highlight role induct ifn earli stage viru infect endoplasm reticulum er adaptor stimul interferon gene sting protein call mita eri mpy plai pivot role respons nonselfcytosol rna dsdna studi clone sting cdna zebrafish ortholog mammalian sting demonstr overexpress er protein fish cell led constitut induct ifn interferonstimul gene isg stingoverexpress cell fulli protect rna viru infect strong inhibit dna rna viru replic addit mav sting player rigi ifninduc pathwai report demonstr teleost fish possess function rlr pathwai mav sting downstream signal molecul rigi sequenc present articl submit genbank access number zebrafish sting epc sting epc irf epc ifn promot he
J Occup Med Toxicol	31682659	2009-09-01	PMC3474162	22553942	introduct healthcar worker hcw expos infecti agent diseas surveil need order foster prevent method data compens board cover hcw nongovernment healthcar provid germani analys fiveyear period hepat viru hbv hepat viru hcv infect period analys extend year annual rate occup infecti diseas oid employe calcul needlestick injuri nsi rate employe calcul year total hcv infect recognis oid employe activ tb second frequent oid number hbv hcv infect decreas number activ tb follow clear pattern needlestick injuri nsi report hospit versu employe hcw conclus declin hcv infect remain frequent hcw nsi reinforc recommend safeti devic germani will prevent nsi hcv infect close observ
BMC Res Notes	16498157	2011-01-01	PMC3475085	22852767	background gene express profil gep cell peripher blood approach biomark discoveri studi molecular pathogenesi preval diseas limit literatur gene express marker associ chronic obstruct pulmonari diseas copd transcriptom pictur associ critic respiratori ill diseas moment find agil microarrai chip profil gene express signatur blood copd patient hospit degre respiratori compromis need admiss icu whilst admit respiratori medicin servic genespr gx softwar perform statist comparison transcript level icu nonicu patient ingenu pathwai analysi ipa kyoto encyclopedia gene genom kegg select annot visual gene function pathwai gene ontolog ttest evid gene differenti express icu nonicu patient ipa kegg analysi repres biolog function reveal icu patient increas level neutrophil gene transcript cathepsin ctsg elastas neutrophil express elan proteinas prtn myeloperoxidas mpo cathepsin ctsd defensin alpha neutrophilspecif defa azurocidin azu bactericidalpermeabilityincreas protein bpi repres protein codifi gene form azurophil granul neutrophil involv antimicrobi defenc tissu damag neutrophil signatur parallel necess advanc respiratori vital support presenc bacteri infect conclus studi transcriptom signatur blood suggest essenti role neutrophil proteas copd patient critic respiratori ill measur modul express gene option clinic monitor treatment sever copd exacerb
Virol J	19581125	2009-04-13	PMC3477084	22947270	background novel human enteroviru hev type speci hevc name ev discov case respiratori ill nicaragua septemb aim studi retrospect examin presenc role ev respiratori sampl patient popul infant ag year hospit acut respiratori diseas ard adult hematopoiet stem cell transplant recipi total nasopharing aspir collect test presenc ev revers transcriptionpcr rtpcr posit sampl presenc common respiratori virus assai clinic symptom evalu sampl infant test posit ev rna belong patient lower ard coinfect viral pathogen studi observ case transplant recipi sampl analyz patient upper respiratori simptom test posit hev absenc coinfect virus sequenc analysi amplifi ev genom region nucleotid differ compar nicaraguan strain conclus indic hev variant circul differenti lineag worldwid case larger studi need hev infect associ ard infant hematopoiet stem cell transplant recipi preliminari observ will confirm improv molecular method wider panel potenti pathogen will monitor categori patient
J Pathog	21233513	2014-08-01	PMC3477565	23097708	besid common threat farm anim poultri coronaviru cov respons human sever acut respiratori syndrom sar epidem aspect cov behavior includ mode transmiss fulli understood amount peculiar distribut protein intrins disord viral effici analysi behavior transmiss mode cov propos model allow categor cov peculiar disord distribut membran nucleocapsid categor enabl quick identif virus behavior transmiss genet proxim base analysi empir model predict viral transmiss behavior develop model explain behavior aspect coronavirus fulli understood predictor tool better epidemiolog clinic structur understand behavior newli emerg virus virus long time vaccin strategi involv search viral strain character evolutionari misfit peculiar disord distribut shell behavior
BMC Genomics	19365076	2009-01-01	PMC3478160	22559730	background fusarium graminearum viru straindk fgvdk mycoviru confer hypovirul graminearum primari phytopathogen fungu fusarium head blight fhb diseas cereal understand interact mycovirus plant pathogen fungi prevent damag caus graminearum investig cellular regulatori process host fgvdk compar uninfect parent transcript approach tile microarrai cover graminearum gene carri genomewid express analys graminearum time point earli point growth infect strain compar uninfect strain gene associ protein synthesi includ ribosom assembl nucleolu ribosom rna process upregul addit gene requir transcript signal transduct includ fungalspecif transcript factor camp signal activ upregul contrast gene involv metabol pathwai produc carboxyl acid aromat amino acid nitrogen compound polyamin dramat downregul earli time point gene associ transport system local transmembran downregul time point conclus report global chang promin cellular pathwai fusarium host fgvdk increas transcript transcript translat machineri fungal host cell to viru replic addit downregul gene requir metabol transport system fungal host viru appear to host defens mechan fungal virul data aid understand fgvdk regul transcript reprogram graminearum
Virol J	25085912	2011-07-28	PMC3478227	22616823	background glycyrrhizin ga primari metabolit glycyrrhetin acid gra pharmacolog activ compon medicin licoric root antivir immunomodulatori properti properti establish mechan action complet understood studi ga gra test abil inhibit rotaviru replic cell cultur long term goal discov natur compound complement exist vaccin method epitheli cell treat ga gra time pre postinfect viru yield measur immunofluoresc focu assai level viral protein vp vp nsp gra treat cell measur immunoblot determin gra treatment accumul viral protein gra treatment reduc rotaviru yield infect cultur post viru adsorpt viru yield ga treat cultur mock treat control time addit experi indic gramedi replic inhibit occur step step subsequ viru entri amount vp vp nsp reduc gra cultur hour postentri conclus gra ga antivir activ rotaviru replic vitro studi determin gra attenu rotaviru replic vivo underwai
Vet Res	19057454	2009-06-01	PMC3479418	22934974	footandmouth diseas viru fmdv highli infecti member picornavirida induc acut diseas clovenhoof speci vaccineinduc immun protect correl presenc high level neutral antibodi opsonis antibodi propos mechan immun respons contribut viru clearanc macrophag lead product typei interferon ifn plasmacytoid dendrit cell pdc studi demonstr opsonis antibodi titr mediat enhanc ifn respons pdc neutral titr antigen virus serotyp emploi sera crossreact nonneutr isol multipl serotyp test assai uncomplex viru immun complex viru stimul pdc tolllik receptor addit find potenti strainspecif differ virul andor immunogen pdc activ fmdv differ viral isol altogeth indic opsonis antibodi broader reactiv neutral antibodi contribut antivir respons induc antigen distant virus
PLoS One	21793746	2016-12-07	PMC3480448	23112871	tickborn flavivirus tbfv sustain natur cycl mammalian tick host studi african green monkei kidnei cell vero ixod scapulari tick cell is compar virusinduc chang mammalian arthropod cell confoc microscopi transmiss electron microscopi tem electron tomographi examin viral protein distribut ultrastructur chang occur tbfv infect host cell flavivirus complex rearrang cellular membran purpos viru replic viru infect accompani mark expans endoplasm reticulum er stain marker tbfv replic local er cell line tem vero cell membranebound vesicl enclos network dilat anastomos er cisterna virion er paracrystallin arrai tubular structur elong vesicl occasion acut persist infect is cell membran prolifer vesicl extent membran expans abund vesicl lower viral particl observ tubular profil preval persist infect is cell acut infect cell tubular profil persist infect tick cell crosssect diamet nm reach nm length close end arrang fasciclelik bundl shroud er membran experi provid analysi viral protein local context mammalian arthropod cell line acut persist arthropod cell infect addition time flaviviru infect vector cell persist flaviviru infect
Parasit Vectors	19428587	2010-05-27	PMC3480843	22992281	background toxoplasma gondii intracellular protozoan parasit infect warmblood anim includ bird worldwid distribut survei gondii infect wild bird report extens gondii infect peafowl worldwid studi perform determin seropreval gondii infect peafowl yunnan provinc southwestern china method sera peafowl includ blue peafowl pavo cristatu green peafowl pavo muticu origin geograph area yunnan provinc assai gondii antibodi modifi agglutin test mat specif gondii antibodi detect peafowl mat titer seroposit bird speci blue peafowl green peafowl differ gondii seropreval adolesc bird adult bird geograph origin peafowl highli associ gondii infect studi statist differ gondii seroposit observ peafowl kunm xishuangbanna dai autonom prefectur ci statist analys interact ag geograph origin peafowl conclus the survei indic infect peafowl gondii widespread yunnan provinc public health concern implic prevent control toxoplamosi provinc knowledg seropreval report gondii infect china southwestern yunnan provinc
BMC Mol Biol	27925149	2016-06-30	PMC3482582	22747760	background select stabl suitabl refer gene realtim quantit pcr rtqpcr crucial prerequisit reliabl gene express analysi experiment condit studi aim identifi refer gene intern control gene express studi rtqpcr azolestimul candida glabrata express stabil refer gene fluconazol stress evalu fold chang standard deviat comput hkgfinder tool data reveal mrna express level three ribosom rna rdn rdn rdn remain stabl respons fluconazol pgk ubc ubc mrna fold induct azol contrast mrna level refer gene ef gapdh ppia rpla rpl rpla sdha tub ubc dramat increas glabrata antifung treatment exhibit chang rang fold assess express stabil refer gene ct method three softwar packag stabil rank refer gene genorm ct method ident hkgfinder stabil rank bestkeep normfind notabl valid suitabl candid refer gene pgk rdn rdn ubc ubc intern control ten target gene system compar ct method valid experi pass refer gene analyz rdn amplif effici rdn ten target gene final demonstr rel quantif target gene express vari endogen control highlight the choic intern control experi conclus recommend rdn ubc pgk combin rdn ubc pgk refer gene rtqpcr analysi gene express glabrata azol treatment contrast commonli refer gene gapdh ppia rpla tub valid good intern control current model
PLoS One	20507279	2016-06-30	PMC3483271	23144730	thi studi evalu perform maxwel system promega extract influenza viru fluv rna divers sampl compar classic manual method qiaamp kit qiagen extract method sampl analyz realtim rtpcr reveal standard maxwel protocol maxwel good linear precis wide concentr rang higher sensit detect fluv stock suspens manual method compar method maxwel extract rna effici higher rna yield andor fewer pcr inhibitor throat swab bronchoalveolar lavag fluid method perform compar fecal sampl human poultri term threshold cycl valu detect rate maxwel copurifi inhibitor fecal sampl capac system remov inhibitor fecal matrix improv modifi maxwel protocol reduc sampl input elimin falseneg produc maxwel find maxwel system suitabl rna extract multiplesourc sampl diagnosi influenza viral load determin proper reduct start sampl volum improv detect fluv complex matric fece addition system allow flexibl sampl throughput laborsav sampl process risk crosscontamin
J Glob Health	27362358	2010-08-16	PMC3484775	23198121	china progress communic diseas control cdc year establish peopl republ regard remark life expect soar year infant mortal plummet smallpox sexual transmit diseas infect elimin decreas massiv incid result cdc mid china undergo epidemiolog transit year ahead nation econom statu earli success attribut popul mobil mass campaign focu sanit hygien clean water clean deliveri occur despit polit instabl slow econom progress year cultur revolut brought hardship clinic care continu public health program mass communityfund medic scheme establish communitybas health worker peoplefocus approach broke china market reform villag doctor turn privat practic commun fund ceas attent paid rural public health declin cdc reli vertic program success elimin lymphat filariasi child immunis control schistosomiasi tuberculosi demonstr intermitt progress fail strategi relianc support poorest govern health worker collabor addit china laissezfair approach public health great risk evidenc outbreak sever acut respiratori syndrom major chang diseas report prioriti cdc includ major domest resourc reform china health system offer encourag cdc decentr fund vari qualiti diagnosi report treatment infecti diseas remain major challeng nation prioriti cdc china high
PLoS One	27364157	2006-08-15	PMC3485247	23118877	introduct burden influenza ahnpdm north america data exist burden south america method april decemb activ search person sever acut respiratori infect influenzalik ill ili three sentinel citi proport casepati provid swab influenza test estim number casepati test posit influenza multipli number untest casepati proport test posit estim rate divid estim number casepati censu popul adjust proport casepati miss ill onset ili casepati visit physician multipl time ill event estim influenza ahnpdm mortal rate personyear py rang person ag year person ag year ahnpdm hospit rate py rang children ag year person ag year influenza ahnpdm ili rate py rang children ag person ag year influenza ahnpdm deced data obes diabet surviv influenza ahnpdm casepati preexist condit conclus influenza ahnpdm caus burden diseas argentina countri diseas burden suggest potenti time influenza vaccin
PLoS One	20713356	2013-10-23	PMC3486865	23133677	two glycoprotein hemagglutinin ha neuraminidas surfac influenza virus plai crucial role transfaun membran fusion releas progeni virion explor distribut nglycosyl site glycosit glycoprotein collect align amino acid sequenc ha subtyp glycosit locat ha cleavag site fusion peptid strikingli conserv ha subtyp remain glycosit uniqu subtyp conserv glycosit stalk domain delet specif stalk domain sequenc highli conserv glycosit appear top center tetramer global domain glycosit distribut global domain detail investig distribut evolutionari pattern glycosit envelop glycoprotein iv focu hn viru conclud glycosit hn complic ha influenti year
PLoS One	16912115	2009-07-13	PMC3487904	23133587	background serolog studi influenza infect vaccin respons involv microneutr hemagglutin inhibit assai evalu neutral antibodi human avian influenza virus includ hn character lentivir particl pseudotyp hha hpp valid hppbase assai safe altern highthroughput serolog studi bsl facil hha clade rise effici product hpp underli mechan address methodologyfind carri mutat analysi delin molecular determin respons effici packag ha acambodia hcam aanhui hanh hpp demonstr singl av mutat loop receptor bind domain suffici render hanh abil gener hanhpp effici revers va mutat greatli hamper product hcampp protein express total cell lysat hanh hcam cell surfac express hcam detect higher level hanh demonstr independ line evid behaviour hanh explain stronger bind sialic acid receptor implic residu conclus identifi singl av mutat molecular determin hha effici incorpor hpp envelop delin underli mechan reduc bind sialic acid receptor result av mutat exert critic influenc pseudotyp effici hha impact viru level av substitut report natur occur mutat human host implic understand human host adapt avian influenza hn virus
Virol J	24153118	2016-10-25	PMC3487928	22838725	background human metapneumoviru hmpv major acut respiratori infect rang wheez bronchiol pneumonia children worldwid object studi develop visual revers transcript loopmedi isotherm amplif rtlamp assai detect hmpv appli clinic sampl studi visual rtlamp assai hmpv perform step addit hydroxynaphthol blue hnb detect respiratori sampl primer includ outer primer inner primer fip bip loop primer lf lb design hmpv gene onlin softwar rtlamp assai good specif crossreact observ human rhinoviru hrv human respiratori syncyti viru rsv influenza viru apr hn detect limit rtlamp assai ten viral rna copi lower tradit revers transcriptas polymeras chain reaction rtpcr rna copi nasopharyng sampl conform hmpv posit rtlamp posit rtpcr conclus compar convent rtpcr visual hmpv rtlamp assai perform aspect detect time sensit specif visibl anticip rtlamp will clinic test hospit field test outbreak emerg
Virol J	19596899	2015-08-01	PMC3487931	22967434	an outbreak diarrhea pig start guangdong south china januari case character wateri diarrhea dehydr vomit morbid mortal suckl piglet caus agent diarrhea ultim identifi porcin epidem diarrhea viru pedv studi isol pedv strain design chgd piglet intestin vero cell cultur specif cytopath effect confirm suscept cell direct immunofluoresc test electron microscopi complet genom chgd nucleotid length structur pedv refer strain phylogenet analys base genom reveal chgd share nucleotid sequenc ident chines isol report year constitut cluster amino acid sequenc analysi base individu viru gene indic close relationship spike protein gene chgd field strain knu korea orf nucleoprotein gene diverg sequenc pedv isol cluster form group suggest variant pedv isol china studi will requir determin immunogen pathogen variant
Case Rep Med	28979541	2006-08-08	PMC3488377	23193411	we report young girl di streptococcu pneumonia pneumonia septic shock hemolyt urem syndrom despit prior pneumococc vaccin appropri antibiot aggress intens care support serotyp cover valent pneumococc vaccin mycoplasma pneumonia metapneumoviru simultan detect pcr nasopharyng tracheal aspir pneumococcu penicillin sensit infect pathogen typic mild case highlight coinfect tripl respiratori pathogen contribut fatal outcom child polici hong kong pcv help prevent case serotyp infect
Case Rep Pulmonol	26066940	2003-07-28	PMC3488388	23150842	pregnant postpartum women consid popul increas risk hospit hn infect report case young postpartum woman develop evid respiratori failur reach point requir intub hn influenza viru infect dai caesarean deliveri emphas diagnosi manag outcom focus question care provid includ obstetr health care worker diagnost manag strategi pregnant postpartum women novel influenza hn viral infect increas awar patient health care profession result improv surviv
Virol J	16895992	2013-03-13	PMC3489719	22995185	background sublingu sl administr solubl protein antigen inactiv virus viruslik particl induc broad immun respons mucos extramucos tissu recombin replicationdefect adenoviru vector radv infect mucosa surfac serv mucos antigen deliveri vehicl studi examin sl immun radv encod spike protein radv sever acut respiratori syndromeassoci coronaviru sarscov induc protect immun sarscov serv safe mucos rout deliveri radv sl administr radv induc serum sarscov neutral airwai iga antibodi mice antibodi respons compar induc intranas administr addit sl immun induc antigenspecif cd cell respons lung superior induc intramuscular immun importantli administr sl immun radv redirect radv vector olfactori bulb conclus studi indic sl immun radv safe effect induct broad spectrum immun respons presum protect infect sarscov
Respir Res	12885896	2013-07-31	PMC3489803	22992220	asthmat suscept influenza infect mechan mediat enhanc suscept unknown influenza viru hemagglutinin ha protein bind sialic acid residu host cell ha requir cleavag allow fusion viral ha host cell membran mediat host trypsinlik serin proteas data demonstr proteaseantiproteas ratio increas nasal mucosa asthmat chang associ increas proteolyt activ influenza data disrupt proteas balanc asthmat enhanc activ infect influenza viru
Brain Behav	23487457	2007-12-01	PMC3489815	23139908	nicotin acetylcholin receptor alpha express examin develop adult auditori system mice modifi homolog recombin coexpress gfp alphagfp cre alphacr express alphagfp detect embryon dai cell spiral promin sensori region includ put outer hair cell deiter cell express alphagfp solitari effer fiber pattern diminish basal apex progress hensen cell cell spiral ligament acquir alphagfp express birth alphagfp identifi subset spiral ganglion cell process termin inner hair cell effer fiber identifi peripherin calcitonin generel protein coexpress alphagfp addit cochlear structur strong express alphagfp cell central auditori pathwai includ ventral posterior cochlear nucleu later lemniscu central inferior colliculu medial genicul nucleu find alpha express neuron nonneuron cell potenti impact multipl auditori function mechan tradition attribut receptor
BMC Public Health	23903543	2003-12-11	PMC3490743	22935365	background taxat alcohol increasingli common practic countri public health measur hong kong special administr region govern buck trend lower duti wine beer percent in hong kong remov duti alcohol spirit aim paper examin case hong kong histori chang alcohol taxat explor factor driven unpreced polici evolut method base analysi primari document search offici govern document alcoholrel industri materi media report alcohol taxat period systemat carri kei term alcohol tax alcohol industri relev document index topic undertak chronolog themat analysi nvivo softwar analysi demonstr citi chang financi circumst hong kong special administr region govern strong propens econom liber contribut dramat transform alcohol industri lobbi tactic influenc clearli main driver polici decis alcohol industri lobbi tactic twofold forg coalit encompass rang cater trade industri alcohol industryfriendli lawmak likemind actor find common ground pursu chang taxat polici second deliber promot blend idea garner support gener public influenc percept kei polici maker conclus find success aggress industri lobbi coupl absenc robust public health advocaci main drive forc unparallel abolit wine beer duti hong kong strong public health allianc advocaci movement need counteract industri continu aggress lobbi promot alcohol beverag
Virol J	18056295	2012-09-19	PMC3490746	22863531	background hepat steatosi recogn major risk factor liver diseas progress impair respons interferon base therapi chronic hepat chc patient mechan respons interferonalpha ifn therapi condit hepat steatosi unexplor investig hepatocellular steatosi hepat viru hcv replic ifn antivir respons cell cultur model method subgenom replicon sgfp hcv infect huh cell cultur mixtur satur palmit unsatur oleat longchain free fatti acid ffa intracytoplasm fat accumul cell visual nile red stain electron microscopi quantifi microfluorometri ffa treatment hcv replic ifn antivir respons measur flow cytometr analysi renilla luciferas activ realtim rtpcr ffa treatment induc dose depend hepatocellular steatosi lipid droplet accumul hcv replicon cell confirm nile red stain microfluorometri electron microscopi intracellular fat accumul support replic persist hcv infect cultur subgenom replicon sgfp cell ffa treatment partial block ifn respons viral clearanc reduc phosphoryl stat stat depend ifn promot activ ffa treatment induc endoplasm reticulum er stress respons regul ifnar chain type ifn receptor lead defect jakstat signal impair antivir respons conclus intracellular fat accumul hcv cell cultur induc er stress defect jakstat signal attenu antivir respons provid explan clinic observ hepatocellular steatosi influenc ifn respons chc
Proteome Sci	14671103	2011-04-01	PMC3492009	22873815	background porcin reproduct respiratori syndrom prr swine diseas worldwid despit relev serum biomark associ earlyonset viral infect clinic sign detect diseas character weak antivir respons persist infect identifi surfaceenhanc laser desorpt ioniz time flight mass spectrometri selditof ms reproduc accur simpl method identif biomark protein diseas serum work describ selditof ms analys sera prrsvposit prrsvneg measur pcr asymptomat larg white piglet wean sera compar low content hemoglobin gml fraction fraction anionexchang chromatographi protein profil mass rang kda cm imac surfac total peak identifi initi discoveri phase studi confirm valid phase major peak upregul prrsvposit piglet downregul panel discriminatori peak identifi fraction ph surfac cm acquir low focu mass provid serum protein profil diagnost pattern enabl discrimin prrsvposit neg piglet sensit specif conclus selditof ms profil sera prrsvposit prrsvneg asymptomat piglet provid proteom signatur larg scale diagnost potenti earli identif prrsv infect wean piglet selditof protein marker repres refin phenotyp prrsv infect genom associ studi
Virol J	22935026	2013-03-27	PMC3492083	22929207	background transmiss gastroenter tge highli contagi viral diseas swine character sever vomit diarrhea high mortal current vaccin partial effect specif drug treatment tge viru tgev infect rna interfer confirm approach control viral infect studi inhibitori short hairpin rna shrna target orf gene tgev viru replic examin theoret effect sequenc tgev orf gene design select construct shrna express plasmid report assai three shrna express plasmid inhibit express orf gene replic tgev realtim quantit rtpcr analysi viral orf gene detect viru titer tcidml stabl swine testicular st cell express shrna establish observ cytopath apoptosi cell prolifer assai demonstr three shrna capabl protect st cell tgev destruct high specif effici conclus indic plasmidtranscrib shrna target orf gene tgev genom effect inhibit express viral target gene viral replic vitro find provid evid shrna potenti therapeut applic treatment tge
Virol J	21354178	2012-08-09	PMC3492202	23062147	background genu ebolaviru famili filovirida current consist speci speci except reston ebolaviru africa caus sever human diseas bat implic reservoir ebolaviru reston ebolaviru discov philippin ebolaviru speci identifi asia viru preval china unknown find studi develop enzym link immunosorb assai elisa ebolaviru recombin nucleocapsid protein perform serosurveil viru chines bat popul reveal presenc antibodi ebolaviru bat sera sampl confirm western blot analysi conclus knowledg report filoviru infect china
PLoS One	23536651	2018-01-24	PMC3492310	23145096	background gene select provid ecolog conserv issu major histocompat complex mhc class ii gene essenti immun defenc pathogen intracellular virus extracellular helminth origin serosurvei studi namibian cheetah acinonyx juabut reveal higher exposur viral pathogen individu northcentr eastcentr region examin observ differ exposur virus influenc pattern genet variat differenti mhc loci freerang namibian cheetah methodologyprincip find genet variat mhc ii loci assess singlestrand conform polymorph sscp analysi sequenc allel divers differ observ high genet differenti mhc class loci cheetah northcentr eastcentr namibia differenti mhc class ii neutral marker conclusionssignific mhc class variat mirror variat select pressur impos virus freerang cheetah namibian farmland high signific futur manag conserv program speci
Virol J	22879620	2008-02-19	PMC3493341	22971578	background analysi human monoclon antibodi mab develop hiv infect donor enorm contribut identif neutral sensit epitop hiv envelop glycoprotein third variabl region crucial target gp involv coreceptor cxcr ccr bind presenc epitop recogn broadli neutral antibodi method thirtythre hiv seroposit drug naiv patient male femal ag rang year median year recruit studi mab product mab select ebv transform cultur conformation constrain choleratoxinb vc vcctb fusion protein test mab bind hiv deriv protein peptid elisa neutral hiv virus tzmbl assai isol three antiv mab cell individu elisa bind reveal subtypec subtypea specif bind antibodi mab exhibit cross reactiv subtypeb epitop map mab overlap peptid exclus bind crown antibodi displai high low neutral activ tier tier virus observ resist tier virus neutral antiv mab despit exposur epitop recogn antibodi repres nativ virus du jrfl suggest affin mab equal crucial neutral epitop recognit conclus studi suggest antiv antibodi deriv subtypec infect indian patient displai neutral potenti tier virus activ limit resist tier virus defin fine epitop specif mab experiment manipul will help identif epitop uniqu clade share nonclad virus context region
Isr J Health Policy Res	29367253	2012-10-17	PMC3494498	23098065	background decad respond recov type emerg includ mass casualti event mce mass toxicologicalchem event mte biolog event pandem bioterror agent effect emerg prepared achiev allhazard respons plan adopt object investig relationship hospit prepared emerg scenario compon emerg scenario correl prepared emerg scenario method emerg prepared level acutecar hospit mce mte biolog event evalu util structur evalu tool base measur paramet evalu profession expert phase evalu standard oper procedur sop site visit relationship total prepared compon score type emerg analyz relationship prepared emerg standard oper procedur sop biolog event correl prepared investig emerg scenario strong correl train drill prepared investig emerg scenario conclus fundament critic build block sop train drill program improv prepared emerg includ mce mte biolog event build block equip knowledg personnel sop unfamiliar emerg scenario find support adopt allhazard approach emerg prepared
PLoS One	18287023	2018-09-21	PMC3494670	23152833	background human papillomavirus hpv classifi highrisk hpv lowrisk hpv common highrisk hpv type cervic cancer hpv and common lowrisk type caus genit wart hpv hpv studi appli novel allglo fluoresc probe establish quadruplex quantit pcr method simultan detect differenti hpv singl tube method specif sensit detect limit reproduc standard curv method examin final clinic sampl test taqman pcr hpv genoarrai ga test verifi accuraci sensit method assai sensit copiestest linear detect rang copiestest amplif effici hpv correl coeffici standard curv plasmid templat rang copiestest agreement allglo quadruplex quantit pcr hpv ga test taqman uniplex qpcr method conclus allglo quadruplex quantit pcr singl tube advantag high throughput good reproduc high sensit high specif wide linear rang detect conveni singl tube format assai power tool studi mix infect multipl pathogen viral type viral load quantif
Virol J	23077302	2015-09-14	PMC3495767	23006741	background type ii integr membran protein express extracellular envelop form vaccinia viru vacv passiv transfer adirect monoclon antibodi vaccin subunit vaccin confer protect lethal poxviru challeng anim model homolog highli conserv member orthopoxviru genu potenti candid inclus vaccin assai target extracellular envelop viru activ monoclon antibodi direct vacv mabg target conformationdepend epitop interestingli recogn vacv correspond variola homolog bind monkeypox homolog studi util random phage displai librari investig epitop recogn mabg critic facilit celltocel spread vaccinia viru screen linear conform random phage librari phage bind mabg displai consensu motif ceplc disulfid bond form cystein residu requir mabg bind phage motif contain linear sequenc homolog vacv structur model analysi suggest residu form minim epitop core panel point mutant express ectodomain protein gener analyz bind assai elisa immunoprecipit function assess block mabg mediat comet inhibit cell cultur conclus confirm compon mabg bind epitop identifi essenti residu defin minimum conform structur conform arrang short peptid sequenc recogn mabg introduc possibl design small molecul mimet interfer function vivo will design improv assai evalu potenc monoclon polyclon product target amodul ev dissemin
Viruses	30242123	2006-02-10	PMC3497033	23202445	virus modul number host biolog respons includ cell cycl favor replic studi develop highcont imag hci assai measur dna content identifi phase cell cycl investig potenti effect cell cycl arrest ebola viru ebov infect cell arrest phase serum starvat gs phase aphidicolin gm phase nocodazol reduc ebov infect compar untreat control releas cell serum starvat aphidicolin block timedepend increas percentag ebov infect cell ebov infect cell cycl progress celltyp depend infect asynchron mcfa cell ebov reduc number cell gm phase concomit increas cell phase effect observ hela cell studi ebov requir activ prolifer cell effici replic multiplex hci base assai detect viral infect cell cycl statu phenotyp chang singl cell popul will provid screen campaign sirna small molecul therapeut
Viruses	26371245	2017-09-01	PMC3497034	23202446	in report filoviru hemorrhag fever outbreak place germani yugoslavia caus agent identifi outbreak marburg viru deadli human pathogen articl comprehens overview current knowledg marburg viru diseas rang ecolog pathogenesi molecular biologi
Viruses	16474129	2017-08-29	PMC3497040	23202452	lassa viru arenaviru famili arenavirida etiolog agent lassa fever sever human diseas report patient annual endem region west africa mortal rate hospit patient vari current approv vaccin lassa fever human review publish literatur life cycl lassa viru specif focu lassa fever pathogenesi human relev anim model advanc knowledg improv understand lassa viru biologi mechan allow viru evad host immun system investig requir order design improv diagnost tool effect vaccin therapeut agent
Viruses	29861509	2012-11-19	PMC3497043	23202455	the famili arenavirida genu arenaviru consist phylogenet independ group ow nw complex lassa lujo virus ow complex guanarito junin machupo sabia chapar virus nw complex viral hemorrhag fever vhf human lead seriou public health concern virus consid potenti bioterror agent great detect pathogen rapidli order minim risk scale arenaviru outbreak arenavirus classifi bsl pathogen make difficult develop diagnost techniqu viru infect institut bsl facil overcom difficulti antibodi detect system form enzymelink immunosorb assai elisa indirect immunofluoresc assai develop recombin nucleoprotein rnp deriv virus antigendetect assai develop exampl novel monoclon antibodi mab rnp lassa junin virus gener sandwich antigencaptur agcaptur elisa mab captur antibodi develop confirm sensit specif detect respect arenaviru np rnpbase assai propos etiolog diagnosi vhf seroepidemiolog studi vhf develop arenaviru neutral assai vesicular stomat viru vsvbase pseudotyp bear arenaviru recombin glycoprotein goal articl review advanc develop laboratori diagnost assai base recombin viral protein diagnosi vhf epidemiolog studi vhf caus arenavirus
Viruses	28851744	2012-08-15	PMC3497045	23202457	arenavirus merit interest famili member etiolog agent sever hemorrhag fever repres major burden public health current fdalicens vaccin arenavirus antivir therapi limit ribavirin partial effect arenaviru nucleoprotein np associ genom rna form viral ribonucleoprotein vrnp polymeras direct viral replic transcript virion format requir recruit vrnp bud site process arenaviru matrixlik protein plai major role proper npnp npz interact requir gener infecti progeni work demonstr role amino acid residu selfassoci lymphocyt choriomening viru nucleoprotein lcmvnp amino acid substitut posit abrog np oligomer abil mediat replic transcript minigenom report plasmid abil interact protein counteract cellular interferon respons bind dsrna analog retain addition document domin neg dg mutat viral infect suggest np selfassoci excel target develop antivir arenavirus
Viruses	23166259	2005-03-28	PMC3497051	23202463	infect hepat viru hcv lead risk factor chronic liver diseas progress includ steatosi cirrhosi hepatocellular carcinoma human popul infect worldwid hcv infect remain global public health challeng efficaci current therapi limit patient infect hcv greater understand pathogenesi hcv infect desper need emerg line evid indic hcv trigger wide rang cellular stress respons includ cell cycl arrest apoptosi endoplasm reticulum er stressunfold protein respons upr autophagi studi hcvinduc cellular respons contribut chronic liver diseas modul cell prolifer alter lipid metabol potenti oncogen pathwai molecular mechan underli hcv infect pathogenesi chronic liver diseas remain determin review stress respons activ hcv infect vitro vivo explor relationship varieti cellular respons pathogen hcvassoci diseas comprehens knowledg hcvmediat diseas progress insight discoveri novel therapeut target develop intervent strategi
Int J Mol Sci	22896611	2015-04-02	PMC3497300	23202926	fragmentbas drug discoveri fbdd concern screen lowmolecular weight compound macromolecular target clinic relev compound start point develop drug fbdd evolv grown popular year paper rational technolog xrai crystallographi fragment base screen fb will describ includ fragment librari design synchrotron radiat robot highthroughput xrai data collect crystallographi fb will describ detail includ interrog drug target secretas phenylethanolamin nmethyltransferas phosphodiesteras hsp exampl provid illustr project crystallographi straightforward difficult screen method help overcom limit crystallographi necessit diffract qualiti
Int J Mol Sci	15795262	2007-08-13	PMC3497335	23202961	multipl sclerosi clinic featur patholog correl describ charcot chronic neuroinflammatori diseas unknown etiolog variabl clinic evolut neuroinflamm descript denomin multipl sclerosi base histopatholog observ penetr leukocyt central nervou system clinic symptom relaps remiss progress paralysi result loss myelin neuron absenc etiolog factor target prevent therapi definit molecular mechan form basi inflamm demyelin toxic neuron led number treatment slow diseas progress specif patient cohort cure diseas current therapi direct block immun process innat adapt associ multipl sclerosi review analyz role cytokin multipl sclerosi pathogenesi currentfutur treatment multipl sclerosi
Int J Mol Sci	25838371	2019-05-01	PMC3497352	23202978	epsteinbarr viru ebv associ nasopharyng carcinoma npc remain obscur ebv viral accompani npc will discuss accumul evid point relationship ebv infect npc initi epidemiolog pathogen molecular oncogen experiment anim studi convinc evid perspect provid ascertain causal role ebv infect npc epidemiolog studi reveal ebv infect risk factor introduct ebv anim model produc npc anim model npc main molecular event involv signal pathwai ident human npc final importantli prevent ebv infect clearanc ebv infect individu reduc incid rate npc
PLoS One	17690221	2016-05-11	PMC3498275	23155387	background the time collect diagnost biosampl symptomat episod repres major obstacl largescal studi acut respiratori infect ari epidemiolog circumv particip collect nasal swab compar staffcollect swab term swab qualiti detect viral respiratori pathogen methodologyprincip find conduct prospect studi employe institut ari season decembermarch weekli email particip remind to studi center case symptom particip selfcollect anterior nasal swab nostril train studi personnel collect nostril particip selfcollect swab nostril subsequ dai human actin dna concentr determin swab qualiti control viral respiratori pathogen detect multiplex rtpcr seeplex rv kit seegen eschborn germani particip report ari episod particip particip three selfswab highli accept particip amount actin dna swab higher the staffcollect swab actin concentr lower selfswab collect dai collect subsequ dai respiratori viral pathogen detect staff selfcollect swab approach frequent identifi pathogen human rhinovirus abc swab human coronaviru oc swab perfect agreement staffcollect swab term pathogen detect agreement kappa conclusionssignific nasal selfswab identif viral ari pathogen prove equival staffswab popul term accept pathogen detect
Open Biol	31043527	2014-05-22	PMC3498833	23155484	program ribosom frameshift express viru gene cellular gene eukaryot system wellcharacter mechan involv tandem trna slippag xxxyyyz motif contrast mechan involv program slippag vari character novel gene pax discov influenza viru express shift read frame identifi mass spectrometr analysi site uccuuucgu direct frameshift involv pax express site identifi viru gene propos express frameshift virus infect insect chronic bee paralysi viru plant fijivirus amalgamavirus vertebr influenza viru motif form class frameshiftinduc sequenc activ divers eukaryot
Virol J	27166578	2004-11-01	PMC3499178	23043930	background requisit quantit revers transcript pcr qrtpcr normalis data intern refer gene invari treatment viru infect studi variabl express commonli housekeep gene betaactin actb glyceraldehydephosph dehydrogenas gapdh experiment set actb gapdh remain studi host gene respons viru infect includ influenza virus detail studi describ compar suitabl commonli housekeep gene influenza viru infect studi evalu commonli housekeep gene actb gapdh ribosom rna rrna atp synthas transport mitochondri complex beta polypeptid atpb atp synthas transport mitochondri fo complex subunit subunit atpg identifi stabli express gene human pig chicken duck cell infect rang influenza viru subtyp rel express stabil commonli housekeep gene determin primari human bronchial epitheli cell hbec pig tracheal epitheli cell ptec chicken duck primari lungderiv cell infect influenza viru subtyp analysi qrtpcr data viru mock infect cell normfind bestkeep softwar programm rrna stabl gene hbec ptec avian lung cell conclus base present data cell cultur model hbec ptec chicken duck lung cell infect rang influenza virus rrna stabl refer gene normalis qrtpcr data express level housekeep gene evalu studi includ actb gpadh highli influenza viru infect reliabl refer gene rna normalis
PLoS One	24855065	2015-02-01	PMC3499507	23166591	the transactiv tat protein viral regulatori protein essenti hiv replic tat traffick nucleoplasm nucleolu nucleolu highli dynam structur membraneless subnuclear compart site rrna ribosom biogenesi involv numer cellular function includ transcript regul cell cycl control viral infect importantli transient nucleolar traffick tat hiv viral transcript critic hiv replic role nucleolu hiv replic remain unclear better understand interact tat nucleolar machineri contribut hiv pathogenesi investig quantit chang composit nucleolar proteom jurkat tcell stabli express hiv tat fuse tap tag organellar proteom approach base mass spectrometri coupl stabl isotop label cell cultur silac quantifi protein includ protein show chang abund jurkat tcell nucleolu tat express numer protein exhibit fold chang characteris tat interactor andor critic hiv replic suggest spatial control subcellular compartimentali cellular cofactor tat provid addit layer control regul cellular machineri involv hiv pathogenesi pathwai analysi network reconstruct reveal tat express nucleolar enrich protein collect particip ribosom biogenesi protein homeostasi metabol pathwai includ glycolyt pentos phosphat nucleotid amino acid biosynthet pathwai stress respons tcell signal pathwai genom integr differenti profil nucleolar proteom tcell express hiv tat discuss protein collect particip interconnect network converg adapt nucleolu dynam activ favor host biosynthet activ contribut creat cellular environ support robust hiv product
PLoS One	15496687	2013-02-20	PMC3499540	23166619	the translocon endoplasm reticulum er membran form aqueou pore allow polypeptid transfer integr membran protein transloc er occur posttranslation yeast posttransl transloc involv heptamer translocas complex includ secp secp subunit mammalian er membran ortholog yeast secp secp function understood analyz effect excess deficit er cargo human cell cultur system overexpress reduc steadyst level viral cellular multispan membran protein cotransl mode solubl singlespan er report consist knockdown increas steadyst pool polytop er protein suggest substratespecif regulatori function er import overexpress exert downregul activ polytop protein level independ secinteract motif indic conjunct human cell specif action sustain observ upregul er protein lumen domain erdj erdj compromis steadyst level multispan membran report domainspecif mutat propos weaken interact er resid bip chaperon reduc downregul capac excess suggest involv bip process perform substrateselect quantiti control function cotransl er import
Front Microbiol	25485794	2008-04-16	PMC3499792	23162545	virus manipul cellular machineri ensur continu surviv parasit live organ delin sophist host respons viru infect challeng task li identifi repertoir host factor activ involv viral infecti cycl character host respons qualit quantit viral pathogenesi mass spectrometri base proteom effici studi pathogenhost interact virushijack cellular signal pathwai direct host viral respons infect investig activitybas function valid studi approach involv drug inhibit secretori pathwai immunofluoresc stain domin neg mutant protein target realtim pcr small interf sirnamedi knockdown molecular clone studi function valid gain novel insight highcont proteom dataset unbias comprehens wai
Viruses	23427150	2012-03-07	PMC3499819	23170172	bacteriophag abund entiti aquat environ knowledg ecolog limit fecal sourcetrack studi genet novel levivirida strain discov novel strain isol coastal water apart north carolina rhode island usa strain share nucleotid similar amino acid similar novel strain compar leviviru genogroup strain share similar matur capsid lysi protein rnadepend rna polymeras gene bioinformat analys suggest recombin event occur best knowledg descript viral recombin environment levivirida ssrna bacteriophag
Viruses	18417581	2012-08-06	PMC3499821	23170174	health program target popul gabon equatori africa intern center medic francevil cirmf gabon evolv year incept in emerg diseas reemerg ebola viru central africa cirmf emerg viral diseas unit develop diagnost tool epidemiolog strategi transfer technolog support respons nation public health system health organ epidem ebola viru diseas unit carri uniqu investig program natur histori filovirus emerg epidem ebola viru pathogenesi addit academ train provid level region intern student cover emerg condit host factor molecular biologi genet favor spread viral diseas
Viruses	22398294	2018-11-22	PMC3499823	23170176	virus famili filovirida repres health risk emerg infecti diseas engin biothreat effort publish offer possibl mitig filovir infect remain sanction therapeut vaccin strategi current progress develop filoviru therapeut vaccin outlin respect current level test evalu proxim human implement regard human clinic trial nonhuman primat studi small anim studi vitro develop contemporari method support care previou treatment approach human patient discuss
Viruses	22869577	2013-08-30	PMC3499828	23170181	the immun respons viral pathogen caus chronic infect ineffect notwithstand robust humor neutral respons evas mechan capabl subvert activ neutral antibodi nab describ elicit nonneutr interf ab hypothes evas mechan acquir increas interest impact novel nabbas antivir therapeut prophylact approach review illustr mechan abmedi interfer viral pathogen describ literatur adopt novel evas strategi
PLoS One	30375075	2013-10-01	PMC3500305	23166682	backgroundobject describ transmiss paramet pandem divers geograph site remain critic plan respons futur outbreak character transmiss influenza ahnpdm phn south africa estim serial interv si initi effect reproduct number initi tempor variat method data central registri phn laboratoryconfirm case detect south africa symptom onset miss estim specimen collect multipl imput approach repeat time miss appli likelihoodbas method method simultan estim initi si estim initi si distribut establish prior field studi method wallinga teuni method method model tempor variat confirm phn case report central registri period exponenti growth epidem june august simultan estim ci si dai ci method field studi si dai primari case laboratoryconfirm secondari case dai consid suspect confirm secondari case incorpor si estim field studi laboratoryconfirm case initi ci method peak ci june epidem commenc sustain august method conclus transmiss characterist phn south africa estim report countri africa estim likelihoodbas method agreement field find
Front Genet	23997214	2010-02-01	PMC3500957	23181069	frameshift main mechan genom insert delet indel program ribosom frameshift indel disrupt normal protein function program ribosom frameshift result dualcod gene produc multipl function product summar technic advanc identifi program ribosom frameshift event systemat studi frameshift occur genom will discuss method help character altern proteom
Isr J Health Policy Res	23948771	2014-03-03	PMC3502095	23098101	in paper appear issu adini al describ struggl familiar emerg plannersth challeng plan scenario author contend allhazard capabilitiesbas plan set core capabl applic numer type event develop effici achiev gener health care system emerg prepared scenariobas plan essenti core plan respond kind disast biolog event plan respond type disast allow improv plan maxim effici adini al advanc scienc health care emerg prepared consider measur assess prepared shorter set valid prepared measur support dual goal account improv outcom provid basi determin action prepared matter
BMC Res Notes	19797223	2013-01-09	PMC3502135	22830499	background ascertain understand pandem hn influenza relev infect control measur emerg depart popul assess effect educ campaign inform public pandem method questionnair administ patient visitor nonclin staff volunt data collect knowledg prevent measur sourc attitud govern media report perceiv serious behaviour chang intend complianc futur measur construct knowledg score particip tradit form mass media remain princip sourc accur describ mode transmiss recommend precaut report behaviour chang pandem gap knowledg includ failur identifi high risk group recal govern campaign associ higher knowledg score thought author media exagger threat compli recommend measur futur pandem conclus knowledg pandem influenza high popul posit offici campaign pandem plan address knowledg gap impress author exagger publichealth threat
Virol J	24591597	2017-06-01	PMC3502331	22978358	background bovin herpesviru type bhv pathogen cattl respons substanti econom loss previou studi bhv induc apoptosi madindarbi bovin kidnei mdbk cell mechan involv caspas mechan bhvinduc mdbk cell apoptosi requir method mdbk model studi precis signal pathwai apoptosi induc bhv infect bhv infect activ fasfaslmedi apoptot pathwai activ caspas cleavag bid addit bhv infect downregul bcl upregul bax express initi releas cytochrom caspas activ combin activ extrins intrins pathwai activ downstream effect caspas poli adpribos polymeras parp lead apoptosi block apoptosi caspas inhibitor improv bhvinfect mdbk cell viabil extent bhv infect induc dna fragment mdbk cell pretreat ammonium chlorid nhcl cell infect uvinactiv bhv block caspas activ increas bhv replic conclus bhv induc apoptosi mdbk cell extrins intrins pathwai crosstalk pathwai addit bhv replic induct apoptosi bhvinfect cell prolong cell viabil benefit bhv replic
J Infect Dis	23303501	2011-02-07	PMC3502370	23169974	background influenza data gap subsaharan africa includ incid case fatal season pattern associ preval disord method nasopharyng sampl children ag year admit kilifi district hospit sever sever pneumonia resid local demograph surveil system screen influenza virus molecular method outpati children provid compar data admiss influenza viru infect diagnos influenza viru infect influenza viru infect test patient influenza di outpati acut respiratori infect acut respiratori infect influenza posit annual incid sever sever pneumonia influenza type influenza case year ag peak occurr quarter year case involv infant tempor associ bacteremia absent hypoxia frequent pneumonia case involv influenza odd ratio confid interv influenza viru subtyp season hn season hn pandem hn conclus burden influenza small pediatr hospit kenya influenza viru subtyp hn predomin pandem influenza viru subtyp hn impact
Virol J	28592496	2010-03-10	PMC3502403	22998755	a coloni domest rabbit tennesse usa experienc highmort outbreak enterocol clinic characterist dai lethargi bloat diarrhea death heavi intestin coccidi load consist find mucoid enteropathi cecal impact preliminari analysi electron microscopi reveal presenc viruslik particl stool rabbit analysi virochip viral detect microarrai suggest presenc astroviru followup pcr sequenc determin reveal uncharacter member famili metagenom sequenc enabl recoveri complet viral genom characterist attribut astroviru genom attempt propag viru tissu cultur succe astrovirus gastroenter diseas mammal pathogen viru relationship outbreak remain determin studi defin viral speci potenti rabbit pathogen
Virol J	21300837	2017-02-01	PMC3502414	22992336	background infecti bronchiti viru ibv gammacoronaviru famili coronavirida caus agent econom diseas poultri spike glycoprotein ibv essenti host cell attach neutral involv induct protect immun sequenc data spike gene ibv qxlike massachusett strain subject bioinformat analysi find analysi potenti phosphoryl site ser ser site massachusett strain qxlike isol ser site massachusett qxlike strain cleavag site motif nglycosyl site asnxaaserthr addition qxlike strain leucinerich repeat region massachusett strain consist stretch amino acid qxlike strain contain amino acid length addit palmitoyl site observ ckswe qxlike strain primari structur data differ physic properti hydrophob natur genotyp comparison secondari structur reveal structur domain genotyp variant phylogenet analys base avian mammalian coronavirus analys ibv close turkei coronavirus distantli thrush munia coronavirus conclus studi demonstr spike glycoprotein massachusett qxlike variant ibv molecularli distinct reflect differ behavior virus vivo
BMC Immunol	20220170	2012-09-12	PMC3503649	23013063	background despit develop system gener live recombin salmonella typhimurium vaccin strain work perform systemat evalu compar rel immunogen provid invalu guidanc futur ration design live recombin salmonella oral vaccin result compar vaccin strain encod antigen deliveri express strategi seri recombin salmonella typhimurium strain construct express enhanc green fluoresc protein egfp fragment hemagglutinin ha protein hn influenza viru model antigen antigen express chromosom high lowcopi plasmid encod eukaryot express plasmid antigen target express cytoplasm outer membran combin strategi emploi evalu efficaci combin deliveryexpress approach investig vitro vivo antigen express growth infect abil immunogen construct recombin salmonella strain evalu mice solubl model antigen egfp indic vaccin strain high stabl antigen express exhibit high cell respons whilst eukaryot express colon good construct stabil critic cell respons insolubl model antigen ha outer membran express strategi induc better cell cell respons cytoplasm strategi notabl combin express strategi increas immun respons elicit conclus systemat evalu compar immunogen construct recombin salmonella strain mice identifi respect advantag deleteri synergist effect construct strategi optimallyrequir solubl versu insolubl form protein antigen antigen egfp solubl express high level lowcopi plasmidcytoplasm express strategi recommend provok highest cell respons induc good cell respons cell respons prefer eukaryot express plasmid chromosomebas cytoplasmicexpress strategi effect insolubl antigen ha outer membran express strategi recommend
BMC Gastroenterol	28148787	2013-09-11	PMC3503792	23122361	background oral lichen planu olp frequent patient hepat viru hcv infect aim studi evalu occurr oral candidiasi mucos lesion xerostomia interferon ifn therapi hcv infect method patient hcvinfect liver diseas treat ifn therapi hospit ag year attend receiv administr ifn week identifi examin candida infect oral lesion measur salivari flow serolog assai carri cultur candida tongu surfac posit patient hcv infect ifn therapi albican common speci isol incid candida treatment ifn increas treatment addit oral mucos lesion observ patient olp three angular cheiliti three recurr aphthou stomat olp occur patient treatment ifn treatment treatment oral lesion treat topic steroid compar characterist patient candida detect ifn therapi group patient candida detect ifn therapi group preval oral mucos lesion incid extern steroid group higher group averag bodi weight group decreas compar group salivari flow decreas subject cours ifn treatment return month treatment group level albumin the month ifn administr lower group multivari analysi factor presenc oral mucos lesion associ detect candida adjust odd ratio factor confid interv conclus pai attent oral candidiasi oral mucos lesion patient weight loss ifn treatment
PLoS One	22973042	2004-03-16	PMC3503966	23185609	immun sera convalesc patient effect treatment patient infect sever acut respiratori syndrom viru sarscov make passiv immun therapi human monoclon antibodi attract treatment strategi sar xenomous amgen british columbia produc panel neutral human monoclon antibodi hmab bind ectodomain sarscov spike glycoprotein hmab domain specif studi describ non bind neutral hmab bind conserv domain protein specif hmab specif hmab neutral pseudotyp virus express protein receptor bind domain sequenc clinic isol data indic hmab bind conserv region protein suitabl confer protect wide rang sarscov variant implic gener therapeut antibodi subunit vaccin envelop virus
PLoS One	24027329	2010-02-24	PMC3504085	23185456	background gp protein avian reticuloendotheliosisassoci viru reva envelop glycoprotein respons induc protect antibodi immun respons anim bcell epitop gp protein rev studi report method studi describ identif linear bcell epitop gp protein screen phagedisplai mer random peptid librari neutral monoclon antibodi mab ae direct gp mab ae recogn phage displai peptid consensu motif svqyhpl amino acid sequenc motif exactli match svqyhpl gp identif displai cell epitop conduct set truncat peptid express gst fusion protein western blot indic svqyhpl minim determin linear cell epitop recogn mab ae amino acid peptid svqyhpla proven minim unit epitop maxim bind activ mab ae revaposit chicken serum react minim linear epitop western blot reveal the amino acid epitop antibodyepitop bind activ epitop common motif share reva member rev group conclus signific identifi svqyhpl gpspecif linear bcell epitop recogn neutral mab ae studi potenti applic develop diagnost techniqu epitopebas marker vaccin reva virus rev group
PLoS One	15023903	2009-05-01	PMC3504146	23185364	background entri sever acut respiratori syndrom coronaviru sarscov envelop fusion host cell membran control seri complex molecular mechan depend viral envelop glycoprotein spike unknown implic cellular factor regul entri process methodologyprincip find perform yeast twohybrid screen bait carboxytermin endodomain face cytosol open fusion pore earli stage viru life cycl ezrin membraneactin linker interact endodomain lobe ferm domain carboxytermin aminoacid membraneproxim cystein cluster endodomain interact vitro interestingli ezrin site entri spseudotyp lentivir particl vero cell target ezrin function small interf rna increas smediat entri pseudotyp particl epitheli cell delet carboxytermin amino acid enhanc spseudotyp particl infect express ezrin domin neg ferm domain enhanc cell suscept infect sarscov spseudotyp particl potenti sdepend membran fusion conclusionssignific ezrin interact sarscov endodomain limit viru entri fusion data novel mechan involv cellular factor regul sdepend earli event infect
Case Rep Transplant	20181718	2015-01-01	PMC3505633	23213611	human metapneumoviru hmpv emerg sever respiratori tract infect immunocompromis patient hmpv pneumonia seldom report nonpulmonari solid organ transplant patient renal transplant recipi report case yearold patient present fever cough interstiti opac ct scan diagnos nonsever hmpv pneumonia year renal transplant infect resolv spontan differenti diagnosi pneumocysti pneumonia discuss review medic literatur discuss clinic present detect method propos solid organ transplant recipi
BMC Biochem	19387084	2012-02-17	PMC3506457	22590978	background nuclear factor kappa nfb kei transcript factor plai crucial role host surviv infect pathogen prioriti pathogen manipul cellular nfb activ order creat favor environ surviv insid host observ heterolog express open read frame orf protein human hepatoma cell led stabil cellular kappa alpha ib pool concomit reduct nuclear local subunit nfb inhibit nfb activ basal tpa induc phosphoryl ib alter ubiquitin markedli reduc orf express cell analysi reveal orf protein directli associ fbox protein beta transducin repeat protein trcp orf express reduc associ ib skp cul compon scftrcp complex chromatin immunoprecipit chip assai proxim promot region mhci heavi chain il gene antibodi lp stimul orf express cell extract reveal decreas associ region indic orf inhibit bind endogen promot conclus report mechan orf protein hev inhibit host cell nfb activ cours viral infect
PLoS One	26279987	2013-11-06	PMC3506642	23189161	in decad search vaccin canin viscer leishmaniasi intensifi pattern immun protect long period experiment infect vaccin trial fulli understood investig immunogen parasitolog level intraderm challeng leishmania infantum salivari gland extract dog immun vaccin compos braziliensi antigen saponin adjuv lbsap vaccin lbsap vaccin elicit higher level total antileishmania igg igg igg dog vaccin increas level lymphocyt circul cell cd cd cd lymphocyt lbsap elicit intens vitro cell prolifer associ higher level cd lymphocyt specif vaccin solubl antigen solubl lysat infantum antigen dai experiment challeng lbsap vaccin dog present high ifn low il tgf express spleen reduct parasit load tissu valid potenti lbsap vaccin protect infantum experiment infect support evalu effici lbsap cvl natur infect condit
Theor Biol Med Model	22345665	2005-01-28	PMC3507676	23062055	background hn influenza viru circul human popul year manifest pandem initi mortal extrem high drop exponenti time influenza virus high mutat rate hn undergon genet chang exact natur hn mutat accumul time fulli explor method comprehens histor analysi mutat chang hn examin fullysequenc hn genom allow examin genet chang aris hn document multipl extinct event includ extinct human hn lineag appar second extinct human hn lineag extinct appear to continu accumul mutat time disappear human hn lineag accumul point mutat genom includ nonsynonym chang codon accumul point mutat nonsynonym amino acid chang occur constant rate mutationsyear mutat accumul uniformli entir influenza genom observ continu eros time codonspecif hn includ shift host human swine bird duck codon prefer pattern conclus numer adapt hn genom genet chang document appear nonadapt chang appear degen hn undergo natur genet attenu attenu occur singl pandem process plai role natur pandem cessat contribut exponenti declin mortal rate time major human influenza strain find relev develop strategi manag influenza pandem strain evolut
J Clin Bioinforma	24026469	2007-09-12	PMC3508620	22472218	background domain swap novel structur phenomenon observ divers set protein structur oligomer conform distinct structur featur structur segment protein dimer higher oligom share chain protein structur character domain swap domain swap observ kei mediat numer function mechan plai pathogen role diseas includ conform diseas amyloidosi alzheim diseas parkinson diseas prion diseas report studi focu identifi function class pathwai diseas mediat domain swap human proteom method panel enrich tool ontolog annot databas deriv biolog clinic relev associ domain swap protein domain enrich analysi gene ontolog term enrich analysi reveal function repertoir protein involv swap pathwai analysi kegg annot reveal divers pathwai associ human protein involv domain swap diseas ontolog find statist associ protein swap conform diseas categori pvalu report metaanalysi literaturecur dataset human gene product involv domain swap discuss insight function repertoir pathwai associ diseas implic protein involv domain swap conclus integr bioinformat pipelin compris enrich tool ontolog annot reveal insight function diseas correl domain swap term enrich infer term associ three categori protein domain enrich identifi conserv domain enrich swap protein pathwai enrich analysi kegg annot reveal protein swap conform class kegg brite hierarchi enrich kegg pathwai observ class major class diseas associ domain swap function diseas ontolog base enrich analysi class human diseas cancer diseas respiratori pulmonari system degen diseas central nervou system vascular diseas enceph conclus studi bioinformat base analyt approach curat data enhanc understand function diseas implic domain swap
Virol J	15681462	2010-04-28	PMC3508965	22920192	background incid phe pig countri rise caus great econom loss pig industri develop sensit specif easilyperform assai crucial rapid detect surveil phecov infect transmiss immunochromatograph strip develop detect phecov colloid goldlabel mab detect reagent mab goat antimous igg coat strip test control line immunochromatograph strip capabl detect phecov ha unit min storag strip room temperatur month month chang sensit specif rtpcr refer test rel specif sensit immunochromatograph strip determin excel agreement rtpcr immunochromatograph strip kappa addition strong agreement sandwich enzymelink immunosorb assai elisa immunochromatograph strip kappa immunochromatograph strip diagnos phecov infect jilin provinc phecovposit rate rang jilin district songyuan district conclus base high specif sensit stabil immunochromatograph strip suitabl onsit detect phecov surveil epidemiolog purpos
BMC Public Health	17855553	2018-08-20	PMC3508974	23127166	background influenza surveil system allow identif true burden ill caus influenza commun restrict consult case studi conduct estim incid burden selfdefin influenza describ healthcar seek behavior selfdefin influenza ahn pandem french popul method conduct randombas retrospect crosssect telephon survei april random sampl french popul peopl includ episod selfdefin influenza report annual incid selfdefin influenza estim case inhabit ci ci case consult physician ci face mask recommend ci peopl survei report wash hand pandem season posit associ vaccin ahn influenza women child year live big citi inhabit conclus selfdefin influenza burden ill french popul frequent consult allow accur interpret influenza surveil data opportun adapt futur health educ messag
Front Cell Infect Microbiol	20427526	2015-02-19	PMC3509329	23226686	the mode infect transmiss profound implic effect contain public health intervent mode smallpox transmiss conclus establish respiratori droplet transmiss gener regard primari mode transmiss rel larg ballist droplet fine particl aerosol remain suspend air second resolv review examin evid histori variol data mucos infect collect decad smallpox transmiss aerosol measur anim model report smallpox lung healthcar worker epidemiolog smallpox potenti fine particl aerosol mediat transmiss introduc term anisotrop infect describ behavior variola major rout infect appear alter sever diseas
Viruses	30126896	2012-12-01	PMC3509667	23202499	the ki nephropathogen kii genotyp infecti bronchiti viru ibv isol korea commerci inactiv oilemuls vaccin kii type massachusett strain field genom analys korean ibv strain anim model test pathogen korean ibv reproduct organ rare studi compar genom snu ki type ibv perform anim model test pathogen snu establish appli vaccin efficaci test genom size snu nt nt nucleotid amino acid ident gene lower gene recombin analysi reveal snu recombin viru kmlike backbon gene unknown viru snu infect inhibit format hierarch ovarian follicl oviduct matur control group vaccin chicken protect lesion
Viruses	25697341	2012-09-19	PMC3509668	23202500	felin leukemia viru felv felin immunodefici viru fiv retrovirus global impact health domest cat virus differ potenti diseas felv pathogen long consid respons clinic syndrom agent cat felv tumor lymphoma bone marrow suppress syndrom anemia lead secondari infecti diseas caus suppress effect viru bone marrow immun system todai felv commonli diagnos previou year preval decreas countri felv underestim regress infect cat neg routin felv test develop clinic sign fiv acquir immunodefici syndrom increas risk opportunist infect neurolog diseas tumor natur infect cat fiv sever clinic sign fivinfect cat live year health problem articl review clinic syndrom progress regress felvinfect cat fivinfect cat
Viruses	22981627	2014-08-27	PMC3509671	23202503	we investig proport mono mix infect human metapneumoviru hmpv compar adenoviru adv type coronaviru crv parainfluenza viru piv rsv enterovirusrhinoviru erv alberta canada data integr alberta laboratori dial platform respiratori specimen provlab juli june select includ studi respiratori viru panel specimen test posit respiratori viru neg influenza subset hmpv fourth common viru identifi mix infect dial mix infect hmpv commonli infant month erv commonli mix infect hmpv ag group proport mixedinfect monoinfect highest adv crv crv hku crv nl crv oc piv rsv hmpv erv hmpv identifi mono infect compar adv crv piv rsv except erv p
Viruses	22993152	2014-04-15	PMC3509677	23202509	a respiratori diseas caus novel coronaviru term sever acut respiratori syndrom coronaviru sarscov report china late subsequ effici humantohuman transmiss viru eventu countri worldwid mortal rate of infect individu spread viru ultim control isol infect individu infect report april natur reservoir viru identifi viru will reemerg viru continu sarscov genom kb length predict function open read frame orf genom encod protein homolog coronaviru protein replicas protein orf major structur protein nucleocapsid spike membran envelop sarscov encod uniqu protein call accessori protein homologu review will summar current knowledg sarscov accessori protein will includ express process ii effect cellular process iii function studi
Viruses	25165103	2013-08-05	PMC3509683	23202515	the coronavirida famili envelop rna viru famili human coronavirus hcov histor respons larg portion common cold upper respiratori tract infect hcov involv seriou respiratori diseas bronchiti bronchiol pneumonia young children neonat elderli peopl immunosuppress patient involv nosocomi viral infect outbreak sever acut respiratori syndrom sar newli discov coronaviru sarsassoci coronaviru sarscov led awar medic coronavirida famili pathogen respons emerg diseas human high risk fatal outcom underlin press approach manag infect prevent interest featur coronavirus potenti environment resist despit accept fragil envelop virus studi describ abil hcov hcov hcov oc betacoronaviru nl hku sarscov surviv environment condit temperatur humid support hospit set aluminum steril spong latex surgic glove biolog fluid final account persist lack specif antivir treatment fact specif treatment fight coronavirus infect coronavirida specif pathogen potenti environment resist challeng model develop effici prevent adapt antisepsisdisinfect prevent environment spread infect agent review will summar current knowledg capac human coronavirus surviv environ efficaci wellknown antisepticdisinfect focu develop methodolog evalu activ antisepticdisinfect virus
Viruses	27358855	2011-03-23	PMC3509692	23202524	coronavirus positivestrand rna virus infecti agent anim human common featur positivestrand rna virus assembl replicationtranscript complex associ cytoplasm membran infect coronavirus extens rearrang cellular membran organellelik replic structur consist doublemembran vesicl convolut membran nonstructur protein involv rna synthesi local doublestrand rna presum function replic intermedi viral rna synthesi detect doublemembran vesicl interior studi provid insight assembl function coronaviru replic structur review will summar current knowledg biogenesi replic structur membran anchor replicationtranscript complex locat viral rna synthesi focu dynam coronaviru replic structur individu replicationassoci protein
PLoS Pathog	23918354	2002-01-01	PMC3510238	23209401	chronic infect repres continu battl host immun system pathogen replic protozoan parasit evolv cyst lifecycl stage increas protect environment degrad endogen host mechan attack case toxoplasma gondii cyst immun protect brain make clearanc parasit difficult lifelong infect current natur immun respons stimul presenc cyst propag establish novel chitinasedepend mechan cyst control infect brain despit domin immun respons toxoplasma infect exist popul altern activ macrophag aam infect cn cell capabl cyst lysi product amcas reveal live imag chitinas protect immun cn data demonstr chitinas activ brain respons protozoan pathogen provid novel mechan facilit cyst clearanc chronic infect
Virol J	21430057	2016-03-16	PMC3511061	23164039	background acut respiratori tract infect public health problem sensit rapid diagnost techniqu develop daili clinic practic evalu clinic relev detect common respiratori pathogen molecular method gener pediatr clinic method nasopharynx sampl children year ag respiratori symptom refer gener pediatr clinic test presenc virus mycoplasma pneumonia realtim polymeras chain reaction patient includ retrospect studi posit viru respiratori syncyti viru human rhinoviru frequent detect patient respiratori viru mycoplasma pneumonia detect younger versu month hospit versu patient respiratori pathogen detect feed problem dyspnea rhinorrhea wheez patient respiratori pathogen major case clinician chang antibiot manag detect viral respiratori pathogen differ ct patient respiratori pathogen respiratori pathogen versu conclus routin test common respiratori pathogen lead better understand role diseas children respiratori symptom
Transl Neurodegener	12378631	2006-11-01	PMC3514090	23210447	it centuri earli descript microglia riohortega biolog patholog featur microglia recogn todai microglia gener consid benefici homeostasi rest state abil survei environ phagocytos debri activ microglia assum divers phenotyp rang fulli inflam involv releas proinflammatori cytokin altern activ releas antiinflammatori cytokin neurotrophin consequ neuron rang detriment support experiment set condit contradictori controversi question microglia good bad understood dual role activ microglia depend specif situat underli mechan remain unclear interpret find divers microgli phenotyp continu problemat review discuss function microglia neuron surviv neurogenesi crosstalk microglia surround cell potenti factor influenc eventu manifest microglia
BMC Vet Res	26984724	2008-12-01	PMC3514206	23098237	background salmonellosi water buffalo bubalu bubali calv widespread diseas character sever gastrointestin lesion profus diarrhea sever dehydr occasion exhibit system cours salmonella serovar to infect water buffalo salmonella isol collect anim speci character studi preval salmonella spp water buffalo calv lethal gastroenter assess polyphas character isol strain typhimurium perform microbiolog analysi intestin content water buffalo calv lethal gastroenter exhibit preval salmonella spp character serovar frequent typhimurium muenster typhimurium isol associ enterocol character sever damag intestin sporad isol caus agent respons gastroenter cryptosporidium spp rotaviru clostridium perfringen salmonella isol isol minor intestin lesion case isol microorgan toxinogen escherichia coli cryptosporidium spp rotaviru typhimurium strain character phage type genotyp polymeras chain reaction pcr detect virul gene isol exhibit phage type genet profil three monophas typhimurium bi isol character displai three phage type three virulotyp molecular character extend muenster isol collect indic exist virulotyp serovar three repres strain typhimurium test vivo mous model mix infect pathogen strain character high number virul factor presenc locu agfa code thin aggreg fimbria conclus provid evid salmonella frequent associ gastroenter water buffalo calv typhimurium varieti number distribut virul marker collect typhimurium strain suggest serovar pathotyp respons clinic syndrom
PLoS One	17228566	2004-11-01	PMC3514223	23226502	background cerebr malaria cm sever malari anemia sma seriou lifethreaten clinic syndrom plasmodium falciparum infect childhood understand patholog underli develop cm sma oppos uncompl malaria um host respons infect reflect plasma proteomepattern associ clinic statu provid indic pathogenesi syndrom method find plasma comprehens clinic data discoveri valid cohort prospect casecontrol studi sever childhood malaria main tertiari hospit citi ibadan urban dens popul holoendem malaria area nigeria total children particip studi plasma subject highthroughput proteom profil statist patternrecognit method find proteomepattern defin diseas group plasma proteomepattern accur distinguish children cm sma um healthi sever malarianeg children conclus report accur definit major childhood malaria syndrom achiev plasma proteomepattern proteom data exploit understand pathogenesi childhood sever malaria syndrom
BMC Vet Res	18492055	2019-01-24	PMC3514250	22974242	background popul dog cat pass rescu shelter subject compromis welfar increas suscept diseas exist describ popul dynam associ manag practic aim studi carri censu unown cat dog uk document origin destin husbandri cost associ care anim sampl frame construct search databas publicli regist chariti england scotland wale regist breed rescu internet search anim welfar websit contact organis identifi postal questionnair data number dog cat hous origin eventu outcom detail husbandri januari st decemb st regist chariti financi record respons rate dog cat enter care particip organis half anim relinquish owner origin includ strai confisc welfar purpos seventyf cent dog cat rehom common outcom euthanasia account dog cat dog cat particip report wait list frequent exceed actual capac facil peopl involv care anim paid voluntari basi financi record regist chariti total expenditur conclus studi larg number anim unown year consider implic welfar despit resourc expend demand exce capac organis substanti number cat dog euthanas suggest understand anim unown essenti order target intervent
BMC Vet Res	15539525	2018-12-03	PMC3514351	23110781	background porcin reproduct respiratori syndrom viru prrsv major pathogen swine worldwid emerg novel highli pathogen prrsv hpprrsv isol china necessit compar investig host transcriptom respons tracheobronchi lymph node tbln dai postinfect hpprrsv rjxwn prrsv strain vr sham inocula rna prepar nextgener sequenc amplifi librari construct directli sequenc list sequenc transcript count gener rnaseq analysi pipelin determin differenti gene express transcript annot rel abund calcul base number time transcript repres librari major chang transcript abund occur respons infect prrsv strain differenti express transcript largest increas transcript level viru versu shaminocul control three serum amyloid acutephas isoform degre downregul transcript infect hpprrsv rjxwn greater transcript chang observ prrsv vr alter transcript hpprrsv rjxwn librari upregul downregul fold whilst prrsv vr librari transcript upregul downregul fold conclus magnitud differenti express gene profil detect hpprrsv rjxwn infect pig compar vr infect pig consist increas pathogen hpprrsv vivo
Cell Commun Signal	30679380	2018-06-01	PMC3515343	23176204	background epitheli invagin initi ectoderm organogenesi factor regul ectoderm organogenesi report function realtim studi electr cellsubstr imped sens eci noninvas realtim surveil system detect chang organ cell layer thick quantit monitor imped celltomicroelectrod interfac time good method identifi realtim chang cell purpos studi establish combin bioengin organeci model investig real time effect fibroblast growth factor fgf epitheli invagin bioengin ectoderm organ dissect epitheli mesenchym cell stage murin molar tooth germ identifi realtim effect fgf epithelialmesenchym interact combin bioengin organeci model measur bioengin ectoderm organ thick fibroblast growth factor fgf acceler epitheli invagin reaggreg mesenchym cell layer dai gene express analysi reveal fgf stimul sustain earli ameloblastin amelogenin express odontogenesi conclus realtim studi fgf plai role epitheli invagin initi ectoderm organogenesi base find fgf appli studi ectoderm organ regener propos fgfbmp balanc system manipul morphogenesi ectoderm organ combin bioengin organeci model promis method ectoderm organ engin regener research
PLoS One	30509975	2014-08-25	PMC3516468	23239991	object compar expel air dispers distanc cough human patient simul hp ly wear surgic mask mask neg pressur isol room method airflow mark intrapulmonari smoke cough bout gener short burst oxygen flow lmin simul normal mild poor cough effort cough jet reveal laser lightsheet imag captur high definit video smoke concentr plume estim light scatter smoke particl exposur arbitrarili defin normal smoke concentr normal cough expel air dispers distanc cm median sagitt plane hp wore mask surgic mask mask moder lung injuri correspond air dispers distanc mild cough effort reduc cm distanc reduc cm poor cough effort sever lung injuri later dispers distanc normal cough cm hp wore mask surgic mask mask conclus normal cough produc turbul jet the bed recumb subject mask effect surgic mask prevent expel air leakag cough sidewai leakag
PLoS One	30069386	2012-03-01	PMC3516535	23236475	thetadefensin defensin macrocycl antimicrobi peptid express leukocyt monkei peptid broad spectrum microbicid vitro numer defensin isoform identifi granulocyt rhesu macaqu oliv baboon mammalian defensin genet defensin proinflammatori immuneactiv properti bridg innat acquir immun current studi analyz immunoregulatori properti rhesu defensin rtd rtd abund defensin macaqu reduc level tnf il il il il secret blood leukocyt stimul tlr agonist rtd suppress level solubl tnf releas bacteria lpsstimul blood leukocyt thp monocyt despit highli conserv conform amino acid sequenc antitnf activ rtd vari fold system administ rtd nontox balbc mice escal intraven dose toler nonimmunogen adult chimpanze peptid highli stabl serum plasma singl dose administr rtd mgkg improv surviv balbc mice coli periton cecal ligationandpunctur induc polymicrobi sepsi peptid treatment reduc serum level inflammatori cytokineschemokin bacterem anim collect indic antiinflammatori properti defensin vitro vivo mediat suppress numer proinflammatori cytokin blockad tnf releas primari effect
PLoS Pathog	25157137	2007-11-21	PMC3516559	23236278	all posit strand rna virus replic genom close associ intracellular membran case hepat viru hcv member famili flavivirida infect cell accumul vesicl form membran web mw thought site viral rna replic biogenesi threedimension structur mw studi combin immunofluoresc electron microscopi embas method analyz membran structur induc hcv infect cell mw deriv endoplasm reticulum er marker rough er marker earli late endosom cop vesicl mitochondria lipid droplet ld main constitu mw singl doubl membran vesicl dmv predomin kinet appear correl kinet viral rna replic dmv induc nsa nsb induc singl membran vesicl argu mw format requir concert action hcv replicas protein threedimension reconstruct identifi dmv protrus er membran cytosol frequent connect er membran necklik structur addit late infect multimembran vesicl evid presum result stressinduc reaction morpholog membran rearrang induc hcvinfect cell resembl unrel picorna corona arterivirus clearli distinct close flavivirus reveal unexpect similar hcv distantli positivestrand rna virus presum reflect similar cellular pathwai exploit virus establish membran replic factori
PLoS Negl Trop Dis	22404920	2015-05-01	PMC3516577	23236527	ebola viru ebov famili filovirida emerg african contin caus outbreak viral hemorrhag fever human case fatal rate remain seriou public health concern biothreat pathogen pathogen beststudi speci zair ebolaviru zebov ebov encod viral surfac glycoprotein gp essenti replic determin pathogen immunogen gp mediat viral entri interact cellular surfac molecul uptak viru particl macropinocytosi pathwai endosom acidif activ cystein proteas cathepsin catb catl cleav zebovgp lead subsequ exposur put receptorbind fusion domain product infect studi catb catl vitro vivo replic ebov previou find catb catl zebov entri cultur cell interestingli cell entri ebov speci bundibugyo cte divoir reston sudan ebolaviru independ catb catl ebov replic gener investig catb catl role vivo infect util mous model zebov wildtyp control catb catl mice equal suscept lethal challeng mouseadapt zebov differ viru replic time death conclus catb catl activ requir ebov replic ebov glycoprotein cleavag mediat arrai proteas make target therapeut approach difficult
PLoS One	18032499	2016-04-07	PMC3517447	23236444	a dearth obscur true scale global illeg trade wildlif introduc autom web crawl surveil system develop monitor report illeg trade wildlif resourc enforc offici gener public freeli websit httpwwwhealthmaporgwildlifetrad customiz visual worldwid report intercept illeg trade wildlif wildlif product august juli publicli english languag illeg wildlif trade report offici unoffici sourc collect categor locat speci involv interv illeg wildlif trade report collect countri countri highest number report includ india unit state south africa china vietnam speci report trade poach includ eleph rhinocero tiger leopard pangolin unoffici data sourc onlin new site social network collect intern wildlif trade augment tradit approach draw offici report present novel sourc intellig monitor collect new support enforc threat wildlif conserv worldwid
PLoS One	25536401	2010-11-01	PMC3517467	23236482	polyriboinosinicpolyribocytoidyl acid pic synthet dsrna act adjuv boost immun respons protect intranas administr pic adjuv influenza viru vaccin effect pic administr pulmonari cell respons remain unclear singl administ dose dsrna mice induc local chemokin product lung airwai gener biphas sustain migrat lymphocyt airwai picinduc chemokin product cell recruit airwai interferon receptor ifnar signal depend dsrna cell recruit airwai depend presenc high molecular weight hmw pic low molecular weight lmw pic prepar interact tlr elicit cell migrat airwai suggest observ effect depend dsrna recognit multipl pattern recognit receptor ppr pic addition capabl stimul low level cell prolifer drain lymph node dai treatment preced small popul denovo cell airwai dai demonstr adjuv pic enhanc cell prolifer sustain cell recruit airwai requir multipl prr ifnar signal
Int J Emerg Med	27061619	2002-11-01	PMC3518169	23114079	background emerg depart ed basic unit emerg care perform nation inventori singapor ed describ characterist capabl method singapor ed access gener public survei nation inventori instrument httpwwwemnetnediorg staff member ask characterist refer calendar year fourteen ed particip respons ed locat hospit independ depart psychiatr rest gener ed gener ed contigu layout medic surgic care provid area ed adult children adultonli children public sector privat healthcar institut public ed major patient privat annual patient censu ed receiv ambul inpati admiss rate public annual censu receiv ambul inpati admiss rate public ed report overcapac privat ed public privat ed avail consult resourc ed high technolog resourc vari conclus characterist capabl singapor ed vari depend public privat hospit initi inventori establish benchmark monitor develop emerg care singapor
BMC Res Notes	21045553	2013-10-01	PMC3519610	23009598	background highli infecti diseas hid defin transmiss person person caus lifethreaten ill present seriou public health hazard sampl handl transport specimen patient hid specif biosafeti concern find european network project aim record crosssect studi infect control capabl referr center hid europ assess level achiev publish guidelin paper report current diagnost capabl biosafeti measur appli diagnost procedur referr center isol facil european countri evalu referr center locat biosafeti level laboratori perform microbiolog routin diagnost analys biosafeti measur conclus discrep referr center survei level practic european network infecti diseas eunid recommend multipl reason interest individu charg invest prepared emerg outbreak despit fact prepar center improv updat practic polici support help achiev accept level biosecur welcom
Virol J	12368349	2018-09-02	PMC3519612	23025700	background major structur protein coronavirus membran protein elicit format protect antibodi protein porcin epidem diarrhea viru pedv identif epitop pedv protein will help elucid antigen properti protein hybridoma cell secret antim protein monoclon antibodi mcab gener design map epitop pedv protein total partial overlap fragment cover cterminu protein express fusion protein tag gst tag linear motif tgwafyvr identifi enzymelink immunosorb assai elisa western blot wb analysi mcab motif wafyvr minim requir reactiv demonstr remov amino acid individu end motif tgwafyvr result wb analysi ddefin epitop recogn pedvposit serum transmiss gastroenter viru tgevposit serum epitop highli conserv pedv strain align comparison sequenc conclus mcab direct protein pedv ddefin minim epitop sequenc wafyvr mcab serv candid develop mcabbas antigen captur elisa detect pedv epitop identifi basi develop epitopebas differenti diagnost techniqu design epitopebas vaccin
PLoS One	24115772	2001-05-15	PMC3519632	23251541	nullbas mutant hiv tat protein antihiv activ mechan includ inhibit rev function redistribut hiv rev protein nucleolu nucleoplasm cytoplasm investig mechan time establish redistribut rev nullbas direct interact protein nullbas subcellular local cellular protein regul rev traffick nullbas induc redistribut exportin crm nucleophosmin nucleolin nucleolu nucleu rev coexpress absenc inhibit revcrm interact leptomycin noninteract revm mutant complet block redistribut rev nullbas final nullbas inhibit importin transportin mediat nuclear import suggest cytoplasm accumul rev increas export crm data support conclus crmdepend subcellular redistribut rev nucleolu nullbas gener perturb nuclear import export nullbas appear interact disrupt specif compon rev traffick complex requir nucleocytoplasm shuttl nucleolar accumul
BMC Infect Dis	30285587	2004-07-14	PMC3519643	22828244	background broad spectrum pathogen caus respiratori tract infect symptom identif caus virus bacteria feasibl multiplex pcr monoplex pcr test parallel method analyt sensit three multiplex pcr assai respifind respifindersmart xtagrespiratoryviruspanelfastassai rvp compar monoplex realtim pcr quantifi standard control materi assai includ common respiratori pathogen compar analyt sensit multiplex assai sampl inocul quantifi virus rang copiesml concord receiv rhinoviru rvp detect influenzaviru rsv hmpv frequent low concentr respifind respifindersmart higher analyt sensit adenovirus coronavirus rvp incap detect adenoviru coronaviru concentr copiesml respifind respifindersmarta detect influenzavirus copiesml rsv copiesml detect virus sampl achiev monoplex pcr analyz competit amplif reaction virus sampl inocul virus sampl compar detect virus parallel differ incid respiratori virus compar tracheal secret sampl mechan ventil patient winter summer winter respiratori virus detect sampl respifind detect rate rvp frequent virus adenoviru piv multipl infect detect sampl respifind fewer infect summer respifind rvp posit verifi monoplex pcr conclus multiplex pcr test broad spectrum pathogen test time analysi multipl inocul sampl reveal focu detect viru type three assai analysi clinic sampl high concord detect virus respifind compar monoplex test
BMC Mol Biol	11312360	2016-04-20	PMC3519679	22994806	background recombinatori clone gatewaytm technolog method choic highthroughput omic project avail entir orfeom gatewaytm compat vector multisit gatewaytm system allow combin multipl genet fragment promot orf epitop tag singl reaction technolog access yeast saccharomyc cerevisia experiment system molecular biologi lack appropri destin vector set threefrag multisit gatewaytm destin vector develop gene express cerevisia allow assembl promot open read frame epitop tag arrang combin auxotroph marker three distinct replic mechan exampl applic yeast threehybrid provid evid assembl ternari complex plant protein involv jasmon signal consist jaz ninja topless protein conclus vector multisit gatewaytm clone access cerevisia implement fast versatil clone method highthroughput function analysi heterolog protein model organ molecular biologi research
PLoS One	15254185	2003-07-01	PMC3519774	23239996	theoret homogen environ favor evolut specialist heterogen environ favor generalist canin distemp multihost carnivor diseas caus canin distemp viru cdv describ cell receptor cdv slam cd attach cdv hemagglutinin protein cdvh receptor facilit fusion viru entri cooper fusion protein cdvf investig cdv strain coevolv larg homogen domest dog popul exhibit specialist trait strain adapt heterogen environ smaller popul carnivor exhibit generalist trait comparison amino acid sequenc slam bind region reveal higher similar sequenc canida speci sequenc carnivor famili vitro assai quantifi syncytia format mediat cdvh protein dog nondog cdv strain cell express dog lion cat slam cdvh protein dog strain produc higher valu cell express dog slam cell express lion cat slam cdvh protein strain nondog speci produc valu three cell type lower valu cell express dog slam valu cdvh protein dog strain experiment chang amino acid yh cdvh protein dog strain decreas express specialist trait increas express generalist trait confirm function viru titer assai demonstr dog strain produc higher titer cell express dog slam cell express slam nondog host suggest fit benefit special postcel entri provid vitro evid express specialist generalist trait cdv strain fit tradeoff carnivor host environ caus antagonist pleiotropi find extend knowledg cdv molecular epidemiolog relev wild carnivor
PLoS One	27099317	2008-03-19	PMC3519901	23240068	all virus depend host cell replic infect induc profound chang cell includ apoptosi morpholog chang activ signal pathwai alter analyz gene arrai measur cellular transcriptom silac stabl isotop label amino acid cell cultur combin highthroughput hplcmass spectrometri determin rel quantit differ host protein hour infect hek cell reoviru serotyp lang tl host protein detect hpi protein regul cellular protein regul identifi hpi ipa david analys indic protein involv cell death cell growth factor oxygen transport cell structur organ inflammatori defens respons viru upregul protein involv apoptosi isomeras activ metabol downregul protein pathwai suitabl target intervent attenu viru infect enhanc oncolyt potenti
PLoS One	12938762	2007-04-11	PMC3519908	23240064	biodegrad nanoparticlebas vaccin develop unexplor larg anim human studi illustr efficaci nanoparticleentrap uvkil viru vaccin econom respiratori viral diseas pig call porcin reproduct respiratori syndrom viru prrsv entrap plga poli lactidecoglycolid nanoparticl kill prrsv antigen nanokag detect phagocytosi pig alveolar macrophag singl dose nanokag vaccin administ intranas pig upregul innat prrsv specif adapt respons virul heterolog prrsv challeng studi nanokag vaccin reduc lung patholog viremia viral load lung immunolog enhanc innat adapt immun cell popul associ cytokin decreas secret immunosuppress mediat observ mucos site blood summari demonstr benefit intranas deliveri nanoparticlebas viral vaccin elicit crossprotect immun respons pig potenti larg anim model
Respir Res	18353922	2011-11-14	PMC3520784	22672594	background influenza viru iav infect target respiratori epitheli cell produc clinic outcom rang mild upper respiratori infect sever pneumonia studi lung antioxid defens system injuri iav nuclear factorerythroid factor nrf activ major antioxid gene method alveolar type ii atii cell alveolar macrophag isol human lung suitabl transplant donat medic studi atii cell transdifferenti alveolar type ilik atilik cell alveolar epitheli cell infect apr pr viru analyz pr viru product influenza nucleoprotein level ro gener express antivir gene immunocytofluoresc determin nrf transloc western blot detect nrf ho caspas cleavag analyz ingest pr viru infect apoptot atii cell cytokin level elisa glutathion level necrosi apoptosi tunel assai determin critic nrf adenoviru nrf adnrf nrf sirna overexpress knockdown nrf iav induc oxid stress cytotox apoptosi atilik atii cell ingest pr virusinduc apoptot atii cell efferocytosi viabl cell atii cell ingest apoptot cell pr viru increas ro product nrf ho mx oa express nrf transloc nucleu nrf knockdown sirna sensit atilik cell atii cell injuri induc iav overexpress nrf adnrf protect cell nrf overexpress infect pr viru decreas viru replic influenza nucleoprotein express antivir respons oxid stress adnrf increas ifn il level conclus indic iav induc alveolar epitheli injuri nrf protect cell cytopath effect iav increas express antioxid gene identifi pathwai involv protect cell injuri influenza infect develop therapeut strategi
BMC Biol	17425653	2003-12-23	PMC3520816	23017270	background varieti anim produc polyclon antibodi antigen product antigenspecif monoclon antibodi anim remain challeng propos simpl rapid strategi produc monoclon antibodi varieti anim stain lymph node cell antibodi immunoglobulin fluoresc dye specif endoplasm reticulum plasmaplasmablast cell identifi seri antibodi lineag marker fluoresc label antigen tag complementari cell surfac immunoglobulin antigenspecif plasmaplasmablast cell sort rest cell popul fluorescenceactiv cell sort amplif cognat pair immunoglobulin heavi light chain gene dna transfect ft cell highli effici product antigenspecif monoclon antibodi varieti immun anim conclus technolog elimin cell propag screen process offer advantag hybridoma displai strategi
PLoS One	22084096	2013-02-13	PMC3520906	23251633	the voltageg kcnq potassium channel express cardiac tissu coassembl kcnq auxiliari kcne subunit mediat slowli activ current acceler repolar action potenti cardiomyocyt mutat kcnq gene result reduct loss channel activ prolong repolar action potenti caus long qt syndrom lqt small molecul activ kcnqkcne understand mechan complex activ develop therapeut lqt studi report hexachlorophen hcp activ compon topic antiinfect prescript drug phisohex kcnqkcne activ hcp potent increas current amplitud kcnqkcne express stabil channel open state ec studi cardiomyocyt hcp shorten action potenti durat addit hcp capabl rescu loss function lqt mutant caus impair activ gate phosphatidylinositolbisphosph pip bind affin indic hcp novel kcnqkcne activ tool compound develop lqt therapeut
Epidemiol Health	14694098	2017-10-03	PMC3521104	23251837	object despit extens term surveil take mean scientif literatur pertin public health anim health critic apprais literatur reveal ambigu relat scope structur compon underpin surveil process author hypothes inconsist translat real perceiv defici conceptu framework popul health surveil paper present popul health surveil theori frame explicit conceptu system rel health surveil perform human anim popul method popul health surveil theori reflect author system think base creativ process popul health surveil includ broad compon relat human organ includ expertis administr program relat system se includ element design method view process popul health surveil process sequenti interrel step trigger problem formul surveil plan surveil implement commun audit conclus popul health surveil theori systemat understand organ evalu popul health surveil process
Front Immunol	23408839	2016-04-27	PMC3521240	23248627	pentraxin ptx solubl pattern recognit receptor classifi longpentraxin pentraxin famili plai role innat immun inflammatori regul femal fertil ptx synthes specif cell respons inflammatori signal cell neutrophil uniqu ptx product system neutrophil store ptx neutrophilspecif granul store ptx releas local neutrophil extracellular trap net net compon identifi histon antimicrobi protein detail mechan net local captur kill microb fulli elucid ptx candid diagnost marker infect vascular damag sever infecti diseas sepsi circul ptx concentr increas greatli ngml fold normal level clearli impli ptx plai protect role sepsi disord detail mechan remain unclear proteom studi ptx ligand septic patient reveal ptx form complex net compon protein suggest role ptx facilit effici antimicrobi protein pathogen clearanc interact pathogen antimicrobi protein discuss relationship ptx net compon protein host protect afford innat immun respons ptx complex potenti highli diagnost marker sepsi inflammatori diseas
Evid Based Complement Alternat Med	29073020	2003-09-01	PMC3521454	23259003	porcin epidem diarrhea viru pedv diarrhea pig ageindepend death young piglet econom loss porcin industri screen natur orient herbal medicin search antivir candid pedv herbal extract kiom kiom antip viral kiom kiom identifi epimedium koreanum nakai lonicera japonica thunberg plaqu cpe inhibit assai vitro kiom stronger antivir activ kiom addition kiom exhibit extent antivir subtyp corona viru sm tge virus cytotox kiom nontox cell deliv safe therapi oral administ kiom piglet infect pedv piglet diseas symptom diarrhea biopsi clean intestin control pig kiom treatment exhibit pedrel sever symptom impli kiom strong antivir activ potenti develop antivir phytomedicin treat pedvrel diseas pig
PLoS Pathog	27122380	2014-03-01	PMC3521666	23271969	in addit surfac glycoprotein gp ebola viru ebov direct product larg quantiti truncat glycoprotein isoform sgp secret extracellular space gener secret antigen studi virus suggest mechan host immun evas absorpt antibodi interfer antibodymedi clearanc role conclus determin ebola viru sgp studi immun mice dna construct express gp andor sgp demonstr sgp effici compet antigp antibodi mice immun sgp term phenomenon antigen subvers propos model sgp redirect host antibodi respons focu epitop share membranebound gp allow absorb antigp antibodi unexpectedli sgp subvert immun host antigp respons strong crossreact sgp find relev ebov vaccinolog underscor elicit robust immun suffici rapidli clear infect antigen subvers occur antigen subvers repres novel viru escap strategi help ebov evad host immun repres obstacl ebov vaccin design
Iran J Radiol	12937045	2014-04-13	PMC3522360	23329946	background swine influenza hn contagi respiratori infect health organ rais alert level phase pandem studi clinic laboratori manifest radiolog imag find help earli diagnosi object aim studi evalu imag find patient document hn infect refer center patient method thirtyon patient men document hn infect includ studi initi radiographi patient review pattern consolid ground glass nodul reticul distribut focal multifoc diffus lung zone involv comput tomographi ct scan review abnorm patient file studi underli diseas ag year seventeen patient coexist condit respiratori cardiovascular immunodefici cancer twelv patient requir intens care unit icu admiss patient di normal initi radiograph common abnorm consolid peripher region peribronchovascular area commonli observ lower zone patient admit icu lung zone involv conclus patient novel swine flu infect common radiograph abnorm observ consolid lower lung zone patient admit icu lung zone involv
PLoS One	24700974	2015-08-31	PMC3522717	23272110	background swineorigin influenza ahnpdm pandem slower spread europ expect human rhinoviru hrv suggest delai pandem viral interfer coinfect time pandem term sever diseas assess object aim studi investig respiratori virus presenc coinfect influenza ahnpdm hn hospit children hn pandem secondari aim investig coinfect associ sever diseas method retrospect studi perform children influenzalik ill admit inpati care pediatr hospit stockholm sweden month span hn pandem respiratori sampl analyz panel virus realtim polymeras chain reaction virus detect sampl singl infect coinfect virus number coinfect increas studi period hn children coinfect hrv hn circul larg extent time hnposit children posit hrv correl coinfect sever diseas children hn conclus viral coinfect common hn infect hospit children consid estim morbid attribut hn populationbas longitudin studi repeat sampl need improv understand coinfect viral interfer
Adv Virol	25674604	2009-01-21	PMC3523128	23304142	retrovirus includ infecti agent induc sever diseas human anim addit retrovirus tool transfer gene interest target cell understand entri mechan retrovirus contribut develop novel therapeut approach retrovirusinduc diseas effici exploit retrovir vector entri envelop virus host cell cytoplasm achiev fusion viral envelop host cell membran cell surfac intracellular vesicl anim retrovirus enter host cell endosom requir endosom acidif ecotrop murin leukemia viru entri requir cathepsin proteas activ endosom acidif cddepend human immunodefici viru hiv infect thought occur endosom endosom acidif entri entri cdindepend hiv thought prototyp cddepend virus low ph depend controversi retrovir entri pathwai endocytosi endosom acidif complicatedli control cellular mechan retroviru entri pathwai cell line
PLoS One	26190522	2015-05-18	PMC3524174	23284733	chronic hepat caus infect hepat viru hcv global health problem mous model hepat examin therapeut effect recombin vaccinia viru rvv encod hcv protein gener immunocompet mice express multipl hcv protein creloxp switch system establish distinct attenu rvv strain hcv core protein express consist liver polyinosin acidpolycytidyl acid inject mice chronic hepat crelat patholog find hepatocyt abnorm accumul glycogen steatosi liver fibrosi hepatocellular carcinoma immun rvv strain rvvn encod nonstructur hcv protein suppress serum inflammatori cytokin level allevi symptom patholog chronic hepat dai inject hcv protein level liver tissu decreas cd cd tcelldepend manner consist rvvn immun induc robust cd tcell immun respons specif hcv nonstructur protein demonstr onset chronic hepat cnmxcre mice attribut inflammatori cytokin tumor necrosi factor tnf interleukin il gener mice model investig immunolog process associ persist express hcv protein mice develop immun toler hcv antigen addit propos rvvn develop effect therapeut vaccin
Clin Infect Dis	26038567	2020-03-20	PMC3526251	23024295	communityacquir respiratori viru carv infect recogn morbid mortal patient leukemia undergo hematopoiet stem cell transplant hsct progress lower respiratori tract infect clinic radiolog sign pneumonia respiratori failur appear depend intrins virul specif carv factor specif patient underli diseas treatment better defin current state knowledg carv leukemia hsct patient improv carv diagnosi manag work group fourth european confer infect leukaemia ecil review literatur carv grade qualiti evid recommend infecti diseas societi america grade system differ screen clinic present therapi influenza adenoviru ecil recommend summar carv influenza adenoviru
Retrovirology	31142667	2006-12-13	PMC3526565	23206338	background role disulfid bond remodel hiv infect describ process remain incomplet character data establish cell line andor cxcrtropic laboratoryadapt viru strain ambigu disulfid isomeras reductas plai major role hiv entri protein disulfid isomeras pdi andor thioredoxin trx emerg enzym implic process extend previou find focus ccruse hiv strain natur target primari human macrophag cd lymphocyt nonspecif thioldisulfid exchang inhibitor dithiobisnitrobenzo acid dtnb reduc hiv entri infect cell line human monocytederiv macrophag mdm phytohemagglutinin phastimul peripher blood mononuclear cell pbmc subsequ studi perform specif antipdi trx monoclon antibodi mab hiv envelop pseudotyp wild type wt viru infect system human donortodonor variabl observ expect trx appear plai greater role pdi hiv infect mdm contrast pdi trx involv hiv entri infect cdccr cell pm phastimul primari human lymphocyt intriguingli pdi trx surfac mdm pm phastimul cd cell consider lower level trx detect freshli isol cd lymphocyt compar phastimul cell conclus find clearli demonstr role thioldisulfid exchang hiv entri primari lymphocyt mdm establish celltyp specif involv disulfid isomerasesreductas process provid explan differ publish studi importantli vivo perspect preferenti util pdi relev hiv entri establish viru reservoir rest cd cell elev level trx report chronic stage hiv infect facilit viru entri macrophag help sustain high viremia declin lymphocyt
PLoS One	32198177	2012-11-28	PMC3527446	23284702	the spontan revers format foci filament protein involv metabol process common nucleu cytoplasm stress granul sg process bodi pb belong novel famili cellular structur collect mrna silenc foci harbour repress mrna associ protein sg pb highli dynam form stress dissolv releas repress mrna chang cell physiolog addit aggreg abnorm protein frequent neurodegen disord spite grow relev supramolecular aggreg divers cellular function reliabl autom tool systemat analysi lack report matlab script term buho highthroughput imag analysi cellular foci buho assess number size distribut distinct object minim deviat manual paramet buho address induct sg pb mammalian insect cell expos stress stimuli buho assess dynam specif mrnasilenc foci term smaug foci sfoci primari neuron synapt stimul final buho analyz role candid gene sg format rnaibas experi fakd gcn govern sg format role conserv mammalian cell judg the inhibitor salubrin involv dephosphoryl translat factor eif experi analyz manual buho differ averag autom analysi userfriendli method will allow highthroughput imag process short time provid robust flexibl reliabl altern labori unfeas visual scrutini
Mar Drugs	17166901	2016-06-06	PMC3528116	23342387	thi studi evalu effect sargassum pallidum polysaccharid spp immun respons chicken model adjuvant sargassum pallidum polysaccharid newcastl diseas infecti bronchiti ib avian influenza ai investig examin antibodi titer lymphocyt prolifer immun chicken chicken administr combin ib ai inactiv vaccin spp mgml oil adjuv vaccin control ib ai antibodi titer lymphocyt prolifer enhanc mgml spp conclus appropri dose spp safe efficaci immun stimul candid suitabl vaccin produc earli persist prophylaxi
Viruses	23192868	2013-03-13	PMC3528269	23342362	filovirus sever hemorrhag fever human high casefat rate cellular factor exploit filovirus spread constitut potenti target intervent incomplet defin viral glycoprotein gp mediat filoviru entri host cell studi reveal insight host cell molecul engag gp cellular entri bind gp cellular lectin concentr virion suscept cell contribut earli sustain infect macrophag dendrit cell viral target tyrosin kinas receptor promot macropinocyt uptak filovirus subset suscept cell bind gp interact gp human cell ig mucin tim contribut filoviru infect mucos epitheli cell gp engag cholesterol transport niemannpick demonstr essenti gpmediat fusion viral envelop host cell membran final mutagen structur analys defin gp domain interact host cell factor will review progress elucid molecular interact underli filoviru entri discuss implic understand viral cell tropism
Viruses	27573107	2007-02-01	PMC3528270	23342363	avian influenza viru infect human popul rare ineffici direct humantohuman transmiss human infect strong inflammatori respons induc character elev level cytokin chemokin serum believ sever pathogenesi develop high proport patient extens perform understand molecular viral mechan involv hn pathogenesi human provid interest insight virushost interact regul innat immun respons highli pathogen virus review summar discuss find field focus hn virul factor impact modul innat immun human
Viruses	23486707	2018-10-01	PMC3528273	23202545	coronavirus singl strand posit sens rna virus induc rearrang cellular membran infect host cell viru platform assembl viral replic complex improv effici rna synthesi membran observ coronaviru infect cell includ doubl membran vesicl natur doubl membran vesicl resembl cellular autophagosom gener cellular autophagi pathwai addit coronaviru infect demonstr induc autophagi review current knowledg coronaviru induc membran rearrang involv autophagi autophagi protein microtubul associ protein light chain lc coronaviru replic
Viruses	17272548	2019-04-01	PMC3528274	23202546	the bovin respiratori syncyti viru brsv envelop neg sens singlestrand rna viru belong pneumoviru genu famili paramyxovirida brsv recogn major respiratori diseas young calv earli analysi brsv infect origin hamper characterist labil poor growth vitro advent numer immunolog molecular method facilit studi brsv enorm knowledg gain studi provid opportun develop safe stabl attenu viru vaccin candid aspect epidemiolog molecular epidemiolog evolut viru fulli understood natur cours infect complex complic diagnosi treatment implement prevent measur aim control diseas understand mechan brsv establish infect need prevent viral diseas spread review discuss epidemiolog molecular epidemiolog brsv worldwid highlight viral evolut viru transmiss
Viruses	30153701	2016-01-01	PMC3528286	23235471	in novel coronaviru associ acut respiratori diseas alpaca alpaca coronaviru acov isol fulllength genom sequenc acov demonstr genom consist alphacoronavirus put addit openread frame identifi nucleocapsid gene utr acov genet common human coronaviru hcov nucleotid ident entir genom comparison spike gene sequenc acov hcove isol recov span decad acov to virus isol earli true origin acov unknown common ancestor acov hcove appear exist prior suggest viru transmiss zoonosi anthroponosi occur alpaca human
BMC Vet Res	30936208	2009-01-15	PMC3528418	23009687	background concurr infect porcin circoviru type pcv porcin reproduct respiratori syndrom viru prrsv major porcin respiratori diseas complex prdc dual infect pcv prrsv consist sever clinic present pulmonari lesion infect pcv prrsv dual infect pcv prrsv infect order lead clinic symptom host mimic field condit swine alveolar macrophag am inocul pcv prrsv vitro simultan viru earlier the cell viabil cytopath effect antigencontain rate phagocytot microbi kill capabl cytokin profil il tnf ifn fasl transcript determin analyz compar prove hypothesi mark reduct prrsv antigencontain rate cytopath tnf express level reveal am inocul pcv prrsv simultan am inocul pcv prrsv am inocul prrsv pcv transient decreas phagocytosi constant reduct microbicid capabl am group inocul pcv constant decreas phagocytosi microbicid capabl am prrsvinocul group level il tnf ifn fasl transcript am group dual inocul pcv prrsv increas infect order compar infect pcv prrsv conclus swine am infect pcv prrsv infect pcv prrsv simultan displai mark reduct prrsv antigencontain rate cytopath tnf express level inocul order pcv prrsv am lead viral antigen posit cytopatholog cytokin profil explain partial underli mechan enhanc pulmonari lesion prdc exert dual infect pcv prrsv variabl clinic manifest prdcaffect pig field
BMC Vet Res	27579473	2009-10-21	PMC3528628	23057674	background ebolavirus induc lethal viral hemorrhag fever vhf human nonhuman primat except reston viru restv pathogen human human vhf case extens analys humor immun respons survivor nonsurvivor igg respons nucleoprotein np viral protein associ asymptomat surviv outcom neutral antibodi respons target ebolavirus glycoprotein gp major indic protect immun hand immun respons nonhuman primat natur infect elucid detail signific antibodi respons np gp restvinfect cynomolgu macaqu unclear studi analyz humor immun respons cynomolgu macaqu serum specimen restv epizoot in philippin expand knowledg immun respons natur restvinfect nonhuman primat antibodi respons analyz iggelisa indirect immunofluoresc antibodi assai ifa pseudotyp vsvbase neutral nt assai antigencaptur agelisa perform detect viral antigen serum specimen antigp respons antinp respons close correl neutral respons clearanc viremia sera restvinfect cynomolgu macaqu addition analyz cytokinechemokin concentr serum specimen high concentr proinflammatori cytokineschemokin ifn il il mip convalesc phase sera conclus impli antibodi respons gp proinflammatori innat respons plai role recoveri restv infect cynomolgu macaqu
Case Rep Infect Dis	18838615	2017-12-18	PMC3530861	23304580	here case yearold indian man histori extramarit relationship present pleurisi skin rash radiolog find pleural effus thorough investig etiolog acut ill posit syphili review literatur reveal small number case report pleural effus manifest secondari syphili review criteria propos literatur util diagnos patient case pulmonari syphili
Front Plant Sci	19846526	2016-04-01	PMC3531707	23293645	the accumul unfold misfold protein lumen endoplasm reticulum er er stress trigger cytoprotect signal pathwai term unfold protein respons upr restor maintain homeostasi er induc apoptosi er stress remain unmitig upr signal network encompass three core element pkrlike er kinas perk activ transcript factor atf inositolrequir protein ir activ three branch pathwai upr lead translat arrest degrad misfold protein express er molecular chaperon expans er membran decreas load protein increas proteinfold capac er essenti role upr implic number mammalian diseas viral diseas virusinfect cell cellular translat machineri hijack infect viru produc larg amount viral protein inevit perturb er homeostasi er stress review summar current knowledg upr signal pathwai highlight identifi upr pathwai plant discuss progress elucid upr virusinfect cell function role viral infect
PLoS One	29251553	2012-03-23	PMC3532156	23285230	a seri phenanthroquinolizidin alkaloid prepar evalu antivir activ tobacco mosaic viru tmv bioassai compound exhibit good excel vivo antitmv activ compound displai higher activ rantofin commerci ningnanmycin test condit substitu phenanthren moieti plai role maintain high vivo antivir activ introduct hydroxyl propos interact tmv rna increas antitmv activ arconfigur confirm prefer antivir configur phenanthroquinolizidin alkaloid introduct hydroxi group posit phenanthroquinolizidin alkaloid increas activ sconfigur decreas activ rconfigur studi fundament support develop optim phenanthroquinolizidin alkaloid potenti inhibitor plant viru
BMC Complement Altern Med	26766602	2015-04-15	PMC3533872	23190501	background cinnamon bark popular herbal ingredi tradit orient medicin possess divers pharmacolog activ includ antibacteri antivir anticanc properti goal studi investig vivo vitro inhibitori cinnamon water extract cwe lipopolysaccharid lpsinduc tumor necrosi factor tnf underli intracellular mechan method cwe oral administr mice dai prior intraperiton inject lp serum level tnf interleukin il determin hour lp stimul periton macrophag thioglycollateinject mice isol assai viabil cytokin express signal molecul lp stimul cwe fraction molecular size level total polyphenol biolog activ fraction measur oral administr cwe mice decreas serum level tnf il cwe treatment vitro decreas mrna express tnf cwe block lpsinduc degrad ib activ jnk erk sizebas fraction cwe observ inhibitori cwe vitro occur fraction highest level total polyphenol conclus treatment cwe decreas lpsinduc tnf serum vitro inhibit tnf gene cwe occur modul ib degrad jnk erk activ indic observ antiinflammatori action cwe origin presenc polyphenol
PLoS One	22447610	2007-10-17	PMC3534092	23300528	to examin impact multic hiv prevent public health program china global fund round project condom hiv infect analyz yearli crosssect survei men sex men msm chines citi selfreport condom sex male partner increas trend test hiv preval increas multivari logist regress analysi selfreport receipt intervent independ predictor increas condom sex male partner time adjust odd ratio aor lower hiv preval aor hiv preval increas particip selfreport receipt intervent intervent chines public health program posit impact behavior diseas rate msm popul escal coverag intens effect intervent need increas condom revers rise trend hiv epidem
Virol J	25877393	2018-07-05	PMC3534549	23158906	background hepat viru hbv infect major health concern billion individu current infect worldwid limit effect exist vaccin drug develop novel antivir strategi urgent need heat stress cognat hsc atpbind protein heat stress protein famili hsc requir hbv dna replic report time combin sirna target viral gene sihsc highli effect suppress ongo hbv express replic method construct plasmid s express short hairpin rna shrna target surfac open read frame hbvhbv plasmid express shrna target hsc sihsc egfpspecif sirna plasmid siegfp describ evalu genesilenc efficaci shrna enhanc green fluoresc protein egfp report system flow cytometri hek tg cell antivir potenc hbvspecif sirna sihbv combin sihsc hepg cell investig type ifn tnf induct measur quantit realtim pcr elisa cotransfect s egfp plasmid produc reduct egfp signal rel control combin rnai effect inhibit hbv protein mrna hbv dna log reduct hbv load hepg cell cultur supernat combin sirna potent sihbv sihsc separ approach enhanc potenc suppress ongo viral gene express replic hepg cell forestal escap mutant hbv antivir synergi sihbv combin sihsc produc cytotox induc product ifn ifn tnf transfect cell conclus combin rnai sequencespecif effect wildtyp mutant drugresist hbv strain trigger interferon respons produc side effect find indic combin rnai tremend promis develop innov therapi viral infect
Epidemiol Health	17942549	2013-04-24	PMC3535160	23316418	object quarantin measur prevent epidem diseas evalu effici elabor analys import case purpos studi analyz descript epidemiolog characterist pandem influenza hn case import korea method collect set data set compris daili report case hn local citi govern polici mandatori report hn case august second set includ confirm import hn case identifi nation quarantin station korea center diseas control prevent decemb lack natur import hn case data set lap period august express number import case rang period estim number import hn case august and total number case number import case diminish august analysi second data set distribut sex male femal ag distribut wa case identifi countri peopl infect hn travel asia proport case region oceania south america southeast asia north america europ northeast asia order order hn peak southern hemispher tropic nothern hemispher conclus studi provid evalu govern quarantin measur stop import diseas caus communityacquir spread futur
Clin Dev Immunol	29976554	2016-12-21	PMC3536062	23316255	we describ associ caspasedepend caspaseindepend mechan macrophag apoptosi induc lpqh kda mycobacterium tuberculosi lipoprotein lpqh trigger tlr activ upregul death receptor ligand death receptor signal cascad activ initi caspas execution caspas caspasemedi phase mitochondri factor involv loss mitochondri transmembran potenti releas cytochrom caspas activ interestingli caspaseindepend pathwai identifi immunoblot mitochondri apoptosi induc factor aif demonstr nuclei cytosol lpqhtreat macrophag confoc microscopi reveal transloc aif nuclei major apoptot cell find emphas complex redund natur macrophag death respons mycobacteria
BMC Biotechnol	23616462	2013-04-03	PMC3536577	23153214	background product human monoclon antibodi exhibit broadli neutral activ need prevent hiv infect antibodi gener till isol antibodi hybridoma technolog cumbersom process fewer yield loss unstabl slowli grow clone uniqu bind specif occur clone propag posit clone lost avoid process describ paper combin strategi ebv transform recombin dna technolog construct human singl chain variabl fragment scfv third variabl region clade hiv envelop antigen specif phage librari clone construct enrich posit antibodi secret ebv transform cell ligat digest scfv dna phagemid vector bio pan hiv consensu peptid random select clone identifi clone reactiv phage elisa dna fingerprint analysi sequenc clone distinct express posit clone test sdspage western blot antiv scfv crossreact clade peptid reactiv unrel peptid elisa preliminari neutral assai indic vari degre neutral clade virus ebv transform antigen select line identifi specif binder enabl select phage unclon line scfv gener avoid problem hybridoma technolog clone pretest antigen bind compar small librari suffic select consider number uniqu antigen bind phage select phage clone propag clonal manner conclus strategi effici cost effect gener divers recombin antibodi studi gener antiv scfv hiv clade c
Vet Res	27936982	2016-03-23	PMC3537549	22906110	domest cat commonli viral pathogen induc lengthi infect fatal outcom prevent viral propag primordi shelter catteri cat background narrow contact oligonucleotid odn cytosinephosphateguanosin motif class cpga highli potent synthet induc innat antivir mechan aim studi test abil modul innat immun respons prevent viral replic standalon agent domest cat cpga stimul felin peripher blood mononuclear cell pbmc enhanc prolifer increas presenc costimulatori molecul surfac influenc gene express profil antivir orient incub supernat cpga stimul pbmc felin cell line epitheli fibroblast origin induc express antivir myxoviru resist mx gene target cell enhanc resist felin virus distinct famili coronavirida herpesvirida calicivirida parvovirida retrovirida importantli subcutan administr cpga domest cat system increas express mx reach maxim level plasma treat cat inhibit viral replic vitro altogeth data highlight promis potenti cpga induc prevent antivir state cat protect felin popul broad rang viru infect
Cancer Cell Int	23552422	2007-03-28	PMC3537594	23176676	background lycorin natur alkaloid extract amaryllidacea pharmacolog effect studi focus potenti antitumor activ lycorin previou studi lycorin decreas cell viabil leukemia hl cell multipl myeloma cell induc cell apoptosi molecular mechan lycorin human chronic myelocyt leukemia cell determin method human chronic myelocyt leukemia cell treat lycorin cell viabil monitor method cck histon deacetylas hdac enzymat activ detect hdac colorimetr assai cell cycl analyz flow cytometri express cellcycl protein identifi western blot studi reveal lycorin inhibit prolifer cell analysi hdac activ lycroin decreas hdac enzymat activ cell dosedepend manner inhibit hdac activ associ cellcycl arrest growth inhibit evalu cell cycl distribut lycorin treatment lycorin cellcycl arrest gg phase investig mechan cell cycl arrest grelat protein assai western blot lycorin treatment cyclin cyclindepend kinas express inhibit retinoblastoma protein phosphoryl reduc lycorin treatment upregul express target gene product conclus inhibit hdac activ respons induct cellcycl arrest gg phase lycorin provid mechanist framework explor lycorin novel antitumor agent
PLoS One	27009949	2005-04-27	PMC3537714	23308103	background hivinfect patient predict cytomegaloviru cmv diseas remain difficult protect role mannanbind lectin mbl ficolin cmv diseas report transplant impact hivinfect patient unclear method casecontrol studi nest swiss hiv cohort studi investig associ plasma level mblficolin cmv diseas compar hivinfect patient cmv diseas case cmvseroposit patient cmv diseas control match cd tcell sampl time combin antiretrovir therapi mbl mficolin lficolin hficolin quantifi elisa analys case match control cmv diseas associ mbl odd ratio log ngml increas ci ficolin log ngml increas ci ci ci mficolin lficolin hficolin evid greater associ mbl cmv diseas patient low cd count multivari analysi cmv diseas patient increas hiv rna log copiesml ci shorter durat hivinfect year ci conclus cmv diseas associ low level mblficolin suggest lack protect role hivinfect patient
PLoS One	17392363	2015-09-23	PMC3538733	23308125	there overwhelm bodi evid implic bat dissemin long list emerg reemerg viral agent caus ill death anim human despit pauciti immunolog mechan bat coexist highli pathogen virus immunoglobulin major compon adapt immun system earli studi bat quantit lower antibodi respons model antigen compar convent laboratori anim understand antibodi respons bat studi purifi characteris major immunoglobulin class healthi black fly fox pteropu alecto emploi novel strategi igg initi purifi gener antifab specif antibodi immobilis antifab specif antibodi captur immunoglobulin igg deplet serum high quantiti igm isol serum iga trace quantiti iga detect serum mass spectrometri immobilis ligand specif iga jacalin peptid staphylococc superantigenlik protein fail captur alecto iga serum igm second abund serum antibodi igg survei mucos secret igg domin antibodi class iga studi demonstr healthi alecto bat markedli serum iga expect higher quantiti igg mucos secret compens low abund lack iga knowledg reagent develop studi futur examin classspecif antibodi respons viral host
PLoS One	15857995	2013-11-06	PMC3538747	23308134	the control infecti diseas swine influenza virus swiv plai role food product anim health public health point view probiot microorgan health improv food supplement increas attent year effect probiot swine influenza viru address question assess inhibitori potenti probiot enterococcu faecium ncimb faecium replic porcin strain influenza viru hn hn strain continu porcin macrophag cell mdbk cell cell cultur treat faecium nontox concentr cfuml growth medium min swiv infect incub cultur probioticfre growth medium cell viabil viru propag determin post infect reveal complet recoveri viabil swiv infect cell inhibit viru multipl log unit faecium treat cell mdbkcell min treatment faecium stimul nitric oxid releas publish evid antivir function faecium caus modifi cellular express select mediat defenc dcell express tnf tlr il decreas swivinfect probiot treat cell il increas experiment evid direct adsorpt trap swiv faecium probiot microorgan inhibit influenza virus mechan direct physic interact strengthen innat defenc cellular level
PLoS One	26401005	2012-02-21	PMC3538757	23308119	the high mutat rate rna virus enabl divers genet popul viral genotyp exist singl infect host inhost genet divers better posit viru popul respond adapt divers arrai select pressur hostswitch event multipl coronavirus includ sar identifi human sampl ten year demonstr potenti coronavirus emerg human pathogen deep sequenc character genom chang coronaviru quasispeci simul hostswitch three bovin nasal sampl infect bovin coronaviru infect human bovin macrophag lung cell line viru reproduc macrophag lung cell line infect effici allow passag labadapt sampl kb genom amplifi passag sequenc averag coverag sequenc illumina consensu sequenc of passag sampl nucleotid insert consensu sequenc spike gene multipl point mutat associ presenc insert deep sequenc reveal insert rare unpassag sampl shift domin popul environ insert code three arginin residu occur region associ fusion entri host cell allow infect cell type heparin sulfat bind analysi deep sequenc data indic distinct genotyp circul frequenc level sampl support hypothesi mutat passag strain select preexist pool de novo mutat subsequ popul fixat
Front Immunol	24198407	2009-02-25	PMC3539679	23316195	innat immun repres defens pathogen plai kei role activ orient adapt immun respons innat immun system compris cellular humor arm compon humor arm includ solubl pattern recognit molecul prm recogn pathogenassoci molecular pattern initi immun respons coordin cellular arm act function ancestor antibodi long pentraxin ptx prototyp solubl prm produc site infect inflamm somat immun cell gene target evolutionarili conserv protein reveal nonredund role resist select pathogen ptx exert function crossroad innat immun inflamm femal fertil human ptx protein singl nglycosyl site fulli occupi complex type oligosaccharid fucosyl sialyl biantennari glycan glycosyl implic number ptx activ includ neutral influenza virus modul complement system attenu leukocyt recruit post translat modif fine tuner ptx function nativ immun inflamm review studi ptx emphasi glycandepend mechan underli pathogen recognit crosstalk compon innat immun system
PLoS One	22354946	2016-07-20	PMC3539987	23320093	the highli pathogen avian influenza hpai hn virus laboratorygener hn mutant demonstr potenti cross speci barrier infect mammal human consequ design effect safe antihn vaccin essenti demonstr fulllength hemagglutinin ha induc neutral antibodi respons protect intend identifi critic neutral domain cnd optim conform elicit strong crossneutr antibodi protect diverg hn strain construct recombin protein cover region ha aanhuihn fuse foldon fd fc human igg critic fragment fuse fdfc hafdc number elicit strongest neutral antibodi respons locat ntermin region ha residu cover receptorbind domain rbd residu construct three addit recombin fuse fd tag hafdhi fc hafc tag hahi hafdc form oligomer conform induc strongest neutral antibodi respons crossprotect challeng test hn viru strain cover clade avietnam vn clade ashenzhenh szh hafc dimer hafdhi trimer elicit higher neutral antibodi respons protect hahi monom oligomer form cnd rbd develop effect safe vaccin crossprotect diverg strain hn virus
PLoS One	19244315	2007-06-05	PMC3540029	23320106	the unfold protein respons upr stressinduc cytoprotect mechan elicit influx larg amount protein endoplasm reticulum er studi evalu aav manipul upr pathwai infect examin role three major upr ax endoribonucleas inositolrequir enzym ir activ transcript factor atf pkrlike er kinas perk aav infect cell total rna mock aav infect hela cell determin level erstress respons transcript pathwai observ upregul ir fold perk fold gene hour infect selfcomplementari scaav promin singlestrand ssaav vector studi demonstr scaav scaav induc cellular upr vitro aav vector activ perk pathwai fold aav vector induc increas three major upr pathwai fold data type strength upr activ depend viral capsid examin transient inhibit upr pathwai rna interfer aav transduct sirna mediat silenc perk ir modest aav aav mediat gene express fold vitro hepat gene transfer scaav vector vivo elev ir perk pathwai fold anim pretreat pharmacolog upr inhibitor metformin scaav gene transfer upr signal subsequ inflammatori respons attenu concomit modest fold increas transgen express collect data aav vector activ cellular upr pathwai select inhibit benefici aav mediat gene transfer
J Ophthalmol	27440895	2017-09-01	PMC3541562	23326647	ocular gene therapi rapidli realiti novemb clinic trial approv assess novel gene therapi agent viral infect herpet kerat caus herp simplex viru hsv seriou complic lead blind recurr diseas cornea transplant ideal therapeut solut paper will focu current situat ocular gene therapi herpet kerat includ viral nonvir vector rout deliveri therapeut gene techniqu kei strategi correct inherit diseas initi goal field gene therapi discuss transgen express gene replac silenc clip gene therapi herpet kerat report literatur screen emphas candid gene therapi target commonli adopt strategi discuss assess rel advantag protect therapi antivir drug common gene therapi longterm hsv ocular infect sign inflamm neovascular success gene therapi provid innov physiolog pharmaceut solut herpet kerat
PLoS Pathog	17551004	2006-10-25	PMC3542112	23326235	schmallenberg viru sbv emerg orthobunyaviru rumin associ outbreak congenit malform abort stillborn anim discoveri novemb sbv spread rapidli european countri develop molecular serolog tool experiment vivo model platform studi sbv pathogenesi tropism virushost cell interact synthet biologi approach develop revers genet system rapid rescu genet manipul sbv sbv wide tropism cell cultur synthet sbv replic vitro effici wild type viru develop experiment mous model studi sbv infect viru replic abundantli neuron cerebr malacia vacuol cerebr cortex virusinduc acut lesion understand progress vacuol porencephali extens tissu destruct observ abort lamb calv natur occur schmallenberg case detect high level sbv antigen neuron grai matter brain spinal cord natur lamb calv suggest muscular hypoplasia observ sbvinfect lamb secondari central nervou system damag final investig molecular determin sbv virul interestingli biolog sbv clone passag cell cultur displai increas virul mice sbv delet mutant nonstructur nss protein sbvnss virul mice wild type sbv attenu sbv virul depend inabl sbvnss block ifn synthesi viru infect cell conclus work experiment framework studi biologi pathogenesi sbv
PLoS Pathog	28533327	2013-03-13	PMC3542149	23326226	respiratori infecti diseas caus virus bacteria interact presenc prerequisit subsequ infect virus bacteria nasopharynx caus respiratori symptom upper respiratori tract host vast rang commens potenti pathogen bacteria form complex microbi commun commun assum constantli subject synergist competit interspeci interact disturb equilibrium instanc acquisit bacteria virus lead overgrowth invas better understand dynam commens pathogen upper respiratori tract provid better insight pathogenesi respiratori diseas review current knowledg specif bacterialbacteri viralbacteri interact occur upper respiratori nich discuss mechan interact mediat final propos theoret model summar illustr mechan
PLoS Negl Trop Dis	17065270	2012-07-03	PMC3542170	23326610	cystic echinococcosi major concern south america region advanc control diseas highest incid revers situat pan american health organ paho launch region project cystic echinococcosi control surveil earli concern program lack standard diagnost tool monitor infect dog kei target control program premis develop coproelisa test extens screen larg panel monoclon antibodi mab polyclon sera perform high standard sensit specif establish necropsi diagnosi dog kei compon test mabeg conveni igg isotyp react periodateresist epitop high molecular weight compon worm timecours analysi experiment infect dog anim low number parasit detect earli dai post infect test formul readytous kit format proven stabil compon minimum month room temperatur characterist facilit standard ship laboratori demonstr ident laboratori peru laboratori larg number field sampl analyz independ blind fashion
J Gen Virol	23487465	2007-08-30	PMC3542712	22205718	bat constitut reservoir zoonot infect bat paramyxovirus capabl crossspeci transmiss fatal consequ determin level viral divers reservoir popul fundament understand predict viral emerg relev rna virus adapt mutat requir crossspeci transmiss reservoir host report noninvas collect pool neat urin sampl robust sampl type investig paramyxovirus bat popul consensu pcr assai detect high incid genet divers novel paramyxovirus urban fruit bat popul short period time uniqu relationship bat member famili paramyxovirida propos viral famili addition high rate bathuman contact studi site call zoonot potenti detect virus investig further
J Gen Virol	22758929	2005-08-09	PMC3542720	23052390	interferon ifn induc antivir state cell alter pattern level parainfluenza viru type piv transcript protein studi report ifnstimul gene ifninduc protein tetratricopeptid repeat isgifit respons effect ifn treat cell ifn infect increas viru transcript decreas viru protein synthesi obviou decreas level cellular protein synthesi infect cell treat ifn suggest isgifit select inhibit translat viral mrna conclus support vitro translat studi previou work isgifit restrict replic virus lack omethyltransferas activ enzym methyl hydroxyl group ribos sugar cap structur mrna data current studi suggest piv mrna methyl hydroxyl group isgifit select inhibit translat piv mrna unrecogn mechan isgifit respons ifninduc inhibit piv
Microbiology	17761676	2010-03-10	PMC3542731	23175507	over centuri success attenu multipl bacteri viral pathogen led effect robust safe form vaccin vaccin evalu deliveri vector heterolog antigen simultan vaccin pathogen gener consensu publish studi vaccin vector potenti safe efficaci commonli emploi vector exampl salmonella adenoviru preexist immun respons host potenti modifi subsequ immun respons vector antigen review examin literatur topic conclud bacteri vector fact case enhanc immunogen typic humor viral vector preexist immun hindranc subsequ induct cellmedi respons
J Gen Virol	16191602	2014-07-24	PMC3542737	22535777	viral protein synthesi complet depend translat machineri host cell rna viru transcript mark structur differ cellular mrna preclud canon translat initi absenc cap structur presenc highli structur utr replic andor packag signal whilst great major cellular mrna monocistron rna virus express multipl protein mrna addit rna virus compact genom intens select pressur optim usag sequenc space featur driven evolut plethora noncanon translat mechan rna virus help meet challeng review mechan util rna virus eukaryot focus intern ribosom entri leaki scan nonaug initi ribosom shunt reiniti ribosom frameshift stopcodon readthrough review will highlight discov exampl unusu translat strategi revisit classic case
BMC Public Health	20219909	2010-11-17	PMC3543161	23259484	background tuberculosi devast diseas rapid transmiss high rate mortal ningxia hui autonom region nhar locat northwest poorest provinc china nation survei tb hyper endem nhar decad activ survei undertaken initi dot control program nhar method retrospect studi undertaken clinic record tb patient regist januari septemb poisson regress perform investig chang incid time account ag sex counti length time treatment diseas sever patient delai assess counti patient treatment month year reflect drugresist failur dot patient grade iii diseas time diagnosi patient sever diseas grade ivv nhar counti patient diagnos month onset symptom high counti report incid tb grossli underestim data indic tb major public health concern nhar conclus clear activ surveil determin full extent burden tb nhar control treatment strategi tb requir increas awar healthcar system individu commun level
BMC Infect Dis	25058539	2009-10-01	PMC3544582	23206689	background school foci influenza transmiss potenti target surveil intervent compar schoolbas influenza monitor system clinicbas influenzalik ill ili surveil assess variat ill rate school method initi wave pandem hn pdmhn infect june sept singapor collect data nationwid laboratori confirm case schlcc daili temperatur monitor schdtm teacherl febril respiratori ill report sentinel school schfri comparison agestratifi clinicbas influenzalik ill ili data primari care clinic gpili proport ili test posit pdmhn labili comput fraction cumul incid occur epidemiolog week gpili incid peak cumul incid rate schoolbas indic seroepidemiolog pdmhn incid estim chang preval acalifornia hn hemagglutin inhibit titer preepidem postepidem sera variat schfri rate school investig bayesian hierarch model week primari secondari school children incid schlcc occur compar gpili data and schfri notifi case episod schlcc schdtm system school enrol children repres case episod children schfri rate children ci school estim serolog ci primari ci secondari schoolag children infect schfri rate school episod children widespread variat classroom hierarch model omit ag school effect inconsequenti neglect classroom level effect led highli reduct good fit conclus epidem curv schfri compar gpili data schfri detect infect schlcc schdtm variabl classroom attack rate suggest local classroom transmiss
BMC Health Serv Res	21084459	2015-05-06	PMC3544629	23217103	background pediatr lrti hospit burden patient famili healthcar system studi determin burden pediatr lrti hospit set british columbia benefit prevent strategi relat healthcar resourc demand method lrti inpati episod patient year ag extract bc discharg abstract databas annual number acut care bed requir treat pediatr lrti estim subanalys determin burden infant year ag highrisk infant popul project forecast lrti hospit effect public health initi reduc incid lrti lrti primari diagnosi account hospit diseas respiratori system children year ag infant year ag infant year ag account hospit pediatr lrti pediatr lrti hospit respiratori syncyti viru rsv averag length stai dai healthi infant year ag dai highrisk infant pediatr lrti hospit occur novemb april studi timefram acut care bed requir averag care pediatr lrti increas bed peak lrti hospit increas lrti beddai year old predict implement appropri prevent strategi lrti hospit year old conclus pediatr lrti hospit requir acut care infrastructur novemb april popul project burden increas year implement effect public health prevent strategi contribut reduc acut care demand support effort pediatr healthcar sustain
BMC Vet Res	19563829	2007-05-07	PMC3544736	23289366	background felin immunodefici viru fiv felin leukemia viru felv risk factor control measur infect rate specul vari geograph distribut north america infect endem north america assum work hypothesi geograph distribut purpos exploratori analysi investig compar geograph distribut viral infect count fiv felv posit serolog fiv antibodi felv elisa contigu state district columbia unit state america idexx laboratori websit proport morbid ratio fiv felv infect estim administr region geograph distribut pattern visual choropleth map statist evid excess proport morbid ratio uniti assess spatial scan test normal probabl model studi reveal distinct spatial distribut pattern proport morbid ratio suggest presenc relev geograph vari risk factor diseas map indic higher preval fiv infect southern eastern compar felv contrast felv infect observ frequent western compar fiv respect excess proport morbid ratio respect spatial scan test conclus observ variabl geograph distribut proport morbid ratio fiv felv presenc addit uniqu unknown spatial risk factor put factor geograph variat specif viru strain rate vaccin knowledg factor geograph distribut infect inform recommend test manag prevent studi requir investig potenti associ factor fiv felv
PLoS One	25948743	2014-01-06	PMC3544850	23341874	to evalu role protein cleavag site replic pathogen avian paramyxovirus apmv construct revers genet system recoveri infecti recombin apmv clone cdna recov recombin apmv resembl biolog viru growth characterist vitro pathogen vivo cleavag site sequenc apmv diqprf singl basic amino acid posit mutant apmv virus recov protein cleavag site mutat increas number basic amino acid mimic natur occur cleavag site paramyxovirus includ neurovirul avirul strain ndv presenc glutamin residu posit mutant viru recoveri addit cleavag site furin proteas motif confer increas replic syncytium format vitro analysi viral pathogen dayold embryon chicken egg dayold weekold chicken weekold duck protein cleavag site mutat alter replic tropism pathogen apmv differ observ parent mutant apmv virus vivo parent mutant virus replic better duck chicken highli restrict avirul speci suggest cleavag site sequenc protein limit determin apmv pathogen chicken duck
PLoS One	17485503	2013-03-25	PMC3544913	23341959	purpos advers effect antihypertens therapi incur substanti cost evalu major class antihypertens drug associ switch proxi measur medic side effect larg chines popul hong kong method clinic databas adult patient newli prescrib antihypertens monotherapi hong kong year includ paid visit di stai cohort dai prescript prescrib antihypertens agent exclud factor associ switch dai evalu multivari regress analys ag gender payment statu servic type district resid drug class systol diastol blood pressur level predictor variabl subject patient elig total switch medic dai patient prescrib thiazid diuret highest switch rate acei ccb betablock compar acei patient thiazid diuret switcher adjust odd ratio aor ci whilst patient prescrib ccb betablock switch patient year thiazid mark increas switch rate conclus higher rate switch thiazid diuret studi rais greater incid advers effect chines popul factor influenc switch rate patient prescrib thiazid diuret longer term observ intoler
J Neuroinflammation	24565272	2016-01-01	PMC3545890	23237504	background antivir cd tcell activ enhanc prolong cd tcellmedi help neg regul inhibitori bh interact viral encephalomyel absenc cd cell decreas cd cell activ imped viral control central nervou system cn contrast absenc bh enhanc cd tcell function acceler viral control increas morbid rel contribut cd cell cd function cn absenc bh remain unclear method wildtyp wt bh mice infect gliatrop coronaviru cd cell deplet block helper function cn flow cytometri gene express analysi purifi tcell popul lymph node cn directli monitor vivo tcell effector function biolog alter tcell respons evalu analysi viral control spinalcord patholog increas antivir activ cd cell cn bh mice lost deplet cd cell despit concomit loss viral control clinic diseas sever cd deplet bh mice decreas induc nitric oxid synthas express microglia macrophag consist decreas microgliamacrophag activ reduc interferon ifn enhanc product ifn interleukin il il mrna cd cell infect bh compar wt mice suggest overactiv cd cell contribut increas patholog conclus local requir cd tcell help cd tcell function overcom bh inhibitori signal lost increas effector activ cd cell cn bh mice attribut absenc bh upregul major histocompat complex class ipres resid target cell enhanc local cd tcell function bhmediat restraint cd tcell activ crucial dampen cd tcell function microgliamacrophag activ provid protect tcellmedi bystand damag
BMC Microbiol	23524517	2012-04-11	PMC3547691	23268691	background identif viru strain studi infecti diseas current exist molecular biologi method limit target sequenc design genomespecif pcr primer develop method discoveri unknown virus base cdna random amplifi polymorph dna cdnarapd techniqu getah viru belong famili togavirida genu alphaviru mosquitoborn envelop rna viru identifi virusdiscoverycdna rapd vidiscr method novel getah viru identifi vidiscr suckl mice expos mosquito aed albopictu collect yunnan provinc china nonstructur protein gene nsp structur protein gene capsid protein gene untransl region utr novel getah viru isol clone sequenc nucleotid sequenc ident gene determin compar genom repres strain getah viru conclus vidiscr method identifi viru isol novel isol getah viru infect mice phylogenet analysi indic yn isol close hebei hb strain yn strain genet distinct mm malaysia primit strain
Virol J	27709137	2012-05-30	PMC3547719	23244491	background rotaviru lead pathogen sever gastroenter repres seriou threat human anim health research search cheap safe effect antirotavir drug widespread interest natur product antivir agent licoric deriv glycyrrhiza spp exert antivir properti virus studi antirotavir efficaci glycyrrhiza uralensi extract gue effect cheaper remedi sideeffect evalu colostrumsdepriv piglet induct rotaviru diarrhea method colostrumsdepriv piglet inocul porcin rotaviru gp strain onset diarrhea piglet treat concentr gue evalu antivir efficaci gue fecal consist score fecal viru shed histolog chang small intestin mrna express level inflammationrel cytokin il il ifn ifn tnf signal molecul jnk transcript factor nfb small intestin spleen determin dosag mgml administr anim mgml gue cure diarrhea markedli improv small intestin lesion score fecal viru shed mrna express level inflammationrel cytokin il il ifn ifn tnf signal molecul jnk transcript factor nfb small intestin spleen markedli increas anim rvainduc diarrhea dose depend decreas gue treat anim rvainduc diarrhea conclus gue cure rotavir enter coordin antivir antiinflammatori effect therapi herbal medicin viabl medic cure rotavir enter anim human
PLoS One	22496215	2007-03-24	PMC3547949	23349942	mizoribin monophosph mzp specif inhibitor cellular inosinemonophosph dehydrogenas impdh enzym catalyz ratelimit step de novo guanin nucleotid biosynthesi mzp highli potent antagonist inhibitor impdh block prolifer lymphocyt de novo pathwai guanin nucleotid synthesi exclus studi investig abil mzp directli inhibit human rna cap enzym hce protein harbor rna triphosphatas rna guanylyltransferas activ hce involv synthesi cap structur eukaryot mrna critic splice capproxim intron transport mrna nucleu cytoplasm stabil translat mrna biochem studi provid insight mzp inhibit format rna cap structur catalyz hce presenc mzp rna triphosphatas activ appear unaffect rna guanylyltransferas activ inhibit indic rna guanylyltransferas activ main target mzp inhibit kinet studi reveal mzp noncompetit inhibitor target alloster site hce mizoribin impair mrna cap live cell account global mechan action therapeut agent studi clearli demonstr mizoribin monophosph inhibit human rna guanylyltransferas vitro impair mrna cap cellulo
Virol J	22647692	2019-08-02	PMC3548747	23131097	background highthroughput environ pcr amplifi sequenc larg set viral isol popul heterogen continu evolv degener pcr primer strategi degener primer allow pcr amplif wider rang viral isol set premix primer increas amplif success rate minim necess genom finish activ select larg set degener pcr primer tile entir viral genom maxim success process best perform computation develop fulli autom degener pcr primer design system plai kei role craig venter institut jcvi highthroughput viral sequenc pipelin consensu viral genom set consensu segment sequenc case segment viru iupac ambigu code consensu templat sequenc repres allel divers target popul pcr primer pair select computation produc minim amplicon set capabl tile full length target region tile process primer pair computation screen meet criteria success pcr describ amplif protocol actual sequenc success rate design primer measl viru mump viru human parainfluenza viru human respiratori syncyti viru human metapneumoviru describ design primer pair consist amplifi isol conclus augment develop publish jcvi primer design pipelin achiev high sequenc success rate minor softwar modif recommend methodolog construct consensu sequenc encapsul allel variat target popul kei step prior design degener primer formal describ
BMC Infect Dis	17384942	2014-09-15	PMC3549728	23324497	background hemophagocyt syndrom hp clinic defin combin fever liver dysfunct coagul abnorm pancytopenia progress macrophag prolifer reticuloendotheli system cytokin overproduct primari secondari infecti autoimmun tumor diseas consist associ viral infect debat microorgan involv pathogenesi critic apprais literatur concern hp relationship infect discuss infectiondepend hp observ data concern incid children better understand pathophysiolog hp clarifi interact immun system various implic potenti infecti agent epsteinbarr viru ebv infect promin associ hp clonal prolifer hyperactiv ebvinfect cell number viral bacteri fungal parasit infect report associ hp case lowrisk hp corticosteroid andor intraven immunoglobulin cyclosporin suffici control biolog process etoposid recommend revers infectiondepend lymphohistiocyt dysregul highrisk case summari hp potenti complic infect polymeras chain reaction search infecti agent includ ebv cytomegaloviru leishmania recommend clinic set characteris nonremit fever organomegali cytopenia hyperferritinemia
PLoS One	31375588	2018-01-01	PMC3551756	23349893	a strategi antivir drug discoveri elucid imit viral interfer mechan hiv patient benefit coinfect gb viru gbvc hivposit individu longterm gbvc viraemia better surviv rate hiv patient persist gbvc direct influenc gbvc hiv replic coinfect experi gbvc human nonpathogen member flavivirida famili replic cell gbvc share partli ecolog nich hiv earlier work demonstr recombin glycoprotein gbvc peptid deriv nterminu interfer hiv entri studi investig underli mechan perform viruscel fusion assai temperaturearrest hivinfect kinet provid evid hivinhibitori peptid interfer late hiv entri step engag gp cd receptor coreceptor bind competit experi reveal ntermin peptid bind disulfid loop region hiv transmembran protein gp conjunct comput analys identifi sequenc similar ntermini gbvc hiv glycoprotein gp similar appear enabl gbvc nterminu interact hiv gp disulfid loop crucial domain involv gpgp interfac the studi provid initi proof concept peptid target gp disulfid loop inhibit hiv fusion inspir develop class hiv entri inhibitor
J Transl Med	24898518	2008-11-01	PMC3551837	23294544	background chemokin cxcl report plai role progress malign breast cancer papillari thyroid carcinoma role cxcl colorect carcinoma crc remain establish purpos studi investig express pattern signific cxcl crc progress method colorect carcinoma specimen match adjac normal colorect mucosa specimen collect express cxcl clinic sampl examin immunostain cxcl colorect carcinoma cell prolifer measur mtt assai brdu incorpor assai coloni format assai impact cxcl migrat invas colorect carcinoma cell determin transwel assai matrigel invas assai cxcl express upregul tumor tissu compar adjac nontumor mucosa tissu tumor cxcl express level correl tnm tumornodemetastasi stage histodifferenti tumor size multivari cox regress analysi high cxcl express tumor specimen stage iii patient associ increas risk diseas recurr risk ratio ci elev cxcl express tumor specimen stage iiiiv patient correl wors surviv risk ratio ci function studi demonstr enforc express cxcl sw colorect carcinoma cell aggress phenotyp contrast knockdown cxcl express mitig prolif migratori invas potenti hct colorect carcinoma cell conclus cxcl potenti novel prognost factor predict diseas recurr surviv potenti target postop adjuv therapi crc patient
Mol Oncol	18809447	2013-07-03	PMC3553581	22951279	bacteriophag phage virus infect bacteria promis vehicl target cancer gene therapi albeit poor effici gener improv version phage vector incorpor ci genet element adenoassoci viru aav novel aavphag hybrid aavp effici deliv system administ therapeut gene tumor target displai integrin tumortarget ligand phage capsid inher limit bacteriophag aavp vector improv limit aavp mammalian cell suscept proteasom degrad proteasom upregul cancer constitut barrier gene deliveri eukaryot virus report inhibit proteasom improv target report gene deliveri aavp cancer cell vitro tumor vivo intraven vector administr tumorbear mice enhanc target tumor cell kill aavp proteasom inhibit aavp particl persist cancer cell vitro tumor vivo system administr accumul polyubiquitin coat protein proteasom barrier tumor target aavp indic combin proteasomeinhibit drug aavp consid clinic anticanc therapi
BMC Vet Res	24145548	2013-01-15	PMC3554491	23332090	background swine influenza si acut respiratori diseas caus swine influenza viru siv swine influenza gener character acut onset fever respiratori symptom frequent complic influenza secondari bacteri pneumonia object work studi acut phase protein app respons coinfect piglet hn swine influenza viru swhn pasteurella multocida pm order identifi individu app respons correl diseas sever app marker health statu coinfect pig coinfect pig clinic sing includ fever cough dyspnea viral shed observ dpi level antibodi pm dermonecrotoxin infect piglet increas dpi antiswhn antibodi serum detect dpi concentr creactiv protein crp increas dpi compar control pig remain higher dpi level serum amyloid saa higher dpi haptoglobin hp elev dpi studi pig major acut phase protein pigmap dpi concentr crp hp saa increas specif antibodi detect posit correl serum concentr hp saa lung score clinic score concentr pigmap saa conclus current studi confirm monitor app reveal ongo infect select clinic healthi pig integr uninfect herd corrobor previou find saa indic experiment infect studi vaccin effici investig marker diseas sever correl observ concentr serum diseas sever lung score clinic score
PLoS Comput Biol	23824818	2011-03-30	PMC3554532	23357871	the immun system rapidli respond intracellular infect detect mhc class restrict tcell epitop present infect cell origin thought viral peptid liber constitut protein turnov conflict observ viral epitop detect minut synthesi sourc protein exhibit halfliv dai drip hypothesi propos epitop deriv defect ribosom product drip degrad matur protein product potenti sourc drip prematur translat termin major sourc drip reflect posit bia nterminu contrast downstream initi major sourc drip posit bia cterminu systemat assess posit bia epitop viral antigen exploit larg set data immun epitop databas analysi resourc statist degre posit skew epitop epitop end antigen tend underrepres centricskew correl bia class bind peptid overrepres middl parallel higher degre evolutionari conserv
PLoS Pathog	23225163	2018-11-29	PMC3554583	23358889	the interferoninduc transmembran ifitm protein famili repres class cellular restrict factor block earli stage viral replic underli mechan current provid evid ifitm protein restrict membran fusion induc repres three class viral membran fusion protein ifitm profoundli suppress syncytia format cellcel fusion induc viral fusion protein examin ifitm ifitm inhibit fusion effici depend cell type treatment cell ifn markedli inhibit viral membran fusion entri jaagsiekt sheep retroviru envelop influenza viru hemagglutinin model studi ifitmmedi restrict membran fusion step receptor andor low phmediat trigger creation hemifus essenti block ifitm chlorpromazin cpz chemic promot transit hemifus full fusion unabl rescu ifitmmedi restrict fusion contrast oleic acid oa lipid analog gener neg spontan curvatur promot hemifus virtual overcam restrict explor ifitm protein membran molecular order fluiditi perform fluoresc label laurdan conjunct twophoton laser scan fluorescencelifetim imag microscopi flim observ gener polar gp fluoresc lifetim cell membran express ifitm protein greatli enhanc indic higher molecularli order fluidiz membran collect data demonstr ifitm protein suppress viral membran fusion creation hemifus suggest reduc membran fluiditi confer posit spontan curvatur outer leaflet cell membran studi novel insight understand ifitm protein famili restrict viral membran fusion infect
J Pathog	21450959	2004-09-27	PMC3556854	23365758	aerobiolog plai fundament role transmiss infecti diseas infecti diseas infect control practition continu emploi contemporari techniqu comput fluid dynam studi particl flow polymeras chain reaction methodolog quantifi particl concentr set epidemiolog track spread diseas central variabl airborn transmiss pathogen better paper review aerobiolog variabl particl size particl type durat particl remain airborn distanc particl travel meteorolog environment factor common origin infecti particl review realworld set difficulti control airborn transmiss infecti particl offic build healthcar facil commerci airplan detail respect measur industri undertak effort amelior transmiss airborn infecti diseas
BMC Infect Dis	30637630	2013-04-01	PMC3557153	23256846	background acut viral respiratori infect morbid mortal human worldwid etiolog background infect remain unconfirm clinic case aim studi estim preval human coronaviru infect seri children hospit symptom acut respiratori tract diseas oneyear period slovenia method specimen children year ag hospit univers children hospit ljubljana routin laboratori detect respiratori virus respiratori virus detect direct immunofluoresc assai human coronavirus detect modifi realtim rtpcr hcov rna detect ci sampl specimen identifi speci hku oc nl infect hcov occur coinfect virus sampl hcovposit children lower respiratori tract infect conclus studi hcov frequent detect human pathogen associ respiratori virus acut respiratori tract infect hospit children associ ag viral load highest viral load detect children month ag
Emerg Health Threats J	15452205	2014-09-11	PMC3557908	23362411	the mekong basin diseas surveil mbd network formal establish memorandum understand sign minist health countri greater mekong subregion cambodia china yunnan guangxi lao pdr myanmar thailand vietnam main area focu network improv crossbord infecti diseas outbreak investig respons share surveil data best practic diseas recognit report jointli respond outbreak ii develop expertis epidemiolog surveil countri iii enhanc commun countri compris senior health offici epidemiologist health practition profession mbd grown matur year entiti base mutual trust sustain futur region start emul network pioneer work paper describ develop mbd oper todai achiev kei challeng network face lesson member learn develop suffici trust health profession alert diseas threat nation border effect combat threat
Emerg Health Threats J	23889030	2006-06-09	PMC3557910	23362413	form intern negoti revis intern health regul ihr middl east consortium infecti diseas surveil mecid region collabor aim facilit implement revis ihr broadli improv detect control infecti diseas outbreak neighbor countri area continu disput initi focus enhanc foodborn diseas surveil mecid expand scope work includ avian pandem influenza emerg reemerg infecti diseas describ histori govern mecid highlight kei achiev consortium sevenyear histori discuss futur mecid
BMC Biotechnol	16752044	2014-07-02	PMC3558383	23009349	background viru rescu transfect cell extrem techniqu allow defin viral clone engin purpos ration vaccin design fundament revers genet studi hinder low primari rescu success rate yield fieldderiv viral strain approach investig possibl enhanc influenza viru rescu elicit cell fusion increas chanc plasmid express polykaryon maedivisna viru envelop protein potent fusion activ cell wide rang speci cotransfect cell plasmid rescu influenza viru plasmid express maedivisna viru envelop protein increas rescu effici addit partial complement plasmid rescu system transfect separ popul cell fusion led live viru rescu conclus simpl modif describ potenti improv effici viru rescu process expand potenti applic revers genet studi
PLoS One	25424803	2012-06-01	PMC3559585	23383205	human bocaviru hbov discov children respiratori distress andor diarrhea knowledg previou studi report exist bocaviru saudi arabia swab sampl children respiratori tract infect examin presenc hbov realtim polymeras chain reaction sensit method detect hbov direct gene sequenc determin genotyp detect viru isol hbov detect examin patient np partial gene sequenc patient circul strain hbov genotyp hbov infect patient evid mix coinfect viral pathogen current studi clearli demonstr genet conserv hbov circul saudi arabia interestingli hbov infect case associ high rate coinfect virus
Virol J	24991004	2016-03-14	PMC3560205	23332027	background porcin epidem diarrhea viru pedv pathogen swine respons substanti econom loss previou studi pedv protein plai role viral assembl process subcellular local function pedv protein requir method subcellular local function pedv protein investig examin effect cell growth cell cycl progress interleukin il express cell surviv plenti pedv protein local er small quantiti local nucleu pedv protein intestin epitheli cell iec growth cell cycl cyclin express cell express pedv protein express higher level il control cell studi pedv protein induc endoplasm reticulum er stress activ nfb respons upregul il bcl express conclus studi pedv protein local er nucleu er stress pedv protein iec growth cell cycl addit pedv protein upregul il bcl express
BMC Infect Dis	22692799	2017-11-07	PMC3560251	23343342	background human parainfluenza virus hpiv upper respiratori tract ill urti lower respiratori tract ill lrti analys epidemiolog clinic characterist type human parainfluenza virus hpiv patient acut respiratori tract ill arti studi guangzhou southern china method throat swab collect test children adult arti month period patient clinic present record analysi patient test posit hpiv ninetynin sampl posit hpiv hpiv hpiv hpiv hpivposit sampl paediatr patient younger year infant month ag hpiv posit season peak hpiv hpiv occur autumn turn winter summer turn autumn hpiv hpiv detect frequent frequenc isol increas frequenc hpiv hpiv declin hpiv infect led wide spectrum symptom hoars abnorm pulmonari breath sound dyspnoea pneumonia diarrhoea present hpivposit patient hpivneg patient hpivposit adult patient year present system influenzalik symptom hpivposit paediatr patient year present symptom differ clinic present hpiv type expector coinfect common sampl posit hpiv type test posit respiratori pathogen differ clinic present patient sole infect hpiv patient coinfect hpiv respiratori pathogen conclus hpiv infect led wide spectrum symptom clinic manifest patient type hpiv studi suggest pathogen activ hpiv gastrointestin ill clinic present hpiv infect differ patient ag
J Neuroinflammation	26976607	2017-07-12	PMC3560265	23244217	monocyt heterogen popul bone marrowderiv cell recruit site infect inflamm model human diseas includ central nervou system cn lychiccrhi inflammatori monocyt identifi circul precursor brain macrophag dendrit cell arguabl microglia experiment autoimmun encephalomyel alzheim diseas stroke cn infect caus herp simplex viru murin hepat viru theiler murin encephalomyel viru japanes enceph viru west nile viru precis differenti pathwai function inflammatori monocytederiv popul inflam cn remain contenti issu regard exist monocytederiv microglia contribut monocytederiv subset viral clearanc immunopatholog welldefin understand pathwai inflammatori monocyt migrat brain function capac cn critic inform futur therapeut strategi review discuss kei aspect inflammatori monocyt traffick brain address role cell viral enceph
Front Plant Sci	29434691	2009-08-01	PMC3560349	23386855	dure infect rna virus produc characterist inclus bodi viral host compon structur describ centuri ago origin term xbodi function appreci whilst inclus bodi repres cytopath byproduct viral protein overaccumul xbodi emerg viru factori quasiorganel coordin divers viral infect process replic protein express evas host defens virion assembl intercellular transport gener refer viral replic complex vrc confoc fluoresc microscopi unravel complex structur xbodi produc potato viru pvx dstructur illumin dsim superresolut microscopi map pvx xbodi finer scale identifi unrecogn membran structur induc pvx tripl gene block tgb protein provid insight complex interplai viru host xbodi
PLoS Pathog	28701473	2018-07-09	PMC3561151	23382671	dure diseas progress aid hiv infect individu increasingli immunosuppress suscept opportunist infect demonstr multipl subset dendrit cell dc includ dcsign cell deplet blood lymphoid tissu aid patient contribut failur initi effect host immun respons mechan dc deplet unclear vast quantiti viral envelop protein gp matur hiv virion form circul immun complex serum hivinfect individu patholog role gp hiv pathogenesi remain elus describ unrecogn mechan dc death chronic hiv infect ligat dcsign gp sensit dc undergo acceler apoptosi respons varieti activ stimuli cultur monocytederiv dc freshlyisol dcsign blood dc expos crosslink recombin gp immunecomplex gp hiv serum underw consider apoptosi cd ligat exposur bacteri lipopolysaccharid lp proinflammatori cytokin tnf il circul dcsign dc isol directli hiv individu presensit serum gp activationinduc exorbit apoptosi case dc apoptosi inhibit dcsign blockad final acceler dc apoptosi direct consequ excess activ proapoptot molecul transfect sirna prevent activationinduc excess dc death studi disclos unknown mechan immun modul envelop protein gp insight hiv immunopathogenesi suggest potenti therapeut approach prevent dc deplet chronic hiv infect
PLoS One	19494175	2008-02-27	PMC3561226	23383221	the alveolar epithelium serv barrier organ environ function protect potenti respiratori pathogen alveolar type ii tii cell tradition consid immun cell alveolar epithelium possess immunomodulatori function precis role alveolar type ti cell compris alveolar epitheli surfac area lung immun clear sought determin differ respons ti tii cell lung injuri ti cell activ particip alveolar immun respons ti cell isol fluoresc activ cell sort fac lpsinjur rat demonstr greater foldinduct multipl inflammatori mediat tii cell isol manner anim level cytokin tnf il il cultur primari rat ti cell lp stimul increas compar studi primari rat tii cell contrari publish report cultur tii cell produc small amount tnf il il lp treatment higher level cytokin express cultur tii cell report literatur macrophag contamin tradit nonfac tii cell isol method cocultur tii cell macrophag prior lp stimul increas tnf il product level report investig tii cell cocultur ti cell macrophag prior lp treatment mark increas tnf il product final exogen surfact blunt il respons lp cultur ti cell find advoc role ti cell innat immun respons ti tii cell activ player host defens mechan lung
PLoS Pathog	29985756	2008-01-22	PMC3561295	23382680	ebolavirus highli lethal zoonot pathogen possess longer genom nonseg negativestrand rna virus long untransl region utr viral transcript unit specif function assign utr report assai demonstr zair ebolaviru ebov utr lack intern ribosom entri site function utr differenti regul capdepend translat upstream gfp report gene dramat utr deriv viral polymeras mrna suppress translat gfp compar actin utr utr viral gene possess upstream aug uaug ablat uaug enhanc translat primari orf porf dramat case utr uaug suffici initi translat surround weak kozak sequenc suppress porf translat positiondepend manner condit eif phosphoryl presenc uorf maintain translat porf indic uorf modul translat respons cellular stress directli address role uaug viru replic recombin ebov gener uaug mutat ucg strikingli mutat nucleotid previouslydefin protein code cisact regulatori sequenc attenu viru growth titer fold lower wildtyp viru vero cell mutant viru exhibit decreas viral rna synthesi earli hour postinfect enhanc sensit stress induc thapsigargin cumul data identifi novel mechan ebov regul polymeras express demonstr relev viru replic identifi potenti therapeut target
Orphanet J Rare Dis	18305135	2008-11-25	PMC3562218	23057704	background primari ciliari dyskinesia pcd rare congenit respiratori disord character abnorm ciliari motil lead chronic airwai infect qualit evalu ciliari beat pattern base digit highspe videomicroscopi analysi propos diagnosi process pcd evalu easi typic case difficult ciliari beat partial maintain postul quantit analysi beat pattern improv pcd diagnosi compar quantit paramet qualit evalu ciliari beat pattern patient diagnosi pcd confirm exclud method nasal nitric oxid measur nasal brush biopsi perform prospect patient suspect pcd combin qualit analysi quantit paramet ciliari beat pattern determin highspe videomicroscopi record beat ciliat edg combin ciliari ultrastructur abnorm transmiss electron microscopi analysi low nasal nitric oxid level gold standard establish diagnosi pcd gold standard exclud pcd patient nonpcd patient confirm pcd patient pcd patient inconclus patient paramet distanc travel cilium weight percentag beat ciliat edg present sensit specif qualit evalu quantit analysi concord nonpcd patient pcd patient quantit analysi concord gold standard qualit evalu discord gold standard case patient inconclus gold standard quantit paramet support pcd diagnosi patient confirm identif diseasecaus mutat patient pcd exclus patient conclus beat pattern normal virtual immotil qualit evalu adequ studi ciliari beat patient suspect pcd cilia beat moder alter patient suspect pcd quantit analysi requir precis diagnosi propos select patient elig tem
Cell Biosci	18212100	2013-09-01	PMC3562259	23311606	follow success clone receptor sar coronaviru year ago dr wenhui li colleagu rais attent publish receptor hepat viru elif will review signific find futur prospect hepat research
BMC Public Health	19033469	2017-08-09	PMC3563464	22905965	background exist epidemiolog model tend neglect impact individu behaviour dynam diseas awar presenc ill peopl chang behaviour exampl stai avoid social contact chang control epidem exact econom cost aim studi cost benefit individualbas social distanc undertaken healthi individu form control method model standard sir model superimpos spatial network addit smallworld interact diseas spread control allow suscept individu temporarili reduc social contact respons presenc infect local neighbourhood ascrib econom cost loss social contact weigh econom benefit gain reduc impact epidem studi sensit kei paramet individu attitud risk size awar neighbourhood depend characterist epidem rel econom make contact versu avoid infect optim control extrem adopt highli cautiou control suppress epidem drastic reduc contact diseas detect forego control allow epidem cours worst outcom aris control attempt cautious epidem suppress main result compar size neighbourhood individu awar neighbourhood transmiss occur control work best size match ineffect awar neighbourhood smaller infect neighbourhood robust respect inclus longrang smallworld link destroi spatial structur individu control addit nonloc link eventu control ineffect conclus implic design control strategi social distanc control weak base inaccur knowledg wors outcom noth
Viruses	23694832	2017-07-26	PMC3564116	23322171	cyclophilin cypa main member immunophilin superfamili peptidylprolyl cistran isomeras activ cypa particip protein fold cell signal inflamm tumorigenesi cypa plai critic role replic virus influenza viru infect cypa inhibit viral replic interact protein addit cypa incorpor influenza viru virion final cyclosporin csa main inhibitor cypa inhibit influenza viru replic cypadepend independ pathwai review summar advanc understand role cypa influenza viru infect
Viruses	28794044	2006-02-01	PMC3564121	23334702	in previou studi differ amount genom subgenom rna produc coronavirus mutat program ribosom frameshift signal orfab observ clear differ chang genom sequenc protein sequenc frequenc frameshift virus synonym codon chang produc ratio genom subgenom rna find demonstr protein sequenc primari alter genom subgenom rna product synonym codon chang affect structur frameshift signal frameshift effici small differ frameshift effici result dramat differ genom rna product tcid suggest frameshift frequenc stai threshold optim viru product data rna sequenc ratio viral protein level frameshift viral replic
Viruses	28747502	2013-05-01	PMC3564125	23340380	influenza viru iav caus season influenza epidem influenza pandem seriou threat public health socioeconom impact drug belong categori prophylaxi treatment iav infect hemagglutinin ha envelop glycoprotein iav plai critic role viral bind fusion entri ha attract target develop antiiav drug block entri step iav infect review progress studi conform chang ha viral fusion process develop habas iav entri inhibitor provid choic control futur influenza pandem
Int J Mol Sci	16455884	2012-07-25	PMC3565336	23344058	the function biolog membran determin specif set integr membran protein embed peripher membran protein attach membran surfac activ protein turn modul phospholipid composit membran reconstitut membran protein model membran allow investig individu featur activ cell membran compon activ membran protein difficult sustain reconstitut composit model phospholipid bilay differ nativ cell membran review will discuss reconstitut membran protein activ type model membranemonolay support lipid bilay liposom nanodisc compar advantag membran protein reconstitut variat surround model environ type membran layer affect threedimension structur reconstitut protein lead loss protein activ discuss exampl membran protein reconstitut model membran system comparison observ activ system understand behavior chang protein model membran system membran reconstitut prerequisit protein essenti find better solut retain membran protein activ measur character vitro
J R Soc Interface	23364191	2011-07-15	PMC3565725	23256186	coinfect multipl parasit common individu interact coinfect parasit includ resourc competit direct competit immunemedi interact alter dynam singl parasit posit coinfect driver variat parasit establish growth ultim alter product parasit transmiss stage test hypothesi three treatment group laboratori mice infect gastrointestin helminth heligmosomoid polygyru respiratori bacteri pathogen bordetella bronchiseptica lux coinfect parasit follow coinfect simultan selfbioluminesc bacteria quantifi infect vivo realtim helminth egg product monitor realtim faecal sampl coinfect high bacteri load earli infect dai host mortal coinfect produc helminth supershedd individu chronic helminth egg larger averag number studi coinfect underli mechan oftenobserv high varianc parasit load shed rate consider diseas manag control selfbioluminesc bacteri report allow quantif progress infect anim individu fine tempor scale daili reduc number anim compar experi vivo techniqu bioluminesc imag novel noninvas tool offer great potenti forward applic infecti diseas ecolog
J R Soc Interface	22837198	2005-08-04	PMC3565785	23034353	model infecti diseas spread incorpor contact heterogen contact network tool epidemiologist studi diseas dynam assess intervent strategi challeng contact network epidemiolog difficulti collect individu populationlevel data need develop accur represent underli host popul contact structur studi evalu util common epidemiolog measur epidem peak size durat final size infer degre heterogen popul unobserv contact structur bayesian approach test method ground truth data find epidemiolog metric effect classifi contact heterogen classif consist pathogen transmiss probabl appli characterist unknown reproduct number turn poor classifi degre heterogen unexpectedli final epidem size power predictor network structur rang heterogen evalu framework empir epidemiolog data outbreak demonstr applic practic gather insight relev contact structur specif system gener class infecti diseas introduc simpl approach light unobserv connect host popul epidem data studi potenti inform futur datacollect effort studi design drive understand german epidem measur highlight gener inferenti approach learn host contact structur contemporari histor popul human anim
BMC Med	21765081	2009-10-08	PMC3565905	23289632	todai licens antivir drug emerg drug resist strain invalid effect current therapi treatment infecti diseas compar convent antivir drug monoclon antibodi mab pharmacolog molecul physic characterist mode action consid distinct therapeut class despit histor valid antibodi repres novel tool combat infecti diseas current high cost mab product storag administr inject consequ obstacl develop outweigh mab clinic advantag low toxic combin high specif versatil allow specif antibodi mediat biolog effect rang viru neutral mechan modul immun respons review summar technolog advanc field immunoglobulin current statu mabbas drug clinic trial hiv hcv diseas clinic trial data report emerg conceptu problem emploi mab highlight overview help clear pictur efficaci challeng mab field infecti diseas global impact
Glob Health Action	16081529	2014-02-26	PMC3566378	23394856	background unit arab emir uae rapidli develop countri compos multin popul vari educ background religi belief cultur practic pose challeng populationbas public health strategi number public health issu contribut morbid mortal uae articl summaris find panel medic public health specialist uae univers govern health agenc commiss report health statu uae popul method systemat literatur search conduct retriev peerreview articl health uae unpublish data provid govern health author local hospit panel review evalu evid list rank highest prioriti top main public health issu cardiovascular diseas account death injuri caus mortal ag group cancer account death incid cancer project doubl respiratori disord second common nonfat condit conclus major public health challeng pose person ethnic famili histori lifestyl occup environment factor associ develop chronic diseas isol uae form global health problem requir intern collabor action futur focu populationbas public health intervent target factor associ develop chronic diseas
Front Neural Circuits	19815574	2009-05-06	PMC3566411	23403489	defin connect neuron critic understand structur function nervou system recombin virus engin transmit synaps provid power approach dissect neuron circuitri vivo demonstr recombin vesicular stomat viru vsv endow anterograd retrograd transsynapt trace abil provid viru glycoprotein extend character transmiss gene express recombin vsv rvsv rabi viru glycoprotein rabvg provid exampl activ rel anterograd transsynapt tracer form rvsv rvsv rabvg drive strong express transgen spread rapidli neuron neuron retrograd manner depend rabvg deliv vsv serv polysynapt monosynapt tracer defin project axon uptak retrograd transport anim coinfect rvsv anterograd form rvsv rabvg to character similar differ connect area rvsv rabvg flexibl rapid versatil trace tool complement describ vsvbase anterograd transsynapt tracer
PLoS Pathog	24574396	2010-10-13	PMC3567177	23408893	of orthomyxovirida famili virus influenza virus thought exist multipl subtyp nonhuman mainten host april nasal swab collect viru isol pig exhibit influenzalik ill subsequ electron microscop biochem genet studi identifi orthomyxoviru rna segment exhibit amino acid ident human influenza viru base genet organiz similar influenza virus viru provision design coklahoma cok phylogenet analysi predict viral protein diverg cok human influenza virus observ influenza virus cross reactiv observ cok human influenza virus hemagglutin inhibit assai addition screen pig human serum sampl individu measur antibodi titer cok viru cok viru infect ferret pig transmit naiv anim direct contact cell cultur studi cok viru displai broader cellular tropism human influenza viru observ differ cellular tropism support structur analysi show hemagglutinin esteras protein virus conserv enzymat diverg receptorbind site cok viru repres subtyp influenza virus current circul pig recogn presenc multipl subtyp cocircul influenza virus rais possibl reassort antigen shift mechan influenza viru evolut
BMC Vet Res	19420077	2007-02-21	PMC3568725	23351150	background anaesthesia rabbit associ high mortal rate compar cat dog total intraven anaesthesia tiva drug provid cardiovascular stabil rapidli metabolis benefit rabbit aim evalu cardiorespiratori effect tiva sufentanilmidazolam zealand white rabbit subcutan premed medetomidin mgkg bw iv administr mixtur gml sufentanil mgml midazolam rate mlkg bwh anaesthet induct addition intraven bolus of mixtur administ right reflex lost endotrach intub anaesthesia maintain min infus rate adjust supress pedal withdraw reflex air oxygen deliv lmin physiolog variabl record induct predefin time point anaesthesia right pedal withdraw reflex lost min dose sufentanil midazolam gkg bw mgkg bw induct gkg bwh mgkg bwh mainten apnoea occur rabbit induct anaesthesia caus increas heart rate cardiac output arteri partial pressur decreas arteri pressur respiratori rate ph time stop infus endotrach extub min return right reflex min anaesthesia character induct recoveri excit muscl relax absenc pedal withdraw reflex conclus tiva sufentanilmidazolam provid smooth induct recoveri anaesthesia rabbit mark hypotens respiratori depress requir mechan ventil evalu need establish protocol rabbit undergo surgeri
Virol J	20943966	2009-11-01	PMC3568730	23171743	background felin infecti periton viru fipv felin enter coronaviru fecv coronavirus domest cat worldwid fcov preval cat fastidi natur type fcov grow cell cultur limit studi tissu tropism pathogenesi fcov studi report serolog evid fcov malaysia circul fcov isol biotyp determin studi time describ isol biotyp determin type type ii fcov natur infect cat malaysia find total number cat sampl rtpcr posit fcov inocul clinic sampl crandel felin kidnei cell crfk felin catu fetu cell fcwf cytopath cpe character syncyti cell format cell detach differenti fcov biotyp rtpcr assai reveal local isol type type ii fcov isol high sequenc homolog phylogenet similar fcov isol europ south east asia usa conclus studi report success isol local type type ii fcov evid format cytopath effect type cell cultur crfk fcwf cell permiss rtpcr assai sensit detect antigen suspect sampl compar viru isol cell cultur studi indic type fcov preval cat malaysia
Genome Announc	17314167	2018-03-07	PMC3569343	23405345	the canin respiratori coronaviru crcov strain famili coronavirida group isol south korea genom analyz nucleotid sequenc determin bp small open read frame situat spike envelop gene of crcov strain crcov strain encod three nonstructur protein kda kda kda bovin coronaviru bcov encod three nonstructur protein kda kda kda isol bovin respiratori coronaviru brcov encod nonstructur protein kda kda differ gene encod small nonstructur protein associ emerg highli virus host
PLoS One	29514915	2019-01-10	PMC3570528	23424649	dendrit cell express lectin receptor dcsign allow cell sens glycan bacteri viral pathogen interact dcsign carbohydr moieti induc matur dendrit cell promot endocytosi pathogen properti profession antigen present cell uptak pathogen dendrit cell lead crosspresent antigen infect cell ultim activ virusspecif cell drain lymph node interact dcsign influenza virus viru nonfunct receptor bind site hemagglutinin replic cell express dcsign absenc sialic acid receptor influenza virus virus replic dcsign express cell includ human dendrit cell effici dcsign mediat infect depend extent glycosyl viral hemagglutinin
PLoS One	30630868	2002-11-01	PMC3571988	23418548	background nosocomi infect healthcar worker hcw outbreak respiratori infect influenza hn concern public health polici maker health organ whodefin aerosol gener procedur agp thought increas risk aerosol transmiss hcw present insuffici data quantifi risk accur establish hierarchi riskpron procedur methodologyprincip find studi measur amount hn rna aerosol vicin hn posit patient undergo agp help quantifi potenti risk transmiss hcw sampl occas window produc total stage analysi size rang consid stage m compris sampl viral rna detect air sampl patient twenti three air sampl collect potenti agp perform contain viral rna contrast sampl collect defin agp perform contain viral rna unadjust ci adjust conclusionssignific small sampl size agp increas probabl sampl hn posit aerosol ci probabl detect posit hn posit aerosol perform agp intens care patient baselin rate absenc agp reach signific trend hierarchi agp place bronchoscopi respiratori airwai suction baselin background valu larger studi requir preliminari find benefit infect control team
ScientificWorldJournal	25723279	2018-05-03	PMC3572654	23431254	dengu virus arthropodborn virus term morbid mortal dengu vaccin human set investig chloroquin antivir drug dengu chloroquin amin acidotrop drug affect intracellular exocyt pathwai increas endosom ph vitro treatment vero cell infect dengu viru type denv realtim rtpcr plaqu assai quantifi denv load infect vero cell chloroquin treatment dose gml chloroquin toxic cell induc statist inhibit viru product infect vero cell compar untreat cell cell chloroquin induc statist differ viral replic compar untreat cell show viru pathwai penetr cell confirm plaqu assai pfu data inhibit viru infect induc chloroquin interfer acid vesicl mammalian cell
Int J Mol Med	12368318	2019-10-01	PMC3573733	22960954	the object studi screen antigen hepat viru hcv establish doubl antibodi sandwichlater flow immunoassai daslfia method test presenc antihcv antibodi human serum plasma seri recombin hcv protein escherichia coli cell construct express purifi daslfia strip develop sensit specif daslfia strip evalu detect hcvposit sera set qualiti control refer antihcv detect amount antihcv antibodi hcvneg sera total clinic serum sampl examin daslfia strip enzymelink immunosorb assai elisa data analyz spss softwar sensit specif daslfia strip lowest test hcv daslfia strip ncuml addition concord daslfia strip elisa method conclus test method rapid simpl sensit detect presenc antihcv antibodi human serum plasma monitor hcv
Int J Mol Med	31007618	2012-12-01	PMC3573749	22922731	although hepat viru hcv peopl worldwid vaccin hcv chronic hepat cirrhosi hepatocellular carcinoma lead liver transplant studi curcumin constitu tradit chines medicin evalu antihcv activ mechan human hepatoma cell hcv genotyp subgenom replicon concentr cytotox curcumin dosedepend inhibit hcv replic luciferas report gene assai hcv rna detect hcv protein analysi condit curcumin dosedepend induc heme oxygenas highest induct hemin heme oxygenas induc inhibit hcv protein express dosedepend manner knockdown heme oxygenas partial revers curcumininhibit hcv protein express addit heme oxygenas induct signal molecul activ akt extracellular signalregul kinas erk nuclear factorb nfb inhibit curcumin specif inhibitor pikakt mekerk nfb suggest pikakt inhibit posit involv curcumininhibit hcv replic inhibit erk nfb promot hcv protein express summari curcumin inhibit hcv replic heme oxygenas induct akt pathwai inhibit curcumin inhibit erk nfb activ increas hcv protein express result provid curcumin adjuv antihcv therapi
Virol J	31483243	2016-06-15	PMC3573994	23102237	acut respiratori infect major morbid children develop develop countri wide rang respiratori virus includ respiratori syncyti viru rsv influenza virus parainfluenza virus piv adenoviru rhinoviru hrv repeatedli detect acut lower respiratori tract infect lrti children decad ten year progress molecular technolog newli discov virus identifi includ human metapneumoviru hmpv coronavirus nl hcovnl hku hcovhku human bocaviru hbov enteroviru hev parechoviru hpev rhinoviru hrv strain polyomavirus wu wupyv ki kipyv pandem hnv influenza viru discoveri heavili modifi previou knowledg respiratori infect highlight pediatr popul expos varieti virus season pattern context establish causal link newli identifi viru diseas associ mix infect increas diseas sever challeng review will overview newli recogn main emerg respiratori virus seek focu contribut infect coinfect lrti childhood
Chem Cent J	23171359	2015-09-11	PMC3574041	23379693	background cyrtomium fortumei smith chines herbal medicin biolog function systemat comprehens studi phytochem cyrtomium fortumei smith bioactiv limit bioassayguid techniqu ethyl acet nbuoh extract rhizom cyrtomium fortumei smith exhibit good antitumor activ consequ lead isol compound compound isol plant time inhibitori activ compound investig tumor cell mgc pc vitro mtt thiazolyl blue tetrazolium bromid assai pimpinellin potent cytotox activ three cell line ic valu m mechan antitumor action indic pimpinellin inhibit growth mgc cell induct tumor cell apoptosi apoptosi ratio of treatment conclus studi suggest compound root cyrtomium fortumei smith inhibit growth human carcinoma cell pimpinellin inhibit growth tumor cell induct tumor cell apoptosi
BMC Immunol	27307042	2013-01-01	PMC3575293	22963340	background sever acut respiratori syndrom sar emerg infecti diseas caus novel coronaviru sarscov cell epitop sar cov spike protein systemat evalu function structur role residu report antigen epitop analysi function sidechain mutat studi exagger impos structur disturb unusu steric electrostat hydrophob interact demonstr induc ifngamma respons sarscov dna immun mice splenocyt elisa elispot fac predict optim epitop bioinformat tool ann smm arb bima confirm ifngamma respons induc seri sderiv peptid replac alanin lysin aspart acid ann estim bind affin singl mutant kd predic possess role peptid bind addition residu mutat peptid synthes ifngamma product induc mutat decreas conclus demonstr optim kd ctl epitop sar cov protein anchor epitop directli interact tcr surfac cdt cell
BMC Complement Altern Med	26363073	2011-08-04	PMC3575307	22950667	background common cold caus varieti respiratori virus preval children high contribut morbid iotacarragenan polym deriv red seawe reduc viral load nasal secret allevi symptom adult common cold method assess antivir therapeut activ nasal sprai iotacarrageenan children acut symptom common cold cohort children year ag year displai acut symptom common cold randomli assign treatment nasal sprai iotacarrageenan verum sodium chlorid solut placebo dai symptom common cold record viral load respiratori virus nasal secret determin consecut visit the studi differ iota carrageenan placebo group tss studi dai secondari endpoint reduc time clearanc diseas dai reduct viral load lower incid secondari infect respiratori virus indic benefici effect iotacarrageenan popul treatment safe toler side effect observ verum group compar placebo conclus studi iotacarrageenan allevi symptom children acut symptom common cold reduc viral load nasal secret implic futur studi trial registr isrctn httpwwwcontrolledtrialscomisrctn
Virol J	22995837	2018-01-01	PMC3577433	23402347	background bocavirus classifi genu parvovirida famili singlestrand dna virus pathogen mammalian speci speci report dog minut viru canin mvc associ neonat diseas fertil disord canin bocaviru cbov associ respiratori diseas find studi deep sequenc enrich viral particl liver dog sever hemorrhag gastroenter necrot vascul granulomat lymphaden anur renal failur identifi character novel bocaviru name canin bocaviru cnbov three major orf cnbov ns np vp share aa ident bocavirus qualifi novel speci base ictv criteria invers pcr presenc concatemer circular form genom liver conclus genet character bocaviru dog liver highli distinct prior canin bocavirus respiratori fecal sampl role anim complex diseas remain determin
Springerplus	21817167	2011-06-29	PMC3579474	23450039	infecti bronchiti ib highli contagi diseas respiratori urogenit tract chicken caus infecti bronchiti viru ibv member famili coronavirida diseas common chicken produc commerci pcr revers transcrib rna potent techniqu detect ibv comparison classic detect method pcrbase techniqu sensit fast dozen serotyp genotyp ibv detect will sure report futur conduct identifi infecti bronchiti viru group specif primer avian coronavirus zabol southeast iran tracheal swab collect eleven commerci broiler flock swab rna extract gener primer includ xce xce amplifi ibv serotyp primer mce bce dce amplifi specif nucleotid sequenc massachusett serotyp studi sampl flock posit ibv rtpcr massachusett identifi serotyp infecti bronchiti viru provid molecular evid presenc infecti bronchiti viru massachusett serotyp zabol electron supplementari materi onlin version articl doi supplementari materi author user
Int J Health Geogr	29911966	2010-11-01	PMC3579692	23388060	background infecti diseas pose increas threat public health increas popul densiti more sophist social network effort continu studi larg scale dissemin contagi diseas individualbas activ behaviour studi benefit diseas transmiss model control contain prevent decis make local scale potenti track technolog captur detail spacetim trajectori model individu behaviour increas rapidli technolog advanc enabl manufactur small lightweight highli sensit afford receiv routin locationawar devic widespread smart cellular phone lowcost track devic medic prove effect more studi studi describ track devic collect data spacetim trajectori spatiotempor process data facilit microscal flu transmiss studi report preliminari find activ pattern chanc influenza infect pilot studi method studi emploi agp track devic collect data univers campu spatiotempor process conduct data clean segment process data valid tradit activ diari agp data set visual explor includ densiti surfac visual connect analysi examin spacetim activ pattern relat chanc influenza infect compar diari data segment track data demonstr effect altern greater accuraci time detail rout particip comparison spacetim activ pattern particip caught season influenza reveal interest pattern conclus studi prove track technolog effect techniqu obtain data microscal influenza transmiss find reveal microscal transmiss hotspot univers campu provid insight local control prevent strategi
BMC Infect Dis	21715499	2014-10-15	PMC3579720	23347408	background persist digest disord account consider diseas burden tropic despit advanc understand acut gastrointestin infect issu concern epidemiolog diagnosi treatment control persist digest symptomatolog remain elucid helminth intestin protozoa consid plai major role full extent aetiolog spectrum unclear provid overview pathogen caus digest disord tropic evalu refer test method search literatur identifi pathogen rise persist diarrhoea chronic abdomin pain andor blood stool review exist laboratori diagnost method pathogen stratifi microscopi ii cultur techniqu iii immunolog test iv molecular method pathogenspecif refer test provid highest diagnost accuraci describ greater detail pathogen persist digest disord bacteria virus parasit aetiolog agent acut longlast symptomatolog integr approach consist stool cultur microscopi andor specif immunolog techniqu toxin antigen antibodi detect requir accur diagnosi bacteria parasit molecular techniqu essenti sensit diagnosi virus bacteria intestin protozoa increasingli utilis adjunct helminth identif conclus diagnosi broad spectrum intestin pathogen cumbersom rapid diagnost test simpl afford resourceconstrain set manag patient suffer persist digest disord improv
Curr Genomics	21052085	2005-07-01	PMC3580775	23997647	new organ biolog system design satisfi human aim synthet genom synthet biologi synthet biologi seek model construct biolog compon function organ exist natur redesign exist biolog system perform function synthet genom hand encompass technolog gener chemicallysynthes genom larger part genom allow simultan engin myriad chang genet materi organ engin complex function organ synthet biologi progress depend converg synthet genom applic area predict offer great benefit make drug renew chemic clean energi rise concern safeti environment socioeconom risk stir increasingli polar debat intend provid overview progress biomed biotechnolog applic synthet genom synthet biologi argument evid benefit risk govern implic
Biomed Res Int	25320322	2007-07-20	PMC3581269	23509772	syndrom surveil includ prescript surveil offer rapid method earli detect agent bioterror emerg infecti diseas disadvantag consid definit diagnos attempt definit diagnos pathogen polymeras chain reaction pcr prescript surveil system detect outbreak specimen collect patient respiratori infect pcr identifi pathogen includ type common respiratori virus mycoplasma pneumonia infecti agent includ pneumonia respiratori syncyti viru rsv rhinoviru enteroviru parainfluenza viru detect patient rapid rsv diagnosi kit sensit specif rapid adenoviru diagnosi kit posit sensit calcul specif patient treat upper respiratori tract infect diagnosi specif pathogen japan outbreak pneumonia infect began suggest outbreak includ falseposit case combin syndrom surveil pcr rapidli accur identifi caus pathogen respiratori infect outbreak
BMC Med Inform Decis Mak	17641967	2015-09-14	PMC3582628	23249562	background gener method propos estim transmiss paramet outbreak reproduct number todai dedic softwar exist implement method allow comparison review gener method estim transmiss paramet outbreak carri method epidem curv gener time distribut categori method estim initi reproduct number estim time depend reproduct number implement method librari develop sensit analysi tool method provid numer illustr comparison perform method simul dataset report conclus softwar packag allow standard extens approach estim reproduct number gener interv distribut epidem curv
PLoS One	24328747	2012-05-25	PMC3584084	23460818	as bioaerosol sampl standard andersen type impactor includ investig anthrax attack unit state problem impact desicc stress particl bounc solv improv biolog collect effici plate miner oil layer agar plate andersen sixstag sampler biostag impactor test mineraloilspread agar plate collect indoor outdoor bacteri fungal aerosol effect sampl time min studi biostag impactor sampl environment bioaerosol aerosol bacillu subtili escherichia coli addit particl bounc reduct mineraloilpl investig optic particl counter opc experiment reveal mineraloilspread agar plate enhanc cultur bioaerosol recoveri andersen type impactor pvalu recoveri enhanc depend bioaerosol size type sampl time environ gener enhanc extra observ stage andersen sixstag sampler compar biostag impactor min sampl sampl aerosol subtili coli environment aerosol enhanc increas increas sampl time rang increas min min opc indic miner oil effect reduc particl bounc averag min sampl work suggest enhanc fungal aerosol attribut reduc impact stress bacteri aerosol reduc impact desicc particl bounc plai major role develop technolog enhanc agarbas techniqu includ high volum portabl sampler bioaerosol monitor
PLoS One	26369971	2012-08-01	PMC3584100	23573177	background know nation diseas burden sever influenza lowincom countri inform polici decis influenza treatment prevent novel methodolog local gener data estim burden method find method calcul hospit sever acut respiratori ill sari incid children year person year populationbas surveil provinc base rate sari adjust provinc base preval risk factor healthcareseek behavior percentag sari influenza viru detect determin provinciallevel sentinel surveil appli adjust provinci rate hospit sari healthcareseek data healthcar util survei estim nonhospit influenzaassoci sari rate hospit nonhospit influenzaassoci sari appli censu data calcul nation number case method fieldtest kenya valid guatemala data august juli kenya popul person annual number hospit influenzaassoci sari case rang children year person person year person depend year base rate guatemala popul person annual number hospit case influenzaassoci pneumonia rang person children year case person person year depend year base rate countri number nonhospit influenzaassoci case severalfold higher hospit case conclus influenza viru associ substanti amount sever diseas kenya guatemala method perform low lowermiddl incom countri
Retrovirology	22636772	2010-10-01	PMC3584941	23405908	background human cell lymphotrop viru type htlv infect lead develop adult cell leukemialymphoma atl htlvassoci myelopathytrop spastic paraparesi hamtsp subset infect subject htlv basic leucin zipper factor hbz gene critic role htlv infect develop atl hamtsp immun respons hbz htlvinfect individu studi examin antibodi respons hbz serumplasma sampl subject includ htlv seroneg donor asymptomat carrier ac atl hamtsp patient luciferas immunoprecipit system immunoreact hbz detect subset htlvinfect individu test discrimin ac atl hamtsp frequenc detect hbzspecif antibodi serum atl patient chronic subtyp higher atl patient lymphomat subtyp antibodi respons hbz detect cerebrospin fluid hamtsp patient antihbz serum antibodi respons hbz correl provir load hbz mrna express hamtsp patient presenc hbzspecif respons associ reduc cd cell activ hamtsp patient hbzspecif antibodi inhibit lymphoprolifer pbmc hamtsp patient conclus report demonstr humor immun respons hbz associ htlvi infect humor immun respons hbz plai role htlv infect
PLoS Pathog	22850883	2007-03-01	PMC3585141	23468633	genet variat contribut host respons outcom infect influenza viru viral infect narrow window diseas symptom confound environment factor difficult identifi polymorph gene contribut differenti diseas outcom human popul control confound environment variabl system model level genet divers outbr popul human incipi line highli genet divers collabor cross cc recombin inbr ri panel precc popul studi genet variat impact influenza associ diseas genet divers popul wide rang variat influenza diseas phenotyp includ viru replic virusinduc inflamm weight loss observ diseas associ phenotyp correl viral replic virusinduc inflamm predictor virusinduc weight loss despit correl precc mice uniqu novel diseas phenotyp combin observ identifi set transcript modul correl aspect diseas order identifi host genet polymorph contribut observ variat diseas conduct quantit trait loci qtl map identifi qtl contribut specif aspect host respons includ virusinduc weight loss titer pulmonari edema neutrophil recruit airwai transcript express exist wholegenom sequenc data appli identifi high prioriti candid gene qtl region kei host respons qtl locat site antiinfluenza mx gene sequenc code region mx cc founder strain identifi novel mx allel reduc abil inhibit viral replic maintain protect weight loss
PLoS One	20883165	2006-01-01	PMC3585246	23469104	envelop viru releas driven understood protein function analog coat protein assembl mediat intracellular vesicl traffick differenti electron densiti map detect membran integr membranebend protein viru famili demonstr viru matrix protein replac unexpectedli larg portion lipid content inner membran face gener featur plai role reshap cellular membran
Genome Announc	17331895	2011-04-01	PMC3587950	23469356	we report complet genom sequenc porcin epidem diarrhea viru strain chzmdzy isol central china data sequenc data porcin epidem diarrhea viru pedv isol part china will help understand better epidemiolog genet divers pedv field isol china
Acta Crystallogr Sect E Struct Rep Online	16418529	2014-11-17	PMC3588994	23476230	the titl compound chbrno crystal independ molecul asymmetr unit differ twist bromohindol ring respect plane methylhexahydroquinolin ring dihedr angl molecul indol ring planar molecul maximum deviat atom cyclohexen ring adopt sofa conform crystal molecul link pair nho hydrogen bond form dimer ring motif dimer connect nho hydrogen bond gener chain cho contact occur independ molecul
PLoS Med	21316405	2009-02-01	PMC3589342	23472057	background prior emerg human popul zoonos sar occasion infect human popul expos reservoir speci risk widespread epidem human assess monitor reproduct number averag number person infect human case estim requir detail outbreak investig human cluster resourc expertis addition exist method correct select underascertain bias simpl estim method overcom limit method find approach base parsimoni mathemat model diseas transmiss requir data collect routin surveil standard case investig appli assess transmiss swineorigin influenza hnvm viru nipah viru malaysia bangladesh nonzoonot exampl cholera dominican republ estim base simpl summari statist proport infect natur reservoir detect case subset detect case cluster detect case affect detect case cluster find estim estim case detect rate low gener case bound deriv conclus develop simpl approach limit data requir enabl robust assess risk pose emerg zoonos illustr deriv transmiss estim hnvm viru step evalu pandem threat pose viru articl editor summari
PLoS One	25404719	2005-05-01	PMC3589362	23472214	the exact role cd cell mycobacterium tuberculosi mtb infect heavili debat gener accept cd cell contribut protect mtb studi mtbsuscept cbaj mous strain accumul larg number cd cell lung infect progress cell displai dysfunct immunosuppress phenotyp pd tim cd cd cell expans lung mtbinfect cbaj mice capabl secret immunosuppress cytokin interleukin il vivo cd cell deplet alter mtb burden analysi reveal pulmonari cd cell mtbinfect cbaj mice clonal expand preferenti express cell receptor tcr chain v cd cell respons major il product vivo deplet chang outcom mtb infect hypothes consequ dual ilifn secret profil data demonstr ilsecret cd cell chronic mtb infect signific cell popul tuberculosi pathogenesi remain unclear
Front Microbiol	19165726	2014-11-26	PMC3589766	23508802	in eukaryot viru system infect lead induct membran compart replic occur virusencod subunit replic complex mediat interact membran replic platform rna virus cytoplasm surfac membran compart endoplasm reticulum er golgi endolysosom mitochondria chloroplast peroxisom closteroviru infect accompani format multivesicular complex cell membran er mitochondri origin mechan vesicl format obscur replicationassoci polyprotein beet yellow viru byv closterovirus region methyltransferas helicas domain central region cr cr margin conserv computerassist analysi predict put membranebind domain byv cr transient express hydrophob segment refer cr byv nicotiana benthamiana led reorgan er format mobil globul propos cr involv format multivesicular complex byvinfect cell analog membraneassoci protein mediat buildup viru factori cell infect divers positivestrand rna virus alphalik virus picornalik virus flavivirus nidovirus negativestrand rna virus bunyavirus
PLoS One	25428866	2014-01-01	PMC3591392	23505427	background focu earlier detect pathogen introduct human anim popul led develop surveil system base autom monitor health data real realtim monitor prediagnost data requir autom classif record syndromessyndrom surveillanceus algorithm incorpor medic knowledg reliabl effici remain comprehens user method paper describ applic machin learn nave bay decis tree rulebas method extract syndrom laboratori test request submit veterinari diagnost laboratori high perform fmacro achiev rulebas syndrom classifi base rule induct manual modif construct phase clear interpret classif process unmodifi rule induct algorithm achiev fmicro score fell perform individu class averag unweight manner fmacro fact algorithm fail learn class train set decis tree equal interpret rulebas approach achiev fmicro score fall class equal weight nave bay classifi learn class achiev high perform fmicro fmacro classif process transpar domain expert conclus manual customis rule set allow develop system classif laboratori test syndrom group high perform high interpret domain expert requir develop intern valid rule order establish autom method updat model rule user input
J Pept Sci	15356350	2007-08-22	PMC3592999	23349031	thi review highlight grow protein epitop mimet discoveri biolog activ molecul potenti applic drug vaccin focu fold hairpin mimet design mimic hairpin motif biolog peptid protein evergrow number protein crystal structur reveal hairpin motif plai kei role proteinprotein proteinnucl acid interact review illustr protein structur start point smallmolecul mimet design provid novel ligand proteinprotein interact inhibitor proteas inhibitor ligand chemokin receptor fold rna target novel antibiot combat grow health threat pose emerg antibioticresist bacteria hairpin antibiot target barrel outer membran protein lptd pseudomona sp essenti biogenesi outer cell membran excit prospect protein epitop mimet will increas synthet vaccin design emerg field structur vaccinolog crystal structur protect antibodi bound pathogenderiv epitop provid ideal start point design synthet epitop mimet mimet deliv immun system highli immunogen format surfac synthet viruslik particl scientif challeng molecular design remain great potenti signific success area greater copyright european peptid societi john wilei son ltd
Genome Announc	27099867	2012-08-30	PMC3593334	23516180	a diverg human gammapapillomaviru hpv genom nasal swab elderli finnish patient respiratori symptom genet character gene hpvfin share nucleotid ident report hpv genom provision qualifi speci gammapapillomaviru genu
PLoS One	17715240	2013-09-01	PMC3594242	23536756	among adenovirus chimpanze bonobo studi pan adenoviru type panad isol bonobo pan paniscu best profil vaccin vector combin potent transgen immunogen minim preexist immun human popul studi insert replic defect panad transgen express fusion protein conserv influenza antigen nucleoprotein np matrix studi antibodi cell respons protect challeng infect mous model singl intranas administr panadnpm vaccin induc strong antibodi cell respons protect high dose lethal influenza viru challeng panad promis candid vector vaccin includ univers influenza vaccin
Curr Protein Pept Sci	22936052	2006-07-22	PMC3594739	23305363	proteinas inhibitor plai essenti function role basic biolog process host pathogen endolysosom cathepsin particip immun respons pathogen recognit elimin essenti antigen process present host adapt immun respons activ endosom toll receptor innat immun respons pathogen produc proteas natur inhibitor subvert host immun respons pathogen sens intracellular pathogen recognit receptor host proteolyt system escap cytosol review provid updat develop role proteinas inhibitor initi regul immun respons
Front Microbiol	23693158	2003-10-29	PMC3594938	23487416	the sever manifest malaria caus plasmodium falciparum occur direct result parasitemia invas erythrocyt postliv bloodstag merozoit subsequ cytoadher infect erythrocyt vascular endothelium disproportion epidemiolog cluster sever malaria aggress form endem diseas kaposi sarcoma ks neoplasm etiolog link infect ksassoci herpesviru kshv underscor signific unexplor copathogenet interact potenti modifi diseas burden coinfect individu base studi mechan falciparum kshv evolv interact mutual human host perspect emerg highlight surpris converg biolog theme underli associ comorbid background ongo studi rapidli construct fascin paradigm major host receptor control parasit invas basigincd cytoadher cd surprisingli target exploit kshv articl consid major pathobiolog implic cooption basigincd cd signal pathwai falciparum kshv essenti host factor parasit persist mediat proangiogen phenotyp virusinfect endotheli microenviron consequ triangul interact falciparum kshv mutual human host articul syndem relationship point conceptu framework preval aggress form ks malariaendem area implic possibl dualus therapi debilit infect resourcelimit part world
J Pathog	16790404	2012-04-02	PMC3595711	23533775	given interconnect natur todai emerg pathogen pandem outbreak evergrow threat health econom stabil global commun evid influenza hn pandem sar outbreak everpres threat global bioterror fortun biomed commun rapidli gener sequenc data pathogen identifi util sequenc data rapidli produc relev experiment action treatment lag spite sequenc data pathogen threat emerg andor develop pandem rapidli identifi translat identif target therapeut treatment rapidli materi commentari suggest grow technolog dna synthesi fulli implement rapidli gener vivo data action therapeut sequenc data avail
Virol J	14585926	2009-04-01	PMC3598402	23391188	background acut viral respiratori ill children subsaharan africa receiv attent frequent morbid mortal develop countri activ surveil essenti identifi caus agent improv clinic manag context circul pandem virus find prospect studi conduct central african republ car januari decemb infant children ag year attend sentinel site influenzalik ill acut respiratori ill nasopharyng swab collect onestep realtim multiplex revers transcriptionpolymeras chain reaction detect respiratori virus respiratori virus detect nasopharyng sampl contain influenza virus pandem influenza ahn viru influenza virus contain parainfluenza virus type and contain human respiratori syncyti viru case detect raini season car analysi amplicon sequenc confirm ident detect viru conclus influenza surveil system car provid valuabl data season influenza circul respiratori virus network plai valuabl role prevent control influenza epidem car
Clin Mol Allergy	22466659	2004-08-26	PMC3598778	23347774	background regulatori treg cell balanc immun respons dysregul treg cell implic pathogenesi multipl diseas state includ asthma studi primari aim determin treg cell frequenc peripher blood children asthma secondari aim explor associ treg cell frequenc allergen sensit diseas sever medic method peripher blood mononuclear cell healthi control subject asthmat children vari diseas sever character multiparamet flow cytometri find demonstr children asthma increas frequenc treg cell compar children asthma multivari model increas treg cell frequenc children asthma directli associ inhal corticosteroid asthma sever allerg sensit atop statu asthma conclus conclud low dose local airwai administr corticosteroid suffici impact frequenc treg cell peripher blood data highlight consid medic exposur studi treg cell inhal corticosteroid asthmat improv diseas control increas treg cell frequenc
BMC Infect Dis	19339353	2019-02-01	PMC3598993	23351117	background lower respiratori tract infect lrti major pediatr morbid mortal nonafflu commun studi determin impact respiratori virus viral codetectionsinfect affect clinic lrti sever children hospit set method patient younger year ag admit tertiari hospit brazil month high preval respiratori virus sampl collect nasopharyng aspir sampl test respiratori virus realtim pcr rtpcr patient hospit clinic data popul characterist collect period discharg evalu sever marker length hospit stai oxygen univari regress analys identifi potenti risk factor multivari logist regress determin impact specif viral detect viral codetect relat clinic outcom analyz episod lrti viral detect rate codetect observ virusposit episod preval viru respiratori syncyti viru rsv human metapneumoviru hmpv human rhinoviru hrv multivari model infant codetect hrv rsv stai extra dai compar infant codetect trend observ outcom dai supplement oxygen conclus rsv remain main lrti infant studi indic increas length hospit stai oxygen infant hrv detect rtpcr compar hrv specul hrv detect simultan rsv addit reflect sever clinic outcom studi identifi number children infect identifi virus hmpv human bocaviru hbov novel find poor commun develop countri
BMC Vet Res	15331724	2009-04-28	PMC3599620	22894568	background bovin rotaviru brv infect common young calv viral infect acut diarrhea lead death rapid identif infect calv essenti control brv develop simpl highli specif sensit detect method brv need revers transcript loopmedi isotherm amplif rtlamp assai develop optim rapid detect brv specif primer set design target sequenc vp gene neonat calf diarrhea viru ncdv strain brv rtlamp assai perform water bath minut amplif product visual directli ultraviolet light brv specif rtlamp assai detect copi subtyp brv crossreact detect bovin pathogen abil rtlamp detect bovin rotaviru evalu bovin rectal swab sampl twentynin sampl posit brv rtlamp brvspecificrtlamp confirm realtim rtpcr assai conclus bovin rotavirusspecif rtlamp assai highli sensit hold promis prompt simpl diagnost method detect group bovin rotaviru infect young calv
Algorithms Mol Biol	31406497	2011-02-01	PMC3599976	23343437	background phylogeni estim align haplotyp sequenc attract more attent year analysi finescal genet data applic field rang medic drug discoveri epidemiolog popul dynam literatur molecular phylogenet propos number criteria select phylogeni plausibl altern criteria express object function phylogeni optim refer optim estim criteria parsimoni state optim phylogeni tfor set formula text haplotyp sequenc common set variabl loci satisfi requir shortest length ii pair distinct haplotyp formula text sum edg weight belong path hj smaller observ number chang hj find parsimoni phylogeni formula text involv solv optim problem call parsimoni phylogeni estim problem mppep formula texthard version articl investig version mppep aris input data consist singl nucleotid polymorph haplotyp extract popul individu common genom region explor prospect improv implicit enumer strategi implicit enumer strategi previou work novel problem formul seri strengthen valid inequ preliminari symmetri break constraint precis bound solut space acceler implicit enumer optim phylogeni basic formul introduc seri provabl valid constraint reduc solut space prove constraint lead reduct gap optim solut nonintegr linear program bound rel prior art faster process moder hard problem instanc conclus provid indic condit optim enumer approach feasibl suggest strategi usabl larg number taxa stricter limit number variabl site work methodolog suitabl provabl optim solut harder instanc resist prior approach
Virol J	19401302	2013-09-01	PMC3599982	23445530	summari septemb novel coronaviru isol patient saudi arabia di acut respiratori ill renal failur clinic present reminisc outbreak caus sarscoronaviru sarscov exactli ten year ago case sequenc analysi viru reveal member genu sarscov midfebruari laboratoryconfirm case report fatal case individu resid middl east case famili member resid uk case uk famili cluster travel histori pakistan saudi arabia current evid suggest viru highli transmiss human real danger spread part review event provid summar rapidli emerg pictur viru
Zoonoses Public Health	20637863	2015-05-04	PMC3600532	22958281	bat host rang zoonot zoonot pathogen human activ increas exposur bat will increas opportun infect spill futur ecolog driver pathogen spillov emerg novel host includ human involv complex mixtur process understand complex aid predict spillov pathogen host ecolog impact anthropogen chang fulli appreci crossdisciplinari approach requir understand host pathogen ecolog interact bat differ sylvat diseas reservoir uniqu divers lifestyl includ abil fly highli gregari social structur long lifespan low fecund rate highlight trait affect infect dynam host pathogen trait interact affect infect dynam identifi kei question relat ecolog infecti diseas bat propos combin field laboratori studi need creat datadriven mechanist model elucid aspect bat ecolog critic dynam emerg bat virus common predict dynam newli emerg diseas model approach will scenario popul surveil data unavail unclear aspect host ecolog drive infect dynam
PLoS One	23804568	2005-07-01	PMC3602036	23527143	porcin reproduct respiratori syndrom prr devast pig industri worldwid year caus small rna viru prrsv target exclus pig monocyt macrophag studi sage serial analysi gene express librari deriv hour mockinfect and hour prrsvinfect porcin alveolar macrophag pam produc total sequenc tag uniqu tag differenti express de tag detect bayesian framework genemrna assign arbitrari select manual annot determin de gene reactom analysi david kegg reactom databas assign de gene biolog system function categori pathwai system cellular process genet process environment process metabol organism system human diseas defin kegg modif selforgan map som analysi group de gene ten cluster reflect express trend time point base number function categori system cell growth death transcript process signal transduct energi metabol immun system infecti diseas form major reactom pam respond prrsv infect investig focus domin pathwai de gene identifi multipathwai gene involv pathwai exclusivelyexpress gene includ system studi report larg set de gene compil comprehens coverag pathwai reveal systembas reactom pam infect prrsv reactom data insight molecular mechan involv host genet complex antivir activ prrsv lai strong foundat vaccin develop control prr incid pig
Pediatr Rheumatol Online J	26018441	2012-02-01	PMC3602114	23510667	background acut respiratori infect ari frequent children complic occur patient chronic diseas evalu frequenc impact ari influenzalik ill ili episod diseas activ immunogen safeti influenza vaccin cohort juvenil idiopath arthriti jia patient method surveil respiratori virus conduct jia patient ari season march august consecut year patient patient patient ari ili respiratori sampl collect viru detect real time pcr patient immun influenza vaccin jia activ acrp assess surveil period influenza hemagglutin inhibit antibodi titer measur dai vaccin studi period ari episod report ili sampl collect posit viru influenza rhinoviru frequent detect sampl jia flare observ tempor associ ari influenza seroprotect rate higher strain seroconvers rate exceed gener respons influenza vaccin influenc therapi diseas activ patient antitnf alpha drug present lower seroconvers hn strain differ acrp vaccin patient report ili month vaccin conclus ari episod frequent jia patient role trigger jia flare trival split influenza vaccin immunogen safe jia patient
PLoS One	16000466	2006-01-13	PMC3602451	23526943	porcin transmiss gastroenter viru tgev porcin epidem diarrhea viru pdev sever diarrhea pig develop effect vaccin tgev pedv prevent measur spike protein surfac glycoprotein tgev pedv induc specif neutral antibodi candid antigen vaccin attempt studi open read frame tgev protein addit s protein pedv insert eukaryot express vector pire recombin plasmid pirestgevspedv pirestgevspedv subsequ week kunm mice inocul dna plasmid lymphocyt prolifer assai viru neutral assai ifn assai ctl activ assai perform tgevpedv specif antibodi respons kinet chang lymphocyt subgroup immun mice analyz the recombin dna plasmid increas prolifer lymphocyt number cd cd lymphocyt subgroup addit dna vaccin induc high level ifn immun mice specif ctl activ pirestgevspedv group dai postimmun dai postimmun recombin dna plasmid bear fulllength gene tgev pedv stimul higher level specif antibodi neutral antibodi immun mice
Int J Pediatr	22301155	2018-12-19	PMC3603675	23533446	acut diarrhoea lead child mortal develop countri princip pathogen includ escherichia coli rotavirus norovirus diarrhoeal death attribut inadequ sanit acut diarrhoea second lead childhood mortal account death children estim children di diarrhoea death occur ag treatment goal prevent dehydr nutrit damag reduc durat sever diarrhoeal episod recommend therapeut regimen provid oral rehydr solut or continu feed or effect mitig dehydr durat sever frequenc diarrhoeal episod adjuv therapi micronutri probiot antidiarrho agent recommend zinc tablet associ or espghanespid treatment guidelin consid racecadotril diosmectit probiot adjunct therapi or racecadotril diosmectit reduc stool output treatment reduc hospitalis rate mortal appropri manag valid treatment help reduc health econom burden acut diarrhoea children worldwid
PLoS One	16415002	2015-06-03	PMC3603882	23527182	the exposur wild carnivor viral pathogen emphasi parvoviru cpvfplv assess base molecular screen tissu sampl hunt accident roadkil anim collect portug includ egyptian mongoos herpest ichneumon red fox vulp vulp stone marten mart foina common genet genetta genetta eurasian badger mele mele high preval parvoviru dna detect survei speci mongoos red fox presenc cpvfplv circul antibodi identifi subset parvovirusdna posit sampl specimen extens autolys restrict macro microscop investig lesion evalu examin sign activ diseas support hypothesi parvoviru vp gene fragment detect realtim pcr correspond viral dna reminisc previou infect molecular character virus base analysi complet partial sequenc vp gene allow typifi three viral strain mongoos red fox felin panleukopenia viru fplv stone marten newcpvb type genet similar fplv virus freerang captiv wild speci origin portug publicli compar sequenc suggest closer genet related fplv circul portug clinic epidemiolog signific infect establish studi evid exposur sympatr wild carnivor parvoviru common geograph widespread carri risk suscept popul wildlifedomest interfac threaten speci wildcat feli silvestri critic endang iberian lynx lynx pardinu
Scientifica (Cairo)	30567983	2014-01-23	PMC3605697	23526794	retrovir lentivir vector proven effici system deliv gene interest target cell vivo cell cultur time gene therapi develop gene vaccin retrovir lentivir vector gener tolerogen dendrit cell kei profession antigen present cell regul immun respons three main approach undertaken induc immunolog toler deliveri potent immunosuppress cytokin molecul modif intracellular signal pathwai dendrit cell detarget transgen express dendrit cell microrna technolog review describ retrovir lentivir vector biologi applic induc immunolog toler
Front Plant Sci	26041293	2015-08-01	PMC3607795	23533000	rna recombin drive forc genet variabl strand rna virus type rnarna crossov describ includ cross viral rna viral cellular rna likewis varieti molecular mechan support rna recombin replic event base intern endtoend replicas switch nonrepl join rna fragment viral andor cellular origin mechan rna decai rna interfer respons rna fragment transesterif reaction account ligat rna fragment numer host factor affect profil viral rna recombin differ recombin frequenc observ rna virus compar analys viral sequenc allow develop evolutionari model order explain adapt phenotyp chang coevolv site question remain answer forthcom rna recombin factor modul abil viral replicas switch templat intracellular locat rnarna templat switch mechan factor respons nonrepl rna recombin mechan integr rna viral sequenc cellular genom dna role rna splice ribozym activ evolutionari stand point rna virus parasit host speci recombin obviou contribut rna recombin rna modif pathwai understand frequenc rna recombin vari rna virus statu rna recombin form sex document
Cilia	24940306	2017-09-25	PMC3607980	23351276	background analysi ciliari function assess patient suspect primari ciliari dyskinesia pcd studi respiratori ependym cilia requir assess ciliari beat pattern beat frequenc direct measur beat frequenc highspe video record accur reproduc techniqu extrem time consum aim studi develop freeli autom method ciliari beat frequenc analysi digit video avi file run opensourc softwar imagej coupl microsoft excel valid comparison direct measur highspe video record respiratori ependym cilia model allow comparison cilia beat hz method digit video file motil ciliat ependym frequenc rang hz respiratori epitheli cell frequenc hz captur highspe digit video record cover rang hz frequenc ependym cilia slow addit pneumococc toxin pneumolysin measur directli time number individu ciliari beat cycl compar autom ciliafa system differ sd ciliafa direct measur highspe digit imag method hz correl coeffici blandaltman limit agreement hz respiratori hz ependym cilia conclus plugin imagej develop extract pixel intens perform fast fourier transform fft microsoft excel ciliafa softwar allow autom high throughput measur respiratori ependym ciliari beat frequenc rang hz avoid oper error select bia includ free access ciliafa plugin instal instruct addit file accompani manuscript research us
Vet Med Int	26305189	2007-12-05	PMC3608130	23555071	the nasal septa fetal rabbit dai gestat harvest cesarean anesthesia expos bordetella bronchiseptica lipopolysaccharid lp period hour total explant tissu examin hematoxylin eosin techniqu semithin section stain toluidin blue examin indirect immunoperoxidas ipi lectin histochemistri frequent statist find cell death increas goblet cell activ expos bacteria cell death cytoplasm vacuol infiltr polymorphonuclear leukocyt expos lp lesion induc bacterium sever lp cytoplasm vacuol epitheli cell ipi stain ciliat border epithelium bacterium intens lp lectin histochemistri preferenti label cytoplasm goblet cell data indic bronchiseptica lp affin specif glycoprotein adhes receptor locat
Evid Based Complement Alternat Med	28942750	2017-11-15	PMC3608275	23554831	enteroviru ev coxsackieviru cva caus agent hand foot mouth diseas hfmd epidem hfmd china medicin herbal prepar herbal extract demonstr therapeut efficaci rel safeti profil microbiolog studi valid hfmd select commonli herb hfmd govern recommend guidelin publish report test antivir activ antiinflammatori activ water extract houttuynia cordata thunb hct inhibit ev infect margin activ cva infect ic concentr inhibitori valu hct fuyang strain brcr strain ev determin gml gml mentha haplocalyx briq mhb water extract activ cva ic gml extract exhibit activ ev infect major extract activ viral infect extract demonstr activ block proinflammatori respons viral infect studi valid effect chines herb hfmd formul correct combin herb block viral replic proinflammatori respons hfmd
Virol J	18057234	2013-03-18	PMC3610273	23379823	background human coronavirus hcov wellknown respiratori infect role gastrointestin infect unclear object studi assess signific hcov etiolog acut gastroenter ag children year ag method stool sampl nasopharyng np swab collect children hospit ag respiratori symptom healthi control children admit elect surgeri test presenc hcov real time rtpcr regist clinicaltrialsgov reg nct hcov frequent patient ag control versu odd ratio confid interv ci three hcovposit member control group asymptomat sampl recal gastrointestin respiratori symptom previou dai patient ag hcov np sampl stool versu children hcov detect stool virus detect np swab patient higher probabl hcov detect stool ci stool andor np ci healthi control hcov speci detect stool np sampl conclus hcov frequent detect patient ag control group high preval hcov np swab compound low occurr stool sampl detect virus stool sampl indic hcov plai minor role caus gastrointestin ill children year old
Evid Based Complement Alternat Med	29142129	2007-03-01	PMC3610377	23573150	tumor necrosi factoralpha tnf report anticanc therapi cytotox arrai tumor cell undesir respons tnf activ nfb signal prometastat properti limit clinic applic treat cancer sensit agent capabl overcom undesir valuabl facilit usag tnfmediat apoptosi therapi cancer patient saikosaponind ssd triterpen saponin deriv medicin plant bupleurum falcatum umbellifera exhibit varieti pharmacolog activ antiinflamm antibacteria antiviru anticanc ssd inhibit activ lymphocyt suppress nfb nfat ap signal ssd potenti tnfmediat cell death hela hepg cancer cell suppress tnfinduc nfb activ target gene express involv cancer cell prolifer invas angiogenesi surviv ssd reveal potenc abolish tnfinduc cancer cell invas angiogenesi huvec induc apoptosi enhanc loss mitochondri membran potenti hela cell collect find indic ssd potenti develop combin adjuv remedi tnf cancer patient
PLoS Pathog	23324399	2019-07-03	PMC3610696	23555248	human tcell immunoglobulin mucindomain protein tim bind phosphatidylserin ps tim propos serv cellular receptor hepat viru ebola viru entri factor dengu viru tim promot infect retrovirus viruslik particl vlp pseudotyp rang viral entri protein filoviru flaviviru arenaviru alphaviru famili tim robustli enhanc infect replicationcompet virus famili includ dengu tacarib sindbi ross river virus interact tim pseudovirus vlp psmediat demonstr liposom block tim mutagenesi experi addit psbind protein axl tim promot infect tim final block ps receptor macrophag inhibit entri ebola vlp suggest ps receptor contribut infect physiolog relev cell notabl infect mediat entri protein lassa fever viru influenza viru sar coronaviru unaffect tim express data tim psbind protein promot infect divers famili envelop virus target broadspectrum antivir therapi
PLoS One	17486211	2008-08-01	PMC3612040	23555956	the genom hadvbp strain bj isol sixmonthold babi diagnos bronchial pneumonia beij children hospit decemb sequenc analyz compar refer adenoviru genom sequenc archiv genbank genom bp length remark present ident genom hadvp strain isol usa remark ident hadvbp prototyp de wit strain genom isol netherland patient parent presum limit contact person usa ireland report outbreak reemerg viru hadvp genom data analysi report provid refer addit hadvb outbreak china provid basi develop adenoviru vaccin molecular pathogen surveil protocol highrisk area
Acta Naturae	31270230	2018-10-15	PMC3612824	23556129	dure decad numer attempt anim order produc recombin human protein monoclon antibodi therapeut agent isol milk transgen anim inhibitor ruconest antithrombin atryn appear market inspir hope consider number recombin protein creat technolog practic futur review method appli produc transgen anim describ advantag drawback produc recombin human protein monoclon antibodi discuss
PLoS One	18562249	2004-08-01	PMC3613375	23560060	natur human exhal flow cough sneez breath consid jetlik airflow sens produc singl sourc singl exhal effort symmetr conic geometri cough sneez garner attent potenti explos sourc infecti aerosol rare event daili life breath life perform continu realtim shadowgraph imag visualis captur highspe imag healthi volunt sneez breath nose nasal mouth oral volunt respond pepper sneez stimulu recruit sneez experi women year men year maximum visibl distanc sneez plume puff travel maximum sneez veloc deriv measur distanc ms maximum dimension area dissemin sneez correspond deriv paramet maximum area expans rate sneez ms nasal breath maximum propag distanc deriv veloc ms maximum area dissemin deriv expans rate ms mouth breath maximum propag distanc deriv veloc ms maximum area dissemin deriv expans rate ms surprisingli comparison maximum exit veloc sneez report cough publish demonstr extrem high contrast earlier estim sneez veloc reason differ discuss
Virol J	30320601	2009-12-01	PMC3614426	23339605	enteroviru ev human pathogen sever neurolog complic death children viru caus outbreak asiapacif region decad consid public health problem postpolioviru erad era polioviru effect vaccin approv antivir ev explor antiev agent vital strategi emploi develop antivir base molecular characterist viru small molecul develop human rhinovirus polioviru evalu review discuss develop small molecul ev drug resist solut anim model evalu efficaci antivir investig requir clinic applic exist candid molecular mechan reveal inhibit ev replic design molecul viru futur
Int J Biomed Sci	15282380	2005-06-01	PMC3614584	23674957	object order investig clinic epidemiolog rule sever acut respiratori syndrom sar rate level sar coronaviru sarscov igg antibodi patient commun popul area detect method indirect immunofluoresc assai ifa doubleantigen sandwich enzymelink immunosorb assai elisa detect sar coronavirusspecif igg antibodi sera includ gener popul hongkong marco guangzhou peke sar patient guangzhou peke dynam serum antibodi sar patient observ dai onset symptom patient serum specimen dai diseas onset posit sarscov igg elisa ifa sar patient antibodi titer increas steadili earli month onset sar titer case peak month antibodi titer declin rapidli case specimen posit sarscov igg month conclus studi inappar infecti patient exist sar epidem serum igg antibodi diagnost sar late cours diseas antibodi month
PLoS One	20001520	2009-05-13	PMC3614905	23573288	mannosebind lectin mbl kei solubl effector innat immun system recogn pathogenspecif surfac glycan surprisingli lowproduc mbl genet variant predispos children immunocompromis individu infecti diseas common expect human popul immun defens molecul immunoglobulin exploit invas pathogen hypothes mbl enhanc infect circumst consequ low intermedi mbl level commonli human popul result balanc select model infect system pseudotyp authent glycosyl virus demonstr mbl enhanc infect ebola hendra nipah west nile virus low complement condit mechanist studi ebola viru ebov glycoprotein pseudotyp lentivirus confirm mbl bind nlink glycan epitop viral surfac specif manner mbl carbohydr recognit domain enhanc infect mbl mediat lipidraftdepend macropinocytosi ebov pathwai appear requir actin earli endosom process compar filoviru canon endocyt pathwai valid rna interfer screen identifi cqbp gcqr candid surfac receptor mediat mbldepend enhanc ebov infect identifi dectin cleca novel candid attach factor ebov find support concept innat immun haplotyp repres critic interact mbl complement compon gene modifi suscept resist glycosyl pathogen higher level nativ exogen mbl deleteri set rel hypocomplementemia occur genet immunodeplet activ infect find confirm hypothesi pressur infecti diseas contribut evolutionari select mbl mutant haplotyp
Int J Biomed Sci	15937197	2017-09-01	PMC3615292	23675206	function extracellular proteas dipeptidyl peptidas iv dppiv preferenti cleav peptid bond penultim prolin residu report dppiv cleav amino acid insulinlik growth factor igf reveal mass spectrometri kinet paramet proteolyt cleavag indic reaction physiolog relev interestingli truncat igf potent fulllength protein activ igfr bind igfbind protein igfbp quantit rtpcr level dppiv mrna dramat lower lung squamou cell carcinoma tissu adjac nonneoplast lung tissu reduct observ lung adenocarcinoma tissu studi suggest link igf dppiv cancer develop specif tumor nich dppivrel pathwai mitig igf signal consequ robust igf signal pathwai acceler earli carcinogenesi environ lack dppiv
Global Health	19439466	2018-11-26	PMC3615947	23531369	background studi aim evalu length time elaps report incid avian flu hn outbreak publish promedmail major global health surveil system amend intern health regul ihr explor associ countri transpar timeli gap method record initi releas date report avian flu hn list diseas outbreak new site match outbreak report promedmail nongovernment program monitor emerg diseas june timeli gap calcul differ dai report releas date match outbreak promedmail system civil liberti score collect indic transpar countri human develop data indic densiti physician nurs collect reflect countri develop health workforc status logist regress perform determin correl timeli gap civil liberti human develop health workforc statu control year report timeli gap avian flu hn outbreak decreas averag report post sd dai earlier promedmail countri partli free free civil liberti score higher likelihood longer timeli gap nonfre countri countri high human develop statu higher likelihood longer timeli gap countri middl low human develop statu associ timeli gap health workforc densiti conclus studi adopt ihr contribut countri awar time report impact improv report timeli gap addit greater civil liberti countri freedom media longer timeli gap
PLoS Pathog	28892445	2015-01-01	PMC3616983	23592992	the incorpor envelop glycoprotein complex env develop particl crucial step hiv lifecycl long cytoplasm tail ct env requir incorpor env hiv particl cell macrophag identifi rabafipcrcp protein essenti cofactor hiv env incorpor particl relev human cell deplet fipc reduc env incorpor cytoplasm taildepend manner rescu replenish fipc fipc redistribut endosom recycl complex plasma membran wild type env protein cttruncat env rab requir hiv env incorpor fipc mutant incap bind rab fail rescu env incorpor express fipc rab led enhanc env incorpor indic traffick factor limit ctdepend env incorpor particl find support model hiv env incorpor specif target particl assembl microdomain plasma membran mediat fipc rab
PLoS One	30475677	2017-12-15	PMC3618226	23577091	legumainbas dna vaccin potenti protect breast cancer lack safe effici oral deliveri system restrict clinic applic construct algin acidco chitosan nanoparticl acnp oral deliveri carrier legumain dna vaccin test characterist acid environ vitro dna agaros electrophoresi data acnp protect dna better degrad acid solut ph chitosan nanoparticl cnp size distribut analysi acnp tend aggreg form micromet scale complex ph dispers nanoparticl increas ph mice intragastr administr acnp carri egfp plasmid egfp express detect intestin peyer patch fulllength legumain plasmid load deliveri carrier includ cnp attenu salmonella typhimurium acnp acnp load empti plasmid serv control oral vaccin perform murin orthotop breast cancer model data indic tumor volum smaller group acnp attenu salmonella typhimurium carrier splenocyt cocultur cell prestimul cocl influenc transloc legumain cytoplasm plasma membran fold increas activ cytotox lymphocyt cdcdcd treat acnp carrier compar pb cnp studi suggest cnp coat algin acid safe effici tool oral deliveri dna vaccin legumain dna vaccin deliv oral acnp effect improv autoimmun respons protect breast cancer mice
Vet Res	25636444	2010-03-03	PMC3618313	23506546	resist respiratori diseas cattl requir host defens mechan protect pathogen evolv sophist strategi evad includ alter function pulmonari macrophag ms induct inflammatori respons lung injuri sepsi aim studi clarifi mechan respons vascular chang occur lung calv infect bovin viral diarrhea viru bvdv challeng bovin herpesviru type bhv evalu role ms develop patholog lesion organ purpos pulmonari lesion compar coinfect calv healthi anim inocul bhv immunohistochem mac tnf il ino cox factorviii ultrastructur studi group calv present vascular alter produc fibrin microthrombi platelet aggreg blood vessel find earlier sever coinfect group indic concomit bvdv bhv lung disrupt pulmonari homeostasi facilit establish inflammatori procoagul environ modul inflammatori mediat releas pulmonari ms regard coinfect calv spite present greater number im singleinfect group decreas ino express coincid presenc coagul lesion anim preinocul bvdv displai alter respons proinflammatori cytokin tnf il plai kei role activ immun respons local cellmedi respons
BMC Neurosci	28475350	2015-10-07	PMC3618319	23391218	background neuroinflammatori respons aim clearanc herp simplex viru hsv plai kei role pathogenesi neuroaxon damag herpet enceph leukocyt activ adapt immun respons access brain tissu pass bloodbrain barrier chemokin cclrant involv recruit cell brain act receptor ccr ccr ccr evalu role ccr traffic leukocyt brain microvasculatur cellular cytokin profil sever form herpet enceph wild type mice lack ccr ccr inocul intracerebr pfu neurotrop hsv evalu traffic leukocyt brain microvasculatur intravit microscopi profil cytokin enzymelink immunosorb assai dai post infect flow cytometri histopatholog analys carri brain tissu absenc ccr lead lower viral load increas leukocyt adhes brain microvasculatur neutrophil cd lyg cell increas level mipccl rantesccl kccxcl migcxcl brain infect ccr mice conclus absenc ccr boost immun respons high neutrophil recruit help viral clearanc elev immun respons detriment host
Evid Based Complement Alternat Med	20200235	2015-09-23	PMC3619540	23634170	although berberin alkaloid ba report broadspectrum antibacteri antivir activ interact ba elucid studi methicillinresist staphylococcu aureu mrsa chosen model organ modifi broth microdilut appli determin fluoresc absorpt valu calcul antimrsa activ ba initi step seek optim combin ba determin antimrsa activ singl ba investig twocompon combin clarifi interact ba checkerboard assai investig multicompon combin determin optim ratio quadrat rotationorthogon combin design vivo vitro valid optim combin the interact ba concentr synerget combin includ berberin epiberberin jatrorrhizin palmatin jatrorrhizin coptisin antagonist combin includ coptisin epiberberin optim combin berberin coptisin jatrorrhizin palmatin epiberberin potenc optim combin cyclophosphamideimmunocompromis mous model better natur combin herb ba
PLoS One	26446422	2006-02-10	PMC3620113	23577059	empir quantif human mobil pattern paramount better urban plan understand social network structur respond infecti diseas threat light rapid growth urban global relev develop countri host major global urban popul disproportion burden diseas global posit system gp datalogg track finescal citi mobil pattern resid neighborhood citi iquito peru gp datapoint quantifi agespecif mobil paramet dynam coloc network track individu geograph space human mobil rise highli local mobil kernel movement occur individu potenti hourli contact individu highli irregular tempor unstructur track particip regular predict mobil routin sharp contrast situat develop case studi quantifi impact spatial tempor unstructur routin dynam transmiss influenzalik pathogen iquito neighborhood tempor unstructur daili routin domin singl locat workplac individu repeatedli spent amount time increas epidem final size effect reproduct number comparison scenario model tempor structur contact find provid mechanist descript basic rule shape human mobil resourcepoor urban center contribut understand role finescal pattern individu movement coloc infecti diseas dynam gener studi emphas care consider human social interact design infecti diseas mitig strategi resourcepoor urban environ
PLoS One	26640556	2001-03-15	PMC3620170	23593419	coronavirus famili larg positivesens rna virus respons wide rang veterinari human diseas nsp role pathogenet mechan coronavirus vivo assess function conserv domain llrkxgxkg mhv nsp mutant viru mhvnspd nt llrkxgxkg delet nsp construct revers genet system vaccinia viru vector mutant viru growth kinet mhva wildtyp viru ci cell highli attenu vivo mutant viru complet protect cbl mice lethal mhva challeng analyz mechan attenu mutant viru chang report gene express measur nsp nspdexpress cell nsp inhibit report gene express control promot inhibit reduc nspd vivo vitro suggest llrkxgxkg region nsp plai role process
Ital J Pediatr	16474126	2007-02-13	PMC3621398	23536956	background purpos studi determin incid season distribut viral etiolog agent compar clinic manifest diseas sever includ singl infect method multiplex reversetranscript pcr perform detect virus nasopharyng aspirat diseas sever group categor mildmild moderatesever clinic laboratori characterist hospit children viral respiratori tract infect analyz viral pathogen detect patient order frequenc identifi pathogen respiratori syncyti viru adenoviru parainfluenza virus type rhinoviru influenza human metapneumoviru coronaviru bocaviru coinfect sampl children mild mild diseas sever ill wors coinfect common discharg diagnos urti lrtiasthma virus exhibit strong season pattern leukocytosi neutrophilia commonli detect patient adenoviru rhinoviru monocytosi remark find patient patient adenoviru conclus rsv rhv associ higher sever ill hospit children rsv account half lrti hospit adv flua infect fever last longer virus coinfect detect patient presenc coinfect associ increas diseas sever
PLoS One	11222733	2015-02-25	PMC3621892	23593220	background lycori aurea call golden magic lili ornament medicin speci amaryllidacea famili sequenc genom unavail nonmodel organ transcriptom scarc speci studi perform de novo transcriptom sequenc produc comprehens express sequenc tag est dataset aurea highthroughput sequenc technolog methodolog princip find total rna isol leav sodium nitroprussid snp salicyl acid sa methyl jasmon meja treatment stem flower bud bloom wilt stage equal quantiti rna tissu stage pool construct cdna librari pyrosequenc technolog total high qualiti read mb averag read length bp gener cluster assembl read produc nonredund set uniqu sequenc compris contig singleton uniqu sequenc involv biolog process cellular compon molecular function categori analysi potenti gene function predict kegg pathwai map cog analysi base sequenc analysi publish literatur put gene involv amaryllidacea alkaloid synthesi includ pal tydc omt nmt candid gene identifi time lycori ssr highconfid snp identifi est dataset conclus transcriptom invalu data function genom resourc futur biolog aurea molecular marker identifi studi will provid materi basi futur genet linkag quantit trait loci analys will provid function genom futur
PLoS One	17296950	2012-09-07	PMC3622008	23585856	background clinic consequ coinfect respiratori virus understood sought determin coinfect pandem influenza hn phn respiratori viru associ wors clinic outcom method retrospect cohort studi perform hospit patient posit respiratori viral panel rvp virus hour admiss institut octob decemb compar patient infect respiratori viru respiratori viral coinfect identifi inpati posit rvp sampl singl viru inpati posit rvp sampl virus coinfect coinfect patient younger feverchil tachypnea demonstr interstiti opac suggest viral pneumonia present chest radiograph ci likelihood death length stai requir intens care unit level care group patient respiratori viru coinfect experi complic treatment secondari bacteri pneumonia ci patient coinfect phn respiratori viru chest radiograph chang suggest viral pneumonia compar monoinfect phn ci logist regress monoinfect nonphn virus refer group coinfect phn strongest independ predictor treatment secondari bacteri pneumonia ci conclus patient viral coinfect phn chest radiograph featur compat viral pneumonia complic hospit cours treatment secondari bacteri pneumonia despit coinfect associ icu admiss
ScientificWorldJournal	25717043	2013-09-11	PMC3622387	23589704	to evalu controversi issu concern current felin coronaviru fcov virolog coexist hypothes intrahost interhost origin felin infecti periton viru fipv regard pathogenesi felin infecti periton fip studi aim assess molecular divers membran gene fcov sampl cat sign fip faecal sampl cat sign fip sampl nonfip cat sampl fip cat posit fcov membran gene mutat gene consist snp chang randomli scatter sequenc mutat amino acid chang geograph pattern observ cat fip harbour fecov amino acid sequenc ident gene cat cat catteri sequenc ident gene cat lineag fcov enter system segreg apart gene tree conclus vivo mutat transit hypothesi circul high virulentlow virul fcov hypothesi plausibl sequenc gene
Front Microbiol	22961849	2008-11-01	PMC3622897	23596441	import progress understand replic interact host plant evolut closterovirus enabl engin vector gene express virusinduc gene silenc broad host rang closterovirus vector expand vector applic includ woodi plant citru grapevin larg closteroviru genom offer genet capac stabil unriv plant viral vector featur provid immens opportun closteroviru vector function genom studi pathogen control econom valuabl crop review summar advanc closteroviru decad explor relationship viru biologi vector design outlin promis direct futur applic closteroviru vector
PLoS Pathog	24027335	2012-06-20	PMC3623752	23593008	respiratori syncyti viru rsv highli pathogen member paramyxovirida sever respiratori tract infect report literatur indic infect cell incom virus fuse envelop directli plasma membran exploit clathrinmedi endocytosi studi entri process human tissu cultur cell hela fluoresc microscopi develop quantit facsbas assai follow viru bind cell endocytosi intracellular traffick membran fusion infect varieti perturb emploi character cellular process involv bind cell rsv activ signal cascad involv egf receptor cdc pak downstream effector led seri dramat actin rearrang cell round plasma membran bleb form increas fluid uptak effect inhibit compound target nah exchang myosin ii pak factor infect observ rsv rapidli effici intern actindepend process hallmark macropinocytosi fuse plasma membran virus enter rabposit fluidfil macropinosom fuse membran averag min intern rab requir infect find explan endocytosi requir unusu paramyxovirus analyz fusion protein cleav furin famili proteas underw second critic proteolyt cleavag intern cleavag furinlik proteas remov small peptid subunit viru infecti
Virol J	19000291	2008-05-01	PMC3623871	23566284	background acut viral necrosi viru avnv caus agent seriou diseas high mortal cultur chines scallop chlami farreri sequenc analyz complet genom avnv avnv genom linear doublestrand dna molecul bp nucleotid composit total open read frame predict encod function protein rang amino acid residu dna sequenc avnv ident ostreid herpesviru oshv amino acid sequenc encod protein virus ident genom organ avnv oshv consist uniqu region kb kb flank invert repeat kb kb third uniqu region kb situat intern repeat conclus indic avnv variant oshv avnv genom sequenc understand evolut diverg oshv marin mollusc
BMC Genomics	22718819	2006-05-26	PMC3623894	23552196	background avail gene express data correspond pig immun respons challeng compel materi understand host immun system metaanalysi offer opportun confirm expand knowledg combin studi time vast set independ studi creat larg dataset increas statist power studi perform metaanalys porcin transcriptom data scrutin global immun respons challeng ii determin specif respons porcin reproduct respiratori syndrom viru prrsv infect gain indepth knowledg pig respons prrsv infect origin approach compar elimin common gene metaanalys order identifi gene pathwai involv prrsv immun respons softwar pointillist cope highli dispar data circumv bias gener specif respons link singl studi ingenu pathwai analysi ipa softwar survei canon pathwai biolog function transcript factor involv pig immun respons chip correspond dataset pig global immun respons chip dataset pig respons prrsv infect pig global immun respons analysi interconnect canon pathwai involv regul translat mitochondri energi metabol biolog function reveal metaanalysi centr translat regul includ protein synthesi rnapost transcript gene express cellular growth prolifer oxid phosphoryl mitochondria dysfunct associ stress signal highli regul transcript factor mycn myc nfel analysi involv regul immun respons host specif respons prrsv infect engend activ welldefin canon pathwai respons pathogen challeng trem tolllik receptor hypercytokinemia hyperchemokinemia signal analysi brought central role crosstalk innat adapt immun respons regul antiinflammatori respons transcript factor involv analysi hmgb requir innat recognit viral nucleic acid transcript factor interferon regulatori factor irf irf irf irf involv pig specif respons prrsv infect conclus work reveal kei gene canon pathwai biolog function involv pig global immun respons divers challeng includ prrsv infect power statist approach led consolid previou find gain insight pig immun respons common stimuli prrsv infect
PLoS One	18381991	2009-05-01	PMC3625221	23593507	background formul mathemat model infecti diseas captur symptomat asymptomat transmiss greatli influenc effect vaccin presenc vaccin prevent clinic ill studi aim assess impact model build strategi epidem threshold vaccin methodologyprincip find consid type mathemat model base observ variabl includ symptom onset recoveri clinic ill observ model base unobserv infect event infecti unobserv model impos number modifi assumpt observ model mimic unobserv model identifi model fulli consist incub period ident latent period presymptomat transmiss comput reproduct number vaccin demonstr data gener process vaccineinduc reduct symptomat ill consist observ model examin effect reproduct number differ calcul model conclus explicitli incorpor vaccin reduc risk symptomat ill model fruit emploi model directli account diseas progress model studi base observ epidemiolog call for
PLoS One	16731915	2012-08-22	PMC3629100	23613893	cleft palat mixtur genet environment factor occur bilater palat shelv fail fuse object studi search gene involv mous palat format gene express murin embryon palat tissu analyz development stage palat fusion genechip microarrai ceacam highli upregul gene palat format confirm quantit realtim pcr immunohistochem stain ceacam prefus palat epithelium degrad fusion investig development role ceacam functionblock antibodi embryon mous palat organ cultur palat fusion inhibit functionblock antibodi investig subsequ development role ceacam character ceacamdefici ceacam mice epitheli cell persist abnorm midlin embryon palat dai palat fusion delai ceacam mice tgf express apoptosi cell prolifer palat epithelium palat ceacammic ceacam express retain remain mee tgfdefici mice ceacam role initi palat fusion epitheli cell adhes
PLoS One	19144956	2012-02-15	PMC3629225	23613957	the frequenc potenti longterm effect sportrel traumat brain injuri tbi major public health concern cultur contact sport ic hockei encourag aggress put youth risk tbi concuss newspap report plai role convei shape cultur healthrel behavior qualit studi report sportrel tbi major north american newspap quartercenturi groundedtheori approach identifi major theme content analysi compar frequenc kei theme major theme percept brain injuri aggress equip rule regul youth hockei full studi period newspap articl canada america portrai violenc aggress lead tbi integr hockei unavoid risk associ plai game condemn violenc ic hockei critic administr respons tbi recogn signific tbi canada aggress report distinct shift portrai protect equip solut tbi earlier year potenti contribut factor tbi studi period american newspap greater attent percept risk role protect equip discuss tbi broader context time period newspap countri trend rule chang curb youth sportrel tbi studi rich descript report tbi contact sport understand report evalu danger sportrel tbi appropri commun media
PLoS One	22915673	2009-03-18	PMC3630163	23637836	largescal hand foot mouth diseas hfmd outbreak frequent occur china children caus children death year pathogen hfmd human enterovirus hev human enteroviru hev coxsackieviru cva common pathogen hfmd hev hfmd rapidli detect hev cva ensur detect hev caus hfmd realtim hybrid probebas rtpcr assai develop studi multiplex realtim rtpcr assai develop detect differenti hev cva directli clinic specimen broadspectrum realtim rtpcr assai target hev experi confirm assai high sensit specif sensit tcidml detect hev hev cva total clinic specimen simultan detect three kind assai includ realtim rtpcr assai direct convent rtpcr assai viru isol assai human rhabdomyosarcoma cell cell total posit rate hev cva realtim rtpcr assai rtpcr assai viru isol assai hfmd clinic specimen posit hev neg hev cva identifi echoviru echo viru isol rtpcr sequenc vp gene realtim rtpcr assai appli provinci hfmd lab detect pathogen hfmd contribut rapid identif pathogen earli stage hfmd outbreak help clarifi etiolog agent hfmd china
Genome Announc	22345451	2007-12-11	PMC3630398	23599287	a field porcin epidem diarrhea viru pedv strain js isol stool sampl piglet acut diarrhea vaccin farm eastern china sequenc analyz complet genom strain js will help increas understand molecular characterist epidem pedv china
PLoS One	19297500	2011-07-01	PMC3632529	23630620	bat reservoir anim harbor pathogen virus capabl transmit human anim establish effect surveil monitor transboundari spread bat virus myanmar china complet organ thorax abdomen bat speci myanmar counti close yunnan provinc china collect test virom metagenom solexa sequenc bioinformat analysi total read base gener assembl contig averag length bp contig recogniz viral sequenc belong viral famili viral contig vertebr virus insect virus phage contig plant virus metagenom confirm pcr select virus bat sampl phylogenet analysi led discoveri novel bat virus genera mamastroviru bocaviru circoviru iflaviru orthohepadnaviru preval rate bat speci conclus studi aim bat virom myanmar expand spectrum virus harbor bat
Front Microbiol	18077378	2014-03-13	PMC3632782	23630519	amongst closterovirida citru tristeza viru ctv uniqu possess number distinct character strain isol produc wide rang phenotyp combin host understand connect genotyp phenotyp complic matter genotyp member mix popul singl host plant essenti understand combin genotyp affect symptom express diseas sever evolut genotyp character biolog role divers effect recombin addition genotyp group standard studi util extens arrai ctv genom classifi major genotyp determin major evolutionari process led format subsequ retent analys three major process genotyp ancestr diversif major ctv lineag conserv coevolut major function domain ctv genotyp extens recombin lineag rise genotyp subsequ retain global popul effect genotyp divers hostinteract discuss propos standard classif exist novel ctv genotyp
PLoS One	21529875	2009-09-01	PMC3633842	23626859	background morbid mortal rate low birth weight lbw newborn term higher rate normal birth weight nbw newborn lbw newborn greater risk acquir recurr bacteri viral infect week life outcom compromis innat immun function adapt immun naiv state increas risk infect lbw compar nbw newborn reflect impair innat immun methodolog character increas suscept infect lbw newborn microarrai technolog identifi differ gene express lbw newborn compar nbw newborn cord blood the microarrai studi valid larger number sampl real time rtpcr lbw nbw western blot lbw nbw interferom databas identifi interferon ifn signatur gene ingenu pathwai analysi identifi canon pathwai biolog function associ differenti express gene lbw newborn elisa ifn bactericidalpermeabilityincreas protein perform lbw nbw newborn adult lbw nbw adult princip find microarrai analysi identifi differenti express gene gene downregul gene upregul lbw compar nbw newborn note ifnsignatur gene downregul lbw compar nbw newborn ingenu pathwai analysi reveal pattern recognit receptor signal includ tolllik receptor tlr gene ifn signal impact pathwai respiratori infecti diseas biofunct lbw newborn conclus signific diminish prr ifnsignatur bpi gene express rais possibl impair pathwai contribut suscept lbw term infant infect
PLoS One	24627494	2016-07-23	PMC3633953	23626748	ebola virus ebov filament singlestrand rna virus famili filovirida zair ebolaviru zebov sever haemorrhag fever human great ap nonhuman primat nhp high fatal rate contrast reston ebolaviru rebov speci africa lethal nhp link clinic diseas human despit document exposur rebov isol pig philippin subsequ experi confirm suscept pig rebov zebov predilect lung zebov caus sever lung patholog week pig lead respiratori distress elucid mechan lung patholog microarrai analysi chang gene express perform lung tissu zebovinfect pig system effect monitor chang peripher blood leukocyt subset system cytokin respons oronas challeng zebov replic respiratori tract caus sever inflamm lung consequ rapid difficult breath neutrophil macrophag infiltr lung posit zebov antigen gene proinflammatori cytokin chemokin acut phase protein attract immun cell site infect upregul lung caus heavi influx cell site system effect includ declin proport monocytedendrit cell mild proinflammatori cytokin respons serum igm detect dai post infect conclus dysregulationoveractiv pulmonari proinflammatori respons plai crucial role pathogenesi zebov infect week pig attract inflammatori cell lung
PLoS One	19775200	2016-09-14	PMC3634753	23637984	a applic antibodi macromolecular chaperon protein antigen multipl epitop plural antibodi bind antigen antibodi bind antigen chaperon experi screen antihuman creatin kinas singl chain antibodi scfv assist fold stabil enzym built model singl chain antibodi scfva increas stabil human creatin kinas hck homolog model method epitop human creatin kinas predict comput bind scfva hck model comput calcul combin peptid arrai membran experi reliabl model scfvahck complex base studi explan scfva macromolecular chaperon assist fold hck studi approach predict antigenantibodi bind mode theoret guidanc studi antibodi chaperonelik function
PLoS Pathog	27403740	2013-12-01	PMC3635988	23633945	upon recognit viral compon pattern recognit receptor tolllik receptor tlr retino acidinduc gene rigilik helicas cell activ produc type interferon ifn proinflammatori cytokin pathwai tightli regul host prevent inappropri cellular respons virus modul pathwai prolifer spread studi reveal novel mechan hepat viru hcv evad immun surveil system prolifer activ microrna mir demonstr hcv infect upregul mir turn suppress hcvtrigger type ifn product promot hcv replic demonstr mir target factor tlr signal pathwai myeloid differenti factor myd interleukin receptorassoci kinas irak involv hcvinduc type ifn product hcvmediat activ mir express requir viral protein signal compon identifi transcript factor activ protein ap partli respons mir induct respons hcv infect pkcjnkcjun pkcerkcfo cascad indic mir upregul hcv infect neg regul ifn signal myd irak potenti therapeut target antivir intervent
PLoS Pathog	27629894	2014-03-01	PMC3635991	23633948	the rigi receptor pathwai stimul rna viru infect interact cytosol rigi viral rna structur short hairpin dsrna triphosph ppp termin structur studi rna agonist rigi synthes vitro stimul rigidepend antivir respons concentr picomolar rang human lung epitheli cell ppprna stimul multipl paramet innat antivir respons includ irf irf stat activ induct inflammatori interferon stimul gene hallmark fulli function antivir respons evalu magnitud durat gene express transcript profil identifi robust sustain diversifi antivir inflammatori respons character enhanc pathogen recognit interferon ifn signal bioinformat analysi identifi transcript signatur uniqu induc ppprna ifnb includ constel irf nfkb target gene capabl mobil multipl arm innat adapt immun respons treatment primari pbmc lung epitheli cell ppprna provid protect spectrum rna dna virus cbl mice intraven administr ppprna protect anim lethal challeng hn influenza reduc viru titer mous lung protect anim virusinduc pneumonia strikingli rigispecif transcript respons afford partial protect influenza challeng absenc type interferon signal system approach transcript biochem vivo analysi antivir efficaci ppprna highlight therapeut potenti associ rigi agonist broad spectrum antivir agent
BMC Infect Dis	23619279	2004-05-01	PMC3636024	23587047	background activ airborn disinfect bacteria fungi spore report issu virucid disinfect spread fog studi thoroughli method procedur develop determin virucid activ peracet acidbas airborn disinfect resist nonenvelop viru polioviru type viru laid stainless carrier product spread room hot fog minut concentr mlm polioviru inoculum supplement heat inactiv fat dry organ milk appli middl stainless steel disc dri air flow class ii biolog safeti cabinet room temperatur viral prepar recov flock swab titer vero cell classic spearmankrb cpe read method express tcidml infecti titer dri polioviru inocula tcidml minut room temperatur dri inocula expos airborn peracet acid disinfect recov minut postexposit suspend cultur medium cytotox disinfect medium elimin gel filtrat column log reduct infecti titer dri polioviru inocula expos peraceticbas airborn disinfect conclus studi demonstr virucid activ airborn disinfect test dri polioviru
BMC Bioinformatics	24310518	2012-11-16	PMC3636126	23496817	background chloroplast essenti organel plant independ genom chloroplast genom plant phylogenet infer number complet chloroplast genom increas rapidli develop genom sequenc project comprehens platform tool develop compar phylogenet analysi chloroplast genom construct comprehens platform compar phylogenet analysi complet chloroplast genom name chloroplast genom analysi platform cgap cgap interact webbas platform design compar analysi complet chloroplast genom cgap integr genom collect visual content comparison phylogeni analysi annot function cgap implement web server includ creat complet region genom map high qualiti compar genom featur construct phylogenet tree complet genom sequenc annot draft chloroplast genom submit user conclus cgap sourc code httpwwwherbbolorgchloroplast cgap will facilit collect visual comparison annot complet chloroplast genom user custom compar phylogenet analysi unpublish chloroplast genom
BMC Infect Dis	15131168	2012-12-03	PMC3637260	23578215	background diagnosi communityacquir pneumonia cap caus mycoplasma pneumonia adult adolesc hamper lack rapid standard test detect method cap patient teach hospit prospect consecut recruit basic clinic throat swab pair sera collect mycoplasma pneumonia detect igg igm antibodi test fluoresc quantit polymeras chain reaction fqpcr cultur compar studi diagnost valu three method includ sensit specif posit neg predict valu posit likelihood ratio plr conduct fourfold greater increas igg antibodi titer pair sera set diagnost gold standard twentyf cap patient male median ag year rang enrol twentyseven patient diagnos acut mycoplasma pneumonia infect gold standard specif valu three method increas trend sensit posit predict plr lowest igm test intermedi fqpcr and highest cultur conclus defin group patient good agreement posit rate mp cultiv throat swab acut pneumonia infect plr sensit low evalu method logic approach incorpor pcr cultur serolog test optimum diagnosi acut mycoplasma pneumonia infect adult adolesc
J Transl Med	23397352	2009-01-19	PMC3637501	23521917	background treatment ipilimumab fulli human antictla antibodi approv treatment advanc melanoma associ immunerel advers event ira coliti gastrointestin ira gi ira skin rash manag treatment guidelin predict biomark help identifi patient develop ira enhanc manag toxic method identifi candid predict biomark associ gi ira gene express profil perform blood sampl advanc melanoma patient baselin week start ipilimumab treatment phase ii clinic trial ca patient develop grade higher grade gi ira cours treatment repeat measur analysi varianc anova evalu differ express level gi ira nogi ira group patient three time point baselin sampl probe set differenti express fold gi ira nogi ira group probe set belong three function categori immun system cell cycl intracellular traffick chang gene express time character gi ira group probe set fold chang express baselin week ipilimumab dose ontreat express increas cd ceacam neutrophilactiv marker close associ gi ira suggest role neutrophil ipilimumabassoci gi ira addit express immunoglobulin gene increas time greater increas patient grade gi ira conclus gene express profil peripher blood sampl earli cours treatment ipilimumab identif set potenti biomark associ occurr gi ira low sensit biomark predict patient will develop gi ira investig biomark larger patient cohort warrant
Curr Neuropharmacol	23209131	2010-06-23	PMC3637674	23997755	the reninangiotensin system ra brain crucial regul physiolog homeostasi diseas cerebrovascular system ischem stroke overactiv brain angiotensinconvert enzym ac angiotensin ii ang ii angiotensin ii type receptor atr axi involv progress hypertens atherosclerosi thrombogenesi increas suscept ischem stroke brain ang ii level reveal increas ischem tissu stroke contribut neural damag elev oxid stress level induc inflammatori respons ischem hemispher atr year compon ra discov includ ac angiotensin ang ma constitut aceangma axi ac convert ang ii ang ang bind receptor ma exert benef effect cerebrovascular diseas interact nitric oxid bradykinin ang attenu develop hypertens patholog progress atherosclerosi antithrombot activ prevent thrombogen event contribut reduc risk ischem stroke addit ischemia insult aceangma reduc cerebr infarct size improv neurolog deficit antioxid antiinflammatori effect activ aceangma axi novel therapeut target prevent treatment ischemia stroke deserv investig
Comput Math Methods Med	19153232	2018-04-25	PMC3638703	23662161	in modern bioinformat find effici alloc sequenc fragment biolog function issu paper present structur approach base contextfre grammar extract origin dna protein sequenc approach radic statist method approach compar topolog entropybas method consist differ complex result
Parasit Vectors	20573824	2014-11-01	PMC3639113	23587213	background hepatozoon parasit initi report cat india name leucocytozoon feli domestici domest felin hepatozoonosi record europ africa asia america descript classif pathogenesi remain vagu distinct speci hepatozoon infect domest wild carnivor unclear aim studi carri survei domest felin hepatozoonosi character morpholog genet method hepatozoon sp dna amplifi pcr blood of survei cat israel blood sampl addit cat detect parasitem microscopi routin hematolog examin hepatozoon sp form character tissu natur infect cat dna sequenc determin cat infect hepatozoon feli infect hepatozoon cani associ outdoor access feli infect feli meront merozoit character morpholog skelet muscl myocardium lung feli pcrposit cat tissu develop earli matur meront describ distinctlyshap gamont observ measur blood feli infect cat fetus feli pcrposit queen posit pcr fetal tissu includ lung amniot fluid suggest transplacent transmiss genet analysi indic feli dna sequenc isra cat cluster feli spain spain sequenc cat feli sequenc cluster separ felin cani sequenc group isra foreign dog cani sequenc feli cluster distinctli hepatozoon spp mammal felin hepatozoonosi caus feli subclin high proport popul infect appar overt clinic manifest conclus studi aim integr histopatholog hematolog clinic epidemiolog genet find felin hepatozoonosi promot understand infect indic felin infect caus morpholog genet distinct speci feli predilect infect muscular tissu highli preval cat popul studi lack previou comprehens integr data merit redescript parasit elucid parasitolog characterist
PLoS One	29695430	2003-07-15	PMC3639174	23658627	an epidem sever acut respiratori syndrom sar led identif associ coronaviru sarscov viru evad host innat immun respons express nonstructur protein nsp inhibit host gene express viru interferon ifndepend signal nsp promis target drug inhibit nsp sarscov suscept host antivir defens gain better understand nsp mode action gener analyz mutant sarscov nsp target solvent expos residu amino acid protein work identifi class mutant abolish attenu increas nsp inhibit host gene express andor antivir signal class mutant cluster sarscov nsp surfac suggest nsp interact distinct host factor exert inhibitori activ identif nsp residu critic activ pathwai involv activ help design drug target nsp point mutant increas inhibitori activ nsp suggest coronavirus evolv greater abil evad host respons mutat residu
PLoS One	25483702	2006-11-08	PMC3639245	23638024	rna structur unwound decod process paus elong ribosom regul exampl stimul program ribosom frameshift lead direct slippag readingfram elong specif pseudoknot stimul downstream frameshift site investig identifi regulatori element upstream sar coronaviru sarscov frameshift site minim function element hairpin form potenti suffici downregul frameshift activ mutagenesi disrupt restor base pair potenti hairpin stem reveal basepair format requir frameshift attenu vitro cell attenu effici hairpin determin stabil proxim frameshift site insensit site sequenc variat addition dual luciferas assai hairpin stimul frameshift upstream shifti site yeast investig indic hairpin cisact program readingfram switch modul result insight mechan govern frameshift stimul attenu upstream hairpin unwound march ribosom downstream stimul studi find mode translat regul mediat reform stem ribosom unwound rna hairpin elong
Virol J	12829829	2016-12-01	PMC3639867	23575279	background influenza pandem morbid mortal worldwid anim model studi influenza viru pathogenesi limit current laboratori anim model essenti develop altern anim model influenza viru aim understand viral host factor contribut viru infect human method investig replic effici influenza hn viru classic strain influenza apr season influenza isol aguangzhougird swineorigin human influenza viru aguangzhougird dai pi tcid qpcr assai tree shrew model bodi temperatur monitor morn even dai infect dai seroconvers detect determin neutral antibodi titer challeng virus pre exposur serum sampl collect infect dai pi lung trachea tree shew collect dai post pi histopatholog analysi lectinhistochemistri analysi conduct identifi distribut sa gal sa gal receptor lung trachea infect tree shrew displai mild moder system respiratori symptom patholog chang respiratori tract human hn influenza viru replic upper respiratori tract tree shrew analysi receptor distribut respiratori tract tree shrew lectinhistochemistri sialic acid sagal receptor distribut trachea nasal mucosa sagal receptor main receptor lung tissu conclus base find tree shrew mimic influenza viru infect human propos tree shrew altern mammalian model studi pathogenesi influenza hn viru
PLoS One	17093189	2010-01-01	PMC3639905	23646158	background baicalein bioflavon dry root scutellaria baicalensi georgi reduc eotaxin product human fibroblast report antiasthma activ airwai injuri methodologyprincip find standard experiment asthma model male balbc mice sensit ovalbumin ova treat baicalein mgkg ip vehicl control prevent ova challeng therapeut altern model baicalein administ male balbc mice il il intranas featur asthma determin estim airwai hyperrespons ahr histopatholog chang biochem assai kei inflammatori molecul airwai injuri determin apoptot assai transmiss electron microscopi assess kei mitochondri function baicalein treatment reduc ahr inflamm experiment model tgf subepitheli fibrosi goblet cell metaplasia reduc baicalein treatment reduc lox activ featur mitochondri dysfunct apoptosi bronchial epithelia conclusionsignific find demonstr baicalein attenu featur asthma reduct airwai injuri restor mitochondri function
PLoS One	27744095	2003-11-01	PMC3639987	23646149	alter renal renin angiotensin system plai pivot role develop progress cardiovascular renal diseas angiotensin convert enzym ac highli express renal tubul renoprotect diabet proteas disintegrin metalloproteas adam involv ectodomain shed transmembran protein includ ac renal ac adam increas dbdb mice compar control investig the insulin sensit rosiglitazon albuminuria renal adam protein express ac shed dbdb diabet mice rosiglitazon treatment dbdb mice normal hyperglycemia attenu renal injuri decreas urinari ac renal adam protein express urinari excret ac enzymat activ western blot analysi urinari ac demonstr promin immunoreact band kda predomin immunoreact band kda shorter demonstr kidnei lysat indic ectodomain shed activ renal ac urin tempt specul renoprotect rosiglitazon partial mediat downregul renal adam ac shed addit posit correl blood glucos urinari albumin plasma glucagon triglycerid level urinari ac excret conclus urinari ac sensit biomark diabet nephropathi monitor effect renoprotect medic
PLoS One	20533589	2013-10-15	PMC3640090	23638038	human bocaviru hbov parvoviru detect worldwid lower respiratori tract infect lrti pathogen role respiratori ill debat high incid coinfect respiratori virus determin preval hbov infect patient lrti shanghai correl diseas sever perform year prospect studi hbov healthi control outpati inpati year ag xrai diagnos lrti nasopharyng aspir test pcr common respiratori virus real time pcr hbov subtyp nasopharyng swab healthi control serum sampl stool inpati test hbov real time pcr viral load determin quantit real time pcr hbov posit sampl hbov detect inpati annual rate respiratori syncyti viru rsv subtyp frequent coinfect detect hbov rsva appear cocircul season variat high hbov viral load copiesml frequent inpati outpati healthi control direct correl high viral load increas diseas sever patient coinfect hbov respiratori viru summari data hbov lrti symptomat hbov infect observ context high viral load
Viruses	14586041	2007-11-14	PMC3640509	23348060	autoimmun hepat aih primari biliari cirrhosi pbc understood autoimmun liver diseas immunosuppress treat aih ursodeoxychol acid slow progress pbc proport patient disord progress liver failur liver transplant third patient pbc experi recurr diseas syndrom refer de novo aih occur proport patient mainten immunosuppress transplant disord unrel aih note cyclosporin appear protect develop recurr pbc de novo aih potent immunosuppress compar tacrolimu reason cyclosporin protect determin viru resembl mous mammari tumor viru mmtv character patient pbc aih hypothes protect cyclosporin liver transplant recipi mediat antivir activ cyclophilin inhibitor treatment mmtv produc mmmt cell antivir immunosuppress agent cyclosporin analogu nim inhibit mmtv product produc cell discuss evid support role mmtvlike human betaretroviru develop pbc de novo aih specul possibl agent associ diseas transplant review mechan cyclosporin nim inhibit betaretroviru product vitro
Viruses	24129573	2009-04-29	PMC3640523	23435240	the nervou system target acut encephalit viral infect reservoir persist virus intrathec antibodi ab synthesi document human afflict infect associ neurolog complic demyelin diseas multipl sclerosi review focus origin recruit mainten biolog relev absecret cell asc central nervou system cn experiment neurotrop rna viru infect will summar evid highli dynam evolv humor respons character tempor alter cell subset prolifer differenti local ab plai benefici role complementindepend control viru replic cross selfreact ab cn antigen contribut immunemedi pathogenesi infect importantli protect ab exert antivir activ direct neutral bind cell surfaceexpress viral glycoprotein ab engag viral glycoprotein block bud mediat intracellular signal lead restor homeostat innat function sustain ab product local asc chemokin cytokin associ asc recruit retent highlight critic compon immun control
Int J Health Geogr	18003729	2011-01-01	PMC3641965	23425498	background geograph variabl plai role studi epidem role variabl popul densiti spread influenza controversi prior studi test role arbitrari threshold popul densiti place hypothes higher lower mortal studi mix object studi estim assum threshold level popul densiti separ lowdens region highdens region basi popul loss influenza pandem studi case influenza pandem india peopl di short span year method data census district india countri largest number death influenza samplesplit method embed popul growth model explicitli quantifi popul loss pandem estim threshold level popul densiti separ lowdens district highdens district demonstr threshold level popul densiti peopl squar mile concurr find district low side threshold experienc rate popul loss lower district high side threshold conclus paper introduc analyt tool health geograph literatur illustr applic tool demonstr pandem awar prepared effort estim level popul densiti polici social distanc redistribut quarantin popul effect area popul densiti lie threshold
PLoS One	20951776	2016-02-17	PMC3643978	23671624	background winter influenza season republ korea influenza hn predomin viru peak period influenza activ second half januari hand influenza predomin viru second peak period influenza activ second half march object studi compar clinic epidemiolog characterist patient laboratoryconfirm influenza influenza methodologyprincip find analyz data adult patient influenzalik ill visit emerg room univers hospit korea octob patient laboratoryconfirm influenza influenza hn influenza ag frequenc cardiovascular disord diabet hypertens higher patient influenza hn frequenc leukopenia thrombocytopenia patient influenza initi present statist higher patient influenza hn rate hospit length hospit stai statist higher patient influenza hn hospit patient frequenc diabet hypertens case comorbid condit proport elderli higher patient influenza hn conclus proport male femal elderli popul higher influenza hn patient group compar influenza group hypertens diabet chronic lung diseas cardiovascular disord neuromuscular diseas independ associ hospit influenza physician assess treat underli comorbid condit influenza viral infect appropri manag patient influenza
Int J Mol Sci	21330695	2004-01-24	PMC3645688	23549267	influenza virus avian origin continu pose pandem threat human health hn hn viru subtyp induc markedli elev cytokin level compar season hn viru hn hyperinduc tumor necrosi factor tnfalpha mitogen activ protein kinas mapk detail mechan pmapk activ tnfalpha hyperinduct influenza viru infect neg feedback regul cytokin express plai role avoid overwhelm product proinflammatori cytokin hypothes protein phosphatas involv regul cytokin express influenza viru infect investig role protein phosphatas includ mapk phosphatas mkp protein phosphatas type ppa modul pmapk activ downstream tnfalpha express primari human monocytederiv macrophag pbmac infect hng hn influenza viru demonstr hng viru activ pmapk hyperinduc tnfalpha product pbmac compar hn viru hng induc ppa activ pbmac treatment ppa inhibitor pmapk phosphoryl tnfalpha product increas virusinfect macrophag hng induc express ppa indic activ ppa mediat pmapk virusinfect pbmac hand ppa target hng upstream pmapk signal pathwai hn induc ppa activ primari macrophag provid insight control cytokin dysregul
PLoS One	26889022	2007-02-09	PMC3646027	23671673	background cell innat immun system includ monocyt macrophag defenc infect critic regul inflammatori respons cell express tolllik receptor tlr innat immun receptor govern tailor inflammatori gene express pattern monocyt produc proinflammatori mediat recruit central nervou system cn neurodegen diseas method studi explor express receptor cdb tlr tlr circul monocytederiv macrophag mdm peripher blood mononuclear cell pbmc isol healthi elderli adult classifi iq memoryconsist highperform hp iq memorydiscrep lowperform lp express cdb tlr tlr increas mdm lp group compar hp cohort mdm group respond robustli treatment tlr activ lipopolysaccharid lp term cytokin product mdm lp group displai hypersensit lp exposur interpret find defin differenti receptor express cytokin profil occur mdm deriv cohort iq memorydiscrep individu chang indic inflamm involv prodrom process lead develop neurodegen diseas
PLoS Biol	14726369	2009-10-01	PMC3646724	23667322	privat polit interest routin conspir sidelin misrepres scienc evid public polici process center scienc democraci initi union concern scientist endeavor chang dynam strengthen role scienc decis make
PLoS One	17288643	2018-05-19	PMC3648540	23667701	the nss protein bunyavirus viral interferon antagonist counteract host antivir respons infect highmultipl infect cultur mammalian cell bunyamwera orthobunyaviru bunv nss rapidli degrad reach peak level express hpi inhibitor result proteasom degrad recombin viru rbunkr lysin residu nss replac arginin residu express nss protein nsskr resist degrad confirm degrad lysinedepend despit repeat attempt direct ubiquityl nss infect cell demonstr suggest degrad nss lysinedepend achiev indirect mechan infect cultur mammalian cell mice indic disadvantag viru nondegrad nss protein fact rbunkr slight growth advantag wtbunv interferoncompet cell presum increas prolong presenc nss cultur mosquito cell differ growth wildtyp bunv rbunkr surprisingli nsskr stabilis compar wildtyp nss protein
Clin Dev Immunol	19797751	2005-07-13	PMC3649347	23690828	our studi investig epidemiolog respiratori virus adult patient upper respiratori tract infect urti august septemb jinan northern china nasal throat swab collect adult patient urti respiratoryrel virus includ ifv piv hrv hmpv hbov hcov adv rsv ev detect sampl convent revers transcript polymeras chain reaction posit detect rate respiratori viru codetect rate adult acut respiratori tract infect ifv domin agent detect ifvb higher incid ifva detect rate observ hbov hrv ev rsv hcov lowest detect rate hbov hrv ev adv infect rate higher yearold group yearold group codetect rate higher yearold group older ag group spectrum respiratori viru infect adult patient urti jinan compar citi china
PLoS One	30159042	2015-12-28	PMC3650060	23671702	upregul intercellular adhes molecul icam involv adhes circul resid leukocyt human lung epitheli cell lung inflammatori reaction demonstr curcuminload polyvinylpyrrolidon nanoparticl curn improv antiinflammatori antioxid properti curcumin hepatocyt studi focus effect curn express icam tnftreat lung epitheli cell compar effect curcumin water prepar curh tnfinduc icam express ro product cellcel adhes attenu pretreat antioxid dpi apo nac curn curh reveal western blot analysi rtpcr promot assai ro detect adhes assai addit treatment tnftreat cell curn antioxid inhibit activ phox phosphoryl mapk compar curh find phosphoryl mapk eventu lead activ transcript factor observ effect tnf treatment min includ increas bind activ ap phosphoryl cjun cfo gene reduc curn treatment vivo studi reveal curn improv antiinflamm activ curh lung epitheli cell tnftreat mice indic curcuminload polyvinylpyrrolidon nanoparticl serv antiinflammatori drug treatment respiratori diseas
Virol J	16014902	2017-10-03	PMC3653767	23618040	background genet element sm repres exampl mobil genet element virus function remain obscur scatter taxonom distribut report numer group method search genbank order identifi viral access smlike sequenc motif rigor phylogenet analys constrain tree topolog test perform order investig mobil natur sm stemloop sm structur famili ssrna virus astrovirida calicivirida picornavirida coronavirida viru famili except calicivirida multipl gain andor loss sm postul order explain distribut charact conclus sm appear mobil genet element uniqu evolutionari histori viru famili base find review current literatur sm hypothesi impli rnailik function sm element outlin
PLoS Med	26707950	2010-03-01	PMC3653782	23690754	background mycoplasma pneumonia thought common respiratori tract infect rti children diagnosi pneumonia rti current reli serolog method andor detect bacteri dna upper respiratori tract urt conceiv diagnost method yield posit pneumonia carri asymptomat urt posit test indic symptomat infect exist asymptomat carriag pneumonia establish hypothes asymptomat carriag children exist investig colon symptomat infect differenti current diagnost method method find studi conduct erasmu mcsophia children hospit afterhour gener practition cooper rotterdam netherland asymptomat children children rti symptom ag mo enrol crosssect studi juli novemb clinic data pharyng nasopharyng specimen serum sampl collect primari object differenti colon symptomat infect pneumonia current diagnost method realtim pcr pneumonia dna detect ci asymptomat children ci symptomat children serolog quantit pcr cultur differenti asymptomat carriag infect total children test presenc bacteri viral pathogen pathogen asymptomat children symptomat children final longitudin sampl persist pneumonia urt mo fifteen asymptomat children pneumonia symptomat children pneumonia longitudin followup test neg mo conclus studi limit singl studi site limit sampl size data indic presenc pneumonia urt common asymptomat children current diagnost test pneumonia unabl differenti asymptomat carriag symptomat infect articl editor summari
PLoS One	29285099	2017-01-01	PMC3653869	23691184	background acut respiratori infect ari lead children lead killer ari respons percent world disabl death virus common agent caus ari studi viral etiolog clinic characterist ari perform northwest region china includ gansu provinc method clinic demograph throat swab collect patient januari st decemb st multiplex rtpcr perform detect respiratori viral pathogen patient admit ari patient ag month year median ag year posit pathogen total respiratori viral pathogen identifi patient respiratori syncyti viru rsv frequent detect pathogen parainfluenza viru piv human rhinoviru hrv human coronaviru cov human adenoviru hadv influenza flu human metapneumoviru hmpv human bocaviru boca influenza flu season influenza hnshn detect singleinfect detect case rsv common pathogen patient year season variat peak winter spring conclus paper present data epidemiolog viral pathogen associ ari children gansu provinc china rsv frequent detect studi find serv refer local cdc draw plan prevent control ari
PLoS One	20194796	2009-12-03	PMC3654925	23690999	the recombin viral vector express gondii antigen safe effici approach induc immun respons parasit valuabl tool vaccin develop protect mice toxoplasmosi immun anim adenoviru express protein sag adsag gondii wai improv vaccin strategi enhanc protect limit homolog vaccin sequenti dose vector induct antivector immun respons block cell transduct restrict transgen express consequ compromis outcom vaccin avert effect antivector respons virus prime boost heterolog vaccin bear mind gener modifi vaccinia viru ankara encod sag mvasag test boost agent prime adsag minor differ observ magnitud antisag immun respons induc vaccin protocol heterolog immun adsag mvasag improv capac control brain cyst format model chronic toxoplasmosi cbl mice
Virol J	28249256	2018-03-01	PMC3655035	23651577	background influenzalik ill ili subset acut respiratori infect ari sourc morbid mortal worldwid ili caus numer pathogen limit etiolog epidemiolog ili china method perform oneyear surveil studi viral etiolog caus ili investig influenc climat outbreak ili attribut virus outpati depart zhuhai municip peopl hospit zhuhai china outpati sought attent outpati depart zhuhai municip peopl hospit present ili patient present ili sampl enrol studi respiratori viru identifi patient coinfect virus patient coinfect virus respiratori syncyti viru rsv detect common viral pathogen detect differ ag distribut observ season influenza viru sfula hn sflub pandem hn influenza virus hnpdm rsv adenoviru adv infect sflua hn sflub rsv human metapneumoviru hmpv characterist season pattern incid sflua hn adv rsv correl air temperatur altern incid sflub correl rel air humid conclus demonstr wide rang respiratori viral pathogen circul zhuhai citi consid clinician treat patient present ili
Clin Dev Immunol	19959592	2011-02-01	PMC3655463	23710205	hepat viru hcv smallenvelop rna viru belong flavivirida famili identifi hcv estim infect peopl worldwid chronic hepat viru uniform natur histori liver cirrhosi develop hepatocellular carcinoma current therapi hcv infect consist combin pegyl interferon ribavirin hand hcvrelat liver diseas lead indic liver transplant posttranspl hcv reinfect graft report univers graft hcv reinfect acceler progress liver failur addit treatment recurr hcv infect liver transplant compromis enhanc advers effect limit efficaci interferonbas therapi poor outcom hcv reinfect graft recipi pose major issu hepatologist transplant surgeon aim paper review specif aspect hcv reinfect transplant risk factor current therapeut hcv stage liver transplant cellular function hcv protein molecular mechan hcv entri hopefulli paper will inspir strategi novel inhibitor recurr hcv infect liver transplant greatli improv outcom
PLoS Pathog	21379419	2011-06-01	PMC3656114	23696732	sinc kaposi sarcoma associ herpesviru kshv establish persist infect human cell cell critic compart viral pathogenesi rta replic transcript activ kshv directli bind dna cellular dna bind factor includ cbfcsl dna adaptor addit viral factor lana virf bind cbfcsl modul rta activ analyz contribut cbfcsl reactiv human cell infect dg dg cbfcsl knockout cell line recombin kshv select viral mainten select medium line maintain viru irrespect cbfcsl statu viral reactiv initi cell line viral genom replic attenu cbfcsl defici line fail produc detect level infecti viru induct earli earli late viral gene impair cbfcsl defici cell multipl stage reactiv process restor wildtyp level reintroduct cbfcsl identifi addit viral rta target gene directli control cbfcsl analyz promot select subset viral gene induct late viral gene orfa orf rta enhanc cbfcsl ortholog orfa herpesvirus terminas complex requir viral packag orf encod small capsid protein essenti capsid assembl studi demonstr time human cell viral replic initi absenc cbfcsl reactiv process sever attenu stage lead virion product cbfcsl act global hub viru coordin lytic cascad
PLoS One	25022582	2005-08-01	PMC3656839	23691175	background studi carri estim vaccin coverag public percept prevent behavior pandem influenza hn understand motiv barrier vaccin highrisk nonhighrisk group outbreak pandem influenza hn methodologyprincip find crosssect nationwid telephon survei communitydwel korean adult ag year older conduct stage pandem influenza hn outbreak questionnair identifi demograph vaccin statu particip household member barrier nonvaccin perceiv threat prevent behavior korea rate pandem influenza vaccin coverag survei popul vaccin coverag highrisk group nonhighrisk group highrisk group trigger event vaccin receiv notic public health organ nonhighrisk group vaccin influenc previou experi influenza mass media campaign group common reason receiv vaccin health suffici forgo vaccin lack time differ group perceiv threat adopt prevent behavior predict factor pandem influenza vaccin elderli ag year prior season influenza vaccin chronic medic diseas conclusionssignific except vaccin coverag prevent behavior highrisk group nonhighrisk group pandem futur pandem prepared plan crucial reinforc prevent behavior avoid ill vaccin increas vaccin coverag highrisk group
ISRN Vet Sci	21668365	2003-08-12	PMC3658599	23738118	infecti bronchiti viru ibv dynam evolv viru caus major econom loss global poultri industri earli respiratori diseas outbreak investig iraq jordan saudi arabia ibv isol joa joa saudi saudi iraqi ibv detect diagnosticnest nucleocapsid rtpcr strain identif characteris sequenc phylogenet analysi amplifi hypervari region spike gene ibv isol ibv strain ckchldli nucleotid ident ibv isol rang isol ckchldli strain rang sequenc fragment gene ckchldli strain nucleotid ident ibv vaccin strain commonli middl east presenc ckchldlilik strain account vaccin failur ibv ibv isol vaccin chicken paper document time presenc ibv strain ckchldli middl east strain origin china taiwan
Clin Transl Med	16046698	2014-12-07	PMC3658895	23663660	our current health enterpris painstakingli slow cumbersom seldom translat practic slow pace health contribut find relev obsolet produc rapid respons relev propos approach increas relev greater stakehold involv speed innov design streamlin review process creat andor better leverag infrastructur broad stakehold input integr process increas relev facilit studi procedur flexibl rapid design consid default tradit twoarm random control trial rct tradit rct design rapid find review process grant applic irb protocol manuscript submiss better streamlin minim delai infrastructur rapid learn system health technolog leverag rapidli evalu exist treatment allevi extens recruit delai common tradit approach feasibl requir cultur shift commun methodolog rigor pace relev research
Virol J	12915574	2009-07-30	PMC3658953	23517810	background context purpos studi includ bacteri express viral protein vp porcin rotaviru prv gener rabbit polyclon antiserum vp protein establish discrimin elisa distinguish prv panel porcin virus vp gene prv isol dn amplifi revers transcriptionpcr bp complet open read frame orf encod amino acid sequenc comparison phylogenet analysi indic prv dn belong group rotaviru bacteri express vp express ecoli antivp antibodi capabl distinguish prv porcin transmiss gastroenter viru porcin epidem diarrhea viru porcin circoviru type ii porcin reproduct respiratori syndrom viru porcin pseudorabi viru porcin parvoviru conclus prv vp express coli gener antibodi rabbit antivp serum antibodi good diagnost reagent detect prv
PLoS One	25339728	2012-06-21	PMC3659107	23700480	bat propos major reservoir divers emerg infecti viral diseas rabi best europ studi explor ecolog interact lyssavirus natur host scarc studi complet activ surveil work spanish bat coloni began analyz ecolog factor affect infect dynam observ coloni collect test blood sampl dead bat local bat speci dead confirm presenc eblv rna speci analyz time myoti capaccinii sampl posit european bat lyssaviru eblvneutr antibodi detect local sampl bat speci time myoti daubentonii speci link eblv eblv seropreval rang bat speci season variat observ higher antibodi preval summer juli eblv seropreval associ coloni size speci rich higher seropreval percentag larg multispecif coloni suggest intra interspecif contact major risk factor eblv transmiss bat coloni batroost behavior determin eblv variabl evid bat phylogeni involv batspeci seropreval studi highlight life histori roost ecolog understand eblvpreval pattern bat coloni provid public health offici
PLoS One	19644142	2017-05-01	PMC3659117	23700447	sever acut respiratori syndrom coronaviru sarscov membran protein capabl selfassembl releas form membraneenvelop vesicl form viruslik particl vlp coexpress sarscov nucleocapsid protein previou delet analys selfassembl involv multipl sequenc region identifi amino acid residu vlp assembl coexpress multipl mutant substitut mutat aminotermin ectodomain carboxyltermin endodomain transmembran segment indic dileucin motif endodomain tail requir effici packag vlp crosslink vlp analys cystein residu close proxim dimer interfac reduct secret serin replac analysi suggest involv mn interact addit mutat highli conserv swwsfnpe motif substitut codon w reduc vlp yield defect secret vlp product tryptophan replac or phenylalanin replac w combin indic involv specif amino acid sarscov viru assembl aromat residu retent specif posit critic function term direct viru assembl
PLoS One	22723411	2006-05-18	PMC3661466	23717587	background wellconstruct properli oper influenza surveil scheme essenti public health studi conduct evalu distribut respiratori virus patient influenzalik ill ili teach hospitalbas surveil scheme ili south korea method respiratori specimen adult patient year visit emerg depart ili week week multiplex pcr perform detect respiratori virus influenza viru adenoviru coronaviru respiratori syncyti viru rhinoviru human metapneumoviru parainfluenza viru bocaviru enteroviru patient visit ili male median ag patient year influenza vaccin rate season comorbid patient posit rate respiratori virus total number detect virus influenza viru domin agent ag group preval human metapneumoviru higher patient year adenoviru detect younger adult case respiratori virus detect coincid case identifi frequent patient hematolog malign organ transplant recipi clinic outcom conclus studi valuabl extens laboratori surveil epidemiolog respiratori virus ili patient teach hospitalbas influenza surveil system south korea
PLoS One	28118945	2016-12-01	PMC3661600	23717512	we construct stochast sir model influenza spread ddimension lattic repres dynam contact network individu ag distribut popul lattic move displac site nearest neighbor empti site allow individu chang number ident contact dynam lattic govern attract interact individu belong ageclass paramet regul pattern dynam fix fit data agedepend daili contact number furnish polymod survei simpl sir transmiss model nearest neighbor interact basic adapt mobil restrict complet model model valid agedistribut italian epidemiolog data influenza ahn imag text season sensibl predict epidemiolog paramet appropri topolog lattic find the contact pattern model polymod data satisfactori good agreement numer experiment epidemiolog data result rich encod averag contact pattern individu respect analysi epidem spread infecti diseas
PLoS Pathog	16714280	2012-08-22	PMC3662671	23717202	the genom plusstrand rna virus regulatori sequenc structur direct viral process tradit view rna element local structur noncod region view chang discoveri regulatori element code region function longrang intragenom base pair interact kb long rna genom tombusviru tomato bushi stunt viru tbsv type structur featur includ function longdist interact hypothes achiev multipl interact viral genom util largescal organiz strategi sought assess global conform entir tbsv genom atom forc micrograph genom indic condens structur compos interconnect protrus extend central hub configur consist genom secondari structur model gener highthroughput select hydroxyl acyl analys primer extens shape predict size rna domain origin central region rna element identifi domain interdomain region novel structur featur predict function confirm interestingli longrang interact form structur model interact form complementari partner sequenc posit close structur suggest secondari structur level viral genom structur provid basic scaffold format longrang interact higherord structur model tbsv rna genom snapshot complex framework allow multipl function compon oper concert confin context
BMC Microbiol	27010607	2005-05-12	PMC3663648	23663545	background avian influenza remain seriou threat human health consequ human infect vari markedli subtyp avian influenza virus addit viral factor differ host cellular respons plai critic role studi aim elucid avian influenza infect perturb host mirna regulatori pathwai lead advers patholog event cytokin storm mirna microarrai approach dysregul mirna express observ highli pathogen avian influenza hn infect mir mir mir mirp mira mirb differenti express respons influenza viru infect interestingli demonstr mir highli induc hn hn abil suppress express cytokin transform growth factor tgf support observ inhibitori revers antagomir conclus tgf cytokin immunosuppress agent potent proinflammatori molecul abil attract regul inflammatori molecul previou report season influenza hn avian influenza subtyp induc persist express tgf specul modul tgf express influenza subtyp mir critic step determin outcom normal excess inflamm progress
PLoS One	22915814	2015-04-20	PMC3664578	23724103	epsteinbarr viru ebv oncogen viru associ pathogenesi human lymphoid malign includ hodgkin lymphoma infect normal rest cell ebv activ lymphoblast phenotyp gener physiolog stimul cdl il differ infect lead establish perman grow lymphoblastoid cell line cdlil blast finit prolifer lifespan identifi earli event determin ebv infect blast establish transform cell line perform global transcriptom analys rest cell ebv cdlil blast dai cultur anticip consider overlap transcriptom type lymphoblast compar origin rest cell reflect common chang associ lymphocyt activ prolifer interest subset gene differenti express ebv cdlil blast gene highli express ebv blast enrich set interferonstimul gene silico analys repress il cell context upregul microdissect malign cell hodgkin lymphoma biopsi compar normal germin center cell counterpart hypothes ebv il target discordantli regul common set gene support experiment cell model il stimul partial revers transcript chang follow ebv infect impair effici ebvinduc cell transform data discord regul interferon il pathwai gene ebv occur earli infect cell relev develop mainten ebvassoci malign
Emerg Themes Epidemiol	15890951	2009-01-01	PMC3666982	23651557	background volum influenza pandem model studi increas dramat decad model incorpor sophist parameter valid techniqu econom analys behaviour individu method review trend aspect model influenza pandem prepared aim gener polici insight epidem manag publish septemb pandem find influenza pandem model reli paramet previou model studi model rare valid observ data seldom appli lowincom countri mechan intern data share facilit wider adopt model valid varieti model decis difficult compar evalu model systemat conclus propos model characterist construct parameter valid aspect protocol ccpv protocol contribut systematis report model emphasi incorpor econom aspect host behaviour model report exist field model increas confid model transpar assess comparison
PLoS Pathog	25897055	2018-02-26	PMC3667758	23737747	we describ gener novel ebola viru ebov vaccin platform base replicationcompet rabi viru rabv replicationdefici rabv chemic inactiv rabv express ebov glycoprotein gp mous studi demonstr safeti immunogen protect efficaci live inactiv rabvebov vaccin evalu vaccin nonhuman primat indic three vaccin induc potent immun respons rabv ebov protect immun anim ebov depend qualiti humor immun respons ebov gp determin induc antibodi ebov gp differ target affin isotyp iggbias humor respons high level gpspecif antibodi benefici control ebov infect immun support concept success ebov vaccin induc strong antibodi ebov dual vaccin rabv filovirus achiev address concern market urgent need vaccin
PLoS One	19131324	2007-02-01	PMC3667794	23738000	background human papillomaviru hpv highrisk dna tumour viru major caus agent cervic cancer cellular transform associ deregul express e oncogen bind number cellular protein includ cell cycl control protein prb studi rna aptam small singlestrand oligonucleotid select highaffin bind hpv emploi molecular tool investig proteinprotein interact methodologyprincip find studi focus aptam term transfect molecul hpvtransform cell inhibit cell prolifer realtim cell electron sens mtt assai induct apoptosi demonstr annexin vpropidium iodid stain gstpull bead bind assai demonstr bind requir ntermin residu involv interact cell cycl control protein prb approach disrupt interact prb vitro transfect hpvtransform cell appear result loss rise prb level observ immunoblot conclusionssignific paper includ characteris effect rna aptam cell deriv cervic carcinoma transfect cell correl loss induct apoptosi aptam specif number cellular viral protein document aptam macugen approv clinic clinic trial addit role molecular tool applic futur
PLoS One	29483256	2010-02-17	PMC3667820	23750192	sever approach propos realtim detect predict spread influenza includ search queri data influenzarel term explor tool augment tradit surveil method paper method internet search queri data baidu model monitor influenza activ china object studi comprehens techniqu keyword select ii keyword filter iii composit iv model detect influenza activ china sequenti timeseri select composit keyword correl chines influenza case data addit onemonth ahead predict influenza case month absolut percent error knowledg studi search queri data baidu conjunct approach estim influenza activ china
Front Immunol	17049380	2014-03-21	PMC3668324	23755050	pentraxin ptx solubl pattern recognit receptor humor compon innat immun system interact pathogen moieti infect dy host cell facilit remov activ appropri innat adapt mechan ptx secret divers varieti cell rang immun cell structur cell respons toll receptor tlr engag inflammatori stimuli physic chemic stress ptx plai essenti role femal fertil facilit organ extracellular matrix cumulu oophoru activ implic postinflamm tissu repair ptx multifunct protein plai nonredund role provid immun potenti immunolog danger assess role lung immun lung constant risk infect tissu damag attribut perpetu exposur foreign agent
PLoS One	20164235	2011-04-06	PMC3669388	23741397	the anim public health commun address challeng pose zoonot emerg infecti diseas minim impact futur event anim diseas surveil will enabl prompt event detect respons diagnost laboratorybas surveil system target domest anim depend larg privat veterinarian submit sampl case laboratori context prediagnost laboratori surveil system implement group veterinarian ask input data scenario hold true alberta privat cattl veterinarian ask particip alberta veterinari surveil networkveterinari practic surveil platform prediagnost diseas nondiseas case data submit consequ understand factor influenc veterinarian submit case laboratori complex factor affect particip surveil program foundat interpret diseas pattern report laboratori engag veterinarian surveil focus ethnograph studi conduct ten cattl veterinarian alberta individu indepth interview particip record transcrib enabl themat analysi laboratori submiss bias outbreak unknown case unusu mortal rate issu potenti herdlevel implic decreas cattl govern support laboratori test contribut fewer submiss time particip particip surveil govern support collabor chang beef industri veterinari profess cattl produc challeng opportun surveil
Springerplus	24657853	2016-03-10	PMC3669510	23741646	improp manag hospit wast report respons acut outbreak sever acut respiratori syndrom sar spite challeng hospit wast properli handl nigeria adequ studi fate burnt hospit wast agricultur soil burnt hospit wast agricultur soil conduct soil sampl farm settlement obafemi awolowo univers teach hospit complex ileif south west nigeria pix techniqu emploi mv sdh tandem pelletron acceler centr energi develop oau ileif nigeria eleven element si cl ti cr mn fe zr pb detect concentr enrich factor determin presenc pb cl elev concentr rang ppm studi seriou health concern agricultur practic neighborhood studi site proper handl hospit hazard wast possibl pose seriou environment pollut problem
PLoS One	21471348	2014-09-03	PMC3670875	23755110	circul rna result excess cell damag acut viral infect interact vascular endotheli cell despit obviou clinic implic associ presenc circul rna patholog effect endotheli cell govern molecular mechan fulli elucid analyz effect doubl strand rna primari human pulmonari arteri endotheli cell hpaec natur synthet doublestrand rna dsrna hpaec investig transendotheli electr resist molecul traffick calcium homeostasi gene express prolifer studi morpholog mechan chang cell caus synthet dsrna insitu atom forc microscopi vascularendotheli cadherin factin stain indic exposur hpaec synthet dsrna led function deficit reflect morpholog mechan chang increas permeabl endotheli monolay hpaec treat synthet dsrna accumul phase cell cycl addition prolifer rate cell presenc synthet dsrna decreas natur synthet dsrna modul signal hpaec inhibit sarcoendoplasm caatpas serca involv regul intracellular homeostasi cell growth synthet dsrna stimul silenc serca preserv endotheli monolay integr data identifi novel mechan dsrna disrupt endotheli barrier function relev inflammatori process
Parasite	26963739	2008-07-01	PMC3671469	21894260	ferroquin fq ssr current advanc organometal drug candid complet phase ii clinic trial treatment uncompl malaria ferrocenecontain compound activ chloroquinesuscept chloroquineresist plasmodium falciparum vivax strain andor isol articl focus discoveri fq antimalari activ hypothesi mode action current absenc resist vitro clinic trial
Evid Based Complement Alternat Med	25187545	2014-02-12	PMC3671682	23762148	pomegran hundr year multipl health benefit includ antimicrobi activ surg multidrugresist bacteria possibl widespread global viru pandem necessit addit prevent therapeut option convent drug indic pomegran extract serv natur altern potenc wide rang bacteri viral pathogen pomegran plant test antimicrobi activ includ fruit juic peel aril flower bark studi util pomegran peel success phytochem compound pomegran demonstr antimicrobi activ studi ellag acid larger hydrolyz tannin punicalagin highest activ case combin pomegran constitu offer benefit posit clinic pomegran suppress oral bacteria intrigu worthi studi evid pomegran antibacteri antivir activ foodborn pathogen infecti diseas organ vitro cellbas assai necessit confirm vivo efficaci human clinic trial
Vet Res	18461057	2013-07-01	PMC3672080	23675981	porcin reproduct respiratori syndrom prr viru prrsv infect character prolong viremia viral shed consist incomplet immun type interferon ifn essenti mount effici antivir innat adapt immun respons studi north american prrsv genotyp isol induc inhibit ifn plasmacytoid dendrit cell pdc repres profession ifnproduc cell inhibit ifn express initi prrsv pathogenesi character prrsv effect host modifi factor ifn respons pdc surprisingli varieti type type prrsv directli stimul ifn secret pdc requir live viru mediat tlr pathwai ifn il enhanc pdc product ifn respons prrsv exposur prrsv inhibit ifn respons enrich pdc stimul cpg oligodeoxynucleotid weak absent vr prototyp genotyp prrsv suppress respons highest level suppress induc chines highli pathogen prrsv isol find demonstr pdc respond prrsv suppress activ pdc moder straindepend pdc sourc system ifn respons report prrsvinfect anim contribut puzzl immunopathogenesi prr
Vet Med Int	23624792	2017-01-04	PMC3674685	23766929	a costeffect efficaci influenza vaccin commerci poultri farm help protect avian influenza outbreak current influenza vaccin poultri expens subtyp specif urgent develop univers avian influenza vaccin construct live bacteri vaccin avian influenza express conserv peptid ectodomain antigen surfac lactococcu lacti chicken vaccin intranas lactococc vaccin llme subcutan keyholelimpethemocyanin conjug klhme vaccin nonvaccin bird challeng high pathogen avian influenza viru subtyp hn bird vaccin llme klhme median surviv time dai longer nonvaccin bird dai bird vaccin subcutan klhme lower viral burden group correl time surviv mespecif serum igg trial bird vaccin group higher median surviv time nonvaccin bird protect mespecif serum igg
Sensors (Basel)	25855750	2003-04-01	PMC3675524	27879858	thi work present approach detail integr platform hardwar architectur nanorobot applic epidem control enabl real time vivo prognosi biohazard infect develop field nanoelectron transduc progress shrink smaller size nanotechnolog carbon nanotub expect result innov biomed instrument possibl therapi effici diagnosi methodolog integr system smart biosensor programm nanodevic advanc nanoelectron enabl progress develop molecular machin provid high precis pervas biomed monitor real time data transmiss nanobioelectron embed system natur pathwai manufactur methodolog achiev nanorobot applic laboratori sooner demonstr practic applic medic nanorobot simul base clinic data address integr commun nanorobot rfid mobil phone satellit appli long distanc ubiquit surveil health monitor troop conflict zone current model prevent save popul case target epidem diseas
PLoS One	28053107	2013-10-28	PMC3677884	23762269	we report calreticulin crt lumin resid protein sera patient rheumatoid arthriti recombin crt rcrt exhibit extraordinarili strong immunolog activ demonstr rcrt fragment rcrt rcrt rcrt rcrt selfoligomer solut fold potent nativ crt ncrt isol mous liver activ macrophag vitro narrow activ site crt residu activ depend dimer contrast rcrt complet inact rcrt fraction oligom monom gel filtrat oligom maintain immunolog activ term activ macrophag vitro induc specif antibodi vivo monom activ comparison addition rcrt oligom better monom bind uptak macrophag inhibit macrophag endocytosi partial block stimulatori rcrt conclud immunolog activ site crt map residu solubl crt acquir potent immunopatholog activ microenviron favor oligomer
Philos Trans R Soc Lond B Biol Sci	12692096	2014-01-01	PMC3678333	23382432	genet analysi pathogen genom power approach investig popul dynam epidem histori infecti diseas theoret underpin coalesc method question cast doubt interpret aim studi develop robust popul genet infer compartment model epidemiolog gener approach base theori metapopul deriv coalesc model susceptibleinfecti si susceptibleinfectioussuscept si susceptibleinfectiousrecov sir dynam exponenti logist growth model equival si si model coinfect neglig implement si si sir model beast conduct metaanalysi hepat epidem directli estim basic reproduct number preval sir dynam find differ genet divers epidem explain differ underli epidemiolog ag epidem local popul densiti viral subtyp model comparison reveal sir dynam three global restrict epidem better fit simpler si dynam summari metapopul model provid gener practic framework integr epidemiolog popul genet purpos joint infer
PLoS One	24164576	2007-02-28	PMC3679054	23776690	m member novel class potent hiv entri inhibitor base human engin antibodi domain ead exhibit broad inhibitori activ suggest cdinduc epitop highli conserv describ fine map epitop approach panel mimotop affinityselect random peptid librari potenti mbind residu computation predict second homolog model molecular dock gp reveal residu gpm interact third predict contact residu verifi sitedirect mutagenesi epitop compris three discontinu site includ kei gp residu site thr pro site glu il site met trp identifi structur gp site c locat bridg sheet site excurs plai essenti role receptor coreceptorbind major target neutral antibodi base propos precis local epitop mechan broad inhibitori activ help develop novel hiv therapeut base ead
PLoS One	24228674	2003-09-01	PMC3679110	23776451	duck viral enter dve acut contagi herpesviru infect duck gees swan ag speci diseas respons econom loss domest wild waterfowl result mortal decreas egg product resveratrol natur occur phytoalexin specif plant exhibit inhibitori activ kind viru paper resveratrol inhibit duck enter viru dev replic dosedepend manner inhibit concentr gml inhibit viru multipl presenc resveratrol attribut direct inactiv inhibit viru attach host cell inhibit viral multipl host cell assai time addit limit drug infect conclus support ultrastructur imag earli stage dev infect replic viru nucleic acid format capsid cell nucleu suppress indirect immunofluoresc assai protein express dev infect duck embryo fibroblast def postinfect pi effect suppress resveratrol summari resveratrol good activ dev infect vitro attribut fact essenti earli viral protein viru replic impact resveratrol
Implement Sci	17329345	2016-11-02	PMC3680003	23734672	background respons high profil public health crise public health renew underwai canada provinc british columbia ministri health initi collabor evidenceinform process involv steer committe repres health author core function cf framework develop identifi core public health program core program evid review conduct model core program paper develop document distribut health author guid develop renew public health servic cf implement conceptu embed knowledg translat process cf coordin health author facilit gap analysi develop perform improv plan core program post public health author websit method interview focu group conduct total manag front staff health author work healthi live sexual transmit infect prevent core program interview focu group digit record transcrib verifi project coordin member team nvivo manag data conduct themat analysi main theme emerg concern implement cf framework gener program theme told doubl bind sell game find demonstr origin vision cf process lost implement process particip unawar cf framework process conclus discuss respect wellknown framework adopt assimil implement innov health servic organ despit attempt ministri health steer committe develop implement collabor evidenceinform polici intervent barrier realiz vision core public health function implement earli stage neglect implement process expect benefit public health renew process will realiz
BMC Genomics	12933759	2016-08-17	PMC3680065	23711280	background porcin circoviru type pcv causal agent postwean multisystem wast syndrom pmw sever impact swine industri worldwid pcv trigger weak atyp innat immun respons kei gene mechan viru interfer host innat immun elucid studi gene control respons primari porcin alveolar macrophag pam main target pcv profil vitro pam infect pcvwh strain evidenc quantit realtim polymeras chain reaction qpcr immunofluoresc assai ifa infectionrel differenti gene express investig pig microarrai pig genom coordin program valid realtim pcr enzymelink immunosorb assai elisa microarrai analysi hour postinfect hpi reveal uniqu gene differenti express fals discoveri rate foldchang gene differenti express hpi upregul gene princip immun respons cytokin activ locomot regul cell prolifer apoptosi cell growth arrest antigen process present downregul gene involv terpenoid biosynthesi carbohydr metabol translat proteasom degrad signal transduc activ ribosom protein repres reduc vital activ pcvinfect cell conclus pcv infect pam upregul gene inflamm indic pcv induc systemat inflamm pcv persist induc cytokin tolllik receptor tlr tlr pathwai promot high level cytokin secret pcv prevent apoptosi pam upregul serpinb express lengthen durat pcv replicationpermiss condit observ gene express profil provid insight underli immunolog respons patholog chang occur pig pcv infect
Virol J	27807241	2005-12-12	PMC3680276	23706032	background studi sequenc phylogenet analys vp gene twelv canin parvoviru cpv strain eleven domest dog giant panda ailuropoda melanoleuca china novel canin parvoviru cpv detect giant panda china nucleotid phylogenet analysi capsid protein vp gene classifi cpv cpva type substitut gln arg conserv residu cpv present unusu variat cpva amino acid sequenc giant panda evid continu evolut viru conclus find extend knowledg cpv molecular epidemiolog relev wild carnivor
PLoS Negl Trop Dis	27535837	2016-04-15	PMC3681624	23785536	although heterotyp secondari infect dengu viru denv associ sever diseas major secondari infect mild asymptomat mechan antibodymedi protect understood denvposit case enrol pediatr hospitalbas studi managua nicaragua primari secondari infect analyz denvspecif neutral titer nt igm igg avid antibodi titer serum sampl collect acut convalesc phase and month postinfect nt titer peak convalesc decreas igg avid denv increas convalesc month timepoint primari denv infect acut convalesc phase secondari denv infect avid denv previou infect serotyp initi higher avid denv secondari denv infect opposit relat observ month postinfect correl igm avid nt acut primari case igg avid nt secondari denv infect summari find indic igm antibodi plai role earli control denv infect igg serum avid denv analyz time longitudin sampl switch target crossreact serotyp current infect serotyp time final serum avid correl neutral capac
PLoS Pathog	16352549	2009-09-02	PMC3681750	23785283	plasmacytoid dendrit cell pdc effici sens hcv hivinfect cell virionfre pathwai demonstr classic swine fever viru member flavivirida process effici term interferonalpha induct compar direct stimul viru particl employ viru replicon particl infecti rna replic form de novo virion exclud transfer viru donor cell pdc pdc activ infect cell mediat contactdepend rna transfer pdc sensit tlr inhibitor inhibit drug cytoskeleton membran cholesterol demonstr uniqu viral protein ribonucleas activ viral ern protein pestivirus effici prevent process requir intact ribonucleas function intracellular compart propos pathwai activ virus tend cellassoci persist infect noncytopathogen
PLoS One	27081112	2012-09-17	PMC3682957	23799128	highli pathogen avian influenza hn virus result poultri occasion human mortal safe effect hn vaccin urgent need reduc pandem potenti hemagglutinin ha major envelop protein account spike influenza viru major antigen subunit vaccin develop studi conduct systemat studi immun respons influenza viru infect immun recombin ha protein express insect sf cell insect cell exogen gene elabor nlink glycan mimic mammalian cell cho antibodi titer higher insect cell deriv ha protein neutral ha inhibit titer higher mammalian cell produc ha protein recombin ha protein tri tetraantennari complex termin sialyl asialyatedgalactos type nglycan induc better protect immun mice lethal challeng highli relev issu consid product fragment vaccin
Biomolecules	19726603	2015-09-01	PMC3685863	23795346	mani viral protein sumoyl correspond regulatori effect protein function indic host cell modif process exploit viral pathogen control viral activ addit sumoyl regul protein viral pathogen modul host sumoyl level larg number cellular target sumo addit breadth critic cellular process regul sumoyl viral modul sumoyl presum alter cellular environ ensur favor viral reproduct andor persist virus bacteri plant pathogen target sumoyl system decreas sumoyl disrupt host antipathogen respons demonstr listeria monocytogen disrupt host sumoyl requir effici infect extend plant pathogen observ human pathogen suggest pathogen modul host sumoyl widespread appreci review will focu aspect pathogen modul host sumoyl system benefit pathogen
Virol J	22988146	2017-08-01	PMC3686584	23714224	background human adenovirus hadv secondlead childhood gastroenter worldwid viru commonli environment water resist water disinfect environment stressor uv light inactiv molecular techniqu pcrbase method polymeras chain reaction commonli detect identifi viral contamin water pcr allow discrimin infecti noninfecti viral particl combin cell cultur pcr allow detect infecti virus grow slowli fail produc cytopath effect cpe cell cultur studi aim assess integr viabil human adenoviru hadv environment water evalu circul strain molecular character three site water suppli florianpoli santa catarina island brazil peri lagoon water spring sourc water water public water suppli system method water sampl collect concentr hadv quantifi realtim pcr viral integr evalu enzymat assai dnase infect plaqu assai pa integr cell cultur transcrib mrna iccrtqpcr sampl particl infecti hadv select sequenc molecular character analyz site contain undamag hadv particl defin genet materi protect viral capsid peri lagoon spring sourc water public suppli system water particl pa iccrtqpcr hadv infecti undamag peri lagoon pa iccrtqpcr spring sourc water pa iccrtqpcr public water suppli system iccrtqpcr sensit rapid techniqu detect low hadv genom copi millilit infecti viral particl environment water sampl molecular character studi indic hadv preval serotyp conclus indic lack proper public health measur hadv effici marker environment drink water contamin iccrtqpcr demonstr greater sensit speed detect infecti viral particl compar pa
PLoS Pathog	28762491	2006-11-01	PMC3688547	23818848	hepat viru hcv relev liver cirrhosi hepatocellular carcinoma complic lack access small anim model systemat investig virus small mammal guid effort establish model provid insight viral evolutionari biologi assembl sofar largest collect smallmamm sampl qualifi screen bloodborn virus includ sera organ rodent speci sera bat speci three highli diverg rodent hepaciviru clade detect european bank vole myod glareolu south african fourstrip mice rhabdomi pumilio bat antihcv immunoblot reactiv viru detect genet related suggest serolog enabl rna detect broadli reactiv pcr assai develop studi hors cat dog test yield horseassoci hepacivirus dog cat rodent virus equidist hcv exceed divers hcv canineequin hepacivirus full genom sequenc repres viral lineag salient genom featur distanc criteria support classif virus hepacivirus quantit rtpcr rna insitu hybridis histopatholog suggest hepat tropism liver inflamm resembl hepat recombin serolog distinct hepaciviru lineag bank vole identifi seropreval rate antibodi bank vole sera crossreact hcv heterolog bank vole hepaciviru cooccurr rna antibodi pcrposit bank vole sera data enabl hypothes hcv evolut encourag effort develop rodent surrog model hcv
PLoS One	24741091	2014-05-01	PMC3688663	23840680	emerg transmiss infecti diseas enorm impact poultri industri seriou threat health human wild bird noncommerci poultri oper backyard poultri facil china potenti sourc viru exchang commerci poultri wild bird critic wetland area backyard poultri close contact commerci poultri migratori bird increas risk contract infecti diseas evalu transmiss risk crosssect studi undertaken poyang lake area china involv resid backyard poultri farm three counti region jiangxi provinc examin backyard poultri popul poultri speci presenc poultri death infecti diseas food sourc biosecur practic region rank highest biosecur region rank lowest risk infecti diseas assess adjust odd ratio base multivari logist regress analysi potenti risk factor three region studi site compar region factor contact poultri wild bird ci region factor contact poultri neighbor backyard waterfowl ci region factor poultri purchas local live bird market ci contact poultri wild bird ci summari backyard poultri neighbor commerci poultri close contact wild bird expect improv understand transmiss risk infecti diseas typic backyard poultri environ rural china address improv local farm practic prevent measur
PLoS One	17079328	2009-04-01	PMC3688872	23824680	background outbreak emerg infecti diseas caus pathogen sar coronaviru hn hn hn influenza virus associ mortal morbid human neutral antibodi individu recov infect confer therapeut protect infect pathogen survivor provid plasma clone monoclon antibodi mab methodologyprincip find genom immunoglobulin gene rhesu macaqu human highli homolog investig neutral mab highli homolog human humanlik gener hn influenza viru model immun rhesu macaqu recombin adenovirus carri synthet gene encod hemagglutinin ha screen antibodi phage displai librari deriv cell immun monkei clone select macaqu immunoglobulin heavi chain light chain variabl region human igg constant region gener humanmacaqu chimer mab exhibit homolog human antibodi select mab demonstr potent neutral activ three clade hn influenza virus vivo protect experi demonstr mab effect protect mice administ dai infect hn influenza viru mab demonstr subpicomolar bind affin ha superior vivo protect efficaci loss bodi weight obviou lung damag analysi escap mutant demonstr antibodi bound conserv epitop region amino acid globular head ha conclusionssignific studi demonstr gener neutral mab potenti applic human urgent prepared outbreak influenza infect virul infecti diseas
PLoS One	24839316	2017-09-01	PMC3688998	23825668	japanes enceph viru jev nonstructur protein ns contribut viru replic elicit protect immun respons infect jev nsspecif antibodi respons target differenti diagnosi flaviviru infect epitop jev ns character studi describ full map linear bcell epitop jev ns gener eleven nsspecif monoclon antibodi mice immun recombin ns epitop map monoclon antibodi set partiallyoverlap peptid cover entir ns protein express gsttag screen monoclon antibodi enzymelink immunosorb assai elisa linear epitopecontain peptid identifi sequenti remov amino acid residu carboxi amino termin peptid minim unit linear epitop identifi confirm monoclon antibodi linear epitop locat amino acid residu aiditrk rdelnvl kskhnrregi dengivld dettlvr epitop highli conserv jev strain sequenc align notabl homolog region ns protein flavivirus react mab test crossreact epitop peptid recogn sera west nile viru dengu viru novel virusspecif linear bcell epitop jev ns benefit develop vaccin diagnost assai
Clin Dev Immunol	19551239	2011-09-01	PMC3690221	23840243	vaccin strategi depend entir appropri respons immun system antigen activ immun effect neutral antibodi nab effici counter infect propag pathogen virus includ hiv advantag immun respons order evad nab review focus viral immun evas strategi result directli robust immun respons infect vaccin rational multiab therapi circumv phenomenon discuss progress formul product regulatori approv monoclon antibodi mab present
PLoS One	28697896	2018-01-01	PMC3691157	23826190	background disast seriou public health issu health profession commun resid main player disast respons knowledg level disast medicin studi aim evalu knowledg level train disast medicin potenti disast respond present necess popular disast medicin educ method selfreport questionnair survei knowledg level train disast medicin conduct shanghai china total randomli select health profession medic student local resid provid intact total respons rate particip receiv systemat disast medicin train new media common channel acquir disast medicin knowledg health profession knowledg commun resid knowledg structur disast medicin intact medic teacher knowledg medic practition health administr clinician perform better public health physician public health student perform better clinic medic student commun resid educ background knowledg level disast medicin train disast medicin gener high survei lectur practic train prefer teach method select kei interest content disast medicin train health profession medic student prioriti chosen local resid health profession medic student conclus tradit clinicalori medic educ lead huge gap knowledg level disast medicin current disast prepared continu medic educ public educ plan disast medicin media practiceori select appli popul knowledg level train consider
PLoS One	21239608	2012-03-06	PMC3691190	23826109	hospit isol room vital contain neg pressur patient protect posit pressur patient airborn infecti agent facil essenti manag highli contagi patient sever acut respiratori syndrom sar outbreak ahn influenza pandem type door design construct isol room space afford color food dye tracer qualit effect dooropen motion dissemin contamin air singl isol room visual film reynoldsnumberequival smallscal watertank model fit programm dooropen move human figur motion care scale consider involv design construct watertank model enabl accur extrapol fullscal situat simpl type door design test variabl speed singl doubl slide hing door combin move human figur video footag edit synchron present seri splitscreen format experi clear doublehing door pose greatest risk leakag room order decreas risk singlehing doubleslid singleslid door rel move human figur spread potenti contamin greatest slide door bulk airflow induc larg rel dooropen motion hing door airflow induc dooropen motion greater experi involv simul ventil environ requir find appear slidingdoor effect hospit isol room contain
PLoS One	28935640	2002-06-15	PMC3692534	23825585	dasatinib bm fdaapprov multitarget kinas inhibitor bcrabl src kinas treatment chronic myelogen leukemia cml resist intoler prior therapi includ imatinib report novel dasatinib induc differenti acut myeloid leukemia aml cell mekerkdepend activ signal transduc activ transcript stat dasatinib induc differenti aml cell demonstr express differenti marker cdb gg phase arrest decreas ratio nucleu cytoplasm note dasatinib induc robust phosphoryl stat tyr ser redistribut stat cytoplasm nucleu lead transcript stattarget gene knock stat express shrna attenu dasatinibinduc differenti indic role stat myeloid matur dasatinibinduc activ stat regul mekerk kinas phosporyl mek erk occur rapidli dasatinib treatment increas progress differenti induc mek inhibitor pd inhibit phosphoryl stat abrog dasatinibinduc myeloid differenti suggest mekerk depend phosphoryl stat indispens differenti dasatinib aml cell studi suggest stat mediat dasatinibinduc differenti aml cell activ requir activ mekerk cascad
BMC Res Notes	22396546	2012-02-24	PMC3693993	23725338	background current ongo debat limit evid mask respir prevent respiratori infect health care worker hcw studi aim examin polici guidelin mask respir hcw describ area consist guidelin gap recommend refer cdc guidelin method polici guidelin mask respir prevent influenza sar tb examin guidelin health organ center diseas control prevent cdc three highincom countri lowmiddleincom countri select uniform recommend cdc protect hcw season influenza mask low risk situat respir high risk situat tb respir pandem influenza sar recommend mask low risk respir high risk situat cdc recommend respir low high risk situat countri review variat recommend three diseas countri align recommend align cdc choic respir level filter abil vari guidelin diseas lastli polici discuss reus extend us cloth mask conclus current variat polici recommend mask respir protect influenza sar tb differ reflect scarciti levelon evid inform polici develop lack guidelin cloth mask despit widespread low middleincom countri remain polici gap health organ countri jointli evalu evid priorit inform evid gap develop consist polici mask respir health care set
PLoS One	12021336	2015-01-21	PMC3694013	23840781	the avian coronaviru infecti bronchiti viru ibv caus agent respiratori diseas infecti bronchiti domest fowl control routin vaccin explor potenti ibv vaccin vector revers genet system utilis gener infecti recombin ibv ribv express report gene enhanc green fluoresc protein egfp humanis renilla luciferas hrluc infecti ribv replac gene intergen region ir egfp hrluc replac orf hrluc replac gene ibv codonoptimis version hrluc gene success rescu infecti ribv report gene express confirm fluoresc microscopi luciferas activ assai rescu ribv infect primari chick kidnei ck cell genet stabil ribv analys serial passag ck cell recombin ibv stabil vari depend genom region replac report gene maintain passag replac gene replac ir replac orf codonoptimis hrluc gene replac gene increas genom stabil hrluc express stabl compar standard hrluc repeat passag ribv express hrluc moi demonstr increas stabil hrluc express stabl replac gene studi demonstr heterolog gene incorpor express rang ibv genom locat replac accessori gene offer promis target realis potenti ibv vaccin vector avian pathogen
PLoS One	22364540	2016-08-29	PMC3694086	23840401	as consequ innat immun activ granulocyt macrophag produc hypochloritehypochlor acid hocl secret myeloperoxidas mpo the cell hocl react protein protein alter system belong invad microorgan host doubt myeloperoxidas system capabl directli inactiv hiv hypothes addit indirect mode action articl hocl chemic alter protein turn ideap ideap immun defencealt protein potent amyloidlik shgroup captur antivir weapon hiv hoclalt plasma protein ideapp capac bind effici high affin hiv envelop protein gp receptor cd protein disulfid isomeras pdi ideapp inhibit viral infect replic cell cultur system reduc number infect cell syncytia reduct viral capsid protein cultur supernat unmodifi plasma protein fraction hoclalt isol protein antithrombin iii human serum albumin repres exampl pool plasma protein exert activ bind gp inhibit viral prolifer data offer opportun improv understand intricaci hostpathogen interact allow gener hypothet scheme natur immun defens mechan gener posttransl modif plasma protein potent virucid weapon immobil viru inhibit viral fusion entri host cell simul mechan vitro provid interest therapeut approach microorgan
PLoS One	25609249	2018-08-01	PMC3694142	23840600	thi studi analyz heterolog primeboost vaccin approach hiv three antigen unrel negativestrand virus nsv express hiv gag vaccin vector rabi viru rabv vesicular stomat viru vsv newcastl diseas viru ndv hypothes approach result robust cellular immun respons achiev of vaccin homolog primeboost regimen prime balbc mice nsvbase vector prime mice rest thirtyf dai administ second immun heterolog nsvgag virus magnitud qualiti gagspecif cd cell respons vector post boost measur addit perform challeng experi vaccinia viru express hiv gag vvgag thirtythre dai boost inocul choic vaccin prime detect gagspecif cd cell recal respons post boost ndvgag appear result robust recal cd cell respons independ prime vaccin primeboost strategi distinct paramet studi challeng experi vvgag indic benefit compar singl immun data nsv vector individu stimul hivgag specif cd cell effect recal nsv vector heterolog primeboost approach provid evid rabv vsv ndv combin develop vaccin need primeboost regimen stimul effect immun respons
PLoS Pathog	27571349	2010-05-03	PMC3694852	23825954	theiler viru neurotrop picornaviru respons chronic infect central nervou system establish persist infect subsequ demyelin diseas trigger viru depend express viral accessori protein encod altern open read frame viru discov potent inhibit interferoninduc oasrnas pathwai antagon rnase l promin macrophag baselin oligoadenyl synthetas oa rnase express level elev detect fibroblast ifn pretreat mutat theiler viru replic primari macrophag deriv wildtyp rnase ldefici mice counteract oasrnas pathwai direct interact ankyrin domain rnase inhibit enzym interestingli rnase inhibit speciesspecif theiler viru protein block murin rnase human rnase rnase mammal bird direct rnase inhibit speci specif confirm in vitro assai perform purifi protein demonstr novel viral mechan elud antivir oasrnas pathwai target effector enzym antivir pathwai potent inhibit rnase underscor enzym innat immun theiler viru
PLoS One	30068645	2015-06-01	PMC3695084	23826322	old frugivor bat identifi natur host emerg zoonot virus public health concern includ henipavirus nipah hendra viru ebola viru marburg viru epidemiolog studi virus bat util serolog describ viral dynam attent paid juvenil birth increas suscept popul viral outbreak matern immun wane understood bat immunolog includ durat matern antibodi neonat understand durat matern deriv immun critic character viral dynam bat popul help assess risk spillov human conduct separ studi pregnant pteropu bat speci offspr measur halflif durat antibodi canin distemp viru antigen vaccin captiv pteropu hypomelanu hendra viru wildcaught natur infect pteropu alecto pteropid bat speci reservoir henipavirus speci antibodi transfer dam pup hypomelanu pup titer cdv wane period dai ci termin phase halflif dai ci alecto pup antibodi wane dai ci termin phase halflif dai ci speci durat transfer matern immun month longer estim data will allow accur interpret agerel henipaviru serolog data collect wild pteropid bat
J Clin Bioinforma	20440079	2014-09-01	PMC3695838	23724967	background biolog network elucid diseas etiolog abil model complex high dimension data biolog system proteom critic data sourc model current lack robust de novo method network construct bring insight system biologi evalu construct network model method deriv weight gene coexpress network analysi wgcna scalefre peptid network compos statist modul feasibl biolog meaning mous lung experi human plasma experi network peptid deriv protein statist higher topolog overlap concord abund infer protein abund modul repres call eigenpeptid correl biolog phenotyp modul find enrich biolog function interact gene ontolog proteinprotein interact conclus biolog network tool analysi complex system paper evalu applic weight coexpress network analysi quantit proteom data protein coexpress network allow novel approach biolog interpret qualiti control infer protein abund framework resolv degener peptideprotein map biomark signatur discoveri
Case Rep Infect Dis	25970109	2004-03-01	PMC3697188	23840985	influenza viru frequent report viral rhabdomyolysi yearold child present rhabdomyolysi associ parainfluenza type viru case rhabdomyolysi associ parainfluenza viru report complic includ electrolyt disturb acut renal failur compart syndrom
J Toxicol	25007876	2008-12-16	PMC3697785	23843786	sever peptid contain scorpion fluid divers arrai biolog activ high specif target site investig outlin potent effect microb potenti modul biolog mechan involv immun nervou cardiovascular neoplast diseas structur function divers project scorpionderiv peptid develop specif drug review summar relev find improv valuabl tool drug develop
J Mol Signal	14970388	2014-07-01	PMC3697994	23758787	the tumor necrosi factor receptor tnfrassoci factor traf famili intracellular protein origin identifi signal adaptor bind directli cytoplasm region receptor tnfr superfamili decad wit rapid expans receptor famili identifi emploi traf signal includ tolllik receptor tlr nodlik receptor nlr rigilik receptor rlr cell receptor il receptor famili il receptor ifn receptor tgf receptor addit role adaptor protein traf ubiquitin ligas activ downstream signal event trafdepend signal pathwai typic lead activ nuclear factorb nfb mitogenactiv protein kinas mapk interferonregulatori factor irf compel evid germlin cellspecif trafdefici mice demonstr traf plai indispens nonredund physiolog role regul innat adapt immun embryon develop tissu homeostasi stress respons bone metabol notabl mount evid implic traf pathogenesi human diseas cancer autoimmun diseas spark appreci interest traf review present overview current knowledg traf emphasi find concern traf molecul signal human diseas
BMC Infect Dis	19091686	2005-02-01	PMC3698019	23786598	background acut pharyng frequent primari care acut viral pharyng easili misdiagnos acut bacteri pharyng laboratoryconfirm diagnosi respiratori virus recommend purpos studi compar sensit oropharyng swab op nasopharyng swab np nasal wash nw adult acut pharyng method op np nw particip acut pharyng specimen test respiratori virus taqman realtim polymeras chain reaction sampl consid true posit specimen posit sensit sampl compar chisquar test fisher exact test appropri three tripl sampl collect consecut op np nw patient virus detect three method virus sensit np higher nw op conclus flock np collect effect altern nw op detect respiratori virus adult acut pharyng taqman realtim polymeras chain reaction
BMC Complement Altern Med	24209773	2013-01-01	PMC3698045	23777309	background purpos investig determin black tea extract bte consist flavanol compound call theaflavin inhibit herp simplex viru type hsv infect cultur human epitheli vero cell method bte vero cultur cell hsv assess phase contrast fluoresc microscopi cell viabil prolifer assai establish maximum noncytotox concentr bte vero cell hsv virion treat vari concentr bte vero cell infect hsv green fluoresc protein gfp insert ul gene infect determin viral dna extract pcr plaqu assai adsorpt assai electrophoresi pcr product bte cytotox vero cell confirm cell viabil prolifer assai bte treat group parallel posit control group cell line plaqu assai fluoresc microscopi indic invers relationship bte concentr mm hsv infect pcr electrophoresi reduct viral genom treatment bte addit notic decreas amount viral plaqu bte treat sampl adsorpt assai conclus bte consist theaflavin cytotox reduc block product infecti hsv virion cultur vero cell inhibit infect viru interf attach penetr viral dna replic hsv particl find indic bte enrich theaflavin potenti develop safe therapeut antivir agent prevent spread hsv
PLoS One	15695705	2012-04-23	PMC3698095	23840878	the cop signalosom csn evolution highli conserv protein complex compos uniqu subunit csn csn higher eukaryot purport modul protein degrad mediat ubiquitinproteasom system demonstr critic mitot parenchym organ vertebr hepatocytespecif knockout cop gene hscsnko massiv hepatocyt apoptosi liver malfunct underli mechan remain unclear report csncsn exert profound impact hepat function critic stabil proapoptot protein bim decreas ci cytokineinduc src homolog domaincontain protein bim receptor cullinbas ubiquitin ligas coexist mark increas bim protein csn defici decreas proteasom subunit rpt markedli increas high molecular weight neddyl ubiquitin protein surrog substrat reveal sever impair upsmedi proteolysi hscsnko liver inclus bodylik materi accumul csn defici hepatocyt addit bim massiv hepatocyt apoptosi hscsnko liver associ elev express member bcl famili includ proapoptot bax antiapoptot bcl bclxl increas interact bcl bim bcl bax detect conclud hepat csn defici impair liver result bim upregul plai role trigger hepatocyt apoptosi sequest bcl bax
PLoS One	23391695	2011-08-10	PMC3699510	23844250	in novel coronaviru merscov associ sever respiratori diseas emerg arabian peninsula human case report includ fatal case case result humantohuman transmiss emerg novel coronaviru prompt small anim model studi pathogenesi viru test efficaci potenti intervent strategi studi explor syrian hamster small anim diseas model intratrach inocul inocul aerosol clinic sign diseas viru replic histolog lesion cytokin upregul seroconvers observ inocul anim indic merscov replic syrian hamster
PLoS One	22224766	2005-12-01	PMC3699609	23843955	background detect acinetobact baumannii reli bacteri cultur fail return time dnabas assai sensit bacteri cultur detect pathogen molecular inconsist challeng doubt fals posit system environmentderiv contamin addit molecular tool requir expens laboratori instrument establish molecular tool field requir simpler molecular platform loopmedi isotherm amplif method simpl improv better routin clinic bacteriolog laboratori simpl portabl devic capabl perform amplif detect fluoresc lamp platform develop year method refer realtim loopmedi isotherm amplif studi attempt util method rapid detect baumannii methodolog find speciesspecif primer design test util method clinic sampl baumannii determin sensit specif system compar bacteri cultur polymeras chain reaction method posit sampl isol sputum confirm speci acinetobact rrna gene sequenc realamp method simpler allow realtim detect dna amplif distinguish baumannii acinetobact calcoaceticu acinetobact genom speci dna extract simpl boil method compar bacteri cultur sensit specif realamp detect baumannii conclus realamp assai requir singl unit assai posit verifi visual inspect assai great potenti field molecular tool detect baumannii
PLoS One	16308574	2013-11-01	PMC3701015	23843958	atop dermat ad refractori recurr inflammatori skin diseas factor includ hered environment agent innat acquir immun skin barrier function particip pathogenesi ad helper domin immunolog milieu suggest acut phase ad antigen agb kda secretori protein conserv mycobacterium speci agb strong thtype cytokin induc activ expect amelior condit allerg diseas perform agb function vivo effect invas vaccin method requir establish novel function viru vector recombin human parainfluenza type viru vector rhpiv highli express replicationdefici lowpathogen vector studi investig efficaci rhpiv engin express agb rhpivagb mous ad model induc repeat oxazolon ox challeng ear swell dermal cell infiltr serum ig level suppress rhpivagb treat mous group accompani elev ifn il mrna express suppress il tnf mip mrna express treat mice clinic symptom croup system advers reaction respiratori tract epithelium captur rhpiv effect remark cytotox effect suggest rhpivagb potent therapeut tool control allerg disord
BMC Infect Dis	12897794	2014-03-05	PMC3701468	23809195	background dynam transmiss model increasingli improv understand epidemiolog healthcareassoci infect hcai comprehens review emerg field paper summaris mathemat model inform field hcai method develop time method medlin embas scopu cinahl global health databas systemat search dynam mathemat model hcai transmiss andor dynam antimicrobi resist healthcar set total paper met elig criteria main theme consid evalu infect control effect variabl transmiss rout impact movement pattern healthcar institut develop antimicrobi resist strain competit cocolonis strain methicillinresist staphylococcu aureu commonli model hcai vancomycin resist enterococci common hcai clostridum difficil rare investig model publish hcai low middleincom countri hcai model look antimicrobi resist hospit set compartment determinist approach stochast model includ role chanc transmiss process increasingli common model calibr infer unknown paramet fit model data sensit analysi compar uncommon occur studi applic increas model compar predict extern data conclus transmiss model understand complex system predict impact control polici method gener improv increas stochast model advanc method formal model fit sensit analys insight gain model broaden wider rang pathogen set improv avail data statist method enhanc predict abil model
Emerg Health Threats J	24599949	2008-05-21	PMC3701798	23827387	diseas outbreak intern public health continu occur regularli detect track public health threat countri report event global health commun challeng center diseas control prevent cdc global diseas detect gdd oper center establish earli monitor infecti noninfecti public health event identifi unexplain global public health threat better posit cdc respond public health assist request requir time gdd oper center activ monitor public health threat provid perspect top global infecti diseas threat watch avian influenza hn cholera wild polioviru enteroviru extens drugresist tuberculosi
Asia Pac Fam Med	11825958	2011-06-22	PMC3702417	23800113	object effect pandem respons reli frontlin healthcar worker continu work despit increas risk object investig alberta famili physician willing work influenza pandem design crosssect survei set alberta prior fall wave hn epidem particip particip random sampl alberta famili physician stratifi region main outcom measur willing work difficult scenario creat influenza epidem correct respons rate physician respond continu work scenario caus pandem circumst continu men continu work women situat south african british train physician continu work group conclus physician intend maintain practic event pandem circumst fewer work pandem prepar requir ensur workforc healthcar system provid frontlin healthcar worker support resourc enabl continu provid care
BMC Infect Dis	18495857	2009-03-18	PMC3702433	23815298	background lower respiratori tract infect lrti includ communityacquir pneumonia cap common infecti diseas associ morbid mortal pattern aetiolog pathogen differ region countri special attent paid cap southeast asia sea region face rapid demograph transit estim burden aetiolog pattern cap essenti clinic public health manag purpos studi determin incid aetiolog pathogen clinic pictur risk factor communityacquir pneumonia cap vietnames adult popul method prospect surveil hospitalis adult cap conduct khanh hoa provinc central vietnam adult ag year lower respiratori tract infect lrti admit provinci hospit septemb august enrol studi patient classifi cap nonpneumon lrti nplrti radiolog find bacteri pathogen identifi sputum sampl convent cultur polymeras chain reaction pcr streptococcu pneumonia haemophilu influenza moraxella catarrhali respiratori virus identifi nasopharyng specimen pcr lrti episod examin cap older ag presenc underli respiratori condit higher score smoke associ cap oneyear estim incid hospitalis adult cap studi popul person year incid increas consider ag highest elderli case fatal proport hospitalis cap patient sputum sampl test bacteri pcr posit influenza posit pneumonia sampl test viral pcr posit respiratori virus influenza common conclus current adult cap incid vietnam low result attribut young ag studi popul
Viruses	21697488	2010-11-01	PMC3705299	23503326	the central nervou system cn harbor highli differenti cell neuron essenti coordin function complex organ organ partli protect bloodbrain barrier bbb toxic substanc pathogen carri bloodstream neurotrop virus reach cn cross bbb viremia exploit motil infect cell trojan hors axon transport type type iii interferon ifn cytokin critic control earli step viral infect defici ifn pathwai associ fatal viral enceph human mice ifn system essenti protect cn viral infect basal activ ifn system appear low cn toxic ifn organ viral infect neuron oligodendrocyt report poor ifn produc appear suscept neurotrop virus presenc ifn review address trend develop concern role type type iii ifn prevent neuroinvas infect cn cell ii ident ifnproduc cell cn iii antivir activ isg iv activ viral protein neurotrop virus target ifn pathwai
Evid Based Complement Alternat Med	19297504	2016-03-08	PMC3705751	23864896	thi studi rate antivir activ scutellaria baicalensi georgi baicalensi extract influenza viru subtyp exampl pandem hn season hn hn ethyl acet etoac chloroform extract inhibit vitro neuraminidas enzymat activ viral replic methanol meoh extract etoac extract demonstr inhibit ic valu rang gml plaqu reduct ic valu rang gml chloroform extract antivir activ plaqu reduct ic valu rang gml timeofaddit assai indic etoac chloroform extract inhibit viru yield infect hplc analysi demonstr baicalin domin meoh extract baicalein chrysin rich etoac chloroform extract molecular simul reveal baicalein hydrogen bond glu hydrophob van der waal interact il arg ser tyr activ site baicalein inhibit vitro replic influenza virus pandem hn ic season hn plaqu reduct assai combin lowdos baicalein antiinfluenza agent applic develop altern remedi treat influenza viru infect
Virol J	21029937	2004-10-26	PMC3706282	23805898	background febril neutropenia percent infecti agent identifi diagnost gap hypothet reduc broad implement molecular detect techniqu pcr revolution detect infecti diseas decad find perform longitudin prospect studi neutropen patient assess role respiratori virus neutropen fever determin clinic relev blind screen virus respiratori virus recov patient prior neutropenia neutropen patient fever fever respiratori viru detect compar sampl type nasal swab perform better throat swab throat gurgl differ sampl type conclus blind diagnost screen respiratori virus neutropenia nasal swab sensit practic option screen respiratori virus
PLoS One	26956017	2008-08-01	PMC3706321	23874753	understand spatial distribut dynam receptor unperturb membran essenti elucid role antivir signal convent studi detergentresist membran fraction provid caveola integr numer signal pathwai membran domain implic viral entri antivir defens studi time spatiotempor regul signal receptor the regul cluster downstream signal novel mechan viru evas host cell defens demonstr disrupt cluster signal molecul organ caveolinrich domain viral infect lead downregul caveolinb cavb disrupt cluster crfb zebrafish type interferon receptor subunit superresolut microscopi enabl singlemolecul imag crfb associ cavbcontain membran domain strikingli downregul cavb major protein compon caveola caus crfb cluster dispers dispers crfb cluster led suppress antivir immun respons vitro vivo abrog downstream signal respons suggest crfb organ cavbcontain membran domain critic ifnmedi antivir defens present undescrib antivir evas strategi alter ifn signal antivir immun respons
PLoS One	15507657	2013-05-13	PMC3706368	23874742	infect hepat viru hcv etiolog involv liver cirrhosi hepatocellular carcinoma bcell lymphoma demonstr hcv nonstructur protein ns involv cell transform studi yeast twohybrid screen experi conduct identifi cellular protein interact hcv ns protein cytosol deoxyribonucleotidas cdn dnt interact hcv ns protein bind domain hcv ns cellular cdn protein determin yeast twohybrid system interact hcv ns cdn protein demonstr coimmunoprecipit confoc analysi cultur cell cellular cdn activ partial repress ns protein transientlytransfect stablytransfect system hcv partial repress cdn activ protein express system hcv subgenom replicon infecti hcv virion deoxyribonucleotidas mammalian cell involv regul intracellular deoxyribonucleotid pool substrat cycl control dna precursor concentr essenti mainten genet stabil reduct cdn activ result imbal dna precursor concentr suggest hcv partial reduc cdn activ ns protein turn diseas
PLoS One	18570964	2015-01-01	PMC3706414	23874722	an adenoviru vector encod mous interferon alpha subtyp mdef evalu efficaci lethal cowpox brighton strain vaccinia wr strain viru respiratori system infect mice rout mdef administr nasal sinu pulmonari compar differ efficaci prefer treatment human small volum deliv intranas lower respiratori infect lri upper respiratori infect uri system infect induc intranas intranas intraperiton viru challeng mdef treatment prophylact short term longterm prior viru challeng singl nasal sinu treatment pfumous mdef protect mice vacciniainduc lri mortal compar publish studi pulmonari deliv mdef system vaccinia infect respond better nasal sinu deliv mdef pulmonari treatment cowpox lri infect respond mdef treatment dose weakli protect cowpox uri infect equal treatabl nasal sinu pulmonari deliv mdef pfumous doserespons prophylaxi mdef time prior initi vaccinia viru lri infect protect pfumous improv lung hemorrhag score lung weight evid decreas liver lung spleen viru titer mdef treat vaccinia cowpox viru infect nasal sinu pulmonari treatment regimen support develop human
PLoS One	23671097	2003-07-01	PMC3706438	23874452	a suscept locu tuberculosi reemerg infecti diseas discov exist chromosom ifitm gene encod interferon induc transmembran protein locat act effector molecul interferongamma essenti antituberculosi immun respons order investig associ suscept tb genet polymorph ifitm core promot casecontrol studi includ tb patient healthi control perform han chines children northern china rs polymorph associ suscept tb rs allel act recess frequent tb patient confid interv bonferroni pvalu assess rs polymorph ifitm transcript vitro base luciferas promot assai promot activ haplotyp rs allel lower haplotyp rs allel peripheralblood mononuclear cell carri rs gg genotyp reduc ifitm mrna level compar cell carri tt gt genotyp conclus rs function promot polymorph ifitm identifi influenc risk pediatr tb han chines popul
PLoS One	26464752	2016-11-01	PMC3706466	23874461	the hiv pandem continu expand effect vaccin cure exist therapi manag limit mortal control viral prolifer associ side effect cure diseas subject develop resist find therapeut target drug crucial dendrit cell immunoreceptor dcir ctype lectin receptor express dendrit cell dc act attach factor hiv dc contribut hiv transmiss cd lymphocyt cdtl directli involv hiv infect dcir express apoptot infect cdtl promot transinfect bystand cell report model extracellular domain dcir base structur surfac access pocket carbohydr recognit domain ep bind motif target screen chemic will disrupt normal interact hiv particl preliminari screen rajicddcir cell allow identif inhibitor decreas hiv attach propag impact inhibitor infect dc cdtl evalu studi identifi novel molecul capabl block hiv transmiss dc cdtl
Crit Care	12832663	2013-04-29	PMC3706775	23714692	introduct socioeconom impact critic ill patient famili europ determin aim exploratori studi estim chang famili circumst social econom stabil care requir access health servic patient month icu discharg method multicent questionnairebas studi survivor critic ill month icu discharg data consent patient spent greater hour uk icu month posticu discharg evid chang accommod relationship statu preadmiss month discharg icu neg impact famili incom report patient month month reduct number patient report employ sole sourc incom month compar preadmiss quarter patient report care assist month month major care provid famili member half neg impact employ patient receiv care report requir greater hour week discharg patient report attend primari care physician commun nurs mobil problem doubl preadmiss month report moder sever pain month remain anxiou depress conclus survivor critic ill uk face neg impact employ commonli care requir discharg hospit correspond neg impact famili incom major care requir provid famili member appar month materi improv month exploratori studi identifi potenti socioeconom burden critic ill
PLoS One	27803166	2003-12-15	PMC3707868	23875020	stateoftheart monoclon antibodi mab discoveri method util surfac displai techniqu prokaryot eukaryot cell requir multipl step reformat switch host transit displai express separ antibodi affin matur fulllength mab product platform report time method glycoengin pichia pastori enabl simultan surfac displai secret fulllength mab molecul humanlik nglycan yeast cell paradigm take advantag homodimer fc portion igg molecul surfaceanchor bait fc target function half igg cell wall pichia pastori interf secret full length mab util method isol high affin wellexpress antipcsk lead design librari creat mate yeast light chain heavi chain igg librari coupl glycoengin pichia pastori method power tool discoveri product therapeut human mab host improv drug develop shorten discoveri time cycl
J Gen Virol	23630245	2015-03-04	PMC3709572	22647373	the progress scienc punctuat advent revolutionari technolog provid wai scale formul scientif question advanc knowledg electron microscopi cell cultur pcr nextgener sequenc methodolog chang understand virus area genom sequenc evolut ecolog discoveri transcriptom possibl methodolog limit scientif imagin extent cost restrict small number sampl challeng remain includ storag analysi larg amount data gener chemistri emploi matur cost will decreas addit improv method analysi will open applic virolog includ routin diagnost work individu understand interact viral host transcriptom excit era viral explor begun will set challeng understand role newli discov viral divers diseas health
Biol Direct	14654687	2010-04-21	PMC3710099	23768067	background major role enzymat toxin target nucleic acid biolog conflict level increasingli appar larg advanc compar genom typic toxin evolv rapidli hamper identif protein sequenc analysi analyz unexpectedli widespread superfamili toxin domain possess rnase activ hepn superfamili compris helic domain identifi associ dna polymeras type nucleotidyltransferas prokaryot anim sacsin protein sensit sequenc structur comparison method vastli extend hepn superfamili identifi numer novel famili detect diverg hepn domain protein famili hepn famili includ rnase ls lsoa catalyt domain ken domain rnasel ir rnase domain rloc prrc major hepn domain conserv motif constitut metalindepend endornas activ site hepn domain lack motif function noncatalyt rnabind domain case mannitol repressor mtlr analysi hepn domain function toxin share numer system implic intragenom intergenom intraorganism conflict three domain cellular life prokaryot hepn domain essenti compon numer toxinantitoxin ta abort infect abi system addit tightli associ restrictionmodif rm crisprca system occasion defens system pgl ter evid multipl mode action hepn domain system includ direct attack viral rna lsoa rnase ls conjunct rnase domain novel rnase fold domain nama suicid dormancyinduc attack rna rm system crisprca system suicid attack coupl direct interact phage compon abi system find compat hypothesi coupl pathogentarget immun selfdirect program cell death dormanc induct respons evolut robust antivir strategi propos altruist cell suicid mediat hepn domain function rnase essenti evolut kin group select cell cooper hepn domain repeatedli acquir eukaryot incorpor core function endonucleolyt process sss rrna precursor la novel er membraneassoci rna degrad system corf sens unprocess transcript nuclear peripheri swt multipl line evid prokaryot hepn protein recruit antivir antitransposon apoptot system rnalevel respons unfold protein sacsin ken domain group eukaryot conclus extens sequenc structur comparison reveal unexpectedli broad presenc hepn domain enorm varieti defens stress respons system tree life addit hepn domain recruit perform essenti function eukaryot rrna process find expect stimul experi light divers cellular process three domain life review articl review martijn huynen igor zhulin nick grishin
Clin Dev Immunol	25740769	2014-06-01	PMC3710646	23878584	defin immunogen domain viral protein capabl elicit protect immun respons crucial develop novel epitopebas prophylact strategi select target conserv region share hypervari virus studi postinfect postimmun sera clone character monoclon antibodi mab repres best approach identifi protect epitop protect mab direct conserv region plai kei role immunogen design human therapi experiment approach aim character protect mab epitop identifi tcellactiv peptid burden technic limit requir long time correctli address decad epitop predict algorithm develop algorithm continu evolv address empir increas review strategi base experiment techniqu address silico analysi frequent predict immunogen includ novel epitopebas vaccin approach will list main strategi aim design vaccin prepar confer protect neutral mab combin effect cellmedi respons
Viruses	20410261	2016-12-01	PMC3712306	23698397	coronavirus infect varieti mammalian avian speci seriou diseas human cat mice bird form sever acut respiratori syndrom sar felin infecti periton fip mous hepat avian infecti bronchiti effect vaccin treatment develop sarscoronaviru fip viru lethal diseas report cyclophilin inhibitor cyclosporin csa inhibit replic coronavirus csa wellknown immunosuppress drug bind cellular cyclophilin inhibit calcineurin calciumcalmodulinactiv serinethreoninespecif phosphatas inhibit calcineurin block transloc nuclear factor activ cell cytosol nucleu prevent transcript gene encod cytokin interleukin cyclophilin peptidylprolyl isomeras physiolog function describ year includ chaperon foldas activ virus requir cyclophilin replic includ human immunodefici viru vesicular stomat viru hepat viru molecular mechan lead suppress viral replic differ virus review describ suppress effect csa coronaviru replic
PLoS One	24937251	2007-10-03	PMC3712968	23874493	in studi sought determin contribut microbi transloc febril episod attribut microbiolog fever unknown origin fuo adult febril neutropaen cohort endotoxin concentr measur chromogen limulu amoebocyt assai direct measur bacteri product whilst solubl cd scd measur elisa select indic earli host respons endotoxin endotoxin concentr cohort gener elev differ present fever stratif febril episod base microbiolog find reveal elev endotoxin concentr fuo episod compar episod document bacteri viral find scd concentr elev febril episod associ observ scd concentr microbiolog find fuo episod episod gramneg bacteraemia associ higher median scd concentr episod gramposit bacteraemia conclus find absenc microbiolog find microbi transloc contribut febril episod adult neutropaen cohort observ associ prophylact antibiot increas plasma endotoxin concentr 
J Med Internet Res	27806985	2016-07-01	PMC3713905	23856364	background decad wit turbul event public health emerg infect increas antimicrobi resist deliber releas threat ongo battl common ill amplifi spread diseas increas intern travel internet dramat chang avail outbreak compar onlin behavior public profession event media coverag outbreak object investig profession public onlin major infect outbreak correl media coverag question includ health care profession onlin public health infect control differ public dramat media coverag outbreak contribut the public incid diseas major polici event relat profession method three longitudin timebas dataset mid uniqu record profession onlin behavior uk infect portal nation electron librari infect nation resourc infect control nelinr equival public onlin googl trend relev media coverag lexisnexi analysi nelinr log identifi highest interest major infecti diseas clostridium difficil difficilemethicillinresist staphylococcu aureu mrsa tuberculosi mening noroviru influenza preprocess dataset analyz triangul public static actual diseas occurr profession increas public health event mrsac difficil releas major nation polici document media coverag event major public interest uk outbreak difficilemrsa except noroviru show season pattern public profession match period diseas occurr mening clear exampl diseas heighten media coverag tend focu individu celebr case influenza major concern hn outbreak creat massiv public interest spring autumn peak case autumn correspond increas media coverag onlin resourc plai increas role fulfil profession public conclus factor surg profession interest diseas typic kei public major polici chang public interest static correl media influenc lesser extent expect except noroviru exhibit onlin public profession interest correl season occurr diseas public health agenc respons risk commun public health event outbreak emerg collabor media order ensur coverag high qualiti evidencebas profession remain fulfil onlin open access kei resourc
PLoS Pathog	17913802	2014-10-15	PMC3715407	23874204	the small size rna viru genom kb attribut high mutat rate replic thought lack proofread paradigm revisit discoveri exoribonucleas exon nidovirus monophylet group positivestrand rna virus conserv genom architectur exon homolog canon dna proofread enzym exclus encod nidovirus genom larger kb nonseg rna virus smaller genom evolutionari analys threefold expans nidoviru genom accompani larg number replac conserv protein scale compar tree life unravel common evolutionari pattern genet divers virus establish relat genom region nidovirus sequenc alignmentfre manner exploit conserv genom architectur partit genom nonoverlap region untransl region utr open read frame orf orfb orf encompass proxim orf utr region analyz contribut genom size chang model nonlinear model statist outperform linear captur data variat nidoviru genom conclud reach point expans trajectori domin consecut increas orfb orfa orf find indic unidirect hierarch relat genom region distinguish express mechan contrast region cooper bidirection function level viru life cycl control genom replic genom express viru dissemin collect find genom architectur associ regionspecif divis labor leav footprint genom expans limit rna genom size
PLoS One	27196655	2001-11-01	PMC3715454	23874843	glycyrrhizin gl japan treat patient chronic viral hepat antiinflammatori drug reduc serum alanin aminotransferas level gl exhibit biolog activ includ antivir effect antihepat viru hcv gl remain clarifi studi demonstr gl treatment hcvinfect huh cell caus reduct infecti hcv product cell cultureproduc hcv hcvcc determin target step hcv lifecycl gl hcv pseudoparticl hcvpp replicon hcvcc system suppress viral entri replic step observ interestingli extracellular infect decreas intracellular infect increas immunofluoresc electron microscop analysi gl treat cell hcv core antigen electrondens particl accumul endoplasm reticulum attach lipid droplet ld thought platform hcv assembl amount hcv core antigen ld fraction increas gl inhibit releas infecti hcv particl gl inhibitori phospholipas pla group pla plagb inhibitor decreas hcv releas suggest suppress viru releas gl treatment inhibitori plagb final demonstr combin treatment gl augment ifninduc reduct viru hcvcc system gl identifi novel antihcv agent target infecti viru particl releas
Mol Vis	25320308	2012-06-01	PMC3716469	23878501	purpos explor role lithium chlorid licl pseudomona aeruginosa pa kerat method mice subconjunctiv inject licl contrast appropri control sodium chlorid nacl routin infect pa clinic score slitlamp photographi hematoxylin eosin stain bacteri plate count determin role licl pa kerat messeng ribonucl acid protein level inflammatori cytokin pachalleng mous cornea vitro cultur macrophag neutrophil measur realtim pcr enzymelink immunosorb assai elisa apoptosi infiltr inflammatori cell painfect murin cornea assess termin deoxynucleotidyl transferasemedi uridin triphosphatebiotin nick label stain propidium iodid stain associ flow cytometri cultur murin macrophag neutrophil cell apoptosi determin annexin vpropidium iodid doubl stain associ flow cytometri western blot analysi cleav caspas cleav polyadpribos polymeras treatment licl reduc sever corneal diseas reduc corneal inflammatori respons bacteri burden licl increas antiinflammatori cytokin interleukin level decreas proinflammatori cytokin tumor necrosi factor level enhanc apoptosi infiltr macrophag neutrophil painfect mous cornea vitro studi confirm licl elev antiinflammatori cytokin express reduc proinflammatori cytokin product promot cell apoptosi murin macrophag neutrophil conclus studi demonstr protect role licl pa kerat licl promot host resist pa infect suppress inflammatori respons enhanc inflammatori cell apoptosi promot bacteri clearanc
Virol J	11687438	2019-01-01	PMC3716658	23805916	background cryopreserv primari human renal proxim tubul epitheli cell rptec commerci supplier studi simian viru sv twelv hr cell cultur initi cytoplasm vacuol appear rptec rptec henceforth deterior rapidli sv induc format cytoplasm vacuol batch rptec reject sv studi sought the deterior rptec technolog develop effort method adventiti virus rptec isol andor detect identifi isol indic cell line observ cytopatholog immunofluroresc assai electron microscopi pcr sequenc cytomegaloviru cmv detect rptec cytolog immunofluoresc assai pcr human herpesviru detect pcr dna extract rptec isol human coronaviru nl isol identifi rtpcr sequenc replic fresh batch rptec type primari human kidnei cell confirm conclus adventiti virus batch contamin rptec unabl determin origin rptec preinfect prior separ kidnei cell contamin hcovnl laboratori worker prepar commerci sale find remind humanderiv biolog consid potenti sourc infecti agent importantli hcovnl replic high titer primari human kidnei cell
Virol J	30155431	2007-04-25	PMC3716818	23822185	background enteroviru ev common etiolog agent hand foot mouth diseas hfmd children ev epidem report hong kong year genet ev strain circul local limit object studi investig genet evolut ev isol hong kong year period method twentytwo ev isol hong kong includ phylogenet analysi partial vpvp region ev strain select complet genom sequenc recombin analysi ev isol belong subgenotyp belong subgenotyp base phylogenet analysi partial vpvp gene region phylogenet similar plot bootscan analys complet genom sequenc ev isol subgenotyp support doublerecombin strain subgenotyp persist circul hong kong belong newli propos genotyp analysi reveal cluster subgenotyp cb propos genotyp db genotyp db strain predomin year hong kong distinct lineag ev subgenotyp emerg hong kong evolutionari rate ev nucleotid substitut site year enteroviru ev lower echoviru polioviru molecular clock analysi vp gene date time common ancestor ev genotyp ev doublerecombin strain genotyp detect earli conclus studi molecular basi propos genotyp ev assign discret lineag subgenotyp ev strain genotyp circul hong kong year genotyp db predomin
Virol J	31832499	2015-08-26	PMC3720222	23800142	background bamboo mosaic viru bamv potato viru pvx member genu potexviru singlestrand positivesens rna genom untransl region utr bamv rna genom map structur abc cloverleaflik stemloop pseudoknot domain bamv replicas complex isol infect plant recogn utr pvx rna initi minusstrand rna synthesi vitro investig utr pvx rna compat bamv replicas vivo construct chimera mutant bamv backbon pvx utr insert replac domain utr bamv mutant mutant pvx utr insert upstream bamv utr exhibit detect accumul viral rna nicotiana benthamiana plant vitro bamv rdrp replic assai demonstr rna product gener short rna transcript deriv chimera mutant extent vmaxkm bamv utr rabcd three fold higher rabcp rp rde minusstrand rna synthesi mutant fail accumul viral product protoplast plant adequ replic vitro conclus studi bamvpvx chimera mutant bamvspabcd contain noninterrupt bamv utr mutant exhibit wildtyp level viral product accumul protoplast plant indic continu domain utr bamv rna interrupt domain replac utr pvx rna vivo
PLoS One	17459933	2017-11-03	PMC3720278	23936003	porcin reproduct respiratori syndrom prr highli contagi diseas pig caus prr viru prrsv prrsv infectioninduc cell apoptosi establish viral protein unknown report prrsv nonstructur protein nsp critic apoptosi induc nsp activ caspas truncat construct domain nsp demonstr fulllength nsp structur requir apoptosisinduc activ sitedirect mutagenesi inactiv clike serin proteas activ nsp nspinduc apoptosi depend serin proteas activ abil nsp induc apoptosi impair asp ser mutat suggest asp ser essenti nsp trigger apoptosi conclus work prrsv nsp induc apoptosi host cell partial respons apoptosi induc prrsv infect prrsv clike proteasemedi apoptosi repres report genu arteriviru famili arterivirida
Vet Res	26311885	2015-09-01	PMC3720556	23865689	felin infecti periton fip fatal diseas caus felin coronaviru fcov infect fcov divid serotyp ii viru fip fipv believ occur sporad spread infrequ cat cat fip outbreak anim shelter confirm taiwan fcov cat shelter analyz determin epidemiolog outbreak thirteen cat typic sign fip identifi cat confirm necropsi andor histopatholog examin despit fact fcov identifi multicat environ fip cat invari infect type ii fcov sequenc analysi reveal type ii fipv detect fecal sampl bodi effus granulomat tissu homogen cat succumb fip harbor ident recombin site gene cat succumb fip harbor ident nonsens mutat gene fecal shed type ii viru effus form fip detect dai death data demonstr horizont transmiss fipv fip cat pose potenti risk cat live environ
PLoS One	29796095	2013-11-11	PMC3720929	23894547	in mammalian cell defens viral pathogen innat immun respons character induct type interferon ifn proinflammatori cytokin establish antivir milieu infect cell neighbor uninfect cell rotaviru doublestrand rna viru reovirida famili primari etiolog agent sever diarrhea young children worldwid previou studi demonstr rotaviru replic induc mavsdepend type ifn respons involv rigi mda cytoplasm viral rna sensor studi report isol character rotaviru rna activ ifn signal vitro approach purifi rotaviru doublelay particl nascent singlestrand rna ssrna transcript term vitro ssrna potent ifn induc addit larg rna isol rotavirusinfect cell hour postinfect term vivo hr larg rna activ ifn signal compar larg rna fraction isol cell infect hour lack stimulatori activ experi knockout murin embryon fibroblast rigi requir mda partli contribut innat immun signal vitro ssrna vivo hr larg rna enzymat studi demonstr vitro ssrna vivo hr larg rna sampl uncap rna expos phosphat group rna lack omethyl cap structur detect vivo hr larg rna sampl data provid strong evid rotaviru vp enzym encod guanylyltransferas methyltransferas activ complet effici cap omethyl cap structur viral transcript produc rna pattern activ innat immun signal rigilik receptor
PLoS One	26111151	2007-01-01	PMC3720958	23894542	cryptococcu emerg global health threat annual respons infect third aid patient death ongo outbreak cryptococcosi western unit state canada cryptococcosi diseas inhal infecti propagul environ current frequent anim infect model initi infect liquid suspens intranas instil intraven inject model replic typic dry natur aerosol exposur hinder abil deciph initi event lead clearanc establish infect establish standard aerosol model murin infect human fungal pathogen cryptococcu aerosol cell gener util collison nebul wholebodi madison chamber humid condit aerosol insid chamber sampl biosampl determin viabl aerosol concentr sprai factor ratio viabl aerosol concentr total inoculum concentr effect deliv yeast yeastspor mixtur lung mice observ establish diseas observ growth condit prior exposur humid madison chamber exposur alter cryptococcu surviv dose retain mice
Rambam Maimonides Med J	24218476	2016-08-24	PMC3721661	23908776	chronic hepat viru hcv infect lead liver diseas worldwid remain common indic liver transplant current standard care lead sustain viral respons roughli treat patient best antivir therapi expens prolong associ seriou sideeffect evid suggest poor respons treatment result suppress antivir immun presenc increas number activ cdcdfoxp regulatori cell treg cell identifi fibrinogenlik protein fgl put effector treg cell account suppress function bind fc gamma receptor fcr experiment model fulmin viral hepat laboratori increas plasma level fgl pre postvir infect predict suscept sever diseas treatment antibodi fgl fulli protect suscept anim lethal viru adopt transfer wildtyp treg cell resist fgldefici anim acceler mortal postinfect patient hcv infect plasma level fgl express fgl liver correl cours sever diseas collect studi fgl biomark predict diseas progress hcv patient logic target develop novel therapeut approach treatment patient hcv infect
PLoS One	17183035	2001-11-01	PMC3722178	23894604	becaus natur target respiratori pathogen primari human respiratori epitheli cell provid ideal vitro system isol studi human respiratori virus displai high degre cell tissu host specif human coronaviru hku discov worldwid preval associ upper lower respiratori tract diseas children adult hcovhku difficult inabl cultur continu cell line isol clinic specimen primari human ciliat airwai epitheli cell demonstr hcovhku infect serial propag primari human alveolar type ii cell airliquid interfac infect alveolar type ilik cell alveolar macrophag type ii alveolar cell infect hcovhku demonstr format larg syncytium hour post inocul hcovhku infect type ii cell induc increas level mrna encod ilcxcl ccl il increas level ifn studi demonstr type ii cell target cell hcovhku infect lower respiratori tract type ii alveolar cell immunecompet respons infect exhibit type iii interferon proinflammatori chemokin respons cell cell spread major factor spread infect studi demonstr human alveolar cell isol studi novel human respiratori virus lower respiratori tract diseas
PLoS One	27558415	2018-01-04	PMC3723910	23935999	respiratori infect stem influenza virus sever acut respiratori syndrom corona viru sarscov repres seriou public health threat emerg pandem despit effort identifi critic interact virus host machineri kei regulatori event lead diseas patholog remain target therapeut implement integr network interrog approach proteom transcriptom dataset infect virus human lung epitheli cell util predict regulatori gene involv host respons advantag novel crowdbas approach identifi combin rank metric isol genesprotein pathogen sarscov influenza viru subsequ multivari regress model compar predict lung epitheli regulatori influenc data deriv respiratori viru infect model predict small set regulatori factor conserv behavior consider compon viral pathogenesi serv therapeut target intervent demonstr util integr divers omic dataset predict priorit regulatori featur conserv multipl pathogen infect model
Springerplus	11581414	2014-09-17	PMC3724979	23961398	hepat viru protein amino acid polytop protein transmembran domain tmd prime target anti hcv drug develop bioinspir model pathwai gener plausibl comput model tmd form monomer protein model flexibl region leu gly identifi tmd region gly trp tmd mutat tyrosin residu tmd phenylalanin serin simul identifi role shape tmd lowest energi structur tmd connect loop residu pose studi small molecul drug bit amantadin rimantadin nndnj identifi bind loop region bit identifi interact backbon function residu arg trp electron supplementari materi onlin version articl doi supplementari materi author user
Front Immunol	29038338	2004-12-15	PMC3725456	23908655	recombin antibodi highli specif detect probe diagnost emerg decad fastest grow class therapeut protein antibodi gener dramat acceler vitro select system phage displai increas varieti recombin product system develop rang gramneg posit bacteria yeast filament fungi insect cell line mammalian cell transgen plant anim current therapeut antibodi produc mammalian cell line order reduc risk immunogen alter nonhuman glycosyl pattern develop glycosylationengin yeast insect cell line transgen plant promis antibodi humanlik posttransl modif smaller antibodi fragment includ bispecif antibodi glycosyl produc bacteria advanc clinic test therapeut antibodi product nonmammalian sourc expect come year review focu current antibodi product system includ usabl applic
Springerplus	25231310	2010-03-01	PMC3725915	23961369	abstract enforc cell transdifferenti human cancer cell promis altern convent chemotherapi identifi albuminassoci lipid satur fatti acidinduc transdifferenti program human cancer cell hccl studi character adipocytelik cell transdifferenti human cancer cell line mcf malmem propos common mechanist approach transdifferenti program loss pigment malmem cell treat albuminassoci lipid base electron microscop analysi overexpress perilipin plin western blot malmem mcf cell treat unsatur fatti acid compar gene express profil naiv melanoma malmem cell albuminassoci lipidtr cell base rna sequenc confirm transcript upregul kei adipogen gene marker altern splice adipogen master regul pparg report regul express protein importantli upregul gene respons clathrin cltc adaptorrel protein increas cltc express transdifferenti cell confirm western blot inactiv cltc chlorpromazin chp inhibitor ctlc mediat endocytosi cme gene silenc sirna partial revers accumul neutral lipid observ transdifferenti cell find deeper insight phenotyp chang observ hccl adipocytelik transdifferenti point cme kei pathwai distinct transdifferenti program disclosur simon aguilargallardo coinventor intern patent applic pctep entitl method tumor treatment adipogenesi differenti electron supplementari materi onlin version articl doi supplementari materi author user
J Neuroinflammation	15601771	2004-12-01	PMC3726363	23866683	background chemokin cc motif ligand ccl monocyt chemoattract protein mediat macrophag recruit migrat peripher central nervou system cn inflamm method determin impact ccl inflamm vivo elucid cclinduc polar activ brain microglia deliv ccl brain wildtyp mice recombin adenoassoci viru serotyp raav driven chicken actin promot measur microgli activ histolog chemic measur recruit monocyt histolog flow cytometri overexpress ccl cn induc activ brain resid microglia cd major histocompat complex class ii immunoreact increas site ccl administr histolog character microgli phenotyp reveal elev classic activ microgli marker calgranulin il marker associ altern activ microglia includ ym arginas protein express profil hippocampu demonstr markedli increas level il gmcsf eotaxin ccl respons ccl chang level cytokin includ tnf ifn realtim pcr analysi confirm increas mrna level gene transcript associ neuroinflamm ccl overexpress final investig chemotact properti ccl vivo perform adopt transfer bone marrowderiv cell bmdc isol donor mice ubiquit express green fluoresc protein flow cytometri histolog analys indic bmdc extravas brain parenchyma colabel microgli marker conclus ccl activ resid microglia brain pro antiinflammatori activ microglia promin bia phenotyp activ cell expect ccl overexpress activ recruit circul monocyt cn ccl express mous brain induc microgli activ repres effici method recruit peripher macrophag
Retrovirology	20428387	2003-08-01	PMC3726367	23885919	background human immunodefici viru type hiv bias nucleotid composit human gene rais question evolut chosen nucleotid sequenc hiv observ todai extent actual encod contribut viru replic capac evolv pathogenesi appli describ synthet attenu viru engin save approach hiv synonym codon pair ration recod codon pairoptim deoptim moieti hiv gag pol gene deoptim virus lower viral replic capac mt peripher blood mononuclear cell pbmc vari degre vivo attenu depend specif deoptim region number deoptim codon proteas optim viru carri synonym mutat attenu displai replic capac wildtyp viru mt cell pbmc attenu base ten nucleotid chang deoptim hiv revert wildtyp virul serial passag mt cell remark revers observ optim viru conclus data demonstr save strategi phenotyp affect replic properti hiv
PLoS One	15583332	2009-07-01	PMC3726627	23923003	the positivestrand coronaviru genom kilobas length subgenom sg mrna shorter length cotermin virtu common cap leader common polyadenyl untransl region ligat headtotail viral rna bovin coronavirusinfect cell sequenc ligat junction learn time peak viral rna synthesi hour postinfect hpi polya tail genom sgmrna nucleotid nt length surprisingli length vari infect nt viru entri hpi nt hpi nt hpi nt hpi method polyu sequenc length simultan ligat viral negativestrand rna function analys polya tail length specif viral rna speci reveal translat vivo rna longer polya tail enhanc shorter polya mechan tail length vari unknown experiment length polya polyu tail regul potenti function regul polya tail length coronaviru genom longer polya favor translat regul coronaviru translat polya tail length resembl embryon develop suggest mechanist parallel
BMC Infect Dis	12885974	2013-08-23	PMC3728139	23834931	background etiolog epidemiolog diagnosi issu adult communityacquir pneumonia cap identifi pathogen base patient clinic featur challeng capassoci main pathogen adult includ virus bacteria largescal epidemiolog investig adult viral cap china lack studi analyz etiolog adult cap beij china construct diagnost model base combin patient clinic factor method multicent cohort establish adult cap outpati enrol beij novemb octob multiplex quantit realtim fluoresc pcr detect respiratori virus mycoplasma pneumonia bacteria detect cultur enzym immunoassai streptococcu pneumonia urinari antigen univari analysi multivari analysi discriminatori analysi receiv oper characterist roc curv build predict model etiolog diagnosi adult cap pathogen detect studi patient virus account mycoplasma pneumonia bacteria case patient virus viru strain detect includ singl mix viral infect influenza viru repres greatest proport singl mix viral infect factor select predict etiolog diagnost model viral cap includ cough dyspnea absenc chest pain white blood cell count mycoplasma pneumonia cap younger year absenc coexist diseas model low accuraci level etiolog diagnosi area roc curv viru mycoplasma pneumonia conclus greater consider viral mycoplasma pneumonia infect adult cap outpati predict etiolog diagnost model viral mycoplasma pneumonia base combin demograph clinic factor provid indic etiolog diagnost confirm cap remain depend laboratori pathogen test result
PLoS One	19605887	2016-02-10	PMC3728341	23936115	handfootmouth diseas hfmd caus enteroviru ev coxsackieviru cva children sever public health issu asianpacif region develop transgen mice express human scaveng receptor class member hscarb receptor ev cva anim model evalu pathogenesi enteroviru infect studi hscarbtransgen mice investig efficaci confer describ ev neutral antibodi singl inject effect inhibit hfmdlike skin scurf mice preinfect clinic isol ev genotyp prevent sever limb paralysi death mice preinocul genotyp protect correl remark reduct viral load brain spinal cord limb muscl accumul viral load associ proinflammatori cytokin reduc protect efficaci observ anim challeng cva dissimilar sequenc neutral epitop cva indic treat sever ev infect hscarbtransgen mous evalu protect efficaci potenti antienteroviru agent candid
PLoS One	23977435	2018-04-18	PMC3729563	23936066	vaccin protect respiratori infect optim induc mucos immun respons respiratori tract addit system immun respons current parenter immun modal gener fail induc mucos immun mucos vaccin deliveri poor system immun order find immun strategi satisfi induct mucos system immun compar local system immun respons elicit mucos immun intranas intrapulmonari ipl rout respons elicit mucos prime system boost immun studi conduct balbc mice vaccin formul influenza subunit vaccin supplement gpi saponinderiv adjuv optim mucos antibodi titer intrapulmonari vaccin optim system antibodi respons achiev intranas prime intramuscular boost strategi best cell respons ineffect induc nose lung iga success induct secretori iga igg cell respons achiev primeboost strategi involv intrapulmonari immun optim immun intrapulmonari rout underlin immun lung effect prime boost local system immun respons
J R Soc Interface	26864029	2012-05-14	PMC3730687	23864502	viral replic occur cell releas onward infect achiev altern mechan lysi virion emerg infect cell di burst open bud virion emerg gradual live cell appropri small cell membran viru bud understood process challeng current model vesicl format plausibl mechan arenaviru bud present build evid viral protein emb inner lipid layer cell membran experiment confirm viral protein associ increas membran curvatur mathemat model local increas curvatur suffici gener viral bud magnitud proteininduc curvatur calcul size amphipath region hypothet remov inner membran result translat chang membran stiff estim observ differ virion deform result protein deplet numer base experiment data estim three arenavirus mechan describ broadli applic hypothes mechan suffici gener spontan bud match qualit quantit experiment observ
PLoS Pathog	29665881	2013-03-19	PMC3731237	23935496	varicellazost viru vzv neurotrop human alphaherpesviru varicella primari infect establish latenc multipl ganglion neuron reactiv zoster live attenu vzv vaccin establish latent infect reactiv studi vzv latenc limit analys human ganglia remov autopsi viru strictli human pathogen termin differenti human neuron receiv attent studi interact vzv human neuron short lifespan cell cultur limit applic describ construct model normal human neural progenitor cell nhnp tissuelik assembl tla maintain dai threedimension cultur exhibit express profil human trigemin ganglia infect nhnp tla cellfre vzv persist infect maintain three month viru genom remain stabl immediateearli earli late vzv gene transcrib lowlevel infecti vzv recurr detect cultur supernat data nhnp tla effect system investig longterm interact vzv complex assembl human neuron cell
PLoS Pathog	22583661	2015-09-09	PMC3731252	23935499	dengu viru transmit aed mosquito infect peopl year progress urban asia southcentr america geograph expans aed mosquito habitat acceler global spread dengu continu increas number case costeffect safe vaccin confer protect ideal singl inject dengu transmiss current vaccin candid requir booster inject provid protect serotyp demonstr dengu viru mutant lack omethyltransferas activ highli sensit type ifn inhibit mutant virus attenu mice rhesu monkei elicit strong adapt immun respons monkei immun singl dose omethyltransferas mutant viru seroconvers dose low plaqu form unit administr anim fulli protect homolog challeng mosquito feed blood mutant viru infect feed blood wildtyp viru infect transmit potenti omethyltransferas mutant viru safe ration design dengu vaccin restrain increas suscept host innat immun respons
PLoS One	23382420	2016-10-18	PMC3731292	23936490	the lipid phosphatas sac cycl endoplasm reticulum cistern golgi compart prolifer mammalian cell canon dilysin motif cterminu sac requir coatom complexi copibind continu retriev er starvat trigger accumul sac golgi mechan respons golgi retent sac unknown the transmembran region human sac tm function golgi local minim construct tm adjac flank sequenc concentr golgi transplant tm transferrin receptor tfr induc golgi accumul plasma membran endosom protein indic tm suffici golgi local addit determin ntermin cytoplasm domain sac promot golgi local tm mutat absent conclud distribut sac golgi control passiv membran thicknessdepend partit tm retent mechan requir ntermin cytoplasm region
PLoS One	26354436	2006-06-28	PMC3731295	23936359	a sever diseas human caus novel avianorigin influenza hn viru emerg china caus case death rapid detect novel hn viru urgent need differenti diseas infect facilit infect control epidemiolog investig studi revers transcript loopmedi isotherm amplif combin later flow devic rtlamplfd assai rapidli detect hn viru develop evalu rtlamp primer design target haemagglutinin ha neuraminidas gene hn viru fold dilut seri assai analysi rtlamp product lfd method sensit realtim turbid detect analyt sensit ha rtlamp assai copi synthet rna assai clinic specif identif hn viru perform characterist rtlamplfd assai evalu clinic specimen collect suspect hn patient rtlamplfd assai sensit real time rtpcr assai compar combin viru cultur realtim rtpcr sensit specif posit predict neg predict rtlamplfd assai rtlamplfd assai establish studi reliabl method earli diagnosi avianorigin influenza hn viru infect
PLoS One	28018874	2009-10-02	PMC3732256	23936367	porcin epidem diarrhea viru pedv sever econom loss swine industri china asian countri infect lead acut lethal diarrhea piglet despit impact diseas system manipul viral genom sever hamper viru todai establish revers genet system pedv base target rna recombin allow modif the viral genom encod structur protein orf protein system delet orf gene entir viral genom orf protein essenti replic viru vitro addit insert heterolog gene gfp renilla luciferas gene posit viral genom extra express cassett replac orf gene demonstr express gfp renilla luciferas applic virus establish conveni rapid viru neutral assai pedv revers genet system will enabl function studi structur protein accessori orf protein will allow ration design develop gener pedv vaccin
Ital J Pediatr	16809319	2016-01-02	PMC3733658	23663325	background recurr respiratori infect morbid childhood immun function immatur airwai epithelium plai primari defens role provid physic barrier involv innat adapt immun respons studi design evalu vitro pidotimod synthet dipeptid stimul inflammatori immun effector cell activ bronchial epitheli cell function involv respons infect method beasb cell human bronchial epitheli cell infect replicationdefect adenoviru sv viru hybrid cultur presenc pidotimod tumor necrosi factor tnf zymosan assess intercellular adhes molecul icam express flow cytometri tolllik receptor tlr express product immunofluoresc flow cytometri western blot interleukin il releas enzymelink immunosorb assai elisa activ extracellularsignalregul kinas erk phosphoryl nuclear factorkappa nfkb activ western blot constitut express icam il releas upregul tnf icam tnf zymosan il pidotimod contrast increas tlr express exposur pidotimod gml associ pidotimod gml tnf western blot analysi substanti constitut tlr express increas exposur stimuli final remark inhibit tnf induc erk phosphoryl observ presenc pidotimod tnf pidotimod effect induc nfkb protein express cytoplasm nuclear transloc conclus effect erk nfkb pidotimod increas express tlr protein surfac molecul involv initi innat respons infecti stimuli lack icam express receptor rhinoviru il releas potent chemotact factor neutrophil site infect repres protect function confirm vivo activ clarifi mechan action molecul airwai level
PLoS One	19801477	2011-12-07	PMC3733918	23940775	japanes enceph viru jev acut central nervou system cn diseas human clinic symptom vari febril ill mening enceph mechan sever enceph fulli elucid studi mous model investig pathogenet mechan correl fatal jev infect extraneur infect jaoar strain jev infect mice exhibit clinic sign rang mild fatal outcom comparison pathogenet respons sever mild case jaoarsinfect mice reveal increas level tnf brain sever case unexpectedli mortal rate tnf ko mice increas compar wt mice indic tnf plai protect role fatal infect interestingli differ viral load cn wt tnf ko mice exagger inflammatori respons observ cn tnf ko mice observ il ko mice mortal enhanc inflammatori respons pronounc tnf ko mice find provid evid tnf immunoregulatori proinflammatori cytokin cn jev infect consequ protect anim fatal diseas propos increas level tnf sever case result sever diseas secondli immunopatholog effect contribut sever neuron degener fatal diseas futur elucid immunoregulatori mechan tnf will prioriti enabl develop effect treatment strategi japanes enceph
Proteome Sci	27512617	2010-02-01	PMC3734006	23855489	background transmiss gastroenter coronaviru tgev enteropathogen coronaviru diarrhea pig correl high morbid mortal suckl piglet remain limit compar protein express host cell respons tgev infect studi cellular protein respons tgev infect swine test st cell analyz proteom method twodimension differ gel electrophoresi dige coupl malditoftofm identif differenti express protein spot upregul downregul identifi protein spot identifi identifi protein involv regul essenti process cellular structur integr rna process protein biosynthesi modif vesicl transport signal transduct mitochondri pathwai western blot analysi valid chang alpha tubulin keratin prohibitin tgev infect conclus knowledg perform analysi proteom chang host cell tgev infect alter cellular protein differenti express tgev infect identifi studi proteinrel understand host cell respons tgev infect underli mechan tgev replic pathogen
PLoS One	22156526	2014-07-01	PMC3734177	23940536	target papain famili cystein proteas novel strategi develop chemotherapi number diseas novel cystein proteas inhibitor deriv pyridylimidazoapyridin repres pharmacolog class compound report time deriv initi design screen silico molecular dock studi papain explor mode action molecular interact compound cystein proteas papain interact observ respect epoxid inhibitor ec papain subsequ compound synthes valid efficaci wet lab experi character kinet compound ki ic valu rang to thermodynam studi bind papain hydrophob entrop driven inhibitor inhibit growth clinic type gram posit gram neg bacteria mic valu rang gml base lipinski rule propos compound potent antibacteri prodrug activ antibacteri compound pyridylhydroxyphenylimidazoapyridin a
Environ Health Perspect	20101095	2005-08-01	PMC3734490	23665854	background part livestock product undergo process rapid intensif health implic develop uncertain intensif creat cheaper product allow peopl access animalbas food practic associ intensif contribut zoonot diseas emerg spread exampl sustain antibiot concentr anim confin unit long distanc frequent movement livestock object divers rang ecolog biolog socioeconom factor enhanc reduc zoonot risk identifi wai comprehens risk analysi conduct interdisciplinari approach offer conceptu framework guid systemat problem discuss recommend interdisciplinari work zoonot risk account complex risk environ limit studi simpl linear causal relat risk driver diseas emerg andor spread addit interdisciplinari integr need level analysi studi risk environ identif polici option risk manag conclus rapid chang livestock product system potenti health implic local global level problem analyz great environment health develop offer systemat interdisciplinari approach understand address implic recogn need clarifi methodolog practic question aris integr natur social scienc
Int J Health Geogr	24611553	2003-12-01	PMC3735474	23890514	background estim paramet diseas transmiss largescal infecti diseas outbreak repres larg group peopl provid averag divers area control measur effect measur heterogen paramet desir method propos novel extens networkbas approach estim reproduct number incorpor spatial andor demograph similar matrix appli influenza pandem south africa understand spatial variabl provinc explor similar matric illustr impact subsequ epidem paramet estim treat south africa singl entiti homogen transmiss characterist countri basic reproduct number imput rang fit model provinc interprovinc connect estim vari propos method similar measur yield vari model allow vari provinc estim greater consist provinc dens popul provinc gauteng western cape conclus spatial heterogen influenza transmiss compel south africa pandem variabl qualit differ understand epidem fluctuat partial report differ substanti evid warrant investig
ScientificWorldJournal	16081901	2006-03-29	PMC3736420	23970838	the health organ declar erad dread diseas smallpox diseas di caus viru variola preserv high secur laboratorieson usa russia debat remain stock smallpox viru destroi ongo health assembl wha decid postpon review debat wha short questionnairebas inquiri organ onedai stem cell meet explor view health care life scienc specialist student aspect particip meet answer questionnair particip respond questionnair preserv viru futur refer particip destroi viru consid magnitud kill million respond decid verdict inquiri express view creat destroi
PLoS Pathog	14662982	2014-04-28	PMC3738494	23950709	herp simplex viru type hsv neurotrop viru caus vesicular oral genit skin lesion mening diseas harm immunocompromis individu comprehens investig complex interact hsv host combin genomescal screen host factor hf involv viru replic yeast twohybrid screen protein interact rna interfer rnai screen druggabl genom small interf rna sirna librari confirm exist identifi novel hf function influenc hsv infect bioinformat analys hf enrich pathwai multiprotein complex interest identif med antivir compon provir mediat complex link specif transcript factor rna polymeras ii antivir med hsv replic confirm gainoffunct gene overexpress experi inhibitori specif hsv rang virus includ vaccinia viru semliki forest viru unaffect med deplet med upregul express type iii interferon famili ifn mrna protein level directli interact transcript factor irf synergist med irf ifn induct suggest major transcript factor ifn express genotyp analysi patient suffer recurr orofaci hsv outbreak defici ifn secret correl singl nucleotid polymorph ifn ilb promot link hepat diseas treatment outcom paper describ link med ifn evid crucial role ifn hsv immun control highlight power integr genomescal approach identifi hf critic diseas progress outcom
Genome Announc	16571835	2010-05-20	PMC3738886	23929470	porcin epidem diarrhea viru pedv newli emerg unit state pedv strain usacolorado dayold piglet sever diarrhea complet genom sequenc studi pedv outbreak unit state
Viruses	24778221	2017-07-13	PMC3738950	23807710	emerg evid highlight critic role protein acetyl herpesviru infect promin modul protein acetyl histon deacetylas hdac essenti transcript epigenet regul surprisingli virus evolv wide arrai mechan subvert hdac function review mechan underli hdac regul herpesviru infect discuss role acetyl host defens herpesviru infect final provid perspect contribut current mass spectrometrybas omic technolog infecti diseas offer system biologi view infect
Viruses	20489209	2011-07-01	PMC3738956	23852270	cyclophilin peptidylprolyl cistran isomeras proper fold protein mount evid support vari role cyclophilin posit neg life cycl divers virus natur mechan role defin potenti cyclophilin serv drug target antivir therapi evidenc success nonimmunosuppress cyclophilin inhibitor cpi includ alisporivir clinic trial target hepat viru infect addit cyclophilin implic predisposit sever diseas abil effect modul function will prove increasingli diseas intervent review will summar evid cyclophilin kei mediat viral infect prospect drug target
PLoS One	28706037	2016-05-18	PMC3739798	23951120	harm nonindigen speci ni impos great econom environment impact global impact southeast asia lack knowledg magnitud problem hinder alloc appropri resourc ni prevent manag benefitcost analysi embed montecarlo simul model analys econom environment impact ni region estim total burden ni southeast asia total annual loss caus ni agricultur human health environ southeast asia estim billion th percentil billion loss cost agricultur sector estim total billion annual cost associ human health environ billion billion billion billion estim base conserv assumpt demonstr econom environment impact ni low middleincom region consider measur adopt region risk assess protocol inform decis prevent control ni southeast asia benefici
PLoS One	21540646	2016-01-01	PMC3741315	23950875	a cytopath viru isol madindarbi bovin kidnei mdbk cell lung tissu alpaca di sever respiratori infect identifi viru infect cell cultur supernat enrich viru particl gener pcrbase method amplifi potenti viral sequenc genom sequenc data alpaca isol compar sequenc virus alpaca viru sequenc design enteroviru speci bovin enteroviru bev virus global preval cattl appear diseas bovin enterovirus report alpaca suspect type infect fairli rare case appear spread origin outbreak capsid sequenc detect viru greatest homolog enteroviru type indic viru consid member serotyp viru greater homolog proteas sequenc type suggest recombin identifi pathogen infect host speci time challeng diseas host speci origin natur host pathogen suspect base clinic present delai diagnosi viru replic mdbk cell exist standard cultur molecular method identifi case highli sensit gener pcrbase pathogendetect method identifi pathogen
PLoS One	27194691	2011-10-24	PMC3741363	23951084	respiratori syncyti viru rsv respiratori tract diseas infant elderli current licens vaccin rsv describ develop safe effect intranas subunit vaccin base recombin fusion protein bound surfac immunostimulatori bacteriumlik particl blp deriv foodgrad bacterium lactococcu lacti variant analyz respect conform reactiv neutral antibodi assum protein mimick metast prefus form rsv expos extens relev epitop repertoir protein correspond postfus structur indic recombin solubl ectodomain rsv adopt postfus conform gener prevent ctermin addit trimer motif format prevent mutat furin cleavag site put postfus form recogn monoclon antibodi palivizumab potent neutral prefusionspecif antibodi addit trimer motif mutat furin cleavag site increas reactiv with highest reactiv observ protein featur combin intranas vaccin mice cotton rat blp load prefusionlik protein blpf potent induct fspecif immunoglobulin decreas viru titer lung rsv challeng contrast anim vaccin formalininactiv rsv anim receiv blpf exhibit high level fspecif secretori iga nose rsvneutral antibodi sera symptom enhanc diseas challeng rsv
PLoS One	27429716	2013-02-28	PMC3742728	23967138	background time diseas sever central detect manag outbreak acut respiratori infect ari includ influenza ask resourc free text structur data electron medic record emr complement identifi patient pneumonia ari sever landmark method manual emr review outpati ari visit associ chest imag identifi xrai report support diagnosi pneumonia kappa score ci attend case pneumonia add cough sputum feverchillsnight sweat dyspnea pleurit chest pain pneumoniainplan add pneumonia state diagnosi provid xrai report serv refer develop text classifi machinelearn softwar requir custom code identifi pneumonia case classifi combin emrbas structur data text analys aim ari symptom clinic note refer case pneumonia pneumoniainplan identifi xrai report text classifi increas posit predict ident emrbas casedetect algorithm retain sensit perform gain independ case definit patient admit hospit text analys seek ari symptom clinic note add conclus special softwar develop requir autom text analys help identifi pneumonia patient map effici replic strategi emr data stratifi ari sever
PLoS One	22025686	2008-12-01	PMC3743774	23967294	highli pathogen avian influenza viru hpai strain hn direct indirect econom impact aris direct mortal control programm countri report poultri outbreak hpai hn report widespread expens zoonot diseas record continu pose global health threat aim assess potenti utilis hazard analysi critic control point haccp assess provid framework rapid respons emerg infecti diseas outbreak novel approach appli scientif process food product system assess risk specif emerg health threat zoonot diseas hotspot conduct haccp assess hpai virus vietnam domest poultri trade relat find exist literatur haccp assess identifi poultri flock isol transport slaughter prepar consumpt critic control point vietnam domest poultri trade introduct prevent measur highlight haccp evalu reduc risk pose hpai virus pressur nation economi conclud haccp assess compel evid futur potenti haccp analys plai initi rapid respons emerg infecti diseas
PLoS Pathog	23449784	2013-10-01	PMC3744431	23966862	no therapeut vaccin current exist human coronavirus hcov sever acut respiratori syndromeassoci coronaviru sarscov epidem emerg middl east respiratori syndrom coronaviru merscov april emphas high probabl futur zoonot hcov emerg caus sever lethal human diseas addition resist sarscov ribavirin rbv demonstr defin target inhibit cov replic cov express exoribonucleas nonstructur protein nspexon requir highfidel replic conserv cov famili genet biochem data support hypothesi nspexon rna proofread function hypothes exon respons cov resist rna mutagen demonstr wildtyp exon cov resist rbv fluorouracil fu cov lack exon activ exon fold sensit primari antivir activ rbv cov mutagenesi exon cov treat fu demonstr enhanc sensit multicycl replic decreas specif infect consist fu function mutagen comparison fullgenom nextgener sequenc fu treat sarscov popul reveal fold increas number mutat exon popul compar exon percent mutat repres ag uc transit consist fu incorpor rna synthesi constitut direct evid cov exon activ critic proofread function viru replic studi identifi exon viral protein distinct rdrp determin sensit rna virus mutagen final exon target inhibit smallmolecul inhibitor exon activ potenti pancov therapeut combin rbv rna mutagen
Biomed Res Int	19052324	2012-01-11	PMC3747601	23984344	there develop rapid sensit diagnosi respiratori viral pathogen intend applic provinci center diseas control prevent studi twotub multiplex rtpcr assai twotub assai automat electrophoresi simultan detect sixteen common respiratori virus specif sensit assai test assai detect copi reaction viral type assai individu copi premix viral target multiplex assai tube copi premix templat tube total specimen evalu twotub assai compar luminex xtag rvp fast assai discord confirm sequenc seeplex rv ac detect kit fals posit fals neg occur twotub assai conclus twotub assai demonstr great potenti routin surveil respiratori viru infect china
PLoS One	24102432	2014-10-01	PMC3748075	23977186	the design optim nanoparticl offer promis strategi enabl dna vaccin cross physiolog barrier elicit specif protect mucos immun intranas administr report design nanoparticl system incorpor anion liposom al chitosandna csdna complex enhanc cellular uptak construct alcsdna nanoparticl deliv anticari dna vaccin pgjapvax nasal mucosa tem alcsdna spheric structur high dna load abil effect dna protect nucleas prove gel electrophoresi surfac charg alcsdna depend ph environ enabl intracellular releas load dna phmediat manner comparison tradit csdna system design render higher transfect effici longer resid time alcsdna nasal mucos surfac outstand featur enabl alcsdna induc higher level secretori iga siga csdna anim studi longerterm mucos immun hand alcsdna exhibit minim cytotox develop nanoparticl offer potenti platform dna vaccin packag deliveri effici elicit mucos immun
PLoS One	22238299	2012-01-01	PMC3748082	23977082	ferret small anim model number viral infect includ influenza viru sar coronaviru analyz microbiolog statu ferret fecal viral flora studi metagenom approach novel virus famili picorna papilloma anellovirida virus famili astro corona parvo hepevirida identifi ferret cohort ferret kobu hepat viru human household ferret coronavirus household farm ferret studi illumin viral divers ferret provid tool prescreen newli identifi virus influenc diseas outcom experiment viru infect ferret
PLoS One	24670358	2017-01-01	PMC3749132	23990915	background infecti individu emerg depart bring substanti risk cross infect data complex social spatial structur interperson contact will aid construct biolog plausibl transmiss risk model guid cross infect control method find sought determin number durat contact patient staff larg busi prospect studi conduct juli june hour shift week randomli select studi studi conduct urban hospit shift plan random sampl usabl contact data patient encount approach particip agre cours year staff member particip radiofrequ identif rfid system instal divid distinct zone structur copres individu zone impli high probabl contact meter apart space studi observ period patient staff rfid tag wear contact event record broken respect natur contact patient patient patient staff staff staff contact event record median contact event contact distinct individu particip shift staffstaff interact numer longer patientpati patientstaff interact conclus rfid quantifi contact patient staff busi studi spread infect understand contact pattern potenti transmiss effect prevent strategi implement
PLoS One	27293312	2014-05-27	PMC3749149	23991182	background indonesia largest singl sourc pilgrim hajj decad mortal rate indonesian pilgrim rang death pilgrim week hajj period reason high mortal understood verbal autopsi introduc complement routin death certif explor death diagnos studi present pattern death indonesian pilgrim compar routin death certif verbal autopsi find method public health surveil conduct indonesian public health author accompani pilgrim saudi arabia daili report hospit death surveil data analyz time geograph locat site death percentag death categori death certif compar verbal autopsi indonesian undertook hajj death equival death pilgrim year pilgrim di mecca medinah statist discern differ total mortal risk pilgrimag rout mecca medinah number death peak earlier travel mecca death cardiovascular respiratori diseas greater proport death attribut cardiovascular diseas death certif compar verbal autopsi method death illdefin base verbal autopsi method conclus despit predepartur health screen medic servic indonesian pilgrim mortal rate high correct classif of death critic develop risk mitig strategi verbal autopsi classifi death differ death certif studi need assess method util set
J Gen Virol	28782059	2017-01-01	PMC3749523	23620378	coronaviru cov infect commonli associ respiratori enter diseas human anim outbreak sever acut respiratori syndrom sar highlight lethal consequ covinduc diseas human novel cov middl east respiratori syndrom coronaviru merscov emerg caus human case fatal outcom studi character merscov replic cytotox human monkei cell line electron microscopi infect vero cell reveal extens membran rearrang includ format doublemembran vesicl convolut membran implic rna synthesi sarscov cov infect observ rapidli increas viral rna synthesi releas high titr infecti progeni pronounc cytopatholog characterist develop assai antivir compound screen format identifi cyclosporin inhibitor merscov replic cell cultur merscov time sensit alpha interferon ifn treatment sarscov observ implic treatment merscovinfect patient merscov infect prevent ifninduc nuclear transloc phosphoryl stat contrast infect sarscov block inhibit express antivir gene find highlight relev differ distantli zoonot cov term interact evas cellular innat immun respons
J Gen Virol	24911006	2004-07-29	PMC3749525	23677786	human rhinovirus hrv frequent mild upper respiratori tract infect sever diseas manifest bronchiol asthma exacerb hrv classifi three speci genu enteroviru famili picornavirida hrv speci serotyp identifi crossneutr assai assai routin hrv type hamper larg number serotyp replac viru isol molecular method hrv diagnosi poor absent replic hrv speci cell cultur address problem propos altern genotyp classif hrvbase genet related analog enterovirus nucleotid distanc complet vp sequenc current assign hrv serotyp identifi diverg threshold speci divid inter intratyp comparison parallel threshold larger dataset vp region sequenc assign base vp sequenc led minor revis exist type design reclassif serotyp pair aa aa singl serotyp design hrv type cc protocol assign number hrv type vp sequenc restrict vp sequenc comparison type identif provision type assign propos genotyp assign identif hrv type will consider futur investig typeassoci differ diseas outcom transmiss epidemiolog
PLoS Negl Trop Dis	28516121	2011-11-09	PMC3749987	23991243	background penicillium marneffei thermal dimorph fungu caus system mycosi china southeast asia mirna increasingli recogn role posttranscript regul gene express anim plant mirna fungi studi potenti role fungal dimorph unknown base marneffei genom sequenc hypothes mirnalik rna milrna express dimorph fungu methodologyprincip find attempt identifi milrna marneffei myceli yeast phase highthroughput sequenc technolog small rna abundantli express myceli yeast phase sequenc analysi reveal potenti milrna candid includ candid myceli yeast phase gene dcl dcl encod put dicerlik protein gene qde encod argonautelik protein identifi marneffei phylogenet analysi dcl marneffei close homologu thermal dimorph pathogen fungi penicillium chrysogenum aspergillu spp suggest coevolut dcl thermal dimorph fungi dcl demonstr higher mrna express level myceli yeast phase fold northern blot analysi confirm express milrna pmmilrm pmmilrm myceli phase dclko dclko dcldko qdeko delet mutant biogenesi milrna depend dcl dcl qde mrna express level three predict target pmmilrm upregul knockdown strain pmmilrm kd support regulatori function milrna conclusionssignific find provid evid differenti express milrna growth phase thermal dimorph fungi light evolut fungal protein involv milrna biogenesi role posttranscript control govern thermal dimorph
PLoS One	15306392	2015-03-25	PMC3749991	23991117	despit centuri studi fundament transmiss dynam properti cholera remain incomplet character histor timeseri data spread cholera twelv european north american citi second cholera pandem report amariah brigham treatis epidem cholera parameter simpl mathemat model cholera transmiss richard growth model deriv estim basic reproduct number median rang proport unrecogn case sd heterogen modelgener estim consist variabl cholera dynam describ contemporari investig repres differ natur cholera spread subject limit associ measur absenc microbiolog diagnosi histor epidem data rich sourc understand pathogen dynam absenc control measur conjunct simpl interpret mathemat model
PLoS One	22072768	2015-09-23	PMC3750056	23991128	background comprehens analysi viral etiolog clinic character children sever acut respiratori infect sari china hn pandem postpandem period method cohort hospit children month sari march enrol studi nasopharyng aspir npa specimen test commerci assai respiratori viral target viral distribut associ clinic charact statist analyz viral pathogen detect children sari popular virus enterovirusrhinoviru evrv respiratori syncyti viru rsv human bocaviru boca human parainfluenzavirus type piv adenoviru adv pandem hn domin influenza viru ifv detect children detect rate rsv human metapneumoviru hmpv suburb particip higher urban area incid vsari suburb particip higher month group conclus piconavirus evrv paramyxovirus popular viral pathogen children sari studi rsv hmpv increas risk sari children younger month higher incid vsari suscept rsv hmpv infect suburban patient
BMC Gastroenterol	25810418	2015-09-04	PMC3750240	23865596	background oral immun vaccin effect strategi prevent clostridium difficil infect cdi applic develop vaccin prevent cdi limit reason develop recombin lactococcu lacti oral vaccin evalu difficileinfect anim model establish golden hamster attempt provid altern strategi cdi prevent method recombin lacti vaccin develop ptrkh plasmid highcopynumb escherichia colil shuttl vector lacti express secret protein construct recombin ptrkh secretedprotein plasmid carri usp signal peptid spusp nontox adjuv tetanu toxin fragment tetc ctermin repeat cdta nontox difficil toxin tcda lacti express secret membran protein construct recombin ptrkh membraneanchor plasmid carri spusp tetc cdta cell wallanchor sequenc protein cwam male syrian golden hamster randomli divid group gavag normal salin blank control lacti carri empti shuttl vector secretedprotein plasmid membraneanchor plasmid week gavag clindamycin anim administ difficil spore suspens gener symptom intestin patholog chang anim examin nake ey microscopi protein level antitcda iggiga antibodi intestin tissu fluid analyz enzymelink immunosorb assai elisa cell cultur cytotox neutral assai tcda treatment antitcda serum preincub treatment apoptosi intestin epitheli cell examin flow cytometri fl assai express mucos inflammatori cytokin anim detect polym chain reaction pcr assai difficil challeng anim control group sever diarrhea symptom dai di dai indic cdi anim model establish hamster immun group secretedprotein membraneanchor plasmid group lower mortal bodi weight decreas patholog score higher surviv ratetim empti plasmid group tilter igg antibodi direct tcda higher serum intestin fluid secretedprotein membraneanchor plasmid group empti plasmid group correspond titer iga antibodi direct tcda substanti differ antitcda serum membraneanchor plasmid group neutral cytotox ngml tcda best protect achiev antitcda serum preincub incid tcdainduc death apoptosi intestin epitheli cell reduc cell preincub treatment antitcda serum membraneanchor plasmid group mcp icam il gro mrna express level lowest cecum tissu membraneanchor group compar group conclus recombin lacti live vaccin effect prevent cdi hamster model provid altern immun difficileassoci diseas
BMC Cancer	26401035	2012-04-17	PMC3750380	23924238	background paper present level colorect cancer awar multiethn rural popul malaysia method ruralbas cross section survei carri perak state peninsular malaysia march survei recruit populationrepres sampl multistag sampl altogeth particip includ studi valid bowelcolorect cancer awar measur questionnair assess level colorect cancer awar studi popul analysi varianc anova identifi sociodemograph varianc knowledg score warn sign risk factor colorect cancer respond knowledg score warn sign risk factor knowledg score warn sign risk factor sd sd posit correl knowledg score warn sign level confid detect warn sign sociodemograph characterist cancer famili friend plai role level awar conclus level awar colorect cancer warn sign risk factor rural popul malaysia low warrant extens health educ campaign colorect cancer awar commonest cancer malaysia health educ campaign urgent need respond seek medic attent sooner awar problem
Gut Pathog	26337870	2016-07-13	PMC3750464	23924832	background human rotaviru hrv sever diarrhea infant young children probiot lactobacillu rhamnosu gg lgg reduc rotaviru infect diarrhea molecular mechan lggmediat protect rotaviru infect understood autophagi plai essenti role respons microbi pathogen role autophagi hrv infect lgg treatment unknown hypothes rotaviru gastroenter activ autophagi lgg suppress virusinduc autophagi prevent intestin damag infect piglet method lgg feed combat viral gastroenter gnotobiot pig model virul hrv infect lgg feed increas autophagi viru infect induc autophagi piglet intestin viru infect increas protein level autophagi marker atgl beclin autophagi regul mtor lgg treatment viral gastroenter reduc autophagi marker express normal level induc apoptosi partial prevent virusinduc tissu damag conclus studi insight virusinduc autophagi lgg suppress uncontrol autophagi intestin injuri better understand antivir activ lgg will lead novel therapeut strategi infant infecti diseas
Virol J	22510337	2016-10-26	PMC3750554	23680019	background initi contact viru host cell activ seri cellular signal cascad facilit viral entri viral propag cell human astroviru hastv exploit signal cascad establish infect host cell studi activ extracellular signalregul kinas erk hastv infect involv signal cascad remain unclear method panel kinas blocker search cellular signal pathwai hastv infect determin impact infecti process examin viral gene express rna replic viral rna capsid protein releas host cell inhibitor phosphoinositid kinas pik activ interf infect independ erk activ activ pik signal cascad occur earli phase infect judg timefram akt phosphoryl pik inhibit earli time time block viral gene express inhibit downstream target pik activ akt rac block infect inhibit protein kinas pka activ block phase hastv product conclus reveal unknown essenti role pik life cycl hastv pik particip earli stage infect viral entri process reveal role pka viral product
Gut Pathog	27602092	2019-05-29	PMC3750644	23919811	shigella speci common acut diarrheal diseas china studi character chang trend serotyp distribut shigella speci beij total shigella strain isol serotyp hospit beij annual number shigella isol reach peak decreas annual reach lowest point flexneri sonnei frequent isol shigella respect isol make total isol flexneri total isol decreas percentag flexneri time observ sonnei surpass flexneri predomin serotyp isol recov juli septemb isol recov children ag year recov ag year flexneri recov male p flexneri and sonnei isol femal continu monitor shigella speci serotyp beij china studi period emerg sonnei decreas isol rate shigella beij aid develop vaccin control strategi shigellosi citi
BMC Microbiol	27795435	2015-05-22	PMC3750913	23924316	background identifi hydrolyz tannin chebulag acid chla punicalagin pug block herp simplex viru type hsv entri spread compound inhibit viral glycoprotein interact cell surfac glycosaminoglycan gag base properti evalu antivir efficaci virus emploi gag host cell entri extens analysi tannin mechan action perform panel virus attach entri step infect virusspecif bind assai analysi viral spread treatment compound conduct chla pug effect abrog infect human cytomegaloviru hcmv hepat viru hcv dengu viru denv measl viru mv respiratori syncyti viru rsv concentr dosedepend manner cytotox natur compound inhibit viral attach penetr spread degre viru tannin block step infect hcmv hcv mv postfus spread denv rsv intrigu differ role gaginteract virus conclus chla pug broadspectrum antivir limit emergingrecur virus engag host cell gag entri studi test efficaci tannin vivo virus justifi
BMC Med	31142680	2016-08-03	PMC3750926	23945277	exacerb chronic obstruct pulmonari diseas copd event carri consequ patient patient experi frequent exacerb recogn distinct clinic subgroup frequent exacerb phenotyp stabl time occur diseas sever associ poorer health outcom patient prioriti treatment pathophysiolog underli frequent exacerb phenotyp complex increas airwai system inflamm dynam lung hyperinfl chang lower airwai bacteri colon increas suscept viral infect frequent exacerb increas risk comorbid extrapulmonari diseas includ cardiovascular diseas gastroesophag reflux depress osteoporosi cognit impair patient poorer health statu acceler forc expiratori volum fev declin worsen qualiti life increas hospit admiss mortal contribut increas exacerb suscept perpetu frequent exacerb phenotyp review articl set definit frequent exacerb phenotyp detail examin pathophysiolog impact interact comorbid
Retrovirology	25764917	2009-09-02	PMC3751050	23915234	background viral protein vpr protein human immunodefici viru type hiv biolog function blood hivposit patient remain unclear circul vpr patient blood biolog activ examin activ blood vpr assai system retrotransposit long interspers element lrtp detect investig vivo effect recombin vpr rvpr administr transgen mice harbor human transgen hltg mice base data discuss involv blood vpr clinic symptom acquir immunodefici syndrom aid discov rvpr activ induct lrtp biochem analys reveal rvprinduc lrtp depend aryl hydrocarbon receptor mitogenactiv protein kinas ccaatenhancerbind protein sensit lrtp assai system blood sampl hiv patient examin posit induct lrtp note lrtpinduc activ block monoclon antibodi specif vpr lrtp reproduc induc organ includ kidnei rvpr administ hltg mice conclus blood vpr biolog activ suggest monitor worthwhil clarif role vpr pathogenesi aid report demonstr solubl factor patient blood activ lrtp activ impli involv lrtp develop human diseas
Diagn Pathol	27489270	2016-04-18	PMC3751102	23902660	background novel pandem hn pdm viru identifi mexico april spread worldwid short period time viru infect gener associ mild diseas low mortal project mutat specif region viral genom receptor bind domain haemagglutinin ha protein result virul viru stain lead sever pathogen method monitor genet polymorph posit haemagglutinin influenza ahnpdm virus outpati mild influenza individu sever diseas requir hospit season sequencebas genotyp assess viral popul understand preval dg mutat dg identifi clinic specimen case analyz tunisia sever outcom interestingli fatal case virus fatal case studi mutat mild case mild case studi de substitut viru patient sever clinic syndrom sever case analyz ek substitut sever case sever case studi conclus specif mutat viral haemagglutinin dg fatal sever mild case virolog clinic epidemiolog investig need ascertain role mutat alter virul transmiss pandem influenza hnpdm virtual slide virtual slide articl httpwwwdiagnosticpathologydiagnomxeuv
Genome Announc	19726607	2010-10-05	PMC3751604	23969049	the complet genom sequenc reassort field strain bluetongu viru serotyp btv isol cattl apulia region itali determin illumina sequenc sequenc comparison segment seg seg seg btv strain itl belong major eastern topotyp btv
Genome Announc	27091802	2017-11-01	PMC3751607	23969052	the classic symptom porcin epidem diarrhea ped acut diarrhea dehydr isol porcin epidem diarrhea viru pedv chgdgz strain fece diseas pig in southern china report complet genom sequenc strain chgdgz better understand molecular characterist viru
BMC Immunol	20924359	2011-07-20	PMC3751766	23947615	background studi nasal administ immunobiot potenti improv outcom influenza viru infect capac immunobiot improv protect respiratori syncyti viru rsv infect investig object aim studi evalu nasal administr lactobacillu rhamnosu crl lr rhamnosu crl lr improv respiratori antivir defens benefici modul immun respons trigger tlrrigi activ investig viabil lr lr indispens modul respiratori immun evalu capac lr lr improv resist infant mice rsv infect nasal administ lr lr differenti modul tlrrigitrigg antivir respiratori immun respons lr administr modul product ifn ifn il respons polyic challeng nasal prime lr effect improv level ifn il viabl lr lr strain increas resist infant mice rsv infect heatkil lr protect observ viabl strain conclus work demonstr nasal administr immunobiot benefici modul immun respons trigger tlrrigi activ respiratori tract increas resist mice challeng rsv compar studi lactobacillu rhamnosu strain origin technolog properti strain specif immunoregulatori respiratori tract differenti modul immun respons polyic rsv challeng confer degre protect distinct immun mechan demonstr work benefici modul respiratori defens rsv heatkil immunobiot
Virol J	29117564	2009-07-01	PMC3751867	23805945	background suggest hepat viru hbv genotyp distinct virolog characterist correl clinic outcom antivir therapi natur cours infect hydrodynam inject hbv mous model tool studi hbv replic vivo hbv genotyp studi method construct replicationcompet clone fold overlength hbv genotyp genom test vitro vivo hbv genotyp clone base paavmc vector construct fold hbv genom plasmid paavhbvb test cbl mice applic sirna hbx gene test hbv genotyp mous model fold hbv clone higher replic gene express fold hbv clone compar paavhbv genotyp mice paavhbvb higher hbsag hbeag express hbv dna replic level higher clearanc rate applic plasmid psbhbxi psrhbxi express smallshort interf rna sirna hbx gene hbv genotyp mous model lead inhibit hbv gene express replic hbv gene express resum mice despit initi delai suggest transient suppress hbv replic sirna insuffici prevent viral spread gene silenc highli effect conclus mous model hbv genotyp genom establish characterist vivo compar genotyp genom effect gene silenc hbx gene determin hbv replic sustain inhibit sirna vivo
PLoS One	21775464	2006-08-04	PMC3751960	24058410	the molecular diagnosi respiratori infect perform commerci multiplexbas pcr kit perform compar individu convent techniqu studi compar practic diagnost perform cemark kit french market includ detect virus atyp bacteria pathofind seegen compani detect virus abbott genomica qiagen seegen compani respect sensit specif accuraci agreement multiplex techniqu calcul comparison commerci duplex pcr test argenebiomrieux gold standard eightyeight respiratori specimen pathogen singl infect coinfect select cover virus group virus atyp bacteria sampl extract nuclisen easymag instrument biomrieux sensit rang virus test bacteria specif excel pathogen test kit agreement refer test strong virus kappa test moder bacteria extract step handson time vari min complet spectrum test agent technolog reveal pcr product laboratori organ determin select kit
Nucleic Acids Res	19411314	2015-06-17	PMC3753655	23804766	rna emerg major player cellular process understand process molecular level requir homogen rna sampl structur biochem pharmacolog studi devis gener approach allow effici vivo express recombin rna escherichia coli work extend method rnaprotein coexpress engin plasmid allow overexpress rnaprotein complex coli investig potenti tool applic includ product nucleasesensit rna encapsul viral protein pseudoparticl coproduct noncod rna chaperon protein incorpor posttranscript rna modif coproduct appropri modifi enzym final product purif rnahistag protein complex nickel affin chromatographi applic easili pure materi crystallograph studi tool report will pave largescal structur molecular investig rna function interact protein
J Clin Microbiol	16891412	2013-11-06	PMC3754654	23850955	earli diagnosi manag influenza viru infect directli correl effect diseas control current molecular influenza viru test design diagnost test facil sophist equip highli train technician longer turnaround time central test test sampl sourc delai initi medic intervent reduc efficaci antivir treatment assai samba simpl amplificationbas assai flu duplex test dipstickbas molecular assai develop provid simpl accur costeffect solut diagnosi influenza ab virus intend nearpati test test present altern format influenza viru molecular test util isotherm amplif visual detect nucleic acid test strip entir test procedur extract amplif detect integr enclos semiautom system analyt samba flu duplex test detect copi viral genom influenza virus crossreact observ common respiratori pathogen clinic perform establish blind test nasalthroat nasopharyng swab specimen unit kingdom belgium compar quantit revers transcriptionpcr method routin public health laboratori samba flu duplex test clinic sensit specif influenza viru and influenza viru test technolog facilit simpl time identif influenza viru infect effici control measur
PLoS Biol	26085552	2005-10-03	PMC3754884	24013523	paleovirolog studi ancient virus exist paleoviru detect virtu accident insert germlin anim speci allow viru exist ancient modern connect modern virus unexpect origin trace ancient infect genom speci mongoos egglai mammal call echidna viru current poultri reticuloendotheliosi viru rev ancient exot mammalian origin rev spread poultri circuit rout involv isol malaria parasit pheasant borneo hous bronx zoo contamin rev repeat passag viru poultri adapt viru host point viru insert viru call fowlpox viru spread wild rev exist mammalian host modern form link millionyearold infect ancestor mongoos viru circul wild bird malaria studi midth centuri lesson ancient modern virus implic modern human pandem viral reservoir human intervent unintend consequ
PLoS One	24198408	2016-04-01	PMC3755973	24015257	human metapneumoviru hmpv infect acut respiratori tract infect rti result hospit children adult antivir vaccin common viral infect immunomodul repres interest strategi treatment sever viral infect role proteaseactiv receptor par inflamm coagul infect process grow interest effect par agonist par antagonist hmpv infect investig balbc mice intranas administr par agonist increas weight loss mortal infect mice convers par antagonist benefici hmpv infect decreas weight loss clinic sign reduc pulmonari inflamm proinflammatori cytokin level includ il kc mcp recruit immun cell lung addit reduct pulmonari viral titer observ lung par antagonisttr mice despit appar direct viru replic vitro experi role par regul furin express lung time experi indic hmpv fusion protein cleav furin suggest par viral infect addit immunomodulatori properti inhibit par select antagonist repres interest strategi decreas sever paramyxoviru infect
PLoS One	16203977	2018-08-23	PMC3756998	24009675	a nontox residu peptid nivnvslvk interfer insulin fibril biophys method insulin undergo conform chang stress condit lead amyloid fibril fibril insulin pose problem longterm storag reduc efficaci treat type ii diabet dissoci insulin oligom monom kei step onset fibril time cours insulin fibril thioflavin fluoresc increas lag time min peptid min peptid transmiss electron micrograph branch insulin fibril absenc interfibril associ presenc incub ph insulin lost helic structur fourier transform infrar spectroscopi ftir peptid secondari structur fulli maintain lost partial ftir spectroscopi insulin form cross beta structur indic fibril presenc peptid helix retent till size exclus chromatographi dynam light scatter insulin exist trimer convers monom resist peptid satur transfer differ nuclear magnet reson confirm hydrophob residu peptid close contact insulin hydrophob groov molecular dynam simul conjunct princip compon analys reveal peptid interrupt insulin fibril vitro hemolyt activ peptid insignific cytotox ht cell insulin aggreg probe inter plai kei residu pheb tyrb monitor molecular dynam simul studi peptid base lead develop residu peptid
PLoS One	27035805	2016-01-01	PMC3758261	24023656	the rapid discoveri novel virus gener sequenc ng technolog includ dnaseq rnaseq greatli expand understand viral divers year time identif novel virus ng technolog control emerg infecti diseas caus novel virus studi identifi novel duck coronaviru cov distinct chicken infecti bronchiti viru ibv rnaseq novel duckspecif cov potenti novel speci genu gammacoronaviru indic sequenc three region viral gene perform survei cov domest fowl china reversetranscript polymeras chain reaction rtpcr target viral nucleocapsid gene total cov posit identifi survei phylogenet analysi viral sequenc suggest cov domest fowl diverg regionspecif hostspecif clade subclad ibv infect duck gees pigeon circul chicken studi provid novel data support notion hostspecif cov ibv circul duck gees pigeon indic novel duckspecif cov identifi rnaseq studi genet closer cov circul wild water fowl studi insight divers distribut evolut control avian cov
PLoS One	30139911	2013-12-01	PMC3758312	24023659	bat chiroptera host major human pathogen virus includ corona paramyxo rhabdo filovirus analyz cell line yinpterochiroptera includ african fly fox rhinolophid bat yangochiroptera genera carollia tadarida suscept infect envelop rna virus cell sensit infect transmiss gastroenter viru tgev porcin coronaviru infect mediat spike protein sarscoronaviru sarscov incorpor pseudotyp base vesicular stomat viru vsv resist infect overcom cell transfect express respect cellular receptor porcin aminopeptidas tgev angiotensinconvert enzym sarscov vsv pseudotyp protein bat sarsrel cov bg rp unabl infect test bat cell line contrast viral pseudotyp surfac protein gp marburg viru famili filovirida infect cell line effici notabl cell sensit infect paramyxovirus sendai viru bovin respiratori syncyti viru three influenza virus subtyp indic bat cell resist infect coronavirus infect paramyxovirus filovirus influenza virus receptordepend restrict infect bat cell cov implic isol coronavirus bat discuss
Cancers (Basel)	28605344	2013-07-30	PMC3759197	24212956	cancer therapi character histori down ineffect treatment side effect hope realiti complet remiss cure case therapeut arsen alongsid surgeri case solid tumor antitumor drug radiat treatment choic instanc year immunotherapi therapeut altern choic case nanotechnolog arriv scene offer nanostructur therapeut altern control drug deliveri combin imag treatment appli hyperthermia provid direct target therapi therapi appli combin compon antibodi peptid folic acid addit gene therapi offer promis method treatment review evolut cancer treatment start chemotherapi surgeri radiat immunotherapi move promis cuttingedg therapi gene therapi nanomedicin offer histor point view cover arriv therapi clinic practic market promis challeng present
Cancers (Basel)	24261888	2002-12-15	PMC3759217	24212974	therapeut vaccin cancer approach combin therapi improv longterm control cancer fact induct adapt immun respons tumor associ antigen taa innat immun factor tumor stabilizationerad varieti immun technolog explor decad current activ evalu cellbas protein peptid heatshock proteinbas cancer vaccin genet vaccin emerg promis methodolog elicit immun respons wide varieti antigen includ taa adenoviru adbas vector excel immunogen profil achiev immunolog proof concept human vivo electropor plasmid dna dnaep desir vaccin technolog cancer vaccin repeat time paramet requir longterm mainten antitumor immun find combin modal immun heterolog primeboost induc superior immun reaction compar singlemod vaccin review will discuss challeng requir emerg cancer vaccin focus genet cancer vaccin current activ develop promis ad dnaep heterolog primeboost
Front Immunol	24729747	2005-05-01	PMC3759284	24032033	flow cytometrybas analysi lymphocyt divis carboxyfluorescein succinimidyl ester cfse dye dilut permit acquisit data describ cellular prolifer differenti exampl cfse histogram data enabl quantit insight cellular turnov rate appli mathemat model paramet estim techniqu mathemat model develop type determinist stochast approach analysi cfse prolifer assai base premis label halv daughter cell importantli asymmetri protein distribut lymphocyt divis basic biolog featur cell divis degre asymmetri depend factor review literatur asymmetr lymphocyt divis cfsebas lymphocyt prolifer analysi divis labelstructur mathemat model describ cfsebas cell prolifer account asymmetri timelag cell prolifer util improv model algorithm will permit straightforward quantif essenti paramet describ perform activ lymphocyt
Viruses	12438575	2011-08-24	PMC3761233	23896748	the spike protein number coronavirus bind sialic acid cell surfac sialic acid bind abil infect compar spike protein transmiss gastroenter viru tgev spike protein infecti bronchiti viru ibv sialic acid receptor determin ibv tgev requir interact receptor aminopeptidas initi infect cell bind test solubl spike protein carri igg fctag reveal pronounc differ viral protein bind ibv spike protein host cell experi sialic acid depend solubl tgev spike bind apn detect sialic acid bind activ underlin wai bind sialoglycoconjug mediat coronaviru spike protein
Viruses	15872279	2007-10-10	PMC3761238	23955500	between januari march infect rate porcin epidem diarrhea viru pedv increas vaccin swine herd porcin farm gansu provinc china spike glycoprotein determin pedv biolog properti determin distribut profil pedv outbreak strain sequenc fulllength gene sampl farm anim exhibit sever diarrhea high mortal rate pedv variant identifi molecular divers phylogenet relationship antigen analysi gansu field sampl pedv refer strain investig seri insert delet mutat gene pedv variant compar classic vaccin strain mutat provid stronger pathogen antigen pedv variant influenc effect cvbase vaccin pedv variant strain gansu provinc south korean south china effect cvbase vaccin evalu
PLoS One	21865426	2010-02-24	PMC3762858	24023773	estim pathogenspecif child diarrhea death need guid vaccin develop prevent strategi systemat review articl publish report pathogen children year ag hospit diarrhea includ rotaviru data rotaviru surveil network coordin exclud studi conduct diarrhea outbreak discrimin inpati outpati case report nosocomi infect conduct special popul adequ method rotaviru studi countri rotaviru vaccin ageadjust median proport pathogen calcul appli death diarrhea children year assum observ children hospit diarrhea repres caus child diarrhea death articl studi countri select repres inpati studi studi seek pathogen higher proport pathogen studi seek multipl pathogen rotaviru singlepathogen studi studi pathogen percentag episod pathogen identifi estim total ageadjust percentag pathogen nopathogen case adjust proport includ unknown add estim rotaviru caus uncertainti rang enteropathogen coli caliciviru enterotoxigen coli death rotaviru caliciviru enteropathogen enterotoxigen coli half diarrheal death children year world
Environ Health Perspect	17928356	2015-08-26	PMC3764079	23838256	background environ clearli implic risk antibiot resist clinic outcom document approach formal assess risk object examin approach sought identifi enabl human health risk assess hhra focu role environ failur antibiot treatment caus antibioticresist pathogen method author particip workshop held march qubec canada defin scope object environment assess antibioticresist risk human health focus kei element environmentalresistancedevelop hot spot exposur assess unrel food dose respons character risk improv antibioticresist manag option discuss novel aspect tradit risk assess identifi enabl assess environment antibiot resist includ account select pressur environment resistom time allow develop antibioticresist bacteria arb identifi describ rate horizont gene transfer hgt relev environment hot spot compart modifi tradit doserespons approach address dose arb health outcom pathwai conclus propos environment aspect antibioticresist develop includ process hhra address arb limit data multicriteria decis analysi approach undertak hhra environment antibiot resist inform risk manag citat ashbolt nj amzquita backhau borriello brandt kk collignon coor finlei gaze wh heber lawrenc jr larsson dg mcewen sa ryan jj schnfeld sillei snape jr van den eed topp human health risk assess hhra environment develop transfer antibiot resist environ health perspect httpdxdoiorgehp
Malar J	26311869	2013-03-27	PMC3765086	23607541	background lack defin correl immun malaria combin inabl induc longliv steril immun respons human host demonstr improv understand protect immun mechan enhanc vaccin efficaci protect steril immun plasmodium falciparum circumsporozoit protein csp achiev transgen modifi plasmodium berghei sporozoit tgpbpfcsp selfassembl protein nanoparticl sapn vaccin present csp epitop pfcspsapn mechan involv independ protect humor cellular respons induc sapn immun describ method inbr mice vaccin pfcspsapn pb serum antibodi harvest effect falciparum sporozoit mobil integr examin phase contrast microscopi function sapninduc antibodi inhibit sporozoit invas growth primari human hepatocyt examin intern process sapn bone marrowderiv dendrit cell bmddc organellespecif fluorescenttag antibodi goldencapsul sapn observ confoc electron microscopi work demonstr pfcspsapn induc epitopespecif antibodi titer isotyp igg serum antibodi pfcspsapnimmun mice appear target falciparum sporozoit classic pathwai complement sporozoit death indic cessat motil circumsporozoit precipit reaction pfcspsapninduc antibodi inhibit wildtyp falciparum sporozoit invas growth cultur primari human hepatocyt addit observ pfcspsapn process present immun system dendrit cell slow continu fashion transport associ antigen process tap recruit earli endosom ee partial delai process endoplasm reticulum potenti induc longliv effector memori cd tcell describ conclus paper describ examin humor cellular immun mechan induc pfcspsapn vaccin result steril host protect transgen berghei malaria sporozoit express falciparum csp inhibit nativ falciparum sporozoit invad develop cultur human hepatocyt indic type mode action protect antibodi need control falciparum sporozoit infect human potenti mechan induct protect longliv effector memori cd tcell
Respir Res	31138613	2007-04-06	PMC3765474	23941132	background carcinoembryon antigen cearel cell adhes molecul ceacam bgp cda ceacam cea cde ceacam nca cdc express human lung plai role innat adapt immun target bacteri viral adhesin pathogen colon steril lower respiratori tract patient chronic obstruct pulmonari diseas copd nontyp haemophilu influenza nthi moraxella catarrhali pathogen bind ceacam elicit varieti cellular reaction includ bacteri intern cell adhes apoptosi method analyz express ceacam ceacam ceacam lung tissu respect copd smoke statu granulocyt infiltr immunohistochem stain paraffin section donor studi address shortterm effect cigarett smoke acut inflamm transcript regul ceacam ceacam ceacam isoform cigarett smoke extract interferon tolllik receptor agonist bacteria test normal human bronchial epitheli nhbe cell quantit pcr correspond ceacam protein level determin flow cytometri immunohistochem analysi lung section frequent intens stain ceacam ceacam ceacam bronchial alveolar epithelium reveal differ connect copd smoke statu granulocyt infiltr nhbe cell mrna express ceacam isoform ceacaml ceacam ceacaml ceacam upregul interferon alpha beta gamma tlr agonist polyinosinicpolycytidyl acid poli ic interferongamma increas ceacam express confirm protein level fac analysi importantli nthi catarrhali increas ceacam mrna level independ abil bind ceacam express ceacam treatment bacteri infect conclus find direct correl ceacam express copd copdassoci bacteria nthi catarrhali increas express receptor host cell data role ceacam ceacam phenomenon increas host suscept bacteri infect viral challeng human respiratori tract
Vet Res	23536668	2015-01-20	PMC3765525	23964891	felin infecti periton fip fear infecti death cat induc felin infecti periton viru fipv coronaviru virul mutant harmless ubiquit felin enter coronaviru fecv felin coronaviru fcov hamper lack suscept cell line propag serotyp fcov studi longterm felin intestin epitheli cell cultur establish primari ileocyt colonocyt simian viru sv tantigen human telomeras revers transcriptas htertinduc immort subsequ cultur evalu usabl fcov firstli replic capac serotyp ii strain wsu wsu studi continu cultur primari cultur primari cultur fcov wsu replic effici compar fcov wsu continu cultur addit cultur inocul faecal suspens healthi cat faecal tissu suspens fip cat cultur suscept infect serotyp enter strain strain propag infect cultur inocul fipv tissu homogen conclus reliabl model fcov investig growth enter field strain establish contrast fipv strain fecv clear tropism intestin epitheli cell explan observ fecv main pathotyp circul cat
Virol J	17416677	2018-04-24	PMC3765664	23978242	background evid point emerg novel human coronaviru middl east respiratori syndrom coronaviru merscov sever acut respiratori syndrom sarslik diseas respons develop effect vaccin therapeut remain clinic prioriti accomplish evalu neutral antibodi screen merscov entri inhibitor method studi produc pseudoviru bear fulllength spike protein merscov envdefect luciferaseexpress hiv backbon establish pseudovirusbas inhibit assai detect neutral antibodi antimerscov entri inhibitor result demonstr gener merscov pseudoviru allow singlecycl infect varieti cell express dipeptidyl peptidas dpp confirm receptor merscov consist live merscovbas inhibit assai antisera mice vaccin recombin protein receptorbind domain rbd residu merscov fuse fc human igg exhibit neutral antibodi respons infect merscov pseudoviru small molecul hiv entri inhibitor target gp adsj hydroxyphthal anhydridemodifi human serum albumin hphsa inhibit merscov pseudoviru infect conclus establish merscov inhibit assai safe conveni pseudovirusbas altern bsl liveviru restrict rapidli screen merscov entri inhibitor evalu vaccineinduc neutral antibodi highli pathogen merscov
Virol J	25605719	2019-01-14	PMC3765696	23984714	background chikungunya viru chikv alphaviru togavirida famili autoproteolyt cleavag chikv capsid protein cp involv rna bind assembl viral particl monomer cp kda size small passiv transport nuclear pore alphavirus harbor nuclear local signal nl transport protein cellular compart energi depend activ nuclear import cytoplasm protein mediat karyopherin export exportin nuclear cytoplasm traffick plai role life cycl chikv sought identifi nuclear local nuclear export signal chikv cp virusfre system method egfpfus protein chikv cp mutant creat monitor intracellular local bind cellular protein confirm pulldown assai purifi cp coimmuoprecipit nuclear local demonstr virusfre system fluoresc microscopi chikv cp nuclearcytoplasm shuttl protein activ nl bind karyopherin kar nuclear transloc kar ctermin nl bind site suffici interact demonstr chikv cp interact directli export receptor crm transport viral protein nucleu nuclear export signal ne chikv cp ne map amino acid cp deduc silico analys ne mode bind snurportin crm complex conclus virusfre system chikv capsid protein nl ne activ transport cytoplasma nucleu conclud chikv cp abil shuttl interact karyopherin nuclear import vice versa crmdepend nuclear export
PLoS One	29688086	2016-08-03	PMC3770639	24040129	background contact patient patient health care worker hcw hcw repres rout transmiss hospitalacquir infect hai detail descript quantif contact hospit kei hai epidemiolog design valid control measur method find wearabl sensor detect closerang interact contact individu geriatr unit univers hospit contact event measur spatial resolut meter tempor resolut second studi includ hcw patient last dai night contact record daytim number durat contact vari morn afternoon night contact matric describ mix pattern hcw patient built time period contact pattern qualit dai the contact occur pair hcw hcw account contact includ patient suggest popul individu superspread conclus wearabl sensor repres novel tool measur contact pattern hospit collect data provid aspect impact spread pattern infecti diseas strong heterogen contact number durat individu variabl number contact dai fraction repeat contact dai variabl associ mark statist stabil contact mix pattern dai highlight measur effort order correctli inform mathemat model hai inform design evalu prevent strategi
Front Microbiol	30967014	2007-03-15	PMC3771312	24062735	acut respiratori ill ari virus common upper respiratori infect human major morbid mortal lead diseas bronchiol pneumonia previou studi respiratori syncyti viru rsv human rhinoviru hrv human metapneumoviru hmpv human parainfluenza viru hpiv human enteroviru infect associ virusinduc asthma exampl suggest hrv infect detect acut exacerb asthma infect prolong believ main etiolog asthma ari virus number asthma patient industri countri greatli increas morbid rate of popul relationship viral infect host immun respons host factor pathophysiolog asthma remain unclear gain better understand epidemiolog virusinduc asthma assess characterist virus host defens mechan molecular epidemiolog enabl understand pathogenesi microorgan identifi specif pathwai molecul gene influenc risk develop diseas epidemiolog respiratori virus associ virusinduc asthma fulli understood articl review molecular epidemiolog studi rsv hrv hpiv hmpv infect associ virusinduc asthma
PLoS One	27489282	2012-03-21	PMC3771918	24069161	background acut respiratori infect lead infecti diseaserel morbid hospitalis mortal children worldwid develop countri lowincom countri patient acut respiratori infect ari mild sever treat empir aim studi evalu risk factor associ evolut outcom respiratori ill patient ag year materi method conduct prospect studi paediatr ward antananarivo novemb juli includ patient year suffer respiratori infect collect demograph socioeconom clinic epidemiolog data sampl laboratori analysi death rapid progress respiratori distress hospitalis hospitalis dai consid sever outcom multivari analysi studi effect coinfect novemb juli total patient enrol coinfect patient coinfect frequent children month differ monthold group sixtynin percent patient recov fulli sever outcom hospitalis outcom score sever children patient di risk factor associ worsen evolut hospitalis sever outcom admiss ag month comorbid low household incom conclus comordid lowincom ag month increas risk sever outcom children infect numer respiratori pathogen highlight implement target public health polici reduc contribut respiratori diseas childhood morbid mortal low incom countri
PLoS Negl Trop Dis	17357846	2013-09-01	PMC3772029	24069485	for envelop virus fusion viral envelop cellular membran critic product infect occur fusion process mediat three class fusion protein class ii iii base protein sequenc structur rift vallei fever viru rvfv glycoprotein gc class ii fusion protein mediat fusion event entri endocyt pathwai allow viral genom access cell cytoplasm peptid analog rvfv gc stem region inhibit rvfv infect cell cultur inhibit fusion process infect inhibit divers unrel rna virus class ebola viru class ii and viru class iii vesicular stomat viru fusion protein singl peptid find consist inhibit mechan propos stem peptid fusion inhibitor dengu viru rvfv inhibitori peptid bind virion cell membran allow traffic viru endocyt pathwai acidif rearrang gc peptid bind gc prevent fusion viral endocyt membran inhibit viral infect provid novel insight conserv featur three class viral fusion protein offer direct futur develop broadli activ fusion inhibitor
PLoS Negl Trop Dis	22438538	2006-04-17	PMC3772037	24069471	lassa viru lasv caus agent lassa fever respons infect thousand death annual west africa lasv nonpathogen mopeia viru mopv rodentborn african arenavirus live attenu reassort mopv lasv design protect rodent primat lasv challeng appear attenu mopv gain better insight lasvinduc patholog mechan attenu perform gene express profil human peripher blood mononuclear cell pbmc expos lasv vaccin candid pbmc healthi human subject expos lasv pbmc nonpermiss viru replic remain suscept signal transduct viru particl total rna extract global gene express evalu hour highdens microarrai valid rtpcr flow cytometri elisa lasv elicit differenti express interferonstimul gene isg gene involv apoptosi nfkb signal coagul pathwai gene eventu serv biomark predict diseas outcom remark differenti express thrombomodulin kei regul inflamm coagul suggest involv vascular abnorm mortal lassa fever diseas
PLoS Negl Trop Dis	24510791	2010-06-30	PMC3772074	24069479	the mosquitoborn alphaviru chikungunya viru chikv reemerg produc largest epidem record viru case acut chronic rheumat diseas current licens vaccin chikv current antiinflammatori drug treatment inadequ describ isol character human monoclon antibodi chikv infect recov individu determin potent viru neutral antibodi biosensor antibodi bind studi demonstr recogn residu intact chikv vlp shotgun mutagenesi alanin scan percent residu e glycoprotein chikv envelop epitop bound includ aminoacid acidsensit region asr chikv glycoprotein asr critic rearrang chikv fusion viral entri host cell predict prevent event occur prophylact chikv mous model complet protect chikv viremia arthriti observ administ therapeut hour postchikv challeng protect pathogen mous model target novel neutral epitop potent protect vitro vivo region futur antibodi vaccinebas intervent chikv
PLoS One	16618966	2010-01-27	PMC3772926	24058536	the ilst axi involv liver patholog il level increas sera viral hepat patient human cellular sourc il viral hepat remain obscur aim investig express il murin fulmin hepat induc toll receptor tlr viral mimet polyic pathogen mous hepat viru lmhv administr polyic dgalactosamin dgaln mice led acut liver injuri associ induct il express liver sinusoid endotheli cell lsec vascular endotheli cell vec administr polyic led hepatocyt specif il express addit vascular il express hepatocytespecif il express downregul nkdeplet polyic treat mice suggest partial regul il nk cell cdd ko nkt defici mice hepatoprotect polyicinduc hepat associ increas number il express hepatocyt cdd ko mice wt control hepatocytespecif il express polyic induc liver injuri partial depend nk cell limit role nkt cell parallel lmhv infect mice induc fulmin hepat associ upregul il express proinflammatori cytokin microenviron liver lsec vec express induc express il lmhv infect hepatocytespecif il express evid post infect conclus alarmin cytokin il overexpress fulmin hepat mice lsec vec hepatocyt potenti sourc il
Evid Based Complement Alternat Med	20592074	2011-11-01	PMC3773900	24073006	tsl fraction aqueou extract tender leaf toona sinensi roem nutriti veget pandem influenza hn viru describ rapidli contagi respiratori pathogen acut respiratori distress syndrom ard pose major public health threat studi tsl inhibit viral yield mdck plaqu format pandem influenza hn viru infect cell high select tsl suppress viral genom load infect cell quantifi qrtpcr studi demonstr tsl inhibit pandem influenza hn viru activ prevent attach cell penetr tsl inhibit viral attach downregul adhes molecul chemokin vcam icam eselectin il fractalkin compar amantadin tsl altern treatment prophylaxi pandem influenza hn viru
Clin Dev Immunol	20106914	2017-11-29	PMC3775440	24078817	passiv immunotherapi therapi cancer inflammatori condit studi monoclon antibodymab base passiv immunotherapi promis approach combat viru infect specif mous mab routin gener larg amount hybridoma technolog therapi human be immunogen develop chimer human mab therapeut purpos facilit varieti molecular techniqu recombin dna technolog better understand structur function antibodi humanmous chimer form allow detail analysi mechan inhibit potenti therapeut applic stepbystep descript convers process will describ commerci avail reagent requir step experiment easili set laboratori
PLoS One	26388931	2015-01-01	PMC3775774	24069191	object studi aim analyz clinic featur factor associ treatment outcom hn influenza viru infect method clinic progress hninfect patient monitor record clinic featur hn infect factor associ treatment outcom analyz univari analys averag ag patient recov critic condit year year renal insuffici develop frequent critic patient durat tradit chines medicin tcm therapi longer recov patient critic patient laboratori test level creactiv protein serum creatinin myoglobin higher critic patient recov patient level cell subset examin includ total cd cd cd cd cell lower critic patient recov patient logist regress analysi demonstr creactiv protein level myoglobin level tcm therapi durat associ treatment outcom hn infect conclus elderli peopl increas risk hn viru infect cellmedi respons plai role defens hn viru creactiv protein level myoglobin level tcm durat associ treatment outcom hn infect
Springerplus	29187542	2008-07-30	PMC3776089	24052932	china healthcar system experienc growth expand governmentback insur greater publicsector spend hospit introduct privat insur forprofit clinic increment reform process sought develop market incent medic innov liber physician compens hospit financ continu basic care afford larg popul pai compon care outofpocket addit chang present consider policymak restructur insur deliveri care will alter competit dynam major healthcar industri notabl pharmaceut medic devic diagnost test articl describ institut histori china healthcar system identifi dilemma emerg countri negoti divis public privat healthcar build analysi articl consid opportun publicpriv partnership greater system integr reconcil incommensur approach reward innov improv access articl conclud observ public function health insur signific develop china healthcar system
PLoS One	26715805	2014-11-24	PMC3776769	24058703	recent interferoninduc transmembran ifitm famili protein ifitm target activ influenza hn viru infect protein posttransl modif fatti acid coval attach cystein term spalmitoyl plai crucial role antivir activ ifitm possess three cystein residu spalmitoyl transmembran tm domain cytoplasm cp loop cystein conserv mammalian ifitm famili protein spalmitoyl cystein function ifitm ifitm famili protein interact fkbind protein fkbp form higherord complex osteoblast cell induc express immunolog relev gene studi investig role plai spalmitoyl ifitm interact fkbp cell interact kei process gene express investig establish report octadecyno acid odya inhibitor spalmitoyl bromopalmit acid bp reveal ifitm spalmitoyl addit ifitm cystein residu tm domain cp loop spalmitoyl ifitm reveal immunoprecipit western blot analys interact ifitm fkbp inhibit presenc bp mutant lack spalmitoyl site tm domain lost interact fkbp indic spalmitoyl ifitm promot interact fkbp final investig bone nodul format osteoblast cell presenc bp ifitm origin identifi bone format factor experi morpholog aberr bone nodul indic spalmitoyl contribut bone format
PLoS One	18667517	2013-02-07	PMC3776844	24058576	recent report indic replic hepat viru hcv depend gbfarfcopi pathwai gener huhderiv cell line resist brefeldin bfa inhibitor pathwai resist cell line sort phenotyp bfainduc toxic inhibit albumin secret inhibit hcv infect cell line time resist bfa parent huh cell assai resist phenotyp correl presenc point mutat domain gbf impair bind bfa surprisingli morpholog cisgolgi cell remain sensit bfa concentr drug allow albumin secret indic dichotomi phenotyp secret golgi morpholog cell second group time resist parent huh cell bfainduc toxic ec albumin secret fold higher cell huh cell level secret presenc inhibitori dose bfa time higher despit partial effect secretori pathwai presenc bfa hcv infect sensit bfa huh cell suggest function gbf hcv replic simpli reflect role regul secretori pathwai host cell confirm involv gbf hcv replic gbf fulfil function addit regul secretori pathwai hcv replic
PLoS One	25422508	2009-02-25	PMC3776850	24058676	persist infect mous central nervou system cn mous hepat viru mhv induc demyelin diseas patholog multipl sclerosi model system host factor correl contribut mhvinduc demyelin detail gene pathwai associ mhvinduc demyelin diseas spinal cord highthroughput sequenc host transcriptom reveal demyelin accompani numer transcript chang indic immun infiltr chang cytokin milieu lipid metabol evid thbias cytokinechemokin respons eicosanoidderiv inflamm accompani persist mhv infect antigen present ongo interestingli increas express gene involv lipid transport process catabol includ role neurodegen diseas coincid demyelin lastli express gene involv osteoclast boneresid macrophag function notabl trem dap upregul persist infect mous spinal cord studi highlight complex host antivir respons accompani mhvinduc demyelin support previou find mhvinduc demyelin immunemedi interestingli data parallel bone reabsorpt osteoclast myelin debri clearanc microglia bone cn knowledg report rnaseq approach studi host cn respons persist viral infect
PLoS Pathog	23426201	2014-06-04	PMC3777860	24068925	progeni particl nonenvelop lytic parvovirus activ transport cell peripheri vesicl gelsolindepend manner process involv rearrang destruct actin filament microtubul protect infect focu intracellular egress pathwai impact properti releas progeni virion coloc cellular marker protein specif modul pathwai overexpress variant effector gene transduc recombin adenoassoci viru vector progeni pv particl engulf copiivesicl endoplasm reticulum er transport golgi plasma membran factor sar rab erm famili protein radixin moesin plai essenti role formationload target viruscontain copiivesicl protein contribut transport er golgi describ analogu cellular protein secret gaussia luciferas absenc viru infect radixin moesin serv gener function cellular exocytosi final parvoviru egress er golgi appear virion gain full infect postassembl modif phosphoryl absolut requir cytolysi progeni viru releas vesicular transport parvovirus er golgi acceler process point regulatori role transport pathwai
PLoS One	19244326	2013-03-25	PMC3777964	24069231	in model fungu podospora anserina payip gene encod orthologu saccharomyc cerevisia yip rabgdi complex dissoci factor express polypeptid long form produc program translat frameshift inactiv payip delai growth associ modif repartit fruit bodi thallu reduc ascospor product wood long short form payip express mycelium short form appear express matur fruit bodi perithecium frameshift conserv evolut pezizomycotina last year suggest role wild
PLoS One	24899185	2015-10-28	PMC3777972	24069267	background data contribut better understand circul influenza virus northafrica object object surveil detect sever influenza case identifi epidemiolog virolog characterist assess impact healthcar system method describ report find laboratorybas surveil human case influenza viru respiratori virus infect three season tunisia winter influenza season underwai tunisia cocircul influenza ahn influenza ahn sporad influenza virus season circul strain pandem influenza ahnpdm influenza virus sporad virus subtyp ahn unsubtyp influenza countri highest preval influenza viru yamagatalik lineag report tunisia localis clade bbangladesh pandem year influenza ahnpdm predomin influenza virus amino acid chang dg de detect ha gene ahnpdm viru sever case fatal case mild case influenza ahnpdm virus studi frequent report respiratori viru influenza three season rsv conclus articl summaris surveil epidemiolog influenza virus respiratori virus show rapid improv influenza surveil feasibl connect exist structur health care system patient record electron surveil system report ili case
Biomed Res Int	23524656	2011-08-26	PMC3780522	24083230	multipl sclerosi ms inflammatori demyelin diseas human central nervou system cn neurotrop demyelin strain mhv mhva isogen recombin strain rsa induc mslike diseas mice mediat microglia small popul cell mechan demyelin microgliamedi myelin strip direct axon injuri immun myelin oligodendrocyt glycoprotein mog induc experiment autoimmun encephalomyel eae cd tcellmedi diseas cd cell plai role demyelin autoimmun nonimmun mechan direct viral toxic induc ms studi directli compar cn patholog autoimmun viralinduc ms model mice viralinduc eae demyelin diseas demonstr pattern distribut demyelin accumul cours diseas differ acut inflamm inflamm restrict white matter time eae inflamm initi involv grai matter acut mhvinduc diseas subsequ local white matter chronic diseas phase presenc dual mechan demyelin respons failur immunosuppress promot longterm remiss ms patient
Biomed Res Int	26511735	2009-03-06	PMC3780538	24089666	canin parvoviru cpv diseas acut highli infecti diseas threaten dograis industri effect therapeut strategi control diseas canin transferrin receptor tfr identifi receptor cpv infect extracellular domain tfr call solubl tfr stfr possess anticpv activ remain elus recombin stfr prepar hekt cell codonoptim gene structur investig anticpv activ vitro vivo indic codon optim improv stfr express hekt cell prepar recombin stfr possess bind activ cpv cpv vp capsid protein inhibit cpv infect cultur felin cell decreas mortal cpvinfect dog indic stfr anticpv activ vitro vivo
Mediators Inflamm	21884168	2018-01-31	PMC3781841	24194630	dysfunct bloodbrain barrier bbb primari characterist experiment autoimmun encephalomyel eae experiment model multipl sclerosi ms matrin mat quinolizidin alkaloid deriv herb radix sophora flave suppress clinic eae cn inflamm mat protect integr function bbb studi mat treatment therapeut compar dexamethason dex eae rat reduc evan blue extravas increas express collagen iv major compon basement membran structur tight junction tj adaptor protein zonula occluden zo mat treatment attenu express matrix metalloproteinas mmp increas express tissu inhibitor metalloproteinas timp find demonstr mat reduc bbb leakag strengthen basement membran inhibit activ mmp and upregul inhibitor identifi novel mechan underli mat natur compound novel therapi ms
PLoS One	19269968	2008-04-02	PMC3783479	24086536	influenza vaccin target highli variabl surfac glycoprotein hemagglutinin neuraminidas inconveni vaccin year reason develop univers vaccin target conserv viral compon need studi gener recombin adenoviru rad vaccin encod nucleoprotein np apr influenza viru design radnp balbc mice immun intranas sublingu radnp vaccin subsequ challeng lethal dose heterolog homolog influenza virus intranas immun radnp elicit strong mucos iga respons stronger cd tcell respons immunodomin kdrestrict np epitop sublingu immun importantli singl intranas sublingu immun radnp potent protect homolog heterolog influenza viru challeng recombin radnp univers vaccin candid mucos administr influenza viru
Genome Announc	29564125	2010-10-01	PMC3784778	24072858	we report complet genom sequenc felin astroviru fastv fastv strain identifi domest cat genom nucleotid nt length consist three overlap open read frame orfaorfborf sequenc analysi suggest fastv repres fastv genotyp close human astrovirus
PLoS One	18385233	2006-03-01	PMC3785410	24086618	a resequenc pathogen microarrai rpm singl highli multiplex assai detect differenti pathogen close overlap probe set determin target organ nucleotid sequenc studi rpm rpmivdc consist bp detector tile correspond influenza subtyp rhinovirus enterovirus respiratori virus develop optim provid individu simultan detect sensit rang genom copi common respiratori pathogen total consecut patient communityacquir pneumonia cap admit district gener hospit beij year period assess assai children ag adult patient ag respiratori syncyti viru rsv rhinoviru rv common etiolog agent consist refer assai atyp pathogen caplik ill includ rubella viru measl viru influenza type viru human herpesviru hhv detect the capabl rpmivdc accur detect identif multipl viru type epidem surveil outbreak investig atyp pathogen
PLoS One	20700113	2013-03-01	PMC3785445	24086764	background ribosom rna content sampl collect woman bacteri vaginosi bv analys determin activ microbi commun identifi potenti target screen methodologyprincip find sampl bv patient underw total rna extract physic subtract human rrna transcriptom amplif metatranscriptom sequenc roch titanium chemistri bioinformat pipelin mgrast desktop dna analysi platform utilis analys bacteria genu prevotella predomin amnii constitut rrna read megasphaera leptotrichiasneathia fusobacterium comparison abund bacteria quantit pcr qpcr screen extract dna reveal compar rel abund suggest correl transcription activ sampl distinct differ compar microbiom determin rrna gene amplicon sequenc assess presenc amnii larger pool sampl sexual activ women screen qpcr bacterium associ bv ci women conclusionssignific studi highlight potenti metatranscriptom tool characteris metabol activ microbiota identifi target screen prevotella amnii chosen exampl target metabol activ speci singl patient bv detect high concentr qpcr cohort bv associ oral penilevagin sex
PLoS One	16522785	2010-11-17	PMC3785461	24086257	thi paper concern model infecti diseas spread composit spacetim domain condit uncertainti focu stochast model account basic mechan diseas distribut multisourc situ uncertainti start gener formul popul migrat dynam specif transmiss recoveri rate model studi function formul evolut fraction susceptibleinfectedrecov individu suggest approach capabl model popul dynam local integr diseas represent susceptibleinfectedrecov individu observ time seri geograph locat sourc hard soft data empir relationship secondari gener predict diseas spread associ paramet real time consid model observ uncertainti kei aspect propos approach illustr simul synthet studi realworld applic handfootmouth diseas hfmd data china
J Med Internet Res	23488712	2009-10-15	PMC3785982	23896182	background threat global pandem pose outbreak influenza hn sever acut respiratori syndrom sar diseas zoonot origin provok interest improv earli warn system reinforc combin data sourc led search queri data search engin googl yahoo indic influenza occur methodolog subsequ extend diseas led experiment type social media diseas surveil object object scope review formal assess current state knowledg search queri social media diseas surveil order inform futur work earli detect effect mitig effect foodborn ill method structur scope review method identifi character evalu publish primari expert review commentari articl social media surveil infecti diseas thirtytwo primari articl review case studi identifi relev relev citat peerreview journal articl publish report googl program surveil influenza primari articl investig social media context foodborn diseas gastroenter author articl report social mediabas surveil compar perform compar exist surveil program commonli report strength social media surveil program includ effect rapid detect diseas commonli report weak potenti fals posit fals neg author recommend social media program support exist surveil program conclus search queri social media diseas surveil phenomena report tool methodolog exploit evolv time accuraci speed cost compar favor exist surveil system primari challeng refin data signal reduc surround nois develop digit diseas surveil potenti improv sensit specif passiv advanc machin learn activ engag user adopt support system exist surveil will entail high level familiar tool collabor jurisdict
Front Microbiol	21084481	2011-05-02	PMC3787546	24098299	chronic obstruct pulmonari diseas copd character chronic airwai inflamm andor airflow limit pulmonari emphysema chronic bronchiti pulmonari emphysema bronchial asthma associ airflow limit exacerb asthma associ pathophysiolog copd studi suggest exacerb asthma virusinduc asthma associ wide varieti respiratori virus copd asthma underli pathophysiolog process requir individu therapi exacerb copd asthma basic defin diagnos clinic symptom associ rapid declin lung function increas mortal pathogen includ human rhinoviru respiratori syncyti viru influenza viru parainfluenza viru coronaviru frequent detect exacerb asthma andor copd immun respons respiratori viral infect sever exacerb diseas vari patient copd asthma regard crucial recogn understand similar differ clinic featur patient copd andor asthma associ respiratori viral infect exacerb stage relat definit epidemiolog pathophysiolog review aim summar current knowledg concern exacerb copd asthma focus clinic signific associ respiratori viru infect
PLoS One	19833723	2014-01-16	PMC3787967	24098414	molecular dock remain tool structurebas screen find ligand chemic probe dock ambit grow includ score function term address target reliabl extend orient sampl throughput method press explor sampl techniqu elimin stochast behavior dock allow optim method regularli variabl sampl orient enabl focus effort optim code effici threefold increas speed program turn facilit extens test method target ligand decoi directori decoi enhanc dude benchmark set multipl level sampl encouragingli observ sampl increas to to molecular orient bind site to to atom score target multipl conform sampl orient enrich ligand decoi monoton increas dude target includ intern electrostat evalu ligand conform energi restrict aromat hydroxyl low energi rotam improv enrich valu strategi improv effici code broadli applic field
PLoS One	21536871	2012-03-21	PMC3788738	24098563	burkholderia pseudomallei etiolog agent melioidosi saprophyt bacterium isol wet soil countri border equat burkholderia mallei hostadapt clone pseudomallei persist equin reservoir zoonosi glander endem asia africa middl east south america infect organ typic occur percutan inocul inhal aerosol common manifest sever pneumonia lead fatal bacteremia glander melioidosi difficult diagnos requir prolong antibiot therapi low success rate vaccin protect burkholderia speci concern biolog warfar agent mallei util manner experi perform establish mous model aerosol infect studi organ develop countermeasur handheld aerosol balbc mice inocul intratrach strain pseudomallei b mallei atcc growth agent lung dissemin spleen examin mice infect organ unabl control growth mallei lung bacteria rapidli dissemin spleen observ mice inocul pseudomallei cell anim infect organ control bacteri replic lung dissemin spleen extent bacteremia analysi sera mice surviv acut infect reveal anim produc antibodi antigen target immun respons human data small volum aerosol inocul mice acut diseas dosedepend chronic infect immun respons correl human infect
Evid Based Complement Alternat Med	24436283	2004-08-01	PMC3789439	24159339	the develop novel broadspectrum antivir agent hn infect urgent need studi evalu immunomodulatori activ protect eupatorium adenophorum polysaccharid eap highli pathogen hn subtyp influenza viru eap treatment increas product il tnf ifn vivo vitro measur qpcr elisa mous infect model intranas administr eap dose mgkg bodi weight prior hn viral challeng effici inhibit viral replic decreas lung lesion increas surviv rate evalu innat immun recognit eap process regul dectin mannos receptor indic eap immunomodulatori properti potenti prophylact hn influenza infect investig suggest altern strategi develop novel antiinfluenza agent benefit adenophorum product
PLoS One	22438548	2019-04-11	PMC3789674	24098509	littl biologi emerg human group betacoronaviru middl east respiratori syndrom coronaviru merscov coronaviru spike glycoprotein mediat viru entri affect viral host rang elicit neutral antibodi analyz function merscov protein high prioriti merscov lentiviru pseudovirion mediat entri varieti cell type includ embryo cell eptesicu fuscu bat surprisingli polyclon antibodi protein mhv group murin betacoronaviru crossreact immunoblot domain group merscov spike protein mer pseudovirion releas cell contain uncleav pseudoviru entri block lysosomotrop reagent nhcl bafilomycin inhibitor cathepsin mer pseudovirion uncleav protein adsorb vero cell trypsin treatment neutral ph trigger viru entri plasma membran syncytia format cell produc mer pseudotyp coexpress serin proteas tmprss larg syncytia form neutral ph pseudovirion produc noninfecti defici protein experi protein mer pseudovirion uncleav virus enter endocytosi cathepsin ldepend manner merscov cleav viru matur serin proteas pseudovirion trypsin extracellular fluid virus enter plasma membran neutral ph massiv syncytia format cell express merscov receptor merscov enter cell endosom plasma membran depend host cell type tissu determin locat host proteas cleav viral spike glycoprotein activ membran fusion
PLoS Pathog	15282381	2016-12-08	PMC3789756	24098121	virus gener cap rna lack methyl ribos sever antivir activ type interferon proteomewid affin purif coupl mass spectrometri identifi human mous protein bind cap rna methyl state analysi complement function valid experi reveal ifit sole interferoninduc protein displai higher affin unmethyl methyl cap rna ifit tether speciesspecif protein complex consist ifit rna puls stabl isotop label amino acid cell cultur coupl mass spectrometri vitro competit assai indic ifit sequest ounmethyl cap rna impair bind eukaryot translat initi factor ounmethyl rna templat inhibit translat specif ifit ounmethyl rna serv potent antivir mechan virus lack omethyltransferas activ time allow unperturb progress antivir program infect cell
PLoS Comput Biol	30973083	2009-05-01	PMC3789765	24098097	in excess imag text human cancer incid viral cofactor epidemiolog studi idiopath human cancer indic addit tumor virus remain discov advanc sequenc technolog enabl systemat screen human tumor transcriptom viral transcript technic problem low abund viral transcript larg volum sequenc data viral sequenc diverg homolog viral human factor confound identif tumor virus develop novel comput approach detect viral transcript human cancer take aforement confound factor account applic wide varieti virus tumor appli approach conduct systemat search virus neuroblastoma common cancer infanc divers clinic progress diseas epidemiolog virolog find highli suggest pathogen cofactor viral etiolog neuroblastoma current contest map imag text transcriptom neuroblastoma posit neg control human viral genom order detect unknown virus analysi control comparison method statist estim demonstr high sensit approach detail investig put viral transcript neuroblastoma sampl provid evid exist human virus likewis denovo assembl analysi chimer transcript result express signatur associ novel human pathogen confound factor sampl dilut viral clearanc progress tumor mask viral cofactor data principl render high sensit approach number biolog replic analyz frequent viral cofactor metastat neuroblastoma unlik
PLoS Comput Biol	27942586	2015-05-27	PMC3789766	24098099	intrins disord protein idp associ human diseas serv potenti drug design target drug design target idp earli stage progress drug design achiev experiment screen structur disord idp difficult character interact ligand experi better understand structur idp interact small molecul ligand perform extens simul cmyc peptid bind report small molecul inhibitor ligand conform space apo cmyc peptid dispers conform peptid stabil charg interact hydrogen bond bind ligand cmyc remain disord ligand bind cmyc site chain behav ligand cloud contrast ligand bind rigid target protein domin bound structur ligand bind idp better describ ligand cloud protein cloud bind ligand nonligand cmyc target clearli distinguish studi insight will help improv ration drug design target idp
PLoS Pathog	19190536	2014-05-13	PMC3789768	24098128	the contribut host cell transport system intercellular movement turnip mosaic viru tumv investig discrimin primari infect secondari infect associ viru intercellular movement gene cassett express gfphdel insert adjac tumv infecti cassett express kmcherri tdna border binari vector pcambia system gene cassett deliv cell singl binari vector primari infect foci emit green red fluoresc secondarili infect cell emit red fluoresc intercellular movement measur hour post infiltr estim proce averag rate cell infect three hour observ period hour determin secretori pathwai tumv intercellular movement chemic protein inhibitor block earli late secretori pathwai treatment brefeldin concanamycin express arf rabe domin neg mutant inhibit pre postgolgi transport reduc intercellular movement viru treatment inhibit viru replic primari infect cell pharmacolog interfer assai tyrphostin wortmannin endocytosi tumv intercellular movement lack coloc endocytos fm ara atrabfb tumvinduc ktag vesicl support conclus microfila depolymer drug silenc express myosin xi gene myosin viii gene inhibit tumv intercellular movement express domin neg myosin mutant confirm role plai myosin xi myosin xik tumv intercellular movement dual gene cassett express system transport inhibitor compon secretori actomyosin machineri tumv intercellular spread
Biomed Res Int	26018162	2012-04-11	PMC3791577	24163822	the dog consid main domest reservoir trypanosoma cruzi infect suitabl experiment anim model studi patholog chang cours chaga diseas cd vaccin develop cd prevent method protect peopl risk plasmid gene encod transsialidas protein tcsp amastigotespecif glycoprotein tcssp dna vaccin canin model splenomegali recombin plasmidimmun group cardiomegali absent anim immun plasmid tcssp gene inflamm subendocardi myocardi tissu prevent immun tcssp gene conclus vaccin gene partial protect enlarg splenic cardiac tissu chronic cd microscop hearth damag plasmid prevent splenomegali avoid cardiomegali lesion heart tissu dog immun plasmid tcssp gene cover subepicardi tissu
Influenza Res Treat	24825891	2006-03-07	PMC3791816	24163763	the natur influenza viru randomli mutat evolv type challeng control influenza infect monitor viru evolut better understand pandem risk pose variant evidenc highli pathogen avian influenza hpai virus clearli recogn egypt notif hpai hn outbreak continu circul viru mass vaccin programm undertaken poultri progress genet evolut antigen drift major antigen site order establish vaccin suffici provid intra interclad crossprotect lentivir pseudotyp deriv hn hpai virus avietnam achickenegypt antigen drift variant achickenegypt construct pseudotypebas neutral assai ppnt ppnt data confirm correl mn assai panel pseudotyp belong influenza group combin report system emploi test avian sera order support applic ppnt altern valid assai improv avian vaccin efficaci test vaccin viru select reliabl refer sera
PLoS Comput Biol	22496212	2013-07-17	PMC3794897	24130470	despit environment social ecolog depend emerg zoonot virus human popul clearli genet factor determin crossspeci transmiss potenti rna virus pose interest case studi mutat rate order magnitud higher pathogen reflect emerg sar influenza exampl featur select techniqu reliabl classifi viral sequenc host speci identifi crucial minor hostspecif site pathogen genom data variabl allel site translat predict probabl pathogen isol adapt host illustr power method identifi site explain sar coronaviru differ human bat palm civet sampl show cross speci jump rabi viru bat popul identifi de novo identif function influenza host discrimin marker
PLoS One	16537477	2014-10-09	PMC3794941	24130713	avian paramyxovirus apmv serotyp frequent isol domest wild bird worldwid apmv call newcastl diseas viru ndv attenu nonhuman primat develop candid human vaccin vector vector potenti serotyp unknown studi evalu biolog recombinantlyderiv apmv strain abil replic diseas rhesu macaqu model virus biologicallyderiv wild type wt apmv viru recombin version wt apmv remain three virus version wt rapmv cleavag site modifi multibas rhesu macaqu inocul intranas intratrach monitor clinic diseas viru shed upper lower respiratori tract seroconvers viru shed detect wt apmv limit shed detect wt rapmv modifi rapmv subset anim shed virus detect infect anim upper lower respiratori tract shed number dai anim observ modifi rapmv wt apmv modifi rapmv modif protein cleavag site appear increas shed wt rapmv margin wt rapmv apmv wt apmv induc virusspecif serum antibodi respons infect anim anim exhibit clinic diseas sign indic apmv compet infect nonhuman primat moderatelytohighli restrict depend serotyp suggest infect primat natur repres promis attenu candid vector develop
PLoS Pathog	23864614	2008-02-27	PMC3795028	24130483	the larg tegument protein herpesvirus ntermin cystein proteas potent ubiquitin neddspecif deconjugas activ function enzym viru replic remain unknown model bplf homologu encod epsteinbarr viru ebv induct product viru cycl affect total level ubiquitinconjug accompani bplfdepend decreas neddadduct accumul free nedd express bplf promot cullin degrad stabil cullinr ligas crl substrat nucleu cytoplasm crl substrat inactiv nuclear crl revers nterminu cand inhibit bind bplf cullin prevent effici viral dna replic target deneddylas activ nucleu depend process catalyt nterminu caspas inhibit caspas sever impair viral dna synthesi releas infecti viru point unrecogn role cellular respons danger signal trigger ebv reactiv promot viru replic
Genome Announc	25085348	2016-10-19	PMC3795213	24115543	infecti bronchiti viru ibv tremend econom loss poultri industri report complet genom analysi natur recombin nephropathogen ibv strain name saibk isol sichuan provinc china 
PLoS One	18305043	2010-10-06	PMC3795663	24146973	introduct health author find threshold gaug start sever influenza season explor method deriv threshold propos influenza surveil manual publish health organ method analys routin influenzalikeil ili dataset gener practic sentinel surveil locum medic servic sentinel surveil laboratori data hospit admiss influenza sentinel dataset creat composit variabl product weekli ili data relev laboratori data indic proport test specimen posit dataset includ composit dataset align data median week peak influenza ili activ assign three threshold level season threshold determin inspect intens threshold term averag alert threshold determin calcul median confid interv ci percentil threshold compar season onset intens dataset correl dataset assess correl coeffici median week peak activ week dataset hospit data week median compar upper ci percentil comparison threshold reveal variat defin start season good agreement describ intens influenza season hospit admiss data pandem year composit variabl improv agreement ili dataset dataset correl correl coeffici rang combin conclus threshold influenza surveil easili deriv histor surveil laboratori data approach propos composit variabl help describ influenza season characterist
PLoS One	27795420	2001-03-01	PMC3795679	24146739	mount effect innat adapt immun respons critic viral clearanc gener long last immun product inhibitori factor result inabl host clear virus chronic viral persist fibrinogenlik protein fgl identifi novel effector molecul cdcd foxp regulatori treg cell inhibit immun activ bind fcriib express antigen present cell apc studi infect mice lymphocyt choriomening viru lcmv lead increas plasma level fgl detect earli dai postinfect pi persist dai pi mice defici fgl fgl increas viral titer lcmv liver earli pi clear viru dai wild type mice dendrit cell dc isol spleen lcmv infect fgl increas express dc matur marker cd mhc class ii compar wild type fgl frequenc cd cd cell produc ifn respons vivo peptid restimul isol spleen lymph node increas lcmv infect fgl mice increas frequenc cd cell specif lcmv tetram gp np detect liver fgl mice plasma fgl mice contain higher titer total neutral antilcmv antibodi enhanc antivir immun fgl mice associ increas level serum alanin transaminas alt hepat necrosi inflamm lcmv infect data demonstr target fgl lead earli increas viral replic enhanc antivir adapt cell respons target fgl enhanc efficaci current antivir therapi hepatotrop virus
PLoS One	20926566	2004-07-27	PMC3795695	24147000	the cellular entri virus repres critic area studi viral tropism viral entri dictat natur immun respons elicit infect epidem keratoconjunct ekc caus virus human adenoviru speci hadvd sever ocular surfac infect associ corneal inflamm clathrinmedi endocytosi plai critic role entri hadv speci host cell type hadvd endocytosi corneal cell extens studi essenti role cholesterol rich lipid raft microdomain caveolin entri hadvd primari human corneal fibroblast cholesterol deplet methylcyclodextrin mcd profoundli reduc viral infect replenish solubl cholesterol mcd revers allow product viral infect hadvd dna identifi caveolin rich endosom fraction infect src kinas activ increas caveolin rich endosom fraction infect src phosphoryl cxcl induct decreas caveolin mice cornea compar wild type mice sirna knock caveolin corneal cell reduc chemokin induct viral infect caveolin mous cornea reduc cellular entri hadvd control hadvc noncorn pathogen appear util caveolar pathwai entri cell fail infect corneal cell entir indic viru cell specif tropism immunoelectron microscopi confirm presenc caveolin hadvdcontain vesicl earliest stage viral entri collect experi indic time hadvd lipid raft mediat caveolin associ pathwai entri corneal cell connect process viral entri downstream proinflammatori cell signal
J Epidemiol	11160724	2016-05-02	PMC3798579	22123226	background fever common symptom children caus respiratori infect japanes health author long recommend gargl prevent respiratori infect effect children clear method children observ studi enrol nurseri school fukuoka citi japan children exposur group instruct gargl dai endpoint studi incid fever daytim incid sick absenc differ gargl agent endpoint analyz total children ag year observ dai persondai multivari logist regress odd ratio fever onset gargl group lower agestratifi analysi or lower ag or year sick absenc gargl group agestratifi analysi or lower ag or year subgroup analysi lower or fever onset observ children gargl green tea function water or tap water or sick absenc conclus gargl effect prevent febril diseas children
Front Immunol	15280469	2016-03-09	PMC3798782	24151492	the regulatori cell treg balanc effector arm immun system document plai central role prevent autoimmun facilit graft toler organ transplant detriment impact develop antitumor immun regulatori respons varieti mechan mediat suppress includ solubl factor il tgf commonli studi immunosuppress cytokin identifi il potent suppress function vitro vivo il abil directli suppress effector cell respons expand regulatori respons propag infecti toler gener potent popul ilexpress induc treg review summar character structur function il examin role diseas discuss contribut induct distinct popul induc treg
Viruses	27108716	2015-07-08	PMC3798903	24061543	natur killer nk cell gammadelta cell innat lymphocyt respond rapidli nonspecif viral infect pathogen form uniqu link innat adapt immun immun featur effector function accumul evid mice human cell type distinct role control infect west nile viru wnv reemerg pathogen caus fatal enceph north america decad review will discuss studi cell type protect immun viral pathogenesi wnv infect
ScientificWorldJournal	26962217	2011-06-01	PMC3800580	24223508	two type canin adenoviru cav canin adenoviru type cav viru infecti canin hepat canin adenoviru type cav canin infecti laryngotrach dog studi blood sampl dog admit intern medicin clinic selcuk univers faculti veterinari medicin clinic symptom seventyseven dog sampl isparta burdur dog shelter random sampl clinic find dog system diseas character fever diarrhea vomit oculonas discharg conjunct sever moist cough sign pulmonari diseas dehydr dog corneal opac photophobia serolog studi serum sampl investig presenc cav antibodi elisa total blood sampl detect posit cav antibodi elisa blood sampl neg blood leukocyt sampl dog process inocul confluent monolay mdck cell standard virolog techniqu third passag cell examin direct immunoflouresc test viru isol posit result detect conclus studi clearli demonstr high preval cav infect dog
PLoS One	26157117	2015-03-01	PMC3804596	24204675	in studi establish biped anim model steroidassoci hip joint collaps emu test potenti treatment protocol develop prevent steroidassoci joint collaps preclin set adult male emu treat steroidassoci osteonecrosi saon induct protocol combin puls lipopolysaccharid lp methylprednisolon mp addit three emu normal control postinduct emu gait observ magnet reson imag mri perform blood collect routin examin includ test blood coagul lipid metabol emu sacrif week postinduct bilater femora collect microcomput tomographi microct histolog analysi asymmetr limp gait abnorm mri signal steroidtr emu saon emu joint collaps incid percentag neutrophil neut paramet lipid metabol increas induct microct reveal structur deterior subchondr trabecular bone histomorphometri larger fat cell fraction size thin subchondr plate cartilag layer smaller osteoblast perimet percentag blood vessel distribut collaps region saon group compar normal control scan electron microscop sem poor miner matrix osteolacuna outlin collaps region saon group combin puls lp mp develop current studi safe effect induc saon deterior subchondr bone biped emu subsequ femor head collaps typic clinic featur observ patient puls steroid treatment conclus biped emu effect preclin experiment model evalu potenti treatment protocol develop prevent oninduc hip joint collaps patient
PLoS One	21632890	2019-04-11	PMC3806803	24194835	the outbreak hn influenza china high concern public health hemagglutinin ha plai critic role influenza entri ha present attract target antivir previou studi suggest small molecul tertbutyl hydroquinon tbhq inhibit entri influenza ha bind stem loop ha stabil neutral ph conform ha disrupt membran fusion step base amino acid sequenc structur immunogen group ha work pseudoviru entri assai tbhq inhibit hamedi entri hamedi entri ic nmr tbhq bind stem loop region std nmr experi indic aromat ring tbhq extens contact ha surfac limit proteolysi experi indic tbhq inhibit influenza entri stabil ha neutral ph conform work suggest stem loop region ha attract target therapeut intervent tbhq food preserv promis lead compound
J Clin Med Res	25254322	2019-05-21	PMC3808260	24171054	background bronchiol major hospitalis young children winter season respiratori syncyti viru rsv main caus viru apart standard hygien measur cohort rsvinfect patient separ rsvneg patient frequent appli prevent crossinfect evid support practic lack object evalu risk room share rsvposit rsvneg patient method perform prospect observ cohort studi children year hospitalis acut bronchiol dai admiss patient share room pend virolog diagnosi pcr diagnost rsvposit rsvneg patient separ standard hygien measur gown glove mask hand wash patient includ patient rsvposit coinfect patient admiss hospitalis patient acquir coinfect nurs singl room entir admiss patient share room bronchiol patient patient viru coinfect admiss diseas sever coinfect wors monoinfect conclus patient bronchiol coinfect coinfect acquir admiss rare associ sever diseas room share rsvposit rsvneg patient dai admiss influenc risk coinfect suggest cohort rsvinfect patient separ nonrsvinfect patient indic
PLoS One	30973078	2014-06-01	PMC3808413	24204783	in effort circumv resist rapamycin mtor inhibitor search novel rapamycindownstreamtarget kei player respons cancer cell therapi rapamycin nm concentr increas phosphoryl eukaryot initi factor eif rapamycinsensit estrogendepend mcf cell minim eif phosphoryl rapamycininsensit tripleneg mdamb cell addit salubrin inhibitor eif dephosphoryl decreas express surfac marker associ capac renew increas senesc induc clonogen cell death suggest excess phosphoryl eif detriment cell surviv treat cell salubrin enhanc radiationinduc increas eif phosphoryl clonogen death irradi cell sensit increas eif phosphoryl nonirradi salubrin phosphomimet eif variant sd increas sensit radiat abrog radiationinduc increas breast cancer type suscept gene implic enhanc phosphoryl eif modul dna repair salubrin inhibit nonhomolog join homolog recombin repair doubl strand break induc iscei green fluoresc protein report plasmid addit radiat salubrin enhanc eif phosphoryl clonogen death respons histon deacetylas inhibitor vorinostat final catalyt competit inhibitor mtor ku increas phosphoryl eif demonstr involv mtor activ modul eif phosphoryl experi excess phosphoryl eif decreas surviv cancer cell make eif worthi target drug develop potenti enhanc cytotox effect establish antineoplast therapi circumv resist rapalogu drug inhibit upstream compon mtor pathwai
Mediators Inflamm	31113887	2010-11-01	PMC3808714	24223476	sever sepsi septic shock primari death patient intens care unit icu investig genet suscept profil system complic sever infect field increas scientif interest adapt immun system compromis immatur innat immun plai kei role defens invas pathogen mannosebind lectin mbl serum protein recogn wide rang pathogen microorgan activ complement cascad antibodyindepend pathwai human harbor mutat mbl gene mbl reduc plasmat level activ increas risk infect acquisit document mbldefici patient real impact form innat immunosuppress clinic outcom clear critic patient higher incid wors prognosi sever sepsissept shock appear associ lowproduc haplotyp excess mbl activ harm possibl unbalanc proinflammatori respons addit host injuri strategi replac therapi critic patient sever infect investig appli clinic practic
PLoS One	29473568	2015-06-24	PMC3812135	24205026	background attent paid compar set genom sequenc cross genet compon biolog categori diverg larg size rang defin systemat compar genom aim develop methodolog creat method genomefingerprint unambigu produc set threedimension coordin sequenc threedimension plot twodimension trajectori project illustr genom fingerprint genom sequenc second develop set concept tool establish method call univers genom fingerprint analysi ugfa defin total genet compon configur tgcc includ chromosom plasmid phage describ strain systemat unit univers genom fingerprint map ugfm tgcc differenti strain univers system systemat compar genom scg compar set genom cross genet compon biolog categori third construct method quantit analysi compar genom outcom dataset genom fingerprint analysi defin geometr center geometr genom fingerprint map euclidean distanc differenti rate weight differenti rate quantit describ differ genom comparison demonstr applic case studi genom sequenc tremend insight critic issu microbi genom taxonomi conclus creat method genomefingerprint rapidli comput geometr visual intuit compar set genom genom fingerprint level establish method call univers genom fingerprint analysi develop method quantit analysi outcom dataset set methodolog systemat compar genom base genom fingerprint analysi
mBio	20805752	2009-03-18	PMC3812713	24149513	replic positivesens rna virus associ rearrang cellular membran previou work infect tissu cultur cell line betacoronavirus mous hepat viru sever acut respiratori syndrom coronaviru sarscov gener doublemembran vesicl dmv convolut membran reticular membran network describ detail studi membran rearrang induc avian gammacoronaviru infecti bronchiti viru ibv mammalian cell primari avian cell epitheli cell vivo tracheal organ cultur cell type structur novel ibv infect identifi term zipper endoplasm reticulum er spherul zipper er lack lumin space suggest zipper er cisterna spherul appear uniform invagin zipper er electron tomographi ibvinduc spherul tether zipper er channel connect interior spherul cytoplasm featur thought site rna synthesi membran rearrang induc coronavirus identifi dmv ibvinfect cell observ singl individu dmv connect er outer membran zipper er interestingli ibvinduc spherul resembl confirm site rna synthesi alphavirus nodavirus bromovirus indic strategi ibv divers virus assembl rna replic complex positivesens singlestrand rna virus induc rearrang cellular membran provid platform viral replic complex assembl protect viral rna cellular defens studi membran rearrang induc poultri pathogen gammacoronaviru infecti bronchiti viru ibv previou work studi close betacoronavirus identifi doublemembran vesicl dmv convolut membran cm deriv endoplasm reticulum er infect cell role dmv cm viral rna synthesi remain unclear seal vesicl lack deliv viral rna cytoplasm character structur novel ibv infect zipper er small vesicl tether zipper er term spherul spherul channel connect interior cytoplasm resembl confirm site rna synthesi positivesens rna virus make ideal candid site ibv rna synthesi
PLoS One	26109732	2015-06-16	PMC3813428	24205120	therapeut human polyclon antibodi hpab deriv pool plasma human donor food drug administr approv biolog treatment varieti human diseas power natur divers immun respons hpab effect treat diseas caus complex quicklyevolv antigen virus transchromosom tc cattl carri human artifici chromosom hac compris entir unrearrang human immunoglobulin heavychain high kappachain higk germlin loci name hac capabl produc function hpab bovin immunoglobulin mu heavychain bighm bighml homozyg inactiv doubl knockout dko lymphocyt develop tc cattl compromis product hpab low report construct improv hac design ckslhac incorpor human immunoglobulin germlin loci hac avoid humanbovin interspeci incompat human immunoglobulin mu chain protein higm bovin transmembran immunoglobulin big big preb cell receptor prebcr complex partial replac bovin higm constant domain counterpart bovin igm bigm involv interact bigm bigig human igm bovin improv function higm support cell activ prolifer report success product dko tc cattl carri ckslhac ckslhacdko dramat improv cell develop cattl high level product hpab measur human igg isotyp plasma demonstr immun tumor immunogen high titer tumor immunogenspecif human igg higg produc tc cattl
PLoS Pathog	19297321	2014-10-16	PMC3814336	24204261	the innat immun respons virus initi special cellular sensor recogn viral danger signal truncat form viral genom accumul infect cell potent trigger sustain activ transcript factor irf nfb product type ifn mechan independ ifn signal demonstr defect viral genom dvg gener natur respiratori infect vivo mice lack type ifn receptor appear coincid product cytokin infect sendai viru sev influenza viru remark hallmark antivir cytokin ifn express lung epitheli cell dvg cell lung standard viral genom express cytokin data indic dvg gener viral replic primari sourc danger signal initi host immun respons infect
PLoS Negl Trop Dis	26082488	2011-04-06	PMC3814572	24205414	chikungunya viru chikv mosquitoborn arthrogen alphaviru acut febril ill human accompani joint pain case persist arthralgia last week year reemerg chikv numer outbreak eastern hemispher threaten expand forese futur effect treatment current studi report resazurin cellbas highthroughput assai imagebas highcont assai identifi character inhibitor chikvinfect vitro chikv highli cytopath viru rapidli kill infect cell cell viabil huh cell infect chikv presenc compound determin measur metabol reduct resazurin identifi inhibitor chikvassoci cell death kinas inhibitor librari compound screen chikv infect huh cell resazurin reduct assai cell toxic measur noninfect cell seventytwo compound show inhibit properti chikv select primari hit compound benzofuran core scaffold cnd cnd cnd cnd pyrrolopyridin cnd thiazolcarboxamid cnd inhibit chikvassoci cell death dosedepend manner ec valu m base imag analysi hit compound inhibit chikv replic host cell chikvinfect cell manifest promin apoptot bleb typic chikv cytopath compar control infect treatment compound reduc viral titer medium chikvinfect cell fold conclus cellbas highthroughput screen assai resazurin combin imagebas high content assai approach identifi compound chikv novel antivir activ inhibit virusinduc cpe target kinas involv apoptosi
Viruses	25244186	2009-03-01	PMC3814591	24072061	west nile viru genu flaviviru transmit bird occasion anim ornithophil mosquito viru infect human caus asymptomat infect case clinic case progress sever neuroinvas diseas viru present threat infect remain unappar viru contain blood organ asymptomat infect donor transmit recipi infecti tissu paper review present method achiev laboratori diagnosi west nile viru infect human discuss promin advantag disadvantag light extern qualiti assess studi carri european network import viral diseas enivd
Viruses	21471243	2008-09-08	PMC3814593	24084234	twentyseven field sampl posit pedv detect collect farm fujian provinc heterogen investig analysi orf gene potenti function represent virul fujian strain group genotyp uniqu point mutat differenti pedv group brought potenti antigen variat refer strain group long length delet show genotyp involv variat virul phylogenet analysi reveal collect fujian strain distant vaccin develop strain cv reason vaccin ineffici control diseas help reconsid strategi pedv vaccin manag prevent outbreak pedvinduc diarrhea effici
Viruses	19255137	2008-05-01	PMC3814607	24153062	sinc late porcin epidem diarrhea viru pedv rapidli dissemin china caus consider morbid high mortal neonat piglet pig farm provinc exclud tibet hainan china sampl posit pedv confirm revers transcriptionpolymeras chain reaction rtpcr fulllength gene repres field strain sequenc field strain share homolog nucleotid sequenc level homolog amino acid sequenc level field strain nucleotid delet insert region lower homolog chines classic strain ch higher homolog strain chgd phylogenet analysi classic strain variant prevail pig herd china pedv high detect rate pig herd china sequenc analysi indic gene field strain heterogen variant predomin
Ir Vet J	18369195	2010-10-29	PMC3816157	24153100	felin chronic gingivostomat syndrom fcg common diseas clinic practic therapeut option longact corticosteroid frequent antiinflammatori immunosuppress properti improv clinic symptom lead progress form diseas refractori treatment direct relationship type ii diabet mellitu dm consequ drug controversi recommend routin manag fcg recombin felin interferonomega rfeifn immunomodulatori compound daili oral administr success treat refractori case fcg case studi describ clinic case type ii dm complic fcg anim caliciviru posit treat longact corticosteroid major dm cat treat glargin insulin lantu start dose iucat daili bid achiev remiss week consid difficulti control fcg anim oral daili dose rfeifn start altern longact corticosteroid cat oral clinic sign gradual improv dai start therapi owner report relief pain mastic author knowledg case report describ success rfeifn manag fcg type ii diabet cat longact corticosteroid contraind
Emerg Health Threats J	30673536	2004-01-01	PMC3816197	24183326	background emerg infecti diseas outbreak environment disast occur collect epidemiolog data start event onset questionnair built de novo event delai epidemiolog respons detriment understand control event consid public health andor academ institut databas construct respons questionnair difficult merg impair collabor aim ecommerc concept softwar tool adapt enabl rapid collect data infecti diseas outbreak environment disast custom epidemiologist fill shop basket standardis question method epidemiolog field catalogu question constitut identifi relev variabl base review publish literatur circumst question tag sourc paper epidemiologist tailor questionnair choos appropri question catalogu softwar readytous form onlin questionnair databas constitut epibasket user interoper correspond questionnair deriv corpu question proofofconcept prototyp develop knowledg attitud practic kap survei field epidemiolog investig frequent explor outbreak environment disast catalogu question initi review kap studi conduct sever acut respiratori syndrom epidem conclus rapid collect standardis data outbreak environment disast facilit transpos ecommerc paradigm epidemiolog advantag power softwar tool avail
Pharmaceuticals (Basel)	21039991	2000-08-01	PMC3816685	24275949	rna interfer rnai rapidli method analyz gene function eukaryot hold promis develop therapeut gene silenc induct rnai reli small silenc rna affect specif messeng rna mrna degrad type small rna molecul small interf rna sirna microrna mirna central rnai drug discoveri studi novel treatment sirna current target wide rang diseas includ viral infect cancer lung diseas gener attract target sirna therapeut lethal preval addit lung anatom access therapeut agent intrapulmonari rout increas evid indic mirna plai role lung abnorm inflamm oncogenesi mirna target therapeut purpos review strategi rnai deliveri discuss current stateoftheart rnaibas therapeut lung diseas
PLoS One	15162543	2004-07-29	PMC3817128	24223971	glucosephosph dehydrogenas gpd kei enzym pentos phosphat pathwai reduc energi cell maintain redox balanc common clinic manifest patient gpd defici neonat jaundic acut hemolyt anemia effect microbi infect patient gpd defici relat hemolyt anemia caus plasmodium viral infect subsequ medic requir interest studi impact bacteri infect gpddefici cell gpd knock lung carcinoma cell common pathogen staphylococcu aureu emploi cell infect model demonstr lower cell viabil observ gpddefici cell compar scrambl control bacteri infect mtt assai increas intracellular ro detect aureusinfect gpddefici cell observ dichlorofluorescein dcf intens cell fluoresc microscop quantifi signal flow cytometri impair ro remov predict enhanc apoptot activ gpddefici cell enhanc apoptosi observ annexin vpi stain confoc fluoresc microscop quantifi flow cytometri higher express level intrins apoptot initi caspas downstream effector caspas detect western blot analysi gpddefici cell bacteri infect conclus propos bacteri infect secret aureu hemolysin case promot accumul intracellular ro gpddefici cell trigger stronger apoptot activ intrins pathwai reduc cell viabil compar wild type cell
PLoS One	10906106	2014-09-01	PMC3817278	24223808	discoveri virus boost novel deep sequenc technolog current virus identifi sequenc knowledg pathogen viru attribut presenc viru patient materi diseas patient challeng approach meet challeng identif viral sequenc base enrich autolog patient antibodi captur method facilit identif virus provok immun respons patient increas sensit current viru discoveri techniqu demonstr util method viru discoveri deep sequenc vidisca perform clinic sampl patient respiratori viral infect gastrointestin viral infect patient sera collect month acut infect phase input antibodi captur materi sequenc enrich assess patient viral read immunogen virus enrich antibodi captur rang x respiratori materi x stool enrich read determin ident independ manner novel algorithm xcompar patient enrich read deriv infect virus conclus techniqu novel approach identifi immunogen viral sequenc bulk sequenc encount viru discoveri metagenom
J Drug Deliv	15306396	2012-03-26	PMC3817681	24228179	dendrit cell dc highli special antigen present cell immun system plai kei role regul immun respons depend method antigen deliveri dc stimul immun respons induc toler consequ dual function dc dc studi context immunotherapi cancer autoimmun diseas vaccin develop major aim induc strong specif tcell respons achiev target antigen cell surfac molecul dc effici channel antigen endocyt compart load mhc molecul stimul tcell respons attract cell surfac receptor express dc target antigen deliveri cancer diseas discuss
PLoS One	24326537	2013-05-20	PMC3818432	24223923	the intern ribosom entri site ir function capindepend translat initi site eukaryot cell ir element appli tool bicistron express vector current rna structur predict program unabl predict precis potenti ir element design viral ir predict system vip perform ir secondari structur predict order better ir predict vip evalu predict group iress higher accuraci rna secondari structur predict comparison pseudoknot predict program implement form threestag procedur vip backbon vip includ rnal fold program aim predict local rna secondari structur minimum free energi method rna align program intend compar predict structur pknotsrg program calcul pseudoknot structur vip evalu utr databas ir databas viru databas accuraci rate vip assess ir group advanc search approach ir structur will facilit ir studi vip onlin websit servic httpvip
PLoS One	22473375	2005-05-23	PMC3819354	24223117	immunochromatographi ic antigendetect assai plai role rapid diagnosi influenza viru protocol short time easi despit usabl ic sensit pfu reaction addit antigenantibodi interactionbas method detect influenza virus major antigen chang studi establish fluoresc immunochromatographi flic detect broad spectrum subtyp influenza virus method improv sensit fold higher tradit ic fluoresc conjug bead type flic kit detect subtyp influenza virus examin recombin hemagglutinin ha protein rha belong eurasian subtyp virus typen diagnos north american subtyp influenza virus kit improv potenti detect subtyp influenza virus clade type typen flic kit compar pcrbase diagnosi flic strong advantag usabl sampl prepar requir flic mixanddrop addit step rna extract provid strategi spread transmiss hpai hn virus bird mammal includ human
Scientifica (Cairo)	24015364	2014-10-01	PMC3820304	24278777	over decad increas evid patient chronic airwai diseas viral infect common exacerb review will examin evid viralinduc exacerb asthma chronic obstruct lung diseas potenti mechan virus exacerb attent will focus rhinoviru common respiratori exacerb exacerb rhinoviru infect cell airwai cytotox virus influenza respiratori syncyti viru understood innat immun respons plai role rhinovirusinduc exacerb precis role adapt maladapt debat current treatment strategi partial effect examin cellular molecular mechan underli viralinduc exacerb chronic airwai diseas warrant
Scientifica (Cairo)	15911778	2009-08-19	PMC3820481	24278752	thi paper review futur public health surveillanceth ongo systemat collect analysi interpret dissemin health data plan implement evalu public health action public health surveil date record epidem bc egypt hippocr bc bc coin term endem epidem john graunt introduc systemat data analysi samuel pepi start epidem field investig william farr found modern concept surveil john snow link data intervent alexand langmuir comprehens definit surveil current theori principl practic public health surveil summar number surveil dichotomi epidemiolog surveil versu public health surveil describ futur scenario present current activ affect futur summar explor frontier enhanc comput technolog improv epidem investig improv data collect analysi dissemin build lesson build capac enhanc global surveil conclud learn reflect plan futur enhanc public health surveil
Exp Ther Med	19692475	2013-12-01	PMC3820766	24223640	the aim studi analyz chang serum protein level progress hepat isobar tag rel absolut quantit itraq analysi addit compar serum protein level patient chronic hepat chb patient hepat virusinduc acuteonchron liver failur hbvinduc aclf normal individu protein analysi perform serum sampl itraq studi popul includ healthi control patient chb patient hbvinduc aclf western blot verifi addit serum sampl healthi control patient chb patient hbvinduc aclf itraq analysi serum protein fold differ express level identifi patient chb aclf compar healthi control protein creactiv protein precursor hemoglobin chain variant hb swake apolipoprotein precursor platelet factor precursor vitronectin demonstr greatest differ express level correl liver diseas subsequ verifi western blot western blot consist the itraq protein classifi biolog process biolog function protein hbvinduc aclf remain unclear preliminari studi demonstr correl express serum protein pathogenet condit induc hbv exist analysi larger number sampl requir identifi potenti protein biomark involv pathogenesi progress hepat b
PLoS One	22095332	2015-11-11	PMC3823765	24244327	yu ping feng san ypf chines herbal decoct compos astragali radix ar huangqi atractylodi macrocephala rhizoma amr baizhu saposhnikovia radix sr fangfeng weight ratio clinic ypf regul immun function action mechan address issu provid detail analys chemic biolog properti ypf rapid resolut liquid chromatographi coupl mass spectrometri fifteen chemic deriv herb ypf determin serv control standard herbal extract ypf gener amount chosen chemic marker higher prepar ypf compar singl herb twoherb composit order reveal immun function ypf standard extract appli cultur murin macrophag treatment ypf stimul mrna protein express proinflammatori cytokin activ nfb enhanc ib degrad contrast applic ypf suppress express proinflammatori cytokin lipopolysaccharid lpsinduc chronic inflamm model addit ypf regul phagocyt activ cultur macrophag support bidirect immunemodulatori role ypf regul releas cytokin macrophag
Evid Based Complement Alternat Med	24062532	2013-10-02	PMC3824639	24282436	pathogenesi sepsi includ complex interact pathogen activ host respons manifest highli variabl sign symptom delai diagnosi time lifesav intervent studi appli tradit chines medicin tcm zheng diagnosi patient sever sepsi septic shock evalu adapt earli predictor sepsi mortal threeyear prospect observ studi enrol septic patient tcm zheng diagnosi acut physiolog chronic health evalu apach ii score blood sampl host respons cytokin measur tumor necrosi factor interleukin interleukin interleukin interleukin collect hour admiss intens care unit main outcom dai mortal multivari logist regress analysi serv determin predict variabl sepsi mortal apach ii score frequenc nutrientphas heat qixu yangxu zheng higher nonsurvivor multivari logist regress analysi identifi yangxu zheng outcom predictor apach ii score level host respons cytokin patient yangxu zheng reveal differ cool extrem weak puls diagnost sign yangxu zheng proven independ predictor sepsi mortal tcm diagnosi yangxu zheng provid mortal predictor septic patient
Biomed Res Int	26798560	2016-10-01	PMC3825218	24282812	manganes mn essenti normal physiolog function defici excess intak manganes result diseas human prolong exposur manganes neurotox character parkinsonlik symptom mn mediat dna damag gener reactiv oxygen speci public mn induc oxid dna damag caus lesion thymin studi investig mechan cell process mnmediat dna damag yeast cerevisia strain sensit mn defect base excis repair glutathion synthesi superoxid dismutas mutant mn caus dosedepend increas accumul mutat lysa mutat assai spectrum mutant indic exposur mn accumul base substitut frameshift mutat sensit cell mn mutagen reduc nacetylcystein glutathion data mn oxid dna damag requir base excis repair process mn interfer polymeras fidel statu base excis repair provid biomark sensit individu manganes
Virol J	24089566	2013-04-01	PMC3826533	24209904	background revers genet gener recombin lowpathogen lasota strain newcastl diseas viru ndv express glycoprotein gp ebola viru ebov design rlaebovgp evalu biolog characterist vivo vitro introduct express ebov gp gene increas virul ndv vector poultri mice ebov gp incorpor particl vector viru recombin viru rlaebovgp infect cell spread independ exogen trypsin rlaebovgp resist ndv antiserum vector ndv moder sensit ebov gp antiserum importantli infect rlaebovgp markedli inhibit ipa indic rlaebovgp macropinocytosi major intern pathwai cell entri conclus demonstr ebov gp recombin ndv particl function independ mediat viral infect host cell alter cellentri pathwai
PLoS One	27867585	2001-07-15	PMC3827361	24236137	as core mission public health agenc attend wide rang diseas health threat includ requir routin acut emerg respons incid uniqu number type respons activ finit compar analysi learn common respons pattern improv predict expect resourc capabl requir respond futur acut event studi interview repres local health depart experi realworld acut public health incid infecti diseas outbreak sever weather event chemic spill bioterror threat collect highli structur data kei aspect incid public health respons focus public health activ initi commun partner engag respons effort result comparison event type creat respons profil identifi function structur respons pattern import futur public health prepared respons studi contribut clarifi complex public health respons system analysi reveal wai system adapt charact threat differenti activ function partner base type incid continu rigor examin experi health depart nation will refin understand public health respons system will enabl identif organiz event input perform will allow construct rich relev practic model respons oper emploi strengthen public health system
PLoS One	23355384	2016-10-01	PMC3827460	24236203	background sever fever thrombocytopenia syndrom viru sftsv identifi novel member genu phleboviru bunyavirida famili china detail clinic featur case sftsv infect describ risk factor sever patient fatal sever patient remain determin methodologyprincip find clinic laboratori featur hospit patient sftsv infect period june decemb northeast china retrospect review assess risk factor associ sever confirm case fatal sever case multivari analysi three patient present multipl organ dysfunct proceed stage life threaten multipl organ failur patient fatal report multivari analysi demonstr independ predictor risk sever albumin gl ci aptt second ci sodium mmoll ci presenc neurolog manifest ci patient sever diseas presenc acut lung injuryacut respiratori distress syndrom hr ci dissemin intravascular coagul hr ci independ associ fatal conclusionssignific sftsv infect sever symptom laboratori abnorm hitherto report infect novel bunyaviru patient suffer multipl organ dysfunct die multipl organ failur clinic assess case sft independ factor relat prognosi account clinician
Virol J	11413334	2017-03-22	PMC3829811	24209771	background felin infecti periton fip lethal system diseas caus fip viru fipv virul mutant felin enter coronaviru fecv current virus virul determin host gene express fipv infect fulli understood method rna sequenc crandel ree felin kidnei crfk cell infect fipv strain hour post infect hpi sequenc illumina gener sequenc approach bioinformat analysi base feli catu annot shotgun refer genom clc bio genom workbench map control infect cell read gene annot gene kal test statist analysi analys differenti express gene infect crfk cell real time rtqpcr develop transcript profil three gene pd pdl infect crfk cell peripher blood mononuclear cell pbmc healthi fipdiseas cat base kal ztest fals discoveri rate fdr fold chang gene express total gene differenti express sampl gene upregul remaind downregul gene close cluster suggest homogen express major gene regul associ monocytesmacrophag cell function regul apoptosi real time rtqpcr develop focus upregul gene pdl apoptosi associ gene pd express fipv infect crfk cell pbmc healthi fip diagnos cat produc concord transcriptom data conclus role gene felin coronavirus infect discuss
Adv Virol	27472408	2003-10-01	PMC3830837	24288532	the nucleocapsid protein chandipura viru chpv plai crucial role viral life cycl structur compon virion proper organ interact viral protein studi author map associ chpv protein protein interact viral protein phosphoprotein matrix protein glycoprotein studi aim distinguish region chpv protein respons interact viral protein direct gener structur chpv protein homolog model swissmodel workspac accelri discoveri studio client map domain protein pisqrd interact protein fragment protein determin zdock rigidbodi dock method valid yeast twohybrid elisa studi reveal uniqu bind site compris amino acid terminu nucleocapsid protein instrument interact protein observ associ protein interact protein
Front Immunol	28331091	2005-01-13	PMC3831162	24302927	tolllik receptor tlr pattern recognit receptor plai fundament role sens microbi invas initi innat adapt immun respons tlr trigger danger signal releas injur stress cell sepsi focu studi develop tlr agonist antagonist treatment infecti diseas sepsi posit cell surfac tlr essenti sens lipopolysaccharid gramneg bacteria tlr involv recognit larg panel microbi ligand tlr recogn flagellin endosom tlr tlr tlr tlr special sens nucleic acid produc notabl viral infect tlr tlr favorit target develop antisepsi drug antagonist compound effici protect septic shock preclin model clinic trial evalu antitlr antitlr approach present discuss challeng studi design sepsi futur exploit agent infecti diseas report studi suggest tlr agonist flagellin protect infect gastrointestin tract agonist endosom tlr promis treat chronic viral infect altogeth tlrtarget therapi strong potenti prevent intervent infecti diseas notabl sepsi
BMC Vet Res	14573569	2015-01-01	PMC3831758	24206786	background airwai progenitor involv embryogenesi lung repair character popul enabl develop therapeut treat acut chronic lung diseas studi aim establish presenc bronchioloalveolar progenitor ovin lung character potenti differenti special cell lung cell studi immunohistochemistri frozen section lung immunocytochemistri flow cytometri conduct exvivo deriv pulmonari cell bronchioloalveolar progenitor identifi coexpress ccsp spc cd minor popul cdposspcposccsppo cell vivo cell suspens dissoci lung cd magnet positivecel sort undifferenti spcposccsppo cell purifi maintain cultur synthet media extracellular matric spcposccsppo cell differenti club cell name clara cell alveolar epitheli typeii cell vivo vitro deriv bronchioloalveolar progenitor express nanog oct bmi describ progenitor stem cell lung develop conclus report time larg anim exist bronchioloalveolar progenitor dual differenti potenti express special gene newli describ cell popul sheep implic regener lung lesion develop diseas cancer
Iran J Pharm Res	15650225	2012-12-10	PMC3832146	24250485	licoric oldest chines tradit medicin treatment human diseas defici wild resourc select breed kei issu expand suppli licoric spaceflight technolog will method medicin plant aim studi investig spaceflight compon antiinflammatori activ licoric flow recover satellit dai licoric seed germin grown matur parallel groundbas seed plant condit main compon licoric root analyz hplc content compon spaceflight group higher ground control three acut inflammatori model includ xyleneinduc auricular edema carrageenaninduc paw edema acet acidinduc vascular permeabl util compar antiinflammatori activ licoric pre post spaceflight licoric extract antiinflamm activ spaceflight pharmacolog activ licoric higher ground control model gain tendenc spaceflight group speci hangjinqi strongest activ group provid scientif data breed medicin plant spaceflight indic technolog space flight effect method breed cultiv licoric
PLoS One	25354202	2016-06-01	PMC3832446	24260525	ubiquitin deubiquitin emerg critic regulatori process virustrigg type interferon ifn induct pathwai studi carri target sirna screen ubiquitinspecif proteas usp identifi usp neg regul virustrigg type ifn signal pathwai overexpress usp inhibit virusinduc activ ifn interferon regul factor irf nuclear factorkappa nfb phosphoryl irf nfb subunit knockdown usp potenti virusinduc induct ifn addit detail analysi demonstr usp cleav lysin lysin link polyubiquitin chain vitro vivo deubiquitin enzym dub activ depend cystein residu cy histidin residu usp mutant lack dub activ lost abil block virusinduc type ifn degre mechanist usp deubiquitin retino acidinduc gene rigi tumornecrosi factor tnf receptorassoci factor traf traf inhibit rigilik receptormedi ifn signal find usp novel dub neg regul virusinduc type ifn product
PLoS One	23181936	2004-07-01	PMC3832450	24260463	we investig small rna srna sequenc fieldcollect mosquito chironomid diptera proxi signatur viral preval rang speci viral group srna sequenc wildcaught specimen inform total rna deep sequenc sampl interest strategi sequenc adult anophel maculipenni sl mosquito complet genom undescrib viru chronic bee paralysi viru pool ochlerotatu caspiu oc detritu mosquito complet entomobirnaviru genom reconstruct long sequenc nt virus crucial sequenc detect reconstruct host organ highli diverg virus isol discov clear viral transmiss mainten cycl natur complex taxonom divers expect
PLoS One	27318434	2010-02-14	PMC3832587	24260230	object comprehens studi search virus infant young children communityacquir pneumonia cap china aim studi investig role human herp virus hhv respiratori virus cap caus typic bacteri infect determin preval clinic signific method induc sputum sampl collect hospitalis patient infant children respiratori ill cap noncap admit wenl hospit china test hhv respiratori virus pcrbase assai epidemiolog profil analys high rate viru detect coinfect sampl hospitalis infant children respiratori ill studi cap sampl test cmv hhv rsv ebv hbov hhv rhinoviru commonli detect virus cap sampl test cmv rsv hhv ebv hhv hbov domin virus detect preval viral agent rhinoviru bocaviru adenoviru cmv sampl cap higher noncap control group preval rsv coinfect hhv higher cap group noncap control conclus sensit molecular detect techniqu sampl high rate viral identif achiev infant young children respiratori ill rural area china clinic signific rhinoviru bocaviru adenoviru hhv cmv infect receiv greater attent futur treatment prevent studi cap infant children
J Nanobiotechnology	15242944	2015-04-01	PMC3832906	24219600	background limit sideeffect nanoparticl increasingli studi drugcarri target tool report scheme produc proteinbas selfassembl nanoparticl antigen displai platform attempt system cancertarget make ctermin bombesin peptid high affin receptor overexpress tumor ntermin polyhistidin tag radiolabel technetium tricarbonyl order increas circul time experi pegyl unpegyl variti typo particl test incorpor number bombesin nanoparticl biophys character determin configur assembl regular particl monodispers size distribut peak nm carbonyl method label produc label nanoparticl vitro nanoparticl high bind specif nonspecif pc prostat cancer cell vivo high uptak observ nanoparticl type spleen cd nunu mice decreas cours hour high uptak observ liver low uptak pancrea tumor xenograft conclus data nanoparticl nonspecif reticuloendotheli system low uptak pancrea tumor indic specif target pegyl increas amount bombesin nanoparticl improv target uptak spleen primari organ immun system highlight potenti nanoparticl vaccin carrier decreas liver spleen radioact time impli nanoparticl broken clear find nanoparticl safe vaccin platform risk prolong side effect demonstr technetium carbonyl radiolabel proteinbas nanoparticl evalu pharmacokinet properti vivo
BMC Public Health	20154684	2016-05-01	PMC3833669	24225055	background european union eu health mandat initi defin maastricht treati twentieth anniversari treati offer uniqu opportun stock eu health action overview influenti public health eulevel polici output summari polici output action perceiv achiev failur miss opportun method semistructur expert interview conduct focus eulevel action relev health respond ask eu polici action perceiv achiev failur miss opportun direct content analysi approach identifi expert percept achiev failur miss opportun interview addition nomin group techniqu appli identifi influenti public health relev eulevel polici output rank influenti polici output top posit adjud legisl agenc european commiss ec programm strategi offici network cooper structur exchang effort work health determin uptak scientif knowledg assess eu health polici achiev failur miss opportun character diverg respond view recur topic emerg director gener health consum dg sanco eu agenc life style factor intern market provis eu direct patient right crossbord healthcar recur topic expert percept establish dg sanco eu public health agenc success tobacco control domin aspect achiev implement statu health polici approach perceiv miss opportun conclus compar emerg theme interview conduct respons defin eu health mandat identifi respons partli fulfil acknowledg respond gener eu recogn public health player europ decad begun develop compet support coordin supplement member state health action assur health protect european polici requir develop
PLoS One	25878259	2007-01-01	PMC3834272	24260540	background experiment studi provid evid indic manipul mononuclear phagocyt phenotyp feasibl approach alter sever persist pulmonari injuri fibrosi mineralocorticoid receptor report target regul macrophag polar work design investig therapeut potenti antagon bleomycininduc acut lung injuri fibrosi methodologyprincip find demonstr express magnet beadpurifi lygcdb circul monocyt alveolar macrophag harvest bronchoalveolar lavag fluid balf cbl mice pharmacolog intervent studi spironolacton mgkgdai oral gavag reveal antagon led decreas inflammatori cell infiltr cytokin product downregul monocyt chemoattract protein transform growth factor interleukin mrna protein level collagen deposit decreas lung total hydroxyprolin content collagen posit area masson trichrom stain bleomycin treat mgkg oropharyng instil male cbl mice serial flow cytometri analysi blood balf enzymat digest lung tissu reveal spironolacton partial inhibit bleomycininduc circul lychi monocyt expans reduc altern activ fcdccd mononuclear phagocyt alveoli phenotyp interstiti macrophag fcdc remain unaffect spironolacton investig conclusionssignific work experiment evid spironolacton attenu bleomycininduc acut pulmonari injuri fibrosi partial inhibit mrmediat circul monocyt alveolar macrophag phenotyp switch
BMC Genomics	26766144	2001-06-01	PMC3835400	24199871	background honeybe venom complic defens toxin wide rang pharmacolog activ compound compound human therapeut major form honeybe venom pharmacolog applic manual reservoir disrupt extract glandular venom gv venom extract electr stimul esv proteom comparison venom form understand phosphoryl statu esv limit proteom gv esv compar gelbas gelfre proteom approach phosphoproteom esv determin tio enrich protein identifi gv venom toxin protein nontox protein contamin gland tissu damag extract bee death protein identifi esv protein venom toxic protein higher abund gv novel protein dehydrogenasereductas sdr famili member histon hblike three novel phosphoryl site icarapin phospholipas apamin identifi conclus data demonstr venom extract manual venom extract esv differ pharmacolog agent esv effici gv potenti pharmacolog sourc higher venom protein content product effici kill honeybe three newli identifi phosphoryl venom protein esv elicit immun respons specif recognit antigen determin novel venom protein extend proteom coverag honeybe venom
PLoS One	17133182	2016-12-14	PMC3835827	24278234	most novel avianorigin influenza hn viru emerg china associ lot human infect fatal case genet analysi viral genom reveal reassort viru better adapt human avian influenza virus molecular diagnost method urgent need public health laboratori studi sybr greenbas onestep real time revers transcriptionpcr rtpcr develop detect novel hn viru primer pair basi hemagglutinin neuraminidas gene sequenc hn virus amplifi subtypespecif fragment tm valu standard curv dynam linear rang log unit rna copi number copi detect limit copi reaction assai serial tenfold dilut invitro transcrib viral rna addit crossreact observ season hn hn pdm hn hn hn virus human respiratori virus assai evalu hn viru infect clinic sampl posit amplif signal specimen assai establish sybr greenbas real time rtpcr assai provid rapid sensit specif reliabl altern approach lower cost high throughput screen suspect sampl human anim environ public health laboratori
PLoS Negl Trop Dis	11333880	2016-10-10	PMC3836733	24278493	on hurdl understand role viral quasispeci rna viru crossspeci transmiss cst event analyz dens sampl outbreak deep sequenc order measur amount mutat occur small time scale california depart public health report dramat increas number grai fox infect rabi viru variant stripe skunk serv reservoir host humboldt counti better understand evolut rabi deepsequenc appli unpassag rabi viru sampl humboldt outbreak sampl kb kb genom amplifi sequenc illumina platform averag coverag allow character rabi viru popul sampl unpreced depth phylogenet analysi consensu sequenc data demonstr sampl cluster geograph locat northern southern singl amino acid chang protein distinguish subset northern fox haplotyp fox skunk suggest mutat plai role observ increas transmiss fox region deepsequenc data indic genet chang associ cst event occur prior nonsynonym mutat consensu sequenc skunk fox rabi sampl subconsensu level rare variant viral popul skunk fox sampl analysi rare variant viral popul yield clue ancestr genom identifi rare variant potenti select environ condit chang
PLoS Pathog	27974570	2013-05-01	PMC3836734	24278022	the mechan human immunodefici viru type hiv cross mucos surfac establish infect unknown acid genit secret hivinfect women hiv coat antibodi combin acid ph envspecif igg includ cervicovagin semin fluid hivinfect individu augment transcytosi epitheli cell fold compar envspecif igg neutral ph nonspecif igg ph enhanc transcytosi observ clinic hiv isol includ transmittedfound strain elimin fc neonat receptor fcrnknockdown epitheli cell nonneutr antibodi allow transcytosi neutral antibodi ratio totalinfecti viru higher neutral antibodi indic allow transcytosi block infect transcytos viru immunocytochemistri reveal abund fcrn express columnar epithelia line human endocervix penil urethra acid envspecif igg enhanc transcytosi viru epitheli cell fcrn facilit transloc viru suscept target cell sexual exposur
PLoS One	27736772	2012-09-20	PMC3836756	24278312	the interferoninduc transmembran ifitm famili protein restrict broad rang virus vitro vivo halt progress late endosom pathwai singl nucleotid polymorph snp sequenc link risk develop sever influenza viru infect human number virus restrict host protein continu grow demonstr plai antivir role enter cell endosom pathwai sought test limit antimicrobi restrict ifitm knockout mous model ifitm impact restrict pathogenesi bacteri salmonella typhimurium citrobact rodentium mycobacterium tuberculosi protozoan plasmodium berghei pathogen despit vitro evid ifitm capabl restrict respiratori syncyti viru rsv vivo directli restrict rsv cell infect exert uncharacteris function control diseas pathogenesi repres demonstr viru enter directli plasma membran the endosom pathwai restrict ifitm famili defin role antivir protein
PLoS One	23600784	2016-06-08	PMC3836762	24278449	hantaan viru htnv major zoonot pathogen hemorrhag fever renal syndrom hfr asia china shaanxi provinc locat northwest china area china sever afflict hfr epidem annual studi aim establish quantit rtpcr qrtpcr assai detect htnv cell cultur clinic serum sampl establish sybr green base onestep qrtpcr assai target segment htnv genom rapid detect quantif htnv crna standard construct vitro transcript copi number htnv crna quantifi standard curv gener determin cycl threshold ct valu versu fold serial dilut htnv crna rang copiesl standard curv reaction effici correl coeffici slope coeffici variat cv intra interassai rang to cycl interv qrtpcr assai dilut rang cycl lowest detect limit qrtpcr assai copiesl assai exhibit high specif confirm melt curv analysi cross reaction seoul viru seov virus hbv hcv hiv observ htnv rna detect serum sampl clinic hfr patient assai htnv rna viral load rang copiesl sybr green base onestep qrtpcr assai sensit specif reproduc simpl method detect quantifi htnv cell cultur clinic sampl
J Virol	22994417	2003-08-26	PMC3838109	24067955	interferoninduc transmembran protein ifitm effector protein innat immun system confer potent cellintrins resist infect divers envelop virus vitro vivo includ influenza virus west nile viru dengu viru ifitm prevent cytosol entri virus block complet viru envelop fusion cell endosom membran ifitm locu includ ifitm mammalian speci locu unambigu identifi function character avian speci ifitm locu exist chicken synten ifitm locu mammal chicken ifitm protein restrict cell infect influenza virus lyssavirus level human orthologu chicken ifitm function chicken cell knockdown constitut express chicken fibroblast enhanc infect influenza viru chicken ifitm constitut express tissu examin ifitm express bursa fabriciu gastrointestin tract cecal tonsil trachea despit highli diverg amino acid level ifitm protein bird mammal restrict replic virus infect host speci suggest ifitm protein provid crucial barrier zoonot infect
J Virol	27280421	2006-08-01	PMC3838137	24049164	here approach advanc throughput genet analysi positivesens rna viru simplifi viru construct enabl comprehens dissect complex multigen phenotyp rapid deriv larg number chimer virus construct mutant librari directli viru pool versatil approach describ expand applic divers genet approach studi virus
PLoS One	12941911	2016-05-04	PMC3838338	24278125	equin lentiviru receptor elr identifi sole receptor equin infecti anemia viru eiav member tumor necrosi factor receptor tnfr superfamili addit describ membraneassoci form elr major altern splice variant mrna identifi equin monocytederiv macrophag emdm major splice speci elrin contain insert nt prematur codon situat nt upstream predict membran span domain major speci elrd delet nt shift open read frame gener codon nt downstream elrd presum encod peptid mere residu elrin analyz express solubl form elr selr elrin confirm western blot immunofluoresc analys elr transcript level elrin vari individu hors time point individu ratio elrin mrna speci elr mrna preincub recombin selr eiav inhibit eiav infect equin macrophag primari vivo target cell viru fetal equin dermal fed cell suscept eiav vitro replic eiav fed cell transient transfect elrin markedli reduc compar replic cell transfect empti vector final express level form eiav receptor regul infect viru data indic selr act secret cellular factor inhibit eiav infect host cell
ASN Neuro	16880447	2009-04-08	PMC3840398	24156369	infect cn central nervou system subleth neurotrop coronaviru jhmv induc vigor inflammatori respons cd cd cell essenti control infecti viru cost tissu damag enigma understand contribut cell subset pathogenesi resid distinct migrat pattern bbb blood brain barrier cd cell transient accumul perivascular space cd cell migrat directli cn parenchyma mmp matrix metalloproteinas facilit migrat glia limitan specif express timp tissu inhibitor mmp cd cell perivascular cuff suggest timp respons stall cd cell migrat cn parenchyma timp defici mice data demonstr increas decreas cd cell accumul perivascular space jhmv infect viru control perivascular retent cd cell diseas sever decreas associ reduc ifn interferon product decreas cd cell recruit cn parenchyma timp defici mice associ impair cell recruit chemokin mmp express compens timp molecul identifi data mmpindepend role timp regul cd cell access cn parenchyma acut jhmv enceph
Respir Res	19357173	2005-02-24	PMC3840586	24219370	background common cold widespread viral infect human iotacarrageenan antivir effect cold virus clinic trial studi investig efficaci carrageenancontain nasal sprai durat common cold nasal fluid viral load adult patient method random doubleblind placebocontrol trial patient suffer earli symptom common cold treat dai applic perform three time daili carrageenansuppl nasal sprai salin solut placebo observ period dai primari endpoint durat diseas defin time dai symptom dai studi period symptom studi prior unblind definit diseas durat adapt origin protocol defin diseas durat time period symptom hour symptom patient show laboratoryconfirm cold viru infect adher protocol allevi symptom dai faster carrageenan group comparison placebo primari endpoint prespecifi chang unblind met viral titer nasal fluid greater decreas carrageenan patient intentiontotreat popul protocol popul dai conclus adult common cold viru infect direct local administr carrageenan nasal sprai reduc durat cold symptom reduct viral load nasal wash fluid patient confirm find earlier trial children adult trial registr current control trial isrctn
BMC Genomics	20631137	2014-09-24	PMC3840674	24262008	background infecti cdna clone prerequisit direct genet manipul rna virus strategi facilit manipul rescu classic swine fever virus csfv fulllength cdna bacteri artifici chromosom bac describ strategi allow manipul viral cdna target recombinationmedi mutagenesi bacteria csfvbac pbelor deriv riem vaccin strain construct subsequ modifi code sequenc target recombin strategi enabl rescu chimer pestivirus vregif vrtav potenti marker vaccin candid sequenc bac reveal high genet stabil passag bacteria complet genom sequenc rescu virus extens passag mammalian cell modif protein code sequenc stabli maintain singl amino acid substitut dg rna depend rna polymeras observ rescu virus vregif vr revers parent riem sequenc conclus target recombinationmedi mutagenesi power tool expedit construct novel rna genom applic manipul rna virus
PLoS One	15731278	2009-09-27	PMC3841265	24303050	two speci dna viru torqu teno su viru ttsuv ttsuv ttsuv distribut pigfarm countri year studi perform comprehens analysi synonym codon usag bia ttsuv code sequenc cd compar codon usag pattern ttsuv ttsuv ttsuv codon usag pattern phylogenet conserv valu effect number codon enc indic extent codon usag bia ttsuv ttsuv frequent occur codon third codon posit correspond analysi coa perform ttsuv ttsuv sequenc locat quadrant major ax plot enc reveal composit constraint major factor determin codon usag bia ttsuv addit hierarch cluster analysi ttsuv isol base rel synonym codon usag rscu valu suggest associ geograph distribut codon bia ttsuv sequenc final comparison rscu ttsuv ttsuv correspond host sequenc indic codon usag pattern ttsuv ttsuv similar low viru host conclus provid insight synonym codon usag pattern ttsuv better understangd molecular evolut ttsuv genom
Cough	25253797	2008-11-05	PMC3842692	24261680	object cineol mucolyt bronchodil antiinflammatori properti reduc exacerb rate patient suffer copd amelior symptom patient suffer asthma rhinosinus base effect postul hypothesi patient acut bronchiti benefit therapi cineol method doubleblind placebocontrol multicenterstudi total patient confirm acut bronchiti randomli select particip period dai patient administ cineol respect placebo dai primari outcom measur bronchiti sum score summaris relev symptom acut bronchiti dai treatment notabl patient group treat cineol improv bronchitissumscor placebo group statist differ individu outcom measur underlin frequenc cough fit dai conclus effect cineol treatment acut bronchiti clearli measur proven treatment period dai studi corrobor fact cineol activ reduc cough frequenc dai great socioeconom impact trial registr isrctn isrctn
PLoS One	19687045	2009-12-01	PMC3842931	24312302	efficaci antitumor vaccin depend larg extent antigen target dendrit cell dc assess antitumor immun induc attenu coronaviru vector exclus target dc vivo express lymphocyt dcactiv cytokin combin gfptag model antigen track vivo transduc dc reveal vector encod fmslike tyrosin kinas ligand fltl exhibit higher capac induc dc matur compar vector deliv il il fltl vector effici induc tumorspecif cd cell expand epitop repertoir provid prophylact therapeut tumor immun contrast il ilencod vector lower efficaci cd cell prime fail protect host tumor establish specif vivo target dc coronaviru vector conjunct appropri condit microenviron fltl repres effici strategi gener therapeut antitumor immun
BMC Res Notes	18987136	2010-01-20	PMC3843553	24229425	background classic scrapi sheep fatal neurodegen diseas associ convers prpc prpsc genet suscept uptak dissemin prpsc bodi aspect prion diseas unknown proteom techniqu decad investig differ protein profil anim healthi control investig protein profil serum sheep scrapi healthi control selditofm lcmsm latent variabl method princip compon analysi partial squaresdiscrimin analysi target project method describ ms data serum proteom profil variabl differ group incub period clinic stage scrapi stage target project model separ group sensit serum amyloid identifi protein peak differ group conclus clinic stage classic scrapi ten seldi peak discrimin scrapi group healthi control nonclin incub period individu seldi peak differ express group time point investig differ omic profil contribut insight underli diseas process pathwai advanc understand prion diseas comparison valid laboratori difficult challeng
Virol J	19741068	2005-06-14	PMC3844316	23988202	background canin parvoviru cpv pathogen acut enter diseas dog mutat spread dog popul provid updat molecular character cpv circul nanj provinci capit china seventi rectal swab sampl collect dog diagnos cpv infect anim hospit nanj sequenc analysi vp gene sampl reveal viral strain belong cpva subtyp strain classifi cpvb investig pathogen preval viru isol cpva perform anim experi beagl inocul tissu cultur infecti dose tcid viru experiment infect beagl exhibit mild moder mucoid wateri diarrhea dai postinfect pi dai pi characterist histopatholog lesion clearli observ multipl organ infect dog includ liver spleen kidnei brain segment small larg intestin viral dna antigen stain detect sampl tissu notabl canin parvoviru isol brain sampl process conclus indic cpva predomin subtyp nanj china viru caus extens lesion varieti tissu includ brain
ScientificWorldJournal	20087684	2011-11-01	PMC3845513	24324377	free vascular fibular graft fvfg report effect method treat osteonecrosi femor head onfh studi evalu postop mainten dose corticosteroid advers fvfg outcom patient corticosteroidinduc onfh retrospect review record patient hip receiv mainten dose corticosteroid fvfg group match group patient receiv corticosteroid treatment oper followup durat year postop corticosteroid administr group pca group year control group latest followup averag increas harri hip score point hip pca group point hip control group pca group radiograph evalu hip improv hip appear unchang hip appear wors control group hip improv hip appear unchang hip appear wors suggest postop mainten dose corticosteroid advers fvfg outcom patient corticosteroidinduc onfh
BMC Public Health	15956552	2018-04-07	PMC3846148	24010919	background effect recommend measur cover mouth cough disrupt chain transmiss infecti respiratori diseas ird question object current studi determin effect simpl primari respiratori hygienecough etiquett maneuv block droplet expel aerosol cough method studi healthi nonsmok perform cough etiquett maneuv effort cover voluntarili elicit best effort cough open bench format laser diffract system accur noninvas quantit real time measur size number droplet emit assess cough etiquett maneuv recommend cough etiquett maneuv block releas dispers varieti diamet droplet surround environ droplet smaller onemicron size domin total number droplet leak practic assess maneuv conclus assess cough etiquett maneuv perform recommend block droplet expel aerosol cough aerosol penetr profound level respiratori system practic assess primari respiratori hygienecough etiquett maneuv permit direct indirect andor airborn transmiss spread ird influenza tuberculosi assess cough etiquett maneuv recommend fulli interrupt chain transmiss ird knowledg urg critic review recommend ce search evidencebas procedur effect disrupt transmiss respiratori pathogen interrupt chain transmiss ird will optim protect respond paramed nurs doctor work triag site emerg room intens care unit gener public coughdropletspread diseas
Virol J	21799305	2012-03-01	PMC3846606	24010815	background varicella zoster viru vzv neurotrop alphaherpesviru infect human chickenpox herp zoster number vzv gene remain function uncharacter vzv oblig human pathogen rigor evalu vzv mutant vivo remain challeng simian varicella viru svv homolog vzv svv infect rhesu macaqu rm close mimic vzv infect human svv genom clone bacteri artifici chromosom bac bacderiv svv displai replic kinet wildtyp wt svv vitro method rm infect bacderiv svv wt svv pfu intrabronchi group sex ag match collect blood pbmc bronchoalveolar lavag bal dai postinfect dpi sensori ganglia latent infect dpi necropsi compar diseas progress viral replic immun respons establish latenc viral replic kinet magnitud bronchoalveolar lavag cell blood rash sever durat rm infect svv bac wt svv svvspecif cell respons compar bac wtinfect anim lastli measur viral dna sensori ganglia cohort infect rm latent infect conclus svv bac pathogen immunogen wt svv vivo svv bac genet system combin rhesu macaqu anim model understand viral orf vzv pathogenesi develop secondgener vaccin
PLoS One	29635277	2009-09-16	PMC3846664	24312485	bovin neonat pancytopenia bnp high fatal condit caus haemorrhag calv ag week report in germani subsequ observ low incid european countri zealand multicountri match casecontrol studi conduct identifi calflevel risk factor bnp bnp case recruit farm belgium franc germani netherland laboratori confirm farmerreport case calv ag farm select control calv risk factor data collect questionnair multivari model condit logist regress indic pregsurebvd pregsur pfizer anim health vaccin dam associ bnp case adjust match odd ratio amor lactat dam confid interv ci second lactat pregsurevaccin dam case lactat vaccin dam amor second lactat ci amor third lactat ci feed colostrum cow associ bnp dam pregsurevaccin amor ci dam pregsurevaccin amor ci feed exclus dam milk higher risk type milk amor ci popul attribut fraction ci pregsur vaccin ci feed cow colostrum ci feed dam milk calflevel factor identifi suggest factor scope studi genet explain bnp develop pregsurecolostrumexpos calv other
Pediatr Rheumatol Online J	22333577	2013-01-24	PMC3847673	24006904	background genet variant inhibit fcriib mediat antiinflammatori respons influenc ivig refractori ivigr variant rare asian hispan popul gene pathwai involv ivig ineffect mice lack signr molecul human dcsign dcsign receptor sialyl fc compon respons antiinflammatori action ivig hypothes dcsign involv pathwai ivig respons kawasaki diseas kd patient find casecontrol approach perform examin differenti distribut singl nucleotid polymorph snp dcsign promot ivigr white asian hispan kd patient distinct differ allel frequenc distribut variant dcsign promot observ three ethnic group asian major allel rs ivig nonrespond allel minor allel ethnic group associ appar conclus dcsign complement role fcriib antiinflammatori cascad involv ivig respons mechan
BMC Infect Dis	19759148	2011-02-21	PMC3847692	24498873	background pneumonia morbid mortal develop virus contribut pneumonia burden data lowincom tropic countri scarc aim laboratoryenhanc hospitalbas surveil characteris epidemiolog respiratori viru infect refuge live thailandmyanmar border method maela camp shelter refuge insid camp humanitarian organis free hospit care bed inpati depart ipd st april septemb patient admit ipd clinic diagnosi pneumonia invit particip clinic symptom sign record nasopharyng aspir npa collect npa test adenovirus human metapneumoviru hmpv influenza rsv pcr patient episod patient diagnos pneumonia enhanc surveil period includ analysi median patient ag year rang ag year viru detect episod viru detect common children ag year year ci year ci rsv detect adenoviru influenza viru hmpv twentyeight episod multipl viral infect identifi commonli adenoviru viru rsv detect children year ci influenza virus patient year ci ipd treatment document case patient receiv antimicrobi commonli betalactam amoxicillinampicillin gentamicin conclus viral nucleic acid identifi nasopharynx half patient admit clinic diagnos pneumonia develop immunis target common respiratori virus reduc incid pneumonia children live refuge camp set
BMC Vet Res	23072311	2013-07-01	PMC3847877	24028493	background porcin reproduct respiratori syndrom viru prrsv rna viru high genet variat viru econom loss pigproduc countri clinic present prrsv rang asymptomat devast studi develop sensit specif zip nucleic acid probebas realtim pcr assai evalu viremia natur prrsvinfect pig taiwan serum sampl collect pig ag week includ clinic healthi pig symptomat pig confirm porcin respiratori diseas complex prdc viremia quantifi clinic healthi pig prdc case viremia common pig prdc compar clinic healthi pig high viral load major featur prrsvaffect pig conclus zna probebas realtim pcr tool diagnos symptomat asymptomat prrsvinfect pig presenc marker sampl anim high prrsv load prrsv genomesl serum indic correl presenc prdc pig
Virol J	21272046	2011-10-06	PMC3848638	24015922	background avian influenza ai virus subtyp seriou diseas outbreak poultri includ panzoot hn highli pathogen hp virus virus threat anim health public health zoonot potenti domest duck plai major role epidemiolog cycl influenza viru subtyp concern hostpathogen interact influenza infect duck speci studi subtract librari duck trachea primari site influenza viru infect construct analys compar host respons highli low pathogen lp hninfect gene differenti express infect duck trachea degre addit differenti express gene lpai hpaiinfect trachea observ gene ontolog annot specif signal pathwai identifi pathwai lpai hpaiinfect trachea cxcr signal pathwai implic immun respons modul gene cxcr signal pathwai trim induc duck trachea infect hpai lpaihn conclus studi indic suppress subtract hybrid ssh altern approach gain insight pathogenesi influenza infect duck secondli indic cellular gene express duck trachea differ modul infect lpaihn infect hpaihn viru differ infect trachea primari infect site preced continu infect explain appear respiratori symptom not
BMC Infect Dis	23624786	2009-11-11	PMC3848659	24040960	background nonsever acut respiratori syndrom nonsarsrel human coronavirus hcov includ hcove hku nl oc detect respiratori tract sampl children adult natur preval antibodi virus serum popul unknown method measur antibodi spike protein common nonsar hcov recombin protein hcov express characteris cell sproteinbas indirect immunofluoresc assai ifa develop detect anti igg igm individu hcov appli serum sampl gener asymptomat popul children adult beij blood sampl test neg anti igg seroposit anti igg antibodi gener popul major seroconvers fourhcov posit occur children sigg sigm antibodi detect children increas ag reach plateau year ag anti igm detect healthi adult conclus larg proport children adult beij evid anti igg hcov infect nonsar hcov take place childhood
BMC Infect Dis	21980030	2018-12-01	PMC3848773	24053492	background infecti diseas emerg frequent china partli larg highli mobil popul rapid costeffect pathogen screen method broad coverag requir prevent control infecti diseas avail larg number microbi genom sequenc gener convent sanger sequenc gener sequenc enabl develop highthroughput highdens microarrai platform rapid largescal screen vertebr pathogen method easi oper pathogen microarrai eopm design detect pathogen speci base genom sequenc effect identif pathogen eopm data statist enrich algorithm propos implement userfriendli webbas interfac multipl probe design detect microbi genu speci eopm correctli identifi pathogen speci genu level blind test despit lower sensit pcr eopm sensit detect predomin pathogen caus clinic symptom applic clinic infecti diseas outbreak china eopm identifi respons pathogen conclus eopm effect surveil platform infecti diseas plai role infecti diseas control
PLoS One	19906920	2011-06-14	PMC3849185	24312527	individu gene region commonli estim phylogenet relationship viral isol genom region faithfulli provid assess consist predict fulllength genom sequenc prefer serv good candid phylogenet marker molecular epidemiolog studi virus emploi statist method evalu evolutionari relationship individu viral gene fulllength genom tree construct determin gene match genom phylogenet analys method perform calcul linear correl genet distanc matric align individu gene sequenc align genom sequenc appli method phylogenet analys porcin circoviru pcv measl viru mv hepat viru hev japanes enceph viru jev phylogenet tree construct comparison factor method accuraci discuss calcul reveal method produc consist previou studi proper consensu sequenc phylogenet marker suggest evolutionari correl provid identifi gene effect infer genet relationship
BMC Infect Dis	29874100	2017-11-01	PMC3849296	24066865	background accur knowledg incub period investig control infecti diseas transmiss statement incub period literatur uncit inconsist andor evid base method systemat review literatur enter virus public health articl incub period estim includ data pool analysi fit lognorm distribut pool data median incub period dai ci dai astroviru dai ci dai noroviru genogroup ii dai ci dai sapoviru dai ci dai rotaviru conclus estim combin publish data provid suffici quantit detail allow estim wide rang clinic model applic translat improv prevent control effort set transmiss risk transmiss
Virol J	21673029	2015-05-05	PMC3849350	24067107	background human metapneumoviru hmpv major lower respiratori infect children primari isol hmpv achiev cell line low level viru replic subsequ recoveri low level infecti hmpv hamper biochem studi viru experiment methodolog requir higher level biolog materi achiev hmpv infect studi demonstr express hmpv protein mammalian cell lead hmpv viruslik particl vlp format experiment strategi will serv model system allow process hmpv viru assembl examin method hmpv protein express mammalian cell line protein crosslink studi sucros gradient centrifug situ imag examin interact viru protein vlp format examin sucros densiti gradient centrifug electron microscopi analysi analysi cell coexpress protein demonstr protein interact cell coexpress three hmpv protein format vlp observ imag analysi reveal vlp morpholog filament viru morpholog observ hmpvinfect cell capac protein initi vlp format examin vlp format assai individu express viru protein protein form vlp absenc viru protein coexpress protein protein facilit incorpor vlp fraction conclus coexpress protein lead format vlp incorpor protein vlp facilit interact protein data suggest protein plai central role vlp format suggest protein plai role recruit protein site viru particl format hmpv infect
PLoS One	28775098	2015-09-26	PMC3849439	24312629	background felin infecti periton fip lethal immunemedi diseas caus felin coronaviru fcov current therapi proven efficaci search agent prove clinic effect fcov infect analog overlap peptid design synthes base put heptad repeat hr sequenc spike protein fcov antivir efficaci evalu method plaqu reduct assai mtt dimethylthiazolyldiphenyltetrazolium bromid cytotox assai perform studi peptid select plaqu reduct assai inhibit felin coronaviru infect demonstr peptid fp concentr inhibit viral replic peptid fp exhibit effect antivir combin antivir agent human interferon ifn synergist antivir observ conclus data synthet peptid fp serv valuabl addit current fip prevent method
Hum Resour Health	25944345	2011-01-01	PMC3849587	24053689	background infecti diseas spread rapidli border speci grow worldwid increas number public health profession skill control infecti epidem need public health profession skill noncommunic diseas surveil intervent result survei field epidemiolog train programm fetp member train program epidemiolog public health intervent network tephinet evalu progress fetp global appli epidemiolog network increas public health capac global method data fetp programm train provid abstract tephinet membership survei verifi fetp director fetp member tephinet data abstract submit tephinet global scientif confer accomplish fetp qualiti improv compil provid worldwid view public health human resourc capac produc programm total public health profession worldwid graduat fetp center diseas control prevent epidemiolog intellig servic ei fetp resid graduat particip kei public health prevent control respons activ fetp adapt curriculum object time align countri public health prioriti fetp integr nation public health infrastructur partner nation region global level conclus fetp compet divers sourc highli skill public health profession contribut public health global human resourc find evidenc train curricula adapt time meet public health human resourc fetp continu support intern extern partner increas number fetp resid graduat increas contribut effect public health work increas qualiti improv initi facilit fetp membership global network tephinet
Acta Vet Scand	26409239	2001-10-01	PMC3850993	24047612	background swine influenza infecti acut respiratori diseas pig caus influenza viru investig time entri swine influenza finnish pig popul describ molecular detect type influenza hn virus porcin sampl submit retrospect studi base three categori sampl blood sampl collect diseas monitor pig major slaughterhous blood sampl pig farm special health statu and diagnost blood sampl pig farm clinic sign respiratori diseas blood sampl test influenza antibodi antibodi elisa posit sampl analyz hn hn hn antibodi hemagglutin inhibit test diagnost sampl viru detect subject influenza mgenespecif realtim rtpcr pandem influenza hnspecif realtim rtpcr posit sampl analyz rtpcr design purpos pcr product sequenc sequenc analyz phylogenet blood sampl pig special health class farm produc replac anim diagnost blood sampl serolog posit sampl origin period julyaugust sampl collect diseas monitor posit antibodi influenza hn test swine influenza viru avianlik hn detect diagnost sampl februari avianlik hn viru detect farm pandem hn viru ahnpdm detect pig farm farm conclus base studi swine influenza avianlik hn viru introduc finnish pig popul ahnpdm viru sourc avianlik hn infect determin case pandem hn pig coincid period ahnpdm viru spread human finland
BMC Med	21786325	2017-03-22	PMC3851127	24083506	background march human infect novel influenza ahn viru report eastern china outbreak expand rapidli geograph scope size total laboratoryconfirm case report june chines provinc taiwan incid ahn case stall week presum consequ live bird market closur heavili area compar transmiss potenti influenza ahn emerg pathogen evalu impact intervent measur effort guid pandem prepared method bayesian approach combin seir susceptibleexposedinfectiousremov transmiss model fit daili case data assess reproduct number ahn provinc evalu impact live bird market closur april simul studi help quantifi perform approach context emerg pathogen humantohuman transmiss limit case spillov event altern approach estim base individuallevel prior exposur compar transmiss potenti influenza ahn zoonos estim ahn outbreak epidem threshold requir sustain humantohuman transmiss remain studi period broad credibl interv bayesian method bayesian estim approach domin prior distribut contain case data observ statist deceler growth rate april consist reduct ahn transmiss associ preemptiv closur live bird market confid interv broad estim transmiss potenti ahn appear lower zoonot threat includ avian influenza ahn swine influenza hnsw nipah viru conclus uncertainti remain high estim hn limit epidemiolog evid point low transmiss potenti continu monitor transmiss potenti ahn critic come month intervent measur relax season factor promot diseas transmiss colder month
Virol J	11533185	2016-11-04	PMC3851529	24047399	background influenza viru subtyp hn hn hn preval subtyp swine reassort hn swine influenza viru siv subtyp appear preval denmark studi reassort hn subtyp characteris genet infect dynam compar avianlik hn viru experiment infect studi method sequenc analys perform hn viru group pig inocul reassort hn viru avianlik hn viru inocul opposit subtyp week measur antibodi acut phase protein perform nasal viru excret viru load lung determin realtim rtpcr phylogenet analysi reveal reassort hn viru contain european avianlik hgene european swinelik ngene genet distinct hn virus circul europ virus report in sweden itali sequenc analys intern gene reveal reassort aros circul danish avianlik hn hn siv infect pig develop crossreact antibodi increas level acut phase protein inocul pig inocul hn exhibit nasal viru excret dai peak dai inocul dai earlier hn infect pig time higher level differ statist pig euthan dai inocul high viru load lung lobe second inocul nasal viru excret minim clinic sign elev bodi temperatur experiment condit conclus avianlik hn subtyp establish danish pig popul reassort circul swine avianlik hn hn danish hn avianlik differ report hn virus europ north americaasia hgene human classicalswin origin variant circul countri sweden itali infect dynam reassort avianlik hn older avianlik hn subtyp
BMC Res Notes	28331081	2003-10-20	PMC3851545	24099561	background select stabli express refer gene prerequisit evalu gene express realtim pcr cell respons viral infect object studi identifi suitabl refer gene mrna express analysi chicken embryon fibroblast cef infect avian leukosi viru subgroup alvj find express level potenti refer gene cef infect alvj determin realtim pcr express stabil gene analyz rank genorm tool analysi indic gene rpl ribosom protein sdha succin dehydrogenas complex subunit stabli express gene alvj infect cef conclus rpl sdha deem suitabl refer gene realtim pcr analysi mrna gene express alvj infect commonli actb gapdh unsuit refer gene
PLoS One	27811921	2016-10-31	PMC3852489	24324708	an emerg respiratori infecti diseas high mortal middl east respiratori syndrom mer caus novel coronaviru merscov report in saudi arabia spread countri develop effect therapeut vaccin crucial save live halt spread merscov recombin protein amino acid fragment residu truncat receptorbind domain rbd residu merscov spike protein fuse human igg fc fragment sfc highli express cultur supernat transfect cell purifi sfc protein effici bind dipeptidyl peptidas dpp receptor merscov potent inhibit merscov infect suggest potenti develop therapeut modal treat merscov infect save patient live recombin sfc induc vaccin mice strong merscov sspecif antibodi block bind rbd dpp receptor effect neutral merscov infect find indic truncat rbd protein promis develop effect safe vaccin prevent merscov infect
Acta Vet Scand	14569023	2011-07-06	PMC3852515	24020788	in spite yearli vaccin outbreak canin infecti respiratori diseas period domest dog infect compromis host defens mechan combin stress event allow opportunist pathogen streptococcu equi subsp zooepidemicu creat seriou diseas earli recognit treatment tremend success outcom case polyval vaccin race dog three dai competit dai rest dog return regular train cough notic dog dai immunis three dai outbreak dog unusu silent dead morn simultan dog develop haemorrhag expector depress dyspnea brought veterinari hospit streptococcu equi subsp zooepidemicu isol pure cultur three case treat rehabilit won sledg race three month paper discuss necropsi treatment regim rehabilit chronolog vaccin stress event diseas
Evid Based Complement Alternat Med	27799521	2018-02-14	PMC3852580	24348718	mani natur dietari product prevent cure allerg inflamm abil mixtur natur medicin suppress allerg skin inflamm unknown examin inhibitori effect nonanatur product mixtur npm immunoregulatori activ thmediat skin allerg inflamm oral administr npm mice reduc ear thick specif ig product trimellit anhydrid tmainduc contact hypersensit ch npm suppress il il product splenocyt prevent tmainduc il product inflam ear character mechan examin npm immunosuppress ovainduc allerg state oral administr npm inhibit thmediat serum ig overproduct npm downregul polar respons upregul respons splenocyt data npm therapeut agent allerg inflammatori diseas suppress thmediat allerg respons
BMC Vet Res	21734031	2014-05-19	PMC3852778	24119974	background neonat diarrhoea frequent clinic condit commerci swine herd regard uncompl treat neonat diarrhoeic syndrom unrespons antibiot common manag practic emerg routin laboratori examin detect pathogen syndrom primari purpos studi evalu wellknown enter pathogen associ outbreak neonat diarrhoea question hypothes syndrom want evalu macroscop microscop find associ outbreak propos preliminari pigletlevel casedefinit syndrom neonat porcin diarrhoea syndrom nnpd wellmanag herd experienc neonat diarrhoea establish laboratori conclus suspect suffer neonat porcin diarrhoea syndrom select herd diarrhoeic nondiarrho piglet ag three dai necropsi subject histolog microbiolog examin faec nonhaemorrhag enterotoxigen coli clostridium perfringen type clostridium difficil rotaviru coronaviru cryptosporidium spp giardia spp cystoisospora sui strongyloid ransomi associ diarrhoea investig outbreak macroscop diarrhoeic piglet character fill stomach flaccid intestin mucos chang predomin histolog lesion villou atrophi jejunum ileum epitheli lesion colon third case piglet conclus the studi support hypothesi neonat porcin diarrhoea investig herd pathogen manag factor explain diarrhoeal outbreak base find herd casedefinit nnpd suggest nonhaemorrhag diarrhoea week life detect infecti pathogen character milkfil stomach flaccid intestin necropsi
BMC Nephrol	29444830	2015-12-01	PMC3852817	24131581	background balkan endem nephropathi ben repres chronic progress interstiti nephriti strike correl uroepitheli tumour upper urinari tract diseas endem distribut danub river region balkan countri dna methyl primari epigenet modif involv major process cancer genom imprint gene silenc signific cpg island methyl statu normal develop cell differenti gene express recogn stai understood method perform genom dna methyl arrai analysi dna pool sampl peripher blood individu healthi individu techniqu allow determin methyl statu cpg island genom healthi control ben patient methyl profil ben patient bulgarian serbian endem region develop softwar compar methyl profil ben patient correspond control reveal differ methyl region compar dmr patientcontrol pair determin common chang epigenet profil secg ilra hdac prove differ methyl patientcontrol pair cpg island gene hypomethyl compar control suggest dysregul gene involv immunolog respons common mechan ben pathogenesi endem region gender conclus data propos hypothesi immunolog dysregul place ben etiopathogenesi
Virol J	24841269	2009-04-13	PMC3852826	24107353	background newli emerg middl east respiratori syndrom coronaviru merscov appear saudi arabia summer septemb caus human death merscov util dipeptidyl peptidas dpp host cell receptor analysi longterm interact viru receptor kei evolutionari event lead viral emerg find bat dpp gene subject adapt evolut suggest longterm armsrac bat mer cov identifi three posit select residu dpp directli interact viral surfac glycoprotein conclus studi suggest evolutionari lineag lead merscov circul bat substanti time period
